Citrus Sinensis ID: 018204

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------36
Protein Sequence
MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAND
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHHHHcccccccccccEEccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccHHHHHHHHccccccccccccccHHHHHHHHcccHHHHHHHHccccccccccccccccccHHHHcccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccEEEEEEEccEEEEEEEEcccccccHHHHHHHHHHHHHHHHccccccccEEEEEEEcccEEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccEEEEccccEEEcccccEEEEEcccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHcccHHHHHcccHHccccccccccccccEEEEccccccccccccccccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccccccccccHHHHHHHHccccccccccccEEEcEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHcccHHHEEEEEEccccEEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccEEEccccccHEEEcccccccEccccHHEEccccccEEEEEccccccccccc
Coil and Loop (DISEMBL)
MENLTAQLKRGisrqfstgsLRRSLTRQmsrqssfdprrnnmrfsfgrqssldpirrspvqdeltvpenLDSTMQLLFMACRGDVKGVEDLlnegsdvnsidldgrtaLHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKArgakvpktkrtpmtvanprevpeyelnpleLQVRKadgitkgsYQVAKWNGTKVWVKILdkeshkdperiNAFTHELTIVEkarhpnvvQFVGAVTQNIPMMIVLEYHAKGDLASYLqkkgrlspSKVLRFALDLARGmnylheckpdpiihcdlkpknilldnggqlkisgfgllrlqyispekakivfpvshidpand
Flexible Loop (DISEMBL)
menltaqlkrgisrqfstgslrrsltrqmsrqssfdprrnnmrfsfgrqssldpirrspvqDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKkanidardrwgstaaadakyygnVEVYNILkargakvpktkrtpmtvanprevpeyelnpLELQVRKADGitkgsyqvakwngtKVWVKILDkeshkdperINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISpekakivfpvshidpand
Low Complexity Region (SEG)
MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAND
Disordered region (IsUnstruct)
***********************************************************************STMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA********************YELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVS*******
Disordered Region (DISOPRED)
************************************************************************TMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRW******************************************VPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKE******R**AFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY*********FPVSHIDPAN*
Disordered Region (DISEMBL)
********KRGISRQFSTGS***************DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAND
Disordered Region (DISPRO)
*********************************SFDPRRNNMRFSFGRQ*S****RRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG***************PREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAND
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	359	2.2.26 [Sep-21-2011]
Q05609	821	Serine/threonine-protein	no	no	0.426	0.186	0.414	9e-24
P18160	2410	Dual specificity protein	yes	no	0.428	0.063	0.382	7e-19
Q9FPR3	933	Serine/threonine-protein	no	no	0.395	0.152	0.4	2e-18
Q54TA1	749	Probable serine/threonine	no	no	0.420	0.201	0.350	8e-18
Q54N73	691	Seven transmembrane domai	no	no	0.384	0.199	0.393	8e-18
Q55EI8	1385	Probable serine/threonine	no	no	0.401	0.103	0.377	2e-17
Q39202	832	G-type lectin S-receptor-	no	no	0.495	0.213	0.343	2e-17
Q86HG9	1024	Probable serine/threonine	no	no	0.462	0.162	0.363	2e-16
Q86AE1	527	Probable serine/threonine	no	no	0.373	0.254	0.384	2e-16
Q39203	797	G-type lectin S-receptor-	no	no	0.342	0.154	0.387	3e-16

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  111 bits (277), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 68/164 (41%), Positives = 99/164 (60%), Gaps = 11/164 (6%)

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKIL-DKESHKDPERINAFTHELT 237
           ++P  +LN  E    K    + G+   A+W+G+ V VKIL +++ H   ER+N F  E+ 
Sbjct: 545 DIPWCDLNIKE----KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA--ERVNEFLREVA 598

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDL 294
           I+++ RHPN+V F+GAVTQ   + IV EY ++G L   L K G   +L   + L  A D+
Sbjct: 599 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 658

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           A+GMNYLH   P PI+H DLK  N+L+D    +K+  FGL RL+
Sbjct: 659 AKGMNYLHNRNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 701

Acts as a negative regulator in the ethylene response pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3

 Score = 95.1 bits (235), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/178 (38%), Positives = 93/178 (52%), Gaps = 24/178 (13%)

Query: 182  EYELNPLELQVRKADGITKGSYQVAK---WNGTKVWVKILDKESHKDPERINAFTHELTI 238
            EYE++  EL+  +   I KG +   K   W  T V +KI+ ++  K    +  F +E+ I
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164

Query: 239  VEKARHPNVVQFVGAVTQNIP--MMIVLEYHAKGDLASYLQKKGRL---SPSKVLRFALD 293
            + K RHPNVVQF+GA T        IV E+   G L  +L     L   +P   L+ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224

Query: 294  LARGMNYLHECKPDPIIHCDLKPKNILLDNG-------------GQLKISGFGLLRLQ 338
            +A+GMNYLH   P PI+H DL  +NILLD+               + KIS FGL RL+
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLK 2281

Essential for spore differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score = 93.6 bits (231), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 60/150 (40%), Positives = 87/150 (58%), Gaps = 8/150 (5%)

Query: 195 ADGITKGSYQV---AKWNGTKVWVK-ILDKESHKDPERINAFTHELTIVEKARHPNVVQF 250
           A+ I  GSY     A W+GT+V VK  LD++       +  F  E+ I+ + RHPNVV F
Sbjct: 672 AERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSG--AALAEFRSEVRIMRRLRHPNVVFF 729

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
           +GAVT+   + IV E+  +G L   L + K  +   + ++ ALD+A GMN LH   P  I
Sbjct: 730 LGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLHTSTPT-I 788

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
           +H DLK  N+L+DN   +K+  FGL RL++
Sbjct: 789 VHRDLKTPNLLVDNNWNVKVGDFGLSRLKH 818

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1

 Score = 91.7 bits (226), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 55/157 (35%), Positives = 84/157 (53%), Gaps = 6/157 (3%)

Query: 183 YELNPLEL-QVRKADGITKGSYQ---VAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           +E+ P+++ ++   + I +GS        W G  V +K     +  D + +N    E TI
Sbjct: 481 FEIKPIDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNEDDEDFLNELAQEATI 540

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARG 297
           + + RHPN+ QF+G       ++IV+EY   G L   L      L   ++   ALD+A+G
Sbjct: 541 MSQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRMKSMALDIAKG 600

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           MNYLH C P  +IH DLK  N+L+D   ++KIS FGL
Sbjct: 601 MNYLHCCDPI-VIHRDLKSHNLLVDEHYRVKISDFGL 636

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54N73|7TMK1_DICDI Seven transmembrane domain-containing tyrosine-protein kinase 1 OS=Dictyostelium discoideum GN=7tmk1 PE=3 SV=1

 Score = 91.7 bits (226), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 57/145 (39%), Positives = 79/145 (54%), Gaps = 7/145 (4%)

Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPE---RINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           G  + A W G  V VKIL + S ++ +     N F  E+ I+   RHPNV+QF+G  ++ 
Sbjct: 375 GEVRKAVWKGAVVAVKILHRNSFRNTDGNKEENVFLKEVAILSILRHPNVLQFLGVCSET 434

Query: 258 IPMMIVLEYHAKGDLASYLQKKGRL---SPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
               IV EY   G L   L  +  L   +P      A+ +ARGM YLH+ KP+PI+H DL
Sbjct: 435 NLNGIVTEYMGGGSLDRLLTDRYFLIKQNPILAWNMAISIARGMFYLHDWKPNPILHRDL 494

Query: 315 KPKNILLDNGGQL-KISGFGLLRLQ 338
             KNILLD    + K++ FGL + Q
Sbjct: 495 STKNILLDESLTIAKVADFGLSKEQ 519

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 1

>sp|Q55EI8|Y9956_DICDI Probable serine/threonine-protein kinase DDB_G0268876 OS=Dictyostelium discoideum GN=DDB_G0268876 PE=3 SV=1

 Score = 90.5 bits (223), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/151 (37%), Positives = 83/151 (54%), Gaps = 7/151 (4%)

Query: 188 LELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           LEL      G++ G  +  KW G ++ VK  ++E     ER   F  E TI+   RH N+
Sbjct: 758 LELTKEIGRGVS-GVVKRGKWKGYEIAVKQFNEEELGFSER--EFHSEATIMSVLRHDNI 814

Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKP 306
           V  VG   Q   M +V +Y+++G L S +      LS ++++  AL +A+GMNYLH    
Sbjct: 815 VHCVGGSAQPGKMYLVCDYYSRGSLYSVITANICPLSNARIVHLALQVAKGMNYLHSLG- 873

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
             IIH DLKP N+L+D    ++IS FGL R+
Sbjct: 874 --IIHRDLKPGNLLIDQDWNIRISDFGLSRV 902

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score = 90.1 bits (222), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 14/192 (7%)

Query: 155 NILKARGAKVPKTKRTPMTVANP--------REVPEYELNPLELQVRKADGIT-KGSYQV 205
           N++K +   + +T  T  T AN          E+ E   +  E   R A GI  KG  +V
Sbjct: 495 NMMKNQARDIGRT--TATTTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEV 552

Query: 206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
           A  +   V VK LD+    D +    F +E+ ++ +  H N+V+ +G   +    MIV E
Sbjct: 553 AGGSEVTVAVKKLDR---LDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYE 609

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
           +  +G LA++L ++ R S       A+ +ARG+ YLHE   + IIHCD+KP+NILLD   
Sbjct: 610 FLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYY 669

Query: 326 QLKISGFGLLRL 337
             +IS FGL +L
Sbjct: 670 TPRISDFGLAKL 681

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86HG9|Y9871_DICDI Probable serine/threonine-protein kinase DDB_G0271682 OS=Dictyostelium discoideum GN=DDB_G0271682 PE=3 SV=2

 Score = 87.4 bits (215), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/176 (36%), Positives = 93/176 (52%), Gaps = 10/176 (5%)

Query: 166 KTKRTPMTVANPRE--VPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESH 223
           K + TP+ V +  +  + E EL    L ++K      G     +W GT V VK + K   
Sbjct: 339 KRENTPVIVEDSLKLNIQENEL----LFIKKIGSGACGEVCQYEWKGTPVAVKTIFKSLL 394

Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--QKKGR 281
           +  ++      E++I++  RHPNVV F+G    N  + I+ EY  +G L   L    K  
Sbjct: 395 RKDKKEEF-EKEVSILKCLRHPNVVLFMGTCLLNGNLAIITEYLNRGSLRDVLTTMNKSE 453

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           LS S  ++  +D+A+GMNYLH   P PIIH DLK  N+L+DN   +K+S FGL R 
Sbjct: 454 LSLSVKVKMLIDVAQGMNYLHTYSP-PIIHRDLKSLNLLVDNNFNVKVSDFGLSRF 508

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q86AE1|Y9853_DICDI Probable serine/threonine-protein kinase DDB_G0271538 OS=Dictyostelium discoideum GN=DDB_G0271538 PE=3 SV=1

 Score = 86.7 bits (213), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/143 (38%), Positives = 75/143 (52%), Gaps = 9/143 (6%)

Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM 260
           G  Q A + GT V VK L      DP+       E+ I++  RHPN+VQ++GA       
Sbjct: 45  GQVQKASYFGTDVAVKQLSTLVSIDPDYFKFMLREIKILKGMRHPNIVQYIGACCHEGRY 104

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLR--FALDLARGMNYLHECKPDPIIHCDLKPKN 318
           MIV EY   GDL  +++ +G  + S  LR   ALD+A   +YLH  K   +I  DLK KN
Sbjct: 105 MIVTEYIKGGDLHQFIKARGVSNISWTLRMKLALDIASAFSYLHSKK---VIFRDLKAKN 161

Query: 319 ILLDNGG----QLKISGFGLLRL 337
           IL+D  G    + K+  FG  R+
Sbjct: 162 ILVDEIGDGLYRAKVIDFGFARI 184

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score = 86.7 bits (213), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/129 (38%), Positives = 74/129 (57%), Gaps = 6/129 (4%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK L++    + E    F  E+  +   +H N+V+  G  ++N+  ++V +Y  +G
Sbjct: 485 TFVAVKRLERPGSGESE----FRAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQG 540

Query: 271 DLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            L+SYL +     LS     R AL  A+G+ YLHE   D IIHCD+KP+NILLD+    K
Sbjct: 541 SLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAK 600

Query: 329 ISGFGLLRL 337
           +S FGL +L
Sbjct: 601 VSDFGLAKL 609

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	359
255577895	482	ankyrin-kinase, putative [Ricinus commun	0.994	0.740	0.833	1e-179
356512588	474	PREDICTED: serine/threonine-protein kina	0.988	0.748	0.831	1e-178
18700701	477	ankyrin-kinase [Medicago truncatula]	0.997	0.750	0.817	1e-177
225434181	472	PREDICTED: dual specificity protein kina	0.988	0.752	0.833	1e-176
449438147	473	PREDICTED: serine/threonine-protein kina	0.994	0.754	0.818	1e-175
356525359	475	PREDICTED: serine/threonine-protein kina	0.988	0.747	0.817	1e-175
449520086	473	PREDICTED: serine/threonine-protein kina	0.994	0.754	0.818	1e-174
147802196	495	hypothetical protein VITISV_010336 [Viti	0.988	0.717	0.806	1e-174
297828101	479	hypothetical protein ARALYDRAFT_903788 [	0.997	0.747	0.804	1e-173
116643248	490	flag-tagged protein kinase domain of put	0.997	0.730	0.802	1e-173

>gi|255577895|ref|XP_002529820.1| ankyrin-kinase, putative [Ricinus communis] gi|223530697|gb|EEF32569.1| ankyrin-kinase, putative [Ricinus communis]

 Score =  632 bits (1630), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 301/361 (83%), Positives = 333/361 (92%), Gaps = 4/361 (1%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           ME +T QLKRGISRQFSTGSLRR+ +RQ SRQ+S DPRR+N+RFSFGRQSSLDPIRRSP 
Sbjct: 1   MEGITTQLKRGISRQFSTGSLRRTFSRQFSRQTSLDPRRHNLRFSFGRQSSLDPIRRSPG 60

Query: 61  ---QDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH 117
              +++  VPENLDSTMQLLFMACRGDVKGVEDLLNEG DVNSIDLDGRTALHIAACEGH
Sbjct: 61  HHDEEQFAVPENLDSTMQLLFMACRGDVKGVEDLLNEGIDVNSIDLDGRTALHIAACEGH 120

Query: 118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANP 177
           VEVV+LLL++KANIDARDRWGSTA ADAKYYGNVEVYNILKARGAK PKT++TPMTVANP
Sbjct: 121 VEVVRLLLTRKANIDARDRWGSTACADAKYYGNVEVYNILKARGAKAPKTRKTPMTVANP 180

Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           REVPEYELNPLELQVRK+DGI+KG+YQ+AKWNGTKV VKILDK+S+ DPE INAF HELT
Sbjct: 181 REVPEYELNPLELQVRKSDGISKGTYQLAKWNGTKVTVKILDKDSYSDPESINAFKHELT 240

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARG 297
           ++EK RHPNVVQFVGAVTQNIPMMIV EYH KGDL SYLQKKGRLSPSKVLRF+LD+ARG
Sbjct: 241 LLEKVRHPNVVQFVGAVTQNIPMMIVSEYHPKGDLGSYLQKKGRLSPSKVLRFSLDIARG 300

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
           MNYLHECKPDPIIHCDLKPKN+LLD+GGQLK++GFGL+RL  ISP+KAKI  P + IDP+
Sbjct: 301 MNYLHECKPDPIIHCDLKPKNVLLDSGGQLKVAGFGLIRLSKISPDKAKIA-PGTLIDPS 359

Query: 358 N 358
           N
Sbjct: 360 N 360

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356512588|ref|XP_003525000.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  629 bits (1623), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 297/357 (83%), Positives = 331/357 (92%), Gaps = 2/357 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           ME++ AQLKRGISRQFS+GSLRR+L+RQ +RQ+S DPRRNN RFSFGRQSSLDPIRRSP 
Sbjct: 1   MESIAAQLKRGISRQFSSGSLRRNLSRQFTRQASLDPRRNNQRFSFGRQSSLDPIRRSPC 60

Query: 61  QD--ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV 118
               ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG DVNSIDLDGRTALH+AACEGHV
Sbjct: 61  SGNAELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGIDVNSIDLDGRTALHVAACEGHV 120

Query: 119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPR 178
           EV +LLLS+KAN+DARDRWGSTAAADAKYYGN E+Y +LKARGAKVPKT++TPMTVANPR
Sbjct: 121 EVARLLLSRKANLDARDRWGSTAAADAKYYGNTEIYYMLKARGAKVPKTRKTPMTVANPR 180

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           EVPEYELNP+ELQVRK+DGI+KG+YQVAKWNGTKV VKILDK+S+ DP+ INAF HELT+
Sbjct: 181 EVPEYELNPVELQVRKSDGISKGTYQVAKWNGTKVAVKILDKDSYSDPDTINAFKHELTL 240

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +E+ RHPNVVQFVGAVTQNIPMMIV EYH+KGDLASYLQKKGRLSPSKVLRFALD+ARGM
Sbjct: 241 LERVRHPNVVQFVGAVTQNIPMMIVREYHSKGDLASYLQKKGRLSPSKVLRFALDIARGM 300

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
           NYLHECKPDP+IHCDLKPKNILLDNGGQLKI+GFG +R   ISP++AK+V P  +ID
Sbjct: 301 NYLHECKPDPVIHCDLKPKNILLDNGGQLKIAGFGTVRFSLISPDEAKLVQPEPNID 357

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|18700701|gb|AAL78674.1|AF458699_1 ankyrin-kinase [Medicago truncatula]

 Score =  626 bits (1615), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 296/362 (81%), Positives = 331/362 (91%), Gaps = 4/362 (1%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           MEN+ AQLKRGISRQFS+GSLR++L+RQ +RQ+S DPRRNN+RFSFGRQSSLDPIRRSP 
Sbjct: 1   MENIAAQLKRGISRQFSSGSLRKTLSRQFTRQASLDPRRNNLRFSFGRQSSLDPIRRSPG 60

Query: 61  QDE----LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG 116
            DE    LTVPENLDSTMQLLFMACRGDVKGVEDLLNEG DVNSIDLDGRTALHIAACEG
Sbjct: 61  DDEDQAELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGIDVNSIDLDGRTALHIAACEG 120

Query: 117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN 176
           HV+V KLLLS+KAN+DARDRWGSTAAADAKYYGN EVY +LKARGAKVPKT++TPMTVAN
Sbjct: 121 HVDVAKLLLSRKANLDARDRWGSTAAADAKYYGNTEVYYMLKARGAKVPKTRKTPMTVAN 180

Query: 177 PREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHEL 236
           PREVPEYELNPLELQVRK+DGI+ G+YQVAKWNGTKV VKILDK+S+ DP+ IN F HEL
Sbjct: 181 PREVPEYELNPLELQVRKSDGISTGTYQVAKWNGTKVAVKILDKDSYSDPDTINIFKHEL 240

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR 296
           T++EK RHPNVVQFVGAVTQNIPMMIV EYHAKGDL  Y+QKKGRLSPSKVLRF+LD+AR
Sbjct: 241 TLLEKVRHPNVVQFVGAVTQNIPMMIVREYHAKGDLTGYIQKKGRLSPSKVLRFSLDIAR 300

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           GMNYLHECKPDPIIHCDLKPKNILLDNGGQLK++GFG +R   I+P+KA +  P ++IDP
Sbjct: 301 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKVAGFGTVRFSLITPDKALLEQPEANIDP 360

Query: 357 AN 358
           ++
Sbjct: 361 SS 362

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225434181|ref|XP_002279175.1| PREDICTED: dual specificity protein kinase shkC-like [Vitis vinifera]

 Score =  625 bits (1612), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 296/355 (83%), Positives = 326/355 (91%)

Query: 4   LTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDE 63
           + AQLKRGISRQFSTGSL R+L+RQ SRQSS DPRR N+RFS GRQSSLDPIRRSPV +E
Sbjct: 3   IAAQLKRGISRQFSTGSLLRTLSRQFSRQSSLDPRRTNLRFSLGRQSSLDPIRRSPVNEE 62

Query: 64  LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL 123
           L+VPENLDSTMQ+LFMACRGDVKGVEDLLNEG+DVNSIDLDGRTALHIAACEG +EVVKL
Sbjct: 63  LSVPENLDSTMQMLFMACRGDVKGVEDLLNEGTDVNSIDLDGRTALHIAACEGQIEVVKL 122

Query: 124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEY 183
           LLS+KANIDARDRWGSTAAADAKYYGNVE+YNILKARGAK PK ++TPM VANPREVPEY
Sbjct: 123 LLSRKANIDARDRWGSTAAADAKYYGNVEIYNILKARGAKTPKIRKTPMAVANPREVPEY 182

Query: 184 ELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           ELNPLELQVRK+DGITKGSYQVAKWNGTKV VKILDK+S+ DP+ INAF +ELT++EK R
Sbjct: 183 ELNPLELQVRKSDGITKGSYQVAKWNGTKVSVKILDKDSYSDPDSINAFKYELTLLEKVR 242

Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE 303
           HPNVVQFVGAVTQNIPMMIV EYH KGDL SYLQKKGRLS SK LR+ALD+ARGMNYLHE
Sbjct: 243 HPNVVQFVGAVTQNIPMMIVSEYHPKGDLGSYLQKKGRLSLSKALRYALDIARGMNYLHE 302

Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
           CKPDP+IHCDLKPKNILLD+GGQLK++GFGLLRL  +SP+K K+    SHID +N
Sbjct: 303 CKPDPVIHCDLKPKNILLDSGGQLKVAGFGLLRLSKMSPDKVKLAQSGSHIDASN 357

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449438147|ref|XP_004136851.1| PREDICTED: serine/threonine-protein kinase TNNI3K-like [Cucumis sativus]

 Score =  620 bits (1599), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 294/359 (81%), Positives = 331/359 (92%), Gaps = 2/359 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           M+N+TAQLKRGISRQFSTGSLRR+L+RQ +RQSS DPRRNN+RFSFGRQSSLDPIRR P 
Sbjct: 1   MDNITAQLKRGISRQFSTGSLRRTLSRQFTRQSSLDPRRNNLRFSFGRQSSLDPIRRCPD 60

Query: 61  QD-ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE 119
           +D EL++P+NLDSTMQLLFMACRGDV+GVEDLLN+G+DVNSIDLDGRTALHIAACEGH  
Sbjct: 61  EDNELSIPDNLDSTMQLLFMACRGDVRGVEDLLNDGTDVNSIDLDGRTALHIAACEGHAA 120

Query: 120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPRE 179
           VVKLLLS+KANIDARDRWGSTAAADAKYYGN E+YNILKARGAKVPK ++TPMTVANPRE
Sbjct: 121 VVKLLLSRKANIDARDRWGSTAAADAKYYGNTEIYNILKARGAKVPKFRKTPMTVANPRE 180

Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           VPEYELNPLELQ+R++DGI+KG+YQVAKWNGTKV VKILDK+ + +P+ INAF HELT++
Sbjct: 181 VPEYELNPLELQIRRSDGISKGAYQVAKWNGTKVSVKILDKDCYCNPDSINAFKHELTLL 240

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
           EK RHPNVVQFVGAVTQN+PMMIV EYH KGDL  YLQKKGRLSPSK LRFALD+ARGMN
Sbjct: 241 EKVRHPNVVQFVGAVTQNLPMMIVSEYHPKGDLGCYLQKKGRLSPSKALRFALDVARGMN 300

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
           YLHECKPDPIIHCDLKPKNILLDNGGQLK++GFGL+RL  +S +KAK+  PV  ID +N
Sbjct: 301 YLHECKPDPIIHCDLKPKNILLDNGGQLKVAGFGLIRLSKMSQDKAKLAHPVV-IDYSN 358

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356525359|ref|XP_003531292.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  620 bits (1599), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 292/357 (81%), Positives = 329/357 (92%), Gaps = 2/357 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSP- 59
           ME++ AQLKRGISRQFS+GSLRR+L+RQ +RQ+S DPRRNN RFS GRQSSLDPIRRSP 
Sbjct: 1   MESIAAQLKRGISRQFSSGSLRRNLSRQFTRQASLDPRRNNQRFSIGRQSSLDPIRRSPG 60

Query: 60  -VQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV 118
            VQ ELTVPENLDSTMQLLFMACRGD KGV+DLLNEG DVNSIDLDGRTALH+AACEGHV
Sbjct: 61  PVQPELTVPENLDSTMQLLFMACRGDAKGVDDLLNEGIDVNSIDLDGRTALHVAACEGHV 120

Query: 119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPR 178
           EV +LLL++KAN+DARDRWGSTAAADAKYYGN E+Y +LKARGAKVPKT++TPMTVANPR
Sbjct: 121 EVARLLLTRKANLDARDRWGSTAAADAKYYGNTEIYYMLKARGAKVPKTRKTPMTVANPR 180

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           EVPEYELNPLELQVRK+DGI+KG+YQVAKWNGTKV VKILDK+S+ DP+ INAF HELT+
Sbjct: 181 EVPEYELNPLELQVRKSDGISKGTYQVAKWNGTKVAVKILDKDSYSDPDTINAFKHELTL 240

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +E+ RHPNVVQFVGAVTQNIPMMIV EYH+KGDLASYLQKKGRLSPSKVLRF  D+ARGM
Sbjct: 241 LERVRHPNVVQFVGAVTQNIPMMIVREYHSKGDLASYLQKKGRLSPSKVLRFCHDIARGM 300

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
           NYLHECKPDP+IHCDLKPKNILLD+GGQLKI+GFG +R   ISP++A++V P  +ID
Sbjct: 301 NYLHECKPDPVIHCDLKPKNILLDSGGQLKIAGFGTVRFSLISPDEAQLVQPEPNID 357

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449520086|ref|XP_004167065.1| PREDICTED: serine/threonine-protein kinase TNNI3K-like [Cucumis sativus]

 Score =  619 bits (1595), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 294/359 (81%), Positives = 331/359 (92%), Gaps = 2/359 (0%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
           M+N+TAQLKRGISRQFSTGSLRR+L+RQ +RQSS DPRRNN+RFSFGRQSSLDPIRR P 
Sbjct: 1   MDNITAQLKRGISRQFSTGSLRRTLSRQFTRQSSPDPRRNNLRFSFGRQSSLDPIRRCPD 60

Query: 61  QD-ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE 119
           +D EL++P+NLDSTMQLLFMACRGDV+GVEDLLN+G+DVNSIDLDGRTALHIAACEGH  
Sbjct: 61  EDNELSIPDNLDSTMQLLFMACRGDVRGVEDLLNDGTDVNSIDLDGRTALHIAACEGHAA 120

Query: 120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPRE 179
           VVKLLLS+KANIDARDRWGSTAAADAKYYGN E+YNILKARGAKVPK ++TPMTVANPRE
Sbjct: 121 VVKLLLSRKANIDARDRWGSTAAADAKYYGNTEIYNILKARGAKVPKFRKTPMTVANPRE 180

Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           VPEYELNPLELQ+R++DGI+KG+YQVAKWNGTKV VKILDK+ + +P+ INAF HELT++
Sbjct: 181 VPEYELNPLELQIRRSDGISKGAYQVAKWNGTKVSVKILDKDCYCNPDSINAFKHELTLL 240

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
           EK RHPNVVQFVGAVTQN+PMMIV EYH KGDL  YLQKKGRLSPSK LRFALD+ARGMN
Sbjct: 241 EKVRHPNVVQFVGAVTQNLPMMIVSEYHPKGDLGCYLQKKGRLSPSKALRFALDVARGMN 300

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
           YLHECKPDPIIHCDLKPKNILLDNGGQLK++GFGL+RL  +S +KAK+  PV  ID +N
Sbjct: 301 YLHECKPDPIIHCDLKPKNILLDNGGQLKVAGFGLIRLSKMSQDKAKLAHPVV-IDYSN 358

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147802196|emb|CAN63815.1| hypothetical protein VITISV_010336 [Vitis vinifera]

 Score =  617 bits (1591), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 296/367 (80%), Positives = 326/367 (88%), Gaps = 12/367 (3%)

Query: 4   LTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDE 63
           + AQLKRGISRQFSTGSL R+L+RQ SRQSS DPRR N+RFS GRQSSLDPIRRSPV +E
Sbjct: 3   IAAQLKRGISRQFSTGSLLRTLSRQFSRQSSLDPRRTNLRFSLGRQSSLDPIRRSPVNEE 62

Query: 64  LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL 123
           L+VPENLDSTMQ+LFMACRGDVKGVEDLLNEG+DVNSIDLDGRTALHIAACEG +EVVKL
Sbjct: 63  LSVPENLDSTMQMLFMACRGDVKGVEDLLNEGTDVNSIDLDGRTALHIAACEGQIEVVKL 122

Query: 124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEY 183
           LLS+KANIDARDRWGSTAAADAKYYGNVE+YNILKARGAK PK ++TPM VANPREVPEY
Sbjct: 123 LLSRKANIDARDRWGSTAAADAKYYGNVEIYNILKARGAKTPKIRKTPMAVANPREVPEY 182

Query: 184 ELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           ELNPLELQVRK+DGITKGSYQVAKWNGTKV VKILDK+S+ DP+ INAF +ELT++EK R
Sbjct: 183 ELNPLELQVRKSDGITKGSYQVAKWNGTKVSVKILDKDSYSDPDSINAFKYELTLLEKVR 242

Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR------- 296
           HPNVVQFVGAVTQNIPMMIV EYH KGDL SYLQKKGRLS SK LR+ALD+AR       
Sbjct: 243 HPNVVQFVGAVTQNIPMMIVSEYHPKGDLGSYLQKKGRLSLSKALRYALDIARHVYMQNN 302

Query: 297 -----GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
                GMNYLHECKPDP+IHCDLKPKNILLD+GGQLK++GFGLLRL  +SP+K K+    
Sbjct: 303 IVKCLGMNYLHECKPDPVIHCDLKPKNILLDSGGQLKVAGFGLLRLSKMSPDKVKLAQSG 362

Query: 352 SHIDPAN 358
           SHID +N
Sbjct: 363 SHIDASN 369

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297828101|ref|XP_002881933.1| hypothetical protein ARALYDRAFT_903788 [Arabidopsis lyrata subsp. lyrata] gi|297327772|gb|EFH58192.1| hypothetical protein ARALYDRAFT_903788 [Arabidopsis lyrata subsp. lyrata]

 Score =  614 bits (1584), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 293/364 (80%), Positives = 333/364 (91%), Gaps = 6/364 (1%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSP- 59
           MEN+TAQLKRGISRQFSTGS+RR+L+RQ +RQSS DPRR NMRFSFGRQSSLDPIRRSP 
Sbjct: 1   MENITAQLKRGISRQFSTGSIRRTLSRQFTRQSSLDPRRTNMRFSFGRQSSLDPIRRSPD 60

Query: 60  ---VQDE--LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC 114
                DE  ++VPENLDSTMQLLFMA +GDV+G+E+LL+EG DVNSIDLDGRTALHIAAC
Sbjct: 61  SVRSDDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLDEGIDVNSIDLDGRTALHIAAC 120

Query: 115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV 174
           EGH+ VVK LLS++ANIDARDRWGSTAAADAKYYGN++VYN+LKARGAKVPKT++TPMTV
Sbjct: 121 EGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDVYNLLKARGAKVPKTRKTPMTV 180

Query: 175 ANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH 234
           +NPREVPEYELNPLE+QVRKADGI+KG+YQVAKWNGT+V VKILDK+S+ DPERINAF H
Sbjct: 181 SNPREVPEYELNPLEIQVRKADGISKGAYQVAKWNGTRVSVKILDKDSYSDPERINAFRH 240

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           ELT++EK RHPNV+QFVGAVTQNIPMMIV+EY+ KGDL+ YLQKKGRLSPSK LRFALD+
Sbjct: 241 ELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRFALDI 300

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           ARGMNYLHECKPDPIIHCDLKPKNILLD GGQLKISGFG++RL  IS +KAK+    +HI
Sbjct: 301 ARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFGMIRLSKISQDKAKVANHKAHI 360

Query: 355 DPAN 358
           D +N
Sbjct: 361 DLSN 364

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|116643248|gb|ABK06432.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct]

 Score =  613 bits (1580), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 292/364 (80%), Positives = 333/364 (91%), Gaps = 6/364 (1%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSP- 59
           MEN+TAQLKRGISRQFSTGS+RR+L+RQ +RQSS DPRR NMRFSFGRQSSLDPIRRSP 
Sbjct: 1   MENITAQLKRGISRQFSTGSIRRTLSRQFTRQSSLDPRRTNMRFSFGRQSSLDPIRRSPD 60

Query: 60  ---VQDE--LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC 114
                DE  ++VPENLDSTMQLLFMA +GDV+G+E+LL+EG DVNSIDLDGRTALHIAAC
Sbjct: 61  SSKSDDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLDEGIDVNSIDLDGRTALHIAAC 120

Query: 115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV 174
           EGH+ VVK LLS++ANIDARDRWGSTAAADAKYYGN++VYN+LKARGAKVPKT++TPMTV
Sbjct: 121 EGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDVYNLLKARGAKVPKTRKTPMTV 180

Query: 175 ANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH 234
           +NPREVPEYELNPLE+QVRK+DGI+KG+YQVAKWNGT+V VKILDK+S+ DPERINAF H
Sbjct: 181 SNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRVSVKILDKDSYSDPERINAFRH 240

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           ELT++EK RHPNV+QFVGAVTQNIPMMIV+EY+ KGDL+ YLQKKGRLSPSK LRFALD+
Sbjct: 241 ELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRFALDI 300

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
           ARGMNYLHECKPDPIIHCDLKPKNILLD GGQLKISGFG++RL  IS +KAK+    +HI
Sbjct: 301 ARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFGMIRLSKISQDKAKVANHKAHI 360

Query: 355 DPAN 358
           D +N
Sbjct: 361 DLSN 364

Source: synthetic construct

Species: synthetic construct

Genus: N/A

Family: N/A

Order: N/A

Class: N/A

Phylum: N/A

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	359
TAIR|locus:2044034	479	AT2G43850 [Arabidopsis thalian	0.997	0.747	0.802	2.1e-157
TAIR|locus:2045258	476	AT2G31800 [Arabidopsis thalian	0.997	0.752	0.795	2.7e-155
TAIR|locus:2080517	477	AT3G59830 [Arabidopsis thalian	0.997	0.750	0.776	7.4e-153
TAIR|locus:2117129	459	AT4G18950 [Arabidopsis thalian	0.832	0.651	0.491	1.3e-75
TAIR|locus:2098999	471	AT3G58760 [Arabidopsis thalian	0.810	0.617	0.5	3.5e-75
TAIR|locus:2014849	438	VIK "VH1-interacting kinase" [	0.802	0.657	0.389	1e-45
TAIR|locus:2144613	821	CTR1 "CONSTITUTIVE TRIPLE RESP	0.409	0.179	0.419	9.9e-24
TAIR|locus:2084314	773	AT3G06620 [Arabidopsis thalian	0.434	0.201	0.393	5e-23
TAIR|locus:2200296	765	AT1G67890 [Arabidopsis thalian	0.434	0.203	0.375	1.3e-22
TAIR|locus:2084304	671	AT3G06630 [Arabidopsis thalian	0.362	0.193	0.413	5.7e-22

TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)]

 Score = 1534 (545.1 bits), Expect = 2.1e-157, P = 2.1e-157
 Identities = 292/364 (80%), Positives = 333/364 (91%)

Query:     1 MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSP- 59
             MEN+TAQLKRGISRQFSTGS+RR+L+RQ +RQSS DPRR NMRFSFGRQSSLDPIRRSP 
Sbjct:     1 MENITAQLKRGISRQFSTGSIRRTLSRQFTRQSSLDPRRTNMRFSFGRQSSLDPIRRSPD 60

Query:    60 ---VQDE--LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC 114
                  DE  ++VPENLDSTMQLLFMA +GDV+G+E+LL+EG DVNSIDLDGRTALHIAAC
Sbjct:    61 SSKSDDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLDEGIDVNSIDLDGRTALHIAAC 120

Query:   115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV 174
             EGH+ VVK LLS++ANIDARDRWGSTAAADAKYYGN++VYN+LKARGAKVPKT++TPMTV
Sbjct:   121 EGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDVYNLLKARGAKVPKTRKTPMTV 180

Query:   175 ANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH 234
             +NPREVPEYELNPLE+QVRK+DGI+KG+YQVAKWNGT+V VKILDK+S+ DPERINAF H
Sbjct:   181 SNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRVSVKILDKDSYSDPERINAFRH 240

Query:   235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
             ELT++EK RHPNV+QFVGAVTQNIPMMIV+EY+ KGDL+ YLQKKGRLSPSK LRFALD+
Sbjct:   241 ELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLSVYLQKKGRLSPSKALRFALDI 300

Query:   295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHI 354
             ARGMNYLHECKPDPIIHCDLKPKNILLD GGQLKISGFG++RL  IS +KAK+    +HI
Sbjct:   301 ARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFGMIRLSKISQDKAKVANHKAHI 360

Query:   355 DPAN 358
             D +N
Sbjct:   361 DLSN 364

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)]

 Score = 1514 (538.0 bits), Expect = 2.7e-155, P = 2.7e-155
 Identities = 287/361 (79%), Positives = 326/361 (90%)

Query:     1 MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPV 60
             M N+  QLKRGISRQFSTGSLRR+L+RQ +RQ+S DPRRNNMRFSFGRQSSLDPIRRSP 
Sbjct:     1 MANVVGQLKRGISRQFSTGSLRRTLSRQFTRQASHDPRRNNMRFSFGRQSSLDPIRRSPD 60

Query:    61 QD---ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH 117
                  +L VP+NLD+TMQLLF+ACRGDV+GV+DLL+EG DVNSIDLDGRTALHIAACEGH
Sbjct:    61 GSNGPQLAVPDNLDATMQLLFVACRGDVEGVQDLLDEGIDVNSIDLDGRTALHIAACEGH 120

Query:   118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANP 177
             V+VVKLLL++KANIDARDRWGSTAAADAKYYGN++V+NILKARGAKVPKTKRTPM VANP
Sbjct:   121 VDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFNILKARGAKVPKTKRTPMVVANP 180

Query:   178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
             REVPEYELNP ELQVRKADGI+KG YQVAKWNGTKV VKILDK+ +KD + INAF HELT
Sbjct:   181 REVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSVKILDKDLYKDSDTINAFKHELT 240

Query:   238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARG 297
             + EK RHPNVVQFVGAVTQN+PMMIV EYH KGDL SYLQKKGRLSP+KVLRFALD+ARG
Sbjct:   241 LFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQKKGRLSPAKVLRFALDIARG 300

Query:   298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPA 357
             MNYLHECKP+P+IHCDLKPKNI+LD+GG LK++GFGL+    +S +K+KI+   +HIDP+
Sbjct:   301 MNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGLISFAKLSSDKSKILNHGAHIDPS 360

Query:   358 N 358
             N
Sbjct:   361 N 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)]

 Score = 1491 (529.9 bits), Expect = 7.4e-153, P = 7.4e-153
 Identities = 281/362 (77%), Positives = 324/362 (89%)

Query:     1 MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSP- 59
             M+N+ AQLKRGISRQFSTGS+RR+L+RQ +RQ+S DPRRNNMRFSFGRQSSLDPIRRSP 
Sbjct:     1 MDNIAAQLKRGISRQFSTGSMRRTLSRQFTRQNSLDPRRNNMRFSFGRQSSLDPIRRSPE 60

Query:    60 ---VQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG 116
                 +  ++VPENLDSTMQLLFMA +GDV GVE+LLNEG DVNSIDLDGRTALHIA+CEG
Sbjct:    61 SLSCEPHMSVPENLDSTMQLLFMASKGDVNGVEELLNEGIDVNSIDLDGRTALHIASCEG 120

Query:   117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN 176
             H +VVK+LLS++ANIDARDRWGSTAA DAKYYGNVEVYN+LKARGAK PKT++TPMTV N
Sbjct:   121 HYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVYNLLKARGAKAPKTRKTPMTVGN 180

Query:   177 PREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHEL 236
             P+EVPEYELNPLELQVRK DGI+KG+YQVAKWNGT+V VKI DK+S+ DPER+NAFT+EL
Sbjct:   181 PKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVSVKIFDKDSYSDPERVNAFTNEL 240

Query:   237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR 296
             T++ KARHPN+VQFVGAVTQN+PMMIV+E + KGDL+ YLQKKGRLSPSK LRFALD+AR
Sbjct:   241 TLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQKKGRLSPSKALRFALDIAR 300

Query:   297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
             GMNYLHECKPDPIIHC+L PKNILLD GGQLKISGFGL++L  I  + AK+V   + ID 
Sbjct:   301 GMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGLIKLSKIGEDSAKVVNHEAQIDK 360

Query:   357 AN 358
             +N
Sbjct:   361 SN 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)]

 Score = 762 (273.3 bits), Expect = 1.3e-75, P = 1.3e-75
 Identities = 151/307 (49%), Positives = 211/307 (68%)

Query:    43 RFSFGRQSSLDP--IRRSPVQDELTV---PENLDSTMQLLFMACRGDVKGVEDLLNEGSD 97
             RF+ GRQSS+ P  I    V  E  V    E +D  ++L+++A  GD++G+++L++ G D
Sbjct:     9 RFTIGRQSSMAPEKIPEPSVHSEEEVFEDGEEIDGGVRLMYLANEGDIEGIKELIDSGID 68

Query:    98 VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
              N  D+D RTALH+AAC+G  +VV+LLL +KA +D +DRWGST  ADA +Y N++V  IL
Sbjct:    69 ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPKDRWGSTPFADAIFYKNIDVIKIL 128

Query:   158 KARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKI 217
             +  GAK P     PM V   REVPEYE+NP EL   ++  ITKG+Y +A W G +V VK 
Sbjct:   129 EIHGAKHPMA---PMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRGIQVAVKK 185

Query:   218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
             LD E   D +++  F  EL ++++ RHPN+VQF+GAVTQ+ PMMIV EY  +GDL   L+
Sbjct:   186 LDDEVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRELLK 245

Query:   278 KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
             +KG+L P+  +R+ALD+ARGM+YLHE K DPIIH DL+P NIL D+ G LK++ FG+ +L
Sbjct:   246 RKGQLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNILRDDSGHLKVADFGVSKL 305

Query:   338 QYISPEK 344
               +  +K
Sbjct:   306 VTVKEDK 312

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)]

 Score = 758 (271.9 bits), Expect = 3.5e-75, P = 3.5e-75
 Identities = 153/306 (50%), Positives = 208/306 (67%)

Query:    43 RFSFGRQSSLDPIRRSPVQDELTVPEN--L---------DSTMQLLFMACRGDVKGVEDL 91
             RF  GRQSSL P  R+P+ D LT  E+  L         D T++L+++A  GD+ G+  +
Sbjct:    10 RFKLGRQSSLAPESRTPI-DTLTEDEDDDLAAAATAGIGDPTIRLMYLANEGDIDGINKM 68

Query:    92 LNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNV 151
             L+ G++V+  D+D RTALH+AAC+G  +VV+LLLS+ A +D +DRWGST  ADA YY N 
Sbjct:    69 LDSGTNVDYRDIDARTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADAVYYKNH 128

Query:   152 EVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT 211
             +V  +L+  GAK P     PM V   +EVPEYE++P EL    +  I+KG++  A W G 
Sbjct:   129 DVIKLLEKHGAK-PTI--APMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASWRGI 185

Query:   212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
              V VK   +E   D +++NAF  EL +++K RHPNVVQF+GAVTQ+ PMMIV EY  KGD
Sbjct:   186 DVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLPKGD 245

Query:   272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             L  YL +KG L P+  ++FAL++ARGMNYLHE KP+ IIHCDL+P NIL D+ G LK++ 
Sbjct:   246 LRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHLKVAD 305

Query:   332 FGLLRL 337
             FG+ +L
Sbjct:   306 FGVSKL 311

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 480 (174.0 bits), Expect = 1.0e-45, P = 1.0e-45
 Identities = 118/303 (38%), Positives = 171/303 (56%)

Query:    47 GRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD-VNSIDLDG 105
             G Q++      SP  D+      +  T  +L+ A + D   V  LL E    V++ D D 
Sbjct:    12 GEQAAAGTSVPSPSYDKQKEKARVSRTSLILWHAHQNDAAAVRKLLEEDPTLVHARDYDK 71

Query:   106 RTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP 165
             RT LH+A+  G ++VVK LL   A+++A+DRW +T  ADA+     ++  +LK+ G    
Sbjct:    72 RTPLHVASLHGWIDVVKCLLEFGADVNAQDRWKNTPLADAEGARKQKMIELLKSHGGLSY 131

Query:   166 KTKRT---PMTVANPREVP---EYELNPLELQVRKADGITKGSY-QVAK--WNGTKVWVK 216
                 +   P  V  P  +P   ++E+ P EL    A  I KGS+ ++ K  W GT V VK
Sbjct:   132 GQNGSHFEPKPVPPP--IPKKCDWEIEPAELDFSNAAMIGKGSFGEIVKAYWRGTPVAVK 189

Query:   217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
              +      D   I  F HE+ ++ K RHPN+VQF+GAVT+  P+M++ EY   GDL  YL
Sbjct:   190 RILPSLSDDRLVIQDFRHEVDLLVKLRHPNIVQFLGAVTERKPLMLITEYLRGGDLHQYL 249

Query:   277 QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--QLKISGFGL 334
             ++KG L+P+  + FALD+ARGM YLH  +P+ IIH DLKP+N+LL N     LK+  FGL
Sbjct:   250 KEKGGLTPTTAVNFALDIARGMTYLHN-EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGL 308

Query:   335 LRL 337
              +L
Sbjct:   309 SKL 311

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009734 "auxin mediated signaling pathway" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0005829 "cytosol" evidence=RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 283 (104.7 bits), Expect = 9.9e-24, P = 9.9e-24
 Identities = 65/155 (41%), Positives = 96/155 (61%)

Query:   189 ELQVRKADGITK-GSYQVAKWNGTKVWVKIL-DKESHKDPERINAFTHELTIVEKARHPN 246
             +L +++  G    G+   A+W+G+ V VKIL +++ H   ER+N F  E+ I+++ RHPN
Sbjct:   550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA--ERVNEFLREVAIMKRLRHPN 607

Query:   247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHE 303
             +V F+GAVTQ   + IV EY ++G L   L K G   +L   + L  A D+A+GMNYLH 
Sbjct:   608 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 667

Query:   304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
               P PI+H DLK  N+L+D    +K+  FGL RL+
Sbjct:   668 RNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 701

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009744 "response to sucrose stimulus" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0010105 "negative regulation of ethylene mediated signaling pathway" evidence=TAS

GO:0010182 "sugar mediated signaling pathway" evidence=TAS

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009686 "gibberellin biosynthetic process" evidence=IMP

GO:0048510 "regulation of timing of transition from vegetative to reproductive phase" evidence=IMP

GO:2000035 "regulation of stem cell division" evidence=IMP

GO:2000069 "regulation of post-embryonic root development" evidence=IMP

GO:0071281 "cellular response to iron ion" evidence=IEP

GO:0009750 "response to fructose stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP

TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)]

 Score = 276 (102.2 bits), Expect = 5.0e-23, P = 5.0e-23
 Identities = 63/160 (39%), Positives = 95/160 (59%)

Query:   182 EYELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVE 240
             EYE+   +L + +  G    G+     W G+ V VK+  K+ +   E I +F  E+ +++
Sbjct:   486 EYEILWDDLTIGEQVGQGSCGTVYHGLWFGSDVAVKVFSKQEYS-AEVIESFKQEVLLMK 544

Query:   241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMN 299
             + RHPNV+ F+GAVT    + IV E+  +G L   LQK   +L   + +  ALD+ARGMN
Sbjct:   545 RLRHPNVLLFMGAVTSPQRLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIHMALDIARGMN 604

Query:   300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             YLH C P PIIH DLK  N+L+D    +K++ FGL R+++
Sbjct:   605 YLHHCSP-PIIHRDLKSSNLLVDKNWTVKVADFGLSRIKH 643

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0000956 "nuclear-transcribed mRNA catabolic process" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)]

 Score = 272 (100.8 bits), Expect = 1.3e-22, P = 1.3e-22
 Identities = 60/160 (37%), Positives = 96/160 (60%)

Query:   182 EYELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVE 240
             +YE+   +L + +  G    G+     W G+ V VK+  K+ + + E I +F  E+++++
Sbjct:   479 DYEILWEDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEYSE-EIITSFKQEVSLMK 537

Query:   241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
             + RHPNV+ F+GAV     + IV E+  +G L   LQ+ K +L   + +  A D+ARGMN
Sbjct:   538 RLRHPNVLLFMGAVASPQRLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGMN 597

Query:   300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             YLH C P PIIH DLK  N+L+D    +K++ FGL R+++
Sbjct:   598 YLHHCSP-PIIHRDLKSSNLLVDRNWTVKVADFGLSRIKH 636

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2084304 AT3G06630 [Arabidopsis thaliana (taxid:3702)]

 Score = 265 (98.3 bits), Expect = 5.7e-22, P = 5.7e-22
 Identities = 55/133 (41%), Positives = 85/133 (63%)

Query:   208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
             W G+ V VK+  K+ + +   I +F  E++++++ RHPNV+ F+GAVT    + IV E+ 
Sbjct:   453 WFGSDVAVKVFSKQEYSESV-IKSFEKEVSLMKRLRHPNVLLFMGAVTSPQRLCIVSEFV 511

Query:   268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              +G L   LQ+   +L   + +  ALD+ARGMNYLH C P PIIH DLK  N+L+D    
Sbjct:   512 PRGSLFRLLQRSMSKLDWRRRINMALDIARGMNYLHCCSP-PIIHRDLKSSNLLVDRNWT 570

Query:   327 LKISGFGLLRLQY 339
             +K++ FGL R+++
Sbjct:   571 VKVADFGLSRIKH 583

GO:0000155 "phosphorelay sensor kinase activity" evidence=IEA

GO:0000160 "phosphorelay signal transduction system" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0046777 "protein autophosphorylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: scaffold_403289.1 annotation not avaliable (479 aa) (Arabidopsis lyrata)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	359
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-36
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-35
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-34
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	8e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-33
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-30
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	6e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-21
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-20
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-20
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	1e-19
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	3e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-19
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	2e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-18
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-18
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-17
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-17
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	9e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-14
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-13
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	1e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-12
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-12
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-12
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-11
pfam00023	33	pfam00023, Ank, Ankyrin repeat	3e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-11
PTZ00322	664	PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct	5e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	8e-11
PLN03192	823	PLN03192, PLN03192, Voltage-dependent potassium ch	8e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-10
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-10
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-10
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	5e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-10
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-10
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-09
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-09
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-09
pfam13857	56	pfam13857, Ank_5, Ankyrin repeats (many copies)	5e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-09
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	5e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-09
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-09
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	1e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-08
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	1e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-08
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-08
smart00248	30	smart00248, ANK, ankyrin repeats	4e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-08
PLN03192	823	PLN03192, PLN03192, Voltage-dependent potassium ch	8e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-08
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	8e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-07
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-07
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	2e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-07
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-07
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-07
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-07
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-07
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	8e-07
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	1e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-06
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-06
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	2e-06
TIGR00870	743	TIGR00870, trp, transient-receptor-potential calci	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-06
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-06
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	4e-06
PHA02874	434	PHA02874, PHA02874, ankyrin repeat protein; Provis	4e-06
pfam13606	30	pfam13606, Ank_3, Ankyrin repeat	4e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-05
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-05
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-05
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	5e-05
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-04
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-04
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-04
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	3e-04
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	4e-04
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	4e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-04
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-04
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	5e-04
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	5e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.001
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.001
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
PHA02743	166	PHA02743, PHA02743, Viral ankyrin protein; Provisi	0.002
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.002
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	0.003
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  131 bits (332), Expect = 4e-36
 Identities = 55/138 (39%), Positives = 75/138 (54%), Gaps = 6/138 (4%)

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI 262
                    +V VK L +++    ++I  F  E  I+ K  HPNVV+ +G  T+  P+ I
Sbjct: 21  KGKGGKKKVEVAVKTLKEDA--SEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYI 78

Query: 263 VLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           V+EY   GDL SYL+K + +LS S +L FAL +ARGM YL        IH DL  +N L+
Sbjct: 79  VMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLV 135

Query: 322 DNGGQLKISGFGLLRLQY 339
                +KIS FGL R  Y
Sbjct: 136 GENLVVKISDFGLSRDLY 153

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  129 bits (326), Expect = 3e-35
 Identities = 58/160 (36%), Positives = 79/160 (49%), Gaps = 24/160 (15%)

Query: 191 QVRKA--DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV 248
           +V K    G    + +VA        VK L KE   + ER   F  E  +++K  HPNVV
Sbjct: 10  EVYKGKLKGKDGKTTEVA--------VKTL-KEDASEEERK-DFLKEARVMKKLGHPNVV 59

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQK---------KGRLSPSKVLRFALDLARGMN 299
           + +G  T+  P+ +VLEY   GDL  YL+K         K  LS   +L FA+ +A+GM 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
           YL   K    +H DL  +N L+     +KIS FGL R  Y
Sbjct: 120 YLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  128 bits (325), Expect = 4e-35
 Identities = 54/132 (40%), Positives = 73/132 (55%), Gaps = 6/132 (4%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
             TKV VK L KE   + ER   F  E +I++K  HPN+V+ +G  TQ  P+ IV EY  
Sbjct: 27  TETKVAVKTL-KEGASEEERE-EFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMP 84

Query: 269 KGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            GDL  +L+K G  L+   +L+ AL +A+GM YL        +H DL  +N L+     +
Sbjct: 85  GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN---FVHRDLAARNCLVTENLVV 141

Query: 328 KISGFGLLRLQY 339
           KIS FGL R  Y
Sbjct: 142 KISDFGLSRDIY 153

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  127 bits (322), Expect = 9e-35
 Identities = 59/170 (34%), Positives = 82/170 (48%), Gaps = 24/170 (14%)

Query: 191 QVRKA---DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           +V K            +VA        VK L +++    ++I  F  E  I+ K  HPN+
Sbjct: 14  EVYKGTLKGKGDGKEVEVA--------VKTLKEDA--SEQQIEEFLREARIMRKLDHPNI 63

Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECK 305
           V+ +G  T+  P+MIV+EY   GDL  YL+K     LS S +L FAL +ARGM YL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
               IH DL  +N L+     +KIS FGL R      Y   +  K+  P+
Sbjct: 124 ---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PI 168

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  126 bits (319), Expect = 3e-34
 Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 24/165 (14%)

Query: 198 ITKGSY-QV--AKWNGTKVWV--KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           + +GS+ +V  A+   T   V  K++ K+  K  +       E+ I++K +HPN+V+   
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKK--KIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
                  + +V+EY   GDL   L+K+GRLS  +   +   +   + YLH      I+H 
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVHR 121

Query: 313 DLKPKNILLDNGGQLKISGFGLLR--------------LQYISPE 343
           DLKP+NILLD  G +K++ FGL R               +Y++PE
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  123 bits (312), Expect = 8e-34
 Identities = 50/144 (34%), Positives = 77/144 (53%), Gaps = 12/144 (8%)

Query: 198 ITKGSY-QV--AKWNGTKVWV--KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           + +G +  V  A+   T   V  KI+ KE       +     E+ I++K  HPN+V+  G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +V+EY   G L   L++  G+LS  ++LR  L +  G+ YLH      IIH
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115

Query: 312 CDLKPKNILLDNG-GQLKISGFGL 334
            DLKP+NILLD+  G++K++ FGL
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGL 139

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  125 bits (315), Expect = 1e-33
 Identities = 59/154 (38%), Positives = 80/154 (51%), Gaps = 9/154 (5%)

Query: 198 ITKGSYQV---AKWNGT--KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           +  GS+     AK  GT   V VKIL K S K  +   A   E+ I+ +  HPN+V+ + 
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLID 65

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           A      + +V+EY   GDL  YL + G LS  +  + AL + RG+ YLH      IIH 
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG---IIHR 122

Query: 313 DLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           DLKP+NILLD  G +KI+ FGL +    S     
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLT 156

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  115 bits (291), Expect = 3e-30
 Identities = 40/130 (30%), Positives = 68/130 (52%), Gaps = 6/130 (4%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM--IVLEY 266
            G  + VK ++  S    E + A   E+ I+   +HPN+V++ G+          I LEY
Sbjct: 24  TGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            + G L+S L+K G+L    + ++   +  G+ YLH      I+H D+K  NIL+D+ G 
Sbjct: 83  VSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGV 139

Query: 327 LKISGFGLLR 336
           +K++ FG  +
Sbjct: 140 VKLADFGCAK 149

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 95.1 bits (237), Expect = 6e-24
 Identities = 47/104 (45%), Positives = 66/104 (63%), Gaps = 4/104 (3%)

Query: 76  LLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
            L +A   G ++ V+ LL  G+DVN+ D DGRT LH+AA  GH+E+VKLLL K A+++AR
Sbjct: 10  PLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNAR 69

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
           D+ G+T    A   GN++V  +L   GA V    K  RTP+ +A
Sbjct: 70  DKDGNTPLHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLA 113

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 1e-23
 Identities = 61/174 (35%), Positives = 89/174 (51%), Gaps = 16/174 (9%)

Query: 183 YELNPLELQVRKADGITKGSY---QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           + +N  EL++     I KG +    +  + G KV VK L  +S        AF  E +++
Sbjct: 1   WAINSKELKLG--ATIGKGEFGDVMLGDYRGQKVAVKCLKDDS----TAAQAFLAEASVM 54

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARG 297
              RHPN+VQ +G V Q  P+ IV EY AKG L  YL+ +GR  ++ ++ L FALD+  G
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
           M YL E      +H DL  +N+L+      K+S FGL +      +  K   PV
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK--LPV 163

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 92.0 bits (229), Expect = 2e-21
 Identities = 58/153 (37%), Positives = 79/153 (51%), Gaps = 16/153 (10%)

Query: 206 AKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
             WNG TKV VK L K     PE   AF  E  I++K RH  +VQ     ++  P+ IV 
Sbjct: 25  GTWNGTTKVAVKTL-KPGTMSPE---AFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80

Query: 265 EYHAKGDLASYLQK-KGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           EY +KG L  +L+  +G+ L   +++  A  +A GM YL        IH DL  +NIL+ 
Sbjct: 81  EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVG 137

Query: 323 NGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
                KI+ FGL RL    +Y + E AK  FP+
Sbjct: 138 ENLVCKIADFGLARLIEDDEYTAREGAK--FPI 168

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 90.3 bits (225), Expect = 7e-21
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 28/170 (16%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KGS+        K +G    +K +D  +  + ER +A  +E+ I++K  HPN++++  
Sbjct: 8   IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL-NEVKILKKLNHPNIIKYYE 66

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPDP 308
           +  +   + IV+EY   GDL+  ++K+ +        ++L + + L   + YLH  K   
Sbjct: 67  SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--- 123

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRL---------------QYISPE 343
           I+H D+KP+NI L + G +K+  FG+ ++                Y+SPE
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPE 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 1e-20
 Identities = 44/114 (38%), Positives = 63/114 (55%), Gaps = 8/114 (7%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSP 284
           P+    F  E  I+++  HPN+V+ +G   Q  P+ IV+E    G L ++L+K K RL+ 
Sbjct: 33  PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV 92

Query: 285 SKVLRFALDLARGMNYLHE--CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            K+L+ +LD A GM YL    C     IH DL  +N L+     LKIS FG+ R
Sbjct: 93  KKLLQMSLDAAAGMEYLESKNC-----IHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 89.3 bits (222), Expect = 1e-20
 Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 6/126 (4%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
            V +K L K    D +R++ F  E +I+ +  HPN+++  G VT++ P+MI+ EY   G 
Sbjct: 34  DVAIKTL-KAGSSDKQRLD-FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGS 91

Query: 272 LASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           L  +L++  G+ +  +++     +A GM YL E      +H DL  +NIL+++    K+S
Sbjct: 92  LDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVS 148

Query: 331 GFGLLR 336
            FGL R
Sbjct: 149 DFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 45/137 (32%), Positives = 70/137 (51%), Gaps = 6/137 (4%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           KG Y +      +V VK L +E     ++   F  E +++ +  HP +V+ +G V +  P
Sbjct: 13  KGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCIVRLIG-VCKGEP 69

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           +M+V+E    G L  YL+K+  +  S +   A  +A GM YL        +H DL  +N+
Sbjct: 70  LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNV 126

Query: 320 LLDNGGQLKISGFGLLR 336
           LL N  Q KIS FG+ R
Sbjct: 127 LLVNRHQAKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.4 bits (219), Expect = 3e-20
 Identities = 61/181 (33%), Positives = 89/181 (49%), Gaps = 20/181 (11%)

Query: 185 LNPLELQVRKADGITKGSYQV---AKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +NP EL   K  G   G + V    KW    KV +K +++ +  + +    F  E  ++ 
Sbjct: 1   INPSELTFMKELG--SGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMM 54

Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMN 299
           K  HP +VQ  G  TQ  P+ IV E+   G L +YL Q++G+LS   +L    D+  GM 
Sbjct: 55  KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL     +  IH DL  +N L+ + G +K+S FG+ R     +Y S   AK  FPV    
Sbjct: 115 YLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK--FPVKWSP 169

Query: 356 P 356
           P
Sbjct: 170 P 170

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 9e-20
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 18/143 (12%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K+L K+     + +     E  I+ +  HP +V+   A      + +VLEY   G+L S+
Sbjct: 24  KVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSH 83

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           L K+GR S  +   +A ++   + YLH      II+ DLKP+NILLD  G +K++ FGL 
Sbjct: 84  LSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLA 140

Query: 336 R---------------LQYISPE 343
           +                +Y++PE
Sbjct: 141 KELSSEGSRTNTFCGTPEYLAPE 163

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 9e-20
 Identities = 58/174 (33%), Positives = 86/174 (49%), Gaps = 16/174 (9%)

Query: 185 LNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   K  G  + G   + KW G   V +K++ + +  + +    F  E  ++ K 
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMMKL 56

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HPN+VQ  G  T+  P+ IV EY A G L +YL+ +KG+L    +L    D+   M YL
Sbjct: 57  SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYL 116

Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
                +  IH DL  +N L+     +K+S FGL R     QY S +  K  FPV
Sbjct: 117 ES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTK--FPV 165

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 83.2 bits (206), Expect = 1e-19
 Identities = 36/82 (43%), Positives = 55/82 (67%), Gaps = 1/82 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A + G ++ V+ LL +G+DVN+ D DG T LH+AA  G+++VVKLLL   A+++ARD
Sbjct: 44  LHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARD 103

Query: 136 RWGSTAAADAKYYGNVEVYNIL 157
           + G T    A   G++EV  +L
Sbjct: 104 KDGRTPLHLAAKNGHLEVVKLL 125

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 81.1 bits (201), Expect = 3e-19
 Identities = 38/89 (42%), Positives = 58/89 (65%), Gaps = 2/89 (2%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A  G+++ V+ LL +G+DVN  D D  TALH+AA  G++E+VKLLL   A+++A+D
Sbjct: 1   LHLAAKNGNLELVKLLLEKGADVNLGDTD--TALHLAARNGNLEIVKLLLEHGADVNAKD 58

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           + G+TA   A   GN+E+  +L   GA +
Sbjct: 59  KDGNTALHLAARNGNLEIVKLLLEHGADI 87

Length = 91

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 48/155 (30%), Positives = 80/155 (51%), Gaps = 21/155 (13%)

Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G+ KG         T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V
Sbjct: 27  AKGVVKGE------PETRVAIKTVN-ENASMRERIE-FLNEASVMKEFNCHHVVRLLGVV 78

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKK--------GRLSPS--KVLRFALDLARGMNYLHEC 304
           +   P ++V+E  AKGDL SYL+ +        G   P+  K ++ A ++A GM YL   
Sbjct: 79  STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK 138

Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
           K    +H DL  +N ++     +KI  FG+ R  Y
Sbjct: 139 K---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIY 170

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 85.3 bits (211), Expect = 4e-19
 Identities = 61/174 (35%), Positives = 90/174 (51%), Gaps = 16/174 (9%)

Query: 185 LNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ K 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMKL 56

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYL 301
            H  +VQ  G  T+  P+ IV EY + G L +YL++ G R  PS++L    D+  GM YL
Sbjct: 57  SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116

Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
            E K    IH DL  +N L+D+ G +K+S FGL R     +Y S   +K  FPV
Sbjct: 117 -ESK--QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK--FPV 165

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 85.6 bits (213), Expect = 5e-19
 Identities = 37/103 (35%), Positives = 61/103 (59%), Gaps = 5/103 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E++++++ +HPN+V+ +  +     + +V EY    DL  YL K+   LSP+ +      
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L RG+ Y H  +   I+H DLKP+NIL++  G LK++ FGL R
Sbjct: 107 LLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 78.8 bits (195), Expect = 2e-18
 Identities = 33/68 (48%), Positives = 47/68 (69%), Gaps = 1/68 (1%)

Query: 69  NLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           NL  T   L +A R G+++ V+ LL  G+DVN+ D DG TALH+AA  G++E+VKLLL  
Sbjct: 24  NLGDTDTALHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEH 83

Query: 128 KANIDARD 135
            A+I+ +D
Sbjct: 84  GADINLKD 91

Length = 91

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 38/132 (28%), Positives = 70/132 (53%), Gaps = 10/132 (7%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG---AVTQNIPMMIVLEY 266
           G +V VK L+     + +  + F  E+ I+    H N+V++ G            +++EY
Sbjct: 33  GEQVAVKSLNHSG--EEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR-LIMEY 89

Query: 267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              G L  YLQ+ + +++  ++L F+  + +GM+YL   +    IH DL  +NIL+++  
Sbjct: 90  LPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESED 146

Query: 326 QLKISGFGLLRL 337
            +KIS FGL ++
Sbjct: 147 LVKISDFGLAKV 158

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 82.6 bits (205), Expect = 3e-18
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 12/149 (8%)

Query: 192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
               + I KG +        K  G +V +K++  ES +  E+I     E+ I++K +HPN
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHPN 58

Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECK 305
           +V++ G+  +   + IV+E+ + G L   L+     L+ S++     +L +G+ YLH   
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGL 334
              IIH D+K  NILL + G++K+  FGL
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGL 144

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 82.4 bits (204), Expect = 4e-18
 Identities = 39/110 (35%), Positives = 60/110 (54%), Gaps = 5/110 (4%)

Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP 284
           DP+ I     E+ ++E  +HPN+V++ G       + I +EY + G L   L + GR+  
Sbjct: 39  DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL-EHGRILD 97

Query: 285 SKVLR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             V+R + L L  G+ YLH      I+H D+KP NI LD+ G +K+  FG
Sbjct: 98  EHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFG 144

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 83.6 bits (205), Expect = 7e-18
 Identities = 46/147 (31%), Positives = 72/147 (48%), Gaps = 10/147 (6%)

Query: 198 ITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP-NVVQFVGAV 254
           + +GS+       +   V +K+L K+     + +  F  E+ I+    HP N+V+     
Sbjct: 8   LGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67

Query: 255 TQNIPMMIVLEYHAKGDLASYLQK---KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                + +V+EY   G L   L+K   KG LS S+ L     +   + YLH      IIH
Sbjct: 68  QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIH 124

Query: 312 CDLKPKNILLD-NGGQLKISGFGLLRL 337
            D+KP+NILLD +G  +K+  FGL +L
Sbjct: 125 RDIKPENILLDRDGRVVKLIDFGLAKL 151

Length = 384

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 81.1 bits (200), Expect = 1e-17
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 24/183 (13%)

Query: 185 LNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           ++P EL + +  G      +  G +        KV +K + + +  + +    F  E  +
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGAMSEED----FIEEAQV 52

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARG 297
           + K  HP +VQ  G  T+  P+ +V E+   G L+ YL+ ++G+ S   +L   LD+  G
Sbjct: 53  MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEG 112

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSH 353
           M YL       +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV  
Sbjct: 113 MAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK--FPVKW 167

Query: 354 IDP 356
             P
Sbjct: 168 SSP 170

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 14/178 (7%)

Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           + LN  EL++ +  G  + G   +  + G KV VK +     K+     AF  E +++ +
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQ 55

Query: 242 ARHPNVVQFVGA-VTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGM 298
            RH N+VQ +G  V +   + IV EY AKG L  YL+ +GR  L    +L+F+LD+   M
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
            YL   + +  +H DL  +N+L+      K+S FGL +    + +  K+  PV    P
Sbjct: 116 EYL---EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAP 168

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 53/158 (33%), Positives = 87/158 (55%), Gaps = 13/158 (8%)

Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM 260
           G+    ++ G KV VK +     K      AF  E  ++ K  H N+V+ +G +  N  +
Sbjct: 20  GAVLQGEYTGQKVAVKNI-----KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL 73

Query: 261 MIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
            IV+E  +KG+L ++L+ +GR  +S  ++L+F+LD+A GM YL   K   ++H DL  +N
Sbjct: 74  YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARN 130

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           IL+   G  K+S FGL R+  +  + +K+  PV    P
Sbjct: 131 ILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVKWTAP 166

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 47/142 (33%), Positives = 73/142 (51%), Gaps = 8/142 (5%)

Query: 198 ITKGSY-QV--AKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I+KG+Y +V  AK   T     +K++ K       +++    E  I+ +A+ P VV+   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           +      + +V+EY   GDLAS L+  G L       +  ++   + YLH      IIH 
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHR 117

Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLKP NIL+D+ G LK++ FGL
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGL 139

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 46/145 (31%), Positives = 65/145 (44%), Gaps = 21/145 (14%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V +K L KE+ +   +   F  E  ++   +HPN+V  +G  T+  P  ++ EY A G
Sbjct: 36  TSVAIKTL-KENAEPKVQ-QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHG 93

Query: 271 DLASYL----------------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           DL  +L                  K  L  S  L  A+ +A GM YL        +H DL
Sbjct: 94  DLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDL 150

Query: 315 KPKNILLDNGGQLKISGFGLLRLQY 339
             +N L+  G  +KIS FGL R  Y
Sbjct: 151 AARNCLVGEGLTVKISDFGLSRDIY 175

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.8 bits (197), Expect = 4e-17
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 10/149 (6%)

Query: 193 RKADGITKGSY-QV----AKWNGTKVWVK--ILDKESHKDPERINAFTHELTIVEKARHP 245
           RK + +  GS+  V       +G    VK   L  +     E +     E+ ++ K +HP
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK 305
           N+VQ++G   +   + I LE    G LA  L+K G      +  +   +  G+ YLH+  
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGL 334
               +H D+K  NIL+D  G +K++ FG+
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGM 148

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 29/153 (18%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L + +      +     E  ++++  HP+V++  GA +Q+ P+++++EY   G
Sbjct: 31  TTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 88

Query: 271 DLASYLQKKGRLSPSKV------------------------LRFALDLARGMNYLHECKP 306
            L S+L++  ++ PS +                        + FA  ++RGM YL E K 
Sbjct: 89  SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK- 147

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             ++H DL  +N+L+  G ++KIS FGL R  Y
Sbjct: 148 --LVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.3 bits (199), Expect = 4e-17
 Identities = 48/145 (33%), Positives = 74/145 (51%), Gaps = 23/145 (15%)

Query: 215 VKILDKES---HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +KIL K      K  E +     E  I++  RHP +V   G+   +  + +V+EY   G+
Sbjct: 31  LKILSKAKIVKLKQVEHVLN---EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGE 87

Query: 272 LASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           L S+L+K GR  P  V RF A  +   + YLH      I++ DLKP+N+LLD+ G +KI+
Sbjct: 88  LFSHLRKSGRF-PEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKIT 143

Query: 331 GFGLLRL------------QYISPE 343
            FG  +             +Y++PE
Sbjct: 144 DFGFAKRVKGRTYTLCGTPEYLAPE 168

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 5e-17
 Identities = 37/126 (29%), Positives = 67/126 (53%), Gaps = 4/126 (3%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G  V +K +  E     E + +   E+ +++  +HPN+V+++G++  +  + I+LEY  
Sbjct: 24  TGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82

Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   ++K G    S V  +   + +G+ YLHE     +IH D+K  NIL    G +K
Sbjct: 83  NGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVK 139

Query: 329 ISGFGL 334
           ++ FG+
Sbjct: 140 LADFGV 145

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 78.6 bits (194), Expect = 9e-17
 Identities = 52/151 (34%), Positives = 70/151 (46%), Gaps = 16/151 (10%)

Query: 208 WNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           WN  T V VK L K    DP+    F  E  I++K RHP ++Q     T   P+ IV E 
Sbjct: 27  WNNTTPVAVKTL-KPGTMDPK---DFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82

Query: 267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
              G L  YLQ      L   +++  A  +A GM YL        IH DL  +N+L+   
Sbjct: 83  MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGEN 139

Query: 325 GQLKISGFGLLRL----QYISPEKAKIVFPV 351
              K++ FGL R+     Y + E AK  FP+
Sbjct: 140 NICKVADFGLARVIKEDIYEAREGAK--FPI 168

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 45/106 (42%), Positives = 62/106 (58%), Gaps = 4/106 (3%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRF 290
           F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  S+L +KK  L   ++++F
Sbjct: 39  FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF 98

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           ALD A GM YL E K    IH DL  +N L+     LKIS FG+ R
Sbjct: 99  ALDAAAGMAYL-ESK--NCIHRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 77.6 bits (192), Expect = 3e-16
 Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 11/107 (10%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIP--MMIVLEY--HAKGDLASYL-QKKGRLSPSKVLR 289
           E+ +++K RHPN+V+    VT      + +V EY  H   DL   L   + + + S++  
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKC 104

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           +   L  G+ YLH      I+H D+K  NIL++N G LK++ FGL R
Sbjct: 105 YMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 42/134 (31%), Positives = 67/134 (50%), Gaps = 17/134 (12%)

Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP 284
           D E       EL  +     P VV+  GA  +   + IVLEY   G LA  L+K G++  
Sbjct: 39  DEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE 98

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------- 336
             +   A  + +G++YLH  +   IIH D+KP N+L+++ G++KI+ FG+ +        
Sbjct: 99  PVLAYIARQILKGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156

Query: 337 -------LQYISPE 343
                  + Y+SPE
Sbjct: 157 CNTFVGTVTYMSPE 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.4 bits (188), Expect = 5e-16
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 15/158 (9%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           V K     V VK L KE   D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ 
Sbjct: 26  VWKKYSLTVAVKTL-KE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81

Query: 265 EYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           E+   G+L  YL++  R  ++   +L  A  ++  M YL +      IH DL  +N L+ 
Sbjct: 82  EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVG 138

Query: 323 NGGQLKISGFGLLRLQ----YISPEKAKIVFPVSHIDP 356
               +K++ FGL RL     Y +   AK  FP+    P
Sbjct: 139 ENHLVKVADFGLSRLMTGDTYTAHAGAK--FPIKWTAP 174

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 21/169 (12%)

Query: 189 ELQVRKADGITKGSYQVAKWNGTK-----VWVKILDKESHKDPERINAFTHELTIVEKAR 243
           E+ + +ADG+   S +    N        V VK+L +    D  R   F  E+ I+ +  
Sbjct: 20  EVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR-EDFLKEVKILSRLS 77

Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-----------KGRLSPSKVLRFAL 292
            PN+ + +G  T + P+ +++EY   GDL  +LQK              LS S +L  A 
Sbjct: 78  DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMAT 137

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
            +A GM YL        +H DL  +N L+     +KI+ FG+ R  Y S
Sbjct: 138 QIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.0 bits (187), Expect = 9e-16
 Identities = 42/116 (36%), Positives = 66/116 (56%), Gaps = 5/116 (4%)

Query: 221 ESHKDPER--INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
            S KD +R  ++A   E+ ++++ +H N+VQ++G+      + I LEY   G +A+ L  
Sbjct: 40  ASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN 99

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            G    + V  F   + +G+NYLH      IIH D+K  NIL+DN G +KIS FG+
Sbjct: 100 YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGI 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 48/130 (36%), Positives = 71/130 (54%), Gaps = 12/130 (9%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H   ER  A   EL I+     H N+V  +GA T   P++++ EY   G
Sbjct: 67  KVAVKMLKPTAHSS-ER-EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124

Query: 271 DLASYLQKKGR--LSPSKVLRFALDLARGMNYL--HECKPDPIIHCDLKPKNILLDNGGQ 326
           DL ++L++K    L+   +L F+  +A+GM +L    C     IH DL  +N+LL +G  
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC-----IHRDLAARNVLLTHGKI 179

Query: 327 LKISGFGLLR 336
           +KI  FGL R
Sbjct: 180 VKICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 16/154 (10%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
             TKV +K L K+    PE   AF  E  ++++ +HP +V+    VTQ  P+ I+ EY  
Sbjct: 29  GHTKVAIKSL-KQGSMSPE---AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYME 83

Query: 269 KGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            G L  +L+     +L+ +K++  A  +A GM ++        IH DL+  NIL+     
Sbjct: 84  NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLC 140

Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
            KI+ FGL RL    +Y + E AK  FP+    P
Sbjct: 141 CKIADFGLARLIEDNEYTAREGAK--FPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 74.3 bits (183), Expect = 3e-15
 Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 14/146 (9%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK L  +  K  + ++ F  E  I+    H N+++  G V  + P+M+V E    G L
Sbjct: 26  VAVKCLKSD--KLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH-PLMMVTELAPLGSL 82

Query: 273 ASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
              L+K   G    S +  +A+ +A GM YL   +    IH DL  +NILL +  ++KI 
Sbjct: 83  LDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIG 139

Query: 331 GFGLLRL------QYISPEKAKIVFP 350
            FGL+R        Y+  E  K+ F 
Sbjct: 140 DFGLMRALPQNEDHYVMEEHLKVPFA 165

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 47/117 (40%), Positives = 62/117 (52%), Gaps = 16/117 (13%)

Query: 235 ELTIVEKARHPNVVQF----VGAVTQNIPMMIVLEY--HAKGDLASYL-QKKGRLSPSKV 287
           E+ I+ K +HPN+V      VG+    I M  V+EY  H   DL S +   K     S+V
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYM--VMEYVEH---DLKSLMETMKQPFLQSEV 108

Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
               L L  G+ +LH+     I+H DLK  N+LL+N G LKI  FGL R +Y SP K
Sbjct: 109 KCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLK 161

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 26/163 (15%)

Query: 191 QVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ 249
           QV KA+ +      +   N T  V VK+L K+   + +  +  +    +    +H N++ 
Sbjct: 27  QVVKAEAVG-----LDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIIN 80

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALD 293
            +G  TQ  P+ +V+EY A G+L  +L+ +                  L+   ++ FA  
Sbjct: 81  LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ 140

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           +ARGM +L   K    IH DL  +N+L+     +KI+ FGL R
Sbjct: 141 VARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 74.1 bits (182), Expect = 4e-15
 Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 7/126 (5%)

Query: 215 VKILDKESHKDPER----INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V++    + +   R    + A   E+  ++   H N+VQ++G  T    + I LEY   G
Sbjct: 34  VELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGG 93

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
            + S L+  GR     V  F   +  G+ YLH      I+H DLK  N+L+D  G  KIS
Sbjct: 94  SIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKIS 150

Query: 331 GFGLLR 336
            FG+ +
Sbjct: 151 DFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 37/132 (28%), Positives = 58/132 (43%), Gaps = 23/132 (17%)

Query: 235 ELTIVEKARHPNVVQFVG--AVTQNIPMMIVLEYHAKGDLASYLQK----KGRLSPSKVL 288
           E+ I+ + +HPN+V++        N  + IV+EY   GDLA  +QK    +  +    + 
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 289 RFALDLARGMNYLHECKPDP--IIHCDLKPKNILLDNGGQLKISGFGLLRL--------- 337
           R    L   +   H        ++H DLKP NI LD    +K+  FGL ++         
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 338 ------QYISPE 343
                  Y+SPE
Sbjct: 169 TYVGTPYYMSPE 180

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.5 bits (180), Expect = 5e-15
 Identities = 41/112 (36%), Positives = 62/112 (55%), Gaps = 4/112 (3%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSP 284
           P+    F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  ++L+ +G RL  
Sbjct: 34  PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV 93

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            ++++   + A GM YL E K    IH DL  +N L+     LKIS FG+ R
Sbjct: 94  KELIQMVENAAAGMEYL-ESK--HCIHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 73.6 bits (181), Expect = 5e-15
 Identities = 39/135 (28%), Positives = 66/135 (48%), Gaps = 9/135 (6%)

Query: 206 AKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
             W    +V +KIL  +   D  +   F  E+  +++ RH +++      +   P+ I+ 
Sbjct: 25  GLWKNRVRVAIKILKSD---DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81

Query: 265 EYHAKGDLASYLQK-KGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           E   KG L ++L+  +G+ L  + ++  A  +A GM YL E      IH DL  +NIL+ 
Sbjct: 82  ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVG 138

Query: 323 NGGQLKISGFGLLRL 337
                K++ FGL RL
Sbjct: 139 EDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 60/163 (36%), Positives = 84/163 (51%), Gaps = 17/163 (10%)

Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  WNG TKV VK L K     PE   +F  E  I++K RH  +VQ    V++  P
Sbjct: 20  GEVWMGTWNGNTKVAVKTL-KPGTMSPE---SFLEEAQIMKKLRHDKLVQLYAVVSEE-P 74

Query: 260 MMIVLEYHAKGDLASYLQK-KGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + IV EY +KG L  +L+  +GR L    ++  A  +A GM Y+        IH DL+  
Sbjct: 75  IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSA 131

Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +G   KI+ FGL RL    +Y + + AK  FP+    P
Sbjct: 132 NILVGDGLVCKIADFGLARLIEDNEYTARQGAK--FPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 22/149 (14%)

Query: 198 ITKGSYQVAKWNGTKVWV------------KILDKESHKDPERINAFTHELTIVEKARHP 245
           I KG++        KV +            K ++K+   +   +    +E  I+++  HP
Sbjct: 8   IGKGAF-------GKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK 305
            +V    +      M +V++    GDL  +L +K + S  +V  +  ++   + YLH   
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGL 334
              IIH D+KP NILLD  G + I+ F +
Sbjct: 121 ---IIHRDIKPDNILLDEQGHVHITDFNI 146

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 40/106 (37%), Positives = 60/106 (56%), Gaps = 11/106 (10%)

Query: 239 VEKARHPNVVQF--VGAVTQN---IPMMIVLEYHAKGDLASYLQK--KGRLSPSKVLRFA 291
           +E   HPN+V+   V    +    + + +V E H   DLA+YL K  K  L P  +    
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFE-HVDQDLATYLSKCPKPGLPPETIKDLM 113

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
             L RG+++LH  +   I+H DLKP+NIL+ + GQ+KI+ FGL R+
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 72.7 bits (178), Expect = 1e-14
 Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 15/154 (9%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N TKV VK L   +      + AF  E  +++  +H  +V+    VT+  P+ I+ EY A
Sbjct: 29  NSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84

Query: 269 KGDLASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           KG L  +L   + G++   K++ F+  +A GM Y+        IH DL+  N+L+     
Sbjct: 85  KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLM 141

Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
            KI+ FGL R+    +Y + E AK  FP+    P
Sbjct: 142 CKIADFGLARVIEDNEYTAREGAK--FPIKWTAP 173

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 42/128 (32%), Positives = 65/128 (50%), Gaps = 5/128 (3%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +  G  + VK +  E   +         EL I+ K   P +V F GA   N  + I +EY
Sbjct: 23  RPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80

Query: 267 HAKGDLASYLQKKGRLSPSKVL-RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              G L   L++     P ++L + A+ + +G+ YLHE     IIH D+KP NIL+++ G
Sbjct: 81  MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRG 138

Query: 326 QLKISGFG 333
           Q+K+  FG
Sbjct: 139 QIKLCDFG 146

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 46/158 (29%), Positives = 81/158 (51%), Gaps = 8/158 (5%)

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVW--VKILDKESHKDPERINAFTHEL 236
           +   ++L+  E+      G + G  ++AK  GT  +  +K L K      +++     E 
Sbjct: 11  DTSSWKLSDFEMGETLGTG-SFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEK 69

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLA 295
           +I+ +  HP +V  + +      +  +LE+   G+L ++L+K GR  P+ V +F   +L 
Sbjct: 70  SILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRF-PNDVAKFYHAELV 128

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
               YLH      II+ DLKP+N+LLDN G +K++ FG
Sbjct: 129 LAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFG 163

Length = 329

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 71.3 bits (175), Expect = 3e-14
 Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 13/147 (8%)

Query: 200 KGS----YQVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           KGS    Y+V + +  + + +K +D  S    ER +A  +E+ I+    HPN++ +  A 
Sbjct: 10  KGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKEAF 68

Query: 255 TQNIPMMIVLEYHAKGDLASYL---QKKGRLSPSK-VLRFALDLARGMNYLHECKPDPII 310
                + IV+EY   GDL+  +   +KK +L P + + R  + L RG+  LHE K   I+
Sbjct: 69  LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---IL 125

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRL 337
           H DLK  NILL     +KI   G+ ++
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKV 152

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 49/147 (33%), Positives = 73/147 (49%), Gaps = 14/147 (9%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV------TQNIP--M 260
            G  V +K +   + KD   I A   E+ I++K +HPNVV  +         ++     +
Sbjct: 32  TGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90

Query: 261 MIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
            +V  Y    DL+  L+    +L+ S++  + L L  G+NYLHE     I+H D+K  NI
Sbjct: 91  YMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANI 146

Query: 320 LLDNGGQLKISGFGLLRLQYISPEKAK 346
           L+DN G LKI+ FGL R     P   K
Sbjct: 147 LIDNQGILKIADFGLARPYDGPPPNPK 173

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 9/145 (6%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G Y   +     V VK     +   P     F  E  I+ +  HP++V+ +G +T+N P
Sbjct: 24  QGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P 80

Query: 260 MMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           + IV+E    G+L SYLQ  K  L  + ++ ++  L+  + YL   +    +H D+  +N
Sbjct: 81  VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARN 137

Query: 319 ILLDNGGQLKISGFGLLRLQYISPE 343
           +L+ +   +K+  FGL R  Y+  E
Sbjct: 138 VLVSSPDCVKLGDFGLSR--YLEDE 160

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 70.9 bits (173), Expect = 5e-14
 Identities = 59/185 (31%), Positives = 89/185 (48%), Gaps = 21/185 (11%)

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELT 237
           E+P      L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  
Sbjct: 2   EIPR---ESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQ 53

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFALDLA 295
           +++K RH  +VQ    V++  P+ IV EY +KG L  +L  +    L   +++  A  +A
Sbjct: 54  VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
            GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+
Sbjct: 113 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPI 167

Query: 352 SHIDP 356
               P
Sbjct: 168 KWTAP 172

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 71.1 bits (174), Expect = 5e-14
 Identities = 45/134 (33%), Positives = 75/134 (55%), Gaps = 6/134 (4%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K L K  + + +R + F  E +I+ +  HPN++   G VT++ P+MIV EY   G L
Sbjct: 35  VAIKTL-KAGYTEKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL 92

Query: 273 ASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
            ++L+K  G+ +  +++     +A GM YL +      +H DL  +NIL+++    K+S 
Sbjct: 93  DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSD 149

Query: 332 FGLLRLQYISPEKA 345
           FGL R+    PE A
Sbjct: 150 FGLSRVLEDDPEAA 163

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 9/152 (5%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVE-KARHPNVVQFV 251
           I+KG++        +  G    +K+L K       ++     E  I+  +   P V +  
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +      + +V+EY   GD AS ++  G L      ++  ++  G+  LH+     IIH
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIH 120

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPE 343
            D+KP+N+L+D  G LK++ FGL R    + +
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 6e-14
 Identities = 36/123 (29%), Positives = 65/123 (52%), Gaps = 4/123 (3%)

Query: 219 DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
           D +S +  + +NA   E+ +++  +H  +VQ+ G +  +  + I +EY   G +   L+ 
Sbjct: 38  DPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA 97

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL-RL 337
            G L+ +   ++   +  G+ YLH    + I+H D+K  NIL D+ G +K+  FG   RL
Sbjct: 98  YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154

Query: 338 QYI 340
           Q I
Sbjct: 155 QTI 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 70.7 bits (173), Expect = 7e-14
 Identities = 32/100 (32%), Positives = 61/100 (61%), Gaps = 4/100 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ ++ +  HP++++ +GA  ++    + +E+ A G ++  L K G    + ++ +   L
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-LKISGFG 333
            RG++YLHE   + IIH D+K  N+L+D+ GQ L+I+ FG
Sbjct: 113 LRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFG 149

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 41/119 (34%), Positives = 59/119 (49%), Gaps = 15/119 (12%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--------LS 283
           F  E  I+ K  H N+V+ +G   + +P  I+LE  A GDL S+L ++ R        L+
Sbjct: 56  FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLT 114

Query: 284 PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A+G  YL E      IH D+  +N LL   G     KI+ FG+ R  Y
Sbjct: 115 MKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY 170

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 70.3 bits (172), Expect = 8e-14
 Identities = 43/140 (30%), Positives = 74/140 (52%), Gaps = 6/140 (4%)

Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G  ++       V +K L K  + + +R   F  E +I+ +  HPN++   G VT++
Sbjct: 20  VCRGRLKLPGKREIFVAIKTL-KSGYTEKQR-RDFLSEASIMGQFDHPNIIHLEGVVTKS 77

Query: 258 IPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            P+MI+ E+   G L S+L Q  G+ +  +++     +A GM YL E      +H DL  
Sbjct: 78  RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAA 134

Query: 317 KNILLDNGGQLKISGFGLLR 336
           +NIL+++    K+S FGL R
Sbjct: 135 RNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 36/105 (34%), Positives = 54/105 (51%), Gaps = 9/105 (8%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMI--VLEYHAKGDLAS----YLQKKGRLSPSKVL 288
           EL I +  + P +V++ GA        I   +EY   G L S      ++ GR+    + 
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           + A  + +G++YLH  K   IIH D+KP NILL   GQ+K+  FG
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 40/122 (32%), Positives = 68/122 (55%), Gaps = 9/122 (7%)

Query: 220 KESHKDPERINAFT--HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           KE H D E     T   E++++++ +H N+V+    +     +M+V EY    DL  Y+ 
Sbjct: 31  KEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY-MDKDLKKYMD 89

Query: 278 ---KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
               +G L P+ V  F   L +G+ + HE +   ++H DLKP+N+L++  G+LK++ FGL
Sbjct: 90  THGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGL 146

Query: 335 LR 336
            R
Sbjct: 147 AR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 21/149 (14%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
            V +K +  E     ER  A  +E  +++   HPN++++     ++  +MIV+EY   G 
Sbjct: 27  LVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85

Query: 272 LASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-LK 328
           LA Y+QK+    L    +L F + +   ++++H      I+H DLK +NILLD     +K
Sbjct: 86  LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVK 142

Query: 329 ISGFGLLRL--------------QYISPE 343
           I  FG+ ++               YISPE
Sbjct: 143 IGDFGISKILSSKSKAYTVVGTPCYISPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.2 bits (169), Expect = 2e-13
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 6/147 (4%)

Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G  ++       V +K L K  + + +R   F  E +I+ +  H N+++  G VT+ 
Sbjct: 21  VFRGILKMPGRKEVAVAIKTL-KPGYTEKQR-QDFLSEASIMGQFSHHNIIRLEGVVTKF 78

Query: 258 IPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            P MI+ EY   G L  YL+   G  S  +++     +A GM YL +      +H DL  
Sbjct: 79  KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAA 135

Query: 317 KNILLDNGGQLKISGFGLLRLQYISPE 343
           +NIL+++  + K+S FGL R+    PE
Sbjct: 136 RNILVNSNLECKVSDFGLSRVLEDDPE 162

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 33/126 (26%), Positives = 66/126 (52%), Gaps = 7/126 (5%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K+L +E+   P+       E  ++    HP+VV+ +G +  +  + ++ +    G L
Sbjct: 39  VAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLGCL 95

Query: 273 ASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             Y+   K  +    +L + + +A+GM+YL E +   ++H DL  +N+L+     +KI+ 
Sbjct: 96  LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITD 152

Query: 332 FGLLRL 337
           FGL +L
Sbjct: 153 FGLAKL 158

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 34/109 (31%), Positives = 61/109 (55%), Gaps = 6/109 (5%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALD 293
           E+ ++++ +HPN++  +        + +V E+  + DL   ++ K   L+P+ +  + L 
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEF-METDLEKVIKDKSIVLTPADIKSYMLM 110

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP 342
             RG+ YLH      I+H DLKP N+L+ + G LK++ FGL R  + SP
Sbjct: 111 TLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR-SFGSP 155

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 68.2 bits (166), Expect = 4e-13
 Identities = 62/185 (33%), Positives = 90/185 (48%), Gaps = 21/185 (11%)

Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELT 237
           E+P      L L V+   G   G   +  WNGT KV +K L K     PE   AF  E  
Sbjct: 2   EIPR---ESLRLDVKLGQGCF-GEVWMGTWNGTTKVAIKTL-KPGTMMPE---AFLQEAQ 53

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGR-LSPSKVLRFALDLA 295
           I++K RH  +V     V++  P+ IV E+  KG L  +L++  G+ L   +++  A  +A
Sbjct: 54  IMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
            GM Y+        IH DL+  NIL+ +    KI+ FGL RL    +Y + + AK  FP+
Sbjct: 113 DGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK--FPI 167

Query: 352 SHIDP 356
               P
Sbjct: 168 KWTAP 172

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 39/139 (28%), Positives = 68/139 (48%), Gaps = 17/139 (12%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK+L  +  K     N F  E+ I+ + ++PN+++ +G    + P+ ++ EY   GDL
Sbjct: 47  VAVKMLRADVTKTAR--NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104

Query: 273 ASYLQKKG------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
             +L ++              +S + +L  A+ +A GM YL        +H DL  +N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161

Query: 321 LDNGGQLKISGFGLLRLQY 339
           + N   +KI+ FG+ R  Y
Sbjct: 162 VGNHYTIKIADFGMSRNLY 180

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 16/149 (10%)

Query: 200 KGSYQ-----VAKWNGTKVWVKILDKESHKDPERINAFT--HELTIVEKARHPNVVQFVG 252
           +GSY      +++ NG  V +K++        E    FT   E ++++  +H N+V    
Sbjct: 15  EGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 253 AVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +     +  V EY    DLA Y+ Q  G L P  V  F   L RG+ Y+H      I+H
Sbjct: 71  IIHTKETLTFVFEY-MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILH 126

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYI 340
            DLKP+N+L+   G+LK++ FGL R + I
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLARAKSI 155

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 63.9 bits (156), Expect = 1e-12
 Identities = 36/83 (43%), Positives = 50/83 (60%), Gaps = 9/83 (10%)

Query: 99  NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYN 155
           N+ D DGRT LH+AA  GH+EVVKLLL   A+++A+D  G T    AA     G++E+  
Sbjct: 1   NARDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAA---KNGHLEIVK 57

Query: 156 ILKARGAKVP---KTKRTPMTVA 175
           +L  +GA V    K   TP+ +A
Sbjct: 58  LLLEKGADVNARDKDGNTPLHLA 80

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 46/151 (30%), Positives = 67/151 (44%), Gaps = 27/151 (17%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L +E+  D +    F  E  ++ +  HPN+V+ +G      PM ++ EY A G
Sbjct: 36  TMVAVKMLKEEASADMQ--ADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYG 93

Query: 271 DLASYL----------------------QKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
           DL  +L                           LS ++ L  A  +A GM YL E K   
Sbjct: 94  DLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--- 150

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
            +H DL  +N L+     +KI+ FGL R  Y
Sbjct: 151 FVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 31/103 (30%), Positives = 56/103 (54%), Gaps = 5/103 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E+ ++++ +H N+V+    +  +  + +V EY    DL  Y     G + P  V  F   
Sbjct: 49  EICLLKELKHKNIVRLYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQ 107

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L +G+ + H      ++H DLKP+N+L++  G+LK++ FGL R
Sbjct: 108 LLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 47/149 (31%), Positives = 68/149 (45%), Gaps = 23/149 (15%)

Query: 198 ITKGSY-QV----AKWNGTKVWVKILDKESHKDPERINAFTHELTI-VEK------ARHP 245
           I +GS+  V     K    +  +KILDK       ++        + +EK        HP
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR------QLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHEC 304
            +++          +  VLEY   G+L  Y++K G L   K  RF A ++   + YLH  
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFYAAEILLALEYLHSK 121

Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFG 333
               IIH DLKP+NILLD    +KI+ FG
Sbjct: 122 G---IIHRDLKPENILLDKDMHIKITDFG 147

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 48/155 (30%), Positives = 80/155 (51%), Gaps = 16/155 (10%)

Query: 194 KADGITKGSYQV-----AKWNGTKVWVKILDKESHKDPERINAFT--HELTIVEKARHPN 246
           K + + +GSY       +K NG  V +K++  +     E    FT   E ++++  +H N
Sbjct: 9   KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE----EEGTPFTAIREASLLKGLKHAN 64

Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECK 305
           +V     +     + +V EY    DL  Y+ K  G L P  V  F   L RG++Y+H+  
Sbjct: 65  IVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ-- 121

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI 340
              I+H DLKP+N+L+ + G+LK++ FGL R + +
Sbjct: 122 -RYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 45/143 (31%), Positives = 74/143 (51%), Gaps = 22/143 (15%)

Query: 211 TKVWVKILDKE-SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  + + KD   + +    + ++ K  H N++  +GA TQ+ P+ +++EY +K
Sbjct: 51  TKVAVKMLKSDATEKDLSDLISEMEMMKMIGK--HKNIINLLGACTQDGPLYVIVEYASK 108

Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YL+ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRD 165

Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +N+L+     +KI+ FGL R
Sbjct: 166 LAARNVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 5/105 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+  ++  +HP VV+ +         ++V+EY    DL+  L+ + R L  ++V  +   
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM 107

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           L +G+ Y+H      I+H DLKP N+L+   G LKI+ FGL RL 
Sbjct: 108 LLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLF 149

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 17/156 (10%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
            +V VK L   +   P+    F  E+    +  HPNV+Q +G   ++IP ++VLE+   G
Sbjct: 23  ARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80

Query: 271 DLASYLQK-----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
           DL +YL+              + R A ++A G+ +LH+      IH DL  +N  L    
Sbjct: 81  DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADL 137

Query: 326 QLKISGFGLLRLQYISPE-----KAKIVFPVSHIDP 356
            +KI  +GL   QY  PE     K     P+  + P
Sbjct: 138 SVKIGDYGLALEQY--PEDYYITKDCHAVPLRWLAP 171

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 59/169 (34%), Positives = 87/169 (51%), Gaps = 26/169 (15%)

Query: 178 REVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAF 232
           R V E+E         K + I +G+Y +        +G  V +K +  ++ +D   I++ 
Sbjct: 4   RSVTEFE---------KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSL 54

Query: 233 THELTIVEKARHPNVVQF----VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKV 287
             E+T++   RHPN+V+     VG    +I   +V+EY  + DLAS L       S S+V
Sbjct: 55  -REITLLLNLRHPNIVELKEVVVGKHLDSI--FLVMEY-CEQDLASLLDNMPTPFSESQV 110

Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
               L L RG+ YLHE   + IIH DLK  N+LL + G LKI+ FGL R
Sbjct: 111 KCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 49/145 (33%), Positives = 73/145 (50%), Gaps = 18/145 (12%)

Query: 198 ITKGSY-QVAKW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I  G+Y  V K      G  V +K++  E   D E I     E++++++ RHPN+V + G
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRHPNIVAYFG 67

Query: 253 AVTQNIPMMIVLEYHAKGDLAS-YLQKKGRLSPSK---VLRFALDLARGMNYLHECKPDP 308
           +  +   + IV+EY   G L   Y   +G LS  +   V R  L   +G+ YLHE     
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---KGLAYLHETG--- 121

Query: 309 IIHCDLKPKNILLDNGGQLKISGFG 333
            IH D+K  NILL   G +K++ FG
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFG 146

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 23/162 (14%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           V I   +   +P++   F  E +++ +  HPN+V  +G VTQ  P+ ++ EY  +GDL  
Sbjct: 37  VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHE 96

Query: 275 YL-----------------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           +L                   K  L     L  A+ +A GM YL        +H DL  +
Sbjct: 97  FLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAAR 153

Query: 318 NILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPVSHIDP 356
           NIL+     +KIS  GL R  Y +     + K + P+  + P
Sbjct: 154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 65.5 bits (160), Expect = 4e-12
 Identities = 44/145 (30%), Positives = 66/145 (45%), Gaps = 27/145 (18%)

Query: 213 VWVKIL----DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           V VK L      ++ KD ER      E  ++   +H N+V+F G  T+  P ++V EY  
Sbjct: 38  VAVKTLKETASNDARKDFER------EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYME 91

Query: 269 KGDLASYL--------------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
            GDL  +L                 G L+ S++L+ A+ +A GM YL        +H DL
Sbjct: 92  HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDL 148

Query: 315 KPKNILLDNGGQLKISGFGLLRLQY 339
             +N L+     +KI  FG+ R  Y
Sbjct: 149 ATRNCLVGYDLVVKIGDFGMSRDVY 173

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 42/171 (24%), Positives = 80/171 (46%), Gaps = 27/171 (15%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG + V        +G  V +K +      D +       E+ ++++  HPNV++++ 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 253 AVTQNIPMMIVLEYHAKGDLA---SYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDP 308
           +  +N  + IVLE    GDL+    + +K+ RL P + + ++ + L   + ++H  +   
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--- 126

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRL---------------QYISPEK 344
           I+H D+KP N+ +   G +K+   GL R                 Y+SPE+
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 14/138 (10%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK L  +  KD    + F  EL +  K  H NVV+ +G   +  P  ++LEY   G
Sbjct: 36  TLVLVKAL--QKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLG 93

Query: 271 DLASYLQ---------KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           DL  +L+         K   LS  + +     +A GM++L   +    +H DL  +N L+
Sbjct: 94  DLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLV 150

Query: 322 DNGGQLKISGFGLLRLQY 339
            +  ++K+S   L +  Y
Sbjct: 151 SSQREVKVSLLSLSKDVY 168

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 43/131 (32%), Positives = 69/131 (52%), Gaps = 9/131 (6%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYH 267
           G  V VK   K  H   E +  F  E+ I++  +H N+V++  V        + +V+EY 
Sbjct: 33  GEVVAVK---KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89

Query: 268 AKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             G L  YLQK + RL   K+L +A  + +GM YL   +    +H DL  +NIL+++  +
Sbjct: 90  PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENR 146

Query: 327 LKISGFGLLRL 337
           +KI  FGL ++
Sbjct: 147 VKIGDFGLTKV 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 29/109 (26%), Positives = 56/109 (51%), Gaps = 5/109 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+ ++++  HPN+++ +        + +V E+    DL   ++ + R L  S +  +   
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF-MDTDLYKLIKDRQRGLPESLIKSYLYQ 106

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP 342
           L +G+ + H      I+H DLKP+N+L++  G LK++ FGL R      
Sbjct: 107 LLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 42/143 (29%), Positives = 63/143 (44%), Gaps = 7/143 (4%)

Query: 198 ITKGSYQV---AKWNGTKVWVKILD-KESHKDPERINAFTHELTIVEKARHPNVVQFVGA 253
           + +G+Y V    +   T   V I   KES  D +       E+ ++ + RH N+V    A
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
             +   + +V EY  +  L       G L P  V  +   L + + Y H      IIH D
Sbjct: 69  FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRD 125

Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           +KP+NIL+   G LK+  FG  R
Sbjct: 126 IKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 11/141 (7%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KGS+        K     V +K++D E  +D   I     E+  + + R P + ++ G
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSPYITKYYG 66

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           +  +   + I++EY   G     L K G+L  + +     ++  G+ YLHE   +  IH 
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHE---EGKIHR 122

Query: 313 DLKPKNILLDNGGQLKISGFG 333
           D+K  NILL   G +K++ FG
Sbjct: 123 DIKAANILLSEEGDVKLADFG 143

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 19/148 (12%)

Query: 198 ITKGSYQ---VAKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEK------ARHPN 246
           + KGS+    +A+  GT     VK+L K+     + +     E T+ EK       +HP 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV-----ECTMTEKRVLALAGKHPF 57

Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + Q          +  V+EY   GDL  ++Q+ GR    +   +A ++  G+ +LHE   
Sbjct: 58  LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG- 116

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             II+ DLK  N+LLD+ G +KI+ FG+
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 39/111 (35%), Positives = 62/111 (55%), Gaps = 6/111 (5%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL-SPSKVLRFALD 293
           E+++++  +H N+V     +     + +V EY    DL  YL   G L S   V  F   
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEY-LDSDLKQYLDNCGNLMSMHNVKIFMFQ 111

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
           L RG++Y H+ K   I+H DLKP+N+L++  G+LK++ FGL R + + P K
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTK 158

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E ++++  +H N+V     +     + +V EY    DL  Y+   G  LS   V  F   
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L RG+ Y H+ +   ++H DLKP+N+L+   G+LK++ FGL R
Sbjct: 112 LLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 22/154 (14%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K+L + + ++  R   F  EL ++ K   HPN++  +GA      + I +EY   G+L 
Sbjct: 34  IKMLKEFASENDHR--DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLL 91

Query: 274 SYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            +L+K                   L+  ++L+FA D+A GM YL E +    IH DL  +
Sbjct: 92  DFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAAR 148

Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
           N+L+      KI+ FGL R + +  +K     PV
Sbjct: 149 NVLVGENLASKIADFGLSRGEEVYVKKTMGRLPV 182

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 47/149 (31%), Positives = 71/149 (47%), Gaps = 26/149 (17%)

Query: 220 KESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
           K+ H+D      F  EL ++ K   HPN++  +GA      + + +EY   G+L  +L+K
Sbjct: 48  KDDHRD------FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 101

Query: 279 K----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
                              LS  ++L FA D+ARGM+YL + +    IH DL  +NIL+ 
Sbjct: 102 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVG 158

Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPV 351
                KI+ FGL R Q +  +K     PV
Sbjct: 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPV 187

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat

 Score = 57.2 bits (139), Expect = 3e-11
 Identities = 20/33 (60%), Positives = 26/33 (78%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
           DG T LH+AA  GH+EVVKLLL   A+++ARD+
Sbjct: 1   DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 62.8 bits (152), Expect = 3e-11
 Identities = 38/126 (30%), Positives = 65/126 (51%), Gaps = 6/126 (4%)

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMIVLEYHAKGDLASY 275
            D ES +  + ++A   E+ +++  +H  +VQ+ G +       + I +EY   G +   
Sbjct: 37  FDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ 96

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL- 334
           L+  G L+ S   ++   +  GM+YLH    + I+H D+K  NIL D+ G +K+  FG  
Sbjct: 97  LKAYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153

Query: 335 LRLQYI 340
            RLQ I
Sbjct: 154 KRLQTI 159

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 11/106 (10%)

Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E   HPNVV+     T     +   + +V E H   DL +YL K     +    +    
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMM 116

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
             L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R+
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 62.3 bits (152), Expect = 4e-11
 Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 14/105 (13%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG---DLASYLQKKGRLSP---SKVL 288
           E++I+++   P +V++ G+  +N  + IV+EY   G   D+     K   L+    + +L
Sbjct: 48  EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAIL 105

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
              L   +G+ YLH  K    IH D+K  NILL+  GQ K++ FG
Sbjct: 106 YQTL---KGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFG 144

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 34/105 (32%), Positives = 61/105 (58%), Gaps = 5/105 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSK-VLRFAL 292
           E  ++ K +HPN+V F  +   +  + IV+EY   GDL   +  ++G+L P   +L++ +
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
            +  G+ ++HE +   ++H D+K KNI L   G++K+  FG  RL
Sbjct: 108 QMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 10/158 (6%)

Query: 198 ITKGSYQ---VAKWNGTKVW--VKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFV 251
           I KGS+    +AK      +  VK+L K++  K  E+ +       +++  +HP +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +      +  VL+Y   G+L  +LQ++      +   +A ++A  + YLH      II+
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIY 119

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            DLKP+NILLD+ G + ++ FGL + + I   K    F
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTF 156

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 43/137 (31%), Positives = 67/137 (48%), Gaps = 18/137 (13%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIP------MM 261
            G  V +KI+D       +       E  I+ K + HPN+  F GA  +  P      + 
Sbjct: 30  TGQLVAIKIMDI----IEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85

Query: 262 IVLEYHAKG---DLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPK 317
           +V+E    G   DL   L+KKG+    + + + L +  RG+ YLHE K   +IH D+K +
Sbjct: 86  LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQ 142

Query: 318 NILLDNGGQLKISGFGL 334
           NILL    ++K+  FG+
Sbjct: 143 NILLTKNAEVKLVDFGV 159

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 62.0 bits (150), Expect = 5e-11
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 22/154 (14%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K + + + KD  R   F  EL ++ K   HPN++  +GA      + + +EY   G+L 
Sbjct: 27  IKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 84

Query: 274 SYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            +L+K                   LS  ++L FA D+ARGM+YL + +    IH DL  +
Sbjct: 85  DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAAR 141

Query: 318 NILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
           NIL+      KI+ FGL R Q +  +K     PV
Sbjct: 142 NILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 175

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 61.8 bits (150), Expect = 5e-11
 Identities = 40/147 (27%), Positives = 65/147 (44%), Gaps = 11/147 (7%)

Query: 198 ITKGSY-----QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KGS+      V K +     +K +D       ER      E  ++ K     ++++  
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER-EEAIDEARVLAKLDSSYIIRYYE 66

Query: 253 AVTQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
           +      + IV+EY   GDL   L  Q+   L   +V RF + +  G+ +LH  K   I+
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---IL 123

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRL 337
           H D+K  N+ LD    +KI   G+ +L
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKL 150

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 39/107 (36%), Positives = 53/107 (49%), Gaps = 4/107 (3%)

Query: 53  DPIRRSPVQDEL--TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALH 110
            P      ++ +   V   L  T++L  +A  GD  G   LL  G+D N  D DGRT LH
Sbjct: 63  TPDHNLTTEEVIDPVVAHML--TVELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLH 120

Query: 111 IAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
           IA   GHV+VV++LL   A+    D+ G T    A+  G  EV  +L
Sbjct: 121 IACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREVVQLL 167

Length = 664

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 33/99 (33%), Positives = 57/99 (57%), Gaps = 3/99 (3%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E  ++++  HP +++          + +++EY   G+L SYL+  GR S S  L +A ++
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
              + YLH  +   I++ DLKP+NILLD  G +K++ FG
Sbjct: 111 VCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFG 146

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 38/130 (29%), Positives = 71/130 (54%), Gaps = 8/130 (6%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMIVLEYH 267
           G +V VK L  ES      I     E+ I+    H N+V++ G  T++    + +++E+ 
Sbjct: 33  GEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 268 AKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             G L  YL + K +++  + L++A+ + +GM+YL   +    +H DL  +N+L+++  Q
Sbjct: 91  PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147

Query: 327 LKISGFGLLR 336
           +KI  FGL +
Sbjct: 148 VKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 39/111 (35%), Positives = 61/111 (54%), Gaps = 6/111 (5%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL-SPSKVLRFALD 293
           E+++++  +H N+V     +     + +V EY  K DL  YL   G   +   V  F   
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
           L RG+NY H  K   ++H DLKP+N+L++  G+LK++ FGL R + I P K
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI-PTK 159

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 61.4 bits (149), Expect = 8e-11
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 17/142 (11%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +V VK L K +  D E+   F  E  ++    HPN+V+ +G    N P  I++E    GD
Sbjct: 28  RVAVKTLRKGA-TDQEKKE-FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGD 85

Query: 272 LASYLQKKGR-------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           L SYL+           L+  ++L   LD+A+G  YL +      IH DL  +N L+   
Sbjct: 86  LLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEK 142

Query: 325 GQ-----LKISGFGLLRLQYIS 341
           G      +KI  FGL R  Y S
Sbjct: 143 GYDADRVVKIGDFGLARDIYKS 164

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 2/92 (2%)

Query: 68  ENLDSTM--QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
           E+ D  M   LL +A  G+   +E+LL    D +  D  GRT LHIAA +G+ + V +LL
Sbjct: 519 EHDDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLL 578

Query: 126 SKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
               N+  RD  G+TA  +A    + +++ IL
Sbjct: 579 KHACNVHIRDANGNTALWNAISAKHHKIFRIL 610

Length = 823

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.9 bits (150), Expect = 8e-11
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 10/158 (6%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFV 251
           I KGS+        K +G+   VK+L K++  K  E+ +       +++  +HP +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +      +  VL+Y   G+L  +LQ++      +   +A ++A  + YLH      II+
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIY 119

Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
            DLKP+NILLD+ G + ++ FGL + + + PE+    F
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTF 156

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 36/109 (33%), Positives = 60/109 (55%), Gaps = 4/109 (3%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS 285
           P   N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+ P 
Sbjct: 40  PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI-PE 98

Query: 286 KVL-RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            +L + ++ + RG+ YL E     I+H D+KP NIL+++ G++K+  FG
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFG 145

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 43/142 (30%), Positives = 72/142 (50%), Gaps = 24/142 (16%)

Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 50  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 106

Query: 271 DLASYLQKKGRLS----------PSKVLRF------ALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +              P + + F         +ARGM YL   K    IH DL
Sbjct: 107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDL 163

Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 164 AARNVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 31/104 (29%), Positives = 56/104 (53%), Gaps = 6/104 (5%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS--PSKVLRFAL 292
           E++++++  HPN+V+ +  V     + +V E+    DL  Y+         P  +  +  
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            L +G+ Y H  +   ++H DLKP+N+L+D  G LK++ FGL R
Sbjct: 107 QLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 33/142 (23%)

Query: 223 HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-ASYLQKKGR 281
           H+D  R      E+ I+    HPNVV+       N  + ++LE+   G L  +++  +  
Sbjct: 111 HEDTVR-RQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF 169

Query: 282 LSPSKVLRFALDLAR----GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR- 336
           L+         D+AR    G+ YLH      I+H D+KP N+L+++   +KI+ FG+ R 
Sbjct: 170 LA---------DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRI 217

Query: 337 --------------LQYISPEK 344
                         + Y+SPE+
Sbjct: 218 LAQTMDPCNSSVGTIAYMSPER 239

Length = 353

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 42/129 (32%), Positives = 68/129 (52%), Gaps = 8/129 (6%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYH 267
           G  V VK L +E     +  + +  E+ I++   H N+V++ G  ++     + +++EY 
Sbjct: 33  GEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90

Query: 268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
             G L  YL K  +L+ +++L FA  +  GM YLH       IH DL  +N+LLDN   +
Sbjct: 91  PLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146

Query: 328 KISGFGLLR 336
           KI  FGL +
Sbjct: 147 KIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 26/164 (15%)

Query: 191 QVRKADGITKGSYQVAKWNGTKVWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVV 248
           QV  A+ I     +  K     V VK+L D  + KD   ++    E+ +++   +H N++
Sbjct: 27  QVVMAEAIGIDKDKPNK--PVTVAVKMLKDDATDKD---LSDLVSEMEMMKMIGKHKNII 81

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFAL 292
             +GA TQ+ P+ +++EY +KG+L  YL+ +                 +L+   ++  A 
Sbjct: 82  NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAY 141

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +ARGM YL   K    IH DL  +N+L+     +KI+ FGL R
Sbjct: 142 QVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.9 bits (147), Expect = 1e-10
 Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 12/154 (7%)

Query: 186 NPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIVE 240
           +P EL   K + I KGS+ +V K   N T+  V +KI+D E  +D   I     E+T++ 
Sbjct: 1   DPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLS 57

Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNY 300
           +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     ++ +G++Y
Sbjct: 58  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDY 116

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           LH  K    IH D+K  N+LL   G++K++ FG+
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 147

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 60.7 bits (147), Expect = 1e-10
 Identities = 42/127 (33%), Positives = 64/127 (50%), Gaps = 8/127 (6%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +  L +    D +R   F  E   + +  H N+V+  G +T+   MMIV EY + G L
Sbjct: 36  VAIHTL-RAGCSDKQRR-GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL 93

Query: 273 ASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
            S+L+K +G+L   +++     LA GM YL E      +H  L    +L+++    KISG
Sbjct: 94  DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISG 150

Query: 332 FGLLRLQ 338
           F   RLQ
Sbjct: 151 FR--RLQ 155

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 17/163 (10%)

Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +A +N  TKV VK +   S      + AF  E  +++  +H  +V+    VT+  P
Sbjct: 20  GEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVTKE-P 74

Query: 260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ E+ AKG L  +L+     +    K++ F+  +A GM ++ +      IH DL+  
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAA 131

Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+      KI+ FGL R+    +Y + E AK  FP+    P
Sbjct: 132 NILVSASLVCKIADFGLARVIEDNEYTAREGAK--FPIKWTAP 172

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 34/122 (27%), Positives = 61/122 (50%), Gaps = 7/122 (5%)

Query: 220 KESHKDPERINAFTHELTIV-EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-- 276
           K+  +  + I     E+TI+ E+ RHPN+V++     +N  + IV++      L  +   
Sbjct: 43  KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102

Query: 277 --QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
             +KK R +  ++    + +   + YLH  K   I+H DL P NI+L    ++ I+ FGL
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160

Query: 335 LR 336
            +
Sbjct: 161 AK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 50/174 (28%), Positives = 89/174 (51%), Gaps = 20/174 (11%)

Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +GI KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 24  EGIAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 79

Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +     +P    K+++ A ++A GM YL+  K
Sbjct: 80  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK 139

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 140 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 42/132 (31%), Positives = 71/132 (53%), Gaps = 9/132 (6%)

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L K   K+ E   A   E+ ++ K +HPN+V F  +  +N  + IV+EY   GDL   + 
Sbjct: 35  LTKMPVKEKE---ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRIN 91

Query: 278 K-KGRL-SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL-KISGFGL 334
           + +G L S  ++L + + ++ G+ ++H+ K   I+H D+K +NI L   G + K+  FG+
Sbjct: 92  RQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI 148

Query: 335 LRLQYISPEKAK 346
            R    S E A 
Sbjct: 149 ARQLNDSMELAY 160

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 11/145 (7%)

Query: 190 LQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ 249
            QVRK  G   G     K    KV  K     + KD     A   E  I+E  +HP +V 
Sbjct: 13  FQVRKVTGADTG-----KIFAMKVLKKATIVRNQKDTAHTKA---ERNILEAVKHPFIVD 64

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
            + A      + ++LEY + G+L  +L+++G         +  +++  + +LH+     I
Sbjct: 65  LIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QGI 121

Query: 310 IHCDLKPKNILLDNGGQLKISGFGL 334
           I+ DLKP+NILLD  G +K++ FGL
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGL 146

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 43/140 (30%), Positives = 65/140 (46%), Gaps = 16/140 (11%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-----TQNIPM-MIVLE 265
           KV VK +  + H   E I  F  E   ++   HPNV++ +G        Q IP  M++L 
Sbjct: 29  KVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILP 87

Query: 266 YHAKGDLASYL------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           +   GDL S+L          +L    +L+F +D+A GM YL        IH DL  +N 
Sbjct: 88  FMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNC 144

Query: 320 LLDNGGQLKISGFGLLRLQY 339
           +L     + ++ FGL +  Y
Sbjct: 145 MLREDMTVCVADFGLSKKIY 164

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 4/123 (3%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 25  MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 84

Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 85  FHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 334 LLR 336
           + +
Sbjct: 142 MCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 44/136 (32%), Positives = 76/136 (55%), Gaps = 15/136 (11%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 37  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94

Query: 271 DLASYLQ--------KKGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 95  DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151

Query: 321 LDNGGQLKISGFGLLR 336
           + +   +KI  FG+ R
Sbjct: 152 VAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 35/110 (31%), Positives = 55/110 (50%), Gaps = 19/110 (17%)

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------GRLSPSKVLRF-- 290
           +H N++  +G  TQ  P+ +++EY AKG+L  +L+ +              P + L F  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 291 ----ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
               A  +ARGM YL   +    IH DL  +N+L+     +KI+ FGL R
Sbjct: 136 LVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 42/139 (30%), Positives = 69/139 (49%), Gaps = 9/139 (6%)

Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNI 258
           G+   +        VK L++ +  D E +  F  E  I++   HPNV+  +G    ++  
Sbjct: 14  GTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71

Query: 259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVL-RFALDLARGMNYLHECKPDPIIHCDLKPK 317
           P+ +VL Y   GDL ++++ +      K L  F L +A+GM YL   K    +H DL  +
Sbjct: 72  PL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAAR 127

Query: 318 NILLDNGGQLKISGFGLLR 336
           N +LD    +K++ FGL R
Sbjct: 128 NCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 37/126 (29%), Positives = 67/126 (53%), Gaps = 6/126 (4%)

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT--QNIPMMIVLEYHAKGDLASY 275
            D +S +  + +NA   E+ +++  RH  +VQ+ G +   +   + I +EY   G +   
Sbjct: 37  FDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQ 96

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           L+  G L+ +   R+   + +G++YLH    + I+H D+K  NIL D+ G +K+  FG  
Sbjct: 97  LKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153

Query: 336 -RLQYI 340
            R+Q I
Sbjct: 154 KRIQTI 159

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 49/185 (26%), Positives = 80/185 (43%), Gaps = 40/185 (21%)

Query: 174 VANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFT 233
           V NP+++P  +       VRK   +              V VKIL  +++K+    N F 
Sbjct: 26  VVNPQDLPTLQF---PFNVRKGRPLL-------------VAVKILRPDANKNAR--NDFL 67

Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGR------ 281
            E+ I+ + + PN+++ +G      P+ ++ EY   GDL  +L       K+        
Sbjct: 68  KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 282 -------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
                  +S S +L  AL +A GM YL        +H DL  +N L+     +KI+ FG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGM 184

Query: 335 LRLQY 339
            R  Y
Sbjct: 185 SRNLY 189

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 16/143 (11%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA-----VTQNIPM-MI 262
           +  KV VK+L  +     + I  F  E   +++  HPNV++ +G          +P+ M+
Sbjct: 26  SFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84

Query: 263 VLEYHAKGDLASYL------QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           +L +   GDL ++L      ++   L    ++RF +D+A GM YL        IH DL  
Sbjct: 85  ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAA 141

Query: 317 KNILLDNGGQLKISGFGLLRLQY 339
           +N +L+    + ++ FGL +  Y
Sbjct: 142 RNCMLNENMTVCVADFGLSKKIY 164

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 4/102 (3%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           EL I+ + +H N++  V    +   + +V++  A  DL   + +K RL+ S+V    L +
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQI 128

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             G+N LH+      +H DL P NI +++ G  KI+ FGL R
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 36/126 (28%), Positives = 64/126 (50%), Gaps = 6/126 (4%)

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASY 275
            D ES +  + +NA   E+ +++   H  +VQ+ G +       + I +E+   G +   
Sbjct: 37  FDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQ 96

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL- 334
           L+  G L+ +   ++   +  G++YLH    + I+H D+K  NIL D+ G +K+  FG  
Sbjct: 97  LKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153

Query: 335 LRLQYI 340
            RLQ I
Sbjct: 154 KRLQTI 159

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 19/124 (15%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F HE  +  + +HPN+V  +G VT+  P+ ++  Y +  DL  +L               
Sbjct: 55  FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114

Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
              K  L P+  +     +A GM +L       ++H DL  +N+L+ +   +KIS  GL 
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLF 171

Query: 336 RLQY 339
           R  Y
Sbjct: 172 REVY 175

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 31/100 (31%), Positives = 54/100 (54%), Gaps = 2/100 (2%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           EL I+ + R P +V F GA      + + +E+   G L    +K G +    + + A+ +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
             G+ YL+      I+H D+KP NIL+++ GQ+K+  FG+
Sbjct: 113 VEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGV 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 45/146 (30%), Positives = 77/146 (52%), Gaps = 11/146 (7%)

Query: 194 KADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVV 248
           K + I KGS+ +V K   N TK  V +KI+D E  +D   I     E+T++ +   P + 
Sbjct: 8   KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYIT 65

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
           ++ G+  +   + I++EY   G  A  L K G L  + +     ++ +G++YLH  +   
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLDYLHSERK-- 122

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGL 334
            IH D+K  N+LL   G +K++ FG+
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGV 147

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 56.6 bits (137), Expect = 5e-10
 Identities = 29/50 (58%), Positives = 37/50 (74%), Gaps = 1/50 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
           L +A R G++  V+ LL  G+DVN+ D DGRT LH+AA  GH+EVVKLLL
Sbjct: 77  LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 34/129 (26%), Positives = 67/129 (51%), Gaps = 22/129 (17%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS---YLQKKGRLSPSK-VLRF 290
           E+ ++++  HPNV++++ +  ++  + IVLE    GDL+    Y +K+ RL P + V ++
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------------- 337
            + L   + ++H  +   ++H D+KP N+ +   G +K+   GL R              
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 338 --QYISPEK 344
              Y+SPE+
Sbjct: 169 TPYYMSPER 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 39/125 (31%), Positives = 66/125 (52%), Gaps = 4/125 (3%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +K+L K + K  +R+     E  I+ +  HP +V+   A      + ++L++   
Sbjct: 24  GQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           GDL + L K+   +   V  +  +LA  +++LH      II+ DLKP+NILLD  G +K+
Sbjct: 83  GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKL 139

Query: 330 SGFGL 334
           + FGL
Sbjct: 140 TDFGL 144

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 35/107 (32%), Positives = 60/107 (56%), Gaps = 5/107 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+++++  +H N+V     V  +  + +V EY  K DL  Y+   G  +S   V  F   
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI 340
           + RG+ Y H  K   ++H DLKP+N+L++  G+LK++ FGL R + +
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 58.9 bits (143), Expect = 6e-10
 Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 8/128 (6%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N  KV +K +D E  K    ++    E+  + +  HPNVV++  +      + +V+ Y +
Sbjct: 25  NNEKVAIKRIDLE--KCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82

Query: 269 KG---DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
            G   D+      +G L  + +     ++ +G+ YLH    +  IH D+K  NILL   G
Sbjct: 83  GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDG 139

Query: 326 QLKISGFG 333
            +KI+ FG
Sbjct: 140 SVKIADFG 147

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 35/110 (31%), Positives = 62/110 (56%), Gaps = 4/110 (3%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS 285
           P   N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+ P 
Sbjct: 44  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI-PE 102

Query: 286 KVL-RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           ++L + ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 103 QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 150

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 33/114 (28%), Positives = 65/114 (57%), Gaps = 5/114 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPS-KVLRFAL 292
           E+ ++   +HPN+VQ+  +  +N  + IV++Y   GDL   +  ++G L P  ++L + +
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
            +   + ++H+ K   I+H D+K +NI L   G +K+  FG+ R+   + E A+
Sbjct: 109 QICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 58.8 bits (143), Expect = 7e-10
 Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 4/100 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+ I++  +HPN+V +  +      + +V+EY   G L   + Q   R++  ++     +
Sbjct: 65  EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCRE 124

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           + +G+ YLH      +IH D+K  NILL   G +K++ FG
Sbjct: 125 VLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFG 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 59.0 bits (143), Expect = 7e-10
 Identities = 37/130 (28%), Positives = 59/130 (45%), Gaps = 24/130 (18%)

Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VE+        HP +            +  V+EY   GDL  ++Q  GR   ++  
Sbjct: 40  ECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARAR 99

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ---------- 338
            +A ++  G+ +LH+     II+ DLK  N+LLD  G +KI+ FG+ +            
Sbjct: 100 FYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF 156

Query: 339 -----YISPE 343
                YI+PE
Sbjct: 157 CGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 37/126 (29%), Positives = 56/126 (44%), Gaps = 19/126 (15%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F  E  ++   +H ++V+F G      P+++V EY   GDL  +L               
Sbjct: 54  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113

Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            Q KG L  S++L  A  +A GM YL        +H DL  +N L+     +KI  FG+ 
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170

Query: 336 RLQYIS 341
           R  Y +
Sbjct: 171 RDVYST 176

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 58.5 bits (141), Expect = 9e-10
 Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 12/154 (7%)

Query: 186 NPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIVE 240
           +P EL   K + I KGS+ +V K   N T+  V +KI+D E  +D   I     E+T++ 
Sbjct: 1   DPEEL-FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLS 57

Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNY 300
           +   P V ++ G+  +   + I++EY   G  A  L + G     ++     ++ +G++Y
Sbjct: 58  QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLKEILKGLDY 116

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           LH  K    IH D+K  N+LL   G +K++ FG+
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEQGDVKLADFGV 147

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 41/137 (29%), Positives = 69/137 (50%), Gaps = 6/137 (4%)

Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG Y++ K   T V VKIL  +++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 11  VKKGMYKMKKSEKT-VAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIG-ICEA 67

Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  +LQK   ++   +      ++ GM YL E      +H DL  +
Sbjct: 68  ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAAR 124

Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 125 NVLLVTQHYAKISDFGL 141

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 23/149 (15%)

Query: 215 VKILDKE-SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           V+I  KE   +D   +     E+ +    +H N+VQ++G+ ++N    I +E    G L+
Sbjct: 34  VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93

Query: 274 SYLQKK-GRLSP--SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKI 329
           + L+ K G L      ++ +   +  G+ YLH+ +   I+H D+K  N+L++   G +KI
Sbjct: 94  ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKI 150

Query: 330 SGFGLLR---------------LQYISPE 343
           S FG  +               LQY++PE
Sbjct: 151 SDFGTSKRLAGINPCTETFTGTLQYMAPE 179

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 11/106 (10%)

Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQK--KGRLSPSKVLRFA 291
           +E   HPN+V+ +         +   + +V E H   DL +YL K     L    +    
Sbjct: 56  LEAFDHPNIVRLMDVCATSRTDRETKVTLVFE-HVDQDLRTYLDKVPPPGLPAETIKDLM 114

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
               RG+++LH    + I+H DLKP+NIL+ +GGQ+K++ FGL R+
Sbjct: 115 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 38/153 (24%), Positives = 77/153 (50%), Gaps = 16/153 (10%)

Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 3   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 59

Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++       +    +  +   L +G+ + H 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 119 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 42/145 (28%), Positives = 72/145 (49%), Gaps = 9/145 (6%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFV 251
           I +GSY        K N     +K++ KE   D E I+    E  + E+A  +P +V   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                   + +V+EY   GDL  ++Q++ +L       +A ++   +N+LHE     II+
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIY 119

Query: 312 CDLKPKNILLDNGGQLKISGFGLLR 336
            DLK  N+LLD  G +K++ +G+ +
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 35/150 (23%), Positives = 66/150 (44%), Gaps = 17/150 (11%)

Query: 198 ITKGSYQVAKWNGTK-VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           I  G     K    + V+VK +  + H    ++     E  ++    H N++  +    +
Sbjct: 22  IFYGILIDEKPGKEEEVFVKTV--KDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79

Query: 257 NI-PMMIVLEYHAKGDLASYLQKKGRLSPSKVLR---------FALDLARGMNYLHECKP 306
           +  P  ++  Y   G+L  +LQ+  RL  +   +          A+ +A GM+YLH+   
Sbjct: 80  DGEPPFVLYPYMNWGNLKLFLQQ-CRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG- 137

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             +IH D+  +N ++D   Q+KI+   L R
Sbjct: 138 --VIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 33/115 (28%), Positives = 53/115 (46%), Gaps = 9/115 (7%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPM-----MIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           E+ ++   RH N++  +  +    P       IV E   + DL   ++    L+   +  
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQPLTDDHIQY 107

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
           F   + RG+ YLH      +IH DLKP NIL+++   LKI  FGL R      ++
Sbjct: 108 FLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 30/105 (28%), Positives = 59/105 (56%), Gaps = 7/105 (6%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ---KKGRLSPSKVLRFA 291
           E++++++ +HPN+V     + Q   + ++ E+ +  DL  YL    K   +    V  + 
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYL 107

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             + +G+ + H  +   ++H DLKP+N+L+DN G +K++ FGL R
Sbjct: 108 YQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 10/114 (8%)

Query: 221 ESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG 280
           ES    +RI             RHP +V           +  V+EY A GDL  ++    
Sbjct: 44  ESLMCEKRI------FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD- 96

Query: 281 RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
             S  + + +A  +  G+ YLHE K   I++ DLK  N+LLD  G +KI+ FGL
Sbjct: 97  VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 9/123 (7%)

Query: 215 VKILDKESHKDPERINAFTHELT---IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +KIL KE     + +    H LT   +++  RHP +     +   +  +  V+EY   G+
Sbjct: 25  MKILKKEVIIAKDEV---AHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81

Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L  +L ++   S  +   +  ++   + YLH C    +++ DLK +N++LD  G +KI+ 
Sbjct: 82  LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITD 138

Query: 332 FGL 334
           FGL
Sbjct: 139 FGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 16/140 (11%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM----- 261
           K     V +K +  E+ K+   I A   E+ I++  +H NVV  +  + +          
Sbjct: 34  KKTKQIVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVNLI-EICRTKATPYNRYK 91

Query: 262 ----IVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
               +V E+    DLA  L  K  + + S++ +    L  G+ Y+H  K   I+H D+K 
Sbjct: 92  GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKA 147

Query: 317 KNILLDNGGQLKISGFGLLR 336
            NIL+   G LK++ FGL R
Sbjct: 148 ANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 53/152 (34%), Positives = 72/152 (47%), Gaps = 22/152 (14%)

Query: 198 ITKGSYQ-----VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I KG+Y      + K NG+K  VKILD   H   E I A   E  I++  + HPNVV+F 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEA---EYNILKALSDHPNVVKFY 81

Query: 252 GA-----VTQNIPMMIVLEYHAKG---DLASYLQKKGRLSPSKVLRFALDLA-RGMNYLH 302
           G      V     + +VLE    G   DL     K+G      ++ + L  A  G+ +LH
Sbjct: 82  GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
             K    IH D+K  NILL   G +K+  FG+
Sbjct: 142 VNK---TIHRDVKGNNILLTTEGGVKLVDFGV 170

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 43/144 (29%), Positives = 76/144 (52%), Gaps = 11/144 (7%)

Query: 198 ITKGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFV 251
           I +GSY     V      +++ +K++ KE   D E I+    E  + E A  HP +V   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
                   +  V+E+ + GDL  ++Q++ +L P +  RF + +++  +N+LHE     II
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKL-PEEHARFYSAEISLALNFLHE---RGII 118

Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           + DLK  N+LLD  G +K++ +G+
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies)

 Score = 51.6 bits (124), Expect = 5e-09
 Identities = 22/52 (42%), Positives = 32/52 (61%), Gaps = 1/52 (1%)

Query: 91  LLNEGS-DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           LL  G  D+N+ D +G T LH+AA  G +E+V+ LL    +++ RD  G TA
Sbjct: 1   LLEHGPIDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTA 52

Length = 56

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 14/160 (8%)

Query: 176 NPREVPEYELNPLELQVRKADGITKGSYQVAKWN-GTKVWVKILDKESHKDPERINAFTH 234
           NP+E         EL  R   G     Y+    N G    +K++  E  +D         
Sbjct: 6   NPQE-------DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED---FAVVQQ 55

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ +++  +H N+V + G+  +   + I +E+   G L       G LS S++   + + 
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            +G+ YLH       +H D+K  NILL + G +K++ FG+
Sbjct: 116 LQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGV 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 51.5 bits (124), Expect = 5e-09
 Identities = 26/54 (48%), Positives = 34/54 (62%), Gaps = 1/54 (1%)

Query: 73  TMQLLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
               L  A   G ++ V+ LL +G D+N  D DG TALHIAA  G++EV+KLLL
Sbjct: 1   GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54

Length = 54

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 55.7 bits (134), Expect = 7e-09
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 10/136 (7%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
              +V VK L        +    F  E       +H N++Q +G  T+  P ++V+E+  
Sbjct: 21  TPAQVVVKEL--RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78

Query: 269 KGDLASYLQ--KKGRL---SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
            GDL  YL+  +K  L    P+ + R A ++A G+ +LH+   +  IH DL  +N LL  
Sbjct: 79  LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTA 135

Query: 324 GGQLKISGFGLLRLQY 339
              +KI  +GL   +Y
Sbjct: 136 DLTVKIGDYGLSHNKY 151

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 37/148 (25%), Positives = 66/148 (44%), Gaps = 22/148 (14%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           VW K ++     + ER +A  +E+ I+   +HPN++ +      +  ++I +EY   G L
Sbjct: 29  VW-KEVNLTRLSEKERRDAL-NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL 86

Query: 273 ASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
              +  QK        VL +   +   ++Y+H+     I+H D+K  NI L   G +K+ 
Sbjct: 87  YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLG 143

Query: 331 GFGLLR---------------LQYISPE 343
            FG+ +                 Y+SPE
Sbjct: 144 DFGISKILGSEYSMAETVVGTPYYMSPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 55.6 bits (134), Expect = 9e-09
 Identities = 36/113 (31%), Positives = 53/113 (46%), Gaps = 5/113 (4%)

Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS- 283
           D  + N    EL I+ KA  P +V F GA      + + +EY   G L            
Sbjct: 39  DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEG 98

Query: 284 -PSKVLRF-ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            P  VLR     + +G+ +L E     IIH D+KP N+L++  GQ+K+  FG+
Sbjct: 99  IPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGV 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 37/138 (26%), Positives = 67/138 (48%), Gaps = 16/138 (11%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK+L ++++K+    N F  E+ I+ + + PN+++ +     + P+ ++ EY   GDL
Sbjct: 49  VAVKMLREDANKNAR--NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 273 ASYLQK-----------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
             +L +              +S S ++  A  +A GM YL        +H DL  +N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLV 163

Query: 322 DNGGQLKISGFGLLRLQY 339
                +KI+ FG+ R  Y
Sbjct: 164 GKNYTIKIADFGMSRNLY 181

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.0 bits (135), Expect = 9e-09
 Identities = 32/120 (26%), Positives = 59/120 (49%), Gaps = 4/120 (3%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K++ K      E ++ F  E  I+  +  P + Q   A      + +V+EY   GDL S
Sbjct: 31  MKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLS 90

Query: 275 YLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            L +        + +F L +L   ++ +H+      +H D+KP+N+L+D  G +K++ FG
Sbjct: 91  LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFG 147

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 50.3 bits (121), Expect = 1e-08
 Identities = 27/56 (48%), Positives = 34/56 (60%), Gaps = 6/56 (10%)

Query: 105 GRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNIL 157
           GRTALH AA  G +E+VK LL K  +I+  D  G+TA   AA     GN+EV  +L
Sbjct: 1   GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAA---ENGNLEVLKLL 53

Length = 54

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 4/99 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E  I+    HP+++Q  G  T N    ++L  + K DL  YL  K  ++   +L     +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSV 191

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            R + YLHE   + IIH D+K +NI +++ G + +  FG
Sbjct: 192 LRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG 227

Length = 391

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 54.8 bits (131), Expect = 1e-08
 Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 3/77 (3%)

Query: 88  VEDLLNEGS---DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD 144
            + LL  G+     N  D DG T LH AA  G  ++V+LLL   A+ ++R+ +G TA   
Sbjct: 127 AKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDP 186

Query: 145 AKYYGNVEVYNILKARG 161
           A   G +E+  +L  +G
Sbjct: 187 AAKNGRIELVKLLLDKG 203

Length = 235

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 32/109 (29%), Positives = 58/109 (53%), Gaps = 2/109 (1%)

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS 285
           P   N    EL ++ +   P +V F GA   +  + I +E+   G L   L++  R+   
Sbjct: 44  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEE 103

Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            + + ++ + RG+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 104 ILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV 150

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 40/173 (23%), Positives = 78/173 (45%), Gaps = 7/173 (4%)

Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E EL  L+L      G       + + +  K+ V I   +     +     T  + 
Sbjct: 2   RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML 61

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLAR 296
            +    H  +V+ +G +     + +V +    G L  ++ Q +  L P ++L + + +A+
Sbjct: 62  AMGSLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAK 120

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVF 349
           GM YL E +   ++H +L  +NILL +   ++I+ FG+  L Y  P+  K  +
Sbjct: 121 GMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY--PDDKKYFY 168

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 34/129 (26%), Positives = 66/129 (51%), Gaps = 22/129 (17%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS---YLQKKGRLSPSK-VLRF 290
           E+ ++++  HPNV+++  +  ++  + IVLE    GDL+    + +K+ RL P K V ++
Sbjct: 52  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------------- 337
            + L   + ++H  +   ++H D+KP N+ +   G +K+   GL R              
Sbjct: 112 FVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 338 --QYISPEK 344
              Y+SPE+
Sbjct: 169 TPYYMSPER 177

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 21/133 (15%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMI--VLEYHAKGDLAS----YLQKKGRLSPSKVL 288
           E+ ++ + +H NVV  V    ++    +  + +Y A+ DL      + Q K    P  ++
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 289 RFAL-DLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLLRLQYISPE 343
           +  L  +  G++YLH    + ++H DLKP NIL+       G +KI   GL RL + +P 
Sbjct: 111 KSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPL 166

Query: 344 KAKIVFPVSHIDP 356
           K     P++ +DP
Sbjct: 167 K-----PLADLDP 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 3/130 (2%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KIL KE     + +     E  +++  RHP +     +      +  V+EY
Sbjct: 17  KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEY 76

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   I++ DLK +N++LD  G 
Sbjct: 77  VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGH 133

Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 134 IKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.8 bits (132), Expect = 2e-08
 Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 12/108 (11%)

Query: 235 ELTIVEKARHPNVVQ----FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  RH N++     F+  +     +  V E     DL   L  +  L    +  F
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLED---IYFVTELLGT-DLHRLLTSR-PLEKQFIQYF 113

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
              + RG+ Y+H      ++H DLKP NIL++    LKI  FGL R+Q
Sbjct: 114 LYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 40/133 (30%), Positives = 59/133 (44%), Gaps = 23/133 (17%)

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL----ASYLQKKGRLSPSKVL 288
             E  ++ K  HP +V+F  +  +     I+ EY    DL             LS ++V 
Sbjct: 50  NQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC 109

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----------- 337
            + + L  G++Y+H+ +   I+H DLK KNI L N   LKI  FG+ RL           
Sbjct: 110 EWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTF 165

Query: 338 ----QYISPEKAK 346
                Y+SPE  K
Sbjct: 166 TGTPYYMSPEALK 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 54.3 bits (130), Expect = 2e-08
 Identities = 35/121 (28%), Positives = 56/121 (46%), Gaps = 16/121 (13%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG----------- 280
           F  E  ++   +H ++V+F G   +  P+++V EY   GDL  +L+  G           
Sbjct: 54  FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113

Query: 281 --RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
              L+ S++L  A  +A GM YL        +H DL  +N L+     +KI  FG+ R  
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 170

Query: 339 Y 339
           Y
Sbjct: 171 Y 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 37/155 (23%), Positives = 78/155 (50%), Gaps = 20/155 (12%)

Query: 191 QVRKADGITKGSYQV---AKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARH- 244
             ++ + I +G+Y      K   T   V +KI++ ++  D   ++    E+ ++ + R  
Sbjct: 2   LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQS 59

Query: 245 --PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP---SKVLRFALDLARGMN 299
             PN+ ++ G+  +   + I++EY   G + + L K G ++    S ++R   ++   + 
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIR---EVLVALK 115

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y+H+     +IH D+K  NIL+ N G +K+  FG+
Sbjct: 116 YIHK---VGVIHRDIKAANILVTNTGNVKLCDFGV 147

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 37/136 (27%), Positives = 68/136 (50%), Gaps = 5/136 (3%)

Query: 215 VKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VK+L K++  K  E  +  +    +++  +HP +V    +      +  VL+Y   G+L 
Sbjct: 25  VKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELF 84

Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            +LQ++      +   +A ++A  + YLH      I++ DLKP+NILLD+ G + ++ FG
Sbjct: 85  YHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFG 141

Query: 334 LLRLQYISPEKAKIVF 349
           L + + I        F
Sbjct: 142 LCK-ENIEHNGTTSTF 156

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 2e-08
 Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 17/80 (21%)

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRF-------ALDLARGMNYLHECKPDPIIHCDL 314
           +V+EY   GDL + L +K    P +  RF       ALD    + +         IH D+
Sbjct: 78  LVMEYMPGGDLMNLLIRKDVF-PEETARFYIAELVLALDSVHKLGF---------IHRDI 127

Query: 315 KPKNILLDNGGQLKISGFGL 334
           KP NIL+D  G +K++ FGL
Sbjct: 128 KPDNILIDADGHIKLADFGL 147

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 21/66 (31%), Positives = 34/66 (51%), Gaps = 3/66 (4%)

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           DL   ++    L+ +    F   +  G+ Y+H      ++H DLKP N+L++   +LKI 
Sbjct: 91  DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC 147

Query: 331 GFGLLR 336
            FGL R
Sbjct: 148 DFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 33/111 (29%), Positives = 56/111 (50%), Gaps = 4/111 (3%)

Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-L 282
           +  E +  F  E+ I+ + +HPN+V    A      + I++E+   G L S + +  R L
Sbjct: 41  ESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGL 100

Query: 283 SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +  ++      +   +N+LH  K   +IH DLK  NILL   G +K++ FG
Sbjct: 101 TEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFG 148

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 36/123 (29%), Positives = 57/123 (46%), Gaps = 18/123 (14%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F  E  ++   +H ++V+F G  T+  P+++V EY   GDL  +L               
Sbjct: 54  FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113

Query: 277 QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              G+L+  ++L  A  +A GM YL        +H DL  +N L+  G  +KI  FG+ R
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Query: 337 LQY 339
             Y
Sbjct: 171 DIY 173

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 8/145 (5%)

Query: 198 ITKGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KGS+    QV K +  +++ +K + K        +     E T++ +   P +V    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           +      + +VL +   G+L  +LQ++GR   S+   +  +L   +  LH+     +I+ 
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYR 117

Query: 313 DLKPKNILLDNGGQLKISGFGLLRL 337
           DLKP+NILLD  G + +  FGL +L
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKL 142

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 33/117 (28%), Positives = 55/117 (47%), Gaps = 9/117 (7%)

Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK        +P +            +  V+E+   GDL  ++Q KGR    +  
Sbjct: 40  ECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRAT 99

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
            +A ++  G+ +LH      II+ DLK  N++LD  G +KI+ FG+ +       +A
Sbjct: 100 FYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 37/122 (30%), Positives = 61/122 (50%), Gaps = 12/122 (9%)

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL---QKKGRLSPSKVL-RFALDLARGM 298
           +HPN++Q +G   + IP ++V EY   GDL SYL   Q   R S   +L R A ++A G+
Sbjct: 53  QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL----LRLQYISPEKAKIVFPVSHI 354
            ++H+      +H DL  +N  L +   +K+  +G+     +  YI  E      P+  +
Sbjct: 113 THMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED-DKCVPLRWL 168

Query: 355 DP 356
            P
Sbjct: 169 AP 170

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 42/147 (28%), Positives = 75/147 (51%), Gaps = 13/147 (8%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQ 249
           I KGS+        K +G    VK+L K+   + K+ + I A  + L  ++  +HP +V 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVL--LKNVKHPFLVG 60

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
              +      +  VL++   G+L  +LQ++      +   +A ++A  + YLH      I
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---I 117

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLR 336
           ++ DLKP+NILLD+ G + ++ FGL +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 37/120 (30%), Positives = 62/120 (51%), Gaps = 7/120 (5%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-AS 274
           K++D +S    E +  +  E+ I+    HPN+V+ + A      + I++E+ A G + A 
Sbjct: 36  KVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 92

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L+ +  L+  ++          +NYLHE K   IIH DLK  NIL    G +K++ FG+
Sbjct: 93  MLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGV 149

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|197603 smart00248, ANK, ankyrin repeats

 Score = 48.4 bits (116), Expect = 4e-08
 Identities = 20/30 (66%), Positives = 25/30 (83%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           DGRT LH+AA  G++EVVKLLL K A+I+A
Sbjct: 1   DGRTPLHLAAENGNLEVVKLLLDKGADINA 30

Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 39/142 (27%), Positives = 64/142 (45%), Gaps = 8/142 (5%)

Query: 198 ITKGSY-QV--AKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           + +G Y QV  AK   T   V +K + K        +     E  I+   +   +V+ + 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           A   +  + + +EY   GD  + L   G LS      +  ++   ++ LHE      IH 
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHR 125

Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLKP+N L+D  G +K++ FGL
Sbjct: 126 DLKPENFLIDASGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 33/120 (27%), Positives = 62/120 (51%), Gaps = 3/120 (2%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL K    + E++     E  I+ +A    VV+   +    + + +++E+   GD+ +
Sbjct: 31  MKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMT 90

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L KK  L+  +   +  +    ++ +H+      IH D+KP N+LLD+ G +K+S FGL
Sbjct: 91  LLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 32/108 (29%), Positives = 57/108 (52%), Gaps = 9/108 (8%)

Query: 235 ELTIVEKA------RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL  ++Q+ G+    + +
Sbjct: 45  ECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 104

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +A +++ G+ +LH      II+ DLK  N++LD+ G +KI+ FG+ +
Sbjct: 105 FYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 53.0 bits (127), Expect = 5e-08
 Identities = 27/102 (26%), Positives = 54/102 (52%), Gaps = 3/102 (2%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ +++  +H N+VQ++G    +  + I +E+   G ++S L + G L      ++   +
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI 111

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             G+ YLH    + ++H D+K  N++L   G +K+  FG  R
Sbjct: 112 LDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 23/58 (39%), Positives = 37/58 (63%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           L   A R D+  +++LL +G +V+S D  G TAL +A  E HV++V+LL+   A++D 
Sbjct: 626 LCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDK 683

Length = 823

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 48/154 (31%), Positives = 69/154 (44%), Gaps = 19/154 (12%)

Query: 198 ITKGSYQVA-----KWNGTKVWVK-ILDKESH-KDPERINAFTHELTIVEKARHPNVVQF 250
           I KGSY V         G KV +K I D   H  D  RI     E+ ++   RHP++V+ 
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRI---LREIKLLRLLRHPDIVEI 64

Query: 251 VGAVTQNIP-----MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK 305
              +          + +V E   + DL   ++    L+P     F   L R + Y+H   
Sbjct: 65  KHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN 123

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
              + H DLKPKNIL +   +LKI  FGL R+ +
Sbjct: 124 ---VFHRDLKPKNILANADCKLKICDFGLARVAF 154

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 30/135 (22%), Positives = 52/135 (38%), Gaps = 22/135 (16%)

Query: 69  NLDSTMQLLFMACRG--DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE-VVKLLL 125
               T   L++          V  LL  G+DVN+ +  G T LH+         V+KLL+
Sbjct: 45  EYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLI 104

Query: 126 SKKANIDARDRWGSTAAADAKYYGNVE----VYNILKARGAKVPKTKRTPMTVANPREVP 181
              A+++A+D+ G T      Y         V  +L  +G             A+   + 
Sbjct: 105 KAGADVNAKDKVGRTPL--HVYLSGFNINPKVIRLLLRKG-------------ADVNALD 149

Query: 182 EYELNPLELQVRKAD 196
            Y + PL + ++  +
Sbjct: 150 LYGMTPLAVLLKSRN 164

Length = 471

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.3 bits (125), Expect = 9e-08
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 10/158 (6%)

Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWN-GTKVWVKILDKESHKDPERINAFTHEL 236
           R  P+++    EL  R   G     Y+    + G    VKI+  E   D   I     E+
Sbjct: 4   RRNPQHDY---ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEI 57

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR 296
            +V++ +H N+V + G+      + I +EY   G L       G LS  ++     +  +
Sbjct: 58  FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ 117

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           G+ YLH       +H D+K  NILL + G +K++ FG+
Sbjct: 118 GLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGV 152

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 8/138 (5%)

Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG Y++ K     V +K+L  E+ K     +    E  I+ +  +P +V+ +G V + 
Sbjct: 11  VKKGVYKMRK-KQIDVAIKVLKNENEKSVR--DEMMREAEIMHQLDNPYIVRMIG-VCEA 66

Query: 258 IPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
             +M+V+E  + G L  +L  KK  ++ S V+     ++ GM YL        +H DL  
Sbjct: 67  EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAA 123

Query: 317 KNILLDNGGQLKISGFGL 334
           +N+LL N    KIS FGL
Sbjct: 124 RNVLLVNQHYAKISDFGL 141

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 51/163 (31%), Positives = 74/163 (45%), Gaps = 22/163 (13%)

Query: 198 ITKGSY-QVAKW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I +G+Y QV K      G  V +K +  ++ K+   I A   E+ I+ +  H N+V    
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA-IREIKILRQLNHRNIVNLKE 73

Query: 253 AVTQNIPMM----------IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYL 301
            VT     +          +V EY    DL   L+      S   +  F   L  G+NY 
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEY-MDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYC 132

Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
           H+      +H D+K  NILL+N GQ+K++ FGL RL Y S E 
Sbjct: 133 HK---KNFLHRDIKCSNILLNNKGQIKLADFGLARL-YNSEES 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 9/108 (8%)

Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL  ++Q+ G+      +
Sbjct: 45  ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAV 104

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +A ++A G+ +LH      II+ DLK  N++LD  G +KI+ FG+ +
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 17/121 (14%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPM------MIVLEYHAKGDLASYLQKKGRLS-- 283
           F  E   +++  HPNV++ +G   Q +        +++L +   GDL S+L    RL   
Sbjct: 47  FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RLGDC 105

Query: 284 ----PSKVL-RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
               P+++L +F  D+A GM YL        IH DL  +N +L+    + ++ FGL +  
Sbjct: 106 PQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162

Query: 339 Y 339
           Y
Sbjct: 163 Y 163

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 44/141 (31%), Positives = 68/141 (48%), Gaps = 23/141 (16%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--------------VGAVTQN 257
           +V VK   K    DP+ +     E+ I+ +  H N+V+               VG++T+ 
Sbjct: 32  RVAVK---KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88

Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             + IV EY  + DLA+ L++ G LS      F   L RG+ Y+H      ++H DLKP 
Sbjct: 89  NSVYIVQEY-METDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143

Query: 318 NILLDNGG-QLKISGFGLLRL 337
           N+ ++     LKI  FGL R+
Sbjct: 144 NVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 34/130 (26%), Positives = 65/130 (50%), Gaps = 2/130 (1%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 17  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 76

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 77  ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGH 134

Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 135 IKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 5/121 (4%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K LDK+  K          E  I+EK   P +V    A      + +V+     GDL  +
Sbjct: 24  KKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYH 83

Query: 276 LQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +   G   L   +V+ ++  +  G+ +LH      I++ D+KP+N+LLD+ G  ++S  G
Sbjct: 84  IYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLG 140

Query: 334 L 334
           L
Sbjct: 141 L 141

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 27/75 (36%), Positives = 45/75 (60%), Gaps = 3/75 (4%)

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           + +V +Y + G+L  +LQK+GR S  +   +  +L   + +LH+     I++ DLKP+NI
Sbjct: 71  LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENI 127

Query: 320 LLDNGGQLKISGFGL 334
           LLD  G + +  FGL
Sbjct: 128 LLDATGHIALCDFGL 142

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 9/108 (8%)

Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL   +Q+ GR      +
Sbjct: 45  ECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAV 104

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +A ++A G+ +LH      II+ DLK  N++LD+ G +KI+ FG+ +
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 21/133 (15%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA--------VTQNIPMMIVL 264
           V +KIL++ +   P+    F  E  I+    HP++V+ +G         VTQ +P   +L
Sbjct: 39  VAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLL 96

Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           +Y          + K  +    +L + + +A+GM YL E +   ++H DL  +N+L+ + 
Sbjct: 97  DY--------VHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSP 145

Query: 325 GQLKISGFGLLRL 337
             +KI+ FGL RL
Sbjct: 146 NHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 27/76 (35%), Positives = 44/76 (57%), Gaps = 3/76 (3%)

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           +V+EY   GD+ S L   G       +++  ++A  ++YLH      IIH DLKP N+L+
Sbjct: 81  LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLI 137

Query: 322 DNGGQLKISGFGLLRL 337
            N G +K++ FGL ++
Sbjct: 138 SNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 3/130 (2%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 17  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 76

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 77  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGH 133

Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 134 IKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 23/58 (39%), Positives = 33/58 (56%), Gaps = 3/58 (5%)

Query: 281 RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
            LS   V  F   + RG+ YLH      I+H D+KP N+L+++   LKI  FGL R++
Sbjct: 99  PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 31/129 (24%), Positives = 53/129 (41%), Gaps = 7/129 (5%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV-GAVTQNIPMMIVLEYHA 268
           G +V +K+L  ++ ++  +   F  E  +  +  HPN+V  +         +  V EY  
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGG 325
              L   L   G L   +  R  L +   +   H      I+H DLKP+NI++       
Sbjct: 63  GRTLREVLAADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119

Query: 326 QLKISGFGL 334
             K+  FG+
Sbjct: 120 HAKVLDFGI 128

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 35/123 (28%), Positives = 61/123 (49%), Gaps = 4/123 (3%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VK+L K+     + +     E  I+  AR HP + Q          +  V+E+   GDL 
Sbjct: 25  VKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLM 84

Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++QK  R   ++   +A ++   + +LH+     II+ DLK  N+LLD+ G  K++ FG
Sbjct: 85  FHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFG 141

Query: 334 LLR 336
           + +
Sbjct: 142 MCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.4 bits (124), Expect = 2e-07
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 25/174 (14%)

Query: 189 ELQVRKADGITKGSYQ---VAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARH 244
             ++ K   +  G +    V K   T K++V+ + K  + +   I    H+L       +
Sbjct: 15  NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--IEPMVHQLM----KDN 68

Query: 245 PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC 304
           PN ++   +VT     +++++Y   GDL   L+K+G+LS ++V +    L   +N LH+ 
Sbjct: 69  PNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKH 128

Query: 305 KPDPIIHCDLKPKNILLD-NGGQLKISGFGLLR-----------LQYISPEKAK 346
               IIH D+K +N+L D    ++ +  +GL +           L Y SPEK K
Sbjct: 129 N---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIK 179

Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 37/127 (29%), Positives = 60/127 (47%), Gaps = 17/127 (13%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K L K    + E++     E  I+ +A +P VV+   +      + +++EY   GD+ +
Sbjct: 31  MKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMT 90

Query: 275 YLQKKGRLSPSKVLRF-------ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            L KK   +  +  RF       A+D    + Y         IH D+KP N+LLD  G +
Sbjct: 91  LLMKKDTFT-EEETRFYIAETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHI 140

Query: 328 KISGFGL 334
           K+S FGL
Sbjct: 141 KLSDFGL 147

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 34/120 (28%), Positives = 59/120 (49%), Gaps = 3/120 (2%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL K    + E++     E  I+ +A    VV+   +      + +++E+   GD+ +
Sbjct: 31  MKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMT 90

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L KK  LS      +  +    ++ +H+      IH D+KP N+LLD  G +K+S FGL
Sbjct: 91  LLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.0 bits (122), Expect = 2e-07
 Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 9/101 (8%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL-RFALD 293
           EL I+ K   P ++ F GA      + I  E+   G L  Y     R  P  VL R A+ 
Sbjct: 49  ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVA 103

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           + +G+ YL   K   I+H D+KP N+L++  GQ+K+  FG+
Sbjct: 104 VVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGV 141

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 27/107 (25%), Positives = 44/107 (41%), Gaps = 18/107 (16%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA--CEGHVEVVKLLLSKKANI 131
           +             VE LL+ G++VN  + DG   LH+     +  ++++KLL+ K  +I
Sbjct: 110 LLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDI 169

Query: 132 DARDR----------------WGSTAAADAKYYGNVEVYNILKARGA 162
           +A++R                +G T    A Y  N E    L   GA
Sbjct: 170 NAKNRVNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGA 216

Length = 422

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 31/116 (26%), Positives = 52/116 (44%), Gaps = 8/116 (6%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMI----VLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL I+   +H N++     +            V++   + DL   +     L+   +  F
Sbjct: 54  ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYF 112

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
              L RG+ Y+H      +IH DLKP N+L++   +L+I  FG+ R    SP + K
Sbjct: 113 LYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 42/148 (28%), Positives = 80/148 (54%), Gaps = 12/148 (8%)

Query: 198 ITKGSY-QVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           + KGSY +V+    + +G +  +K L+  +    ER  A   E  ++ + +HPN+V +  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRE 66

Query: 253 AVT-QNIPMMIVLEYHAKGDLASYL-QKKGRLSP-SKVLRFALDLARGMNYLHECKPDPI 309
           +   ++  + IV+ +   GDL   L ++KG+L P ++V+ + + +A  + YLHE     I
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHI 123

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRL 337
           +H DLK +N+ L     +K+   G+ R+
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARV 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 32/124 (25%), Positives = 64/124 (51%), Gaps = 7/124 (5%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G +V VK +D    +  +R     +E+ I+   +HPN+V+   +      + +V+E+   
Sbjct: 44  GRQVAVKKMDL---RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G L   +    R++  ++    L + + +++LH      +IH D+K  +ILL + G++K+
Sbjct: 101 GALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKL 156

Query: 330 SGFG 333
           S FG
Sbjct: 157 SDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 9/108 (8%)

Query: 235 ELTIVEKA------RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK        HP +            +  V+EY   GDL  ++Q   +    +  
Sbjct: 40  ECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRAT 99

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +A ++  G+ +LH      I++ DLK  NILLD  G +KI+ FG+ +
Sbjct: 100 FYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 50.9 bits (121), Expect = 4e-07
 Identities = 33/137 (24%), Positives = 72/137 (52%), Gaps = 9/137 (6%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G +V +K ++ +     E I    +E+ ++++ ++PN+V F+ +      + +V+EY A 
Sbjct: 44  GQEVAIKQINLQKQPKKELI---INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G L   + +   +  +++     +  + + +LH    + +IH D+K  N+LL   G +K+
Sbjct: 101 GSLTDVVTETC-MDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKL 156

Query: 330 SGFGLLRLQYISPEKAK 346
           + FG      I+PE++K
Sbjct: 157 TDFGF--CAQITPEQSK 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 50.4 bits (120), Expect = 4e-07
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 11/87 (12%)

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
           V  VTQ +P   +L+Y          + K R+    +L + + +A+GM+YL E +   ++
Sbjct: 83  VQLVTQLMPYGCLLDY--------VRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LV 131

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRL 337
           H DL  +N+L+ +   +KI+ FGL RL
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 18/153 (11%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K  +K      ++++    E  I+    HP  V   G+      + +VLE+   G+ 
Sbjct: 59  VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118

Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
            ++L++  R        +A  +     YL       I++ DLKP+N+LLD  G +K++ F
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDF 175

Query: 333 GLLRL------------QYISPEKAKIVFPVSH 353
           G  ++            +YI+PE   I+  V H
Sbjct: 176 GFAKVVDTRTYTLCGTPEYIAPE---ILLNVGH 205

Length = 340

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 29/109 (26%), Positives = 52/109 (47%), Gaps = 5/109 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALD 293
           E  +++   HP+V++    +       +VL  H   DL +YL K+   L   + L     
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLP-HYSSDLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP 342
           +  G+ YLH  +   IIH D+K +NI +++  Q+ I   G  +   ++P
Sbjct: 166 ILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211

Length = 357

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 34/121 (28%), Positives = 60/121 (49%), Gaps = 5/121 (4%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K LDK+  K  +      +E  I+EK     +V    A      + +V+     GDL  +
Sbjct: 24  KKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYH 83

Query: 276 LQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +   G      ++ + +A  +  G+ +LH+ +   I++ DLKP+N+LLD+ G ++IS  G
Sbjct: 84  IYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLG 140

Query: 334 L 334
           L
Sbjct: 141 L 141

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 33/136 (24%), Positives = 62/136 (45%), Gaps = 19/136 (13%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA--------VTQNIPMM 261
             K+ V I +      P+       E  ++    +P+V + +G         +TQ +P  
Sbjct: 34  KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFG 93

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
            +L+Y          + K  +    +L + + +A+GMNYL E +   ++H DL  +N+L+
Sbjct: 94  CLLDY--------VREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLV 142

Query: 322 DNGGQLKISGFGLLRL 337
                +KI+ FGL +L
Sbjct: 143 KTPQHVKITDFGLAKL 158

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 35/122 (28%), Positives = 59/122 (48%), Gaps = 5/122 (4%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K+LDK+      ++     E  I+    HP +     +      + +V++Y   G+L  
Sbjct: 31  LKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFR 90

Query: 275 YLQK-KGRLSPSKVLRF-ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
            LQ+  G+    +V RF A ++   + YLH      I++ DLKP+NILL   G + +S F
Sbjct: 91  LLQRQPGKCLSEEVARFYAAEVLLALEYLH-LLG--IVYRDLKPENILLHESGHIMLSDF 147

Query: 333 GL 334
            L
Sbjct: 148 DL 149

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 49.9 bits (120), Expect = 5e-07
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 21/108 (19%)

Query: 235 ELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-- 290
           E  I+E+  HP +V+        + I M+  +EY   G+L + L+ +G        RF  
Sbjct: 43  EKEILEECNHPFIVKLYRTFKDKKYIYML--MEYCLGGELWTILRDRGLFDEYTA-RFYI 99

Query: 291 -----ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
                A +      YLH      II+ DLKP+N+LLD+ G +K+  FG
Sbjct: 100 ACVVLAFE------YLHN---RGIIYRDLKPENLLLDSNGYVKLVDFG 138

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 19/148 (12%)

Query: 200 KGSY---QVAKWNGT-KVW-VKILDKESHKDPERINAFTHELTIVEK------ARHPNVV 248
           KGS+    +A+  GT +V+ +K+L K+     + +     + T+ EK      A+HP + 
Sbjct: 5   KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDV-----DCTMTEKRILALAAKHPFLT 59

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
                      +  V+EY   GDL   +Q+  +    +   +A ++   + +LH      
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HG 116

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLR 336
           +I+ DLK  NILLD  G  K++ FG+ +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 50.1 bits (119), Expect = 6e-07
 Identities = 40/178 (22%), Positives = 88/178 (49%), Gaps = 15/178 (8%)

Query: 169 RTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPER 228
           R+ ++V +P++    +    E   + A G    +  +A   G +V +K ++ +     E 
Sbjct: 9   RSIVSVGDPKK----KYTRFEKIGQGASGTVYTAIDIA--TGQEVAIKQMNLQQQPKKEL 62

Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           I    +E+ ++ + ++PN+V ++ +      + +V+EY A G L   + +   +   ++ 
Sbjct: 63  I---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIA 118

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
               +  + +++LH    + +IH D+K  NILL   G +K++ FG      I+PE++K
Sbjct: 119 AVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF--CAQITPEQSK 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 36/124 (29%), Positives = 59/124 (47%), Gaps = 11/124 (8%)

Query: 215 VKILDKESHKDPERINAFTH---ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +K L K    D    N   H   E  I+ +A +  VV+   +      +  V++Y   GD
Sbjct: 31  MKTLRK---ADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87

Query: 272 LASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           + S L + G +    + RF + +L   +  +H+      IH D+KP NIL+D  G +K++
Sbjct: 88  MMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLT 143

Query: 331 GFGL 334
            FGL
Sbjct: 144 DFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 49.8 bits (120), Expect = 8e-07
 Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 6/96 (6%)

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-ASYLQKKGRLSPSKVLRFAL-DLARGMNY 300
            HPN+V+      +N  +  V EY  +G+L      +KG+     V+R  +  + +G+ +
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEY-MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           +H+       H DLKP+N+L+     +KI+ FGL R
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 27/81 (33%), Positives = 41/81 (50%), Gaps = 10/81 (12%)

Query: 262 IVLEYHAKGDLASYLQKKGR-----LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           +V EY    DL  ++   GR     L    +  F   L +G+ + H+     ++H DLKP
Sbjct: 83  LVFEY-LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKP 138

Query: 317 KNILLD-NGGQLKISGFGLLR 336
           +N+L+D   G LKI+  GL R
Sbjct: 139 QNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 28/72 (38%), Positives = 42/72 (58%), Gaps = 3/72 (4%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N  +V VK+L   +H D ER  A   EL I+    +H N+V  +GA T   P++++ EY 
Sbjct: 67  NVLRVAVKMLKASAHTD-ER-EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYC 124

Query: 268 AKGDLASYLQKK 279
             GDL ++L+KK
Sbjct: 125 CYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 33/122 (27%), Positives = 56/122 (45%), Gaps = 9/122 (7%)

Query: 51  SLDPIRRSPVQDELTVPENLDSTMQLLFMACRG-DVKGVEDLLNEGSDVNSIDLDGRTAL 109
            +  I+   ++D+L         +  L++A    ++  V+ LL+ G+D+NS   +  T L
Sbjct: 14  KVKNIKYIIMEDDLNDYSYKKPVL-PLYLAKEARNIDVVKILLDNGADINSSTKNNSTPL 72

Query: 110 HIAACEGHV-----EVVKLLLSKKANIDARDRWGST--AAADAKYYGNVEVYNILKARGA 162
           H  +   +      E+VKLLL   AN++A D  G T    A +K   +  +   L   GA
Sbjct: 73  HYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNGA 132

Query: 163 KV 164
            V
Sbjct: 133 NV 134

Length = 422

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 40/143 (27%), Positives = 71/143 (49%), Gaps = 8/143 (5%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           GT V V+I D E+  + E + A  +E+ +    RHPN++      T    + ++  + A 
Sbjct: 25  GTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83

Query: 270 GDLASYLQK---KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           G   S L+    +G +S + +        RG+NYLH+   +  IH ++K  +IL+   G 
Sbjct: 84  GSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGL 139

Query: 327 LKISGFGLLRLQYISPEKAKIVF 349
           + +SG   L     + +KAK+V+
Sbjct: 140 VSLSGLSHLYSLVRNGQKAKVVY 162

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 34/137 (24%), Positives = 70/137 (51%), Gaps = 9/137 (6%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G +V +K ++ +     E I    +E+ ++ + +HPN+V ++ +      + +V+EY A 
Sbjct: 44  GQEVAIKQMNLQQQPKKELI---INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G L   + +   +   ++     +  + + +LH    + +IH D+K  NILL   G +K+
Sbjct: 101 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKL 156

Query: 330 SGFGLLRLQYISPEKAK 346
           + FG      I+PE++K
Sbjct: 157 TDFGF--CAQITPEQSK 171

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 36/121 (29%), Positives = 58/121 (47%), Gaps = 5/121 (4%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K L+K+  K  +  +   +E  I+EK     VV    A      + +VL     GDL  +
Sbjct: 31  KRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFH 90

Query: 276 LQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +   G       + L +A ++  G+  LH    +  ++ DLKP+NILLD+ G ++IS  G
Sbjct: 91  IYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLG 147

Query: 334 L 334
           L
Sbjct: 148 L 148

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 37/140 (26%), Positives = 66/140 (47%), Gaps = 12/140 (8%)

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM-- 260
             + +  G KV +K L +    +     A+  EL +++  +H NV+  +   T ++ +  
Sbjct: 33  SALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLDVFTPDLSLDR 91

Query: 261 ----MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
                +V+ +    DL   L K  +LS  ++      + +G+ Y+H      IIH DLKP
Sbjct: 92  FHDFYLVMPFMGT-DLGK-LMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKP 146

Query: 317 KNILLDNGGQLKISGFGLLR 336
            N+ ++   +LKI  FGL R
Sbjct: 147 GNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 49.0 bits (116), Expect = 1e-06
 Identities = 40/178 (22%), Positives = 87/178 (48%), Gaps = 15/178 (8%)

Query: 169 RTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPER 228
           R+ ++V +P++    +    E   + A G    +  VA   G +V ++ ++ +     E 
Sbjct: 10  RSIVSVGDPKK----KYTRFEKIGQGASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKEL 63

Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           I    +E+ ++ + ++PN+V ++ +      + +V+EY A G L   + +   +   ++ 
Sbjct: 64  I---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIA 119

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
               +  + + +LH    + +IH D+K  NILL   G +K++ FG      I+PE++K
Sbjct: 120 AVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF--CAQITPEQSK 172

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 34/144 (23%), Positives = 68/144 (47%), Gaps = 8/144 (5%)

Query: 206 AKWNGTKVWVKILDKESHKDPER-INAFTHELTIVEKARHPNVVQFVG---AVTQNIP-M 260
             +N  +V ++   K+ HK  +  I+   +E+  + +    N+++  G    +  ++P +
Sbjct: 39  GIFNNKEVIIRTF-KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL 97

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            ++LEY  +G L   L K+  LS    L  A+D  +G+  L++    P  + +L   + L
Sbjct: 98  SLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFL 155

Query: 321 LDNGGQLKISGFGLLRLQYISPEK 344
           +    +LKI   GL ++    P K
Sbjct: 156 VTENYKLKIICHGLEKILSSPPFK 179

Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 35/128 (27%), Positives = 62/128 (48%), Gaps = 7/128 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +V VK +D    +  +R     +E+ I+    H NVV    +      + +V+E+
Sbjct: 44  KHTGKQVAVKKMDL---RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   +    R++  ++    L + R ++YLH      +IH D+K  +ILL + G+
Sbjct: 101 LEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGR 156

Query: 327 LKISGFGL 334
           +K+S FG 
Sbjct: 157 IKLSDFGF 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 26/83 (31%), Positives = 38/83 (45%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           V  LL+ G  +N  D+ G T LH A    + E VK LL   AN +  +++G T    A  
Sbjct: 175 VNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAIL 234

Query: 148 YGNVEVYNILKARGAKVPKTKRT 170
             N E++ +L   G  +     T
Sbjct: 235 NNNKEIFKLLLNNGPSIKTIIET 257

Length = 422

>gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 34/113 (30%), Positives = 47/113 (41%), Gaps = 27/113 (23%)

Query: 49  QSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGD-------------VKGVEDLLN-- 93
            +  D + RS +       ENL+ T  LL ++CRG              V  VE +L   
Sbjct: 45  INCPDRLGRSALFVAAIENENLELTELLLNLSCRGAVGDTLLHAISLEYVDAVEAILLHL 104

Query: 94  ----EGSD----VNSIDLD----GRTALHIAACEGHVEVVKLLLSKKANIDAR 134
                 S      N         G TALH+AA   + E+VKLLL + A++ AR
Sbjct: 105 LAAFRKSGPLELANDQYTSEFTPGITALHLAAHRQNYEIVKLLLERGASVPAR 157

The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 20/108 (18%)

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIH 311
           A      + +V++Y+  GDL + L K     P  + RF L ++   ++ +H+      +H
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVH 125

Query: 312 CDLKPKNILLDNGGQLKISGFG-LLRL---------------QYISPE 343
            D+KP N+LLD  G ++++ FG  LRL                YISPE
Sbjct: 126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 6/103 (5%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF- 290
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +       P K  +F 
Sbjct: 90  FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFY 147

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++   ++ +H      +IH D+KP N+LLD  G LK++ FG
Sbjct: 148 TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 7/102 (6%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR--FAL 292
           E  I+  A +P VV    +      + +V+EY   GD A+ L+  G L P  + R  FA 
Sbjct: 51  ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGAL-PVDMARMYFA- 108

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +    + YLH      I+H DLKP N+L+ + G +K++ FGL
Sbjct: 109 ETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 5/103 (4%)

Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E  I+EK     VV    A      + +VL     GDL  ++   G       + + +A
Sbjct: 49  NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYA 108

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++  G+  LH    + I++ DLKP+NILLD+ G ++IS  GL
Sbjct: 109 AEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGL 148

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 16/108 (14%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPS 285
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +      +K  R   +
Sbjct: 90  FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149

Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +V+  ALD    M ++H          D+KP N+LLD  G LK++ FG
Sbjct: 150 EVV-LALDAIHSMGFIHR---------DVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 5/93 (5%)

Query: 245 PNVVQFVGAVTQNIPMMIVLEYHAKG--DLASYLQKKGRLSPSKVL-RFALDLARGMNYL 301
           P  V F GA+ +   + I +E            +  KG   P  +L + A+ + + + YL
Sbjct: 60  PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           H      +IH D+KP N+L++  GQ+K+  FG+
Sbjct: 120 HS--KLSVIHRDVKPSNVLINRNGQVKLCDFGI 150

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 4/112 (3%)

Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-ASYLQKKGRL 282
           K  E +  +  E+ I+    HP +V+ +GA   +  + I++E+   G + A  L+    L
Sbjct: 48  KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL 107

Query: 283 SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +  ++      +   + YLH  K   IIH DLK  N+LL   G +K++ FG+
Sbjct: 108 TEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGV 156

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 30/117 (25%), Positives = 57/117 (48%), Gaps = 3/117 (2%)

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           K+S ++ E       EL ++   +  N+V+   A  +   + +V EY  K  L    +  
Sbjct: 35  KDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP 94

Query: 280 GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             + P KV  +   L + +++ H+   + I+H D+KP+N+L+ +   LK+  FG  R
Sbjct: 95  NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 47.1 bits (111), Expect = 4e-06
 Identities = 40/102 (39%), Positives = 55/102 (53%), Gaps = 8/102 (7%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA-----CEGHVEVVKL 123
           +LD  + L   A +GD K V+ LL  G+DVN+ D DG T LH+AA      EG++EV KL
Sbjct: 70  DLDGRLPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKL 129

Query: 124 LLSKKA---NIDARDRWGSTAAADAKYYGNVEVYNILKARGA 162
           LL   A     + RD  G+T    A   G+ ++  +L   GA
Sbjct: 130 LLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGA 171

Length = 235

>gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 36/123 (29%), Positives = 59/123 (47%), Gaps = 5/123 (4%)

Query: 82  RGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           +GD++ ++ L   G+DVN  D +G   +HIA      +++KLLL K A  + +D  G + 
Sbjct: 134 KGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESP 193

Query: 142 AADAKYYGNVEVYNILKARGAKVP-KTKR--TPMTVA--NPREVPEYELNPLELQVRKAD 196
             +A  YG+     +L   G  +  K K   TP+  A  + R   E  +N   +  +  D
Sbjct: 194 LHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIHNRSAIELLINNASINDQDID 253

Query: 197 GIT 199
           G T
Sbjct: 254 GST 256

Length = 434

>gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat

 Score = 42.6 bits (101), Expect = 4e-06
 Identities = 17/30 (56%), Positives = 23/30 (76%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           DG T LH+AA  G++E+VKLLL   A+I+A
Sbjct: 1   DGNTPLHLAARNGNLELVKLLLEHGADINA 30

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 5/126 (3%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-C 97

Query: 269 KGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            G  +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   G +
Sbjct: 98  LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLV 154

Query: 328 KISGFG 333
           K+  FG
Sbjct: 155 KLGDFG 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 46.9 bits (111), Expect = 6e-06
 Identities = 36/121 (29%), Positives = 60/121 (49%), Gaps = 5/121 (4%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K L+K+  K  +  +   +E  I+EK     VV    A      + +VL     GDL  +
Sbjct: 31  KKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFH 90

Query: 276 LQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +   G       + + +A ++  G+  LH+   + I++ DLKP+NILLD+ G ++IS  G
Sbjct: 91  IYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLG 147

Query: 334 L 334
           L
Sbjct: 148 L 148

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.4 bits (110), Expect = 7e-06
 Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 4/98 (4%)

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           LTI+     PN+V     +     + +VL++   G L S++ K   +    V R+A ++ 
Sbjct: 37  LTIIPHCV-PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMV 95

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++ LH    + I+  DL P NILLD+ G ++++ F 
Sbjct: 96  VALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFS 130

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 12/123 (9%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
            KV VK +     K P R      E+ I++   H  ++  + A  +    + ++    K 
Sbjct: 120 KKVIVKAVTG--GKTPGR------EIDILKTISHRAIINLIHAY-RWKSTVCMVMPKYKC 170

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           DL +Y+ + G L   + +     L   + YLH      IIH D+K +NI LD      + 
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLG 227

Query: 331 GFG 333
            FG
Sbjct: 228 DFG 230

Length = 392

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 3/99 (3%)

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S +++  +A ++ 
Sbjct: 48  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            G+ ++H      +++ DLKP NILLD  G ++IS  GL
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL 143

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S  ++  +A ++ 
Sbjct: 48  LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            G+ ++H      +++ DLKP NILLD  G ++IS  GL
Sbjct: 108 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL 143

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.5 bits (111), Expect = 9e-06
 Identities = 45/149 (30%), Positives = 67/149 (44%), Gaps = 19/149 (12%)

Query: 201 GSY-QVAK----WNGTKVWVKILDK--ESHKDPERINAFTHELTIVEKARHPNVVQFVGA 253
           G+Y QV        G KV +K L +  +S    +R      EL +++   H NV+  +  
Sbjct: 26  GAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT---YRELRLLKHMDHENVIGLLDV 82

Query: 254 VTQNIPMM----IVLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
            T    +     + L  H  G DL + + K  +LS   +      + RG+ Y+H      
Sbjct: 83  FTPASSLEDFQDVYLVTHLMGADLNNIV-KCQKLSDDHIQFLVYQILRGLKYIHSAG--- 138

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           IIH DLKP NI ++   +LKI  FGL R 
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARH 167

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 5/127 (3%)

Query: 209 NGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N  KV+ +KIL+K           F  E  ++    +  +     A      + +V++Y+
Sbjct: 24  NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83

Query: 268 AKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             GDL + L K     P  + RF L ++   ++ +H+      +H D+KP NIL+D  G 
Sbjct: 84  VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 140

Query: 327 LKISGFG 333
           ++++ FG
Sbjct: 141 IRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 32/122 (26%), Positives = 58/122 (47%), Gaps = 5/122 (4%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K +     +  E+      E+  +++ +HPN +++ G   +     +V+EY   G  
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSA 111

Query: 273 ASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   GQ+K++ 
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLAD 168

Query: 332 FG 333
           FG
Sbjct: 169 FG 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 9/112 (8%)

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
             V +K+L    H+D     AF    +++ +  H ++V+  G V      ++V EY   G
Sbjct: 31  VSVVLKVLGS-DHRDSL---AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFG 85

Query: 271 DLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
            L  +L + K  +S    L  A  LA  ++YL + K   ++H ++  KNIL+
Sbjct: 86  PLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 33/128 (25%), Positives = 63/128 (49%), Gaps = 7/128 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G +V VK++D       +R     +E+ I+   +H NVV+   +      + +++E+
Sbjct: 43  KHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   + +  RL+  ++      + + + YLH      +IH D+K  +ILL   G+
Sbjct: 100 LQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGR 155

Query: 327 LKISGFGL 334
           +K+S FG 
Sbjct: 156 VKLSDFGF 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 22/152 (14%)

Query: 198 ITKGSY----QVA-KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I KG+Y    +V  K +G+   VKILD  S  D E I A   E  I++    HPNVV+F 
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEA---EYNILQSLPNHPNVVKFY 85

Query: 252 GAVTQNI-----PMMIVLEYHAKG---DLASYLQKKGRLSPSKVLRFALDLAR-GMNYLH 302
           G   +        + +VLE    G   +L   L   G+     ++ + L  A  G+ +LH
Sbjct: 86  GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
               + IIH D+K  NILL   G +K+  FG+
Sbjct: 146 N---NRIIHRDVKGNNILLTTEGGVKLVDFGV 174

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 33/122 (27%), Positives = 58/122 (47%), Gaps = 5/122 (4%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK +     +  E+      E+  +++ +HPN +++ G   +     +V+EY   G  
Sbjct: 49  VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY-CLGSA 107

Query: 273 ASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   GQ+K++ 
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLAD 164

Query: 332 FG 333
           FG
Sbjct: 165 FG 166

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 13/108 (12%)

Query: 235 ELTIVEKARH-PNVVQFVGAVTQN----IPM--M-IVLEYHAKGDLASYLQKKGRLSPSK 286
           +L +V ++   P +V+F GA+ +     I M  M I L+   K     Y   K  +    
Sbjct: 52  DLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYK---YVYEVLKSVIPEEI 108

Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           + + A+   + +NYL E     IIH D+KP NILLD  G +K+  FG+
Sbjct: 109 LGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGI 154

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 31/110 (28%), Positives = 59/110 (53%), Gaps = 9/110 (8%)

Query: 231 AFTHELTIVEKA------RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP 284
           A T E T  E+       R P +V    A   +  + ++L+Y   G+L ++L ++   + 
Sbjct: 45  AKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE 104

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           S+V  +  ++   +++LH+     II+ D+K +NILLD+ G + ++ FGL
Sbjct: 105 SEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGL 151

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 34/121 (28%), Positives = 60/121 (49%), Gaps = 5/121 (4%)

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K L+ E  K  ++I A   E+ ++++ RH N+V  +    +   + +V E+     L   
Sbjct: 33  KFLESEDDKMVKKI-AM-REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDL 90

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            +    L  S+V ++   + RG+ + H      IIH D+KP+NIL+   G +K+  FG  
Sbjct: 91  EKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFA 147

Query: 336 R 336
           R
Sbjct: 148 R 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 13/156 (8%)

Query: 192 VRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQF 250
           VRK  G   G     K       V+      H   ER         ++E  R  P +V  
Sbjct: 19  VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTER--------NVLEHVRQSPFLVTL 70

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             A      + ++L+Y + G++ ++L ++   S  +V  ++ ++   + +LH+     I+
Sbjct: 71  HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IV 127

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           + D+K +NILLD+ G + ++ FGL + +++S EK +
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSK-EFLSEEKER 162

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 40/135 (29%), Positives = 56/135 (41%), Gaps = 34/135 (25%)

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF- 290
           F  E  I+  A    +VQ   A   +  + +V+EY   GDL + +       P K  RF 
Sbjct: 90  FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFY 147

Query: 291 ------ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL-LRLQ----- 338
                 ALD    M +         IH D+KP N+LLD  G LK++ FG  +++      
Sbjct: 148 TAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198

Query: 339 ----------YISPE 343
                     YISPE
Sbjct: 199 RCDTAVGTPDYISPE 213

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 32/129 (24%), Positives = 67/129 (51%), Gaps = 16/129 (12%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA-VTQNIPMM-----IVLEYH 267
           +K++D    ++ E       E+ +++K + H N+  + GA + +N P M     +V+E+ 
Sbjct: 36  IKVMDVTGDEEEE----IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 91

Query: 268 AKGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
             G +   ++  K   L    +     ++ RG+++LH+ K   +IH D+K +N+LL    
Sbjct: 92  GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 148

Query: 326 QLKISGFGL 334
           ++K+  FG+
Sbjct: 149 EVKLVDFGV 157

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 28/101 (27%), Positives = 56/101 (55%), Gaps = 4/101 (3%)

Query: 235 ELTIVEKARH-PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
           E  ++E  R  P +V    A   +  + ++L+Y   G+L ++L ++ R    +V  ++ +
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +   + +LH+     II+ D+K +NILLD+ G + ++ FGL
Sbjct: 114 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 151

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 39/143 (27%), Positives = 62/143 (43%), Gaps = 30/143 (20%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTH---------ELTIVEKARHPNVVQFVGAVT-QNI 258
            G KV +K           +I+ F H         E+ I+ + +H N++  +  +   + 
Sbjct: 29  TGVKVAIK-----------KISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77

Query: 259 PMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                  IV E   + DL   + K   LS   +  F   + RG+ Y+H      ++H DL
Sbjct: 78  ESFNDVYIVQEL-METDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDL 132

Query: 315 KPKNILLDNGGQLKISGFGLLRL 337
           KP N+LL+    LKI  FGL R+
Sbjct: 133 KPSNLLLNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 29/105 (27%), Positives = 55/105 (52%), Gaps = 7/105 (6%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS--PSKVLRFAL 292
           E++++++ +H N+V+    V     + +V EY    DL  ++      +  P  +  +  
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY-LDLDLKKHMDSSPDFAKNPRLIKTYLY 109

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLR 336
            + RG+ Y H  +   ++H DLKP+N+L+D     LK++ FGL R
Sbjct: 110 QILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 33/127 (25%), Positives = 58/127 (45%), Gaps = 7/127 (5%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
               V +K +     +  E+      E+  +++ RHPN +++ G   +     +V+EY  
Sbjct: 39  TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-C 97

Query: 269 KGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            G  +  L+  KK  L   ++        +G+ YLH  +    IH D+K  NILL   G 
Sbjct: 98  LGSASDILEVHKKP-LQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGT 153

Query: 327 LKISGFG 333
           +K++ FG
Sbjct: 154 VKLADFG 160

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 33/131 (25%), Positives = 58/131 (44%), Gaps = 10/131 (7%)

Query: 206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
            K   T V VK ++ +S    E +     E+    + +HPN++ +V +   +  + +V  
Sbjct: 21  HKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSP 79

Query: 266 YHAKG---DLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILL 321
             A G   DL      +G   P   + F L D+   ++Y+H       IH  +K  +ILL
Sbjct: 80  LMAYGSCEDLLKTHFPEGL--PELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILL 134

Query: 322 DNGGQLKISGF 332
              G++ +SG 
Sbjct: 135 SGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 13/133 (9%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP--MMIVLEY 266
            G    +K + K+  K  E++N       +   + HPN+++ +  +       + +V E 
Sbjct: 23  TGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81

Query: 267 HAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
               D+  Y   KGR   L   +V  +   L + ++++H      I H D+KP+NIL+ +
Sbjct: 82  M---DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD 135

Query: 324 GGQLKISGFGLLR 336
              LK++ FG  R
Sbjct: 136 -DILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 22/75 (29%), Positives = 43/75 (57%), Gaps = 4/75 (5%)

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKN 318
           + +V++Y+  GDL + L K     P  + RF + ++   ++ +H+      +H D+KP N
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDN 132

Query: 319 ILLDNGGQLKISGFG 333
           +LLD  G ++++ FG
Sbjct: 133 VLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 44.2 bits (104), Expect = 4e-05
 Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 5/103 (4%)

Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E  I+EK     VV    A      + +VL     GDL  ++   G       + + +A
Sbjct: 49  NEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYA 108

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            +L  G+  L     + I++ DLKP+NILLD+ G ++IS  GL
Sbjct: 109 AELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGL 148

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 21/47 (44%), Positives = 27/47 (57%), Gaps = 3/47 (6%)

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           F   L RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R
Sbjct: 113 FLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 21/81 (25%), Positives = 39/81 (48%)

Query: 91  LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN 150
           L+  G+D +  + D  + LH+A   G ++ ++LL+  KA +D  D  G T    A   G+
Sbjct: 121 LIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGD 180

Query: 151 VEVYNILKARGAKVPKTKRTP 171
           + +  +L   GA +    +  
Sbjct: 181 IAICKMLLDSGANIDYFGKNG 201

Length = 413

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.9 bits (103), Expect = 7e-05
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 66  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 126 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 7e-05
 Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 17/107 (15%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E  ++ ++  P VV    +      + +++E+   GDL + L K    S   V RF    
Sbjct: 51  ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFS-EDVTRF---- 105

Query: 295 ARGMNYLHEC--KPDPI-----IHCDLKPKNILLDNGGQLKISGFGL 334
                Y+ EC    + +     IH D+KP NIL+D GG +K+S FGL
Sbjct: 106 -----YMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 8e-05
 Identities = 27/100 (27%), Positives = 50/100 (50%), Gaps = 10/100 (10%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKGDLASYLQKK----GRLSPSKVL 288
           E+ ++ + +H N+V+++       N  + I++E+   GDL+  +QK     G++    ++
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 289 RFALDLARGMNYLHECKPDP----IIHCDLKPKNILLDNG 324
                L   + Y H  K  P    ++H DLKP+NI L  G
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161

Length = 1021

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 5/121 (4%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K L K+   +  ++     E  I+ +A +  VV+   +      +  V++Y   GD+ S
Sbjct: 31  MKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS 90

Query: 275 YLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            L +   + P  + RF + +L   +  +H+      IH D+KP NIL+D  G +K++ FG
Sbjct: 91  LLIRME-VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFG 146

Query: 334 L 334
           L
Sbjct: 147 L 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 13/138 (9%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ----FVGAVTQN--I 258
           + K  G KV +K L +    +     A+  ELT+++  +H NV+     F  AV+ +   
Sbjct: 35  IDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93

Query: 259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
              +V+ Y  + DL   +     LS  KV      +  G+ Y+H      IIH DLKP N
Sbjct: 94  DFYLVMPY-MQTDLQKIMGHP--LSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGN 147

Query: 319 ILLDNGGQLKISGFGLLR 336
           + ++   +LKI  FGL R
Sbjct: 148 LAVNEDCELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 15/148 (10%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I +GSY V      +  G  V +K    ES  DP        E+ ++++ +HPN+V  + 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 253 AVTQNIPMMIVLEY--HAKGDLASYLQKKGRLSPS-KVLRFALDLARGMNYLHECKPDPI 309
              +   + +V EY  H    + + L+K  R  P   + +      + +N+ H+      
Sbjct: 68  VFRRKRKLHLVFEYCDHT---VLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---C 121

Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLRL 337
           IH D+KP+NIL+   GQ+K+  FG  R+
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARI 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 27/100 (27%), Positives = 46/100 (46%), Gaps = 2/100 (2%)

Query: 66  VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
              +  +T  L +     D +  E LL+ G++VN  D    + LH A    +  +V +LL
Sbjct: 163 KDRHKGNT-ALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILL 221

Query: 126 SKKANIDARDRWGSTAAADA-KYYGNVEVYNILKARGAKV 164
              A+ DARD+ G+T    +  Y  + ++  +L   G  V
Sbjct: 222 ENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDV 261

Length = 477

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 5/101 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-D 293
           E  I+ +A +  VV+   +      +  V++Y   GD+ S L + G + P  + RF + +
Sbjct: 51  ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAE 109

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           L   +  +H+      IH D+KP NIL+D  G +K++ FGL
Sbjct: 110 LTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 33/128 (25%), Positives = 63/128 (49%), Gaps = 7/128 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G  V VK +D    +  +R     +E+ I+   +H NVV+   +      + +V+E+
Sbjct: 42  KSSGKLVAVKKMDL---RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G+
Sbjct: 99  LEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGR 154

Query: 327 LKISGFGL 334
           +K+S FG 
Sbjct: 155 VKLSDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 24/65 (36%), Positives = 34/65 (52%), Gaps = 3/65 (4%)

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +ARGM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI 223

Query: 339 YISPE 343
           Y  P+
Sbjct: 224 YKDPD 228

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 19/53 (35%), Positives = 31/53 (58%), Gaps = 3/53 (5%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
               +   +   +  G+ +LH+ +   II+ DLKP+N+LLDN G ++IS  GL
Sbjct: 94  FPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGL 143

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 12/93 (12%)

Query: 55  IRRSPVQDELTVPE------------NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID 102
           I+    QDEL + E            ++     + + A RG+ K V  LL+ G+DVN I 
Sbjct: 149 IKERIQQDELLIAEMLLEGGADVNAKDIYCITPIHYAAERGNAKMVNLLLSYGADVNIIA 208

Query: 103 LDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LD  + L  A    +++ +K ++  ++NI+  D
Sbjct: 209 LDDLSVLECAVDSKNIDTIKAIIDNRSNINKND 241

Length = 682

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 1/95 (1%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK 128
           N D    L      GD+KG+E L++  + ++  D  G T L IA  +G + + K+LL   
Sbjct: 132 NTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSG 191

Query: 129 ANIDARDRWGSTAAADAKYYGN-VEVYNILKARGA 162
           ANID   + G  AA       N +++  +   RGA
Sbjct: 192 ANIDYFGKNGCVAALCYAIENNKIDIVRLFIKRGA 226

Length = 413

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 32/99 (32%), Positives = 48/99 (48%), Gaps = 2/99 (2%)

Query: 68  ENLDSTMQLLFMACRG-DVKGVEDLLNEGSDVNSIDLDGRTALHIAAC-EGHVEVVKLLL 125
           +N+     L  MA  G D + +  L+  G+DVN+ D    T LH A+  + + ++V  LL
Sbjct: 303 KNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLL 362

Query: 126 SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
              AN++ARD    T    A    NV + N L   GA +
Sbjct: 363 ELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADI 401

Length = 682

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 9/107 (8%)

Query: 235 ELTIVEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           EL +++  +H NV+  +   T     +N   + ++      DL + + K  +LS   V  
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV-KCQKLSDEHVQF 122

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
               L RG+ Y+H      IIH DLKP N+ ++   +L+I  FGL R
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 41.4 bits (98), Expect = 4e-04
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L + + Y+H      +IH DLKP NILL++  ++K++ FGL R
Sbjct: 116 LLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 19/56 (33%), Positives = 32/56 (57%), Gaps = 6/56 (10%)

Query: 84  DVKGVEDLLNEGSDVNSIDLDGRTALHI----AACEGHVEVVKLLLSKKANIDARD 135
           + K +  LL +G+DVN++DL G T L +          VE+++LL+   A++ A D
Sbjct: 131 NPKVIRLLLRKGADVNALDLYGMTPLAVLLKSRNAN--VELLRLLIDAGADVYAVD 184

Length = 471

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 20/52 (38%), Positives = 33/52 (63%), Gaps = 1/52 (1%)

Query: 82  RGDVKGVEDLLNEGSDVNSIDL-DGRTALHIAACEGHVEVVKLLLSKKANID 132
            GDVK VE+LL+ G   + +   DG T LH+A     ++++KLL+++ A+ D
Sbjct: 78  EGDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPD 129

Length = 413

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 40.8 bits (95), Expect = 6e-04
 Identities = 31/129 (24%), Positives = 64/129 (49%), Gaps = 16/129 (12%)

Query: 215 VKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIP------MMIVLEYH 267
           +K++D    ++ E       E+ +++K + H N+  + GA  +  P      + +V+E+ 
Sbjct: 46  IKVMDVTEDEEEE----IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFC 101

Query: 268 AKGDLASYLQK-KGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
             G +   ++  KG  L    +     ++ RG+ +LH  K   +IH D+K +N+LL    
Sbjct: 102 GAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENA 158

Query: 326 QLKISGFGL 334
           ++K+  FG+
Sbjct: 159 EVKLVDFGV 167

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 40/181 (22%)

Query: 191 QVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV-- 248
           + ++ DG  +  Y + +  GT + +               +   E+ ++ + +HPNV+  
Sbjct: 19  KAKRKDGKDEKEYALKQIEGTGISM---------------SACREIALLRELKHPNVIAL 63

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDL--------ASYLQKKGRLSPSKVLRFAL-DLARGMN 299
           Q V     +  + ++ +Y A+ DL        AS   KK    P  +++  L  +  G++
Sbjct: 64  QKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 300 YLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
           YLH    + ++H DLKP NIL+       G++KI+  G  RL + SP K     P++ +D
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FNSPLK-----PLADLD 173

Query: 356 P 356
           P
Sbjct: 174 P 174

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 27/68 (39%), Positives = 39/68 (57%), Gaps = 3/68 (4%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L K + +  E+  A   EL I+     H N+V  +GA T++ P+ I+ EY   G
Sbjct: 69  KVAVKML-KPTARSSEK-QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYG 126

Query: 271 DLASYLQK 278
           DL +YL K
Sbjct: 127 DLVNYLHK 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 23/126 (18%)

Query: 222 SHKD-PERI-------NAFTHELTIVEKARHPNV-----VQFVGAVTQNIPMMIVLEYHA 268
           SH D P+R+        +  HE  ++ +  HP V     V+ VG +T     +++ +Y +
Sbjct: 189 SHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLT----CLVLPKYRS 244

Query: 269 KGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
             DL +YL  + R L  ++V   A  L   ++Y+H    + IIH D+K +N+L++    +
Sbjct: 245 --DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDI 299

Query: 328 KISGFG 333
            +  FG
Sbjct: 300 CLGDFG 305

Length = 461

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 26/68 (38%), Positives = 37/68 (54%), Gaps = 3/68 (4%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L K + +  E+  A   EL I+     H N+V  +GA T+  P+ I+ EY   G
Sbjct: 69  KVAVKML-KSTARSSEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYG 126

Query: 271 DLASYLQK 278
           DL  YL +
Sbjct: 127 DLVDYLHR 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 39/136 (28%), Positives = 67/136 (49%), Gaps = 23/136 (16%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY-HAKGDL--------ASYLQKKGRLSPS 285
           E+ ++ + +HPNV+        +    + L + +A+ DL        AS   KK    P 
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107

Query: 286 KVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLLRLQYI 340
            +++  L  +  G++YLH    + ++H DLKP NIL+       G++KI+  G  RL + 
Sbjct: 108 GMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL-FN 163

Query: 341 SPEKAKIVFPVSHIDP 356
           SP K     P++ +DP
Sbjct: 164 SPLK-----PLADLDP 174

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 14/26 (53%), Positives = 19/26 (73%)

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGL 334
           +IH D+KP NILLD  G +K+  FG+
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGI 161

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 23/57 (40%), Positives = 31/57 (54%), Gaps = 7/57 (12%)

Query: 282 LSPSKVLRFALDLARGMNYL--HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L    +L F+  +A+GM++L    C     IH DL  +NILL +G   KI  FGL R
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC-----IHRDLAARNILLTHGRITKICDFGLAR 262

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 22/54 (40%), Positives = 29/54 (53%), Gaps = 3/54 (5%)

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE 343
           ++  +ARGM +L   K    IH DL  +NILL     +KI  FGL R  Y  P+
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 229

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|222925 PHA02743, PHA02743, Viral ankyrin protein; Provisional

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 6/94 (6%)

Query: 75  QLLFMACRGDVKG----VEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSK-K 128
           Q   M    D       +E L+N G+D+N+ +L  G T LHIAA   + E+ + L  +  
Sbjct: 59  QCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLG 118

Query: 129 ANIDARDRWGSTAAADAKYYGNVEVYNILKARGA 162
            N+ A +    TA   A    +  +  IL+A GA
Sbjct: 119 VNLGAINYQHETAYHIAYKMRDRRMMEILRANGA 152

Length = 166

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 23/65 (35%), Positives = 34/65 (52%), Gaps = 3/65 (4%)

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDI 229

Query: 339 YISPE 343
           Y  P+
Sbjct: 230 YKDPD 234

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 38.3 bits (88), Expect = 0.003
 Identities = 26/55 (47%), Positives = 31/55 (56%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L  A   GD   VE LL  G+D NS +  G TAL  AA  G +E+VKLLL K  +
Sbjct: 151 LHWAALNGDADIVELLLEAGADPNSRNSYGVTALDPAAKNGRIELVKLLLDKGLH 205

Length = 235

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 22/57 (38%), Positives = 32/57 (56%), Gaps = 7/57 (12%)

Query: 282 LSPSKVLRFALDLARGMNYL--HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L    +LRF+  +A+GM++L    C     IH D+  +N+LL +G   KI  FGL R
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNC-----IHRDVAARNVLLTDGRVAKICDFGLAR 260

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.4 bits (87), Expect = 0.003
 Identities = 17/50 (34%), Positives = 24/50 (48%)

Query: 280 GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
             +S  +    A  LA  +  LH+     + H DL P NIL+D+G  L I
Sbjct: 81  DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGI 130

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 30/85 (35%), Positives = 45/85 (52%), Gaps = 10/85 (11%)

Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVT 255
           GI K S      +   V VK+L KE     E   A   EL I +    H NVV  +GA T
Sbjct: 30  GIDKKS------SCNTVAVKML-KEGATASEH-KALMSELKILIHIGNHLNVVNLLGACT 81

Query: 256 Q-NIPMMIVLEYHAKGDLASYLQKK 279
           + N P+M+++E+   G+L+++L+ K
Sbjct: 82  KPNGPLMVIVEFCKYGNLSNFLRAK 106

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	359
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.97
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.97
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.97
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.96
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.96
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.96
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.95
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.95
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.95
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.95
KOG0198	313	consensus MEKK and related serine/threonine protei	99.95
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.95
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.94
KOG0605	550	consensus NDR and related serine/threonine kinases	99.94
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.94
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.94
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.94
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.94
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.94
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.94
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.94
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.93
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.93
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.93
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.93
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.93
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.93
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.93
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.93
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.93
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.93
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.93
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.93
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.93
KOG0610	459	consensus Putative serine/threonine protein kinase	99.93
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.93
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.93
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.93
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.93
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.93
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.93
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.93
KOG0589	426	consensus Serine/threonine protein kinase [General	99.92
KOG0578	550	consensus p21-activated serine/threonine protein k	99.92
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.92
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.92
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.92
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.92
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.92
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.92
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.92
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.92
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.92
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.92
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.92
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.92
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.92
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.92
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.92
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.92
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.92
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.92
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.92
PHA02988	283	hypothetical protein; Provisional	99.92
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.92
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.92
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.92
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.92
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.91
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.91
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.91
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.91
KOG0584	632	consensus Serine/threonine protein kinase [General	99.91
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.91
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.91
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.91
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.91
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.91
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.91
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.91
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.91
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.91
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.91
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.91
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.91
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.91
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.91
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.91
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.91
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.91
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.91
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.91
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.91
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.91
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.91
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.9
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.9
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.9
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.9
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.9
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.9
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.9
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.9
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.9
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.9
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.9
PHA03212	391	serine/threonine kinase US3; Provisional	99.9
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.9
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.9
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.89
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.89
PTZ00267	478	NIMA-related protein kinase; Provisional	99.89
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.89
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.89
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.89
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.89
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.89
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.89
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.89
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.89
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.89
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.89
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.89
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.89
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.89
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.89
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.89
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.89
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.89
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.89
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.89
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.88
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.88
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.88
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.88
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.88
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.88
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.88
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.88
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.88
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.88
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.88
PTZ00283	496	serine/threonine protein kinase; Provisional	99.88
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.88
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.88
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.88
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.88
KOG3653	534	consensus Transforming growth factor beta/activin	99.88
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.88
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.88
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.88
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.88
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.88
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.88
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.88
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.88
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.88
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.88
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.88
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.88
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.88
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.88
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.88
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.88
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.88
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.88
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.88
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.88
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.88
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.87
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.87
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.87
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.87
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.87
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.87
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.87
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.87
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.87
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.87
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.87
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.87
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.87
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.87
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.87
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.87
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.87
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.87
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.87
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.87
PTZ00036	440	glycogen synthase kinase; Provisional	99.87
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.87
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.87
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.87
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.87
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.87
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.87
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.87
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.87
PHA03209	357	serine/threonine kinase US3; Provisional	99.87
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.87
PHA02743	166	Viral ankyrin protein; Provisional	99.87
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.87
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.87
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.87
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.87
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.87
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.87
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.87
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.87
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.87
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.87
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.87
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.87
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.87
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.87
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.87
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.87
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.87
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.87
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.87
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.87
PHA03207	392	serine/threonine kinase US3; Provisional	99.87
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.87
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.87
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.87
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.87
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.87
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.86
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.86
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.86
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.86
PHA03211	461	serine/threonine kinase US3; Provisional	99.86
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.86
PHA02791	284	ankyrin-like protein; Provisional	99.86
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.86
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.86
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.86
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.86
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.86
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.86
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.86
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.86
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.86
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.86
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.86
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.86
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.86
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.86
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.86
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.86
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.86
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.86
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.86
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.86
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.86
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.86
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.86
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.86
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.86
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.86
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.86
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.86
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.86
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.85
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.85
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.85
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.85
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.85
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.85
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.85
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.85
KOG1152	772	consensus Signal transduction serine/threonine kin	99.85
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.85
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.85
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.85
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.85
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.85
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.85
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.85
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.85
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.85
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.85
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.85
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.85
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.85
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.85
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.85
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.85
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.85
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.85
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.85
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.85
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.85
KOG0508	615	consensus Ankyrin repeat protein [General function	99.85
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.85
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.85
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.85
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.85
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.85
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.85
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.85
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.85
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.85
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.85
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.85
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.85
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.84
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.84
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.84
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.84
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.84
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.84
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.84
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.84
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.84
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.84
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.84
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.84
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.84
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.84
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.84
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.84
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.84
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.84
PHA02859	209	ankyrin repeat protein; Provisional	99.84
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.84
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.84
PHA02791	284	ankyrin-like protein; Provisional	99.84
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.84
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.84
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.84
PLN00009	294	cyclin-dependent kinase A; Provisional	99.84
PHA02875	413	ankyrin repeat protein; Provisional	99.84
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.84
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.84
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.83
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.83
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.83
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.83
PTZ00284	467	protein kinase; Provisional	99.83
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.83
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.83
PHA03210	501	serine/threonine kinase US3; Provisional	99.83
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.83
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.83
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.83
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.83
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.83
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.83
PHA02859	209	ankyrin repeat protein; Provisional	99.83
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.83
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.83
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.83
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.83
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.83
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.83
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.82
KOG0508	615	consensus Ankyrin repeat protein [General function	99.82
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.82
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.82
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.82
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.82
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.82
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.82
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.82
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.82
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.82
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.82
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.82
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.82
PHA02878	477	ankyrin repeat protein; Provisional	99.82
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.82
PHA02878	477	ankyrin repeat protein; Provisional	99.82
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.81
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.81
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.81
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.81
PHA02741	169	hypothetical protein; Provisional	99.81
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.81
KOG0502	296	consensus Integral membrane ankyrin-repeat protein	99.81
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.81
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.81
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.81
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.81
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.81
PHA02741	169	hypothetical protein; Provisional	99.81
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.81
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.81
PHA02884	300	ankyrin repeat protein; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.8
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.8
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.8
PHA03095	471	ankyrin-like protein; Provisional	99.8
PHA02875	413	ankyrin repeat protein; Provisional	99.8
PHA02946	446	ankyin-like protein; Provisional	99.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.8
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.8
PHA02884	300	ankyrin repeat protein; Provisional	99.79
PHA02874	434	ankyrin repeat protein; Provisional	99.79
KOG0505	527	consensus Myosin phosphatase, regulatory subunit [	99.79
PHA02736	154	Viral ankyrin protein; Provisional	99.79
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.79
PHA03100	480	ankyrin repeat protein; Provisional	99.79
PHA02795	437	ankyrin-like protein; Provisional	99.79
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.79
PHA02874	434	ankyrin repeat protein; Provisional	99.79
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.78
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.78
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.78
PHA03100	480	ankyrin repeat protein; Provisional	99.78
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.78
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.78
PRK10345	210	hypothetical protein; Provisional	99.78
PHA02882	294	putative serine/threonine kinase; Provisional	99.78
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.77
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.77
PHA02798	489	ankyrin-like protein; Provisional	99.77
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.77
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.77
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.77
KOG0510	929	consensus Ankyrin repeat protein [General function	99.77
KOG0510	929	consensus Ankyrin repeat protein [General function	99.77
PHA02946	446	ankyin-like protein; Provisional	99.76
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.76
PHA02917	661	ankyrin-like protein; Provisional	99.76
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.76
PHA02743	166	Viral ankyrin protein; Provisional	99.76
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.76
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.75
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.75
PHA03095	471	ankyrin-like protein; Provisional	99.75
PHA02798	489	ankyrin-like protein; Provisional	99.75
PHA02876	682	ankyrin repeat protein; Provisional	99.74
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.74
KOG0514	452	consensus Ankyrin repeat protein [General function	99.74
PHA02989	494	ankyrin repeat protein; Provisional	99.74
PHA02917	661	ankyrin-like protein; Provisional	99.73
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.73
PHA02795	437	ankyrin-like protein; Provisional	99.73
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.73
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.73
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.72
PRK12274	218	serine/threonine protein kinase; Provisional	99.72
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.72
PHA02989	494	ankyrin repeat protein; Provisional	99.72
PHA02876	682	ankyrin repeat protein; Provisional	99.72
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
PHA02736	154	Viral ankyrin protein; Provisional	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
PHA02730	672	ankyrin-like protein; Provisional	99.71
KOG0514	452	consensus Ankyrin repeat protein [General function	99.7
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.7
PF13857	56	Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A	99.7
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG0515	752	consensus p53-interacting protein 53BP/ASPP, conta	99.68
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.67
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
PHA02730	672	ankyrin-like protein; Provisional	99.66
smart00090	237	RIO RIO-like kinase.	99.66
PF13637	54	Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A	99.66
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.65
PTZ00322	664	6-phosphofructo-2-kinase/fructose-2,6-biphosphatas	99.62
PHA02792	631	ankyrin-like protein; Provisional	99.61
KOG0502	296	consensus Integral membrane ankyrin-repeat protein	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.6
KOG0515	752	consensus p53-interacting protein 53BP/ASPP, conta	99.6
cd00204	126	ANK ankyrin repeats; ankyrin repeats mediate prote	99.59
PHA02792	631	ankyrin-like protein; Provisional	99.59
TIGR00870	743	trp transient-receptor-potential calcium channel p	99.59
KOG0507	854	consensus CASK-interacting adaptor protein (caskin	99.58
TIGR00870	743	trp transient-receptor-potential calcium channel p	99.58
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.58
PLN00181	793	protein SPA1-RELATED; Provisional	99.57
COG0666	235	Arp FOG: Ankyrin repeat [General function predicti	99.57
KOG1710	396	consensus MYND Zn-finger and ankyrin repeat protei	99.57
cd00204	126	ANK ankyrin repeats; ankyrin repeats mediate prote	99.56
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.55
PF13857	56	Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A	99.54
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.54
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.54
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.52
COG0666	235	Arp FOG: Ankyrin repeat [General function predicti	99.51
PTZ00322	664	6-phosphofructo-2-kinase/fructose-2,6-biphosphatas	99.51

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=284.65  Aligned_cols=302  Identities=29%  Similarity=0.442  Sum_probs=245.0

Q ss_pred             cceeeccCCCCCcCcCCcccccCCCCC-CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      ..|.+|++|+.-.|+--+.+..-+.+. |..|.+||||||..||..+|+.||..|+.||.+|....||||+||..||.+|
T Consensus         3 dif~wcregna~qvrlwld~tehdln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdi   82 (448)
T KOG0195|consen    3 DIFGWCREGNAFQVRLWLDDTEHDLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDI   82 (448)
T ss_pred             hhhhhhhcCCeEEEEEEecCcccccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHH
Confidence            357889999999998888877777777 7789999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccCCCC-----------------CC
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPR-----------------EV  180 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~~~-----------------~~  180 (359)
                      |+.|++..+|+|+.|.+|+|||||||++|+..+++-|+..||.+   ++.+.||+..+.+.                 .+
T Consensus        83 vqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nri  162 (448)
T KOG0195|consen   83 VQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRI  162 (448)
T ss_pred             HHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCcc
Confidence            99999999999999999999999999999999999999999987   67778887665321                 00


Q ss_pred             C----ccc----------C------CcceeeEe-eccCcccceeEEEEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHH
Q 018204          181 P----EYE----------L------NPLELQVR-KADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIV  239 (359)
Q Consensus       181 ~----~~~----------l------~~~~~~~~-~~~~ig~g~~~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il  239 (359)
                      +    .|.          +      +-..+++. .....-+|..+..+|.|..+++|++..... .......|..|.-.+
T Consensus       163 pfkdt~wkgtktr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~l  241 (448)
T KOG0195|consen  163 PFKDTTWKGTKTRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPAL  241 (448)
T ss_pred             cccccccccccccccccccccccCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcce
Confidence            0    000          0      00000000 011123455566789999999999864432 344556799999999


Q ss_pred             HhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC-CCCC
Q 018204          240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHC-DLKP  316 (359)
Q Consensus       240 ~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHr-Dlk~  316 (359)
                      +.+.||||+.+++.|.....+.++..|++.|||+..++....  ++..++.+++.+++.|++|||+..|  +|-| -|..
T Consensus       242 rifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns  319 (448)
T KOG0195|consen  242 RIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNS  319 (448)
T ss_pred             eeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhccc
Confidence            999999999999999999999999999999999999988654  6778899999999999999999874  7766 7899


Q ss_pred             CcEEEcCCCcEEEe--cccccc--------ccccCccccc
Q 018204          317 KNILLDNGGQLKIS--GFGLLR--------LQYISPEKAK  346 (359)
Q Consensus       317 ~NIll~~~~~~kl~--DFGla~--------~~~~~PE~~~  346 (359)
                      ..++||++.+.+|+  |--+|-        +.||+||..+
T Consensus       320 ~hvmidedltarismad~kfsfqe~gr~y~pawmspealq  359 (448)
T KOG0195|consen  320 KHVMIDEDLTARISMADTKFSFQEVGRAYSPAWMSPEALQ  359 (448)
T ss_pred             ceEEecchhhhheecccceeeeeccccccCcccCCHHHHh
Confidence            99999998876665  422221        3578888765

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=254.96  Aligned_cols=152  Identities=34%  Similarity=0.619  Sum_probs=135.8

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|+|.++     +..+..||||.+.+... .+...+.+..|+++++.++|||||.+++++..++.+|+|||
T Consensus        11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             cceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            3445556899999865     34678999999976654 45667788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC------CcEEEecccccc---
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG------GQLKISGFGLLR---  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~------~~~kl~DFGla~---  336 (359)
                      ||.||+|.+|++..+.+++.+++.++.|++.||++||+++   ||||||||+||||+..      -.+||+|||+||   
T Consensus        90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            9999999999999999999999999999999999999999   9999999999999875      459999999998   


Q ss_pred             -----------ccccCccccc
Q 018204          337 -----------LQYISPEKAK  346 (359)
Q Consensus       337 -----------~~~~~PE~~~  346 (359)
                                 +.|||||...
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~  187 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIM  187 (429)
T ss_pred             chhHHHHhhCCccccCHHHHH
Confidence                       4699999864

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=239.69  Aligned_cols=150  Identities=32%  Similarity=0.518  Sum_probs=132.7

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc-EEEEEec
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-MMIVLEY  266 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lv~e~  266 (359)
                      ...+.+|.|..+.+     +.++..+|+|++..  ..++...+++.+|+++++.++||+||.+|++|..+.. ++|+|||
T Consensus        82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            34455666666544     45689999999943  3466777889999999999999999999999999995 9999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |++|||.++++..+.+++.....++.+|++||.|||. ++   ||||||||+|||++..|.+||||||.|+         
T Consensus       160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~t  236 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANT  236 (364)
T ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhhhccc
Confidence            9999999999988899999999999999999999995 77   9999999999999999999999999997         


Q ss_pred             ----ccccCcccccc
Q 018204          337 ----LQYISPEKAKI  347 (359)
Q Consensus       337 ----~~~~~PE~~~~  347 (359)
                          ..|||||+++.
T Consensus       237 fvGT~~YMsPERi~g  251 (364)
T KOG0581|consen  237 FVGTSAYMSPERISG  251 (364)
T ss_pred             ccccccccChhhhcC
Confidence                36999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-32  Score=240.93  Aligned_cols=154  Identities=31%  Similarity=0.493  Sum_probs=140.6

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      -+|.....+|+|+|+.+     +.+++.+|+|++.+.........+....|..++..++||+||+++-.|++...+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            35667778999999854     3468999999999887777777788899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      ||+.||.|...|++.+.+++..++.|+.+|+.||.|||+++   ||||||||+|||+|.+|+++|+||||++        
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            99999999999999999999999999999999999999999   9999999999999999999999999997        


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|||||...
T Consensus       182 t~tfcGT~eYmAPEil~  198 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILL  198 (357)
T ss_pred             cccccCCccccChHHHh
Confidence                   3588888654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.3e-31  Score=239.04  Aligned_cols=156  Identities=29%  Similarity=0.427  Sum_probs=134.5

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCc----HHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKD----PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      ..|.....+|+|+|+.+     +.+|+.||||++.+.....    ........+|+++|++|+|||||+++++|......
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            34566778899999876     3579999999997654332    11223357999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC---CcEEEeccccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLRL  337 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DFGla~~  337 (359)
                      |+||||++||+|.+++-.++.+.+...+.+++|++.|+.|||++|   |+||||||+|||+..+   ..+||+|||+|+.
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhc
Confidence            999999999999999999999999999999999999999999999   9999999999999876   6799999999983


Q ss_pred             --------------cccCccccccc
Q 018204          338 --------------QYISPEKAKIV  348 (359)
Q Consensus       338 --------------~~~~PE~~~~~  348 (359)
                                    .|.|||.++..
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~k  353 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASK  353 (475)
T ss_pred             cccceehhhhcCCccccChhheecC
Confidence                          58888876644

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.4e-30  Score=245.57  Aligned_cols=175  Identities=29%  Similarity=0.431  Sum_probs=150.1

Q ss_pred             CCCcccCCcceeeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceee
Q 018204          179 EVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA  253 (359)
Q Consensus       179 ~~~~~~l~~~~~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  253 (359)
                      ++++...++....|..+.-+|+|+|..+     ..+|+.+|+|++.+.......+.+.+.+|+++.+.|+|||||+|+++
T Consensus         7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~   86 (592)
T KOG0575|consen    7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF   86 (592)
T ss_pred             CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence            4455555555567888889999998643     25799999999988777777788889999999999999999999999


Q ss_pred             EEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       254 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      |++.+.+|||+|+|+.++|..++++.+.+++.+++.+++||+.||.|||+++   |||||||..|+|++++.++||+|||
T Consensus        87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence            9999999999999999999999998899999999999999999999999999   9999999999999999999999999


Q ss_pred             cccccccC-cccccccCCccCCCC
Q 018204          334 LLRLQYIS-PEKAKIVFPVSHIDP  356 (359)
Q Consensus       334 la~~~~~~-PE~~~~~~~~~~~~p  356 (359)
                      ||..--.+ --+.+.|+++.|+||
T Consensus       164 LAt~le~~~Erk~TlCGTPNYIAP  187 (592)
T KOG0575|consen  164 LATQLEYDGERKKTLCGTPNYIAP  187 (592)
T ss_pred             eeeeecCcccccceecCCCcccCh
Confidence            99733222 123344566666665

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4.7e-31  Score=237.44  Aligned_cols=163  Identities=30%  Similarity=0.538  Sum_probs=147.3

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|+|+|+.++     ..|..||||.+++....+...+-.+.+|++||+.|+||||+.+|.+|...+.+.||||
T Consensus        54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME  133 (668)
T KOG0611|consen   54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME  133 (668)
T ss_pred             HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence            45556778999998663     4689999999999888888888889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |..+|.|.+|+.+++.+++.+++.|++||+.|+.|||.++   ++|||||.+|||+|.++++||+|||||.+        
T Consensus       134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence            9999999999999999999999999999999999999998   99999999999999999999999999963        


Q ss_pred             ------cccCcccccccCCccCCCCCCC
Q 018204          338 ------QYISPEKAKIVFPVSHIDPAND  359 (359)
Q Consensus       338 ------~~~~PE~~~~~~~~~~~~p~~~  359 (359)
                            .|.+||..-   ..+|.-|-+|
T Consensus       211 TFCGSPLYASPEIvN---G~PY~GPEVD  235 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVN---GTPYKGPEVD  235 (668)
T ss_pred             HhcCCcccCCccccC---CCCCCCCccc
Confidence                  488999754   5566666554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-30  Score=237.85  Aligned_cols=152  Identities=47%  Similarity=0.737  Sum_probs=130.5

Q ss_pred             CcccCCcceeeEeeccCcccceeEE---EEecCcE-EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe
Q 018204          181 PEYELNPLELQVRKADGITKGSYQV---AKWNGTK-VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ  256 (359)
Q Consensus       181 ~~~~l~~~~~~~~~~~~ig~g~~~~---~~~~g~~-vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  256 (359)
                      ..+.++...+...  ..+|.|+|+.   +.|.|.. +|||.+......... .+.|.+|+.++.+++|||||+|+|++..
T Consensus        34 ~~~~i~~~~l~~~--~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   34 PEEEIDPDELPIE--EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             cceecChHHhhhh--hhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4444444443333  3377777764   4688998 999999876655444 7889999999999999999999999998


Q ss_pred             CC-cEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEecc
Q 018204          257 NI-PMMIVLEYHAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGF  332 (359)
Q Consensus       257 ~~-~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DF  332 (359)
                      .. .+++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+++|  ||||||||+|||++.++ ++||+||
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCC
Confidence            87 79999999999999999987  5679999999999999999999999985  99999999999999998 9999999


Q ss_pred             ccccc
Q 018204          333 GLLRL  337 (359)
Q Consensus       333 Gla~~  337 (359)
                      |+|+.
T Consensus       189 Glsr~  193 (362)
T KOG0192|consen  189 GLSRE  193 (362)
T ss_pred             cccee
Confidence            99973

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=224.47  Aligned_cols=153  Identities=31%  Similarity=0.583  Sum_probs=138.4

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|+|+.+     +.+|.-+|+|++.++....-.+.+...+|..+++.+.||+++++++.|.+...+|+|||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            3445556789999854     34689999999988776677777888999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |++||.|+.++++.++++++.++.++.||+.||+|||+++   |++|||||+|||+|.+|.+||+|||+|+         
T Consensus       125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~Tl  201 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWTL  201 (355)
T ss_pred             ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCcEEEe
Confidence            9999999999999999999999999999999999999999   9999999999999999999999999997         


Q ss_pred             ---ccccCccccc
Q 018204          337 ---LQYISPEKAK  346 (359)
Q Consensus       337 ---~~~~~PE~~~  346 (359)
                         +.|+|||.+.
T Consensus       202 CGTPeYLAPEii~  214 (355)
T KOG0616|consen  202 CGTPEYLAPEIIQ  214 (355)
T ss_pred             cCCccccChHHhh
Confidence               3588888755

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=236.37  Aligned_cols=157  Identities=39%  Similarity=0.664  Sum_probs=139.4

Q ss_pred             EeeccCcccceeEEE---EecCc-EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA---KWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~~g~-~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      +.....+|.|-|+.+   .|+|. +||+|.+.......    +.|.+|+.+|++|+|++||+++++|..+.++||||||+
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence            344567899999854   67887 99999997654322    35889999999999999999999999989999999999


Q ss_pred             CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----cccC
Q 018204          268 AKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYIS  341 (359)
Q Consensus       268 ~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----~~~~  341 (359)
                      +.|+|.++|+.  ...+.......++.||++||+||++++   +|||||.++||||+.+..+||+||||||.    .|.+
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            99999999987  346899999999999999999999999   99999999999999999999999999996    5778


Q ss_pred             cccccccCCccCCCCC
Q 018204          342 PEKAKIVFPVSHIDPA  357 (359)
Q Consensus       342 PE~~~~~~~~~~~~p~  357 (359)
                      -+..+  +|++|+||-
T Consensus       361 ~~~~k--fPIkWtAPE  374 (468)
T KOG0197|consen  361 SEGGK--FPIKWTAPE  374 (468)
T ss_pred             cCCCC--CCceecCHH
Confidence            88777  999999994

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.96  E-value=9.2e-30  Score=236.76  Aligned_cols=145  Identities=30%  Similarity=0.508  Sum_probs=132.9

Q ss_pred             eeeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEE
Q 018204          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l  262 (359)
                      ..+|..++.+|.|+|..+     ...+..+|||++.+........++....|-.+|.+| +||.|++|+..|.+...+|+
T Consensus        72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF  151 (604)
T KOG0592|consen   72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF  151 (604)
T ss_pred             hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence            346777888999999754     346899999999877666666677888999999999 89999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+||+++|+|.++|++.+.+++..++.|+.||+.||+|||++|   ||||||||+|||++.+|++||+|||.|+
T Consensus       152 vLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  152 VLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999999999999999999999999999999   9999999999999999999999999997

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=2.4e-29  Score=218.89  Aligned_cols=148  Identities=26%  Similarity=0.473  Sum_probs=128.7

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|+|+++     +.+|+.||||.+.. ...++...+-.++|++++++++|||+|.++++|.....+++|+|||
T Consensus         5 E~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E-sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~   83 (396)
T KOG0593|consen    5 EKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE-SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC   83 (396)
T ss_pred             hhhhccccCcceEEEEeccCCcccEEEEEeecc-CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence            34456899999976     35799999999964 4456666777899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          268 AKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       268 ~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +. ++.+-|.+ ...++...+..|+.|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+||.         
T Consensus        84 dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   84 DH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             ch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            87 55555554 456999999999999999999999999   99999999999999999999999999983         


Q ss_pred             ------cccCcccc
Q 018204          338 ------QYISPEKA  345 (359)
Q Consensus       338 ------~~~~PE~~  345 (359)
                            .|+|||-.
T Consensus       160 DYVATRWYRaPELL  173 (396)
T KOG0593|consen  160 DYVATRWYRAPELL  173 (396)
T ss_pred             hhhhhhhccChhhh
Confidence                  37888864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7.2e-29  Score=229.04  Aligned_cols=143  Identities=29%  Similarity=0.497  Sum_probs=124.2

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv  263 (359)
                      .|...+++|+|+|+.+     ..+|+.||+|.++..... ++......+||.||++|+||||+++.+.....  ..+|+|
T Consensus       118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4666778999999844     246899999999765532 33344578999999999999999999998876  689999


Q ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccccc
Q 018204          264 LEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~~  338 (359)
                      +|||+. +|.-++...+ .|++.+++.|+.|++.||.|||+++   |+|||||.+|||||.+|.+||+|||||+++
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            999987 9998887643 6999999999999999999999999   999999999999999999999999999853

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.4e-30  Score=221.48  Aligned_cols=156  Identities=26%  Similarity=0.465  Sum_probs=133.4

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCcccccee-eEEeCCc-EEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-AVTQNIP-MMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~~-~~lv  263 (359)
                      +|.+.+.+|.|.|+.+     .++|..+|.|.+. -...+....+....|+.+|++|+|||||++++ .|..+.. ++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4667778999999743     4689999999997 44456667788999999999999999999998 5655555 9999


Q ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEeCCCCCCcEEEcCCCcEEEecccccc--
Q 018204          264 LEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPD-PIIHCDLKPKNILLDNGGQLKISGFGLLR--  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DFGla~--  336 (359)
                      ||||.+|+|.+.++..    +.++++++++++.|++.||.+||+.-|. -|+||||||.||+++.+|.+||+||||+|  
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999999653    4599999999999999999999994322 28999999999999999999999999997  


Q ss_pred             -------------ccccCcccccc
Q 018204          337 -------------LQYISPEKAKI  347 (359)
Q Consensus       337 -------------~~~~~PE~~~~  347 (359)
                                   ++||+||.+..
T Consensus       179 ~s~~tfA~S~VGTPyYMSPE~i~~  202 (375)
T KOG0591|consen  179 SSKTTFAHSLVGTPYYMSPERIHE  202 (375)
T ss_pred             cchhHHHHhhcCCCcccCHHHHhc
Confidence                         46999998763

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.95  E-value=2.6e-28  Score=209.03  Aligned_cols=141  Identities=30%  Similarity=0.562  Sum_probs=123.4

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|+|+|+++     ..+|+.||||.+......+ .......+|+..++.++|+||+.++++|.....+.||+||
T Consensus         4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            445567899999865     3478999999997654332 2223568999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ++. +|...++... .+++..++.|+.++++||+|||++.   |+||||||.|+||+.+|.+||+|||+||.
T Consensus        83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhc
Confidence            986 9999998764 5999999999999999999999998   99999999999999999999999999983

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.4e-28  Score=229.24  Aligned_cols=175  Identities=33%  Similarity=0.565  Sum_probs=144.7

Q ss_pred             CCCCCCcccCCcceeeEeeccCcccceeEEEE-----e-cC--cE-EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc
Q 018204          176 NPREVPEYELNPLELQVRKADGITKGSYQVAK-----W-NG--TK-VWVKILDKESHKDPERINAFTHELTIVEKARHPN  246 (359)
Q Consensus       176 ~~~~~~~~~l~~~~~~~~~~~~ig~g~~~~~~-----~-~g--~~-vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hpn  246 (359)
                      .|.....|++...++.+.  +.+|+|+|+.+.     . .+  .. ||+|...............|++|++++++++|||
T Consensus       145 ~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~N  222 (474)
T KOG0194|consen  145 RPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPN  222 (474)
T ss_pred             ccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCC
Confidence            444555677766665555  789999998652     1 12  23 8999987656667888999999999999999999


Q ss_pred             cccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 018204          247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (359)
Q Consensus       247 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~  325 (359)
                      |++|||+.....++++|||+|+||+|.++|++.+ .++..+...++.+.+.||+|||+++   +|||||.++|+|++.++
T Consensus       223 VVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~  299 (474)
T KOG0194|consen  223 VVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKG  299 (474)
T ss_pred             EEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCC
Confidence            9999999999999999999999999999999876 4999999999999999999999999   99999999999999999


Q ss_pred             cEEEecccccccc--cc-CcccccccCCccCCCCC
Q 018204          326 QLKISGFGLLRLQ--YI-SPEKAKIVFPVSHIDPA  357 (359)
Q Consensus       326 ~~kl~DFGla~~~--~~-~PE~~~~~~~~~~~~p~  357 (359)
                      .+||+|||+|+..  |. .+...+  .|..|.||-
T Consensus       300 ~vKISDFGLs~~~~~~~~~~~~~k--lPirWLAPE  332 (474)
T KOG0194|consen  300 VVKISDFGLSRAGSQYVMKKFLKK--LPIRWLAPE  332 (474)
T ss_pred             eEEeCccccccCCcceeecccccc--CcceecChh
Confidence            9999999999854  22 222222  566666653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.9e-28  Score=225.75  Aligned_cols=155  Identities=33%  Similarity=0.580  Sum_probs=133.5

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCC-c-HHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHK-D-PERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~-~-~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  262 (359)
                      .|..+..+|.|.|+.+.     .+|..+|+|++...... . ....+.+.+|+.+++.+. ||||+++++++.....+|+
T Consensus        18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i   97 (370)
T KOG0583|consen   18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI   97 (370)
T ss_pred             ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence            56677788999998653     36799999987654221 1 123345568999999999 9999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CcEEEeccccccc----
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGFGLLRL----  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DFGla~~----  337 (359)
                      |||||.||+|++++.+.+++++..+..++.|++.|++|||+++   |+||||||+|||++.+ +.+||+|||+|..    
T Consensus        98 vmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~  174 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE  174 (370)
T ss_pred             EEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence            9999999999999999889999999999999999999999999   9999999999999999 9999999999962    


Q ss_pred             -----------cccCccccccc
Q 018204          338 -----------QYISPEKAKIV  348 (359)
Q Consensus       338 -----------~~~~PE~~~~~  348 (359)
                                 .|+|||.....
T Consensus       175 ~~~l~t~cGsp~Y~aPEvl~~~  196 (370)
T KOG0583|consen  175 DGLLKTFCGSPAYAAPEVLSGK  196 (370)
T ss_pred             CCcccCCCCCcccCCHHHhCCC
Confidence                       48899887643

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.2e-28  Score=224.77  Aligned_cols=145  Identities=37%  Similarity=0.553  Sum_probs=125.2

Q ss_pred             eeEeeccCcccceeEEEE----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC-cEEEEE
Q 018204          190 LQVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-PMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lv~  264 (359)
                      -.|.....+|.|.|+.+.    .+|..+|||.+.......   ..+|.+|+.++.+++|||+++++|||.+.+ ..+||+
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            355556678888877542    345899999886544321   345999999999999999999999999988 499999


Q ss_pred             ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          265 EYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ||+++|+|.++|....  .++|....+|+.++++||+|||+..+++||||||||+|||+|.+..+||+|||+|+.
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~  226 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL  226 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence            9999999999998764  799999999999999999999998877899999999999999999999999999863

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.95  E-value=1.9e-27  Score=212.41  Aligned_cols=160  Identities=28%  Similarity=0.513  Sum_probs=131.3

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc-cccceeeEEeCC------c
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN-VVQFVGAVTQNI------P  259 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~------~  259 (359)
                      |...+.+|.|+|+.+     +.+|+.||+|.++.+... +..-....+|+.+++.++|+| |+.+++++...+      .
T Consensus        13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            444556899999865     357899999999765432 111124578999999999999 999999998877      8


Q ss_pred             EEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                      +++|+||++. +|..++....    .++...++.++.||+.||.|||+++   |+||||||+||||+..|.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence            9999999975 9999998754    5888899999999999999999999   999999999999999999999999999


Q ss_pred             cc---------------cccCcccccccCCccCCCCCCC
Q 018204          336 RL---------------QYISPEKAKIVFPVSHIDPAND  359 (359)
Q Consensus       336 ~~---------------~~~~PE~~~~~~~~~~~~p~~~  359 (359)
                      +.               .|.|||.   .....++++.+|
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEv---LlGs~~Ys~~vD  203 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEV---LLGSTSYSTSVD  203 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHH---hcCCCcCCCCcc
Confidence            83               3777776   334445666555

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=5.5e-27  Score=212.43  Aligned_cols=141  Identities=32%  Similarity=0.611  Sum_probs=122.1

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC--cEEE
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMI  262 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~l  262 (359)
                      ..+...+.+|+|+|+.+.     .+|...|||.+....  .+. .+.+.+|+.+|..++|||||++++......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            345567778999998652     236899999997652  222 677899999999999999999999755444  6999


Q ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGla~  336 (359)
                      .|||+++|+|.+++.+.+ .+++..++.+.+||++||.|||+++   ||||||||+|||++. ++.+||+|||+++
T Consensus        94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~  166 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAK  166 (313)
T ss_pred             eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccc
Confidence            999999999999999876 7999999999999999999999999   999999999999999 7999999999886

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.3e-27  Score=225.20  Aligned_cols=152  Identities=31%  Similarity=0.510  Sum_probs=134.2

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      +.++.+|.|.-+.+     ..+|+.+|||++.+...........+.+|+-+|+.+.|||++++|++|....++|+|+||+
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv   94 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV   94 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence            34555666666544     3579999999998765444455567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----------
Q 018204          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----------  337 (359)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----------  337 (359)
                      +||.|++++.+++++++.++.+++.||+.|+.|||..+   |+||||||+|+|++..+.+||+|||+|.+          
T Consensus        95 ~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS  171 (786)
T KOG0588|consen   95 PGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS  171 (786)
T ss_pred             CCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence            99999999999999999999999999999999999999   99999999999999999999999999974          


Q ss_pred             ----cccCcccccc
Q 018204          338 ----QYISPEKAKI  347 (359)
Q Consensus       338 ----~~~~PE~~~~  347 (359)
                          -|.+||.+..
T Consensus       172 CGSPHYA~PEIV~G  185 (786)
T KOG0588|consen  172 CGSPHYAAPEIVSG  185 (786)
T ss_pred             CCCcccCCchhhcC
Confidence                4899997653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.9e-28  Score=222.09  Aligned_cols=141  Identities=24%  Similarity=0.395  Sum_probs=122.6

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCC-cEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNI-PMMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~-~~~lv  263 (359)
                      .|....++|.|+|+.+     ...|..||||.+++.... .++.. =.+|+..+++++ ||||+++.+++.+.. .+|+|
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            4556678899999854     346889999999766554 33322 268999999998 999999999999887 99999


Q ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          264 LEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ||||+. +|.++++.++ .+++..++.|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+||-
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            999975 9999998764 5999999999999999999999999   99999999999999999999999999983

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.94  E-value=4.9e-27  Score=218.61  Aligned_cols=143  Identities=25%  Similarity=0.401  Sum_probs=134.4

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|+|+||.+     +.+|+.+|+|+|++.......+++....|-.+|...++|.||++|-.|.+...+|||||
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME  221 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME  221 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence            4666778999999855     35799999999998888888888999999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |++||++..+|.+.+.+++..++.|+.+++.|+.-+|.+|   +|||||||+|+|||..|++||+|||||.
T Consensus       222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence            9999999999999999999999999999999999999999   9999999999999999999999999995

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.94  E-value=4e-27  Score=219.84  Aligned_cols=150  Identities=33%  Similarity=0.605  Sum_probs=135.6

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.+...+|.|.|+.+     +++.+.||+|.+.+.... ....+.+.+|+++++.++||||+.++++|+...++|+|.||
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            445567899998765     456789999999877654 44567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------  336 (359)
                      |.| +|..++...+.++++.+..++.+++.||.|||+++   |+|||+||+|||++..|.+|++|||+||          
T Consensus        83 a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   83 AVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             hhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            987 99999999999999999999999999999999998   9999999999999999999999999997          


Q ss_pred             -----ccccCccccc
Q 018204          337 -----LQYISPEKAK  346 (359)
Q Consensus       337 -----~~~~~PE~~~  346 (359)
                           +.|||||..+
T Consensus       159 sikGtPlYmAPElv~  173 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVE  173 (808)
T ss_pred             eccCcccccCHHHHc
Confidence                 4699999876

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-27  Score=224.68  Aligned_cols=155  Identities=28%  Similarity=0.432  Sum_probs=137.2

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEE
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv  263 (359)
                      .++.....+|+|.|+.+     +.+++.+|||++++......+.++....|-+|+.... ||.++.++.+|.+..++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            35777788999999865     3467899999999988777888889999999999885 99999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      |||+.||++..+ +..+.+++..++.|+..|+.||.|||+++   |||||||.+|||+|.+|++||+|||+++       
T Consensus       448 mey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  448 MEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            999999994433 44467999999999999999999999999   9999999999999999999999999997       


Q ss_pred             --------ccccCccccccc
Q 018204          337 --------LQYISPEKAKIV  348 (359)
Q Consensus       337 --------~~~~~PE~~~~~  348 (359)
                              +.|||||.++..
T Consensus       524 ~TsTfCGTpey~aPEil~e~  543 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQ  543 (694)
T ss_pred             ccccccCChhhcChhhhccC
Confidence                    358888877654

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.94  E-value=5.9e-27  Score=206.52  Aligned_cols=141  Identities=38%  Similarity=0.543  Sum_probs=120.2

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv  263 (359)
                      .|...+.++.|+|+++     +.+++.||+|.++.+...+.--+ .-.+||.++.+++|||||.+-.+....  +.+|+|
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPI-tsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPI-TSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcc-hhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            3555677899999976     24678999999976543221111 247899999999999999999887654  569999


Q ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||+. +|..++..-+ ++...+++.++.|++.|++|||.+.   |+||||||+|+|++..|.+||+|||+||
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhh
Confidence            999987 9999998764 7999999999999999999999998   9999999999999999999999999998

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.94  E-value=3.2e-26  Score=216.55  Aligned_cols=142  Identities=26%  Similarity=0.433  Sum_probs=125.2

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+     ..+++.+|+|++.+...........+..|+.++..++||||+++++++.+...+|+||||
T Consensus         3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~   82 (363)
T cd05628           3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF   82 (363)
T ss_pred             ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence            445566788888754     235789999999765443445556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~  149 (363)
T cd05628          83 LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCT  149 (363)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence            999999999988888999999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.9e-26  Score=205.87  Aligned_cols=141  Identities=23%  Similarity=0.421  Sum_probs=122.0

Q ss_pred             eEeeccCcccceeEE-----EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQV-----AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~-----~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.-..     ....+..||||++..+...+.  ++.+.+|+..++.++||||++++.+|..+..+|+||.
T Consensus        27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            344444556664322     234679999999987665443  6789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||.+||+.++++..  ..+.+..+..|.++++.||.|||.+|   .||||||+.||||+.+|.+||+|||.+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence            99999999999874  45999999999999999999999999   9999999999999999999999999874

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.94  E-value=7.9e-27  Score=200.65  Aligned_cols=149  Identities=32%  Similarity=0.521  Sum_probs=127.4

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccC-----CCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKE-----SHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~-----~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +.+|.|...++     +..|+.+|+|++...     +....+..+.-..|+.|++++ .||+|+.+.++|.++..+++|+
T Consensus        23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVF  102 (411)
T KOG0599|consen   23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVF  102 (411)
T ss_pred             HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhh
Confidence            34555555432     456888999998532     222333445667899999998 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      |.|+.|.|+++|.+.-.++++..+.|++|+..|+.|||.++   ||||||||+|||++++..+||+|||+|+        
T Consensus       103 dl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekL  179 (411)
T KOG0599|consen  103 DLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKL  179 (411)
T ss_pred             hhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCchhH
Confidence            99999999999998888999999999999999999999999   9999999999999999999999999996        


Q ss_pred             ------ccccCcccccc
Q 018204          337 ------LQYISPEKAKI  347 (359)
Q Consensus       337 ------~~~~~PE~~~~  347 (359)
                            ++|.|||.++.
T Consensus       180 relCGTPgYLAPEtikC  196 (411)
T KOG0599|consen  180 RELCGTPGYLAPETIKC  196 (411)
T ss_pred             HHhcCCCcccChhheee
Confidence                  47999998774

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-26  Score=211.81  Aligned_cols=143  Identities=34%  Similarity=0.530  Sum_probs=119.5

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCc-----------HHHHHHHHHHHHHHHhCCCCccccceeeE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKD-----------PERINAFTHELTIVEKARHPNVVQFVGAV  254 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~-----------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  254 (359)
                      +|.+...+|.|.|+.++     ..++.+|+|++.+.....           ....+...+||.+|+++.|||||+++++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            57777889999999764     358899999996543211           11235778999999999999999999998


Q ss_pred             EeC--CcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecc
Q 018204          255 TQN--IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (359)
Q Consensus       255 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DF  332 (359)
                      .+.  ..+|+|+|||..|.+...-..+..+++.++++|+++++.||+|||.++   ||||||||+|+||+.+|++||+||
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecc
Confidence            654  579999999999887654333333899999999999999999999999   999999999999999999999999


Q ss_pred             cccc
Q 018204          333 GLLR  336 (359)
Q Consensus       333 Gla~  336 (359)
                      |.|-
T Consensus       255 GVs~  258 (576)
T KOG0585|consen  255 GVSN  258 (576)
T ss_pred             ceee
Confidence            9985

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=3.3e-27  Score=199.47  Aligned_cols=143  Identities=28%  Similarity=0.460  Sum_probs=125.4

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|..+..+|.|.|+.+     +.++..+|+|++.+........-..+.+|++|-+.|+||||+++|++|.+...+|+++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            3556667788888733     34678999999976554444444678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |.++|++...|+  ...++++.....++.|++.||.|+|..+   ||||||||+|+|++..+.+||+|||.|-
T Consensus       103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCcee
Confidence            999999999999  4567999999999999999999999998   9999999999999999999999999985

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.93  E-value=6.1e-26  Score=211.79  Aligned_cols=153  Identities=27%  Similarity=0.484  Sum_probs=132.8

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|.|.|+.+     ...++.+|+|++...........+.+.+|+.++..++||||+++++++......|+|||
T Consensus        19 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            3555667788888743     23578999999975443334455678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus        99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  175 (329)
T PTZ00263         99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL  175 (329)
T ss_pred             CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCccee
Confidence            9999999999988888999999999999999999999998   99999999999999999999999999862        


Q ss_pred             ----cccCccccc
Q 018204          338 ----QYISPEKAK  346 (359)
Q Consensus       338 ----~~~~PE~~~  346 (359)
                          .|+|||...
T Consensus       176 ~gt~~y~aPE~~~  188 (329)
T PTZ00263        176 CGTPEYLAPEVIQ  188 (329)
T ss_pred             cCChhhcCHHHHc
Confidence                488999754

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.93  E-value=9.9e-26  Score=209.81  Aligned_cols=146  Identities=27%  Similarity=0.492  Sum_probs=127.4

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCH
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      +|+|.|+.+     ...|+.+|+|++.............+.+|+.++..++||||+++++++.....+|+||||+++++|
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L   82 (323)
T cd05571           3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGEL   82 (323)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcH
Confidence            567777643     246889999999765443445556788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------------
Q 018204          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------------  337 (359)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------------  337 (359)
                      .+++...+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.               
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          83 FFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            999988888999999999999999999999999   99999999999999999999999999862               


Q ss_pred             cccCccccc
Q 018204          338 QYISPEKAK  346 (359)
Q Consensus       338 ~~~~PE~~~  346 (359)
                      .|+|||...
T Consensus       160 ~y~aPE~~~  168 (323)
T cd05571         160 EYLAPEVLE  168 (323)
T ss_pred             cccChhhhc
Confidence            478888654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=7.9e-26  Score=214.93  Aligned_cols=142  Identities=25%  Similarity=0.390  Sum_probs=124.9

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+     ..+++.+|+|++...........+.+..|+.++..++||||+++++++.....+|+||||
T Consensus         3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~   82 (377)
T cd05629           3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF   82 (377)
T ss_pred             ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence            445566788888754     236889999998654433445566788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          83 LPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999988888999999999999999999999999   9999999999999999999999999884

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.93  E-value=1.2e-25  Score=213.95  Aligned_cols=142  Identities=23%  Similarity=0.336  Sum_probs=126.0

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|+|+.+     ..++..+|+|++.............+..|+.++..++||||+++++++.+...+|+||||
T Consensus         3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~   82 (381)
T cd05626           3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (381)
T ss_pred             ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence            445667889988754     235789999999765544455667789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++...+.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~  149 (381)
T cd05626          83 IPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCT  149 (381)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence            999999999988888999999999999999999999998   9999999999999999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.93  E-value=1.1e-25  Score=213.35  Aligned_cols=153  Identities=27%  Similarity=0.387  Sum_probs=129.6

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|+|+.+   .  ..++.+|+|++.+...........+..|+.+++.++||||+++++++.....+|+|||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            4556667888888754   2  3578899999965333333344567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++|+|.+++... .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.        
T Consensus       124 y~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         124 YMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCcee
Confidence            99999999999764 5899999999999999999999998   99999999999999999999999998852        


Q ss_pred             --------cccCcccccc
Q 018204          338 --------QYISPEKAKI  347 (359)
Q Consensus       338 --------~~~~PE~~~~  347 (359)
                              .|+|||....
T Consensus       200 ~~~~~gt~~Y~aPE~~~~  217 (370)
T cd05621         200 CDTAVGTPDYISPEVLKS  217 (370)
T ss_pred             cccCCCCcccCCHHHHhc
Confidence                    4888887653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.93  E-value=1e-25  Score=214.10  Aligned_cols=141  Identities=24%  Similarity=0.347  Sum_probs=123.6

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+     ...+..+|+|++.............+.+|+.++..++||||+++++.+...+.+|+||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            455667888888754     235789999999654333333456688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                      +++|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a  148 (376)
T cd05598          83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC  148 (376)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence            999999999988888999999999999999999999998   999999999999999999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.93  E-value=1.2e-25  Score=213.98  Aligned_cols=142  Identities=23%  Similarity=0.348  Sum_probs=125.1

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|+|.|+.+     ...+..+|+|++.............+..|+.+++.++||||+++++++.....+|+||||
T Consensus         3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            445566888888754     235788999999755443445567789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++.+.+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~  149 (382)
T cd05625          83 IPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (382)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCc
Confidence            999999999988778999999999999999999999998   9999999999999999999999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=8.3e-26  Score=207.20  Aligned_cols=152  Identities=25%  Similarity=0.485  Sum_probs=130.9

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  ..|+.+|+|.+...........+.+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            444556788887643   2  35889999999654433334556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------  336 (359)
                      +++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++          
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (291)
T cd05612          83 VPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC  159 (291)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCccccc
Confidence            999999999988888999999999999999999999998   9999999999999999999999999986          


Q ss_pred             --ccccCccccc
Q 018204          337 --LQYISPEKAK  346 (359)
Q Consensus       337 --~~~~~PE~~~  346 (359)
                        ..|+|||...
T Consensus       160 gt~~y~aPE~~~  171 (291)
T cd05612         160 GTPEYLAPEVIQ  171 (291)
T ss_pred             CChhhcCHHHHc
Confidence              2488999754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.93  E-value=2.6e-26  Score=205.23  Aligned_cols=148  Identities=30%  Similarity=0.490  Sum_probs=124.8

Q ss_pred             ceeeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC----
Q 018204          188 LELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----  258 (359)
Q Consensus       188 ~~~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----  258 (359)
                      ..+.+...+.+|.|+|+.+     ...++.+|||.........       .+|+.+|+.++|||||++.-+|....    
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            3567777788999999865     3457899999986544322       46999999999999999988876432    


Q ss_pred             -cEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CcEEEecc
Q 018204          259 -PMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGF  332 (359)
Q Consensus       259 -~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DF  332 (359)
                       ...+||||++. +|.+.++.    +..++.-.++.++.||.+||.|||+++   |+||||||+|+|+|.+ |.+|||||
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccC
Confidence             46799999987 99999874    457899999999999999999999998   9999999999999986 89999999


Q ss_pred             ccccc--------------cccCccccc
Q 018204          333 GLLRL--------------QYISPEKAK  346 (359)
Q Consensus       333 Gla~~--------------~~~~PE~~~  346 (359)
                      |.|+.              +|+|||-+-
T Consensus       171 GSAK~L~~~epniSYicSRyYRaPELif  198 (364)
T KOG0658|consen  171 GSAKVLVKGEPNISYICSRYYRAPELIF  198 (364)
T ss_pred             CcceeeccCCCceeEEEeccccCHHHHc
Confidence            99973              699999754

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.93  E-value=1.3e-25  Score=210.46  Aligned_cols=153  Identities=24%  Similarity=0.437  Sum_probs=131.4

Q ss_pred             eEeeccCcccceeEEE---Ee--c-CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---KW--N-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~-g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|.....+|.|+|+.+   ..  . +..+|+|.+...........+.+..|+.++..++||||+++++++.....+|+||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            3555566788888743   22  2 2579999986544334445567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      ||+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.       
T Consensus       111 Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~  187 (340)
T PTZ00426        111 EFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT  187 (340)
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCcce
Confidence            99999999999998888999999999999999999999998   99999999999999999999999999862       


Q ss_pred             -----cccCccccc
Q 018204          338 -----QYISPEKAK  346 (359)
Q Consensus       338 -----~~~~PE~~~  346 (359)
                           .|+|||...
T Consensus       188 ~~gt~~y~aPE~~~  201 (340)
T PTZ00426        188 LCGTPEYIAPEILL  201 (340)
T ss_pred             ecCChhhcCHHHHh
Confidence                 489999764

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.93  E-value=2.4e-25  Score=207.66  Aligned_cols=146  Identities=27%  Similarity=0.471  Sum_probs=127.6

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCH
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      +|.|.|+.+     ..+|..+|+|++.............+.+|+.+++.++||||+++++++.....+|+||||+++|+|
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L   82 (328)
T cd05593           3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL   82 (328)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCH
Confidence            567777643     246889999999765444455567788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------------
Q 018204          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------------  337 (359)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------------  337 (359)
                      ..++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.               
T Consensus        83 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          83 FFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            999988878999999999999999999999998   99999999999999999999999998762               


Q ss_pred             cccCccccc
Q 018204          338 QYISPEKAK  346 (359)
Q Consensus       338 ~~~~PE~~~  346 (359)
                      .|+|||...
T Consensus       160 ~y~aPE~~~  168 (328)
T cd05593         160 EYLAPEVLE  168 (328)
T ss_pred             CccChhhhc
Confidence            478888654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.93  E-value=1.8e-25  Score=208.13  Aligned_cols=146  Identities=25%  Similarity=0.461  Sum_probs=127.1

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCH
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      +|+|.|+.+     ..+|..+|+|++.............+..|+.+++.++||||+++++++.....+|+||||+++|+|
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L   82 (323)
T cd05595           3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL   82 (323)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcH
Confidence            567777643     246889999999765443445566788899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------------
Q 018204          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------------  337 (359)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------------  337 (359)
                      ..++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.               
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          83 FFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            999988878999999999999999999999998   99999999999999999999999998752               


Q ss_pred             cccCccccc
Q 018204          338 QYISPEKAK  346 (359)
Q Consensus       338 ~~~~PE~~~  346 (359)
                      .|+|||...
T Consensus       160 ~y~aPE~~~  168 (323)
T cd05595         160 EYLAPEVLE  168 (323)
T ss_pred             CcCCccccc
Confidence            478888654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.1e-25  Score=212.88  Aligned_cols=142  Identities=26%  Similarity=0.418  Sum_probs=125.2

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+     ...|+.+|+|++.............+..|+.++..++||||+++++++.....+|+||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            455566888888754     235789999999754433444556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          83 LPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             CCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccce
Confidence            999999999988888999999999999999999999999   9999999999999999999999999874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=1.4e-25  Score=203.07  Aligned_cols=149  Identities=28%  Similarity=0.383  Sum_probs=130.3

Q ss_pred             EeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      ++....+|.|..+.+   ..  .+..+|+|++.+..............|..||+.++||.++.+|..|..+...|++|||
T Consensus        79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey  158 (459)
T KOG0610|consen   79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY  158 (459)
T ss_pred             HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence            444556677766533   33  3489999999988777777788889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccccccCcc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE  343 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~~~~~PE  343 (359)
                      |+||+|..+++++  +.++++.++.|+.+|+.||+|||..|   ||+|||||+||||-++|++.|+||.||......|.
T Consensus       159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            9999999999876  45999999999999999999999999   99999999999999999999999999975444444

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.1e-25  Score=206.55  Aligned_cols=146  Identities=27%  Similarity=0.430  Sum_probs=126.2

Q ss_pred             cccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCH
Q 018204          198 ITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       198 ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      +|.|.|+.+   .  .++..+|+|.+.............+..|+.++..++||||+++++++......|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            356666543   2  35788999999754433445566788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------------
Q 018204          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------------  337 (359)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------------  337 (359)
                      .+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.               
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  157 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTP  157 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCc
Confidence            999988888999999999999999999999998   99999999999999999999999999863               


Q ss_pred             cccCccccc
Q 018204          338 QYISPEKAK  346 (359)
Q Consensus       338 ~~~~PE~~~  346 (359)
                      .|+|||...
T Consensus       158 ~y~aPE~~~  166 (312)
T cd05585         158 EYLAPELLL  166 (312)
T ss_pred             ccCCHHHHc
Confidence            477888654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.93  E-value=6.7e-27  Score=188.27  Aligned_cols=130  Identities=30%  Similarity=0.357  Sum_probs=109.2

Q ss_pred             eccCCCCCcCcCCcccccCC-CCCCCCCccHHHHHHHcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHH
Q 018204           46 FGRQSSLDPIRRSPVQDELT-VPENLDSTMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKL  123 (359)
Q Consensus        46 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~-ga~v~~~d~~g~TpLh~A~~~g~~~~v~~  123 (359)
                      +|..|-.+.+.-++.+.... ..+|..||||||+||..|+.++|+.|+.+ |+|||+++..|+|||||||..|+.+|+++
T Consensus        45 a~S~g~~eiv~fLlsq~nv~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaql  124 (226)
T KOG4412|consen   45 ACSFGHVEIVYFLLSQPNVKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQL  124 (226)
T ss_pred             eeecCchhHHHHHHhcCCCCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHH
Confidence            44455555555555444333 34477899999999999999999999998 99999999999999999999999999999


Q ss_pred             HHhcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccC
Q 018204          124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA  175 (359)
Q Consensus       124 Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a  175 (359)
                      |+++||.++.+|+.|.||||-|+.-|..+++++|+..|+.+   ++.++||++.+
T Consensus       125 Lle~ga~i~~kD~~~qtplHRAAavGklkvie~Li~~~a~~n~qDk~G~TpL~~a  179 (226)
T KOG4412|consen  125 LLEKGALIRIKDKQGQTPLHRAAAVGKLKVIEYLISQGAPLNTQDKYGFTPLHHA  179 (226)
T ss_pred             HHhcCCCCcccccccCchhHHHHhccchhhHHHHHhcCCCCCcccccCccHHHHH
Confidence            99999999999999999999999999999999999999877   56678998887

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.93  E-value=4.1e-25  Score=205.78  Aligned_cols=146  Identities=26%  Similarity=0.465  Sum_probs=126.7

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCH
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      +|.|.|+.+     ...|..+|+|++.............+..|+.++..++||||+++++++.....+|+||||+++|+|
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L   82 (325)
T cd05594           3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL   82 (325)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcH
Confidence            567777644     236889999999765444444556778899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------------
Q 018204          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------------  336 (359)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------------  336 (359)
                      ..++...+.+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++               
T Consensus        83 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          83 FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            9999888889999999999999999999997 67   9999999999999999999999999875               


Q ss_pred             ccccCccccc
Q 018204          337 LQYISPEKAK  346 (359)
Q Consensus       337 ~~~~~PE~~~  346 (359)
                      ..|+|||...
T Consensus       160 ~~y~aPE~~~  169 (325)
T cd05594         160 PEYLAPEVLE  169 (325)
T ss_pred             cccCCHHHHc
Confidence            2488888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=3e-25  Score=209.88  Aligned_cols=144  Identities=31%  Similarity=0.531  Sum_probs=129.8

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      -.|...+.+|+|.|..+.     .++..||+|++.+.... ......+.+|+++|..++|||||+++.+...+..+|+||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            356777789999998653     36899999999776554 444445899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ||+.+|.+++++.+.+.+.+..+..++.|++.|++|||+++   |||||||++|||++.+..+||+|||+|..
T Consensus       135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence            99999999999999999999999999999999999999999   99999999999999999999999999963

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.6e-25  Score=207.85  Aligned_cols=152  Identities=26%  Similarity=0.425  Sum_probs=131.4

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  .++..+|+|++.............+..|+.++..++||||+++++++......|+||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            445566788887643   2  25789999999754433344556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------  336 (359)
                      +++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++          
T Consensus        83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~  159 (333)
T cd05600          83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV  159 (333)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCcc
Confidence            999999999988888999999999999999999999999   9999999999999999999999999986          


Q ss_pred             --ccccCccccc
Q 018204          337 --LQYISPEKAK  346 (359)
Q Consensus       337 --~~~~~PE~~~  346 (359)
                        ..|+|||...
T Consensus       160 gt~~y~aPE~~~  171 (333)
T cd05600         160 GSPDYMAPEVLR  171 (333)
T ss_pred             cCccccChhHhc
Confidence              2488898755

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.93  E-value=2.7e-25  Score=209.92  Aligned_cols=142  Identities=27%  Similarity=0.415  Sum_probs=124.3

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+     ...+..+|+|++.............+..|+.++..++||+|+++++++.....+|+||||
T Consensus         3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~   82 (360)
T cd05627           3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF   82 (360)
T ss_pred             ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            444556788888754     235789999999754433444566788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++.+.+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~  149 (360)
T cd05627          83 LPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCT  149 (360)
T ss_pred             CCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCc
Confidence            999999999988888999999999999999999999998   9999999999999999999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=8.5e-26  Score=201.56  Aligned_cols=139  Identities=28%  Similarity=0.484  Sum_probs=122.1

Q ss_pred             ccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe-----CCcEEEEE
Q 018204          195 ADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-----NIPMMIVL  264 (359)
Q Consensus       195 ~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~~~~~lv~  264 (359)
                      ...+|.|+|+++.     .+|..||+|.+.. .....-..+.-.+|+.+++.++|+||+.+++++..     -+.+|+|+
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~  105 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF  105 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence            5668999998763     4689999999953 33445556778899999999999999999999865     24699999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~~  338 (359)
                      |+|+ .+|.+.++....++...+..++.|++.||+|+|+.+   |+||||||+|+|++.+..+||+|||+||..
T Consensus       106 elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~  175 (359)
T KOG0660|consen  106 ELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYL  175 (359)
T ss_pred             hHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeec
Confidence            9995 599999998877999999999999999999999999   999999999999999999999999999853

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.93  E-value=4.2e-25  Score=209.41  Aligned_cols=154  Identities=27%  Similarity=0.375  Sum_probs=130.1

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      .+|.....+|.|+|+.+     ...+..+|+|++.............+..|+.+++.++||||+++++++.....+|+||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            35666677888888754     2357889999986533333344456788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      ||+++|+|.+++... .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++        
T Consensus       123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            999999999998764 5899999999999999999999999   9999999999999999999999999985        


Q ss_pred             --------ccccCcccccc
Q 018204          337 --------LQYISPEKAKI  347 (359)
Q Consensus       337 --------~~~~~PE~~~~  347 (359)
                              ..|+|||....
T Consensus       199 ~~~~~~gt~~y~aPE~l~~  217 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKS  217 (371)
T ss_pred             cccCcccCccccCHHHHhc
Confidence                    24888887653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=1.3e-25  Score=208.79  Aligned_cols=154  Identities=27%  Similarity=0.514  Sum_probs=135.6

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc-EEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-MMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lv~  264 (359)
                      .|.....+|.|+|+.+     +..++.+++|.+......+++.. ....|+.+++++.|||||.+.+.|..++. .+|||
T Consensus         5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~-~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR-SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH-HHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            3555678899999865     44678999999987766665554 67889999999999999999999999888 99999


Q ss_pred             ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc------
Q 018204          265 EYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR------  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~------  336 (359)
                      +||+||++.+.+.+.+  .++++.+..|+.|++.|+.|||++.   |+|||||+.|||+++++.+||.|||+|+      
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999997654  5999999999999999999999888   9999999999999999999999999997      


Q ss_pred             ---------ccccCccccccc
Q 018204          337 ---------LQYISPEKAKIV  348 (359)
Q Consensus       337 ---------~~~~~PE~~~~~  348 (359)
                               ..||+||..+..
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~  181 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDI  181 (426)
T ss_pred             hhhheecCCCcccCHHHhCCC
Confidence                     359999987744

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-25  Score=208.93  Aligned_cols=139  Identities=26%  Similarity=0.467  Sum_probs=121.1

Q ss_pred             eEeeccCcccceeEE---E--EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQV---A--KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~--~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|....++|+|.-+.   +  ...++.||||.+........+   -+.+|+.+|+..+|+|||.+++.|.....+|+|||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke---LilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE---LLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh---hhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            355556677776653   2  346788999999766554433   57899999999999999999999998899999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |++||+|.+.+... .+++.++..|++++++||+|||.++   |||||||.+|||++.+|.+||+|||++.
T Consensus       351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeee
Confidence            99999999998765 5999999999999999999999999   9999999999999999999999999986

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.1e-25  Score=204.48  Aligned_cols=162  Identities=27%  Similarity=0.484  Sum_probs=140.6

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|.|.|.+++     ..|.+||||++.+...++ .....+..|++.|+..+|||||++|++...+..+|||+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            35566778999998763     579999999998766543 344567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCcEEEecccccc-------
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLR-------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DFGla~-------  336 (359)
                      +=++|+|++||.+. ..+.+..+.+|+.||+.|+.|+|...   +|||||||+|+.+. +-|-+||+|||++.       
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            99999999999765 46999999999999999999999988   99999999999775 57899999999995       


Q ss_pred             -------ccccCcccccccCCccCCCCCCC
Q 018204          337 -------LQYISPEKAKIVFPVSHIDPAND  359 (359)
Q Consensus       337 -------~~~~~PE~~~~~~~~~~~~p~~~  359 (359)
                             +.|-|||.   ...-.|.+|++|
T Consensus       175 L~TsCGSLAYSAPEI---LLGDsYDAPAVD  201 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEI---LLGDSYDAPAVD  201 (864)
T ss_pred             hhcccchhhccCchh---hhcCccCCcchh
Confidence                   35999996   457889999887

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.92  E-value=5.9e-25  Score=208.36  Aligned_cols=152  Identities=26%  Similarity=0.378  Sum_probs=128.0

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+     ...+..+|+|.+.+...........+..|+.+++.++||||+++++++.....+|+|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            4555566788888744     23578999999965433333344567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++|+|.+++... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus       124 y~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         124 YMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             CCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCccc
Confidence            99999999998764 5889999999999999999999998   99999999999999999999999999752        


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       200 ~~~~~gt~~y~aPE~~~  216 (370)
T cd05596         200 CDTAVGTPDYISPEVLK  216 (370)
T ss_pred             CCCCCCCcCeECHHHhc
Confidence                    378888654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=8e-25  Score=204.39  Aligned_cols=152  Identities=24%  Similarity=0.406  Sum_probs=129.5

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|.|.|+.+     ...+..+|+|++.+.........+.+..|+.++..++|+||+++++++.....+|+||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            445566788888744     235789999999754333344556688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      +++|+|.+++.. ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++         
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999976 456999999999999999999999999   9999999999999999999999999874         


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|+|||...
T Consensus       160 ~~~~~gt~~y~aPE~~~  176 (331)
T cd05597         160 SNVAVGTPDYISPEILQ  176 (331)
T ss_pred             ccceeccccccCHHHHh
Confidence                   2478888754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.92  E-value=8.6e-25  Score=204.01  Aligned_cols=152  Identities=24%  Similarity=0.418  Sum_probs=131.0

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+     ..+|+.+|+|++.............+..|+.++..++||||+++++++......|+||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            445566788888754     236889999999765443444566788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++|+|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus        83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999876 67999999999999999999999998   99999999999999999999999999852        


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       160 ~~~~~gt~~y~aPE~~~  176 (330)
T cd05601         160 SKLPVGTPDYIAPEVLT  176 (330)
T ss_pred             eecccCCccccCHHHhc
Confidence                    488888754

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.92  E-value=1.9e-25  Score=210.47  Aligned_cols=152  Identities=32%  Similarity=0.607  Sum_probs=132.9

Q ss_pred             eEeeccCcccceeEEE---EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      ++.+...+|+|.|+.+   .|.| .||||+|..... .+++.+.|.+|+.++++-+|.||+-|+|++..+.. .||+.+|
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC  469 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC  469 (678)
T ss_pred             Hhhccceeccccccceeeccccc-ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence            3455667899999865   5666 599999976654 55689999999999999999999999999988766 9999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------
Q 018204          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------  336 (359)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------  336 (359)
                      +|.+|+.+|+-. .++...+...|+.||++||.|||.++   |||||||..||++.+++.|||+||||+.          
T Consensus       470 eGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q  546 (678)
T KOG0193|consen  470 EGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ  546 (678)
T ss_pred             cCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccc
Confidence            999999999754 45888899999999999999999999   9999999999999999999999999985          


Q ss_pred             -------ccccCccccccc
Q 018204          337 -------LQYISPEKAKIV  348 (359)
Q Consensus       337 -------~~~~~PE~~~~~  348 (359)
                             +.|||||.+++-
T Consensus       547 ~~qp~gsilwmAPEvIRmq  565 (678)
T KOG0193|consen  547 LEQPHGSLLWMAPEVIRMQ  565 (678)
T ss_pred             cCCCccchhhhcHHHHhhc
Confidence                   249999988744

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.92  E-value=1.2e-24  Score=203.18  Aligned_cols=152  Identities=24%  Similarity=0.385  Sum_probs=129.1

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|+|.|+.+     ...+..+|+|++.+...........+..|..++..++|++|+++++++...+..|+||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            455567788888743     235788999998653333344455688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      ++||+|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++         
T Consensus        83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999987 457899999999999999999999998   9999999999999999999999999874         


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|+|||...
T Consensus       160 ~~~~~gt~~y~aPE~~~  176 (331)
T cd05624         160 SSVAVGTPDYISPEILQ  176 (331)
T ss_pred             eccccCCcccCCHHHHh
Confidence                   2488888654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.92  E-value=1.5e-24  Score=201.87  Aligned_cols=147  Identities=29%  Similarity=0.493  Sum_probs=125.0

Q ss_pred             CcccceeEEE---E-----ecCcEEEEEEeccCCC-CcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          197 GITKGSYQVA---K-----WNGTKVWVKILDKESH-KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       197 ~ig~g~~~~~---~-----~~g~~vavK~l~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .+|.|.|+.+   .     ..++.+|+|++..... ........+..|+.+++.++||||+++++++...+..|+||||+
T Consensus         3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~   82 (323)
T cd05584           3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL   82 (323)
T ss_pred             eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence            4677777643   1     2578899999965321 12233445778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-----------
Q 018204          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-----------  336 (359)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-----------  336 (359)
                      ++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++           
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          83 SGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            99999999988888999999999999999999999998   9999999999999999999999999875           


Q ss_pred             ----ccccCccccc
Q 018204          337 ----LQYISPEKAK  346 (359)
Q Consensus       337 ----~~~~~PE~~~  346 (359)
                          ..|+|||...
T Consensus       160 ~~gt~~y~aPE~~~  173 (323)
T cd05584         160 FCGTIEYMAPEILM  173 (323)
T ss_pred             cCCCccccChhhcc
Confidence                2488888754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.92  E-value=2.3e-24  Score=201.21  Aligned_cols=146  Identities=32%  Similarity=0.516  Sum_probs=126.8

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|+|.|+.+     ...+..+|+|++.+....+......+..|+.++..+ +||||+++++++......|+||||+++|+
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~   82 (329)
T cd05618           3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGD   82 (329)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCC
Confidence            577777643     235788999999866544555666788899988876 89999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |..++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          83 LMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            9999988888999999999999999999999998   99999999999999999999999998852              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|+|||...
T Consensus       160 ~~y~aPE~~~  169 (329)
T cd05618         160 PNYIAPEILR  169 (329)
T ss_pred             ccccCHHHHc
Confidence             478888654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.92  E-value=1.6e-24  Score=202.87  Aligned_cols=140  Identities=32%  Similarity=0.548  Sum_probs=116.7

Q ss_pred             EeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC-Cc
Q 018204          192 VRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN-IP  259 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-~~  259 (359)
                      |.....+|.|.|+.+.          ..+..+|+|.+....  .......+.+|+.++..+ +||||+++++++... ..
T Consensus         9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             ceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            4556678888887541          124679999986432  233456789999999999 899999999988764 46


Q ss_pred             EEEEEecCCCCCHHHHHHhc------------------------------------------------------------
Q 018204          260 MMIVLEYHAKGDLASYLQKK------------------------------------------------------------  279 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------  279 (359)
                      ++++|||+++|+|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            89999999999999998653                                                            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          280 --GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       280 --~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                        ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~  222 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR  222 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccc
Confidence              23677888999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.92  E-value=1.3e-24  Score=202.12  Aligned_cols=146  Identities=29%  Similarity=0.465  Sum_probs=124.7

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+     ..++..+|+|++.+...........+..|..++..+ +||||+++++++.....+|+||||+++|+
T Consensus         3 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~   82 (320)
T cd05590           3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGD   82 (320)
T ss_pred             eeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCch
Confidence            566776643     235788999999754333334456678888888876 69999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          83 LMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            9999988888999999999999999999999998   99999999999999999999999998752              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|+|||...
T Consensus       160 ~~y~aPE~~~  169 (320)
T cd05590         160 PDYIAPEILQ  169 (320)
T ss_pred             ccccCHHHHc
Confidence             488888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.92  E-value=1.9e-24  Score=200.98  Aligned_cols=146  Identities=26%  Similarity=0.434  Sum_probs=124.9

Q ss_pred             cccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+   .  ..+..+|+|++.............+..|..++..+ +||||+++++++.....+|+||||+++++
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   82 (321)
T cd05591           3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGD   82 (321)
T ss_pred             cccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCc
Confidence            577777643   2  34678999999764433344556678899988866 79999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |..++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          83 LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            9999988888999999999999999999999998   99999999999999999999999998752              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|+|||...
T Consensus       160 ~~y~aPE~~~  169 (321)
T cd05591         160 PDYIAPEILQ  169 (321)
T ss_pred             ccccCHHHHc
Confidence             488888654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.92  E-value=2.2e-24  Score=201.47  Aligned_cols=152  Identities=22%  Similarity=0.394  Sum_probs=128.5

Q ss_pred             EeeccCcccceeEEEE--------ecCcEEEEEEeccCCC-CcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVAK--------WNGTKVWVKILDKESH-KDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~--------~~g~~vavK~l~~~~~-~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~  261 (359)
                      |.....+|.|.|+.+.        ..+..+|+|++.+... ......+.+..|+.++..+ +||+|+++++++.....++
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            4455667888887442        2578899999964322 1223345678899999999 5899999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----  337 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----  337 (359)
                      +||||+++|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.    
T Consensus        82 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~  158 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence            99999999999999988888999999999999999999999998   99999999999999999999999999852    


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~  179 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIR  179 (332)
T ss_pred             CCCccccccCCccccCHHHhc
Confidence                        488888754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.92  E-value=2.5e-24  Score=200.86  Aligned_cols=146  Identities=30%  Similarity=0.503  Sum_probs=127.0

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+     ...+..+|+|++.+.........+.+..|..++..+ +||||+++++++.....+|+||||+++|+
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~   82 (329)
T cd05588           3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGD   82 (329)
T ss_pred             EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCC
Confidence            567777643     235789999999765544455566788999999988 79999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          83 LMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            9999988888999999999999999999999998   99999999999999999999999998852              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|+|||...
T Consensus       160 ~~y~aPE~~~  169 (329)
T cd05588         160 PNYIAPEILR  169 (329)
T ss_pred             ccccCHHHHc
Confidence             478888754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.92  E-value=2.1e-24  Score=200.22  Aligned_cols=146  Identities=28%  Similarity=0.470  Sum_probs=122.5

Q ss_pred             cccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHh-CCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+   .  ..+..+|+|++...........+.+..|..++.. .+||||+++++++.....+|+||||+++|+
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~   82 (316)
T cd05592           3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGD   82 (316)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCc
Confidence            577777644   2  3577899999975433333344556667777765 489999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |..++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          83 LMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            9999988888999999999999999999999998   99999999999999999999999999852              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|++||...
T Consensus       160 ~~y~aPE~~~  169 (316)
T cd05592         160 PDYIAPEILK  169 (316)
T ss_pred             ccccCHHHHc
Confidence             478888654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.92  E-value=2.7e-25  Score=207.74  Aligned_cols=134  Identities=33%  Similarity=0.554  Sum_probs=119.6

Q ss_pred             ceeEEEEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC
Q 018204          201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG  280 (359)
Q Consensus       201 g~~~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  280 (359)
                      |+....+..++.||||.++...          ..+|.-|++|+||||+.|.++|.....+|||||||..|-|...|+...
T Consensus       138 GAVF~Grl~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~  207 (904)
T KOG4721|consen  138 GAVFLGRLHNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR  207 (904)
T ss_pred             cceeeeeccCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC
Confidence            3333456788999999885322          357889999999999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------------ccccCccccc
Q 018204          281 RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------------LQYISPEKAK  346 (359)
Q Consensus       281 ~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------------~~~~~PE~~~  346 (359)
                      .+++...+.|..+|+.||.|||.++   |||||||.-||||..+..+||+|||-++              ..|||||.++
T Consensus       208 ~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIr  284 (904)
T KOG4721|consen  208 PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIR  284 (904)
T ss_pred             ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhh
Confidence            9999999999999999999999999   9999999999999999999999999987              2478888766


Q ss_pred             c
Q 018204          347 I  347 (359)
Q Consensus       347 ~  347 (359)
                      .
T Consensus       285 n  285 (904)
T KOG4721|consen  285 N  285 (904)
T ss_pred             c
Confidence            3

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.92  E-value=2.5e-24  Score=200.32  Aligned_cols=146  Identities=30%  Similarity=0.496  Sum_probs=121.4

Q ss_pred             cccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHH-HHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELT-IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+   .  .+|..+|+|++.............+..|.. +++.++||||+++++++......|+||||+++|+
T Consensus         3 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~   82 (323)
T cd05575           3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGE   82 (323)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCC
Confidence            566666543   2  368899999997543323333344555554 5678999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |..++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          83 LFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            9999988888999999999999999999999998   99999999999999999999999998752              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|++||...
T Consensus       160 ~~y~aPE~~~  169 (323)
T cd05575         160 PEYLAPEVLR  169 (323)
T ss_pred             hhhcChhhhc
Confidence             478888654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.92  E-value=1.6e-26  Score=218.67  Aligned_cols=179  Identities=24%  Similarity=0.294  Sum_probs=148.5

Q ss_pred             CcceeeccCCCCCcCcCCccc-ccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQ-DELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEGHV  118 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d-~~g~TpLh~A~~~g~~  118 (359)
                      ...++++..|+++.++.+++. +..+++.|.+|.|+|||||.+++++++++||++|||||+.+ .-|.|||||||++|++
T Consensus        46 ~~~v~A~q~G~l~~v~~lve~~g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~  125 (600)
T KOG0509|consen   46 DDIVKATQYGELETVKELVESEGESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHI  125 (600)
T ss_pred             hhhhhHhhcchHHHHHHHHhhcCcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcH
Confidence            345689999999999999999 55555568899999999999999999999999999999999 8899999999999999


Q ss_pred             HHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccCCCCCCCcc--cCCcceeeEe
Q 018204          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPREVPEY--ELNPLELQVR  193 (359)
Q Consensus       119 ~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~~~~~~~~--~l~~~~~~~~  193 (359)
                      .+|++|+++|||++.+|..|.||+|.|+.+|+.-.+.+|+.+|+++   |..++||++.|........  .+-.....+.
T Consensus       126 ~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTpLmwAaykg~~~~v~~LL~f~a~~~  205 (600)
T KOG0509|consen  126 SVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTPLMWAAYKGFALFVRRLLKFGASLL  205 (600)
T ss_pred             HHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCHHHHHHHhcccHHHHHHHHhccccc
Confidence            9999999999999999999999999999999999999999999998   4556899998865544331  1111122223


Q ss_pred             ecc-CcccceeEEEEecCcEEEEEEec
Q 018204          194 KAD-GITKGSYQVAKWNGTKVWVKILD  219 (359)
Q Consensus       194 ~~~-~ig~g~~~~~~~~g~~vavK~l~  219 (359)
                      ..+ .-|.++++.+...|..-+++++.
T Consensus       206 ~~d~~~g~TpLHwa~~~gN~~~v~Ll~  232 (600)
T KOG0509|consen  206 LTDDNHGNTPLHWAVVGGNLTAVKLLL  232 (600)
T ss_pred             ccccccCCchHHHHHhcCCcceEehhh
Confidence            333 55777887777778888888443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.92  E-value=5.1e-25  Score=215.46  Aligned_cols=141  Identities=30%  Similarity=0.532  Sum_probs=123.4

Q ss_pred             eEeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      +......+|+|.|+.+.          .....||||.|+...  +.....+|.+|++++..++|||||+|+|+|...+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            34445678999998652          235689999996543  455667899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc
Q 018204          261 MIVLEYHAKGDLASYLQKKG--------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~  326 (359)
                      ++|+|||..|+|.+||....              +++..+.+.|+.||+.||.||-++.   +|||||.++|+||+.+..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            99999999999999996431              2778899999999999999999998   999999999999999999


Q ss_pred             EEEecccccc
Q 018204          327 LKISGFGLLR  336 (359)
Q Consensus       327 ~kl~DFGla~  336 (359)
                      |||+||||+|
T Consensus       642 VKIsDfGLsR  651 (774)
T KOG1026|consen  642 VKISDFGLSR  651 (774)
T ss_pred             EEecccccch
Confidence            9999999998

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.92  E-value=2.6e-24  Score=200.36  Aligned_cols=152  Identities=26%  Similarity=0.401  Sum_probs=127.4

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC-ccccceeeEEeCCcEEEEEe
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP-NVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~e  265 (359)
                      |...+.+|.|.|+.+   .  ..++.+|+|++...........+.+..|..++..+.|+ +|+++++++.....+|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            344556788888744   2  24678999999764433344556788899999999765 57888999998899999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+++|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++         
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCce
Confidence            9999999999988888999999999999999999999998   9999999999999999999999999875         


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|+|||...
T Consensus       159 ~~~~gt~~y~aPE~~~  174 (324)
T cd05587         159 RTFCGTPDYIAPEIIA  174 (324)
T ss_pred             eeecCCccccChhhhc
Confidence                  2478888654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PHA02988 hypothetical protein; Provisional

Probab=99.92  E-value=3.2e-24  Score=195.97  Aligned_cols=141  Identities=21%  Similarity=0.287  Sum_probs=123.6

Q ss_pred             EEEEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe----CCcEEEEEecCCCCCHHHHHHhc
Q 018204          204 QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPMMIVLEYHAKGDLASYLQKK  279 (359)
Q Consensus       204 ~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~  279 (359)
                      ..+..+|+.+|||.+...........+.|.+|+.++.+++||||+++++++.+    ...+++||||+++|+|.+++...
T Consensus        37 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~  116 (283)
T PHA02988         37 YKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE  116 (283)
T ss_pred             EEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC
Confidence            34577899999999976555455556788999999999999999999999876    35789999999999999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCcEEEeccccccc------------cccCccccc
Q 018204          280 GRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------------QYISPEKAK  346 (359)
Q Consensus       280 ~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~------------~~~~PE~~~  346 (359)
                      +.+++.....++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||+++.            .|+|||...
T Consensus       117 ~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~  193 (283)
T PHA02988        117 KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLN  193 (283)
T ss_pred             CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhh
Confidence            8899999999999999999999984 6   88999999999999999999999999872            488888765


Q ss_pred             c
Q 018204          347 I  347 (359)
Q Consensus       347 ~  347 (359)
                      .
T Consensus       194 ~  194 (283)
T PHA02988        194 D  194 (283)
T ss_pred             h
Confidence            3

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-24  Score=203.82  Aligned_cols=141  Identities=30%  Similarity=0.539  Sum_probs=123.8

Q ss_pred             EeeccCcccceeEEE---Eec-CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA---KWN-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~~-g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      ...++++|+|.|+.+   ... +.+||||.++.....  ...++|.+|+++|.+|+||||+.++++|..++++++|+||+
T Consensus       540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             eehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            456778999999855   333 489999999876543  34578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          268 AKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       268 ~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ++|+|.+|+....  .+.......|+.||+.||+||.+.+   +|||||.+.|||++.++++||+|||+||.
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence            9999999998763  2345566789999999999999999   99999999999999999999999999993

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3e-24  Score=200.35  Aligned_cols=146  Identities=28%  Similarity=0.443  Sum_probs=122.2

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCccccceeeEEeCCcEEEEEecCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      +|.|.|+.+     ...+..+|+|++.............+..|..++...   +||+|+++++++.....+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            356666643     235789999999654332333444556677777665   699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc------------
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------------  337 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~------------  337 (359)
                      |+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.            
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~  157 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC  157 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCcc
Confidence            999999988888999999999999999999999998   99999999999999999999999999852            


Q ss_pred             ---cccCccccc
Q 018204          338 ---QYISPEKAK  346 (359)
Q Consensus       338 ---~~~~PE~~~  346 (359)
                         .|+|||...
T Consensus       158 gt~~y~aPE~~~  169 (330)
T cd05586         158 GTTEYLAPEVLL  169 (330)
T ss_pred             CCccccCHHHHc
Confidence               488998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.92  E-value=4.7e-24  Score=196.66  Aligned_cols=140  Identities=29%  Similarity=0.528  Sum_probs=118.6

Q ss_pred             EeeccCcccceeEEEE---e------------------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccc
Q 018204          192 VRKADGITKGSYQVAK---W------------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF  250 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~---~------------------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  250 (359)
                      |...+.+|.|.|+.+.   .                  .+..+|+|.+....  .......|.+|+.++..++||||+++
T Consensus         7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            4455667888887542   1                  23469999986543  34455679999999999999999999


Q ss_pred             eeeEEeCCcEEEEEecCCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 018204          251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKG-------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIH  311 (359)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiH  311 (359)
                      ++++......+++|||+++++|.+++....                   .+++..+..++.||+.||.|||+++   |+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence            999999999999999999999999986531                   3677888999999999999999998   999


Q ss_pred             CCCCCCcEEEcCCCcEEEecccccc
Q 018204          312 CDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       312 rDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||||+|||++.++.+||+|||+++
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~  186 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSR  186 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccce
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.92  E-value=3e-24  Score=199.65  Aligned_cols=146  Identities=31%  Similarity=0.494  Sum_probs=121.4

Q ss_pred             cccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHH-HHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELT-IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+   .  ..+..+|+|++.+...........+..|.. +++.++||||+++++++......|+||||+++++
T Consensus         3 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   82 (321)
T cd05603           3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGE   82 (321)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCC
Confidence            567777643   2  357899999997543323333344555554 6788999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |...+.....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          83 LFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            9999988778999999999999999999999998   99999999999999999999999998762              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|++||...
T Consensus       160 ~~y~aPE~~~  169 (321)
T cd05603         160 PEYLAPEVLR  169 (321)
T ss_pred             cccCCHHHhc
Confidence             478888654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.91  E-value=3.6e-26  Score=193.82  Aligned_cols=154  Identities=25%  Similarity=0.407  Sum_probs=131.5

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      -+|.+.+.+|+|+|.++     ..+|+.+++|++........ ..+.+.+|++|.+.|+||||+++.+.+......|+|+
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            35666778999999865     45788999999865544332 5567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC---CcEEEecccccc-----
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLR-----  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DFGla~-----  336 (359)
                      |++.|++|..-+..+.-.++..+..+++||+++|.|+|.++   |||||+||+|+|+...   .-+||+|||+|.     
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            99999999877665556888999999999999999999999   9999999999999653   359999999995     


Q ss_pred             ---------ccccCcccccc
Q 018204          337 ---------LQYISPEKAKI  347 (359)
Q Consensus       337 ---------~~~~~PE~~~~  347 (359)
                               +.||+||..+.
T Consensus       167 ~~~~G~~GtP~fmaPEvvrk  186 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKK  186 (355)
T ss_pred             cccccccCCCcccCHHHhhc
Confidence                     46999998763

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.91  E-value=5e-24  Score=194.75  Aligned_cols=151  Identities=28%  Similarity=0.380  Sum_probs=127.3

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|.|+.+     ..+|..+|+|.+.............+.+|+.++..++|++|+++++++......++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            44456788888754     2468899999987554333334456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          268 AKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       268 ~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      ++|+|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.        
T Consensus        83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            999999888643  35899999999999999999999998   99999999999999999999999999852        


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||...
T Consensus       160 ~~~g~~~y~aPE~~~  174 (285)
T cd05631         160 GRVGTVGYMAPEVIN  174 (285)
T ss_pred             CCCCCCCccCHhhhc
Confidence                  478888654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.91  E-value=5.2e-24  Score=200.04  Aligned_cols=145  Identities=26%  Similarity=0.465  Sum_probs=127.9

Q ss_pred             eeeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEE
Q 018204          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l  262 (359)
                      ...|.....+|.|.|+.+.     .+|..+|+|.+.+.........+.+.+|+.+|+.+. ||||+.++++|.+...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4456777889999998652     358999999998766555445567899999999998 9999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC----CcEEEeccccccc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG----GQLKISGFGLLRL  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~----~~~kl~DFGla~~  337 (359)
                      |||+|.||.|++.+... .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|++|||+|..
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            99999999999999776 5999999999999999999999998   9999999999999643    4799999999973

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.91  E-value=3.7e-24  Score=199.98  Aligned_cols=152  Identities=24%  Similarity=0.390  Sum_probs=128.3

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|+|.|+.+     ...+..+|+|++.+...........+..|+.++..++|++|+++++++.....+|+||||
T Consensus         3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey   82 (332)
T cd05623           3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY   82 (332)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence            455567888888744     234678999998643322333445688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      +++|+|.+++.+ ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++         
T Consensus        83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999977 356899999999999999999999998   9999999999999999999999999874         


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|++||...
T Consensus       160 ~~~~~gt~~y~aPE~~~  176 (332)
T cd05623         160 SSVAVGTPDYISPEILQ  176 (332)
T ss_pred             ecccccCccccCHHHHh
Confidence                   2488888654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.91  E-value=8.8e-25  Score=207.04  Aligned_cols=153  Identities=24%  Similarity=0.476  Sum_probs=127.8

Q ss_pred             cCCcceeeEeeccCcccceeEEEE-----ecCcEEEEEEec-cCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC
Q 018204          184 ELNPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILD-KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN  257 (359)
Q Consensus       184 ~l~~~~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~-~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  257 (359)
                      ..++.....+....+|+|+|..+.     ..|..||.-.+. .+....+...+.|..|+.+|+.|+||||++||++|.+.
T Consensus        34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT  113 (632)
T ss_pred             ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence            344445555666678899887552     356667654443 23344667778999999999999999999999999876


Q ss_pred             Cc--EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEecccc
Q 018204          258 IP--MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGL  334 (359)
Q Consensus       258 ~~--~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGl  334 (359)
                      ..  +-+|+|++..|+|..|+++.+.+..+.++.|++||++||.|||++. +||||||||.+||+|+. .|.|||+|+||
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhH
Confidence            54  8899999999999999999999999999999999999999999998 48999999999999986 58999999999


Q ss_pred             ccc
Q 018204          335 LRL  337 (359)
Q Consensus       335 a~~  337 (359)
                      |.+
T Consensus       193 Atl  195 (632)
T KOG0584|consen  193 ATL  195 (632)
T ss_pred             HHH
Confidence            974

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.91  E-value=4.8e-24  Score=198.44  Aligned_cols=152  Identities=28%  Similarity=0.419  Sum_probs=127.5

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEe
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      |.....+|+|.|+.+     ..++..+|+|++.+...........+..|..++..+ .|++|+++++++.....+|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            344556788888754     225678999999765433344445677788888877 57899999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus        82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcc
Confidence            9999999999988888999999999999999999999998   99999999999999999999999998862        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       159 ~~~~gt~~y~aPE~~~  174 (323)
T cd05616         159 KTFCGTPDYIAPEIIA  174 (323)
T ss_pred             ccCCCChhhcCHHHhc
Confidence                   488888755

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.91  E-value=5e-24  Score=197.78  Aligned_cols=146  Identities=28%  Similarity=0.451  Sum_probs=122.3

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHh-CCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+     ..+|..+|+|.+.............+..|..++.. ++||||+++++++...+.+|+||||+.+|+
T Consensus         3 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~   82 (316)
T cd05620           3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGD   82 (316)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCc
Confidence            567777643     23678999999975432222334456778888775 489999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------------  336 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------------  336 (359)
                      |..++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++               
T Consensus        83 L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          83 LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            9999988888999999999999999999999998   9999999999999999999999999875               


Q ss_pred             ccccCccccc
Q 018204          337 LQYISPEKAK  346 (359)
Q Consensus       337 ~~~~~PE~~~  346 (359)
                      ..|+|||...
T Consensus       160 ~~y~aPE~~~  169 (316)
T cd05620         160 PDYIAPEILQ  169 (316)
T ss_pred             cCccCHHHHc
Confidence            2478888654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.91  E-value=5.5e-24  Score=198.20  Aligned_cols=146  Identities=29%  Similarity=0.460  Sum_probs=119.9

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHH-HHHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHEL-TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+     ...+..+|+|++.............+..|. .+++.++||||+++++++......|+||||+++++
T Consensus         3 lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~   82 (325)
T cd05602           3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGE   82 (325)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCc
Confidence            567777643     235678999999754322222233444444 45678899999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------------  336 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------------  336 (359)
                      |.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++               
T Consensus        83 L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          83 LFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            9999988878999999999999999999999999   9999999999999999999999999875               


Q ss_pred             ccccCccccc
Q 018204          337 LQYISPEKAK  346 (359)
Q Consensus       337 ~~~~~PE~~~  346 (359)
                      ..|+|||...
T Consensus       160 ~~y~aPE~~~  169 (325)
T cd05602         160 PEYLAPEVLH  169 (325)
T ss_pred             ccccCHHHHc
Confidence            2478888654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.3e-24  Score=201.54  Aligned_cols=142  Identities=25%  Similarity=0.431  Sum_probs=124.5

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  ..|+.+|+|++.............+..|+.++..++||||+++++++......|+||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY   82 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence            445566788887744   2  24889999999754433334556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          83 MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            999999999988888999999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.91  E-value=1.4e-23  Score=196.01  Aligned_cols=152  Identities=28%  Similarity=0.481  Sum_probs=130.7

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+     ...|..+|+|++....  .....+.+.+|+.+++.++||||+++++++......++|||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            4556667888888754     2357889999986542  34455679999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||+++         
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  161 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  161 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence            9999999999988888999999999999999999999853  29999999999999999999999999985         


Q ss_pred             ----ccccCccccc
Q 018204          337 ----LQYISPEKAK  346 (359)
Q Consensus       337 ----~~~~~PE~~~  346 (359)
                          ..|+|||...
T Consensus       162 ~~g~~~y~aPE~~~  175 (331)
T cd06649         162 FVGTRSYMSPERLQ  175 (331)
T ss_pred             CCCCcCcCCHhHhc
Confidence                2588888765

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.91  E-value=4.8e-24  Score=198.48  Aligned_cols=151  Identities=26%  Similarity=0.408  Sum_probs=126.4

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEec
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      .....+|.|.|+.+     ..+|+.+|+|++...........+.+..|..++..+. |++|+++++++.....+|+||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey   82 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY   82 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence            34455788888744     2357899999997543333344556788999998886 46788899999988999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.         
T Consensus        83 ~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          83 VNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            999999999988888999999999999999999999998   99999999999999999999999998752         


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||...
T Consensus       160 ~~~gt~~y~aPE~~~  174 (323)
T cd05615         160 TFCGTPDYIAPEIIA  174 (323)
T ss_pred             CccCCccccCHHHHc
Confidence                  488888654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.6e-25  Score=221.81  Aligned_cols=167  Identities=25%  Similarity=0.330  Sum_probs=147.5

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      -+|.+.+.+|.|+||.+     +.+++.+|+|++.+...........|..|-.+|..-+.+-|+.++-+|.+..++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            35777888999999844     3468899999998754444445567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      ||++||+|..++.+.+++|+..+++|+..|+.||.-+|+.|   +|||||||+|||||..|++||+|||.+-        
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            99999999999999889999999999999999999999999   9999999999999999999999999762        


Q ss_pred             --------ccccCcccccccCCc-cCCCCCCC
Q 018204          337 --------LQYISPEKAKIVFPV-SHIDPAND  359 (359)
Q Consensus       337 --------~~~~~PE~~~~~~~~-~~~~p~~~  359 (359)
                              +-|+|||.++.+..- ..+.|.||
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecD  263 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECD  263 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccc
Confidence                    459999999888766 77777776

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.91  E-value=8.4e-25  Score=177.59  Aligned_cols=142  Identities=27%  Similarity=0.527  Sum_probs=122.1

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |..-+++|+|+|+.+     ..+++.||+|.++..... ...-....+|+.+++.++|.||++++++...+..+.+|+||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            344567899999865     235789999999754432 22224578999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccccc
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ  338 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~~  338 (359)
                      |.. +|..+.... +.+..+.++.++.|++.||.|+|+++   ++||||||+|+||+.+|.+|++|||+||-+
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhc
Confidence            976 999998764 56999999999999999999999999   999999999999999999999999999843

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.7e-25  Score=208.56  Aligned_cols=152  Identities=24%  Similarity=0.409  Sum_probs=132.2

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|+|+.+     ..+.+.||||.+...+....+..+++++|+..+.++.|||++.+-++|......|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3444456899999854     24678999999988888888888899999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      ||-| |-.+++.- ++++.+-.+..|..+.+.||+|||+++   .||||||+.|||++..|.|||+|||.|.        
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsF  182 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSF  182 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchhcc
Confidence            9965 88888854 457999999999999999999999999   9999999999999999999999999985        


Q ss_pred             ---ccccCccccc
Q 018204          337 ---LQYISPEKAK  346 (359)
Q Consensus       337 ---~~~~~PE~~~  346 (359)
                         ++|||||.+=
T Consensus       183 vGTPywMAPEVIL  195 (948)
T KOG0577|consen  183 VGTPYWMAPEVIL  195 (948)
T ss_pred             cCCccccchhHhe
Confidence               3566776543

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.91  E-value=5e-24  Score=198.40  Aligned_cols=149  Identities=29%  Similarity=0.456  Sum_probs=123.0

Q ss_pred             eccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHH---HhCCCCccccceeeEEeCCcEEEEEe
Q 018204          194 KADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIV---EKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       194 ~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      ..+.+|.|.|+.+     ..+|..+|+|++...........+.+..|+.++   ..++||||+++++++......|+|||
T Consensus         3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E   82 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVME   82 (324)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEc
Confidence            3455677777643     235789999999754433334455677776665   45689999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++++|..++.. +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus        83 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          83 YAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             CCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            9999999988865 46999999999999999999999998   99999999999999999999999998752        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       159 ~~~~g~~~y~aPE~~~  174 (324)
T cd05589         159 STFCGTPEFLAPEVLT  174 (324)
T ss_pred             cccccCccccCHhHhc
Confidence                   478888654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.91  E-value=8.3e-24  Score=197.00  Aligned_cols=146  Identities=29%  Similarity=0.499  Sum_probs=122.5

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHH-HHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELT-IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+     ..+|+.+|+|++.............+..|.. +++.++||||+++++++......|+||||+++|+
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~   82 (325)
T cd05604           3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGE   82 (325)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCC
Confidence            567777643     2358899999997543333334445555654 4677899999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |..++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          83 LFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            9999988888999999999999999999999998   99999999999999999999999999862              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|++||...
T Consensus       160 ~~y~aPE~~~  169 (325)
T cd05604         160 PEYLAPEVIR  169 (325)
T ss_pred             hhhCCHHHHc
Confidence             378888654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.91  E-value=1.9e-25  Score=179.84  Aligned_cols=126  Identities=22%  Similarity=0.298  Sum_probs=115.0

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCC-CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v  121 (359)
                      +..+|.-|+.+.|+.++...+++++. +..|.|+||+||.+|..+++++|+++|+.|+++|..|.||||.||.-|.++++
T Consensus        76 lhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtplHRAAavGklkvi  155 (226)
T KOG4412|consen   76 LHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTPLHRAAAVGKLKVI  155 (226)
T ss_pred             hhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCchhHHHHhccchhhH
Confidence            34556678888888888886777766 88999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccccccccccccccccccccceeEeeccccCccccccC
Q 018204          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (359)
Q Consensus       122 ~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~  168 (359)
                      ++|+..||.+|.+|+.|+||||.|.-.|+.++..+|+++||+.+..+
T Consensus       156 e~Li~~~a~~n~qDk~G~TpL~~al~e~~~d~a~lLV~~gAd~~~ed  202 (226)
T KOG4412|consen  156 EYLISQGAPLNTQDKYGFTPLHHALAEGHPDVAVLLVRAGADTDRED  202 (226)
T ss_pred             HHHHhcCCCCCcccccCccHHHHHHhccCchHHHHHHHhccceeecc
Confidence            99999999999999999999999977889999999999999985443

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.91  E-value=9.3e-24  Score=196.89  Aligned_cols=146  Identities=32%  Similarity=0.511  Sum_probs=126.7

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+     ...+..+|+|++...........+.+..|+.++..+ +||+|+++++++.....+|+||||+++|+
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (327)
T cd05617           3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGD   82 (327)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCc
Confidence            577777643     235788999999865544555667788999999888 69999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |..++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          83 LMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            9999988788999999999999999999999998   99999999999999999999999998862              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|+|||...
T Consensus       160 ~~y~aPE~~~  169 (327)
T cd05617         160 PNYIAPEILR  169 (327)
T ss_pred             cccCCHHHHC
Confidence             377888654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.91  E-value=8e-24  Score=192.90  Aligned_cols=145  Identities=26%  Similarity=0.390  Sum_probs=122.7

Q ss_pred             ccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHH
Q 018204          199 TKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA  273 (359)
Q Consensus       199 g~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~  273 (359)
                      |.|.|+.+     ..+|+.+|+|.+...........+.+..|+.+++.++||||+++.+++......++||||+++|+|.
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~   81 (280)
T cd05608           2 GKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR   81 (280)
T ss_pred             CCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHH
Confidence            55666533     3467899999997554433444567788999999999999999999999999999999999999999


Q ss_pred             HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------------
Q 018204          274 SYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------------  336 (359)
Q Consensus       274 ~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------------  336 (359)
                      .++..    ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++             
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          82 YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccC
Confidence            88743    245899999999999999999999998   9999999999999999999999999985             


Q ss_pred             --ccccCccccc
Q 018204          337 --LQYISPEKAK  346 (359)
Q Consensus       337 --~~~~~PE~~~  346 (359)
                        ..|++||...
T Consensus       159 g~~~y~aPE~~~  170 (280)
T cd05608         159 GTPGFMAPELLQ  170 (280)
T ss_pred             CCcCccCHHHhc
Confidence              2488888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.91  E-value=7.7e-24  Score=197.95  Aligned_cols=140  Identities=30%  Similarity=0.502  Sum_probs=117.3

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----CcEE
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~  261 (359)
                      |.....+|.|.|+.+     ..+|..+|+|.+..... .......+.+|+.+++.++||||+++++++...     ..+|
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            445556777877643     24688999999864322 223335688999999999999999999987643     2489


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +||||+. ++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence            9999995 699999988878999999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.91  E-value=7.1e-24  Score=196.88  Aligned_cols=146  Identities=30%  Similarity=0.503  Sum_probs=125.0

Q ss_pred             cccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|+|+.+   .  ..+..+|+|++.+...........+..|..++..+ +||||+++++++.....+|+||||+++|+
T Consensus         3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   82 (318)
T cd05570           3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGD   82 (318)
T ss_pred             eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCC
Confidence            566776643   2  25778999999754433344556678899999888 79999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |..++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          83 LMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            9999988888999999999999999999999998   99999999999999999999999998752              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|+|||...
T Consensus       160 ~~y~aPE~~~  169 (318)
T cd05570         160 PDYIAPEILS  169 (318)
T ss_pred             ccccCHHHhc
Confidence             478888754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.91  E-value=1.9e-23  Score=195.25  Aligned_cols=151  Identities=29%  Similarity=0.506  Sum_probs=129.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  ..+..+++|.+....  .......+.+|++++..++||||+++++++...+.+++|||
T Consensus         6 ~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            4556667888888744   2  257788999886542  33445678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++.       
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  160 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  160 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccc
Confidence            999999999998887899999999999999999999975 5   99999999999999999999999999852       


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||...
T Consensus       161 ~~~~~~~y~aPE~~~  175 (333)
T cd06650         161 SFVGTRSYMSPERLQ  175 (333)
T ss_pred             cCCCCccccCHHHhc
Confidence                  488898765

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.91  E-value=1.2e-23  Score=195.39  Aligned_cols=146  Identities=29%  Similarity=0.439  Sum_probs=124.2

Q ss_pred             CcccceeEEE--------EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          197 GITKGSYQVA--------KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       197 ~ig~g~~~~~--------~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      .+|.|+|+.+        ...|..+|+|++...... ......+..|+.++..++||||+++++++.....+|+||||++
T Consensus         3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            3567776633        135789999999753321 2233456789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----------
Q 018204          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----------  337 (359)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----------  337 (359)
                      +|+|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.           
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence            9999999988778999999999999999999999998   99999999999999999999999998852           


Q ss_pred             ----cccCccccc
Q 018204          338 ----QYISPEKAK  346 (359)
Q Consensus       338 ----~~~~PE~~~  346 (359)
                          .|++||...
T Consensus       159 ~g~~~y~aPE~~~  171 (318)
T cd05582         159 CGTVEYMAPEVVN  171 (318)
T ss_pred             cCChhhcCHHHHc
Confidence                378888654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.2e-25  Score=194.21  Aligned_cols=152  Identities=26%  Similarity=0.433  Sum_probs=136.9

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +...+.+|+|+|+.+     +..|+.+|+|+++++.....+.+..-..|-++++..+||.+..+--.|.....+|+||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            444566899999854     457899999999988877777777788999999999999999998899999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------  336 (359)
                      ..||.|+-.|.+...+++...+.+-.+|+.||.|||+++   ||+||||.+|+|+|++|++||+|||+++          
T Consensus       250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k  326 (516)
T KOG0690|consen  250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK  326 (516)
T ss_pred             ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence            999999999999888999999999999999999999998   9999999999999999999999999997          


Q ss_pred             -----ccccCccccc
Q 018204          337 -----LQYISPEKAK  346 (359)
Q Consensus       337 -----~~~~~PE~~~  346 (359)
                           +.|.|||.+.
T Consensus       327 TFCGTPEYLAPEVle  341 (516)
T KOG0690|consen  327 TFCGTPEYLAPEVLE  341 (516)
T ss_pred             cccCChhhcCchhhc
Confidence                 3477777654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=2.8e-24  Score=188.61  Aligned_cols=136  Identities=27%  Similarity=0.424  Sum_probs=120.2

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCC
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      .+.+|.|+|..+     ..+|.++|||++.+.....   .....+|++++.++ .|+||++++++|.++..+|||||-|.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHs---R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHS---RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchH---HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            345789998744     4679999999998875433   34578899999988 69999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---cEEEecccccc
Q 018204          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISGFGLLR  336 (359)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DFGla~  336 (359)
                      ||+|...|++...+++.++.+++++|+.||.|||.+|   |.||||||+|||-....   -+||+||.|..
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccc
Confidence            9999999999999999999999999999999999999   99999999999987654   38999998874

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.91  E-value=1.4e-23  Score=199.36  Aligned_cols=141  Identities=32%  Similarity=0.526  Sum_probs=119.8

Q ss_pred             eEeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  259 (359)
                      ++...+.+|.|.|+.+.          ..+..+|||++.....  ....+.+.+|+.++..+ +||||+++++++.....
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45667788999998551          1345899999864432  23345788999999999 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-----------------------------------------------------------
Q 018204          260 MMIVLEYHAKGDLASYLQKKG-----------------------------------------------------------  280 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  280 (359)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986431                                                           


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          281 ----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       281 ----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                                      .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~  262 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR  262 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccce
Confidence                            3677888999999999999999998   9999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.91  E-value=3.7e-24  Score=201.90  Aligned_cols=166  Identities=29%  Similarity=0.546  Sum_probs=140.1

Q ss_pred             CcccCCcceeeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEE
Q 018204          181 PEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT  255 (359)
Q Consensus       181 ~~~~l~~~~~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  255 (359)
                      .+|+++..++..  ..++|.|-|+.+     +.....||||.|+..    .-.++.|+.|+.+|+.++|||+|+++++|.
T Consensus       260 DkWEmeRtdItM--khKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT  333 (1157)
T KOG4278|consen  260 DKWEMERTDITM--KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT  333 (1157)
T ss_pred             chhhccchheee--eeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhc
Confidence            456665554443  445677777632     344678999999653    345678999999999999999999999999


Q ss_pred             eCCcEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          256 QNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      ...++|||+|||..|+|.+||.++.+  ++.-..+.++.||..||+||..++   +|||||.++|+|+.++..+|++|||
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccc
Confidence            99999999999999999999988754  777777888999999999999999   9999999999999999999999999


Q ss_pred             cccc----cccCcccccccCCccCCCCC
Q 018204          334 LLRL----QYISPEKAKIVFPVSHIDPA  357 (359)
Q Consensus       334 la~~----~~~~PE~~~~~~~~~~~~p~  357 (359)
                      |+|+    .|.+--.+|  ||.+|.+|-
T Consensus       411 LsRlMtgDTYTAHAGAK--FPIKWTAPE  436 (1157)
T KOG4278|consen  411 LSRLMTGDTYTAHAGAK--FPIKWTAPE  436 (1157)
T ss_pred             hhhhhcCCceecccCcc--CcccccCcc
Confidence            9996    377777667  999999985

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.90  E-value=6.9e-25  Score=191.06  Aligned_cols=152  Identities=24%  Similarity=0.444  Sum_probs=133.6

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      -|.+..++|.|+|+.+     +.+|+.+|+|.+...     ...+.+.+|+.++++++.|++|++|+.|.....+|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            3566778899999844     678999999998543     245678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      ||..||+.+++..+ +.+++.++..+++..+.||+|||-..   =||||||+.|||++.+|.+||+|||.|.        
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            99999999999754 67999999999999999999999887   7999999999999999999999999995        


Q ss_pred             -------ccccCcccccccCC
Q 018204          337 -------LQYISPEKAKIVFP  350 (359)
Q Consensus       337 -------~~~~~PE~~~~~~~  350 (359)
                             ++||+||.+..++.
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY  206 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGY  206 (502)
T ss_pred             hCccccCcccccHHHHHHhcc
Confidence                   46888887765543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.90  E-value=1.6e-23  Score=193.13  Aligned_cols=150  Identities=31%  Similarity=0.569  Sum_probs=124.1

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  .++..+|+|++.......  ....+.+|+.+++.++||||+++++++......++|||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            3555667788887643   2  357899999986543221  22346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      |+. ++|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.       
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            996 5888887654 56899999999999999999999998   99999999999999999999999998852       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       160 ~~~~~~~~~y~aPE~~~  176 (303)
T cd07869         160 YSNEVVTLWYRPPDVLL  176 (303)
T ss_pred             CCCCcccCCCCChHHHc
Confidence                    388888643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.90  E-value=1.4e-23  Score=192.08  Aligned_cols=149  Identities=31%  Similarity=0.521  Sum_probs=124.1

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|.|.|+.+     ..++..+|+|.+......  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            455566788887754     235789999998644321  1223567899999999999999999999998899999999


Q ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++ +|.+++...+ .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            975 9999887654 4789999999999999999999998   99999999999999999999999999852        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       161 ~~~~~~~~y~aPE~~~  176 (288)
T cd07871         161 SNEVVTLWYRPPDVLL  176 (288)
T ss_pred             cCceecccccChHHhc
Confidence                   478888653

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.90  E-value=1.9e-23  Score=190.75  Aligned_cols=151  Identities=25%  Similarity=0.404  Sum_probs=124.4

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  .++..+|+|.+..... .....+.+.+|+.+++.++||||+++++++......|+||||
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            344555677777643   2  3578899999865432 233445678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      ++++.+..+......+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.         
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          82 VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence            998776655555567999999999999999999999998   99999999999999999999999999852         


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       159 ~~~~~~~~y~aPE~~~  174 (287)
T cd07848         159 TEYVATRWYRSPELLL  174 (287)
T ss_pred             cccccccccCCcHHHc
Confidence                   378888654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.90  E-value=2.5e-23  Score=193.13  Aligned_cols=146  Identities=26%  Similarity=0.408  Sum_probs=122.3

Q ss_pred             cccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHh-CCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+   .  ..+..+|+|.+.............+..|..++.. ++||||+++++++.....+++||||+++|+
T Consensus         3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~   82 (316)
T cd05619           3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGD   82 (316)
T ss_pred             eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCc
Confidence            567777643   2  3467899999975432222334456678888876 499999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------  337 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------  337 (359)
                      |.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.              
T Consensus        83 L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          83 LMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            9999988778999999999999999999999998   99999999999999999999999998752              


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|+|||...
T Consensus       160 ~~y~aPE~~~  169 (316)
T cd05619         160 PDYIAPEILL  169 (316)
T ss_pred             ccccCHHHHc
Confidence             478888654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.90  E-value=2.1e-23  Score=199.05  Aligned_cols=152  Identities=29%  Similarity=0.420  Sum_probs=129.7

Q ss_pred             cceeeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-C-----CccccceeeEE
Q 018204          187 PLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-H-----PNVVQFVGAVT  255 (359)
Q Consensus       187 ~~~~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~~  255 (359)
                      .....|.+.+.+|+|+|+.+     ..+++.||||+++.+    +....+-..|+.+|..++ |     -|+|+++++|.
T Consensus       183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~  258 (586)
T KOG0667|consen  183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY  258 (586)
T ss_pred             eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence            33446788899999999854     236899999999754    344556678999999997 4     38999999999


Q ss_pred             eCCcEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC--cEEEec
Q 018204          256 QNIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--QLKISG  331 (359)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~--~~kl~D  331 (359)
                      ..+++|||+|.+.. +|.++++.+  ..++...++.|+.||+.||.+||+.+   |||+||||+||||...+  .+||+|
T Consensus       259 fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVID  334 (586)
T KOG0667|consen  259 FRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVID  334 (586)
T ss_pred             cccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEe
Confidence            99999999999965 999999876  35999999999999999999999999   99999999999997654  699999


Q ss_pred             ccccc------------ccccCccccc
Q 018204          332 FGLLR------------LQYISPEKAK  346 (359)
Q Consensus       332 FGla~------------~~~~~PE~~~  346 (359)
                      ||+|.            .+|+|||.+=
T Consensus       335 FGSSc~~~q~vytYiQSRfYRAPEVIL  361 (586)
T KOG0667|consen  335 FGSSCFESQRVYTYIQSRFYRAPEVIL  361 (586)
T ss_pred             cccccccCCcceeeeeccccccchhhc
Confidence            99996            3699999754

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.2e-23  Score=189.47  Aligned_cols=152  Identities=28%  Similarity=0.384  Sum_probs=126.7

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |+....+|.|.|+.+     ..++..+|+|.+.............+.+|+.+++.++||||+++++++.....+++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            344455788887744     235789999999754433333445678899999999999999999999998999999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.       
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            9999999888653  35899999999999999999999998   99999999999999999999999998863       


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|++||...
T Consensus       159 ~~~~~~~~y~aPE~~~  174 (285)
T cd05605         159 RGRVGTVGYMAPEVVK  174 (285)
T ss_pred             ccccCCCCccCcHHhc
Confidence                   477788653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.90  E-value=2.2e-23  Score=197.89  Aligned_cols=141  Identities=33%  Similarity=0.569  Sum_probs=119.6

Q ss_pred             eEeeccCcccceeEEEE---e-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  259 (359)
                      +|.....+|.|.|+.+.   +       .+..+|+|.+.....  ......+.+|+.+++.+ +|+||+++++++.....
T Consensus        39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            45566778999987542   1       234799999965432  33456788999999999 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhc------------------------------------------------------------
Q 018204          260 MMIVLEYHAKGDLASYLQKK------------------------------------------------------------  279 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------  279 (359)
                      .++||||+++|+|.+++...                                                            
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            99999999999999998542                                                            


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          280 ----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       280 ----------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                                ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~  260 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR  260 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeee
Confidence                      13677889999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.90  E-value=4.1e-23  Score=186.76  Aligned_cols=141  Identities=28%  Similarity=0.430  Sum_probs=121.3

Q ss_pred             eEeeccCcccceeEEE---E-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---K-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .+.....+|+|.|+.+   .     ..+..+|+|.+....  .......|.+|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            3555666888888754   1     235689999986542  33445678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||+++|+|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+|||++.++.++++|||.+.
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence            99999999999999764 46899999999999999999999998   9999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.4e-23  Score=212.26  Aligned_cols=161  Identities=35%  Similarity=0.557  Sum_probs=134.4

Q ss_pred             eeeEeeccCcccceeEEEEe------cC----cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC
Q 018204          189 ELQVRKADGITKGSYQVAKW------NG----TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI  258 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~~------~g----~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  258 (359)
                      .........+|+|.|+.+..      .|    ..||+|.+.+  ..+.+....|.+|..+|+.++||||++++|++.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            34455667789999986521      22    3478888754  346777889999999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhc------C-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEec
Q 018204          259 PMMIVLEYHAKGDLASYLQKK------G-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~------~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  331 (359)
                      ..+|++|||+||+|..||++.      . .++......++.||++|+.||+++.   +|||||.++|+|++....+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcc
Confidence            999999999999999999876      2 3889999999999999999999998   99999999999999999999999


Q ss_pred             cccccc-----cccCcccccccCCccCCCC
Q 018204          332 FGLLRL-----QYISPEKAKIVFPVSHIDP  356 (359)
Q Consensus       332 FGla~~-----~~~~PE~~~~~~~~~~~~p  356 (359)
                      ||+||-     +|..-..  .+.|++|++|
T Consensus       846 FGlArDiy~~~yyr~~~~--a~lPvkWm~P  873 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGE--AMLPVKWMPP  873 (1025)
T ss_pred             cchhHhhhhchheeccCc--cccceecCCH
Confidence            999982     2332222  4577777777

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.90  E-value=5.1e-23  Score=209.16  Aligned_cols=142  Identities=23%  Similarity=0.308  Sum_probs=121.9

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|+|+.+     ...|+.+|+|.+...........+.|.+|+.+++.++||||+++++++...+..|++|||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY   83 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY   83 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence            455667788888754     235789999999765544555567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          267 HAKGDLASYLQKK-----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       267 ~~~gsL~~~l~~~-----------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                      ++|++|.+++...           ..++...+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999998642           23556778899999999999999998   999999999999999999999999998


Q ss_pred             c
Q 018204          336 R  336 (359)
Q Consensus       336 ~  336 (359)
                      +
T Consensus       161 k  161 (932)
T PRK13184        161 I  161 (932)
T ss_pred             e
Confidence            6

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=3.4e-23  Score=197.55  Aligned_cols=143  Identities=26%  Similarity=0.397  Sum_probs=123.5

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|.|+|+.+     ...++.+|+|....         ..+.+|+.+++.++||||+++++++......++++|
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            4666677888888754     23578899996532         246789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      ++. ++|..++.....+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+         
T Consensus       164 ~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        164 RYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             cCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            995 699999988778999999999999999999999998   9999999999999999999999999985         


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|+|||...
T Consensus       240 ~~~~~gt~~y~aPE~~~  256 (391)
T PHA03212        240 YYGWAGTIATNAPELLA  256 (391)
T ss_pred             cccccCccCCCChhhhc
Confidence                   2477888654

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.90  E-value=4.7e-23  Score=195.55  Aligned_cols=140  Identities=28%  Similarity=0.427  Sum_probs=119.7

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC-----cEE
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----PMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~  261 (359)
                      +...+.+|.|.|+.+   .  .+|+.+|+|.+.... .+....+.+.+|+.+++.++||||+++++++....     ..|
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            344556788888754   2  368899999986432 23344567889999999999999999999998766     799


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +||||+. ++|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEecccccee
Confidence            9999996 589998887778999999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.90  E-value=5e-23  Score=193.95  Aligned_cols=146  Identities=25%  Similarity=0.450  Sum_probs=122.3

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +...+.+|.|.|+.+   .  .+++.+|+|++....  .......+.+|+.+++.++|+||+++++++.....+++||||
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            444566788888744   2  257899999986432  334456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +++++|...    ...++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.         
T Consensus       154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  226 (353)
T PLN00034        154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN  226 (353)
T ss_pred             CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence            999998653    23567788899999999999999998   99999999999999999999999999852         


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|++||...
T Consensus       227 ~~~gt~~y~aPE~~~  241 (353)
T PLN00034        227 SSVGTIAYMSPERIN  241 (353)
T ss_pred             ccccCccccCccccc
Confidence                  488898653

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=4.7e-23  Score=202.44  Aligned_cols=144  Identities=27%  Similarity=0.495  Sum_probs=121.0

Q ss_pred             eeeEeeccCcccceeEEE---Ee-c-CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceee-EEeC----
Q 018204          189 ELQVRKADGITKGSYQVA---KW-N-GTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGA-VTQN----  257 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~~-~-g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~~----  257 (359)
                      ...+++.+.+.+|.|..+   .. . |.++|+|.+...   +....+.+.+|+.+|+.|+ |+|||.+++. ....    
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            345666777888888643   22 2 389999998643   6777888999999999996 9999999993 2211    


Q ss_pred             --CcEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          258 --IPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       258 --~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                        -..+|+||||.||+|-+++..+  ..|++.++++|+.|+++|+.+||... +||||||||.+||||+.+|..||||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence              2488999999999999999753  45999999999999999999999997 589999999999999999999999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      .+.
T Consensus       192 Sat  194 (738)
T KOG1989|consen  192 SAT  194 (738)
T ss_pred             ccc
Confidence            985

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.89  E-value=9.4e-23  Score=194.84  Aligned_cols=141  Identities=33%  Similarity=0.517  Sum_probs=118.9

Q ss_pred             eEeeccCcccceeEEEE---e-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~  259 (359)
                      .+.....+|.|.|+.+.   .       .+..+|||.+....  .....+.|.+|+.++..+. ||||+++++++.....
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            45666778999888552   1       12469999986443  2344567899999999996 9999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhc------------------------------------------------------------
Q 018204          260 MMIVLEYHAKGDLASYLQKK------------------------------------------------------------  279 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------  279 (359)
                      .|+|||||++|+|.+++...                                                            
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            99999999999999988642                                                            


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC
Q 018204          280 ------------------------------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN  323 (359)
Q Consensus       280 ------------------------------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~  323 (359)
                                                          ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                                13677788899999999999999998   999999999999999


Q ss_pred             CCcEEEecccccc
Q 018204          324 GGQLKISGFGLLR  336 (359)
Q Consensus       324 ~~~~kl~DFGla~  336 (359)
                      ++.+||+|||+++
T Consensus       273 ~~~~kL~DfGla~  285 (400)
T cd05105         273 GKIVKICDFGLAR  285 (400)
T ss_pred             CCEEEEEeCCcce
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.89  E-value=1.9e-22  Score=197.37  Aligned_cols=140  Identities=20%  Similarity=0.301  Sum_probs=117.8

Q ss_pred             eEeeccCcccceeEEE---E--ec-CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WN-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~-g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      .|.....+|.|.++.+   .  .. +..+++|.+...   +......+..|+.++..++||||+++++++...+..|+||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            3555666777776533   1  22 567888876432   3444556788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||+++|+|.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCce
Confidence            99999999988754    345899999999999999999999998   9999999999999999999999999986

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.89  E-value=1.7e-22  Score=204.77  Aligned_cols=144  Identities=25%  Similarity=0.462  Sum_probs=127.3

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   ..  .+..||+|++.............+..|+.++..++||||+++++++.....+|+|||
T Consensus         5 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            3555667788888744   22  478999999976555555666788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |+.+++|.+++...+.+++..++.|+.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++.
T Consensus        85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~  153 (669)
T cd05610          85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV  153 (669)
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence            9999999999988778999999999999999999999998   99999999999999999999999999973

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.89  E-value=1.6e-22  Score=184.00  Aligned_cols=145  Identities=29%  Similarity=0.428  Sum_probs=120.0

Q ss_pred             ccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHH
Q 018204          199 TKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA  273 (359)
Q Consensus       199 g~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~  273 (359)
                      |.|.|+.+     ...|+.+|+|.+.............+..|+.+++.++||||+++++++......++||||+++++|.
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~   81 (277)
T cd05607           2 GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK   81 (277)
T ss_pred             CCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHH
Confidence            55666533     2358899999986543322223345567999999999999999999999999999999999999999


Q ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------------c
Q 018204          274 SYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------------L  337 (359)
Q Consensus       274 ~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------------~  337 (359)
                      +++....  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.              .
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          82 YHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCC
Confidence            8886543  4888999999999999999999998   9999999999999999999999999875              2


Q ss_pred             cccCccccc
Q 018204          338 QYISPEKAK  346 (359)
Q Consensus       338 ~~~~PE~~~  346 (359)
                      .|++||...
T Consensus       159 ~y~aPE~~~  167 (277)
T cd05607         159 GYMAPEILK  167 (277)
T ss_pred             CccCHHHHc
Confidence            477888654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.89  E-value=1.3e-22  Score=187.19  Aligned_cols=141  Identities=27%  Similarity=0.427  Sum_probs=121.8

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|.|+.+     ...+..+++|.+.............+..|+.+++.++||||+++++.+.....+++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            33445666666533     2356889999987654334445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||+++
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          84 EGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            99999999988888999999999999999999999998   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.89  E-value=1.5e-22  Score=181.28  Aligned_cols=134  Identities=34%  Similarity=0.573  Sum_probs=116.2

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCH
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      +|.|.|+.+     ..++..+++|.+....  ..+....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus         3 lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           3 IGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             cCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            466666533     2368889999875432  344556789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          273 ASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       273 ~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .+++...+ .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  142 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR  142 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCc
Confidence            99997643 5899999999999999999999998   9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.89  E-value=1.7e-22  Score=184.93  Aligned_cols=152  Identities=30%  Similarity=0.511  Sum_probs=129.6

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+   .  ..++.+++|.+...........+.+.+|+.+++.++||||+++++++......++||||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            334445666666532   2  35789999999755444445567789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.         
T Consensus        83 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~  159 (290)
T cd05580          83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC  159 (290)
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCC
Confidence            999999999988888999999999999999999999998   99999999999999999999999999863         


Q ss_pred             ---cccCccccc
Q 018204          338 ---QYISPEKAK  346 (359)
Q Consensus       338 ---~~~~PE~~~  346 (359)
                         .|++||...
T Consensus       160 ~~~~y~aPE~~~  171 (290)
T cd05580         160 GTPEYLAPEIIL  171 (290)
T ss_pred             CCccccChhhhc
Confidence               477888653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.9e-22  Score=181.62  Aligned_cols=142  Identities=25%  Similarity=0.484  Sum_probs=121.9

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCC--cHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK--DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      |...+.+|.|.++.+     ...+..+++|.+......  .......+.+|+.+++.++||||+++++++.....+++++
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            444556777776532     235789999998644322  2234567889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+++
T Consensus        84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~  152 (263)
T cd06625          84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  152 (263)
T ss_pred             EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence            99999999999988778999999999999999999999998   9999999999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.89  E-value=1.9e-22  Score=184.32  Aligned_cols=149  Identities=28%  Similarity=0.371  Sum_probs=125.0

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      .+.+|.|.|+.+     ..+++.+|+|.+.............+.+|+.+++.++|++|+.+++++...+..+++|||+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence            345677877643     235789999999765443333445678899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-----------
Q 018204          270 GDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-----------  336 (359)
Q Consensus       270 gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-----------  336 (359)
                      ++|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+++           
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (285)
T cd05632          85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR  161 (285)
T ss_pred             ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence            9999888653  35999999999999999999999998   9999999999999999999999999884           


Q ss_pred             ---ccccCccccc
Q 018204          337 ---LQYISPEKAK  346 (359)
Q Consensus       337 ---~~~~~PE~~~  346 (359)
                         ..|++||...
T Consensus       162 ~g~~~~~aPE~~~  174 (285)
T cd05632         162 VGTVGYMAPEVLN  174 (285)
T ss_pred             CCCcCccChHHhc
Confidence               2477777653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.89  E-value=8.2e-23  Score=189.74  Aligned_cols=149  Identities=27%  Similarity=0.501  Sum_probs=126.4

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      +.+|+|-|+.+     +.+|+.||||++.+........ ..+.+|+.|++.+.||.||.+.-.|++.+.+++|||-+.| 
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            45788888865     5689999999998776654443 6789999999999999999999999999999999999965 


Q ss_pred             CHHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---cEEEeccccccc--------
Q 018204          271 DLASYL-Q-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISGFGLLRL--------  337 (359)
Q Consensus       271 sL~~~l-~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DFGla~~--------  337 (359)
                      +..+.| . +.+++++...+.++.||+.||.|||-++   |+|.||||+|||+....   .+||+|||+||+        
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRr  724 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRR  724 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhhh
Confidence            655554 3 4567999999999999999999999999   99999999999997643   699999999984        


Q ss_pred             ------cccCcccccccC
Q 018204          338 ------QYISPEKAKIVF  349 (359)
Q Consensus       338 ------~~~~PE~~~~~~  349 (359)
                            .|.+||.++.-+
T Consensus       725 sVVGTPAYLaPEVLrnkG  742 (888)
T KOG4236|consen  725 SVVGTPAYLAPEVLRNKG  742 (888)
T ss_pred             hhcCCccccCHHHHhhcc
Confidence                  488888766433

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.89  E-value=2.6e-22  Score=183.47  Aligned_cols=150  Identities=28%  Similarity=0.398  Sum_probs=126.2

Q ss_pred             eccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ..+.+|.|.|+.+     ...+..+|+|.+.............+..|+.+++.++|++|+++++.+......++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            3345677877643     23578999999876544444444567889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          269 KGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       269 ~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +++|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..         
T Consensus        84 g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            99999988654  35899999999999999999999998   99999999999999999999999998852         


Q ss_pred             -----cccCccccc
Q 018204          338 -----QYISPEKAK  346 (359)
Q Consensus       338 -----~~~~PE~~~  346 (359)
                           .|+|||...
T Consensus       161 ~~g~~~y~aPE~~~  174 (285)
T cd05630         161 RVGTVGYMAPEVVK  174 (285)
T ss_pred             CCCCccccChHHHc
Confidence                 477888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.89  E-value=4.4e-23  Score=197.92  Aligned_cols=140  Identities=31%  Similarity=0.457  Sum_probs=117.4

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------CcE
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IPM  260 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~  260 (359)
                      +...+.+|+|+|+-+     +.+|..+|||.+.+...  ....+...+|++++++++|||||+++++-.+.      ...
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            444556889998744     34699999999986553  33446789999999999999999999876543      357


Q ss_pred             EEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC--CC--cEEEeccc
Q 018204          261 MIVLEYHAKGDLASYLQKK---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GG--QLKISGFG  333 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~--~~--~~kl~DFG  333 (359)
                      .++||||.||||...+.+.   ..+++..+..++..+..||.|||+++   |+||||||.||++-.  +|  ..||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            8999999999999999753   45999999999999999999999999   999999999999843  34  48999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      .||
T Consensus       170 ~Ar  172 (732)
T KOG4250|consen  170 AAR  172 (732)
T ss_pred             ccc
Confidence            998

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.89  E-value=6.5e-23  Score=170.04  Aligned_cols=152  Identities=26%  Similarity=0.472  Sum_probs=125.9

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCC
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ...+|.|+|+++     .++|...|+|.+.....  ....+.+..|+.+..+. ..|.+|.||+.+......|+.||.|.
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~  128 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD  128 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence            445789999854     46899999999975543  34445677888877665 79999999999999999999999996


Q ss_pred             CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          269 KGDLASYLQ----KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       269 ~gsL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      . ||..+-+    ..+.+++..+-+|+..|..||.|||++-  .+||||+||+||||+.+|.+|+||||+|..       
T Consensus       129 t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk  205 (282)
T KOG0984|consen  129 T-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK  205 (282)
T ss_pred             h-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence            5 8877653    4567999999999999999999999975  499999999999999999999999999963       


Q ss_pred             -------cccCcccccccCCc
Q 018204          338 -------QYISPEKAKIVFPV  351 (359)
Q Consensus       338 -------~~~~PE~~~~~~~~  351 (359)
                             .|||||....-...
T Consensus       206 t~daGCkpYmaPEri~~e~n~  226 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQ  226 (282)
T ss_pred             HHhcCCCccCChhhcCcccCc
Confidence                   59999987644433

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.89  E-value=4.9e-22  Score=183.69  Aligned_cols=150  Identities=30%  Similarity=0.522  Sum_probs=127.9

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+     ..++..+++|.+....  .......+.+|+.++..++||||+++++++...+..+++|||
T Consensus         3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            455566788888744     2357788999886432  344456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++++|.+++...+.+++..+..++.|++.||.|||+ ++   ++||||||+|||++.++.+||+|||+++.        
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  157 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccccccc
Confidence            9999999999888889999999999999999999997 46   99999999999999999999999998752        


Q ss_pred             -----cccCccccc
Q 018204          338 -----QYISPEKAK  346 (359)
Q Consensus       338 -----~~~~PE~~~  346 (359)
                           .|++||...
T Consensus       158 ~~~~~~~~aPE~~~  171 (308)
T cd06615         158 FVGTRSYMSPERLQ  171 (308)
T ss_pred             CCCCcCccChhHhc
Confidence                 577888654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.89  E-value=2.9e-22  Score=181.23  Aligned_cols=135  Identities=30%  Similarity=0.495  Sum_probs=112.2

Q ss_pred             CcccceeEEEE----ec---CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          197 GITKGSYQVAK----WN---GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       197 ~ig~g~~~~~~----~~---g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      .+|.|.|+.+.    ..   ...+++|.+....  .......|.+|+.+++.++||||+++++++......++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            35777776431    22   3467777765332  334456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          270 GDLASYLQKKG-----RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+|.+++....     ..++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  148 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLAL  148 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccc
Confidence            99999997642     2467788899999999999999998   9999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.89  E-value=4.3e-22  Score=179.78  Aligned_cols=142  Identities=22%  Similarity=0.433  Sum_probs=122.0

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|.|.|+.+     ...+..+|+|.+......+......+..|+.+++.++||||+++++++...+..++++||
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence            445556777777633     236889999988654444556667789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||+++
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccce
Confidence            999999988853    234889999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.89  E-value=2.8e-22  Score=182.22  Aligned_cols=140  Identities=27%  Similarity=0.484  Sum_probs=116.4

Q ss_pred             EeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      |.....+|.|+|+.+.          ..+..+|+|.+....  .......|.+|+.+++.++||||+++++++......+
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            4455567777776431          124679999885432  2334456889999999999999999999999889999


Q ss_pred             EEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEec
Q 018204          262 IVLEYHAKGDLASYLQKKG----------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  331 (359)
                      +||||+++++|.+++....          .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECC
Confidence            9999999999999997532          2567788999999999999999998   99999999999999999999999


Q ss_pred             ccccc
Q 018204          332 FGLLR  336 (359)
Q Consensus       332 FGla~  336 (359)
                      ||+++
T Consensus       163 fg~~~  167 (277)
T cd05062         163 FGMTR  167 (277)
T ss_pred             CCCcc
Confidence            99885

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=8.4e-24  Score=192.76  Aligned_cols=154  Identities=27%  Similarity=0.497  Sum_probs=136.5

Q ss_pred             eeeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      ...|.....+|.|.|+.+     ...++.||+|++..+..  ...++.+..|+.++.+++++||.++|+.|.....+|++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            345666678999999855     23578999999976543  44567889999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      ||||.||++.+.++.+..+.+..+..++++++.||.|+|+++   .+|||||+.|||+...|.+|++|||++.       
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999999998877799999999999999999999999   9999999999999999999999999984       


Q ss_pred             --------ccccCcccccc
Q 018204          337 --------LQYISPEKAKI  347 (359)
Q Consensus       337 --------~~~~~PE~~~~  347 (359)
                              ++|||||.++.
T Consensus       167 rr~tfvGTPfwMAPEVI~~  185 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQ  185 (467)
T ss_pred             ccccccccccccchhhhcc
Confidence                    47999998874

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.89  E-value=4.1e-22  Score=179.62  Aligned_cols=139  Identities=40%  Similarity=0.691  Sum_probs=118.3

Q ss_pred             eccCcccceeEEE---Eec------CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          194 KADGITKGSYQVA---KWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       194 ~~~~ig~g~~~~~---~~~------g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      ..+.+|.|.|+.+   .+.      +..|+||.+..  .......+.|.+|++.+++++||||+++++++......++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeecccccccccccccccccccccccccccccc
Confidence            3456788888743   344      67899999954  234555788999999999999999999999999888899999


Q ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          265 EYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ||+++|+|.+++...  ..+++.....|+.|++.||.|||+++   ++|++|+++||+++.++.+||+|||+++.
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~  152 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP  152 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            999999999999886  57999999999999999999999998   99999999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.89  E-value=3.7e-22  Score=183.03  Aligned_cols=141  Identities=29%  Similarity=0.523  Sum_probs=120.6

Q ss_pred             eEeeccCcccceeEEEEe---------------------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCcccc
Q 018204          191 QVRKADGITKGSYQVAKW---------------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ  249 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~~---------------------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  249 (359)
                      .|.....+|.|.|+.+..                     .+..+++|.+....  .....+.+.+|+.++..++||||++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            345556677887764321                     23568999986543  2345677899999999999999999


Q ss_pred             ceeeEEeCCcEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCc
Q 018204          250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-----------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN  318 (359)
Q Consensus       250 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~N  318 (359)
                      +++++......+++|||+++++|.+++....           .+++..+..++.|++.||.|||+++   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999899999999999999999997765           6899999999999999999999998   9999999999


Q ss_pred             EEEcCCCcEEEecccccc
Q 018204          319 ILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       319 Ill~~~~~~kl~DFGla~  336 (359)
                      |+++.++.++|+|||+++
T Consensus       161 ili~~~~~~~l~dfg~~~  178 (296)
T cd05051         161 CLVGKNYTIKIADFGMSR  178 (296)
T ss_pred             eeecCCCceEEcccccee
Confidence            999999999999999987

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=5.4e-23  Score=194.46  Aligned_cols=142  Identities=24%  Similarity=0.350  Sum_probs=128.1

Q ss_pred             EeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|-|+|+.+.     .+...+|.|.|++.......++.....|-.||...+.+-||+||-.|.+...+|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            5556678999998542     24567899999877666677777788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++||++..+|-+.+-|++..+++|+.+++.|+++.|..|   +|||||||+|||||.+|++||+||||+.
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCT  777 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  777 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccc
Confidence            999999999998889999999999999999999999999   9999999999999999999999999985

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.88  E-value=2.8e-22  Score=179.94  Aligned_cols=151  Identities=36%  Similarity=0.613  Sum_probs=127.9

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |+..+.+|+|.|+.+   .  ..++.+|+|.+...... .........|+.+++.++||||+++++++......+++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence            345667888888754   2  34678999999765432 22233445699999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +++++|.+++...+.+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..         
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            999999999997778999999999999999999999998   99999999999999999999999999852         


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||..+
T Consensus       157 ~~~~~~~y~aPE~~~  171 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQ  171 (260)
T ss_dssp             SSSSSGGGSCHHHHT
T ss_pred             ccccccccccccccc
Confidence                  377787755

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.88  E-value=6.2e-22  Score=178.72  Aligned_cols=142  Identities=24%  Similarity=0.436  Sum_probs=119.0

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCC--CCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEE
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKES--HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMI  262 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~l  262 (359)
                      |.....+|.|.|+.+     ..+|..+++|.+....  .......+.+.+|+.+++.++||||+++++++...  ..+++
T Consensus         4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (265)
T cd06652           4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI   83 (265)
T ss_pred             ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence            344555677776543     2357899999885432  22334567889999999999999999999988763  46889


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence            9999999999999988777899999999999999999999998   9999999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.88  E-value=5.3e-22  Score=180.95  Aligned_cols=140  Identities=31%  Similarity=0.540  Sum_probs=117.5

Q ss_pred             EeeccCcccceeEEE---E------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          192 VRKADGITKGSYQVA---K------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      +.....+|+|.|+.+   .      ..+..+++|.+....  .......|.+|+.+++.++||||+++++++......|+
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            344455777777643   1      135688999986432  34455678899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 018204          263 VLEYHAKGDLASYLQKK-----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~  325 (359)
                      +|||+++++|.+++...                 ..+++..+..++.|++.||.|||+++   ++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            99999999999998532                 13778889999999999999999998   99999999999999999


Q ss_pred             cEEEecccccc
Q 018204          326 QLKISGFGLLR  336 (359)
Q Consensus       326 ~~kl~DFGla~  336 (359)
                      .+||+|||+++
T Consensus       162 ~~kl~dfg~~~  172 (283)
T cd05090         162 HVKISDLGLSR  172 (283)
T ss_pred             cEEeccccccc
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=9.6e-22  Score=179.25  Aligned_cols=138  Identities=32%  Similarity=0.582  Sum_probs=116.6

Q ss_pred             eeccCcccceeEEEE---------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEE
Q 018204          193 RKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMM  261 (359)
Q Consensus       193 ~~~~~ig~g~~~~~~---------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~  261 (359)
                      .....+|.|.|+.+.         ..+..+|+|.+....  .......|.+|+.+++.++||||+++++++...  ...+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            444567778776541         246789999986542  233446788999999999999999999987653  4589


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++|||+++++|.+++... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++|+|||+++
T Consensus        85 lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence            999999999999999764 5999999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.88  E-value=1.5e-23  Score=183.41  Aligned_cols=142  Identities=26%  Similarity=0.432  Sum_probs=117.7

Q ss_pred             eEeeccCcccceeEEEEe------c---CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe-CCcE
Q 018204          191 QVRKADGITKGSYQVAKW------N---GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~~------~---g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~  260 (359)
                      .|.....+|.|+|+.+..      +   ...+|+|.++.+...+ ......++|+.+++.++|||++.+..+|.. +..+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            456667789999985521      1   3368899886553221 222457899999999999999999999877 7889


Q ss_pred             EEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC----CcEEEec
Q 018204          261 MIVLEYHAKGDLASYLQKK-----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG----GQLKISG  331 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~----~~~kl~D  331 (359)
                      ++++||.+. +|..+|+-.     ..++...++.|+-||+.|+.|||++-   |+||||||.|||+..+    |.+||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987 999988642     35999999999999999999999998   9999999999999887    8999999


Q ss_pred             cccccc
Q 018204          332 FGLLRL  337 (359)
Q Consensus       332 FGla~~  337 (359)
                      ||++|+
T Consensus       180 lGlaR~  185 (438)
T KOG0666|consen  180 LGLARL  185 (438)
T ss_pred             ccHHHH
Confidence            999984

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.88  E-value=6.7e-22  Score=180.29  Aligned_cols=140  Identities=31%  Similarity=0.574  Sum_probs=118.7

Q ss_pred             eEeeccCcccceeEEEE---------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCc
Q 018204          191 QVRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~  259 (359)
                      .+.....+|.|.|+.+.         ..+..+++|.+...   .....+.|.+|+.+++.++||||+++++++..  ...
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            45556667888876442         24778999998643   34455678999999999999999999998754  346


Q ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence            89999999999999999764 45899999999999999999999998   9999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.88  E-value=4.7e-22  Score=179.61  Aligned_cols=149  Identities=26%  Similarity=0.472  Sum_probs=127.7

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  .++..+++|++.....   .....+.+|+.++..++||||+++++++......++|||
T Consensus        10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646          10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            4566677788887643   2  3578899999864432   223457889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||+++         
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            9999999999987778999999999999999999999998   9999999999999999999999999875         


Q ss_pred             ------ccccCcccc
Q 018204          337 ------LQYISPEKA  345 (359)
Q Consensus       337 ------~~~~~PE~~  345 (359)
                            ..|++||..
T Consensus       164 ~~~~~~~~y~~PE~~  178 (267)
T cd06646         164 KSFIGTPYWMAPEVA  178 (267)
T ss_pred             CccccCccccCHhHc
Confidence                  247888864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.88  E-value=7.8e-22  Score=178.13  Aligned_cols=140  Identities=31%  Similarity=0.536  Sum_probs=119.7

Q ss_pred             EeeccCcccceeEEE---Ee-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA---KW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      |.....+|.|.|+.+   .+     ....+++|.+....  .......|..|+.++..++||||+++++++......+++
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            445566788887644   22     13578999886432  344456788999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||+++
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhh
Confidence            9999999999999764 46899999999999999999999998   9999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.88  E-value=4.7e-22  Score=183.35  Aligned_cols=150  Identities=31%  Similarity=0.560  Sum_probs=121.7

Q ss_pred             EeeccCcccceeEEE---E--ecCc--EEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA---K--WNGT--KVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~--~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      +.....+|.|.|+.+   .  .++.  .+++|.+..  .........+.+|+.++.++ +||||+++++++......|++
T Consensus         9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            344456778887643   2  2344  346666543  22344556788999999999 899999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcE
Q 018204          264 LEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL  327 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~  327 (359)
                      |||+++++|.+++...+                .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence            99999999999997542                4788999999999999999999998   9999999999999999999


Q ss_pred             EEecccccc--------------ccccCccccc
Q 018204          328 KISGFGLLR--------------LQYISPEKAK  346 (359)
Q Consensus       328 kl~DFGla~--------------~~~~~PE~~~  346 (359)
                      ||+|||+++              ..|++||...
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  196 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN  196 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHh
Confidence            999999985              2378888654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=5.3e-22  Score=182.16  Aligned_cols=141  Identities=28%  Similarity=0.555  Sum_probs=119.0

Q ss_pred             eEeeccCcccceeEEEEe-----------------c--CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccce
Q 018204          191 QVRKADGITKGSYQVAKW-----------------N--GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV  251 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~~-----------------~--g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  251 (359)
                      +|...+.+|+|+|+.+..                 .  ...+|+|.+....  .....+.|.+|++++..++||||++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            455566788888875421                 1  2358899986542  344556799999999999999999999


Q ss_pred             eeEEeCCcEEEEEecCCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcE
Q 018204          252 GAVTQNIPMMIVLEYHAKGDLASYLQKKG------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI  319 (359)
Q Consensus       252 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NI  319 (359)
                      +++......++||||+++++|.+++....            .+++..+..++.|++.||.|||+++   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999986532            3678889999999999999999998   99999999999


Q ss_pred             EEcCCCcEEEecccccc
Q 018204          320 LLDNGGQLKISGFGLLR  336 (359)
Q Consensus       320 ll~~~~~~kl~DFGla~  336 (359)
                      +++.++.+||+|||+++
T Consensus       161 ll~~~~~~kl~dfg~~~  177 (295)
T cd05097         161 LVGNHYTIKIADFGMSR  177 (295)
T ss_pred             EEcCCCcEEeccccccc
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.88  E-value=5.6e-22  Score=180.65  Aligned_cols=140  Identities=33%  Similarity=0.600  Sum_probs=117.9

Q ss_pred             EeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +.....+|.|.|+.+   ..       ....+++|.+....  .......|.+|+.++..++||||+++++++......+
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            444556777777533   11       12568999886433  3445567899999999999999999999999888999


Q ss_pred             EEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 018204          262 IVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~  325 (359)
                      ++|||+++++|.+++...                ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            999999999999999764                34788899999999999999999998   99999999999999999


Q ss_pred             cEEEecccccc
Q 018204          326 QLKISGFGLLR  336 (359)
Q Consensus       326 ~~kl~DFGla~  336 (359)
                      .++|+|||+++
T Consensus       162 ~~~L~dfg~~~  172 (283)
T cd05048         162 TVKISDFGLSR  172 (283)
T ss_pred             cEEECCCccee
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=5.8e-22  Score=194.41  Aligned_cols=143  Identities=20%  Similarity=0.289  Sum_probs=121.1

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC------
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------  258 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------  258 (359)
                      ..|.....+|.|.|+.+     ..+|..+|+|.+..... .......+.+|+.++..++|+||++++..+....      
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            46777778899998754     23688999999975543 3455667889999999999999999887765432      


Q ss_pred             --cEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecc
Q 018204          259 --PMMIVLEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (359)
Q Consensus       259 --~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DF  332 (359)
                        .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence              378999999999999998653    35899999999999999999999998   999999999999999999999999


Q ss_pred             cccc
Q 018204          333 GLLR  336 (359)
Q Consensus       333 Gla~  336 (359)
                      |+++
T Consensus       188 Gls~  191 (496)
T PTZ00283        188 GFSK  191 (496)
T ss_pred             ccCe
Confidence            9985

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.88  E-value=7.5e-22  Score=178.01  Aligned_cols=138  Identities=28%  Similarity=0.517  Sum_probs=117.8

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +.....+|.|.++.+     ...+..+++|.+....    .....+.+|+.+++.++||||+++++++.....++++|||
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            344455677776533     2357889999986432    2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccc
Confidence            9999999999764  35899999999999999999999998   9999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.88  E-value=6e-22  Score=177.87  Aligned_cols=136  Identities=34%  Similarity=0.614  Sum_probs=115.9

Q ss_pred             eccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          194 KADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       194 ~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      ..+.+|.|.|+.+   .+ .+..+++|.+..... .   ...+..|+.+++.++||||+++++++......+++|||+++
T Consensus         8 ~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~   83 (256)
T cd05114           8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-S---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN   83 (256)
T ss_pred             EeeEecCCcCceEEEEEeccCceEEEEecccCCc-c---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence            3455777777633   33 346889998764322 1   24578899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          270 GDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+|.+++... +.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCcc
Confidence            9999999754 45899999999999999999999998   9999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.88  E-value=8.9e-22  Score=180.05  Aligned_cols=140  Identities=28%  Similarity=0.510  Sum_probs=119.0

Q ss_pred             eEeeccCcccceeEEE---E-------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---K-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      ++.....+|.|.|+.+   .       ..+..+++|.+...   .....+.+.+|+.++..++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3555666788887643   1       12355888887543   234456789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcE
Q 018204          261 MIVLEYHAKGDLASYLQKKG-------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL  327 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~  327 (359)
                      +++|||+++++|.+++...+             .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence            99999999999999997543             3899999999999999999999998   9999999999999999999


Q ss_pred             EEecccccc
Q 018204          328 KISGFGLLR  336 (359)
Q Consensus       328 kl~DFGla~  336 (359)
                      ||+|||+++
T Consensus       160 kl~dfg~~~  168 (288)
T cd05093         160 KIGDFGMSR  168 (288)
T ss_pred             EeccCCccc
Confidence            999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=7.6e-22  Score=180.09  Aligned_cols=140  Identities=27%  Similarity=0.575  Sum_probs=119.2

Q ss_pred             EeeccCcccceeEEE---E------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcE
Q 018204          192 VRKADGITKGSYQVA---K------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPM  260 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~  260 (359)
                      |.....+|+|.|+.+   .      ..+..+++|.+....  .......+.+|+.+++.++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            344556788888754   1      247789999986443  344456799999999999999999999988775  568


Q ss_pred             EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence            9999999999999999765 35899999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-22  Score=185.10  Aligned_cols=145  Identities=34%  Similarity=0.553  Sum_probs=123.5

Q ss_pred             ccCcccceeEEE---EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHh--CCCCccccceeeEEeCC----cEEEEEe
Q 018204          195 ADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK--ARHPNVVQFVGAVTQNI----PMMIVLE  265 (359)
Q Consensus       195 ~~~ig~g~~~~~---~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~----~~~lv~e  265 (359)
                      ...+|+|.|+.+   ...++.||||++.      .+....|.+|-+|.+.  ++|+||++|+++-....    .++||++
T Consensus       215 ~eli~~Grfg~V~KaqL~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~  288 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE  288 (534)
T ss_pred             HHHhhcCccceeehhhccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence            345678888754   5678999999995      3455678888888876  48999999998865444    7999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC------CCeEeCCCCCCcEEEcCCCcEEEecccccc---
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKP------DPIIHCDLKPKNILLDNGGQLKISGFGLLR---  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~------~~iiHrDlk~~NIll~~~~~~kl~DFGla~---  336 (359)
                      |.+.|||.+||+.+ .++|....+++..+++||+|||+.-|      ++|+|||||.+||||..++++.|+|||||.   
T Consensus       289 fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~  367 (534)
T KOG3653|consen  289 FHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE  367 (534)
T ss_pred             eccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence            99999999999875 68999999999999999999997543      469999999999999999999999999995   


Q ss_pred             --------------ccccCccccc
Q 018204          337 --------------LQYISPEKAK  346 (359)
Q Consensus       337 --------------~~~~~PE~~~  346 (359)
                                    ..|||||.+.
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLE  391 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLE  391 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHh
Confidence                          3599999876

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.88  E-value=6e-23  Score=198.29  Aligned_cols=162  Identities=28%  Similarity=0.465  Sum_probs=135.3

Q ss_pred             eeEeeccCcccceeEEEE--------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          190 LQVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      ....+.+.+|.|.|+.+.        .....||||.|+.  .....+..+|+.|+.||.+++||||++|.++.....+..
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~--GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA--GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeecc--CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            345556678999998652        2346899999954  345667778999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI  340 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~~~~  340 (359)
                      ||.|||++|+|..||..+ +.++.-+...+++.|+.||+||-..+   +|||||.++|||++.+-.+|++|||+||..--
T Consensus       707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            999999999999999765 57999999999999999999999999   99999999999999999999999999996533


Q ss_pred             Cccc----ccccCCccCCCC
Q 018204          341 SPEK----AKIVFPVSHIDP  356 (359)
Q Consensus       341 ~PE~----~~~~~~~~~~~p  356 (359)
                      +||.    ...-.|.-|+||
T Consensus       784 d~~~~ytt~GGKIPiRWTAP  803 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAP  803 (996)
T ss_pred             CCCccccccCCccceeecCh
Confidence            4432    222245666666

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.88  E-value=3.3e-23  Score=180.53  Aligned_cols=138  Identities=27%  Similarity=0.449  Sum_probs=114.6

Q ss_pred             EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEe----CCcEEEEEecCCCCCHHHHHHhcCC
Q 018204          207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ----NIPMMIVLEYHAKGDLASYLQKKGR  281 (359)
Q Consensus       207 ~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~  281 (359)
                      +.+|+++|+|+|....        ...+|++.--.. .|||||.++++|..    ...+.+|||.++||.|++.++.++.
T Consensus        84 k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~  155 (400)
T KOG0604|consen   84 KRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD  155 (400)
T ss_pred             ccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc
Confidence            5678999999986332        245677655444 79999999998764    4579999999999999999988765


Q ss_pred             --CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCcEEEecccccc--------------ccccCc
Q 018204          282 --LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLR--------------LQYISP  342 (359)
Q Consensus       282 --l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DFGla~--------------~~~~~P  342 (359)
                        ++++++..|++||..|+.|||+.+   |.||||||+|+|...   +..+||+|||+|+              ++|.+|
T Consensus       156 ~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaP  232 (400)
T KOG0604|consen  156 QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAP  232 (400)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCH
Confidence              999999999999999999999999   999999999999975   4569999999997              468999


Q ss_pred             ccccccCCccCCCCCCC
Q 018204          343 EKAKIVFPVSHIDPAND  359 (359)
Q Consensus       343 E~~~~~~~~~~~~p~~~  359 (359)
                      |...    .+..|.+||
T Consensus       233 evlg----~eKydkscd  245 (400)
T KOG0604|consen  233 EVLG----PEKYDKSCD  245 (400)
T ss_pred             HHhC----chhcCCCCC
Confidence            8744    344677776

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.88  E-value=6.8e-22  Score=186.65  Aligned_cols=149  Identities=26%  Similarity=0.401  Sum_probs=122.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC------c
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------P  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~  259 (359)
                      .|.....+|.|.|+.+     ...|..+|+|.+.... .+......+.+|+.+++.++||||+++++++....      .
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            4666677888888754     2358899999996543 23344567889999999999999999999886543      4


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.  
T Consensus       101 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         101 VYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             eEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            7999999975 67776643  4888999999999999999999999   99999999999999999999999999852  


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~  195 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVIL  195 (359)
T ss_pred             cCccCCCCcccCCCCCchhcc
Confidence                        488888754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=8.2e-22  Score=182.63  Aligned_cols=142  Identities=26%  Similarity=0.416  Sum_probs=121.8

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+   .  ..+..+++|.+.............+..|+.++..++||||+++++.+......|++|||
T Consensus         3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   82 (316)
T cd05574           3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY   82 (316)
T ss_pred             eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence            444455677766533   2  24789999999766544445567789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  151 (316)
T cd05574          83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSK  151 (316)
T ss_pred             cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhh
Confidence            9999999999754  46899999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.88  E-value=5.6e-22  Score=179.02  Aligned_cols=141  Identities=23%  Similarity=0.460  Sum_probs=120.7

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|.++.+     ..++..+++|.+......+......+.+|+.+++.++||||+++++++......+++|||+
T Consensus         5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08229           5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA   84 (267)
T ss_pred             hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence            33445677766533     2468899999886554445555678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++|.+++..    ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||+++
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            99999998864    345899999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.88  E-value=4.1e-22  Score=179.09  Aligned_cols=152  Identities=26%  Similarity=0.400  Sum_probs=129.8

Q ss_pred             EeeccCcccceeEE---EE--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQV---AK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~---~~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|.|.|+.   +.  .+++.+++|++...........+.+.+|+.++++++||||+++++++......++|+||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            34445566666642   22  35889999999766555555667899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +.+++|.+++.....+++..+..++.|+++||.|||+++   ++|+||+|+||+++.++.++|+|||++..         
T Consensus        82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCccccc
Confidence            999999999987778999999999999999999999998   99999999999999999999999998853         


Q ss_pred             -----cccCccccc
Q 018204          338 -----QYISPEKAK  346 (359)
Q Consensus       338 -----~~~~PE~~~  346 (359)
                           .|++||...
T Consensus       159 ~~~~~~y~~PE~~~  172 (258)
T cd05578         159 TSGTPGYMAPEVLC  172 (258)
T ss_pred             cCCChhhcCHHHHc
Confidence                 367777644

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.88  E-value=6.7e-22  Score=178.39  Aligned_cols=142  Identities=24%  Similarity=0.481  Sum_probs=121.7

Q ss_pred             EeeccCcccceeEEE----EecCcEEEEEEeccCCCC---cHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          192 VRKADGITKGSYQVA----KWNGTKVWVKILDKESHK---DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +.....+|.|.|+.+    ...+..+|+|.+......   .......+.+|+.+++.++|+||+++++++......++++
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            344556777777643    236788999998644321   2334466889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||+++
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  150 (265)
T cd06631          82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCAR  150 (265)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhH
Confidence            99999999999988778999999999999999999999998   9999999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.3e-22  Score=183.59  Aligned_cols=151  Identities=31%  Similarity=0.546  Sum_probs=126.9

Q ss_pred             eeeEeeccCcccceeEEE---EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHh--CCCCccccceeeEEeCC----c
Q 018204          189 ELQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK--ARHPNVVQFVGAVTQNI----P  259 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~----~  259 (359)
                      ..+....+.+|+|.|+.+   +|.|+.||||++.....      .++.+|.+|.+.  |+|+||+.|+++-..+.    .
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            446667778899999854   79999999999964332      246778887775  69999999998765432    5


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-----CKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-----~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                      +|||++|.+.|||++||.+ ..++.....+++..++.||+|||.     +|.+.|.|||||..|||+.+++.+-|+|+||
T Consensus       284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            9999999999999999988 479999999999999999999994     4545699999999999999999999999999


Q ss_pred             cc-------------------ccccCccccc
Q 018204          335 LR-------------------LQYISPEKAK  346 (359)
Q Consensus       335 a~-------------------~~~~~PE~~~  346 (359)
                      |-                   ..|||||.+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLd  393 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD  393 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhh
Confidence            93                   3599999765

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=9.7e-22  Score=177.01  Aligned_cols=138  Identities=31%  Similarity=0.462  Sum_probs=117.3

Q ss_pred             EeeccCcccceeEEE----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      +...+.+|.|.++.+    ...+..+++|.+.....    ..+.+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            444455677766532    23457899999865432    2345889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~  151 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLAR  151 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEE
Confidence            9999999997653  6899999999999999999999998   9999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.88  E-value=8.8e-22  Score=181.51  Aligned_cols=141  Identities=32%  Similarity=0.528  Sum_probs=120.0

Q ss_pred             eEeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  259 (359)
                      .+.....+|.|.|+.+.          ..+..+|+|.+....  .....+.+..|+.+++++ +||||+++++++...+.
T Consensus        36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            45556677888876431          124578999886543  234456789999999999 79999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .+++|||+++++|.++++...  .+++..+..++.|++.||.|||+++   |+|+||||+|||++.++.++|+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            999999999999999997643  3899999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=9.1e-22  Score=176.59  Aligned_cols=147  Identities=38%  Similarity=0.652  Sum_probs=126.0

Q ss_pred             eeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          193 RKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       193 ~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      .....+|.|.|+.   +...|+.+++|.+.....    ..+.+..|+.++..++|+||+++++++......++||||+++
T Consensus         9 ~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           9 KLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             cceeeeecCCCceEEEEEecCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            3345567776653   356789999999965432    456789999999999999999999999988899999999999


Q ss_pred             CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----------
Q 018204          270 GDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----------  337 (359)
Q Consensus       270 gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----------  337 (359)
                      ++|.+++....  .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.          
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~  161 (256)
T cd05039          85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL  161 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccccCCC
Confidence            99999998765  6899999999999999999999998   99999999999999999999999998863          


Q ss_pred             --cccCccccc
Q 018204          338 --QYISPEKAK  346 (359)
Q Consensus       338 --~~~~PE~~~  346 (359)
                        .|++||...
T Consensus       162 ~~~~~ape~~~  172 (256)
T cd05039         162 PVKWTAPEALR  172 (256)
T ss_pred             cccccCchhhc
Confidence              367777643

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.88  E-value=1e-21  Score=183.08  Aligned_cols=123  Identities=20%  Similarity=0.348  Sum_probs=109.3

Q ss_pred             ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhc--CCCCHH
Q 018204          208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK--GRLSPS  285 (359)
Q Consensus       208 ~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~  285 (359)
                      .+|..+|+|.+..... .......+..|+.+++.++||||+++++++..+...++||||+++|+|.+++...  ..+++.
T Consensus        23 ~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~  101 (327)
T cd08227          23 PTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL  101 (327)
T ss_pred             ccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHH
Confidence            4688999999865432 3344566788999999999999999999999999999999999999999999653  458999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       286 ~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                      .+..++.|++.||.|||+++   |+||||||+|||++.++.++++|||.
T Consensus       102 ~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~  147 (327)
T cd08227         102 AIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRS  147 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccch
Confidence            99999999999999999998   99999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.88  E-value=1.3e-21  Score=175.28  Aligned_cols=138  Identities=26%  Similarity=0.410  Sum_probs=118.0

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      ...+|.|.++.+     ..++..+++|.+...... ......+..|+.+++.++||||+++++++......++||||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence            344556655432     236789999998654332 44556789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          270 GDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~  149 (256)
T cd08529          84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAK  149 (256)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccce
Confidence            9999999764  46899999999999999999999998   9999999999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.88  E-value=1.1e-21  Score=176.60  Aligned_cols=133  Identities=27%  Similarity=0.502  Sum_probs=112.3

Q ss_pred             cccceeEEE---Ee----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          198 ITKGSYQVA---KW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       198 ig~g~~~~~---~~----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      +|.|.|+.+   .+    .+..+|+|++....  .....+.|.+|+.+++.++||||+++++++. ....++||||++++
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            466666533   22    34568999886442  3444567899999999999999999999875 45789999999999


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          271 DLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       271 sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|.+++.. ...+++..+..++.|++.||.|||+++   ++||||||+|||++.++.+||+|||+++
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccc
Confidence            99999975 346899999999999999999999998   9999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.88  E-value=9.5e-22  Score=177.74  Aligned_cols=140  Identities=30%  Similarity=0.531  Sum_probs=118.7

Q ss_pred             EeeccCcccceeEEE---Ee-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA---KW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      +...+.+|.|.|+.+   ..     .+..+++|.+....  .......|..|+.++..++||||+++++++......+++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            445566788877643   21     12368899886432  234456789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||+++
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccc
Confidence            9999999999999765 45899999999999999999999998   9999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.88  E-value=4.8e-22  Score=179.51  Aligned_cols=148  Identities=26%  Similarity=0.476  Sum_probs=127.0

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  .++..+++|.+....   ......+.+|+.+++.++||||+++++++......|++|||
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            444556777777643   2  357899999986543   22345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------  336 (359)
                      +++++|.+++...+.+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||+++          
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          88 CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            999999999988888999999999999999999999998   9999999999999999999999999874          


Q ss_pred             -----ccccCcccc
Q 018204          337 -----LQYISPEKA  345 (359)
Q Consensus       337 -----~~~~~PE~~  345 (359)
                           ..|+|||..
T Consensus       165 ~~~~~~~y~aPE~~  178 (267)
T cd06645         165 SFIGTPYWMAPEVA  178 (267)
T ss_pred             cccCcccccChhhh
Confidence                 248888864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.88  E-value=6.9e-22  Score=177.55  Aligned_cols=138  Identities=33%  Similarity=0.588  Sum_probs=117.3

Q ss_pred             EeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      +.....+|.|.++.+   .+ .+..+++|.+......    ...|..|+.+++.++||||+++++++......++||||+
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             cchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            445556778777643   22 3457899988643322    235788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++|.+++... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccce
Confidence            999999999764 46899999999999999999999998   9999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.88  E-value=7.8e-22  Score=177.33  Aligned_cols=138  Identities=34%  Similarity=0.606  Sum_probs=117.1

Q ss_pred             EeeccCcccceeEEE---Eec-CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA---KWN-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~~-g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      +.....+|.|.++.+   .+. +..+|+|.+......    .+.|.+|+.++..++||||+++++++......+++|||+
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            444556777776543   333 346999988643321    246889999999999999999999999888999999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .+++|.+++... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccce
Confidence            999999999764 36899999999999999999999998   9999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.88  E-value=9.8e-22  Score=177.42  Aligned_cols=141  Identities=28%  Similarity=0.541  Sum_probs=120.5

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCc---HHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKD---PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      .....+|.|.++.+     ..++..+++|.+.......   ....+.+..|+.+++.++|+||+++++++...+..++|+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~   82 (268)
T cd06630           3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV   82 (268)
T ss_pred             cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence            33455677777643     2468899999986433221   234577899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DFGla~  336 (359)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++ .++|+|||+++
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          83 EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             eccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            99999999999988788999999999999999999999998   99999999999998776 59999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.7e-23  Score=195.56  Aligned_cols=147  Identities=22%  Similarity=0.421  Sum_probs=125.4

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .+...+|.|+|+.+     +..+-..|.|++...   ..+..+.++-||.||..++||+|+++++.|...+.+|++.|||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            34456789999854     223445566777543   4567788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------
Q 018204          268 AKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------  336 (359)
Q Consensus       268 ~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------  336 (359)
                      .||....++-. ...+++..+.-+++|++.||.|||+++   |||||||+.|||++.+|.++|+|||.|.          
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            99998887654 346999999999999999999999999   9999999999999999999999999884          


Q ss_pred             -----ccccCcccc
Q 018204          337 -----LQYISPEKA  345 (359)
Q Consensus       337 -----~~~~~PE~~  345 (359)
                           ++|||||..
T Consensus       189 sFIGTPYWMAPEVv  202 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVV  202 (1187)
T ss_pred             cccCCcccccchhe
Confidence                 478999864

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.88  E-value=1.4e-21  Score=181.15  Aligned_cols=151  Identities=28%  Similarity=0.534  Sum_probs=125.5

Q ss_pred             eEeeccCcccceeEEEE---e---------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC
Q 018204          191 QVRKADGITKGSYQVAK---W---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~---------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  257 (359)
                      .+...+.+|.|.|+.+.   .         ....+++|.+....  .......+..|+.++..+ +||||+++++++...
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            45566778888887432   1         23468899886432  234456788999999999 699999999999998


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 018204          258 IPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll  321 (359)
                      ...+++|||+++|+|.+++...                ..+++..+..++.|++.||.|||+++   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            9999999999999999999753                23788899999999999999999998   9999999999999


Q ss_pred             cCCCcEEEeccccccc-----------------cccCccccc
Q 018204          322 DNGGQLKISGFGLLRL-----------------QYISPEKAK  346 (359)
Q Consensus       322 ~~~~~~kl~DFGla~~-----------------~~~~PE~~~  346 (359)
                      +.++.+||+|||+++.                 .|++||...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  209 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF  209 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHc
Confidence            9999999999999862                 388888653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.87  E-value=1.9e-21  Score=174.42  Aligned_cols=149  Identities=26%  Similarity=0.463  Sum_probs=125.4

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|+|+.+     ...+..+++|.+....  .....+.+..|+.+++.++||||+++++++.....+|++|||+
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            34456777777633     2367899999986433  2334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          268 AKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       268 ~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||+++.        
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  157 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA  157 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence            999999988653  35889999999999999999999998   99999999999999999999999999862        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|++||...
T Consensus       158 ~~~~~~~~~~aPE~~~  173 (255)
T cd08219         158 CTYVGTPYYVPPEIWE  173 (255)
T ss_pred             ccccCCccccCHHHHc
Confidence                   378888654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.87  E-value=3.3e-22  Score=188.96  Aligned_cols=155  Identities=25%  Similarity=0.520  Sum_probs=128.4

Q ss_pred             ccCcccceeEEE---Ee----cC--cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          195 ADGITKGSYQVA---KW----NG--TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       195 ~~~ig~g~~~~~---~~----~g--~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      ...+|.|-|+-+   .+    .|  --||||..+.+.  +++..+.|..|..+|+.++||||++++|+|.. .++|||||
T Consensus       394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             HHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            445788887633   11    23  357788775433  45557889999999999999999999999876 47899999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----cc
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QY  339 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----~~  339 (359)
                      +++-|.|..||+.+ ..++..+...++.||+.||.|||+..   +|||||..+|||+.....+||+|||+||+     +|
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            99999999999875 46999999999999999999999998   99999999999999999999999999995     35


Q ss_pred             cCcccccccCCccCCCCCC
Q 018204          340 ISPEKAKIVFPVSHIDPAN  358 (359)
Q Consensus       340 ~~PE~~~~~~~~~~~~p~~  358 (359)
                      .|-   +.-.|.+|++|-+
T Consensus       548 kaS---~~kLPIKWmaPES  563 (974)
T KOG4257|consen  548 KAS---RGKLPIKWMAPES  563 (974)
T ss_pred             hcc---ccccceeecCccc
Confidence            544   3347888888853

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.87  E-value=1.6e-21  Score=176.48  Aligned_cols=144  Identities=29%  Similarity=0.452  Sum_probs=118.1

Q ss_pred             cccceeEEE---Ee----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          198 ITKGSYQVA---KW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       198 ig~g~~~~~---~~----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      +|.|.|+.+   ..    .+..+++|.+.....  ......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         3 lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             ccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            566766543   21    235688998865432  233346888999999999999999999999888999999999999


Q ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          271 DLASYLQKKG-----RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       271 sL~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +|.+++....     ..++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.        
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999996532     3567788899999999999999998   99999999999999999999999998852        


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|++||...
T Consensus       158 ~~~~~~~~~~y~aPE~~~  175 (269)
T cd05087         158 TPDQLWVPLRWIAPELVD  175 (269)
T ss_pred             cCCCcCCcccccCHhHhc
Confidence                     378888654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.87  E-value=1.4e-21  Score=175.50  Aligned_cols=146  Identities=33%  Similarity=0.621  Sum_probs=121.5

Q ss_pred             eeccCcccceeE---EEEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEE-eCCcEEEEEecCC
Q 018204          193 RKADGITKGSYQ---VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT-QNIPMMIVLEYHA  268 (359)
Q Consensus       193 ~~~~~ig~g~~~---~~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lv~e~~~  268 (359)
                      .....+|.|.++   .+...|..+++|.+....     ..+.|..|+.+++.++|+|++++++++. .....+++|||++
T Consensus         9 ~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           9 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             eeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            334456666654   345678899999985432     2346889999999999999999999764 4567899999999


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          269 KGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       269 ~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +++|.+++...+  .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++.         
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  160 (256)
T cd05082          84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCCCc
Confidence            999999997653  3889999999999999999999998   99999999999999999999999999873         


Q ss_pred             ---cccCccccc
Q 018204          338 ---QYISPEKAK  346 (359)
Q Consensus       338 ---~~~~PE~~~  346 (359)
                         .|++||...
T Consensus       161 ~~~~y~aPE~~~  172 (256)
T cd05082         161 LPVKWTAPEALR  172 (256)
T ss_pred             cceeecCHHHHc
Confidence               488999654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.87  E-value=1.3e-21  Score=180.30  Aligned_cols=141  Identities=28%  Similarity=0.566  Sum_probs=118.2

Q ss_pred             eEeeccCcccceeEEEE---e---------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC
Q 018204          191 QVRKADGITKGSYQVAK---W---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~---------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  257 (359)
                      ++.....+|.|.|+.+.   .         .+..+++|.+....  .......+.+|+.+++.+ +||||+++++++...
T Consensus        16 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            45556678888886441   1         23468999886432  234456788999999999 899999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 018204          258 IPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll  321 (359)
                      ...+++|||+++++|.+++...                ..++...+..++.|++.||.|||+++   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            9999999999999999999763                23677889999999999999999998   9999999999999


Q ss_pred             cCCCcEEEecccccc
Q 018204          322 DNGGQLKISGFGLLR  336 (359)
Q Consensus       322 ~~~~~~kl~DFGla~  336 (359)
                      +.++.+||+|||+++
T Consensus       171 ~~~~~~kl~D~g~~~  185 (304)
T cd05101         171 TENNVMKIADFGLAR  185 (304)
T ss_pred             cCCCcEEECCCccce
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.87  E-value=1.4e-21  Score=182.94  Aligned_cols=141  Identities=33%  Similarity=0.568  Sum_probs=117.5

Q ss_pred             eEeeccCcccceeEEEEe----------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC-C
Q 018204          191 QVRKADGITKGSYQVAKW----------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN-I  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~~----------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-~  258 (359)
                      .|+..+.+|.|+|+.+..          .++.+|+|++....  .....+.+..|+.++.++ +|+||+++++++... .
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            355567789998875521          24689999986432  234456788899999999 899999999987654 5


Q ss_pred             cEEEEEecCCCCCHHHHHHhc-----------------------------------------------------------
Q 018204          259 PMMIVLEYHAKGDLASYLQKK-----------------------------------------------------------  279 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------------  279 (359)
                      .++++|||+++++|.+++...                                                           
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            689999999999999998642                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          280 --GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       280 --~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                        ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~  221 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR  221 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccch
Confidence              25788999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.87  E-value=1.3e-21  Score=180.70  Aligned_cols=141  Identities=31%  Similarity=0.568  Sum_probs=119.7

Q ss_pred             eEeeccCcccceeEEEE---e---------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC
Q 018204          191 QVRKADGITKGSYQVAK---W---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~---------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  257 (359)
                      .|...+.+|+|.|+.+.   .         .+..+|+|.+....  .......+..|+.++..+ +||||+++++++...
T Consensus        19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            46667788898887542   1         12469999986542  233445688899999999 799999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 018204          258 IPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll  321 (359)
                      ...|+||||+++++|.+++....                .+++..+..++.|++.||+|||+++   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            99999999999999999997532                3788899999999999999999998   9999999999999


Q ss_pred             cCCCcEEEecccccc
Q 018204          322 DNGGQLKISGFGLLR  336 (359)
Q Consensus       322 ~~~~~~kl~DFGla~  336 (359)
                      +.++.+||+|||+++
T Consensus       174 ~~~~~~kL~dfg~a~  188 (307)
T cd05098         174 TEDNVMKIADFGLAR  188 (307)
T ss_pred             cCCCcEEECCCcccc
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.87  E-value=1.5e-21  Score=176.27  Aligned_cols=138  Identities=33%  Similarity=0.538  Sum_probs=118.2

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccCCCCc------HHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKD------PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      ..+|.|.++.+     ...+..+++|.+.......      ....+.+..|+.+++.++||||+++++++......+++|
T Consensus         6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (267)
T cd06628           6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL   85 (267)
T ss_pred             ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence            34566666532     2357889999886543322      123467889999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||+++
T Consensus        86 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          86 EYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999988778999999999999999999999998   9999999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.87  E-value=1.1e-21  Score=179.48  Aligned_cols=150  Identities=29%  Similarity=0.501  Sum_probs=117.5

Q ss_pred             EeeccCcccceeEEE---Ee---cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCccccceeeEEe-----C
Q 018204          192 VRKADGITKGSYQVA---KW---NGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQ-----N  257 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~---~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~  257 (359)
                      |.....+|.|.|+.+   ..   .+..+|+|.+....... .....+.+|+.+++.+   +||||+++++++..     .
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            445566788888744   22   35789999986543222 1223456677777665   69999999998852     3


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          258 IPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                      ..+++||||++ ++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56899999996 5999998754  34899999999999999999999998   999999999999999999999999998


Q ss_pred             cc--------------cccCccccc
Q 018204          336 RL--------------QYISPEKAK  346 (359)
Q Consensus       336 ~~--------------~~~~PE~~~  346 (359)
                      +.              .|+|||...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~  182 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLL  182 (290)
T ss_pred             EeccCCcccccccccccccChHHHh
Confidence            52              478888653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.87  E-value=7.8e-22  Score=185.05  Aligned_cols=150  Identities=27%  Similarity=0.412  Sum_probs=122.7

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------Cc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~  259 (359)
                      .|.....+|.|.|+.+     ...+..+|+|.+..... .......+.+|+.+++.++||||+++++++...      ..
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            4555667888888754     23578899999864322 223345677899999999999999999887543      35


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.  
T Consensus        95 ~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          95 VYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             EEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence            79999988 6799888754 46999999999999999999999998   99999999999999999999999999862  


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|+|||...
T Consensus       170 ~~~~~~~~t~~y~aPE~~~  188 (343)
T cd07878         170 DEMTGYVATRWYRAPEIML  188 (343)
T ss_pred             CCcCCccccccccCchHhc
Confidence                      488888754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.87  E-value=1.2e-21  Score=179.38  Aligned_cols=140  Identities=29%  Similarity=0.576  Sum_probs=117.5

Q ss_pred             EeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcE
Q 018204          192 VRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  260 (359)
                      |.....+|.|.|+.+   ..       ....+++|.+....  .......+.+|+.++..+ +||||+++++++......
T Consensus        14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            444556777777643   21       22578999886432  234456788999999999 899999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC
Q 018204          261 MIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~  324 (359)
                      +++|||+++|+|..++...                +.+++..+..++.|++.||.|||+++   |+||||||+||+++.+
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~  168 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTED  168 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCC
Confidence            9999999999999999642                35888999999999999999999998   9999999999999999


Q ss_pred             CcEEEecccccc
Q 018204          325 GQLKISGFGLLR  336 (359)
Q Consensus       325 ~~~kl~DFGla~  336 (359)
                      +.+||+|||+++
T Consensus       169 ~~~kL~Dfg~~~  180 (293)
T cd05053         169 HVMKIADFGLAR  180 (293)
T ss_pred             CeEEeCcccccc
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.87  E-value=1.4e-21  Score=178.69  Aligned_cols=141  Identities=27%  Similarity=0.468  Sum_probs=116.9

Q ss_pred             eEeeccCcccceeEEEEe----------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVAKW----------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~~----------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      +|.....+|.|.|+.+..          .+..+|+|.+....  .......+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            345566788888874421          23478999875433  233344688899999999999999999999998999


Q ss_pred             EEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEe
Q 018204          261 MIVLEYHAKGDLASYLQKK----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~  330 (359)
                      ++||||+++|+|.+++...          ..++...+..++.|++.||.|||+++   |+||||||+||+++.++.++|+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999753          12456788899999999999999998   9999999999999999999999


Q ss_pred             cccccc
Q 018204          331 GFGLLR  336 (359)
Q Consensus       331 DFGla~  336 (359)
                      |||+++
T Consensus       162 Dfg~~~  167 (288)
T cd05061         162 DFGMTR  167 (288)
T ss_pred             cCCccc
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.87  E-value=1.4e-21  Score=177.70  Aligned_cols=140  Identities=29%  Similarity=0.505  Sum_probs=118.9

Q ss_pred             EeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      |.....+|.|+|+.+.          ..+..+++|.+....  ..+..+.+.+|+.+++.++||||+++++++......+
T Consensus         7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            4445567888776431          124679999986443  2334568999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcE
Q 018204          262 IVLEYHAKGDLASYLQKKG--------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL  327 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~--------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~  327 (359)
                      ++|||+++++|.+++...+              .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999997542              3788899999999999999999998   9999999999999999999


Q ss_pred             EEecccccc
Q 018204          328 KISGFGLLR  336 (359)
Q Consensus       328 kl~DFGla~  336 (359)
                      ||+|||+++
T Consensus       162 kl~d~g~~~  170 (280)
T cd05049         162 KIGDFGMSR  170 (280)
T ss_pred             EECCcccce
Confidence            999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.87  E-value=2.4e-21  Score=173.18  Aligned_cols=134  Identities=37%  Similarity=0.578  Sum_probs=115.1

Q ss_pred             cccceeEEE----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHH
Q 018204          198 ITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA  273 (359)
Q Consensus       198 ig~g~~~~~----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~  273 (359)
                      +|.|.|+.+    ...+..+++|.+....  .......+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         3 ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             cCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            466666533    2356789999886443  2334456889999999999999999999999999999999999999999


Q ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          274 SYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       274 ~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++... ..+++..+..++.|++.||.|+|+++   ++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~  141 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR  141 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccce
Confidence            998754 45889999999999999999999998   9999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.87  E-value=2e-21  Score=177.84  Aligned_cols=141  Identities=23%  Similarity=0.389  Sum_probs=119.3

Q ss_pred             eeccCcccceeEEE---E-----ecCcEEEEEEeccCCCC-cHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEE
Q 018204          193 RKADGITKGSYQVA---K-----WNGTKVWVKILDKESHK-DPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~-----~~g~~vavK~l~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .....+|.|.|+.+   .     .+|..+|+|.+...... .....+.+..|+.++..+ +|+||+++++++......|+
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            34455677777632   2     26788999998643221 222345678899999999 58999999999999899999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||+++
T Consensus        83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999988888999999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.3e-22  Score=190.91  Aligned_cols=144  Identities=33%  Similarity=0.576  Sum_probs=123.7

Q ss_pred             CcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          197 GITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       197 ~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      .+|+|+|+++.     .+....|||-+...   +....+-+..|+.+-+.++|.|||+++|++..++.+-|.||-++|||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            36899998652     23456788887543   33445568899999999999999999999999999999999999999


Q ss_pred             HHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEecccccc-----------
Q 018204          272 LASYLQKK-GRL--SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR-----------  336 (359)
Q Consensus       272 L~~~l~~~-~~l--~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGla~-----------  336 (359)
                      |.+++... +++  .+.++-.+.+||++||.|||.+.   |||||||-+|+||+. .|.+||+|||-|+           
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence            99999876 556  78899999999999999999999   999999999999975 7899999999886           


Q ss_pred             ----ccccCccccc
Q 018204          337 ----LQYISPEKAK  346 (359)
Q Consensus       337 ----~~~~~PE~~~  346 (359)
                          +.|||||.+.
T Consensus       736 FTGTLQYMAPEvID  749 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVID  749 (1226)
T ss_pred             cccchhhhChHhhc
Confidence                3599999765

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.87  E-value=3.5e-21  Score=173.03  Aligned_cols=134  Identities=28%  Similarity=0.501  Sum_probs=115.2

Q ss_pred             cccceeEEE---E----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          198 ITKGSYQVA---K----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       198 ig~g~~~~~---~----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      +|+|.|+.+   .    ..+..+|+|++.... .+....+.+..|+.+++.++||||+++++++. ....++||||++++
T Consensus         3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             CCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            566666533   1    246889999986443 34455678999999999999999999999875 45679999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~  143 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSK  143 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCcccc
Confidence            99999988778999999999999999999999998   9999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.87  E-value=2.2e-21  Score=174.78  Aligned_cols=135  Identities=25%  Similarity=0.439  Sum_probs=121.0

Q ss_pred             cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHH
Q 018204          209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL  288 (359)
Q Consensus       209 ~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~  288 (359)
                      .+..+++|.+...........+.+.+|+.+++.++||||+++++++......++++||+++++|.+++.+...+++..+.
T Consensus        17 ~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~   96 (262)
T cd05572          17 KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR   96 (262)
T ss_pred             CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHH
Confidence            38899999997655544555678999999999999999999999999999999999999999999999887779999999


Q ss_pred             HHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------cccCccccc
Q 018204          289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------QYISPEKAK  346 (359)
Q Consensus       289 ~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------~~~~PE~~~  346 (359)
                      .++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||+++.              .|++||...
T Consensus        97 ~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~  165 (262)
T cd05572          97 FYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIIL  165 (262)
T ss_pred             HHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhc
Confidence            99999999999999998   99999999999999999999999999862              377787643

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.87  E-value=1.2e-21  Score=187.16  Aligned_cols=141  Identities=31%  Similarity=0.518  Sum_probs=118.4

Q ss_pred             eEeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~  259 (359)
                      ++.....+|.|+|+.+   .+       .+..+|+|++.....  ......+..|+.++..+. ||||+++++++.....
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            3455678899999854   22       235799999965432  233456889999999997 9999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-----------------------------------------------------------
Q 018204          260 MMIVLEYHAKGDLASYLQKKG-----------------------------------------------------------  280 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  280 (359)
                      .++||||+++|+|.++++..+                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999996431                                                           


Q ss_pred             ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 018204          281 ---------------------------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (359)
Q Consensus       281 ---------------------------------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll  321 (359)
                                                             .+++..+..++.|++.||.|||+.+   ++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                   2566778889999999999999988   9999999999999


Q ss_pred             cCCCcEEEecccccc
Q 018204          322 DNGGQLKISGFGLLR  336 (359)
Q Consensus       322 ~~~~~~kl~DFGla~  336 (359)
                      +.++.+||+|||+++
T Consensus       273 ~~~~~~kL~DfGla~  287 (401)
T cd05107         273 CEGKLVKICDFGLAR  287 (401)
T ss_pred             eCCCEEEEEecCcce
Confidence            999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.87  E-value=1.7e-21  Score=182.80  Aligned_cols=141  Identities=31%  Similarity=0.539  Sum_probs=117.6

Q ss_pred             eEeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC-C
Q 018204          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN-I  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-~  258 (359)
                      .|.....+|.|+|+.+.          ..++.+|||.+....  .......+.+|+.++..+ +||||+++++++... .
T Consensus         8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46667778999988542          246789999996543  233456788999999999 689999999987654 5


Q ss_pred             cEEEEEecCCCCCHHHHHHhc-----------------------------------------------------------
Q 018204          259 PMMIVLEYHAKGDLASYLQKK-----------------------------------------------------------  279 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~-----------------------------------------------------------  279 (359)
                      ..+++|||+++|+|.+++...                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            689999999999999998642                                                           


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          280 --------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       280 --------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                              ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~  227 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR  227 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEeccccc
Confidence                    12577788899999999999999998   9999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.87  E-value=1.7e-21  Score=188.76  Aligned_cols=145  Identities=26%  Similarity=0.391  Sum_probs=117.3

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-------
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-------  257 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-------  257 (359)
                      ..|.....+|.|+|+.+.     ..+..+|||.+.....       ...+|+.+++.++||||+++++++...       
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            357777888999988542     3578999998854321       235699999999999999998877532       


Q ss_pred             -CcEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEec
Q 018204          258 -IPMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISG  331 (359)
Q Consensus       258 -~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~D  331 (359)
                       ..+++||||+++ +|.+++..    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence             247799999975 78776643    356999999999999999999999998   99999999999999765 799999


Q ss_pred             cccccc--------------cccCcccc
Q 018204          332 FGLLRL--------------QYISPEKA  345 (359)
Q Consensus       332 FGla~~--------------~~~~PE~~  345 (359)
                      ||+|+.              .|+|||..
T Consensus       215 FGla~~~~~~~~~~~~~~t~~y~aPE~~  242 (440)
T PTZ00036        215 FGSAKNLLAGQRSVSYICSRFYRAPELM  242 (440)
T ss_pred             cccchhccCCCCcccCCCCcCccCHHHh
Confidence            999962              37888864

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=3.2e-21  Score=173.33  Aligned_cols=149  Identities=30%  Similarity=0.529  Sum_probs=126.2

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+   .  ..+..+++|.+.....   ...+.+.+|+.+++.++||||+++++++.....+|++|||
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            444455677766532   2  3467899999865432   2456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++++|.+++... ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++..        
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  158 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR  158 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence            9999999998776 67999999999999999999999998   99999999999999999999999998752        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|++||...
T Consensus       159 ~~~~~~~~y~~Pe~~~  174 (262)
T cd06613         159 KSFIGTPYWMAPEVAA  174 (262)
T ss_pred             ccccCCccccCchhhc
Confidence                   378888754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.87  E-value=1.6e-21  Score=175.11  Aligned_cols=127  Identities=27%  Similarity=0.412  Sum_probs=109.8

Q ss_pred             EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHH
Q 018204          212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRF  290 (359)
Q Consensus       212 ~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i  290 (359)
                      .+++|.+.....    ....|.+|+.+++.++||||+++++++.. ...++||||+++|+|.+++.... .++...+..+
T Consensus        32 ~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  106 (259)
T cd05037          32 SVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDV  106 (259)
T ss_pred             eeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHH
Confidence            467777643321    14678899999999999999999999888 77899999999999999998765 6899999999


Q ss_pred             HHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-------cEEEeccccccc-----------cccCccccc
Q 018204          291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-------QLKISGFGLLRL-----------QYISPEKAK  346 (359)
Q Consensus       291 ~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-------~~kl~DFGla~~-----------~~~~PE~~~  346 (359)
                      +.|++.||.|||+++   |+||||||+|||++.++       .+||+|||+++.           .|++||...
T Consensus       107 ~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~  177 (259)
T cd05037         107 AKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIR  177 (259)
T ss_pred             HHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcccccccccccccCCCccChhhhc
Confidence            999999999999998   99999999999999887       799999999863           477888754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.87  E-value=2.5e-21  Score=174.94  Aligned_cols=143  Identities=24%  Similarity=0.482  Sum_probs=120.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCC--cHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCcEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK--DPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~  261 (359)
                      .|.....+|.|.|+.+     ...+..+++|.+......  .......+.+|+.+++.++||||+++++++..  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            3555666788887643     235789999998654322  23445678899999999999999999998875  35689


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||+++++|.+++...+.+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            99999999999999988778999999999999999999999998   9999999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.87  E-value=2.6e-21  Score=173.55  Aligned_cols=141  Identities=21%  Similarity=0.402  Sum_probs=121.2

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|.|.|+.+     ..+++.+++|.+..... .......+.+|+.++++++|+||+++++++.....++++|||
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            344556777777622     34578999999865443 334456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~  149 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISK  149 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceE
Confidence            9999999999765  45899999999999999999999998   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.87  E-value=2.2e-21  Score=179.93  Aligned_cols=140  Identities=24%  Similarity=0.529  Sum_probs=117.5

Q ss_pred             eEeeccCcccceeEEE---Ee--cCc----EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVA---KW--NGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~----~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +|.....+|+|.|+.+   .+  .+.    .+|+|.+....  .....+.+..|+.+++.++||||+++++++... ..+
T Consensus         8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            4566677888888754   22  233    48999986432  334456788999999999999999999988764 578


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||+++|+|.+++... ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence            999999999999999874 35889999999999999999999998   9999999999999999999999999996

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.87  E-value=1.9e-21  Score=180.21  Aligned_cols=132  Identities=23%  Similarity=0.437  Sum_probs=108.1

Q ss_pred             cCcccceeEEE---E----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCcEEEEEec
Q 018204          196 DGITKGSYQVA---K----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEY  266 (359)
Q Consensus       196 ~~ig~g~~~~~---~----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~e~  266 (359)
                      ..+|.|.|+.+   .    ..+..+|+|.+.....     ...+.+|+.+++.++||||+++++++..  ....|++|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            46788888754   2    1357899999864432     1246789999999999999999998864  4568999999


Q ss_pred             CCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE----cCCCcEEEeccc
Q 018204          267 HAKGDLASYLQKK---------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFG  333 (359)
Q Consensus       267 ~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DFG  333 (359)
                      +.+ +|.+++...         ..+++..+..++.||+.||.|||+++   |+||||||+|||+    +..+.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence            965 888887532         24889999999999999999999998   9999999999999    456789999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      +|+
T Consensus       158 ~a~  160 (317)
T cd07868         158 FAR  160 (317)
T ss_pred             cee
Confidence            985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.87  E-value=2.4e-21  Score=175.21  Aligned_cols=140  Identities=31%  Similarity=0.541  Sum_probs=118.6

Q ss_pred             EeeccCcccceeEEE---E--ecC---cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA---K--WNG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g---~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      ++....+|.|.|+.+   .  ..+   ..+++|.+....  +......|..|+.+++.++||||+++++++......++|
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            344556677777533   2  222   369999986432  345567899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~  154 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  154 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccc
Confidence            9999999999999764 45899999999999999999999998   9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.87  E-value=2.6e-21  Score=176.00  Aligned_cols=140  Identities=25%  Similarity=0.561  Sum_probs=116.8

Q ss_pred             eEeeccCcccceeEEE---Ee--cCc----EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVA---KW--NGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~----~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      ++.....+|.|+|+.+   .+  +|+    .+|+|.+....  .......+.+|+.++..++||||+++++++.. ...+
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            4555566788887644   22  344    47999986443  34445678899999999999999999998875 4578


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||+++|+|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence            999999999999999764 46899999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=1.4e-21  Score=184.47  Aligned_cols=143  Identities=25%  Similarity=0.365  Sum_probs=119.9

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   ..  .+..+|+|+.....         ...|+.+++.++||||+++++++......++|||
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            4666677888888744   22  45789999754321         3468999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      ++. ++|.+++... ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.       
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCccc
Confidence            995 5888888654 56999999999999999999999998   99999999999999999999999999863       


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|++||...
T Consensus       214 ~~~~gt~~y~aPE~~~  229 (357)
T PHA03209        214 LGLAGTVETNAPEVLA  229 (357)
T ss_pred             ccccccccccCCeecC
Confidence                   477787654

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.87  E-value=3e-21  Score=177.25  Aligned_cols=140  Identities=26%  Similarity=0.514  Sum_probs=117.8

Q ss_pred             EeeccCcccceeEEEEe---------------------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccc
Q 018204          192 VRKADGITKGSYQVAKW---------------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF  250 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~~---------------------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l  250 (359)
                      |.....+|.|.|+.+..                     .+..+|+|.+....  .....+.|..|+.+++.++|+||+++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            44555677777764421                     23468899886442  34445678999999999999999999


Q ss_pred             eeeEEeCCcEEEEEecCCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcE
Q 018204          251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKG-----------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI  319 (359)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NI  319 (359)
                      ++++......+++|||+++++|.+++....           .+++..+..++.|++.||.|||+++   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            999999999999999999999999997642           3667789999999999999999998   99999999999


Q ss_pred             EEcCCCcEEEecccccc
Q 018204          320 LLDNGGQLKISGFGLLR  336 (359)
Q Consensus       320 ll~~~~~~kl~DFGla~  336 (359)
                      |++.++.++|+|||+++
T Consensus       162 li~~~~~~~l~dfg~~~  178 (296)
T cd05095         162 LVGKNYTIKIADFGMSR  178 (296)
T ss_pred             EEcCCCCEEeccCcccc
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.87  E-value=3e-23  Score=174.14  Aligned_cols=131  Identities=22%  Similarity=0.201  Sum_probs=112.4

Q ss_pred             CCCCcceeeccCCCCCcCcC----CcccccCCCCCCCCCccHHHHHHHcCCHHH---HHHHHHcCCCCCCCC-CCCCcHH
Q 018204           38 RRNNMRFSFGRQSSLDPIRR----SPVQDELTVPENLDSTMQLLFMACRGDVKG---VEDLLNEGSDVNSID-LDGRTAL  109 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~---v~~Ll~~ga~v~~~d-~~g~TpL  109 (359)
                      ......+.+|+.|+++.+.+    +...+......|.+|+||||+||..|+.+.   +++|++.|+++|.+| ..|+|||
T Consensus        19 ~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpL   98 (166)
T PHA02743         19 DEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLL   98 (166)
T ss_pred             CCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHH
Confidence            44456778899999865554    334444445568899999999999998654   899999999999998 5899999


Q ss_pred             HHHHHcCCHHHHHHHHh-cCCCccccccccccccccccccccceeEeeccccCccccccC
Q 018204          110 HIAACEGHVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (359)
Q Consensus       110 h~A~~~g~~~~v~~Ll~-~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~  168 (359)
                      |+|+..|+.+++++|++ .|++++.+|..|+||||+|+..++.+++++|+++|++++.+.
T Consensus        99 h~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~  158 (166)
T PHA02743         99 HIAASTKNYELAEWLCRQLGVNLGAINYQHETAYHIAYKMRDRRMMEILRANGAVCDDPL  158 (166)
T ss_pred             HHHHHhCCHHHHHHHHhccCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcc
Confidence            99999999999999995 799999999999999999999999999999999999986543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.87  E-value=1.5e-21  Score=184.01  Aligned_cols=149  Identities=25%  Similarity=0.387  Sum_probs=122.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------Cc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~  259 (359)
                      .|...+.+|.|.|+.+     ...+..+|+|.+..... .......+.+|+.+++.++||||+++++++...      ..
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   96 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD   96 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence            4666677899988855     23578999999865432 334456778899999999999999999988643      34


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .|+||||+++ ++.+.+..  .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.  
T Consensus        97 ~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          97 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             eEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            7999999975 77777754  4889999999999999999999998   99999999999999999999999999862  


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~  191 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVIL  191 (355)
T ss_pred             CccccCCccccCCccCHHHHc
Confidence                        478888754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.87  E-value=4.2e-21  Score=175.87  Aligned_cols=149  Identities=23%  Similarity=0.460  Sum_probs=126.8

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |+....+|.|.|+.+   .  ..+..+++|.+...   +......+..|+.+++.++||||+++++++..+..+++||||
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            445566777877643   2  35788999998643   345567788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      +++++|..++.. ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||+++         
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~  167 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR  167 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence            999999888754 356899999999999999999999998   9999999999999999999999999875         


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|++||...
T Consensus       168 ~~~~~~~~y~aPE~~~  183 (292)
T cd06644         168 DSFIGTPYWMAPEVVM  183 (292)
T ss_pred             ceecCCccccCceeec
Confidence                  2488998753

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.87  E-value=2.5e-21  Score=176.37  Aligned_cols=145  Identities=27%  Similarity=0.382  Sum_probs=117.5

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHH---hCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVE---KARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      +|+|.|+.+     ...+..+|+|.+.+...........+..|..++.   ...||+|+.+++++...+..++||||+++
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG   81 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence            456666543     2357899999987554332222233444544333   34799999999999988899999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------------
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------------  336 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------------  336 (359)
                      ++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++|+|||+++             
T Consensus        82 ~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  158 (279)
T cd05633          82 GDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT  158 (279)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCC
Confidence            999999988888999999999999999999999998   9999999999999999999999999885             


Q ss_pred             ccccCcccc
Q 018204          337 LQYISPEKA  345 (359)
Q Consensus       337 ~~~~~PE~~  345 (359)
                      ..|++||..
T Consensus       159 ~~y~aPE~~  167 (279)
T cd05633         159 HGYMAPEVL  167 (279)
T ss_pred             cCccCHHHh
Confidence            257888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.87  E-value=4.1e-21  Score=174.97  Aligned_cols=146  Identities=26%  Similarity=0.479  Sum_probs=123.6

Q ss_pred             eccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ..+.+|.|.|+.+   .  ..+..+++|.+...   .....+.+.+|+.+++.++||||+++++++......++|+||++
T Consensus         9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            4455777777643   2  24677888887533   34456678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-----------
Q 018204          269 KGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-----------  336 (359)
Q Consensus       269 ~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-----------  336 (359)
                      +++|..++.. ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++           
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence            9999988765 456899999999999999999999998   9999999999999999999999999884           


Q ss_pred             ----ccccCcccc
Q 018204          337 ----LQYISPEKA  345 (359)
Q Consensus       337 ----~~~~~PE~~  345 (359)
                          ..|++||..
T Consensus       163 ~~~~~~y~aPE~~  175 (282)
T cd06643         163 FIGTPYWMAPEVV  175 (282)
T ss_pred             ccccccccCHhhc
Confidence                248889865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.87  E-value=2.3e-21  Score=174.48  Aligned_cols=139  Identities=31%  Similarity=0.537  Sum_probs=118.6

Q ss_pred             eEeeccCcccceeEEE----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      ++.....+|.|.++.+    ...+..+++|.+....    ...+.+..|+.+++.++|+||+++++++......+++|||
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            3555566788877643    2345779999875432    2345788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~  151 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLAR  151 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccce
Confidence            9999999999753  45888999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.87  E-value=2.4e-21  Score=175.70  Aligned_cols=150  Identities=28%  Similarity=0.485  Sum_probs=125.5

Q ss_pred             EeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +.....+|.|+|+.+   ..       ....+++|.+....  .....+.+..|+++++.++||||+++++++......+
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            444556788888643   21       24568888875432  3335567899999999999999999999999888999


Q ss_pred             EEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecc
Q 018204          262 IVLEYHAKGDLASYLQKKG---------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DF  332 (359)
                      +||||+++++|.+++....         .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997655         6899999999999999999999998   999999999999999999999999


Q ss_pred             ccccc----------------cccCccccc
Q 018204          333 GLLRL----------------QYISPEKAK  346 (359)
Q Consensus       333 Gla~~----------------~~~~PE~~~  346 (359)
                      |+++.                .|++||...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  191 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQ  191 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhc
Confidence            99752                288888654

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.87  E-value=3e-21  Score=175.45  Aligned_cols=130  Identities=27%  Similarity=0.417  Sum_probs=110.4

Q ss_pred             cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHh-cCCCCHHHHHH
Q 018204          211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLR  289 (359)
Q Consensus       211 ~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~  289 (359)
                      ..+++|++....   ......|..|+.+++.++||||+++++++......++||||+++|+|..++.. .+.+++..+..
T Consensus        45 ~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~  121 (274)
T cd05076          45 LRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT  121 (274)
T ss_pred             eeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHH
Confidence            458888885432   23345688899999999999999999999999999999999999999999865 45689999999


Q ss_pred             HHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-------cEEEecccccc-----------ccccCccccc
Q 018204          290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-------QLKISGFGLLR-----------LQYISPEKAK  346 (359)
Q Consensus       290 i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-------~~kl~DFGla~-----------~~~~~PE~~~  346 (359)
                      ++.|++.||.|||+.+   |+||||||+|||++..+       .+|++|||++.           ..|++||...
T Consensus       122 i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~  193 (274)
T cd05076         122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVP  193 (274)
T ss_pred             HHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhc
Confidence            9999999999999998   99999999999997644       38999999874           2477888654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.87  E-value=4.8e-21  Score=172.72  Aligned_cols=142  Identities=25%  Similarity=0.473  Sum_probs=122.0

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|.|.++.+     ..+|+.+++|.+......+......+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            445556777777533     226889999998754444555567889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+++
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceee
Confidence            999999999864    234899999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.87  E-value=2.5e-21  Score=175.24  Aligned_cols=134  Identities=27%  Similarity=0.479  Sum_probs=109.8

Q ss_pred             cccceeEEE---E-ecC---cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          198 ITKGSYQVA---K-WNG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       198 ig~g~~~~~---~-~~g---~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      +|.|.|+.+   . ..+   ..+++|.+....  .....+.|.+|+.+++.++||||+++++.+......|+||||+++|
T Consensus         3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            566666533   1 122   235566654332  2334567999999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          271 DLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       271 sL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|.+++...    ..++...+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~  147 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGP  147 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEeccccccc
Confidence            999999754    23667778899999999999999998   9999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.87  E-value=3.7e-21  Score=175.17  Aligned_cols=143  Identities=27%  Similarity=0.462  Sum_probs=120.1

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      ...+|.|.++.+     ..+++.+|+|.+....  .......+..|+.++..++||||+++++++......++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            344566666532     2467899999986542  334456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc------------
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------------  337 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~------------  337 (359)
                      ++|..+    ..+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++..            
T Consensus        84 ~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  156 (279)
T cd06619          84 GSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT  156 (279)
T ss_pred             CChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCC
Confidence            999765    35788899999999999999999998   99999999999999999999999999852            


Q ss_pred             -cccCccccc
Q 018204          338 -QYISPEKAK  346 (359)
Q Consensus       338 -~~~~PE~~~  346 (359)
                       .|++||...
T Consensus       157 ~~y~aPE~~~  166 (279)
T cd06619         157 NAYMAPERIS  166 (279)
T ss_pred             hhhcCceeec
Confidence             478888654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=2.5e-21  Score=176.72  Aligned_cols=150  Identities=29%  Similarity=0.514  Sum_probs=126.3

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +.....+|.|.|+.+   .  ..+..+|+|.+....  +......+.+|+.++..++||||+++++++...+..++||||
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            344556777777643   2  258899999886432  334456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----
Q 018204          267 HAKGDLASYLQKK---GRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----  337 (359)
                      +++++|..++...   ..+++..+..++.|++.||.|||+ .+   |+||||||+||+++.++.++|+|||+++.     
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999999998763   368999999999999999999996 46   99999999999999999999999998852     


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|++||...
T Consensus       158 ~~~~~~~~~y~aPE~~~  174 (286)
T cd06622         158 AKTNIGCQSYMAPERIK  174 (286)
T ss_pred             cccCCCccCccCcchhc
Confidence                    488888754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.87  E-value=5.9e-23  Score=187.74  Aligned_cols=154  Identities=29%  Similarity=0.410  Sum_probs=131.6

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      ++.-..+|+|.|+.+     +.+|+-+|.|.+.+........-....+|-.++++++.++||.+--+|.+...+|+||..
T Consensus       187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl  266 (591)
T KOG0986|consen  187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL  266 (591)
T ss_pred             eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence            333445677777633     567899999998766554444445568899999999999999998899999999999999


Q ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      |.||+|.-+|.+.+  .++++.+..|+.+|+.||++||+..   ||+|||||+|||+|+.|+++|+|+|||.        
T Consensus       267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~  343 (591)
T KOG0986|consen  267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI  343 (591)
T ss_pred             ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence            99999999887765  6999999999999999999999998   9999999999999999999999999994        


Q ss_pred             ------ccccCccccccc
Q 018204          337 ------LQYISPEKAKIV  348 (359)
Q Consensus       337 ------~~~~~PE~~~~~  348 (359)
                            .+|||||....-
T Consensus       344 ~~rvGT~GYMAPEvl~ne  361 (591)
T KOG0986|consen  344 RGRVGTVGYMAPEVLQNE  361 (591)
T ss_pred             ccccCcccccCHHHHcCC
Confidence                  469999987654

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.87  E-value=2.4e-21  Score=176.14  Aligned_cols=136  Identities=28%  Similarity=0.410  Sum_probs=118.2

Q ss_pred             ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC--CCCHH
Q 018204          208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG--RLSPS  285 (359)
Q Consensus       208 ~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~  285 (359)
                      .+|+.+++|.+.............+..|+.+++.++||||+++++++...+..|+||||+++++|.+++...+  .+++.
T Consensus        16 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~   95 (277)
T cd05577          16 ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA   95 (277)
T ss_pred             CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHH
Confidence            3588999999875443333344567789999999999999999999999999999999999999999997755  69999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------cccCccccc
Q 018204          286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------QYISPEKAK  346 (359)
Q Consensus       286 ~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------~~~~PE~~~  346 (359)
                      .+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+++.              .|++||...
T Consensus        96 ~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~  167 (277)
T cd05577          96 RAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ  167 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhc
Confidence            99999999999999999998   99999999999999999999999998852              477888643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.87  E-value=3.5e-21  Score=175.38  Aligned_cols=139  Identities=29%  Similarity=0.502  Sum_probs=117.8

Q ss_pred             EeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +.....+|.|.|+.+.          ..+..+++|.+...   .......+.+|+++++.++|+||+++++++......+
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            4445667778776431          13557888887543   3344567999999999999999999999999989999


Q ss_pred             EEEecCCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc
Q 018204          262 IVLEYHAKGDLASYLQKKG---------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~  326 (359)
                      ++|||+++++|.+++...+               .+++..+..++.|++.||.|||+++   ++||||||+|||++.++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            9999999999999997642               3788999999999999999999998   999999999999999999


Q ss_pred             EEEecccccc
Q 018204          327 LKISGFGLLR  336 (359)
Q Consensus       327 ~kl~DFGla~  336 (359)
                      +||+|||+++
T Consensus       161 ~kL~dfg~~~  170 (280)
T cd05092         161 VKIGDFGMSR  170 (280)
T ss_pred             EEECCCCcee
Confidence            9999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=4.9e-21  Score=172.01  Aligned_cols=134  Identities=31%  Similarity=0.538  Sum_probs=114.8

Q ss_pred             CcccceeEEE---Ee-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          197 GITKGSYQVA---KW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       197 ~ig~g~~~~~---~~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      .+|.|.|+.+   .+     .+..+++|.+......  ...+.+..|+.+++.++||||+++++++. ....+++|||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence            3577777643   12     2267999998755432  34467899999999999999999999876 456899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|.+++.....+++..+..++.|++.||.|||..+   ++|+||||+|||++.++.+||+|||+++
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~  143 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSR  143 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccc
Confidence            9999999988778999999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.87  E-value=2.2e-21  Score=179.36  Aligned_cols=139  Identities=30%  Similarity=0.538  Sum_probs=117.5

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|.|.|+.+     ...+..+|+|.+.......  ....+.+|+.+++.++||||+++++++......++||||
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            555667788888754     2357889999986443221  223567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++ +|.+++...+ .++...+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~  152 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLAR  152 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccce
Confidence            975 8888886653 4889999999999999999999998   9999999999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=4.5e-21  Score=173.03  Aligned_cols=143  Identities=26%  Similarity=0.489  Sum_probs=120.4

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCC--CCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKES--HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~  261 (359)
                      .|.....+|.|.|+.+     ..++..+++|.+....  .........+.+|+.+++.++||||+++++++...  ..++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            3455566777777643     2468899999875322  22344567889999999999999999999988764  4588


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||+++++|.+++...+.+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||+++
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence            99999999999999988777999999999999999999999998   9999999999999999999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=3.1e-21  Score=175.12  Aligned_cols=141  Identities=28%  Similarity=0.490  Sum_probs=117.9

Q ss_pred             eEeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      ++.....+|.|+|+.+   ..       .+..+++|.+....  .......+.+|+.++..++||||+++++++......
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            3445566788888643   11       23679999985432  233445788999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEe
Q 018204          261 MIVLEYHAKGDLASYLQKKG----------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~  330 (359)
                      ++||||+++++|.+++....          .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999996532          3678889999999999999999998   9999999999999999999999


Q ss_pred             cccccc
Q 018204          331 GFGLLR  336 (359)
Q Consensus       331 DFGla~  336 (359)
                      |||+++
T Consensus       162 dfg~~~  167 (277)
T cd05032         162 DFGMTR  167 (277)
T ss_pred             Ccccch
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.87  E-value=1.9e-21  Score=177.22  Aligned_cols=150  Identities=27%  Similarity=0.521  Sum_probs=123.3

Q ss_pred             EeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +.....+|.|+|+.+   ..       .+..+|+|.+....  .......+..|+.++..++||||+++++++......+
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            344556677777643   11       24679999986433  2334567889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 018204          262 IVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~  325 (359)
                      +++||+.+++|.+++...                ..+++..+..++.|++.||.|+|+++   |+||||||+||+++.++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998532                24788889999999999999999998   99999999999999999


Q ss_pred             cEEEeccccccc-----------------cccCccccc
Q 018204          326 QLKISGFGLLRL-----------------QYISPEKAK  346 (359)
Q Consensus       326 ~~kl~DFGla~~-----------------~~~~PE~~~  346 (359)
                      .+||+|||+++.                 .|++||...
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  199 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIM  199 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHh
Confidence            999999998752                 488888753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.87  E-value=4.7e-21  Score=171.82  Aligned_cols=134  Identities=38%  Similarity=0.647  Sum_probs=117.3

Q ss_pred             cccceeEEE---Eec-----CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          198 ITKGSYQVA---KWN-----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       198 ig~g~~~~~---~~~-----g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      +|.|.|+.+   ...     +..+++|.+.......  ..+.+..|+..+..++|+||+++++++......+++|||+++
T Consensus         3 ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             cccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            566666533   222     7789999987544322  467789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          270 GDLASYLQKK---------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++|.+++...         ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||.++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~  153 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR  153 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccc
Confidence            9999999875         67999999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=2.2e-21  Score=185.44  Aligned_cols=135  Identities=24%  Similarity=0.345  Sum_probs=117.1

Q ss_pred             eeEeeccCcccceeEEEE---e----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          190 LQVRKADGITKGSYQVAK---W----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~---~----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .+|.....+|.|.|+.+.   .    .+..+++|.+....        .+.+|+.+++.++||||+++++++......|+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            357777788899887542   1    34678889875431        24679999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +||++. ++|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.++|+|||+++
T Consensus       164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            999996 589999977778999999999999999999999998   9999999999999999999999999985

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.87  E-value=4.2e-21  Score=173.65  Aligned_cols=139  Identities=28%  Similarity=0.486  Sum_probs=115.8

Q ss_pred             eccCcccceeEEEE---e-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc------
Q 018204          194 KADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP------  259 (359)
Q Consensus       194 ~~~~ig~g~~~~~~---~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~------  259 (359)
                      ....+|.|.|+.+.   .     .+..+|+|.+..... .......+..|+..++.++||||+++++++.....      
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            34557788876442   1     236799999865433 34456779999999999999999999998765443      


Q ss_pred             EEEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          260 MMIVLEYHAKGDLASYLQKK------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      .+++|||+++++|..++...      ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence            79999999999999988542      25899999999999999999999998   9999999999999999999999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      +++
T Consensus       159 ~~~  161 (273)
T cd05035         159 LSK  161 (273)
T ss_pred             cee
Confidence            986

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.87  E-value=3.4e-21  Score=178.28  Aligned_cols=139  Identities=21%  Similarity=0.297  Sum_probs=118.4

Q ss_pred             eccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          194 KADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       194 ~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      .+.+.|.|.+..   ...+++.+|+|.+.... ........+..|+.+++.++||||+++++++......+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344445554432   23468999999997542 23455678999999999999999999999999999999999999999


Q ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          271 DLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       271 sL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||.+.
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~  149 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSV  149 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccce
Confidence            999999763  45899999999999999999999998   9999999999999999999999999774

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.87  E-value=3e-21  Score=182.59  Aligned_cols=149  Identities=26%  Similarity=0.386  Sum_probs=122.8

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------Cc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~  259 (359)
                      .|.....+|+|.|+.+     ...+..+|||.+..... .......+.+|+.+++.++||||+++++++...      ..
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~  103 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  103 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence            5666777899988754     23578899999865432 333445678899999999999999999987543      35


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .|+||||+++ +|.+++..  .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.  
T Consensus       104 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         104 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             EEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            7999999975 78887754  4888999999999999999999998   99999999999999999999999999862  


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~  198 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVIL  198 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHh
Confidence                        488888754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.87  E-value=2.5e-21  Score=174.01  Aligned_cols=126  Identities=32%  Similarity=0.550  Sum_probs=115.0

Q ss_pred             cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHH
Q 018204          209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL  288 (359)
Q Consensus       209 ~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~  288 (359)
                      +|+.+++|.+.............+..|+.+++.++||||+++++.+......|+++||+++++|.+++.+.+.+++..+.
T Consensus        17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~   96 (265)
T cd05579          17 TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR   96 (265)
T ss_pred             CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHH
Confidence            48899999997654444456677899999999999999999999999999999999999999999999887789999999


Q ss_pred             HHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       289 ~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      .++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        97 ~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~  142 (265)
T cd05579          97 IYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKV  142 (265)
T ss_pred             HHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchh
Confidence            99999999999999998   99999999999999999999999998864

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.87  E-value=2.7e-21  Score=175.00  Aligned_cols=139  Identities=26%  Similarity=0.465  Sum_probs=113.4

Q ss_pred             ccCcccceeEEEE---e--cCc--EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------CcEE
Q 018204          195 ADGITKGSYQVAK---W--NGT--KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IPMM  261 (359)
Q Consensus       195 ~~~ig~g~~~~~~---~--~g~--~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~  261 (359)
                      ...+|.|+|+.+.   .  .+.  .+|+|.+.... ......+.+..|+.+++.++||||+++++++...      ...+
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            4567888887542   1  222  58899886543 3445567889999999999999999999976432      2578


Q ss_pred             EEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          262 IVLEYHAKGDLASYLQKK------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                      ++|||+++|+|.+++...      ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence            999999999999987421      24889999999999999999999998   999999999999999999999999998


Q ss_pred             cc
Q 018204          336 RL  337 (359)
Q Consensus       336 ~~  337 (359)
                      +.
T Consensus       160 ~~  161 (272)
T cd05075         160 KK  161 (272)
T ss_pred             cc
Confidence            63

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.86  E-value=3e-21  Score=180.42  Aligned_cols=149  Identities=30%  Similarity=0.582  Sum_probs=121.8

Q ss_pred             CcccCCcceeeEeeccCcccceeEEE---Ee---------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCcc
Q 018204          181 PEYELNPLELQVRKADGITKGSYQVA---KW---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNV  247 (359)
Q Consensus       181 ~~~~l~~~~~~~~~~~~ig~g~~~~~---~~---------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnI  247 (359)
                      ++|++..  ..+.....+|.|.|+.+   ..         .+..+++|.+....  .......+.+|+.++.++ +||||
T Consensus         5 ~~~~~~~--~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i   80 (334)
T cd05100           5 PKWELSR--TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNI   80 (334)
T ss_pred             cccccCH--hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCe
Confidence            3444433  24566777888888643   11         12368999876432  334556789999999999 89999


Q ss_pred             ccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 018204          248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIH  311 (359)
Q Consensus       248 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiH  311 (359)
                      +++++++......+++|||+++|+|.+++....                .+++..+..++.|++.||.|||+++   ++|
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH  157 (334)
T cd05100          81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH  157 (334)
T ss_pred             eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence            999999999999999999999999999997532                3778888999999999999999998   999


Q ss_pred             CCCCCCcEEEcCCCcEEEecccccc
Q 018204          312 CDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       312 rDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||||+|||++.++.+||+|||+++
T Consensus       158 ~dlkp~Nill~~~~~~kL~Dfg~~~  182 (334)
T cd05100         158 RDLAARNVLVTEDNVMKIADFGLAR  182 (334)
T ss_pred             cccccceEEEcCCCcEEECCcccce
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.86  E-value=2.5e-21  Score=178.26  Aligned_cols=150  Identities=29%  Similarity=0.514  Sum_probs=124.0

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|.|.|+.+     ..++..+|+|.+.......  ....+.+|+.+++.++||||+++++++......++|||
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            3555666788887644     2357889999986443221  22346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      |++ ++|.+++... ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||+++.       
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            997 4999988764 45899999999999999999999998   99999999999999999999999998852       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|++||...
T Consensus       161 ~~~~~~~~~y~~PE~~~  177 (301)
T cd07873         161 YSNEVVTLWYRPPDILL  177 (301)
T ss_pred             ccccceeecccCcHHHh
Confidence                    377888643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.86  E-value=3.2e-21  Score=197.04  Aligned_cols=155  Identities=24%  Similarity=0.421  Sum_probs=125.2

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv  263 (359)
                      .|.+...+|.|.|+.+     ...+..+++|++..... .......|..|+.++..++||||++++++|...  ..+|||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            4666777888888754     23567899999865443 344456789999999999999999999988653  569999


Q ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeCCCCCCcEEEcC------------
Q 018204          264 LEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKP----DPIIHCDLKPKNILLDN------------  323 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~----~~iiHrDlk~~NIll~~------------  323 (359)
                      |||+++++|.++|...    +.+++..++.|+.||+.||.|||+.++    .+||||||||+||||+.            
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            9999999999998652    469999999999999999999998542    23999999999999964            


Q ss_pred             -----CCcEEEecccccc--------------ccccCccccc
Q 018204          324 -----GGQLKISGFGLLR--------------LQYISPEKAK  346 (359)
Q Consensus       324 -----~~~~kl~DFGla~--------------~~~~~PE~~~  346 (359)
                           .+.+||+|||+++              ..|+|||...
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~  214 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL  214 (1021)
T ss_pred             cccCCCCceEEccCCccccccccccccccCCCccccCHHHHh
Confidence                 2358999999875              2588888753

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.86  E-value=3.4e-21  Score=176.12  Aligned_cols=140  Identities=33%  Similarity=0.536  Sum_probs=118.0

Q ss_pred             EeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +.....+|.|.|+.+   ..       .+..+++|.+....  .......|.+|+.+++.++||||+++++++......+
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            455566777777633   21       45789999886432  3444567899999999999999999999999888999


Q ss_pred             EEEecCCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcE
Q 018204          262 IVLEYHAKGDLASYLQKKG----------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI  319 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NI  319 (359)
                      ++|||+++++|.+++....                      .+++..+..++.|++.||.|||+++   ++||||||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence            9999999999999997431                      3678888999999999999999998   99999999999


Q ss_pred             EEcCCCcEEEecccccc
Q 018204          320 LLDNGGQLKISGFGLLR  336 (359)
Q Consensus       320 ll~~~~~~kl~DFGla~  336 (359)
                      +++.++.++|+|||+++
T Consensus       162 l~~~~~~~~l~dfg~~~  178 (288)
T cd05050         162 LVGENMVVKIADFGLSR  178 (288)
T ss_pred             EecCCCceEECccccce
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.86  E-value=2.2e-21  Score=187.97  Aligned_cols=133  Identities=24%  Similarity=0.293  Sum_probs=114.1

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+.     ..+..|+||....         ..+.+|+.+++.++|+||+++++++...+..++|||
T Consensus       170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46666678888887542     2467899995421         235689999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++. ++|.+++... ..+++..+..++.|++.||.|||+++   ||||||||+|||++.++.+||+|||+++
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~  308 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAAC  308 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCce
Confidence            995 6899888664 46999999999999999999999998   9999999999999999999999999985

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.86  E-value=5.3e-21  Score=175.19  Aligned_cols=139  Identities=28%  Similarity=0.487  Sum_probs=115.4

Q ss_pred             EeeccCcccceeEEE---E-------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVA---K-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~-------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +.....+|.|.|+.+   .       ..+..+++|.+...   .....+.+.+|+.+++.++||||+++++++......+
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            334455667766532   2       12345788887533   2334457889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 018204          262 IVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~  325 (359)
                      +||||+++++|.+++...                +.+++..+..++.|++.||+|||+++   |+||||||+|||++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            999999999999999653                23788999999999999999999998   99999999999999999


Q ss_pred             cEEEecccccc
Q 018204          326 QLKISGFGLLR  336 (359)
Q Consensus       326 ~~kl~DFGla~  336 (359)
                      .++|+|||+++
T Consensus       161 ~~~l~dfg~a~  171 (291)
T cd05094         161 LVKIGDFGMSR  171 (291)
T ss_pred             cEEECCCCccc
Confidence            99999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PHA02791 ankyrin-like protein; Provisional

Probab=99.86  E-value=5.7e-23  Score=185.82  Aligned_cols=141  Identities=18%  Similarity=0.115  Sum_probs=117.1

Q ss_pred             cCCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH
Q 018204           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (359)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~  114 (359)
                      .|......++.++..|+.+.++.++..+......  +|.||||+||..|+.++|++|++.|+++|.+|..|+||||+||.
T Consensus        26 ~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~--d~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~  103 (284)
T PHA02791         26 ADVHGHSALYYAIADNNVRLVCTLLNAGALKNLL--ENEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVD  103 (284)
T ss_pred             CCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCC--CCCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHH
Confidence            3444556666777788888888877766443332  47899999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHHHhcCCCccccccccc-cccccccccccceeEeeccccCccc-c-ccCCCCcccCCC
Q 018204          115 EGHVEVVKLLLSKKANIDARDRWGS-TAAADAKYYGNVEVYNILKARGAKV-P-KTKRTPMTVANP  177 (359)
Q Consensus       115 ~g~~~~v~~Ll~~ga~~~~~d~~g~-tpl~~A~~~~~~~~~~~L~~~ga~~-~-~~~~tpl~~a~~  177 (359)
                      .|+.++|++|+++|++++.++..|+ ||||+|+..|+.+++++|++++++. + ..+.||+++|..
T Consensus       104 ~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~~~d~~~g~TpLh~Aa~  169 (284)
T PHA02791        104 SGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPSTFDLAILLSCIHITIK  169 (284)
T ss_pred             cCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCcccccccCccHHHHHHH
Confidence            9999999999999999999999886 8999999999999999999987654 3 236789988843

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.86  E-value=6e-21  Score=173.76  Aligned_cols=146  Identities=27%  Similarity=0.386  Sum_probs=117.4

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHH---HHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELT---IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~---il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      +|.|.|+.+     ...++.+|+|.+.............+..|..   .+....||+|+++++++......++||||++|
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g   81 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG   81 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence            355665533     2357899999987654332222222344433   44456899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------------
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------------  336 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------------  336 (359)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++             
T Consensus        82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (278)
T cd05606          82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT  158 (278)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCC
Confidence            999999988778999999999999999999999998   9999999999999999999999999875             


Q ss_pred             ccccCccccc
Q 018204          337 LQYISPEKAK  346 (359)
Q Consensus       337 ~~~~~PE~~~  346 (359)
                      ..|++||...
T Consensus       159 ~~y~aPE~~~  168 (278)
T cd05606         159 HGYMAPEVLQ  168 (278)
T ss_pred             cCCcCcHHhc
Confidence            2478888754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.86  E-value=7e-21  Score=172.44  Aligned_cols=144  Identities=31%  Similarity=0.573  Sum_probs=117.8

Q ss_pred             cccceeEEE---E--ecCc--EEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCC
Q 018204          198 ITKGSYQVA---K--WNGT--KVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       198 ig~g~~~~~---~--~~g~--~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      +|.|.|+.+   .  ..+.  .+++|.+...  ......+.+..|+.++.++ +||||+++++++......+++|||+++
T Consensus         3 lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            466666532   2  2333  4677777532  2344456788999999999 899999999999999999999999999


Q ss_pred             CCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          270 GDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       270 gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      ++|.+++....                .+++..+..++.|++.||+|||+++   ++||||||+||+++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999997532                3788999999999999999999998   9999999999999999999999999


Q ss_pred             ccc--------------ccccCccccc
Q 018204          334 LLR--------------LQYISPEKAK  346 (359)
Q Consensus       334 la~--------------~~~~~PE~~~  346 (359)
                      +++              ..|++||...
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~  184 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLN  184 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHc
Confidence            984              1378888653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.86  E-value=3e-21  Score=175.97  Aligned_cols=149  Identities=30%  Similarity=0.528  Sum_probs=121.7

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|.++.+     ..++..+++|.+..... +......+.+|+.+++.++||||+++++++..+...|+||||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            34445666666532     23588999999864332 2223356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          268 AKGDLASYLQKK---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       268 ~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      + ++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++        
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV  157 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence            7 5898888643   45899999999999999999999998   9999999999999999999999999875        


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|++||...
T Consensus       158 ~~~~~~~~~y~aPE~~~  174 (285)
T cd07861         158 YTHEVVTLWYRAPEVLL  174 (285)
T ss_pred             ccCCcccccccChHHhc
Confidence                   2478888643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.86  E-value=5.4e-21  Score=175.70  Aligned_cols=149  Identities=20%  Similarity=0.442  Sum_probs=125.5

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.++.+     ...+..+++|.+......   ..+.+..|+.+++.++||||+++++.+......|+|||
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            4555556777776533     235789999998654432   23568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++++|.+++.. ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.        
T Consensus        98 ~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             ccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence            9999999999865 35889999999999999999999998   99999999999999999999999998752        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|++||...
T Consensus       174 ~~~~~~~~y~aPE~~~  189 (296)
T cd06654         174 STMVGTPYWMAPEVVT  189 (296)
T ss_pred             CcccCCccccCHHHHc
Confidence                   478888654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.86  E-value=4.4e-21  Score=176.11  Aligned_cols=139  Identities=29%  Similarity=0.539  Sum_probs=118.3

Q ss_pred             eccCcccceeEEE-----EecCcEEEEEEeccCCCC--cHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          194 KADGITKGSYQVA-----KWNGTKVWVKILDKESHK--DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       194 ~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      ..+.+|.|.++.+     ..+|..+++|.+......  .......+..|+.+++.++|+||+++++++......++||||
T Consensus         4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (298)
T cd07841           4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF   83 (298)
T ss_pred             eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence            3445666666532     235789999999755432  122334577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      + +++|.+++.... .+++..+..++.||++||.|||+++   ++|+||||+||+++.++.++|+|||+++
T Consensus        84 ~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          84 M-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             c-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeee
Confidence            9 889999998765 7999999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.86  E-value=5.8e-21  Score=175.48  Aligned_cols=140  Identities=32%  Similarity=0.552  Sum_probs=115.6

Q ss_pred             EeeccCcccceeEEE---E--ecC--cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA---K--WNG--TKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g--~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      |.....+|.|.|+.+   .  ..+  ..+++|.+...  ......+.+..|+.++.++ +||||+++++++......+++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            444556788888643   1  223  24678877532  2333456788999999999 799999999999998899999


Q ss_pred             EecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcE
Q 018204          264 LEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL  327 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~  327 (359)
                      |||+++++|.+++....                .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999997532                4788999999999999999999998   9999999999999999999


Q ss_pred             EEecccccc
Q 018204          328 KISGFGLLR  336 (359)
Q Consensus       328 kl~DFGla~  336 (359)
                      ||+|||+++
T Consensus       159 kl~dfg~~~  167 (297)
T cd05089         159 KIADFGLSR  167 (297)
T ss_pred             EECCcCCCc
Confidence            999999984

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=8e-21  Score=172.83  Aligned_cols=140  Identities=24%  Similarity=0.510  Sum_probs=117.8

Q ss_pred             eEeeccCcccceeEEE---E--ecC----cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNG----TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g----~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      ++.....+|.|.|+.+   .  ..|    ..+++|.+....  .......+.+|+.++..++||||+++++++.. ...+
T Consensus         8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3455566788887643   1  123    258888876443  24455678999999999999999999999887 7899


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++|||+++|+|.+++... ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence            999999999999999774 46899999999999999999999988   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=5.4e-21  Score=171.99  Aligned_cols=146  Identities=29%  Similarity=0.501  Sum_probs=119.1

Q ss_pred             cccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHH-HhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIV-EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+   .  ..|+.+|+|.+.............+..|..++ ...+|+||+++++++.....+|+++||+++++
T Consensus         4 l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   83 (260)
T cd05611           4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGD   83 (260)
T ss_pred             CCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCC
Confidence            456666532   2  35789999998654332233333445555444 45589999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----------ccc
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----------QYI  340 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----------~~~  340 (359)
                      |.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.           .|+
T Consensus        84 L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~  160 (260)
T cd05611          84 CASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYL  160 (260)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCcc
Confidence            9999988888999999999999999999999998   99999999999999999999999998863           477


Q ss_pred             Cccccc
Q 018204          341 SPEKAK  346 (359)
Q Consensus       341 ~PE~~~  346 (359)
                      +||...
T Consensus       161 ~pe~~~  166 (260)
T cd05611         161 APETIL  166 (260)
T ss_pred             Chhhhc
Confidence            888654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.86  E-value=4.3e-21  Score=172.23  Aligned_cols=119  Identities=34%  Similarity=0.569  Sum_probs=108.1

Q ss_pred             EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC--CCCHHHHHH
Q 018204          212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLR  289 (359)
Q Consensus       212 ~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~  289 (359)
                      .+++|.+......  ...+.+..|+.++++++||||+++++++.. ...+++|||+++++|.+++....  .+++..+..
T Consensus        25 ~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~  101 (257)
T cd05040          25 PVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD  101 (257)
T ss_pred             EEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHH
Confidence            6899998765432  566789999999999999999999999888 88999999999999999997754  589999999


Q ss_pred             HHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       290 i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++
T Consensus       102 ~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~  145 (257)
T cd05040         102 YAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMR  145 (257)
T ss_pred             HHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccc
Confidence            9999999999999998   9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.86  E-value=5.8e-21  Score=171.24  Aligned_cols=146  Identities=35%  Similarity=0.643  Sum_probs=121.1

Q ss_pred             EeeccCcccceeEEE---EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          192 VRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      +.....+|.|.|+.+   ...++.+++|.+....     ....+.+|+.++..++||||+++++++... ..+++|||++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             ceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            344555677776643   4578889999985432     234688999999999999999999988654 4799999999


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          269 KGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       269 ~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +++|.+++....  .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.         
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSK  158 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCCC
Confidence            999999997643  4889999999999999999999998   99999999999999999999999998863         


Q ss_pred             ---cccCccccc
Q 018204          338 ---QYISPEKAK  346 (359)
Q Consensus       338 ---~~~~PE~~~  346 (359)
                         .|++||...
T Consensus       159 ~~~~y~~pe~~~  170 (254)
T cd05083         159 LPVKWTAPEALK  170 (254)
T ss_pred             CCceecCHHHhc
Confidence               377777543

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.86  E-value=1.9e-22  Score=203.93  Aligned_cols=147  Identities=27%  Similarity=0.438  Sum_probs=129.4

Q ss_pred             CcceeeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          186 NPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       186 ~~~~~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      .........+..+|.|.|+.+     ..+|...|+|-+.-+... ....+...+|..++..++|||+|++|++-..+...
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            444556667778899999854     346889999988765543 45556778999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|.||||++|+|.+++...+-.++.....+..|++.|+.|||++|   ||||||||.||+++.+|.+|++|||.|.
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence            999999999999999988877888888889999999999999999   9999999999999999999999999996

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.86  E-value=7.2e-21  Score=170.47  Aligned_cols=136  Identities=40%  Similarity=0.670  Sum_probs=116.8

Q ss_pred             cCcccceeEEE---Eec------CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          196 DGITKGSYQVA---KWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       196 ~~ig~g~~~~~---~~~------g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      ..+|.|.|+.+   ...      +..+++|.+....  .......+..|+.++..++|+||+++++++......+++|||
T Consensus         5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            44566666532   222      3789999986443  222556789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++.....  +++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCce
Confidence            999999999976544  899999999999999999999998   9999999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.86  E-value=7.7e-21  Score=173.96  Aligned_cols=139  Identities=31%  Similarity=0.610  Sum_probs=115.7

Q ss_pred             eeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          193 RKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .....+|.|.|+.+   ..       ....+++|.+....  .......+..|+.+++.++||||+++++.+......++
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            34455677777643   11       12468888876433  33445678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCc
Q 018204          263 VLEYHAKGDLASYLQKK------------------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN  318 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~N  318 (359)
                      ++||+++++|.+++...                        ..+++..+..++.|++.||.|||+++   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            99999999999998642                        23778899999999999999999998   9999999999


Q ss_pred             EEEcCCCcEEEecccccc
Q 018204          319 ILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       319 Ill~~~~~~kl~DFGla~  336 (359)
                      ||++.++.+||+|||+++
T Consensus       158 ill~~~~~~kl~dfg~~~  175 (290)
T cd05045         158 VLVAEGRKMKISDFGLSR  175 (290)
T ss_pred             EEEcCCCcEEeccccccc
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.86  E-value=7e-21  Score=171.23  Aligned_cols=139  Identities=32%  Similarity=0.499  Sum_probs=118.2

Q ss_pred             eEeeccCcccceeEEE---E-ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      ++.....+|.|.++.+   . ..+..+++|.+.....    ..+.+..|+.+++.++||||+++++++......+++|||
T Consensus         7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3455566777777633   2 2456789999865432    224688999999999999999999999988899999999


Q ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++....  .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~  151 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLAR  151 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccce
Confidence            99999999997643  5899999999999999999999998   9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.86  E-value=1.7e-21  Score=165.77  Aligned_cols=144  Identities=26%  Similarity=0.385  Sum_probs=122.8

Q ss_pred             eeeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----C
Q 018204          189 ELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----I  258 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~  258 (359)
                      ...|++...+|.|.|..+     ..+++.+|+|.+....   .+..+..++|++..++++|||+++++++...+     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            345777777888888644     3468899999997554   44566789999999999999999999876543     3


Q ss_pred             cEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          259 PMMIVLEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                      ..||+++|...|||.+.+...    ..+++.++..|+.+|++||++||+..| ++.||||||.|||++..+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccC
Confidence            499999999999999998753    259999999999999999999999984 799999999999999999999999999


Q ss_pred             cc
Q 018204          335 LR  336 (359)
Q Consensus       335 a~  336 (359)
                      ++
T Consensus       176 ~~  177 (302)
T KOG2345|consen  176 AT  177 (302)
T ss_pred             cc
Confidence            86

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.86  E-value=3e-21  Score=176.02  Aligned_cols=141  Identities=25%  Similarity=0.455  Sum_probs=120.1

Q ss_pred             EeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   ..  .++.+|+|.+....... ...+.+.+|+.+++.++||||+++++++......++|+||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            344556777777643   22  57899999986544322 3445688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|..+......+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~  148 (286)
T cd07846          82 VDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR  148 (286)
T ss_pred             CCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeee
Confidence            999888888776667999999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.86  E-value=8.4e-21  Score=170.26  Aligned_cols=150  Identities=27%  Similarity=0.448  Sum_probs=121.9

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe-CCcEEEEEec
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVLEY  266 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~e~  266 (359)
                      ...+.+|.|.++.+     ...++.+++|.+..... .....+.+..|+.+++.++|+|++++++.+.. ...+|++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            34445566666532     33578899999864432 33445668899999999999999999988764 4468999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      +++++|.+++...  ..+++.++..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||+++        
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence            9999999999763  35899999999999999999999998   9999999999999999999999999885        


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|++||...
T Consensus       159 ~~~~~~~~~y~aPE~~~  175 (257)
T cd08223         159 ASTLIGTPYYMSPELFS  175 (257)
T ss_pred             cccccCCcCccChhHhc
Confidence                   2477788644

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.86  E-value=4.5e-21  Score=176.29  Aligned_cols=140  Identities=21%  Similarity=0.436  Sum_probs=120.2

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      ..|.....+|.|.++.+     ...++.+++|.+......   ..+.+..|+.+++.++||||+++++++......++||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence            34555666788777643     246889999998654322   2356788999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||+++++|.+++.+ ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||+++
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccce
Confidence            99999999999865 35889999999999999999999998   9999999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.86  E-value=6.5e-21  Score=173.69  Aligned_cols=141  Identities=26%  Similarity=0.449  Sum_probs=118.3

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+   .  .+|+.+++|.+..... .....+.+..|+.+++.++||||+++++++......++||||
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            334445667766533   2  2588999999864432 222234578899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|..++.....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  148 (286)
T cd07847          82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFAR  148 (286)
T ss_pred             cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccce
Confidence            999888888776667999999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.86  E-value=9.5e-21  Score=170.47  Aligned_cols=141  Identities=28%  Similarity=0.528  Sum_probs=122.7

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+     ..++..+++|.+...... ....+.+..|+.+++.++|+||+++++++......++|+||
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            344456677776533     236789999999765433 45667899999999999999999999999989999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++.....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~  147 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV  147 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccc
Confidence            999999999988777899999999999999999999998   9999999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.86  E-value=7.8e-21  Score=173.07  Aligned_cols=140  Identities=23%  Similarity=0.510  Sum_probs=114.6

Q ss_pred             eEeeccCcccceeEEE---Ee--cCc----EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVA---KW--NGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~----~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +++..+.+|.|+|+.+   .+  .+.    ++++|.+...  ........+..|+..+..++||||+++++++.. ...+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            3455567888888644   22  344    4677776432  223445678889999999999999999998754 4578


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||+++|+|.+++... +.+++..+..++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence            999999999999999764 46899999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=8.8e-21  Score=171.74  Aligned_cols=142  Identities=32%  Similarity=0.478  Sum_probs=120.9

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCC-------cHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK-------DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  259 (359)
                      |...+.+|.|.++.+     ..+|+.+++|.+......       .....+.+..|+.+++.++||||+++++++.....
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            445566788877643     236889999988532111       11234568889999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||+++
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence            9999999999999999988788999999999999999999999998   9999999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=5.9e-21  Score=173.68  Aligned_cols=148  Identities=26%  Similarity=0.445  Sum_probs=125.5

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  .++..+++|.+...   .....+.|..|+.+++.++||||+++++++......|+||||
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            344455677776533   2  35788999998643   344556789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      +++++|.+++... ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.         
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            9999999998764 46999999999999999999999998   9999999999999999999999999874         


Q ss_pred             ------ccccCcccc
Q 018204          337 ------LQYISPEKA  345 (359)
Q Consensus       337 ------~~~~~PE~~  345 (359)
                            ..|++||..
T Consensus       161 ~~~~~~~~y~~PE~~  175 (280)
T cd06611         161 DTFIGTPYWMAPEVV  175 (280)
T ss_pred             ceeecchhhcCHHHH
Confidence                  247888864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.86  E-value=7.8e-21  Score=171.71  Aligned_cols=140  Identities=31%  Similarity=0.516  Sum_probs=117.8

Q ss_pred             EeeccCcccceeEEE---E--ecC---cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA---K--WNG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g---~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      +.....+|.|.++.+   .  ..+   ..+++|.+....  .....+.+..|+.++..++||||+++++++......++|
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            344455777777633   1  123   368888885432  234456789999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+++++|.+++... +.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence            9999999999999764 46899999999999999999999998   9999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=1.6e-20  Score=167.85  Aligned_cols=150  Identities=29%  Similarity=0.558  Sum_probs=127.8

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|.++..     ...+..+++|.+...... ......+.+|+.+++.++|||++++++++......+++|||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            34455666666532     235788999999765432 345678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----------
Q 018204          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----------  337 (359)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----------  337 (359)
                      ++++|.+++.....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.          
T Consensus        82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcccccc
Confidence            99999999988788999999999999999999999998   99999999999999999999999998862          


Q ss_pred             -----cccCccccc
Q 018204          338 -----QYISPEKAK  346 (359)
Q Consensus       338 -----~~~~PE~~~  346 (359)
                           .|++||...
T Consensus       159 ~~~~~~y~~pe~~~  172 (254)
T cd06627         159 VVGTPYWMAPEVIE  172 (254)
T ss_pred             cccchhhcCHhhhc
Confidence                 377888654

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.86  E-value=1.7e-21  Score=177.55  Aligned_cols=147  Identities=27%  Similarity=0.540  Sum_probs=120.7

Q ss_pred             ccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          195 ADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       195 ~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      ...+|.|.++.+   .  .+|..+++|.+..... .......+.+|+.+++.++||||+++++++......++++||+++
T Consensus         5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (284)
T cd07839           5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ   83 (284)
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC
Confidence            344566666532   2  3688999999865432 222234577899999999999999999999999999999999975


Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----------
Q 018204          270 GDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----------  337 (359)
Q Consensus       270 gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----------  337 (359)
                       +|.+++.. .+.+++..+..++.||+.||.|||+++   ++||||||+||+++.++.+||+|||+++.           
T Consensus        84 -~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (284)
T cd07839          84 -DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE  159 (284)
T ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence             88888765 456999999999999999999999998   99999999999999999999999998862           


Q ss_pred             ----cccCccccc
Q 018204          338 ----QYISPEKAK  346 (359)
Q Consensus       338 ----~~~~PE~~~  346 (359)
                          .|++||...
T Consensus       160 ~~~~~y~aPE~~~  172 (284)
T cd07839         160 VVTLWYRPPDVLF  172 (284)
T ss_pred             ccccCCcChHHHh
Confidence                378888643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.86  E-value=1.2e-20  Score=171.70  Aligned_cols=141  Identities=24%  Similarity=0.426  Sum_probs=118.6

Q ss_pred             eEeeccCcccceeEEE---Ee-c-----CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe-CCcE
Q 018204          191 QVRKADGITKGSYQVA---KW-N-----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-~-----g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~  260 (359)
                      .|.....+|.|.|+.+   .. .     +..+++|.+...  ........+.+|+.+++.++||||+++++++.. ....
T Consensus         7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4555566788887643   22 2     577888987533  245556778999999999999999999998765 4678


Q ss_pred             EEEEecCCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecc
Q 018204          261 MIVLEYHAKGDLASYLQKK--------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DF  332 (359)
                      ++++||+++++|.+++...        ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999999753        34889999999999999999999998   999999999999999999999999


Q ss_pred             cccc
Q 018204          333 GLLR  336 (359)
Q Consensus       333 Gla~  336 (359)
                      |+++
T Consensus       162 g~~~  165 (280)
T cd05043         162 ALSR  165 (280)
T ss_pred             CCcc
Confidence            9987

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.86  E-value=4.4e-21  Score=172.56  Aligned_cols=150  Identities=27%  Similarity=0.468  Sum_probs=125.7

Q ss_pred             eEeeccCcccceeEEE---E-ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +|.....+|.|.++.+   . ..+..+++|.+....   ....+.+..|+.+++.++||||+++++++......+++|||
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            3455566777777633   2 236789999986543   22345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.       
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            9999999999763  35899999999999999999999998   99999999999999999999999999852       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|++||...
T Consensus       161 ~~~~~~~~~~~~PE~~~  177 (261)
T cd05148         161 SSDKKIPYKWTAPEAAS  177 (261)
T ss_pred             ccCCCCceEecCHHHHc
Confidence                    377888653

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.86  E-value=8.9e-21  Score=175.11  Aligned_cols=150  Identities=25%  Similarity=0.453  Sum_probs=126.8

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+     ...++.+++|.+.............+.+|+.+++.++||||+++++++......++||||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            445556777777643     235889999998765555556667789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +. |++.+++.. .+.+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||+++.        
T Consensus        97 ~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~  172 (307)
T cd06607          97 CL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV  172 (307)
T ss_pred             hC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCCCCcc
Confidence            97 478777754 456899999999999999999999998   99999999999999999999999998852        


Q ss_pred             ---cccCcccc
Q 018204          338 ---QYISPEKA  345 (359)
Q Consensus       338 ---~~~~PE~~  345 (359)
                         .|++||..
T Consensus       173 ~~~~y~aPE~~  183 (307)
T cd06607         173 GTPYWMAPEVI  183 (307)
T ss_pred             CCccccCceee
Confidence               47888864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.85  E-value=1.2e-20  Score=170.34  Aligned_cols=130  Identities=26%  Similarity=0.449  Sum_probs=111.1

Q ss_pred             cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhc-CCCCHHHHHH
Q 018204          211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLR  289 (359)
Q Consensus       211 ~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~  289 (359)
                      ..+++|.+....   ......|..|+.++..++||||+++++++......+++|||+++++|..++... ..+++..+..
T Consensus        33 ~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~  109 (262)
T cd05077          33 IKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFK  109 (262)
T ss_pred             eeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHH
Confidence            458888875432   234457888999999999999999999999988999999999999999988754 4689999999


Q ss_pred             HHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc-------EEEeccccccc-----------cccCccccc
Q 018204          290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-------LKISGFGLLRL-----------QYISPEKAK  346 (359)
Q Consensus       290 i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~-------~kl~DFGla~~-----------~~~~PE~~~  346 (359)
                      ++.||+.||.|||+++   |+||||||+|||++.++.       ++++|||++..           .|+|||...
T Consensus       110 i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~  181 (262)
T cd05077         110 VAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVE  181 (262)
T ss_pred             HHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCcccccccccccChhhhc
Confidence            9999999999999998   999999999999987664       89999998852           488888654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.85  E-value=4.2e-21  Score=174.21  Aligned_cols=142  Identities=30%  Similarity=0.500  Sum_probs=123.4

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEe
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      |...+.+|.|.++.+     ..+|..+++|++.............+..|..++..+. ||||+++++++......+++||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            344455677776533     2368999999997654444445567889999999998 9999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCcccc
Confidence            9999999999988878999999999999999999999998   9999999999999999999999999876

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.85  E-value=1.2e-20  Score=171.72  Aligned_cols=149  Identities=26%  Similarity=0.483  Sum_probs=118.5

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHH-HHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      |.....+|.|.|+.+     ..+|..+|+|.+....... .. ..+..|+.+ ++.++||||+++++++......|++||
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            344455677777643     2358999999987543322 22 344556554 666799999999999999999999999


Q ss_pred             cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---
Q 018204          266 YHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---  337 (359)
                      |++ ++|.+++..    ...+++..+..++.|++.||.|||++ +   ++||||||+||+++.++.+||+|||+++.   
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 588888754    23589999999999999999999997 6   99999999999999999999999999862   


Q ss_pred             -----------cccCccccc
Q 018204          338 -----------QYISPEKAK  346 (359)
Q Consensus       338 -----------~~~~PE~~~  346 (359)
                                 .|++||...
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~  176 (283)
T cd06617         157 SVAKTIDAGCKPYMAPERIN  176 (283)
T ss_pred             ccccccccCCccccChhhcC
Confidence                       378888654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.85  E-value=1e-20  Score=169.61  Aligned_cols=139  Identities=27%  Similarity=0.506  Sum_probs=120.1

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCC--CcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESH--KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .+.+|.|.++.+     ..++..+++|.+.....  ...+..+.+..|+.+++.++|+||+++++++......++++||+
T Consensus         5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (258)
T cd06632           5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV   84 (258)
T ss_pred             cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence            344666666533     23688999999865332  23445677899999999999999999999999989999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++|.+++.+.+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          85 PGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccce
Confidence            99999999988777999999999999999999999998   9999999999999999999999999885

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.85  E-value=5.7e-21  Score=174.88  Aligned_cols=140  Identities=31%  Similarity=0.550  Sum_probs=115.5

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+     ...|..+++|.+.......  ....+.+|+.+++.++|+||+++++++......|+|||
T Consensus         6 ~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             eeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            3555566778777643     2358899999986543221  12346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+. +++.+++... ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.+||+|||+++
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence            996 5787776543 45788889999999999999999998   9999999999999999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.85  E-value=1.3e-20  Score=171.34  Aligned_cols=139  Identities=28%  Similarity=0.582  Sum_probs=118.0

Q ss_pred             eeccCcccceeEEE---Ee------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCcEE
Q 018204          193 RKADGITKGSYQVA---KW------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMM  261 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~~------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~  261 (359)
                      .....+|.|.|+.+   .+      .+..+|+|.+......  .....|.+|+.+++.++||||+++++++..  ....+
T Consensus         7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            33455677777643   22      3678999999754432  455679999999999999999999998877  55799


Q ss_pred             EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++|||+++++|.+++.... .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||+++
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999997654 5899999999999999999999998   9999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.85  E-value=6.5e-21  Score=171.76  Aligned_cols=148  Identities=32%  Similarity=0.527  Sum_probs=125.5

Q ss_pred             eccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ....+|.|.++.+   .  ..++.+++|.+.....  ......+.+|+.+++.++||||+++++++......++++||++
T Consensus         5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            3345666666532   2  3578899999865432  3455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          269 KGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       269 ~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +++|.+++... ..+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||++..         
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  159 (265)
T cd06605          83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF  159 (265)
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence            99999999876 679999999999999999999999 87   99999999999999999999999998752         


Q ss_pred             ----cccCccccc
Q 018204          338 ----QYISPEKAK  346 (359)
Q Consensus       338 ----~~~~PE~~~  346 (359)
                          .|++||...
T Consensus       160 ~~~~~y~~PE~~~  172 (265)
T cd06605         160 VGTSSYMAPERIQ  172 (265)
T ss_pred             cCChhccCHHHHc
Confidence                488888654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.85  E-value=1.3e-20  Score=173.14  Aligned_cols=150  Identities=21%  Similarity=0.450  Sum_probs=126.1

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      ..|.....+|.|.++.+     ...++.+++|.+.....   ...+.+.+|+.+++.++||||+++++++......++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            34555566777776533     24688999999865432   23356789999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      ||+++++|..++... .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++.       
T Consensus        96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            999999999998654 6899999999999999999999998   99999999999999999999999998752       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|++||...
T Consensus       172 ~~~~~~~~~y~aPE~~~  188 (296)
T cd06655         172 RSTMVGTPYWMAPEVVT  188 (296)
T ss_pred             CCCcCCCccccCcchhc
Confidence                    478888654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-21  Score=183.85  Aligned_cols=154  Identities=22%  Similarity=0.349  Sum_probs=129.8

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHH-----HHHHHHHHHHHHhCC---CCccccceeeEEeC
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPER-----INAFTHELTIVEKAR---HPNVVQFVGAVTQN  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~-----~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~  257 (359)
                      .|......|.|+|+.+     +.+...|++|.+.++......-     ....-.|+.||..++   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            4666778899999854     3457899999997654322111     122346999999997   99999999999999


Q ss_pred             CcEEEEEecCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          258 IPMMIVLEYHA-KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       258 ~~~~lv~e~~~-~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +.+||+||--. |-+|++++..++.+++.++..|++||+.|+++||+.+   |||||||-+|+.++.+|.+||+|||.|.
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa  718 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAA  718 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchh
Confidence            99999999753 4599999999999999999999999999999999999   9999999999999999999999999985


Q ss_pred             -------------ccccCcccccc
Q 018204          337 -------------LQYISPEKAKI  347 (359)
Q Consensus       337 -------------~~~~~PE~~~~  347 (359)
                                   ..|.|||....
T Consensus       719 ~~ksgpfd~f~gtv~~aapevl~g  742 (772)
T KOG1152|consen  719 YTKSGPFDVFVGTVDYAAPEVLGG  742 (772)
T ss_pred             hhcCCCcceeeeeccccchhhhCC
Confidence                         35888987664

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-22  Score=187.81  Aligned_cols=143  Identities=26%  Similarity=0.397  Sum_probs=129.3

Q ss_pred             EeeccCcccceeEEE---EecCcE--EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---KWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~~g~~--vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +.....+|.|.|+.+   +.+++.  +|+|++++....+..+.+....|-++|..++.|.||++|..|.++.++|++||-
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            344456788888744   445554  799999888777778888889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |-||.|...+..++.+...+++.++.-+++|++|||+++   ||+|||||+|+|++.+|.+||.|||+|+.
T Consensus       502 ClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  502 CLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999999999999999999999999999999999   99999999999999999999999999973

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.85  E-value=1.4e-20  Score=170.37  Aligned_cols=149  Identities=26%  Similarity=0.507  Sum_probs=121.8

Q ss_pred             EeeccCcccceeEEE---Eec-----CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA---KWN-----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~~-----g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      +.....+|.|.|+.+   ...     ...+++|......  .....+.+.+|+.+++.++||||+++++++.. ...++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            444556777777643   211     2357888875432  24455678999999999999999999998865 557899


Q ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----
Q 018204          264 LEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----  337 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----  337 (359)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++.     
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            99999999999997654 5899999999999999999999998   99999999999999999999999999862     


Q ss_pred             -----------cccCccccc
Q 018204          338 -----------QYISPEKAK  346 (359)
Q Consensus       338 -----------~~~~PE~~~  346 (359)
                                 .|++||...
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~  181 (270)
T cd05056         162 YYKASKGKLPIKWMAPESIN  181 (270)
T ss_pred             ceecCCCCccccccChhhhc
Confidence                       478888654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.85  E-value=1.5e-22  Score=191.85  Aligned_cols=167  Identities=27%  Similarity=0.257  Sum_probs=137.0

Q ss_pred             CCCcceeecc-CCCCCcCcCCcccccCCCCCC-CCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018204           39 RNNMRFSFGR-QSSLDPIRRSPVQDELTVPEN-LDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (359)
Q Consensus        39 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g  116 (359)
                      .+-.++.+|+ .++++.++.+++.++..+... .-+-|||||||++|++.+|++|+++|||++.+|..|.||||.||..|
T Consensus        77 ~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~  156 (600)
T KOG0509|consen   77 EGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFG  156 (600)
T ss_pred             CCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhC
Confidence            3344556655 677888888888888777775 56899999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccc----cccCCCCcccCC---CCCCCcccCCcce
Q 018204          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV----PKTKRTPMTVAN---PREVPEYELNPLE  189 (359)
Q Consensus       117 ~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~----~~~~~tpl~~a~---~~~~~~~~l~~~~  189 (359)
                      +.-+|-|||.+|+|+|.+|..|.||||+|++.|+...+..|+..|+.+    +..+.||+|.+.   ...... ++....
T Consensus       157 ~~~~vayll~~~~d~d~~D~~grTpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~TpLHwa~~~gN~~~v~-Ll~~g~  235 (600)
T KOG0509|consen  157 HTALVAYLLSKGADIDLRDNNGRTPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTPLHWAVVGGNLTAVK-LLLEGG  235 (600)
T ss_pred             chHHHHHHHHhcccCCCcCCCCCCHHHHHHHhcccHHHHHHHHhcccccccccccCCchHHHHHhcCCcceEe-hhhhcC
Confidence            999999999999999999999999999999999988788999999987    366789999873   223333 343334


Q ss_pred             eeEeeccCcccceeEEE
Q 018204          190 LQVRKADGITKGSYQVA  206 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~  206 (359)
                      ..+...+..|++++..+
T Consensus       236 ~~~d~~~~~g~tp~~LA  252 (600)
T KOG0509|consen  236 ADLDKTNTNGKTPFDLA  252 (600)
T ss_pred             CcccccccCCCCHHHHH
Confidence            44555555577777654

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.85  E-value=7.1e-21  Score=173.67  Aligned_cols=150  Identities=27%  Similarity=0.479  Sum_probs=127.5

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |+....+|+|.|+.+   .  ..|..+++|++....  .....+.+.+|+.+++.++||||+++++++......++||||
T Consensus         7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            445566788887644   2  247889999886432  233456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      +++++|.+++...+.+++..+..++.+++.||.|||+ ++   ++||||||+||+++.++.++|+|||+++         
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~  161 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT  161 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhccCc
Confidence            9999999999887789999999999999999999997 56   9999999999999999999999999875         


Q ss_pred             ----ccccCccccc
Q 018204          337 ----LQYISPEKAK  346 (359)
Q Consensus       337 ----~~~~~PE~~~  346 (359)
                          ..|++||...
T Consensus       162 ~~~~~~~~aPE~~~  175 (284)
T cd06620         162 FVGTSTYMSPERIQ  175 (284)
T ss_pred             cccCcccCCHHHHc
Confidence                2477888643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=4.6e-22  Score=175.83  Aligned_cols=154  Identities=29%  Similarity=0.449  Sum_probs=136.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      ++.....+|.|+|..+     +.+.+.+|+|+++++...+.+.++....|-.+..+. +||.+|-++.+|.+...+++|.
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi  330 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI  330 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence            4566667899998643     346789999999988888888888888998888876 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      ||++||+|.-.+++..+++++.++.+..+|+.||.|||+.|   ||+||||..|+|++..|++||+|+|+++        
T Consensus       331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence            99999999999988889999999999999999999999999   9999999999999999999999999997        


Q ss_pred             -------ccccCcccccc
Q 018204          337 -------LQYISPEKAKI  347 (359)
Q Consensus       337 -------~~~~~PE~~~~  347 (359)
                             +.|++||..+.
T Consensus       408 tstfcgtpnyiapeilrg  425 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRG  425 (593)
T ss_pred             cccccCCCcccchhhhcc
Confidence                   34778876654

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.85  E-value=1.5e-20  Score=168.02  Aligned_cols=122  Identities=39%  Similarity=0.621  Sum_probs=110.0

Q ss_pred             CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhc-CCCCHHHHH
Q 018204          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVL  288 (359)
Q Consensus       210 g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~  288 (359)
                      ++.+++|.+.....  ......+..|+.+++.++||||+++++++......++||||+++++|.+++... ..++...+.
T Consensus        19 ~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~   96 (251)
T cd05041          19 NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL   96 (251)
T ss_pred             CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHH
Confidence            88999998865433  234567899999999999999999999999999999999999999999999664 458899999


Q ss_pred             HHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       289 ~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .++.+++.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        97 ~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~  141 (251)
T cd05041          97 QMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR  141 (251)
T ss_pred             HHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccc
Confidence            99999999999999998   9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.85  E-value=4.6e-21  Score=174.22  Aligned_cols=146  Identities=27%  Similarity=0.528  Sum_probs=123.4

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      .+.+|.|.|+.+     ...+..+|+|.+....  .....+.+.+|+.+++.++||||+++++++......++||||+++
T Consensus         9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06642           9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG   86 (277)
T ss_pred             HHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence            344566766533     2357789999886433  234456789999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc------------
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------------  337 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~------------  337 (359)
                      ++|.+++.. ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||+++.            
T Consensus        87 ~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06642          87 GSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhhhccc
Confidence            999999865 46899999999999999999999998   99999999999999999999999998852            


Q ss_pred             ---cccCccccc
Q 018204          338 ---QYISPEKAK  346 (359)
Q Consensus       338 ---~~~~PE~~~  346 (359)
                         .|++||...
T Consensus       163 ~~~~y~aPE~~~  174 (277)
T cd06642         163 GTPFWMAPEVIK  174 (277)
T ss_pred             CcccccCHHHhC
Confidence               478888754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=9.3e-21  Score=171.85  Aligned_cols=149  Identities=27%  Similarity=0.483  Sum_probs=125.9

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|.++.+     ..+++.+++|.+....  .......+..|+.+++.++||||+++++++.....+++|+||+
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC   81 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence            33445666666533     2367899999986443  2344567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----------
Q 018204          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----------  337 (359)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----------  337 (359)
                      ++++|.+++... .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.          
T Consensus        82 ~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          82 GGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999765 7899999999999999999999998   99999999999999999999999998852          


Q ss_pred             -----cccCcccccc
Q 018204          338 -----QYISPEKAKI  347 (359)
Q Consensus       338 -----~~~~PE~~~~  347 (359)
                           .|++||....
T Consensus       158 ~~~~~~y~~PE~~~~  172 (274)
T cd06609         158 FVGTPFWMAPEVIKQ  172 (274)
T ss_pred             ccCCccccChhhhcc
Confidence                 3788887653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.85  E-value=1.5e-20  Score=170.84  Aligned_cols=140  Identities=31%  Similarity=0.504  Sum_probs=115.2

Q ss_pred             EeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +...+.+|.|.++.+   ..       .+..+++|.+....  .......|..|+.+++.++|+||+++++++......+
T Consensus         8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            444455677766532   22       34678888775332  2334456899999999999999999999999888999


Q ss_pred             EEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---cEEEec
Q 018204          262 IVLEYHAKGDLASYLQKKG-------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISG  331 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~---~~kl~D  331 (359)
                      ++|||+++++|.+++....       .+++..+..++.||+.||.|||+++   ++||||||+||+++.++   .+||+|
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d  162 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence            9999999999999997653       4889999999999999999999998   99999999999998765   599999


Q ss_pred             ccccc
Q 018204          332 FGLLR  336 (359)
Q Consensus       332 FGla~  336 (359)
                      ||+++
T Consensus       163 fg~~~  167 (277)
T cd05036         163 FGMAR  167 (277)
T ss_pred             Ccccc
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.8e-22  Score=182.69  Aligned_cols=153  Identities=27%  Similarity=0.414  Sum_probs=128.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      ++.....+|+|+|+.+     +.+.+.+|||+|++........++.-+.|-++|... +-|.+++++.+|.+-+.+|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            4555566899999854     234578999999876544333444456677888776 4679999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      ||+.||+|.-.++.-+.+.+..+..++.+|+.||-|||+++   ||+||||.+|||++.+|++||+|||+++        
T Consensus       430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence            99999999999999999999999999999999999999999   9999999999999999999999999997        


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             +.|+|||.+.
T Consensus       507 TkTFCGTPdYiAPEIi~  523 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIA  523 (683)
T ss_pred             eeeecCCCcccccceEE
Confidence                   3477777643

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.85  E-value=1.1e-20  Score=170.55  Aligned_cols=137  Identities=31%  Similarity=0.537  Sum_probs=113.5

Q ss_pred             EeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      |.....+|.|.|+.+   .. ....+++|.+......    .+.|..|+.+++.++||||+++++.+. ....++||||+
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             eeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            555556777776532   22 3357999998653321    245889999999999999999998774 45689999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++|.+++...  ..+++..+..++.|++.||.|+|+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~  150 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  150 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCcee
Confidence            999999999763  34889999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-22  Score=175.36  Aligned_cols=151  Identities=26%  Similarity=0.472  Sum_probs=126.2

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC-----cE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----PM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~  260 (359)
                      +..-..-+|.|+|+++     -.+|+.+++|.+.. ....-...+.+.+|+.++..++|.|++..+++.....     .+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            3344456899999865     24689999998853 3333344567889999999999999999988776442     47


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----  336 (359)
                      |+++|++. .+|..++.....++...++-++.||++||+|||+.+   |+||||||.|+|++.+..+||+|||++|    
T Consensus       133 YV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  133 YVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            88999995 599999988888999999999999999999999999   9999999999999999999999999998    


Q ss_pred             ------------ccccCccccc
Q 018204          337 ------------LQYISPEKAK  346 (359)
Q Consensus       337 ------------~~~~~PE~~~  346 (359)
                                  .+|.+||..-
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLM  230 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLM  230 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhh
Confidence                        3699999643

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.85  E-value=2e-20  Score=173.57  Aligned_cols=150  Identities=24%  Similarity=0.447  Sum_probs=126.1

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  ..+..+++|.+.............+..|+.+++.++|||++++++++......++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            445556777777633   2  35789999998765444555567789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      +.+ ++.+++.. ...+++..+..++.|++.||.|||+++   |+||||+|+||+++.++.++|+|||++.         
T Consensus       107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (317)
T cd06635         107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV  182 (317)
T ss_pred             CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCccccc
Confidence            975 78777754 456899999999999999999999998   9999999999999999999999999875         


Q ss_pred             --ccccCcccc
Q 018204          337 --LQYISPEKA  345 (359)
Q Consensus       337 --~~~~~PE~~  345 (359)
                        ..|++||..
T Consensus       183 ~~~~y~aPE~~  193 (317)
T cd06635         183 GTPYWMAPEVI  193 (317)
T ss_pred             CCccccChhhh
Confidence              248888874

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.85  E-value=6.1e-22  Score=170.02  Aligned_cols=147  Identities=28%  Similarity=0.444  Sum_probs=120.9

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCC
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ...+|.|.|+.+     +..|+..|||.++....  ....+++..|.....+- +.||||+|||+....+..|+.||+|+
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            446799999866     45799999999976543  44456778887766554 78999999999999999999999996


Q ss_pred             CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          269 KGDLASYLQK-----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       269 ~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      - ||..+.+.     +..+++.-+-.|..-.+.||.||-+.-  .|||||+||+|||++..|.+||+|||++.       
T Consensus       147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA  223 (361)
T KOG1006|consen  147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA  223 (361)
T ss_pred             h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence            4 77665432     346899888889999999999998653  39999999999999999999999999995       


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             .-|||||++.
T Consensus       224 kT~daGCrpYmAPERi~  240 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERID  240 (361)
T ss_pred             hhhccCCccccChhccC
Confidence                   2599999876

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.85  E-value=4.8e-21  Score=172.31  Aligned_cols=130  Identities=26%  Similarity=0.394  Sum_probs=111.2

Q ss_pred             cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC-CCCHHHHHH
Q 018204          211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLR  289 (359)
Q Consensus       211 ~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~  289 (359)
                      .++++|.+...   .....+.+..|+.+++.++||||+++++++......++||||+++|+|.+++...+ .+++..+..
T Consensus        28 ~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~  104 (258)
T cd05078          28 TEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE  104 (258)
T ss_pred             chhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHH
Confidence            34777776432   23345678889999999999999999999999889999999999999999997654 589999999


Q ss_pred             HHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc--------EEEecccccc-----------ccccCccccc
Q 018204          290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ--------LKISGFGLLR-----------LQYISPEKAK  346 (359)
Q Consensus       290 i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~--------~kl~DFGla~-----------~~~~~PE~~~  346 (359)
                      ++.||+.||.|||+++   |+||||||+||+++.++.        ++++|||++.           ..|++||...
T Consensus       105 ~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~  177 (258)
T cd05078         105 VAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIE  177 (258)
T ss_pred             HHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCCchhccccCCccCchhcc
Confidence            9999999999999998   999999999999987764        6999999885           3588898765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.85  E-value=1e-20  Score=173.10  Aligned_cols=139  Identities=32%  Similarity=0.562  Sum_probs=116.3

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+     ...++.+++|.+.......  ....+.+|+.+++.++||||+++++++......++||||
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            445556677776543     2357899999986543221  123467899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +.+ +|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  151 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLAR  151 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccc
Confidence            975 999988764 46899999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.85  E-value=8.5e-21  Score=173.28  Aligned_cols=150  Identities=29%  Similarity=0.516  Sum_probs=116.8

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCccccceeeEEeC-----C
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQN-----I  258 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~-----~  258 (359)
                      |.....+|.|.|+.+     ..+|+.+|+|.+......+ .....+.+|+.+++.+   +||||+++++++...     .
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            344556778877644     2357899999986543221 1112345676666655   799999999987642     4


Q ss_pred             cEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          259 PMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .++++|||+++ +|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence            58999999975 899988764  34899999999999999999999998   9999999999999999999999999986


Q ss_pred             c--------------cccCccccc
Q 018204          337 L--------------QYISPEKAK  346 (359)
Q Consensus       337 ~--------------~~~~PE~~~  346 (359)
                      .              .|+|||...
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~  180 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLL  180 (288)
T ss_pred             cccCcccCCCccccccccCchHhh
Confidence            2              388888653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.85  E-value=1.4e-20  Score=171.17  Aligned_cols=148  Identities=27%  Similarity=0.523  Sum_probs=125.0

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|.|+.+     ...+..+|+|.+....  .......+.+|+.+++.+.||||+++++++......++||||+
T Consensus         7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            34455677777633     2357889999986432  2344567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----------
Q 018204          268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----------  337 (359)
Q Consensus       268 ~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----------  337 (359)
                      ++++|.+++.. +.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.          
T Consensus        85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999865 46899999999999999999999998   99999999999999999999999999842          


Q ss_pred             -----cccCccccc
Q 018204          338 -----QYISPEKAK  346 (359)
Q Consensus       338 -----~~~~PE~~~  346 (359)
                           .|++||...
T Consensus       161 ~~~~~~y~apE~~~  174 (277)
T cd06640         161 FVGTPFWMAPEVIQ  174 (277)
T ss_pred             ccCcccccCHhHhc
Confidence                 378888653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.85  E-value=1.4e-20  Score=184.22  Aligned_cols=145  Identities=26%  Similarity=0.476  Sum_probs=122.2

Q ss_pred             CcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEe-----CCcEEEEEe
Q 018204          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ-----NIPMMIVLE  265 (359)
Q Consensus       197 ~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-----~~~~~lv~e  265 (359)
                      .+|.|+|+.+     +.+++..|+|++......+    ++...|.++++.+ .|||++.++++|..     .+.+|||||
T Consensus        26 vig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME  101 (953)
T KOG0587|consen   26 VIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME  101 (953)
T ss_pred             EEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence            3555555433     4578999999997654333    3467788999887 69999999999864     357999999


Q ss_pred             cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      ||.|||..++++.-  ..+.+..+..|++.++.|+.+||.+.   +||||+|=.|||++.++.+||.|||+|.       
T Consensus       102 fC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g  178 (953)
T KOG0587|consen  102 FCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG  178 (953)
T ss_pred             ccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence            99999999999764  46999999999999999999999998   9999999999999999999999999985       


Q ss_pred             --------ccccCccccccc
Q 018204          337 --------LQYISPEKAKIV  348 (359)
Q Consensus       337 --------~~~~~PE~~~~~  348 (359)
                              ++|||||.+...
T Consensus       179 rRnT~iGtP~WMAPEViac~  198 (953)
T KOG0587|consen  179 RRNTFIGTPYWMAPEVIACD  198 (953)
T ss_pred             cccCcCCCcccccceeeecc
Confidence                    469999987754

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.85  E-value=1.9e-20  Score=168.40  Aligned_cols=138  Identities=31%  Similarity=0.519  Sum_probs=120.1

Q ss_pred             eccCcccceeEE---E--EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQV---A--KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~---~--~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ....+|.|.++.   +  ..++..+++|.+......  .....+..|+..+..++|+||+++++++......+++|||++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06623           5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD   82 (264)
T ss_pred             eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence            344556665542   2  235889999998755432  455678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|.+++.....+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||+++
T Consensus        83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~  148 (264)
T cd06623          83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISK  148 (264)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccce
Confidence            99999999887789999999999999999999999 88   9999999999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.85  E-value=1.5e-20  Score=175.31  Aligned_cols=123  Identities=28%  Similarity=0.412  Sum_probs=109.9

Q ss_pred             ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhc--CCCCHH
Q 018204          208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK--GRLSPS  285 (359)
Q Consensus       208 ~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~  285 (359)
                      ..|+.+|+|++..... .....+.+.+|+.+++.++||||++++++|......++||||+.+++|.+++...  ..+++.
T Consensus        23 ~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~  101 (328)
T cd08226          23 PTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEA  101 (328)
T ss_pred             CCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHH
Confidence            3689999999865433 3345678899999999999999999999999999999999999999999998764  348999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       286 ~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                      .+..++.|++.||.|||+++   |+||||||+|||++.++.++++||+.
T Consensus       102 ~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~  147 (328)
T cd08226         102 LIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSH  147 (328)
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHH
Confidence            99999999999999999998   99999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.85  E-value=6.3e-23  Score=187.22  Aligned_cols=134  Identities=24%  Similarity=0.352  Sum_probs=121.6

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      +|.++..|-++.|+.+++.+..++.......|||--||.-||+++|++|+++|||++..|..|.|.||+||+.||.+|++
T Consensus        88 LWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~q  167 (615)
T KOG0508|consen   88 LWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQ  167 (615)
T ss_pred             hhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHH
Confidence            45667788899999999888554455667779999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCccccccccccccccccccccceeEeeccccCccc--cccCCCCcccCC
Q 018204          123 LLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV--PKTKRTPMTVAN  176 (359)
Q Consensus       123 ~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~--~~~~~tpl~~a~  176 (359)
                      +|++.|||+|.++..|+|+||.++..|+.+++++|+.+|+.+  +..+.||+..|.
T Consensus       168 yLle~gADvn~ks~kGNTALH~caEsG~vdivq~Ll~~ga~i~~d~~GmtPL~~Aa  223 (615)
T KOG0508|consen  168 YLLEQGADVNAKSYKGNTALHDCAESGSVDIVQLLLKHGAKIDVDGHGMTPLLLAA  223 (615)
T ss_pred             HHHHhCCCcchhcccCchHHHhhhhcccHHHHHHHHhCCceeeecCCCCchHHHHh
Confidence            999999999999999999999999999999999999999987  555788987774

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.85  E-value=1.1e-20  Score=173.77  Aligned_cols=143  Identities=27%  Similarity=0.469  Sum_probs=121.5

Q ss_pred             CcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       197 ~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      .+|.|.|+.+     ...+..+++|.+.....   ...+.+.+|+.++..++||||+++++++......++++||+++++
T Consensus        28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            4567776533     23578999999864332   223567899999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------------
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------------  336 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------------  336 (359)
                      |..++.. ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++               
T Consensus       105 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~  180 (297)
T cd06659         105 LTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGT  180 (297)
T ss_pred             HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecC
Confidence            9998765 46899999999999999999999998   9999999999999999999999999875               


Q ss_pred             ccccCccccc
Q 018204          337 LQYISPEKAK  346 (359)
Q Consensus       337 ~~~~~PE~~~  346 (359)
                      ..|++||...
T Consensus       181 ~~y~aPE~~~  190 (297)
T cd06659         181 PYWMAPEVIS  190 (297)
T ss_pred             ccccCHHHHc
Confidence            2488888654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.85  E-value=1e-20  Score=173.57  Aligned_cols=133  Identities=28%  Similarity=0.490  Sum_probs=114.9

Q ss_pred             CcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          197 GITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       197 ~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      .+|.|.|+.+   .  ..+..+++|.+....   ....+.+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus        29 ~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             cccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            4566666533   2  357889999885432   3345668899999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++.
T Consensus       106 L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~  166 (292)
T cd06658         106 LTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCA  166 (292)
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchh
Confidence            9998854 46899999999999999999999998   9999999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.85  E-value=8.9e-21  Score=175.64  Aligned_cols=132  Identities=24%  Similarity=0.445  Sum_probs=106.9

Q ss_pred             cCcccceeEEE---Ee----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCcEEEEEec
Q 018204          196 DGITKGSYQVA---KW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEY  266 (359)
Q Consensus       196 ~~ig~g~~~~~---~~----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~e~  266 (359)
                      ..+|.|.|+.+   ..    .+..+|+|.+.....     ...+.+|+.+++.++||||+++++++..  ....+++|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            35678887644   21    346899998864432     1246789999999999999999998854  4578999999


Q ss_pred             CCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE----cCCCcEEEeccc
Q 018204          267 HAKGDLASYLQKK---------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFG  333 (359)
Q Consensus       267 ~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DFG  333 (359)
                      +.+ +|.+++...         ..+++..+..++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            965 888877521         24888999999999999999999998   9999999999999    456789999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      +++
T Consensus       158 ~a~  160 (317)
T cd07867         158 FAR  160 (317)
T ss_pred             cee
Confidence            986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.85  E-value=2.5e-20  Score=168.47  Aligned_cols=134  Identities=26%  Similarity=0.520  Sum_probs=113.3

Q ss_pred             CcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       197 ~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      .+|.|.|+.+     ..++..+++|.+....   ....+.+.+|+.+++.++|+||+++++++......++++||+++++
T Consensus        15 ~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   91 (268)
T cd06624          15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS   91 (268)
T ss_pred             EEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence            3566666543     2356789999886432   3345678999999999999999999999999999999999999999


Q ss_pred             HHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEecccccc
Q 018204          272 LASYLQKK-GRL--SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR  336 (359)
Q Consensus       272 L~~~l~~~-~~l--~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGla~  336 (359)
                      |.+++... ..+  ++..+..++.|++.||.|||+.+   |+||||||+||+++. .+.++|+|||++.
T Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            99999764 345  78888999999999999999998   999999999999986 6789999999874

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.85  E-value=3e-20  Score=166.50  Aligned_cols=150  Identities=30%  Similarity=0.515  Sum_probs=123.9

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|.|+.+     ...++.+++|.+..... .......+..|+.+++.++||||+++++.+......++||||+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            34445666666532     24678999999875443 3344577899999999999999999999999889999999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CcEEEeccccccc-------
Q 018204          268 AKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGFGLLRL-------  337 (359)
Q Consensus       268 ~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DFGla~~-------  337 (359)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.+ +.+||+|||+++.       
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence            999999999764  34899999999999999999999998   9999999999999865 4689999998852       


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|++||...
T Consensus       159 ~~~~~~~~y~aPE~~~  174 (256)
T cd08220         159 YTVVGTPCYISPELCE  174 (256)
T ss_pred             cccccCCcccCchhcc
Confidence                   477787654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.85  E-value=1.7e-20  Score=168.26  Aligned_cols=137  Identities=31%  Similarity=0.598  Sum_probs=116.3

Q ss_pred             eeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          193 RKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      .....+|.|.|+.+   .+ .+..+++|.+......    ...|..|+.+++.++||||+++++++......+++|||++
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            33455677776533   22 4778999988654332    2357889999999999999999999999899999999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          269 KGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       269 ~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|.+++... +.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCccee
Confidence            99999999764 45899999999999999999999998   9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.85  E-value=1.2e-20  Score=174.46  Aligned_cols=140  Identities=26%  Similarity=0.444  Sum_probs=114.5

Q ss_pred             eeccCcccceeEEE---E--e--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEE
Q 018204          193 RKADGITKGSYQVA---K--W--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIV  263 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~--~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv  263 (359)
                      .....+|.|.++.+   .  .  .+..+|+|.+.............+.+|+.++..++||||+++++++...  ..+++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            34445677776533   2  2  5789999999764322233345678899999999999999999999988  789999


Q ss_pred             EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC----CCcEEEecccc
Q 018204          264 LEYHAKGDLASYLQKK-----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN----GGQLKISGFGL  334 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~----~~~~kl~DFGl  334 (359)
                      |||+++ ++.+++...     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.    ++.+||+|||+
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999975 777776432     25889999999999999999999998   999999999999999    89999999998


Q ss_pred             cc
Q 018204          335 LR  336 (359)
Q Consensus       335 a~  336 (359)
                      ++
T Consensus       159 ~~  160 (316)
T cd07842         159 AR  160 (316)
T ss_pred             cc
Confidence            76

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.85  E-value=2.6e-21  Score=166.83  Aligned_cols=145  Identities=26%  Similarity=0.482  Sum_probs=120.2

Q ss_pred             CcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEecCCCC
Q 018204          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       197 ~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      .+|.|+-+.+     +..|+..|||.+....  +.+..+.++..+.++.... .|+||+.+++|..+...++.||.|.. 
T Consensus        99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-  175 (391)
T KOG0983|consen   99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-  175 (391)
T ss_pred             hhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence            3566665532     4568999999998765  4556677888888887764 89999999999999999999999853 


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------------
Q 018204          271 DLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------------  336 (359)
Q Consensus       271 sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------------  336 (359)
                      .+..++++ .+++++..+-.+...++.||.||-++.  +|||||+||+|||+|..|.+|++|||+|.             
T Consensus       176 C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAG  253 (391)
T KOG0983|consen  176 CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAG  253 (391)
T ss_pred             HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccccccC
Confidence            55666654 356999988899999999999999765  39999999999999999999999999995             


Q ss_pred             -ccccCccccc
Q 018204          337 -LQYISPEKAK  346 (359)
Q Consensus       337 -~~~~~PE~~~  346 (359)
                       ..||+||++.
T Consensus       254 C~~YMaPERid  264 (391)
T KOG0983|consen  254 CAAYMAPERID  264 (391)
T ss_pred             CccccCccccC
Confidence             3599999977

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.85  E-value=2.6e-20  Score=167.04  Aligned_cols=141  Identities=26%  Similarity=0.509  Sum_probs=119.9

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+..     ...|..+++|.+..... .....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            344556777777632     23678999999864432 233456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++....  .+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~  149 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIAR  149 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeecccee
Confidence            99999999987643  4789999999999999999999998   9999999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.85  E-value=1.9e-20  Score=168.57  Aligned_cols=138  Identities=30%  Similarity=0.488  Sum_probs=116.1

Q ss_pred             eEeeccCcccceeEEE----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      .++....+|.|.|+.+    ...+..+|+|.+......    ...+.+|+.+++.++||||+++++++. ....+++|||
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             HceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3455566788887643    235688999998654332    246889999999999999999998764 5678999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  150 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLAR  150 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCccee
Confidence            9999999998653  35889999999999999999999998   9999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.6e-20  Score=175.07  Aligned_cols=134  Identities=19%  Similarity=0.215  Sum_probs=104.1

Q ss_pred             eeeEeeccCcccceeEEEE---e---cCcEEEEEEeccCCC--CcHHHHHHHHHHHHHHHhCCCCcccc-ceeeEEeCCc
Q 018204          189 ELQVRKADGITKGSYQVAK---W---NGTKVWVKILDKESH--KDPERINAFTHELTIVEKARHPNVVQ-FVGAVTQNIP  259 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~---~---~g~~vavK~l~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~~~~~  259 (359)
                      .-.|.....+|+|.|+.+.   .   .+..+|||.+.....  ........|.+|+.+++.++|+|+++ ++++    ..
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            4457777788999997542   2   466779998753321  12334567899999999999999985 4432    45


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCcEEEcCCCcEEEecccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL-KPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDl-k~~NIll~~~~~~kl~DFGla~  336 (359)
                      .|+||||++|++|... ..   ..   ...++.|+++||.|||+++   |+|||| ||+|||++.++.+||+|||+|+
T Consensus        93 ~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         93 DGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             cEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            7999999999999732 11   11   1467889999999999998   999999 9999999999999999999997

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.85  E-value=1.6e-20  Score=168.95  Aligned_cols=137  Identities=33%  Similarity=0.515  Sum_probs=114.6

Q ss_pred             EeeccCcccceeEEE---E-ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      +.....+|.|.|+.+   . ..+..+++|.+......    ...+.+|+.+++.++|+|++++++++. ....+++|||+
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            444556777777633   2 34567999998754332    235889999999999999999998875 45689999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||+++
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~  150 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLAR  150 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeee
Confidence            999999999764  35899999999999999999999998   9999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.85  E-value=2.2e-20  Score=168.10  Aligned_cols=137  Identities=32%  Similarity=0.533  Sum_probs=112.3

Q ss_pred             EeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      +.....+|.|.++.+   .. .+..+++|.+.....    ..+.+.+|+.+++.++|||++++++++. ....+++|||+
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            344445677776533   22 335789998764332    2245788999999999999999998875 45689999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence            9999999997642  4789999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.84  E-value=2.1e-22  Score=161.18  Aligned_cols=102  Identities=36%  Similarity=0.427  Sum_probs=69.4

Q ss_pred             cHHHHHHHcCCHHHHHHHHHcCCC-CCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccce
Q 018204           74 MQLLFMACRGDVKGVEDLLNEGSD-VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVE  152 (359)
Q Consensus        74 t~l~~aa~~g~~~~v~~Ll~~ga~-v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~  152 (359)
                      .-+.|||..+.+..|+.||+..|+ ||.+|.+|.||||.|+++||++||+.|+..||+++++...||||||-||.+.+.+
T Consensus        65 rl~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~  144 (228)
T KOG0512|consen   65 RLLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFE  144 (228)
T ss_pred             HHHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchh
Confidence            345666667777777777766664 6777777777777777777777777777777777777777777777777777777


Q ss_pred             eEeeccccCcccccc---CCCCcccC
Q 018204          153 VYNILKARGAKVPKT---KRTPMTVA  175 (359)
Q Consensus       153 ~~~~L~~~ga~~~~~---~~tpl~~a  175 (359)
                      ++-+|+++|++++..   ..||++.+
T Consensus       145 va~~LLqhgaDVnA~t~g~ltpLhla  170 (228)
T KOG0512|consen  145 VAGRLLQHGADVNAQTKGLLTPLHLA  170 (228)
T ss_pred             HHHHHHhccCcccccccccchhhHHh
Confidence            777777777766433   34666665

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.84  E-value=3e-20  Score=165.82  Aligned_cols=125  Identities=34%  Similarity=0.545  Sum_probs=115.3

Q ss_pred             cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHH
Q 018204          209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL  288 (359)
Q Consensus       209 ~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~  288 (359)
                      .+..+++|.+.............+..|+.+++.++||||+++++.+......+++|||+++++|.+++.....+++..+.
T Consensus        17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~   96 (250)
T cd05123          17 TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERAR   96 (250)
T ss_pred             CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHH
Confidence            57899999997765555556678899999999999999999999999999999999999999999999887789999999


Q ss_pred             HHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       289 ~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        97 ~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~  141 (250)
T cd05123          97 FYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAK  141 (250)
T ss_pred             HHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcce
Confidence            99999999999999988   9999999999999999999999999885

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.84  E-value=1.8e-20  Score=170.95  Aligned_cols=141  Identities=28%  Similarity=0.470  Sum_probs=118.4

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+   .  .+++.+++|.+..... .....+.+..|+.+++.++|+||+++++++...+..+++|||
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            444555677766532   2  2578899998864332 333446788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++.+..+......+++..+..++.||+.||.|||+++   ++|+||+|+||+++.++.+||+|||+++
T Consensus        82 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~  148 (288)
T cd07833          82 VERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFAR  148 (288)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeeccc
Confidence            998777766666667999999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.84  E-value=1.9e-20  Score=169.43  Aligned_cols=148  Identities=22%  Similarity=0.450  Sum_probs=120.7

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC------Cc
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN------IP  259 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~------~~  259 (359)
                      |.....+|.|.|+.+     ...++.+|+|.+.....    ....+..|+.++..+ +||||+++++++...      ..
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            334455677777643     23578899999865432    223577899999998 799999999998753      45


Q ss_pred             EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      +|++|||+++++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||+++.
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            89999999999999999764  35899999999999999999999998   99999999999999999999999999852


Q ss_pred             ---------------cccCccccc
Q 018204          338 ---------------QYISPEKAK  346 (359)
Q Consensus       338 ---------------~~~~PE~~~  346 (359)
                                     .|++||...
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~  184 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIA  184 (272)
T ss_pred             cccccccCCcccccccccCHhHhc
Confidence                           378888653

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.84  E-value=4.8e-20  Score=170.76  Aligned_cols=147  Identities=26%  Similarity=0.466  Sum_probs=124.3

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      ..+|.|.|+.+     ...|..+++|.+.............+..|+.+++.++|||++++++++......|+||||+. +
T Consensus        27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  105 (313)
T cd06633          27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G  105 (313)
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence            34677776533     23678999999976555555566678899999999999999999999999999999999996 4


Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----------c
Q 018204          271 DLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----------Q  338 (359)
Q Consensus       271 sL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----------~  338 (359)
                      ++.+++.. ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.+||+|||++..           .
T Consensus       106 ~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~  182 (313)
T cd06633         106 SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY  182 (313)
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCCCCcccccc
Confidence            78887765 346899999999999999999999998   99999999999999999999999998752           4


Q ss_pred             ccCccccc
Q 018204          339 YISPEKAK  346 (359)
Q Consensus       339 ~~~PE~~~  346 (359)
                      |++||...
T Consensus       183 y~aPE~~~  190 (313)
T cd06633         183 WMAPEVIL  190 (313)
T ss_pred             ccChhhcc
Confidence            88998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.84  E-value=3.2e-20  Score=169.13  Aligned_cols=140  Identities=29%  Similarity=0.467  Sum_probs=119.0

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|.|.++.+   .  .+|..+++|.+...... ......+.+|+.+++.++||||+++++++......++|+||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            344555677776533   2  35789999998754322 23345788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      + +++|.+++... ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||+++
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~  147 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLAR  147 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence            9 99999998653 56899999999999999999999998   9999999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.84  E-value=3e-20  Score=168.96  Aligned_cols=137  Identities=28%  Similarity=0.551  Sum_probs=117.6

Q ss_pred             eccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ....+|.|.|+.+     ..++..+|+|.+....  .......+.+|+.++..++||||+++++++......++||||++
T Consensus         8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            3445677777643     2357899999885432  23445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|.+++.. ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||+++
T Consensus        86 ~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          86 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccce
Confidence            9999999865 46899999999999999999999998   9999999999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.84  E-value=1.9e-20  Score=171.49  Aligned_cols=140  Identities=35%  Similarity=0.474  Sum_probs=116.5

Q ss_pred             EeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEEE
Q 018204          192 VRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVL  264 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~  264 (359)
                      |.....+|.|.++.+   ..  ++..+++|.+...... ......+.+|+.++..++||||+++++++...  ...|+||
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            444556677777643   22  4788999999654332 22334567899999999999999999998877  8899999


Q ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||+++ +|.+++.... .+++..+..++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||+++
T Consensus        86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCcee
Confidence            99975 9999887654 4899999999999999999999998   9999999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.84  E-value=1.9e-20  Score=170.78  Aligned_cols=139  Identities=31%  Similarity=0.429  Sum_probs=114.6

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEE-----eCCc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVT-----QNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~-----~~~~  259 (359)
                      +|.....+|.|.|+.+     ...+..+++|++.....    ....+..|+.++..+ +||||+++++++.     ....
T Consensus        19 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             ceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            4555666788877643     23578999998854221    224577899999999 6999999999874     3356


Q ss_pred             EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          260 MMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                      +++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCce
Confidence            8999999999999998753    245888999999999999999999998   999999999999999999999999998


Q ss_pred             c
Q 018204          336 R  336 (359)
Q Consensus       336 ~  336 (359)
                      +
T Consensus       172 ~  172 (286)
T cd06638         172 A  172 (286)
T ss_pred             e
Confidence            5

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.84  E-value=3.8e-20  Score=166.71  Aligned_cols=140  Identities=27%  Similarity=0.456  Sum_probs=119.1

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+     ...+..+++|++.......  ....+.+|+.+++.++|+||+++++.+......+++||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            344455666666533     2357889999986443222  556789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~  150 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSA  150 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHH
Confidence            9999999999764   45899999999999999999999998   9999999999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.84  E-value=1.4e-20  Score=171.42  Aligned_cols=149  Identities=25%  Similarity=0.530  Sum_probs=121.7

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      .....+|.|.++.+     ..+|..+++|.+..... .......+..|+.+++.++||||+++++++......++||||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             eeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            34445566665532     23688999998864432 2223356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          268 AKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       268 ~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      . ++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.        
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence            6 5899988653  45899999999999999999999998   99999999999999999999999998752        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|++||...
T Consensus       158 ~~~~~~~~y~aPE~~~  173 (284)
T cd07860         158 THEVVTLWYRAPEILL  173 (284)
T ss_pred             ccccccccccCCeEEe
Confidence                   378888653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.84  E-value=6.2e-22  Score=158.55  Aligned_cols=136  Identities=21%  Similarity=0.182  Sum_probs=111.2

Q ss_pred             cceeeccCCCCCcCcCCcccccCC-CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELT-VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      +.+-++..+.+..|+++|+....- +.+|.||+||||-||.+||+++|+.|+..|||++++...||||||-||...+.+|
T Consensus        66 l~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~v  145 (228)
T KOG0512|consen   66 LLLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEV  145 (228)
T ss_pred             HHHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhH
Confidence            355677789999999999877554 4559999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCccccccccccccccccccccc-eeEeecc-ccCccc---cccCCCCcccCCC
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNV-EVYNILK-ARGAKV---PKTKRTPMTVANP  177 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~-~~~~~L~-~~ga~~---~~~~~tpl~~a~~  177 (359)
                      +-.||++|||||+..+..+||||.|+...+. ..+.+|+ ..+...   +....|++.+|..
T Consensus       146 a~~LLqhgaDVnA~t~g~ltpLhlaa~~rn~r~t~~~Ll~dryi~pg~~nn~eeta~~iARR  207 (228)
T KOG0512|consen  146 AGRLLQHGADVNAQTKGLLTPLHLAAGNRNSRDTLELLLHDRYIHPGLKNNLEETAFDIARR  207 (228)
T ss_pred             HHHHHhccCcccccccccchhhHHhhcccchHHHHHHHhhccccChhhhcCccchHHHHHHH
Confidence            9999999999999999999999999976653 3444444 334433   2223455555543

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.84  E-value=4.6e-20  Score=166.08  Aligned_cols=138  Identities=28%  Similarity=0.493  Sum_probs=116.2

Q ss_pred             eEeeccCcccceeEEE---E-ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      .+...+.+|.|.|+.+   . ..+..+++|.+...    ......+.+|+.+++.++|+||+++++++.. ...+++|||
T Consensus         7 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             ceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            4555666788887643   2 24567899987542    2234578899999999999999999998877 778999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCccee
Confidence            9999999999763  34788899999999999999999988   9999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.84  E-value=2.1e-20  Score=170.23  Aligned_cols=148  Identities=29%  Similarity=0.617  Sum_probs=121.8

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+   .  .+|..+++|.+......  .....+..|+.+++.++||||+++++++...+..++||||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence            344455666666532   2  35888999998654322  2234567899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          267 HAKGDLASYLQKK---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      +++ +|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++       
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            985 899888654   35899999999999999999999998   9999999999999999999999999885       


Q ss_pred             --------ccccCcccc
Q 018204          337 --------LQYISPEKA  345 (359)
Q Consensus       337 --------~~~~~PE~~  345 (359)
                              ..|++||..
T Consensus       156 ~~~~~~~~~~y~~PE~~  172 (284)
T cd07836         156 TFSNEVVTLWYRAPDVL  172 (284)
T ss_pred             ccccccccccccChHHh
Confidence                    247888864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=2.4e-20  Score=169.37  Aligned_cols=136  Identities=22%  Similarity=0.483  Sum_probs=116.2

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC---CCccccceeeEEeCCcEEEEEec
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR---HPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      ...+|.|.|+.+     ..++..+++|.+....  .......+.+|+.+++.+.   |||++++++++......+++|||
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~   83 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY   83 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence            344566666532     2467899999986543  2334557889999999986   99999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++... .+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          84 AEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             CCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence            9999999998664 7899999999999999999999998   9999999999999999999999999885

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.84  E-value=3.5e-20  Score=166.82  Aligned_cols=122  Identities=31%  Similarity=0.550  Sum_probs=104.9

Q ss_pred             CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEE-eCCcEEEEEecCCCCCHHHHHHhc-CCCCHHHH
Q 018204          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT-QNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKV  287 (359)
Q Consensus       210 g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~  287 (359)
                      +..+|+|.+...  ......+.+..|+.+++.++||||+++++++. .+...+++|||+.+++|.+++... ...++..+
T Consensus        23 ~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  100 (262)
T cd05058          23 KIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL  100 (262)
T ss_pred             eEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHH
Confidence            357899987532  23445677889999999999999999999765 455689999999999999999764 34677888


Q ss_pred             HHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       288 ~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++
T Consensus       101 ~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~  146 (262)
T cd05058         101 IGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLAR  146 (262)
T ss_pred             HHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccc
Confidence            899999999999999998   9999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-20  Score=172.43  Aligned_cols=141  Identities=30%  Similarity=0.449  Sum_probs=117.3

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccCCCCc----HHHHHHHHHHHHHHHhCCCCccccceeeEEe-CCcEEEEEe
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKD----PERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVLE  265 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~e  265 (359)
                      .-+|.|.|..+     ......||||+-..+....    ....+..++|.+|-+.|+||-||++|++|.- ...+|.|+|
T Consensus       469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE  548 (775)
T KOG1151|consen  469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE  548 (775)
T ss_pred             HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence            34688887532     3456788999865433221    2234566889999999999999999999975 456999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCcEEEeccccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRL  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DFGla~~  337 (359)
                      ||+|.+|.-||+..+.+++++++.|+.||+.||.||.+.. +||||-||||.|||+..   -|.+||+|||||++
T Consensus       549 YceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  549 YCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            9999999999999889999999999999999999999998 58999999999999954   47899999999983

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.84  E-value=1.9e-20  Score=169.23  Aligned_cols=121  Identities=36%  Similarity=0.588  Sum_probs=105.7

Q ss_pred             cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhc-------CCCC
Q 018204          211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-------GRLS  283 (359)
Q Consensus       211 ~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~l~  283 (359)
                      ..+++|.+....  .......+.+|+.+++.++||||+++++++......+++|||+++++|.+++...       ..++
T Consensus        27 ~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~  104 (269)
T cd05044          27 IRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT  104 (269)
T ss_pred             eeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCcccc
Confidence            568888875432  2334567889999999999999999999999989999999999999999999642       2378


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-----cEEEecccccc
Q 018204          284 PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-----QLKISGFGLLR  336 (359)
Q Consensus       284 ~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-----~~kl~DFGla~  336 (359)
                      +..+..++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||+++
T Consensus       105 ~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044         105 LKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            8899999999999999999998   99999999999999877     89999999985

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.84  E-value=5.6e-22  Score=172.69  Aligned_cols=118  Identities=17%  Similarity=0.154  Sum_probs=55.4

Q ss_pred             eeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHc--CCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHc---CC
Q 018204           44 FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR--GDVKGVEDLLNEGSDVNSID-LDGRTALHIAACE---GH  117 (359)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~--g~~~~v~~Ll~~ga~v~~~d-~~g~TpLh~A~~~---g~  117 (359)
                      +.++..|+++.++.+++.   ....|..|.||||+|+..  |+.+++++|+++|+|+|.+| ..|+||||+|+..   ++
T Consensus        26 ~~A~~~~~~~~vk~Li~~---~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~  102 (209)
T PHA02859         26 FYYVEKDDIEGVKKWIKF---VNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVE  102 (209)
T ss_pred             HHHHHhCcHHHHHHHHHh---hhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCcccc
Confidence            344444455544444432   112344455555555442  24555555555555555544 2455555554432   24


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccc--cccceeEeeccccCccc
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKY--YGNVEVYNILKARGAKV  164 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~--~~~~~~~~~L~~~ga~~  164 (359)
                      .+++++|+++|+|+|.+|..|.||||+|+.  .++.+++++|+++|+++
T Consensus       103 ~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadi  151 (209)
T PHA02859        103 PEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSF  151 (209)
T ss_pred             HHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCc
Confidence            455555555555555555555555554432  23444555555555544

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.84  E-value=3.1e-20  Score=171.24  Aligned_cols=141  Identities=28%  Similarity=0.452  Sum_probs=114.6

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC-------
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-------  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------  258 (359)
                      .|.....+|.|.|+.+   .  .+++.+|+|.+....... .....+.+|+.+++.++||||+++++++....       
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            4556666788877643   2  358899999986433221 22234568999999999999999999887643       


Q ss_pred             -cEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          259 -PMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       259 -~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                       ..++||||+.+ +|.+++.... .+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence             35999999965 8888886643 6899999999999999999999998   9999999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.84  E-value=6.3e-20  Score=164.09  Aligned_cols=139  Identities=28%  Similarity=0.536  Sum_probs=119.0

Q ss_pred             eccCcccceeEE---EEe--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQV---AKW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~---~~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ....+|.|.++.   +..  ++..+++|.+..... .......+..|+++++.++|||++++++.+......++++||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd08215           4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD   82 (258)
T ss_pred             EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence            344456666543   233  478999999865433 34455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          269 KGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       269 ~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|.+++...    ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~  151 (258)
T cd08215          83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISK  151 (258)
T ss_pred             CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcccee
Confidence            99999999764    56999999999999999999999998   9999999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA02791 ankyrin-like protein; Provisional

Probab=99.84  E-value=8.7e-22  Score=178.11  Aligned_cols=143  Identities=12%  Similarity=0.035  Sum_probs=115.9

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC-cHHHHHHHcCCHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR-TALHIAACEGHVE  119 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~-TpLh~A~~~g~~~  119 (359)
                      ..+..++..|+.+.++.++..+......|.+|+||||+||..|+.+++++|+++|+++|.++..|+ ||||+|+..|+.+
T Consensus        63 TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~e  142 (284)
T PHA02791         63 FPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVS  142 (284)
T ss_pred             CHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHH
Confidence            334455667888888888877766666788999999999999999999999999999999999886 8999999999999


Q ss_pred             HHHHHHhcCCCccccc-cccccccccccccccceeEeeccccCccccccC---CCC-cccCC---CCCCCcccC
Q 018204          120 VVKLLLSKKANIDARD-RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTP-MTVAN---PREVPEYEL  185 (359)
Q Consensus       120 ~v~~Ll~~ga~~~~~d-~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~---~tp-l~~a~---~~~~~~~~l  185 (359)
                      +|++|+++|++.  .| ..|.||||+|+..|+.+++++|+++|++++..+   .|| ++.|.   ..+..++++
T Consensus       143 ivk~LL~~~~~~--~d~~~g~TpLh~Aa~~g~~eiv~lLL~~gAd~n~~d~~g~t~~L~~Aa~~~~~e~v~lLl  214 (284)
T PHA02791        143 IVSYFLSEIPST--FDLAILLSCIHITIKNGHVDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDLEMLQALF  214 (284)
T ss_pred             HHHHHHhcCCcc--cccccCccHHHHHHHcCCHHHHHHHHHCCCCCCcccCCCCChHHHHHHHcCCHHHHHHHH
Confidence            999999987653  23 358999999999999999999999999986553   445 77763   333444444

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.84  E-value=2.8e-20  Score=171.51  Aligned_cols=139  Identities=26%  Similarity=0.536  Sum_probs=114.5

Q ss_pred             EeeccCcccceeEEE---E--ecCc----EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          192 VRKADGITKGSYQVA---K--WNGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~----~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      ++....+|.|.|+.+   .  ..|.    .+++|.+....  .......+.+|+.+++.++||||+++++++... ..++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            445566788887643   1  1343    46888875433  233344688999999999999999999988654 4679


Q ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++||+++|+|.+++.... .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence            999999999999997654 5899999999999999999999998   9999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.84  E-value=4.5e-20  Score=165.34  Aligned_cols=137  Identities=27%  Similarity=0.513  Sum_probs=118.1

Q ss_pred             EeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   ..  .+..+++|.+....     ..+.+.+|+.+++.++||||+++++++......|+++||
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            445556677776532   22  36889999986432     156789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999763 46899999999999999999999998   9999999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=6e-20  Score=166.04  Aligned_cols=149  Identities=28%  Similarity=0.475  Sum_probs=121.3

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCC------
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI------  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~------  258 (359)
                      .|.....+|.|.++.+   .  ..+..+++|++.....    ....+..|+.+++.+ +|+||+++++++....      
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            3444555666665432   2  3567899999864432    335688999999998 7999999999997655      


Q ss_pred             cEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          259 PMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                      .++++|||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            38999999999999998865    246899999999999999999999998   99999999999999999999999998


Q ss_pred             ccc---------------cccCccccc
Q 018204          335 LRL---------------QYISPEKAK  346 (359)
Q Consensus       335 a~~---------------~~~~PE~~~  346 (359)
                      ++.               .|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~  186 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIA  186 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhc
Confidence            742               388888643

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.84  E-value=4.2e-20  Score=169.33  Aligned_cols=150  Identities=27%  Similarity=0.485  Sum_probs=119.2

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.++.+     ..+|+.+++|.+..... .....+.+.+|+.+++.++||||+++++++......|+||||
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            344445566665532     23578999999865432 223345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEeccccccc------
Q 018204          267 HAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLRL------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGla~~------  337 (359)
                      ++ ++|.+++.....  +++..+..++.||+.||.|||+++   ++||||+|+||+++. ++.+||+|||+++.      
T Consensus        83 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         83 LD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             cc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            96 488888865433  578888899999999999999998   999999999999985 55799999998852      


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|++||...
T Consensus       159 ~~~~~~~~~~y~~PE~~~  176 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILL  176 (294)
T ss_pred             ccccCceeecccCHHHHh
Confidence                     378888653

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.84  E-value=1.2e-21  Score=188.38  Aligned_cols=139  Identities=18%  Similarity=0.216  Sum_probs=121.7

Q ss_pred             CCCCCcceeeccCCCCCcCcCCcccccCCCCC-CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      +.....++.++..|+.+.++.++..+...... +.+|.||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..
T Consensus        66 ~~~~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~  145 (413)
T PHA02875         66 PDIESELHDAVEEGDVKAVEELLDLGKFADDVFYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMM  145 (413)
T ss_pred             CCcccHHHHHHHCCCHHHHHHHHHcCCcccccccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHc
Confidence            33445567788899999999988877654433 66899999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccccccC----CCCcccC
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVA  175 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~----~tpl~~a  175 (359)
                      |+.++|++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++...    .++++.|
T Consensus       146 ~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~~~~t~l~~A  209 (413)
T PHA02875        146 GDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKNGCVAALCYA  209 (413)
T ss_pred             CCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCCchHHHHH
Confidence            99999999999999999999999999999999999999999999999986443    3555544

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.84  E-value=7e-20  Score=167.37  Aligned_cols=144  Identities=26%  Similarity=0.483  Sum_probs=121.3

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      ..+|.|.++.+     ...+..+++|.+...   .....+.+.+|+.+++.++||||+++++++......++++||++++
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~  101 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG  101 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence            34566665432     235788999988533   2233456889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------------
Q 018204          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------------  337 (359)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------------  337 (359)
                      +|.+++.. ..+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||+++.             
T Consensus       102 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  177 (285)
T cd06648         102 ALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVG  177 (285)
T ss_pred             CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccC
Confidence            99999977 57899999999999999999999998   99999999999999999999999997642             


Q ss_pred             --cccCccccc
Q 018204          338 --QYISPEKAK  346 (359)
Q Consensus       338 --~~~~PE~~~  346 (359)
                        .|++||...
T Consensus       178 ~~~y~aPE~~~  188 (285)
T cd06648         178 TPYWMAPEVIS  188 (285)
T ss_pred             CccccCHHHhc
Confidence              478888654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.84  E-value=4.5e-20  Score=168.68  Aligned_cols=141  Identities=24%  Similarity=0.387  Sum_probs=118.1

Q ss_pred             eeccCcccceeEEE---E-----ecCcEEEEEEeccCCCC-cHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEE
Q 018204          193 RKADGITKGSYQVA---K-----WNGTKVWVKILDKESHK-DPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~-----~~g~~vavK~l~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .....+|.|+++.+   .     ..+..+++|.+...... .....+.+..|+.++..+ +||||+++++++......++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            33445677766532   1     24678999998643221 223345688999999999 69999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999987778999999999999999999999988   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.83  E-value=9.8e-20  Score=166.25  Aligned_cols=148  Identities=25%  Similarity=0.485  Sum_probs=124.9

Q ss_pred             EeeccCcccceeEE---EEe--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQV---AKW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~---~~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....++.|.++.   +..  .+..+++|.+.....    ....+..|+..++.++|+||+++++++......|+++||
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            44444556666542   222  478899999965432    345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      +++++|.+++.... .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.         
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  173 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR  173 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence            99999999998876 7999999999999999999999988   9999999999999999999999999764         


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|++||...
T Consensus       174 ~~~~~~~~y~~PE~~~  189 (286)
T cd06614         174 NSVVGTPYWMAPEVIK  189 (286)
T ss_pred             ccccCCcccCCHhHhc
Confidence                  2478888654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.83  E-value=8.7e-20  Score=163.97  Aligned_cols=140  Identities=29%  Similarity=0.497  Sum_probs=116.7

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCcEEEEEe
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLE  265 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~e  265 (359)
                      ...+.+|.|.|+.+     ...+..+++|.+..... .....+.+..|+.+++.++||||+++++++..  ....+++||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            34455667766533     23678899999865433 34555678899999999999999999998764  456899999


Q ss_pred             cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLH-----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH-----~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||     +.+   ++|+||||+||+++.++.+||+|||++.
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccc
Confidence            9999999999875    356899999999999999999999     777   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.83  E-value=5.8e-20  Score=168.62  Aligned_cols=139  Identities=22%  Similarity=0.453  Sum_probs=118.3

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+     ...++.+++|.+....   ....+.+..|+.+++.++||||+++++++......|+|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            3445556777777643     2357889999985432   2234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+++++|.+++.+. .+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.
T Consensus        97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             cCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCccee
Confidence            99999999998754 5889999999999999999999998   9999999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.83  E-value=4.1e-21  Score=183.67  Aligned_cols=139  Identities=32%  Similarity=0.588  Sum_probs=121.7

Q ss_pred             EeeccCcccceeEEEE---e---cC--cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVAK---W---NG--TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~---~---~g--~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      +...+.+|.|.|+++.   |   .|  -.||||.+.......  .+.+|++|+.+|.+|+|||++++|++..+ .++.+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            4456678999999764   2   23  468999997655432  67899999999999999999999999887 678999


Q ss_pred             EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||+++.|||.+.|.+.  ..|.......|+.||+.||.||.++.   +|||||..+|+|+.....+||+||||.|
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence            9999999999999873  45888899999999999999999998   9999999999999999999999999998

>PTZ00284 protein kinase; Provisional

Probab=99.83  E-value=4.3e-20  Score=180.48  Aligned_cols=149  Identities=21%  Similarity=0.324  Sum_probs=117.9

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC------CccccceeeEEeC-
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH------PNVVQFVGAVTQN-  257 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~-  257 (359)
                      -.|.....+|.|.|+.+     ...++.||||++....    .....+..|+.++..+.|      ++++++++++... 
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~  204 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET  204 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence            45777778899999855     2357889999996422    122345567777776654      4588888888754 


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCC-----------
Q 018204          258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGG-----------  325 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~-----------  325 (359)
                      ..+|+|||++ +++|.+++...+.+++..+..|+.||+.||.|||+ .+   ||||||||+|||++.++           
T Consensus       205 ~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        205 GHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             ceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccccc
Confidence            5789999988 67999999888889999999999999999999998 47   99999999999998765           


Q ss_pred             -----cEEEecccccc------------ccccCccccc
Q 018204          326 -----QLKISGFGLLR------------LQYISPEKAK  346 (359)
Q Consensus       326 -----~~kl~DFGla~------------~~~~~PE~~~  346 (359)
                           .+||+|||++.            ..|+|||...
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~  318 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVL  318 (467)
T ss_pred             CCCCceEEECCCCccccCccccccccCCccccCcHHhh
Confidence                 49999999764            3588998754

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.83  E-value=7.5e-20  Score=172.36  Aligned_cols=149  Identities=26%  Similarity=0.406  Sum_probs=122.2

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------Cc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~  259 (359)
                      .|.....+|.|.|+.+     ...|..+|+|.+..... +......+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            4556667788888744     23688999999864332 334445678899999999999999999988643      35


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .|+||||+.+ +|.+.+...  ++...+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.  
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          96 VYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             EEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            7999999965 898888654  899999999999999999999998   99999999999999999999999999862  


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|++||...
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~  190 (353)
T cd07850         170 TSFMMTPYVVTRYYRAPEVIL  190 (353)
T ss_pred             CCCCCCCCcccccccCHHHHh
Confidence                        377888654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.83  E-value=5.1e-20  Score=168.74  Aligned_cols=149  Identities=26%  Similarity=0.413  Sum_probs=118.1

Q ss_pred             eeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCc-----EE
Q 018204          193 RKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIP-----MM  261 (359)
Q Consensus       193 ~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~-----~~  261 (359)
                      .....+|.|.|+.+     ..+++.+|+|.+..... .......+.+|+.+++.+. ||||+++++++.....     .|
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~   82 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY   82 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence            34445666666533     23588999999865432 1222345788999999995 6999999999887665     89


Q ss_pred             EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEeccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLL  335 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGla  335 (359)
                      ++|||+++ +|.+++...     ..+++..+..++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||++
T Consensus        83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccc
Confidence            99999986 898888643     34799999999999999999999998   999999999999998 889999999988


Q ss_pred             cc---------------cccCccccc
Q 018204          336 RL---------------QYISPEKAK  346 (359)
Q Consensus       336 ~~---------------~~~~PE~~~  346 (359)
                      +.               .|++||...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~  184 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLL  184 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhh
Confidence            63               377888653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.83  E-value=2.4e-20  Score=183.40  Aligned_cols=143  Identities=17%  Similarity=0.293  Sum_probs=109.8

Q ss_pred             eeEeeccCcccceeEEEEe------cCcEEEEE--------------EeccCCCCcHHHHHHHHHHHHHHHhCCCCcccc
Q 018204          190 LQVRKADGITKGSYQVAKW------NGTKVWVK--------------ILDKESHKDPERINAFTHELTIVEKARHPNVVQ  249 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~~------~g~~vavK--------------~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  249 (359)
                      ..|.....+|.|.|+.+..      .+...+.|              .+.+...........+.+|+.++..++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            3577778899999984421      11111111              111111122234456889999999999999999


Q ss_pred             ceeeEEeCCcEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC
Q 018204          250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKK-----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (359)
Q Consensus       250 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~  324 (359)
                      +++++......|++++++. ++|.+++...     .......+..++.||+.||.|||+++   ||||||||+|||++.+
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~  303 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD  303 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence            9999999999999999995 5888877543     22445677889999999999999998   9999999999999999


Q ss_pred             CcEEEecccccc
Q 018204          325 GQLKISGFGLLR  336 (359)
Q Consensus       325 ~~~kl~DFGla~  336 (359)
                      +.+||+|||+++
T Consensus       304 ~~vkL~DFGla~  315 (501)
T PHA03210        304 GKIVLGDFGTAM  315 (501)
T ss_pred             CCEEEEeCCCce
Confidence            999999999986

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.83  E-value=5.8e-20  Score=163.33  Aligned_cols=129  Identities=26%  Similarity=0.346  Sum_probs=111.5

Q ss_pred             EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHH
Q 018204          207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK  286 (359)
Q Consensus       207 ~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~  286 (359)
                      ..+++.+|+|.+....        .+..|...+....||||+++++++......+++|||+++|+|.+++.+...+++..
T Consensus        15 ~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~   86 (237)
T cd05576          15 TRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC   86 (237)
T ss_pred             ccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHH
Confidence            3468899999996543        12345555566689999999999999999999999999999999998777899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc------------ccccCccccc
Q 018204          287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR------------LQYISPEKAK  346 (359)
Q Consensus       287 ~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~------------~~~~~PE~~~  346 (359)
                      +..++.|++.||.|||+.+   |+||||||+||+++.++.++++|||+++            ..|++||...
T Consensus        87 ~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          87 VKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             HHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence            9999999999999999998   9999999999999999999999999764            2488999654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.83  E-value=3.7e-20  Score=173.06  Aligned_cols=141  Identities=26%  Similarity=0.494  Sum_probs=117.2

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe----CCcEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~  261 (359)
                      .|.....+|.|.++.+     ..+|..+++|.+..... .......+..|+.+++.++||||+++++++..    ....+
T Consensus         6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            3444556677777643     34688999999865432 22344567789999999999999999988753    34689


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +||||+. ++|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence            9999996 599999987778999999999999999999999998   9999999999999999999999999885

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.83  E-value=1.4e-19  Score=165.37  Aligned_cols=149  Identities=30%  Similarity=0.523  Sum_probs=121.1

Q ss_pred             eeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEEEe
Q 018204          193 RKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLE  265 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~e  265 (359)
                      .....+|.|.++.+   .  ..+..+++|.+.....  ......+.+|+++++.++||||+++++++...  ..+++|||
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            33445666666532   2  3578899999865432  24456789999999999999999999988653  46899999


Q ss_pred             cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----
Q 018204          266 YHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----  337 (359)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..    
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999988753    245889999999999999999999998   99999999999999999999999998752    


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|++||...
T Consensus       159 ~~~~~~~~~~y~~pE~~~  176 (287)
T cd06621         159 LAGTFTGTSFYMAPERIQ  176 (287)
T ss_pred             ccccccCCccccCHHHhc
Confidence                     477887654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.83  E-value=8.7e-20  Score=168.65  Aligned_cols=148  Identities=27%  Similarity=0.461  Sum_probs=122.9

Q ss_pred             eccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ....+|.|.++.+     ..++..+++|.+.............+..|+.+++.++|+|++++++++......++||||+.
T Consensus        19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   98 (308)
T cd06634          19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL   98 (308)
T ss_pred             HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC
Confidence            3445666666532     23578899999865444444555678899999999999999999999999999999999996


Q ss_pred             CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-----------
Q 018204          269 KGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-----------  336 (359)
Q Consensus       269 ~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-----------  336 (359)
                       |++.+++.. ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.           
T Consensus        99 -~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (308)
T cd06634          99 -GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT  174 (308)
T ss_pred             -CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCcccccCC
Confidence             588887754 445899999999999999999999998   9999999999999999999999999876           


Q ss_pred             ccccCcccc
Q 018204          337 LQYISPEKA  345 (359)
Q Consensus       337 ~~~~~PE~~  345 (359)
                      ..|++||..
T Consensus       175 ~~y~aPE~~  183 (308)
T cd06634         175 PYWMAPEVI  183 (308)
T ss_pred             ccccCHHHH
Confidence            358889874

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.83  E-value=9.1e-20  Score=165.06  Aligned_cols=138  Identities=29%  Similarity=0.488  Sum_probs=113.9

Q ss_pred             cccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHh-CCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       198 ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.|.|+.+     ..++..+++|.+.......        .|+..... .+||||+++++++...+..++||||+++++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~   95 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD   95 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence            477777633     2457889999986543211        12222222 279999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEecccccc-----------ccc
Q 018204          272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLR-----------LQY  339 (359)
Q Consensus       272 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DFGla~-----------~~~  339 (359)
                      |.+++.....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++ .++|+|||+++           ..|
T Consensus        96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y  172 (267)
T PHA03390         96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDY  172 (267)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcc
Confidence            9999988778999999999999999999999998   99999999999999998 99999999885           358


Q ss_pred             cCccccc
Q 018204          340 ISPEKAK  346 (359)
Q Consensus       340 ~~PE~~~  346 (359)
                      ++||...
T Consensus       173 ~aPE~~~  179 (267)
T PHA03390        173 FSPEKIK  179 (267)
T ss_pred             cChhhhc
Confidence            8898764

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.83  E-value=1.1e-19  Score=166.47  Aligned_cols=149  Identities=30%  Similarity=0.439  Sum_probs=120.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC-----Cc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN-----IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-----~~  259 (359)
                      +|.....+|.|.|+.+     ...++.+++|.+.....    ....+..|+.++..+ +|||++++++++...     ..
T Consensus        23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            3555556677777643     23578899999864321    234567899999998 899999999998754     35


Q ss_pred             EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          260 MMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                      .++||||+++++|.++++.    ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~  175 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVS  175 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccc
Confidence            8999999999999998863    346899999999999999999999998   999999999999999999999999987


Q ss_pred             cc---------------cccCccccc
Q 018204          336 RL---------------QYISPEKAK  346 (359)
Q Consensus       336 ~~---------------~~~~PE~~~  346 (359)
                      +.               .|++||...
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~  201 (291)
T cd06639         176 AQLTSTRLRRNTSVGTPFWMAPEVIA  201 (291)
T ss_pred             hhcccccccccCccCCccccChhhhc
Confidence            52               378888643

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.83  E-value=1.2e-21  Score=170.56  Aligned_cols=129  Identities=15%  Similarity=0.200  Sum_probs=111.1

Q ss_pred             CCCCcCcCCcccccCCCCCC-CCCccHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH--cCCHHHHHH
Q 018204           50 SSLDPIRRSPVQDELTVPEN-LDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC--EGHVEVVKL  123 (359)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~~-~~~~t~l~~aa~~---g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~--~g~~~~v~~  123 (359)
                      ++.+.++.+++.+......+ .+|.||||+|+..   ++.+++++|+++|+|+|.+|..|.||||+|+.  .++.+++++
T Consensus        64 ~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~  143 (209)
T PHA02859         64 VNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKL  143 (209)
T ss_pred             CCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHH
Confidence            46777888887776555555 5899999998863   58999999999999999999999999999976  478999999


Q ss_pred             HHhcCCCcccccccccccccc-ccccccceeEeeccccCcccc---ccCCCCcccCCCC
Q 018204          124 LLSKKANIDARDRWGSTAAAD-AKYYGNVEVYNILKARGAKVP---KTKRTPMTVANPR  178 (359)
Q Consensus       124 Ll~~ga~~~~~d~~g~tpl~~-A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~~~  178 (359)
                      |++.|+|++.+|..|.||||. |+..++.+++++|+++|++++   ..+.||++.+..+
T Consensus       144 Li~~gadin~~d~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~~d~~g~tpl~la~~~  202 (209)
T PHA02859        144 LIDSGVSFLNKDFDNNNILYSYILFHSDKKIFDFLTSLGIDINETNKSGYNCYDLIKFR  202 (209)
T ss_pred             HHHcCCCcccccCCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHhhh
Confidence            999999999999999999995 567789999999999999984   4567888887543

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.83  E-value=1.6e-19  Score=163.45  Aligned_cols=139  Identities=28%  Similarity=0.485  Sum_probs=113.1

Q ss_pred             ccCcccceeEEE---E-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC------cE
Q 018204          195 ADGITKGSYQVA---K-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------PM  260 (359)
Q Consensus       195 ~~~ig~g~~~~~---~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~  260 (359)
                      ...+|.|.|+.+   .     ..+..+|+|++..... .....+.+.+|+.+++.++||||+++++++....      ..
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            344666666532   1     1368899999965443 3445677889999999999999999999876532      35


Q ss_pred             EEEEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          261 MIVLEYHAKGDLASYLQKK------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                      ++++||+.+|+|..++...      ..++...+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccc
Confidence            7899999999999887432      14788999999999999999999998   99999999999999999999999999


Q ss_pred             ccc
Q 018204          335 LRL  337 (359)
Q Consensus       335 a~~  337 (359)
                      ++.
T Consensus       160 ~~~  162 (273)
T cd05074         160 SKK  162 (273)
T ss_pred             ccc
Confidence            863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.83  E-value=9.5e-20  Score=171.01  Aligned_cols=150  Identities=27%  Similarity=0.484  Sum_probs=122.7

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC------c
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------P  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~  259 (359)
                      .|.....+|.|.|+.+     ...|..+|+|.+.... ........+..|+.+++.++||||+++++++....      .
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            3555667788887644     2358899999986432 23334456789999999999999999999887543      3


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+++.  
T Consensus        95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence            58999999 6799888864 46999999999999999999999998   99999999999999999999999998862  


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|++||...
T Consensus       170 ~~~~~~~~~~~y~aPE~~~  188 (343)
T cd07880         170 SEMTGYVVTRWYRAPEVIL  188 (343)
T ss_pred             cCccccccCCcccCHHHHh
Confidence                      467888654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.83  E-value=6.8e-20  Score=171.44  Aligned_cols=139  Identities=28%  Similarity=0.479  Sum_probs=114.8

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----CcE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~  260 (359)
                      +|.....+|.|.++.+     ..+|..+|+|.+....  .......+..|+.+++.++||||+++++++...     ...
T Consensus         6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            4555666777777643     2468899999985422  223445678899999999999999999886643     358


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++||+.+ +|.+++.. ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            999999965 88888754 46999999999999999999999998   9999999999999999999999999885

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.83  E-value=6e-20  Score=171.66  Aligned_cols=137  Identities=28%  Similarity=0.419  Sum_probs=116.0

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccCCCCcHH-----------HHHHHHHHHHHHHhCCCCccccceeeEEeCCc
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPE-----------RINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~-----------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  259 (359)
                      ..+|.|.|+.+     ...++.+|+|.+.........           ....+.+|+.+++.++||||+++++++.....
T Consensus        15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   94 (335)
T PTZ00024         15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF   94 (335)
T ss_pred             hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence            44677777643     235889999998654322100           01246789999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .+++|||+. ++|.+++.....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++
T Consensus        95 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~  167 (335)
T PTZ00024         95 INLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR  167 (335)
T ss_pred             EEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcccee
Confidence            999999997 599999988778999999999999999999999998   9999999999999999999999999875

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.83  E-value=1.1e-19  Score=165.56  Aligned_cols=137  Identities=31%  Similarity=0.520  Sum_probs=115.5

Q ss_pred             ccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEEEecC
Q 018204          195 ADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEYH  267 (359)
Q Consensus       195 ~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~e~~  267 (359)
                      ...+|.|.++.+   .  ..++.+++|.+.... ........+..|+.+++.++|||++++++++...  ...++|+||+
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            334566665432   2  247899999997654 2333445688999999999999999999999887  7899999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++ +|.+++... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          83 DH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             cc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEcccccee
Confidence            75 899988765 57999999999999999999999998   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.83  E-value=4.6e-20  Score=169.62  Aligned_cols=140  Identities=31%  Similarity=0.470  Sum_probs=113.5

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC--------
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--------  258 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--------  258 (359)
                      |...+.+|.|.++.+     ...|+.+++|.+....... .....+..|+.+++.++||||+++++++....        
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~   87 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD   87 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence            344455677766533     2357899999986543211 22245678999999999999999999887654        


Q ss_pred             --cEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          259 --PMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       259 --~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                        .+++++||+++ ++..++... ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++
T Consensus        88 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          88 KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             CCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccccc
Confidence              79999999976 787777654 46899999999999999999999998   999999999999999999999999988


Q ss_pred             c
Q 018204          336 R  336 (359)
Q Consensus       336 ~  336 (359)
                      +
T Consensus       164 ~  164 (302)
T cd07864         164 R  164 (302)
T ss_pred             c
Confidence            6

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.82  E-value=8e-20  Score=166.42  Aligned_cols=135  Identities=31%  Similarity=0.593  Sum_probs=114.3

Q ss_pred             CcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       197 ~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      .+|.|.++.+     ..+|..+++|.+..... .......+.+|+.+++.++||||+++++++......+++|||++ ++
T Consensus         6 ~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~   83 (283)
T cd07835           6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD   83 (283)
T ss_pred             EecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence            4555555432     23688999999865432 22233457889999999999999999999999999999999995 59


Q ss_pred             HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          272 LASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       272 L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |.+++....  .+++..+..++.|++.||.|||+++   ++||||+|+||+++.++.++|+|||+++
T Consensus        84 l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999997765  6899999999999999999999998   9999999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.82  E-value=7.9e-22  Score=180.09  Aligned_cols=182  Identities=21%  Similarity=0.234  Sum_probs=142.7

Q ss_pred             cCCCCCCcceeeccCCCCCcCcCCcccccCCC------CC---CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCC
Q 018204           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTV------PE---NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDG  105 (359)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g  105 (359)
                      .....+..++.+|+.|-.+.|+.+++.-...+      ..   ..+|-+||-.|+..||+++|+.|+++||+||.+..-.
T Consensus        38 ~~~~g~tPL~iaaRnGH~~vVeyLle~~~a~~e~~GsV~FDge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TN  117 (615)
T KOG0508|consen   38 EVQNGGTPLLIAARNGHADVVEYLLEHCRASPEQGGSVRFDGETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTN  117 (615)
T ss_pred             cccCCCCceeeehhcCcHHHHHHHHHHhcCCccCCceEEeCCcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccC
Confidence            44666777889999999999999988443332      22   3467888888888999999999999999999999999


Q ss_pred             CcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCCC---CC
Q 018204          106 RTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVANP---RE  179 (359)
Q Consensus       106 ~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~~---~~  179 (359)
                      .|||--||.-||.++|++|+++|||++..|++|.|.||.|++.|+.+++++|++.|||++   .+++|++|.+..   .+
T Consensus       118 StPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kGNTALH~caEsG~vd  197 (615)
T KOG0508|consen  118 STPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKGNTALHDCAESGSVD  197 (615)
T ss_pred             CccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccCchHHHhhhhcccHH
Confidence            999999999999999999999999999999999999999999999999999999999995   457899998753   33


Q ss_pred             CCcccCCcceeeEeeccCcccceeEEEEecCcEEEEEEe
Q 018204          180 VPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKIL  218 (359)
Q Consensus       180 ~~~~~l~~~~~~~~~~~~ig~g~~~~~~~~g~~vavK~l  218 (359)
                      +.++++... .... .++-|.+++..+..+|+.-.|..+
T Consensus       198 ivq~Ll~~g-a~i~-~d~~GmtPL~~Aa~tG~~~iVe~L  234 (615)
T KOG0508|consen  198 IVQLLLKHG-AKID-VDGHGMTPLLLAAVTGHTDIVERL  234 (615)
T ss_pred             HHHHHHhCC-ceee-ecCCCCchHHHHhhhcchHHHHHH
Confidence            334443221 1111 233466666656555554444333

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.82  E-value=1.1e-19  Score=162.64  Aligned_cols=149  Identities=30%  Similarity=0.463  Sum_probs=123.7

Q ss_pred             eccCcccceeEE---E--EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQV---A--KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~---~--~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ....+|.|.|+.   +  ...++.+++|.+...... ......+..|+.+++.++|+||+++++++......++|+||++
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            344455555542   2  235788999998654432 3445677889999999999999999999999999999999999


Q ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          269 KGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       269 ~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      +++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++        
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  159 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK  159 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence            9999999866    345899999999999999999999998   9999999999999999999999999875        


Q ss_pred             -----ccccCccccc
Q 018204          337 -----LQYISPEKAK  346 (359)
Q Consensus       337 -----~~~~~PE~~~  346 (359)
                           ..|++||...
T Consensus       160 ~~~~~~~~~~Pe~~~  174 (256)
T cd08530         160 TQIGTPHYMAPEVWK  174 (256)
T ss_pred             cccCCccccCHHHHC
Confidence                 2477888654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=6.2e-22  Score=168.80  Aligned_cols=141  Identities=30%  Similarity=0.473  Sum_probs=114.1

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--------CC
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--------NI  258 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------~~  258 (359)
                      |.....+|+|.|+.+     ...|++||+|++..+.....- -....+|+.++..++|+|++.++++|..        ..
T Consensus        19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGf-pitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCC-cHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            444567899998832     346778888776532211111 1235789999999999999999887753        23


Q ss_pred             cEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          259 PMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      .+|+||++|+. +|.-++... .+++..++.+++.+++.||.|+|...   |+|||+||.|+||+.+|.+||+|||++|.
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence            59999999987 999999765 46999999999999999999999999   99999999999999999999999999974

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.82  E-value=2.1e-19  Score=160.61  Aligned_cols=137  Identities=31%  Similarity=0.561  Sum_probs=118.7

Q ss_pred             cCcccceeEE---EE--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEEEecCC
Q 018204          196 DGITKGSYQV---AK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEYHA  268 (359)
Q Consensus       196 ~~ig~g~~~~---~~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~e~~~  268 (359)
                      ..+|.|.++.   +.  .++..+++|++...... ....+.+.+|+.++++++||||+++++.+...  ...++++||++
T Consensus         6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            3445555542   22  25889999998654432 45667899999999999999999999999888  88999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|.+++.....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~  149 (260)
T cd06606          85 GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAK  149 (260)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEE
Confidence            9999999988778999999999999999999999988   9999999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=4.4e-20  Score=158.25  Aligned_cols=135  Identities=21%  Similarity=0.239  Sum_probs=101.3

Q ss_pred             CcccceeEEE---E-ecCcEEEEEEeccCCCCcHHH-----------------------HHHHHHHHHHHHhCCCCcccc
Q 018204          197 GITKGSYQVA---K-WNGTKVWVKILDKESHKDPER-----------------------INAFTHELTIVEKARHPNVVQ  249 (359)
Q Consensus       197 ~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~~~~-----------------------~~~~~~Ei~il~~l~HpnIv~  249 (359)
                      .+|.|+++.+   . .+|..+|+|++..........                       ......|+.++..+.++++..
T Consensus         4 ~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~   83 (190)
T cd05147           4 CISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPC   83 (190)
T ss_pred             ccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Confidence            4677777643   2 268999999997542211100                       112345999999998888755


Q ss_pred             ceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCCcEEEcCCCcEE
Q 018204          250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYL-HECKPDPIIHCDLKPKNILLDNGGQLK  328 (359)
Q Consensus       250 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~~~~iiHrDlk~~NIll~~~~~~k  328 (359)
                      ...+...  ..++||||++|+++.........++...+..++.|++.+|.|+ |+.+   |+||||||+|||++ ++.++
T Consensus        84 p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          84 PEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEE
Confidence            4433222  2389999999887766544456799999999999999999999 6888   99999999999998 57899


Q ss_pred             Eeccccccc
Q 018204          329 ISGFGLLRL  337 (359)
Q Consensus       329 l~DFGla~~  337 (359)
                      |+|||+|..
T Consensus       158 LiDFG~a~~  166 (190)
T cd05147         158 IIDVSQSVE  166 (190)
T ss_pred             EEEcccccc
Confidence            999999973

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.82  E-value=1.7e-19  Score=169.50  Aligned_cols=150  Identities=27%  Similarity=0.433  Sum_probs=121.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------Cc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~  259 (359)
                      .|.....+|+|.|+.+     ..+++.+|+|.+..... .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus        18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            4555667788887643     24688999999865322 233345678899999999999999999987643      34


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .+++++++ +++|.+++... .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.  
T Consensus        97 ~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             EEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccc
Confidence            78888887 77998887653 6999999999999999999999998   99999999999999999999999999862  


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|++||...
T Consensus       172 ~~~~~~~~~~~y~aPE~~~  190 (345)
T cd07877         172 DEMTGYVATRWYRAPEIML  190 (345)
T ss_pred             ccccccccCCCccCHHHHh
Confidence                      478888653

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.82  E-value=8.8e-20  Score=165.78  Aligned_cols=136  Identities=33%  Similarity=0.632  Sum_probs=115.8

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      ..+|.|.++.+     ..+++.+++|.+.... ......+.+..|+.+++.++|+||+++++++......++|+||++ +
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~   82 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M   82 (282)
T ss_pred             hcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence            44566655432     2358899999997654 222334567889999999999999999999999999999999997 4


Q ss_pred             CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          271 DLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       271 sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|.+++... ..+++..+..++.|++.||.|||+++   |+||||+|+||+++.++.++|+|||+++
T Consensus        83 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          83 DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccc
Confidence            999999876 57999999999999999999999998   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.82  E-value=1.5e-19  Score=167.02  Aligned_cols=141  Identities=37%  Similarity=0.556  Sum_probs=115.7

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv  263 (359)
                      .|.....+|.|.|+.+     ..+|..+|+|.+....... .....+.+|+.+++.++|+||+++++++...  ..+++|
T Consensus         8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            4555666788877643     2358899999986443221 1222456799999999999999999998765  468999


Q ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+.+ +|.+++... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceee
Confidence            999975 898888753 56899999999999999999999998   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.82  E-value=3e-19  Score=158.94  Aligned_cols=137  Identities=33%  Similarity=0.600  Sum_probs=117.8

Q ss_pred             eccCcccceeEE---EEe--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQV---AKW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~---~~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ....+|.|.++.   +..  ++..+++|.+.....   .....+.+|+.+++.++|++++++++++......++++||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            334456665543   232  578899999965432   345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          269 KGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       269 ~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|.+++... ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~  146 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSA  146 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccc
Confidence            99999999776 57999999999999999999999988   9999999999999999999999999885

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.82  E-value=3.8e-21  Score=199.18  Aligned_cols=132  Identities=23%  Similarity=0.223  Sum_probs=115.5

Q ss_pred             CCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc-
Q 018204           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE-  115 (359)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~-  115 (359)
                      +.....++.+|..|+.+.++.++..+......|.+|+||||+||.+|+.++|++|+++|+|+|.+|.+|+||||+|+.. 
T Consensus       523 ~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g  602 (823)
T PLN03192        523 PNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAK  602 (823)
T ss_pred             ccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhC
Confidence            3334556788899999999999988776677799999999999999999999999999999999999999999866554 


Q ss_pred             ------------------------------CCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc
Q 018204          116 ------------------------------GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP  165 (359)
Q Consensus       116 ------------------------------g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~  165 (359)
                                                    |+.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++
T Consensus       603 ~~~iv~~L~~~~~~~~~~~~~~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~  682 (823)
T PLN03192        603 HHKIFRILYHFASISDPHAAGDLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVD  682 (823)
T ss_pred             CHHHHHHHHhcCcccCcccCchHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCC
Confidence                                          55556677888999999999999999999999999999999999999986


Q ss_pred             ccC
Q 018204          166 KTK  168 (359)
Q Consensus       166 ~~~  168 (359)
                      ..+
T Consensus       683 ~~~  685 (823)
T PLN03192        683 KAN  685 (823)
T ss_pred             CCC
Confidence            543

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.82  E-value=2.4e-19  Score=162.06  Aligned_cols=141  Identities=23%  Similarity=0.472  Sum_probs=114.8

Q ss_pred             eeccCcccceeEEE---Ee---cCcEEEEEEeccCC-------CCcHHHHHHHHHHHHHHHh-CCCCccccceeeEEeCC
Q 018204          193 RKADGITKGSYQVA---KW---NGTKVWVKILDKES-------HKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNI  258 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~~---~g~~vavK~l~~~~-------~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~~~  258 (359)
                      .....+|.|.|+.+   ..   .+..+++|.+....       .........+..|+.++.. ++||||+++++++....
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            34455677777533   22   35789999875322       1233445667889888875 79999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          259 PMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      ..+++|||+++++|.+++..    ...+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEeccc
Confidence            99999999999999988743    3458999999999999999999996 55   9999999999999999999999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      ++.
T Consensus       160 ~~~  162 (269)
T cd08528         160 LAK  162 (269)
T ss_pred             cee
Confidence            986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.82  E-value=2.1e-19  Score=163.61  Aligned_cols=148  Identities=22%  Similarity=0.443  Sum_probs=119.9

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEe------CCc
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ------NIP  259 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------~~~  259 (359)
                      |.....+|.|.|+.+     ...++.+++|++...    ......+..|+.++..+ +|+||+++++++..      ...
T Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            334445677777643     235788999988543    22335678899999988 79999999999853      457


Q ss_pred             EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      .|++|||+++|+|.+++...  ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||+++.
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            89999999999999999763  34888889999999999999999998   99999999999999999999999999752


Q ss_pred             ---------------cccCccccc
Q 018204          338 ---------------QYISPEKAK  346 (359)
Q Consensus       338 ---------------~~~~PE~~~  346 (359)
                                     .|++||...
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~  194 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIA  194 (282)
T ss_pred             hhccccCCCcccccccccCHhhcC
Confidence                           388898643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.82  E-value=1.3e-19  Score=162.47  Aligned_cols=139  Identities=28%  Similarity=0.512  Sum_probs=115.0

Q ss_pred             eccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          194 KADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       194 ~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ..+.+|.|.++.+     ...|..+++|.+...... ....+.+.+|+.+++.++|+||+++++.+......++++||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            3344555555422     235788999998654322 2334567899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEecccccc
Q 018204          269 KGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLR  336 (359)
Q Consensus       269 ~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DFGla~  336 (359)
                      +++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++ .+||+|||.+.
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~  150 (257)
T cd08225          83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIAR  150 (257)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccch
Confidence            999999997643  4789999999999999999999998   99999999999999886 46999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.82  E-value=1.3e-20  Score=141.29  Aligned_cols=88  Identities=41%  Similarity=0.571  Sum_probs=81.5

Q ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEe
Q 018204           76 LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYN  155 (359)
Q Consensus        76 l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~  155 (359)
                      ||+||..|+.+++++|++.|++++.    |+||||+||.+|+.+++++|++.|++++.+|..|+||||+|+.+|+.++++
T Consensus         1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~   76 (89)
T PF12796_consen    1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK   76 (89)
T ss_dssp             HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred             CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence            7999999999999999999998887    999999999999999999999999999999999999999999999999999


Q ss_pred             eccccCcccccc
Q 018204          156 ILKARGAKVPKT  167 (359)
Q Consensus       156 ~L~~~ga~~~~~  167 (359)
                      +|+++|++++..
T Consensus        77 ~Ll~~g~~~~~~   88 (89)
T PF12796_consen   77 LLLEHGADVNIR   88 (89)
T ss_dssp             HHHHTTT-TTSS
T ss_pred             HHHHcCCCCCCc
Confidence            999999988654

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.82  E-value=4.8e-21  Score=187.53  Aligned_cols=152  Identities=19%  Similarity=0.179  Sum_probs=112.3

Q ss_pred             cCcCCcccccCCCCCCCC-CccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcc
Q 018204           54 PIRRSPVQDELTVPENLD-STMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID  132 (359)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~-~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~  132 (359)
                      .++.++..+......+.+ |.||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|++.|++++
T Consensus       149 iv~~Ll~~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in  228 (477)
T PHA02878        149 ITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTD  228 (477)
T ss_pred             HHHHHHHcCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCC
Confidence            455556555444445666 8999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccccccc-ccceeEeeccccCccccc----cCCCCcccCCCC-CCCcccCCcceeeEeeccCcccceeEEE
Q 018204          133 ARDRWGSTAAADAKYY-GNVEVYNILKARGAKVPK----TKRTPMTVANPR-EVPEYELNPLELQVRKADGITKGSYQVA  206 (359)
Q Consensus       133 ~~d~~g~tpl~~A~~~-~~~~~~~~L~~~ga~~~~----~~~tpl~~a~~~-~~~~~~l~~~~~~~~~~~~ig~g~~~~~  206 (359)
                      .+|..|.||||+|+.. ++.+++++|+++|++++.    .+.||++.|... +...+++. ...+....+..|.+++..+
T Consensus       229 ~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~g~TpLh~A~~~~~~v~~Ll~-~gadin~~d~~g~TpL~~A  307 (477)
T PHA02878        229 ARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSSIKSERKLKLLLE-YGADINSLNSYKLTPLSSA  307 (477)
T ss_pred             CCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCCCCCHHHHHccCHHHHHHHHH-CCCCCCCcCCCCCCHHHHH
Confidence            9999999999998865 678889999999988853    467888887321 11222221 1233344455566665443

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.82  E-value=1.8e-19  Score=168.31  Aligned_cols=139  Identities=22%  Similarity=0.355  Sum_probs=112.5

Q ss_pred             eeccCcccceeEEE---Ee--c--CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEe----CCcE
Q 018204          193 RKADGITKGSYQVA---KW--N--GTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ----NIPM  260 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~~--~--g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~~~  260 (359)
                      .....+|.|.|+.+   ..  .  +..+|+|.+.... ......+.+.+|+.++..+ +||||+++++.+..    ....
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            34445677776643   22  3  6689999986432 2233345678899999999 59999999987543    2458


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++||+. ++|.+++.....+++..+..++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            89999986 599999987778999999999999999999999998   9999999999999999999999999885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.82  E-value=2.4e-21  Score=189.65  Aligned_cols=135  Identities=20%  Similarity=0.173  Sum_probs=119.9

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc-CCH
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE-GHV  118 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~-g~~  118 (359)
                      ...+..++..|+.+.++.+++.+......|.+|.||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+.. ++.
T Consensus       169 ~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~  248 (477)
T PHA02878        169 NTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDY  248 (477)
T ss_pred             CCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCH
Confidence            3345567778889989988888766666788999999999999999999999999999999999999999999975 799


Q ss_pred             HHHHHHHhcCCCcccccc-ccccccccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          119 EVVKLLLSKKANIDARDR-WGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       119 ~~v~~Ll~~ga~~~~~d~-~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      +++++|+++|+|+|.++. .|.||||+|  .++.+++++|+++|++++   ..+.||++.|.
T Consensus       249 ~iv~~Ll~~gadvn~~~~~~g~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~TpL~~A~  308 (477)
T PHA02878        249 DILKLLLEHGVDVNAKSYILGLTALHSS--IKSERKLKLLLEYGADINSLNSYKLTPLSSAV  308 (477)
T ss_pred             HHHHHHHHcCCCCCccCCCCCCCHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence            999999999999999986 799999999  467789999999999984   55788988874

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.81  E-value=9.3e-20  Score=168.11  Aligned_cols=141  Identities=33%  Similarity=0.517  Sum_probs=113.8

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--------
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--------  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--------  257 (359)
                      .|.....+|.|.|+.+   .  .++..+++|.+......+. ....+.+|+.+++.++||||+++++++...        
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            4556666777777643   2  3578899999865432221 123467899999999999999999887543        


Q ss_pred             CcEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ..+++||||+.+ ++...+.. ...+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.++|+|||+++
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccch
Confidence            347999999965 78777764 346999999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.81  E-value=2.4e-19  Score=167.83  Aligned_cols=141  Identities=27%  Similarity=0.437  Sum_probs=117.4

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----CcE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~  260 (359)
                      .|.....+|.|.|+.+     ..++..+++|.+..... .......+..|+.+++.++||||+++++++...     ...
T Consensus         6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            3455556777777643     23578999999865432 223345677899999999999999999987644     358


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+++||+. ++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            99999996 699999988788999999999999999999999998   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.81  E-value=2.3e-19  Score=163.84  Aligned_cols=146  Identities=29%  Similarity=0.490  Sum_probs=118.2

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEecCC
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ...+|.|.|+.+     ...+..+|+|.+......  .....+..|+.++.++. ||||+++++++......+++|||+.
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~   86 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD   86 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence            345677777643     235789999998754332  44567889999999996 9999999999998889999999986


Q ss_pred             CCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCcEEEecccccc------
Q 018204          269 KGDLASYLQ-----KKGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLR------  336 (359)
Q Consensus       269 ~gsL~~~l~-----~~~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~------  336 (359)
                      . ++.++..     ....+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||+++      
T Consensus        87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            4 6655432     235699999999999999999999975 6   9999999999999999999999999985      


Q ss_pred             --------ccccCccccc
Q 018204          337 --------LQYISPEKAK  346 (359)
Q Consensus       337 --------~~~~~PE~~~  346 (359)
                              ..|++||...
T Consensus       163 ~~~~~~~~~~y~aPE~~~  180 (288)
T cd06616         163 AKTRDAGCRPYMAPERID  180 (288)
T ss_pred             ccccccCccCccCHHHhc
Confidence                    2478888654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.81  E-value=1.8e-19  Score=168.58  Aligned_cols=139  Identities=24%  Similarity=0.453  Sum_probs=114.7

Q ss_pred             EeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC--CcEEEE
Q 018204          192 VRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN--IPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~~~lv  263 (359)
                      |.....+|.|.|+.+     ...|..+++|.+..... .......+.+|+.+++++ +||||+++++++...  ..+|+|
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv   87 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV   87 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence            444556777776543     22578899998864322 233345677899999999 999999999988653  368999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+++ +|..++... .+++.....++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        88 ~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          88 FEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             eccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            999974 999998765 7888899999999999999999998   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA02741 hypothetical protein; Provisional

Probab=99.81  E-value=6.2e-21  Score=160.69  Aligned_cols=127  Identities=19%  Similarity=0.213  Sum_probs=98.6

Q ss_pred             CCCCcceeeccCCCCCcCcCCcc------cccCCCCCCCCCccHHHHHHHcCC----HHHHHHHHHcCCCCCCCCC-CCC
Q 018204           38 RRNNMRFSFGRQSSLDPIRRSPV------QDELTVPENLDSTMQLLFMACRGD----VKGVEDLLNEGSDVNSIDL-DGR  106 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~t~l~~aa~~g~----~~~v~~Ll~~ga~v~~~d~-~g~  106 (359)
                      .....+..+++.|+.+.++.++.      .+.....+|..|.||||+|+..|+    .+++++|++.|+|+|.+|. .|+
T Consensus        20 ~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~   99 (169)
T PHA02741         20 EGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEGD   99 (169)
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCC
Confidence            34455666777888877776532      122233457788888888888888    5788888888888888884 888


Q ss_pred             cHHHHHHHcCCHHHHHHHHh-cCCCccccccccccccccccccccceeEeeccccCccc
Q 018204          107 TALHIAACEGHVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       107 TpLh~A~~~g~~~~v~~Ll~-~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~  164 (359)
                      ||||+|+..++.+++++|+. .|++++.+|..|+||||+|+..++.+++++|++.++..
T Consensus       100 TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tpL~~A~~~~~~~iv~~L~~~~~~~  158 (169)
T PHA02741        100 TALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSPFELAIDNEDVAMMQILREIVATS  158 (169)
T ss_pred             CHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCHHHHHHHCCCHHHHHHHHHHHHHh
Confidence            88888888888888888887 48888888888888888888888888888888877653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=2.5e-20  Score=187.84  Aligned_cols=142  Identities=26%  Similarity=0.470  Sum_probs=115.6

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--------
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--------  256 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------  256 (359)
                      .+|.....+|+|+||-+     +.+|..+|||.+....  .......+.+|+.++++|+|||||++|..|..        
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            34555566899999843     4579999999997655  34455668899999999999999999854300        


Q ss_pred             --------------------------------------------------------------------------------
Q 018204          257 --------------------------------------------------------------------------------  256 (359)
Q Consensus       257 --------------------------------------------------------------------------------  256 (359)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------C--------CcEEEEEecCCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhC
Q 018204          257 -----------------------N--------IPMMIVLEYHAKGDLASYLQKKGRL-SPSKVLRFALDLARGMNYLHEC  304 (359)
Q Consensus       257 -----------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~qi~~aL~~lH~~  304 (359)
                                             .        ..+||-||||+...+.+++..+... .....+++++||++||.|+|+.
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~  716 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ  716 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                   0        1378999999997777777665433 4778899999999999999999


Q ss_pred             CCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       305 ~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +   ||||||||.||+++.++.|||+|||+|.
T Consensus       717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt  745 (1351)
T KOG1035|consen  717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLAT  745 (1351)
T ss_pred             c---eeeccCCcceeEEcCCCCeeecccccch
Confidence            9   9999999999999999999999999996

>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]

Probab=99.81  E-value=1.5e-20  Score=156.08  Aligned_cols=102  Identities=25%  Similarity=0.338  Sum_probs=97.2

Q ss_pred             CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccc
Q 018204           67 PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK  146 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~  146 (359)
                      ..|..|.|||+|||.+||+.+|++||+.|||+++.-+...|+|++|+..|..+||++||+.+.|+|..|-+|-|||.||+
T Consensus       155 ~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAv  234 (296)
T KOG0502|consen  155 ACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYAV  234 (296)
T ss_pred             CccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeeee
Confidence            44889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccceeEeeccccCccccccC
Q 018204          147 YYGNVEVYNILKARGAKVPKTK  168 (359)
Q Consensus       147 ~~~~~~~~~~L~~~ga~~~~~~  168 (359)
                      +.+|.+|++.|+..||+++...
T Consensus       235 rgnhvkcve~Ll~sGAd~t~e~  256 (296)
T KOG0502|consen  235 RGNHVKCVESLLNSGADVTQED  256 (296)
T ss_pred             cCChHHHHHHHHhcCCCccccc
Confidence            9999999999999999986543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.81  E-value=3.8e-19  Score=161.71  Aligned_cols=144  Identities=23%  Similarity=0.420  Sum_probs=115.9

Q ss_pred             ccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeC--CcEEEEEec
Q 018204          195 ADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQN--IPMMIVLEY  266 (359)
Q Consensus       195 ~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lv~e~  266 (359)
                      ...+|.|.|+.+     ..++..+|+|.+...... .... ....|+.++..+. |+||+++++++.+.  +.+++||||
T Consensus         4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             EeeccccccceEEEEEEcCCCcEEEEEEehhccCC-chhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            344566666532     236789999998654322 2222 3457888888885 99999999999987  889999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++ +|.+++... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++. +.+||+|||+++.        
T Consensus        82 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          82 MDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             CCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            974 888888764 46899999999999999999999998   999999999999999 9999999998862        


Q ss_pred             ------cccCcccc
Q 018204          338 ------QYISPEKA  345 (359)
Q Consensus       338 ------~~~~PE~~  345 (359)
                            .|++||..
T Consensus       157 ~~~~~~~y~aPE~~  170 (282)
T cd07831         157 EYISTRWYRAPECL  170 (282)
T ss_pred             CCCCCcccCChhHh
Confidence                  37888853

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.81  E-value=1.7e-20  Score=182.14  Aligned_cols=158  Identities=23%  Similarity=0.480  Sum_probs=132.3

Q ss_pred             eeeEeeccCcccceeEEEE---------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc
Q 018204          189 ELQVRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~---------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  259 (359)
                      +...+..+.+|+|+|+.+.         .-.-+||+|++....  ......+|..|+.+|..++|||++++++++..+. 
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            4455666778999998542         124589999986544  3344567999999999999999999999998765 


Q ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-
Q 018204          260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-  337 (359)
                      +.||++|++.|+|.++++.. ..+..+..+.|..||++||.|||.+.   ++||||.++|+|+.....+||+|||+++. 
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            88999999999999999865 46889999999999999999999998   99999999999999999999999999984 


Q ss_pred             -----cccCcccccccCCccCCC
Q 018204          338 -----QYISPEKAKIVFPVSHID  355 (359)
Q Consensus       338 -----~~~~PE~~~~~~~~~~~~  355 (359)
                           .|.+|+..   .|.+|++
T Consensus       849 ~~d~~ey~~~~gK---~pikwma  868 (1177)
T KOG1025|consen  849 APDEKEYSAPGGK---VPIKWMA  868 (1177)
T ss_pred             Ccccccccccccc---cCcHHHH
Confidence                 47677642   5777764

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.81  E-value=5.6e-19  Score=162.03  Aligned_cols=134  Identities=27%  Similarity=0.441  Sum_probs=115.3

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCC
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG  270 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g  270 (359)
                      ..+|.|.|+.+     ..++..+++|.+....   ......+.+|+.+++.++|+||+++++++......+++|||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            34677776533     2367899999885322   234556889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       271 sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|.+++.. ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus       103 ~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~  164 (292)
T cd06657         103 ALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA  164 (292)
T ss_pred             cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccce
Confidence            99998754 46899999999999999999999998   9999999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.81  E-value=3.9e-19  Score=161.79  Aligned_cols=145  Identities=26%  Similarity=0.422  Sum_probs=119.2

Q ss_pred             ccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEecCC
Q 018204          195 ADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       195 ~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      ...+|.|.++.+   ..  .+..+++|.+....... . .....+|+..+..+. ||||+++++++......++||||+ 
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-E-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccch-h-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            345666666533   22  57789999986543321 1 123457899999998 999999999999999999999999 


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          269 KGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       269 ~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +++|.+++....  .+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||+++.         
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            779999887754  6899999999999999999999998   99999999999999999999999998852         


Q ss_pred             -----cccCcccc
Q 018204          338 -----QYISPEKA  345 (359)
Q Consensus       338 -----~~~~PE~~  345 (359)
                           .|++||..
T Consensus       158 ~~~~~~~~aPE~~  170 (283)
T cd07830         158 YVSTRWYRAPEIL  170 (283)
T ss_pred             CCCcccccCceee
Confidence                 37788864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.81  E-value=2.2e-19  Score=179.82  Aligned_cols=168  Identities=30%  Similarity=0.558  Sum_probs=133.3

Q ss_pred             cccCCcceeeEeeccCcccceeEEEEe------------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccc
Q 018204          182 EYELNPLELQVRKADGITKGSYQVAKW------------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVV  248 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~~~------------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv  248 (359)
                      .|+++...+.  ....+|.|.|+.+..            ....||||.+......  ...+.+..|+.+++.+ .||||+
T Consensus       290 ~~e~~~~~l~--~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  290 KWEIPRENLK--LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             ceeechhhcc--ccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchh
Confidence            4444444432  233778888874311            1457999999755433  5667899999999998 599999


Q ss_pred             cceeeEEeCCcEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 018204          249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHC  312 (359)
Q Consensus       249 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHr  312 (359)
                      .+++++...+++++|+||+..|+|..++..++                .++......++.||+.||+||++..   +|||
T Consensus       366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR  442 (609)
T KOG0200|consen  366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR  442 (609)
T ss_pred             hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence            99999999999999999999999999998765                3888999999999999999999998   9999


Q ss_pred             CCCCCcEEEcCCCcEEEecccccccc-----ccCcccccccCCccCCCCC
Q 018204          313 DLKPKNILLDNGGQLKISGFGLLRLQ-----YISPEKAKIVFPVSHIDPA  357 (359)
Q Consensus       313 Dlk~~NIll~~~~~~kl~DFGla~~~-----~~~PE~~~~~~~~~~~~p~  357 (359)
                      ||.++|||+..+..+||+|||+||..     |...-.... .|..|+||-
T Consensus       443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApE  491 (609)
T KOG0200|consen  443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPE  491 (609)
T ss_pred             hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHH
Confidence            99999999999999999999999832     221111112 677788773

>PHA02741 hypothetical protein; Provisional

Probab=99.81  E-value=1.6e-20  Score=158.15  Aligned_cols=111  Identities=21%  Similarity=0.236  Sum_probs=99.0

Q ss_pred             CCCCCCccHHHHHHHcCCHHHHHHHHH------cCCCCCCCCCCCCcHHHHHHHcCC----HHHHHHHHhcCCCcccccc
Q 018204           67 PENLDSTMQLLFMACRGDVKGVEDLLN------EGSDVNSIDLDGRTALHIAACEGH----VEVVKLLLSKKANIDARDR  136 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g~~~~v~~Ll~------~ga~v~~~d~~g~TpLh~A~~~g~----~~~v~~Ll~~ga~~~~~d~  136 (359)
                      .++.+|.||||+||..|+.++|+.|+.      .|+++|.+|..|+||||+|+..|+    .+++++|+++|+++|.+|.
T Consensus        16 ~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~   95 (169)
T PHA02741         16 EKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEM   95 (169)
T ss_pred             ccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCc
Confidence            446789999999999999999999854      378999999999999999999999    5899999999999999995


Q ss_pred             -ccccccccccccccceeEeeccc-cCccc---cccCCCCcccCCC
Q 018204          137 -WGSTAAADAKYYGNVEVYNILKA-RGAKV---PKTKRTPMTVANP  177 (359)
Q Consensus       137 -~g~tpl~~A~~~~~~~~~~~L~~-~ga~~---~~~~~tpl~~a~~  177 (359)
                       .|+||||+|+..++.+++++|+. .|+++   +..+.||++.+..
T Consensus        96 ~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tpL~~A~~  141 (169)
T PHA02741         96 LEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSPFELAID  141 (169)
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCHHHHHHH
Confidence             99999999999999999999997 58887   4456788888743

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1e-19  Score=170.32  Aligned_cols=155  Identities=23%  Similarity=0.315  Sum_probs=125.9

Q ss_pred             eeEeeccCcccceeE----EEEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQ----VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~----~~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      ..|.+.+.+|+|.-.    +.......+|+|.+... ..+......|..|+..|.+| .|.+|+++++|-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            345666677877643    22333466777777543 34677889999999999999 5899999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          265 EYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      ||= ..+|..+|+.... ++.-.++.|..|++.++.++|.++   |||.||||.|+|+. .|.+||+|||+|.       
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence            965 4599999988755 443578899999999999999999   99999999999995 4789999999996       


Q ss_pred             ----------ccccCcccccccCC
Q 018204          337 ----------LQYISPEKAKIVFP  350 (359)
Q Consensus       337 ----------~~~~~PE~~~~~~~  350 (359)
                                +.||+||..+.+-+
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s  538 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSS  538 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccc
Confidence                      36999998876643

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.81  E-value=2.3e-19  Score=167.28  Aligned_cols=140  Identities=29%  Similarity=0.483  Sum_probs=118.2

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC-----cEE
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-----PMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~  261 (359)
                      |.....+|.|.++.+   .  ..++.+++|.+.... .+....+.+..|+.+++.++||||+++++++....     .+|
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            344455677766533   2  347899999986543 22444567899999999999999999999988765     799


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++|||+++ +|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.++|+|||++.
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            99999974 89999988778999999999999999999999998   9999999999999999999999999886

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.81  E-value=5.4e-21  Score=173.05  Aligned_cols=132  Identities=17%  Similarity=0.102  Sum_probs=99.3

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCC----CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCC-CCCCCcHHHHHHHcCC
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPE----NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSI-DLDGRTALHIAACEGH  117 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~-d~~g~TpLh~A~~~g~  117 (359)
                      ++.+++.|+.+.++.+++.|......    +.+|.||||+||..|+.+++++|+++|||+|.+ +..|.||||+|+..|+
T Consensus        37 L~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~  116 (300)
T PHA02884         37 LYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGC  116 (300)
T ss_pred             HHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCC
Confidence            33445567777777777776544333    347888999998889999999999999999886 4678899999988899


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccccccCCCCcccCC
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN  176 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~~tpl~~a~  176 (359)
                      .+++++|+++|||++.+|..|+||||+|+..++.+++.++.  |...+....+|.+...
T Consensus       117 ~eivklLL~~GAdin~kd~~G~TpL~~A~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  173 (300)
T PHA02884        117 LKCLEILLSYGADINIQTNDMVTPIELALMICNNFLAFMIC--DNEISNFYKHPKKILI  173 (300)
T ss_pred             HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHhCChhHHHHhc--CCcccccccChhhhhc
Confidence            99999999889999888888899999888877777664444  4444445555655543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=9.6e-20  Score=173.58  Aligned_cols=154  Identities=29%  Similarity=0.488  Sum_probs=123.9

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      .|.....+|.|+|..++     .+++..++|++.+....       -.+|+.++... +||||+++.+.+.+....|+||
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            34445557888887653     35788999999765322       23566555554 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE-cCCCcEEEecccccc-------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFGLLR-------  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll-~~~~~~kl~DFGla~-------  336 (359)
                      |++.|+-+.+.+.....++ ..+..|+++|+.|+.|||+++   ||||||||+|||+ +..++++|+|||.++       
T Consensus       396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~  471 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD  471 (612)
T ss_pred             hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence            9999999988887765555 788899999999999999998   9999999999999 689999999999986       


Q ss_pred             -----ccccCcccccccCCccCCCCCCC
Q 018204          337 -----LQYISPEKAKIVFPVSHIDPAND  359 (359)
Q Consensus       337 -----~~~~~PE~~~~~~~~~~~~p~~~  359 (359)
                           ..|.|||..+    ..=.+++||
T Consensus       472 tp~~t~~y~APEvl~----~~~yt~acD  495 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLA----IQEYTEACD  495 (612)
T ss_pred             ccchhhcccChhhhc----cCCCCcchh
Confidence                 2588999766    333456665

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.80  E-value=1e-18  Score=159.16  Aligned_cols=138  Identities=31%  Similarity=0.528  Sum_probs=110.7

Q ss_pred             ccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCccccceeeEEeCCc-----EE
Q 018204          195 ADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQNIP-----MM  261 (359)
Q Consensus       195 ~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~-----~~  261 (359)
                      ...+|.|.++.+   ..  +++.+++|.+..... .......+.+|+.++..+   +||||+++++++.....     .+
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            334566665432   32  478999999964433 222234566787777665   69999999999988776     99


Q ss_pred             EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          262 IVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ++|||+.+ +|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+++.
T Consensus        83 l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          83 LVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             EEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence            99999975 8999887643  4899999999999999999999998   99999999999999999999999998853

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.80  E-value=6.3e-19  Score=160.27  Aligned_cols=135  Identities=27%  Similarity=0.513  Sum_probs=113.9

Q ss_pred             CcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          197 GITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       197 ~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      .+|.|.++.+     ..++..+++|.+..... .......+..|+.+++.++|+||+++++++......++++||+++ +
T Consensus         6 ~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~   83 (283)
T cd05118           6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D   83 (283)
T ss_pred             eeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence            3455555422     23588899999865433 223445788899999999999999999999999999999999975 8


Q ss_pred             HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          272 LASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       272 L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +.+++... ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||.+.
T Consensus        84 l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          84 LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             HHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            88888664 57899999999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.80  E-value=1.1e-18  Score=160.12  Aligned_cols=149  Identities=25%  Similarity=0.485  Sum_probs=118.2

Q ss_pred             EeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEe
Q 018204          192 VRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +.....+|.|.++.+   ..  +++.+|||.+.....  ......+..|+.++... .||||+++++++......|++||
T Consensus        17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            344556677776533   33  388999999965432  22344566777766666 59999999999999999999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc------
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~------  337 (359)
                      |+.+ ++.+++.. ...+++..+..++.|++.||.|||+ ++   |+||||+|+||+++.++.+||+|||+++.      
T Consensus        95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            9854 78777765 3568999999999999999999997 46   99999999999999999999999999852      


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|++||...
T Consensus       171 ~~~~~~~~~y~aPE~~~  187 (296)
T cd06618         171 KTRSAGCAAYMAPERID  187 (296)
T ss_pred             ccCCCCCccccCHhhcC
Confidence                    477888654

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA03095 ankyrin-like protein; Provisional

Probab=99.80  E-value=1.8e-20  Score=183.40  Aligned_cols=118  Identities=25%  Similarity=0.280  Sum_probs=63.4

Q ss_pred             ccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC-CHHHHH
Q 018204           47 GRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG-HVEVVK  122 (359)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g---~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g-~~~~v~  122 (359)
                      +..++++.++.++..+......+..|.||||+|+..|   +.+++++|++.|+|+|.+|..|+||||+|+..| +.++++
T Consensus        22 ~~~~~~~~v~~Ll~~ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~  101 (471)
T PHA03095         22 ASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIK  101 (471)
T ss_pred             CCCCCHHHHHHHHHcCCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHH
Confidence            3444455555555444333333445555555555555   555555555555555555555555555555555 355555


Q ss_pred             HHHhcCCCcccccccccccccccc--ccccceeEeeccccCccc
Q 018204          123 LLLSKKANIDARDRWGSTAAADAK--YYGNVEVYNILKARGAKV  164 (359)
Q Consensus       123 ~Ll~~ga~~~~~d~~g~tpl~~A~--~~~~~~~~~~L~~~ga~~  164 (359)
                      +|+++|+++|.+|..|.||||+|+  ..++.+++++|+++|+++
T Consensus       102 lLl~~ga~in~~~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~  145 (471)
T PHA03095        102 LLIKAGADVNAKDKVGRTPLHVYLSGFNINPKVIRLLLRKGADV  145 (471)
T ss_pred             HHHHcCCCCCCCCCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCC
Confidence            555555555555555555555555  333445555555555554

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.80  E-value=2.2e-20  Score=179.78  Aligned_cols=128  Identities=24%  Similarity=0.245  Sum_probs=116.3

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCH
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~  118 (359)
                      ....+..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.
T Consensus       102 g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~  181 (413)
T PHA02875        102 GMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDI  181 (413)
T ss_pred             CCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCH
Confidence            34445566778888888888888766666688999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCCCccccccccc-cccccccccccceeEeeccccCccccc
Q 018204          119 EVVKLLLSKKANIDARDRWGS-TAAADAKYYGNVEVYNILKARGAKVPK  166 (359)
Q Consensus       119 ~~v~~Ll~~ga~~~~~d~~g~-tpl~~A~~~~~~~~~~~L~~~ga~~~~  166 (359)
                      +++++|+++|++++..+..|. ||+|+|+..|+.+++++|+++|++++.
T Consensus       182 eiv~~Ll~~ga~~n~~~~~~~~t~l~~A~~~~~~~iv~~Ll~~gad~n~  230 (413)
T PHA02875        182 AICKMLLDSGANIDYFGKNGCVAALCYAIENNKIDIVRLFIKRGADCNI  230 (413)
T ss_pred             HHHHHHHhCCCCCCcCCCCCCchHHHHHHHcCCHHHHHHHHHCCcCcch
Confidence            999999999999999999885 889999999999999999999999854

>PHA02946 ankyin-like protein; Provisional

Probab=99.80  E-value=2.4e-20  Score=180.17  Aligned_cols=124  Identities=18%  Similarity=0.128  Sum_probs=92.0

Q ss_pred             CCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHhcC
Q 018204           51 SLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG--HVEVVKLLLSKK  128 (359)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g--~~~~v~~Ll~~g  128 (359)
                      +.+.++.++..+......|.+|.||||+||..|+.++|++||++|||+|.+|..|+||||+|+..+  ..+++++|+++|
T Consensus        51 ~~~iv~~Ll~~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~G  130 (446)
T PHA02946         51 DERFVEELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYG  130 (446)
T ss_pred             CHHHHHHHHHCcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcC
Confidence            344566666666555556888888888888888888888888888888888888888888888765  477888888888


Q ss_pred             CCccc-cccccccccccccccccceeEeeccccCccc---cccCCCCcccC
Q 018204          129 ANIDA-RDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA  175 (359)
Q Consensus       129 a~~~~-~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a  175 (359)
                      |++|. .|..|.|||| |+..++.+++++|+++|+++   +..++||++.+
T Consensus       131 adin~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~G~t~Lh~A  180 (446)
T PHA02946        131 AKINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKFGKNHIHRH  180 (446)
T ss_pred             CCcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCCCCCCHHHHH
Confidence            88874 5777777776 44456677777777777765   33455666543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=8.8e-19  Score=150.50  Aligned_cols=135  Identities=17%  Similarity=0.161  Sum_probs=101.8

Q ss_pred             CcccceeEEE---E-ecCcEEEEEEeccCCCCc---------------------HH--HHHHHHHHHHHHHhCCCCcccc
Q 018204          197 GITKGSYQVA---K-WNGTKVWVKILDKESHKD---------------------PE--RINAFTHELTIVEKARHPNVVQ  249 (359)
Q Consensus       197 ~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~---------------------~~--~~~~~~~Ei~il~~l~HpnIv~  249 (359)
                      .+|.|+++.+   . .+|+.+|||++.......                     ..  ....+..|...+..+.|+++..
T Consensus         4 ~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (190)
T cd05145           4 CISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPV   83 (190)
T ss_pred             eeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            3566666533   2 268999999997653210                     00  1123467899999999998865


Q ss_pred             ceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEE
Q 018204          250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLK  328 (359)
Q Consensus       250 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~k  328 (359)
                      ...+....  .++||||++|+++.........++...+..++.|++.++.++|+ .+   |+||||||+|||++ ++.++
T Consensus        84 p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          84 PEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             ceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEE
Confidence            55444332  48999999987654443334568888999999999999999999 88   99999999999999 88999


Q ss_pred             Eeccccccc
Q 018204          329 ISGFGLLRL  337 (359)
Q Consensus       329 l~DFGla~~  337 (359)
                      |+|||+|+.
T Consensus       158 liDFG~a~~  166 (190)
T cd05145         158 IIDVSQAVE  166 (190)
T ss_pred             EEEccccee
Confidence            999999973

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.80  E-value=5.9e-19  Score=165.55  Aligned_cols=149  Identities=30%  Similarity=0.464  Sum_probs=119.5

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC------c
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------P  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~  259 (359)
                      .|.....+|.|.|+.+     ...|..+|+|.+..... .......+.+|+.+++.++||||+++++++....      .
T Consensus        16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4555566777777643     23588999999865322 2223346788999999999999999999887543      4


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .++|+||+.. +|..++.  ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.  
T Consensus        95 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             EEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            6999999964 7777653  35899999999999999999999998   99999999999999999999999999863  


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|++||...
T Consensus       169 ~~~~~~~~~~~y~aPE~~~  187 (342)
T cd07879         169 AEMTGYVVTRWYRAPEVIL  187 (342)
T ss_pred             CCCCCceeeecccChhhhc
Confidence                      378899754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.80  E-value=2.5e-20  Score=186.49  Aligned_cols=124  Identities=14%  Similarity=0.141  Sum_probs=73.2

Q ss_pred             CCCcCcCCcccccCCCCCCCCCccHHHHHHHcCC--HHHHHHHHHcCCCCCCCCCCCCcHHHHH----------------
Q 018204           51 SLDPIRRSPVQDELTVPENLDSTMQLLFMACRGD--VKGVEDLLNEGSDVNSIDLDGRTALHIA----------------  112 (359)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~--~~~v~~Ll~~ga~v~~~d~~g~TpLh~A----------------  112 (359)
                      +.+.++.+++.+......|.+|.||||+||..|+  .++|++||++|||||.+|..|+||||+|                
T Consensus       191 ~~eIVklLLe~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLi  270 (764)
T PHA02716        191 DIDILEWLCNNGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYI  270 (764)
T ss_pred             CHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHH
Confidence            3445555555544444445666666666666663  3666666666666666666666666643                


Q ss_pred             ---------------------HHcCCHHHHHHHHhcCCCcccccccccccccccc--ccccceeEeeccccCcccc---c
Q 018204          113 ---------------------ACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK--YYGNVEVYNILKARGAKVP---K  166 (359)
Q Consensus       113 ---------------------~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~--~~~~~~~~~~L~~~ga~~~---~  166 (359)
                                           |..|+.++|++|+++|+++|.+|..|+||||+|+  .+++.+++++|+++|++++   .
T Consensus       271 e~~d~n~~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~  350 (764)
T PHA02716        271 ESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDN  350 (764)
T ss_pred             HhccccccccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCC
Confidence                                 2345566666666666666666666666666654  2345566666666666653   3


Q ss_pred             cCCCCccc
Q 018204          167 TKRTPMTV  174 (359)
Q Consensus       167 ~~~tpl~~  174 (359)
                      .++||++.
T Consensus       351 ~G~TPLH~  358 (764)
T PHA02716        351 IGNTVLHT  358 (764)
T ss_pred             CCCCHHHH
Confidence            34566654

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.79  E-value=4.8e-20  Score=166.91  Aligned_cols=109  Identities=18%  Similarity=0.150  Sum_probs=95.9

Q ss_pred             CCCCCCccHHHH-HHHcCCHHHHHHHHHcCCCCCCCC----CCCCcHHHHHHHcCCHHHHHHHHhcCCCcccc-cccccc
Q 018204           67 PENLDSTMQLLF-MACRGDVKGVEDLLNEGSDVNSID----LDGRTALHIAACEGHVEVVKLLLSKKANIDAR-DRWGST  140 (359)
Q Consensus        67 ~~~~~~~t~l~~-aa~~g~~~~v~~Ll~~ga~v~~~d----~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~-d~~g~t  140 (359)
                      .+|.+|+|++++ |+..|+.++|++|+++|||+|.+|    ..|.||||+|+..|+.+++++|+++|||+|.+ +..|.|
T Consensus        27 ~~d~~~~~~lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~T  106 (300)
T PHA02884         27 KKNKICIANILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKIT  106 (300)
T ss_pred             ccCcCCCCHHHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCC
Confidence            346677775555 555689999999999999999974    69999999999999999999999999999996 468999


Q ss_pred             ccccccccccceeEeeccccCccccc---cCCCCcccC
Q 018204          141 AAADAKYYGNVEVYNILKARGAKVPK---TKRTPMTVA  175 (359)
Q Consensus       141 pl~~A~~~~~~~~~~~L~~~ga~~~~---~~~tpl~~a  175 (359)
                      |||+|+..++.+++++|+.+|++++.   .+.||++.|
T Consensus       107 pLh~Aa~~~~~eivklLL~~GAdin~kd~~G~TpL~~A  144 (300)
T PHA02884        107 PLYISVLHGCLKCLEILLSYGADINIQTNDMVTPIELA  144 (300)
T ss_pred             HHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence            99999999999999999999999854   467898877

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.79  E-value=2.8e-20  Score=180.04  Aligned_cols=135  Identities=24%  Similarity=0.305  Sum_probs=114.5

Q ss_pred             CcceeeccCCCCCcCcCCccccc-----------------------CCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCC
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDE-----------------------LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD   97 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~   97 (359)
                      ..++.++..|+.+.++.+++.+.                       .....+.+|.||||+|+..|+.++|++|++.|+|
T Consensus        70 t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ll~~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad  149 (434)
T PHA02874         70 HPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGAD  149 (434)
T ss_pred             CHHHHHHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHHHHHCcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCC
Confidence            34455666777666666655432                       2233477899999999999999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCccc
Q 018204           98 VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTV  174 (359)
Q Consensus        98 v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~  174 (359)
                      +|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||++.
T Consensus       150 ~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~tpL~~A~~~g~~~iv~~Ll~~g~~i~~~~~~g~TpL~~  229 (434)
T PHA02874        150 VNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHN  229 (434)
T ss_pred             CCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCcCCCCCCCCHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999873   456788777


Q ss_pred             C
Q 018204          175 A  175 (359)
Q Consensus       175 a  175 (359)
                      +
T Consensus       230 A  230 (434)
T PHA02874        230 A  230 (434)
T ss_pred             H
Confidence            6

>KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms]

Probab=99.79  E-value=1.9e-20  Score=173.98  Aligned_cols=95  Identities=24%  Similarity=0.299  Sum_probs=79.0

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      -..+.+|.+|+.+.++.++..+......|.||.|+||-++...+.+||++|+++|++||.+|..||||||.|+.+||..+
T Consensus        42 a~~l~A~~~~d~~ev~~ll~~ga~~~~~n~DglTalhq~~id~~~e~v~~l~e~ga~Vn~~d~e~wtPlhaaascg~~~i  121 (527)
T KOG0505|consen   42 AVFLEACSRGDLEEVRKLLNRGASPNLCNVDGLTALHQACIDDNLEMVKFLVENGANVNAQDNEGWTPLHAAASCGYLNI  121 (527)
T ss_pred             HHHHhccccccHHHHHHHhccCCCccccCCccchhHHHHHhcccHHHHHHHHHhcCCccccccccCCcchhhcccccHHH
Confidence            34567888899999999888887777778889999999999999999999999999999999999999999988888888


Q ss_pred             HHHHHhcCCCccccc
Q 018204          121 VKLLLSKKANIDARD  135 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d  135 (359)
                      |++|+.+||++-+.|
T Consensus       122 ~~~li~~gA~~~avN  136 (527)
T KOG0505|consen  122 VEYLIQHGANLLAVN  136 (527)
T ss_pred             HHHHHHhhhhhhhcc
Confidence            888888877544333

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.79  E-value=2.4e-20  Score=154.75  Aligned_cols=99  Identities=22%  Similarity=0.243  Sum_probs=92.2

Q ss_pred             CCCCCCccHHHHHHHcCCHH---HHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHhc-CCCccccccccccc
Q 018204           67 PENLDSTMQLLFMACRGDVK---GVEDLLNEGSDVNSID-LDGRTALHIAACEGHVEVVKLLLSK-KANIDARDRWGSTA  141 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g~~~---~v~~Ll~~ga~v~~~d-~~g~TpLh~A~~~g~~~~v~~Ll~~-ga~~~~~d~~g~tp  141 (359)
                      ..|.+|.||||+||..|+.+   ++++|++.|+|+|.+| ..|+||||+|+..|+.+++++|+.. |+|++.+|..|.||
T Consensus        50 ~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tp  129 (154)
T PHA02736         50 EYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTP  129 (154)
T ss_pred             HhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCH
Confidence            34778999999999999874   6899999999999998 5999999999999999999999984 99999999999999


Q ss_pred             cccccccccceeEeeccccCcccc
Q 018204          142 AADAKYYGNVEVYNILKARGAKVP  165 (359)
Q Consensus       142 l~~A~~~~~~~~~~~L~~~ga~~~  165 (359)
                      ||+|+..|+.+++++|+++|++.+
T Consensus       130 L~~A~~~~~~~i~~~Ll~~ga~~~  153 (154)
T PHA02736        130 YYVACERHDAKMMNILRAKGAQCK  153 (154)
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCC
Confidence            999999999999999999998764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.79  E-value=1.4e-18  Score=162.13  Aligned_cols=149  Identities=27%  Similarity=0.445  Sum_probs=121.4

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe-CCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~  264 (359)
                      .|.....+|.|.|+.+     ...++.+++|.+..... .......+..|+.+++.++||||+++++++.. ....++++
T Consensus        11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             ceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            4555666777777643     23688999998864332 22334567889999999999999999998875 45789999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      ||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||+++.       
T Consensus        90 e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  164 (328)
T cd07856          90 ELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG  164 (328)
T ss_pred             ehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence            999 5689888864 35888889999999999999999998   99999999999999999999999998852       


Q ss_pred             -----cccCcccc
Q 018204          338 -----QYISPEKA  345 (359)
Q Consensus       338 -----~~~~PE~~  345 (359)
                           .|++||..
T Consensus       165 ~~~~~~y~aPE~~  177 (328)
T cd07856         165 YVSTRYYRAPEIM  177 (328)
T ss_pred             CcccccccCceee
Confidence                 47888864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.79  E-value=2.6e-21  Score=189.73  Aligned_cols=128  Identities=28%  Similarity=0.319  Sum_probs=76.7

Q ss_pred             cCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcC--CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH
Q 018204           48 RQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRG--DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL  125 (359)
Q Consensus        48 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g--~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll  125 (359)
                      ..|+.+.++.+++.+......+.+|.||||+|+..|  +.+++++|+++|+|+|.+|..|+||||+|+..|+.+++++|+
T Consensus       117 ~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll  196 (480)
T PHA03100        117 KSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIAVEKGNIDVIKFLL  196 (480)
T ss_pred             ccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHHHHhCCHHHHHHHH
Confidence            555555555555554444444556666666666666  666666666666666666666666666666666666666666


Q ss_pred             hcCCCcccccccc------cccccccccccc--ceeEeeccccCcccc---ccCCCCcccC
Q 018204          126 SKKANIDARDRWG------STAAADAKYYGN--VEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       126 ~~ga~~~~~d~~g------~tpl~~A~~~~~--~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      ++|++++..+..|      .||||+|+..++  .+++++|+++|++++   ..+.||++.|
T Consensus       197 ~~ga~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din~~d~~g~TpL~~A  257 (480)
T PHA03100        197 DNGADINAGDIETLLFTIFETPLHIAACYNEITLEVVNYLLSYGVPINIKDVYGFTPLHYA  257 (480)
T ss_pred             HcCCCccCCCCCCCcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence            6666666666655      566666666666  666666666666542   3345566555

>PHA02795 ankyrin-like protein; Provisional

Probab=99.79  E-value=1.7e-20  Score=176.37  Aligned_cols=127  Identities=18%  Similarity=0.084  Sum_probs=92.2

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCC------CCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPEN------LDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g  116 (359)
                      .+.++..++.+.++-++..+..+.+..      ..+.|++|.|+..|+.+++++|+++|||+|.+|..|+||||+|+..|
T Consensus       153 lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g  232 (437)
T PHA02795        153 YFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAG  232 (437)
T ss_pred             HHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcC
Confidence            334444566666666666664333221      23677788888888888888888888888888888888888888888


Q ss_pred             CHHHHHHHHhcCCCcccccccccccccccccccc--------ceeEeeccccCccccccCC
Q 018204          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN--------VEVYNILKARGAKVPKTKR  169 (359)
Q Consensus       117 ~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~--------~~~~~~L~~~ga~~~~~~~  169 (359)
                      +.++|++|+++|||+|.+|..|+||||+|+..|+        .+++++|+++|++++....
T Consensus       233 ~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g~~~~~~~~~~eIvelLL~~gadI~~~~~  293 (437)
T PHA02795        233 YIDLVSWLLENGANVNAVMSNGYTCLDVAVDRGSVIARRETHLKILEILLREPLSIDCIKL  293 (437)
T ss_pred             CHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCcccccccHHHHHHHHHhCCCCCCchhH
Confidence            8888888888888888888888888888877763        5788888888887765443

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.79  E-value=7.1e-19  Score=165.06  Aligned_cols=150  Identities=27%  Similarity=0.429  Sum_probs=122.1

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc------
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP------  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~------  259 (359)
                      .|.....+|.|.++.+   .  ..+..+++|.+.... ......+.+.+|+.+++.++||||+++++++.....      
T Consensus        16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            3555556677776543   2  257889999886432 233344567889999999999999999988776554      


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..  
T Consensus        95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccc
Confidence            89999999 5699999875 46999999999999999999999998   99999999999999999999999999863  


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|++||...
T Consensus       170 ~~~~~~~~~~~y~aPE~~~  188 (343)
T cd07851         170 DEMTGYVATRWYRAPEIML  188 (343)
T ss_pred             ccccCCcccccccCHHHHh
Confidence                      378888653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.79  E-value=3.1e-20  Score=179.71  Aligned_cols=138  Identities=20%  Similarity=0.178  Sum_probs=120.9

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcC-----------------------
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG-----------------------   95 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~g-----------------------   95 (359)
                      ....+..++..|+.+.++.+++.+......+..|.||||.|+..|+.+++++|+++|                       
T Consensus        35 ~~tpL~~A~~~g~~~iv~~Ll~~Ga~~n~~~~~~~t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~~i~~ll~~g  114 (434)
T PHA02874         35 TTTPLIDAIRSGDAKIVELFIKHGADINHINTKIPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKDMIKTILDCG  114 (434)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcchhccCCHHHHHHHHHCc
Confidence            445566778899999999988877655566888999999999999999999998766                       


Q ss_pred             CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCc
Q 018204           96 SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPM  172 (359)
Q Consensus        96 a~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl  172 (359)
                      +|+|.+|..|.||||+|+..|+.++|++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||+
T Consensus       115 ~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~tpL  194 (434)
T PHA02874        115 IDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGESPL  194 (434)
T ss_pred             CCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHH
Confidence            4577889999999999999999999999999999999999999999999999999999999999999874   4567888


Q ss_pred             ccCC
Q 018204          173 TVAN  176 (359)
Q Consensus       173 ~~a~  176 (359)
                      +.|.
T Consensus       195 ~~A~  198 (434)
T PHA02874        195 HNAA  198 (434)
T ss_pred             HHHH
Confidence            8873

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=1.1e-18  Score=154.46  Aligned_cols=150  Identities=22%  Similarity=0.333  Sum_probs=127.8

Q ss_pred             cceeeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcE
Q 018204          187 PLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       187 ~~~~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~  260 (359)
                      .....|++++++|.|.|++.     ..+++.||||.-......     ..+..|.+..+.|. .++|...|-+.....+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            34567899999999999864     457899999987554432     24677888888885 68999988777778888


Q ss_pred             EEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-----cEEEecccc
Q 018204          261 MIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-----QLKISGFGL  334 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-----~~kl~DFGl  334 (359)
                      .+|+|++ |.||.+++.-++ .++.+++..++.|++.-++|+|++.   +|+|||||+|+||...+     .+.|+|||+
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence            9999988 789999998775 5999999999999999999999999   99999999999998654     499999999


Q ss_pred             ccccccCccccc
Q 018204          335 LRLQYISPEKAK  346 (359)
Q Consensus       335 a~~~~~~PE~~~  346 (359)
                      |+ .|++|++.+
T Consensus       176 AK-~YrDp~Tkq  186 (449)
T KOG1165|consen  176 AK-EYRDPKTKQ  186 (449)
T ss_pred             hh-hhcCccccc
Confidence            99 899998765

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.78  E-value=2.7e-20  Score=177.35  Aligned_cols=151  Identities=28%  Similarity=0.492  Sum_probs=130.8

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|+|+|+-+     ...++..|+|+++.....+.   .....|+-+++.++||||+.+++.+.....+|++||
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~---~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF---SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeeccCCccc---cccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3444556788888733     35688999999987665443   346789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      ||.||+|++.-+-.+++++.++..+.++.++||+|||+.+   =+|||||=.|||++..|.+|++|||.+.         
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence            9999999999888889999999999999999999999998   8999999999999999999999999984         


Q ss_pred             ------ccccCcccccc
Q 018204          337 ------LQYISPEKAKI  347 (359)
Q Consensus       337 ------~~~~~PE~~~~  347 (359)
                            .+||+||.+.+
T Consensus       170 ksfiGtpywmapEvaav  186 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAV  186 (829)
T ss_pred             hcccCCccccchhHHHH
Confidence                  35788876553

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.78  E-value=1.1e-18  Score=156.89  Aligned_cols=140  Identities=29%  Similarity=0.461  Sum_probs=111.0

Q ss_pred             eeccCcccceeEEEE-----ecCcEEEEEEeccCCC--CcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          193 RKADGITKGSYQVAK-----WNGTKVWVKILDKESH--KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       193 ~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .....+|.|+|+.+.     ..+..+++|++.....  ........+..|+.+++.++||||+++++++......++++|
T Consensus         3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (260)
T cd08222           3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE   82 (260)
T ss_pred             eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence            344567777776432     2244566666543221  112223456779999999999999999999998889999999


Q ss_pred             cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++|+||||+||+++. +.++|+|||+++
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~  153 (260)
T cd08222          83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSR  153 (260)
T ss_pred             eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCcee
Confidence            9999999998864    345899999999999999999999998   999999999999975 569999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.78  E-value=1.1e-18  Score=163.82  Aligned_cols=139  Identities=29%  Similarity=0.445  Sum_probs=113.6

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-------
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-------  257 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-------  257 (359)
                      ..|.....+|.|.|+.+     ..+|..+++|.+.....   ...+.+.+|+.+++.++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            35666667788877644     23578999999865432   3445688899999999999999999776543       


Q ss_pred             -------CcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEE
Q 018204          258 -------IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKI  329 (359)
Q Consensus       258 -------~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl  329 (359)
                             ...|++|||++ ++|.+++.. ..+++..+..++.|++.||.|||+++   |+||||||+||+++. ++.+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence                   35799999997 489888864 46899999999999999999999998   999999999999985 557899


Q ss_pred             ecccccc
Q 018204          330 SGFGLLR  336 (359)
Q Consensus       330 ~DFGla~  336 (359)
                      +|||+++
T Consensus       157 ~dfg~~~  163 (342)
T cd07854         157 GDFGLAR  163 (342)
T ss_pred             CCcccce
Confidence            9999885

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.78  E-value=3.8e-20  Score=181.48  Aligned_cols=137  Identities=28%  Similarity=0.353  Sum_probs=121.1

Q ss_pred             CCCcceeeccCC--CCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCC------CcHHH
Q 018204           39 RNNMRFSFGRQS--SLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDG------RTALH  110 (359)
Q Consensus        39 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g------~TpLh  110 (359)
                      .......++..|  +.+.++.+++.+......+.+|.||||+|+..|+.+++++|+++|++++..+..|      .||||
T Consensus       141 g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~~t~l~  220 (480)
T PHA03100        141 GENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIETLLFTIFETPLH  220 (480)
T ss_pred             CCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCCCCcHHHHHhHHH
Confidence            334445556677  7777888887776656668899999999999999999999999999999999999      99999


Q ss_pred             HHHHcCC--HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          111 IAACEGH--VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       111 ~A~~~g~--~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +|+..|+  .++|++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||++.|
T Consensus       221 ~a~~~~~~~~~iv~~Ll~~g~din~~d~~g~TpL~~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpl~~A  290 (480)
T PHA03100        221 IAACYNEITLEVVNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIA  290 (480)
T ss_pred             HHHHhCcCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHH
Confidence            9999999  999999999999999999999999999999999999999999999884   4567888877

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.78  E-value=3.7e-19  Score=153.46  Aligned_cols=151  Identities=20%  Similarity=0.345  Sum_probs=121.2

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceee-EEeCCcEEE
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGA-VTQNIPMMI  262 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~~~~~~l  262 (359)
                      -.|.+.+.+|.|-|+..     +.+...+++|.+...    .....+|.+|...--.|. |.||+.-|++ |...+.+.+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            35777888999999843     345678899988542    335567999988776674 7899987765 667788899


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC--CcEEEeccccccc---
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG--GQLKISGFGLLRL---  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~--~~~kl~DFGla~~---  337 (359)
                      ++||++.|+|.+-+... .+-+.....++.|++.||.|||+++   +||||||.+||||-..  -.+||||||+++.   
T Consensus       100 ~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            99999999999887653 5888889999999999999999999   9999999999999543  3799999999973   


Q ss_pred             ---------cccCccccccc
Q 018204          338 ---------QYISPEKAKIV  348 (359)
Q Consensus       338 ---------~~~~PE~~~~~  348 (359)
                               .|.+||.....
T Consensus       176 tV~~~~~~~~y~~pe~~~~~  195 (378)
T KOG1345|consen  176 TVKYLEYVNNYHAPELCDTV  195 (378)
T ss_pred             eehhhhhhcccCCcHHHhhc
Confidence                     47778765543

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.78  E-value=7.5e-20  Score=183.11  Aligned_cols=132  Identities=19%  Similarity=0.176  Sum_probs=111.1

Q ss_pred             cceeeccCCCC--CcCcCCcccccCCCCCCCCCccHHHHH-------------------------------------HHc
Q 018204           42 MRFSFGRQSSL--DPIRRSPVQDELTVPENLDSTMQLLFM-------------------------------------ACR   82 (359)
Q Consensus        42 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~t~l~~a-------------------------------------a~~   82 (359)
                      .+..+++.|..  +.++.+++.+.....++.+|+||||+|                                     |..
T Consensus       215 PLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~i~AA~~  294 (764)
T PHA02716        215 PLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIPMILHSYITLARN  294 (764)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccccchhhhHHHHHHHHc
Confidence            34455566754  557777777766566688999999975                                     456


Q ss_pred             CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH--cCCHHHHHHHHhcCCCccccccccccccccccc-------------
Q 018204           83 GDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC--EGHVEVVKLLLSKKANIDARDRWGSTAAADAKY-------------  147 (359)
Q Consensus        83 g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~--~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~-------------  147 (359)
                      |+.++|++|++.|+++|.+|..|+||||+|+.  +++.++|++|+++|||+|.+|..|+||||+|+.             
T Consensus       295 g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~~G~TPLH~A~~~lav~~~ld~~~~  374 (764)
T PHA02716        295 IDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVLHTYLSMLSVVNILDPETD  374 (764)
T ss_pred             CCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCCCCCCHHHHHHHhhhhhcccccccc
Confidence            89999999999999999999999999999864  568999999999999999999999999998754             


Q ss_pred             -cccceeEeeccccCccc---cccCCCCcc
Q 018204          148 -YGNVEVYNILKARGAKV---PKTKRTPMT  173 (359)
Q Consensus       148 -~~~~~~~~~L~~~ga~~---~~~~~tpl~  173 (359)
                       .++.+++++|+++|+++   +..+.||++
T Consensus       375 ~~~~~eVVklLL~~GADIn~kn~~G~TPLh  404 (764)
T PHA02716        375 NDIRLDVIQCLISLGADITAVNCLGYTPLT  404 (764)
T ss_pred             ccChHHHHHHHHHCCCCCCCcCCCCCChHH
Confidence             36789999999999998   455789997

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=2.4e-18  Score=149.08  Aligned_cols=132  Identities=14%  Similarity=0.207  Sum_probs=100.2

Q ss_pred             eccCcccceeEEEEe---cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-----CCCccccceeeEEeCC---c-EE
Q 018204          194 KADGITKGSYQVAKW---NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-----RHPNVVQFVGAVTQNI---P-MM  261 (359)
Q Consensus       194 ~~~~ig~g~~~~~~~---~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~-~~  261 (359)
                      ....+|+|+++.+..   .+.. +||++.....   ...+.+.+|+.+++.+     .||||+++++++.++.   . +.
T Consensus         6 ~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          6 EQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CcceecCCCceEEEECCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            345678888886632   2333 6887754322   2335689999999999     5799999999999873   3 33


Q ss_pred             EEEec--CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeCCCCCCcEEEcCC----CcEEEecccc
Q 018204          262 IVLEY--HAKGDLASYLQKKGRLSPSKVLRFALDLARGM-NYLHECKPDPIIHCDLKPKNILLDNG----GQLKISGFGL  334 (359)
Q Consensus       262 lv~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL-~~lH~~~~~~iiHrDlk~~NIll~~~----~~~kl~DFGl  334 (359)
                      +|+||  +++++|.+++++. .+++.  ..++.|++.++ +|||+++   ||||||||+|||++..    +.++|+||+.
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            78999  5579999999764 46655  35678888888 9999999   9999999999999743    3799999444


Q ss_pred             c
Q 018204          335 L  335 (359)
Q Consensus       335 a  335 (359)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            4

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.78  E-value=3.8e-18  Score=156.67  Aligned_cols=143  Identities=17%  Similarity=0.216  Sum_probs=104.2

Q ss_pred             eeEeeccCcccceeEEE---Ee--c---CcEEEEEEeccCCCCcHHH--------HHHHHHHHHHHHhCCCCccccceee
Q 018204          190 LQVRKADGITKGSYQVA---KW--N---GTKVWVKILDKESHKDPER--------INAFTHELTIVEKARHPNVVQFVGA  253 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~---~~--~---g~~vavK~l~~~~~~~~~~--------~~~~~~Ei~il~~l~HpnIv~l~~~  253 (359)
                      ..|...+.+|+|+|+.+   ..  .   +..+++|+...........        ......+...+..+.|++|++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            45777778899999854   22  1   3456666543222111000        0112233445566789999999987


Q ss_pred             EEeCC----cEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEE
Q 018204          254 VTQNI----PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI  329 (359)
Q Consensus       254 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl  329 (359)
                      +....    ..++++|++.. ++.+.+......++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence            66543    35788888754 77777776555788889999999999999999998   999999999999999999999


Q ss_pred             ecccccc
Q 018204          330 SGFGLLR  336 (359)
Q Consensus       330 ~DFGla~  336 (359)
                      +|||+|+
T Consensus       168 ~DFGla~  174 (294)
T PHA02882        168 IDYGIAS  174 (294)
T ss_pred             EEcCCce
Confidence            9999985

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.77  E-value=3e-19  Score=157.26  Aligned_cols=132  Identities=27%  Similarity=0.417  Sum_probs=112.6

Q ss_pred             ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC------cEEEEEecCCCCCHHHHHHhcCC
Q 018204          208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------PMMIVLEYHAKGDLASYLQKKGR  281 (359)
Q Consensus       208 ~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~  281 (359)
                      -.+..+++|.+... .......+...+|..++..++|+||++++.+|....      ..|+|||++.. +|...+..  .
T Consensus        39 v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~--e  114 (369)
T KOG0665|consen   39 VLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILM--E  114 (369)
T ss_pred             hccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHH--h
Confidence            35788999988655 333444456789999999999999999999987543      58999999965 99998874  4


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------------cccCccccc
Q 018204          282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------QYISPEKAK  346 (359)
Q Consensus       282 l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------------~~~~PE~~~  346 (359)
                      +.-.++..++.|++.|++|||+.+   |+||||||+||++..++.+||.|||+|+.              +|.+||.+=
T Consensus       115 lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil  190 (369)
T KOG0665|consen  115 LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVIL  190 (369)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchhee
Confidence            778899999999999999999999   99999999999999999999999999972              588998643

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.77  E-value=4.4e-18  Score=165.34  Aligned_cols=153  Identities=20%  Similarity=0.325  Sum_probs=113.7

Q ss_pred             eEeeccCcccceeEEEE---------------------ecCcEEEEEEeccCCCCcHH-----------HHHHHHHHHHH
Q 018204          191 QVRKADGITKGSYQVAK---------------------WNGTKVWVKILDKESHKDPE-----------RINAFTHELTI  238 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---------------------~~g~~vavK~l~~~~~~~~~-----------~~~~~~~Ei~i  238 (359)
                      +|...+.+|+|.|+.+.                     ..+..||||.+.........           ..+.+..|+.+
T Consensus       146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~  225 (507)
T PLN03224        146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM  225 (507)
T ss_pred             CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence            46666778999988542                     23467999998643221111           01223456777


Q ss_pred             HHhCCCCcc-----ccceeeEEe--------CCcEEEEEecCCCCCHHHHHHhcC------------------------C
Q 018204          239 VEKARHPNV-----VQFVGAVTQ--------NIPMMIVLEYHAKGDLASYLQKKG------------------------R  281 (359)
Q Consensus       239 l~~l~HpnI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~------------------------~  281 (359)
                      +.+++|.++     ++++++|..        ....++|+||+++++|.++++...                        .
T Consensus       226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~  305 (507)
T PLN03224        226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK  305 (507)
T ss_pred             HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence            777766554     566666643        356899999999999999886421                        1


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------------ccccCcccc
Q 018204          282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------------LQYISPEKA  345 (359)
Q Consensus       282 l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------------~~~~~PE~~  345 (359)
                      +++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++                ..|++||..
T Consensus       306 ~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        306 RDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            356678899999999999999998   9999999999999999999999999984                248999976


Q ss_pred             c
Q 018204          346 K  346 (359)
Q Consensus       346 ~  346 (359)
                      .
T Consensus       383 ~  383 (507)
T PLN03224        383 V  383 (507)
T ss_pred             c
Confidence            5

>PHA02798 ankyrin-like protein; Provisional

Probab=99.77  E-value=1.2e-19  Score=178.19  Aligned_cols=126  Identities=17%  Similarity=0.206  Sum_probs=111.1

Q ss_pred             CCCCCcCcCCcccccCCCCCCCCCccHHHHHHHc-----CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC---CHHH
Q 018204           49 QSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR-----GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG---HVEV  120 (359)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~-----g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g---~~~~  120 (359)
                      .++.+.++.+++.+......+.+|.||||.|+.+     ++.+++++|+++|||+|.+|..|+||||+|+.+|   +.++
T Consensus        48 ~~~~~iv~~Ll~~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~i  127 (489)
T PHA02798         48 SPSTDIVKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEI  127 (489)
T ss_pred             CCCHHHHHHHHHCCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHH
Confidence            4567778888887776666789999999999864     7899999999999999999999999999999986   7899


Q ss_pred             HHHHHhcCCCcccccccccccccccccccc---ceeEeeccccCcccccc----CCCCccc
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGN---VEVYNILKARGAKVPKT----KRTPMTV  174 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~---~~~~~~L~~~ga~~~~~----~~tpl~~  174 (359)
                      +++|+++|||++.+|..|.||||+|+..++   .+++++|+++|++++..    +.||++.
T Consensus       128 v~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~~~~~~~t~Lh~  188 (489)
T PHA02798        128 LLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTHNNKEKYDTLHC  188 (489)
T ss_pred             HHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccccCcCCCcHHHH
Confidence            999999999999999999999999999887   89999999999998543    4567653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.77  E-value=3.3e-18  Score=181.37  Aligned_cols=141  Identities=23%  Similarity=0.413  Sum_probs=114.5

Q ss_pred             ccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          195 ADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       195 ~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      ...+|+|.|+.+   .  ..+..+|+|.+......       ...|+..+++++||||+++++++......|+||||+++
T Consensus       695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            345788887744   2  46889999998643321       12467889999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-----------cc
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-----------LQ  338 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-----------~~  338 (359)
                      |+|.++++.   +++..+..++.|++.||+|||.....+|+||||||+||+++.++..++. ||.++           ..
T Consensus       768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~  843 (968)
T PLN00113        768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA  843 (968)
T ss_pred             CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCcccccc
Confidence            999999963   8899999999999999999995533349999999999999998887765 55542           46


Q ss_pred             ccCccccc
Q 018204          339 YISPEKAK  346 (359)
Q Consensus       339 ~~~PE~~~  346 (359)
                      |+|||...
T Consensus       844 y~aPE~~~  851 (968)
T PLN00113        844 YVAPETRE  851 (968)
T ss_pred             ccCccccc
Confidence            99999754

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.77  E-value=4e-19  Score=149.80  Aligned_cols=134  Identities=22%  Similarity=0.462  Sum_probs=112.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeC--CcEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQN--IPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~l  262 (359)
                      +|.+..++|.|.|..+     ..+.++++||++++      -..+.+.+|+.++..|. ||||++++++..++  ..+.+
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            4566677888888533     35678999999953      34456899999999996 99999999998764  45889


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DFGla~  336 (359)
                      |+||+.+.+...+.   ..++...++.++.|++.||.|||+.|   |+|||+||.|++||.. -.++|+|+|+|-
T Consensus       113 iFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAE  181 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAE  181 (338)
T ss_pred             HhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHh
Confidence            99999987776665   34788899999999999999999999   9999999999999975 469999999995

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.77  E-value=1.1e-17  Score=147.70  Aligned_cols=123  Identities=38%  Similarity=0.663  Sum_probs=111.6

Q ss_pred             cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHH
Q 018204          209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL  288 (359)
Q Consensus       209 ~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~  288 (359)
                      +|+.+++|++........  .+.+..|+..++.++|+||+++++++......++++||+++++|.+++.....++...+.
T Consensus        13 ~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~   90 (244)
T smart00220       13 TGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEAR   90 (244)
T ss_pred             CCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHH
Confidence            578999999975543322  567899999999999999999999999989999999999999999999877668999999


Q ss_pred             HHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       289 ~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .++.+++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        91 ~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~  135 (244)
T smart00220       91 FYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLAR  135 (244)
T ss_pred             HHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEcccccee
Confidence            99999999999999998   9999999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.77  E-value=1.2e-19  Score=175.57  Aligned_cols=134  Identities=31%  Similarity=0.331  Sum_probs=118.6

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHH-cC-CCCCCCCCCCCcHHHHHHHcCC
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLN-EG-SDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~-~g-a~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      ...+.++|++|..+.+.-++..+.....++.|+.||||.||..|..++|+.||+ .| ...|..|-.|+||||+|+.+||
T Consensus       274 ~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH  353 (929)
T KOG0510|consen  274 CTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGH  353 (929)
T ss_pred             CchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCH
Confidence            444567888999999999999888888889999999999999999999999999 55 5789999999999999999999


Q ss_pred             HHHHHHHHhcCCCcc---ccccccccccccccccccceeEeeccccCccc---cccCCCCcc
Q 018204          118 VEVVKLLLSKKANID---ARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMT  173 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~---~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~  173 (359)
                      ..+|++|++.||+.+   ..|.+|.||||.|+++|+..++++|+.+|+++   ++.+.++++
T Consensus       354 ~~v~qlLl~~GA~~~~~~e~D~dg~TaLH~Aa~~g~~~av~~Li~~Ga~I~~~n~~g~SA~~  415 (929)
T KOG0510|consen  354 DRVVQLLLNKGALFLNMSEADSDGNTALHLAAKYGNTSAVQKLISHGADIGVKNKKGKSAFD  415 (929)
T ss_pred             HHHHHHHHhcChhhhcccccccCCchhhhHHHHhccHHHHHHHHHcCCceeecccccccccc
Confidence            999999999999988   56999999999999999999999999999998   344455554

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.77  E-value=9.6e-20  Score=176.25  Aligned_cols=169  Identities=19%  Similarity=0.225  Sum_probs=133.1

Q ss_pred             cCCCCCCcceeeccCCCCCcCcCCcccccC---------------CCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCC
Q 018204           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDEL---------------TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVN   99 (359)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~   99 (359)
                      ++++..+.+..+..-|+++.++..|.++..               .+..|.||.||||+||+.|+.+.|+.|+..||++|
T Consensus       221 ~~n~~~~pLhlAve~g~~e~lk~~L~n~~~~a~~~~~~~~q~kelv~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~  300 (929)
T KOG0510|consen  221 DNNEKATPLHLAVEGGDIEMLKMCLQNGKKIADVQLDAMQQEKELVNDEDNDGCTPLHYAARQGGPESVDNLLGFGASIN  300 (929)
T ss_pred             ccCCCCcchhhhhhcCCHHHHHHHHhCccccchhhhHHHHHHHHHhhcccccCCchHHHHHHcCChhHHHHHHHcCCccc
Confidence            345555555566677888888887776532               23458899999999999999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHcCCHHHHHHHHh-cC-CCccccccccccccccccccccceeEeeccccCccc------cccCCCC
Q 018204          100 SIDLDGRTALHIAACEGHVEVVKLLLS-KK-ANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV------PKTKRTP  171 (359)
Q Consensus       100 ~~d~~g~TpLh~A~~~g~~~~v~~Ll~-~g-a~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~------~~~~~tp  171 (359)
                      .++.++.||||.||.+|+.++|+-||+ .| ...|..|-.|.||||.|+..||..++++|+++||..      +..+.|+
T Consensus       301 ~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~~~~e~D~dg~Ta  380 (929)
T KOG0510|consen  301 SKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFLNMSEADSDGNTA  380 (929)
T ss_pred             ccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhhcccccccCCchh
Confidence            999999999999999999999999999 54 678999999999999999999999999999999976      4567899


Q ss_pred             cccCCCCC---CCcccCCcceeeEeeccCcccceeE
Q 018204          172 MTVANPRE---VPEYELNPLELQVRKADGITKGSYQ  204 (359)
Q Consensus       172 l~~a~~~~---~~~~~l~~~~~~~~~~~~ig~g~~~  204 (359)
                      +|.|.-..   ...+++.. ..+....++.|..+|.
T Consensus       381 LH~Aa~~g~~~av~~Li~~-Ga~I~~~n~~g~SA~~  415 (929)
T KOG0510|consen  381 LHLAAKYGNTSAVQKLISH-GADIGVKNKKGKSAFD  415 (929)
T ss_pred             hhHHHHhccHHHHHHHHHc-CCceeecccccccccc
Confidence            99984332   22222211 2233333445555655

>PHA02946 ankyin-like protein; Provisional

Probab=99.76  E-value=1.5e-19  Score=174.63  Aligned_cols=169  Identities=12%  Similarity=0.128  Sum_probs=130.3

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcC--CHHHHHHHHHcCCCCCC-CCCCCCcHHHHHHHc
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRG--DVKGVEDLLNEGSDVNS-IDLDGRTALHIAACE  115 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g--~~~~v~~Ll~~ga~v~~-~d~~g~TpLh~A~~~  115 (359)
                      ..+.+..++..|+.+.++.+++.+.....+|.+|.||||+|+..+  ..+++++|+++|+|+|. .|..|.|||| ||..
T Consensus        72 G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-aa~~  150 (446)
T PHA02946         72 GNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-ACTD  150 (446)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-HHHC
Confidence            344455667788888888888877665666899999999998865  48999999999999995 6899999997 7778


Q ss_pred             CCHHHHHHHHhcCCCcccccccccccccccccccc--ceeEeeccccCcccc---ccCCCCcccCCCCC-----CCcccC
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN--VEVYNILKARGAKVP---KTKRTPMTVANPRE-----VPEYEL  185 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~--~~~~~~L~~~ga~~~---~~~~tpl~~a~~~~-----~~~~~l  185 (359)
                      |+.+++++|++.|++++.+|..|+||||+|+..++  .+++++|+++|++++   ..+.||+|.+....     ..++++
T Consensus       151 ~~~~vv~~Ll~~gad~~~~d~~G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~~G~TpLH~Aa~~~~~~~~iv~lLl  230 (446)
T PHA02946        151 PSERVFKKIMSIGFEARIVDKFGKNHIHRHLMSDNPKASTISWMMKLGISPSKPDHDGNTPLHIVCSKTVKNVDIINLLL  230 (446)
T ss_pred             CChHHHHHHHhccccccccCCCCCCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCCcHHHHHHHH
Confidence            99999999999999999999999999999876554  578999999999884   46789999875322     223333


Q ss_pred             CcceeeEeeccCcccceeEEEEecC
Q 018204          186 NPLELQVRKADGITKGSYQVAKWNG  210 (359)
Q Consensus       186 ~~~~~~~~~~~~ig~g~~~~~~~~g  210 (359)
                      .  ..+....+..|.+++..+...+
T Consensus       231 ~--gadin~~d~~G~TpLh~A~~~~  253 (446)
T PHA02946        231 P--STDVNKQNKFGDSPLTLLIKTL  253 (446)
T ss_pred             c--CCCCCCCCCCCCCHHHHHHHhC
Confidence            3  2445555666777776544333

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.76  E-value=2.5e-19  Score=182.89  Aligned_cols=110  Identities=30%  Similarity=0.268  Sum_probs=95.9

Q ss_pred             cCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccc
Q 018204           54 PIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA  133 (359)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~  133 (359)
                      ....+++.+.....++.+|.||||+|+..|++++|++||++|||++++|+.|+||||.||..|+.+|+++|+++||++|+
T Consensus       522 ~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna  601 (1143)
T KOG4177|consen  522 VAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNA  601 (1143)
T ss_pred             HHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCc
Confidence            33334444443445577889999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccccccccccccccceeEeeccccCcc
Q 018204          134 RDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       134 ~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      .|.+|.|||++|++.|+.+++++|...+++
T Consensus       602 ~d~~g~TpL~iA~~lg~~~~~k~l~~~~~~  631 (1143)
T KOG4177|consen  602 ADLDGFTPLHIAVRLGYLSVVKLLKVVTAT  631 (1143)
T ss_pred             ccccCcchhHHHHHhcccchhhHHHhccCc
Confidence            999999999999999999999999999888

>PHA02917 ankyrin-like protein; Provisional

Probab=99.76  E-value=1.9e-19  Score=180.62  Aligned_cols=166  Identities=16%  Similarity=0.095  Sum_probs=113.6

Q ss_pred             CCcCcCCcccccCCCCCCCCCccHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc-------------
Q 018204           52 LDPIRRSPVQDELTVPENLDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE-------------  115 (359)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~---g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~-------------  115 (359)
                      ++.++.++.++.+....|.+|.||||+||..   |+.++|++||+.|+|++.+|..|+||||+|+..             
T Consensus        12 ~~~~~~l~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~L   91 (661)
T PHA02917         12 LDELKQMLRDRDPNDTRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMAL   91 (661)
T ss_pred             HHHHHHHHhccCcccccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHH
Confidence            4556666666655555577777777776443   667777777777777777777777777766653             


Q ss_pred             ----------------------CCHHHHHHHHhcCCCccccccccccccccc--cccccceeEeeccccCccccccC---
Q 018204          116 ----------------------GHVEVVKLLLSKKANIDARDRWGSTAAADA--KYYGNVEVYNILKARGAKVPKTK---  168 (359)
Q Consensus       116 ----------------------g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A--~~~~~~~~~~~L~~~ga~~~~~~---  168 (359)
                                            |+.++|++|+++|||+|.+|..|+||||.|  +..|+.+++++|+++|++++..+   
T Consensus        92 l~~~~~~n~~~~~~~~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~  171 (661)
T PHA02917         92 LEATGYSNINDFNIFSYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDD  171 (661)
T ss_pred             HhccCCCCCCCcchHHHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCcccccccc
Confidence                                  466789999999999999999999999954  46789999999999999985322   


Q ss_pred             --------------CCCcccCCC--------------CCCCcccCCcceeeEeeccCcccceeEEEEecCcE--EEEEEe
Q 018204          169 --------------RTPMTVANP--------------REVPEYELNPLELQVRKADGITKGSYQVAKWNGTK--VWVKIL  218 (359)
Q Consensus       169 --------------~tpl~~a~~--------------~~~~~~~l~~~~~~~~~~~~ig~g~~~~~~~~g~~--vavK~l  218 (359)
                                    .||++.+..              .+..++++.. ..+....+..|.+++..+...|+.  -.||.|
T Consensus       172 ~~g~~~~~~~~~~~~t~L~~a~~~~~~~~~~~~~~~~~eiv~~Li~~-Gadvn~~d~~G~TpLh~A~~~g~~~~eivk~L  250 (661)
T PHA02917        172 EYGYAYDDYQPRNCGTVLHLYIISHLYSESDTRAYVRPEVVKCLINH-GIKPSSIDKNYCTALQYYIKSSHIDIDIVKLL  250 (661)
T ss_pred             ccccccccccccccccHHHHHHhhcccccccccccCcHHHHHHHHHC-CCCcccCCCCCCcHHHHHHHcCCCcHHHHHHH
Confidence                          388877632              1223333322 234444555667777666555543  244544

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.76  E-value=1.4e-18  Score=169.67  Aligned_cols=121  Identities=32%  Similarity=0.505  Sum_probs=99.9

Q ss_pred             EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC-C--
Q 018204          206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-R--  281 (359)
Q Consensus       206 ~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~--  281 (359)
                      ..+.|+.||||.+..+.      ..-..+|+..++.- .||||+++|+.-.++...||..|.|.. +|.+++.... .  
T Consensus       529 G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~  601 (903)
T KOG1027|consen  529 GVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVE  601 (903)
T ss_pred             EeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchh
Confidence            35678999999986433      23457899999887 699999999998899999999999965 9999997731 1  


Q ss_pred             -CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CC--cEEEecccccc
Q 018204          282 -LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GG--QLKISGFGLLR  336 (359)
Q Consensus       282 -l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~--~~kl~DFGla~  336 (359)
                       ...-....++.|++.||++||+.+   ||||||||+||||+.   ++  .++|+|||+++
T Consensus       602 ~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  602 MQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             hcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccc
Confidence             111345678899999999999998   999999999999976   34  69999999997

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.76  E-value=2.8e-19  Score=150.00  Aligned_cols=110  Identities=22%  Similarity=0.254  Sum_probs=97.1

Q ss_pred             CCCCCCccHHHHHHHcCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH---HHHHHhcCCCccccc-ccc
Q 018204           67 PENLDSTMQLLFMACRGDV----KGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV---VKLLLSKKANIDARD-RWG  138 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g~~----~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~---v~~Ll~~ga~~~~~d-~~g  138 (359)
                      ..+.++.++||.||..|++    +++++|++.|+++|.+|..|+||||+||..|+.++   +++|++.|+++|.+| ..|
T Consensus        15 ~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g   94 (166)
T PHA02743         15 EIDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTG   94 (166)
T ss_pred             hhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCC
Confidence            3466788999999999998    66678889999999999999999999999998664   899999999999998 589


Q ss_pred             ccccccccccccceeEeeccc-cCcccc---ccCCCCcccCC
Q 018204          139 STAAADAKYYGNVEVYNILKA-RGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       139 ~tpl~~A~~~~~~~~~~~L~~-~ga~~~---~~~~tpl~~a~  176 (359)
                      +||||+|+..++.+++++|+. .|++++   ..+.||++.+.
T Consensus        95 ~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~tpL~~A~  136 (166)
T PHA02743         95 NTLLHIAASTKNYELAEWLCRQLGVNLGAINYQHETAYHIAY  136 (166)
T ss_pred             CcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCCCCHHHHHH
Confidence            999999999999999999994 799874   45678888874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.76  E-value=2.2e-17  Score=144.47  Aligned_cols=124  Identities=40%  Similarity=0.693  Sum_probs=111.7

Q ss_pred             cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCC-CCHHHH
Q 018204          209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKV  287 (359)
Q Consensus       209 ~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~  287 (359)
                      .++.+++|.+......  ...+.+.+|+..+..++|+|++++++++......++++||+++++|.+++..... +++..+
T Consensus        23 ~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~  100 (225)
T smart00221       23 TGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEA  100 (225)
T ss_pred             CCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHH
Confidence            3688999999754432  2456788999999999999999999999988899999999999999999988766 899999


Q ss_pred             HHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       288 ~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ..++.+++.++.|||+++   ++|+|++|+||+++.++.++|+|||++..
T Consensus       101 ~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221      101 RFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             HHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            999999999999999998   99999999999999999999999998864

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.75  E-value=5.5e-19  Score=126.96  Aligned_cols=98  Identities=27%  Similarity=0.327  Sum_probs=82.5

Q ss_pred             ccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHh
Q 018204           47 GRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS  126 (359)
Q Consensus        47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~  126 (359)
                      .+.|.+|+|+....++ .+++.-..|+||||+||..|+++++++|+..||||+.+|+.|-|||--|+..||.++|++|++
T Consensus        10 vkNG~~DeVk~~v~~g-~nVn~~~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~   88 (117)
T KOG4214|consen   10 VKNGEIDEVKQSVNEG-LNVNEIYGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQ   88 (117)
T ss_pred             hccCcHHHHHHHHHcc-ccHHHHhCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHH
Confidence            3467888888877666 566666688999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCccccccccccccccc
Q 018204          127 KKANIDARDRWGSTAAADA  145 (359)
Q Consensus       127 ~ga~~~~~d~~g~tpl~~A  145 (359)
                      .|||-..+..+|.+.+..+
T Consensus        89 ~GAdrt~~~PdG~~~~eat  107 (117)
T KOG4214|consen   89 NGADRTIHAPDGTALIEAT  107 (117)
T ss_pred             cCcccceeCCCchhHHhhc
Confidence            9999888888887776554

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.75  E-value=4.1e-18  Score=153.37  Aligned_cols=157  Identities=22%  Similarity=0.336  Sum_probs=124.6

Q ss_pred             eeeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC--C----ccccceeeEEeC
Q 018204          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH--P----NVVQFVGAVTQN  257 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~~~  257 (359)
                      .-.|.+.+..|.|+|+.+.     ..+..+|||+++.-    ....+...-|++++.++.+  |    -++.+.++|...
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            3456777788999998552     34788999998642    2334556789999999943  2    266778889999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC------------
Q 018204          258 IPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN------------  323 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~------------  323 (359)
                      +++|||+|.+ |.|+.+++++++  +++..+++.++.|++++++|||+.+   ++|-||||+|||+..            
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence            9999999988 669999998764  5999999999999999999999999   999999999999942            


Q ss_pred             --------CCcEEEeccccccc------------cccCcccccccCCccCCCC
Q 018204          324 --------GGQLKISGFGLLRL------------QYISPEKAKIVFPVSHIDP  356 (359)
Q Consensus       324 --------~~~~kl~DFGla~~------------~~~~PE~~~~~~~~~~~~p  356 (359)
                              +..++|+|||.|+.            -|.|||.+   ..++|--|
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEVi---LgLGwS~p  289 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVI---LGLGWSQP  289 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchhe---eccCcCCc
Confidence                    23489999999973            49999963   45555433

>PHA03095 ankyrin-like protein; Provisional

Probab=99.75  E-value=3.6e-19  Score=174.13  Aligned_cols=135  Identities=25%  Similarity=0.232  Sum_probs=112.7

Q ss_pred             CcceeeccCC---CCCcCcCCcccccCCCCCCCCCccHHHHHHHcC-CHHHHHHHHHcCCCCCCCCCCCCcHHHHHH--H
Q 018204           41 NMRFSFGRQS---SLDPIRRSPVQDELTVPENLDSTMQLLFMACRG-DVKGVEDLLNEGSDVNSIDLDGRTALHIAA--C  114 (359)
Q Consensus        41 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g-~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~--~  114 (359)
                      +.+..++..|   ..+.++.+++.+......+.+|.||||+|+..| +.+++++|+++|+|+|.+|..|+||||+|+  .
T Consensus        49 t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~~~~g~tpLh~a~~~~  128 (471)
T PHA03095         49 TPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAKDKVGRTPLHVYLSGF  128 (471)
T ss_pred             CHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHhhCC
Confidence            3344455555   667777777777666666889999999999999 599999999999999999999999999999  5


Q ss_pred             cCCHHHHHHHHhcCCCccccccccccccccccccc--cceeEeeccccCcccc---ccCCCCcccC
Q 018204          115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYG--NVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       115 ~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~--~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      .++.+++++|+++|+|++.+|..|.||||+|+..+  +.+++++|+++|++++   ..+.|+++.+
T Consensus       129 ~~~~~iv~~Ll~~gad~~~~d~~g~tpL~~a~~~~~~~~~iv~~Ll~~g~~~~~~d~~g~t~Lh~~  194 (471)
T PHA03095        129 NINPKVIRLLLRKGADVNALDLYGMTPLAVLLKSRNANVELLRLLIDAGADVYAVDDRFRSLLHHH  194 (471)
T ss_pred             cCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCcccCCCCCCHHHHH
Confidence            67899999999999999999999999999987655  5678999999998873   4456776654

>PHA02798 ankyrin-like protein; Provisional

Probab=99.75  E-value=3.3e-19  Score=175.01  Aligned_cols=85  Identities=25%  Similarity=0.360  Sum_probs=66.4

Q ss_pred             CCCCcCcCCcccccCCCCCCCCCccHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC---HHHHHH
Q 018204           50 SSLDPIRRSPVQDELTVPENLDSTMQLLFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH---VEVVKL  123 (359)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g---~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~---~~~v~~  123 (359)
                      +..+.++-+++.+......|.+|.||||+|+.+|   +.+++++|+++|||+|.+|..|+||||+|+..|+   .+++++
T Consensus        87 ~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~  166 (489)
T PHA02798         87 HMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKL  166 (489)
T ss_pred             hHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHH
Confidence            3455666666666555555788889998888875   7888888888888888888888889988888887   888888


Q ss_pred             HHhcCCCcccc
Q 018204          124 LLSKKANIDAR  134 (359)
Q Consensus       124 Ll~~ga~~~~~  134 (359)
                      |+++|+|++.+
T Consensus       167 Ll~~gadin~~  177 (489)
T PHA02798        167 LLEKGVDINTH  177 (489)
T ss_pred             HHHhCCCcccc
Confidence            88887776654

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.74  E-value=3.9e-19  Score=181.40  Aligned_cols=106  Identities=25%  Similarity=0.370  Sum_probs=55.6

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC-HHHHHHHHhcCCCccccccccccccccccc
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH-VEVVKLLLSKKANIDARDRWGSTAAADAKY  147 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~-~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~  147 (359)
                      |.+|.||||+||..|+.+++++|++.|+|++..+..|.||||+|+..++ ..++++|++.|+|+|.+|..|+||||+|+.
T Consensus       372 d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~~G~TpLh~Aa~  451 (682)
T PHA02876        372 DYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNKDLSTPLHYACK  451 (682)
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCCCCChHHHHHHH
Confidence            4455555555555555555555555555555555555555555554333 334555555555555555555555555554


Q ss_pred             cc-cceeEeeccccCcccc---ccCCCCccc
Q 018204          148 YG-NVEVYNILKARGAKVP---KTKRTPMTV  174 (359)
Q Consensus       148 ~~-~~~~~~~L~~~ga~~~---~~~~tpl~~  174 (359)
                      .+ +.+++++|+++|++++   ..+.||++.
T Consensus       452 ~~~~~~iv~lLl~~Gad~n~~d~~g~tpl~~  482 (682)
T PHA02876        452 KNCKLDVIEMLLDNGADVNAINIQNQYPLLI  482 (682)
T ss_pred             hCCcHHHHHHHHHCCCCCCCCCCCCCCHHHH
Confidence            43 3455555555555542   233444444

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.74  E-value=9.4e-19  Score=131.16  Aligned_cols=87  Identities=32%  Similarity=0.471  Sum_probs=75.8

Q ss_pred             eeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHH
Q 018204           45 SFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLL  124 (359)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~L  124 (359)
                      .+++.|+++.++.+++.+ .+...   |.||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+.+|+.+++++|
T Consensus         3 ~A~~~~~~~~~~~ll~~~-~~~~~---~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~L   78 (89)
T PF12796_consen    3 IAAQNGNLEILKFLLEKG-ADINL---GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLL   78 (89)
T ss_dssp             HHHHTTTHHHHHHHHHTT-STTTS---SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHH
T ss_pred             HHHHcCCHHHHHHHHHCc-CCCCC---CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHH
Confidence            467788888888888844 33333   89999999999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCccccc
Q 018204          125 LSKKANIDARD  135 (359)
Q Consensus       125 l~~ga~~~~~d  135 (359)
                      +++|++++.+|
T Consensus        79 l~~g~~~~~~n   89 (89)
T PF12796_consen   79 LEHGADVNIRN   89 (89)
T ss_dssp             HHTTT-TTSS-
T ss_pred             HHcCCCCCCcC
Confidence            99999999876

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.74  E-value=9.6e-19  Score=155.38  Aligned_cols=139  Identities=27%  Similarity=0.301  Sum_probs=116.1

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccccCCCCC-CCCCccHHHHHHHc-----CCHHHHHHHHHcCCCCCCCC-CCCCcH
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACR-----GDVKGVEDLLNEGSDVNSID-LDGRTA  108 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~-----g~~~~v~~Ll~~ga~v~~~d-~~g~Tp  108 (359)
                      |-+.+..+.++-.-++++.|..+|..+..+++. |.-|+||+|+||..     .+.++|+.|...| |||++- ..|+|+
T Consensus       265 DsNGNTALHYsVSHaNF~VV~~LLDSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mg-nVNaKAsQ~gQTA  343 (452)
T KOG0514|consen  265 DSNGNTALHYAVSHANFDVVSILLDSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMG-DVNAKASQHGQTA  343 (452)
T ss_pred             cCCCCeeeeeeecccchHHHHHHhccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhcc-Ccchhhhhhcchh
Confidence            466777777777788899999999888777766 88899999988863     6788888888876 777764 679999


Q ss_pred             HHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccC-ccc---cccCCCCcccC
Q 018204          109 LHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG-AKV---PKTKRTPMTVA  175 (359)
Q Consensus       109 Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g-a~~---~~~~~tpl~~a  175 (359)
                      ||+|+.+|++++|+.||..|||||.+|.+|.|+|++|+..||.+++++|+... .+.   +..+.|++.++
T Consensus       344 LMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTAl~IA  414 (452)
T KOG0514|consen  344 LMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTALSIA  414 (452)
T ss_pred             hhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchhhhhH
Confidence            99999999999999999999999999999999999999999999999998753 343   55566666665

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.74  E-value=7.2e-19  Score=172.85  Aligned_cols=128  Identities=22%  Similarity=0.171  Sum_probs=101.0

Q ss_pred             CCCCCcCcCCcccccCC-CCCCCCCccHHHHHHH--cCCHHHHHHHHHcCCCCCC-CCCCCCcHHHHHHHcC----CHHH
Q 018204           49 QSSLDPIRRSPVQDELT-VPENLDSTMQLLFMAC--RGDVKGVEDLLNEGSDVNS-IDLDGRTALHIAACEG----HVEV  120 (359)
Q Consensus        49 ~~~~~~~~~~~~~~~~~-~~~~~~~~t~l~~aa~--~g~~~~v~~Ll~~ga~v~~-~d~~g~TpLh~A~~~g----~~~~  120 (359)
                      .++.+.++-+++.+... ...+.+|+||||+|+.  .++.++|++|+++|+|++. .|..|.||||+|+..+    +.++
T Consensus       121 ~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~~~~~g~tpL~~a~~~~~~~~~~~i  200 (494)
T PHA02989        121 INNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEKTSLYGLTPMNIYLRNDIDVISIKV  200 (494)
T ss_pred             cCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccccccCCChHHHHHhcccccccHHH
Confidence            45667777777766544 3457889999998865  4688999999999999988 6788999999887654    8889


Q ss_pred             HHHHHhcCCCcccc--------------------------------------ccccccccccccccccceeEeeccccCc
Q 018204          121 VKLLLSKKANIDAR--------------------------------------DRWGSTAAADAKYYGNVEVYNILKARGA  162 (359)
Q Consensus       121 v~~Ll~~ga~~~~~--------------------------------------d~~g~tpl~~A~~~~~~~~~~~L~~~ga  162 (359)
                      |++|+++|+++|.+                                      |..|+||||+|+..|+.+++++|+++|+
T Consensus       201 v~~Ll~~Ga~vn~~~~~~~t~l~~~~~~~~~~~~~~~~il~~l~~~advn~~d~~G~TpL~~Aa~~~~~~~v~~LL~~Ga  280 (494)
T PHA02989        201 IKYLIKKGVNIETNNNGSESVLESFLDNNKILSKKEFKVLNFILKYIKINKKDKKGFNPLLISAKVDNYEAFNYLLKLGD  280 (494)
T ss_pred             HHHHHhCCCCccccCCccccHHHHHHHhchhhcccchHHHHHHHhCCCCCCCCCCCCCHHHHHHHhcCHHHHHHHHHcCC
Confidence            99998888876544                                      4558899999999999999999999999


Q ss_pred             ccc---ccCCCCcccCC
Q 018204          163 KVP---KTKRTPMTVAN  176 (359)
Q Consensus       163 ~~~---~~~~tpl~~a~  176 (359)
                      +++   ..+.||++.|.
T Consensus       281 din~~d~~G~TpL~~A~  297 (494)
T PHA02989        281 DIYNVSKDGDTVLTYAI  297 (494)
T ss_pred             CccccCCCCCCHHHHHH
Confidence            884   45678888773

>PHA02917 ankyrin-like protein; Provisional

Probab=99.73  E-value=6.5e-19  Score=176.82  Aligned_cols=128  Identities=16%  Similarity=0.128  Sum_probs=100.7

Q ss_pred             CCCCCcCcCCcccccCCCCCCCCCccHHHHHHH-----------------------------------cCCHHHHHHHHH
Q 018204           49 QSSLDPIRRSPVQDELTVPENLDSTMQLLFMAC-----------------------------------RGDVKGVEDLLN   93 (359)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~-----------------------------------~g~~~~v~~Ll~   93 (359)
                      .|+.+.++.++..+......+.+|+||||+|+.                                   +|+.++|++|++
T Consensus        45 ~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n~~~~~~~~~~a~~~~~~e~vk~Ll~  124 (661)
T PHA02917         45 CNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSNINDFNIFSYMKSKNVDVDLIKVLVE  124 (661)
T ss_pred             cCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCCCCCcchHHHHHhhcCCHHHHHHHHH
Confidence            355666666666555444455666666665554                                   456788999999


Q ss_pred             cCCCCCCCCCCCCcHHHHHH--HcCCHHHHHHHHhcCCCcccccc---cc-----------ccccccccc----------
Q 018204           94 EGSDVNSIDLDGRTALHIAA--CEGHVEVVKLLLSKKANIDARDR---WG-----------STAAADAKY----------  147 (359)
Q Consensus        94 ~ga~v~~~d~~g~TpLh~A~--~~g~~~~v~~Ll~~ga~~~~~d~---~g-----------~tpl~~A~~----------  147 (359)
                      +|+|+|.+|.+|+||||+|+  .+|+.++|++|+++|||+|.+|.   .|           .||||+|+.          
T Consensus       125 ~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~~d~~~~~g~~~~~~~~~~~~t~L~~a~~~~~~~~~~~~  204 (661)
T PHA02917        125 HGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLYEDEDDEYGYAYDDYQPRNCGTVLHLYIISHLYSESDTR  204 (661)
T ss_pred             cCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccccccccccccccccccccccccHHHHHHhhccccccccc
Confidence            99999999999999999654  57899999999999999987654   34           599999975          


Q ss_pred             -cccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          148 -YGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       148 -~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                       +++.+++++|+++|++++   ..+.||++.+.
T Consensus       205 ~~~~~eiv~~Li~~Gadvn~~d~~G~TpLh~A~  237 (661)
T PHA02917        205 AYVRPEVVKCLINHGIKPSSIDKNYCTALQYYI  237 (661)
T ss_pred             ccCcHHHHHHHHHCCCCcccCCCCCCcHHHHHH
Confidence             568899999999999995   45679999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.73  E-value=1.6e-16  Score=136.70  Aligned_cols=122  Identities=39%  Similarity=0.737  Sum_probs=110.2

Q ss_pred             CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhc-CCCCHHHHH
Q 018204          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVL  288 (359)
Q Consensus       210 g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~  288 (359)
                      ++.+++|.+.......  ....+.+|+..++.+.|++++++++++......++++|++++++|.+++... ..+++..+.
T Consensus        18 ~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~   95 (215)
T cd00180          18 GKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL   95 (215)
T ss_pred             CcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHH
Confidence            8899999997544321  3457899999999999999999999999988999999999989999999876 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEecccccc
Q 018204          289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR  336 (359)
Q Consensus       289 ~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGla~  336 (359)
                      .++.+++.++.|||+.+   ++|+||+|.||+++. ++.++|+|||.+.
T Consensus        96 ~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~  141 (215)
T cd00180          96 RILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSK  141 (215)
T ss_pred             HHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceE
Confidence            99999999999999998   999999999999999 8999999999886

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PHA02795 ankyrin-like protein; Provisional

Probab=99.73  E-value=5.1e-19  Score=166.48  Aligned_cols=134  Identities=19%  Similarity=0.185  Sum_probs=113.5

Q ss_pred             Ccceeecc--CCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCC-CCCC-----CCCCcHHHHH
Q 018204           41 NMRFSFGR--QSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDV-NSID-----LDGRTALHIA  112 (359)
Q Consensus        41 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v-~~~d-----~~g~TpLh~A  112 (359)
                      ..+..++.  .|+++.++-+++.|+....  .++.||||+|+.+|+.++|++|+++|++. |..+     ..|.||+|.|
T Consensus       118 ~~L~~~~~n~~n~~eiV~~LI~~GADIn~--~~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a  195 (437)
T PHA02795        118 DLLLYYLSNAYVEIDIVDFMVDHGAVIYK--IECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLV  195 (437)
T ss_pred             HHHHHHHHhcCCCHHHHHHHHHCCCCCCC--CCCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHH
Confidence            33444555  6788888888877765443  35689999999999999999999999853 3322     4588999999


Q ss_pred             HHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          113 ACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       113 ~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      +..++.+++++|+++|||+|.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||++.|.
T Consensus       196 ~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa  262 (437)
T PHA02795        196 DEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAV  262 (437)
T ss_pred             HhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence            99999999999999999999999999999999999999999999999999984   45689999884

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.73  E-value=3.8e-17  Score=138.94  Aligned_cols=139  Identities=20%  Similarity=0.278  Sum_probs=117.0

Q ss_pred             eEeeccCcccceeEE-----EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC-CccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQV-----AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~-----~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv~  264 (359)
                      .|+...++|+|+|+-     ...+|.+||+|+-.......     .+..|..+...|++ ..|+.+..+.....+-.+||
T Consensus        16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-----chhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            467778899999972     24579999999876554332     36789999999976 68888888888888999999


Q ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC---CcEEEecccccccc
Q 018204          265 EYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLRLQ  338 (359)
Q Consensus       265 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DFGla~~~  338 (359)
                      |++ |.||.+++.-+ ..++.+++..++-|++.-++|+|.++   +|||||||+|.|..-+   ..+.++|||+|+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            988 78999999765 45999999999999999999999999   9999999999999754   35899999999843

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.73  E-value=2e-17  Score=164.29  Aligned_cols=145  Identities=21%  Similarity=0.307  Sum_probs=100.6

Q ss_pred             eEeeccCcccceeEEEE-----ec----CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceee------EE
Q 018204          191 QVRKADGITKGSYQVAK-----WN----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA------VT  255 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~----g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~------~~  255 (359)
                      +|...+.+|+|+|+.+.     ..    +..+|+|.+......     +.+..|  .+....+.++..++..      ..
T Consensus       133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            46667778999998552     23    678999987543211     111111  1122222233322222      13


Q ss_pred             eCCcEEEEEecCCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 018204          256 QNIPMMIVLEYHAKGDLASYLQKKGR--------------------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK  315 (359)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk  315 (359)
                      .....++|+||+++++|.+++.....                    .....+..++.|++.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            45679999999999999999875421                    112346679999999999999998   9999999


Q ss_pred             CCcEEEcC-CCcEEEeccccccc----------------cccCcccc
Q 018204          316 PKNILLDN-GGQLKISGFGLLRL----------------QYISPEKA  345 (359)
Q Consensus       316 ~~NIll~~-~~~~kl~DFGla~~----------------~~~~PE~~  345 (359)
                      |+|||++. ++.+||+|||+|+.                .|++||..
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~  329 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY  329 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence            99999986 57999999999962                58999954

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.72  E-value=2.1e-17  Score=153.81  Aligned_cols=149  Identities=24%  Similarity=0.345  Sum_probs=124.0

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC------CCccccceeeEEeCC
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR------HPNVVQFVGAVTQNI  258 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~------HpnIv~l~~~~~~~~  258 (359)
                      -.|.+....|+|.|..+.     ..|..||||++..+.    ...+.-+.|+.+|.+|+      --++++|+..|...+
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            356666678999998542     357899999997543    23345678999999995      238999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEecccc
Q 018204          259 PMMIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGL  334 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DFGl  334 (359)
                      ++|+|+|.+. .+|.+.|++.+   .+....+..|+.|+..||..|-..+   |+|.||||.|||++..- .+||||||.
T Consensus       508 HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS  583 (752)
T KOG0670|consen  508 HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS  583 (752)
T ss_pred             eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence            9999999885 59999998865   3888999999999999999999999   99999999999998764 699999999


Q ss_pred             cc-------------ccccCccccc
Q 018204          335 LR-------------LQYISPEKAK  346 (359)
Q Consensus       335 a~-------------~~~~~PE~~~  346 (359)
                      |.             .+|.|||.+=
T Consensus       584 A~~~~eneitPYLVSRFYRaPEIiL  608 (752)
T KOG0670|consen  584 ASFASENEITPYLVSRFYRAPEIIL  608 (752)
T ss_pred             ccccccccccHHHHHHhccCcceee
Confidence            85             2699999754

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=5.3e-17  Score=138.69  Aligned_cols=125  Identities=16%  Similarity=0.133  Sum_probs=93.1

Q ss_pred             cccceeEEE---EecCcEEEEEEeccCCCCcHHH-HHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEecCCCCCH
Q 018204          198 ITKGSYQVA---KWNGTKVWVKILDKESHKDPER-INAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       198 ig~g~~~~~---~~~g~~vavK~l~~~~~~~~~~-~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      ++.+.|+.+   ...+.+++.+.+.......... ...|.+|+++++++. |+++++++++    ...+++|||+.|.+|
T Consensus        10 l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L   85 (218)
T PRK12274         10 LKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAM   85 (218)
T ss_pred             ecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccH
Confidence            345555533   3356677766665433211111 124789999999995 4789998885    346999999999998


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCcEEEcCCCcEEEecccccc
Q 018204          273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL-KPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       273 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDl-k~~NIll~~~~~~kl~DFGla~  336 (359)
                      .+.+...       ...++.|++.+|.++|++|   |+|||| ||+|||++.++.++|+|||+|.
T Consensus        86 ~~~~~~~-------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         86 YQRPPRG-------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             Hhhhhhh-------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            7554221       1357789999999999999   999999 7999999999999999999996

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.72  E-value=2e-18  Score=176.40  Aligned_cols=137  Identities=24%  Similarity=0.306  Sum_probs=116.2

Q ss_pred             CCCcceeecc-CCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           39 RNNMRFSFGR-QSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        39 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      .+..++..++ .|..+.+.-+++....+......+.|+||.|+..+.+.+++.++++|++++.++.+|.||||.||.+|+
T Consensus       473 ~G~T~Lhlaaq~Gh~~~~~llle~~~~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~  552 (1143)
T KOG4177|consen  473 QGFTPLHLAAQEGHTEVVQLLLEGGANDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGN  552 (1143)
T ss_pred             ccCcchhhhhccCCchHHHHhhhcCCccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCC
Confidence            4444555555 444444444454443333445579999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +++|++|+++|||++++|+.|+||||.|+..|+.+|+.+|+++||++|   ..+.||++.+
T Consensus       553 v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d~~g~TpL~iA  613 (1143)
T KOG4177|consen  553 VDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAADLDGFTPLHIA  613 (1143)
T ss_pred             chHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCcccccCcchhHHH
Confidence            999999999999999999999999999999999999999999999995   4567888876

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.72  E-value=2.3e-18  Score=169.32  Aligned_cols=124  Identities=19%  Similarity=0.158  Sum_probs=98.5

Q ss_pred             CCCcCcCCcccccCCCCCCCCCccHHHHHHHcC------CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc---CCHHHH
Q 018204           51 SLDPIRRSPVQDELTVPENLDSTMQLLFMACRG------DVKGVEDLLNEGSDVNSIDLDGRTALHIAACE---GHVEVV  121 (359)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g------~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~---g~~~~v  121 (359)
                      ..+.++.+++.+ ++++....+.||||.|+.++      +.++|++|+++|||+|.+|..|+||||.|+..   |+.++|
T Consensus        49 ~~~iv~~Ll~~G-Advn~~~~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv  127 (494)
T PHA02989         49 KIKIVKLLIDNG-ADVNYKGYIETPLCAVLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDML  127 (494)
T ss_pred             ChHHHHHHHHcC-CCccCCCCCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHH
Confidence            456666666655 44444346789999887654      57899999999999999999999999988765   678999


Q ss_pred             HHHHhcCCCc-cccccccccccccccc--cccceeEeeccccCccccc----cCCCCcccC
Q 018204          122 KLLLSKKANI-DARDRWGSTAAADAKY--YGNVEVYNILKARGAKVPK----TKRTPMTVA  175 (359)
Q Consensus       122 ~~Ll~~ga~~-~~~d~~g~tpl~~A~~--~~~~~~~~~L~~~ga~~~~----~~~tpl~~a  175 (359)
                      ++|+++|||+ +.+|..|+||||+|+.  .++.+++++|+++|++++.    .+.||++.+
T Consensus       128 ~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~~~~~~g~tpL~~a  188 (494)
T PHA02989        128 RFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFEKTSLYGLTPMNIY  188 (494)
T ss_pred             HHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccccccCCChHHHH
Confidence            9999999999 7899999999998764  4578899999999998754    456777643

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.72  E-value=2.2e-18  Score=175.95  Aligned_cols=134  Identities=27%  Similarity=0.272  Sum_probs=84.0

Q ss_pred             cceeeccCCCCCcCcCCc-ccccCCCCCCCCCccHHHHHHHcC-CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc-CCH
Q 018204           42 MRFSFGRQSSLDPIRRSP-VQDELTVPENLDSTMQLLFMACRG-DVKGVEDLLNEGSDVNSIDLDGRTALHIAACE-GHV  118 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~t~l~~aa~~g-~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~-g~~  118 (359)
                      .+..++..|+...+..++ +.+......|.+|.||||+||..| +.++++.|+..|+|+|.+|..|+||||+|+.. ++.
T Consensus       276 pLh~Aa~~~~~~~iv~lLl~~gadin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~  355 (682)
T PHA02876        276 PLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNK  355 (682)
T ss_pred             HHHHHHhCCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcH
Confidence            334444455544333333 333333334667777777777777 46777777777777777777777777777664 456


Q ss_pred             HHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       119 ~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus       356 ~iv~lLl~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A  415 (682)
T PHA02876        356 DIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFA  415 (682)
T ss_pred             HHHHHHHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHH
Confidence            67777777777777777777777777777777777777777666653   2344555554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=9.5e-17  Score=139.87  Aligned_cols=135  Identities=11%  Similarity=0.195  Sum_probs=106.1

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHH------HHHHHHHHHhCCCCccccceeeEEeC----
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINA------FTHELTIVEKARHPNVVQFVGAVTQN----  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~~~----  257 (359)
                      .|+....++.|.|+.   +...+..+|+|++.+.....+.....      +.+|+..+.++.||+|..+.+++...    
T Consensus        32 ~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~  111 (232)
T PRK10359         32 NIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT  111 (232)
T ss_pred             ceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence            455555555665543   33457789999998766555555444      57899999999999999998886643    


Q ss_pred             ----CcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          258 ----IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       258 ----~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                          ...+++|||++|.+|.++..    +++    ....+++.+|..+|.++   ++|||+||+||+++.+| ++|+|||
T Consensus       112 ~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg  179 (232)
T PRK10359        112 LRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLS  179 (232)
T ss_pred             ccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECC
Confidence                35899999999999988732    333    34569999999999999   99999999999999988 9999999


Q ss_pred             cccc
Q 018204          334 LLRL  337 (359)
Q Consensus       334 la~~  337 (359)
                      .++.
T Consensus       180 ~~~~  183 (232)
T PRK10359        180 GKRC  183 (232)
T ss_pred             Cccc
Confidence            8863

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.71  E-value=1.1e-18  Score=144.75  Aligned_cols=111  Identities=23%  Similarity=0.345  Sum_probs=90.6

Q ss_pred             CCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCC--C-----CCCCCCCCCcHHHHHHHcCCHH---HHHHHHhcCCCccc
Q 018204           64 LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGS--D-----VNSIDLDGRTALHIAACEGHVE---VVKLLLSKKANIDA  133 (359)
Q Consensus        64 ~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga--~-----v~~~d~~g~TpLh~A~~~g~~~---~v~~Ll~~ga~~~~  133 (359)
                      .....|.+|.||||+||..|+.  +++++..++  +     ++.+|..|+||||+|+..|+.+   ++++|++.|+|+|.
T Consensus         9 ~~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~   86 (154)
T PHA02736          9 FASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADING   86 (154)
T ss_pred             HHHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccc
Confidence            3345577899999999999984  444443332  2     3457899999999999999874   68999999999999


Q ss_pred             cc-cccccccccccccccceeEeeccc-cCcccc---ccCCCCcccCC
Q 018204          134 RD-RWGSTAAADAKYYGNVEVYNILKA-RGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       134 ~d-~~g~tpl~~A~~~~~~~~~~~L~~-~ga~~~---~~~~tpl~~a~  176 (359)
                      +| ..|+||||+|+..++.+++++|+. .|++++   ..+.||++.+.
T Consensus        87 ~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~tpL~~A~  134 (154)
T PHA02736         87 KERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKTPYYVAC  134 (154)
T ss_pred             cCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCCHHHHHH
Confidence            98 499999999999999999999997 488874   45678888774

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=2.4e-16  Score=137.50  Aligned_cols=133  Identities=26%  Similarity=0.391  Sum_probs=108.4

Q ss_pred             CcccceeEE---EEecCcEEEEEEeccCCCCcHH-----HHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          197 GITKGSYQV---AKWNGTKVWVKILDKESHKDPE-----RINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       197 ~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      .+|+|.++.   +.+.|..+++|+........+.     ....+.+|+.++..+.|++|.....++......+++|||++
T Consensus         3 ~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   82 (211)
T PRK14879          3 LIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIE   82 (211)
T ss_pred             ccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeC
Confidence            356666654   3557889999987644332221     22457889999999999999888777777788899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |++|.+++....   + ....++.+++.+|.++|+.+   ++|+|++|+|||++ ++.++|+|||+++.
T Consensus        83 G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         83 GEPLKDLINSNG---M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999986542   2 77889999999999999998   99999999999999 78899999999874

>PHA02730 ankyrin-like protein; Provisional

Probab=99.71  E-value=3.1e-18  Score=168.58  Aligned_cols=124  Identities=19%  Similarity=0.167  Sum_probs=102.1

Q ss_pred             CCcCcCCcccccCCCCCCCCCccHHHHHHHcCC----HHHHHHHHHcCC--CCCCCCCCCCcHHHH---HHHcC------
Q 018204           52 LDPIRRSPVQDELTVPENLDSTMQLLFMACRGD----VKGVEDLLNEGS--DVNSIDLDGRTALHI---AACEG------  116 (359)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~----~~~v~~Ll~~ga--~v~~~d~~g~TpLh~---A~~~g------  116 (359)
                      .+.++-+++. +++++.+.+|.||||+||..++    .+++++||++|+  |+|.+|..|.||||.   |+..+      
T Consensus       359 ieIvelLIs~-GAdIN~k~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~  437 (672)
T PHA02730        359 IPILRCMLDN-GATMDKTTDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCY  437 (672)
T ss_pred             HHHHHHHHHC-CCCCCcCCCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhcccccccc
Confidence            4444444444 4555566799999999999875    899999999998  699999999999994   33332      


Q ss_pred             ---CHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccccc----CCCCcccCC
Q 018204          117 ---HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT----KRTPMTVAN  176 (359)
Q Consensus       117 ---~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~----~~tpl~~a~  176 (359)
                         ..+++++|+.+|||+|++|..|.||||+|+..++.+++++|+++||+++..    +.||++.+.
T Consensus       438 e~~~~~ivk~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d~~~g~TaL~~Aa  504 (672)
T PHA02730        438 ETILIDVFDILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTSRSIINTAIQKSS  504 (672)
T ss_pred             chhHHHHHHHHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCCCcCCcCHHHHHH
Confidence               235799999999999999999999999999999999999999999998543    467887764

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.70  E-value=2e-18  Score=153.41  Aligned_cols=112  Identities=34%  Similarity=0.363  Sum_probs=101.2

Q ss_pred             CCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhc-
Q 018204           49 QSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK-  127 (359)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~-  127 (359)
                      +.+...|.+++.-++........|.|+||+|..+|..++|+.||..|||||.+|.+|.|+||.||.+||+|||++||.. 
T Consensus       317 ~~d~~vV~~LF~mgnVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p  396 (452)
T KOG0514|consen  317 PADRTVVERLFKMGDVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVP  396 (452)
T ss_pred             hhhHHHHHHHHhccCcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccC
Confidence            3445667777777776666678899999999999999999999999999999999999999999999999999999988 


Q ss_pred             CCCccccccccccccccccccccceeEeecccc
Q 018204          128 KANIDARDRWGSTAAADAKYYGNVEVYNILKAR  160 (359)
Q Consensus       128 ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~  160 (359)
                      ++|+...|.+|.|+|..|-..|+.+|.-+|-.+
T Consensus       397 ~cd~sLtD~DgSTAl~IAleagh~eIa~mlYa~  429 (452)
T KOG0514|consen  397 SCDISLTDVDGSTALSIALEAGHREIAVMLYAH  429 (452)
T ss_pred             cccceeecCCCchhhhhHHhcCchHHHHHHHHH
Confidence            899999999999999999999999998777654

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.70  E-value=2.8e-18  Score=123.31  Aligned_cols=95  Identities=32%  Similarity=0.502  Sum_probs=88.9

Q ss_pred             cHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccccccccee
Q 018204           74 MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEV  153 (359)
Q Consensus        74 t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~  153 (359)
                      ..++|+..+|..+-|+..+..|-|||.+ ..|+||||+||-+|.+++.++|+..||+++.+|+.|.|||.-|...||.++
T Consensus         4 ~~~~W~vkNG~~DeVk~~v~~g~nVn~~-~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~c   82 (117)
T KOG4214|consen    4 MSVAWNVKNGEIDEVKQSVNEGLNVNEI-YGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDC   82 (117)
T ss_pred             hhHhhhhccCcHHHHHHHHHccccHHHH-hCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHH
Confidence            4589999999999999999999999976 499999999999999999999999999999999999999999999999999


Q ss_pred             EeeccccCccccccCC
Q 018204          154 YNILKARGAKVPKTKR  169 (359)
Q Consensus       154 ~~~L~~~ga~~~~~~~  169 (359)
                      +++|++.||+......
T Consensus        83 VklLL~~GAdrt~~~P   98 (117)
T KOG4214|consen   83 VKLLLQNGADRTIHAP   98 (117)
T ss_pred             HHHHHHcCcccceeCC
Confidence            9999999998755543

>PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A

Probab=99.70  E-value=7.8e-18  Score=114.27  Aligned_cols=55  Identities=49%  Similarity=0.613  Sum_probs=32.8

Q ss_pred             HHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccc
Q 018204           91 LLNEG-SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (359)
Q Consensus        91 Ll~~g-a~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  145 (359)
                      ||++| +++|.+|..|.||||+||.+|+.++|++|++.|+|++.+|..|+||||+|
T Consensus         1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A   56 (56)
T PF13857_consen    1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA   56 (56)
T ss_dssp             -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred             CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence            67888 89999999999999999999999999999999999999999999999987

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=3e-16  Score=135.68  Aligned_cols=129  Identities=25%  Similarity=0.333  Sum_probs=102.8

Q ss_pred             cccceeEE---EEecCcEEEEEEeccCCCCcH-----HHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          198 ITKGSYQV---AKWNGTKVWVKILDKESHKDP-----ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       198 ig~g~~~~---~~~~g~~vavK~l~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      +|+|.++.   +.+.|..+++|..........     .....+.+|+.++..+.|+++....-++......+++|||++|
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            45666653   356788999999754332221     1235678899999999998877666666667778999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ++|.+++.....       .++.+++.+|.++|+.+   ++|+|++|+||+++ ++.++++|||+++.
T Consensus        82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998765321       78999999999999998   99999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0515 consensus p53-interacting protein 53BP/ASPP, contains ankyrin and SH3 domains [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=4.4e-18  Score=157.35  Aligned_cols=101  Identities=28%  Similarity=0.252  Sum_probs=55.5

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      +++++-.|.+|.|++.+.+-......|.+|.|+||-|.|.||.+||++||+.|+|||+.|.+||||||.||.++++.+++
T Consensus       554 LLDaaLeGEldlVq~~i~ev~DpSqpNdEGITaLHNAiCaghyeIVkFLi~~ganVNa~DSdGWTPLHCAASCNnv~~ck  633 (752)
T KOG0515|consen  554 LLDAALEGELDLVQRIIYEVTDPSQPNDEGITALHNAICAGHYEIVKFLIEFGANVNAADSDGWTPLHCAASCNNVPMCK  633 (752)
T ss_pred             HHhhhhcchHHHHHHHHHhhcCCCCCCccchhHHhhhhhcchhHHHHHHHhcCCcccCccCCCCchhhhhhhcCchHHHH
Confidence            44555555555555555544444444555555555555555555555555555555555555555555555555555555


Q ss_pred             HHHhcCCCccccc-cccccccc
Q 018204          123 LLLSKKANIDARD-RWGSTAAA  143 (359)
Q Consensus       123 ~Ll~~ga~~~~~d-~~g~tpl~  143 (359)
                      .|++.||-|-+.. .++.||..
T Consensus       634 qLVe~GaavfAsTlSDmeTa~e  655 (752)
T KOG0515|consen  634 QLVESGAAVFASTLSDMETAAE  655 (752)
T ss_pred             HHHhccceEEeeecccccchhh
Confidence            5555555554433 23344443

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.67  E-value=3.3e-17  Score=169.99  Aligned_cols=108  Identities=29%  Similarity=0.345  Sum_probs=92.8

Q ss_pred             CCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccc
Q 018204           68 ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY  147 (359)
Q Consensus        68 ~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~  147 (359)
                      .+.++.++||.||..|+.++++.|++.|+|+|.+|..|+||||+||..|+.++|++|+++|+|+|.+|.+|+||||+|+.
T Consensus       521 ~~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~  600 (823)
T PLN03192        521 DDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAIS  600 (823)
T ss_pred             CCccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHH
Confidence            34467899999999999999999999999999999999999999999999999999999999999999999999999888


Q ss_pred             cccceeEeeccccCcccc-ccCCCCcccC
Q 018204          148 YGNVEVYNILKARGAKVP-KTKRTPMTVA  175 (359)
Q Consensus       148 ~~~~~~~~~L~~~ga~~~-~~~~tpl~~a  175 (359)
                      .|+.+++++|.+.++..+ ..+.++++.|
T Consensus       601 ~g~~~iv~~L~~~~~~~~~~~~~~~L~~A  629 (823)
T PLN03192        601 AKHHKIFRILYHFASISDPHAAGDLLCTA  629 (823)
T ss_pred             hCCHHHHHHHHhcCcccCcccCchHHHHH
Confidence            888887777776655442 2233444444

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=1.3e-15  Score=135.17  Aligned_cols=138  Identities=17%  Similarity=0.179  Sum_probs=105.1

Q ss_pred             eccCcccceeEEEEecCcEEEEEEeccCCC----------CcHHHHHHHHHHHHHHHhCCCCcc--ccceeeEEeC-C--
Q 018204          194 KADGITKGSYQVAKWNGTKVWVKILDKESH----------KDPERINAFTHELTIVEKARHPNV--VQFVGAVTQN-I--  258 (359)
Q Consensus       194 ~~~~ig~g~~~~~~~~g~~vavK~l~~~~~----------~~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~-~--  258 (359)
                      .++..|.|+...+...+..++||.+.....          .+......+.+|+.++..+.|++|  +.++++.... .  
T Consensus        39 lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~  118 (239)
T PRK01723         39 VGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLF  118 (239)
T ss_pred             eecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcc
Confidence            345678888887777888999998853211          112233567889999999998875  5666654332 2  


Q ss_pred             -cEEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          259 -PMMIVLEYHAK-GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       259 -~~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                       ..++|||+++| .+|.+++... .++..    .+.|++.+|.+||++|   |+||||||+|||++.++.++|+|||.++
T Consensus       119 ~~~~lV~e~l~G~~~L~~~l~~~-~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~  190 (239)
T PRK01723        119 YRADILIERIEGARDLVALLQEA-PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGE  190 (239)
T ss_pred             eeeeEEEEecCCCCCHHHHHhcC-CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence             23599999997 6899888653 45554    3578999999999999   9999999999999999999999999998


Q ss_pred             ccc
Q 018204          337 LQY  339 (359)
Q Consensus       337 ~~~  339 (359)
                      ...
T Consensus       191 ~~~  193 (239)
T PRK01723        191 LRT  193 (239)
T ss_pred             cCC
Confidence            543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=7.4e-16  Score=152.83  Aligned_cols=133  Identities=22%  Similarity=0.239  Sum_probs=105.9

Q ss_pred             eeccCcccceeEEE---EecCcEEEEEEeccCCCC-----cHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          193 RKADGITKGSYQVA---KWNGTKVWVKILDKESHK-----DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       193 ~~~~~ig~g~~~~~---~~~g~~vavK~l~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      ...+.+|+|.|+.+   .+.+..+++|........     .....+.+.+|+.++..++|++++.+..++......++||
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            34566788888755   344556666654332211     1123356889999999999999998877777777789999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ||++|++|.+++.        ....++.|++.+|.|||+.+   ++||||||+|||+ .++.++|+|||+++.
T Consensus       416 E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        416 EYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999999885        34678999999999999998   9999999999999 678899999999984

>PHA02730 ankyrin-like protein; Provisional

Probab=99.66  E-value=5.9e-17  Score=159.61  Aligned_cols=99  Identities=15%  Similarity=0.121  Sum_probs=77.8

Q ss_pred             CCCCCCccHHHHHHHcC---CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC--CHHHHHHHHhcCC--Cccccccccc
Q 018204           67 PENLDSTMQLLFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG--HVEVVKLLLSKKA--NIDARDRWGS  139 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g---~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g--~~~~v~~Ll~~ga--~~~~~d~~g~  139 (359)
                      .+|.+|.||||+|+.+|   +.++|++||++|||+|++|..|+||||+|+..|  +.|+|++|+++|+  +++..|.-++
T Consensus        36 ~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~~~~d  115 (672)
T PHA02730         36 HIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTSNIND  115 (672)
T ss_pred             hcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCcccccccCC
Confidence            45677888888888876   588888888888888888888888888888866  6888888888854  4477777788


Q ss_pred             cccccccc--cccceeEeeccc-cCcccc
Q 018204          140 TAAADAKY--YGNVEVYNILKA-RGAKVP  165 (359)
Q Consensus       140 tpl~~A~~--~~~~~~~~~L~~-~ga~~~  165 (359)
                      +||+.++.  +++.+++++|++ .+++++
T Consensus       116 ~~l~~y~~s~n~~~~~vk~Li~~~~~~~~  144 (672)
T PHA02730        116 FDLYSYMSSDNIDLRLLKYLIVDKRIRPS  144 (672)
T ss_pred             chHHHHHHhcCCcHHHHHHHHHhcCCChh
Confidence            88887766  777788888885 555653

>smart00090 RIO RIO-like kinase

Probab=99.66  E-value=5.6e-16  Score=137.37  Aligned_cols=138  Identities=17%  Similarity=0.152  Sum_probs=101.5

Q ss_pred             EeeccCcccceeEEE---E---ecCcEEEEEEeccCCCC-------------------cHH--HHHHHHHHHHHHHhCCC
Q 018204          192 VRKADGITKGSYQVA---K---WNGTKVWVKILDKESHK-------------------DPE--RINAFTHELTIVEKARH  244 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~---~~g~~vavK~l~~~~~~-------------------~~~--~~~~~~~Ei~il~~l~H  244 (359)
                      +.....+|.|.++.+   .   .+|..+|+|++......                   ++.  ....+..|+.++..+.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            445556777777633   2   46899999998753211                   011  11345789999999976


Q ss_pred             Cc--cccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc
Q 018204          245 PN--VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD  322 (359)
Q Consensus       245 pn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~  322 (359)
                      ..  +++++.   . ...++||||++|.+|..+......+....+..++.|++.++.+||.++  .|+||||||+||+++
T Consensus       110 ~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~  183 (237)
T smart00090      110 AGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH  183 (237)
T ss_pred             cCCCCCeeeE---e-cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE
Confidence            33  333333   2 235899999999888776544445666677899999999999999986  399999999999999


Q ss_pred             CCCcEEEecccccc
Q 018204          323 NGGQLKISGFGLLR  336 (359)
Q Consensus       323 ~~~~~kl~DFGla~  336 (359)
                       ++.++|+|||+++
T Consensus       184 -~~~i~LiDFg~a~  196 (237)
T smart00090      184 -DGKVVIIDVSQSV  196 (237)
T ss_pred             -CCCEEEEEChhhh
Confidence             8899999999987

>PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A

Probab=99.66  E-value=2.5e-16  Score=106.22  Aligned_cols=54  Identities=43%  Similarity=0.657  Sum_probs=46.8

Q ss_pred             CccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH
Q 018204           72 STMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL  125 (359)
Q Consensus        72 ~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll  125 (359)
                      |+||||+||..|+.+++++|++.|+|+|.+|.+|+||||+|+..|+.+++++||
T Consensus         1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll   54 (54)
T PF13637_consen    1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL   54 (54)
T ss_dssp             SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred             CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence            789999999999999999999999999999999999999999999999999996

...

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.65  E-value=1.7e-17  Score=143.32  Aligned_cols=105  Identities=23%  Similarity=0.262  Sum_probs=89.1

Q ss_pred             cceeeccCCCCCcCc-CCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           42 MRFSFGRQSSLDPIR-RSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      .++.++..+...++. .++..+.-.+..|....||||.||.+||.++|+.||+..+|||+.|..|+|||||||..|...|
T Consensus        36 splhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqi  115 (448)
T KOG0195|consen   36 SPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQI  115 (448)
T ss_pred             chhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHH
Confidence            344455444444444 4454444455557788999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCcccccccccccccccc
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAK  146 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~  146 (359)
                      ++-|+..||-++..|+.|.|||..|.
T Consensus       116 aedli~~ga~v~icnk~g~tpldkak  141 (448)
T KOG0195|consen  116 AEDLISCGAAVNICNKKGMTPLDKAK  141 (448)
T ss_pred             HHHHHhccceeeecccCCCCchhhhc
Confidence            99999999999999999999999875

>PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

Probab=99.62  E-value=4.3e-16  Score=157.35  Aligned_cols=92  Identities=40%  Similarity=0.526  Sum_probs=88.2

Q ss_pred             cHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccccccccee
Q 018204           74 MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEV  153 (359)
Q Consensus        74 t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~  153 (359)
                      +.|+.||..|+.++|+.|++.|+|+|.+|..|+||||+||.+|+.++|++|+++|+|+|.+|..|+||||+|+..|+.++
T Consensus        84 ~~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~i  163 (664)
T PTZ00322         84 VELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREV  163 (664)
T ss_pred             HHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHH
Confidence            46899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             Eeecccc-------Ccccc
Q 018204          154 YNILKAR-------GAKVP  165 (359)
Q Consensus       154 ~~~L~~~-------ga~~~  165 (359)
                      +++|+++       |++.+
T Consensus       164 v~~Ll~~~~~~~~~ga~~~  182 (664)
T PTZ00322        164 VQLLSRHSQCHFELGANAK  182 (664)
T ss_pred             HHHHHhCCCcccccCCCCC
Confidence            9999998       66653

>PHA02792 ankyrin-like protein; Provisional

Probab=99.61  E-value=1.1e-16  Score=156.11  Aligned_cols=124  Identities=16%  Similarity=0.155  Sum_probs=77.6

Q ss_pred             cceeeccCCCCCcCcCCcccccCCCCCCCC--CccHHHHHHHcCCH---HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELTVPENLD--STMQLLFMACRGDV---KGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~t~l~~aa~~g~~---~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g  116 (359)
                      ..+.+|..|+.+.++.|+..+......|.+  +.||||+|+..+..   +++++|+++|||+|.+|..|+||||+|+..+
T Consensus       342 ~~~~Aa~~gn~eIVelLIs~GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs~GADIN~kD~~G~TPLh~Aa~~~  421 (631)
T PHA02792        342 KYFQKFDNRDPKVVEYILKNGNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKPYIDDINKIDKHGRSILYYCIESH  421 (631)
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHhcCCccccccccCcchHHHHHHcC
Confidence            345556666666666666665444444444  34677765554443   3466667777777777777777777777777


Q ss_pred             CHHHHHHHHhcCCCccccccccccccccccc----------cccceeEeeccccCcccc
Q 018204          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKY----------YGNVEVYNILKARGAKVP  165 (359)
Q Consensus       117 ~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~----------~~~~~~~~~L~~~ga~~~  165 (359)
                      +.+++++|+++|||+|.+|..|.|||++|+.          ....+++++|+++|.+++
T Consensus       422 n~eivelLLs~GADIN~kD~~G~TpL~~A~~~~~~~~~~i~~~~~~il~lLLs~~p~i~  480 (631)
T PHA02792        422 SVSLVEWLIDNGADINITTKYGSTCIGICVILAHACIPEIAELYIKILEIILSKLPTIE  480 (631)
T ss_pred             CHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHhcCCChh
Confidence            7777777777777777777777777777653          112345666666665543

>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]

Probab=99.61  E-value=3.8e-17  Score=136.02  Aligned_cols=128  Identities=20%  Similarity=0.092  Sum_probs=106.8

Q ss_pred             cCCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH
Q 018204           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (359)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~  114 (359)
                      .|...-..+.-+++.|-+..|+-+|..+...-.......|+|..|+..|..++|++||..+.|||.-|.+|-|||-||++
T Consensus       156 ~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLlyAvr  235 (296)
T KOG0502|consen  156 CDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLLYAVR  235 (296)
T ss_pred             ccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceeeeeec
Confidence            33444444445667888887777777665554446678899999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcc
Q 018204          115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       115 ~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      .||++||+.|++.|||++..|..|.+++..|+..|+. +++..++..+.
T Consensus       236 gnhvkcve~Ll~sGAd~t~e~dsGy~~mdlAValGyr-~Vqqvie~h~l  283 (296)
T KOG0502|consen  236 GNHVKCVESLLNSGADVTQEDDSGYWIMDLAVALGYR-IVQQVIEKHAL  283 (296)
T ss_pred             CChHHHHHHHHhcCCCcccccccCCcHHHHHHHhhhH-HHHHHHHHHHH
Confidence            9999999999999999999999999999999999988 45444444443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.60  E-value=4.7e-15  Score=128.19  Aligned_cols=132  Identities=17%  Similarity=0.085  Sum_probs=97.2

Q ss_pred             EeeccCcccceeEEE----EecCcEEEEEEeccCCCCcH-------------------HHHHHHHHHHHHHHhCCCCc--
Q 018204          192 VRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDP-------------------ERINAFTHELTIVEKARHPN--  246 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~~~-------------------~~~~~~~~Ei~il~~l~Hpn--  246 (359)
                      +.....+|.|.++.+    ..+|..++||++........                   .....+..|+.++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            334456777777643    22588999998764321100                   01123677899999998774  


Q ss_pred             cccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc
Q 018204          247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (359)
Q Consensus       247 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~  326 (359)
                      ++..++    ....+++|||++|++|..+...      .....++.+++.++.++|+.+   |+||||||+||+++.++.
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCc
Confidence            333333    2456899999999998776431      345678899999999999998   999999999999999999


Q ss_pred             EEEecccccc
Q 018204          327 LKISGFGLLR  336 (359)
Q Consensus       327 ~kl~DFGla~  336 (359)
                      ++|+|||++.
T Consensus       164 ~~liDfg~~~  173 (198)
T cd05144         164 IYIIDWPQMV  173 (198)
T ss_pred             EEEEECCccc
Confidence            9999999995

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0515 consensus p53-interacting protein 53BP/ASPP, contains ankyrin and SH3 domains [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=4.4e-16  Score=144.20  Aligned_cols=93  Identities=35%  Similarity=0.396  Sum_probs=88.1

Q ss_pred             ccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccce
Q 018204           73 TMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVE  152 (359)
Q Consensus        73 ~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~  152 (359)
                      .--|+-||..|.+|+|+..+..--|+...|..|-||||-|++.||++||++|++.|||||+.|.+||||||+|+..++..
T Consensus       551 LaLLLDaaLeGEldlVq~~i~ev~DpSqpNdEGITaLHNAiCaghyeIVkFLi~~ganVNa~DSdGWTPLHCAASCNnv~  630 (752)
T KOG0515|consen  551 LALLLDAALEGELDLVQRIIYEVTDPSQPNDEGITALHNAICAGHYEIVKFLIEFGANVNAADSDGWTPLHCAASCNNVP  630 (752)
T ss_pred             HHHHHhhhhcchHHHHHHHHHhhcCCCCCCccchhHHhhhhhcchhHHHHHHHhcCCcccCccCCCCchhhhhhhcCchH
Confidence            33467789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEeeccccCcccc
Q 018204          153 VYNILKARGAKVP  165 (359)
Q Consensus       153 ~~~~L~~~ga~~~  165 (359)
                      +++.|+++|+.+.
T Consensus       631 ~ckqLVe~Gaavf  643 (752)
T KOG0515|consen  631 MCKQLVESGAAVF  643 (752)
T ss_pred             HHHHHHhccceEE
Confidence            9999999999874

>cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

Probab=99.59  E-value=1.4e-15  Score=120.22  Aligned_cols=107  Identities=44%  Similarity=0.625  Sum_probs=93.2

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccccc
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYY  148 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~  148 (359)
                      |.+|.||||+|+..|+.+++++|++.|++++..|..|.||||+|+..++.+++++|++.|++++..+..|.||+|+|+..
T Consensus         4 ~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~~   83 (126)
T cd00204           4 DEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARN   83 (126)
T ss_pred             CcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHc
Confidence            46799999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccceeEeeccccCcccccc---CCCCcccC
Q 018204          149 GNVEVYNILKARGAKVPKT---KRTPMTVA  175 (359)
Q Consensus       149 ~~~~~~~~L~~~ga~~~~~---~~tpl~~a  175 (359)
                      ++.+++++|.+.|.+.+..   +.++++.+
T Consensus        84 ~~~~~~~~L~~~~~~~~~~~~~~~~~l~~~  113 (126)
T cd00204          84 GNLDVVKLLLKHGADVNARDKDGRTPLHLA  113 (126)
T ss_pred             CcHHHHHHHHHcCCCCcccCCCCCCHHHHH
Confidence            9999999999988655333   34444443

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats.

>PHA02792 ankyrin-like protein; Provisional

Probab=99.59  E-value=3.6e-16  Score=152.65  Aligned_cols=122  Identities=17%  Similarity=0.102  Sum_probs=101.5

Q ss_pred             CCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCC--CcHHHHHHHcCCHH---HHHHHHh
Q 018204           52 LDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDG--RTALHIAACEGHVE---VVKLLLS  126 (359)
Q Consensus        52 ~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g--~TpLh~A~~~g~~~---~v~~Ll~  126 (359)
                      ++.++-+++.+.... + .....+++.||..|+.++|++|+++|||+|.+|.+|  .||||+|+.....+   ++++|++
T Consensus       321 ieiIK~LId~Ga~~~-r-~~~~n~~~~Aa~~gn~eIVelLIs~GADIN~kD~~g~~~TpLh~A~~n~~~~v~~IlklLIs  398 (631)
T PHA02792        321 INVIKCMIDEGATLY-R-FKHINKYFQKFDNRDPKVVEYILKNGNVVVEDDDNIINIMPLFPTLSIHESDVLSILKLCKP  398 (631)
T ss_pred             HHHHHHHHHCCCccc-c-CCcchHHHHHHHcCCHHHHHHHHHcCCchhhhcCCCCChhHHHHHHHhccHhHHHHHHHHHh
Confidence            344555555554432 2 235667999999999999999999999999999875  69999988776654   6899999


Q ss_pred             cCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       127 ~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +|||+|.+|..|+||||+|+..++.+++++|+++|++++   ..+.||++.+
T Consensus       399 ~GADIN~kD~~G~TPLh~Aa~~~n~eivelLLs~GADIN~kD~~G~TpL~~A  450 (631)
T PHA02792        399 YIDDINKIDKHGRSILYYCIESHSVSLVEWLIDNGADINITTKYGSTCIGIC  450 (631)
T ss_pred             cCCccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHH
Confidence            999999999999999999999999999999999999985   4467888876

>TIGR00870 trp transient-receptor-potential calcium channel protein

Probab=99.59  E-value=8.1e-16  Score=158.45  Aligned_cols=111  Identities=25%  Similarity=0.283  Sum_probs=94.3

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC--------------CCCCcHHHHHHHcCCHHHHHHHHhcCCCcccc
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID--------------LDGRTALHIAACEGHVEVVKLLLSKKANIDAR  134 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d--------------~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~  134 (359)
                      +..|.||||+||.+|+.++|++|+++|||||.++              ..|.||||+|+..|+.+++++|+++|||+|.+
T Consensus       125 ~~~G~TpLhlAa~~~~~eiVklLL~~GAdv~~~~~~~~~~~~~~~~~~~~g~tpL~~Aa~~~~~~iv~lLl~~gadin~~  204 (743)
T TIGR00870       125 FTPGITALHLAAHRQNYEIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLNAAACLGSPSIVALLSEDPADILTA  204 (743)
T ss_pred             cCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCcCcCCchhhcCCCCCcccccccHHHHHHHhCCHHHHHHHhcCCcchhhH
Confidence            3469999999999999999999999999999764              36999999999999999999999999999999


Q ss_pred             ccccccccccccccc---------cceeEeeccccCccc----------cccCCCCcccCCCCC
Q 018204          135 DRWGSTAAADAKYYG---------NVEVYNILKARGAKV----------PKTKRTPMTVANPRE  179 (359)
Q Consensus       135 d~~g~tpl~~A~~~~---------~~~~~~~L~~~ga~~----------~~~~~tpl~~a~~~~  179 (359)
                      |..|+||||+|+..+         ...+.+++++.++..          |..+.||++.|....
T Consensus       205 d~~g~T~Lh~A~~~~~~~~~~~~l~~~~~~~l~~ll~~~~~~~el~~i~N~~g~TPL~~A~~~g  268 (743)
T TIGR00870       205 DSLGNTLLHLLVMENEFKAEYEELSCQMYNFALSLLDKLRDSKELEVILNHQGLTPLKLAAKEG  268 (743)
T ss_pred             hhhhhHHHHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCChHhhhhhcCCCCCCchhhhhhcC
Confidence            999999999999876         233556666655542          667889999885443

after chronic exposure to capsaicin. (McCleskey and Gold, 1999).

>KOG0507 consensus CASK-interacting adaptor protein (caskin) and related proteins with ankyrin repeats and SAM domain [Signal transduction mechanisms]

Probab=99.58  E-value=1.7e-16  Score=152.94  Aligned_cols=133  Identities=21%  Similarity=0.192  Sum_probs=101.1

Q ss_pred             ceeeccCCCCCcCcCCcccccC-------------CCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDEL-------------TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTAL  109 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpL  109 (359)
                      +.++++.|+.+.+..++.....             .+-.|.+|.|+||+|+.+|+.+++++|+++.+-++..|..|.+||
T Consensus         7 l~~a~ka~d~~tva~ll~~~~~r~~~l~~~trsds~n~qd~~gfTalhha~Lng~~~is~llle~ea~ldl~d~kg~~pl   86 (854)
T KOG0507|consen    7 LIDACKAGDYDTVALLLSSKKGRSGLLFFTTRSDSHNLQDYSGFTLLHHAVLNGQNQISKLLLDYEALLDLCDTKGILPL   86 (854)
T ss_pred             HHHhhhcccHHHHHHhccCCCCCCCCCCCCCCCccccccCccchhHHHHHHhcCchHHHHHHhcchhhhhhhhccCcceE
Confidence            3455666666666555553311             123366888888888888888888888888888888888888888


Q ss_pred             HHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccC
Q 018204          110 HIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA  175 (359)
Q Consensus       110 h~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a  175 (359)
                      |+||++|+.++|+.|+.++..+|+.+..|.||||.|+..|+.+++.+|+++|++.   +..+.|++..+
T Consensus        87 hlaaw~g~~e~vkmll~q~d~~na~~~e~~tplhlaaqhgh~dvv~~Ll~~~adp~i~nns~~t~ldlA  155 (854)
T KOG0507|consen   87 HLAAWNGNLEIVKMLLLQTDILNAVNIENETPLHLAAQHGHLEVVFYLLKKNADPFIRNNSKETVLDLA  155 (854)
T ss_pred             EehhhcCcchHHHHHHhcccCCCcccccCcCccchhhhhcchHHHHHHHhcCCCccccCcccccHHHHH
Confidence            8888888888888888888888888888888888888888888888888888887   33344555544

>TIGR00870 trp transient-receptor-potential calcium channel protein

Probab=99.58  E-value=3.3e-16  Score=161.38  Aligned_cols=134  Identities=24%  Similarity=0.257  Sum_probs=99.4

Q ss_pred             ceeeccCCCCCcCcCCcccc-cCCCC-CCCCCccHHH-HHHHcCCHHHHHHHHHcCC-----------------------
Q 018204           43 RFSFGRQSSLDPIRRSPVQD-ELTVP-ENLDSTMQLL-FMACRGDVKGVEDLLNEGS-----------------------   96 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~t~l~-~aa~~g~~~~v~~Ll~~ga-----------------------   96 (359)
                      .+.+++.|+++.++.+++.. +.+++ .|..|+|||| .|+.+++.+++++|++.|+                       
T Consensus        21 ~l~A~~~g~~~~v~~lL~~~~~~~in~~d~~G~t~Lh~~A~~~~~~eiv~lLl~~g~~~~~G~T~Lh~A~~~~~~~v~~l  100 (743)
T TIGR00870        21 FLPAAERGDLASVYRDLEEPKKLNINCPDRLGRSALFVAAIENENLELTELLLNLSCRGAVGDTLLHAISLEYVDAVEAI  100 (743)
T ss_pred             HHHHHHcCCHHHHHHHhccccccCCCCcCccchhHHHHHHHhcChHHHHHHHHhCCCCCCcChHHHHHHHhccHHHHHHH
Confidence            34566677777776666552 22222 3566777777 5555666677777766663                       


Q ss_pred             ---------C------CC----CCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccc--------------cccccccc
Q 018204           97 ---------D------VN----SIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD--------------RWGSTAAA  143 (359)
Q Consensus        97 ---------~------v~----~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d--------------~~g~tpl~  143 (359)
                               +      ++    ..+..|.||||+||.+|+.++|++|+++|||++.++              ..|.||||
T Consensus       101 l~~l~~~~~~~~~~~~~~~~~~~~~~~G~TpLhlAa~~~~~eiVklLL~~GAdv~~~~~~~~~~~~~~~~~~~~g~tpL~  180 (743)
T TIGR00870       101 LLHLLAAFRKSGPLELANDQYTSEFTPGITALHLAAHRQNYEIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLN  180 (743)
T ss_pred             HHHHhhcccccCchhhhccccccccCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCcCcCCchhhcCCCCCcccccccHHH
Confidence                     0      01    112469999999999999999999999999999764              36899999


Q ss_pred             cccccccceeEeeccccCccc---cccCCCCcccCC
Q 018204          144 DAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN  176 (359)
Q Consensus       144 ~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~  176 (359)
                      .|+..|+.+++++|+++|+++   +..++|+++.+.
T Consensus       181 ~Aa~~~~~~iv~lLl~~gadin~~d~~g~T~Lh~A~  216 (743)
T TIGR00870       181 AAACLGSPSIVALLSEDPADILTADSLGNTLLHLLV  216 (743)
T ss_pred             HHHHhCCHHHHHHHhcCCcchhhHhhhhhHHHHHHH
Confidence            999999999999999999987   455688888763

after chronic exposure to capsaicin. (McCleskey and Gold, 1999).

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.58  E-value=5.5e-14  Score=128.79  Aligned_cols=138  Identities=32%  Similarity=0.540  Sum_probs=115.8

Q ss_pred             cCcccceeEEEE--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC-ccccceeeEEeCCcEEEEEecCCCCCH
Q 018204          196 DGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP-NVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       196 ~~ig~g~~~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      ..+|.|.|+.+.  .....+++|.+.............+.+|+.++..+.|+ +|+++++.+......+++++++.++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l   85 (384)
T COG0515           6 RKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSL   85 (384)
T ss_pred             EeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcH
Confidence            344555554321  12267899999876655544567899999999999988 799999999777778999999999999


Q ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEecccccc
Q 018204          273 ASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLR  336 (359)
Q Consensus       273 ~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DFGla~  336 (359)
                      .+++....   .++......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||+++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          86 EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             HHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            98877664   6999999999999999999999999   99999999999999988 79999999886

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.57  E-value=1.4e-15  Score=157.78  Aligned_cols=92  Identities=15%  Similarity=0.239  Sum_probs=74.9

Q ss_pred             hCCC-CccccceeeE-------EeCCcEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 018204          241 KARH-PNVVQFVGAV-------TQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIH  311 (359)
Q Consensus       241 ~l~H-pnIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiH  311 (359)
                      .+.| +||.+++++|       .....+++++|++ +++|.+++... ..+++..+..++.||+.||.|||+++   |||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence            3445 5777788876       2334678889988 55999999753 45999999999999999999999998   999


Q ss_pred             CCCCCCcEEEcC-------------------CCcEEEecccccc
Q 018204          312 CDLKPKNILLDN-------------------GGQLKISGFGLLR  336 (359)
Q Consensus       312 rDlk~~NIll~~-------------------~~~~kl~DFGla~  336 (359)
                      |||||+||||+.                   ++.+|++|||+++
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~  147 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSR  147 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccc
Confidence            999999999953                   4567888888875

>COG0666 Arp FOG: Ankyrin repeat [General function prediction only]

Probab=99.57  E-value=1.3e-15  Score=133.20  Aligned_cols=113  Identities=27%  Similarity=0.378  Sum_probs=67.3

Q ss_pred             CCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCC-----HHHHHHHHHcCC---CCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           49 QSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGD-----VKGVEDLLNEGS---DVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        49 ~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~-----~~~v~~Ll~~ga---~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      .++...+..++..+......+.+|.||||+|+..|+     .++++.|++.|+   +.+.+|..|+||||+|+..|+.++
T Consensus        83 ~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~~~~~ll~~g~~~~~~~~~~~~g~tpl~~A~~~~~~~~  162 (235)
T COG0666          83 KGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADI  162 (235)
T ss_pred             cCcHHHHHHHHHcCCCcccccCCCCcHHHHHHhcCCcccchHHHHHHHHHcCCCCCCccccCCCCCchhHHHHHcCchHH
Confidence            344444444444444334445666666666666666     666666666666   444446666666666666666666


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccccC
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g  161 (359)
                      +++|++.|++++.++..|.|++++|+..++.+++..+...+
T Consensus       163 ~~~ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~l~~~~  203 (235)
T COG0666         163 VELLLEAGADPNSRNSYGVTALDPAAKNGRIELVKLLLDKG  203 (235)
T ss_pred             HHHHHhcCCCCcccccCCCcchhhhcccchHHHHHHHHhcC
Confidence            66666666666666666666666666666666666666554

>KOG1710 consensus MYND Zn-finger and ankyrin repeat protein [General function prediction only]

Probab=99.57  E-value=4.3e-16  Score=134.59  Aligned_cols=118  Identities=25%  Similarity=0.219  Sum_probs=104.3

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCC-CCCCCCcHHHHHHHcCCHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNS-IDLDGRTALHIAACEGHVEVV  121 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~-~d~~g~TpLh~A~~~g~~~~v  121 (359)
                      +|.+...++.+....+|....-.+..|..|.|+|..||..|+++.|++||+.|||||. ++..+.||||+||..|+.+|.
T Consensus        16 Lle~i~Kndt~~a~~LLs~vr~vn~~D~sGMs~LahAaykGnl~~v~lll~~gaDvN~~qhg~~YTpLmFAALSGn~dvc   95 (396)
T KOG1710|consen   16 LLEAIDKNDTEAALALLSTVRQVNQRDPSGMSVLAHAAYKGNLTLVELLLELGADVNDKQHGTLYTPLMFAALSGNQDVC   95 (396)
T ss_pred             HHHHHccCcHHHHHHHHHHhhhhhccCCCcccHHHHHHhcCcHHHHHHHHHhCCCcCcccccccccHHHHHHHcCCchHH
Confidence            3456667777777777776655667799999999999999999999999999999997 467899999999999999999


Q ss_pred             HHHHhcCCCccccccccccccccccccccceeEeecccc
Q 018204          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKAR  160 (359)
Q Consensus       122 ~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~  160 (359)
                      ++|++.||.....|.-|+|+-..|++-|+.++|.++-.+
T Consensus        96 rllldaGa~~~~vNsvgrTAaqmAAFVG~H~CV~iINN~  134 (396)
T KOG1710|consen   96 RLLLDAGARMYLVNSVGRTAAQMAAFVGHHECVAIINNH  134 (396)
T ss_pred             HHHHhccCccccccchhhhHHHHHHHhcchHHHHHHhcc
Confidence            999999999999999999999999999999988765443

>cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

Probab=99.56  E-value=2e-15  Score=119.31  Aligned_cols=120  Identities=32%  Similarity=0.396  Sum_probs=108.0

Q ss_pred             CCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      .....++.+++.|+.+.+..++..+......+..|.||||.|+..++.+++++|++.|++++..|..|.||+|+|+..++
T Consensus         6 ~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~~~~   85 (126)
T cd00204           6 DGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGN   85 (126)
T ss_pred             CCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCc
Confidence            34455667788888888888887776667778899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeec
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL  157 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L  157 (359)
                      .+++++|++.|.+++..|..|.||+++|...++.+++++|
T Consensus        86 ~~~~~~L~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L  125 (126)
T cd00204          86 LDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLL  125 (126)
T ss_pred             HHHHHHHHHcCCCCcccCCCCCCHHHHHHhcCCHHHHHHh
Confidence            9999999999999999999999999999988888777665

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.55  E-value=1.3e-14  Score=132.35  Aligned_cols=135  Identities=23%  Similarity=0.385  Sum_probs=115.0

Q ss_pred             eEeeccCcccceeEEEE-----e---cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVAK-----W---NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~---~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~  261 (359)
                      .+...+.+|.|+|..+.     .   ..+.+|+|.+.....  +   ..+..|++++..+ .+.||+++.+++..++...
T Consensus        37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--P---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--c---hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            46667789999998551     2   567899999865443  2   2478899999998 5899999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGla~  336 (359)
                      +|+||++.-...++...   ++...+..+++.++.||.++|.+|   ||||||||+|+|.+. .+.-.|.|||+|.
T Consensus       112 ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence            99999999888888753   678899999999999999999999   999999999999986 4678899999996

>PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A

Probab=99.54  E-value=6.1e-15  Score=100.01  Aligned_cols=54  Identities=30%  Similarity=0.326  Sum_probs=32.3

Q ss_pred             cccccCC-CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHH
Q 018204           59 PVQDELT-VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIA  112 (359)
Q Consensus        59 ~~~~~~~-~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A  112 (359)
                      ++.+..+ ...|..|.||||+||..|+.++|++|++.|+|++.+|.+|+||||+|
T Consensus         2 L~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A   56 (56)
T PF13857_consen    2 LEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA   56 (56)
T ss_dssp             ----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred             CccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence            4445233 44588999999999999999999999999999999999999999998

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.54  E-value=4.3e-14  Score=131.45  Aligned_cols=139  Identities=22%  Similarity=0.351  Sum_probs=111.2

Q ss_pred             eEeeccCcccceeEEE---Ee-c--CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC----CccccceeeE-EeCCc
Q 018204          191 QVRKADGITKGSYQVA---KW-N--GTKVWVKILDKESHKDPERINAFTHELTIVEKARH----PNVVQFVGAV-TQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-~--g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~  259 (359)
                      .|.+...+|+|.|+.+   .. .  ...+|+|+..........   .+..|..++..+..    +++..+++.. .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            6778888999998744   22 1  236788877643222211   36678888888863    5888888888 47778


Q ss_pred             EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-----CcEEEecc
Q 018204          260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-----GQLKISGF  332 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~-----~~~kl~DF  332 (359)
                      .|+||+.+ |.+|.++....  +.++..++..++.|++.+|+++|+.|   +|||||||+|+++...     ..+.|.||
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence            99999988 77999988654  46999999999999999999999999   9999999999999865     35999999


Q ss_pred             cccc
Q 018204          333 GLLR  336 (359)
Q Consensus       333 Gla~  336 (359)
                      |+|+
T Consensus       172 Glar  175 (322)
T KOG1164|consen  172 GLAR  175 (322)
T ss_pred             CCCc
Confidence            9998

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=4.5e-14  Score=131.00  Aligned_cols=128  Identities=23%  Similarity=0.324  Sum_probs=103.9

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-----C---CccccceeeEEe
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-----H---PNVVQFVGAVTQ  256 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~~  256 (359)
                      -.|.+..++|.|-|..+     ......||+|+.+..    ....+..+.||.+|+++.     |   ..||+|++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            45777788899988643     235678999998632    234456788999999873     3   369999999975


Q ss_pred             C----CcEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC
Q 018204          257 N----IPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG  324 (359)
Q Consensus       257 ~----~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~  324 (359)
                      .    .++|+|+|++ |-+|..+|...  +.++...++.|++||+.||.|||...  +|||-||||+|||+...
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence            4    4799999999 66999999875  46999999999999999999999887  49999999999999654

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.52  E-value=9.6e-14  Score=118.67  Aligned_cols=137  Identities=19%  Similarity=0.188  Sum_probs=89.4

Q ss_pred             CcccceeEEE----EecCcEEEEEEeccCCCCcHHHHHH---------------------HHHHHHHHHhCCCCc--ccc
Q 018204          197 GITKGSYQVA----KWNGTKVWVKILDKESHKDPERINA---------------------FTHELTIVEKARHPN--VVQ  249 (359)
Q Consensus       197 ~ig~g~~~~~----~~~g~~vavK~l~~~~~~~~~~~~~---------------------~~~Ei~il~~l~Hpn--Iv~  249 (359)
                      .+|+|.++.+    ..+|..+|||++.............                     ...|...+..+.+..  +.+
T Consensus         4 ~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~   83 (187)
T cd05119           4 PIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPK   83 (187)
T ss_pred             ccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCc
Confidence            4566766533    2358999999986543221111111                     134555565554432  334


Q ss_pred             ceeeEEeCCcEEEEEecCCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcE
Q 018204          250 FVGAVTQNIPMMIVLEYHAKGDLAS-YLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQL  327 (359)
Q Consensus       250 l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~  327 (359)
                      ++++    ...+++|||++++++.. .+.... .. ..+..++.+++.++.++|. ++   |+||||||+||+++ ++.+
T Consensus        84 ~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          84 PIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             eEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcE
Confidence            4432    24689999999854321 121111 11 5678899999999999999 88   99999999999999 8999


Q ss_pred             EEeccccccccccCccc
Q 018204          328 KISGFGLLRLQYISPEK  344 (359)
Q Consensus       328 kl~DFGla~~~~~~PE~  344 (359)
                      +|+|||.++ ....|+.
T Consensus       154 ~liDfg~a~-~~~~~~~  169 (187)
T cd05119         154 YIIDVPQAV-EIDHPNA  169 (187)
T ss_pred             EEEECcccc-cccCcch
Confidence            999999997 3333443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>COG0666 Arp FOG: Ankyrin repeat [General function prediction only]

Probab=99.51  E-value=2.3e-14  Score=125.20  Aligned_cols=112  Identities=37%  Similarity=0.452  Sum_probs=101.0

Q ss_pred             CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC-----HHHHHHHHhcCC---Ccccccccc
Q 018204           67 PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH-----VEVVKLLLSKKA---NIDARDRWG  138 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~-----~~~v~~Ll~~ga---~~~~~d~~g  138 (359)
                      ..+..+.+++|.++..|..+++++|+..|++++.+|.+|.||||+|+.+|+     .+++++|++.|+   +.+.+|..|
T Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~~~~~ll~~g~~~~~~~~~~~~g  147 (235)
T COG0666          68 ARDLDGRLPLHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADLDVNNLRDEDG  147 (235)
T ss_pred             cCCccccCHHHHHHHcCcHHHHHHHHHcCCCcccccCCCCcHHHHHHhcCCcccchHHHHHHHHHcCCCCCCccccCCCC
Confidence            345568999999999999999999999999999999999999999999999     999999999999   677779999


Q ss_pred             ccccccccccccceeEeeccccCcccc---ccCCCCcccCCCC
Q 018204          139 STAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVANPR  178 (359)
Q Consensus       139 ~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~~~  178 (359)
                      +||||+|+..|+.+++.+|++.|++++   ..+.|+++.+...
T Consensus       148 ~tpl~~A~~~~~~~~~~~ll~~~~~~~~~~~~g~t~l~~a~~~  190 (235)
T COG0666         148 NTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDPAAKN  190 (235)
T ss_pred             CchhHHHHHcCchHHHHHHHhcCCCCcccccCCCcchhhhccc
Confidence            999999999999999999999999874   4456777766543

>PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

Probab=99.51  E-value=1.4e-14  Score=146.48  Aligned_cols=104  Identities=24%  Similarity=0.245  Sum_probs=95.1

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      ++.++..|+.+.++.++..+......|.+|+||||+||.+|+.++|++|++.|+|+|.+|..|+||||+|+.+|+.++++
T Consensus        86 L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~  165 (664)
T PTZ00322         86 LCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREVVQ  165 (664)
T ss_pred             HHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHH
Confidence            34567899999999888877666667899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhc-------CCCcccccccccccccccc
Q 018204          123 LLLSK-------KANIDARDRWGSTAAADAK  146 (359)
Q Consensus       123 ~Ll~~-------ga~~~~~d~~g~tpl~~A~  146 (359)
                      +|+++       |++++..+..|.+|+..+.
T Consensus       166 ~Ll~~~~~~~~~ga~~~~~~~~g~~~~~~~~  196 (664)
T PTZ00322        166 LLSRHSQCHFELGANAKPDSFTGKPPSLEDS  196 (664)
T ss_pred             HHHhCCCcccccCCCCCccccCCCCccchhh
Confidence            99999       9999999999998887664

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	359
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-24
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-14
4hqd_A	169	Crystal Structure Of Engineered Protein. Northeast		2e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-14
4gpm_A	169	Crystal Structure Of Engineered Protein. Northeast		3e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-13
1n0r_A	126	4ank: A Designed Ankyrin Repeat Protein With Four I		3e-13
4gmr_A	169	Crystal Structure Of Engineered Protein. Northeast		3e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-13
4dui_A	169	Darpin D1 Binding To Tubulin Beta Chain (not In Com		3e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-13
4drx_E	169	Gtp-Tubulin In Complex With A Darpin Length = 169		6e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-13
2l6b_A	115	Nrc Consensus Ankyrin Repeat Protein Solution Struc		7e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-13
4hb5_A	169	Crystal Structure Of Engineered Protein. Northeast		9e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-12
4f6r_D	169	Tubulin:stathmin-Like Domain Complex Length = 169		2e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
4atz_D	154	Ad5 Knob In Complex With A Designed Ankyrin Repeat		2e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-12
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-12
2xeh_A	157	Structural Determinants For Improved Thermal Stabil		6e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-12
2xee_A	157	Structural Determinants For Improved Thermal Stabil		7e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-12
1mj0_A	166	Sank E3_5: An Artificial Ankyrin Repeat Protein Len		8e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		9e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-11
1svx_A	169	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
1n0q_A	93	3ank: A Designed Ankyrin Repeat Protein With Three		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-11
2j8s_D	169	Drug Export Pathway Of Multidrug Exporter Acrb Reve		3e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-11
2qyj_A	166	Crystal Structure Of A Designed Full Consensus Anky		5e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-11
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-11
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-11
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-11
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-11
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-11
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-11
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		6e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-11
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-11
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-11
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-11
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-11
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-11
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-11
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-11
2bkg_A	166	Crystal Structure Of E3_19 An Designed Ankyrin Repe		8e-11
2v5q_C	167	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		8e-11
3q9u_C	158	In Silico And In Vitro Co-Evolution Of A High Affin		8e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-11
2xzd_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4		8e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-10
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-10
2y0b_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4_		1e-10
3noc_D	169	Designed Ankyrin Repeat Protein (Darpin) Binders To		1e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-10
2bkk_B	169	Crystal Structure Of Aminoglycoside Phosphotransfer		2e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-10
2xzt_G	136	Caspase-3 In Complex With Darpin-3.4_i78s Length =		3e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
2y1l_E	169	Caspase-8 In Complex With Darpin-8.4 Length = 169		4e-10
2y1l_E	169	Caspase-8 In Complex With Darpin-8.4 Length = 169		4e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-10
3zu7_B	169	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-10
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-10
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-10
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-10
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		8e-10
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-10
3zuv_B	136	Crystal Structure Of A Designed Selected Ankyrin Re		8e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-10
2xen_A	91	Structural Determinants For Improved Thermal Stabil		9e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-09
2p2c_P	169	Inhibition Of Caspase-2 By A Designed Ankyrin Repea		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-09
3nog_D	169	Designed Ankyrin Repeat Protein (Darpin) Binders To		1e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-09
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-09
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-09
2v4h_C	136	Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-09
3hg0_D	136	Crystal Structure Of A Darpin In Complex With Orf49		3e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-09
2jab_A	136	A Designed Ankyrin Repeat Protein Evolved To Picomo		4e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-09
1n11_A	437	D34 Region Of Human Ankyrin-R And Linker Length = 4		9e-09
1n11_A	437	D34 Region Of Human Ankyrin-R And Linker Length = 4		2e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
4grg_A	135	Crystal Structure Of Ige Complexed With E2_79, An A		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
2zgg_A	92	Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-08
2zgd_A	110	Asn-Hydroxylation Stabilises The Ankyrin Repeat Dom		3e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-08
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-08
3c5r_A	137	Crystal Structure Of The Bard1 Ankyrin Repeat Domai		4e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		5e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-08
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		7e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-08
1s70_B	299	Complex Between Protein Ser/thr Phosphatase-1 (delt		9e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
1myo_A	118	Solution Structure Of Myotrophin, Nmr, 44 Structure		1e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3twr_A	165	Crystal Structure Of Arc4 From Human Tankyrase 2 In		1e-07
3twu_A	167	Crystal Structure Of Arc4 From Human Tankyrase 2 In		1e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
3twq_A	175	Crystal Structure Of Arc4 From Human Tankyrase 2 (A		1e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-07
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-07
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
1mx4_A	168	Structure Of P18ink4c (F82q) Length = 168		2e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-07
1mx6_A	168	Structure Of P18ink4c (F92n) Length = 168		2e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-07
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-07
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-07
3aaa_C	123	Crystal Structure Of Actin Capping Protein In Compl		4e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-07
1ihb_A	162	Crystal Structure Of P18-Ink4c(Ink6) Length = 162		4e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-07
1bu9_A	168	Solution Structure Of P18-Ink4c, 21 Structures Leng		4e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-07
3utm_A	351	Crystal Structure Of A Mouse Tankyrase-Axin Complex		4e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-07
1mx2_A	168	Structure Of F71n Mutant Of P18ink4c Length = 168		5e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-07
2rfm_A	192	Structure Of A Thermophilic Ankyrin Repeat Protein		6e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-07
3f6q_A	179	Crystal Structure Of Integrin-Linked Kinase Ankyrin		8e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-07
1ycs_B	239	P53-53bp2 Complex Length = 239		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-06
4a63_B	239	Crystal Structure Of The P73-Aspp2 Complex At 2.6a		1e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
4g8k_A	337	Intact Sensor Domain Of Human Rnase L In The Inacti		2e-06
1wdy_A	285	Crystal Structure Of Ribonuclease Length = 285		2e-06
2kbx_A	171	Solution Structure Of Ilk-Pinch Complex Length = 17		2e-06
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-06
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-06
1uoh_A	226	Human Gankyrin Length = 226		4e-06
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-06
4b93_B	269	Complex Of Vamp7 Cytoplasmic Domain With 2nd Ankyri		5e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-06
1qym_A	227	X-Ray Structure Of Human Gankyrin Length = 227		5e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-06
1ot8_A	239	Structure Of The Ankyrin Domain Of The Drosophila N		5e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-06
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-06
3aji_A	231	Structure Of Gankyrin-S6atpase Photo-Cross-Linked S		8e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-06
2dvw_A	231	Structure Of The Oncoprotein Gankyrin In Complex Wi		9e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-05
3b7b_A	237	Euhmt1 (Glp) Ankyrin Repeat Domain (Structure 1) Le		2e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-05
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-05
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-05
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-05
1awc_B	153	Mouse Gabp AlphaBETA DOMAIN BOUND TO DNA Length = 1		5e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		7e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-05
3uxg_A	172	Crystal Structure Of Rfxank Length = 172		8e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-04
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-04
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-04
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-04
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-04
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-04
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
3t9k_A	390	Crystal Structure Of Acap1 C-portion Mutant S554d F		2e-04
3jue_A	368	Crystal Structure Of Arfgap And Ank Repeat Domain O		2e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-04
4f1p_A	368	Crystal Structure Of Mutant S554d For Arfgap And An		2e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-04
3v30_A	172	Crystal Structure Of The Peptide Bound Complex Of T		3e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-04
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-04
3ehq_A	222	Crystal Structure Of Human Osteoclast Stimulating F		4e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-04
4hbd_A	276	Crystal Structure Of Kank2 Ankyrin Repeats Length =		5e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		7e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		7e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		7e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-04
3eu9_A	240	The Ankyrin Repeat Domain Of Huntingtin Interacting		9e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-04

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 68/164 (41%), Positives = 99/164 (60%), Gaps = 11/164 (6%)
Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKIL-DKESHKDPERINAFTHELT 237
           ++P  +LN  E    K    + G+   A+W+G+ V VKIL +++ H   ER+N F  E+ 
Sbjct: 33  DIPWCDLNIKE----KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHA--ERVNEFLREVA 86
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDL 294
           I+++ RHPN+V F+GAVTQ   + IV EY ++G L   L K G   +L   + L  A D+
Sbjct: 87  IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           A+GMNYLH   P PI+H DLK  N+L+D    +K+  FGL RL+
Sbjct: 147 AKGMNYLHNRNP-PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLK 189

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/163 (41%), Positives = 96/163 (58%), Gaps = 9/163 (5%)
Query: 179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           ++P  +LN  E    K    + G+   A+W+G+ V VKIL  E     ER+N F  E+ I
Sbjct: 33  DIPWCDLNIKE----KIGAGSFGTVHRAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAI 87
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLA 295
           +++ RHPN+V F+GAVTQ   + IV EY ++G L   L K G   +L   + L  A D+A
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           +GMNYLH   P PI+H +LK  N+L+D    +K+  FGL RL+
Sbjct: 148 KGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/162 (33%), Positives = 82/162 (50%), Gaps = 15/162 (9%)
Query: 201 GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G  ++ KW G   V VK++ + S  + E    F  E   + K  HP +V+F G  ++  P
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTMMKLSHPKLVKFYGVCSKEYP 77
Query: 260 MMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           + IV EY + G L +YL+  G+ L PS++L    D+  GM +L   +    IH DL  +N
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARN 134
Query: 319 ILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
            L+D    +K+S FG+ R     QY+S    K  FPV    P
Sbjct: 135 CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK--FPVKWSAP 174

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 80/152 (52%), Gaps = 16/152 (10%)
Query: 189 ELQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP 245
           E++V +  G  +G++ V   AKW    V +K ++ ES +      AF  EL  + +  HP
Sbjct: 10  EIEVEEVVG--RGAFGVVCKAKWRAKDVAIKQIESESER-----KAFIVELRQLSRVNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL---SPSKVLRFALDLARGMNYLH 302
           N+V+  GA     P+ +V+EY   G L + L     L   + +  + + L  ++G+ YLH
Sbjct: 63  NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 120
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQ-LKISGFG 333
             +P  +IH DLKP N+LL  GG  LKI  FG
Sbjct: 121 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 152

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/257 (29%), Positives = 121/257 (47%), Gaps = 35/257 (13%)
Query: 113 ACEGHVEVVKLLL-SKKANIDARDRWGSTAAADAKYYGN----VEVYNILKARG--AKVP 165
           +CEG VE  +++  + K +ID           +  Y+ N    VE Y    A G   ++ 
Sbjct: 121 SCEGKVEHYRIMYHASKLSID-----------EEVYFENLMQLVEHYTT-DADGLCTRLI 168
Query: 166 KTKRTPMTVANPREV--PEYELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKES 222
           K K    TVA   E     + LN  EL++ +  G  + G   +  + G KV VK +    
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI---- 224
Query: 223 HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR 281
            K+     AF  E +++ + RH N+VQ +G + +    + IV EY AKG L  YL+ +GR
Sbjct: 225 -KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 283
Query: 282 --LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             L    +L+F+LD+   M YL   + +  +H DL  +N+L+      K+S FGL +   
Sbjct: 284 SVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340
Query: 340 ISPEKAKIVFPVSHIDP 356
            + +  K+  PV    P
Sbjct: 341 STQDTGKL--PVKWTAP 355

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 80/152 (52%), Gaps = 16/152 (10%)
Query: 189 ELQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP 245
           E++V +  G  +G++ V   AKW    V +K ++ ES +      AF  EL  + +  HP
Sbjct: 9   EIEVEEVVG--RGAFGVVCKAKWRAKDVAIKQIESESER-----KAFIVELRQLSRVNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL---SPSKVLRFALDLARGMNYLH 302
           N+V+  GA     P+ +V+EY   G L + L     L   + +  + + L  ++G+ YLH
Sbjct: 62  NIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 303 ECKPDPIIHCDLKPKNILLDNGGQ-LKISGFG 333
             +P  +IH DLKP N+LL  GG  LKI  FG
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFG 151

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 14/178 (7%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           + LN  EL++ +  G  + G   +  + G KV VK +     K+     AF  E +++ +
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQ 70
Query: 242 ARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGM 298
            RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+   M
Sbjct: 71  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
            YL   + +  +H DL  +N+L+      K+S FGL +    + +  K+  PV    P
Sbjct: 131 EYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAP 183

>pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 89/155 (57%), Gaps = 9/155 (5%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +L+  A  G+   V+DL+  G+DVN+ D DGRT LH AA EGH E+VKLL+SK A+++A+
Sbjct: 7   RLIEAAENGNKDRVKDLIENGADVNASDSDGRTPLHYAAKEGHKEIVKLLISKGADVNAK 66
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA---NPREVPEYELNP- 187
           D  G T    A   G+ E+  +L ++GA V       RTP+  A     +E+ +  ++  
Sbjct: 67  DSDGRTPLHYAAKEGHKEIVKLLISKGADVNAKDSDGRTPLHYAAKEGHKEIVKLLISKG 126
Query: 188 LELQVRKADGITKGSYQVAKWNGTKVWVKILDKES 222
            ++    +DG T     +A+ +G +  VK+L+K+ 
Sbjct: 127 ADVNTSDSDGRT--PLDLAREHGNEEIVKLLEKQG 159

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 14/178 (7%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           + LN  EL++ +  G  + G   +  + G KV VK +     K+     AF  E +++ +
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQ 61
Query: 242 ARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGM 298
            RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+   M
Sbjct: 62  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
            YL   + +  +H DL  +N+L+      K+S FGL +    + +  K+  PV    P
Sbjct: 122 EYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAP 174

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 90/178 (50%), Gaps = 14/178 (7%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           + LN  EL++ +  G  + G   +  + G KV VK +     K+     AF  E +++ +
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI-----KNDATAQAFLAEASVMTQ 55
Query: 242 ARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGM 298
            RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+   M
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
            YL   + +  +H DL  +N+L+      K+S FGL +    + +  K+  PV    P
Sbjct: 116 EYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAP 168

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 86/187 (45%), Gaps = 16/187 (8%)
Query: 177 PREVPEYELNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTH 234
           PR      ++P EL   +  G  + G   +  W N  KV +K + + S  + +    F  
Sbjct: 16  PRGSLHMVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD----FIE 71
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALD 293
           E  ++ K  HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD
Sbjct: 72  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 131
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVF 349
           +  GM YL E     +IH DL  +N L+     +K+S FG+ R     QY S    K  F
Sbjct: 132 VCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--F 186
Query: 350 PVSHIDP 356
           PV    P
Sbjct: 187 PVKWASP 193

>pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/155 (36%), Positives = 88/155 (56%), Gaps = 9/155 (5%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +L+  A  G+   V+DL+  G+DVN+ D DGRT LH AA  GH EVVKLL+SK A+++A+
Sbjct: 7   RLIEAAENGNKDRVKDLIENGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAK 66
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA---NPREVPEYELNP- 187
           D  G T    A   G+ EV  +L ++GA V       RTP+  A     +EV +  ++  
Sbjct: 67  DSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKG 126
Query: 188 LELQVRKADGITKGSYQVAKWNGTKVWVKILDKES 222
            ++    +DG T     +A+ +G +  VK+L+K+ 
Sbjct: 127 ADVNTSDSDGRT--PLDLAREHGNEEVVKLLEKQG 159

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ K 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKL 59
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM YL
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
            E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV    P
Sbjct: 120 EEAS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVKWASP 173

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ K 
Sbjct: 4   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKL 59
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM YL
Sbjct: 60  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 119
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
            E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV    P
Sbjct: 120 EEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVKWASP 173

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVE 240
           + ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ 
Sbjct: 5   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 60
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMN 299
           K  HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM 
Sbjct: 61  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 120
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV    
Sbjct: 121 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVKWAS 175
Query: 356 P 356
           P
Sbjct: 176 P 176

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ K 
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKL 57
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYL 301
            HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM YL
Sbjct: 58  SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
            E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV    P
Sbjct: 118 EEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVKWASP 171

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 16/181 (8%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKW-NGTKVWVKILDKESHKDPERINAFTHELTIVE 240
           + ++P EL   +  G  + G   +  W N  KV +K + + +  + +    F  E  ++ 
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 58
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMN 299
           K  HP +VQ  G   +  P+ +V E+   G L+ YL+ ++G  +   +L   LD+  GM 
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV    
Sbjct: 119 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPVKWAS 173
Query: 356 P 356
           P
Sbjct: 174 P 174

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 59
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 60  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 120 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSK--FPVRWSP 174
Query: 356 P 356
           P
Sbjct: 175 P 175

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 74/138 (53%), Gaps = 5/138 (3%)
Query: 199 TKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           T G  +V K    G KV VKIL+++  +  + +     E+  ++  RHP++++    ++ 
Sbjct: 28  TFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
              + +V+EY + G+L  Y+ K GRL   +  R    +  G++Y   C    ++H DLKP
Sbjct: 88  PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY---CHRHMVVHRDLKP 144
Query: 317 KNILLDNGGQLKISGFGL 334
           +N+LLD     KI+ FGL
Sbjct: 145 ENVLLDAHMNAKIADFGL 162

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 82/163 (50%), Gaps = 11/163 (6%)
Query: 184 ELNPLELQVRKADGITK-GSYQVAKWNGTKVWVKILDKESHKD-PERINAFTHELTIVEK 241
           E++  EL + +  GI   G    A W G +V VK    +  +D  + I     E  +   
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYL 301
            +HPN++   G   +   + +V+E+   G L   L  K R+ P  ++ +A+ +ARGMNYL
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYL 121
Query: 302 HECKPDPIIHCDLKPKNILL----DNGGQ----LKISGFGLLR 336
           H+    PIIH DLK  NIL+    +NG      LKI+ FGL R
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164

>pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/103 (44%), Positives = 65/103 (63%), Gaps = 4/103 (3%)
Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G ++ V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           + G T    A   G++EV  +L   GA V    K  RTP+ +A
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLA 108

>pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/156 (37%), Positives = 89/156 (57%), Gaps = 11/156 (7%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +L+  A  G+   V+DLL  G+DVN+ D DG+T LH+AA  GH EVVKLLLS+ A+ +A+
Sbjct: 7   RLIEAAENGNKDRVKDLLENGADVNASDSDGKTPLHLAAENGHKEVVKLLLSQGADPNAK 66
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVA---NPREVPEYELNP 187
           D  G T    A   G+ EV  +L ++GA  P  K    +TP+ +A     +EV +  L+ 
Sbjct: 67  DSDGKTPLHLAAENGHKEVVKLLLSQGAD-PNAKDSDGKTPLHLAAENGHKEVVKLLLSQ 125
Query: 188 -LELQVRKADGITKGSYQVAKWNGTKVWVKILDKES 222
             +     +DG T     +A+ +G +  VK+L+K+ 
Sbjct: 126 GADPNTSDSDGRT--PLDLAREHGNEEVVKLLEKQG 159

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 71/140 (50%), Gaps = 20/140 (14%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 78  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 271 DLASYLQKKGR--------------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           DL ++L++K R              LS   +L F+  +A+GM +L        IH D+  
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 192
Query: 317 KNILLDNGGQLKISGFGLLR 336
           +N+LL NG   KI  FGL R
Sbjct: 193 RNVLLTNGHVAKIGDFGLAR 212

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 58
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 59  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 118
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 119 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVRWSP 173
Query: 356 P 356
           P
Sbjct: 174 P 174

>pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNATDASGLTPLHLAATYGHLEIVEVLLKHGADVNAI 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA---NPREVPEYELNPL 188
           D  GST    A   G++E+  +L   GA V        TP+ +A      E+ E  L   
Sbjct: 77  DIXGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVLLKH- 135
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
              V   D   K ++ ++  NG +   +IL K
Sbjct: 136 GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 65
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 66  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 125
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 126 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVRWSP 180
Query: 356 P 356
           P
Sbjct: 181 P 181

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 59
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 60  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 120 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVRWSP 174
Query: 356 P 356
           P
Sbjct: 175 P 175

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 29/153 (18%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L + +   P  +     E  ++++  HP+V++  GA +Q+ P+++++EY   G
Sbjct: 54  TTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 271 DLASYLQKKGRLSP------------------------SKVLRFALDLARGMNYLHECKP 306
            L  +L++  ++ P                          ++ FA  +++GM YL E K 
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK- 170
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             ++H DL  +NIL+  G ++KIS FGL R  Y
Sbjct: 171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVY 201

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 29/153 (18%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L + +   P  +     E  ++++  HP+V++  GA +Q+ P+++++EY   G
Sbjct: 54  TTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 271 DLASYLQKKGRLSP------------------------SKVLRFALDLARGMNYLHECKP 306
            L  +L++  ++ P                          ++ FA  +++GM YL E K 
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK- 170
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             ++H DL  +NIL+  G ++KIS FGL R  Y
Sbjct: 171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVY 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 88/181 (48%), Gaps = 16/181 (8%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 74
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHID 355
           YL   +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    
Sbjct: 135 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVRWSP 189
Query: 356 P 356
           P
Sbjct: 190 P 190

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 182 EYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           E E + + L  R   G + G+    KW+G  V VKIL K     PE+  AF +E+ ++ K
Sbjct: 32  EIEASEVMLSTRIGSG-SFGTVYKGKWHG-DVAVKIL-KVVDPTPEQFQAFRNEVAVLRK 88
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNY 300
            RH N++ F+G +T++  + IV ++     L  +L  ++ +    +++  A   A+GM+Y
Sbjct: 89  TRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDY 147
Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           LH      IIH D+K  NI L  G  +KI  FGL
Sbjct: 148 LH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGL 178

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 12/179 (6%)
Query: 183 YELNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVE 240
           +E++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++ 
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 74
Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M 
Sbjct: 75  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 134
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKI--VFPVSHIDP 356
           YL   +    +H DL  +N L+++ G +K+S FGL R      E + +   FPV    P
Sbjct: 135 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPP 190

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 18/193 (9%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K     PE  
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE-- 224
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 225 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 283 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 344 KAKIVFPVSHIDP 356
            AK  FP+    P
Sbjct: 340 GAK--FPIKWTAP 350

>pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 7/152 (4%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNATDASGLTPLHLAATYGHLEIVEVLLKHGADVNAI 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA---NPREVPEYELNPL 188
           D  GST    A   G++E+  +L   GA V        TP+ +A      E+ E  L   
Sbjct: 77  DIMGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVLLKH- 135
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
              V   D   K ++ ++  NG +   +IL K
Sbjct: 136 GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 18/193 (9%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K     PE  
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE-- 224
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 225 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 283 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 344 KAKIVFPVSHIDP 356
            AK  FP+    P
Sbjct: 340 GAK--FPIKWTAP 350

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 71/140 (50%), Gaps = 20/140 (14%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 78  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 271 DLASYLQKKGRL--------------SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           DL ++L++K R+              S   +L F+  +A+GM +L        IH D+  
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAA 192
Query: 317 KNILLDNGGQLKISGFGLLR 336
           +N+LL NG   KI  FGL R
Sbjct: 193 RNVLLTNGHVAKIGDFGLAR 212

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 18/193 (9%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K     PE  
Sbjct: 252 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE-- 307
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 308 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQL 365
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 366 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
Query: 344 KAKIVFPVSHIDP 356
            AK  FP+    P
Sbjct: 423 GAK--FPIKWTAP 433

>pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/94 (43%), Positives = 59/94 (62%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D    L   A  G  + V+ LL++G+DVN+   DG T LH+AA  GH E+VKLLL+K A+
Sbjct: 8   DGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGAD 67
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++AR + G+T    AK  G+ E+  +L A+GA V
Sbjct: 68  VNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADV 101

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADGI------TKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  E++   +++ K  G+        G  +V       V +K
Sbjct: 4   RTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIK 63
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + D +R + F  E +I+ +  HPN++   G VT+  P+MI+ EY   G L ++L
Sbjct: 64  TL-KAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL 121
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K  GR +  +++     +  GM YL +      +H DL  +NIL+++    K+S FG+ 
Sbjct: 122 RKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFGMS 178
Query: 336 RLQYISPEKA 345
           R+    PE A
Sbjct: 179 RVLEDDPEAA 188

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 95/193 (49%), Gaps = 18/193 (9%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K  +  PE  
Sbjct: 170 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGNMSPE-- 225
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 226 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL 283
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 284 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQ 340
Query: 344 KAKIVFPVSHIDP 356
            AK  FP+    P
Sbjct: 341 GAK--FPIKWTAP 351

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N TKV VK L   +      + AF  E  +++  +H  +V+    VT+  P+ I+ EY A
Sbjct: 36  NSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMA 91
Query: 269 KGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           KG L  +L+  + G++   K++ F+  +A GM Y+        IH DL+  N+L+     
Sbjct: 92  KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLM 148
Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
            KI+ FGL R+    +Y + E AK  FP+    P
Sbjct: 149 CKIADFGLARVIEDNEYTAREGAK--FPIKWTAP 180

>pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 85/157 (54%), Gaps = 13/157 (8%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +L+  A  G+   V+DLL  G+D N+ D DGRT LH AA  GH E+VKLLLSK A+ +A+
Sbjct: 7   RLIEAAENGNKDRVKDLLENGADPNASDSDGRTPLHYAAENGHKEIVKLLLSKGADPNAK 66
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVANPREVPEYELNPLEL 190
           D  G T    A   G+ E+  +L ++GA  P  K    RTP+  A   E    E+  L L
Sbjct: 67  DSDGRTPLHYAAENGHKEIVKLLLSKGAD-PNAKDSDGRTPLHYA--AENGHKEIVKL-L 122
Query: 191 QVRKADGITKGS-----YQVAKWNGTKVWVKILDKES 222
             + AD  T  S       +A+ +G +  VK+L+K+ 
Sbjct: 123 LSKGADPNTSDSDGRTPLDLAREHGNEEIVKLLEKQG 159

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 90/176 (51%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV+EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 184

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 94/193 (48%), Gaps = 18/193 (9%)
Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERI 229
           P T    ++  E     L L+V+   G   G   +  WNGT +V +K L K     PE  
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE-- 224
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKV 287
            AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   ++
Sbjct: 225 -AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQL 282
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPE 343
           +  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + +
Sbjct: 283 VDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
Query: 344 KAKIVFPVSHIDP 356
            AK  FP+    P
Sbjct: 340 GAK--FPIKWTAP 350

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 29/153 (18%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T V VK+L + +   P  +     E  ++++  HP+V++  GA +Q+ P+++++EY   G
Sbjct: 54  TTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 111
Query: 271 DLASYLQKKGRLSP------------------------SKVLRFALDLARGMNYLHECKP 306
            L  +L++  ++ P                          ++ FA  +++GM YL E   
Sbjct: 112 SLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS- 170
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             ++H DL  +NIL+  G ++KIS FGL R  Y
Sbjct: 171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVY 201

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 90/176 (51%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV+EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 184

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 13  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 67
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 68  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 126
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 127 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 177

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 184

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKIRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 184

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 9   LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 63
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 64  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 122
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 123 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 173

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 11  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 65
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 66  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 124
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 125 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 175

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 49  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 108
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 109 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 165
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +P  AK  FP+    P
Sbjct: 166 TYTAPAGAK--FPIKWTAP 182

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 184

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 61/113 (53%), Gaps = 6/113 (5%)
Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSP 284
           P+    F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  ++L+ +G RL  
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV 212
Query: 285 SKVLRFALDLARGMNYLH-ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             +L+   D A GM YL  +C     IH DL  +N L+     LKIS FG+ R
Sbjct: 213 KTLLQMVGDAAAGMEYLESKC----CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 61/113 (53%), Gaps = 6/113 (5%)
Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSP 284
           P+    F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  ++L+ +G RL  
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV 212
Query: 285 SKVLRFALDLARGMNYLH-ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             +L+   D A GM YL  +C     IH DL  +N L+     LKIS FG+ R
Sbjct: 213 KTLLQMVGDAAAGMEYLESKC----CIHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 79/152 (51%), Gaps = 7/152 (4%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G+T LH+AA +GH+E+V++LL   A+++A 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNAEDDSGKTPLHLAAIKGHLEIVEVLLKHGADVNAA 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTV---ANPREVPEYELNPL 188
           D+ G T    A  YG++E+  +L   GA V  T     TP+ +   A   E+ E  L   
Sbjct: 77  DKMGDTPLHLAALYGHLEIVEVLLKNGADVNATDTYGFTPLHLAADAGHLEIVEVLL-KY 135
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
              V   D   K ++ ++  NG +   +IL K
Sbjct: 136 GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 50  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 109
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 110 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +P  AK  FP+    P
Sbjct: 167 TYTAPAGAK--FPIKWTAP 183

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/136 (35%), Positives = 71/136 (52%), Gaps = 16/136 (11%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 78  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 271 DLASYLQKK---------GR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL ++L++K         GR L    +L F+  +A+GM +L        IH D+  +N+L
Sbjct: 136 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 192
Query: 321 LDNGGQLKISGFGLLR 336
           L NG   KI  FGL R
Sbjct: 193 LTNGHVAKIGDFGLAR 208

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/136 (35%), Positives = 71/136 (52%), Gaps = 16/136 (11%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 70  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 127
Query: 271 DLASYLQKK---------GR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL ++L++K         GR L    +L F+  +A+GM +L        IH D+  +N+L
Sbjct: 128 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 184
Query: 321 LDNGGQLKISGFGLLR 336
           L NG   KI  FGL R
Sbjct: 185 LTNGHVAKIGDFGLAR 200

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 16/179 (8%)
Query: 185 LNPLELQVRKADGITK-GSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKA 242
           ++P +L   K  G  + G  +  KW G   V +K++ + S  + E    F  E  ++   
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNL 56
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYL 301
            H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R    ++L    D+   M YL
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 116
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
              +    +H DL  +N L+++ G +K+S FGL R     +Y S   +K  FPV    P
Sbjct: 117 ---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK--FPVRWSPP 170

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 69/127 (54%), Gaps = 5/127 (3%)
Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           K  + D +R + F  E +I+ +  HPN++   G VT+  P+MI+ EY   G L ++L+K 
Sbjct: 51  KAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN 109
Query: 280 -GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
            GR +  +++     +  GM YL +      +H DL  +NIL+++    K+S FG+ R+ 
Sbjct: 110 DGRFTVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVL 166
Query: 339 YISPEKA 345
              PE A
Sbjct: 167 EDDPEAA 173

>pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 56/103 (54%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+D N+ D  GRT LH+AA  GH+E+V++LL   A+
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGADANAYDHYGRTPLHMAAAVGHLEIVEVLLRNGAD 60
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           ++A D  G+T    A   G++E+  +L   GA V     T +T
Sbjct: 61  VNAVDTNGTTPLHLAASLGHLEIVEVLLKYGADVNAKDATGIT 103

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 15/190 (7%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKA 345
           R+    PE A
Sbjct: 195 RVLEDDPEAA 204

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 69/127 (54%), Gaps = 5/127 (3%)
Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           K  + D +R + F  E +I+ +  HPN++   G VT+  P+MI+ EY   G L ++L+K 
Sbjct: 45  KAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKN 103
Query: 280 -GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
            GR +  +++     +  GM YL +      +H DL  +NIL+++    K+S FG+ R+ 
Sbjct: 104 DGRFTVIQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVL 160
Query: 339 YISPEKA 345
              PE A
Sbjct: 161 EDDPEAA 167

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N TKV VK L   +      + AF  E  +++  +H  +V+    VT+  P+ I+ E+ A
Sbjct: 35  NSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMA 90
Query: 269 KGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           KG L  +L+  + G++   K++ F+  +A GM Y+        IH DL+  N+L+     
Sbjct: 91  KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLM 147
Query: 327 LKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
            KI+ FGL R+    +Y + E AK  FP+    P
Sbjct: 148 CKIADFGLARVIEDNEYTAREGAK--FPIKWTAP 179

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L+K   + +  +++  
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A
Sbjct: 153 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 15/190 (7%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTYVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKA 345
           R+    PE A
Sbjct: 195 RVLEDDPEAA 204

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L+K   + +  +++  
Sbjct: 81  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 140
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A
Sbjct: 141 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L+K   + +  +++  
Sbjct: 64  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 123
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A
Sbjct: 124 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 15/190 (7%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 18  RTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 77
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 78  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 135
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 136 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 192
Query: 336 RLQYISPEKA 345
           R+    PE A
Sbjct: 193 RVLEDDPEAA 202

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 22  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 76
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 133
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+    P
Sbjct: 134 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIKWTAP 174

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/163 (36%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHEL 236
           ++V E     L+L  R  +G   G   +  WNG TKV +K L K     PE   +F  E 
Sbjct: 1   KDVWEIPRESLQLIKRLGNG-QFGEVWMGTWNGNTKVAIKTL-KPGTMSPE---SFLEEA 55
Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGR-LSPSKVLRFALDL 294
            I++K +H  +VQ    V++  P+ IV EY  KG L  +L+  +GR L    ++  A  +
Sbjct: 56  QIMKKLKHDKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQV 114
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           A GM Y+        IH DL+  NIL+ NG   KI+ FGL RL
Sbjct: 115 AAGMAYIERMN---YIHRDLRSANILVGNGLICKIADFGLARL 154

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 67/126 (53%), Gaps = 3/126 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G KV VKIL+++  +  + +     E+  ++  RHP++++    ++      +V+EY +
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G+L  Y+ K GR+   +  R    +   ++Y   C    ++H DLKP+N+LLD     K
Sbjct: 95  GGELFDYICKHGRVEEMEARRLFQQILSAVDY---CHRHMVVHRDLKPENVLLDAHMNAK 151
Query: 329 ISGFGL 334
           I+ FGL
Sbjct: 152 IADFGL 157

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 184

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L+K   + +  +++  
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A
Sbjct: 153 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 96/190 (50%), Gaps = 15/190 (7%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKA 345
           R+    PE A
Sbjct: 195 RVLEDDPEAA 204

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 67/126 (53%), Gaps = 3/126 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G KV VKIL+++  +  + +     E+  ++  RHP++++    ++      +V+EY +
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G+L  Y+ K GR+   +  R    +   ++Y   C    ++H DLKP+N+LLD     K
Sbjct: 95  GGELFDYICKHGRVEEMEARRLFQQILSAVDY---CHRHMVVHRDLKPENVLLDAHMNAK 151
Query: 329 ISGFGL 334
           I+ FGL
Sbjct: 152 IADFGL 157

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++          + ++LE+  +G+L   LQK GR    +   F  +L
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 123
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y HE K   +IH D+KP+N+L+   G+LKI+ FG
Sbjct: 124 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 159

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 56/99 (56%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++          + ++LE+  +G+L   LQK GR    +   F  +L
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y HE K   +IH D+KP+N+L+   G+LKI+ FG
Sbjct: 125 ADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFG 160

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L+K   + +  +++  
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A
Sbjct: 153 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/176 (32%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL   NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 134 N---YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 184

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 165 TYTAHAGAK--FPIKWTAP 181

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+    P
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIKWTAP 179

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 165 TYTAHAGAK--FPIKWTAP 181

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 33  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 87
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 144
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+    P
Sbjct: 145 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIKWTAP 185

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 71/142 (50%), Gaps = 22/142 (15%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 78  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           DL ++L++K                 +LS   +L F+  +A+GM +L        IH D+
Sbjct: 136 DLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDV 192
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+LL NG   KI  FGL R
Sbjct: 193 AARNVLLTNGHVAKIGDFGLAR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 32  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 86
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 87  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 143
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+    P
Sbjct: 144 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIKWTAP 184

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY  +G++   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN++   G VT++ P+MIV EY   G L ++L+K  G+ +  +++  
Sbjct: 70  FLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGM 129
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              ++ GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A
Sbjct: 130 LRGISAGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 181

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 65/115 (56%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV EY   G L S+L+K   + +  +++  
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM 152
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A
Sbjct: 153 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY  +G++   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   ARGM+YLH    
Sbjct: 83  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGL 166

>pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/103 (41%), Positives = 64/103 (62%), Gaps = 4/103 (3%)
Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G ++ VE LL  G+DVN+ D DG T LH+AA EGH+E+V++LL   A+++A+D
Sbjct: 39  LHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKD 98
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           + G T    A   G++E+  +L   GA V    K  +TP  +A
Sbjct: 99  KDGYTPLHLAAREGHLEIVEVLLKAGADVNAQDKFGKTPFDLA 141

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 37  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 91
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 92  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 148
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +Y + E AK  FP+    P
Sbjct: 149 NILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIKWTAP 189

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 149 GNVEVYNILKARGAKVPKTKRTPMTVANP-REVPEY--ELNPLELQVRKADG------IT 199
           G+ E+Y   K  G K   T   P T  +P R V ++  EL+   +++ +  G      + 
Sbjct: 4   GDEELYFHFKFPGTK---TYIDPETYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVC 60
Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
            G  ++       V +K L K  + + +R + F  E +I+ +  HPNVV   G VT+  P
Sbjct: 61  SGRLKLPGKRDVAVAIKTL-KVGYTEKQRRD-FLCEASIMGQFDHPNVVHLEGVVTRGKP 118
Query: 260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +MIV+E+   G L ++L+K  G+ +  +++     +A GM YL +      +H DL  +N
Sbjct: 119 VMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMG---YVHRDLAARN 175
Query: 319 ILLDNGGQLKISGFGLLRLQYISPE 343
           IL+++    K+S FGL R+    PE
Sbjct: 176 ILVNSNLVCKVSDFGLSRVIEDDPE 200

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 13  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   ARGM+YLH    
Sbjct: 71  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 126
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGL 154

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 95/184 (51%), Gaps = 18/184 (9%)
Query: 181 PEYELNPLELQVRKADGITK-GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTI 238
           PE+E+    L++ +  G  + G   +  +NG TKV VK L K+    P   +AF  E  +
Sbjct: 2   PEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANL 57
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLAR 296
           +++ +H  +V+    VTQ  P+ I+ EY   G L  +L+     +L+ +K+L  A  +A 
Sbjct: 58  MKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 116
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVS 352
           GM ++ E      IH +L+  NIL+ +    KI+ FGL RL    +Y + E AK  FP+ 
Sbjct: 117 GMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK--FPIK 171
Query: 353 HIDP 356
              P
Sbjct: 172 WTAP 175

>pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D DG T LH+AA EGH+E+V++LL   A+
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGAD 60
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPR---EVPEYE 184
           ++A+D+ G T    A   G++E+  +L   GA V    K   TP+ +A      E+ E  
Sbjct: 61  VNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVL 120
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKES 222
           L      V   D   K  + +A  NG +   ++L K +
Sbjct: 121 LKA-GADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAA 157

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 195 ADGITKGSYQVAKW----------------NGTKVWVKILDKESHKDPERINAFTHELTI 238
           ADG   G+YQ+ K                  G KV +KI++K+     +       E++ 
Sbjct: 7   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 66
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +   RHP++++    +     +++V+EY A  +L  Y+ ++ ++S  +  RF   +   +
Sbjct: 67  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 125
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            Y H  K   I+H DLKP+N+LLD    +KI+ FGL
Sbjct: 126 EYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 158

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 17  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 71
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY  KG L  +L+ + G+ L   +++  +  +A GM Y+   
Sbjct: 72  LVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+    P
Sbjct: 131 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPIKWTAP 181

>pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 39/94 (41%), Positives = 55/94 (58%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D    L   A  G ++ VE LL  G+DVN+ DL G T LH+AA  GH+E+V++LL   A+
Sbjct: 46  DGYTPLHLAASNGHLEIVEVLLKNGADVNASDLTGITPLHLAAATGHLEIVEVLLKHGAD 105
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++A D  G T    A  YG++E+  +L   GA V
Sbjct: 106 VNAYDNDGHTPLHLAAKYGHLEIVEVLLKHGADV 139

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 195 ADGITKGSYQVAKW----------------NGTKVWVKILDKESHKDPERINAFTHELTI 238
           ADG   G+YQ+ K                  G KV +KI++K+     +       E++ 
Sbjct: 8   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 67
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +   RHP++++    +     +++V+EY A  +L  Y+ ++ ++S  +  RF   +   +
Sbjct: 68  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 126
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            Y H  K   I+H DLKP+N+LLD    +KI+ FGL
Sbjct: 127 EYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 159

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 195 ADGITKGSYQVAKW----------------NGTKVWVKILDKESHKDPERINAFTHELTI 238
           ADG   G+YQ+ K                  G KV +KI++K+     +       E++ 
Sbjct: 2   ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISY 61
Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           +   RHP++++    +     +++V+EY A  +L  Y+ ++ ++S  +  RF   +   +
Sbjct: 62  LRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAV 120
Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            Y H  K   I+H DLKP+N+LLD    +KI+ FGL
Sbjct: 121 EYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGL 153

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 193 RKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
            K  G   G   V  W    + V +  K   +D   +  F  E  ++++ +HPN+VQ +G
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAV--KTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKV--LRFALDLARGMNYLHECKPDPII 310
             T   P  IV EY   G+L  YL++  R   + V  L  A  ++  M YL +      I
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK---KNFI 152
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAKIVFPVSHIDP 356
           H DL  +N L+     +K++ FGL RL     Y +   AK  FP+    P
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAK--FPIKWTAP 200

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 80/153 (52%), Gaps = 12/153 (7%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 20  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 74
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV+EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 75  LVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 133
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
                +H DL+  NIL+      K++ FGL RL
Sbjct: 134 N---YVHRDLRAANILVGENLVCKVADFGLARL 163

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 165 TYTAHAGAK--FPIKWTAP 181

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 113 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 170 TYTAHAGAK--FPIKWTAP 186

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T    + IV ++     L  +L   + +    K++  A   ARGM+YLH    
Sbjct: 83  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---A 138
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGL 166

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 165 TYTAHAGAK--FPIKWTAP 181

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 60/107 (56%), Gaps = 4/107 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRF 290
           F  E +I+ +  HPNV+   G VT++ P+MI+ E+   G L S+L Q  G+ +  +++  
Sbjct: 81  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 140
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
              +A GM YL +      +H DL  +NIL+++    K+S FGL R 
Sbjct: 141 LRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 184

>pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/99 (39%), Positives = 56/99 (56%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A++DA 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDAS 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           D +G T    A Y+G++E+  +L   GA V       MT
Sbjct: 77  DVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMT 115

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 69/139 (49%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 113 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 170 TYTAHAGAK--FPIKWTAP 186

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 46  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 105
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL
Sbjct: 106 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 22/143 (15%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 50  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 107
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 108 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 164
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +N+L+     +KI+ FGL R
Sbjct: 165 LAARNVLVTEDNVMKIADFGLAR 187

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 24/144 (16%)
Query: 211 TKVWVKILDKE-SHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           TKV VK+L  + + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +
Sbjct: 61  TKVAVKMLKSDATEKD---LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 117
Query: 269 KGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           KG+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH 
Sbjct: 118 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHR 174
Query: 313 DLKPKNILLDNGGQLKISGFGLLR 336
           DL  +N+L+     +KI+ FGL R
Sbjct: 175 DLAARNVLVTEDNVMKIADFGLAR 198

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 22/143 (15%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 61  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 118
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 119 GNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 175
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +N+L+     +KI+ FGL R
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR 198

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 24/144 (16%)
Query: 211 TKVWVKILDKE-SHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           TKV VK+L  + + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +
Sbjct: 54  TKVAVKMLKSDATEKD---LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 110
Query: 269 KGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
           KG+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH 
Sbjct: 111 KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHR 167
Query: 313 DLKPKNILLDNGGQLKISGFGLLR 336
           DL  +N+L+     +KI+ FGL R
Sbjct: 168 DLAARNVLVTEDNVMKIADFGLAR 191

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 22/143 (15%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 61  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 118
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 119 GNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 175
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +N+L+     +KI+ FGL R
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR 198

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 22/143 (15%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 53  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 110
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 111 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 167
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +N+L+     +KI+ FGL R
Sbjct: 168 LAARNVLVTEDNVMKIADFGLAR 190

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 22/143 (15%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 46  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 103
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 104 GNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 160
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +N+L+     +KI+ FGL R
Sbjct: 161 LAARNVLVTEDNVMKIADFGLAR 183

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 61/107 (57%), Gaps = 4/107 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT ++P+MI+ E+   G L S+L+   G+ +  +++  
Sbjct: 62  FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM 121
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
              +A GM YL E      +H DL  +NIL+++    K+S FGL R 
Sbjct: 122 LRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRF 165

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 26/149 (17%)
Query: 220 KESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
           K+ H+D      F  EL ++ K   HPN++  +GA      + + +EY   G+L  +L+K
Sbjct: 66  KDDHRD------FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119
Query: 279 K----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
                              LS  ++L FA D+ARGM+YL +      IH DL  +NIL+ 
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG 176
Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPV 351
                KI+ FGL R Q +  +K     PV
Sbjct: 177 ENYVAKIADFGLSRGQEVYVKKTMGRLPV 205

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 10  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 64
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY +KG L  +L+ + G+ L   +++  A  +A GM Y+   
Sbjct: 65  LVQLYAVVSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 123
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
                +H DL+  NIL+      K++ FGL RL
Sbjct: 124 N---YVHRDLRAANILVGENLVCKVADFGLARL 153

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 61/107 (57%), Gaps = 4/107 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT ++P+MI+ E+   G L S+L+   G+ +  +++  
Sbjct: 64  FLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM 123
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
              +A GM YL E      +H DL  +NIL+++    K+S FGL R 
Sbjct: 124 LRGIASGMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRF 167

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 26/149 (17%)
Query: 220 KESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
           K+ H+D      F  EL ++ K   HPN++  +GA      + + +EY   G+L  +L+K
Sbjct: 56  KDDHRD------FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 109
Query: 279 K----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
                              LS  ++L FA D+ARGM+YL +      IH DL  +NIL+ 
Sbjct: 110 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVG 166
Query: 323 NGGQLKISGFGLLRLQYISPEKAKIVFPV 351
                KI+ FGL R Q +  +K     PV
Sbjct: 167 ENYVAKIADFGLSRGQEVYVKKTMGRLPV 195

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G    +  + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y H  K   +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 118 ANALSYCHSKK---VIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 22/143 (15%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 61  TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 118
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 119 GNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 175
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +N+L+     +KI+ FGL R
Sbjct: 176 LAARNVLVTEDNVMKIADFGLAR 198

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 70/123 (56%), Gaps = 4/123 (3%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           KV +K + ++  K  +       E++ ++  RHP++++    +T    +++V+EY A G+
Sbjct: 36  KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGE 94
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L  Y+ +K R++  +  RF   +   + Y H  K   I+H DLKP+N+LLD+   +KI+ 
Sbjct: 95  LFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIAD 151
Query: 332 FGL 334
           FGL
Sbjct: 152 FGL 154

>pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/87 (45%), Positives = 57/87 (65%), Gaps = 1/87 (1%)
Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G ++ V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
           + G T    A   G++EV  +L   GA
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGA 92

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 76/143 (53%), Gaps = 22/143 (15%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           TKV VK+L  ++ +  + ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +K
Sbjct: 102 TKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 159
Query: 270 GDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
           G+L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH D
Sbjct: 160 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRD 216
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +N+L+     +KI+ FGL R
Sbjct: 217 LAARNVLVTEDNVMKIADFGLAR 239

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 188 LELQVRKADGITKGSYQVAKWNGT-KVWVKILDKESHKDPERINAFTHELTIVEKARHPN 246
           L L+V+   G   G   +  WNGT +V +K L K     PE   AF  E  +++K RH  
Sbjct: 17  LRLEVKLGQGCF-GEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQVMKKLRHEK 71
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGR-LSPSKVLRFALDLARGMNYLHEC 304
           +VQ    V++  P+ IV EY  KG L  +L+ + G+ L   +++  +  +A GM Y+   
Sbjct: 72  LVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM 130
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
                +H DL+  NIL+      K++ FGL RL    ++ + + AK  FP+    P
Sbjct: 131 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAK--FPIKWTAP 181

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 26/169 (15%)
Query: 190 LQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ 249
            QVRK  G   G     K    KV  K +   + KD     A   E  I+E+ +HP +V 
Sbjct: 34  FQVRKVTGANTG-----KIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVKHPFIVD 85
Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
            + A      + ++LEY + G+L   L+++G         +  +++  + +LH+     I
Sbjct: 86  LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGI 142
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLR---------------LQYISPE 343
           I+ DLKP+NI+L++ G +K++ FGL +               ++Y++PE
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 26/169 (15%)
Query: 190 LQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ 249
            QVRK  G   G     K    KV  K +   + KD     A   E  I+E+ +HP +V 
Sbjct: 34  FQVRKVTGANTG-----KIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVKHPFIVD 85
Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
            + A      + ++LEY + G+L   L+++G         +  +++  + +LH+     I
Sbjct: 86  LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ---KGI 142
Query: 310 IHCDLKPKNILLDNGGQLKISGFGLLR---------------LQYISPE 343
           I+ DLKP+NI+L++ G +K++ FGL +               ++Y++PE
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 22/166 (13%)
Query: 184 ELNPLELQVRK--ADGITKGSYQVAKWNGTKVWV--KILDKESHKDPERINAFTHELTIV 239
           EL  L L+VR+  A+G     Y+       + +   ++L  E  K+     A   E+  +
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN----RAIIQEVCFM 79
Query: 240 EK-ARHPNVVQFVGAV--------TQNIPMMIVLEYHAKGDLASYLQK---KGRLSPSKV 287
           +K + HPN+VQF  A         T     +++ E   KG L  +L+K   +G LS   V
Sbjct: 80  KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSCDTV 138
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           L+      R + ++H  KP PIIH DLK +N+LL N G +K+  FG
Sbjct: 139 LKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFG 183

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  R    +   +  +L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 122 ANALSY---CHSKRVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  R    +   +  +L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL 121
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 122 ANALSY---CHSKRVIHRDIKPENLLLGSNGELKIADFG 157

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 69/141 (48%), Gaps = 11/141 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 46  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 105
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 106 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 162
Query: 339 -YISPEKAKIVFPVSHIDPAN 358
            + +   AK  FP+    P +
Sbjct: 163 TFTAHAGAK--FPIKWTAPES 181

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 46  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 105
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
            S V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL
Sbjct: 106 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 50  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 109
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 110 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 167 TYTAHAGAK--FPIKWTAP 183

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 71/149 (47%), Gaps = 29/149 (19%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           KV VK+L   +H D +   A   EL I+    +H N+V  +GA T   P++++ EY   G
Sbjct: 63  KVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 120
Query: 271 DLASYLQKKGR--LSPS---------------------KVLRFALDLARGMNYLHECKPD 307
           DL ++L++K    L PS                      +L F+  +A+GM +L      
Sbjct: 121 DLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASK 177
Query: 308 PIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             IH D+  +N+LL NG   KI  FGL R
Sbjct: 178 NCIHRDVAARNVLLTNGHVAKIGDFGLAR 206

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 113 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 170 TYTAHAGAK--FPIKWTAP 186

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 50  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 109
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 110 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 166
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 167 TYTAHAGAK--FPIKWTAP 183

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 165 TYTAHAGAK--FPIKWTAP 181

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           GD+ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +K+
Sbjct: 126 GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 ADFGFAK 189

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 61  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 120
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 121 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 177
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 178 TYTAHAGAK--FPIKWTAP 194

>pdb|2J8S|D Chain D, Drug Export Pathway Of Multidrug Exporter Acrb Revealed By Darpin Inhibitors Length = 169

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 7/156 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D+ G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGRDDEVRILMANGADVNAADVVGWTPLHLAAYWGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPR---EVPEYE 184
           ++A D  GST    A ++G++E+  +L   GA V        TP+ +A  R   E+ E  
Sbjct: 73  VNAYDTLGSTPLHLAAHFGHLEIVEVLLKNGADVNAKDDNGITPLHLAANRGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           L      V   D   K ++ ++  NG +   +IL K
Sbjct: 133 L-KYGADVNAQDKFGKTAFDISINNGNEDLAEILQK 167

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           GD+ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +K+
Sbjct: 126 GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 ADFGFAK 189

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 113 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 170 TYTAHAGAK--FPIKWTAP 186

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 52  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 111
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 112 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 169 TYTAHAGAK--FPIKWTAP 185

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 120 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIANFG 155

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 48  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 107
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL    
Sbjct: 108 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 165 TYTAHAGAK--FPIKWTAP 181

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV E    G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKA 345
           R+    PE A
Sbjct: 195 RVLEDDPEAA 204

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT++ P+MIV E    G L S+L+K   + +  +++  
Sbjct: 64  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGM 123
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              +A GM YL +      +H DL  +NIL+++    K+S FGL R+    PE A
Sbjct: 124 LRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I++E+   G+L  YL++  R  
Sbjct: 49  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQE 108
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL
Sbjct: 109 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL 161

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 70/142 (49%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +P  +     E+ I++   HPN+V+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y H+     I+H 
Sbjct: 82  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ---KYIVHR 138
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 139 DLKAENLLLDGDMNIKIADFGF 160

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIANFG 156

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 166 KTKRTPMTVANPRE-VPEY--ELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVK 216
           +T   P T  +P + V E+  EL+   + + K  G      +  G  ++       V +K
Sbjct: 20  RTYVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK 79
Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
            L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV E    G L S+L
Sbjct: 80  TL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
Query: 277 QKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
           +K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S FGL 
Sbjct: 138 RKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLS 194
Query: 336 RLQYISPEKA 345
           R+    PE A
Sbjct: 195 RVLEDDPEAA 204

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 134
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 135 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 170

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 144 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 179

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 119 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V +KI+DK +  +P  +     E+ I++   HPN+V+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +++EY + G++  YL   GR+   +       +   + Y H+ +   I+H 
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHR 135
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 136 DLKAENLLLDADMNIKIADFGF 157

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 144 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 179

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 255 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 314
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            S V  L  A  ++  M YL +      IH +L  +N L+     +K++ FGL RL    
Sbjct: 315 VSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 372 TYTAHAGAK--FPIKWTAP 388

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +  + E AK  FP+    P
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIKWTAP 179

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V +KI+DK +  +P  +     E+ I++   HPN+V+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +++EY + G++  YL   GR+   +       +   + Y H+ +   I+H 
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHR 138
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 139 DLKAENLLLDADMNIKIADFGF 160

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 28  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 82
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 139
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +  + E AK  FP+    P
Sbjct: 140 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIKWTAP 180

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 119
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 120 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 155

>pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 79/154 (51%), Gaps = 7/154 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D DG T LH+AA EGH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA---NPREVPEYE 184
           ++A+D+ G T    A   G++E+  +L   GA V    K   TP+ +A      E+ E  
Sbjct: 73  VNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKIL 218
           L      V   D   K ++ ++  NG +   +IL
Sbjct: 133 LKA-GADVNAQDKFGKTAFDISIDNGNEDLAEIL 165

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 123 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 158

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 119 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 27  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 84  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 140
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 118
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 119 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 154

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +  + E AK  FP+    P
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDAEXTAREGAK--FPIKWTAP 179

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 118 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 118 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 121 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 156

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 37/215 (17%)
Query: 161 GAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QVAKWNGTK------V 213
           GA   K K  P    +P   P  + N ++ Q    D I +G++ QV K    K       
Sbjct: 1   GALNRKVKNNP----DPTIYPVLDWNDIKFQ----DVIGEGNFGQVLKARIKKDGLRMDA 52
Query: 214 WVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
            +K + + + KD  R   F  EL ++ K   HPN++  +GA      + + +EY   G+L
Sbjct: 53  AIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 110
Query: 273 ASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
             +L+K                   LS  ++L FA D+ARGM+YL +      IH +L  
Sbjct: 111 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRNLAA 167
Query: 317 KNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
           +NIL+      KI+ FGL R Q +  +K     PV
Sbjct: 168 RNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 202

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 29  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 85
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 86  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 142
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 143 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 181

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 29  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 83
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 84  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 140
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +  + E AK  FP+    P
Sbjct: 141 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIKWTAP 181

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 116
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 117 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 152

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 33  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 87
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 144
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +  + E AK  FP+    P
Sbjct: 145 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIKWTAP 185

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 121
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 122 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 157

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 114
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 115 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 150

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +  + E AK  FP+    P
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIKWTAP 179

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 35  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 89
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 90  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 146
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +  + E AK  FP+    P
Sbjct: 147 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIKWTAP 187

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 31  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 87
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 88  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 144
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 145 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 183

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 28  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 84
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 85  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 141
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 142 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 180

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 66  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 125
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 126 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 182
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 183 VTDFGFAK 190

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 83/163 (50%), Gaps = 17/163 (10%)
Query: 201 GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           G   +  +NG TKV VK L K+    P   +AF  E  ++++ +H  +V+    VTQ  P
Sbjct: 36  GEVWMGYYNGHTKVAVKSL-KQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQE-P 90
Query: 260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           + I+ EY   G L  +L+     +L+ +K+L  A  +A GM ++ E      IH DL+  
Sbjct: 91  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 147
Query: 318 NILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPVSHIDP 356
           NIL+ +    KI+ FGL RL    +  + E AK  FP+    P
Sbjct: 148 NILVSDTLSCKIADFGLARLIEDNEXTAREGAK--FPIKWTAP 188

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y H  +   +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 121 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG 156

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I    RHPN+++  G       + ++LEY   G +   LQK  +    +   +  +L
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  ++Y   C    +IH D+KP+N+LL + G+LKI+ FG
Sbjct: 118 ANALSY---CHSKRVIHRDIKPENLLLGSAGELKIADFG 153

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 55  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 168
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 207

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 137
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 23  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 79
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 80  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 136
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 137 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 175

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 30  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 86
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 87  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 143
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 144 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 182

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 86  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 145
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 146 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 202
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 203 VTDFGFAK 210

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 52  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 111
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 112 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDEQGYIQ 168
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 169 VTDFGFAK 176

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 137
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 22  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 78
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 79  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 135
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 136 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 174

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 67/127 (52%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 72/138 (52%), Gaps = 6/138 (4%)
Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G  K +Y      G KV +KI++K+     +       E++ +   RHP++++    +  
Sbjct: 18  GKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS 75
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
              +++V+EY A  +L  Y+ ++ ++S  +  RF   +   + Y H  K   I+H DLKP
Sbjct: 76  KDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKP 131
Query: 317 KNILLDNGGQLKISGFGL 334
           +N+LLD    +KI+ FGL
Sbjct: 132 ENLLLDEHLNVKIADFGL 149

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 71/139 (51%), Gaps = 6/139 (4%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKGDL 272
           V  + K  H   E +  F  E+ I++  +H N+V++ G         + +++EY   G L
Sbjct: 59  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 118
Query: 273 ASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             YLQK K R+   K+L++   + +GM YL   +    IH DL  +NIL++N  ++KI  
Sbjct: 119 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGD 175
Query: 332 FGLLRLQYISPEKAKIVFP 350
           FGL ++     E  K+  P
Sbjct: 176 FGLTKVLPQDKEXXKVKEP 194

>pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 7/150 (4%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNAEDTYGDTPLHLAARVGHLEIVEVLLKNGADVNAL 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPR---EVPEYELNPL 188
           D  GST    A   G++E+  +L   GA V        TP+ +A      E+ E  L   
Sbjct: 77  DFSGSTPLHLAAKRGHLEIVEVLLKYGADVNADDTIGSTPLHLAADTGHLEIVEVLL-KY 135
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKIL 218
              V   D   K ++ ++  NG +   +IL
Sbjct: 136 GADVNAQDKFGKTAFDISIDNGNEDLAEIL 165

>pdb|2V5Q|C Chain C, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 167

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 7/148 (4%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN++D  G T LH+AA  GH+E+V++LL   A++DA 
Sbjct: 17  KLLEAARAGQDDEVRILIANGADVNAVDNTGLTPLHLAAVSGHLEIVEVLLKHGADVDAA 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPR---EVPEYELNPL 188
           D +G T    A   G++E+  +L   GA V     T  TP+ +A      E+ E  L   
Sbjct: 77  DVYGFTPLHLAAMTGHLEIVEVLLKYGADVNAFDMTGSTPLHLAADEGHLEIVEVLL-KY 135
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVK 216
              V   D   K ++ ++  NG +   K
Sbjct: 136 GADVNAQDKFGKTAFDISIDNGNEDLAK 163

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 42  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 98
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 99  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 155
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 156 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 194

>pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D +G T LH+AA  G +E+V++LL   A+++A 
Sbjct: 9   KLLEAAAAGQDDEVRILMANGADVNATDDNGLTPLHLAAANGQLEIVEVLLKNGADVNAS 68
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVA 175
           D  G T    A Y G++E+  +L   GA V    R   TP+ +A
Sbjct: 69  DSAGITPLHLAAYDGHLEIVEVLLKHGADVNAYDRAGWTPLHLA 112

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 53  EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 112
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
            + V  L  A  ++  M YL +      IH DL  +N L+     +K++ FGL RL
Sbjct: 113 VNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 36/83 (43%), Positives = 56/83 (67%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A RG ++ VE LL  G+DVN+ D+ GRT LH+AA  GH+E+V++LL   A+++A+D
Sbjct: 51  LHLAAKRGHLEIVEVLLKHGADVNASDIWGRTPLHLAATVGHLEIVEVLLEYGADVNAQD 110
Query: 136 RWGSTAAADAKYYGNVEVYNILK 158
           ++G TA   +   GN ++  IL+
Sbjct: 111 KFGKTAFDISIDNGNEDLAEILQ 133

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 59/107 (55%), Gaps = 4/107 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRF 290
           F  E +I+ +  HPNV+   G VT++ P+MI+ E+   G L S+L Q  G+ +  +++  
Sbjct: 55  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 114
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
              +A GM YL +      +H  L  +NIL+++    K+S FGL R 
Sbjct: 115 LRGIAAGMKYLADMN---YVHRALAARNILVNSNLVCKVSDFGLSRF 158

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     + I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +K+
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKV 182
Query: 330 SGFGLLR 336
           + FGL +
Sbjct: 183 TDFGLAK 189

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G ++
Sbjct: 125 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLIIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/146 (30%), Positives = 76/146 (52%), Gaps = 15/146 (10%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 137
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRL 337
            DL  +NIL++N  ++KI  FGL ++
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKV 163

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/134 (35%), Positives = 69/134 (51%), Gaps = 8/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +GT V VK L +E  +  E    F  E+ ++  A H N+++  G        ++V  Y A
Sbjct: 61  DGTLVAVKRLKEERXQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 118
Query: 269 KGDLASYLQKKGRLSPS----KVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDN 323
            G +AS L+++    P     K  R AL  ARG+ YLH+ C P  IIH D+K  NILLD 
Sbjct: 119 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDE 177
Query: 324 GGQLKISGFGLLRL 337
             +  +  FGL +L
Sbjct: 178 EFEAVVGDFGLAKL 191

>pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/83 (43%), Positives = 56/83 (67%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A RG ++ VE LL  G+DVN+ D+ GRT LH+AA  GH+E+V++LL   A+++A+D
Sbjct: 51  LHLAAKRGHLEIVEVLLKHGADVNARDIWGRTPLHLAATVGHLEIVEVLLEYGADVNAQD 110
Query: 136 RWGSTAAADAKYYGNVEVYNILK 158
           ++G TA   +   GN ++  IL+
Sbjct: 111 KFGKTAFDISIDNGNEDLAEILQ 133

>pdb|3NOC|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 78/156 (50%), Gaps = 7/156 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNARDFTGWTPLHLAAHFGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVANPR---EVPEYE 184
           ++A+D  G T    A   G++E+  +L   GA V  +     TP+ +A  R   E+ E  
Sbjct: 73  VNAKDSLGVTPLHLAARRGHLEIVEVLLKNGADVNASDSHGFTPLHLAAKRGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           L      V   D   K ++ ++  NG +   +IL K
Sbjct: 133 LKN-GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 19/151 (12%)
Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           KV +K +     +  E +  F  E+    +  H N+V  +    ++    +V+EY     
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L+ Y++  G LS    + F   +  G+ + H+ +   I+H D+KP+NIL+D+   LKI  
Sbjct: 98  LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154
Query: 332 FGLLR----------------LQYISPEKAK 346
           FG+ +                +QY SPE+AK
Sbjct: 155 FGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR +      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 27  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++E+   G L  YLQK K R+   K+L++   + +GM YL   +    IH
Sbjct: 84  YSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIH 140
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I +    P +V+   +   N  + +VLEY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +K+
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 ADFGFAK 190

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +K+
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 ADFGFAK 189

>pdb|2BKK|B Chain B, Crystal Structure Of Aminoglycoside Phosphotransferase Aph (3')-Iiia In Complex With The Inhibitor Ar_3a Length = 169

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 7/156 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+    GH+E++++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNANDWFGITPLHLVVNNGHLEIIEVLLKYAAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---RTPMTVA---NPREVPEYE 184
           ++A D+ G T    A Y G++E+  +L   GA V        TP+ +A      E+ E  
Sbjct: 73  VNASDKSGWTPLHLAAYRGHLEIVEVLLKYGADVNAMDYQGYTPLHLAAEDGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           L      V   D   K ++ ++  NG +   +IL K
Sbjct: 133 L-KYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +K+
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +K+
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 95  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 150
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 178

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 95  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 150
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 178

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 36  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 94  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 149
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 177

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS 283
           +D   +  F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  
Sbjct: 294 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE 353
Query: 284 PSKV--LRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ--- 338
            + V  L  A  ++  M YL +      IH +L  +N L+     +K++ FGL RL    
Sbjct: 354 VNAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 410
Query: 339 -YISPEKAKIVFPVSHIDP 356
            Y +   AK  FP+    P
Sbjct: 411 TYTAHAGAK--FPIKWTAP 427

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 29  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 87  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 142
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 170

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 60  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 119
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 120 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 176
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 177 VTDFGFAK 184

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 11  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 69  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 124
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 152

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 72  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 155

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 67/125 (53%), Gaps = 5/125 (4%)
Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           K  + + +R++ F  E  I+ +  H N+++  G +++  PMMI+ EY   G L  +L++K
Sbjct: 82  KAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK 140
Query: 280 -GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
            G  S  +++     +A GM YL        +H DL  +NIL+++    K+S FGL R+ 
Sbjct: 141 DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 339 YISPE 343
              PE
Sbjct: 198 EDDPE 202

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 72  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 127
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 155

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     + I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FGL +
Sbjct: 183 TDFGLAK 189

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 86  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 145
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 146 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 202
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 203 VTDFGFAK 210

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY A
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 125 GGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 181
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 182 VTDFGFAK 189

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 17/148 (11%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           NG    +K+L KE     +++     E  ++    HP +++  G       + ++++Y  
Sbjct: 30  NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE 89
Query: 269 KGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            G+L S L+K  R  P+ V +F A ++   + YLH      II+ DLKP+NILLD  G +
Sbjct: 90  GGELFSLLRKSQRF-PNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHI 145
Query: 328 KISGFGLLRL------------QYISPE 343
           KI+ FG  +              YI+PE
Sbjct: 146 KITDFGFAKYVPDVTYXLCGTPDYIAPE 173

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 67  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 150

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T+   + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 67  LLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 150

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 71/135 (52%), Gaps = 5/135 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K+L K + K  +R+     E  I+    HP VV+   A      + ++L++   GDL +
Sbjct: 61  MKVLKKATLKVRDRVRT-KMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFT 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L K+   +   V  +  +LA G+++LH      II+ DLKP+NILLD  G +K++ FGL
Sbjct: 120 RLSKEVMFTEEDVKFYLAELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 176
Query: 335 LRLQYISPEKAKIVF 349
            + + I  EK    F
Sbjct: 177 SK-EAIDHEKKAYSF 190

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 4/123 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 50  MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 109
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 110 FHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG 166
Query: 334 LLR 336
           + +
Sbjct: 167 MCK 169

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 93/188 (49%), Gaps = 18/188 (9%)
Query: 177 PREVPEYELNPLELQVRKADGITK-GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTH 234
           P E   +E+    L++ K  G  + G   +A +N  TKV VK +   S      + AF  
Sbjct: 177 PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLA 232
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSP-SKVLRFAL 292
           E  +++  +H  +V+    VT+  P+ I+ E+ AKG L  +L+  +G   P  K++ F+ 
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIV 348
            +A GM ++ +      IH DL+  NIL+      KI+ FGL R+    +Y + E AK  
Sbjct: 292 QIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK-- 346
Query: 349 FPVSHIDP 356
           FP+    P
Sbjct: 347 FPIKWTAP 354

>pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/83 (43%), Positives = 55/83 (66%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A RG ++ VE LL  G+DVN+ D  GRT LH+AA  GH+E+V++LL   A+++A+D
Sbjct: 51  LHLAAKRGHLEIVEVLLKHGADVNASDSWGRTPLHLAATVGHLEIVEVLLEYGADVNAQD 110
Query: 136 RWGSTAAADAKYYGNVEVYNILK 158
           ++G TA   +   GN ++  IL+
Sbjct: 111 KFGKTAFDISIDNGNEDLAEILQ 133

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 72/136 (52%), Gaps = 9/136 (6%)
Query: 205 VAKWNGTKVWVKILDKESHK-DPERIN----AFTHELTIVEK-ARHPNVVQFVGAVTQNI 258
           V +  G +  VKI++  + +  PE++     A   E  I+ + A HP+++  + +   + 
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173
Query: 259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
            M +V +   KG+L  YL +K  LS  +       L   +++LH    + I+H DLKP+N
Sbjct: 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPEN 230
Query: 319 ILLDNGGQLKISGFGL 334
           ILLD+  Q+++S FG 
Sbjct: 231 ILLDDNMQIRLSDFGF 246

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 59  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 118
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 119 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 175
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 176 TDFGFAK 182

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 67/126 (53%), Gaps = 6/126 (4%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKGDL 272
           V  + K  H   E +  F  E+ I++  +H N+V++ G         + +++EY   G L
Sbjct: 42  VVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 101
Query: 273 ASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             YLQK K R+   K+L++   + +GM YL   +    IH +L  +NIL++N  ++KI  
Sbjct: 102 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRNLATRNILVENENRVKIGD 158
Query: 332 FGLLRL 337
           FGL ++
Sbjct: 159 FGLTKV 164

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 66/128 (51%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 51  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 110
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 111 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 167
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 168 VTDFGFAK 175

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 66/128 (51%), Gaps = 3/128 (2%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY  
Sbjct: 86  TGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVP 145
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G ++
Sbjct: 146 GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQ 202
Query: 329 ISGFGLLR 336
           ++ FG  +
Sbjct: 203 VTDFGFAK 210

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y H+     I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 138 DLKAENLLLDADMNIKIADFGF 159

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 4/123 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 35  MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 94
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 95  FHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 151
Query: 334 LLR 336
           + +
Sbjct: 152 MCK 154

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y H+     I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 138 DLKAENLLLDADMNIKIADFGF 159

>pdb|2Y1L|E Chain E, Caspase-8 In Complex With Darpin-8.4 Length = 169

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/83 (40%), Positives = 55/83 (66%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A  G ++ VE LL  G+DVN+ D++G T LH+AA  GH+E+V++LL   A+++A+D
Sbjct: 84  LRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQD 143
Query: 136 RWGSTAAADAKYYGNVEVYNILK 158
           ++G TA   +   GN ++  IL+
Sbjct: 144 KFGKTAFDISIDNGNEDLAEILQ 166

>pdb|2Y1L|E Chain E, Caspase-8 In Complex With Darpin-8.4 Length = 169

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 69/136 (50%), Gaps = 7/136 (5%)
Query: 91  LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN 150
           L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A D  G T    A  +G+
Sbjct: 33  LMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGH 92
Query: 151 VEVYNILKARGAKVPKTK---RTPMTVA---NPREVPEYELNPLELQVRKADGITKGSYQ 204
           +E+  +L   GA V        TP+ +A      E+ E  L      V   D   K ++ 
Sbjct: 93  LEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKN-GADVNAQDKFGKTAFD 151
Query: 205 VAKWNGTKVWVKILDK 220
           ++  NG +   +IL K
Sbjct: 152 ISIDNGNEDLAEILQK 167

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y H+     I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 138 DLKAENLLLDADMNIKIADFGF 159

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 66/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +++
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+     I  GS+      KW+G  V VK+L+  +   P+++ AF +E+ ++ K RH N+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKP 306
           + F+G  T    + IV ++     L  +L   + +    K++  A   A+GM+YLH    
Sbjct: 67  LLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---A 122
Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             IIH DLK  NI L     +KI  FGL
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGL 150

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 93/188 (49%), Gaps = 18/188 (9%)
Query: 177 PREVPEYELNPLELQVRKADGITK-GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTH 234
           P E   +E+    L++ K  G  + G   +A +N  TKV VK +   S      + AF  
Sbjct: 4   PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLA 59
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSP-SKVLRFAL 292
           E  +++  +H  +V+    VT+  P+ I+ E+ AKG L  +L+  +G   P  K++ F+ 
Sbjct: 60  EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 118
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIV 348
            +A GM ++ +      IH DL+  NIL+      KI+ FGL R+    +Y + E AK  
Sbjct: 119 QIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK-- 173
Query: 349 FPVSHIDP 356
           FP+    P
Sbjct: 174 FPIKWTAP 181

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 4/123 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           +K++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 39  MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 98
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 99  FHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 155
Query: 334 LLR 336
           + +
Sbjct: 156 MCK 158

>pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 7/156 (4%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAHDDQGSTPLHLAAWIGHPEIVEVLLKHGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVANPR---EVPEYE 184
           ++ARD  G T    A   G++E+  +L   GA V        TP+ +A  R   E+ E  
Sbjct: 73  VNARDTDGWTPLHLAADNGHLEIVEVLLKYGADVNAQDAYGLTPLHLAADRGHLEIVEVL 132
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           L      V   D   K ++ ++  NG +   +IL K
Sbjct: 133 LKH-GADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 13/156 (8%)
Query: 187 PLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
           P E Q+   + I KG + QV   +W+G +V ++++D E   + +++ AF  E+    + R
Sbjct: 31  PFE-QLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNE-DQLKAFKREVMAYRQTR 87
Query: 244 HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYL 301
           H NVV F+GA   + P + ++    KG     + +  +  L  +K  + A ++ +GM YL
Sbjct: 88  HENVVLFMGACM-SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           H      I+H DLK KN+  DN G++ I+ FGL  +
Sbjct: 147 H---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSI 178

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P + +   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +K+
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P + +   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+++D  G +K+
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 72/142 (50%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT-- 255
           +  G Y     N  +  +K L + +  + +++ AF  E  ++    HPNV+  +G +   
Sbjct: 37  VYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94
Query: 256 QNIPMMIVLEYHAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDL 314
           + +P  ++L Y   GDL  +++   R    K ++ F L +ARGM YL E K    +H DL
Sbjct: 95  EGLPH-VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDL 150
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N +LD    +K++ FGL R
Sbjct: 151 AARNCMLDESFTVKVADFGLAR 172

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G +         V VK L  +    PE ++ F  E+  +    H N+++  G V   
Sbjct: 34  VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-T 92
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            PM +V E    G L   L+K +G      + R+A+ +A GM YL   +    IH DL  
Sbjct: 93  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAA 149
Query: 317 KNILLDNGGQLKISGFGLLRL------QYISPEKAKIVF 349
           +N+LL     +KI  FGL+R        Y+  E  K+ F
Sbjct: 150 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G +         V VK L  +    PE ++ F  E+  +    H N+++  G V   
Sbjct: 28  VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-T 86
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            PM +V E    G L   L+K +G      + R+A+ +A GM YL   +    IH DL  
Sbjct: 87  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAA 143
Query: 317 KNILLDNGGQLKISGFGLLRL------QYISPEKAKIVF 349
           +N+LL     +KI  FGL+R        Y+  E  K+ F
Sbjct: 144 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 182

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H   E +  F  E+ I++  +H N+V++ G  
Sbjct: 27  GSVEMCRYDPLQDNTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +++EY   G L  YLQ    R+   K+L++   + +GM YL   +    IH
Sbjct: 84  YSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR---YIH 140
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
            DL  +NIL++N  ++KI  FGL ++     E  K+  P
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+++D  G +K+
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 116 VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 172
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 173 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 229
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 230 AARNVLVTENNVMKIADFGLAR 251

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 66/123 (53%), Gaps = 4/123 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           ++++ KE   D E I+    E  + E+A  HP +V           +  V+EY   GDL 
Sbjct: 82  MRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLM 141
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            ++Q++ +L       ++ +++  +NYLHE     II+ DLK  N+LLD+ G +K++ +G
Sbjct: 142 FHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 334 LLR 336
           + +
Sbjct: 199 MCK 201

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK L +E  +  E    F  E+ ++  A H N+++  G        ++V  Y A
Sbjct: 53  DGXLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMA 110
Query: 269 KGDLASYLQKKGRLSPS----KVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDN 323
            G +AS L+++    P     K  R AL  ARG+ YLH+ C P  IIH D+K  NILLD 
Sbjct: 111 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDE 169
Query: 324 GGQLKISGFGLLRL 337
             +  +  FGL +L
Sbjct: 170 EFEAVVGDFGLAKL 183

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 36  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 91
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 92  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 151
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 152 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 37  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 92
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 93  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 152
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 153 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G +         V VK L  +    PE ++ F  E+  +    H N+++  G V   
Sbjct: 28  VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-T 86
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            PM +V E    G L   L+K +G      + R+A+ +A GM YL   +    IH DL  
Sbjct: 87  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAA 143
Query: 317 KNILLDNGGQLKISGFGLLRL------QYISPEKAKIVF 349
           +N+LL     +KI  FGL+R        Y+  E  K+ F
Sbjct: 144 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 182

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G +         V VK L  +    PE ++ F  E+  +    H N+++  G V   
Sbjct: 24  VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-T 82
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            PM +V E    G L   L+K +G      + R+A+ +A GM YL   +    IH DL  
Sbjct: 83  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAA 139
Query: 317 KNILLDNGGQLKISGFGLLRL------QYISPEKAKIVF 349
           +N+LL     +KI  FGL+R        Y+  E  K+ F
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 184 AARNVLVTENNVMKIADFGLAR 205

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 68  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 127
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 128 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 170

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 184 AARNVLVTENNVMKIADFGLAR 205

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 34  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 89
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 90  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 149
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 150 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 184 AARNVLVTENNVMKIADFGLAR 205

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 62  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 118
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 119 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 175
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 176 AARNVLVTENNVMKIADFGLAR 197

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 30  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 85
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 86  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 145
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 146 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 11/159 (6%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G +         V VK L  +    PE ++ F  E+  +    H N+++  G V   
Sbjct: 24  VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-T 82
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            PM +V E    G L   L+K +G      + R+A+ +A GM YL   +    IH DL  
Sbjct: 83  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAA 139
Query: 317 KNILLDNGGQLKISGFGLLRL------QYISPEKAKIVF 349
           +N+LL     +KI  FGL+R        Y+  E  K+ F
Sbjct: 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 73/141 (51%), Gaps = 22/141 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L  ++ +  E ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG+
Sbjct: 70  VAVKMLKDDATE--EDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 127
Query: 272 LASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
           L  YL+ +                 +++   ++     LARGM YL   K    IH DL 
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 184
Query: 316 PKNILLDNGGQLKISGFGLLR 336
            +N+L+     +KI+ FGL R
Sbjct: 185 ARNVLVTENNVMKIADFGLAR 205

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 43  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 98
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 159 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 19/124 (15%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F HE  +  + +HPNVV  +G VT++ P+ ++  Y + GDL  +L               
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
              K  L P   +     +A GM YL       ++H DL  +N+L+ +   +KIS  GL 
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 192
Query: 336 RLQY 339
           R  Y
Sbjct: 193 REVY 196

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 59  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 115
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 116 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 172
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 173 AARNVLVTENNVMKIADFGLAR 194

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 184 AARNVLVTENNVMKIADFGLAR 205

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 36  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 91
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 92  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 151
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 152 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V V+I+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y H+     I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 138 DLKAENLLLDADMNIKIADFGF 159

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 76  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 135
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 136 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 178

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 57  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 113
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 114 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 170
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 171 TARNVLVTENNVMKIADFGLAR 192

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 184 AARNVLVTENNVMKIADFGLAR 205

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V V+I+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   GR+   +       +   + Y H+     I+H 
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ---KFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 138 DLKAENLLLDADMNIKIADFGF 159

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 111 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 170
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 171 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 213

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 19/124 (15%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F HE  +  + +HPNVV  +G VT++ P+ ++  Y + GDL  +L               
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
              K  L P   +     +A GM YL       ++H DL  +N+L+ +   +KIS  GL 
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
Query: 336 RLQY 339
           R  Y
Sbjct: 176 REVY 179

>pdb|3ZUV|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 136

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN++D DG T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNALDEDGLTPLHLAAQLGHLEIVEVLLKYGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           ++A D +G T    A   G++E+  +L   GA V    +   T
Sbjct: 73  VNAEDNFGITPLHLAAIRGHLEIVEVLLKHGADVNAQDKFGKT 115

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 20/161 (12%)
Query: 185 LNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH 244
           L  LE++ R   G    +  + ++   K++  I DK+S ++        +E+  +   +H
Sbjct: 26  LQLLEVKARGRFGCVWKAQLLNEYVAVKIF-PIQDKQSWQNE-------YEVYSLPGMKH 77
Query: 245 PNVVQFVGA----VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNY 300
            N++QF+GA     + ++ + ++  +H KG L+ +L K   +S +++   A  +ARG+ Y
Sbjct: 78  ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAY 136
Query: 301 LHECKPD-------PIIHCDLKPKNILLDNGGQLKISGFGL 334
           LHE  P         I H D+K KN+LL N     I+ FGL
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 65  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 120
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 121 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 180
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 181 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 61/115 (53%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT+    MIV EY   G L ++L+   G+ +  +++  
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              +  GM YL +      +H DL  +N+L+D+    K+S FGL R+    P+ A
Sbjct: 157 LRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 33  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 88
Query: 256 QNIPMMIVLEYHAKGDLASYLQK-------KGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL+           L+P   SK+++ A ++A GM YL+  K
Sbjct: 89  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 148
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 149 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199

>pdb|2XEN|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module Length = 91

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 36/88 (40%), Positives = 55/88 (62%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D DG T LH+AA EGH+E+V++LL   A+
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGAD 60
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILK 158
           ++A+D++G TA   +   GN ++  IL+
Sbjct: 61  VNAQDKFGKTAFDISIDNGNEDLAEILQ 88

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 82/151 (54%), Gaps = 17/151 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 37  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 92
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 93  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 152
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
               +H DL  +N ++     +KI  FG+ R
Sbjct: 153 ---FVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 43  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 98
Query: 256 QNIPMMIVLEYHAKGDLASYLQK-------KGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL+           L+P   SK+++ A ++A GM YL+  K
Sbjct: 99  QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK 158
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N ++     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 159 ---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 52  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 111
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 112 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 154

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 61/115 (53%), Gaps = 4/115 (3%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRF 290
           F  E +I+ +  HPN+++  G VT+    MIV EY   G L ++L+   G+ +  +++  
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
              +  GM YL +      +H DL  +N+L+D+    K+S FGL R+    P+ A
Sbjct: 157 LRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 35/166 (21%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA 253
           A GI+K    +      +V VK+L KE     ER  A   EL ++ +   H N+V  +GA
Sbjct: 66  AYGISKTGVSI------QVAVKML-KEKADSSER-EALMSELKMMTQLGSHENIVNLLGA 117
Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKK-----------------------GRLSPSKVLRF 290
            T + P+ ++ EY   GDL +YL+ K                         L+   +L F
Sbjct: 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           A  +A+GM +L   +    +H DL  +N+L+ +G  +KI  FGL R
Sbjct: 178 AYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + +G+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 109 VSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV 151

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 82/151 (54%), Gaps = 17/151 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 28  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 83
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 84  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 143
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
               +H DL  +N ++     +KI  FG+ R
Sbjct: 144 ---FVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|2P2C|P Chain P, Inhibition Of Caspase-2 By A Designed Ankyrin Repeat Protein (Darpin) Length = 169

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNATDWLGHTPLHLAAKTGHLEIVEVLLKYGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYE--LNPL 188
           ++A D +G+T    A   G++E+  +L   GA V        T   P  +  Y+  L  +
Sbjct: 73  VNAWDNYGATPLHLAADNGHLEIVEVLLKHGADVNAKDYEGFT---PLHLAAYDGHLEIV 129
Query: 189 EL------QVRKADGITKGSYQVAKWNGTKVWVKILDK 220
           E+       V   D   K ++ ++  NG +   +IL K
Sbjct: 130 EVLLKYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 59  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 118
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 119 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 175
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 176 TDFGFAK 182

>pdb|3NOG|D Chain D, Designed Ankyrin Repeat Protein (Darpin) Binders To Acrb: Plasticity Of The Interface Length = 169

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNASDHVGWTPLHLAAYFGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVANPREVPEYELNP 187
           ++A D  G T    A   G++EV  +L   GA V        TP+ +A    +   E+  
Sbjct: 73  VNADDSLGVTPLHLAADRGHLEVVEVLLKNGADVNANDHNGFTPLHLA--ANIGHLEIVE 130
Query: 188 LELQ----VRKADGITKGSYQVAKWNGTKVWVKILDK 220
           + L+    V   D   K ++ ++  NG +   +IL K
Sbjct: 131 VLLKHGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 167

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 183 TDFGFAK 189

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKG 270
           VW K LD  S  + E+      E+ ++ + +HPN+V++   +    N  + IV+EY   G
Sbjct: 35  VW-KELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 92
Query: 271 DLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPD---PIIHCDLKPKNILLDN 323
           DLAS + K  +    L    VLR    L   +   H  + D    ++H DLKP N+ LD 
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG 151
Query: 324 GGQLKISGFGLLRL 337
              +K+  FGL R+
Sbjct: 152 KQNVKLGDFGLARI 165

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+L+D  G +++
Sbjct: 127 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 73/143 (51%), Gaps = 10/143 (6%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G K+  KI+     KD E +    +E++++ +  H N++Q   A      +++V+EY   
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170
Query: 270 GDLAS-YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQ 326
           G+L    + +   L+    + F   +  G+ ++H+     I+H DLKP+NIL  N    Q
Sbjct: 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQ 227
Query: 327 LKISGFGLLRLQYISPEKAKIVF 349
           +KI  FGL R +Y   EK K+ F
Sbjct: 228 IKIIDFGLAR-RYKPREKLKVNF 249

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 18/159 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 162
Query: 321 LDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
           + +   +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 163 VAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKG 270
           VW K LD  S  + E+      E+ ++ + +HPN+V++   +    N  + IV+EY   G
Sbjct: 35  VW-KELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 92
Query: 271 DLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPD---PIIHCDLKPKNILLDN 323
           DLAS + K  +    L    VLR    L   +   H  + D    ++H DLKP N+ LD 
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG 151
Query: 324 GGQLKISGFGLLRL 337
              +K+  FGL R+
Sbjct: 152 KQNVKLGDFGLARI 165

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 66/134 (49%), Gaps = 12/134 (8%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKG 270
           VW K LD  S  + E+      E+ ++ + +HPN+V++   +    N  + IV+EY   G
Sbjct: 35  VW-KELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 92
Query: 271 DLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPD---PIIHCDLKPKNILLDN 323
           DLAS + K  +    L    VLR    L   +   H  + D    ++H DLKP N+ LD 
Sbjct: 93  DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDG 151
Query: 324 GGQLKISGFGLLRL 337
              +K+  FGL R+
Sbjct: 152 KQNVKLGDFGLARI 165

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 5/140 (3%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G +         V VK L  +    PE ++ F  E+  +    H N+++  G V   
Sbjct: 34  VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-T 92
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            PM +V E    G L   L+K +G      + R+A+ +A GM YL   +    IH DL  
Sbjct: 93  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAA 149
Query: 317 KNILLDNGGQLKISGFGLLR 336
           +N+LL     +KI  FGL+R
Sbjct: 150 RNLLLATRDLVKIGDFGLMR 169

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     ++I+ FGL R
Sbjct: 184 AARNVLVTENNVMRIADFGLAR 205

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 77/139 (55%), Gaps = 15/139 (10%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 47  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 104
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 105 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 161
Query: 321 LDNGGQLKISGFGLLRLQY 339
           + +   +KI  FG+ R  Y
Sbjct: 162 VAHDFTVKIGDFGMTRDIY 180

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/139 (32%), Positives = 77/139 (55%), Gaps = 15/139 (10%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 162
Query: 321 LDNGGQLKISGFGLLRLQY 339
           + +   +KI  FG+ R  Y
Sbjct: 163 VAHDFTVKIGDFGMTRDIY 181

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FA 291
           +E   HPNVV+     T     +   + +V E H   DL +YL K      P++ ++   
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
             L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R+
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 76/136 (55%), Gaps = 15/136 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 45  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 102
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 103 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 159
Query: 321 LDNGGQLKISGFGLLR 336
           + +   +KI  FG+ R
Sbjct: 160 VAHDFTVKIGDFGMTR 175

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 76/136 (55%), Gaps = 15/136 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 162
Query: 321 LDNGGQLKISGFGLLR 336
           + +   +KI  FG+ R
Sbjct: 163 VAHDFTVKIGDFGMTR 178

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 76/136 (55%), Gaps = 15/136 (11%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H DL  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 162
Query: 321 LDNGGQLKISGFGLLR 336
           + +   +KI  FG+ R
Sbjct: 163 VAHDFTVKIGDFGMTR 178

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 64/127 (50%), Gaps = 3/127 (2%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G    +KILDK+     ++I    +E  I++    P + +   +   N  + +V+EY   
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++ S+L++ GR        +A  +     YLH      +I+ DLKP+N+++D  G +K+
Sbjct: 127 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLMIDQQGYIKV 183
Query: 330 SGFGLLR 336
           + FG  +
Sbjct: 184 TDFGFAK 190

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 65/140 (46%), Gaps = 5/140 (3%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G +         V VK L  +    PE ++ F  E+  +    H N+++  G V   
Sbjct: 24  VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-T 82
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            PM +V E    G L   L+K +G      + R+A+ +A GM YL   +    IH DL  
Sbjct: 83  PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAA 139
Query: 317 KNILLDNGGQLKISGFGLLR 336
           +N+LL     +KI  FGL+R
Sbjct: 140 RNLLLATRDLVKIGDFGLMR 159

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 57/114 (50%), Gaps = 4/114 (3%)
Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP 284
           D E    F  E+ ++    HPNV++F+G + ++  +  + EY   G L   ++      P
Sbjct: 47  DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP 106
Query: 285 -SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
            S+ + FA D+A GM YLH      IIH DL   N L+     + ++ FGL RL
Sbjct: 107 WSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL 157

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 65/120 (54%), Gaps = 4/120 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K+L K + K  +R+     E  I+ +  HP +V+   A      + ++L++   GDL +
Sbjct: 57  MKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L K+   +   V  +  +LA  +++LH      II+ DLKP+NILLD  G +K++ FGL
Sbjct: 116 RLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 172

>pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 55/103 (53%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T LH+AA   H+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNANDRKGNTPLHLAADYDHLEIVEVLLKHGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           ++A D  GST    A  +G++E+  +L   GA V    +   T
Sbjct: 73  VNAHDNDGSTPLHLAALFGHLEIVEVLLKHGADVNAQDKFGKT 115

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FA 291
           +E   HPNVV+     T     +   + +V E H   DL +YL K      P++ ++   
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
             L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R+
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 11/106 (10%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FA 291
           +E   HPNVV+     T     +   + +V E H   DL +YL K      P++ ++   
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
             L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R+
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 90/174 (51%), Gaps = 20/174 (11%)
Query: 196 DGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT 255
           +G+ KG   V     T+V +K ++ E+    ERI  F +E +++++    +VV+ +G V+
Sbjct: 30  EGVAKGV--VKDEPETRVAIKTVN-EAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVS 85
Query: 256 QNIPMMIVLEYHAKGDLASYL-------QKKGRLSP---SKVLRFALDLARGMNYLHECK 305
           Q  P ++++E   +GDL SYL       +    L+P   SK+++ A ++A GM YL+  K
Sbjct: 86  QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK 145
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP---EKAKIVFPVSHIDP 356
               +H DL  +N  +     +KI  FG+ R  Y +    +  K + PV  + P
Sbjct: 146 ---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 65/120 (54%), Gaps = 4/120 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K+L K + K  +R+     E  I+ +  HP +V+   A      + ++L++   GDL +
Sbjct: 58  MKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 116
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L K+   +   V  +  +LA  +++LH      II+ DLKP+NILLD  G +K++ FGL
Sbjct: 117 RLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 173

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 65/120 (54%), Gaps = 4/120 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +K+L K + K  +R+     E  I+ +  HP +V+   A      + ++L++   GDL +
Sbjct: 57  MKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L K+   +   V  +  +LA  +++LH      II+ DLKP+NILLD  G +K++ FGL
Sbjct: 116 RLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 172

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 81  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 139
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 140 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 195

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 139
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 140 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 195

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 59/107 (55%), Gaps = 5/107 (4%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL-SPSKVLRFALD 293
           E+++++  +H N+V     +     + +V EY  K DL  YL   G + +   V  F   
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYI 340
           L RG+ Y H  K   ++H DLKP+N+L++  G+LK++ FGL R + I
Sbjct: 109 LLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 107 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 165
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 166 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 221

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 138
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 139 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 98  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 156
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 157 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 212

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGL 334
           FGL
Sbjct: 148 FGL 150

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGL 334
           FGL
Sbjct: 149 FGL 151

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 97  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 155
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 156 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 211

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 87  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 145
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 146 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 201

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 179
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 180 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 66/157 (42%), Gaps = 19/157 (12%)
Query: 191 QVRKADGITKGSY---QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+   + + KG Y       W G  V VKI      K   R      EL      RH N+
Sbjct: 38  QITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFR----ETELYNTVMLRHENI 93
Query: 248 VQFVGAVT----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH- 302
           + F+ +       +  + ++  YH  G L  YLQ    L     LR  L +A G+ +LH 
Sbjct: 94  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 152
Query: 303 -----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
                + KP  I H DLK KNIL+   GQ  I+  GL
Sbjct: 153 EIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGL 188

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 73/143 (51%), Gaps = 10/143 (6%)
Query: 214 WVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----MMIVLEYHAK 269
           W ++ D++  K  ER   F  E   ++  +HPN+V+F  +    +     +++V E    
Sbjct: 56  WCELQDRKLTKS-ER-QRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTS 113
Query: 270 GDLASYLQKKGRLSPSKVLR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQL 327
           G L +YL K+ ++   KVLR +   + +G+ +LH   P PIIH DLK  NI +    G +
Sbjct: 114 GTLKTYL-KRFKVXKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSV 171
Query: 328 KISGFGLLRLQYISPEKAKIVFP 350
           KI   GL  L+  S  KA I  P
Sbjct: 172 KIGDLGLATLKRASFAKAVIGTP 194

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I +   HPN+V+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V EY + G++  YL   GR    +       +   + Y H+     I+H 
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ---KFIVHR 137
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 138 DLKAENLLLDADXNIKIADFGF 159

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 72  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 130
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 131 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 186

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 95  FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 153
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 154 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209

>pdb|3HG0|D Chain D, Crystal Structure Of A Darpin In Complex With Orf49 From Lactococcal Phage Tp901-1 Length = 136

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DVN+ D  G T LH+AA   H+E+V++LL   A+++A 
Sbjct: 17  KLLEAARAGQDDEVRILMANGADVNAEDKVGLTPLHLAAMNDHLEIVEVLLKNGADVNAI 76
Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           D  G T       YG++E+  +L   GA V
Sbjct: 77  DAIGETPLHLVAMYGHLEIVEVLLKHGADV 106

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 61/103 (59%), Gaps = 5/103 (4%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E++++++  HPN+V  +  +     + +V E+  K DL   L + K  L  S++  +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L RG+ + H+ +   I+H DLKP+N+L+++ G LK++ FGL R
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSK-----------VLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +L++YL+ K+    P K           ++ ++  +A+GM +L   K    IH DL  +N
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAARN 174
Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAK 346
           ILL     +KI  FGL R  Y  P+  +
Sbjct: 175 ILLSEKNVVKIXDFGLARDIYKDPDYVR 202

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGL 334
           FGL
Sbjct: 149 FGL 151

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGL 334
           FGL
Sbjct: 149 FGL 151

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 61/103 (59%), Gaps = 5/103 (4%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E++++++  HPN+V  +  +     + +V E+  K DL   L + K  L  S++  +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L RG+ + H+ +   I+H DLKP+N+L+++ G LK++ FGL R
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 35  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 92  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 148
Query: 332 FGL 334
           FGL
Sbjct: 149 FGL 151

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 60  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 118
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 119 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 175
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 176 L--PIKWMAP 183

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/119 (36%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 153
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 154 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 63  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 122 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 179 L--PIKWMAP 186

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 34  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 90
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 91  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 147
Query: 332 FGL 334
           FGL
Sbjct: 148 FGL 150

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 497 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 554 L--PIKWMAP 561

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 61/123 (49%), Gaps = 7/123 (5%)
Query: 213 VWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+
Sbjct: 33  VAVKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89
Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS 
Sbjct: 90  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISD 146
Query: 332 FGL 334
           FGL
Sbjct: 147 FGL 149

>pdb|2JAB|A Chain A, A Designed Ankyrin Repeat Protein Evolved To Picomolar Affinity To Her2 Length = 136

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 54/103 (52%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DVN+ D  G T L++A   GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           ++A D  G T    A + G++E+  +L   GA V    +   T
Sbjct: 73  VNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKT 115

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++ Y +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 184 AARNVLVTENNVMKIADFGLAR 205

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 116
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 117 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 174 L--PIKWMAP 181

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 37  VKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 150
Query: 334 L 334
           L
Sbjct: 151 L 151

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 61  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 119
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 120 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 176
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 177 L--PIKWMAP 184

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
             +NILL     +KI  FGL R  Y  P+  +
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDXVR 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 37  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 150
Query: 334 L 334
           L
Sbjct: 151 L 151

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 86  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 144
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 145 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 201
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 202 L--PIKWMAP 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 37  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 150
Query: 334 L 334
           L
Sbjct: 151 L 151

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 116
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 117 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 174 L--PIKWMAP 181

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 97  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
             +NILL     +KI  FGL R  Y  P+  +
Sbjct: 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVR 243

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 67/157 (42%), Gaps = 19/157 (12%)
Query: 191 QVRKADGITKGSY---QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q+   + + KG Y       W G  V VKI      K   R     + + +    RH N+
Sbjct: 9   QITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENI 64
Query: 248 VQFVGAVT----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH- 302
           + F+ +       +  + ++  YH  G L  YLQ    L     LR  L +A G+ +LH 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 303 -----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
                + KP  I H DLK KNIL+   GQ  I+  GL
Sbjct: 124 EIFGTQGKP-AIAHRDLKSKNILVKKNGQCCIADLGL 159

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 68/142 (47%), Gaps = 9/142 (6%)
Query: 198 ITKGSYQVAKW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I KG++   K       G +V VKI+DK +  +   +     E+ I++   HPN+V+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +     + +V+EY + G++  YL   G +   +       +   + Y H+     I+H 
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ---KFIVHR 130
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           DLK +N+LLD    +KI+ FG 
Sbjct: 131 DLKAENLLLDADMNIKIADFGF 152

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I++E  A GDL S+L ++ R  PS+     
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLA 138
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 139 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 55  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K
Sbjct: 114 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 171 L--PIKWMAP 178

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I +   H NVV+F G   +     + LEY + G+L 
Sbjct: 36  VKIVDMKRAVDCPENIKK---EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 149
Query: 334 L 334
           L
Sbjct: 150 L 150

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 72/131 (54%), Gaps = 8/131 (6%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
            G +V VK L  ES  +   I     E+ I+    H N+V++ G  T++    + +++E+
Sbjct: 49  TGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              G L  YL K K +++  + L++A+ + +GM+YL   +    +H DL  +N+L+++  
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEH 163
Query: 326 QLKISGFGLLR 336
           Q+KI  FGL +
Sbjct: 164 QVKIGDFGLTK 174

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
             +NILL     +KI  FGL R  Y  P+  +
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSK-----------VLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +L++YL+ K+    P K           ++ ++  +A+GM +L   K    IH DL  +N
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK---XIHRDLAARN 174
Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAK 346
           ILL     +KI  FGL R  Y  P+  +
Sbjct: 175 ILLSEKNVVKICDFGLARDIYKDPDYVR 202

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 8/143 (5%)
Query: 197 GITKGSYQ---VAKWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
            I KGS+    + + N TK    +K ++K+   +   +     EL I++   HP +V   
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +      M +V++    GDL  +LQ+        V  F  +L   ++YL   +   IIH
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIH 138
Query: 312 CDLKPKNILLDNGGQLKISGFGL 334
            D+KP NILLD  G + I+ F +
Sbjct: 139 RDMKPDNILLDEHGHVHITDFNI 161

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 90/191 (47%), Gaps = 19/191 (9%)
Query: 177 PREVPEYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERIN 230
           PR  P+Y +   ++ + +  G      + +G Y   K     V VK   K+   D +   
Sbjct: 13  PRGSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-- 70
Query: 231 AFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLR 289
            F  E  I++   HP++V+ +G + +  P  I++E +  G+L  YL++ K  L    ++ 
Sbjct: 71  KFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVL 129
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE---KAK 346
           ++L + + M YL        +H D+  +NIL+ +   +K+  FGL R  YI  E   KA 
Sbjct: 130 YSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR--YIEDEDYYKAS 184
Query: 347 IV-FPVSHIDP 356
           +   P+  + P
Sbjct: 185 VTRLPIKWMSP 195

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 18/177 (10%)
Query: 177 PREVPEYELNPLELQVRKADGITK-GSYQVAKWNG-TKVWVKILDKESHKDPERINAFTH 234
           P E   +E+    L++ K  G  + G   +A +N  TKV VK +   S      + AF  
Sbjct: 171 PWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLA 226
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSP-SKVLRFAL 292
           E  +++  +H  +V+    VT+  P+ I+ E+ AKG L  +L+  +G   P  K++ F+ 
Sbjct: 227 EANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 285
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR------LQYISPE 343
            +A GM ++ +      IH DL+  NIL+      KI+ FGL R      +++ +PE
Sbjct: 286 QIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTAPE 339

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 24/142 (16%)
Query: 213 VWVKIL-DKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           V VK+L D  + KD   ++    E+ +++   +H N++  +GA TQ+ P+ +++ Y +KG
Sbjct: 70  VAVKMLKDDATEKD---LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKG 126
Query: 271 DLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L  YL+ +                 +++   ++     LARGM YL   K    IH DL
Sbjct: 127 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDL 183
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +N+L+     +KI+ FGL R
Sbjct: 184 AARNVLVTENNVMKIADFGLAR 205

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 60/119 (50%), Gaps = 15/119 (12%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I++E  A GDL S+L ++ R  PS+     
Sbjct: 95  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLA 153
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRLQY 339
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+ R  Y
Sbjct: 154 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 209

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 77/139 (55%), Gaps = 15/139 (10%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 49  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 106
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H +L  +N +
Sbjct: 107 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCM 163
Query: 321 LDNGGQLKISGFGLLRLQY 339
           + +   +KI  FG+ R  Y
Sbjct: 164 VAHDFTVKIGDFGMTRDIY 182

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/139 (31%), Positives = 77/139 (55%), Gaps = 15/139 (10%)
Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
           T+V VK ++ ES    ERI  F +E ++++     +VV+ +G V++  P ++V+E  A G
Sbjct: 48  TRVAVKTVN-ESASLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 105
Query: 271 DLASYLQK--------KGRLSPS--KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           DL SYL+          GR  P+  ++++ A ++A GM YL+  K    +H +L  +N +
Sbjct: 106 DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCM 162
Query: 321 LDNGGQLKISGFGLLRLQY 339
           + +   +KI  FG+ R  Y
Sbjct: 163 VAHDFTVKIGDFGMTRDIY 181

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 72/130 (55%), Gaps = 8/130 (6%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEYH 267
           G +V VK L  ES  +   I     E+ I+    H N+V++ G  T++    + +++E+ 
Sbjct: 38  GEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 95
Query: 268 AKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             G L  YL K K +++  + L++A+ + +GM+YL   +    +H DL  +N+L+++  Q
Sbjct: 96  PSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 152
Query: 327 LKISGFGLLR 336
           +KI  FGL +
Sbjct: 153 VKIGDFGLTK 162

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 67  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLK 126
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 127 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 183
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 184 AKV--LSPE 190

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 7/123 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           VK+++K S K+ +  +    E+ +++K  HPN+++    +  +    IV E +  G+L  
Sbjct: 52  VKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISG 331
            + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL++  +   +KI  
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIID 167
Query: 332 FGL 334
           FGL
Sbjct: 168 FGL 170

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 37  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 96
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 97  YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 153
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 154 AKV--LSPE 160

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 60  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 176
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 177 AKV--LSPE 183

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY 116
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           A  L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R
Sbjct: 117 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 60  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 176
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 177 AKV--LSPE 183

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 179 AKV--LSPE 185

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 60  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 176
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 177 AKV--LSPE 183

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/121 (36%), Positives = 59/121 (48%), Gaps = 7/121 (5%)
Query: 215 VKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
           VKI+D +   D PE I     E+ I     H NVV+F G   +     + LEY + G+L 
Sbjct: 37  VKIVDMKRAVDCPENIKK---EICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    LKIS FG
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFG 150
Query: 334 L 334
           L
Sbjct: 151 L 151

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 39  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 98
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 99  YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 155
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 156 AKV--LSPE 162

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 38  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 98  YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 154
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 155 AKV--LSPE 161

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 60  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 120 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 176
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 177 AKV--LSPE 183

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 59  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 118
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 119 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 175
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 176 AKV--LSPE 182

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 56  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 109
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 44  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 103
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 104 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 160
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 161 AKV--LSPE 167

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 179 AKV--LSPE 185

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 56  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 109
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 179 AKV--LSPE 185

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 179 AKV--LSPE 185

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 23/152 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M++ E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
             +NILL     +KI  FGL R  Y  P+  +
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVR 197

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 63  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 122
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 123 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 179
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 180 AKV--LSPE 186

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 40  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 99
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 100 YIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGT 156
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 157 AKV--LSPE 163

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 179 AKV--LSPE 185

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 63  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 122
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 123 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 179
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 180 AKV--LSPE 186

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 59  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 118
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 119 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 175
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 176 AKV--LSPE 182

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 23/152 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M++ E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
             +NILL     +KI  FGL R  Y  P+  +
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVR 197

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 61/144 (42%), Gaps = 16/144 (11%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT----Q 256
           G      W G  V VKI      K   R     + + +    RH N++ F+ +       
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIASDMTSRHS 77
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
           +  + ++  YH  G L  YLQ    L     LR  L +A G+ +LH      + KP  I 
Sbjct: 78  STQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIA 135
Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           H DLK KNIL+   GQ  I+  GL
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGL 159

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 67/130 (51%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 58  FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY 116
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+     +K+  FGL R      Y    K K
Sbjct: 117 AYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 174 L--PIKWMAP 181

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 58/114 (50%), Gaps = 15/114 (13%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK----- 286
           F  E  I+ K  H N+V+ +G   Q++P  I+LE  A GDL S+L ++ R  PS+     
Sbjct: 81  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 139
Query: 287 ---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGL 334
              +L  A D+A G  YL E   +  IH D+  +N LL   G     KI  FG+
Sbjct: 140 MLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 190

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 62/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++LE  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 63/112 (56%), Gaps = 6/112 (5%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+ ++++  HPN++  + A      + +V ++  + DL   ++     L+PS +  + L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDF-METDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
             +G+ YLH+     I+H DLKP N+LLD  G LK++ FGL +  + SP +A
Sbjct: 121 TLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRA 168

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E+ ++++ +H N+V+    +  +  + +V E+    DL  Y     G L P  V  F   
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L +G+ + H      ++H DLKP+N+L++  G+LK++ FGL R
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 62/129 (48%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G+L  
Sbjct: 65  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 124
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 125 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 181
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 182 AKV--LSPE 188

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 67/130 (51%), Gaps = 11/130 (8%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRF 290
           F  E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +K  L  + ++ +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ----YISPEKAK 346
           A  L+  + YL   +    +H D+  +N+L+     +K+  FGL R      Y    K K
Sbjct: 497 AYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 347 IVFPVSHIDP 356
           +  P+  + P
Sbjct: 554 L--PIKWMAP 561

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  HPN++           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E+ ++++ +H N+V+    +  +  + +V E+    DL  Y     G L P  V  F   
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEF-CDQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L +G+ + H      ++H DLKP+N+L++  G+LK++ FGL R
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|1N11|A Chain A, D34 Region Of Human Ankyrin-R And Linker Length = 437

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A +  V+    LL  G   N+  + G T LH+AA EGH E+V LLLSK+AN +  +
Sbjct: 216 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 275
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVAN 176
           + G T        G+V V ++L   G  V  T R   TP+ VA+
Sbjct: 276 KSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVAS 319

>pdb|1N11|A Chain A, D34 Region Of Human Ankyrin-R And Linker Length = 437

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAA 142
           G +  V++LL  G+  N  ++   T LH+AA  GH EV K LL  KA ++A+ +   T  
Sbjct: 25  GHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPL 84
Query: 143 ADAKYYGNVEVYNILKARGAK---VPKTKRTPMTVANPREVPEYELNPLELQVRKADGIT 199
             A   G+  +  +L    A          TP+ +A      E  L  LE +  +A    
Sbjct: 85  HCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTK 144
Query: 200 KGS---YQVAKWNGTKVWVKILDKESHKDPERINAFT 233
           KG    +  AK+   +V   +L++++H +    N  T
Sbjct: 145 KGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLT 181

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 62  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 271 DLASYLQ-KKGRLSPSK---------------VLRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P K               ++ ++  +A+GM +L   K    IH DL
Sbjct: 120 NLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 176
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
             +NILL     +KI  FGL R  Y  P+  +
Sbjct: 177 AARNILLSEKNVVKICDFGLARDIYKDPDYVR 208

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 7/123 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           VK+++K S K+ +  +    E+ +++K  HPN+++    +  +    IV E +  G+L  
Sbjct: 52  VKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISG 331
            + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL++  +   +KI  
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIID 167
Query: 332 FGL 334
           FGL
Sbjct: 168 FGL 170

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 66/123 (53%), Gaps = 7/123 (5%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           VK+++K S K+ +  +    E+ +++K  HPN+++    +  +    IV E +  G+L  
Sbjct: 52  VKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFD 110
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISG 331
            + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL++  +   +KI  
Sbjct: 111 EIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIID 167
Query: 332 FGL 334
           FGL
Sbjct: 168 FGL 170

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 65/156 (41%), Gaps = 25/156 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NIL+     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANILISATNAVK 156
Query: 329 ISGFGLLR------------------LQYISPEKAK 346
           +  FG+ R                   QY+SPE+A+
Sbjct: 157 VVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G Y   K     V VK   K+   D +    F  E  I++   HP++V+ +G + + 
Sbjct: 28  VYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIGIIEEE 85
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            P  I++E +  G+L  YL++ K  L    ++ ++L + + M YL        +H D+  
Sbjct: 86  -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAV 141
Query: 317 KNILLDNGGQLKISGFGLLRLQYISPE---KAKIV-FPVSHIDP 356
           +NIL+ +   +K+  FGL R  YI  E   KA +   P+  + P
Sbjct: 142 RNILVASPECVKLGDFGLSR--YIEDEDYYKASVTRLPIKWMSP 183

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 57/105 (54%), Gaps = 2/105 (1%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           N    EL ++ +   P +V F GA   +  + I +E+   G L   L++  R+    + +
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 118
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++ + RG+ YL E     I+H D+KP NIL+++ G++K+  FG+
Sbjct: 119 VSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV 161

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 64/120 (53%), Gaps = 8/120 (6%)
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L+KE    P   +    E++I+++ +H N+V+    +     +++V E H   DL   L 
Sbjct: 36  LEKEDEGIP---STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE-HLDQDLKKLLD 91
Query: 278 K-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             +G L       F L L  G+ Y H+ +   ++H DLKP+N+L++  G+LKI+ FGL R
Sbjct: 92  VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 25/156 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 156
Query: 329 ISGFGLLR------------------LQYISPEKAK 346
           +  FG+ R                   QY+SPE+A+
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 64/120 (53%), Gaps = 8/120 (6%)
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L+KE    P   +    E++I+++ +H N+V+    +     +++V E H   DL   L 
Sbjct: 36  LEKEDEGIP---STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE-HLDQDLKKLLD 91
Query: 278 K-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             +G L       F L L  G+ Y H+ +   ++H DLKP+N+L++  G+LKI+ FGL R
Sbjct: 92  VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 64/120 (53%), Gaps = 8/120 (6%)
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L+KE    P   +    E++I+++ +H N+V+    +     +++V E H   DL   L 
Sbjct: 36  LEKEDEGIP---STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE-HLDQDLKKLLD 91
Query: 278 K-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             +G L       F L L  G+ Y H+ +   ++H DLKP+N+L++  G+LKI+ FGL R
Sbjct: 92  VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 198 ITKGSYQ---VAKWNGTKVW--VKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFV 251
           I KGS+    +A+    +V+  VK+L K++  K  E  +  +    +++  +HP +V   
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            +      +  VL+Y   G+L  +LQ++      +   +A ++A  + YLH      I++
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVY 162
Query: 312 CDLKPKNILLDNGGQLKISGFGLLR 336
            DLKP+NILLD+ G + ++ FGL +
Sbjct: 163 RDLKPENILLDSQGHIVLTDFGLCK 187

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + +G Y   K     V VK   K+   D +    F  E  I++   HP++V+ +G + + 
Sbjct: 24  VYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIGIIEEE 81
Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            P  I++E +  G+L  YL++ K  L    ++ ++L + + M YL        +H D+  
Sbjct: 82  -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAV 137
Query: 317 KNILLDNGGQLKISGFGLLRLQYISPE---KAKIV-FPVSHIDP 356
           +NIL+ +   +K+  FGL R  YI  E   KA +   P+  + P
Sbjct: 138 RNILVASPECVKLGDFGLSR--YIEDEDYYKASVTRLPIKWMSP 179

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 63/120 (52%), Gaps = 7/120 (5%)
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-AS 274
           K++D +S    E +  +  E+ I+    HPN+V+ + A      + I++E+ A G + A 
Sbjct: 68  KVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L+ +  L+ S++          +NYLH+ K   IIH DLK  NIL    G +K++ FG+
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGV 181

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 63/120 (52%), Gaps = 7/120 (5%)
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-AS 274
           K++D +S    E +  +  E+ I+    HPN+V+ + A      + I++E+ A G + A 
Sbjct: 68  KVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L+ +  L+ S++          +NYLH+ K   IIH DLK  NIL    G +K++ FG+
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGV 181

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 63/120 (52%), Gaps = 7/120 (5%)
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL-AS 274
           K++D +S    E +  +  E+ I+    HPN+V+ + A      + I++E+ A G + A 
Sbjct: 68  KVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV 124
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L+ +  L+ S++          +NYLH+ K   IIH DLK  NIL    G +K++ FG+
Sbjct: 125 MLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGV 181

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 10/104 (9%)
Query: 235 ELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS---KVLRF 290
           E+ I+ K   HPN++Q       N    +V +   KG+L  YL +K  LS     K++R 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L++   ++ L+      I+H DLKP+NILLD+   +K++ FG 
Sbjct: 133 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 170

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 37/206 (17%)
Query: 165 PKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNG-------TKVWVKI 217
           P  +R P+ +       EY  N +E      +G     +Q A+  G       T V VK+
Sbjct: 26  PMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQ-ARAPGLLPYEPFTMVAVKM 84
Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ 277
           L +E+  D +    F  E  ++ +  +PN+V+ +G      PM ++ EY A GDL  +L+
Sbjct: 85  LKEEASADMQ--ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 142
Query: 278 K----------------KGR--------LSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
                            + R        LS ++ L  A  +A GM YL E K    +H D
Sbjct: 143 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199
Query: 314 LKPKNILLDNGGQLKISGFGLLRLQY 339
           L  +N L+     +KI+ FGL R  Y
Sbjct: 200 LATRNCLVGENMVVKIADFGLSRNIY 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 10/104 (9%)
Query: 235 ELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS---KVLRF 290
           E+ I+ K   HPN++Q       N    +V +   KG+L  YL +K  LS     K++R 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L++   ++ L+      I+H DLKP+NILLD+   +K++ FG 
Sbjct: 133 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 170

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 23/142 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 108
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +NILL     +KI  FGL R
Sbjct: 166 AARNILLSEKNVVKICDFGLAR 187

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 24/143 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 56  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 113
Query: 272 LASYLQKK------GRLSPSKV------------LRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+ +            L F+  +A+GM +L        IH D
Sbjct: 114 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRD 170
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +NILL +G   KI  FGL R
Sbjct: 171 LAARNILLTHGRITKICDFGLAR 193

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 25/156 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 156
Query: 329 ISGFGLLR------------------LQYISPEKAK 346
           +  FG+ R                   QY+SPE+A+
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 10/104 (9%)
Query: 235 ELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS---KVLRF 290
           E+ I+ K   HPN++Q       N    +V +   KG+L  YL +K  LS     K++R 
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L++   ++ L+      I+H DLKP+NILLD+   +K++ FG 
Sbjct: 120 LLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGF 157

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 191 QVRKADGITKGSY---QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           Q++    I KG Y    + KW G KV VK+          R       + +    RH N+
Sbjct: 38  QIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM----RHENI 93
Query: 248 VQFVGAVTQNI----PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH- 302
           + F+ A  +       + ++ +YH  G L  YL K   L    +L+ A     G+ +LH 
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 303 -----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
                + KP  I H DLK KNIL+   G   I+  G L +++IS
Sbjct: 153 EIFSTQGKP-AIAHRDLKSKNILVKKNGTCCIADLG-LAVKFIS 194

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 64/130 (49%), Gaps = 6/130 (4%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
           +GT   V +   ++   P+  + +  E+ I+    H +++++ G         + +V+EY
Sbjct: 57  DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH DL  +N+LLDN   
Sbjct: 117 VPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRL 172
Query: 327 LKISGFGLLR 336
           +KI  FGL +
Sbjct: 173 VKIGDFGLAK 182

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 25/156 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 156
Query: 329 ISGFGLLR------------------LQYISPEKAK 346
           +  FG+ R                   QY+SPE+A+
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 72/141 (51%), Gaps = 14/141 (9%)
Query: 200 KGSY-----QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           +GSY      + K  G  V +K +  ES      +     E++I+++   P+VV++ G+ 
Sbjct: 39  EGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
            +N  + IV+EY   G ++  ++ + + L+  ++        +G+ YLH  +    IH D
Sbjct: 94  FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRD 150
Query: 314 LKPKNILLDNGGQLKISGFGL 334
           +K  NILL+  G  K++ FG+
Sbjct: 151 IKAGNILLNTEGHAKLADFGV 171

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + I++EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
             +   I H DLK +N LLD     +LKI  FG  +   +  +    V   ++I P
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 186

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 61/132 (46%), Gaps = 7/132 (5%)
Query: 209 NGTKVWVKILDKESHKDPERI-NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ ++ K +H N+V+ +G  +    + +V  Y 
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 268 AKGDLA---SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L    S L     LS     + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169
Query: 325 GQLKISGFGLLR 336
              KIS FGL R
Sbjct: 170 FTAKISDFGLAR 181

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 25/156 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 156
Query: 329 ISGFGLLR------------------LQYISPEKAK 346
           +  FG+ R                   QY+SPE+A+
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 13/155 (8%)
Query: 191 QVRKADGITKGSY-QVAKWNGTKVWVKILDKESHKDPERINAFT--HELTIVEKARHPNV 247
           Q ++ + +  G+Y  V K       V +  KE   D E     T   E++++++ +H N+
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG------RLSPSKVLRFALDLARGMNYL 301
           V+    +     + +V E+    DL  Y+  +        L  + V  F   L +G+ + 
Sbjct: 66  VRLYDVIHTENKLTLVFEF-MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           HE K   I+H DLKP+N+L++  GQLK+  FGL R
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 61/132 (46%), Gaps = 7/132 (5%)
Query: 209 NGTKVWVKILDKESHKDPERI-NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ ++ K +H N+V+ +G  +    + +V  Y 
Sbjct: 47  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 106
Query: 268 AKGDLA---SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L    S L     LS     + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 107 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 163
Query: 325 GQLKISGFGLLR 336
              KIS FGL R
Sbjct: 164 FTAKISDFGLAR 175

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 61/132 (46%), Gaps = 7/132 (5%)
Query: 209 NGTKVWVKILDKESHKDPERI-NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ ++ K +H N+V+ +G  +    + +V  Y 
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 268 AKGDLA---SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L    S L     LS     + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169
Query: 325 GQLKISGFGLLR 336
              KIS FGL R
Sbjct: 170 FTAKISDFGLAR 181

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 16/187 (8%)
Query: 165 PKTKRTPMTVANPREVPEYE---LNPLELQVRKADGITKGSYQVAKW------NGTKVWV 215
           P T    ++  NP  V   +   + P  L V   + I +G +           +G K+  
Sbjct: 2   PGTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 61
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKGDLA 273
            +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y   GDL 
Sbjct: 62  AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLR 120
Query: 274 SYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
           ++++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD    +K++ F
Sbjct: 121 NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADF 177
Query: 333 GLLRLQY 339
           GL R  Y
Sbjct: 178 GLARDMY 184

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 24/143 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 72  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 129
Query: 272 LASYLQKK------GRLSPSKV------------LRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+ +            L F+  +A+GM +L        IH D
Sbjct: 130 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRD 186
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +NILL +G   KI  FGL R
Sbjct: 187 LAARNILLTHGRITKICDFGLAR 209

>pdb|4GRG|A Chain A, Crystal Structure Of Ige Complexed With E2_79, An Anti-Ige Inhibitor Length = 135

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 50/94 (53%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L   G+DVN+ D  G T LH+AA  GH+E+V++LL   A+
Sbjct: 13  DLGKKLLEAARAGQDDEVRILTANGADVNANDYWGHTPLHLAAMLGHLEIVEVLLKNGAD 72
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++A    G T    A +  ++E+  +L   GA V
Sbjct: 73  VNATGNTGRTPLHLAAWADHLEIVEVLLKHGADV 106

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 24/143 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 74  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 131
Query: 272 LASYLQKK------GRLSPSKV------------LRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+ +            L F+  +A+GM +L        IH D
Sbjct: 132 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRD 188
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +NILL +G   KI  FGL R
Sbjct: 189 LAARNILLTHGRITKICDFGLAR 211

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 23/142 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +NILL     +KI  FGL R
Sbjct: 175 AARNILLSEKNVVKICDFGLAR 196

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 5/129 (3%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y   G L  
Sbjct: 62  IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLK 121
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    ++I+ FG 
Sbjct: 122 YIRKIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 335 LRLQYISPE 343
            ++  +SPE
Sbjct: 179 AKV--LSPE 185

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 60/132 (45%), Gaps = 7/132 (5%)
Query: 209 NGTKVWVKILDKESHKDPERI-NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ +  K +H N+V+ +G  +    + +V  Y 
Sbjct: 44  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYX 103
Query: 268 AKGDLA---SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L    S L     LS     + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 104 PNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 160
Query: 325 GQLKISGFGLLR 336
              KIS FGL R
Sbjct: 161 FTAKISDFGLAR 172

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 24/143 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 79  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 136
Query: 272 LASYLQKK------GRLSPS------------KVLRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+             +L F+  +A+GM +L        IH D
Sbjct: 137 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRD 193
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +NILL +G   KI  FGL R
Sbjct: 194 LAARNILLTHGRITKICDFGLAR 216

>pdb|2ZGG|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 92

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/84 (41%), Positives = 52/84 (61%)
Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +LL  A  G    V  L+  G+DV + D +G T LH+AA  GH+EVVKLLL   A+++A+
Sbjct: 9   KLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVNAQ 68
Query: 135 DRWGSTAAADAKYYGNVEVYNILK 158
           D++G TA   +   GN ++  IL+
Sbjct: 69  DKFGKTAFDISIDNGNEDLAEILQ 92

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 65/130 (50%), Gaps = 2/130 (1%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 30  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 89
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 90  ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGH 147
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 148 IKITDFGLCK 157

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + IV+EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
             +   + H DLK +N LLD     +LKI  FG  +   +  +    V   ++I P
Sbjct: 133 AMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAP 185

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 65/130 (50%), Gaps = 2/130 (1%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 32  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 91
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 92  ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGH 149
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 150 IKITDFGLCK 159

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 65/130 (50%), Gaps = 2/130 (1%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY
Sbjct: 31  KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 90
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G 
Sbjct: 91  ANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGH 148
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 149 IKITDFGLCK 158

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 25/156 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM----MIVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V          P      IV+EY  
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 116
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+   + IIH D+KP NI++     +K
Sbjct: 117 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVK 173
Query: 329 ISGFGLLR------------------LQYISPEKAK 346
           +  FG+ R                   QY+SPE+A+
Sbjct: 174 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 69/143 (48%), Gaps = 24/143 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L   +H   ER  A   EL ++     H N+V  +GA T   P +++ EY   GD
Sbjct: 79  VAVKMLKPSAHLT-ER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGD 136
Query: 272 LASYLQKK------GRLSPS------------KVLRFALDLARGMNYLHECKPDPIIHCD 313
           L ++L++K       + SP+             +L F+  +A+GM +L        IH D
Sbjct: 137 LLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRD 193
Query: 314 LKPKNILLDNGGQLKISGFGLLR 336
           L  +NILL +G   KI  FGL R
Sbjct: 194 LAARNILLTHGRITKICDFGLAR 216

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/140 (32%), Positives = 70/140 (50%), Gaps = 21/140 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 62  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 271 DLASYLQ-KKGRLSPSK-------------VLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           +L++YL+ K+    P K             ++ ++  +A+GM +L   K    IH DL  
Sbjct: 120 NLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAA 176
Query: 317 KNILLDNGGQLKISGFGLLR 336
           +NILL     +KI  FGL R
Sbjct: 177 RNILLSEKNVVKICDFGLAR 196

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + IV+EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
             +   + H DLK +N LLD     +LKI  FG  +   +  +    V   ++I P
Sbjct: 133 AMQ---VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAP 185

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 15/146 (10%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG-A 253
           GS ++ +++      G  V VK L    H  P++   F  E+ I++      +V++ G +
Sbjct: 21  GSVELCRYDPLGDNTGALVAVKQL---QHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 77
Query: 254 VTQNIP-MMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                P + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H
Sbjct: 78  YGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVH 134
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRL 337
            DL  +NIL+++   +KI+ FGL +L
Sbjct: 135 RDLAARNILVESEAHVKIADFGLAKL 160

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 63/122 (51%), Gaps = 2/122 (1%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY   G+L  
Sbjct: 181 MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFF 240
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G +KI+ FGL
Sbjct: 241 HLSRERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGL 298
Query: 335 LR 336
            +
Sbjct: 299 CK 300

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 73  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 131
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 132 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 188
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 189 TVKVADFGLARDMY 202

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 54  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 112
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 113 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 169
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 170 TVKVADFGLARDMY 183

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/122 (26%), Positives = 63/122 (51%), Gaps = 2/122 (1%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           +KIL KE     + +     E  +++ +RHP +     +   +  +  V+EY   G+L  
Sbjct: 178 MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFF 237
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +L ++   S  +   +  ++   ++YLH  K   +++ DLK +N++LD  G +KI+ FGL
Sbjct: 238 HLSRERVFSEDRARFYGAEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGL 295
Query: 335 LR 336
            +
Sbjct: 296 CK 297

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 47  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 105
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 106 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 162
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 163 TVKVADFGLARDMY 176

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 57/116 (49%), Gaps = 5/116 (4%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + IV+EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH 132
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
             +   + H DLK +N LLD     +LKI+ FG  +   +  +    V   ++I P
Sbjct: 133 AMQ---VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAP 185

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 84/155 (54%), Gaps = 12/155 (7%)
Query: 185 LNPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIV 239
           L+P EL   K + I KGS+ +V K   N T+  V +KI+D E  +  + I     E+T++
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVL 59
Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
            +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     ++ +G++
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 118
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           YLH  K    IH D+K  N+LL   G++K++ FG+
Sbjct: 119 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 150

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 43  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 98
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 99  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 156
Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           H DLK KNIL+   G   I+  GL
Sbjct: 157 HRDLKSKNILVKKNGTCCIADLGL 180

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 113
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 114 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 170
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 171 TVKVADFGLARDMY 184

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 69/142 (48%), Gaps = 23/142 (16%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M++ E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 271 DLASYLQ-KKGRLSPSKV---------------LRFALDLARGMNYLHECKPDPIIHCDL 314
           +L++YL+ K+    P KV               + ++  +A+GM +L   K    IH DL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 315 KPKNILLDNGGQLKISGFGLLR 336
             +NILL     +KI  FGL R
Sbjct: 166 AARNILLSEKNVVKICDFGLAR 187

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 111
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 112 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 169
Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           H DLK KNIL+   G   I+  GL
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGL 193

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E H   DL +++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFE-HVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 23  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 78
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 79  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 136
Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           H DLK KNIL+   G   I+  GL
Sbjct: 137 HRDLKSKNILVKKNGTCCIADLGL 160

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 18  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 73
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 74  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 131
Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           H DLK KNIL+   G   I+  GL
Sbjct: 132 HRDLKSKNILVKKNGTCCIADLGL 155

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/107 (34%), Positives = 56/107 (52%), Gaps = 13/107 (12%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E   HPNVV+ +         + I + +V E H   DL +YL K     L    +    
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 292 LDLARGMNYLH-ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
               RG+++LH  C    I+H DLKP+NIL+ +GG +K++ FGL R+
Sbjct: 119 RQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 75/146 (51%), Gaps = 15/146 (10%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H  P++   F  E+ I++      +V++ G  
Sbjct: 24  GSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVS 80
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H
Sbjct: 81  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVH 137
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRL 337
            DL  +NIL+++   +KI+ FGL +L
Sbjct: 138 RDLAARNILVESEAHVKIADFGLAKL 163

>pdb|2ZGD|A Chain A, Asn-Hydroxylation Stabilises The Ankyrin Repeat Domain Fold Length = 110

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 52/88 (59%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D   +LL  A  G    V  L+  G+DV + D +G T LH+AA  GH+EVVKLLL   A+
Sbjct: 23  DLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGAD 82
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILK 158
           + A+D++G TA   +   GN ++  IL+
Sbjct: 83  VXAQDKFGKTAFDISIDNGNEDLAEILQ 110

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 74  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 132
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 133 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 189
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 190 TVKVADFGLARDMY 203

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 53  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 111
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 112 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 168
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 169 TVKVADFGLARDMY 182

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 72
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 73  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 130
Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           H DLK KNIL+   G   I+  GL
Sbjct: 131 HRDLKSKNILVKKNGTCCIADLGL 154

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 56/106 (52%), Gaps = 11/106 (10%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E   HPNVV+ +         + I + +V E H   DL +YL K     L    +    
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
               RG+++LH    + I+H DLKP+NIL+ +GG +K++ FGL R+
Sbjct: 119 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 84/155 (54%), Gaps = 12/155 (7%)
Query: 185 LNPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIV 239
           L+P EL   K + I KGS+ +V K   N T+  V +KI+D E  +  + I     E+T++
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVL 59
Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
            +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     ++ +G++
Sbjct: 60  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLD 118
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           YLH  K    IH D+K  N+LL   G++K++ FG+
Sbjct: 119 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 150

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 52  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 110
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 167
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 168 TVKVADFGLARDMY 181

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 56/106 (52%), Gaps = 11/106 (10%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E   HPNVV+ +         + I + +V E H   DL +YL K     L    +    
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
               RG+++LH    + I+H DLKP+NIL+ +GG +K++ FGL R+
Sbjct: 127 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARI 169

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 56/106 (52%), Gaps = 11/106 (10%)
Query: 239 VEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E   HPNVV+ +         + I + +V E H   DL +YL K     L    +    
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYLDKAPPPGLPAETIKDLM 118
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
               RG+++LH    + I+H DLKP+NIL+ +GG +K++ FGL R+
Sbjct: 119 RQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 75/146 (51%), Gaps = 15/146 (10%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H  P++   F  E+ I++      +V++ G  
Sbjct: 37  GSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H
Sbjct: 94  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVH 150
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRL 337
            DL  +NIL+++   +KI+ FGL +L
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKL 176

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
            E+T++ +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     +
Sbjct: 74  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILRE 132
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           + +G++YLH  K    IH D+K  N+LL   G++K++ FG+
Sbjct: 133 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 170

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 16/144 (11%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--- 257
           G     KW G +V VKI      +   R       + +    RH N++ F+ A  ++   
Sbjct: 20  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML----RHENILGFIAADNKDNGT 75
Query: 258 -IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH------ECKPDPII 310
              + +V +YH  G L  YL +   ++   +++ AL  A G+ +LH      + KP  I 
Sbjct: 76  WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIA 133
Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           H DLK KNIL+   G   I+  GL
Sbjct: 134 HRDLKSKNILVKKNGTCCIADLGL 157

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + IV+EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
             +   + H DLK +N LLD     +LKI  FG  +   +  +    V   ++I P
Sbjct: 133 AMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 185

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
            E+T++ +   P V ++ G+  ++  + I++EY   G     L+  G L  +++     +
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILRE 127
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           + +G++YLH  K    IH D+K  N+LL   G++K++ FG+
Sbjct: 128 ILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV 165

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/114 (35%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPS 285
           E+   F  E+ I+    HPN+V+  G +  N P M V+E+   GDL   L  K   +  S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGL 334
             LR  LD+A G+ Y+    P PI+H DL+  NI L +  +      K++ FGL
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 113
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 114 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 170
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 171 TVKVADFGLARDMY 184

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           RHPN+V+F   +     + IV+EY + G+L   +   GR S  +   F   L  G++Y H
Sbjct: 72  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 303 ECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
             +   + H DLK +N LLD     +LKI  FG  +   +  +    V   ++I P
Sbjct: 132 AMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 184

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 58/105 (55%), Gaps = 5/105 (4%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFAL 292
           E+ ++   +HPN+VQ+  +  +N  + IV++Y   GDL   +  QK       ++L + +
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
            +   + ++H+ K   I+H D+K +NI L   G +++  FG+ R+
Sbjct: 133 QICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV 174

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 54  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 112
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 113 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 169
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 170 TVKVADFGLARDMY 183

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 62/128 (48%), Gaps = 4/128 (3%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KI++K        ++ F  E  ++       + Q   A      + +V+EY
Sbjct: 83  KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
           +  GDL + L K G   P+++ RF L ++   ++ +H       +H D+KP NILLD  G
Sbjct: 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCG 199
Query: 326 QLKISGFG 333
            ++++ FG
Sbjct: 200 HIRLADFG 207

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 50  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 108
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM YL   K    +H DL  +N +LD   
Sbjct: 109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKF 165
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 166 TVKVADFGLARDMY 179

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 75/146 (51%), Gaps = 15/146 (10%)
Query: 201 GSYQVAKWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           GS ++ +++      G  V VK L    H  P++   F  E+ I++      +V++ G  
Sbjct: 25  GSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVS 81
Query: 255 TQ--NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                  + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H
Sbjct: 82  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVH 138
Query: 312 CDLKPKNILLDNGGQLKISGFGLLRL 337
            DL  +NIL+++   +KI+ FGL +L
Sbjct: 139 RDLAARNILVESEAHVKIADFGLAKL 164

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 185 LNPLELQVRKADGITKGSY-QVAKW--NGTK--VWVKILDKESHKDPERINAFTHELTIV 239
           ++P EL   K D I KGS+ +V K   N TK  V +KI+D E  +  + I     E+T++
Sbjct: 15  VDPEEL-FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAE--DEIEDIQQEITVL 71
Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
            +   P + ++ G+  ++  + I++EY   G  A  L K G L  + +     ++ +G++
Sbjct: 72  SQCDSPYITRYFGSYLKSTKLWIIMEYLGGGS-ALDLLKPGPLEETYIATILREILKGLD 130
Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           YLH  +    IH D+K  N+LL   G +K++ FG+
Sbjct: 131 YLHSERK---IHRDIKAANVLLSEQGDVKLADFGV 162

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 56/121 (46%), Gaps = 16/121 (13%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG----------- 280
           F  E  ++   +H ++V+F G   +  P+++V EY   GDL  +L+  G           
Sbjct: 62  FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNP 121
Query: 281 --RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
              L+ S++L  A  +A GM YL        +H DL  +N L+     +KI  FG+ R  
Sbjct: 122 PTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 178
Query: 339 Y 339
           Y
Sbjct: 179 Y 179

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 70/141 (49%), Gaps = 22/141 (15%)
Query: 213 VWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKG 270
           V VK+L + +     R  A   EL I +    H NVV  +GA T+   P+M+++E+   G
Sbjct: 61  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 118
Query: 271 DLASYLQ-KKGRLSPSK--------------VLRFALDLARGMNYLHECKPDPIIHCDLK 315
           +L++YL+ K+    P K              ++ ++  +A+GM +L   K    IH DL 
Sbjct: 119 NLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175
Query: 316 PKNILLDNGGQLKISGFGLLR 336
            +NILL     +KI  FGL R
Sbjct: 176 ARNILLSEKNVVKICDFGLAR 196

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 9/108 (8%)
Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK        HP +            +  V+EY   GDL  ++Q   +   S+  
Sbjct: 62  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 121
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +A ++  G+ +LH      I++ DLK  NILLD  G +KI+ FG+ +
Sbjct: 122 FYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 63/132 (47%), Gaps = 4/132 (3%)
Query: 206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVL 264
            K  G    VK+L K+     + +     E  I+  AR HP + Q          +  V+
Sbjct: 44  VKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103
Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           E+   GDL  ++QK  R   ++   +A ++   + +LH+     II+ DLK  N+LLD+ 
Sbjct: 104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHE 160
Query: 325 GQLKISGFGLLR 336
           G  K++ FG+ +
Sbjct: 161 GHCKLADFGMCK 172

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 9/108 (8%)
Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK        HP +            +  V+EY   GDL  ++Q   +   S+  
Sbjct: 63  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT 122
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +A ++  G+ +LH      I++ DLK  NILLD  G +KI+ FG+ +
Sbjct: 123 FYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 167

>pdb|3C5R|A Chain A, Crystal Structure Of The Bard1 Ankyrin Repeat Domain And Its Functional Consequences Length = 137

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 47/87 (54%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   + +GD+  VE LL  GSD N  D  G T LH A   GH++VV+LLL  KA ++   
Sbjct: 14  LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
               +   DA   G+V++  +L + GA
Sbjct: 74  YQNDSPLHDAAKNGHVDIVKLLLSYGA 100

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 10/138 (7%)
Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIV 263
           ++K  G +   K L K       R     HE+ ++E A+  P V+           ++++
Sbjct: 49  ISKSTGQEYAAKFLKKRRRGQDCRAEIL-HEIAVLELAKSCPRVINLHEVYENTSEIILI 107
Query: 264 LEYHAKGDLASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           LEY A G++ S    +    +S + V+R    +  G+ YLH+   + I+H DLKP+NILL
Sbjct: 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILL 164
Query: 322 DNG---GQLKISGFGLLR 336
            +    G +KI  FG+ R
Sbjct: 165 SSIYPLGDIKIVDFGMSR 182

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 55/124 (44%), Gaps = 19/124 (15%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL--------------- 276
           F  E  ++   +H ++V+F G      P+++V EY   GDL  +L               
Sbjct: 64  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 277 -QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            Q KG L  S++L  A  +A GM YL        +H DL  +N L+     +KI  FG+ 
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 336 RLQY 339
           R  Y
Sbjct: 181 RDVY 184

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 60/107 (56%), Gaps = 7/107 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA---SYLQKKGRLSPSK-VLRF 290
           E+ ++++  HPNV+++  +  ++  + IVLE    GDL+    + +K+ RL P + V ++
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
            + L   + ++H  +   ++H D+KP N+ +   G +K+   GL R 
Sbjct: 142 FVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF 185

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I+ + RHPN++           ++++LE  + G+L  +L +K  L+  +  +F   +
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
             G++YLH  +   I H DLKP+NI+L +      ++K+  FG+
Sbjct: 118 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 49/87 (56%), Gaps = 3/87 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I+ + RHPN++           ++++LE  + G+L  +L +K  L+  +  +F   +
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILL 321
             G++YLH  +   I H DLKP+NI+L
Sbjct: 139 LDGVHYLHSKR---IAHFDLKPENIML 162

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I+ + RHPN++           ++++LE  + G+L  +L +K  L+  +  +F   +
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
             G++YLH  +   I H DLKP+NI+L +      ++K+  FG+
Sbjct: 125 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 165

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 114 DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 172
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD   
Sbjct: 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKF 229
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 230 TVKVADFGLARDMY 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 61/117 (52%), Gaps = 13/117 (11%)
Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
           S +D ER      E++I+++ +HPNV+           ++++ E  A G+L  +L +K  
Sbjct: 57  SREDIER------EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES 110
Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
           L+  +   F   +  G+ YLH  +   I H DLKP+NI+L +      ++KI  FGL
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 78/153 (50%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E H   DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFE-HVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPS 285
           E+   F  E+ I+    HPN+V+  G +  N P M V+E+   GDL   L  K   +  S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
             LR  LD+A G+ Y+    P PI+H DL+  NI L +
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQS 159

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 19/157 (12%)
Query: 191 QVRKADGITKGSY-QVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
           QV   + + KG Y +V +  W+G  V VKI      +   R     + + +    RH N+
Sbjct: 9   QVALVECVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNI 64
Query: 248 VQFVGA----VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH- 302
           + F+ +       +  + ++  YH  G L  +LQ++  L P   LR A+  A G+ +LH 
Sbjct: 65  LGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ-TLEPHLALRLAVSAACGLAHLHV 123
Query: 303 -----ECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
                + KP  I H D K +N+L+ +  Q  I+  GL
Sbjct: 124 EIFGTQGKP-AIAHRDFKSRNVLVKSNLQCCIADLGL 159

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPS 285
           E+   F  E+ I+    HPN+V+  G +  N P M V+E+   GDL   L  K   +  S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYG-LMHNPPRM-VMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
             LR  LD+A G+ Y+    P PI+H DL+  NI L +
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQS 159

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
            G  V VK L  +    P+  + +  E+ I+    H +++++ G         + +V+EY
Sbjct: 42  TGEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH +L  +N+LLDN   
Sbjct: 100 VPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDRL 155
Query: 327 LKISGFGLLR 336
           +KI  FGL +
Sbjct: 156 VKIGDFGLAK 165

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 55/108 (50%), Gaps = 9/108 (8%)
Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL  ++Q+ GR      +
Sbjct: 386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV 445
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +A ++A G+ +L       II+ DLK  N++LD+ G +KI+ FG+ +
Sbjct: 446 FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 113
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD   
Sbjct: 114 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKF 170
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 171 TVKVADFGLARDMY 184

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 56  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 114
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD   
Sbjct: 115 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKF 171
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 172 TVKVADFGLARDMY 185

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165

>pdb|1S70|B Chain B, Complex Between Protein Ser/thr Phosphatase-1 (delta) And The Myosin Phosphatase Targeting Subunit 1 (mypt1) Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 63/140 (45%), Gaps = 7/140 (5%)
Query: 38  RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD 97
           R   ++   G ++ L+P    PV          D     L     GD + V  LL  G+D
Sbjct: 10  RNEQLKRWIGSETDLEP----PVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD 65
Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
           +N  ++DG TALH A  + +V++VK L+   ANI+  D  G      A   G +++   L
Sbjct: 66  INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYL 125
Query: 158 KARGAKVPKTKR---TPMTV 174
            ++GA V        TP+ +
Sbjct: 126 ISQGAHVGAVNSEGDTPLDI 145

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 60  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 118
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD   
Sbjct: 119 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKF 175
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 176 TVKVADFGLARDMY 189

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 40/195 (20%)
Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKW----NGTKVWVKILDKE-SHKDPERINAFTH 234
           +P     P E++ R   G   G   V +W     G +V +K   +E S K+ ER   +  
Sbjct: 8   LPTQTCGPWEMKERLGTG---GFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER---WCL 61
Query: 235 ELTIVEKARHPNVVQF------VGAVTQNIPMMIVLEYHAKGDLASYL---QKKGRLSPS 285
           E+ I++K  HPNVV        +  +  N   ++ +EY   GDL  YL   +    L   
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL---KISGFGLLR------ 336
            +     D++  + YLHE   + IIH DLKP+NI+L  G Q    KI   G  +      
Sbjct: 122 PIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 337 --------LQYISPE 343
                   LQY++PE
Sbjct: 179 LCTEFVGTLQYLAPE 193

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
            G  V VK L  +    P+  + +  E+ I+    H +++++ G         + +V+EY
Sbjct: 42  TGEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEY 99
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH +L  +N+LLDN   
Sbjct: 100 VPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRL 155
Query: 327 LKISGFGLLR 336
           +KI  FGL +
Sbjct: 156 VKIGDFGLAK 165

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 86/195 (44%), Gaps = 40/195 (20%)
Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKW----NGTKVWVKILDKE-SHKDPERINAFTH 234
           +P     P E++ R   G   G   V +W     G +V +K   +E S K+ ER   +  
Sbjct: 9   LPTQTCGPWEMKERLGTG---GFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER---WCL 62
Query: 235 ELTIVEKARHPNVVQF------VGAVTQNIPMMIVLEYHAKGDLASYL---QKKGRLSPS 285
           E+ I++K  HPNVV        +  +  N   ++ +EY   GDL  YL   +    L   
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL---KISGFGLLR------ 336
            +     D++  + YLHE   + IIH DLKP+NI+L  G Q    KI   G  +      
Sbjct: 123 PIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 179
Query: 337 --------LQYISPE 343
                   LQY++PE
Sbjct: 180 LCTEFVGTLQYLAPE 194

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 53  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 111
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD   
Sbjct: 112 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKF 168
Query: 326 QLKISGFGLLRLQY 339
            +K++ FGL R  Y
Sbjct: 169 TVKVADFGLARDMY 182

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++I+ +  H NV+           ++++LE  + G+L  +L +K  LS  +   F   +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGL 334
             G+NYLH  K   I H DLKP+NI+L +       +K+  FGL
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K + KE+ +  E   +  +E+ ++ K +HPN+V           + ++++  + G+L
Sbjct: 46  VAIKCIAKEALEGKE--GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL---LDNGGQLKI 329
              + +KG  +     R    +   + YLH+     I+H DLKP+N+L   LD   ++ I
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMI 160
Query: 330 SGFGLLRLQ 338
           S FGL +++
Sbjct: 161 SDFGLSKME 169

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K + KE+ +  E   +  +E+ ++ K +HPN+V           + ++++  + G+L
Sbjct: 46  VAIKCIAKEALEGKE--GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL---LDNGGQLKI 329
              + +KG  +     R    +   + YLH+     I+H DLKP+N+L   LD   ++ I
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMI 160
Query: 330 SGFGLLRLQ 338
           S FGL +++
Sbjct: 161 SDFGLSKME 169

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL  ++Q+ GR      +
Sbjct: 65  ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV 124
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +A ++A G+ +L   +   II+ DLK  N++LD+ G +KI+ FG+ +
Sbjct: 125 FYAAEIAIGLFFL---QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169

>pdb|1MYO|A Chain A, Solution Structure Of Myotrophin, Nmr, 44 Structures Length = 118

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 2/89 (2%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAA 142
           GD+  V+D + +G DVN     GR  LH AA  G +E+++ LL K A+I+A D+   T  
Sbjct: 13  GDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPL 72
Query: 143 ADAKYYGNVEVYNILKARGAKVPKTKRTP 171
             A Y G+V    +L ++GA   KT + P
Sbjct: 73  LSAVYEGHVSCVKLLLSKGAD--KTVKGP 99

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 66/129 (51%), Gaps = 8/129 (6%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K + KE+ +  E   +  +E+ ++ K +HPN+V           + ++++  + G+L
Sbjct: 46  VAIKCIAKEALEGKE--GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL---LDNGGQLKI 329
              + +KG  +     R    +   + YLH+     I+H DLKP+N+L   LD   ++ I
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMI 160
Query: 330 SGFGLLRLQ 338
           S FGL +++
Sbjct: 161 SDFGLSKME 169

>pdb|3TWR|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human 3bp2 Length = 165

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/128 (37%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR--TALHIAACEGHVEVVKLLLS 126
           N ++  QLL  A  GDV+ V+ L    S VN  D++GR  T LH AA    V VV+ LL 
Sbjct: 5   NSEADRQLLEAAKAGDVETVKKLCTVQS-VNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQ 63
Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT---KRTPMTVANPREVPEY 183
             A++ A+D+ G     +A  YG+ EV  +L   GA V      K TP+  A  +   +Y
Sbjct: 64  HGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAK--GKY 121
Query: 184 ELNPLELQ 191
           E+  L LQ
Sbjct: 122 EICKLLLQ 129

>pdb|3TWU|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 In Complex With Peptide From Human Mcl1 Length = 167

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/128 (37%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR--TALHIAACEGHVEVVKLLLS 126
           N ++  QLL  A  GDV+ V+ L    S VN  D++GR  T LH AA    V VV+ LL 
Sbjct: 7   NSEADRQLLEAAKAGDVETVKKLCTVQS-VNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQ 65
Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT---KRTPMTVANPREVPEY 183
             A++ A+D+ G     +A  YG+ EV  +L   GA V      K TP+  A  +   +Y
Sbjct: 66  HGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAK--GKY 123
Query: 184 ELNPLELQ 191
           E+  L LQ
Sbjct: 124 EICKLLLQ 131

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 3/130 (2%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 30  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 89
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 90  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGH 146
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 147 IKITDFGLCK 156

>pdb|3TWQ|A Chain A, Crystal Structure Of Arc4 From Human Tankyrase 2 (Apo Form) Length = 175

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/128 (37%), Positives = 66/128 (51%), Gaps = 8/128 (6%)
Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR--TALHIAACEGHVEVVKLLLS 126
           N ++  QLL  A  GDV+ V+ L    S VN  D++GR  T LH AA    V VV+ LL 
Sbjct: 9   NSEADRQLLEAAKAGDVETVKKLCTVQS-VNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQ 67
Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT---KRTPMTVANPREVPEY 183
             A++ A+D+ G     +A  YG+ EV  +L   GA V      K TP+  A  +   +Y
Sbjct: 68  HGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAK--GKY 125
Query: 184 ELNPLELQ 191
           E+  L LQ
Sbjct: 126 EICKLLLQ 133

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 3/130 (2%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 144 IKITDFGLCK 153

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPS 285
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +      +K  R   +
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 175
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +V+  ALD    M +         IH D+KP N+LLD  G LK++ FG
Sbjct: 176 EVV-LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFG 213

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 3/130 (2%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 144 IKITDFGLCK 153

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 3/130 (2%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 144 IKITDFGLCK 153

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPS 285
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +      +K  R   +
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 180
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +V+  ALD    M +         IH D+KP N+LLD  G LK++ FG
Sbjct: 181 EVV-LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 80/153 (52%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL +++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 80/153 (52%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+++ H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPS 285
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +      +K  R   +
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 180
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +V+  ALD    M +         IH D+KP N+LLD  G LK++ FG
Sbjct: 181 EVV-LALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFG 218

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 3/130 (2%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 144 IKITDFGLCK 153

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 18/120 (15%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK------------ 279
           F  E  ++   +H ++V+F G  T+  P+++V EY   GDL  +L+              
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 280 ---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              G L   ++L  A  +A GM YL        +H DL  +N L+  G  +KI  FG+ R
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 18/120 (15%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK------------ 279
           F  E  ++   +H ++V+F G  T+  P+++V EY   GDL  +L+              
Sbjct: 61  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 120
Query: 280 ---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              G L   ++L  A  +A GM YL        +H DL  +N L+  G  +KI  FG+ R
Sbjct: 121 VAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 84/170 (49%), Gaps = 21/170 (12%)
Query: 176 NPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPER 228
            P   PE+  N      +K + I +G+Y V      K  G  V +K   LD E+   P  
Sbjct: 1   GPLGSPEFMEN-----FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-- 53
Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKV 287
            +    E++++++  HPN+V+ +  +     + +V E+  + DL  ++        P  +
Sbjct: 54  -STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 111
Query: 288 LR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           ++ +   L +G+ + H  +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 112 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 84/170 (49%), Gaps = 21/170 (12%)
Query: 176 NPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPER 228
            P   PE+  N      +K + I +G+Y V      K  G  V +K   LD E+   P  
Sbjct: 1   GPLGSPEFMEN-----FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-- 53
Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKV 287
            +    E++++++  HPN+V+ +  +     + +V E+  + DL  ++        P  +
Sbjct: 54  -STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 111
Query: 288 LR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           ++ +   L +G+ + H  +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 112 IKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 3/130 (2%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 143
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 144 IKITDFGLCK 153

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G+    Y+    +G KV +K    ES +  E        L+     RHP++V  +G   +
Sbjct: 50  GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF---CRHPHLVSLIGFCDE 106
Query: 257 NIPMMIVLEYHAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
              M+++ +Y   G+L  +L         +S  + L   +  ARG++YLH      IIH 
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHR 163
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           D+K  NILLD     KI+ FG+
Sbjct: 164 DVKSINILLDENFVPKITDFGI 185

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 55/120 (45%), Gaps = 18/120 (15%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK------------ 279
           F  E  ++   +H ++V+F G  T+  P+++V EY   GDL  +L+              
Sbjct: 67  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 126
Query: 280 ---GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              G L   ++L  A  +A GM YL        +H DL  +N L+  G  +KI  FG+ R
Sbjct: 127 VAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 10/114 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIP------MMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL I++  +H N++     +   +P      + +VL+   + DL   +     L+   V 
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDL-MESDLHQIIHSSQPLTLEHVR 161
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP 342
            F   L RG+ Y+H  +   +IH DLKP N+L++   +LKI  FG+ R    SP
Sbjct: 162 YFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 58/108 (53%), Gaps = 9/108 (8%)
Query: 235 ELTIVEK------ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           E T+VEK       + P + Q          +  V+EY   GDL  ++Q+ G+    + +
Sbjct: 64  ECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +A +++ G+ +LH+     II+ DLK  N++LD+ G +KI+ FG+ +
Sbjct: 124 FYAAEISIGLFFLHK---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK 168

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/130 (24%), Positives = 62/130 (47%), Gaps = 3/130 (2%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 32  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 91
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 92  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGH 148
Query: 327 LKISGFGLLR 336
           +KI+ FGL +
Sbjct: 149 IKITDFGLCK 158

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 10/114 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIP------MMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL I++  +H N++     +   +P      + +VL+   + DL   +     L+   V 
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDL-MESDLHQIIHSSQPLTLEHVR 162
Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISP 342
            F   L RG+ Y+H  +   +IH DLKP N+L++   +LKI  FG+ R    SP
Sbjct: 163 YFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 213

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 10/142 (7%)
Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G+    Y+    +G KV +K    ES +  E        L+     RHP++V  +G   +
Sbjct: 50  GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF---CRHPHLVSLIGFCDE 106
Query: 257 NIPMMIVLEYHAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
              M+++ +Y   G+L  +L         +S  + L   +  ARG++YLH      IIH 
Sbjct: 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHR 163
Query: 313 DLKPKNILLDNGGQLKISGFGL 334
           D+K  NILLD     KI+ FG+
Sbjct: 164 DVKSINILLDENFVPKITDFGI 185

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 66/131 (50%), Gaps = 7/131 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEY 266
           +G K+   +       D   ++ F  E  I++   HPNV+  +G    ++  P+ +VL Y
Sbjct: 56  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPY 114
Query: 267 HAKGDLASYLQKKGRLSPSK-VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              GDL ++++ +      K ++ F L +A+GM +L   K    +H DL  +N +LD   
Sbjct: 115 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKF 171
Query: 326 QLKISGFGLLR 336
            +K++ FGL R
Sbjct: 172 TVKVADFGLAR 182

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 8   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 64
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+ +  DL  ++        P  +++ +   L +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G +V +K++DK++      +    +E+ I  + +HP++++       +  + +VLE    
Sbjct: 36  GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 270 GDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
           G++  YL+ + +  S ++   F   +  GM YLH      I+H DL   N+LL     +K
Sbjct: 96  GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIK 152
Query: 329 ISGFGL---LRL------------QYISPEKA 345
           I+ FGL   L++             YISPE A
Sbjct: 153 IADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 10  QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 66
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+ +  DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1MX4|A Chain A, Structure Of P18ink4c (F82q) Length = 168

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 48/81 (59%), Gaps = 1/81 (1%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTA 141
           G +  ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA
Sbjct: 81  GQLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 140
Query: 142 AADAKYYGNVEVYNILKARGA 162
              A+ YG  EV ++++A GA
Sbjct: 141 CDLARLYGRNEVVSLMQANGA 161

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+ +  DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 125 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 56/107 (52%), Gaps = 9/107 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++++++ +H N+++    +  N  + ++ EY A+ DL  Y+ K   +S   +  F   L
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLR 336
             G+N+ H  +    +H DLKP+N+LL          LKI  FGL R
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+ +  DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 8   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 64
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1MX6|A Chain A, Structure Of P18ink4c (F92n) Length = 168

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 48/81 (59%), Gaps = 1/81 (1%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTA 141
           G +  ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA
Sbjct: 81  GFLDTLQTLLENQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 140
Query: 142 AADAKYYGNVEVYNILKARGA 162
              A+ YG  EV ++++A GA
Sbjct: 141 CDLARLYGRNEVVSLMQANGA 161

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 10  QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 66
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 8   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 64
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 74/141 (52%), Gaps = 26/141 (18%)
Query: 226 PERINAFTH----ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-G 280
           PER + ++     E+ + +  +H N+VQ++G+ ++N  + I +E    G L++ L+ K G
Sbjct: 56  PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 281 RLSPSK--VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR- 336
            L  ++  +  +   +  G+ YLH+   + I+H D+K  N+L++   G LKIS FG  + 
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 337 --------------LQYISPE 343
                         LQY++PE
Sbjct: 173 LAGINPCTETFTGTLQYMAPE 193

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 9   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 65
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 8   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 64
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 124 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 7   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 63
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 43  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 99
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 100 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 156
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 157 NVLLVTQHYAKISDFGL 173

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 43  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 99
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 100 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 156
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 157 NVLLVTQHYAKISDFGL 173

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V +K   LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 198 ITKGSYQVAKWNGTKVWVKI--LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV- 254
           + +G+ +       KV VK   LD  S ++   I  F  E   ++   HPNV++ +G   
Sbjct: 50  VMEGNLKQEDGTSLKVAVKTMKLDNSSQRE---IEEFLSEAACMKDFSHPNVIRLLGVCI 106
Query: 255 ---TQNIPM-MIVLEYHAKGDLASY-LQKKGRLSPSKV-----LRFALDLARGMNYLHEC 304
              +Q IP  M++L +   GDL +Y L  +    P  +     L+F +D+A GM YL   
Sbjct: 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR 166
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
                +H DL  +N +L +   + ++ FGL
Sbjct: 167 N---FLHRDLAARNCMLRDDMTVCVADFGL 193

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 71  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 130
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++  +
Sbjct: 131 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 187
Query: 327 ---LKISGFGL 334
              ++I  FGL
Sbjct: 188 DANIRIIDFGL 198

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/112 (25%), Positives = 57/112 (50%), Gaps = 6/112 (5%)
Query: 230 NAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
            +  +E+ ++ K +HPN+V           + ++++  + G+L   + +KG  +     R
Sbjct: 61  GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR 120
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNIL---LDNGGQLKISGFGLLRLQ 338
               +   + YLH+     I+H DLKP+N+L   LD   ++ IS FGL +++
Sbjct: 121 LIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 169

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 48  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++  +
Sbjct: 108 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 164
Query: 327 ---LKISGFGL 334
              ++I  FGL
Sbjct: 165 DANIRIIDFGL 175

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 72  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 131
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++  +
Sbjct: 132 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 188
Query: 327 ---LKISGFGL 334
              ++I  FGL
Sbjct: 189 DANIRIIDFGL 199

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 41  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 97
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 98  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 154
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 155 NVLLVTQHYAKISDFGL 171

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/114 (25%), Positives = 62/114 (54%), Gaps = 8/114 (7%)
Query: 226 PERINAFT--HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RL 282
           P  ++ +T  +E++I+ +  HP ++    A      M+++LE+ + G+L   +  +  ++
Sbjct: 87  PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM 146
Query: 283 SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGL 334
           S ++V+ +      G+ ++HE     I+H D+KP+NI+ +      +KI  FGL
Sbjct: 147 SEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGL 197

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 68/126 (53%), Gaps = 7/126 (5%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +KIL++ +   P+    F  E  I+    HP++V+ +G V  +  + +V +    G L
Sbjct: 47  VAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCL 103
Query: 273 ASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             Y+ + K  +    +L + + +A+GM YL E +   ++H DL  +N+L+ +   +KI+ 
Sbjct: 104 LEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITD 160
Query: 332 FGLLRL 337
           FGL RL
Sbjct: 161 FGLARL 166

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 33  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 89
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 90  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 146
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 147 NVLLVTQHYAKISDFGL 163

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 68/126 (53%), Gaps = 7/126 (5%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +KIL++ +   P+    F  E  I+    HP++V+ +G V  +  + +V +    G L
Sbjct: 70  VAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCL 126
Query: 273 ASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             Y+ + K  +    +L + + +A+GM YL E +   ++H DL  +N+L+ +   +KI+ 
Sbjct: 127 LEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITD 183
Query: 332 FGLLRL 337
           FGL RL
Sbjct: 184 FGLARL 189

>pdb|3AAA|C Chain C, Crystal Structure Of Actin Capping Protein In Complex With V-1 Length = 123

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 50/89 (56%), Gaps = 2/89 (2%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAA 142
           GD+  V+D + +G DVN     GR  LH AA  G +E+++ LL K A+I+A D+   T  
Sbjct: 18  GDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPL 77
Query: 143 ADAKYYGNVEVYNILKARGAKVPKTKRTP 171
             A Y G+V    +L ++GA   KT + P
Sbjct: 78  LSAVYEGHVSCVKLLLSKGAD--KTVKGP 104

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 21  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 77
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 78  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 134
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 135 NVLLVTQHYAKISDFGL 151

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 23  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 79
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 80  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 136
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 137 NVLLVTQHYAKISDFGL 153

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 27  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 83
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 84  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 140
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 141 NVLLVTQHYAKISDFGL 157

>pdb|1IHB|A Chain A, Crystal Structure Of P18-Ink4c(Ink6) Length = 162

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 48/81 (59%), Gaps = 1/81 (1%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTA 141
           G +  ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA
Sbjct: 81  GFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 140
Query: 142 AADAKYYGNVEVYNILKARGA 162
              A+ YG  EV ++++A GA
Sbjct: 141 CDLARLYGRNEVVSLMQANGA 161

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 74/141 (52%), Gaps = 26/141 (18%)
Query: 226 PERINAFTH----ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-G 280
           PER + ++     E+ + +  +H N+VQ++G+ ++N  + I +E    G L++ L+ K G
Sbjct: 42  PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 101
Query: 281 RLSPSK--VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR- 336
            L  ++  +  +   +  G+ YLH+   + I+H D+K  N+L++   G LKIS FG  + 
Sbjct: 102 PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 158
Query: 337 --------------LQYISPE 343
                         LQY++PE
Sbjct: 159 LAGINPCTETFTGTLQYMAPE 179

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 27  VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 83
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 84  ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 140
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 141 NVLLVTQHYAKISDFGL 157

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 385 VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 441
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 442 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 498
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 499 NVLLVTQHYAKISDFGL 515

>pdb|1BU9|A Chain A, Solution Structure Of P18-Ink4c, 21 Structures Length = 168

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 48/81 (59%), Gaps = 1/81 (1%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTA 141
           G +  ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA
Sbjct: 81  GFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 140
Query: 142 AADAKYYGNVEVYNILKARGA 162
              A+ YG  EV ++++A GA
Sbjct: 141 CDLARLYGRNEVVSLMQANGA 161

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 19/101 (18%)
Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL--DLARGMNYLHECKPDPIIHCDLKPK 317
           + I +E+  KG L  +++K+      KVL   L   + +G++Y+H  K   +IH DLKP 
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LIHRDLKPS 165
Query: 318 NILLDNGGQLKISGFGLL--------------RLQYISPEK 344
           NI L +  Q+KI  FGL+               L+Y+SPE+
Sbjct: 166 NIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQ 206

>pdb|3UTM|A Chain A, Crystal Structure Of A Mouse Tankyrase-Axin Complex Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/78 (39%), Positives = 43/78 (55%)
Query: 85  VKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD 144
           V+ V+ LL  G+DV++ D  G   LH A   GH EV +LLL   A ++A D W  T   +
Sbjct: 71  VRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHE 130
Query: 145 AKYYGNVEVYNILKARGA 162
           A     VEV ++L + GA
Sbjct: 131 AASKNRVEVCSLLLSHGA 148

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 6/137 (4%)
Query: 198 ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
           + KG YQ+ K   T   VKIL  E++ DP   +    E  ++++  +P +V+ +G + + 
Sbjct: 386 VKKGYYQMKKVVKTVA-VKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIG-ICEA 442
Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
              M+V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +
Sbjct: 443 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 499
Query: 318 NILLDNGGQLKISGFGL 334
           N+LL      KIS FGL
Sbjct: 500 NVLLVTQHYAKISDFGL 516

>pdb|1MX2|A Chain A, Structure Of F71n Mutant Of P18ink4c Length = 168

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/81 (39%), Positives = 48/81 (59%), Gaps = 1/81 (1%)
Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTA 141
           G +  ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA
Sbjct: 81  GFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 140
Query: 142 AADAKYYGNVEVYNILKARGA 162
              A+ YG  EV ++++A GA
Sbjct: 141 CDLARLYGRNEVVSLMQANGA 161

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 63/131 (48%), Gaps = 6/131 (4%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 54  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 113
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++  +
Sbjct: 114 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 170
Query: 327 ---LKISGFGL 334
              ++I  FGL
Sbjct: 171 DANIRIIDFGL 181

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 235 ELTIVEKARHPNVVQFVGAV--TQNIPMMIVLEYHAKG--DLASYLQKKGRLSPSKVLRF 290
           E+ ++ + RH NV+Q V  +   +   M +V+EY   G  ++   + +K R    +   +
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGY 114
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
              L  G+ YLH      I+H D+KP N+LL  GG LKIS  G+
Sbjct: 115 FCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 75/138 (54%), Gaps = 9/138 (6%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K+++ +S +  +   A T  +  +    H ++V+ +G +     + +V +Y   G L
Sbjct: 63  VCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSL 119
Query: 273 ASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             ++ Q +G L P  +L + + +A+GM YL E     ++H +L  +N+LL +  Q++++ 
Sbjct: 120 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVAD 176
Query: 332 FGLLRLQYISPEKAKIVF 349
           FG+  L  + P+  ++++
Sbjct: 177 FGVADL--LPPDDKQLLY 192

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 80/153 (52%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWV-KI-LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V + KI LD E+   P   +    E++++++  HP
Sbjct: 6   QKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVP---STAIREISLLKELNHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 80/153 (52%), Gaps = 16/153 (10%)
Query: 193 RKADGITKGSYQVA-----KWNGTKVWV-KI-LDKESHKDPERINAFTHELTIVEKARHP 245
           +K + I +G+Y V      K  G  V + KI LD E+   P   +    E++++++  HP
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVP---STAIREISLLKELNHP 61
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVLR-FALDLARGMNYLHE 303
           N+V+ +  +     + +V E+  + DL  ++        P  +++ +   L +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 304 CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 180 VPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           VP   L  LE++ R   G    +  +  +   K+   + DK+S +  ER      E+   
Sbjct: 12  VPRGSLQLLEIKARGRFGCVWKAQLMNDFVAVKI-FPLQDKQSWQS-ER------EIFST 63
Query: 240 EKARHPNVVQFVGAVTQN----IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
              +H N++QF+ A  +     + + ++  +H KG L  YL K   ++ +++   A  ++
Sbjct: 64  PGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL-KGNIITWNELCHVAETMS 122
Query: 296 RGMNYLHE----CKPD----PIIHCDLKPKNILLDNGGQLKISGFGL 334
           RG++YLHE    C+ +     I H D K KN+LL +     ++ FGL
Sbjct: 123 RGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGL 169

>pdb|2RFM|A Chain A, Structure Of A Thermophilic Ankyrin Repeat Protein Length = 192

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 60/121 (49%), Gaps = 2/121 (1%)
Query: 77  LFMACRGDVKGV-EDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A + +  G+ E LL++GS+VN+ D  G+T L  +   G+ E+   LL   AN++ R+
Sbjct: 72  LIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRN 131
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV-ANPREVPEYELNPLELQVRK 194
             G T    A  YG  E+   L   GA +     T +T  A+ R     E+  +  +VR+
Sbjct: 132 LEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVRR 191
Query: 195 A 195
           A
Sbjct: 192 A 192

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/138 (23%), Positives = 75/138 (54%), Gaps = 9/138 (6%)
Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +K+++ +S +  +   A T  +  +    H ++V+ +G +     + +V +Y   G L
Sbjct: 45  VCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSL 101
Query: 273 ASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
             ++ Q +G L P  +L + + +A+GM YL E     ++H +L  +N+LL +  Q++++ 
Sbjct: 102 LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVAD 158
Query: 332 FGLLRLQYISPEKAKIVF 349
           FG+  L  + P+  ++++
Sbjct: 159 FGVADL--LPPDDKQLLY 174

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 8/130 (6%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
            G  V VK L +     P+  + +  E+ I+    H ++V++ G         + +V+EY
Sbjct: 37  TGEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 94
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH  L  +N+LLDN   
Sbjct: 95  VPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRL 150
Query: 327 LKISGFGLLR 336
           +KI  FGL +
Sbjct: 151 VKIGDFGLAK 160

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 188 LELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPN 246
           +EL       + +G Y++ K     V +K+L + + K D E +     E  I+ +  +P 
Sbjct: 16  IELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPY 71
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECK 305
           +V+ +G V Q   +M+V+E    G L  +L  K+  +  S V      ++ GM YL E  
Sbjct: 72  IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-- 128
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGL 334
               +H DL  +N+LL N    KIS FGL
Sbjct: 129 -KNFVHRDLAARNVLLVNRHYAKISDFGL 156

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 62/130 (47%), Gaps = 8/130 (6%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY 266
            G  V VK L +     P+  + +  E+ I+    H ++V++ G         + +V+EY
Sbjct: 36  TGEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 93
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YL +   +  +++L FA  +  GM YLH       IH  L  +N+LLDN   
Sbjct: 94  VPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRL 149
Query: 327 LKISGFGLLR 336
           +KI  FGL +
Sbjct: 150 VKIGDFGLAK 159

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 6/108 (5%)
Query: 229 INAFTHELTIVEKARHPNVVQFVGAVT--QNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           I     E+ I++K  HPNVV+ V  +       + +V E   +G +      K  LS  +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQ 138
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
              +  DL +G+ YLH  K   IIH D+KP N+L+   G +KI+ FG+
Sbjct: 139 ARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183

>pdb|3F6Q|A Chain A, Crystal Structure Of Integrin-Linked Kinase Ankyrin Repeat Domain In Complex With Pinch1 Lim1 Domain Length = 179

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 2/169 (1%)
Query: 44  FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSID 102
           F+  R+ +   +R      E  + +  D     L  ACR G    VE L+  G+ +N ++
Sbjct: 10  FTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMN 69
Query: 103 LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA 162
               T LH+AA  GH ++V+ LL  KA+I+A +  G+     A ++G  +V   L A GA
Sbjct: 70  RGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGA 129
Query: 163 KVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGT 211
            V    +      +  + P  EL   E   +    + +  Y+   W GT
Sbjct: 130 LVSICNKYGEMPVDKAKAPLREL-LRERAEKMGQNLNRIPYKDTFWKGT 177

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 32  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 86
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH D+
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRDI 142
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           K  NILL   G +K++ FG      I+PE++K
Sbjct: 143 KSDNILLGMDGSVKLTDFGF--CAQITPEQSK 172

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 32  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 86
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH D+
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRDI 142
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           K  NILL   G +K++ FG      I+PE++K
Sbjct: 143 KSDNILLGMDGSVKLTDFGF--CAQITPEQSK 172

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 32  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 86
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH D+
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRDI 142
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           K  NILL   G +K++ FG      I+PE++K
Sbjct: 143 KSDNILLGMDGSVKLTDFGF--CAQITPEQSK 172

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 33  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 87
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH D+
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRDI 143
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           K  NILL   G +K++ FG      I+PE++K
Sbjct: 144 KSDNILLGMDGSVKLTDFGF--CAQITPEQSK 173

>pdb|1YCS|B Chain B, P53-53bp2 Complex Length = 239

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 48/100 (48%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  +  G+   V+ ++ E  D +  + +G TALH A C GH E+VK L+    N++A D
Sbjct: 41  LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVA 175
             G T    A    NV+V   L   GA V     + M  A
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTA 140

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPS 285
           F  E  I+  A  P VVQ   A   +  + +V+EY   GDL + +      +K  +   +
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA 181
Query: 286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           +V+  ALD    M          +IH D+KP N+LLD  G LK++ FG
Sbjct: 182 EVV-LALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 62/128 (48%), Gaps = 7/128 (5%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +V VK +D    +  +R     +E+ I+    H NVV    +      + +V+E+
Sbjct: 67  KHTGKQVAVKKMDL---RKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEF 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   +    R++  ++    L + R ++YLH      +IH D+K  +ILL + G+
Sbjct: 124 LEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGR 179
Query: 327 LKISGFGL 334
           +K+S FG 
Sbjct: 180 IKLSDFGF 187

>pdb|4A63|B Chain B, Crystal Structure Of The P73-Aspp2 Complex At 2.6a Resolution Length = 239

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 48/100 (48%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  +  G+   V+ ++ E  D +  + +G TALH A C GH E+VK L+    N++A D
Sbjct: 41  LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVA 175
             G T    A    NV+V   L   GA V     + M  A
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTA 140

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 61/131 (46%), Gaps = 6/131 (4%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+ +            +V E 
Sbjct: 48  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEV 107
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + R S     R    +  G+ Y H+ K   I+H DLKP+N+LL++  +
Sbjct: 108 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK---IVHRDLKPENLLLESKSK 164
Query: 327 ---LKISGFGL 334
              ++I  FGL
Sbjct: 165 DANIRIIDFGL 175

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 6/104 (5%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
           +E+++++   HPN+++            +V E++  G+L   +  + +            
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL---KISGFGL 334
           +  G+ YLH      I+H D+KP+NILL+N   L   KI  FGL
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/123 (30%), Positives = 56/123 (45%), Gaps = 15/123 (12%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVTQNIPMMIVLEYHAKGDLAS 274
           ++I+ F H         E+ I+ + RH N++     + A T      + L  H  G    
Sbjct: 74  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY 133
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL
Sbjct: 134 KLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGL 190
Query: 335 LRL 337
            R+
Sbjct: 191 ARV 193

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 20/128 (15%)
Query: 225 DPERINAFTHELTIVEKARHPNVVQF--------------VGAVTQNIPMMIVLEYHAKG 270
           DP+ +     E+ I+ +  H N+V+               VG++T+   + IV EY  + 
Sbjct: 48  DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-MET 106
Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-LKI 329
           DLA+ L+ +G L       F   L RG+ Y+H      ++H DLKP N+ ++     LKI
Sbjct: 107 DLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162
Query: 330 SGFGLLRL 337
             FGL R+
Sbjct: 163 GDFGLARI 170

>pdb|4G8K|A Chain A, Intact Sensor Domain Of Human Rnase L In The Inactive Signaling State Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 46/83 (55%)
Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+D      +G T   +AA  G V+++KL LSK A+++  D +G TA  +A  
Sbjct: 75  VELLLRHGADPVLRKKNGATPFILAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAV 134
Query: 148 YGNVEVYNILKARGAKVPKTKRT 170
           YG V+    L  RGA V   ++T
Sbjct: 135 YGKVKALKFLYKRGANVNLRRKT 157

>pdb|1WDY|A Chain A, Crystal Structure Of Ribonuclease Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 46/83 (55%)
Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+D      +G T   +AA  G V+++KL LSK A+++  D +G TA  +A  
Sbjct: 55  VELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAV 114
Query: 148 YGNVEVYNILKARGAKVPKTKRT 170
           YG V+    L  RGA V   ++T
Sbjct: 115 YGKVKALKFLYKRGANVNLRRKT 137

>pdb|2KBX|A Chain A, Solution Structure Of Ilk-Pinch Complex Length = 171

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 1/143 (0%)
Query: 44  FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSID 102
           F+  R+ +   +R      E  + +  D     L  ACR G    VE L+  G+ +N ++
Sbjct: 5   FTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMN 64
Query: 103 LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA 162
               T LH+AA  GH ++V+ LL  KA+I+A +  G+     A ++G  +V   L A GA
Sbjct: 65  RGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGA 124
Query: 163 KVPKTKRTPMTVANPREVPEYEL 185
            V    +      +  + P  EL
Sbjct: 125 LVSICNKYGEMPVDKAKAPLREL 147

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/112 (25%), Positives = 58/112 (51%), Gaps = 4/112 (3%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-L 282
           K  E +  +  E+ I+    HP +V+ +GA   +  + I++E+   G + + + +  R L
Sbjct: 55  KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL 114
Query: 283 SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +  ++      +   +N+LH  +   IIH DLK  N+L+   G ++++ FG+
Sbjct: 115 TEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGV 163

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 27/163 (16%)
Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV 248
           E Q+++ DG           +  KV VK+L  +     + I  F  E   +++  HP+V 
Sbjct: 41  EAQLKQEDG-----------SFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVA 88
Query: 249 QFVGAVTQN-----IPM-MIVLEYHAKGDLASYL------QKKGRLSPSKVLRFALDLAR 296
           + VG   ++     +P+ M++L +   GDL ++L      +    L    ++RF +D+A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
           GM YL        IH DL  +N +L     + ++ FGL R  Y
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/112 (25%), Positives = 58/112 (51%), Gaps = 4/112 (3%)
Query: 224 KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-L 282
           K  E +  +  E+ I+    HP +V+ +GA   +  + I++E+   G + + + +  R L
Sbjct: 47  KSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL 106
Query: 283 SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +  ++      +   +N+LH  +   IIH DLK  N+L+   G ++++ FG+
Sbjct: 107 TEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGV 155

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 35/142 (24%)
Query: 235 ELTIVEKARHPNVVQFVG----------------AVTQNIPMMIVLEYHAKGDLASYLQK 278
           E+  + K  H N+V + G                + ++   + I +E+  KG L  +++K
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 279 KGRLSPSKVLRFAL--DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL- 335
           +      KVL   L   + +G++Y+H  K   +I+ DLKP NI L +  Q+KI  FGL+ 
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 336 -------------RLQYISPEK 344
                         L+Y+SPE+
Sbjct: 171 SLKNDGKRXRSKGTLRYMSPEQ 192

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 188 LELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPN 246
           +EL       + +G Y++ K     V +K+L + + K D E +     E  I+ +  +P 
Sbjct: 342 IELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPY 397
Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECK 305
           +V+ +G V Q   +M+V+E    G L  +L  K+  +  S V      ++ GM YL E  
Sbjct: 398 IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-- 454
Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGL 334
               +H +L  +N+LL N    KIS FGL
Sbjct: 455 -KNFVHRNLAARNVLLVNRHYAKISDFGL 482

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 5/126 (3%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY  
Sbjct: 78  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-C 136
Query: 269 KGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            G  +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   G +
Sbjct: 137 LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV 193
Query: 328 KISGFG 333
           K+  FG
Sbjct: 194 KLGDFG 199

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    +  VA   G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ + 
Sbjct: 33  ASGTVYTAMDVA--TGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSY 87
Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                + +V+EY A G L   + +   +   ++     +  + + +LH    + +IH ++
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHS---NQVIHRNI 143
Query: 315 KPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           K  NILL   G +K++ FG      I+PE++K
Sbjct: 144 KSDNILLGMDGSVKLTDFGF--CAQITPEQSK 173

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/161 (23%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E EL  +++    A G       +      K+ V I     +  P+       E  
Sbjct: 12  RILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLAR 296
           ++     P V + +G    +  + +V +    G L  ++ + +GRL    +L + + +A+
Sbjct: 72  VMAGVGSPYVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GM+YL + +   ++H DL  +N+L+ +   +KI+ FGL RL
Sbjct: 131 GMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 168

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 57/126 (45%), Gaps = 5/126 (3%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-C 97
Query: 269 KGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            G  +  L+  K  L   ++        +G+ YLH      +IH D+K  NILL   G +
Sbjct: 98  LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLV 154
Query: 328 KISGFG 333
           K+  FG
Sbjct: 155 KLGDFG 160

>pdb|1UOH|A Chain A, Human Gankyrin Length = 226

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 4/126 (3%)
Query: 68  ENLDSTMQLLFMACRGDVKGV-EDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           E   S + +  +A  G ++ + E +L + S     D D RTALH A   GH E+V+ LL 
Sbjct: 2   EGCVSNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQ 61
Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVANPREVPEY 183
               ++ +D  G +    A   G  E+   L  +GA+V    +   TP+  A  +   E 
Sbjct: 62  LGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEI 121
Query: 184 ELNPLE 189
            +  LE
Sbjct: 122 AVMLLE 127

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E  I+EK     VV    A      + +VL     GDL  ++   G+     ++ + +A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++  G+  LH    + I++ DLKP+NILLD+ G ++IS  GL
Sbjct: 293 AEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGL 332

>pdb|4B93|B Chain B, Complex Of Vamp7 Cytoplasmic Domain With 2nd Ankyrin Repeat Domain Of Varp Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +AC+ G  + V+ LL+  +  N  DL G T L  A   GH E+V LLL   A+I+A +
Sbjct: 123 LHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASN 182
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
             G+TA  +A    +V V  +L   GA V    K +RT +  A
Sbjct: 183 NKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTAVDCA 225

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 61/131 (46%), Gaps = 6/131 (4%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  +KI+ K S        A   E+ ++++  HPN+++            +V+E 
Sbjct: 26  KLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEV 85
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + + S          +  G  YLH+     I+H DLKP+N+LL++  +
Sbjct: 86  YRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSR 142
Query: 327 ---LKISGFGL 334
              +KI  FGL
Sbjct: 143 DALIKIVDFGL 153

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 61/131 (46%), Gaps = 6/131 (4%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  +KI+ K S        A   E+ ++++  HPN+++            +V+E 
Sbjct: 43  KLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEV 102
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
           +  G+L   +  + + S          +  G  YLH+     I+H DLKP+N+LL++  +
Sbjct: 103 YRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK---HNIVHRDLKPENLLLESKSR 159
Query: 327 ---LKISGFGL 334
              +KI  FGL
Sbjct: 160 DALIKIVDFGL 170

>pdb|1QYM|A Chain A, X-Ray Structure Of Human Gankyrin Length = 227

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 4/126 (3%)
Query: 68  ENLDSTMQLLFMACRGDVKGV-EDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           E   S + +  +A  G ++ + E +L + S     D D RTALH A   GH E+V+ LL 
Sbjct: 3   EGCVSNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQ 62
Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKR---TPMTVANPREVPEY 183
               ++ +D  G +    A   G  E+   L  +GA+V    +   TP+  A  +   E 
Sbjct: 63  LGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEI 122
Query: 184 ELNPLE 189
            +  LE
Sbjct: 123 AVMLLE 128

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S + +  +A ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            G+ ++H      +++ DLKP NILLD  G ++IS  GL
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL 338

>pdb|1OT8|A Chain A, Structure Of The Ankyrin Domain Of The Drosophila Notch Receptor Length = 239

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 38/60 (63%), Gaps = 1/60 (1%)
Query: 77  LFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R  ++G VEDL+   +D+N+ D  G+TALH AA   + E V +LL   AN DA+D
Sbjct: 122 LILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQD 181

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S + +  +A ++ 
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            G+ ++H      +++ DLKP NILLD  G ++IS  GL
Sbjct: 302 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL 337

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S + +  +A ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            G+ ++H      +++ DLKP NILLD  G ++IS  GL
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL 338

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           L++V     P +V    A      +  +L+    GDL  +L + G  S + +  +A ++ 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            G+ ++H      +++ DLKP NILLD  G ++IS  GL
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL 338

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 5/103 (4%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFA 291
           +E  I+EK     VV    A      + +VL     GDL  ++   G+     ++ + +A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            ++  G+  LH    + I++ DLKP+NILLD+ G ++IS  GL
Sbjct: 293 AEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGL 332

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/101 (26%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
            E+T++ +     V ++ G+  +   + I++EY   G  A  L + G     ++     +
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGS-ALDLLRAGPFDEFQIATMLKE 128
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           + +G++YLH  K    IH D+K  N+LL   G +K++ FG+
Sbjct: 129 ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGV 166

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 7/103 (6%)
Query: 235 ELTIVEKARH-PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS-PSKVL-RFA 291
           +L +V K+   P +VQ  G    N  + I +E    G  A  L+K+ +   P ++L +  
Sbjct: 73  DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMT 130
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           + + + + YL E     +IH D+KP NILLD  GQ+K+  FG+
Sbjct: 131 VAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGI 171

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI GFGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLAR 173

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 26/103 (25%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+  +   RHP +V    A   +  M+++ E+ + G+L   +  +  ++S  + + +   
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 157
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGL 334
           + +G+ ++HE   +  +H DLKP+NI+       +LK+  FGL
Sbjct: 158 VCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGL 197

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 54  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 113
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 114 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFG 169
Query: 334 LLRL 337
           L R+
Sbjct: 170 LARV 173

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 5/127 (3%)
Query: 209 NGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N  KV+ +KIL+K           F  E  ++       +     A   +  + +V++Y+
Sbjct: 97  NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY 156
Query: 268 AKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             GDL + L K     P ++ RF L ++   ++ +H+      +H D+KP NIL+D  G 
Sbjct: 157 VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH 213
Query: 327 LKISGFG 333
           ++++ FG
Sbjct: 214 IRLADFG 220

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 62  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 121
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 122 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 177
Query: 334 LLRL 337
           L R+
Sbjct: 178 LARV 181

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 54  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 113
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 114 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 169
Query: 334 LLRL 337
           L R+
Sbjct: 170 LARV 173

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 58  KKISPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 117
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 118 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFG 173
Query: 334 LLRL 337
           L R+
Sbjct: 174 LARV 177

>pdb|3AJI|A Chain A, Structure Of Gankyrin-S6atpase Photo-Cross-Linked Site-Specifically, And Incoporated By Genetic Code Expansion Length = 231

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 3/107 (2%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A  G  + V+ LL +G+ VN+++ +G T LH AA +   E+  +LL   AN DA+D
Sbjct: 77  LHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKD 136
Query: 136 RWGSTAAADAKYYGNVEVYNIL---KARGAKVPKTKRTPMTVANPRE 179
            + +TA   A   GN+++ +IL   KA          TP+ +A   E
Sbjct: 137 HYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEE 183

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 56  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 115
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 116 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 171
Query: 334 LLRL 337
           L R+
Sbjct: 172 LARV 175

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/124 (27%), Positives = 60/124 (48%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVVQ----FVGAVTQNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH NV+        +  + +  + +++   + DL 
Sbjct: 74  KKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLY 133
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K  +LS   +  F   + RG+ Y+H      ++H DLKP N+L++    LKI  FG
Sbjct: 134 KLL-KSQQLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFG 189
Query: 334 LLRL 337
           L R+
Sbjct: 190 LARI 193

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 54  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 113
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 114 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 169
Query: 334 LLRL 337
           L R+
Sbjct: 170 LARV 173

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 54  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 113
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 114 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFG 169
Query: 334 LLRL 337
           L R+
Sbjct: 170 LARV 173

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 54  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 113
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 114 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFG 169
Query: 334 LLRL 337
           L R+
Sbjct: 170 LARV 173

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 59  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 118
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 119 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 174
Query: 334 LLRL 337
           L R+
Sbjct: 175 LARV 178

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 60  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 119
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 120 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 175
Query: 334 LLRL 337
           L R+
Sbjct: 176 LARV 179

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 51  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 110
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 111 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 166
Query: 334 LLRL 337
           L R+
Sbjct: 167 LARV 170

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 58  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 117
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 118 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 334 LLRL 337
           L R+
Sbjct: 174 LARV 177

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 58  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 117
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 118 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 334 LLRL 337
           L R+
Sbjct: 174 LARV 177

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 52  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 111
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 112 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 167
Query: 334 LLRL 337
           L R+
Sbjct: 168 LARV 171

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 59  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 118
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 119 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 174
Query: 334 LLRL 337
           L R+
Sbjct: 175 LARV 178

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 52  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 111
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 112 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 167
Query: 334 LLRL 337
           L R+
Sbjct: 168 LARV 171

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 8/107 (7%)
Query: 235 ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           E+ I+ + RH N++     + A T + +  + +++   + DL   L K   LS   +  F
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL-KTQHLSNDHICYF 133
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
              + RG+ Y+H      ++H DLKP N+LL+    LKI  FGL R+
Sbjct: 134 LYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 58  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 117
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 118 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFG 173
Query: 334 LLRL 337
           L R+
Sbjct: 174 LARV 177

>pdb|2DVW|A Chain A, Structure Of The Oncoprotein Gankyrin In Complex With S6 Atpase Of The 26s Proteasome Length = 231

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           V+ LL +G+ VN+++ +G T LH AA +   E+  +LL   AN DA+D + +TA   A  
Sbjct: 89  VKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAA 148
Query: 148 YGNVEVYNIL---KARGAKVPKTKRTPMTVANPRE 179
            GN+++ +IL   KA          TP+ +A   E
Sbjct: 149 KGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEE 183

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 26/103 (25%), Positives = 54/103 (52%), Gaps = 6/103 (5%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+  +   RHP +V    A   +  M+++ E+ + G+L   +  +  ++S  + + +   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGL 334
           + +G+ ++HE   +  +H DLKP+NI+       +LK+  FGL
Sbjct: 264 VCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGL 303

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 15/141 (10%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDP----ERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G  ++A   GT++      + + K P    E ++ F  E+ I++   HPN+++       
Sbjct: 23  GEVKIAVQKGTRI-----RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           N  + +V+E    G+L   +  K     S   R   D+   + Y H+     + H DLKP
Sbjct: 78  NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKP 134
Query: 317 KNILL---DNGGQLKISGFGL 334
           +N L         LK+  FGL
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGL 155

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 74  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 133
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 134 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 189
Query: 334 LLRL 337
           L R+
Sbjct: 190 LARV 193

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 15/141 (10%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDP----ERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G  ++A   GT++      + + K P    E ++ F  E+ I++   HPN+++       
Sbjct: 40  GEVKIAVQKGTRI-----RRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 94
Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           N  + +V+E    G+L   +  K     S   R   D+   + Y H+     + H DLKP
Sbjct: 95  NTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKP 151
Query: 317 KNILL---DNGGQLKISGFGL 334
           +N L         LK+  FGL
Sbjct: 152 ENFLFLTDSPDSPLKLIDFGL 172

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 60/124 (48%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+   RH N++     + A T + +  + +++   + DL 
Sbjct: 56  KKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 115
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 116 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFG 171
Query: 334 LLRL 337
           L R+
Sbjct: 172 LARV 175

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 14/189 (7%)
Query: 157 LKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKG----------SYQVA 206
           L +  A + K    P    +P+  P  E+  + +  R      +G           Y++ 
Sbjct: 3   LGSMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEIT 62
Query: 207 KWNGTKVWV-KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
             +  +V+  K++ K     P +    + E+ I +   +P+VV F G    +  + +VLE
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              +  L    +++  ++  +   F     +G+ YLH  +   +IH DLK  N+ L++  
Sbjct: 123 ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDM 179
Query: 326 QLKISGFGL 334
            +KI  FGL
Sbjct: 180 DVKIGDFGL 188

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 244 HPNVVQFVGA---VTQN--IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           H N+ +F+     VT +  +  ++V+EY+  G L  YL        S   R A  + RG+
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC-RLAHSVTRGL 124
Query: 299 NYLHECKPD------PIIHCDLKPKNILLDNGGQLKISGFGL 334
            YLH   P        I H DL  +N+L+ N G   IS FGL
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/115 (25%), Positives = 58/115 (50%), Gaps = 5/115 (4%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           NG +  VKI++K++     R+  F    T+ +   + N+++ +     +    +V E   
Sbjct: 37  NGKEYAVKIIEKQAGHSRSRV--FREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQ 94
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
            G + +++QK+   +  +  R   D+A  +++LH      I H DLKP+NIL ++
Sbjct: 95  GGSILAHIQKQKHFNEREASRVVRDVAAALDFLH---TKGIAHRDLKPENILCES 146

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 14/189 (7%)
Query: 157 LKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKG----------SYQVA 206
           L +  A + K    P    +P+  P  E+  + +  R      +G           Y++ 
Sbjct: 3   LGSMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEIT 62
Query: 207 KWNGTKVWV-KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
             +  +V+  K++ K     P +    + E+ I +   +P+VV F G    +  + +VLE
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              +  L    +++  ++  +   F     +G+ YLH  +   +IH DLK  N+ L++  
Sbjct: 123 ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDM 179
Query: 326 QLKISGFGL 334
            +KI  FGL
Sbjct: 180 DVKIGDFGL 188

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/189 (22%), Positives = 81/189 (42%), Gaps = 14/189 (7%)
Query: 157 LKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKG----------SYQVA 206
           L +  A + K    P    +P+  P  E+  + +  R      +G           Y++ 
Sbjct: 3   LGSMSAAIAKPSAKPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEIT 62
Query: 207 KWNGTKVWV-KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE 265
             +  +V+  K++ K     P +    + E+ I +   +P+VV F G    +  + +VLE
Sbjct: 63  DMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLE 122
Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              +  L    +++  ++  +   F     +G+ YLH  +   +IH DLK  N+ L++  
Sbjct: 123 ICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDM 179
Query: 326 QLKISGFGL 334
            +KI  FGL
Sbjct: 180 DVKIGDFGL 188

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 61/110 (55%), Gaps = 5/110 (4%)
Query: 235 ELTIVEKARH-PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
           E  ++E  R  P +V    A      + ++L+Y   G+L ++L ++ R +  +V  +  +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE 343
           +   + +LH+     II+ D+K +NILLD+ G + ++ FGL + ++++ E
Sbjct: 168 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADE 213

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCR 173

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+ + RH N++     + A T + +  + +++   + DL 
Sbjct: 58  KKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 117
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 118 KLL-KCQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 173
Query: 334 LLRL 337
           L R+
Sbjct: 174 LARV 177

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 75/161 (46%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I++      P+       E  
Sbjct: 44  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 104 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 162
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 163 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 200

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 76/168 (45%), Gaps = 9/168 (5%)
Query: 168 KRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWV-KILDKESHKDP 226
           K  P  + +PR +  Y    +  +     G  K  Y++   +  +V+  K++ K     P
Sbjct: 13  KEIPDVLVDPRTMKRY----MRGRFLGKGGFAK-CYEITDMDTKEVFAGKVVPKSMLLKP 67
Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
            +    + E+ I +   +P+VV F G    +  + +VLE   +  L    +++  ++  +
Sbjct: 68  HQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPE 127
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
              F     +G+ YLH  +   +IH DLK  N+ L++   +KI  FGL
Sbjct: 128 ARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGL 172

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/124 (29%), Positives = 60/124 (48%), Gaps = 17/124 (13%)
Query: 227 ERINAFTH---------ELTIVEKARHPNVV---QFVGAVT-QNIPMMIVLEYHAKGDLA 273
           ++I+ F H         E+ I+   RH N++     + A T + +  + +++   + DL 
Sbjct: 56  KKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY 115
Query: 274 SYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+    LKI  FG
Sbjct: 116 KLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG 171
Query: 334 LLRL 337
           L R+
Sbjct: 172 LARV 175

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 75/161 (46%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 17  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 77  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 75/161 (46%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 71  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 130 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 10/146 (6%)
Query: 195 ADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           A G    SY V   +G K+ VK L +           +  EL +++  +H NV+  +   
Sbjct: 63  AYGSVCSSYDVK--SGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVF 119
Query: 255 TQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
           T    +     + L  H  G   + + K  +L+   V      + RG+ Y+H      II
Sbjct: 120 TPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---II 176
Query: 311 HCDLKPKNILLDNGGQLKISGFGLLR 336
           H DLKP N+ ++   +LKI  FGL R
Sbjct: 177 HRDLKPSNLAVNEDCELKILDFGLAR 202

>pdb|3B7B|A Chain A, Euhmt1 (Glp) Ankyrin Repeat Domain (Structure 1) Length = 237

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 68/137 (49%), Gaps = 13/137 (9%)
Query: 41  NMRFSFGRQSSLDPIRRSPVQDELTVPE-------NLDSTMQ-----LLFMACRGDVKGV 88
           +M F    Q+   P+  +     + +         N+D+  +     L+  A    ++ V
Sbjct: 1   HMNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAV 60
Query: 89  EDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK-KANIDARDRWGSTAAADAKY 147
           + L+  G+ V+  D +G T LH+AA +GH EVV+ LLS  + +++ +D  G T    A  
Sbjct: 61  KYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATE 120
Query: 148 YGNVEVYNILKARGAKV 164
           Y +V++  +L ++G+ +
Sbjct: 121 YKHVDLVKLLLSKGSDI 137

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 83/186 (44%), Gaps = 10/186 (5%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 4   KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 63
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 123
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL-LRLQYISPEKAKIVFP 350
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL  +++Y    K  +   
Sbjct: 124 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 351 VSHIDP 356
            ++I P
Sbjct: 181 PNYIAP 186

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 83/186 (44%), Gaps = 10/186 (5%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 4   KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 63
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 64  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 123
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL-LRLQYISPEKAKIVFP 350
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL  +++Y    K  +   
Sbjct: 124 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 180
Query: 351 VSHIDP 356
            ++I P
Sbjct: 181 PNYIAP 186

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 75/161 (46%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 74  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 133 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 170

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 26  KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 85
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 86  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 145
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL
Sbjct: 146 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL 185

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 83/186 (44%), Gaps = 10/186 (5%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 8   KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 67
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 68  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 127
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL-LRLQYISPEKAKIVFP 350
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL  +++Y    K  +   
Sbjct: 128 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGT 184
Query: 351 VSHIDP 356
            ++I P
Sbjct: 185 PNYIAP 190

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 67/147 (45%), Gaps = 9/147 (6%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM 260
           G     +W G  + VK+L K       +   F  E   +    HPNV+  +GA  Q+ P 
Sbjct: 24  GELWKGRWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA-CQSPPA 81
Query: 261 ---MIVLEYHAKGDLASYLQKKGRL--SPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
               ++  +   G L + L +        S+ ++FALD+ARGM +LH  +P    H  L 
Sbjct: 82  PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA-LN 140
Query: 316 PKNILLDNGGQLKISGFGLLRLQYISP 342
            +++++D     +IS    ++  + SP
Sbjct: 141 SRSVMIDEDMTARIS-MADVKFSFQSP 166

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 173

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 2   KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 61
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 62  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 121
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
             +  G  YLH    + +IH DLK  N+ L+   ++KI  FGL
Sbjct: 122 RQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGL 161

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/129 (23%), Positives = 65/129 (50%), Gaps = 16/129 (12%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIP------MMIVLEYH 267
           +K++D    ++ E       E+ +++K + H N+  + GA  +  P      + +V+E+ 
Sbjct: 54  IKVMDVTGDEEEE----IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109
Query: 268 AKGDLASYLQ--KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
             G +   ++  K   L    +     ++ RG+++LH+ K   +IH D+K +N+LL    
Sbjct: 110 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166
Query: 326 QLKISGFGL 334
           ++K+  FG+
Sbjct: 167 EVKLVDFGV 175

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 9/163 (5%)
Query: 178 REVPEYELNPLELQVRK-----ADGITKGSYQVAKWNGTKVWV-KILDKESHKDPERINA 231
           +E+PE  ++P   +          G     ++++  +  +V+  KI+ K     P +   
Sbjct: 28  KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK 87
Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
            + E++I     H +VV F G    N  + +VLE   +  L    +++  L+  +   + 
Sbjct: 88  MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYL 147
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
             +  G  YLH  +   +IH DLK  N+ L+   ++KI  FGL
Sbjct: 148 RQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL 187

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 75/161 (46%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 75/161 (46%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 11  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 71  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 129
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 130 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 75/161 (46%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 75/161 (46%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 73  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 65/137 (47%), Gaps = 14/137 (10%)
Query: 209 NGTKVWVKILDKESHKDP-ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           +G +  +K ++K+  + P E+I A   E+ +++   HPN+++          M IV+E  
Sbjct: 46  SGLERVIKTINKDRSQVPMEQIEA---EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102
Query: 268 AKGDLASYL---QKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
             G+L   +   Q +G+ LS   V      +   + Y H      ++H DLKP+NIL  +
Sbjct: 103 EGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQD 159
Query: 324 G---GQLKISGFGLLRL 337
                 +KI  FGL  L
Sbjct: 160 TSPHSPIKIIDFGLAEL 176

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 133 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 175

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 137 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLAR 179

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL 126
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 127 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAF 232
           ++ P Y+   L+L   K   + +GS+ +      K +     VKI+ K    + ++    
Sbjct: 2   KDSPFYQHYDLDL---KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---- 54
Query: 233 THELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFA 291
             E+T ++    HPN+V+        +   +V+E    G+L   ++KK   S ++     
Sbjct: 55  --EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM 112
Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQ 338
             L   ++++H+     ++H DLKP+N+L    ++  ++KI  FG  RL+
Sbjct: 113 RKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 8/132 (6%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
            G KV +K L +    +     A+  EL +++  RH NV+  +   T +  +    +++ 
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 107
Query: 269 ----KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
                G     L K  +L   ++      + +G+ Y+H      IIH DLKP N+ ++  
Sbjct: 108 VMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNED 164
Query: 325 GQLKISGFGLLR 336
            +LKI  FGL R
Sbjct: 165 CELKILDFGLAR 176

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 17  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 77  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 136 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 136 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 178

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 182 EYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           +YEL   E+    A  + + +Y   K    KV +K ++ E  K    ++    E+  + +
Sbjct: 11  DYELQ--EVIGSGATAVVQAAYCAPK--KEKVAIKRINLE--KCQTSMDELLKEIQAMSQ 64
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ--------KKGRLSPSKVLRFALD 293
             HPN+V +  +      + +V++  + G +   ++        K G L  S +     +
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +  G+ YLH+   +  IH D+K  NILL   G ++I+ FG+
Sbjct: 125 VLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGV 162

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 64/128 (50%), Gaps = 7/128 (5%)
Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G +V VK++D    +  +R     +E+ I+   +H NVV+   +      + +++E+
Sbjct: 67  KHSGRQVAVKMMDL---RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123
Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   + +  RL+  ++      + + + YLH      +IH D+K  +ILL   G+
Sbjct: 124 LQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGR 179
Query: 327 LKISGFGL 334
           +K+S FG 
Sbjct: 180 VKLSDFGF 187

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 138 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 81  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 140
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 141 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 183

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 142 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLAR 184

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 138 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 136 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 70  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 129
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 130 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 172

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 6/106 (5%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ ++ +  HPN+++          + +VLE    G+L   + +KG  S          +
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRL 337
              + YLHE   + I+H DLKP+N+L         LKI+ FGL ++
Sbjct: 158 LEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 182 EYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
           +YEL   E+    A  + + +Y   K    KV +K ++ E  K    ++    E+  + +
Sbjct: 16  DYELQ--EVIGSGATAVVQAAYCAPK--KEKVAIKRINLE--KCQTSMDELLKEIQAMSQ 69
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ--------KKGRLSPSKVLRFALD 293
             HPN+V +  +      + +V++  + G +   ++        K G L  S +     +
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +  G+ YLH+   +  IH D+K  NILL   G ++I+ FG+
Sbjct: 130 VLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGV 167

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 138 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 154 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 133 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 133 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 133 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 175

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 138 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 137 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 143 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 143 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1AWC|B Chain B, Mouse Gabp AlphaBETA DOMAIN BOUND TO DNA Length = 153

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 45/92 (48%)
Query: 73  TMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID 132
           T  L   A  G     E LL  G   ++     RT LH+AA EGH  +V++LL   A+++
Sbjct: 35  TSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVN 94
Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           A+D    TA   A  + + EV  +L   GA V
Sbjct: 95  AKDMLKMTALHWATEHNHQEVVELLIKYGADV 126

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 142
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 143 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 185

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 14/137 (10%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIP-------M 260
            G KV +K +  E+ K+   I A   E+ I++  +H NVV  +    T+  P       +
Sbjct: 42  TGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 100
Query: 261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
            +V ++  + DLA  L     + + S++ R    L  G+ Y+H  K   I+H D+K  N+
Sbjct: 101 YLVFDF-CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV 156
Query: 320 LLDNGGQLKISGFGLLR 336
           L+   G LK++ FGL R
Sbjct: 157 LITRDGVLKLADFGLAR 173

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 142 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 184

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 137 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 127 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 136 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 178

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 128 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 151 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 69  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 128
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 129 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 171

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 127 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 150 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 137 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 179

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 128 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 170

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 173

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 52/107 (48%), Gaps = 9/107 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           EL +++  +H NV+  +   T     ++   + ++      DL + ++ +  LS   V  
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQA-LSDEHVQF 135
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
               L RG+ Y+H      IIH DLKP N+ ++   +L+I  FGL R
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 150 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 192

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 151 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 127 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 154 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 196

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 151 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 193

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I     HPN+++          + ++LEY  +G+L   LQK       +      +L
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL 132
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           A  + Y H  K   +IH D+KP+N+LL   G+LKI+ FG
Sbjct: 133 ADALMYCHGKK---VIHRDIKPENLLLGLKGELKIADFG 168

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 6/102 (5%)
Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLS---PSKVL-RFAL 292
            ++  +  P +VQF GA+ +     I +E  +      Y      L    P ++L +  L
Sbjct: 73  VVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
              + +N+L E     IIH D+KP NILLD  G +K+  FG+
Sbjct: 133 ATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI 172

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 43/75 (57%), Gaps = 4/75 (5%)
Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKN 318
           + +V++Y+  GDL + L K     P  + RF + ++   ++ +H+      +H D+KP N
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH---YVHRDIKPDN 205
Query: 319 ILLDNGGQLKISGFG 333
           +LLD  G ++++ FG
Sbjct: 206 VLLDVNGHIRLADFG 220

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 35  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 95  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 153
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 154 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 191

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 73  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 17  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 77  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 73  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 13  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 73  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 131
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 14/137 (10%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIP-------M 260
            G KV +K +  E+ K+   I A   E+ I++  +H NVV  +    T+  P       +
Sbjct: 42  TGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVNLIEICRTKASPYNRCKASI 100
Query: 261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
            +V ++  + DLA  L     + + S++ R    L  G+ Y+H  K   I+H D+K  N+
Sbjct: 101 YLVFDF-CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV 156
Query: 320 LLDNGGQLKISGFGLLR 336
           L+   G LK++ FGL R
Sbjct: 157 LITRDGVLKLADFGLAR 173

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 20  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 80  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 138
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 139 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 176

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 67/130 (51%), Gaps = 14/130 (10%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
           VK + K++ K  E  ++  +E+ ++ K +H N+V           + +V++  + G+L  
Sbjct: 52  VKCIPKKALKGKE--SSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFD 109
Query: 275 YLQKKGRLS---PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLK 328
            + +KG  +    S ++R  LD    + YLH      I+H DLKP+N+L    D   ++ 
Sbjct: 110 RIVEKGFYTEKDASTLIRQVLD---AVYYLHRM---GIVHRDLKPENLLYYSQDEESKIM 163
Query: 329 ISGFGLLRLQ 338
           IS FGL +++
Sbjct: 164 ISDFGLSKME 173

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 43/75 (57%), Gaps = 4/75 (5%)
Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKN 318
           + +V++Y+  GDL + L K     P  + RF + ++   ++ +H+      +H D+KP N
Sbjct: 165 LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH---YVHRDIKPDN 221
Query: 319 ILLDNGGQLKISGFG 333
           +LLD  G ++++ FG
Sbjct: 222 VLLDVNGHIRLADFG 236

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 20/149 (13%)
Query: 198 ITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I  GSY V K         +  VKI+DK S +DP      T E+ I+ +  +HPN++   
Sbjct: 30  IGVGSYSVCKRCIHKATNXEFAVKIIDK-SKRDP------TEEIEILLRYGQHPNIITLK 82
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                   + +V E    G+L   + ++   S  +       + + + YLH      ++H
Sbjct: 83  DVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139
Query: 312 CDLKPKNIL-LDNGG---QLKISGFGLLR 336
            DLKP NIL +D  G    ++I  FG  +
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAK 168

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 16  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 76  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 134
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 135 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 172

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 14/137 (10%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIP-------M 260
            G KV +K +  E+ K+   I A   E+ I++  +H NVV  +    T+  P       +
Sbjct: 42  TGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 100
Query: 261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
            +V ++  + DLA  L     + + S++ R    L  G+ Y+H  K   I+H D+K  N+
Sbjct: 101 YLVFDF-CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV 156
Query: 320 LLDNGGQLKISGFGLLR 336
           L+   G LK++ FGL R
Sbjct: 157 LITRDGVLKLADFGLAR 173

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 14/137 (10%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIP-------M 260
            G KV +K +  E+ K+   I A   E+ I++  +H NVV  +    T+  P       +
Sbjct: 41  TGQKVALKKVLMENEKEGFPITAL-REIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 99
Query: 261 MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
            +V ++  + DLA  L     + + S++ R    L  G+ Y+H  K   I+H D+K  N+
Sbjct: 100 YLVFDF-CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANV 155
Query: 320 LLDNGGQLKISGFGLLR 336
           L+   G LK++ FGL R
Sbjct: 156 LITRDGVLKLADFGLAR 172

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 73/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 4   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 123 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160

>pdb|3UXG|A Chain A, Crystal Structure Of Rfxank Length = 172

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 55/103 (53%), Gaps = 3/103 (2%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L++ +  G+++ V  LL  G+D + +  +  +AL +A+  G+ ++V LLL +  +I+  D
Sbjct: 40  LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
             G T    A +  +V+    L ARGA +     +  TPM +A
Sbjct: 100 WNGGTPLLYAVHGNHVKCVEALLARGADLTTEADSGYTPMDLA 142

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/151 (23%), Positives = 68/151 (45%), Gaps = 17/151 (11%)
Query: 198 ITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINA--FTHELTIVEKARHPNVVQF 250
           I KG++ V +       G +  VKI+D         ++      E +I    +HP++V+ 
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKP 306
           +   + +  + +V E+    DL   + K+       S +    +   +   + Y H+   
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--- 148
Query: 307 DPIIHCDLKPKNILL---DNGGQLKISGFGL 334
           + IIH D+KP+N+LL   +N   +K+  FG+
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGV 179

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 212 KVWVKILDKES-------HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           KV +KI+ K           DP  +N  T E+ I++K  HP +++            IVL
Sbjct: 36  KVAIKIISKRKFAIGSAREADP-ALNVET-EIEILKKLNHPCIIKIKNFFDAE-DYYIVL 92
Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           E    G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL + 
Sbjct: 93  ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQ 149
Query: 325 GQ---LKISGFG 333
            +   +KI+ FG
Sbjct: 150 EEDCLIKITDFG 161

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 66/149 (44%), Gaps = 20/149 (13%)
Query: 198 ITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFV 251
           I  GSY V K         +  VKI+DK S +DP      T E+ I+ +  +HPN++   
Sbjct: 30  IGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDP------TEEIEILLRYGQHPNIITLK 82
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                   + +V E    G+L   + ++   S  +       + + + YLH      ++H
Sbjct: 83  DVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139
Query: 312 CDLKPKNIL-LDNGG---QLKISGFGLLR 336
            DLKP NIL +D  G    ++I  FG  +
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAK 168

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I++K  HP +++            IVLE    G+L   +    RL  +    +   +
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFG 333
              + YLHE   + IIH DLKP+N+LL +  +   +KI+ FG
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 287

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 73/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 212 KVWVKILDKES-------HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           KV +KI+ K           DP  +N  T E+ I++K  HP +++            IVL
Sbjct: 37  KVAIKIISKRKFAIGSAREADP-ALNVET-EIEILKKLNHPCIIKIKNFFDAE-DYYIVL 93
Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           E    G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL + 
Sbjct: 94  ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQ 150
Query: 325 GQ---LKISGFG 333
            +   +KI+ FG
Sbjct: 151 EEDCLIKITDFG 162

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 212 KVWVKILDKES-------HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           KV +KI+ K           DP  +N  T E+ I++K  HP +++            IVL
Sbjct: 37  KVAIKIISKRKFAIGSAREADPA-LNVET-EIEILKKLNHPCIIKIKNFFDAE-DYYIVL 93
Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           E    G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL + 
Sbjct: 94  ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQ 150
Query: 325 GQ---LKISGFG 333
            +   +KI+ FG
Sbjct: 151 EEDCLIKITDFG 162

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ I++K  HP +++            IVLE    G+L   +    RL  +    +   +
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFG 333
              + YLHE   + IIH DLKP+N+LL +  +   +KI+ FG
Sbjct: 263 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 301

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 212 KVWVKILDKES-------HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           KV +KI+ K           DP  +N  T E+ I++K  HP +++            IVL
Sbjct: 37  KVAIKIISKRKFAIGSAREADP-ALNVET-EIEILKKLNHPCIIKIKNFFDAE-DYYIVL 93
Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           E    G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL + 
Sbjct: 94  ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQ 150
Query: 325 GQ---LKISGFG 333
            +   +KI+ FG
Sbjct: 151 EEDCLIKITDFG 162

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 52/107 (48%), Gaps = 9/107 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           EL +++  +H NV+  +   T     ++   + ++      DL + ++ +  LS   V  
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQA-LSDEHVQF 135
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
               L RG+ Y+H      IIH DLKP N+ ++   +L+I  FGL R
Sbjct: 136 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 16/132 (12%)
Query: 212 KVWVKILDKES-------HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           KV +KI+ K           DP  +N  T E+ I++K  HP +++            IVL
Sbjct: 43  KVAIKIISKRKFAIGSAREADP-ALNVET-EIEILKKLNHPCIIKIKNFFDAE-DYYIVL 99
Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           E    G+L   +    RL  +    +   +   + YLHE   + IIH DLKP+N+LL + 
Sbjct: 100 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQ 156
Query: 325 GQ---LKISGFG 333
            +   +KI+ FG
Sbjct: 157 EEDCLIKITDFG 168

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 55  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 111
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 112 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 167
Query: 329 ISGFGL 334
           +S FG 
Sbjct: 168 LSDFGF 173

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  +GL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLAR 173

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 44  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 101 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 156
Query: 329 ISGFGL 334
           +S FG 
Sbjct: 157 LSDFGF 162

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 53  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 109
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 110 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 165
Query: 329 ISGFGL 334
           +S FG 
Sbjct: 166 LSDFGF 171

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 175 SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 232 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVK 287
Query: 329 ISGFGL 334
           +S FG 
Sbjct: 288 LSDFGF 293

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/161 (22%), Positives = 72/161 (44%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 7   RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +   +I  +    G L  Y+++ K  +    +L + + +A 
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAE 125
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FGL +L
Sbjct: 126 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 163

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/114 (22%), Positives = 57/114 (50%), Gaps = 6/114 (5%)
Query: 228 RINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKV 287
           R ++  +E+ +++K +H N+V             +V++  + G+L   + ++G  +    
Sbjct: 49  RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA 108
Query: 288 LRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRLQ 338
                 +   + YLHE   + I+H DLKP+N+L    +   ++ I+ FGL +++
Sbjct: 109 SLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 98  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 155 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 210
Query: 329 ISGFGL 334
           +S FG 
Sbjct: 211 LSDFGF 216

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 61/126 (48%), Gaps = 7/126 (5%)
Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           +G  V VK +D       +R     +E+ I+   +H NVV+   +      + +V+E+  
Sbjct: 48  SGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 104
Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            G L   +    R++  ++    L + + ++ LH      +IH D+K  +ILL + G++K
Sbjct: 105 GGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVK 160
Query: 329 ISGFGL 334
           +S FG 
Sbjct: 161 LSDFGF 166

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  +L
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 52/107 (48%), Gaps = 9/107 (8%)
Query: 235 ELTIVEKARHPNVVQFVGAVT-----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR 289
           EL +++  +H NV+  +   T     ++   + ++      DL + ++ +  LS   V  
Sbjct: 69  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQA-LSDEHVQF 127
Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
               L RG+ Y+H      IIH DLKP N+ ++   +L+I  FGL R
Sbjct: 128 LVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  +L
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/161 (21%), Positives = 74/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 14  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++++    G L  Y+++ K  +    +L + + +A+
Sbjct: 74  VMASVDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 132
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  +L
Sbjct: 133 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKL 170

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 5/108 (4%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   ++++G L   +
Sbjct: 127 RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDR 186
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFG 333
            L +      G+ YLH  +   I+H D+K  N+LL  +G    +  FG
Sbjct: 187 ALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFG 231

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/151 (23%), Positives = 66/151 (43%), Gaps = 17/151 (11%)
Query: 198 ITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINA--FTHELTIVEKARHPNVVQF 250
           I KG + V +       G +  VKI+D         ++      E +I    +HP++V+ 
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKP 306
           +   + +  + +V E+    DL   + K+       S +    +   +   + Y H+   
Sbjct: 94  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--- 150
Query: 307 DPIIHCDLKPKNILL---DNGGQLKISGFGL 334
           + IIH D+KP  +LL   +N   +K+ GFG+
Sbjct: 151 NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 181

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 5/108 (4%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   ++++G L   +
Sbjct: 108 RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDR 167
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFG 333
            L +      G+ YLH  +   I+H D+K  N+LL  +G    +  FG
Sbjct: 168 ALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFG 212

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 11/153 (7%)
Query: 191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP 245
           +  K   I +GSY V      +  G  V +K    ES  DP        E+ ++++ +HP
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKHP 62
Query: 246 NVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLR-FALDLARGMNYLHEC 304
           N+V  +    +   + +V EY     +   L +  R  P  +++       + +N+   C
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF---C 118
Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
                IH D+KP+NIL+     +K+  FG  RL
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARL 151

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 15/110 (13%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIP--------MMIVLEYHAKGDLASYLQKKGRLSPSK 286
           E+TI+ + +   +++    +   IP        + IVLE  A  DL    +    L+   
Sbjct: 75  EITILNRLKSDYIIRLYDLI---IPDDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEEH 130
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           +     +L  G N++HE     IIH DLKP N LL+    +K+  FGL R
Sbjct: 131 IKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|3T9K|A Chain A, Crystal Structure Of Acap1 C-portion Mutant S554d Fused With Integrin Beta1 Peptide Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 39/88 (44%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D+   L+       +   E LL  G++VN  D  GR  LH A   GH  +  L L + A+
Sbjct: 234 DNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGAD 293
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILK 158
           + ARD  G      A    N ++  +L+
Sbjct: 294 LGARDSEGRDPLTIAMETANADIVTLLR 321

>pdb|3JUE|A Chain A, Crystal Structure Of Arfgap And Ank Repeat Domain Of Acap1 Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 39/88 (44%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D+   L+       +   E LL  G++VN  D  GR  LH A   GH  +  L L + A+
Sbjct: 234 DNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGAD 293
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILK 158
           + ARD  G      A    N ++  +L+
Sbjct: 294 LGARDSEGRDPLTIAMETANADIVTLLR 321

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/151 (23%), Positives = 66/151 (43%), Gaps = 17/151 (11%)
Query: 198 ITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINA--FTHELTIVEKARHPNVVQF 250
           I KG + V +       G +  VKI+D         ++      E +I    +HP++V+ 
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKP 306
           +   + +  + +V E+    DL   + K+       S +    +   +   + Y H+   
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD--- 148
Query: 307 DPIIHCDLKPKNILL---DNGGQLKISGFGL 334
           + IIH D+KP  +LL   +N   +K+ GFG+
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179

>pdb|4F1P|A Chain A, Crystal Structure Of Mutant S554d For Arfgap And Ank Repeat Domain Of Acap1 Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/88 (29%), Positives = 39/88 (44%)
Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           D+   L+       +   E LL  G++VN  D  GR  LH A   GH  +  L L + A+
Sbjct: 234 DNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGAD 293
Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILK 158
           + ARD  G      A    N ++  +L+
Sbjct: 294 LGARDSEGRDPLTIAMETANADIVTLLR 321

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/119 (25%), Positives = 56/119 (47%), Gaps = 5/119 (4%)
Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG-DLAS 274
           K+L+    +DP ++   T E+ I+ +  H N+++ +          +V+E H  G DL +
Sbjct: 61  KVLEDCWIEDP-KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFA 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           ++ +  RL           L   + YL   +   IIH D+K +NI++     +K+  FG
Sbjct: 120 FIDRHPRLDEPLASYIFRQLVSAVGYL---RLKDIIHRDIKDENIVIAEDFTIKLIDFG 175

>pdb|3V30|A Chain A, Crystal Structure Of The Peptide Bound Complex Of The Ankyrin Repeat Domains Of Human Rfxank Length = 172

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/103 (29%), Positives = 54/103 (52%), Gaps = 3/103 (2%)
Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L++ +  G+++ V  LL  G+D + +  +  +AL +A+  G+ ++V LLL +  +I+  D
Sbjct: 40  LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99
Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
             G T    A    +V+    L ARGA +     +  TPM +A
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLA 142

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 245 PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ--KKGRLSPSKVL-RFALDLARGMNYL 301
           P  V F GA+ +   + I +E         Y Q   KG+  P  +L + A+ + + + +L
Sbjct: 66  PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           H      +IH D+KP N+L++  GQ+K+  FG+
Sbjct: 126 HS--KLSVIHRDVKPSNVLINALGQVKMCDFGI 156

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 10/114 (8%)
Query: 228 RINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA-----KGDLASYLQKKGR- 281
           + + F +EL I+   ++   +   G +T    + I+ EY       K D   ++  K   
Sbjct: 86  KYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 282 -LSPSKVLRFAL-DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
              P +V++  +  +    +Y+H  K   I H D+KP NIL+D  G++K+S FG
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFG 197

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 5/108 (4%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   +++ G L   +
Sbjct: 92  RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR 151
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFG 333
            L +      G+ YLH  +   I+H D+K  N+LL  +G +  +  FG
Sbjct: 152 ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFG 196

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 5/93 (5%)
Query: 245 PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ--KKGRLSPSKVL-RFALDLARGMNYL 301
           P  V F GA+ +   + I +E         Y Q   KG+  P  +L + A+ + + + +L
Sbjct: 110 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 169
Query: 302 HECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           H      +IH D+KP N+L++  GQ+K+  FG+
Sbjct: 170 HS--KLSVIHRDVKPSNVLINALGQVKMCDFGI 200

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 5/108 (4%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   +++ G L   +
Sbjct: 106 RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR 165
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFG 333
            L +      G+ YLH  +   I+H D+K  N+LL  +G +  +  FG
Sbjct: 166 ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFG 210

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/137 (25%), Positives = 63/137 (45%), Gaps = 11/137 (8%)
Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT-----QNIP 259
           + K +G KV +K L +    +     A+  EL +++  +H NV+  +   T     +N  
Sbjct: 44  IDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLDVFTPASSLRNFY 102
Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
              ++    + DL   +  K   S  K+      + +G+ Y+H      ++H DLKP N+
Sbjct: 103 DFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNL 157
Query: 320 LLDNGGQLKISGFGLLR 336
            ++   +LKI  FGL R
Sbjct: 158 AVNEDCELKILDFGLAR 174

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 48/108 (44%), Gaps = 5/108 (4%)
Query: 228 RINAF-THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
           R+  F   EL        P +V   GAV +   + I +E    G L   +++ G L   +
Sbjct: 108 RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR 167
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DNGGQLKISGFG 333
            L +      G+ YLH  +   I+H D+K  N+LL  +G +  +  FG
Sbjct: 168 ALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFG 212

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/102 (25%), Positives = 46/102 (45%), Gaps = 3/102 (2%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E+ ++++ RH N+V  +    +     +V E+     L         L    V ++   +
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI 133
Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             G+ +   C    IIH D+KP+NIL+   G +K+  FG  R
Sbjct: 134 INGIGF---CHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/161 (21%), Positives = 73/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 12  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 72  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 130
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  +L
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|3EHQ|A Chain A, Crystal Structure Of Human Osteoclast Stimulating Factor Length = 222

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 48/86 (55%), Gaps = 1/86 (1%)
Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK-KANIDARDRWG 138
           A RG++  + + L+    VN +D  G TAL+ A   GH ++V+ L ++    ++ +++ G
Sbjct: 81  AKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEXLFTQPNIELNQQNKLG 140
Query: 139 STAAADAKYYGNVEVYNILKARGAKV 164
            TA   A + G  ++  +L A+GA+ 
Sbjct: 141 DTALHAAAWKGYADIVQLLLAKGART 166

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/161 (21%), Positives = 73/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 17  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 77  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 135
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  +L
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKL 173

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/161 (21%), Positives = 73/161 (45%), Gaps = 5/161 (3%)
Query: 178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELT 237
           R + E E   +++    A G       + +    K+ V I +      P+       E  
Sbjct: 10  RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++    +P+V + +G    +  + ++ +    G L  Y+++ K  +    +L + + +A+
Sbjct: 70  VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           GMNYL + +   ++H DL  +N+L+     +KI+ FG  +L
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKL 166

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI  F L R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLAR 173

>pdb|4HBD|A Chain A, Crystal Structure Of Kank2 Ankyrin Repeats Length = 276

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 23/55 (41%), Positives = 36/55 (65%)
Query: 105 GRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKA 159
           G+TAL +A   G V+VVK LL+ +A+++ +D  GSTA   A  +G+ E+  +L A
Sbjct: 183 GQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLA 237

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 16/146 (10%)
Query: 192 VRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
           VR+   I  G    AK   TK     L    H+  ER      E  I    +HPN+V+  
Sbjct: 20  VRRCMKIPTGQEYAAKIINTKK----LSARDHQKLER------EARICRLLKHPNIVRLH 69
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            ++++     +V +    G+L   +  +   S +        +   +N+   C  + I+H
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH---CHLNGIVH 126
Query: 312 CDLKPKNILL---DNGGQLKISGFGL 334
            DLKP+N+LL     G  +K++ FGL
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGL 152

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 63/146 (43%), Gaps = 16/146 (10%)
Query: 192 VRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
           VR+   I  G    AK   TK     L    H+  ER      E  I    +HPN+V+  
Sbjct: 20  VRRCMKIPTGQEYAAKIINTKK----LSARDHQKLER------EARICRLLKHPNIVRLH 69
Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            ++++     +V +    G+L   +  +   S +        +   +N+   C  + I+H
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNH---CHLNGIVH 126
Query: 312 CDLKPKNILL---DNGGQLKISGFGL 334
            DLKP+N+LL     G  +K++ FGL
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGL 152

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 59/135 (43%), Gaps = 8/135 (5%)
Query: 201 GSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM 260
           G     +W G  + VK+L K       +   F  E   +    HPNV+  +GA  Q+ P 
Sbjct: 24  GELWKGRWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC-QSPPA 81
Query: 261 ---MIVLEYHAKGDLASYLQKKGRL--SPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
               ++  +   G L + L +        S+ ++FALD ARG  +LH  +P    H  L 
Sbjct: 82  PHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHA-LN 140
Query: 316 PKNILLDNGGQLKIS 330
            +++ +D     +IS
Sbjct: 141 SRSVXIDEDXTARIS 155

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 63/135 (46%), Gaps = 7/135 (5%)
Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           + K +G KV +K L +    +     A+  EL +++  +H NV+  +   T    +    
Sbjct: 62  IDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLDVFTPASSLRNFY 120
Query: 265 EYH-AKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           +++     + + LQK      S  K+      + +G+ Y+H      ++H DLKP N+ +
Sbjct: 121 DFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAV 177
Query: 322 DNGGQLKISGFGLLR 336
           +   +LKI  FGL R
Sbjct: 178 NEDCELKILDFGLAR 192

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 16/147 (10%)
Query: 198 ITKGSYQVA-----KWNGTKVWVKILD--KESHKDPERINAFTHELTIVEKARHPNVVQF 250
           + KG++ V      K  G +   KI++  K S +D +++     E  I  K +HPN+V+ 
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRL 93
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             ++ +     +V +    G+L   +  +   S +        +   + Y   C  + I+
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY---CHSNGIV 150
Query: 311 HCDLKPKNILLDN---GGQLKISGFGL 334
           H +LKP+N+LL +   G  +K++ FGL
Sbjct: 151 HRNLKPENLLLASKAKGAAVKLADFGL 177

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 57/127 (44%), Gaps = 18/127 (14%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIP--------MMIVLEYHAKGDLASYLQKKGRLSPSK 286
           E+ I+ +  H +VV+ +  V   IP        + +VLE  A  D     +    L+   
Sbjct: 102 EIAILNRLNHDHVVKVLDIV---IPKDVEKFDELYVVLEI-ADSDFKKLFRTPVYLTELH 157
Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-LQYISPEKA 345
           +     +L  G+ Y+H      I+H DLKP N L++    +K+  FGL R + Y  PE  
Sbjct: 158 IKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY--PENG 212
Query: 346 KIVFPVS 352
               P+S
Sbjct: 213 NSQLPIS 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI   GL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLAR 173

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 23/84 (27%), Positives = 43/84 (51%), Gaps = 7/84 (8%)
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL----SPSKVLRFALDLARG 297
            +H +VV++  A  ++  M+I  EY   G LA  + +  R+      +++    L + RG
Sbjct: 64  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 123
Query: 298 MNYLHECKPDPIIHCDLKPKNILL 321
           + Y+H      ++H D+KP NI +
Sbjct: 124 LRYIHSMS---LVHMDIKPSNIFI 144

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/123 (25%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 215 VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS 274
            K L    H+  ER      E  I    +HPN+V+   ++++     +V +    G+L  
Sbjct: 66  TKKLSARDHQKLER------EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFE 119
Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISG 331
            +  +   S +        +   +N++H+     I+H DLKP+N+LL +   G  +K++ 
Sbjct: 120 DIVAREYYSEADASHCIHQILESVNHIHQ---HDIVHRDLKPENLLLASKCKGAAVKLAD 176
Query: 332 FGL 334
           FGL
Sbjct: 177 FGL 179

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 23/84 (27%), Positives = 43/84 (51%), Gaps = 7/84 (8%)
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL----SPSKVLRFALDLARG 297
            +H +VV++  A  ++  M+I  EY   G LA  + +  R+      +++    L + RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 298 MNYLHECKPDPIIHCDLKPKNILL 321
           + Y+H      ++H D+KP NI +
Sbjct: 126 LRYIHSMS---LVHMDIKPSNIFI 146

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 23/84 (27%), Positives = 43/84 (51%), Gaps = 7/84 (8%)
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL----SPSKVLRFALDLARG 297
            +H +VV++  A  ++  M+I  EY   G LA  + +  R+      +++    L + RG
Sbjct: 66  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 125
Query: 298 MNYLHECKPDPIIHCDLKPKNILL 321
           + Y+H      ++H D+KP NI +
Sbjct: 126 LRYIHSMS---LVHMDIKPSNIFI 146

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 23/84 (27%), Positives = 43/84 (51%), Gaps = 7/84 (8%)
Query: 242 ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRL----SPSKVLRFALDLARG 297
            +H +VV++  A  ++  M+I  EY   G LA  + +  R+      +++    L + RG
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 298 MNYLHECKPDPIIHCDLKPKNILL 321
           + Y+H      ++H D+KP NI +
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFI 148

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI   GL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLAR 173

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 7/106 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRF 290
           EL +++  +H NV+  +   T    +     + L  H  G   + + K  +L+   V   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              + RG+ Y+H      IIH DLKP N+ ++   +LKI   GL R
Sbjct: 131 IYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLAR 173

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 49/104 (47%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS----KVLRF 290
           E  I+ K     +V    A      + +V+     GD+  ++      +P     + + +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
              +  G+ +LH+     II+ DLKP+N+LLD+ G ++IS  GL
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL 335

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 16/147 (10%)
Query: 198 ITKGSYQVA-----KWNGTKVWVKILD--KESHKDPERINAFTHELTIVEKARHPNVVQF 250
           + KG++ V      K  G +   KI++  K S +D +++     E  I  K +HPN+V+ 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRL 70
Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             ++ +     +V +    G+L   +  +   S +        +   + Y   C  + I+
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY---CHSNGIV 127
Query: 311 HCDLKPKNILLDN---GGQLKISGFGL 334
           H +LKP+N+LL +   G  +K++ FGL
Sbjct: 128 HRNLKPENLLLASKAKGAAVKLADFGL 154

>pdb|3EU9|A Chain A, The Ankyrin Repeat Domain Of Huntingtin Interacting Protein 14 Length = 240

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 55  IRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC 114
           I +  + D+L    +L+ST  L +   +G +  V  L+  G+D + ID +G + +H+AA 
Sbjct: 62  ISKGAIVDQL--GGDLNST-PLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQ 118
Query: 115 EGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
            GH  +V  L++K  ++D  D+ G T    A Y
Sbjct: 119 FGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAY 151

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 49/104 (47%), Gaps = 7/104 (6%)
Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS----KVLRF 290
           E  I+ K     +V    A      + +V+     GD+  ++      +P     + + +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
              +  G+ +LH+     II+ DLKP+N+LLD+ G ++IS  GL
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGL 335

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	359
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-51
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-48
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-48
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-46
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-45
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-44
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-43
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-43
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-39
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-39
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-39
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-38
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-35
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-34
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-33
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-32
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-31
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-30
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-30
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-30
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-30
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-29
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-29
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-29
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-29
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-29
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-28
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-28
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-28
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-28
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-27
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-27
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-27
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-27
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-27
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-26
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	1e-26
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	1e-23
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	1e-19
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	8e-12
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-26
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	2e-26
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	1e-21
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	2e-17
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	8e-09
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-26
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-26
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	2e-26
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	2e-22
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	1e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-26
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-25
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	1e-25
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	1e-22
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	8e-20
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	2e-19
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	6e-17
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	6e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-25
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-25
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	1e-22
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-19
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-07
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	5e-05
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	2e-25
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	7e-23
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	3e-21
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	8e-15
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	3e-25
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	4e-25
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	1e-23
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	4e-18
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	3e-17
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-25
3v30_A	172	DNA-binding protein rfxank; structural genomics co	5e-25
3v30_A	172	DNA-binding protein rfxank; structural genomics co	9e-25
3v30_A	172	DNA-binding protein rfxank; structural genomics co	3e-23
3v30_A	172	DNA-binding protein rfxank; structural genomics co	9e-15
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	7e-25
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	1e-21
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	2e-21
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	4e-20
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	1e-17
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	2e-07
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-25
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	7e-25
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	4e-15
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	9e-15
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	4e-13
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	3e-09
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	8e-25
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	6e-21
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	2e-20
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	8e-16
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	8e-13
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	6e-11
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-25
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	1e-24
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	8e-23
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	3e-19
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	2e-13
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-24
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-24
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	5e-24
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	2e-23
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	7e-21
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	5e-13
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	5e-12
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	5e-24
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	2e-23
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	4e-15
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-24
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	8e-24
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	7e-19
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	1e-23
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	2e-20
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	5e-19
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	1e-23
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	8e-23
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	4e-18
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-23
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	5e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	8e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	2e-20
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-18
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	5e-17
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	3e-15
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	2e-12
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-23
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	4e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	4e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-21
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-21
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	5e-18
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-14
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	2e-23
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	2e-22
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	2e-21
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	1e-17
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	3e-12
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	2e-23
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	2e-21
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	1e-17
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	3e-11
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-23
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	3e-23
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	5e-22
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	2e-17
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	3e-17
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	1e-14
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	1e-11
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	6e-04
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	4e-23
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	5e-18
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	7e-14
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	7e-08
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	5e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-23
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-23
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-23
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-23
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	8e-23
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	1e-19
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	4e-19
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	2e-12
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	9e-06
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	9e-23
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	1e-22
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	7e-14
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	2e-09
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	9e-23
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	3e-22
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	1e-21
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	6e-20
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	3e-19
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	3e-12
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-22
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	1e-22
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	1e-22
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	2e-09
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-22
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-22
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	3e-21
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-19
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	3e-18
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	3e-13
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	8e-13
3hra_A	201	Ankyrin repeat family protein; structural protein;	1e-22
3hra_A	201	Ankyrin repeat family protein; structural protein;	3e-18
3hra_A	201	Ankyrin repeat family protein; structural protein;	3e-18
3hra_A	201	Ankyrin repeat family protein; structural protein;	5e-16
3hra_A	201	Ankyrin repeat family protein; structural protein;	1e-11
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	1e-22
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	4e-20
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	1e-18
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	1e-14
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	6e-13
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-22
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	2e-22
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	2e-22
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	3e-21
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	6e-16
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	2e-22
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	4e-22
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	2e-21
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	3e-16
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	3e-22
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	3e-22
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	6e-22
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	2e-14
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	7e-22
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-21
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-20
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	2e-20
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	5e-19
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-16
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	2e-16
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	3e-14
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	1e-21
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	2e-21
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	3e-20
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	5e-20
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	4e-19
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	2e-17
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	6e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-21
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	1e-21
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-20
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-20
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	5e-20
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	8e-16
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	6e-12
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-21
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-21
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	4e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	8e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	1e-20
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	1e-18
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	1e-11
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	5e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-21
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-21
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	5e-21
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	5e-21
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	1e-19
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	1e-18
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	1e-18
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	6e-14
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-21
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	6e-21
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	2e-19
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	6e-18
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	8e-18
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	2e-14
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	1e-11
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-20
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	9e-19
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-18
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	9e-17
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	3e-16
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-13
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	2e-13
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-20
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	5e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	3e-19
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	3e-18
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	4e-18
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	1e-17
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-17
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-14
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-20
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-19
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	3e-19
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	1e-18
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	6e-13
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-19
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-19
2rfa_A	232	Transient receptor potential cation channel subfa	1e-18
2rfa_A	232	Transient receptor potential cation channel subfa	3e-16
2rfa_A	232	Transient receptor potential cation channel subfa	3e-16
2rfa_A	232	Transient receptor potential cation channel subfa	1e-15
2rfa_A	232	Transient receptor potential cation channel subfa	7e-13
2rfa_A	232	Transient receptor potential cation channel subfa	3e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-18
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-18
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	9e-18
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	9e-15
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	2e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-17
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-17
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-17
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-17
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-16
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-16
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-16
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-16
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	4e-16
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	4e-13
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	2e-10
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	7e-10
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	9e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	9e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-15
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-15
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-15
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-15
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-15
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	4e-15
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	5e-14
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	3e-07
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	3e-05
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	4e-04
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-15
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-15
2pnn_A	273	Transient receptor potential cation channel subfa	4e-15
2pnn_A	273	Transient receptor potential cation channel subfa	2e-12
2pnn_A	273	Transient receptor potential cation channel subfa	6e-11
2pnn_A	273	Transient receptor potential cation channel subfa	1e-10
2pnn_A	273	Transient receptor potential cation channel subfa	9e-08
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-15
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-14
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-14
2etb_A	256	Transient receptor potential cation channel subfam	2e-14
2etb_A	256	Transient receptor potential cation channel subfam	5e-14
2etb_A	256	Transient receptor potential cation channel subfam	2e-13
2etb_A	256	Transient receptor potential cation channel subfam	3e-11
2etb_A	256	Transient receptor potential cation channel subfam	2e-04
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-14
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-14
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-14
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-14
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-14
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	1e-13
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	7e-09
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	4e-05
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	1e-13
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	1e-08
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	3e-05
3jxi_A	260	Vanilloid receptor-related osmotically activated p	1e-13
3jxi_A	260	Vanilloid receptor-related osmotically activated p	3e-12
3jxi_A	260	Vanilloid receptor-related osmotically activated p	4e-10
3jxi_A	260	Vanilloid receptor-related osmotically activated p	4e-10
3jxi_A	260	Vanilloid receptor-related osmotically activated p	3e-06
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-13
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-13
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	6e-13
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	9e-09
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-12
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-12
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-12
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	9e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-10
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	2e-10
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	3e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-10
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-10
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-10
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-04
3uo9_A	534	Glutaminase kidney isoform, mitochondrial; hydrola	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  171 bits (436), Expect = 4e-51
 Identities = 67/191 (35%), Positives = 103/191 (53%), Gaps = 10/191 (5%)

Query: 162 AKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKIL 218
           +         +      +  + ++   +L +++   I  GS+  V  A+W+G+ V VKIL
Sbjct: 11  SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK--IGAGSFGTVHRAEWHGSDVAVKIL 68

Query: 219 DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
             E     ER+N F  E+ I+++ RHPN+V F+GAVTQ   + IV EY ++G L   L K
Sbjct: 69  -MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK 127

Query: 279 KGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            G    L   + L  A D+A+GMNYLH   P PI+H +LK  N+L+D    +K+  FGL 
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLS 186

Query: 336 RLQYISPEKAK 346
           RL+  +   +K
Sbjct: 187 RLKASTFLSSK 197

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  164 bits (416), Expect = 3e-48
 Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 16/164 (9%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
            + ++  E++V +   + +G++  V  AKW    V +K ++ ES +      AF  EL  
Sbjct: 2   LHMIDYKEIEVEEV--VGRGAFGVVCKAKWRAKDVAIKQIESESERK-----AFIVELRQ 54

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLA 295
           + +  HPN+V+  GA     P+ +V+EY   G L + L         + +  + + L  +
Sbjct: 55  LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-LKISGFGLLRLQ 338
           +G+ YLH  +P  +IH DLKP N+LL  GG  LKI  FG     
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  162 bits (411), Expect = 7e-48
 Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 15/168 (8%)

Query: 184 ELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPER-INAFTHELTIV 239
           E++  EL + +   I  G + +V  A W G +V VK    +  +D  + I     E  + 
Sbjct: 3   EIDFAELTLEEI--IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMN 299
              +HPN++   G   +   + +V+E+   G L   L  K R+ P  ++ +A+ +ARGMN
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQ--------LKISGFGLLRLQY 339
           YLH+    PIIH DLK  NIL+    +        LKI+ FGL R  +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  158 bits (401), Expect = 3e-46
 Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 20/172 (11%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKW--NGTKVWVKIL----DKESHKDPERINAF 232
              L   E++  K   I KG +  V   +   + + V +K L     +   +  E+   F
Sbjct: 13  LPTLADNEIEYEKQ--IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFA 291
             E+ I+    HPN+V+  G +    P  +V+E+   GDL   L  K   +  S  LR  
Sbjct: 71  QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLRLQ 338
           LD+A G+ Y+    P PI+H DL+  NI L +  +      K++ FGL +  
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  155 bits (393), Expect = 3e-45
 Identities = 37/179 (20%), Positives = 73/179 (40%), Gaps = 21/179 (11%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
              ++  +L       + +    ++   +W G  + VK+L K       +   F  E   
Sbjct: 4   HSGIDFKQLNFLTK--LNENHSGELWKGRWQGNDIVVKVL-KVRDWSTRKSRDFNEECPR 60

Query: 239 VEKARHPNVVQFVGAVTQ--NIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDL 294
           +    HPNV+  +GA          ++  +   G L + L +     +  S+ ++FALD+
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------LQYISPE 343
           ARGM +LH  +P  I    L  +++++D     +IS   +              +++PE
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPE 178

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  156 bits (396), Expect = 4e-45
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 12/175 (6%)

Query: 176 NPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAF 232
               + E+++   +L++ +   I KG + QV   +W+G  V ++++      + +++ AF
Sbjct: 21  TSIFLQEWDIPFEQLEIGEL--IGKGRFGQVYHGRWHGE-VAIRLI-DIERDNEDQLKAF 76

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFA 291
             E+    + RH NVV F+GA      + I+        L S ++  K  L  +K  + A
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
            ++ +GM YLH      I+H DLK KN+  DN G++ I+ FGL  +  +     +
Sbjct: 137 QEIVKGMGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRR 187

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  150 bits (382), Expect = 2e-43
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 12/161 (7%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           ++E+   ++ V +   I  GS+  V   KW+G  V VK+L   +   P+++ AF +E+ +
Sbjct: 18  DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGV 73

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARG 297
           + K RH N++ F+G  T    + IV ++     L  +L   + +    K++  A   ARG
Sbjct: 74  LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           M+YLH      IIH DLK  NI L     +KI  FGL   +
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  151 bits (384), Expect = 2e-43
 Identities = 43/163 (26%), Positives = 71/163 (43%), Gaps = 10/163 (6%)

Query: 180 VPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHEL 236
           +P     P +L   +   + KG + Q        T   + +  +    D E    F  E+
Sbjct: 2   MPHRIFRPSDLIHGEV--LGKGCFGQAIKVTHRETGEVMVMK-ELIRFDEETQRTFLKEV 58

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLA 295
            ++    HPNV++F+G + ++  +  + EY   G L   ++        S+ + FA D+A
Sbjct: 59  KVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA 118

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
            GM YLH      IIH DL   N L+     + ++ FGL RL 
Sbjct: 119 SGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLM 158

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  145 bits (367), Expect = 8e-41
 Identities = 48/187 (25%), Positives = 71/187 (37%), Gaps = 27/187 (14%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFT 233
           P  V       +++  +      KG Y +V   KW G KV VK+              + 
Sbjct: 28  PLLVQRTIAKQIQMVKQIG----KGRYGEVWMGKWRGEKVAVKVFFTTEEAS------WF 77

Query: 234 HELTI--VEKARHPNVVQFVGAVTQ----NIPMMIVLEYHAKGDLASYLQKKGRLSPSKV 287
            E  I      RH N++ F+ A  +       + ++ +YH  G L  YL+    L    +
Sbjct: 78  RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSM 136

Query: 288 LRFALDLARGMNYLHE------CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
           L+ A     G+ +LH        KP  I H DLK KNIL+   G   I+  GL       
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195

Query: 342 PEKAKIV 348
             +  I 
Sbjct: 196 TNEVDIP 202

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  140 bits (356), Expect = 2e-39
 Identities = 47/156 (30%), Positives = 65/156 (41%), Gaps = 23/156 (14%)

Query: 198 ITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI--VEKARHPNVVQFVG 252
           + KG Y +V    W G  V VKI      K       +  E  +      RH N++ F+ 
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKS------WFRETELYNTVMLRHENILGFIA 69

Query: 253 AVT----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE----- 303
           +       +  + ++  YH  G L  YLQ    L     LR  L +A G+ +LH      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 304 -CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
             KP  I H DLK KNIL+   GQ  I+  GL  + 
Sbjct: 129 QGKP-AIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  141 bits (356), Expect = 4e-39
 Identities = 50/177 (28%), Positives = 74/177 (41%), Gaps = 27/177 (15%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFT 233
           P  V       + LQ      I KG + +V   KW G +V VKI      +       + 
Sbjct: 33  PLLVQRTIARTIVLQES----IGKGRFGEVWRGKWRGEEVAVKIFSSREERS------WF 82

Query: 234 HELTI--VEKARHPNVVQFVGAVTQN----IPMMIVLEYHAKGDLASYLQKKGRLSPSKV 287
            E  I      RH N++ F+ A  ++      + +V +YH  G L  YL +   ++   +
Sbjct: 83  REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGM 141

Query: 288 LRFALDLARGMNYLHE------CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           ++ AL  A G+ +LH        KP  I H DLK KNIL+   G   I+  GL    
Sbjct: 142 IKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  137 bits (346), Expect = 9e-38
 Identities = 44/176 (25%), Positives = 68/176 (38%), Gaps = 25/176 (14%)

Query: 179 EVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHE 235
              E  L+   L++ +   I +G Y  V     +   V VK+    + ++      F +E
Sbjct: 4   AASEPSLDLDNLKLLEL--IGRGRYGAVYKGSLDERPVAVKVFSFANRQN------FINE 55

Query: 236 LTIVE--KARHPNVVQFVGA-----VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVL 288
             I       H N+ +F+           +  ++V+EY+  G L  YL            
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114

Query: 289 RFALDLARGMNYLHECKPD------PIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           R A  + RG+ YLH   P        I H DL  +N+L+ N G   IS FGL    
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  134 bits (340), Expect = 7e-37
 Identities = 45/173 (26%), Positives = 79/173 (45%), Gaps = 23/173 (13%)

Query: 181 PEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELT 237
                  + LQ+ +     +G +  V  A+     V VKI   +  +  +       E+ 
Sbjct: 17  ENLYFQSMPLQLLEV--KARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY----EVY 70

Query: 238 IVEKARHPNVVQFVGAVTQ----NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALD 293
            +   +H N++QF+GA  +    ++ + ++  +H KG L+ +L+    +S +++   A  
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129

Query: 294 LARGMNYLHE--------CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           +ARG+ YLHE         KP  I H D+K KN+LL N     I+ FGL    
Sbjct: 130 MARGLAYLHEDIPGLKDGHKP-AISHRDIKSKNVLLKNNLTACIADFGLALKF 181

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  135 bits (342), Expect = 4e-36
 Identities = 58/195 (29%), Positives = 90/195 (46%), Gaps = 18/195 (9%)

Query: 163 KVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILD 219
             PK     +   +      + LN  EL++ +  G  KG +  V    + G KV VK + 
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIG--KGEFGDVMLGDYRGNKVAVKCI- 224

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQK 278
           K          AF  E +++ + RH N+VQ +G + +    + IV EY AKG L  YL+ 
Sbjct: 225 KNDATA----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 280

Query: 279 KGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           +GR  L    +L+F+LD+   M YL        +H DL  +N+L+      K+S FGL +
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK 337

Query: 337 LQYISPEKAKIVFPV 351
               + +  K   PV
Sbjct: 338 EASSTQDTGK--LPV 350

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  129 bits (326), Expect = 3e-35
 Identities = 56/177 (31%), Positives = 86/177 (48%), Gaps = 18/177 (10%)

Query: 181 PEYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELT 237
             + LN  EL++ +  G  KG +  V    + G KV VK + K          AF  E +
Sbjct: 14  SGWALNMKELKLLQTIG--KGEFGDVMLGDYRGNKVAVKCI-KNDATA----QAFLAEAS 66

Query: 238 IVEKARHPNVVQFVGAVTQNIP-MMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDL 294
           ++ + RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPV 351
              M YL        +H DL  +N+L+      K+S FGL +    + +  K   PV
Sbjct: 127 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--LPV 178

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  130 bits (328), Expect = 9e-35
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 18/197 (9%)

Query: 165 PKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY---QVAKWNG--TKVWVKILD 219
           P TK++ + +       ++ LN  +L + +  G  +G++      +     T V VK   
Sbjct: 91  PLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIG--RGNFGEVFSGRLRADNTLVAVKSC- 147

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           +E+     +   F  E  I+++  HPN+V+ +G  TQ  P+ IV+E    GD  ++L+ +
Sbjct: 148 RETLPPDLKA-KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE 206

Query: 280 GR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL- 337
           G  L    +L+   D A GM YL        IH DL  +N L+     LKIS FG+ R  
Sbjct: 207 GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263

Query: 338 ---QYISPEKAKIVFPV 351
               Y +    +   PV
Sbjct: 264 ADGVYAASGGLRQ-VPV 279

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  125 bits (317), Expect = 3e-34
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 20/179 (11%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKESHKDPERINAFTHELT 237
           ++ ++P EL   +  G   G +  V    W    KV +K + +E     E    F  E  
Sbjct: 2   KWVIDPSELTFVQEIG--SGQFGLVHLGYWLNKDKVAIKTI-REGAMSEE---DFIEEAE 55

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLAR 296
           ++ K  HP +VQ  G   +  P+ +V E+   G L+ YL+  +G  +   +L   LD+  
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
           GM YL E     +IH DL  +N L+     +K+S FG+ R     QY S    K  FPV
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK--FPV 169

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  129 bits (327), Expect = 6e-34
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 22/206 (10%)

Query: 157 LKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG--T 211
           L          +  P          ++E+   ++ ++   G   G Y +V    W     
Sbjct: 189 LITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLG--GGQYGEVYEGVWKKYSL 246

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
            V VK L KE   + E    F  E  ++++ +HPN+VQ +G  T+  P  I+ E+   G+
Sbjct: 247 TVAVKTL-KEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 302

Query: 272 LASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           L  YL++  R  +S   +L  A  ++  M YL +      IH +L  +N L+     +K+
Sbjct: 303 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKV 359

Query: 330 SGFGLLRL----QYISPEKAKIVFPV 351
           + FGL RL     Y +   AK  FP+
Sbjct: 360 ADFGLSRLMTGDTYTAHAGAK--FPI 383

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  125 bits (316), Expect = 9e-34
 Identities = 53/182 (29%), Positives = 87/182 (47%), Gaps = 22/182 (12%)

Query: 181 PEYELNPLELQVRKADGITKGSY-QV--AKWNG--TKVWVKILDKESHKDPERINAFTHE 235
            ++E+   ++ ++   G   G Y +V    W      V VK L KE   + E    F  E
Sbjct: 6   DKWEMERTDITMKHKLG--GGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVE---EFLKE 59

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALD 293
             ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  +S   +L  A  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVF 349
           ++  M YL +      IH DL  +N L+     +K++ FGL RL     Y +   AK  F
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK--F 174

Query: 350 PV 351
           P+
Sbjct: 175 PI 176

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  125 bits (317), Expect = 1e-33
 Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 23/203 (11%)

Query: 165 PKTKRTPMTVANPREVP---EYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWV 215
           P+    P T   P         E+    + + K  G      +  G  +V       V +
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82

Query: 216 KILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
           K L K  + + +R + F  E +I+ +  HPN+++  G VT+    MIV EY   G L ++
Sbjct: 83  KAL-KAGYTERQRRD-FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140

Query: 276 LQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           L+   G+ +  +++     +  GM YL +      +H DL  +N+L+D+    K+S FGL
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL 197

Query: 335 LRL------QYISPEKAKIVFPV 351
            R+         +    K   P+
Sbjct: 198 SRVLEDDPDAAYTTTGGK--IPI 218

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  123 bits (312), Expect = 2e-33
 Identities = 60/177 (33%), Positives = 87/177 (49%), Gaps = 20/177 (11%)

Query: 184 ELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKESHKDPERINAFTHELTIV 239
           EL   E+ + K  G   G +  V   KW G   V VK++ KE     +    F  E   +
Sbjct: 4   ELKREEITLLKELG--SGQFGVVKLGKWKGQYDVAVKMI-KEGSMSED---EFFQEAQTM 57

Query: 240 EKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGM 298
            K  HP +V+F G  ++  P+ IV EY + G L +YL+  G+ L PS++L    D+  GM
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
            +L   +    IH DL  +N L+D    +K+S FG+ R     QY+S    K  FPV
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK--FPV 169

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  123 bits (312), Expect = 3e-33
 Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 22/194 (11%)

Query: 167 TKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKES 222
           +K  P T         +E++P +L   K  G   G +  V   KW G   V +K++ KE 
Sbjct: 5   SKNAPSTAGLGYG--SWEIDPKDLTFLKELG--TGQFGVVKYGKWRGQYDVAIKMI-KEG 59

Query: 223 HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGR 281
               +    F  E  ++    H  +VQ  G  T+  P+ I+ EY A G L +YL++ + R
Sbjct: 60  SMSED---EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR 116

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---- 337
               ++L    D+   M YL   +    +H DL  +N L+++ G +K+S FGL R     
Sbjct: 117 FQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

Query: 338 QYISPEKAKIVFPV 351
           +Y S   +K  FPV
Sbjct: 174 EYTSSVGSK--FPV 185

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  123 bits (310), Expect = 5e-33
 Identities = 60/185 (32%), Positives = 94/185 (50%), Gaps = 22/185 (11%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKESHKDPERINAF 232
           P    E+E+    L++ +  G   G + +V    +NG TKV VK L K+    P+   AF
Sbjct: 2   PWWEDEWEVPRETLKLVERLG--AGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPD---AF 55

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRF 290
             E  ++++ +H  +V+    VTQ  P+ I+ EY   G L  +L+      L+ +K+L  
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAK 346
           A  +A GM ++ E      IH DL+  NIL+ +    KI+ FGL RL    +Y + E AK
Sbjct: 115 AAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171

Query: 347 IVFPV 351
             FP+
Sbjct: 172 --FPI 174

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  121 bits (306), Expect = 2e-32
 Identities = 45/184 (24%), Positives = 84/184 (45%), Gaps = 19/184 (10%)

Query: 179 EVPEYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAF 232
              +YE+    +++ +  G      + +G Y   +     V +K   K    D  R   F
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVRE-KF 63

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFA 291
             E   + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ  K  L  + ++ +A
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKI 347
             L+  + YL   +    +H D+  +N+L+ +   +K+  FGL R      Y    K K 
Sbjct: 123 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK- 178

Query: 348 VFPV 351
             P+
Sbjct: 179 -LPI 181

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  121 bits (306), Expect = 3e-32
 Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 19/188 (10%)

Query: 177 PREVPEYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERIN 230
           P +     +   +L++ +  G      + +G +         V VK L  +    PE ++
Sbjct: 7   PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66

Query: 231 AFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLR 289
            F  E+  +    H N+++  G V    PM +V E    G L   L+K +G      + R
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR 125

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPE 343
           +A+ +A GM YL   +    IH DL  +N+LL     +KI  FGL+R        Y+  E
Sbjct: 126 YAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

Query: 344 KAKIVFPV 351
             K   P 
Sbjct: 183 HRK--VPF 188

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  121 bits (306), Expect = 5e-32
 Identities = 51/221 (23%), Positives = 96/221 (43%), Gaps = 27/221 (12%)

Query: 151 VEVYNILKARGAKVPKTKRT---PMTVANPREVP---EYELNPLELQVRKADG------I 198
           +  Y+        +P T+         ++P +       E++P  +  +K  G      +
Sbjct: 1   MSYYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEV 60

Query: 199 TKGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
            KG  + +       V +K L K  + + +R++ F  E  I+ +  H N+++  G +++ 
Sbjct: 61  YKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKY 118

Query: 258 IPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
            PMMI+ EY   G L  +L++  G  S  +++     +A GM YL        +H DL  
Sbjct: 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAA 175

Query: 317 KNILLDNGGQLKISGFGLLRLQ------YISPEKAKIVFPV 351
           +NIL+++    K+S FGL R+         +    K   P+
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK--IPI 214

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  119 bits (301), Expect = 1e-31
 Identities = 42/182 (23%), Positives = 81/182 (44%), Gaps = 19/182 (10%)

Query: 181 PEYELNPLELQVRKADG------ITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH 234
           P+Y +   ++ + +  G      + +G Y   K     V VK   K+      +   F  
Sbjct: 5   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKE-KFMS 62

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALD 293
           E  I++   HP++V+ +G + +  P  I++E +  G+L  YL++ K  L    ++ ++L 
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVF 349
           + + M YL        +H D+  +NIL+ +   +K+  FGL R      Y      +   
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR--L 176

Query: 350 PV 351
           P+
Sbjct: 177 PI 178

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  122 bits (308), Expect = 2e-31
 Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 25/199 (12%)

Query: 163 KVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKIL 218
            VP     P     P E   +E+    L++ K  G   G + +V  A +N  TKV VK +
Sbjct: 166 SVPCMSSKPQ---KPWEKDAWEIPRESLKLEKKLG--AGQFGEVWMATYNKHTKVAVKTM 220

Query: 219 DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK 278
            K      E   AF  E  +++  +H  +V+    VT+  P+ I+ E+ AKG L  +L+ 
Sbjct: 221 -KPGSMSVE---AFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKS 275

Query: 279 KGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
                    K++ F+  +A GM ++ +      IH DL+  NIL+      KI+ FGL R
Sbjct: 276 DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 332

Query: 337 L----QYISPEKAKIVFPV 351
           +    +Y + E AK  FP+
Sbjct: 333 VIEDNEYTAREGAK--FPI 349

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  118 bits (298), Expect = 3e-31
 Identities = 41/156 (26%), Positives = 65/156 (41%), Gaps = 17/156 (10%)

Query: 206 AKWNG----TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM 261
             +        V VKIL K    DP   +    E  ++++  +P +V+ +G        M
Sbjct: 36  GYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWM 93

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           +V+E    G L  YLQ+   +    ++     ++ GM YL E      +H DL  +N+LL
Sbjct: 94  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLL 150

Query: 322 DNGGQLKISGFGLLRL------QYISPEKAKIVFPV 351
                 KIS FGL +        Y +    K  +PV
Sbjct: 151 VTQHYAKISDFGLSKALRADENYYKAQTHGK--WPV 184

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  118 bits (298), Expect = 1e-30
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 17/195 (8%)

Query: 163 KVPKTKR--TPMTVANPREVP---EYELNPLELQVRKADG------ITKGSYQVAKWNGT 211
           K+P  +    P T  +P +       EL+   + + K  G      +  G  ++      
Sbjct: 15  KLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEI 74

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
            V +K L K  + + +R + F  E +I+ +  HPN+++  G VT++ P+MIV EY   G 
Sbjct: 75  SVAIKTL-KVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGS 132

Query: 272 LASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           L S+L+K   + +  +++     +A GM YL +      +H DL  +NIL+++    K+S
Sbjct: 133 LDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVS 189

Query: 331 GFGLLRLQYISPEKA 345
            FGL R+    PE A
Sbjct: 190 DFGLGRVLEDDPEAA 204

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  119 bits (300), Expect = 2e-30
 Identities = 56/180 (31%), Positives = 90/180 (50%), Gaps = 22/180 (12%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILDKESHKDPERINAFTHELT 237
            +E+    L++    G  +G + +V    WNG T+V +K L K     PE   AF  E  
Sbjct: 178 AWEIPRESLRLEVKLG--QGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPE---AFLQEAQ 231

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLA 295
           +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ +    L   +++  A  +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
            GM Y+        +H DL+  NIL+      K++ FGL RL    +Y + + AK  FP+
Sbjct: 291 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK--FPI 345

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  116 bits (292), Expect = 6e-30
 Identities = 35/159 (22%), Positives = 71/159 (44%), Gaps = 15/159 (9%)

Query: 200 KGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
           KG +          V +K L +E+            E  ++    +P+V + +G    + 
Sbjct: 33  KGLWIPEGEKVKIPVAIKEL-REATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTS- 89

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            + ++ +    G L  Y+++ K  +    +L + + +A+GMNYL + +   ++H DL  +
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146

Query: 318 NILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPV 351
           N+L+     +KI+ FGL +L     +    E  K   P+
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--VPI 183

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  119 bits (299), Expect = 6e-30
 Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 26/198 (13%)

Query: 164 VPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-TKVWVKILD 219
            P +K     +A       +E+    L++    G  +G + +V    WNG T+V +K L 
Sbjct: 247 CPTSKPQTQGLAKD----AWEIPRESLRLEVKLG--QGCFGEVWMGTWNGTTRVAIKTL- 299

Query: 220 KESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK 279
           K     PE   AF  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ +
Sbjct: 300 KPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGE 355

Query: 280 GR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
               L   +++  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412

Query: 338 ----QYISPEKAKIVFPV 351
               +Y + + AK  FP+
Sbjct: 413 IEDNEYTARQGAK--FPI 428

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  115 bits (290), Expect = 8e-30
 Identities = 35/159 (22%), Positives = 77/159 (48%), Gaps = 15/159 (9%)

Query: 200 KGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
           KG +     +    V +K++ ++         A T  +  +    H ++V+ +G    + 
Sbjct: 31  KGVWIPEGESIKIPVCIKVI-EDKSGRQSF-QAVTDHMLAIGSLDHAHIVRLLGLCPGS- 87

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            + +V +Y   G L  ++++ +G L P  +L + + +A+GM YL E     ++H +L  +
Sbjct: 88  SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAAR 144

Query: 318 NILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPV 351
           N+LL +  Q++++ FG+  L     + +   +AK   P+
Sbjct: 145 NVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK--TPI 181

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  115 bits (290), Expect = 9e-30
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 18/162 (11%)

Query: 200 KGSYQ-VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
              Y  +    G  V VK L + S   P++   F  E+ I++      +V++ G      
Sbjct: 41  LCRYDPLGDNTGALVAVKQL-QHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97

Query: 259 --PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
              + +V+EY   G L  +LQ+ + RL  S++L ++  + +GM YL   +    +H DL 
Sbjct: 98  RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLA 154

Query: 316 PKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPV 351
            +NIL+++   +KI+ FGL +L       Y+  E  +   P+
Sbjct: 155 ARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ--SPI 194

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  114 bits (287), Expect = 2e-29
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 30/202 (14%)

Query: 167 TKRTPMTVANPREVPEYELNPLEL-------QVRKADGITKGSYQVAKWN-GTKVWVKIL 218
           +++ P T  +P    +  L  +         +V          Y     N G +V VK L
Sbjct: 5   SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVEL------CRYDPEGDNTGEQVAVKSL 58

Query: 219 DKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMIVLEYHAKGDLASYL 276
            K              E+ I+    H N+V++ G  T++    + +++E+   G L  YL
Sbjct: 59  -KPESGGNHI-ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL 116

Query: 277 QK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL 335
            K K +++  + L++A+ + +GM+YL   +    +H DL  +N+L+++  Q+KI  FGL 
Sbjct: 117 PKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173

Query: 336 RL------QYISPEKAKIVFPV 351
           +        Y   +      PV
Sbjct: 174 KAIETDKEYYTVKDDRD--SPV 193

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  118 bits (297), Expect = 2e-29
 Identities = 42/157 (26%), Positives = 75/157 (47%), Gaps = 13/157 (8%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G Y   +     V +K   K    D  R   F  E   + +  HP++V+ +G +T+N P
Sbjct: 408 QGIYMSPENPAMAVAIKTC-KNCTSDSVREK-FLQEALTMRQFDHPHIVKLIGVITEN-P 464

Query: 260 MMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           + I++E    G+L S+LQ  K  L  + ++ +A  L+  + YL   +    +H D+  +N
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARN 521

Query: 319 ILLDNGGQLKISGFGLLRL----QYISPEKAKIVFPV 351
           +L+ +   +K+  FGL R      Y    K K+  P+
Sbjct: 522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PI 556

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  114 bits (288), Expect = 2e-29
 Identities = 53/223 (23%), Positives = 97/223 (43%), Gaps = 33/223 (14%)

Query: 147 YYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV 205
           ++ +   Y+I             +     +P +  E  L       +    + KG++  V
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHL-------KFLQQLGKGNFGSV 57

Query: 206 --AKWNG------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN 257
              +++         V VK L + S ++  R   F  E+ I++  +H N+V++ G     
Sbjct: 58  EMCRYDPLQDNTGEVVAVKKL-QHSTEEHLR--DFEREIEILKSLQHDNIVKYKGVCYSA 114

Query: 258 I--PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
               + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH DL
Sbjct: 115 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDL 171

Query: 315 KPKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPV 351
             +NIL++N  ++KI  FGL ++       Y   E  +   P+
Sbjct: 172 ATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE--SPI 212

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  113 bits (284), Expect = 4e-29
 Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 18/162 (11%)

Query: 200 KGSYQVAKWN-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
              Y   + N G  V VK L + S ++  R   F  E+ I++  +H N+V++ G      
Sbjct: 28  MCRYDPLQDNTGEVVAVKKL-QHSTEEHLR--DFEREIEILKSLQHDNIVKYKGVCYSAG 84

Query: 259 --PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
              + +++EY   G L  YLQK K R+   K+L++   + +GM YL   +    IH DL 
Sbjct: 85  RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLA 141

Query: 316 PKNILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPV 351
            +NIL++N  ++KI  FGL ++       +   E  +   P+
Sbjct: 142 TRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE--SPI 181

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  113 bits (284), Expect = 5e-29
 Identities = 61/213 (28%), Positives = 90/213 (42%), Gaps = 46/213 (21%)

Query: 176 NPREVP---EYELNPLELQVRKADGITKGSY-QV--AKWNG-------TKVWVKILDKES 222
           +P ++P   ++E     L   K  G   G++ +V  A   G         V VK+L K S
Sbjct: 8   DPTQLPYDHKWEFPRNRLSFGKTLG--AGAFGKVVEATAYGLIKSDAAMTVAVKML-KPS 64

Query: 223 HKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-- 279
               ER  A   EL ++     H N+V  +GA T   P +++ EY   GDL ++L++K  
Sbjct: 65  AHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 280 ----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
                             L    +L F+  +A+GM +L        IH DL  +NILL +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTH 180

Query: 324 GGQLKISGFGLLRL-----QYISPEKAKIVFPV 351
           G   KI  FGL R       Y+    A+   PV
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNAR--LPV 211

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  113 bits (284), Expect = 6e-29
 Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 35/196 (17%)

Query: 172 MTVANPR--------EVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-------TKV 213
           M   NP            E+E+   ++ + +  G  +GS+  V      G       T+V
Sbjct: 1   MASVNPEYFSAADVYVPDEWEVAREKITMSRELG--QGSFGMVYEGVAKGVVKDEPETRV 58

Query: 214 WVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
            +K +  E+    ERI  F +E +++++    +VV+ +G V+Q  P ++++E   +GDL 
Sbjct: 59  AIKTV-NEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLK 116

Query: 274 SYLQKK----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           SYL+               S SK+++ A ++A GM YL+  K    +H DL  +N ++  
Sbjct: 117 SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173

Query: 324 GGQLKISGFGLLRLQY 339
              +KI  FG+ R  Y
Sbjct: 174 DFTVKIGDFGMTRDIY 189

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  113 bits (285), Expect = 6e-29
 Identities = 53/170 (31%), Positives = 80/170 (47%), Gaps = 28/170 (16%)

Query: 203 YQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPM 260
           + + K +   KV VK+L K +    E+  A   EL I+    +H N+V  +GA T   P+
Sbjct: 68  FGLGKEDAVLKVAVKML-KSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPV 125

Query: 261 MIVLEYHAKGDLASYLQKKGR--------------LSPSKVLRFALDLARGMNYLHECKP 306
           +++ EY   GDL ++L++K R               S   +L F+  +A+GM +L     
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN- 184

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPV 351
              IH D+  +N+LL NG   KI  FGL R       YI    A+   PV
Sbjct: 185 --CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR--LPV 230

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  111 bits (280), Expect = 1e-28
 Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 7/142 (4%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-I 258
            G+            VK L        E    F  E  I++   HPNV+  +G   ++  
Sbjct: 43  HGTLLDNDGKKIHCAVKSL-NRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEG 100

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             ++VL Y   GDL ++++      +   ++ F L +A+GM YL   K    +H DL  +
Sbjct: 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAAR 157

Query: 318 NILLDNGGQLKISGFGLLRLQY 339
           N +LD    +K++ FGL R  Y
Sbjct: 158 NCMLDEKFTVKVADFGLARDMY 179

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  112 bits (282), Expect = 1e-28
 Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 35/214 (16%)

Query: 164 VPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG----TKVWVK 216
           + K         NP       L+  +++ +   G  +G++ QV  A+           +K
Sbjct: 1   MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIG--EGNFGQVLKARIKKDGLRMDAAIK 58

Query: 217 ILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY 275
            + KE     +    F  EL ++ K   HPN++  +GA      + + +EY   G+L  +
Sbjct: 59  RM-KEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 116

Query: 276 LQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           L+K                   LS  ++L FA D+ARGM+YL + +    IH DL  +NI
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI 173

Query: 320 LLDNGGQLKISGFGLLRLQ--YISPEKAKIVFPV 351
           L+      KI+ FGL R Q  Y+     ++  PV
Sbjct: 174 LVGENYVAKIADFGLSRGQEVYVKKTMGRL--PV 205

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  111 bits (279), Expect = 2e-28
 Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 15/152 (9%)

Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           G+ +      + + T+V +K+L  ++H++     +F    +++ K  H ++V   G    
Sbjct: 27  GVRREVGDYGQLHETEVLLKVL-DKAHRNYSE--SFFEAASMMSKLSHKHLVLNYGVCVC 83

Query: 257 NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
               ++V E+   G L +YL+K K  ++    L  A  LA  M++L E     +IH ++ 
Sbjct: 84  GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVC 140

Query: 316 PKNILLDNGGQL--------KISGFGLLRLQY 339
            KNILL              K+S  G+     
Sbjct: 141 AKNILLIREEDRKTGNPPFIKLSDPGISITVL 172

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  110 bits (278), Expect = 2e-28
 Identities = 41/185 (22%), Positives = 75/185 (40%), Gaps = 23/185 (12%)

Query: 181 PEYELNPLELQVRKADGITKGSY---QVAKWNG----TKVWVKILDKESHKDPERINAFT 233
            +  L    L +   + +  G++   +   +        V +K+L K+  +  +      
Sbjct: 2   KKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADT-EEMM 58

Query: 234 HELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFAL 292
            E  I+ +  +P +V+ +G       +M+V+E    G L  +L   +  +  S V     
Sbjct: 59  REAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------QYISPEKAK 346
            ++ GM YL E      +H DL  +N+LL N    KIS FGL +        Y +    K
Sbjct: 118 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174

Query: 347 IVFPV 351
             +P+
Sbjct: 175 --WPL 177

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  110 bits (278), Expect = 4e-28
 Identities = 40/152 (26%), Positives = 65/152 (42%), Gaps = 16/152 (10%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +   +    +  KV VK+L K        I  F  E   +++  HP+V + VG   ++  
Sbjct: 41  EAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99

Query: 260 ------MMIVLEYHAKGDLASYLQK------KGRLSPSKVLRFALDLARGMNYLHECKPD 307
                  M++L +   GDL ++L           L    ++RF +D+A GM YL      
Sbjct: 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN-- 157

Query: 308 PIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
             IH DL  +N +L     + ++ FGL R  Y
Sbjct: 158 -FIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  110 bits (278), Expect = 5e-28
 Identities = 35/159 (22%), Positives = 71/159 (44%), Gaps = 15/159 (9%)

Query: 200 KGSYQVAKWNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
           KG +          V +K L +E+            E  ++    +P+V + +G    + 
Sbjct: 33  KGLWIPEGEKVKIPVAIKEL-REATSPKAN-KEILDEAYVMASVDNPHVCRLLGICLTS- 89

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
            + ++ +    G L  Y+++ K  +    +L + + +A+GMNYL + +   ++H DL  +
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146

Query: 318 NILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPV 351
           N+L+     +KI+ FGL +L     +    E  K   P+
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--VPI 183

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  110 bits (278), Expect = 6e-28
 Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 51/236 (21%)

Query: 158 KARGAKVPKTKRTPMTVANPREVP---EYELNPLELQVRKADGITKGSY-QV--AKWNG- 210
           + +  +V  +        + RE     ++E     L+  K  G   G++ +V  A   G 
Sbjct: 12  QLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLG--SGAFGKVMNATAYGI 69

Query: 211 ------TKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIV 263
                  +V VK+L KE     ER  A   EL ++ +   H N+V  +GA T + P+ ++
Sbjct: 70  SKTGVSIQVAVKML-KEKADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 127

Query: 264 LEYHAKGDLASYLQKK-----------------------GRLSPSKVLRFALDLARGMNY 300
            EY   GDL +YL+ K                         L+   +L FA  +A+GM +
Sbjct: 128 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 187

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPV 351
           L        +H DL  +N+L+ +G  +KI  FGL R       Y+    A+   PV
Sbjct: 188 LEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNAR--LPV 238

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  111 bits (279), Expect = 8e-28
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 43/221 (19%)

Query: 165 PKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG---------TK 212
            +     ++     E P +EL    L + K  G  +G++ QV  A+  G         TK
Sbjct: 46  FQGMLAGVSEYELPEDPRWELPRDRLVLGKPLG--EGAFGQVVLAEAIGLDKDKPNRVTK 103

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           V VK+L K    + +  +    E+ +++   +H N++  +GA TQ+ P+ +++EY +KG+
Sbjct: 104 VAVKML-KSDATEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161

Query: 272 LASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK 315
           L  YLQ +                 +LS   ++  A  +ARGM YL   K    IH DL 
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA 218

Query: 316 PKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPV 351
            +N+L+     +KI+ FGL R       Y      +   PV
Sbjct: 219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR--LPV 257

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  109 bits (274), Expect = 8e-28
 Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 28/157 (17%)

Query: 206 AKWNG-------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
               G         V +K L K+  + P R   F HE  +  + +HPNVV  +G VT++ 
Sbjct: 28  GHLFGPAPGEQTQAVAIKTL-KDKAEGPLR-EEFRHEAMLRARLQHPNVVCLLGVVTKDQ 85

Query: 259 PMMIVLEYHAKGDLASYLQK----------------KGRLSPSKVLRFALDLARGMNYLH 302
           P+ ++  Y + GDL  +L                  K  L P   +     +A GM YL 
Sbjct: 86  PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 145

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
                 ++H DL  +N+L+ +   +KIS  GL R  Y
Sbjct: 146 SHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  110 bits (276), Expect = 1e-27
 Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 29/177 (16%)

Query: 197 GITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVT 255
               G  +        V VK+L K+   + +  +    E+ +++   +H N++  +GA T
Sbjct: 54  AEAVGIDKDKPKEAVTVAVKML-KDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLGACT 111

Query: 256 QNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMN 299
           Q+ P+ +++EY +KG+L  YL+ +                 +++   ++     LARGM 
Sbjct: 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGME 171

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPV 351
           YL   K    IH DL  +N+L+     +KI+ FGL R       Y      +   PV
Sbjct: 172 YLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR--LPV 223

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  109 bits (275), Expect = 1e-27
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 30/198 (15%)

Query: 165 PKTKRTPMTVANPREVP---EYELNPLELQVRKADGITKGSY-QV--AKWNG-------T 211
                 P      +        E+    + + +  G   G++ +V   + +G        
Sbjct: 4   HHHHHNPNYCFAGKTSSISDLKEVPRKNITLIRGLG--HGAFGEVYEGQVSGMPNDPSPL 61

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD 271
           +V VK L  E   + + ++ F  E  I+ K  H N+V+ +G   Q++P  I++E  A GD
Sbjct: 62  QVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 119

Query: 272 LASYLQK-------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           L S+L++          L+   +L  A D+A G  YL E      IH D+  +N LL   
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 176

Query: 325 GQ---LKISGFGLLRLQY 339
           G     KI  FG+ R  Y
Sbjct: 177 GPGRVAKIGDFGMARDIY 194

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  110 bits (277), Expect = 1e-27
 Identities = 38/142 (26%), Positives = 63/142 (44%), Gaps = 7/142 (4%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-I 258
            G+            VK L        E    F  E  I++   HPNV+  +G   ++  
Sbjct: 107 HGTLLDNDGKKIHCAVKSL-NRITDIGEVSQ-FLTEGIIMKDFSHPNVLSLLGICLRSEG 164

Query: 259 PMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             ++VL Y   GDL ++++      +   ++ F L +A+GM +L   K    +H DL  +
Sbjct: 165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAAR 221

Query: 318 NILLDNGGQLKISGFGLLRLQY 339
           N +LD    +K++ FGL R  Y
Sbjct: 222 NCMLDEKFTVKVADFGLARDMY 243

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  108 bits (273), Expect = 2e-27
 Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 7/142 (4%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
            G Y     N  +  +K L     +  +   AF  E  ++    HPNV+  +G +     
Sbjct: 39  HGEYIDQAQNRIQCAIKSL-SRITEMQQV-EAFLREGLLMRGLNHPNVLALIGIMLPPEG 96

Query: 260 M-MIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           +  ++L Y   GDL  +++   R  +   ++ F L +ARGM YL E K    +H DL  +
Sbjct: 97  LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAAR 153

Query: 318 NILLDNGGQLKISGFGLLRLQY 339
           N +LD    +K++ FGL R   
Sbjct: 154 NCMLDESFTVKVADFGLARDIL 175

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  108 bits (273), Expect = 2e-27
 Identities = 31/141 (21%), Positives = 68/141 (48%), Gaps = 12/141 (8%)

Query: 200 KGS----YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN--VVQFVGA 253
            G     +QV         +K ++ E   D + ++++ +E+  + K +  +  +++    
Sbjct: 38  SGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
              +  + +V+E     DL S+L+KK  + P +   +  ++   ++ +H+     I+H D
Sbjct: 97  EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSD 152

Query: 314 LKPKNILLDNGGQLKISGFGL 334
           LKP N L+ + G LK+  FG+
Sbjct: 153 LKPANFLIVD-GMLKLIDFGI 172

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  109 bits (275), Expect = 2e-27
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 31/210 (14%)

Query: 153 VYNILKARGAKVPKTKRTPMTVANPREVP---EYELNPLELQVRKADGITKGSY-QV--A 206
            Y + K R      T   P      +        E+    + + +  G   G++ +V   
Sbjct: 34  EYKLSKLR-TSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLG--HGAFGEVYEG 90

Query: 207 KWNG-------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           + +G        +V VK L  E   + + ++ F  E  I+ K  H N+V+ +G   Q++P
Sbjct: 91  QVSGMPNDPSPLQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLP 148

Query: 260 MMIVLEYHAKGDLASYLQK-------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
             I+LE  A GDL S+L++          L+   +L  A D+A G  YL E      IH 
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHR 205

Query: 313 DLKPKNILLDNGGQ---LKISGFGLLRLQY 339
           D+  +N LL   G     KI  FG+ R  Y
Sbjct: 206 DIAARNCLLTCPGPGRVAKIGDFGMARDIY 235

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  107 bits (270), Expect = 6e-27
 Identities = 44/150 (29%), Positives = 67/150 (44%), Gaps = 16/150 (10%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMMIVLEYH 267
           G  V VK L K     P+  + +  E+ I+    H +++++ G         + +V+EY 
Sbjct: 60  GEMVAVKAL-KADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117

Query: 268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
             G L  YL +   +  +++L FA  +  GM YLH       IH DL  +N+LLDN   +
Sbjct: 118 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLV 173

Query: 328 KISGFGLLRL------QYISPEKAKIVFPV 351
           KI  FGL +        Y   E      PV
Sbjct: 174 KIGDFGLAKAVPEGHEYYRVREDGD--SPV 201

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  107 bits (270), Expect = 7e-27
 Identities = 57/221 (25%), Positives = 86/221 (38%), Gaps = 47/221 (21%)

Query: 155 NILKARGAKVPKTKRTPMTVANPREVPEYELNPLEL----------QVRK--ADGITKGS 202
            +L  R    P  +R P+ +       EY  N +E           +V +  A G+    
Sbjct: 16  ELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYE 75

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI 262
                   T V VK+L KE      +   F  E  ++ +  +PN+V+ +G      PM +
Sbjct: 76  PF------TMVAVKML-KEEASADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127

Query: 263 VLEYHAKGDLASYLQKK------------------------GRLSPSKVLRFALDLARGM 298
           + EY A GDL  +L+                            LS ++ L  A  +A GM
Sbjct: 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
            YL E K    +H DL  +N L+     +KI+ FGL R  Y
Sbjct: 188 AYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  107 bits (269), Expect = 8e-27
 Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 36/202 (17%)

Query: 166 KTKRTPMTVANPREVP---EYELNPLELQVRKADGITKGSY-QV--AKWNG-------TK 212
            +      + NP+       + +   ++ ++   G  +G++ +V  A+ +          
Sbjct: 16  GSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELG--EGAFGKVFLAECHNLLPEQDKML 73

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V VK L KE+ +       F  E  ++   +H ++V+F G  T+  P+++V EY   GDL
Sbjct: 74  VAVKAL-KEASESAR--QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130

Query: 273 ASYLQK---------------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             +L+                 G L   ++L  A  +A GM YL        +H DL  +
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATR 187

Query: 318 NILLDNGGQLKISGFGLLRLQY 339
           N L+  G  +KI  FG+ R  Y
Sbjct: 188 NCLVGQGLVVKIGDFGMSRDIY 209

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  107 bits (270), Expect = 9e-27
 Identities = 31/141 (21%), Positives = 68/141 (48%), Gaps = 12/141 (8%)

Query: 200 KGS----YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN--VVQFVGA 253
            G     +QV         +K ++ E   D + ++++ +E+  + K +  +  +++    
Sbjct: 19  SGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
              +  + +V+E     DL S+L+KK  + P +   +  ++   ++ +H+     I+H D
Sbjct: 78  EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSD 133

Query: 314 LKPKNILLDNGGQLKISGFGL 334
           LKP N L+ + G LK+  FG+
Sbjct: 134 LKPANFLIVD-GMLKLIDFGI 153

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  106 bits (268), Expect = 9e-27
 Identities = 37/151 (24%), Positives = 66/151 (43%), Gaps = 15/151 (9%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G+ +       KV VK +  ++    E    F  E   ++   HPNV++ +G   +   
Sbjct: 52  EGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDFSHPNVIRLLGVCIEMSS 110

Query: 260 M-----MIVLEYHAKGDLASYLQK------KGRLSPSKVLRFALDLARGMNYLHECKPDP 308
                 M++L +   GDL +YL           +    +L+F +D+A GM YL       
Sbjct: 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--- 167

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
            +H DL  +N +L +   + ++ FGL +  Y
Sbjct: 168 FLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  106 bits (268), Expect = 9e-27
 Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 42/187 (22%)

Query: 194 KADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA 253
            A  +   +        T V VK+L KE+    E       E  ++++  HP+V++  GA
Sbjct: 43  TAFHLKGRA------GYTTVAVKML-KENASPSEL-RDLLSEFNVLKQVNHPHVIKLYGA 94

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKK------------------------GRLSPSKVLR 289
            +Q+ P+++++EY   G L  +L++                           L+   ++ 
Sbjct: 95  CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEK 344
           FA  +++GM YL E K   ++H DL  +NIL+  G ++KIS FGL R       Y+   +
Sbjct: 155 FAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQ 211

Query: 345 AKIVFPV 351
            +   PV
Sbjct: 212 GR--IPV 216

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  107 bits (270), Expect = 1e-26
 Identities = 47/180 (26%), Positives = 82/180 (45%), Gaps = 33/180 (18%)

Query: 194 KADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVG 252
           +A GI K   +        V VK+L K+   + +  +    E+ +++   +H N++  +G
Sbjct: 101 EAVGIDKDKPK----EAVTVAVKML-KDDATEKDL-SDLVSEMEMMKMIGKHKNIINLLG 154

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLAR 296
           A TQ+ P+ +++EY +KG+L  YL+ +                 +++   ++     LAR
Sbjct: 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLAR 214

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----QYISPEKAKIVFPV 351
           GM YL   K    IH DL  +N+L+     +KI+ FGL R       Y      +   PV
Sbjct: 215 GMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR--LPV 269

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score =  102 bits (256), Expect = 1e-26
 Identities = 35/103 (33%), Positives = 49/103 (47%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A   GD+  VE LL  GSD N  D  G T LH A   GH++VV+LLL  KA ++   
Sbjct: 14  LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               +   DA   G+V++  +L + GA           P+   
Sbjct: 74  YQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYT 116

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 93.6 bits (234), Expect = 1e-23
 Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 1/87 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  AC  G +K VE LL   + VN+      + LH AA  GHV++VKLLLS  A+ +A +
Sbjct: 47  LHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVN 106

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
            +G              +  + +   +
Sbjct: 107 IFGLRPVDYTDDESMKSLLLLPEKNES 133

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 82.9 bits (206), Expect = 1e-19
 Identities = 21/70 (30%), Positives = 37/70 (52%), Gaps = 1/70 (1%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           G D  + +  G T LHIA+ +G +  V+ LL   ++ + +D  G T   +A  +G+++V 
Sbjct: 1   GIDPFT-NHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59

Query: 155 NILKARGAKV 164
            +L    A V
Sbjct: 60  ELLLQHKALV 69

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 61.3 bits (150), Expect = 8e-12
 Identities = 12/55 (21%), Positives = 26/55 (47%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L  A + G V  V+ LL+ G+  N++++ G   +     E    ++ L    +++
Sbjct: 80  LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNESS 134

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  110 bits (275), Expect = 1e-26
 Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 16/159 (10%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G Y++ K     V +K+L + +  +         E  I+ +  +P +V+ +G       
Sbjct: 354 QGVYRMRKKQ-IDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A 409

Query: 260 MMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +M+V+E    G L  +L   +  +  S V      ++ GM YL E      +H +L  +N
Sbjct: 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARN 466

Query: 319 ILLDNGGQLKISGFGLLRL------QYISPEKAKIVFPV 351
           +LL N    KIS FGL +        Y +    K  +P+
Sbjct: 467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGK--WPL 503

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score =  100 bits (253), Expect = 2e-26
 Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 4/110 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
              A + GD+  V+D + +G DVN     GR  LH AA  G +E+++ LL K A+I+A D
Sbjct: 11  FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVANPREVPE 182
           +   T    A Y G+V    +L ++GA    K     T     + + +  
Sbjct: 71  KHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKA 120

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 87.8 bits (219), Expect = 1e-21
 Identities = 25/66 (37%), Positives = 33/66 (50%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           +E LL +G+D+N+ D    T L  A  EGHV  VKLLLSK A+   +   G TA      
Sbjct: 56  LEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATDN 115

Query: 148 YGNVEV 153
                +
Sbjct: 116 QAIKAL 121

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 76.3 bits (189), Expect = 2e-17
 Identities = 12/61 (19%), Positives = 23/61 (37%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
                   A   G ++ VK  ++K  +++     G      A   G +E+   L  +GA 
Sbjct: 6   MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGAD 65

Query: 164 V 164
           +
Sbjct: 66  I 66

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 52.4 bits (127), Expect = 8e-09
 Identities = 13/47 (27%), Positives = 21/47 (44%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK 122
           LL     G V  V+ LL++G+D      DG TA      +    +++
Sbjct: 77  LLSAVYEGHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ 123

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  105 bits (265), Expect = 2e-26
 Identities = 34/164 (20%), Positives = 62/164 (37%), Gaps = 24/164 (14%)

Query: 200 KGS----YQVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
            GS    ++V      +++ VK          +R        +  +  +HP  V+   A 
Sbjct: 67  HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
            +   + +  E      L  + +  G  L  ++V  +  D    + +LH      ++H D
Sbjct: 127 EEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLD 182

Query: 314 LKPKNILLDNGGQLKISGFGLLRL--------------QYISPE 343
           +KP NI L   G+ K+  FGLL                +Y++PE
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  107 bits (269), Expect = 2e-26
 Identities = 32/143 (22%), Positives = 69/143 (48%), Gaps = 12/143 (8%)

Query: 198 ITKGS----YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN--VVQFV 251
           I  G     +QV         +K ++ E   D + ++++ +E+  + K +  +  +++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
                +  + +V+E     DL S+L+KK  + P +   +  ++   ++ +H+     I+H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVH 178

Query: 312 CDLKPKNILLDNGGQLKISGFGL 334
            DLKP N L+ + G LK+  FG+
Sbjct: 179 SDLKPANFLIVD-GMLKLIDFGI 200

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score =  101 bits (255), Expect = 2e-26
 Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 6/110 (5%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRT-ALHIAACEGHVEVVKLLLSKKANIDARD 135
           + +   G  +  E LL  G++ N  D    T  +H AA EG ++ + +L    A +D RD
Sbjct: 49  IQVMMMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRD 108

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVA---NPREVPE 182
            WG      A+  G+ +V   L+A              +     P ++P+
Sbjct: 109 AWGRLPVDLAEELGHRDVARYLRAAAGGT--RGSNHARIDAAEGPSDIPD 156

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 91.4 bits (228), Expect = 2e-22
 Identities = 28/104 (26%), Positives = 45/104 (43%), Gaps = 6/104 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G V+ V  LL  G++ N+ +  GR  + +    G   V +LLL   A  +  D
Sbjct: 16  LATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCAD 74

Query: 136 RWGSTAAA-DAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               T    DA   G ++   +L   GA++  +    R P+ +A
Sbjct: 75  PATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLA 118

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 78.3 bits (194), Expect = 1e-17
 Identities = 18/76 (23%), Positives = 28/76 (36%), Gaps = 9/76 (11%)

Query: 92  LNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYY 148
           +   +  +         L  AA  G VE V+ LL   AN +A + +G             
Sbjct: 1   MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM----M 54

Query: 149 GNVEVYNILKARGAKV 164
           G+  V  +L   GA+ 
Sbjct: 55  GSARVAELLLLHGAEP 70

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  105 bits (264), Expect = 4e-26
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 42/208 (20%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-------TKVWVKILDKESHKDP 226
           P +  ++E     L++ K  G  +G++ QV  A   G         V VK+L KE     
Sbjct: 16  PYDASKWEFPRDRLKLGKPLG--RGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHS 72

Query: 227 ERINAFTHELTIVEK-ARHPNVVQFVGAVTQ-NIPMMIVLEYHAKGDLASYLQK------ 278
           E   A   EL I+     H NVV  +GA T+   P+M+++E+   G+L++YL+       
Sbjct: 73  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131

Query: 279 ----------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
                     K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +K
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK 188

Query: 329 ISGFGLLRL-----QYISPEKAKIVFPV 351
           I  FGL R       Y+    A+   P+
Sbjct: 189 ICDFGLARDIYKDPDYVRKGDAR--LPL 214

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  104 bits (261), Expect = 7e-26
 Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 32/172 (18%)

Query: 206 AKWNG-------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI 258
           A+            V VK L K+          F  E  ++   +H ++V+F G      
Sbjct: 34  AECYNLSPTKDKMLVAVKAL-KDPTLAAR--KDFQREAELLTNLQHEHIVKFYGVCGDGD 90

Query: 259 PMMIVLEYHAKGDLASYLQK----------------KGRLSPSKVLRFALDLARGMNYLH 302
           P+++V EY   GDL  +L+                 KG L  S++L  A  +A GM YL 
Sbjct: 91  PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 150

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE---KAKIVFPV 351
                  +H DL  +N L+     +KI  FG+ R  Y +         + P+
Sbjct: 151 SQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  104 bits (262), Expect = 1e-25
 Identities = 40/166 (24%), Positives = 78/166 (46%), Gaps = 26/166 (15%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           +GS+  A       +G +  +K ++       ER  +   E+ ++   +HPN+VQ+  + 
Sbjct: 34  EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-REVAVLANMKHPNIVQYRESF 92

Query: 255 TQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHC 312
            +N  + IV++Y   GDL   +  QK       ++L + + +   + ++H+ K   I+H 
Sbjct: 93  EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHR 149

Query: 313 DLKPKNILLDNGGQLKISGFGLLRL---------------QYISPE 343
           D+K +NI L   G +++  FG+ R+                Y+SPE
Sbjct: 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  104 bits (261), Expect = 1e-25
 Identities = 49/208 (23%), Positives = 77/208 (37%), Gaps = 36/208 (17%)

Query: 158 KARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAK-------WNG 210
               A  P  K  P  + +PR    Y              + KG +  AK          
Sbjct: 18  PGAPAAAPPAKEIPEVLVDPRSRRRYVRGRF---------LGKGGF--AKCFEISDADTK 66

Query: 211 TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKG 270
                KI+ K     P +    + E++I     H +VV F G    N  + +VLE   + 
Sbjct: 67  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
            L    +++  L+  +   +   +  G  YLH  +   +IH DLK  N+ L+   ++KI 
Sbjct: 127 SLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIG 183

Query: 331 GFGL--------LRLQ-------YISPE 343
            FGL         R +       YI+PE
Sbjct: 184 DFGLATKVEYDGERKKVLCGTPNYIAPE 211

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score =  101 bits (255), Expect = 2e-25
 Identities = 39/146 (26%), Positives = 58/146 (39%), Gaps = 9/146 (6%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDL-DGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           LLF+A  G  K V  L   G+D++  D+  G TALH+AA     EVV+ L+   A+I+  
Sbjct: 81  LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVE 140

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRK 194
           D  G TA   A+              G ++   K   +      E  E      E+  ++
Sbjct: 141 DERGLTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFEYAE----VDEIVEKR 196

Query: 195 ADGITKGSYQVAKWNGTK--VWVKIL 218
             G         +W       WVK +
Sbjct: 197 GKGKDVEYL--VRWKDGGDCEWVKGV 220

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 94.2 bits (235), Expect = 1e-22
 Identities = 44/173 (25%), Positives = 70/173 (40%), Gaps = 14/173 (8%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            + A R  D + +  LL E  DV+++D +GRTAL   A  G  + V+LL    A++D RD
Sbjct: 49  WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 107

Query: 136 -RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA---NPREVPEYELNPL 188
            R G TA   A  Y   EV   L   GA +  + +   T + +A              P+
Sbjct: 108 MRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGN---PM 164

Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDKESH-KDPERINAFTHELTIVE 240
           +   R          +   +   +V  +I++K    KD E +  +        
Sbjct: 165 QFGRRIGLEKVINVLEGQVFEYAEV-DEIVEKRGKGKDVEYLVRWKDGGDCEW 216

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 85.0 bits (211), Expect = 2e-19
 Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 8/109 (7%)

Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           +  M+ L     G            +DV S   +  T    AA +   + +  LL +  +
Sbjct: 14  EGAMEYLIEWKDGHSPSWVPSSYIAADVVS---EYETPWWTAARKADEQALSQLL-EDRD 69

Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKV----PKTKRTPMTVA 175
           +DA D  G TA       G+ +   +L   GA +     +   T + +A
Sbjct: 70  VDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMA 118

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 5/43 (11%), Positives = 14/43 (32%)

Query: 93  NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            E  ++      G+   ++   +   +   +     A   A+D
Sbjct: 187 AEVDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD 229

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 43.0 bits (102), Expect = 5e-05
 Identities = 7/89 (7%), Positives = 23/89 (25%), Gaps = 12/89 (13%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A          + +  G  +    +     +       + EV +++  +        
Sbjct: 148 LELAREILKTTPKGNPMQFGRRIGLEKV---INVLEGQVFEYAEVDEIVEKRG------- 197

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G       ++    +   +     A+ 
Sbjct: 198 -KGKDVEYLVRWKDGGDCEWVKGVHVAED 225

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 98.7 bits (247), Expect = 2e-25
 Identities = 23/87 (26%), Positives = 38/87 (43%), Gaps = 1/87 (1%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRT-ALHIAACEGHVEVVKLLLSKKANIDARD 135
           + +   G  +  E LL  G++ N  D    T  +H AA EG ++ + +L    A +D  D
Sbjct: 49  IQVMMMGSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCD 108

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
            WG      A+  G+ ++   L A   
Sbjct: 109 AWGRLPVDLAEEQGHRDIARYLHAATG 135

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 91.7 bits (229), Expect = 7e-23
 Identities = 29/104 (27%), Positives = 46/104 (44%), Gaps = 6/104 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G V+ V  LL  G+D N+++  GR  + +    G  +V +LLL   A  +  D
Sbjct: 16  LATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGSAQVAELLLLHGAEPNCAD 74

Query: 136 RWGSTAA-ADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               T    DA   G ++   +L   GA++       R P+ +A
Sbjct: 75  PATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLA 118

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 87.1 bits (217), Expect = 3e-21
 Identities = 18/73 (24%), Positives = 30/73 (41%), Gaps = 7/73 (9%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNV 151
              ++ +       L  AA  G VE V+ LL   A+ +A +R+G             G+ 
Sbjct: 2   SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM----MGSA 57

Query: 152 EVYNILKARGAKV 164
           +V  +L   GA+ 
Sbjct: 58  QVAELLLLHGAEP 70

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 69.8 bits (172), Expect = 8e-15
 Identities = 12/62 (19%), Positives = 26/62 (41%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK 128
               T  +   A  G +  +  L   G+ ++  D  GR  + +A  +GH ++ + L +  
Sbjct: 75  PATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGHRDIARYLHAAT 134

Query: 129 AN 130
            +
Sbjct: 135 GD 136

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 99.4 bits (249), Expect = 3e-25
 Identities = 21/89 (23%), Positives = 41/89 (46%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  +A +G++  +   + + + +N  D +G T L  AA  G + VV+ LL   A+     
Sbjct: 7   VHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLG 66

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           +   +A + A   G  ++  +L   G  V
Sbjct: 67  KGRESALSLACSKGYTDIVKMLLDCGVDV 95

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 99.0 bits (248), Expect = 4e-25
 Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 5/91 (5%)

Query: 77  LFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           L +AC     D+  V+ LL+ G DVN  D +G T L  A    HV+ VK+LL   A+   
Sbjct: 73  LSLACSKGYTDI--VKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTI 130

Query: 134 RDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
               G  +   A   G   V  ++++   K+
Sbjct: 131 ETDSGYNSMDLAVALGYRSVQQVIESHLLKL 161

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 94.8 bits (237), Expect = 1e-23
 Identities = 28/103 (27%), Positives = 47/103 (45%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G +  VE LL  G+D   +     +AL +A  +G+ ++VK+LL    +++  D
Sbjct: 40  LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYD 99

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    A +  +V+   +L   GA    +T      M +A
Sbjct: 100 WNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLA 142

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 79.7 bits (198), Expect = 4e-18
 Identities = 14/61 (22%), Positives = 25/61 (40%), Gaps = 1/61 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A     VK V+ LL  G+D       G  ++ +A   G+  V +++ S    +    
Sbjct: 106 LLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKLLQNI 165

Query: 136 R 136
           +
Sbjct: 166 K 166

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 77.4 bits (192), Expect = 3e-17
 Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 3/75 (4%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
               ++H  A +G +  +   + ++  I+  D  G T    A  +G + V   L   GA 
Sbjct: 2   ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61

Query: 164 V-PKTK--RTPMTVA 175
                K   + +++A
Sbjct: 62  PQLLGKGRESALSLA 76

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  102 bits (257), Expect = 3e-25
 Identities = 38/150 (25%), Positives = 62/150 (41%), Gaps = 18/150 (12%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
                  KI+ K     P +    + E++I     H +VV F G    N  + +VLE   
Sbjct: 39  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98

Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
           +  L    +++  L+  +   +   +  G  YLH  +   +IH DLK  N+ L+   ++K
Sbjct: 99  RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVK 155

Query: 329 ISGFGL--------LRLQ-------YISPE 343
           I  FGL         R +       YI+PE
Sbjct: 156 IGDFGLATKVEYDGERKKVLCGTPNYIAPE 185

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 98.6 bits (247), Expect = 5e-25
 Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G+++ V  LL  G+D + +  +  +AL +A+  G+ ++V LLL +  +I+  D
Sbjct: 40  LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    A    +V+    L ARGA +  +     TPM +A
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLA 142

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 97.9 bits (245), Expect = 9e-25
 Identities = 27/101 (26%), Positives = 42/101 (41%), Gaps = 8/101 (7%)

Query: 77  LFMACRG---DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           L +A  G   D+  V  LL    D+N  D +G T L  A    HV+ V+ LL++ A++  
Sbjct: 73  LSLASTGGYTDI--VGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTT 130

Query: 134 RDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTP 171
               G T    A   G  +V  +++    K+         P
Sbjct: 131 EADSGYTPMDLAVALGYRKVQQVIENHILKLFQSNLVPADP 171

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 94.0 bits (235), Expect = 3e-23
 Identities = 21/90 (23%), Positives = 40/90 (44%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSD-VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +      G++  +++ L +G + VN  D  G T L  A+  G +E V+ LL   A+    
Sbjct: 6   IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            +   +A + A   G  ++  +L  R   +
Sbjct: 66  AKERESALSLASTGGYTDIVGLLLERDVDI 95

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 70.5 bits (174), Expect = 9e-15
 Identities = 18/78 (23%), Positives = 33/78 (42%), Gaps = 10/78 (12%)

Query: 105 GRTALHIAACEGHVEVVKLLLSKKAN-IDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
              ++H  A +G ++ +K  L K  N ++  D  G T    A+    +G +E    L   
Sbjct: 2   DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWAS---AFGEIETVRFLLEW 58

Query: 161 GAKV-PKTK--RTPMTVA 175
           GA      K   + +++A
Sbjct: 59  GADPHILAKERESALSLA 76

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score =  101 bits (254), Expect = 7e-25
 Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 3/102 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  A   G    + +L+++G  VN I  D  + LH A   GH+  VK+LL   A ++   
Sbjct: 63  MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK--RTPMTVA 175
               T   +A   G+ +  N+L   GA V       +P+  A
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHGASVQPESDLASPIHEA 164

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 92.2 bits (230), Expect = 1e-21
 Identities = 24/93 (25%), Positives = 37/93 (39%), Gaps = 3/93 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L++AC       V+ LL  G+DVN       + LH        E+  LL+   A+  A++
Sbjct: 194 LYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVRTASEELACLLMDFGADTQAKN 252

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK 168
             G            +     L+  GA +PK K
Sbjct: 253 AEGKRPVELVPPESPLAQL-FLEREGASLPKPK 284

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 91.4 bits (228), Expect = 2e-21
 Identities = 31/102 (30%), Positives = 41/102 (40%), Gaps = 4/102 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LF AC  G    V  LL  G+ V   + D  + +H AA  GHVE V  L++   NID + 
Sbjct: 129 LFNACVSGSWDCVNLLLQHGASVQP-ESDLASPIHEAARRGHVECVNSLIAYGGNIDHKI 187

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK--RTPMTVA 175
               T    A           L   GA V + K   +P+   
Sbjct: 188 SHLGTPLYLACENQQRACVKKLLESGADVNQGKGQDSPLHAV 229

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 87.9 bits (219), Expect = 4e-20
 Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 2/89 (2%)

Query: 77  LFMAC-RGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  A  RG V+ V  L+  G +++       T L++A        VK LL   A+++   
Sbjct: 161 IHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQ-G 219

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           +   +         + E+  +L   GA  
Sbjct: 220 KGQDSPLHAVVRTASEELACLLMDFGADT 248

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 80.6 bits (200), Expect = 1e-17
 Identities = 20/118 (16%), Positives = 36/118 (30%), Gaps = 32/118 (27%)

Query: 79  MACR-GDVKGVEDLLNEGSDVNSIDL-------------------------------DGR 106
           M            L+  GS + S+D                                   
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPGIRLLSNPLMGDAVSDW 60

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           + +H AA  GH   ++ L+S+   ++       +   +A   G++    IL   GA+V
Sbjct: 61  SPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQV 118

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 51.0 bits (123), Expect = 2e-07
 Identities = 9/67 (13%), Positives = 21/67 (31%), Gaps = 3/67 (4%)

Query: 111 IAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK-- 168
           + +   H      L+ + +++ + D         +K  G  +   I       +      
Sbjct: 1   MGSSHHHHHHSSGLVPRGSHMASMDGKQGGMDG-SKPAGPRDFPGIRLLSNPLMGDAVSD 59

Query: 169 RTPMTVA 175
            +PM  A
Sbjct: 60  WSPMHEA 66

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  101 bits (254), Expect = 7e-25
 Identities = 40/198 (20%), Positives = 79/198 (39%), Gaps = 28/198 (14%)

Query: 170 TPMTVANPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHK 224
            P         P+   N L    R    I +G +          +G  V +K +      
Sbjct: 13  VPQFQPQKALRPDMGYNTLA-NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71

Query: 225 DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--- 281
           D +       E+ ++++  HPNV+++  +  ++  + IVLE    GDL+  ++   +   
Sbjct: 72  DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131

Query: 282 -LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ-- 338
            +    V ++ + L   + ++H  +   ++H D+KP N+ +   G +K+   GL R    
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188

Query: 339 -------------YISPE 343
                        Y+SPE
Sbjct: 189 KTTAAHSLVGTPYYMSPE 206

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score =   99 bits (249), Expect = 7e-25
 Identities = 42/183 (22%), Positives = 63/183 (34%), Gaps = 8/183 (4%)

Query: 76  LLFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +  +A  G +    E +L + S     D D RTALH A   GH E+V+ LL     ++ +
Sbjct: 10  ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA---NPREVPEYELNPL 188
           D  G +    A   G  E+   L  +GA V    +   TP+  A   N  E+    L   
Sbjct: 70  DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLE-G 128

Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV 248
                  D     +   A   G    V IL         +       L +          
Sbjct: 129 GANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA 188

Query: 249 QFV 251
           +F+
Sbjct: 189 KFL 191

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 73.0 bits (179), Expect = 4e-15
 Identities = 22/154 (14%), Positives = 46/154 (29%), Gaps = 7/154 (4%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
                 ++A      E+ + +L+ K+     D+   TA   A   G+ E+   L   G  
Sbjct: 6   SNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVP 65

Query: 164 V-PKTK--RTPMTVA---NPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKI 217
           V  K     +P+ +A      E+ +  L      V   +         A          +
Sbjct: 66  VNDKDDAGWSPLHIAASAGXDEIVKALLVK-GAHVNAVNQNGCTPLHYAASKNRHEIAVM 124

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
           L +       + +     +       +  +V  +
Sbjct: 125 LLEGGANPDAKDHYDATAMHRAAAKGNLKMVHIL 158

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 71.8 bits (176), Expect = 9e-15
 Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 3/112 (2%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
            N +    L + A +   +    LL  G++ ++ D    TA+H AA +G++++V +LL  
Sbjct: 102 VNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFY 161

Query: 128 KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN 176
           KA+ + +D  G+T    A     VE    L  +GA +    K ++TP+ VA 
Sbjct: 162 KASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK 213

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 67.2 bits (164), Expect = 4e-13
 Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 2/97 (2%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           ++      +   A +G++K V  LL   +  N  D +G T LH+A  E  VE  K L+++
Sbjct: 135 KDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQ 194

Query: 128 KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            A+I   ++   T    AK  G + +     A G + 
Sbjct: 195 GASIYIENKEEKTPLQVAK--GGLGLILKRLAEGEEA 229

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 56.0 bits (135), Expect = 3e-09
 Identities = 9/65 (13%), Positives = 27/65 (41%), Gaps = 2/65 (3%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           ++ +    L        V+  + L+ +G+ +   + + +T L +A   G + ++   L++
Sbjct: 168 QDTEGNTPLHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GGLGLILKRLAE 225

Query: 128 KANID 132
                
Sbjct: 226 GEEAS 230

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score =  101 bits (254), Expect = 8e-25
 Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 14/144 (9%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            L     GD + V  LL  G+D+N  ++DG TALH A  + +V++VK L+   ANI+  D
Sbjct: 44  FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA---NPREVPEYELN 186
             G      AA     G +++   L ++GA V        TP+ +A      E+ + E+N
Sbjct: 104 NEGWIPLHAAA---SCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVN 160

Query: 187 PLELQVRKAD--GITKGSYQVAKW 208
              + +  A             +W
Sbjct: 161 RQGVDIEAARKEEERIMLRDARQW 184

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 90.6 bits (226), Expect = 6e-21
 Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 9/94 (9%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AAD 144
            + L +   +       G TALH+AA +G+ EV+KLL+  + +++ +D  G T    AA 
Sbjct: 182 RQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAA- 240

Query: 145 AKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             ++G  E   IL      +    K  +T   VA
Sbjct: 241 --HWGKEEACRILVENLCDMEAVNKVGQTAFDVA 272

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 88.7 bits (221), Expect = 2e-20
 Identities = 25/94 (26%), Positives = 42/94 (44%), Gaps = 1/94 (1%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
           A +G  + ++ L+    DVN  D DG T LH AA  G  E  ++L+    +++A ++ G 
Sbjct: 207 AAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQ 266

Query: 140 TAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           TA   A       +  + K +       KR   +
Sbjct: 267 TAFDVADEDILGYLEELQKKQNLLH-SEKREKKS 299

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 76.0 bits (188), Expect = 8e-16
 Identities = 20/77 (25%), Positives = 30/77 (38%), Gaps = 1/77 (1%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           +E  + +         DG      A   G  E V  LL + A+I+  +  G TA   A  
Sbjct: 24  LEPPVVKRKKTKVKFDDG-AVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACI 82

Query: 148 YGNVEVYNILKARGAKV 164
             NV++   L   GA +
Sbjct: 83  DDNVDMVKFLVENGANI 99

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 67.1 bits (165), Expect = 8e-13
 Identities = 16/80 (20%), Positives = 25/80 (31%), Gaps = 12/80 (15%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AAD 144
           +++ +N         +D   A          +  + L S   N     + G TA   AA 
Sbjct: 155 LQNEVNRQ------GVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAA- 207

Query: 145 AKYYGNVEVYNILKARGAKV 164
               G  EV  +L      V
Sbjct: 208 --AKGYTEVLKLLIQARYDV 225

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 61.7 bits (151), Expect = 6e-11
 Identities = 10/67 (14%), Positives = 20/67 (29%), Gaps = 1/67 (1%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
           +   D   +    +    G    ++  + K+     +          A   G+ E    L
Sbjct: 1   MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFD-DGAVFLAACSSGDTEEVLRL 59

Query: 158 KARGAKV 164
             RGA +
Sbjct: 60  LERGADI 66

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  100 bits (252), Expect = 9e-25
 Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 22/153 (14%)

Query: 207 KWNGTKVWVKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K +   + +K+L K          ++     E+ I    RHPN+++  G       + ++
Sbjct: 31  KQSKFILALKVLFKAQLEKAGVEHQLR---REVEIQSHLRHPNILRLYGYFHDATRVYLI 87

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           LEY   G +   LQK  +    +   +  +LA  ++Y H  +   +IH D+KP+N+LL +
Sbjct: 88  LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGS 144

Query: 324 GGQLKISGFGL------LRLQ-------YISPE 343
            G+LKI+ FG        R         Y+ PE
Sbjct: 145 AGELKIADFGWSVHAPSSRRTDLCGTLDYLPPE 177

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 99.6 bits (249), Expect = 1e-24
 Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 20/151 (13%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR---DR 136
            C G  + V+ L+  G +VN+ D DG T LH AA   +V+V K L+   A + A    D 
Sbjct: 78  VCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDM 137

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPREVPEYELNPLELQVR 193
             +    +    G  +    L     K+    K     +    P+       N  EL ++
Sbjct: 138 QTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNKGVIYALWDYEPQ-------NDDELPMK 190

Query: 194 KADGIT---KGSYQVAKWNGTKVWVKILDKE 221
           + D +T   +      +W     W ++ DKE
Sbjct: 191 EGDCMTIIHREDEDEIEW----WWARLNDKE 217

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 94.6 bits (236), Expect = 8e-23
 Identities = 32/89 (35%), Positives = 45/89 (50%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  +  G+   V+ ++ E  D +  + +G TALH A C GH E+VK L+    N++A D
Sbjct: 41  LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G T    A    NV+V   L   GA V
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGAAV 129

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 84.6 bits (210), Expect = 3e-19
 Identities = 21/103 (20%), Positives = 38/103 (36%), Gaps = 5/103 (4%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L    R    K   + +  G  V   +      L  ++ EG  ++V+ ++ +  +    +
Sbjct: 9   LPPGKRTNLRKTGSERIAHGMRVK-FNPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPN 67

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G TA  +A   G+ E+   L   G  V        TP+  A
Sbjct: 68  DEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCA 110

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 68.4 bits (168), Expect = 2e-13
 Identities = 4/63 (6%), Positives = 16/63 (25%), Gaps = 1/63 (1%)

Query: 102 DLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG 161
           ++ G+ +L         +     ++    +            D+   G  ++   +    
Sbjct: 2   EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60

Query: 162 AKV 164
              
Sbjct: 61  DDP 63

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =   99 bits (250), Expect = 2e-24
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 22/153 (14%)

Query: 207 KWNGTKVWVKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K N   + +K+L K          ++     E+ I    RHPN+++          + ++
Sbjct: 36  KQNKFIMALKVLFKSQLEKEGVEHQLR---REIEIQSHLRHPNILRMYNYFHDRKRIYLM 92

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           LE+  +G+L   LQK GR    +   F  +LA  ++Y HE K   +IH D+KP+N+L+  
Sbjct: 93  LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGY 149

Query: 324 GGQLKISGFGL------LRLQ-------YISPE 343
            G+LKI+ FG       LR +       Y+ PE
Sbjct: 150 KGELKIADFGWSVHAPSLRRRTMCGTLDYLPPE 182

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  100 bits (252), Expect = 2e-24
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 22/179 (12%)

Query: 183 YELNPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELT 237
            EL  L L+VR+   + +G +          +G +  +K L      + E+  A   E+ 
Sbjct: 23  VELGELRLRVRRV--LAEGGFAFVYEAQDVGSGREYALKRLLS---NEEEKNRAIIQEVC 77

Query: 238 IVEKAR-HPNVVQFVGAVTQNIPMM-------IVLEYHAKGDLASYLQK---KGRLSPSK 286
            ++K   HPN+VQF  A +             ++L    KG L  +L+K   +G LS   
Sbjct: 78  FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137

Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
           VL+      R + ++H  KP PIIH DLK +N+LL N G +K+  FG        P+ +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 99.6 bits (249), Expect = 2e-24
 Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 29/172 (16%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
            GSY        K +G  +  K LD  S  + E+      E+ ++ + +HPN+V++   +
Sbjct: 16  TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHPNIVRYYDRI 74

Query: 255 --TQNIPMMIVLEYHAKGDLASYL----QKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
               N  + IV+EY   GDLAS +    +++  L    VLR    L   +   H      
Sbjct: 75  IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGG 134

Query: 309 --IIHCDLKPKNILLDNGGQLKISGFGLLRL---------------QYISPE 343
             ++H DLKP N+ LD    +K+  FGL R+                Y+SPE
Sbjct: 135 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 95.6 bits (239), Expect = 5e-24
 Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 76  LLFMACRGDVKGVEDLLN-EGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L   A RGDV+ V  LL+ E    ++++  G+TAL +    G   +   LL + A+ + +
Sbjct: 6   LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ 64

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           D  G++   DA   G ++   +L   GA V
Sbjct: 65  DTSGTSPVHDAARTGFLDTLKVLVEHGADV 94

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 94.0 bits (235), Expect = 2e-23
 Identities = 25/102 (24%), Positives = 47/102 (46%), Gaps = 4/102 (3%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
           L +   G      +LL +G+  N  D  G + +H AA  G ++ +K+L+   A+++  D 
Sbjct: 40  LQVMMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDG 99

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
            G+     A   G+  V + L A  + +  +     TP+ +A
Sbjct: 100 TGALPIHLAVQEGHTAVVSFLAA-ESDLHRRDARGLTPLELA 140

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 87.1 bits (217), Expect = 7e-21
 Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 2/82 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  A R G +  ++ L+  G+DVN  D  G   +H+A  EGH  VV  L ++ +++  RD
Sbjct: 72  VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRD 130

Query: 136 RWGSTAAADAKYYGNVEVYNIL 157
             G T    A   G  ++ +IL
Sbjct: 131 ARGLTPLELALQRGAQDLVDIL 152

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 65.1 bits (160), Expect = 5e-13
 Identities = 18/64 (28%), Positives = 29/64 (45%), Gaps = 8/64 (12%)

Query: 105 GRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
               L  AA  G V+ V+ LL ++  + DA +R+G TA         +G+  +   L  +
Sbjct: 2   AGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM----FGSTAIALELLKQ 57

Query: 161 GAKV 164
           GA  
Sbjct: 58  GASP 61

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 62.4 bits (153), Expect = 5e-12
 Identities = 13/50 (26%), Positives = 22/50 (44%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           + +A +     V   L   SD++  D  G T L +A   G  ++V +L  
Sbjct: 105 IHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG 154

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 96.0 bits (240), Expect = 5e-24
 Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 8/93 (8%)

Query: 77  LFMACR-GDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           +F  CR G+   V   L+   +D+N  D  G + LH A  EG   VV++L+ + A I+  
Sbjct: 9   IFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVM 68

Query: 135 DRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
           +R   T    AA    +G+ ++   L    A +
Sbjct: 69  NRGDDTPLHLAA---SHGHRDIVQKLLQYKADI 98

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 94.8 bits (237), Expect = 2e-23
 Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 14/142 (9%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  ACR G    VE L+  G+ +N ++    T LH+AA  GH ++V+ LL  KA+I+A +
Sbjct: 43  LHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVN 102

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA---NPREVPEYELNPLE 189
             G+     A ++G  +V   L A GA V    K    P+  A       + E       
Sbjct: 103 EHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRER------ 156

Query: 190 LQVRKADGITKGSYQVAKWNGT 211
            +    + + +  Y+   W GT
Sbjct: 157 AEKMGQN-LNRIPYKDTFWKGT 177

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 71.7 bits (177), Expect = 4e-15
 Identities = 15/62 (24%), Positives = 25/62 (40%), Gaps = 1/62 (1%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKAN-IDARDRWGSTAAADAKYYGNVEVYNILKARGA 162
           +    +     EG+   V+L L    N ++  D  G +    A   G   V  +L  RGA
Sbjct: 4   EFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGA 63

Query: 163 KV 164
           ++
Sbjct: 64  RI 65

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 99.4 bits (248), Expect = 5e-24
 Identities = 34/178 (19%), Positives = 66/178 (37%), Gaps = 21/178 (11%)

Query: 182 EYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHEL 236
              ++       +   + +G +          +G    +K +     +D E       E 
Sbjct: 23  MVIIDNKHYLFIQK--LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ---REA 77

Query: 237 TIVEKARHPNVVQFVGAVTQNIPMM----IVLEYHAKGDLASYL----QKKGRLSPSKVL 288
            +     HPN+++ V    +         ++L +  +G L + +     K   L+  ++L
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
              L + RG+  +H        H DLKP NILL + GQ  +   G +    I  E ++
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  101 bits (253), Expect = 8e-24
 Identities = 53/176 (30%), Positives = 77/176 (43%), Gaps = 38/176 (21%)

Query: 200 KGSY-QVAKW----NGTKVWVKILDKE-SHKDPERINAFTHELTIVEKARHPNVVQFV-- 251
            G +  V +W     G +V +K   +E S K+ ER      E+ I++K  HPNVV     
Sbjct: 24  TGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW---CLEIQIMKKLNHPNVVSAREV 80

Query: 252 ----GAVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHEC 304
                 +  N   ++ +EY   GDL  YL +      L    +     D++  + YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 305 KPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLR--------------LQYISPE 343
           +   IIH DLKP+NI+L  G Q    KI   G  +              LQY++PE
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 92.8 bits (232), Expect = 8e-24
 Identities = 40/87 (45%), Positives = 57/87 (65%), Gaps = 1/87 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G ++ V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
           + G T    A   G++EV  +L   GA
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGA 92

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 79.3 bits (197), Expect = 7e-19
 Identities = 29/61 (47%), Positives = 40/61 (65%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
           +GRT LH+AA  GH+EVVKLLL   A+++A+D+ G T    A   G++EV  +L   GA 
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAD 60

Query: 164 V 164
           V
Sbjct: 61  V 61

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 93.2 bits (233), Expect = 1e-23
 Identities = 40/89 (44%), Positives = 58/89 (65%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A  G  + V+ LL++G+DVN+   DG T LH+AA  GH E+VKLLL+K A+++AR 
Sbjct: 13  LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           + G+T    AK  G+ E+  +L A+GA V
Sbjct: 73  KDGNTPEHLAKKNGHHEIVKLLDAKGADV 101

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 84.7 bits (211), Expect = 2e-20
 Identities = 24/54 (44%), Positives = 34/54 (62%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           V+ LL +G+DVN+   DG T  H+A   GH E+VKLL +K A+++AR    S  
Sbjct: 58  VKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGSSHH 111

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 80.5 bits (200), Expect = 5e-19
 Identities = 34/84 (40%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           G        DG T LH AA  GH E VK LLSK A+++AR + G+T    A   G+ E+ 
Sbjct: 1   GHMWG--SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIV 58

Query: 155 NILKARGAKV-PKTK--RTPMTVA 175
            +L A+GA V  ++K   TP  +A
Sbjct: 59  KLLLAKGADVNARSKDGNTPEHLA 82

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 93.6 bits (234), Expect = 1e-23
 Identities = 47/103 (45%), Positives = 66/103 (64%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G ++ V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           + G T    A   G++EV  +L   GA V  K K  RTP+ +A
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLA 108

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 91.3 bits (228), Expect = 8e-23
 Identities = 36/75 (48%), Positives = 50/75 (66%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           V+ LL  G+DVN+ D +GRT LH+AA  GH+EVVKLLL   A+++A+D+ G T    A  
Sbjct: 51  VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAAR 110

Query: 148 YGNVEVYNILKARGA 162
            G++EV  +L   GA
Sbjct: 111 NGHLEVVKLLLEAGA 125

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 78.5 bits (195), Expect = 4e-18
 Identities = 34/71 (47%), Positives = 45/71 (63%), Gaps = 3/71 (4%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
           +GRT LH+AA  GH+EVVKLLL   A+++A+D+ G T    A   G++EV  +L   GA 
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAD 60

Query: 164 V-PKTK--RTP 171
           V  K K  RTP
Sbjct: 61  VNAKDKNGRTP 71

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 98.7 bits (247), Expect = 1e-23
 Identities = 39/120 (32%), Positives = 55/120 (45%), Gaps = 13/120 (10%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A     V+ V+ LL  G+DV++ D  G   LH A   GH EV +LLL   A ++A D
Sbjct: 62  LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA---NPREVPEYELN 186
            W  T    AA       VEV ++L + GA         ++ + +A     RE   YE  
Sbjct: 122 LWQFTPLHEAA---SKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFK 178

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 93.3 bits (233), Expect = 1e-21
 Identities = 29/93 (31%), Positives = 44/93 (47%), Gaps = 7/93 (7%)

Query: 76  LLFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           LL  A  G+ +  +  L     + ++ D    T LH+AA    V +V+LLL   A++ A+
Sbjct: 28  LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAK 87

Query: 135 DRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
           D+ G      A     YG+ EV  +L   GA V
Sbjct: 88  DKGGLVPLHNAC---SYGHYEVTELLLKHGACV 117

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 91.8 bits (229), Expect = 5e-21
 Identities = 29/87 (33%), Positives = 38/87 (43%), Gaps = 1/87 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  AC  G  +  E LL  G+ VN++DL   T LH AA +  VEV  LLLS  A+    +
Sbjct: 95  LHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVN 154

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
             G +A   A      E         +
Sbjct: 155 CHGKSAVDMAPTPELRERLTYEFKGHS 181

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 91.0 bits (227), Expect = 8e-21
 Identities = 26/80 (32%), Positives = 43/80 (53%), Gaps = 6/80 (7%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AAD 144
            E LL +G++VN  + D  T LH+AA   H +V+++L    A ++A D  G TA   AA 
Sbjct: 230 AELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAA- 288

Query: 145 AKYYGNVEVYNILKARGAKV 164
               G+++   +L + G+  
Sbjct: 289 --LAGHLQTCRLLLSYGSDP 306

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 28/105 (26%), Positives = 42/105 (40%), Gaps = 12/105 (11%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH---VEVVKLLLSKKANID 132
           LL  A   D+  V+  L              TALH A    H    +V +LLL K AN++
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241

Query: 133 ARDRWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTP 171
            +++   T    AA      + +V  +L   GAK+       +T 
Sbjct: 242 EKNKDFMTPLHVAA---ERAHNDVMEVLHKHGAKMNALDSLGQTA 283

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 84.5 bits (210), Expect = 1e-18
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 7/101 (6%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A        +E L   G+ +N++D  G+TALH AA  GH++  +LLLS  ++     
Sbjct: 251 LHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIIS 310

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTKRTPMTVA 175
             G TAA      GN  V  IL +    +        +  A
Sbjct: 311 LQGFTAA----QMGNEAVQQIL-SESTPMRTSDVDYRLLEA 346

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 80.2 bits (199), Expect = 5e-17
 Identities = 24/93 (25%), Positives = 33/93 (35%), Gaps = 10/93 (10%)

Query: 86  KGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV-EVVKLLLSKKANIDARDRWGSTA--- 141
           K   DL +  +         +  L  AA  G+  +++ LL     N  A D   ST    
Sbjct: 5   KSALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHL 64

Query: 142 AADAKYYGNVEVYNILKARGAKV---PKTKRTP 171
           AA    Y  V +  +L   GA V    K    P
Sbjct: 65  AA---GYNRVRIVQLLLQHGADVHAKDKGGLVP 94

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 74.8 bits (185), Expect = 3e-15
 Identities = 25/123 (20%), Positives = 46/123 (37%), Gaps = 27/123 (21%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL---------------- 123
           A +  V+    LL+ G+D   ++  G++A+ +A      E +                  
Sbjct: 132 ASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHSLLQAAREADL 191

Query: 124 -----LLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPM 172
                 L+ +     + +   TA   A  + +    +V  +L  +GA V  K K   TP+
Sbjct: 192 AKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPL 251

Query: 173 TVA 175
            VA
Sbjct: 252 HVA 254

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 66.7 bits (164), Expect = 2e-12
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 10/76 (13%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G ++    LL+ GSD + I L G TA  +       E V+ +LS+   +   D
Sbjct: 284 LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN-----EAVQQILSESTPMRTSD 338

Query: 136 RWGST-AAADAKYYGN 150
                  A+     G+
Sbjct: 339 VDYRLLEAS---KAGD 351

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 99.9 bits (250), Expect = 1e-23
 Identities = 40/103 (38%), Positives = 48/103 (46%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A R G    V+ LL   ++ N     G T LHIAA EGHVE V  LL K+A+     
Sbjct: 84  LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMT 143

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           + G T    A  YG V V  +L  R A      K   TP+ VA
Sbjct: 144 KKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVA 186

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 10/106 (9%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A   G +  V++LL  G+  N  ++   T LH+AA  GH EV K LL  KA ++A+ 
Sbjct: 18  LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 77

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           +   T    AA     G+  +  +L    A          TP+ +A
Sbjct: 78  KDDQTPLHCAA---RIGHTNMVKLLLENNANPNLATTAGHTPLHIA 120

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 97.2 bits (243), Expect = 1e-22
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 1/88 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A   G++K V+ LL   +DVN+    G + LH AA +GH ++V LLL   A+ +   
Sbjct: 315 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 374

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAK 163
             G+T  A AK  G + V ++LK    +
Sbjct: 375 SDGTTPLAIAKRLGYISVTDVLKVVTDE 402

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A    ++  V+ LL  G   +S   +G T LHIAA +  VEV + LL    + +A  
Sbjct: 183 LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAES 242

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    A   G+ E+  +L ++ A      K   TP+ + 
Sbjct: 243 VQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLV 285

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R G V+ V  LL + +    +   G T LH+AA  G V V +LLL + A+ +A  
Sbjct: 117 LHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAG 176

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           + G T    A ++ N+++  +L  RG           TP+ +A
Sbjct: 177 KNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIA 219

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 95.6 bits (239), Expect = 4e-22
 Identities = 27/103 (26%), Positives = 53/103 (51%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +  + G V   + L+  G  V++    G T LH+A+  G++++VK LL  +A+++A+ 
Sbjct: 282 LHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKT 341

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           + G +    A   G+ ++  +L   GA     +    TP+ +A
Sbjct: 342 KLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIA 384

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 95.6 bits (239), Expect = 4e-22
 Identities = 38/103 (36%), Positives = 48/103 (46%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L MA R G  +  + LL   + VN+   D +T LH AA  GH  +VKLLL   AN +   
Sbjct: 51  LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANPNLAT 110

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    A   G+VE    L  + A     TK   TP+ VA
Sbjct: 111 TAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVA 153

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 35/103 (33%), Positives = 53/103 (51%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A + G  + V  LL++ ++ N  +  G T LH+ A EGHV V  +L+     +DA  
Sbjct: 249 LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATT 308

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           R G T    A +YGN+++   L    A V  KTK   +P+  A
Sbjct: 309 RMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQA 351

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A + G V+  E LL   +  N+   +G T LH+A    ++++VKLLL +  +  +  
Sbjct: 150 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 209

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G T    A     VEV   L   G     ++    TP+ +A
Sbjct: 210 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLA 252

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 83.7 bits (208), Expect = 5e-18
 Identities = 26/84 (30%), Positives = 37/84 (44%), Gaps = 3/84 (3%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           G         G T LH+A+  GH+ +VK LL + A+ +  +    T    A   G+ EV 
Sbjct: 4   GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVA 63

Query: 155 NILKARGAKV---PKTKRTPMTVA 175
             L    AKV    K  +TP+  A
Sbjct: 64  KYLLQNKAKVNAKAKDDQTPLHCA 87

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 73.3 bits (181), Expect = 1e-14
 Identities = 18/75 (24%), Positives = 29/75 (38%), Gaps = 4/75 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLL---LSKKANID 132
           L  A + G    V  LL  G+  N +  DG T L IA   G++ V  +L     + + + 
Sbjct: 348 LHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVL 407

Query: 133 ARDRWGSTAAADAKY 147
             D+   +       
Sbjct: 408 VSDKHRMSFPETVDE 422

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 94.4 bits (236), Expect = 2e-23
 Identities = 35/89 (39%), Positives = 51/89 (57%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  A  G    V  L+  G+DVN+ D  G T LH+AA  GH+E+V++LL   A+++A D
Sbjct: 18  LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVD 77

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G T    A  +G++E+  +L   GA V
Sbjct: 78  HAGMTPLRLAALFGHLEIVEVLLKNGADV 106

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 91.7 bits (229), Expect = 2e-22
 Identities = 34/91 (37%), Positives = 54/91 (59%), Gaps = 3/91 (3%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+DVN++D  G T L +AA  GH+E+V++LL   A+++A D  G T    A  
Sbjct: 63  VEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAM 122

Query: 148 YGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           +G++E+  +L   GA V  + K  +T   ++
Sbjct: 123 FGHLEIVEVLLKNGADVNAQDKFGKTAFDIS 153

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 89.0 bits (222), Expect = 2e-21
 Identities = 31/70 (44%), Positives = 49/70 (70%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+DVN+ D++G T LH+AA  GH+E+V++LL   A+++A+D++G TA   +  
Sbjct: 96  VEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKTAFDISID 155

Query: 148 YGNVEVYNIL 157
            GN ++  IL
Sbjct: 156 NGNEDLAEIL 165

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 78.6 bits (195), Expect = 1e-17
 Identities = 21/71 (29%), Positives = 35/71 (49%), Gaps = 1/71 (1%)

Query: 95  GSDVN-SIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEV 153
           GS  +     D    L  AA  G  + V++L++  A+++A D  G T    A + G++E+
Sbjct: 3   GSHHHHHHGSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEI 62

Query: 154 YNILKARGAKV 164
             +L   GA V
Sbjct: 63  VEVLLKNGADV 73

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 63.5 bits (156), Expect = 3e-12
 Identities = 15/40 (37%), Positives = 24/40 (60%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           VE LL  G+DVN+ D  G+TA  I+   G+ ++ ++L   
Sbjct: 129 VEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL 168

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 93.6 bits (234), Expect = 2e-23
 Identities = 33/89 (37%), Positives = 50/89 (56%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  A  G    V  L+  G+DVN+ D  G T L++A   GH+E+V++LL   A+++A D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVD 77

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G T    A + G++E+  +L   GA V
Sbjct: 78  AIGFTPLHLAAFIGHLEIAEVLLKHGADV 106

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 87.8 bits (219), Expect = 2e-21
 Identities = 30/70 (42%), Positives = 47/70 (67%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+DVN++D  G T LH+AA  GH+E+ ++LL   A+++A+D++G TA   +  
Sbjct: 63  VEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKTAFDISIG 122

Query: 148 YGNVEVYNIL 157
            GN ++  IL
Sbjct: 123 NGNEDLAEIL 132

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 77.4 bits (192), Expect = 1e-17
 Identities = 22/80 (27%), Positives = 41/80 (51%), Gaps = 7/80 (8%)

Query: 85  VKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD 144
           ++G     + GSD+          L  AA  G  + V++L++  A+++A+D +G T    
Sbjct: 1   MRGSHHHHHHGSDLG-------KKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYL 53

Query: 145 AKYYGNVEVYNILKARGAKV 164
           A  +G++E+  +L   GA V
Sbjct: 54  ATAHGHLEIVEVLLKNGADV 73

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 59.7 bits (146), Expect = 3e-11
 Identities = 14/39 (35%), Positives = 23/39 (58%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
            E LL  G+DVN+ D  G+TA  I+   G+ ++ ++L  
Sbjct: 96  AEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQK 134

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 98.3 bits (245), Expect = 2e-23
 Identities = 34/182 (18%), Positives = 69/182 (37%), Gaps = 40/182 (21%)

Query: 200 KGSY---QVAKWNGTKVWVKILDK---ESHKDPERINAFTH-----------ELTIVEKA 242
           +G +    + + +     +K  +K   E  +D  + N               EL I+   
Sbjct: 41  QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100

Query: 243 RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR------ 296
           ++   +   G +T    + I+ EY     +  + +    L  +      + + +      
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160

Query: 297 --GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL------LRLQ-------YIS 341
               +Y+H  K   I H D+KP NIL+D  G++K+S FG        +++       ++ 
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMP 218

Query: 342 PE 343
           PE
Sbjct: 219 PE 220

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 95.4 bits (238), Expect = 3e-23
 Identities = 25/90 (27%), Positives = 50/90 (55%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDAR 134
           L  A + G++  + + L+    VN +D  G TAL+ A   GH ++V++L ++    ++ +
Sbjct: 77  LHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQ 136

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           ++ G TA   A + G  ++  +L A+GA+ 
Sbjct: 137 NKLGDTALHAAAWKGYADIVQLLLAKGART 166

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 91.9 bits (229), Expect = 5e-22
 Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L+ AC  G    VE L  +   ++N  +  G TALH AA +G+ ++V+LLL+K A  D R
Sbjct: 110 LYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLR 169

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           +     A   A       +    +   A  
Sbjct: 170 NIEKKLAFDMATNAACASLLKKKQGTDAVR 199

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 78.8 bits (195), Expect = 2e-17
 Identities = 12/74 (16%), Positives = 25/74 (33%), Gaps = 1/74 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G    V+ LL +G+  +  +++ + A  +A       ++K      A     +
Sbjct: 144 LHAAAWKGYADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSN 203

Query: 136 RWGSTAAADAKYYG 149
                   D+    
Sbjct: 204 AEDYLDDEDSDLEH 217

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 78.8 bits (195), Expect = 3e-17
 Identities = 18/92 (19%), Positives = 36/92 (39%), Gaps = 11/92 (11%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
            +       KG   L+   + V          LH AA  G++  ++  L  +  ++  D+
Sbjct: 49  WWKGTS---KGRTGLI-PSNYVAEQAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDK 104

Query: 137 WGSTA---AADAKYYGNVEVYNIL-KARGAKV 164
            GSTA   A    + G+ ++  +L      ++
Sbjct: 105 AGSTALYWAC---HGGHKDIVEMLFTQPNIEL 133

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 12/89 (13%), Positives = 25/89 (28%), Gaps = 6/89 (6%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +F A    + +  ++L  E  D+  I     T       +G   ++         +  + 
Sbjct: 16  VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
                   +A   GN+            V
Sbjct: 71  ESIDNPLHEAAKRGNLSWLRECLDNRVGV 99

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 62.6 bits (153), Expect = 1e-11
 Identities = 10/72 (13%), Positives = 20/72 (27%), Gaps = 2/72 (2%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
            G+  +  A           L  ++ +I        T        G   +  I     A+
Sbjct: 11  PGQVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGL--IPSNYVAE 68

Query: 164 VPKTKRTPMTVA 175
             ++   P+  A
Sbjct: 69  QAESIDNPLHEA 80

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 39.5 bits (93), Expect = 6e-04
 Identities = 4/43 (9%), Positives = 10/43 (23%), Gaps = 1/43 (2%)

Query: 77  LFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHV 118
             MA        ++      +     + +       +  E H 
Sbjct: 177 FDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDSDLEHHH 219

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 95.4 bits (238), Expect = 4e-23
 Identities = 25/89 (28%), Positives = 44/89 (49%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  A  G+++ V+  + E +D +  + +G TALH A C  +  +V  L++  AN+++ D
Sbjct: 25  LLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPD 84

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G T    A    +  +   L   GA +
Sbjct: 85  SHGWTPLHCAASCNDTVICMALVQHGAAI 113

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 81.2 bits (201), Expect = 5e-18
 Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 6/94 (6%)

Query: 88  VEDLLNEGSDVNSID---LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD 144
           +  +L +           L+    L  AA  G +EVV+  + +  +    +  G TA  +
Sbjct: 1   MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHN 60

Query: 145 AKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           A    N  + + L   GA V        TP+  A
Sbjct: 61  AICGANYSIVDFLITAGANVNSPDSHGWTPLHCA 94

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 69.2 bits (170), Expect = 7e-14
 Identities = 18/102 (17%), Positives = 32/102 (31%), Gaps = 7/102 (6%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDL-DGRTALHIAAC--EGHVEVVKLLLSKKANIDARDR 136
           A   D      L+  G+ + +  L DG TA        EG+ +    L   + ++   + 
Sbjct: 95  ASCNDTVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNS 154

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
               A  D       E+ +  +     V      + T    A
Sbjct: 155 GAVYALWDYSAEFGDEL-SFREGESVTVLRRDGPEETDWWWA 195

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 51.5 bits (124), Expect = 7e-08
 Identities = 9/61 (14%), Positives = 14/61 (22%), Gaps = 1/61 (1%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV-KLLLSKKANIDARD 135
           L+         +     E   V   D    T    AA  G    V +        +  + 
Sbjct: 160 LWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALHGQEGYVPRNYFGLFPRVKPQR 219

Query: 136 R 136
            
Sbjct: 220 S 220

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 35/125 (28%), Positives = 65/125 (52%), Gaps = 4/125 (3%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK 269
           G +V +KI+DK +  +P  +     E+ I++   HPN+V+    +     + +++EY + 
Sbjct: 40  GREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
           G++  YL   GR+   +       +   + Y H+ +   I+H DLK +N+LLD    +KI
Sbjct: 99  GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155

Query: 330 SGFGL 334
           + FG 
Sbjct: 156 ADFGF 160

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 96.1 bits (240), Expect = 5e-23
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 23/153 (15%)

Query: 212 KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYHAK 269
           KV +K +     +  E +  F  E+    +  H N+V    V     +    +V+EY   
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-EEDDCYY-LVMEYIEG 95

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
             L+ Y++  G LS    + F   +  G+ + H+ +   I+H D+KP+NIL+D+   LKI
Sbjct: 96  PTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKI 152

Query: 330 SGFGLLRL----------------QYISPEKAK 346
             FG+ +                 QY SPE+AK
Sbjct: 153 FDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 96.7 bits (241), Expect = 5e-23
 Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 33/172 (19%)

Query: 200 KGSY-QVAKW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VG 252
           +G+   V +      G    +K+ +  S   P   +    E  +++K  H N+V+   + 
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPI 309
             T     ++++E+   G L + L++      L  S+ L    D+  GMN+L E     I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133

Query: 310 IHCDLKPKNILL----DNGGQLKISGFGLLR--------------LQYISPE 343
           +H ++KP NI+     D     K++ FG  R               +Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 97.6 bits (243), Expect = 7e-23
 Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 33/172 (19%)

Query: 200 KGSY-QVAKW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VG 252
           +G+   V +      G    +K+ +  S   P   +    E  +++K  H N+V+   + 
Sbjct: 19  QGATANVFRGRHKKTGDLFAIKVFNNISFLRPV--DVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPI 309
             T     ++++E+   G L + L++      L  S+ L    D+  GMN+L E     I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133

Query: 310 IHCDLKPKNILL----DNGGQLKISGFGLLR--------------LQYISPE 343
           +H ++KP NI+     D     K++ FG  R               +Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 96.5 bits (241), Expect = 7e-23
 Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 12/134 (8%)

Query: 209 NGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           +G KV +K    ES +   E    F  E+  +   RHP++V  +G   +   M+++ +Y 
Sbjct: 62  DGAKVALKRRTPESSQGIEE----FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 268 AKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
             G+L  +L         +S  + L   +  ARG++YLH      IIH D+K  NILLD 
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDE 174

Query: 324 GGQLKISGFGLLRL 337
               KI+ FG+ + 
Sbjct: 175 NFVPKITDFGISKK 188

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 96.5 bits (241), Expect = 7e-23
 Identities = 51/159 (32%), Positives = 72/159 (45%), Gaps = 28/159 (17%)

Query: 208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
            +GT V VK L +E  +  E    F  E+ ++  A H N+++  G        ++V  Y 
Sbjct: 52  ADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 109

Query: 268 AKGDLASYLQKKGRLSPSKVL----RF--ALDLARGMNYLHE-CKPDPIIHCDLKPKNIL 320
           A G +AS L+   R      L    R   AL  ARG+ YLH+ C P  IIH D+K  NIL
Sbjct: 110 ANGSVASCLR--ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANIL 166

Query: 321 LDNGGQLKISGFGLLRLQ----------------YISPE 343
           LD   +  +  FGL +L                 +I+PE
Sbjct: 167 LDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE 205

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 94.0 bits (235), Expect = 8e-23
 Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 4/103 (3%)

Query: 77  LFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R  V+G +EDL+N  +DVN++D  G++ALH AA   +V+   +LL   AN D ++
Sbjct: 96  LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 155

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               T    A   G+ E   +L    A         R P  +A
Sbjct: 156 NREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIA 198

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 85.2 bits (212), Expect = 1e-19
 Identities = 26/93 (27%), Positives = 40/93 (43%), Gaps = 5/93 (5%)

Query: 88  VEDLLNEGSDV-NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK 146
           + D + +G+ + N  D  G TALH+AA     +  K LL   A+ + +D  G T    A 
Sbjct: 7   ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66

Query: 147 YYGNVEVYNILKARGAKVPKTK----RTPMTVA 175
                 V+ IL    A     +     TP+ +A
Sbjct: 67  SADAQGVFQILIRNRATDLDARMHDGTTPLILA 99

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 83.6 bits (208), Expect = 4e-19
 Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 8/93 (8%)

Query: 77  LFMACRGDVKGVEDLL--NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L  A   D +GV  +L  N  +D+++   DG T L +AA      +++ L++  A+++A 
Sbjct: 62  LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAV 121

Query: 135 DRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
           D  G +A   AA      NV+   +L   GA  
Sbjct: 122 DDLGKSALHWAA---AVNNVDAAVVLLKNGANK 151

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 64.7 bits (159), Expect = 2e-12
 Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 1/56 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           LF+A R G  +  + LL+  ++ +  D   R    IA    H ++V+LL       
Sbjct: 162 LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVR 217

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 45.1 bits (108), Expect = 9e-06
 Identities = 12/53 (22%), Positives = 19/53 (35%), Gaps = 7/53 (13%)

Query: 116 GHVEVVKLLLSKKANI-DARDRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
               V+   + + A++ +  DR G TA   AA    Y   +    L    A  
Sbjct: 2   DAPAVISDFIYQGASLHNQTDRTGETALHLAA---RYSRSDAAKRLLEASADA 51

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 92.9 bits (232), Expect = 9e-23
 Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 9/93 (9%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            + A R  D + +  LL E  DV+++D +GRTAL   A  G  + V+LL    A++D RD
Sbjct: 48  WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 106

Query: 136 -RWGSTA---AADAKYYGNVEVYNILKARGAKV 164
            R G TA   AA    Y   EV   L   GA +
Sbjct: 107 MRGGLTALHMAA---GYVRPEVVEALVELGADI 136

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 92.6 bits (231), Expect = 1e-22
 Identities = 30/90 (33%), Positives = 43/90 (47%), Gaps = 1/90 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDL-DGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           LLF+A  G  K V  L   G+D++  D+  G TALH+AA     EVV+ L+   A+I+  
Sbjct: 80  LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVE 139

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           D  G TA   A+              G ++
Sbjct: 140 DERGLTALELAREILKTTPKGNPMQFGRRI 169

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 68.3 bits (168), Expect = 7e-14
 Identities = 13/56 (23%), Positives = 19/56 (33%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           A     + VE L+  G+D+   D  G TAL +A            +     I    
Sbjct: 118 AGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 173

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 55.2 bits (134), Expect = 2e-09
 Identities = 17/115 (14%), Positives = 29/115 (25%), Gaps = 33/115 (28%)

Query: 94  EGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI---------------------- 131
                +    +G     I   +GH           A++                      
Sbjct: 3   NKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYETPWWTAARKADEQALSQ 62

Query: 132 -------DARDRWGSTAAADAKYYGNVEVYNILKARGAKV----PKTKRTPMTVA 175
                  DA D  G TA       G+ +   +L   GA +     +   T + +A
Sbjct: 63  LLEDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMA 117

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 94.4 bits (236), Expect = 9e-23
 Identities = 33/104 (31%), Positives = 46/104 (44%), Gaps = 5/104 (4%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G V     L+  G+++++   D RT L  AA   H+E VK L+   A +D +D
Sbjct: 15  LHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKD 74

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVA 175
             GST    A   G+ EV   L + G      +     TPM  A
Sbjct: 75  AEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWA 118

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 92.9 bits (232), Expect = 3e-22
 Identities = 19/75 (25%), Positives = 35/75 (46%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
            E LL    D++++++ G + LHIAA E   + V L LS+ +++  +++ G T    A  
Sbjct: 160 AEILLAAKCDLHAVNIHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASL 219

Query: 148 YGNVEVYNILKARGA 162
              V     +     
Sbjct: 220 NSQVWSALQMSKALQ 234

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 91.3 bits (228), Expect = 1e-21
 Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +  A     V  V+ LL++GSD+N  D +    LH AA  G V++ ++LL+ K ++ A +
Sbjct: 115 MIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVN 174

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
             G +    A      +   +  +R + V  K K   TP+  A
Sbjct: 175 IHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCA 217

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 86.3 bits (215), Expect = 6e-20
 Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L +A + G  + V+ LL+ G  DVN  D  G T +  A    HV++VKLLLSK ++I+ R
Sbjct: 81  LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIR 140

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           D   +     A + G V++  IL A    +
Sbjct: 141 DNEENICLHWAAFSGCVDIAEILLAAKCDL 170

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 84.8 bits (211), Expect = 3e-19
 Identities = 20/68 (29%), Positives = 30/68 (44%)

Query: 97  DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNI 156
           +      + R+ LH AA  GHV++  +L+   ANID       T   +A    ++E    
Sbjct: 3   NFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKY 62

Query: 157 LKARGAKV 164
           L   GA V
Sbjct: 63  LIKAGALV 70

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 64.4 bits (158), Expect = 3e-12
 Identities = 13/55 (23%), Positives = 20/55 (36%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L +A R      V   L+  SDV   + +G T L  A+    V     +     +
Sbjct: 181 LHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQMSKALQD 235

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 25/156 (16%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMM--IVLEYHA 268
           V VK+L  +  +DP     F  E        HP +V     G        +  IV+EY  
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99

Query: 269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
              L   +  +G ++P + +    D  + +N+ H+     IIH D+KP NI++     +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156

Query: 329 ISGFGLLRL------------------QYISPEKAK 346
           +  FG+ R                   QY+SPE+A+
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 90.3 bits (225), Expect = 1e-22
 Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 6/99 (6%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
           +          L+  GS + S   D    L  AA  G  + V++L++  A++ A+D+ GS
Sbjct: 2   SSHHHHHHSSGLVPRGSHMGS---DLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGS 58

Query: 140 TAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
           T    A   G++EV  +L   GA V    K  +T   ++
Sbjct: 59  TPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDIS 97

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 90.3 bits (225), Expect = 1e-22
 Identities = 35/83 (42%), Positives = 50/83 (60%), Gaps = 1/83 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A R G    V  L+  G+DV + D +G T LH+AA  GH+EVVKLLL   A++ A+D
Sbjct: 28  LLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQD 87

Query: 136 RWGSTAAADAKYYGNVEVYNILK 158
           ++G TA   +   GN ++  IL+
Sbjct: 88  KFGKTAFDISIDNGNEDLAEILQ 110

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 53.3 bits (129), Expect = 2e-09
 Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 6/67 (8%)

Query: 112 AACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK-- 168
            +   H      L+ + +++ +          +A   G  +   IL A GA V  K K  
Sbjct: 1   GSSHHHHHHSSGLVPRGSHMGSD---LGKKLLEAARAGQDDEVRILMANGADVAAKDKNG 57

Query: 169 RTPMTVA 175
            TP+ +A
Sbjct: 58  STPLHLA 64

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 38/169 (22%), Positives = 69/169 (40%), Gaps = 12/169 (7%)

Query: 176 NPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERIN 230
              E     ++     ++    I +GS++            +V    L  +         
Sbjct: 12  EELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQ 70

Query: 231 AFTHELTIVEKARHPNVVQFVGA----VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK 286
            F  E  +++  +HPN+V+F  +    V     +++V E    G L +YL++   +    
Sbjct: 71  RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKV 130

Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGL 334
           +  +   + +G+ +LH   P PIIH DLK  NI +    G +KI   GL
Sbjct: 131 LRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGL 178

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 94.5 bits (236), Expect = 1e-22
 Identities = 35/106 (33%), Positives = 52/106 (49%), Gaps = 10/106 (9%)

Query: 77  LFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A R  V+G +EDL+N  +DVN++D  G++ALH AA   +V+   +LL   AN D ++
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187

Query: 136 RWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
               T    AA     G+ E   +L    A         R P  +A
Sbjct: 188 NREETPLFLAA---REGSYETAKVLLDHFANRDITDHMDRLPRDIA 230

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 90.6 bits (226), Expect = 3e-21
 Identities = 21/83 (25%), Positives = 33/83 (39%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
           A   +V     LL  G++ +  +    T L +AA EG  E  K+LL   AN D  D    
Sbjct: 165 AAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDR 224

Query: 140 TAAADAKYYGNVEVYNILKARGA 162
                A+   + ++  +L     
Sbjct: 225 LPRDIAQERMHHDIVRLLDLEHH 247

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 86.4 bits (215), Expect = 1e-19
 Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 2/90 (2%)

Query: 77  LFMACRGDVKGVEDLL--NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L  A   D +GV  +L  N  +D+++   DG T L +AA      +++ L++  A+++A 
Sbjct: 94  LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAV 153

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           D  G +A   A    NV+   +L   GA  
Sbjct: 154 DDLGKSALHWAAAVNNVDAAVVLLKNGANK 183

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 82.1 bits (204), Expect = 3e-18
 Identities = 25/89 (28%), Positives = 37/89 (41%), Gaps = 5/89 (5%)

Query: 88  VEDLLNEGSDV-NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK 146
           + D + +G+ + N  D  G TALH+AA     +  K LL   A+ + +D  G T    A 
Sbjct: 39  ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 98

Query: 147 YYGNVEVYNILKARGAKVPKTK----RTP 171
                 V+ IL    A     +     TP
Sbjct: 99  SADAQGVFQILIRNRATDLDARMHDGTTP 127

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 67.5 bits (166), Expect = 3e-13
 Identities = 15/56 (26%), Positives = 27/56 (48%), Gaps = 1/56 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           LF+A R G  +  + LL+  ++ +  D   R    IA    H ++V+LL  +  + 
Sbjct: 194 LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHHHH 249

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 66.7 bits (164), Expect = 8e-13
 Identities = 22/82 (26%), Positives = 30/82 (36%), Gaps = 14/82 (17%)

Query: 97  DVNSIDLDGRTALHIAACEG-------------HVEVVKLLLSKKANI-DARDRWGSTAA 142
           DVN    DG T L IA+C G                V+   + + A++ +  DR G TA 
Sbjct: 2   DVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETAL 61

Query: 143 ADAKYYGNVEVYNILKARGAKV 164
             A  Y   +    L    A  
Sbjct: 62  HLAARYSRSDAAKRLLEASADA 83

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 92.9 bits (232), Expect = 1e-22
 Identities = 23/105 (21%), Positives = 41/105 (39%), Gaps = 5/105 (4%)

Query: 76  LLFMACRGDVKG-VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           LL  A + D K   E L +    V+ +D +G T L+IA     +E+ K L+ + A+I+ +
Sbjct: 9   LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTPMTVA 175
           +    +    A   G  E+   +                  +  A
Sbjct: 69  NSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPA 113

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 81.0 bits (201), Expect = 3e-18
 Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 6/84 (7%)

Query: 80  ACRGDVKGVEDLLNEGS-DVNSIDLDGRTALHIAAC-----EGHVEVVKLLLSKKANIDA 133
           A +G +  V+ LL +G  D++  +  G TAL  A       + + ++VKLL+   A+   
Sbjct: 114 AEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSI 173

Query: 134 RDRWGSTAAADAKYYGNVEVYNIL 157
           +D  G TA   A   G  E+  IL
Sbjct: 174 KDNSGRTAMDYANQKGYTEISKIL 197

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 81.0 bits (201), Expect = 3e-18
 Identities = 31/110 (28%), Positives = 49/110 (44%), Gaps = 10/110 (9%)

Query: 76  LLFMACRGDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACEGHVEVVKLLLSK-KANIDA 133
            L+   +G  + +  +L     D+N  +  G  AL  AA +GH++ VKLLL   + +ID 
Sbjct: 76  YLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDF 135

Query: 134 RDRWGSTA---AA--DAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           ++ +G TA   A           ++  +L   GA    K    RT M  A
Sbjct: 136 QNDFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNSGRTAMDYA 185

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 74.8 bits (185), Expect = 5e-16
 Identities = 14/63 (22%), Positives = 25/63 (39%)

Query: 102 DLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG 161
             +    L  A      +V ++L      +D  D  G+T    A +  ++E+   L  RG
Sbjct: 3   TYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRG 62

Query: 162 AKV 164
           A +
Sbjct: 63  ADI 65

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 62.1 bits (152), Expect = 1e-11
 Identities = 14/39 (35%), Positives = 23/39 (58%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           V+ L+  G+D +  D  GRTA+  A  +G+ E+ K+L  
Sbjct: 161 VKLLMENGADQSIKDNSGRTAMDYANQKGYTEISKILAQ 199

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 94.1 bits (235), Expect = 1e-22
 Identities = 21/87 (24%), Positives = 39/87 (44%), Gaps = 1/87 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A     +  V+ LL  G++VN+    G +ALH A+  G + +V+ L+   A+   ++
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 213

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGA 162
               T    A+    +++      R A
Sbjct: 214 CHNDTPLMVARSRRVIDILRGKATRPA 240

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 87.1 bits (217), Expect = 4e-20
 Identities = 21/78 (26%), Positives = 33/78 (42%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           V      G +++  +   +T LH+A       VV+LL++  A+  A DR G TAA  A  
Sbjct: 29  VNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACE 88

Query: 148 YGNVEVYNILKARGAKVP 165
           + +      L    A   
Sbjct: 89  HRSPTCLRALLDSAAPGT 106

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 82.9 bits (206), Expect = 1e-18
 Identities = 28/94 (29%), Positives = 43/94 (45%), Gaps = 6/94 (6%)

Query: 77  LFMACR-GDVKGVEDLLNEG----SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
             +AC       +  LL+       D+ + + DG TALH+A      E V+LLL + A+I
Sbjct: 83  AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADI 142

Query: 132 DARDR-WGSTAAADAKYYGNVEVYNILKARGAKV 164
           DA D   G +    A    ++ +  +L   GA V
Sbjct: 143 DAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANV 176

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 71.3 bits (176), Expect = 1e-14
 Identities = 18/71 (25%), Positives = 26/71 (36%), Gaps = 4/71 (5%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLS----KKANIDARDRWGSTAAADAKYYGNVEV 153
               D DG T LHIA  +G++  V  L++        +D  +    T    A       V
Sbjct: 2   ATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSV 61

Query: 154 YNILKARGAKV 164
             +L   GA  
Sbjct: 62  VRLLVTAGASP 72

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 66.7 bits (164), Expect = 6e-13
 Identities = 10/51 (19%), Positives = 25/51 (49%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           + RG +  V  L+  G+D +  +    T L +A     +++++   ++ A+
Sbjct: 191 SGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILRGKATRPAS 241

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 94.9 bits (237), Expect = 1e-22
 Identities = 39/153 (25%), Positives = 69/153 (45%), Gaps = 23/153 (15%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG--AVTQNIPMMIVLEY 266
            G +V +K++DK++      +    +E+ I  + +HP++++       +  +   +VLE 
Sbjct: 35  TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV--YLVLEM 92

Query: 267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
              G++  YL+ +    S ++   F   +  GM YLH      I+H DL   N+LL    
Sbjct: 93  CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNM 149

Query: 326 QLKISGFGL--------LRLQ-------YISPE 343
            +KI+ FGL         +         YISPE
Sbjct: 150 NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 91.7 bits (229), Expect = 2e-22
 Identities = 22/99 (22%), Positives = 41/99 (41%), Gaps = 4/99 (4%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
           L +   G+ +    LL  G++ +  D  G   +H AA  G ++ ++ LL  +A+++  D 
Sbjct: 42  LQVMKLGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDN 101

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKVPKTK----RTP 171
            G+     A   G++ V   L    A     +     T 
Sbjct: 102 EGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTA 140

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 91.3 bits (228), Expect = 2e-22
 Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 1/89 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A RGD++ +  LL    +VN+ +  GRTAL +    G+ E+ + LL + AN D +D
Sbjct: 9   LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKD 67

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           R G     DA   G ++    L    A V
Sbjct: 68  RTGFAVIHDAARAGFLDTLQTLLEFQADV 96

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 88.2 bits (220), Expect = 3e-21
 Identities = 31/76 (40%), Positives = 46/76 (60%), Gaps = 1/76 (1%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTAAADAK 146
           ++ LL   +DVN  D +G   LH+AA EGH+ VV+ L+   A N+  R+  G TA   A+
Sbjct: 86  LQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLAR 145

Query: 147 YYGNVEVYNILKARGA 162
            YG  EV ++++A GA
Sbjct: 146 LYGRNEVVSLMQANGA 161

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 73.6 bits (182), Expect = 6e-16
 Identities = 19/64 (29%), Positives = 27/64 (42%), Gaps = 7/64 (10%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
                L  AA  G +E +  LL    N++A++ +G TA          GN E+   L  R
Sbjct: 4   PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK----LGNPEIARRLLLR 59

Query: 161 GAKV 164
           GA  
Sbjct: 60  GANP 63

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 91.3 bits (228), Expect = 2e-22
 Identities = 30/85 (35%), Positives = 40/85 (47%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
           A    V  VE LL  G+DV++ D  G   LH A   GH EV +LL+   A ++  D W  
Sbjct: 50  AGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKF 109

Query: 140 TAAADAKYYGNVEVYNILKARGAKV 164
           T   +A   G  E+  +L   GA  
Sbjct: 110 TPLHEAAAKGKYEICKLLLQHGADP 134

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 90.5 bits (226), Expect = 4e-22
 Identities = 26/75 (34%), Positives = 40/75 (53%), Gaps = 1/75 (1%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
            E L+  G+ VN  DL   T LH AA +G  E+ KLLL   A+   ++R G+T     K 
Sbjct: 91  AELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVK- 149

Query: 148 YGNVEVYNILKARGA 162
            G+ ++ ++L+   A
Sbjct: 150 DGDTDIQDLLRGDAA 164

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 88.6 bits (221), Expect = 2e-21
 Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 1/97 (1%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           N ++  QLL  A  GDV+ V+ L      +   I+    T LH AA    V VV+ LL  
Sbjct: 5   NSEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQH 64

Query: 128 KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            A++ A+D+ G     +A  YG+ EV  +L   GA V
Sbjct: 65  GADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVV 101

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 74.3 bits (184), Expect = 3e-16
 Identities = 26/81 (32%), Positives = 31/81 (38%), Gaps = 7/81 (8%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNVEV 153
           G+  NS   +    L  AA  G VE VK L + +  N    +   ST    A  Y  V V
Sbjct: 1   GAMGNS---EADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSV 57

Query: 154 YNILKARGAKV-PKTK--RTP 171
              L   GA V  K K    P
Sbjct: 58  VEYLLQHGADVHAKDKGGLVP 78

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 90.5 bits (226), Expect = 3e-22
 Identities = 27/71 (38%), Positives = 41/71 (57%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           VE LL  G+DVN+ D+   TALH A    H EVV+LL+   A++  + ++  TA   +  
Sbjct: 83  VEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISID 142

Query: 148 YGNVEVYNILK 158
            GN ++  IL+
Sbjct: 143 NGNEDLAEILQ 153

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 90.5 bits (226), Expect = 3e-22
 Identities = 28/77 (36%), Positives = 41/77 (53%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
            E LL  G   ++     RT LH+AA EGH  +V++LL   A+++A+D    TA   A  
Sbjct: 50  TEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATE 109

Query: 148 YGNVEVYNILKARGAKV 164
           + + EV  +L   GA V
Sbjct: 110 HNHQEVVELLIKYGADV 126

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 89.8 bits (224), Expect = 6e-22
 Identities = 27/89 (30%), Positives = 39/89 (43%), Gaps = 1/89 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           LL  A  G    V  L+  G+   + D  G + LH+AA  GH    ++LL    + DAR 
Sbjct: 6   LLEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDART 64

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           +   T    A   G+  +  +L   GA V
Sbjct: 65  KVDRTPLHMAASEGHANIVEVLLKHGADV 93

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 68.6 bits (169), Expect = 2e-14
 Identities = 20/71 (28%), Positives = 30/71 (42%), Gaps = 4/71 (5%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
           D    L  AA  G  + V++L++  A     D  G++    A  YG+     +L   G  
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFTT-DWLGTSPLHLAAQYGHFSTTEVLLRAGVS 59

Query: 164 V-PKTK--RTP 171
              +TK  RTP
Sbjct: 60  RDARTKVDRTP 70

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 93.9 bits (234), Expect = 3e-22
 Identities = 28/131 (21%), Positives = 52/131 (39%), Gaps = 7/131 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           + +G    +K   K      +  NA           +H +VV++  A  ++  M+I  EY
Sbjct: 33  RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEY 92

Query: 267 HAKGDLASYLQKKGR----LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
              G LA  + +  R       +++    L + RG+ Y+H      ++H D+KP NI + 
Sbjct: 93  CNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFIS 149

Query: 323 NGGQLKISGFG 333
                  +   
Sbjct: 150 RTSIPNAASEE 160

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.0 bits (232), Expect = 6e-22
 Identities = 38/127 (29%), Positives = 68/127 (53%), Gaps = 7/127 (5%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYH 267
           G KV VKIL+++  +  + +     E+  ++  RHP++++   V +   +    +V+EY 
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF--FMVMEYV 93

Query: 268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
           + G+L  Y+ K GR+   +  R    +   ++Y H      ++H DLKP+N+LLD     
Sbjct: 94  SGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNA 150

Query: 328 KISGFGL 334
           KI+ FGL
Sbjct: 151 KIADFGL 157

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 92.6 bits (231), Expect = 7e-22
 Identities = 47/141 (33%), Positives = 66/141 (46%), Gaps = 12/141 (8%)

Query: 200 KGSYQVAK-----WNGTKVWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGA 253
           +G+Y   +          V VKI+D +   D PE I     E+ I +   H NVV+F G 
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFYGH 73

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
             +     + LEY + G+L   ++    +      RF   L  G+ YLH      I H D
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 130

Query: 314 LKPKNILLDNGGQLKISGFGL 334
           +KP+N+LLD    LKIS FGL
Sbjct: 131 IKPENLLLDERDNLKISDFGL 151

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 92.5 bits (231), Expect = 1e-21
 Identities = 31/85 (36%), Positives = 43/85 (50%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
                   VE LL  G+D      +G T   +AA  G V+++KL LSK A+++  D +G 
Sbjct: 47  VQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGF 106

Query: 140 TAAADAKYYGNVEVYNILKARGAKV 164
           TA  +A  YG V+    L  RGA V
Sbjct: 107 TAFMEAAVYGKVKALKFLYKRGANV 131

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 89.5 bits (223), Expect = 1e-20
 Identities = 24/78 (30%), Positives = 38/78 (48%), Gaps = 1/78 (1%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAK 146
              LL+ G+DVN     G+T L +A  + H+ +V+ LL ++   I+  D  G TA   A 
Sbjct: 202 THLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAV 261

Query: 147 YYGNVEVYNILKARGAKV 164
                ++  +L  RGA  
Sbjct: 262 ELKLKKIAELLCKRGAST 279

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 89.1 bits (222), Expect = 2e-20
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L  A +  DV  V+ LL  G++VN  + + G T LH A      ++V+LLL   A+   R
Sbjct: 9   LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            + G+T    A   G+V++  +  ++GA V
Sbjct: 69  KKNGATPFLLAAIAGSVKLLKLFLSKGADV 98

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 84.8 bits (211), Expect = 5e-19
 Identities = 36/96 (37%), Positives = 49/96 (51%), Gaps = 11/96 (11%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD---- 135
           A  G VK ++  L++G+DVN  D  G TA   AA  G V+ +K L  + AN++ R     
Sbjct: 80  AIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKTKE 139

Query: 136 ------RWGSTAAADAKYYGNVEVYNIL-KARGAKV 164
                 + G+TA  DA   G+VEV  IL    GA V
Sbjct: 140 DQERLRKGGATALMDAAEKGHVEVLKILLDEMGADV 175

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 77.9 bits (193), Expect = 1e-16
 Identities = 28/109 (25%), Positives = 49/109 (44%), Gaps = 9/109 (8%)

Query: 76  LLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHV----EVVKLLLSKKAN 130
           L+  A +G V+ ++ LL+E G+DVN+ D  GR AL  A           +  LLL   A+
Sbjct: 152 LMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGAD 211

Query: 131 IDARDRWGSTAAADAKYYGNVEVYNIL-KARGAKV-PKTK--RTPMTVA 175
           ++ R   G T    A    ++ +   L +    ++       +T + +A
Sbjct: 212 VNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLA 260

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 77.5 bits (192), Expect = 2e-16
 Identities = 17/57 (29%), Positives = 29/57 (50%), Gaps = 1/57 (1%)

Query: 80  ACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
             +  +  V+ LL  E  ++N  D DG+TAL +A      ++ +LL  + A+ D  D
Sbjct: 227 VEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD 283

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 71.3 bits (176), Expect = 3e-14
 Identities = 14/62 (22%), Positives = 26/62 (41%), Gaps = 1/62 (1%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDR-WGSTAAADAKYYGNVEVYNILKARGA 162
           +    L  A     V++V+ LL   AN++ ++   G T   +A      ++  +L   GA
Sbjct: 4   EDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGA 63

Query: 163 KV 164
             
Sbjct: 64  DP 65

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 91.3 bits (228), Expect = 1e-21
 Identities = 24/90 (26%), Positives = 38/90 (42%), Gaps = 1/90 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           ++     G  +   +L+  G DV   D +  T LH AA    +++VK  +SK A +D   
Sbjct: 13  IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72

Query: 136 R-WGSTAAADAKYYGNVEVYNILKARGAKV 164
               ST    A   G++ +   L   GA  
Sbjct: 73  GDLNSTPLHWATRQGHLSMVVQLMKYGADP 102

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 90.6 bits (226), Expect = 2e-21
 Identities = 27/78 (34%), Positives = 35/78 (44%), Gaps = 1/78 (1%)

Query: 88  VEDLLNEGSDVNSID-LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK 146
              LL     VN  D     TALH A   G+  V+ LLL   AN+DA++  G +A   AK
Sbjct: 159 TRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAK 218

Query: 147 YYGNVEVYNILKARGAKV 164
              NV + N L+      
Sbjct: 219 QRKNVWMINHLQEARQAK 236

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 87.5 bits (218), Expect = 3e-20
 Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 1/78 (1%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           V  L+  G+D + ID +G + +H+AA  GH  +V  L++K  ++D  D+ G T    A Y
Sbjct: 92  VVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAY 151

Query: 148 YGN-VEVYNILKARGAKV 164
             + V+   +L      V
Sbjct: 152 RTHSVDPTRLLLTFNVSV 169

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 86.7 bits (216), Expect = 5e-20
 Identities = 23/90 (25%), Positives = 41/90 (45%), Gaps = 2/90 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L  A     +  V+  +++G+ V+ +  D   T LH A  +GH+ +V  L+   A+    
Sbjct: 46  LHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLI 105

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           D  G +    A  +G+  +   L A+G  V
Sbjct: 106 DGEGCSCIHLAAQFGHTSIVAYLIAKGQDV 135

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 84.4 bits (210), Expect = 4e-19
 Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 6/105 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH-VEVVKLLLSKKANIDAR 134
           + +A + G    V  L+ +G DV+ +D +G T L  AA   H V+  +LLL+   +++  
Sbjct: 113 IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLG 172

Query: 135 DRW-GSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           D++  +TA   A   GN  V ++L   GA V  +     + + +A
Sbjct: 173 DKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLA 217

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 79.8 bits (198), Expect = 2e-17
 Identities = 12/67 (17%), Positives = 24/67 (35%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
           +  ID      +  A   G  E  + L+    ++   D+   T    A     +++    
Sbjct: 2   MTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYY 61

Query: 158 KARGAKV 164
            ++GA V
Sbjct: 62  ISKGAIV 68

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 72.5 bits (179), Expect = 6e-15
 Identities = 13/60 (21%), Positives = 28/60 (46%), Gaps = 1/60 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A   G+   +  LL  G++V++ ++ G +AL +A    +V ++  L   +      +
Sbjct: 181 LHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDN 240

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 92.2 bits (230), Expect = 1e-21
 Identities = 29/99 (29%), Positives = 42/99 (42%), Gaps = 10/99 (10%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
               D + V  L + G+D+N  +   GRT LH+A       V++LLL   A+  AR   G
Sbjct: 166 VIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGG 225

Query: 139 STA---AADAKYYGNVEVYNILKARGAKVP-KTK--RTP 171
            T    A       N  +  +L+A GA  P       +P
Sbjct: 226 RTPLGSAL---LRPNPILARLLRAHGAPEPEDGGDKLSP 261

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 89.1 bits (222), Expect = 2e-20
 Identities = 13/74 (17%), Positives = 25/74 (33%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
                   +E LL  G+D  +    GRT L  A    +  + +LL +  A          
Sbjct: 200 VEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKL 259

Query: 140 TAAADAKYYGNVEV 153
           +  + +    + + 
Sbjct: 260 SPCSSSGSDSDSDN 273

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 25/142 (17%), Positives = 42/142 (29%), Gaps = 17/142 (11%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDL---DGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
                   ++ LL   +    +DL    G+TALH+AA  G    V+ L +  A +   +R
Sbjct: 17  VIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAER 76

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKAD 196
            G TA   A          +L       P+         +    P+    P  +      
Sbjct: 77  GGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVD----- 131

Query: 197 GITKGSYQVAKWNGTKVWVKIL 218
                    ++ N         
Sbjct: 132 ---------SQPNPENEEEPRD 144

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 87.6 bits (218), Expect = 5e-20
 Identities = 21/103 (20%), Positives = 37/103 (35%), Gaps = 10/103 (9%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            +      + +      +    + + + DG T LH+A      E+V+LL    A+++  +
Sbjct: 129 AVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPE 188

Query: 136 R-WGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTP 171
              G T    A          V  +L   GA    +    RTP
Sbjct: 189 PTCGRTPLHLAV---EAQAASVLELLLKAGADPTARMYGGRTP 228

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 75.7 bits (187), Expect = 8e-16
 Identities = 23/73 (31%), Positives = 29/73 (39%), Gaps = 9/73 (12%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN---IDARDRWGSTA---AADAKYYGNV 151
              +  DG TALH+A    H   +  LL   A    +D ++  G TA   AA     G  
Sbjct: 2   FGYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAA---ILGEA 58

Query: 152 EVYNILKARGAKV 164
                L A GA V
Sbjct: 59  STVEKLYAAGAGV 71

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 64.5 bits (158), Expect = 6e-12
 Identities = 21/117 (17%), Positives = 33/117 (28%), Gaps = 25/117 (21%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRT--------------ALHIAACEGHVEVV 121
           L +ACR         LL           D                 A   +      E  
Sbjct: 82  LHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEE 141

Query: 122 KLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKARGAKV----PKTKRTP 171
                 +  ++A +  G T    A     + + E+  +L+  GA +    P   RTP
Sbjct: 142 PRDEDWRLQLEAENYDGHTPLHVAV---IHKDAEMVRLLRDAGADLNKPEPTCGRTP 195

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 5/51 (9%), Positives = 11/51 (21%), Gaps = 1/51 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           L  A    +      L   G+       D  +    +  +   +       
Sbjct: 229 LGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGSDSDSDNRDEGDE 279

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 22/150 (14%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYH 267
             KV +K + ++  K  +       E++ ++  RHP++++   V     +I M  V+EY 
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM--VIEY- 90

Query: 268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
           A G+L  Y+ +K R++  +  RF   +   + Y H  K   I+H DLKP+N+LLD+   +
Sbjct: 91  AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNV 147

Query: 328 KISGFGLLRLQ--------------YISPE 343
           KI+ FGL  +               Y +PE
Sbjct: 148 KIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 47/141 (33%), Positives = 66/141 (46%), Gaps = 12/141 (8%)

Query: 200 KGSYQVAK-----WNGTKVWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGA 253
           +G+Y   +          V VKI+D +   D PE I     E+ I +   H NVV+F G 
Sbjct: 17  EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHENVVKFYGH 73

Query: 254 VTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
             +     + LEY + G+L   ++    +      RF   L  G+ YLH      I H D
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 130

Query: 314 LKPKNILLDNGGQLKISGFGL 334
           +KP+N+LLD    LKIS FGL
Sbjct: 131 IKPENLLLDERDNLKISDFGL 151

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 91.2 bits (227), Expect = 3e-21
 Identities = 39/181 (21%), Positives = 71/181 (39%), Gaps = 47/181 (25%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA- 253
            G +        + +G    +K +   + K          E+  + K  H N+V + G  
Sbjct: 21  SGGFGQVFKAKHRIDGKTYVIKRVKYNNEK-------AEREVKALAKLDHVNIVHYNGCW 73

Query: 254 ---------------VTQNIPMMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFALDLAR 296
                           ++   + I +E+  KG L  ++  ++  +L     L     + +
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------------QYISP 342
           G++Y+H  K   +I+ DLKP NI L +  Q+KI  FGL+                +Y+SP
Sbjct: 134 GVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190

Query: 343 E 343
           E
Sbjct: 191 E 191

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 35/130 (26%), Positives = 67/130 (51%), Gaps = 10/130 (7%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
           N  ++ +K + +    D         E+ + +  +H N+VQ++G+ ++N  + I +E   
Sbjct: 46  NQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102

Query: 269 KGDLASYLQKK-GRLSPSKVL--RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-G 324
            G L++ L+ K G L  ++     +   +  G+ YLH+ +   I+H D+K  N+L++   
Sbjct: 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYS 159

Query: 325 GQLKISGFGL 334
           G LKIS FG 
Sbjct: 160 GVLKISDFGT 169

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 88.6 bits (221), Expect = 4e-21
 Identities = 27/77 (35%), Positives = 40/77 (51%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
            E LL++GS+VN+ D  G+T L  +   G+ E+   LL   AN++ R+  G T    A  
Sbjct: 84  AEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASK 143

Query: 148 YGNVEVYNILKARGAKV 164
           YG  E+   L   GA +
Sbjct: 144 YGRSEIVKKLLELGADI 160

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 87.8 bits (219), Expect = 8e-21
 Identities = 25/89 (28%), Positives = 42/89 (47%), Gaps = 1/89 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +AC  G    ++ L+     +   D++G TAL  A     + + + LLSK +N++ +D
Sbjct: 39  LMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKD 98

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G T    +  +G  E+   L   GA V
Sbjct: 99  FSGKTPLMWSIIFGYSEMSYFLLEHGANV 127

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 87.4 bits (218), Expect = 1e-20
 Identities = 30/70 (42%), Positives = 40/70 (57%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
              LL  G++VN  +L+G T L +A+  G  E+VK LL   A+I ARD  G TA A A+ 
Sbjct: 117 SYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASARI 176

Query: 148 YGNVEVYNIL 157
           +G  EV  I 
Sbjct: 177 FGRQEVIKIF 186

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 82.1 bits (204), Expect = 1e-18
 Identities = 18/89 (20%), Positives = 33/89 (37%), Gaps = 6/89 (6%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
                 +   + ++ L N        D   RT L +A   G    +  L+     ++ +D
Sbjct: 12  EKIKDEKSINQNLDFLRNYR------DSYNRTPLMVACMLGMENAIDKLVENFDKLEDKD 65

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             GSTA   A     + +   L ++G+ V
Sbjct: 66  IEGSTALIWAVKNNRLGIAEKLLSKGSNV 94

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 61.6 bits (151), Expect = 1e-11
 Identities = 15/42 (35%), Positives = 23/42 (54%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA 129
           V+ LL  G+D+++ DL G TA   A   G  EV+K+    + 
Sbjct: 150 VKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVRR 191

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 51.6 bits (125), Expect = 5e-08
 Identities = 11/66 (16%), Positives = 21/66 (31%), Gaps = 6/66 (9%)

Query: 99  NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILK 158
           + +D +G     I   +   + +  L       + RD +  T    A   G     + L 
Sbjct: 2   SHMDKNGEIVEKIKDEKSINQNLDFL------RNYRDSYNRTPLMVACMLGMENAIDKLV 55

Query: 159 ARGAKV 164
               K+
Sbjct: 56  ENFDKL 61

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 49/198 (24%), Positives = 78/198 (39%), Gaps = 41/198 (20%)

Query: 169 RTPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESH 223
             P+ +    +   Y+             I  G++ VA+          V VK +++   
Sbjct: 8   TGPLDMPIMHDSDRYDFVKD---------IGSGNFGVARLMRDKLTKELVAVKYIERG-A 57

Query: 224 KDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYHAKGDLASYLQKKGR 281
              E +     E+      RHPN+V+F  V     ++   I++EY + G+L   +   GR
Sbjct: 58  AIDENV---QREIINHRSLRHPNIVRFKEVILTPTHL--AIIMEYASGGELYERICNAGR 112

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQLKISGFGLLRLQ- 338
            S  +   F   L  G++Y H  +   I H DLK +N LLD     +LKI  FG  +   
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169

Query: 339 -------------YISPE 343
                        YI+PE
Sbjct: 170 LHSQPKSTVGTPAYIAPE 187

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 91.3 bits (227), Expect = 5e-21
 Identities = 45/207 (21%), Positives = 82/207 (39%), Gaps = 22/207 (10%)

Query: 138 GSTAAADAKYYGNVEVYNILKARGAKV----PKTKRTPMTVANPREVP-EYELNPLELQV 192
           GS + +  + +    +     +  AK+    P+T+     +   +  P +YE       +
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60

Query: 193 RKADGITKGSY-QV----AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNV 247
                + +GS+ +V     K  G +  VK +  E  +          EL        P +
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--------EELVACAGLSSPRI 112

Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPD 307
           V   GAV +   + I +E    G L   +++ G L   + L +      G+ YLH  +  
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR-- 170

Query: 308 PIIHCDLKPKNILLD-NGGQLKISGFG 333
            I+H D+K  N+LL  +G +  +  FG
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFG 196

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 90.7 bits (226), Expect = 5e-21
 Identities = 24/103 (23%), Positives = 41/103 (39%), Gaps = 4/103 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L  A    D K V+ LL  G D +  D  G TAL+ A   G+++ VKL + K   +    
Sbjct: 66  LHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYG 125

Query: 136 RWG-STAAADAKYYGNVEVYNILKARGAKVPKTK--RTPMTVA 175
           + G  T+   A    +V + +   +            + + + 
Sbjct: 126 KTGWKTSFYHAVMLNDVSIVSYFLSEIPSTFDLAILLSCIHIT 168

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 90.7 bits (226), Expect = 5e-21
 Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 3/89 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            + A    +V+ V  LLN G+  N ++      LH AA     ++VK+LL    +    D
Sbjct: 35  SYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFD 92

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
             G+TA   A   GN++   +   +  ++
Sbjct: 93  DKGNTALYYAVDSGNMQTVKLFVKKNWRL 121

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 86.8 bits (216), Expect = 1e-19
 Identities = 18/91 (19%), Positives = 34/91 (37%), Gaps = 4/91 (4%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
           M L  +      K ++  L+   D    D+ G +A + A  + +V +V  LL+  A  + 
Sbjct: 2   MDLSRINT-WKSKQLKSFLS-SKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNL 59

Query: 134 RDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
            +         A    + ++  IL   G   
Sbjct: 60  LE--NEFPLHQAATLEDTKIVKILLFSGLDD 88

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 84.1 bits (209), Expect = 1e-18
 Identities = 15/127 (11%), Positives = 46/127 (36%), Gaps = 10/127 (7%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRT-ALHIAACEGHVEVVKLLLSKKANIDAR 134
           + +  + G V  +  LL+  +  N+ +       + +A     +E+++ L     NI + 
Sbjct: 165 IHITIKNGHVDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIYSA 224

Query: 135 DRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTKRTPMTVANPREVPEYELNPLELQVR 193
           +              + E+  ++  +  +    +    + +    ++ E      EL++ 
Sbjct: 225 NLENV-------LLDDAEIAKMIIEKHVEYKSDSYTKDLDIVKNNKLDEIISKNKELRLM 277

Query: 194 KADGITK 200
             + + K
Sbjct: 278 YVNCVKK 284

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 84.1 bits (209), Expect = 1e-18
 Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 3/90 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            + A    DV  V   L+E            + +HI    GHV+++ LLL    + +  +
Sbjct: 133 FYHAVMLNDVSIVSYFLSEIPSTFD-LAILLSCIHITIKNGHVDMMILLLDYMTSTNTNN 191

Query: 136 RWGSTAA-ADAKYYGNVEVYNILKARGAKV 164
                     A    ++E+   L      +
Sbjct: 192 SLLFIPDIKLAIDNKDIEMLQALFKYDINI 221

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 70.3 bits (173), Expect = 6e-14
 Identities = 8/83 (9%), Positives = 23/83 (27%), Gaps = 8/83 (9%)

Query: 76  LLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
            + +A    D++ ++ L     ++        +A          E+ K+++ K     + 
Sbjct: 198 DIKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDDAEIAKMIIEKHVEYKSD 250

Query: 135 DRWGSTAAADAKYYGNVEVYNIL 157
                           +   N  
Sbjct: 251 SYTKDLDIVKNNKLDEIISKNKE 273

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 91.3 bits (227), Expect = 6e-21
 Identities = 32/134 (23%), Positives = 57/134 (42%), Gaps = 9/134 (6%)

Query: 207 KWNGTKVWVKILDKE-----SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM 261
           K    +V VK + KE        +  ++   T E+ I+ +  H N+++ +          
Sbjct: 46  KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105

Query: 262 IVLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
           +V+E H  G DL +++ +  RL           L   + YL       IIH D+K +NI+
Sbjct: 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIV 162

Query: 321 LDNGGQLKISGFGL 334
           +     +K+  FG 
Sbjct: 163 IAEDFTIKLIDFGS 176

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 89.1 bits (222), Expect = 6e-21
 Identities = 22/86 (25%), Positives = 41/86 (47%), Gaps = 1/86 (1%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
           +  G +  VE L++ G+DVN+ +  +GRTALH+A    + ++V LLL   A+++     G
Sbjct: 125 SIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQG 184

Query: 139 STAAADAKYYGNVEVYNILKARGAKV 164
            +         +  +   L     + 
Sbjct: 185 YSPYQLTWGRPSTRIQQQLGQLTLEN 210

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 85.3 bits (212), Expect = 2e-19
 Identities = 15/78 (19%), Positives = 30/78 (38%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
           +  +  + + +N  +   +T LH+A      E+ + LL    + + RD  G+T    A  
Sbjct: 28  IRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACE 87

Query: 148 YGNVEVYNILKARGAKVP 165
            G +    +L        
Sbjct: 88  QGCLASVGVLTQSCTTPH 105

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 81.1 bits (201), Expect = 6e-18
 Identities = 23/86 (26%), Positives = 35/86 (40%), Gaps = 12/86 (13%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN------IDARDRWGSTA 141
            E LL  G D    D  G T LH+A  +G +  V +L            + A +  G T 
Sbjct: 61  AEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTC 120

Query: 142 ---AADAKYYGNVEVYNILKARGAKV 164
              A+    +G + +  +L + GA V
Sbjct: 121 LHLAS---IHGYLGIVELLVSLGADV 143

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 80.7 bits (200), Expect = 8e-18
 Identities = 29/109 (26%), Positives = 53/109 (48%), Gaps = 17/109 (15%)

Query: 77  LFMACR-GDVKGVEDLLNEGSD------VNSIDLDGRTALHIAACEGHVEVVKLLLSKKA 129
           L +AC  G +  V  L    +       + + + +G T LH+A+  G++ +V+LL+S  A
Sbjct: 82  LHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGA 141

Query: 130 NIDARDRW-GSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTP 171
           +++A++   G TA   A       N ++ ++L   GA V   T    +P
Sbjct: 142 DVNAQEPCNGRTALHLAV---DLQNPDLVSLLLKCGADVNRVTYQGYSP 187

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 70.7 bits (174), Expect = 2e-14
 Identities = 10/74 (13%), Positives = 18/74 (24%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS 139
               +   V  LL  G+DVN +   G +   +        + + L               
Sbjct: 159 VDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESE 218

Query: 140 TAAADAKYYGNVEV 153
              +        E 
Sbjct: 219 DEESYDTESEFTEF 232

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 63.0 bits (154), Expect = 1e-11
 Identities = 13/68 (19%), Positives = 25/68 (36%), Gaps = 4/68 (5%)

Query: 101 IDLDGRTALHIAACEGH----VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNI 156
           +  DG + LH+A         +EV++ +    A ++ ++    T    A      E+   
Sbjct: 4   LTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEA 63

Query: 157 LKARGAKV 164
           L   G   
Sbjct: 64  LLGAGCDP 71

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 1/86 (1%)

Query: 80  ACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
           A   ++  V+ L+ E GS+ +  D DG+T + +AA EG +EVV  L+ + A+++A D   
Sbjct: 287 AQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATD 346

Query: 139 STAAADAKYYGNVEVYNILKARGAKV 164
            TA   A+   +  + +I      + 
Sbjct: 347 HTARQLAQANNHHNIVDIFDRCRPER 372

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 6/91 (6%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK---ANIDARDR 136
                 + V  L+  G+D    +   R+ALH AA      ++  +L+      +I+  DR
Sbjct: 174 VLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDR 233

Query: 137 WGSTA---AADAKYYGNVEVYNILKARGAKV 164
            G TA    A  +    V    +L  +GAKV
Sbjct: 234 NGMTALMIVAHNEGRDQVASAKLLVEKGAKV 264

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 14/82 (17%), Positives = 31/82 (37%), Gaps = 3/82 (3%)

Query: 86  KGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA 145
              ++ +  G+DVN++D D  T L +A       +V  L+   A+    ++   +A   A
Sbjct: 147 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 206

Query: 146 KYYGNVEVYNIL---KARGAKV 164
               +  +   +         +
Sbjct: 207 AANRDFGMMVYMLNSTKLKGDI 228

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 79.6 bits (197), Expect = 9e-17
 Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 18/110 (16%)

Query: 81  CRGDVKGVEDLLNEGSDVN--------SIDLDGRTALHIAACEGHVEVVKLLLSKK-ANI 131
            R  V   + L+ +G+ V+        S    GRTALH AA   ++ +VK L+ +K +N 
Sbjct: 247 GRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNK 306

Query: 132 DARDRWGSTA---AADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
           D +D  G T    AA     G +EV   L  +GA V        T   +A
Sbjct: 307 DKQDEDGKTPIMLAA---QEGRIEVVMYLIQQGASVEAVDATDHTARQLA 353

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 19/96 (19%), Positives = 30/96 (31%), Gaps = 9/96 (9%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-------- 128
           L     G     E +  E  ++       RT LH  A     E  + L+  +        
Sbjct: 98  LHTEAAGSYAITEPITRESVNIIDPR-HNRTVLHWIASNSSAEKSEDLIVHEAKECIAAG 156

Query: 129 ANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
           A+++A D   +T    A       +   L   GA  
Sbjct: 157 ADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADP 192

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 12/57 (21%), Positives = 27/57 (47%), Gaps = 1/57 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID 132
           + +A + G ++ V  L+ +G+ V ++D    TA  +A    H  +V +    +   +
Sbjct: 317 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPERE 373

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 6/88 (6%), Positives = 17/88 (19%), Gaps = 9/88 (10%)

Query: 93  NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYG 149
                 N +              G+  +     +        +          A     G
Sbjct: 49  YIKRQRNELQHYSLYPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEA----AG 104

Query: 150 NVEVYNILKARGAKVPKTK--RTPMTVA 175
           +  +   +      +   +  RT +   
Sbjct: 105 SYAITEPITRESVNIIDPRHNRTVLHWI 132

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 31/154 (20%), Positives = 56/154 (36%), Gaps = 26/154 (16%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           +G++          +     +K +     K    ++    E+ ++    H  VV++  A 
Sbjct: 16  QGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS----EVMLLASLNHQYVVRYYAAW 71

Query: 255 TQNIPMM-------------IVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNY 300
            +    +             I +EY   G L   +  +       +  R    +   ++Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
           +H      IIH DLKP NI +D    +KI  FGL
Sbjct: 132 IHSQG---IIHRDLKPMNIFIDESRNVKIGDFGL 162

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 42/127 (33%), Positives = 70/127 (55%), Gaps = 7/127 (5%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYH 267
           G KV VKIL+++  +  + +     E+  ++  RHP++++   V +   +I M  V+EY 
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM--VMEYV 98

Query: 268 AKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
           + G+L  Y+ K GRL   +  R    +  G++Y H      ++H DLKP+N+LLD     
Sbjct: 99  SGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNA 155

Query: 328 KISGFGL 334
           KI+ FGL
Sbjct: 156 KIADFGL 162

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 88.2 bits (219), Expect = 5e-20
 Identities = 33/171 (19%), Positives = 67/171 (39%), Gaps = 25/171 (14%)

Query: 200 KGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA- 253
           +G + V      K +     +K +    +++  R      E+  + K  HP +V++  A 
Sbjct: 15  RGGFGVVFEAKNKVDDCNYAIKRIRL-PNRELAREKV-MREVKALAKLEHPGIVRYFNAW 72

Query: 254 -----------VTQNIPMMIVLEYHAKGDLASYLQKKGRLSP---SKVLRFALDLARGMN 299
                       +  + + I ++   K +L  ++  +  +     S  L   L +A  + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFP 350
           +LH      ++H DLKP NI       +K+  FGL+       E+  ++ P
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 28/127 (22%), Positives = 43/127 (33%), Gaps = 14/127 (11%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           + +A R G    V  L+  G      +  G TALH+A   G V+  K L S         
Sbjct: 24  IHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH 83

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVA---NPREVPEYELNPLELQV 192
             G      A      ++   L     +     + P ++    + REV E   +     V
Sbjct: 84  --GQKPIHLAVMANKTDLVVALVEGAKER---GQMPESLLNECDEREVNEIGSH-----V 133

Query: 193 RKADGIT 199
           +   G T
Sbjct: 134 KHCKGQT 140

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 86.8 bits (216), Expect = 3e-19
 Identities = 18/106 (16%), Positives = 33/106 (31%), Gaps = 4/106 (3%)

Query: 73  TMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID 132
             + L +             + G+ V    +     +  AA     EV++LL  K   + 
Sbjct: 259 LTKEL-LQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVV 317

Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTK--RTPMTVA 175
                G+  A   K      V  +  A  A V  +++       V+
Sbjct: 318 RSLNTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSSAVS 363

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 11/118 (9%), Positives = 33/118 (27%), Gaps = 6/118 (5%)

Query: 77  LFMACR-GDVKGVEDLLNE-----GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L  A    + + ++ +++         ++  +  G + LH A      +V    +    +
Sbjct: 177 LMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGID 236

Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPL 188
           ++  D   +     +     V +   L  +                        L+ +
Sbjct: 237 VNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYHNGTTVLPDRVVWLDFV 294

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 14/89 (15%), Positives = 32/89 (35%), Gaps = 1/89 (1%)

Query: 59  PVQDELTVPENLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH 117
           P  +  TV  +    +  +  A      + ++ L  +  +V      G         +  
Sbjct: 276 PYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRKKKAA 335

Query: 118 VEVVKLLLSKKANIDARDRWGSTAAADAK 146
             V ++ L+  A +  R R  + ++A +K
Sbjct: 336 PAVKRMKLAPSAPVRTRSRSRARSSAVSK 364

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 18/83 (21%), Positives = 36/83 (43%), Gaps = 7/83 (8%)

Query: 97  DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEV 153
           +    D +    +H+AA +G  + V+ L+    +   ++R+G TA   A     +G V+ 
Sbjct: 12  NRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLAC---KFGCVDT 68

Query: 154 YNILKARGAKV-PKTKRTPMTVA 175
              L + G        + P+ +A
Sbjct: 69  AKYLASVGEVHSLWHGQKPIHLA 91

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 14/85 (16%), Positives = 29/85 (34%), Gaps = 11/85 (12%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL-----SKKANIDARDRWGSTA- 141
           ++ L+  G+   + D    T L  A    + E + L++          +D  ++ G++  
Sbjct: 156 IKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHL 215

Query: 142 --AADAKYYGNVEVYNILKARGAKV 164
             A         +V       G  V
Sbjct: 216 HWAI---LINWEDVAMRFVEMGIDV 237

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 18/83 (21%), Positives = 37/83 (44%), Gaps = 7/83 (8%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG--HVEVVKLLLSKKANIDAR 134
             +    D + V ++       +     G+TALH     G  ++E++K+L+   A+  A+
Sbjct: 115 ESLLNECDEREVNEI-----GSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAK 169

Query: 135 DRWGSTAAADAKYYGNVEVYNIL 157
           D+   T    A  + N E  +++
Sbjct: 170 DKADETPLMRAMEFRNREALDLM 192

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 87.7 bits (218), Expect = 7e-20
 Identities = 30/152 (19%), Positives = 57/152 (37%), Gaps = 23/152 (15%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF--VGAVTQNIPMMIVLEYHAKG 270
           V +K++ +    DP        E     + + P+VV     G         + +      
Sbjct: 62  VALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-EIDGQLY-VDMRLINGV 119

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
           DLA+ L+++G L+P + +     +   ++  H        H D+KP+NIL+       + 
Sbjct: 120 DLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLV 176

Query: 331 GFGLLR----------------LQYISPEKAK 346
            FG+                  L Y++PE+  
Sbjct: 177 DFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 84.8 bits (211), Expect = 2e-19
 Identities = 25/113 (22%), Positives = 49/113 (43%), Gaps = 6/113 (5%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK-KANIDAR 134
           L +A      +  + L+  G+ V   D   +  LH AA  G +++++LL    K+ ++ +
Sbjct: 111 LHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQ 170

Query: 135 DRWGSTAAADAKYYGNVEVYNIL-KARGAKV-PKTK--RTPMTVANPREVPEY 183
           D+ G T    A   G+ +   +L +  GA+             VA   +V ++
Sbjct: 171 DKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNEQVKKF 223

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 84.4 bits (210), Expect = 3e-19
 Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 3/89 (3%)

Query: 77  LFMACR-GDVKGVEDLLN--EGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
             +AC  G+++ V+ L +     D+N I   G T LH+A  +   EV + L+   A++  
Sbjct: 76  FHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRI 135

Query: 134 RDRWGSTAAADAKYYGNVEVYNILKARGA 162
           +D++       A   G++++  +L   G 
Sbjct: 136 KDKFNQIPLHRAASVGSLKLIELLCGLGK 164

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 82.9 bits (206), Expect = 1e-18
 Identities = 31/105 (29%), Positives = 43/105 (40%), Gaps = 10/105 (9%)

Query: 77  LFMACR-GDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI--- 131
           L  AC   +   V++LL ++ S +   D DGR  LH +      E+   LLSK  N+   
Sbjct: 6   LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 65

Query: 132 DARDRWGSTAAADAKYYGNVEVYNIL--KARGAKV-PKTK--RTP 171
           D  D  G T    A   GN+EV   L  +     +   T    T 
Sbjct: 66  DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTC 110

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 66.3 bits (163), Expect = 6e-13
 Identities = 14/64 (21%), Positives = 26/64 (40%), Gaps = 7/64 (10%)

Query: 105 GRTALHIAACEGHV-EVVKLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
               LH A  E    +V +LL SK + +  +D+ G      +     +   E+ + L ++
Sbjct: 2   SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSV---SFQAHEITSFLLSK 58

Query: 161 GAKV 164
              V
Sbjct: 59  MENV 62

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 47.4 bits (114), Expect = 2e-06
 Identities = 13/52 (25%), Positives = 22/52 (42%), Gaps = 5/52 (9%)

Query: 77  LFMACR-GDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           LF A   G       L+   G++ + +D  G  A  +A    + +V K  L+
Sbjct: 178 LFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKFFLN 226

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 37/188 (19%), Positives = 74/188 (39%), Gaps = 26/188 (13%)

Query: 170 TPMTVANPREVPEYELNPLELQVRKADGITKGSYQVAK----------------WNGTKV 213
           + +        P  +L+  +L   K     +  YQV                   +   V
Sbjct: 12  SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPV 71

Query: 214 WVKILDKESHKDPERINAFTH---ELTIVEKARH--PNVVQFVGAVTQNIPMMIVLEYHA 268
            +K ++K+   D   +   T    E+ +++K       V++ +    +    +++LE   
Sbjct: 72  AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPE 131

Query: 269 -KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQ 326
              DL  ++ ++G L       F   +   + + H C    ++H D+K +NIL+D N G+
Sbjct: 132 PVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE 188

Query: 327 LKISGFGL 334
           LK+  FG 
Sbjct: 189 LKLIDFGS 196

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 86.4 bits (214), Expect = 4e-19
 Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 11/156 (7%)

Query: 183 YELNPLELQVRKADGITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHELT 237
            EL   + +     G   G+   V K     +G  +  K++  E    P   N    EL 
Sbjct: 28  GELKDDDFEKISELG--AGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQ 83

Query: 238 IVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARG 297
           ++ +   P +V F GA   +  + I +E+   G L   L+K GR+    + + ++ + +G
Sbjct: 84  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG 143

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           + YL E     I+H D+KP NIL+++ G++K+  FG
Sbjct: 144 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFG 177

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 83.0 bits (206), Expect = 1e-18
 Identities = 32/98 (32%), Positives = 43/98 (43%), Gaps = 12/98 (12%)

Query: 76  LLFMACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI--- 131
           LL  A   DV+ +  LL  EG +V+     G TALHIAA   ++E   +L+     +   
Sbjct: 7   LLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFE 66

Query: 132 --DARDRWGSTA---AADAKYYGNVEVYNILKARGAKV 164
              +    G TA   A       NV +   L ARGA V
Sbjct: 67  PMTSELYEGQTALHIAV---INQNVNLVRALLARGASV 101

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 76.1 bits (188), Expect = 3e-16
 Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 18/103 (17%)

Query: 80  ACRGDVKGVEDLLNEGSDV-----NSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           A   +++    L+    ++      S   +G+TALHIA    +V +V+ LL++ A++ AR
Sbjct: 45  ALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSAR 104

Query: 135 DR-------------WGSTAAADAKYYGNVEVYNILKARGAKV 164
                          +G    + A   G+ E+  +L   GA +
Sbjct: 105 ATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADI 147

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 76.1 bits (188), Expect = 3e-16
 Identities = 27/109 (24%), Positives = 39/109 (35%), Gaps = 23/109 (21%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLD-------------GRTALHIAACEGHVEVVK 122
           L       +V  V  LL  G+ V++                 G   L  AAC G  E+V+
Sbjct: 79  LHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR 138

Query: 123 LLLSKKANIDARDRWGSTA---AADAKYYGNVEV----YNILKARGAKV 164
           LL+   A+I A+D  G+T            N       YN+L +     
Sbjct: 139 LLIEHGADIRAQDSLGNTVLHILI---LQPNKTFACQMYNLLLSYDGGD 184

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 74.2 bits (183), Expect = 1e-15
 Identities = 25/99 (25%), Positives = 38/99 (38%), Gaps = 10/99 (10%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV----KLLLSKKANI 131
           L F AC G  + V  L+  G+D+ + D  G T LHI   + +         LLLS     
Sbjct: 125 LSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184

Query: 132 DA------RDRWGSTAAADAKYYGNVEVYNILKARGAKV 164
                    +  G T    A   GN+ ++  L  +   +
Sbjct: 185 HLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRKHI 223

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 64.5 bits (158), Expect = 3e-12
 Identities = 18/67 (26%), Positives = 28/67 (41%), Gaps = 7/67 (10%)

Query: 105 GRTALHIAACEGHVEVV-KLLLSKKANIDARDRWGSTA---AADAKYYGNVEVYNILKAR 160
             + L +AA E  V+ + KLL  +   +  R   G TA   AA    Y N+E   +L   
Sbjct: 3   WESPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAA---LYDNLEAAMVLMEA 59

Query: 161 GAKVPKT 167
             ++   
Sbjct: 60  APELVFE 66

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 84.1 bits (209), Expect = 1e-18
 Identities = 43/133 (32%), Positives = 59/133 (44%), Gaps = 7/133 (5%)

Query: 209 NGTKVWVKILDKESHKDPERINA-FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH 267
           N T V VK L        E +   F  E+ ++ K +H N+V+ +G  +    + +V  Y 
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 268 AKGDLASYLQKKGRLSP---SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
             G L   L       P       + A   A G+N+LHE   +  IH D+K  NILLD  
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169

Query: 325 GQLKISGFGLLRL 337
              KIS FGL R 
Sbjct: 170 FTAKISDFGLARA 182

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 28/160 (17%)

Query: 207 KWNGTKVWVKILDK-----ESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPM 260
           +    KV ++I+ K      S ++ +       E+ I++K  HP +++       ++   
Sbjct: 157 RKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-- 214

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            IVLE    G+L   +    RL  +    +   +   + YLHE     IIH DLKP+N+L
Sbjct: 215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVL 271

Query: 321 L---DNGGQLKISGFGLLRLQ--------------YISPE 343
           L   +    +KI+ FG  ++               Y++PE
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 12/158 (7%)

Query: 182 EYELNPLELQVRKADGITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHEL 236
            Y+    +L+     G   G+  QV K      G  + VK + +    + E       +L
Sbjct: 19  RYQAEINDLENLGEMG--SGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDL 74

Query: 237 TIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLA 295
            +V K+   P +VQ  G    N  + I +E           + +G +    + +  + + 
Sbjct: 75  DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           + + YL E     +IH D+KP NILLD  GQ+K+  FG
Sbjct: 135 KALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFG 170

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 33/146 (22%), Positives = 55/146 (37%), Gaps = 21/146 (14%)

Query: 200 KGSY----QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAV 254
            G+         ++   V VK +  E     +R      E+ ++ +   HPNV+++    
Sbjct: 34  HGAEGTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVIRYFCTE 87

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCD 313
                  I +E      L  Y+++K       + +        G+ +LH      I+H D
Sbjct: 88  KDRQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRD 143

Query: 314 LKPKNILLDNGGQ-----LKISGFGL 334
           LKP NIL+            IS FGL
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGL 169

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 82.4 bits (204), Expect = 5e-18
 Identities = 30/134 (22%), Positives = 55/134 (41%), Gaps = 12/134 (8%)

Query: 210 GTKVWVKILDKESHKDPERINAFTH---ELTIVEKAR----HPNVVQFVGAVTQNIPMMI 262
             +V +K++ +        ++       E+ ++ K      HP V++ +         M+
Sbjct: 56  RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115

Query: 263 VLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           VLE      DL  Y+ +KG L       F   +   + + H      ++H D+K +NIL+
Sbjct: 116 VLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILI 172

Query: 322 D-NGGQLKISGFGL 334
           D   G  K+  FG 
Sbjct: 173 DLRRGCAKLIDFGS 186

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 81.9 bits (203), Expect = 7e-18
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 9/131 (6%)

Query: 209 NGTKVWVKILDKES-HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI--VLE 265
              +  VKIL K+   + P        E+ ++ + RH NV+Q V  +       +  V+E
Sbjct: 29  TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88

Query: 266 YHAKG--DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           Y   G  ++   +  + R    +   +   L  G+ YLH      I+H D+KP N+LL  
Sbjct: 89  YCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTT 144

Query: 324 GGQLKISGFGL 334
           GG LKIS  G+
Sbjct: 145 GGTLKISALGV 155

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 82.2 bits (204), Expect = 8e-18
 Identities = 35/112 (31%), Positives = 61/112 (54%), Gaps = 6/112 (5%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+ ++++  HPN++  + A      + +V ++    DL   +      L+PS +  + L 
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKA 345
             +G+ YLH+     I+H DLKP N+LLD  G LK++ FGL +  + SP +A
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRA 168

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 79.3 bits (196), Expect = 9e-18
 Identities = 15/89 (16%), Positives = 34/89 (38%), Gaps = 7/89 (7%)

Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE------VVKLLLSKK-ANIDARD 135
           G  +  +  L +G+D+ ++    +  +        V+      + KL+ S+    +  +D
Sbjct: 92  GTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKD 151

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV 164
           +WG TA    K         +++    K 
Sbjct: 152 KWGLTALEFVKRCQKPIALKMMEDYIKKY 180

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 70.9 bits (174), Expect = 9e-15
 Identities = 21/120 (17%), Positives = 40/120 (33%), Gaps = 13/120 (10%)

Query: 69  NLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSI---DLDGRTALHIAACEGHVEVVKLL 124
           N  S  + +  A   G  +   +L  +G +              L     E   ++   L
Sbjct: 2   NAMSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFL 61

Query: 125 LSKKANIDARDRWGSTAAADAKYYGN------VEVYNILKARGAKV-PKTK--RTPMTVA 175
           ++K A+I +R + G+T        G        E+  I   +GA +    K  +  +   
Sbjct: 62  INKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKN 121

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 67.0 bits (164), Expect = 2e-13
 Identities = 7/45 (15%), Positives = 14/45 (31%)

Query: 91  LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
               G  +   D  G TAL           +K++       + ++
Sbjct: 140 FSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKYNLKE 184

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 33/103 (32%), Positives = 61/103 (59%), Gaps = 5/103 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E++++++  HPN+V  +  +     + +V E+  K DL   L + K  L  S++  +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L RG+ + H+ +   I+H DLKP+N+L+++ G LK++ FGL R
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.0 bits (201), Expect = 1e-17
 Identities = 31/103 (30%), Positives = 57/103 (55%), Gaps = 5/103 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+ ++++ +H N+V+    +  +  + +V E+  + DL  Y     G L P  V  F   
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L +G+ + H      ++H DLKP+N+L++  G+LK++ FGL R
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 25/140 (17%), Positives = 55/140 (39%), Gaps = 6/140 (4%)

Query: 214 WVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLA 273
                       P  ++A + ++  ++     N V  +   +  + + I ++   K +L 
Sbjct: 90  LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLK 149

Query: 274 SYLQKKGRLSP---SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
            ++ ++  L        L   + +A  + +LH      ++H DLKP NI       +K+ 
Sbjct: 150 DWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 206

Query: 331 GFGLLRLQYISPEKAKIVFP 350
            FGL+       E+  ++ P
Sbjct: 207 DFGLVTAMDQDEEEQTVLTP 226

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 39/152 (25%), Positives = 62/152 (40%), Gaps = 33/152 (21%)

Query: 210 GTKVWVKILDKE-----------------------SHKDPERINAFTHELTIVEKARHPN 246
            T   +K+L K+                         +    I     E+ I++K  HPN
Sbjct: 38  NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97

Query: 247 VVQFV----GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH 302
           VV+ V         ++   +V E   +G +         LS  +   +  DL +G+ YLH
Sbjct: 98  VVKLVEVLDDPNEDHL--YMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLH 154

Query: 303 ECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
             K   IIH D+KP N+L+   G +KI+ FG+
Sbjct: 155 YQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 79.9 bits (198), Expect = 3e-17
 Identities = 33/103 (32%), Positives = 59/103 (57%), Gaps = 5/103 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E++I+++ +H N+V+    +     +++V E+  + DL   L   +G L       F L 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L  G+ Y H+ +   ++H DLKP+N+L++  G+LKI+ FGL R
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 34/131 (25%), Positives = 62/131 (47%), Gaps = 6/131 (4%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +  VK++ K   K      +   E+ ++++  HPN+++            +V E 
Sbjct: 48  KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV 107

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   +  + R S     R    +  G+ Y+H+ K   I+H DLKP+N+LL++   
Sbjct: 108 YTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSK 164

Query: 324 GGQLKISGFGL 334
              ++I  FGL
Sbjct: 165 DANIRIIDFGL 175

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 32/123 (26%), Positives = 57/123 (46%), Gaps = 18/123 (14%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIP--------MMIVLEY--HAKGDLASYL-QKKGRLS 283
           E+ I++  +H NVV  +                + +V ++  H   DLA  L     + +
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFT 122

Query: 284 PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE 343
            S++ R    L  G+ Y+H  K   I+H D+K  N+L+   G LK++ FGL R  +   +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA-FSLAK 178

Query: 344 KAK 346
            ++
Sbjct: 179 NSQ 181

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 31/107 (28%), Positives = 54/107 (50%), Gaps = 9/107 (8%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDL 294
           E++++++ +H N+++    +  N  + ++ EY    DL  Y+ K   +S   +  F   L
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLD-----NGGQLKISGFGLLR 336
             G+N+ H  +    +H DLKP+N+LL          LKI  FGL R
Sbjct: 142 INGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 79.5 bits (197), Expect = 5e-17
 Identities = 25/104 (24%), Positives = 57/104 (54%), Gaps = 6/104 (5%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFAL 292
           E++++++  HPN+V+ +  +     + +V E+  + DL  ++       +    +  +  
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            L +G+ + H  +   ++H DLKP+N+L++  G +K++ FGL R
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 32/179 (17%), Positives = 65/179 (36%), Gaps = 34/179 (18%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV---------AKWNGTKVWVKILDKESHKDPERINA 231
           E++L    + V    G  +G++ QV            N  K  +K+    +  +      
Sbjct: 59  EFQLGSKLVYVHHLLG--EGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT- 115

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-----LSPSK 286
               +  ++ +     ++F  A       ++V E ++ G L + +          +    
Sbjct: 116 --QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGL 173

Query: 287 VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-----------DNGGQLKISGFGL 334
           V+ FA+ +   +  +H+C+   IIH D+KP N +L           D    L +   G 
Sbjct: 174 VISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 81.1 bits (200), Expect = 6e-17
 Identities = 36/154 (23%), Positives = 64/154 (41%), Gaps = 24/154 (15%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ---FVGAVTQNIPMM--IV 263
           NG  V +K L      D E       E   + +  HP++VQ   FV    ++   +  IV
Sbjct: 105 NGRPVVLKGLV--HSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIV 162

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           +EY     L        +L  ++ + + L++   ++YLH      +++ DLKP+NI+L  
Sbjct: 163 MEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTE 217

Query: 324 GGQLKISGFGLLRL-----------QYISPEKAK 346
              LK+   G +              + +PE  +
Sbjct: 218 EQ-LKLIDLGAVSRINSFGYLYGTPGFQAPEIVR 250

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 79.6 bits (197), Expect = 6e-17
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 5/103 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALD 293
           E+++++  +H N+V     +     + +V EY  K DL  YL      ++   V  F   
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           L RG+ Y H  K   ++H DLKP+N+L++  G+LK++ FGL R
Sbjct: 109 LLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 79.3 bits (196), Expect = 8e-17
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 28/160 (17%)

Query: 207 KWNGTKVWVKILDK-----ESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPM 260
           +    KV +KI+ K      S ++ +       E+ I++K  HP +++       ++   
Sbjct: 32  RKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-- 89

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            IVLE    G+L   +    RL  +    +   +   + YLHE     IIH DLKP+N+L
Sbjct: 90  YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVL 146

Query: 321 L---DNGGQLKISGFGLLRLQ--------------YISPE 343
           L   +    +KI+ FG  ++               Y++PE
Sbjct: 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 78.8 bits (195), Expect = 9e-17
 Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 26/168 (15%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKES---HKDPERINAFTHELTIVEKARHPNVVQFV 251
           +GS+       +   ++ + +KIL+K           +     E  ++ +  HP  V+  
Sbjct: 40  EGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR---ERDVMSRLDHPFFVKLY 96

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
                +  +   L Y   G+L  Y++K G    +   RF   ++   + YLH      II
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVSALEYLHGKG---II 152

Query: 311 HCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDPAN 358
           H DLKP+NILL+    ++I+ FG           AK++ P S    AN
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGT----------AKVLSPESKQARAN 190

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 42/177 (23%), Positives = 80/177 (45%), Gaps = 23/177 (12%)

Query: 162 AKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSY-QV----AKWNGTKVWVK 216
            +     R  +   +PR +       L+  V+    I +GS   V     K +G +V VK
Sbjct: 28  EQFKAALRMVVDQGDPRLL-------LDSYVK----IGEGSTGIVCLAREKHSGRQVAVK 76

Query: 217 ILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL 276
           ++D    +  E +    +E+ I+   +H NVV+   +      + +++E+   G L   +
Sbjct: 77  MMDLRKQQRRELL---FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-I 132

Query: 277 QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             + RL+  ++      + + + YLH      +IH D+K  +ILL   G++K+S FG
Sbjct: 133 VSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFG 186

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 24/158 (15%)

Query: 207 KWNGTKVWVKILDKESHKDPER---INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K  G +   K + K   +   R         E++I+ +  H NV+           ++++
Sbjct: 34  KSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI 93

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-- 321
           LE  + G+L  +L +K  LS  +   F   +  G+NYLH  K   I H DLKP+NI+L  
Sbjct: 94  LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLD 150

Query: 322 --DNGGQLKISGFGLLRL--------------QYISPE 343
                  +K+  FGL                 ++++PE
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 25/168 (14%)

Query: 198 ITKGSY---QVAKWNGTKVW--VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           I +G++    V K   T     +KI++K        ++ F  E  ++       + Q   
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 253 AVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPIIH 311
           A      + +V+EY+  GDL + L K G   P+++ RF   ++   ++ +H       +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVH 185

Query: 312 CDLKPKNILLDNGGQLKISGFGL-LRLQ---------------YISPE 343
            D+KP NILLD  G ++++ FG  L+L+               Y+SPE
Sbjct: 186 RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 77.2 bits (191), Expect = 2e-16
 Identities = 37/160 (23%), Positives = 70/160 (43%), Gaps = 24/160 (15%)

Query: 205 VAKWNGTKVWVKILDKESHKDPER---INAFTHELTIVEKARHPNVVQFVGAVTQNIPMM 261
             K  G +   K + K       R         E+ I+ + RHPN++           ++
Sbjct: 25  RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           ++LE  + G+L  +L +K  L+  +  +F   +  G++YLH  +   I H DLKP+NI+L
Sbjct: 85  LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIML 141

Query: 322 DN----GGQLKISGFGLLRL--------------QYISPE 343
            +      ++K+  FG+                 ++++PE
Sbjct: 142 LDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 77.2 bits (191), Expect = 2e-16
 Identities = 34/154 (22%), Positives = 59/154 (38%), Gaps = 21/154 (13%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +   KI++               E  I  K +HPN+V+   ++ +     +V + 
Sbjct: 28  KTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
              G+L   +  +   S +        +   + Y H      I+H +LKP+N+LL     
Sbjct: 87  VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK 143

Query: 324 GGQLKISGFGLLRL--------------QYISPE 343
           G  +K++ FGL                  Y+SPE
Sbjct: 144 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 33/108 (30%), Positives = 57/108 (52%), Gaps = 10/108 (9%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL------QKKGRLSPSKVL 288
           E++++++ +H N+V+    +     + +V E+    DL  Y+           L  + V 
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            F   L +G+ + HE K   I+H DLKP+N+L++  GQLK+  FGL R
Sbjct: 112 YFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 77.3 bits (191), Expect = 3e-16
 Identities = 28/127 (22%), Positives = 63/127 (49%), Gaps = 7/127 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
              G +V ++ ++ +     E I    +E+ ++ + ++PN+V ++ +      + +V+EY
Sbjct: 42  VATGQEVAIRQMNLQQQPKKELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G L   +  +  +   ++     +  + + +LH  +   +IH D+K  NILL   G 
Sbjct: 99  LAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154

Query: 327 LKISGFG 333
           +K++ FG
Sbjct: 155 VKLTDFG 161

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 76.9 bits (190), Expect = 3e-16
 Identities = 33/131 (25%), Positives = 54/131 (41%), Gaps = 9/131 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K    +   K + K   +D +R      E+ I++   HPN+++       N  + +V+E 
Sbjct: 31  KGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
              G+L   +  K     S   R   D+   + Y H+     + H DLKP+N L      
Sbjct: 88  CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSP 144

Query: 324 GGQLKISGFGL 334
              LK+  FGL
Sbjct: 145 DSPLKLIDFGL 155

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 32/156 (20%), Positives = 65/156 (41%), Gaps = 23/156 (14%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
             +  G     K +      D E +     E+  +   RHP +V    A   +  M+++ 
Sbjct: 177 TERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233

Query: 265 EYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           E+ + G+L   +  +  ++S  + + +   + +G+ ++HE      +H DLKP+NI+   
Sbjct: 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTT 290

Query: 324 --GGQLKISGFGLLRL--------------QYISPE 343
               +LK+  FGL                 ++ +PE
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 24/160 (15%)

Query: 205 VAKWNGTKVWVKILDKESHKDPER---INAFTHELTIVEKARHPNVVQFVGAVTQNIPMM 261
             K  G +   K + K   +   R         E++I+ +  HPN++           ++
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91

Query: 262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           ++LE  + G+L  +L +K  LS  +   F   +  G+NYLH  K   I H DLKP+NI+L
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIML 148

Query: 322 ----DNGGQLKISGFGLLRL--------------QYISPE 343
                    +K+  FGL                 ++++PE
Sbjct: 149 LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 77.0 bits (190), Expect = 4e-16
 Identities = 36/145 (24%), Positives = 70/145 (48%), Gaps = 18/145 (12%)

Query: 198 ITKGSY-QV----AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           +  G++ +V     K  G     K+++ +S ++ E       E+ I+    HP +V+ +G
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY---IVEIEILATCDHPYIVKLLG 83

Query: 253 AVTQNIPMMIVLEYHAKGDLAS-YLQKKGRLSPSK---VLRFALDLARGMNYLHECKPDP 308
           A   +  + I++E+   G + +  L+    L+  +   V R  L     +N+LH  +   
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML---EALNFLHSKR--- 137

Query: 309 IIHCDLKPKNILLDNGGQLKISGFG 333
           IIH DLK  N+L+   G ++++ FG
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFG 162

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 35/160 (21%), Positives = 67/160 (41%), Gaps = 15/160 (9%)

Query: 183 YELNPLELQVRKADGITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHELT 237
            E+   +L+     G  +G+Y  V K     +G  + VK +      + +       +L 
Sbjct: 2   MEVKADDLEPIMELG--RGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLD 57

Query: 238 IVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG---DLASYLQKKGRLSPSKVLRFALD 293
           I  +    P  V F GA+ +   + I +E             + K   +    + + A+ 
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVS 117

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           + + + +LH      +IH D+KP N+L++  GQ+K+  FG
Sbjct: 118 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFG 155

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 40/135 (29%), Positives = 61/135 (45%), Gaps = 10/135 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERIN------AFTHELTIVEK-ARHPNVVQFVGAVTQNIP 259
           K    +  VKI+D                 A   E+ I+ K + HPN++Q       N  
Sbjct: 39  KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
             +V +   KG+L  YL +K  LS  +  +    L   +  LH+     I+H DLKP+NI
Sbjct: 99  FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENI 155

Query: 320 LLDNGGQLKISGFGL 334
           LLD+   +K++ FG 
Sbjct: 156 LLDDDMNIKLTDFGF 170

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 18/87 (20%), Positives = 26/87 (29%), Gaps = 2/87 (2%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD--RW 137
            C   +  +  LL     V  I  +   A  +AA  GH+ V+  L               
Sbjct: 103 GCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAE 162

Query: 138 GSTAAADAKYYGNVEVYNILKARGAKV 164
              A   A   G++ V N L       
Sbjct: 163 NYHAFRLAAENGHLHVLNRLCELAPTE 189

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 17/102 (16%), Positives = 27/102 (26%), Gaps = 12/102 (11%)

Query: 77  LFMACRG---DVKGVEDLLNEGSDVNSIDL--DGRTALHIAACEGHVEVVKLLLSKKANI 131
             +A       V  +  L           +  +   A  +AA  GH+ V+  L       
Sbjct: 132 FRLAAENGHLHV--LNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTE 189

Query: 132 DARD--RWGSTAA--ADAKYYGNVEVYNILKARGAKVPKTKR 169
                      A   A A   G+  V N L      +   + 
Sbjct: 190 ATAMIQAENYYAFRWA-AVGRGHHNVINFLLDCPVMLAYAEI 230

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 16/106 (15%), Positives = 29/106 (27%), Gaps = 16/106 (15%)

Query: 77  LFMACRG---DVKGVEDLLNEGSDVNSIDL--DGRTALHIAACE-GHVEVVKLLLSKKAN 130
             +A       V  +  L        +  +  +   A   AA   GH  V+  LL     
Sbjct: 167 FRLAAENGHLHV--LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVM 224

Query: 131 IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN 176
           +   +            YG   V   +     ++ K       ++N
Sbjct: 225 LAYAEIHEFE-------YGEKYVNPFIARHVNRL-KEMHDAFKLSN 262

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 58.8 bits (142), Expect = 7e-10
 Identities = 13/83 (15%), Positives = 25/83 (30%), Gaps = 9/83 (10%)

Query: 63  ELTVPENLDSTMQLLFMACRGDVKGVEDLL---------NEGSDVNSIDLDGRTALHIAA 113
           +L           +L    R + + + D +            +   +I  D    L +A 
Sbjct: 268 DLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLAL 327

Query: 114 CEGHVEVVKLLLSKKANIDARDR 136
             G+     LLLS  + +     
Sbjct: 328 RLGNQGACALLLSIPSVLALTKA 350

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 58.4 bits (141), Expect = 9e-10
 Identities = 20/115 (17%), Positives = 36/115 (31%), Gaps = 11/115 (9%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA---CEGHVEVVKLLL 125
           N++   QLL +      +  + L    SD +   +       +AA   C   ++ + LLL
Sbjct: 59  NMEQVRQLLCLYYAHYNRNAKQLW---SDAHKKGIKSEVICFVAAITGCSSALDTLCLLL 115

Query: 126 SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK-----RTPMTVA 175
           +    +         A   A   G++ V N L                     +A
Sbjct: 116 TSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLA 170

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 76.4 bits (189), Expect = 6e-16
 Identities = 25/103 (24%), Positives = 48/103 (46%), Gaps = 5/103 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+ ++++ +HPN+V  +    +   + +V EY     +   L +  R +    V      
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY-CDHTVLHELDRYQRGVPEHLVKSITWQ 110

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             + +N+ H+      IH D+KP+NIL+     +K+  FG  R
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 76.7 bits (189), Expect = 9e-16
 Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 39/185 (21%)

Query: 183 YELNPLEL-------QVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHE 235
           Y ++  E+       QV K               G K+  KI+     KD E +    +E
Sbjct: 89  YTVSKTEILGGGRFGQVHKC---------EETATGLKLAAKIIKTRGMKDKEEVK---NE 136

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDL 294
           ++++ +  H N++Q   A      +++V+EY   G+L   +  +   L+    + F   +
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRL--------------Q 338
             G+ ++H+     I+H DLKP+NIL  N    Q+KI  FGL R               +
Sbjct: 197 CEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE 253

Query: 339 YISPE 343
           +++PE
Sbjct: 254 FLAPE 258

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 26/103 (25%), Positives = 48/103 (46%), Gaps = 5/103 (4%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALD 293
           E+ ++++ RH N+V  +    +     +V E+     +   L+     L    V ++   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
           +  G+ + H      IIH D+KP+NIL+   G +K+  FG  R
Sbjct: 133 IINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 35/149 (23%), Positives = 59/149 (39%), Gaps = 31/149 (20%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLE 265
            + G  V VK +  +             E+ ++ +   HPNV+++  + T +  + I LE
Sbjct: 36  SFQGRPVAVKRMLIDFCDIALM------EIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89

Query: 266 YHAKGDLASYLQKKG-------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
                +L   ++ K               +     +A G+ +LH  K   IIH DLKP+N
Sbjct: 90  L-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQN 145

Query: 319 ILLDNGG-------------QLKISGFGL 334
           IL+                 ++ IS FGL
Sbjct: 146 ILVSTSSRFTADQQTGAENLRILISDFGL 174

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 75.6 bits (187), Expect = 1e-15
 Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 16/144 (11%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFV 251
            GS+     +   +  + + +K+L KE     K  E  N    E  ++    HP +++  
Sbjct: 16  TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND---ERLMLSIVTHPFIIRMW 72

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
           G       + ++++Y   G+L S L+K  R       +F A ++   + YLH      II
Sbjct: 73  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-KFYAAEVCLALEYLHSKD---II 128

Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           + DLKP+NILLD  G +KI+ FG 
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGF 152

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 41/158 (25%), Positives = 70/158 (44%), Gaps = 24/158 (15%)

Query: 207 KWNGTKVWVKILDKESHKDPER---INAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K  G +   K + K   K   R         E++I+++ +HPNV+           ++++
Sbjct: 33  KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 92

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-- 321
           LE  A G+L  +L +K  L+  +   F   +  G+ YLH  +   I H DLKP+NI+L  
Sbjct: 93  LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLD 149

Query: 322 --DNGGQLKISGFGLLRL--------------QYISPE 343
                 ++KI  FGL                 ++++PE
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 39/134 (29%), Positives = 66/134 (49%), Gaps = 9/134 (6%)

Query: 207 KWNGTKVWVKILDK-----ESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPM 260
           +  G +  VKI++         +  E   A   E  I+ + A HP+++  + +   +  M
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            +V +   KG+L  YL +K  LS  +       L   +++LH      I+H DLKP+NIL
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENIL 232

Query: 321 LDNGGQLKISGFGL 334
           LD+  Q+++S FG 
Sbjct: 233 LDDNMQIRLSDFGF 246

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 34/154 (22%), Positives = 61/154 (39%), Gaps = 21/154 (13%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G +   KI++ +     +       E  I  K +HPN+V+   ++ +     +V + 
Sbjct: 51  KTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 109

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
              G+L   +  +   S +        +   + Y H      I+H +LKP+N+LL     
Sbjct: 110 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAK 166

Query: 324 GGQLKISGFGLLRL--------------QYISPE 343
           G  +K++ FGL                  Y+SPE
Sbjct: 167 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 16/144 (11%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFV 251
            GS+     V        + +KILDK+     K  E       E  I++    P +V+  
Sbjct: 51  TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN---EKRILQAVNFPFLVKLE 107

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
            +   N  + +V+EY A G++ S+L++ GR       RF A  +     YLH      +I
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF-SEPHARFYAAQIVLTFEYLHSLD---LI 163

Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           + DLKP+N+L+D  G ++++ FG 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGF 187

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 11/104 (10%)

Query: 240 EKARHPNVVQ----FVGAVTQNIP-MMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFAL 292
           E   HPNVV+       + T     + +V E+  + DL +YL    +  +    +     
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            L RG+++LH  +   ++H DLKP+NIL+ + GQ+K++ FGL R
Sbjct: 128 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 11/104 (10%)

Query: 240 EKARHPNVVQ----FVGAVTQNIP-MMIVLEYHAKGDLASYL--QKKGRLSPSKVLRFAL 292
           E   HPNVV+       + T     + +V E+  + DL +YL       L    +     
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 127

Query: 293 DLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              RG+++LH      I+H DLKP+NIL+ +GG +K++ FGL R
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 17/159 (10%), Positives = 33/159 (20%), Gaps = 35/159 (22%)

Query: 210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV------ 263
                +K+    +      +           +    +  +        +P   V      
Sbjct: 87  LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 264 -------------------LEYHAKGDLASYL-------QKKGRLSPSKVLRFALDLARG 297
                              L   A  DL             +G      +      L R 
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              L       ++H    P N+ +   G+L +     L 
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW 242

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 31/131 (23%), Positives = 59/131 (45%), Gaps = 7/131 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K    +  +KI+ K S       +    E+ +++   HPN+++            +V+E 
Sbjct: 59  KVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   +  + + +          +  G+ YLH+     I+H DLKP+N+LL++   
Sbjct: 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEK 174

Query: 324 GGQLKISGFGL 334
              +KI  FGL
Sbjct: 175 DALIKIVDFGL 185

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 75.5 bits (186), Expect = 2e-15
 Identities = 34/156 (21%), Positives = 70/156 (44%), Gaps = 23/156 (14%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           V K  G     K ++     D   +    +E++I+ +  HP ++    A      M+++L
Sbjct: 71  VEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127

Query: 265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           E+ + G+L   +  +  ++S ++V+ +      G+ ++HE     I+H D+KP+NI+ + 
Sbjct: 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCET 184

Query: 324 --GGQLKISGFGLLRL--------------QYISPE 343
                +KI  FGL                 ++ +PE
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE 220

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 75.9 bits (187), Expect = 3e-15
 Identities = 35/131 (26%), Positives = 65/131 (49%), Gaps = 7/131 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +    +  VK+++K +    +  +    E+ +++K  HPN+++    +  +    IV E 
Sbjct: 44  RITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--- 323
           +  G+L   + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL++   
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEK 159

Query: 324 GGQLKISGFGL 334
              +KI  FGL
Sbjct: 160 DCDIKIIDFGL 170

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 32/146 (21%), Positives = 63/146 (43%), Gaps = 15/146 (10%)

Query: 198 ITKGSY---QVAKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQ 249
           I +G++    V K         +KIL+K       +         E  ++       +  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE---ERDVLVNGDSKWITT 138

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDP 308
              A   +  + +V++Y+  GDL + L K     P ++ RF   ++   ++ +H+     
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--- 195

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGL 334
            +H D+KP NIL+D  G ++++ FG 
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGS 221

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 16/162 (9%)

Query: 182 EYELNPLELQVRKADGITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHEL 236
            ++    +L+     G  +G+Y  V K     +G  + VK +      D +       +L
Sbjct: 16  HWDFTAEDLKDLGEIG--RGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDL 71

Query: 237 TIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKG---DLASYLQKKGRLSPSKVL-RFA 291
            +V ++   P +VQF GA+ +     I +E  +                + P ++L +  
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 292 LDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           L   + +N+L E     IIH D+KP NILLD  G +K+  FG
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFG 171

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 25/149 (16%), Positives = 50/149 (33%), Gaps = 23/149 (15%)

Query: 215 VKILDKESH-KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA----- 268
           +++L    + K  +    F     +V+  +   +++          +     Y       
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 269 ---KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
                 L S+      L     L+  L + R +  LH      ++H  L+P +I+LD  G
Sbjct: 187 QTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRG 243

Query: 326 QLKISGFGLLR-----------LQYISPE 343
            + ++GF  L              +  PE
Sbjct: 244 GVFLTGFEHLVRDGARVVSSVSRGFEPPE 272

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 74.1 bits (183), Expect = 4e-15
 Identities = 33/158 (20%), Positives = 68/158 (43%), Gaps = 28/158 (17%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
             +  G    +K + K        +     E+ +++K +H N+V             +V+
Sbjct: 29  KQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHENIVTLEDIYESTTHYYLVM 85

Query: 265 EYHAKGDLASYLQKKGRLS---PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           +  + G+L   + ++G  +    S V++    +   + YLHE     I+H DLKP+N+L 
Sbjct: 86  QLVSGGELFDRILERGVYTEKDASLVIQ---QVLSAVKYLHENG---IVHRDLKPENLLY 139

Query: 322 ---DNGGQLKISGFGLLRLQ-------------YISPE 343
              +   ++ I+ FGL +++             Y++PE
Sbjct: 140 LTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPE 177

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 23/133 (17%), Positives = 45/133 (33%), Gaps = 6/133 (4%)

Query: 24  SLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTV----PENLDSTMQLLFM 79
            + + +      D  +     +F ++     I+  P            E   S  Q   +
Sbjct: 44  KIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHV 103

Query: 80  ACRGDVK-GVEDLLNEGSDVNS-IDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRW 137
           +    ++   +   N   ++N  +D  G T LH      ++E+VK L+   +N    D  
Sbjct: 104 SFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNM 163

Query: 138 GSTAAADAKYYGN 150
           G +    A    N
Sbjct: 164 GESCLVKAVKSVN 176

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 14/57 (24%), Positives = 29/57 (50%)

Query: 85  VKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           ++ ++      + +N+ D +G T L+IAA  G++ +V  LL   A+    ++ G   
Sbjct: 263 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 319

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 12/82 (14%), Positives = 29/82 (35%), Gaps = 4/82 (4%)

Query: 87  GVEDLLNEGSDVNSIDLDGRTALHIAA----CEGHVEVVKLLLSKKANIDARDRWGSTAA 142
            +  ++ + +       + + +          +  +E + L       ++A+D  G T  
Sbjct: 228 LMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCL 287

Query: 143 ADAKYYGNVEVYNILKARGAKV 164
             A   GN+ + + L   GA  
Sbjct: 288 NIAARLGNISIVDALLDYGADP 309

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 15/81 (18%), Positives = 28/81 (34%), Gaps = 8/81 (9%)

Query: 89  EDLLNEGSDVNSIDLDGRTALHIAACEGHV-EVVKLLLSKKANIDA-RDRWGSTA---AA 143
             L N+ S+ NS            + +  + EV     + + N++   D  G+T      
Sbjct: 80  TSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLT 139

Query: 144 DAKYYGNVEVYNILKARGAKV 164
                 N+E+   L   G+  
Sbjct: 140 ---SIANLELVKHLVKHGSNR 157

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 9/34 (26%), Positives = 16/34 (47%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA 113
           A  G++  V+ LL+ G+D    +  G   +   A
Sbjct: 291 ARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 324

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 18/164 (10%)

Query: 178 REVPEYELNPLELQVRKADGITKGSY-QV----AKWNGTKVWVKILDKESHKDPERINAF 232
             +   + +P E    K + I KGS+ +V           V +KI+D E  +D   I   
Sbjct: 11  PGMQNLKADP-EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDI 67

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSK---VLR 289
             E+T++ +   P V ++ G+  ++  + I++EY   G     L + G L  ++   +LR
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILR 126

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
             L   +G++YLH  K    IH D+K  N+LL   G++K++ FG
Sbjct: 127 EIL---KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFG 164

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 74.4 bits (183), Expect = 4e-15
 Identities = 36/130 (27%), Positives = 55/130 (42%), Gaps = 9/130 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
             N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY
Sbjct: 76  VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135

Query: 267 HAKGDLASYLQKKGRLSPSK---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
                       K  L   +   V   AL   +G+ YLH      +IH D+K  NILL  
Sbjct: 136 CLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSHN---MIHRDVKAGNILLSE 189

Query: 324 GGQLKISGFG 333
            G +K+  FG
Sbjct: 190 PGLVKLGDFG 199

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 73.7 bits (181), Expect = 4e-15
 Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 16/102 (15%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            L +        ++  +N           G+TALHIA    ++ +V LL+   A++ A  
Sbjct: 74  ALLLDVARKTDSLKQFVNA--SYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAA 131

Query: 136 R--------------WGSTAAADAKYYGNVEVYNILKARGAK 163
                          +G    + A     + +   L     +
Sbjct: 132 NGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQ 173

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 65.6 bits (160), Expect = 2e-12
 Identities = 28/136 (20%), Positives = 43/136 (31%), Gaps = 24/136 (17%)

Query: 77  LFMAC-RGDVKGVEDLLN-------EGSDVNSIDLD-GRTALHIAAC---EGHVEVVKLL 124
           +F A  + + + +E LL          +D    D + G+T L  A      G  + + LL
Sbjct: 17  IFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAMLNLHNGQNDTIALL 76

Query: 125 LSKKANIDA-----------RDRWGSTAAADAKYYGNVEVYNILKARGAKV-PKTKRTPM 172
           L      D+               G TA   A    N+ +  +L   GA V         
Sbjct: 77  LDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFF 136

Query: 173 TVANPREVPEYELNPL 188
                R    +   PL
Sbjct: 137 KKTKGRPGFYFGELPL 152

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 61.3 bits (149), Expect = 6e-11
 Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 23/119 (19%)

Query: 76  LLFMACRGDVKGVEDLLNEGS---DVNSIDLDGRTALHIAACEGH--------------- 117
           L   AC   +  V+ LL       D+++ D  G T LH                      
Sbjct: 152 LSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNE 211

Query: 118 -VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVA 175
            + +   L       +  +R G T  A A   G + V   +  R              A
Sbjct: 212 ILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHE----PECRHAA 266

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 10/63 (15%), Positives = 21/63 (33%), Gaps = 7/63 (11%)

Query: 88  VEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY 147
              L          +  G T L +AA  G + V+  +L ++ +              A +
Sbjct: 216 GAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAH 268

Query: 148 YGN 150
           + +
Sbjct: 269 HHH 271

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 51.7 bits (124), Expect = 9e-08
 Identities = 15/105 (14%), Positives = 33/105 (31%), Gaps = 13/105 (12%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLL-------SKKANIDARDR-WGSTA---AA 143
            +      L  R ++  A  + + + ++ LL        +  + + +D   G T    A 
Sbjct: 3   SAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAM 62

Query: 144 DAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPL 188
              + G  +   +L     K    K+     A+  +        L
Sbjct: 63  LNLHNGQNDTIALLLDVARKTDSLKQ--FVNASYTDSYYKGQTAL 105

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 73.9 bits (182), Expect = 7e-15
 Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 33/164 (20%)

Query: 207 KWNGTKVWVKILDKE--SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           +  G +  VKI+D    +            E +I    +HP++V+ +   + +  + +V 
Sbjct: 46  RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105

Query: 265 EYHAKGDLASYLQKKGRLSP-------SKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
           E+    DL   + K+            S  +R    +   + Y H+     IIH D+KP 
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMR---QILEALRYCHDNN---IIHRDVKPH 159

Query: 318 NILL---DNGGQLKISGFGLLRL---------------QYISPE 343
            +LL   +N   +K+ GFG+                   +++PE
Sbjct: 160 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 73.4 bits (181), Expect = 9e-15
 Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 39/187 (20%)

Query: 183 YELNPLEL------QVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHEL 236
           Y L   EL       VR+          ++K  G +   K L K   +  +      HE+
Sbjct: 30  YILTSKELGRGKFAVVRQC---------ISKSTGQEYAAKFLKK-RRRGQDCRAEILHEI 79

Query: 237 TIVEKARH-PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALD 293
            ++E A+  P V+           ++++LEY A G++ S    +    +S + V+R    
Sbjct: 80  AVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRL------------- 337
           +  G+ YLH+     I+H DLKP+NILL +    G +KI  FG+ R              
Sbjct: 140 ILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGT 196

Query: 338 -QYISPE 343
            +Y++PE
Sbjct: 197 PEYLAPE 203

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 72.7 bits (179), Expect = 9e-15
 Identities = 32/135 (23%), Positives = 58/135 (42%), Gaps = 12/135 (8%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           + +G +  +K ++K+  +    +     E+ +++   HPN+++          M IV+E 
Sbjct: 44  RSSGLERVIKTINKD--RSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101

Query: 267 HAKGDL----ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
              G+L     S   +   LS   V      +   + Y H      ++H DLKP+NIL  
Sbjct: 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQ 158

Query: 323 N---GGQLKISGFGL 334
           +      +KI  FGL
Sbjct: 159 DTSPHSPIKIIDFGL 173

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 72.7 bits (179), Expect = 9e-15
 Identities = 33/138 (23%), Positives = 60/138 (43%), Gaps = 19/138 (13%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
                KV +K ++ E  +    ++    E+  + +  HPN+V +  +      + +V++ 
Sbjct: 37  APKKEKVAIKRINLEKCQT--SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94

Query: 267 HAKG---DLASYLQKKGRLSPSK--------VLRFALDLARGMNYLHECKPDPIIHCDLK 315
            + G   D+  ++  KG              +LR  L    G+ YLH+      IH D+K
Sbjct: 95  LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL---EGLEYLHKNG---QIHRDVK 148

Query: 316 PKNILLDNGGQLKISGFG 333
             NILL   G ++I+ FG
Sbjct: 149 AGNILLGEDGSVQIADFG 166

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 17/124 (13%), Positives = 38/124 (30%), Gaps = 5/124 (4%)

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDL 272
           V +  +D +     + +         + +   P V + +  V      ++V E+   G L
Sbjct: 59  VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL 118

Query: 273 ASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
                     SP   +R    LA   +  H      +      P  + +   G + ++  
Sbjct: 119 QEVAD--TSPSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYP 173

Query: 333 GLLR 336
             + 
Sbjct: 174 ATMP 177

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 72.6 bits (179), Expect = 1e-14
 Identities = 41/154 (26%), Positives = 70/154 (45%), Gaps = 21/154 (13%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +    +  VK+++K S K  +  +    E+ +++K  HPN+++    +  +    IV E 
Sbjct: 44  RITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGEL 102

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
           +  G+L   + K+ R S     R    +  G+ Y+H+     I+H DLKP+NILL   + 
Sbjct: 103 YTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEK 159

Query: 324 GGQLKISGFGLLRL--------------QYISPE 343
              +KI  FGL                  YI+PE
Sbjct: 160 DCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 43/177 (24%), Positives = 76/177 (42%), Gaps = 23/177 (12%)

Query: 172 MTVANPREVPEYELNPLELQVRKADG---------ITKGSYQVA-----KWNGTKVWVKI 217
           +     R  P  +L  L+                 + +GSY        K  G  V +K 
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61

Query: 218 LDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLAS-YL 276
           +  E   D + I     E++I+++   P+VV++ G+  +N  + IV+EY   G ++    
Sbjct: 62  VPVE--SDLQEI---IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR 116

Query: 277 QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
            +   L+  ++        +G+ YLH  +    IH D+K  NILL+  G  K++ FG
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFG 170

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 16/82 (19%), Positives = 28/82 (34%), Gaps = 13/82 (15%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR-------------WGSTA 141
            +        G +ALHIA  +  ++ VKLL+   A++  R               +G   
Sbjct: 80  NAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELP 139

Query: 142 AADAKYYGNVEVYNILKARGAK 163
            + A      +V   L     +
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQ 161

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 70.2 bits (172), Expect = 5e-14
 Identities = 20/109 (18%), Positives = 32/109 (29%), Gaps = 19/109 (17%)

Query: 76  LLFMACRGDVKGVEDLLNEGS---DVNSIDLDGRTALH----------------IAACEG 116
           L   AC      V  LL        + + D  G T LH                I   +G
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDG 199

Query: 117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP 165
            +++   L       +  +  G T    A   G +E++  +  R     
Sbjct: 200 LLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGA 248

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 12/54 (22%), Positives = 23/54 (42%)

Query: 80  ACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
              G ++    L          +  G T L +AA EG +E+ + +L ++ +  A
Sbjct: 196 MYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGAA 249

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 62.1 bits (151), Expect = 3e-11
 Identities = 23/135 (17%), Positives = 36/135 (26%), Gaps = 23/135 (17%)

Query: 77  LFMAC-RGDVKGVEDLL--------NEGSDVNSIDLDGRTALHIAAC---EGHVEVVKLL 124
           LF    RG  + +  LL               +    G+T L  A     +G    +  L
Sbjct: 6   LFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMPL 65

Query: 125 LS-----------KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           L              A        G +A   A    +++   +L   GA V         
Sbjct: 66  LQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFF 125

Query: 174 VANPREVPEYELNPL 188
             +      +   PL
Sbjct: 126 QKHQGTCFYFGELPL 140

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 15/95 (15%), Positives = 20/95 (21%), Gaps = 13/95 (13%)

Query: 105 GRTALHIAACEGHVEVVKLLLSK--------KANIDARDRWGSTA---AADAKYYGNVEV 153
            R  L      G  E +  LL            +       G T    A      G    
Sbjct: 2   DRDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNAC 61

Query: 154 YNILKARGAKVPKTKRTPMTVANPREVPEYELNPL 188
              L          K  P+  A   +      + L
Sbjct: 62  IMPLLQIDKDSGNPK--PLVNAQCTDEFYQGHSAL 94

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 42/144 (29%), Positives = 66/144 (45%), Gaps = 16/144 (11%)

Query: 200 KGSY----QVAKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQF 250
           KGS+     V K N TK    +K ++K+      +   +     EL I++   HP +V  
Sbjct: 25  KGSFGKVCIVQK-NDTKKMYAMKYMNKQKCVERNEVRNVFK---ELQIMQGLEHPFLVNL 80

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
             +      M +V++    GDL  +LQ+        V  F  +L   ++YL   +   II
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---II 137

Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           H D+KP NILLD  G + I+ F +
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNI 161

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 46/171 (26%), Positives = 74/171 (43%), Gaps = 33/171 (19%)

Query: 198 ITKGSY---QVAKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQ 249
           I +G++   Q+ +   T+    +K+L K       D         E  I+  A  P VVQ
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE---ERDIMAFANSPWVVQ 133

Query: 250 FVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDP 308
              A   +  + +V+EY   GDL + +     + P K  RF   ++   ++ +H      
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDV-PEKWARFYTAEVVLALDAIHSMG--- 188

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGL-LRLQ---------------YISPE 343
            IH D+KP N+LLD  G LK++ FG  +++                YISPE
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 26/132 (19%), Positives = 56/132 (42%), Gaps = 12/132 (9%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G  V V+ ++ E+  + E +     EL + +   HPN+V +      +  + +V  +
Sbjct: 49  KPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 107

Query: 267 HAKGDLASYLQ--KKGRLSPSK---VLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
            A G     +       ++      +L+  L   + ++Y+H       +H  +K  +IL+
Sbjct: 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHMG---YVHRSVKASHILI 161

Query: 322 DNGGQLKISGFG 333
              G++ +SG  
Sbjct: 162 SVDGKVYLSGLR 173

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 24/131 (18%), Positives = 55/131 (41%), Gaps = 7/131 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
              G +    I++ +     +       E  I    +HPN+V+   ++++     ++ + 
Sbjct: 33  VLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDL 91

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
              G+L   +  +   S +        +   + + H+     ++H +LKP+N+LL     
Sbjct: 92  VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLK 148

Query: 324 GGQLKISGFGL 334
           G  +K++ FGL
Sbjct: 149 GAAVKLADFGL 159

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 36/144 (25%), Positives = 69/144 (47%), Gaps = 16/144 (11%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFV 251
           KG++ +V   +   T  +  +KIL KE   +  +         E  +++  RHP +    
Sbjct: 15  KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNTRHPFLTALK 71

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
            A   +  +  V+EY   G+L  +L ++   +  +  RF   ++   + YLH      ++
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-RFYGAEIVSALEYLHSRD---VV 127

Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           + D+K +N++LD  G +KI+ FGL
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGL 151

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 21/150 (14%), Positives = 46/150 (30%), Gaps = 30/150 (20%)

Query: 223 HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN----IPMMIVLEYHAKGD------- 271
            K+ ++       +   +  + P   + +          +     L    + +       
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197

Query: 272 LASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
           L S+      L     L+  L + R +  LH      ++H  L+P +I+LD  G + ++G
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254

Query: 332 FGLLRL----------------QYISPEKA 345
           F  L                  +  +    
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERML 284

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 11/143 (7%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHE---LTIVEKARHPNVVQFV 251
           +G +       K +  K++ +K LDK+  K  +      +E   L++V     P +V   
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIH 311
            A      +  +L+    GDL  +L + G  S + +  +A ++  G+ ++H      +++
Sbjct: 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVY 315

Query: 312 CDLKPKNILLDNGGQLKISGFGL 334
            DLKP NILLD  G ++IS  GL
Sbjct: 316 RDLKPANILLDEHGHVRISDLGL 338

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 34/135 (25%), Positives = 64/135 (47%), Gaps = 16/135 (11%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLE 265
                +  VKI++K+      R+     E+ ++ + + H NV++ +    +     +V E
Sbjct: 35  LITSQEYAVKIIEKQPGHIRSRV---FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91

Query: 266 YHAKGDLASYLQKKGRLS---PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
               G + S++ K+   +    S V++   D+A  +++LH      I H DLKP+NIL +
Sbjct: 92  KMRGGSILSHIHKRRHFNELEASVVVQ---DVASALDFLHNKG---IAHRDLKPENILCE 145

Query: 323 NGGQ---LKISGFGL 334
           +  Q   +KI  F L
Sbjct: 146 HPNQVSPVKICDFDL 160

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 30/141 (21%), Positives = 62/141 (43%), Gaps = 16/141 (11%)

Query: 207 KWNGTKVWVKILDK----------ESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ 256
           K   ++  +K++ K          ++    +      +E+++++   HPN+++       
Sbjct: 58  KNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117

Query: 257 NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
                +V E++  G+L   +  + +            +  G+ YLH+     I+H D+KP
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKP 174

Query: 317 KNILLDN---GGQLKISGFGL 334
           +NILL+N      +KI  FGL
Sbjct: 175 ENILLENKNSLLNIKIVDFGL 195

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 70.4 bits (173), Expect = 8e-14
 Identities = 36/156 (23%), Positives = 68/156 (43%), Gaps = 28/156 (17%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLE 265
           K +     VKI+ K    + ++      E+T ++    HPN+V+        +   +V+E
Sbjct: 33  KKSNQAFAVKIISKRMEANTQK------EITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---D 322
               G+L   ++KK   S ++       L   ++++H+     ++H DLKP+N+L    +
Sbjct: 87  LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDEN 143

Query: 323 NGGQLKISGFGLLRL---------------QYISPE 343
           +  ++KI  FG  RL                Y +PE
Sbjct: 144 DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 22/80 (27%), Positives = 40/80 (50%)

Query: 79  MACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
           +A +  +  V+ ++  G  +++   DG TALH AA     + +KLLL  +A +   +  G
Sbjct: 200 VANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAG 259

Query: 139 STAAADAKYYGNVEVYNILK 158
            TA   A+   + E   +L+
Sbjct: 260 ETALDIARKKHHKECEELLE 279

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 55.4 bits (133), Expect = 7e-09
 Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 12/107 (11%)

Query: 81  CRGDVKGVEDLLNEGSDVNSIDL------DGRTALHIA---ACEGHVEVVKLLLSKKANI 131
           C  D+  V +    G D                 LH+A   A +  + +V  ++    ++
Sbjct: 160 CNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHL 219

Query: 132 DARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
           DA+   G+TA   A  Y   +   +L    A V    +   T + +A
Sbjct: 220 DAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIA 266

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 43.8 bits (103), Expect = 4e-05
 Identities = 16/55 (29%), Positives = 25/55 (45%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L  A        ++ LL   + V +++  G TAL IA  + H E  +LL   +A 
Sbjct: 230 LHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQAQAG 284

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 69.3 bits (169), Expect = 1e-13
 Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 4/86 (4%)

Query: 76  LLFMACR----GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
            L +A R      +  V+ L+    +++     G TALH      + E +KLLL  KA+I
Sbjct: 172 ALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASI 231

Query: 132 DARDRWGSTAAADAKYYGNVEVYNIL 157
           +  +  G T    AK   +     +L
Sbjct: 232 EIANESGETPLDIAKRLKHEHCEELL 257

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 54.2 bits (130), Expect = 1e-08
 Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 12/107 (11%)

Query: 81  CRGDVKGVEDLLNEGSDVNSI------DLDGRTALHIAACEG---HVEVVKLLLSKKANI 131
              D+ G+     +G D+              TALH+A        + +V  L+    N+
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198

Query: 132 DARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA 175
           D +   GSTA        N E   +L    A +    ++  TP+ +A
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 245

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 12/55 (21%), Positives = 21/55 (38%), Gaps = 1/55 (1%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L   C   + + ++ LL   + +   +  G T L IA    H    +LL    + 
Sbjct: 209 LHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALSG 263

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 69.0 bits (169), Expect = 1e-13
 Identities = 20/101 (19%), Positives = 36/101 (35%), Gaps = 16/101 (15%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR 136
           + +        + + +N       +   G+TALHIA        V+LL+ K A++ A+ R
Sbjct: 67  ILLDIAEKTGNMREFINS--PFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQAR 124

Query: 137 --------------WGSTAAADAKYYGNVEVYNILKARGAK 163
                         +G    + A       + + L   G K
Sbjct: 125 GRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHK 165

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 23/139 (16%), Positives = 38/139 (27%), Gaps = 29/139 (20%)

Query: 76  LLFMACRGDVKG----VEDLLNEGSDVNSIDL----DGRTALHIAA---CEGHVEVVKLL 124
           L  +  RG   G    +  LL     +   +      G+T L  A      G  + + +L
Sbjct: 9   LFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTIPIL 68

Query: 125 LSK-----------KANIDARDRWGSTA---AADAKYYGNVEVYNILKARGAKVP-KTKR 169
           L              +        G TA   A             +L  +GA V  + + 
Sbjct: 69  LDIAEKTGNMREFINSPFRDVYYRGQTALHIAI---ERRCKHYVELLVEKGADVHAQARG 125

Query: 170 TPMTVANPREVPEYELNPL 188
                 +      +   PL
Sbjct: 126 RFFQPKDEGGYFYFGELPL 144

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 58.6 bits (142), Expect = 4e-10
 Identities = 9/55 (16%), Positives = 24/55 (43%), Gaps = 7/55 (12%)

Query: 88  VEDLLNEGSDVNS-------IDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
            + LL + + +         ++ DG + L +AA  G + + + ++ ++    A  
Sbjct: 201 YDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAAAH 255

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 58.6 bits (142), Expect = 4e-10
 Identities = 21/112 (18%), Positives = 31/112 (27%), Gaps = 19/112 (16%)

Query: 76  LLFMACRGDVKGVEDLLNEGS---DVNSIDLDGRTALHIAACEGH---------VEVVKL 123
           L   AC      V  L   G    D+   D  G T LH                 ++  L
Sbjct: 144 LSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203

Query: 124 LLSKKANIDA-------RDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK 168
           LL K A +          +  G +    A   G + ++  +  R        
Sbjct: 204 LLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAAAH 255

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 47.1 bits (112), Expect = 3e-06
 Identities = 16/95 (16%), Positives = 26/95 (27%), Gaps = 13/95 (13%)

Query: 105 GRTALHIAA----CEGHVEVVKLLLSKKANIDARDRW----GSTA---AADAKYYGNVEV 153
            R  L         +G   ++  LL+ K  +   +      G T    A      G  + 
Sbjct: 5   NRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDT 64

Query: 154 YNILKARGAKVPKTKRTPMTVANPREVPEYELNPL 188
             IL     K    +      +  R+V       L
Sbjct: 65  IPILLDIAEKTGNMR--EFINSPFRDVYYRGQTAL 97

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 28/156 (17%), Positives = 59/156 (37%), Gaps = 24/156 (15%)

Query: 205 VAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           V   +      K +      D   +     E++I+  ARH N++    +      ++++ 
Sbjct: 25  VETSSKKTYMAKFVKV-KGTDQVLVK---KEISILNIARHRNILHLHESFESMEELVMIF 80

Query: 265 EYHAKGDLASY-LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           E+ +  D+          L+  +++ +   +   + +LH      I H D++P+NI+   
Sbjct: 81  EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQT 137

Query: 324 --GGQLKISGFGLLRL--------------QYISPE 343
                +KI  FG  R               +Y +PE
Sbjct: 138 RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 35/140 (25%), Positives = 70/140 (50%), Gaps = 7/140 (5%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           KG++     V +    + + +KIL KE     + +     E  +++ +RHP +     + 
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF 217

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
             +  +  V+EY   G+L  +L ++   S  +   +  ++   ++YLH  K   +++ DL
Sbjct: 218 QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDL 275

Query: 315 KPKNILLDNGGQLKISGFGL 334
           K +N++LD  G +KI+ FGL
Sbjct: 276 KLENLMLDKDGHIKITDFGL 295

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 40/148 (27%), Positives = 61/148 (41%), Gaps = 22/148 (14%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           KG +            K++  K L+K+  K  +      +E  I+EK     VV    A 
Sbjct: 194 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR--------GMNYLHECKP 306
                + +VL     GDL  ++   G+        F    A         G+  LH  + 
Sbjct: 254 ETKDALCLVLTLMNGGDLKFHIYHMGQA------GFPEARAVFYAAEICCGLEDLHRER- 306

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             I++ DLKP+NILLD+ G ++IS  GL
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGL 332

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 25/137 (18%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMI--VLEYHAKGDLASYL---------QKKGRLS 283
           E+ ++ + +HPNV+        +    +  + +Y A+ DL   +         +K  +L 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 126

Query: 284 PSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGLLRLQY 339
              V      +  G++YLH      ++H DLKP NIL+       G++KI+  G  RL +
Sbjct: 127 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL-F 182

Query: 340 ISPEKAKIVFPVSHIDP 356
            SP K     P++ +DP
Sbjct: 183 NSPLK-----PLADLDP 194

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 20/148 (13%)

Query: 200 KGSY----QVAKWNG---TKVW-VKILDKES----HKDPERINAFTHELTIVEKARHPNV 247
           KG Y    QV K  G    K++ +K+L K       KD     A   E  I+E+ +HP +
Sbjct: 27  KGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNILEEVKHPFI 83

Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKP 306
           V  + A      + ++LEY + G+L   L+++G         F   +++  + +LH+   
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CFYLAEISMALGHLHQKG- 141

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             II+ DLKP+NI+L++ G +K++ FGL
Sbjct: 142 --IIYRDLKPENIMLNHQGHVKLTDFGL 167

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.9 bits (168), Expect = 6e-13
 Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 19/146 (13%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKESHKDPERINAFTHELTIVEK------ARHPNVV 248
           KGS+ +V  ++  GT     VKIL K+     + +     E T+VEK       + P + 
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV-----ECTMVEKRVLALPGKPPFLT 405

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDP 308
           Q          +  V+EY   GDL  ++Q+ GR      + +A ++A G+ +L       
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--- 462

Query: 309 IIHCDLKPKNILLDNGGQLKISGFGL 334
           II+ DLK  N++LD+ G +KI+ FG+
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGM 488

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368

 Score = 68.3 bits (166), Expect = 6e-13
 Identities = 36/152 (23%), Positives = 51/152 (33%), Gaps = 1/152 (0%)

Query: 8   LKRGISRQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVP 67
           +    S +   GSLR           S  P     R S    S            ++   
Sbjct: 170 VPPKPSIRPRPGSLRSKPEPPSEDLGSLHPGALLFRASGHPPSLPTMADALAHGADVNWV 229

Query: 68  ENLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
                    L  A     +   E LL  G++VN  D  GR  LH A   GH  +  L L 
Sbjct: 230 NGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLK 289

Query: 127 KKANIDARDRWGSTAAADAKYYGNVEVYNILK 158
           + A++ ARD  G      A    N ++  +L+
Sbjct: 290 RGADLGARDSEGRDPLTIAMETANADIVTLLR 321

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368

 Score = 55.6 bits (133), Expect = 9e-09
 Identities = 31/176 (17%), Positives = 52/176 (29%), Gaps = 8/176 (4%)

Query: 14  RQFSTGSLRRSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDST 73
           ++F T        R    +    P           +     +R  P      +       
Sbjct: 145 KKFLTKLPEIRGRRGGRGRPRGQPPVPP---KPSIRPRPGSLRSKPEPPSEDLGSLHPGA 201

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSI--DLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           +          +  + D L  G+DVN +    D  T L  A     +   + LL   AN+
Sbjct: 202 LLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANV 261

Query: 132 DARDRWGSTAAADAKYYGNVEVYNILKARGAK---VPKTKRTPMTVANPREVPEYE 184
           +  D  G      A   G+  +  +   RGA         R P+T+A      +  
Sbjct: 262 NQADSAGRGPLHHATILGHTGLACLFLKRGADLGARDSEGRDPLTIAMETANADIV 317

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.6 bits (166), Expect = 7e-13
 Identities = 44/144 (30%), Positives = 75/144 (52%), Gaps = 14/144 (9%)

Query: 200 KGSY----QVAKWNGTKVW----VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
           +GS+     V K +G+       +K+L K + K  +R+     E  I+ +  HP +V+  
Sbjct: 34  QGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIVKLH 92

Query: 252 GAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPII 310
            A      + ++L++   GDL + L K+   +   V +F   +LA  +++LH      II
Sbjct: 93  YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALALDHLHSLG---II 148

Query: 311 HCDLKPKNILLDNGGQLKISGFGL 334
           + DLKP+NILLD  G +K++ FGL
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGL 172

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 36/157 (22%), Positives = 63/157 (40%), Gaps = 30/157 (19%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLE 265
           K    +  VKI+DK S +DP        E+ I+ +  +HPN++           + +V E
Sbjct: 44  KATNMEFAVKIIDK-SKRDPTE------EIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---- 321
               G+L   + ++   S  +       + + + YLH      ++H DLKP NIL     
Sbjct: 97  LMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDES 153

Query: 322 DNGGQLKISGFGLLRL---------------QYISPE 343
            N   ++I  FG  +                 +++PE
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 67.6 bits (166), Expect = 7e-13
 Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 17/145 (11%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           KGS+ +V  A++  T  +  +K L K+      D E       E  ++  A  HP +   
Sbjct: 27  KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV---EKRVLSLAWEHPFLTHM 83

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPI 309
                    +  V+EY   GDL  ++Q   +   S+   F A ++  G+ +LH      I
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-TFYAAEIILGLQFLHSKG---I 139

Query: 310 IHCDLKPKNILLDNGGQLKISGFGL 334
           ++ DLK  NILLD  G +KI+ FG+
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFGM 164

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 11/131 (8%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K       +K+L K    D + +     E+ ++ +  HPN+++          + +VLE 
Sbjct: 75  KGTQKPYALKVLKKT--VDKKIVRT---EIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
              G+L   + +KG  S          +   + YLHE     I+H DLKP+N+L      
Sbjct: 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAP 186

Query: 324 GGQLKISGFGL 334
              LKI+ FGL
Sbjct: 187 DAPLKIADFGL 197

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.6 bits (166), Expect = 8e-13
 Identities = 42/145 (28%), Positives = 74/145 (51%), Gaps = 17/145 (11%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           +GSY +V   +   T     +K++ KE     +D + +     E  + E+A  HP +V  
Sbjct: 19  RGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQASNHPFLVGL 75

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPI 309
                    +  V+EY   GDL  ++Q++ +L      RF + +++  +NYLHE     I
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLALNYLHERG---I 131

Query: 310 IHCDLKPKNILLDNGGQLKISGFGL 334
           I+ DLK  N+LLD+ G +K++ +G+
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGM 156

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 35/148 (23%), Positives = 60/148 (40%), Gaps = 20/148 (13%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           +G +            K++  K L+K+  K  +       E  I+ K     +V    A 
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254

Query: 255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLAR--------GMNYLHECKP 306
                + +V+     GD+  ++      +P     F    A         G+ +LH+   
Sbjct: 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNP----GFQEPRAIFYTAQIVSGLEHLHQRN- 309

Query: 307 DPIIHCDLKPKNILLDNGGQLKISGFGL 334
             II+ DLKP+N+LLD+ G ++IS  GL
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGL 335

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 41/145 (28%), Positives = 74/145 (51%), Gaps = 17/145 (11%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           +GSY +V   +   T     ++++ KE     +D + +     E  + E+A  HP +V  
Sbjct: 62  RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT---EKHVFEQASNHPFLVGL 118

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPI 309
                    +  V+EY   GDL  ++Q++ +L      RF + +++  +NYLHE     I
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISLALNYLHERG---I 174

Query: 310 IHCDLKPKNILLDNGGQLKISGFGL 334
           I+ DLK  N+LLD+ G +K++ +G+
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGM 199

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 21/147 (14%)

Query: 200 KGSY----QVAKWNGTKVW-VKILDKESHKDPERINAFTHELTIVEK------ARHPNVV 248
           KGS+       +    +++ VKIL K+     + +     E T+VEK       + P + 
Sbjct: 30  KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV-----ECTMVEKRVLALPGKPPFLT 84

Query: 249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPD 307
           Q          +  V+EY   GDL  ++Q+ GR        F A ++A G+ +L      
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-VFYAAEIAIGLFFLQSKG-- 141

Query: 308 PIIHCDLKPKNILLDNGGQLKISGFGL 334
            II+ DLK  N++LD+ G +KI+ FG+
Sbjct: 142 -IIYRDLKLDNVMLDSEGHIKIADFGM 167

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 45/145 (31%), Positives = 77/145 (53%), Gaps = 17/145 (11%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           KGS+ +V  A+    +V+  VK+L K+     K+ + I +   E  ++ K  +HP +V  
Sbjct: 48  KGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS---ERNVLLKNVKHPFLVGL 104

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPI 309
             +      +  VL+Y   G+L  +LQ++      +  RF A ++A  + YLH      I
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASALGYLHSLN---I 160

Query: 310 IHCDLKPKNILLDNGGQLKISGFGL 334
           ++ DLKP+NILLD+ G + ++ FGL
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGL 185

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 46/211 (21%), Positives = 79/211 (37%), Gaps = 19/211 (9%)

Query: 138 GSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADG 197
           GS+  A A    N    + +     +  + K+   +         +    +  +      
Sbjct: 1   GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60

Query: 198 ITKGSY-QVAK----WNGTKVWVKILDK--ESHKDPERINAFTHELTIVEKARHPNVVQF 250
           I  GSY  V +         V +K + +  E   D +RI     E+ I+ +  H +VV+ 
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAILNRLNHDHVVKV 117

Query: 251 VGAVTQNIPMM-----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK 305
           +  V            +VLE  A  D     +    L+   +     +L  G+ Y+H   
Sbjct: 118 LDIVIPKDVEKFDELYVVLEI-ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG 176

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
              I+H DLKP N L++    +K+  FGL R
Sbjct: 177 ---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 45/164 (27%), Positives = 65/164 (39%), Gaps = 24/164 (14%)

Query: 187 PLELQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR 243
             E+       I  GS+ V   AK   +   V I  K+  +D    N    EL I+   +
Sbjct: 37  QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAI--KKVLQDKRFKN---RELQIMRIVK 90

Query: 244 HPNVVQFVGAVTQNIPMM------IVLEYHAKGDL----ASYLQKKGRLSPSKVLRFALD 293
           HPNVV        N          +VLEY     +      Y + K  +    +  +   
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEY-VPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLR 336
           L R + Y+H      I H D+KP+N+LLD   G LK+  FG  +
Sbjct: 150 LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 65.3 bits (160), Expect = 5e-12
 Identities = 44/145 (30%), Positives = 69/145 (47%), Gaps = 17/145 (11%)

Query: 200 KGSY-QV--AKWNGTKVW--VKILDKE---SHKDPERINAFTHELTIVEKA-RHPNVVQF 250
           KGS+ +V  A+   T     VK+L K+      D E       E  I+  A  HP + Q 
Sbjct: 33  KGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT---EKRILSLARNHPFLTQL 89

Query: 251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECKPDPI 309
                    +  V+E+   GDL  ++QK  R   ++  RF A ++   + +LH+     I
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA-RFYAAEIISALMFLHDKG---I 145

Query: 310 IHCDLKPKNILLDNGGQLKISGFGL 334
           I+ DLK  N+LLD+ G  K++ FG+
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGM 170

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 31/172 (18%), Positives = 57/172 (33%), Gaps = 47/172 (27%)

Query: 207 KWNGTKVWVKILDKE--SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
                   +KI++K      +P+ +     E+ +++K  HPN+ +          + +V+
Sbjct: 48  NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107

Query: 265 EYHAKGDLASYLQKKGRLSPSKVL------------------------------------ 288
           E    G L   L      S  K                                      
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167

Query: 289 RFALDLAR----GMNYLHECKPDPIIHCDLKPKNILL--DNGGQLKISGFGL 334
           +   ++ R     ++YLH      I H D+KP+N L   +   ++K+  FGL
Sbjct: 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGL 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 48/182 (26%), Positives = 73/182 (40%), Gaps = 26/182 (14%)

Query: 169 RTPMTVANPREVPEYELNPLELQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKD 225
           +    VA P + P+    P E+       I  GS+ V   AK   +   V I  K+  +D
Sbjct: 36  KVTTVVATPGQGPDR---PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAI--KKVLQD 90

Query: 226 PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDL----ASY 275
               N    EL I+ K  H N+V+       +          +VL+Y     +      Y
Sbjct: 91  KRFKN---RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY-VPETVYRVARHY 146

Query: 276 LQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGL 334
            + K  L    V  +   L R + Y+H      I H D+KP+N+LLD +   LK+  FG 
Sbjct: 147 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 203

Query: 335 LR 336
            +
Sbjct: 204 AK 205

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 35/153 (22%), Positives = 68/153 (44%), Gaps = 27/153 (17%)

Query: 198 ITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIV-EKARHPNVVQFV 251
           +  G+Y QV K      G    +K++D       +       E+ ++ + + H N+  + 
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 252 GA------VTQNIPMMIVLEYHAKGDLASYLQ--KKGRLSPSK---VLRFALDLARGMNY 300
           GA         +  + +V+E+   G +   ++  K   L       + R  L   RG+++
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL---RGLSH 144

Query: 301 LHECKPDPIIHCDLKPKNILLDNGGQLKISGFG 333
           LH+ K   +IH D+K +N+LL    ++K+  FG
Sbjct: 145 LHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 21/149 (14%)

Query: 200 KGSY----QVAKWNGTKVW----VKILDKES----HKDPERINAFTHELTIVEKARH-PN 246
            G+Y     V K +G        +K+L K +     K  E       E  ++E  R  P 
Sbjct: 64  TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQVLEHIRQSPF 120

Query: 247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRF-ALDLARGMNYLHECK 305
           +V    A      + ++L+Y   G+L ++L ++ R +  +V +    ++   + +LH+  
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QIYVGEIVLALEHLHKLG 179

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGL 334
              II+ D+K +NILLD+ G + ++ FGL
Sbjct: 180 ---IIYRDIKLENILLDSNGHVVLTDFGL 205

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 47/195 (24%), Positives = 76/195 (38%), Gaps = 23/195 (11%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWNG-------TKVWVKILDKESHKDP 226
           P +  ++E     L++ K  G  +G++ QV  A   G         V VK+L KE     
Sbjct: 11  PYDASKWEFPRDRLKLGKPLG--RGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHS 67

Query: 227 ERINAFTHELTI-VEKARHPNVVQFVGAVTQNI-PMMIVLEYHAKGDLASYLQKKGRLSP 284
           E   A   EL I +    H NVV  +GA T+   P+M+++E+   G+L++YL+ K R   
Sbjct: 68  EH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEF 125

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
                      +G +Y+        I  DLK +   + +      SGF   +      E+
Sbjct: 126 VPYKTKGARFRQGKDYVG------AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179

Query: 345 AKIVFPVSHIDPAND 359
                          
Sbjct: 180 EAPEDLYKDFLTLEH 194

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 22/61 (36%), Positives = 32/61 (52%), Gaps = 3/61 (4%)

Query: 279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
           K  L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI  FGL R  
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDI 243

Query: 339 Y 339
           Y
Sbjct: 244 Y 244

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 32/163 (19%), Positives = 67/163 (41%), Gaps = 40/163 (24%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA----VTQNIPMM 261
           +  G K  +K+L         +      E+    + +  P++V  +            ++
Sbjct: 51  RRTGQKCALKLLYD--SPKARQ------EVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102

Query: 262 IVLEYHAKGDLASYLQKKGRLS-----PSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           I++E    G+L S +Q++G  +      ++++R   D+   + +LH      I H D+KP
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMR---DIGTAIQFLHSHN---IAHRDVKP 156

Query: 317 KNILL---DNGGQLKISGFGLLRL-------------QYISPE 343
           +N+L    +    LK++ FG  +               Y++PE
Sbjct: 157 ENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPE 199

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 40/159 (25%), Positives = 63/159 (39%), Gaps = 35/159 (22%)

Query: 198 ITKGSY-QVA----KWNGTKVWVKILDKESHKDPERI-NAFTH---------ELTIVEKA 242
           I +GSY  V     K     V +K           ++   F           E+TI+ + 
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIK-----------KVNRMFEDLIDCKRILREITILNRL 82

Query: 243 RHPNVVQFVGAVT-QNIPMM----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARG 297
           +   +++    +   ++       IVLE  A  DL    +    L+   +     +L  G
Sbjct: 83  KSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            N++HE     IIH DLKP N LL+    +K+  FGL R
Sbjct: 142 ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.2 bits (149), Expect = 9e-11
 Identities = 31/141 (21%), Positives = 60/141 (42%), Gaps = 27/141 (19%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA----VTQNIPMM 261
           K    K  +K+L         R      E+ +  + ++ P++V+ V            ++
Sbjct: 40  KRTQEKFALKMLQD--CPKARR------EVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91

Query: 262 IVLEYHAKGDLASYLQKKGRLSPS-----KVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           IV+E    G+L S +Q +G  + +     ++++    +   + YLH      I H D+KP
Sbjct: 92  IVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSIN---IAHRDVKP 145

Query: 317 KNILL---DNGGQLKISGFGL 334
           +N+L         LK++ FG 
Sbjct: 146 ENLLYTSKRPNAILKLTDFGF 166

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.1 bits (149), Expect = 1e-10
 Identities = 35/148 (23%), Positives = 61/148 (41%), Gaps = 21/148 (14%)

Query: 198 ITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFV 251
           + +G Y          N  KV VKIL     K  +R      E+ I+E  R  PN++   
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR------EIKILENLRGGPNIITLA 97

Query: 252 GAVTQNIPMMIVL--EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPI 309
             V   +     L  E+    D     Q    L+   +  +  ++ + ++Y H      I
Sbjct: 98  DIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---I 151

Query: 310 IHCDLKPKNILLD-NGGQLKISGFGLLR 336
           +H D+KP N+++D    +L++  +GL  
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAE 179

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 22/80 (27%), Positives = 40/80 (50%)

Query: 79  MACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
           +A +  +  V+ ++  G  +++   DG TALH AA     + +KLLL  +A +   +  G
Sbjct: 181 VANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAG 240

Query: 139 STAAADAKYYGNVEVYNILK 158
            TA   A+   + E   +L+
Sbjct: 241 ETALDIARKKHHKECEELLE 260

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 23/118 (19%), Positives = 41/118 (34%), Gaps = 12/118 (10%)

Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNS------IDLDGRTALHIA---ACEGHVEVV 121
               +L    C  D+  V +    G D                 LH+A   A +  + +V
Sbjct: 131 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLV 190

Query: 122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN 176
             ++    ++DA+   G+TA   A  Y   +   +L    A V    +   T + +A 
Sbjct: 191 DFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIAR 248

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 37/158 (23%), Positives = 60/158 (37%), Gaps = 35/158 (22%)

Query: 198 ITKGSY-QVA----KWNGTKVWVKILDKESHKDPERINAFTH---------ELTIVEKAR 243
           + +G+Y  V     K  G  V +K           +I  F           E+ I++  +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIK-----------KIEPFDKPLFALRTLREIKILKHFK 67

Query: 244 HPNVVQFVGAVTQNIPMM-----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
           H N++        +         I+ E   + DL   +     LS   +  F     R +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQEL-MQTDLHRVI-STQMLSDDHIQYFIYQTLRAV 125

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
             LH      +IH DLKP N+L+++   LK+  FGL R
Sbjct: 126 KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 40/165 (24%), Positives = 65/165 (39%), Gaps = 24/165 (14%)

Query: 198 ITKGSY-QVAK---WNGTKVWVKILDKESHKDPERINAFTH---------ELTIVEKARH 244
           I+ GSY  V       G  V +K +   +  D   +N  +          E+ ++    H
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFN-TVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 245 PNVVQFVGAVT-QNIPMM----IVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGM 298
           PN++           P M    +V E   + DLA  +  ++  +SP  +  F   +  G+
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPE 343
           + LHE     ++H DL P NILL +   + I  F L R       
Sbjct: 148 HVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 35/195 (17%), Positives = 76/195 (38%), Gaps = 36/195 (18%)

Query: 161 GAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGITKGSYQV---AKWNGTKVWV-- 215
           G+ +           + +E+  +++     ++       +G++      K   T + V  
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQV----ERM-----AGQGTFGTVQLGKEKSTGMSVAI 53

Query: 216 -KILDKESHKDPERINAFTHELTIVEKARHPNVVQ---FVGAVTQNIP----MMIVLEY- 266
            K++     ++ E        +  +    HPN+VQ   +   + +       + +V+EY 
Sbjct: 54  KKVIQDPRFRNRE-----LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV 108

Query: 267 ----HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
               H      +Y +++    P  +  F   L R +  LH    + + H D+KP N+L++
Sbjct: 109 PDTLHRC--CRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVN 165

Query: 323 NG-GQLKISGFGLLR 336
              G LK+  FG  +
Sbjct: 166 EADGTLKLCDFGSAK 180

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 31/122 (25%), Positives = 53/122 (43%), Gaps = 20/122 (16%)

Query: 230 NAFTH---------ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLAS 274
             F           EL +++  RH NV+  +   T +  +       +V+ +    DL  
Sbjct: 60  RPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MGTDLGK 118

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            + K  +L   ++      + +G+ Y+H      IIH DLKP N+ ++   +LKI  FGL
Sbjct: 119 LM-KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174

Query: 335 LR 336
            R
Sbjct: 175 AR 176

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 28/122 (22%), Positives = 52/122 (42%), Gaps = 21/122 (17%)

Query: 230 NAFTH---------ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLAS 274
             F           EL +++  +H NV+  +   T    +       +V+ +  + DL  
Sbjct: 59  RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-MQTDLQK 117

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            +    + S  K+      + +G+ Y+H      ++H DLKP N+ ++   +LKI  FGL
Sbjct: 118 IM--GLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172

Query: 335 LR 336
            R
Sbjct: 173 AR 174

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 35/164 (21%), Positives = 66/164 (40%), Gaps = 41/164 (25%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGA----VTQNIPMM 261
           K    K  +K+L         R      E+ +  + ++ P++V+ V            ++
Sbjct: 84  KRTQEKFALKMLQD--CPKARR------EVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135

Query: 262 IVLEYHAKGDLASYLQKKGRLS-----PSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           IV+E    G+L S +Q +G  +      S++++    +   + YLH      I H D+KP
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLHSIN---IAHRDVKP 189

Query: 317 KNILL---DNGGQLKISGFGLLRL--------------QYISPE 343
           +N+L         LK++ FG  +                Y++PE
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 58.8 bits (143), Expect = 8e-10
 Identities = 39/142 (27%), Positives = 59/142 (41%), Gaps = 30/142 (21%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTH---------ELTIVEKARHPNVVQFVGAVTQNIP 259
           N  +V +K           +I+ F H         E+ I+ + RH N++     +     
Sbjct: 51  NKVRVAIK-----------KISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99

Query: 260 MM-----IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDL 314
                  IV +   + DL   L K   LS   +  F   + RG+ Y+H      ++H DL
Sbjct: 100 EQMKDVYIVQDL-METDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDL 154

Query: 315 KPKNILLDNGGQLKISGFGLLR 336
           KP N+LL+    LKI  FGL R
Sbjct: 155 KPSNLLLNTTCDLKICDFGLAR 176

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 21/122 (17%)

Query: 230 NAFTH---------ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLAS 274
             F +         EL +++   H N++  +   T    +       IV+E     +L  
Sbjct: 60  RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQ 118

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            +Q +  L   ++      +  G+ +LH      IIH DLKP NI++ +   LKI  FGL
Sbjct: 119 VIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173

Query: 335 LR 336
            R
Sbjct: 174 AR 175

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 11/108 (10%)

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLASYLQKKGRLSPSKVL 288
           EL +++  +H NV+  +   T    +       +V       DL + ++ + +L+   V 
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQ-KLTDDHVQ 135

Query: 289 RFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR 336
                + RG+ Y+H      IIH DLKP N+ ++   +LKI  FGL R
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 30/122 (24%), Positives = 51/122 (41%), Gaps = 21/122 (17%)

Query: 230 NAFTH---------ELTIVEKARHPNVVQFVGAVTQNIPMM------IVLEYHAKGDLAS 274
             F +         EL +++   H N++  +   T    +       +V+E     +L  
Sbjct: 97  RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQ 155

Query: 275 YLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
            +Q +  L   ++      +  G+ +LH      IIH DLKP NI++ +   LKI  FGL
Sbjct: 156 VIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210

Query: 335 LR 336
            R
Sbjct: 211 AR 212

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 38/159 (23%), Positives = 63/159 (39%), Gaps = 28/159 (17%)

Query: 198 ITKGSY-QVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG 252
           +  G    V          +V +K +     +  +       E+ I+ +  H N+V+   
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLDHDNIVKVFE 75

Query: 253 AVTQNIPMM--------------IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGM 298
            +  +   +              IV EY  + DLA+ L ++G L       F   L RG+
Sbjct: 76  ILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVL-EQGPLLEEHARLFMYQLLRGL 133

Query: 299 NYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLR 336
            Y+H      ++H DLKP N+ ++     LKI  FGL R
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 25/63 (39%), Positives = 36/63 (57%), Gaps = 8/63 (12%)

Query: 276 LQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--QLKIS 330
           L KK +    S   V +FA  + + ++ LH+ +   IIHCDLKP+NILL   G   +K+ 
Sbjct: 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI 244

Query: 331 GFG 333
            FG
Sbjct: 245 DFG 247

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 19/81 (23%), Positives = 39/81 (48%), Gaps = 11/81 (13%)

Query: 262 IVLEY-----HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP 316
           +++EY     H    L S+++    +  + +  +   L R + ++H      I H D+KP
Sbjct: 115 VIMEYVPDTLHKV--LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKP 169

Query: 317 KNILLD-NGGQLKISGFGLLR 336
           +N+L++     LK+  FG  +
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAK 190

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 17/64 (26%), Positives = 29/64 (45%), Gaps = 3/64 (4%)

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHID 355
           + + YLH      ++H D+KP NILL+    +K++ FGL R           +    + +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 356 PAND 359
             N 
Sbjct: 177 TENF 180

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 13/42 (30%), Positives = 24/42 (57%), Gaps = 3/42 (7%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
                +  + +++ + +NYL +     + H DLKP+NILLD+
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDD 172

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 13/49 (26%), Positives = 22/49 (44%), Gaps = 3/49 (6%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS 330
                + + A  + + +N+LH  K   + H DLKP+NIL       +  
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAY 160

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.1 bits (120), Expect = 4e-07
 Identities = 21/54 (38%), Positives = 30/54 (55%), Gaps = 3/54 (5%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--QLKISGFG 333
           +S +   +FA  +   + +L   +   IIHCDLKP+NILL N     +KI  FG
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFG 206

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 50.0 bits (120), Expect = 5e-07
 Identities = 15/42 (35%), Positives = 20/42 (47%), Gaps = 3/42 (7%)

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
                V   A  L   + +LHE +   + H DLKP+NIL  N
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVN 158

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 20/76 (26%), Positives = 35/76 (46%), Gaps = 6/76 (7%)

Query: 271 DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQLK 328
           DL     + G    S VL+  + +   + Y+HE +    +H D+K  N+LL   N  Q+ 
Sbjct: 137 DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVY 193

Query: 329 ISGFGLLRLQYISPEK 344
           ++ +GL   +Y     
Sbjct: 194 LADYGLSY-RYCPNGN 208

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.1 bits (116), Expect = 2e-06
 Identities = 55/396 (13%), Positives = 114/396 (28%), Gaps = 109/396 (27%)

Query: 40  NNMRFSFGRQ----SSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG 95
           ++M F  G        +  +      D     +  D    +L        + ++ ++   
Sbjct: 5   HHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSIL------SKEEIDHIIMSK 58

Query: 96  SDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYN 155
             V+         L         E+V+  + +   I+ +           +      +Y 
Sbjct: 59  DAVSGTLR-----LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113

Query: 156 ILKARGAKVPKTKRTPMTVANPREVPEYELNPLELQVRKADGIT----KGS--------- 202
             + R     +       V   R  P  +L    L++R A  +      GS         
Sbjct: 114 EQRDRLYNDNQ-VFAKYNV--SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170

Query: 203 ---YQVAKWNGTKV-WVKI-------------------LDKE-------SHKDPERINAF 232
              Y+V      K+ W+ +                   +D         S     RI++ 
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230

Query: 233 THEL-TIVEKARHPNV------VQ-------F-VGA----VTQNIPMMIVLEYHAKGDLA 273
             EL  +++   + N       VQ       F +       T+   +   L       ++
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

Query: 274 SYLQKKGRLSPSKVLR-FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF 332
                   L+P +V             YL +C+P      DL P+ +L       ++S  
Sbjct: 291 LDHHSMT-LTPDEVKSLLL-------KYL-DCRPQ-----DL-PREVL--TTNPRRLSII 333

Query: 333 G-LLR--------LQYISPEKAKIVFPVS--HIDPA 357
              +R         ++++ +K   +   S   ++PA
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.1 bits (98), Expect = 3e-04
 Identities = 52/421 (12%), Positives = 107/421 (25%), Gaps = 128/421 (30%)

Query: 1   MENLTAQLKRGISRQFSTGSLRRSLTRQMSRQSS----------FDPRRNNMRFSFG--- 47
             N T++     + +    S++  L R +  +             + +  N  F+     
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA-FNLSCKI 268

Query: 48  ----RQSS----LDPIRRSPV-QDELTVPENLDSTMQLL--FMACRGDVKGVEDLLNEGS 96
               R       L     + +  D  ++    D    LL  ++ CR      +DL  E  
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCR-----PQDLPRE-- 321

Query: 97  DVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI-DARDRWGSTAAADAKYYGNVEVYN 155
                               +   + ++     +I D    W          + +V    
Sbjct: 322 ----------------VLTTNPRRLSII---AESIRDGLATW--------DNWKHVNCDK 354

Query: 156 ILKARGAKV------------------PKTKRTPMTV------ANPREVPEYELNPLELQ 191
           +     + +                  P +   P  +         +      +N  +L 
Sbjct: 355 LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVN--KLH 412

Query: 192 VRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV 251
                        V K       + I         +  N +    +IV+    P      
Sbjct: 413 KYSL---------VEKQPKEST-ISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSD 462

Query: 252 GAVTQNIPMMIV--LEYHAKG---------------DLASYLQKKGRLS------PSKVL 288
             +   +       + +H K                D   +L++K R           +L
Sbjct: 463 DLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-RFLEQKIRHDSTAWNASGSIL 521

Query: 289 RFALDLARGMNYLHECKPDPIIH---CDLKPKNILLDNGGQLKISGF-GLLRLQYISPEK 344
                L     Y+  C  DP        +   + L      L  S +  LLR+  ++ ++
Sbjct: 522 NTLQQLKFYKPYI--CDNDPKYERLVNAI--LDFLPKIEENLICSKYTDLLRIALMAEDE 577

Query: 345 A 345
           A
Sbjct: 578 A 578

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 47.0 bits (112), Expect = 5e-06
 Identities = 17/61 (27%), Positives = 30/61 (49%), Gaps = 10/61 (16%)

Query: 280 GRLSPSKVLRFALDLARGMNYLH-ECKPDPIIHCDLKPKNILLDNGGQ------LKISGF 332
             +    V + +  L  G++Y+H  C    IIH D+KP+N+L++          +KI+  
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADL 182

Query: 333 G 333
           G
Sbjct: 183 G 183

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 23/88 (26%), Positives = 32/88 (36%), Gaps = 14/88 (15%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQ 326
            L        R  S   VL  A  +   + Y+H       IH D+KP N L+     G  
Sbjct: 90  SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNL 146

Query: 327 LKISGFGLLRLQYISPEKAKIVFPVSHI 354
           + I  FGL + +Y      +      HI
Sbjct: 147 VYIIDFGLAK-KYRDARTHQ------HI 167

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 43.2 bits (102), Expect = 7e-05
 Identities = 21/79 (26%), Positives = 37/79 (46%), Gaps = 7/79 (8%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQL 327
           DL    +   +  S   VL+ +L +   + Y+HE +    +H D+K  N+LL+  N  Q+
Sbjct: 137 DLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQV 193

Query: 328 KISGFGLLRLQYISPEKAK 346
            +  +GL   +Y      K
Sbjct: 194 YLVDYGLAY-RYCPEGVHK 211

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 42.6 bits (100), Expect = 1e-04
 Identities = 21/75 (28%), Positives = 30/75 (40%), Gaps = 4/75 (5%)

Query: 280 GRLSPSKVLRFALDLARGMNYLH-ECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQ 338
             L    V +    + +G++YLH +C+   IIH D+KP+NILL    Q            
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEW 197

Query: 339 YISPEKAKIVFPVSH 353
             S         VS 
Sbjct: 198 QRSGAPPPSGSAVST 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 27/90 (30%), Positives = 36/90 (40%), Gaps = 16/90 (17%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK- 328
            L        R  S   VL  A+ L   M Y+H      +I+ D+KP+N L+   G    
Sbjct: 90  SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQ 146

Query: 329 ----ISGFGLLRLQYISPEKAKIVFPVSHI 354
               I  F L + +YI PE  K      HI
Sbjct: 147 QVIHIIDFALAK-EYIDPETKK------HI 169

>3uo9_A Glutaminase kidney isoform, mitochondrial; hydrolase-hydrolase inhibitor complex; HET: 04A; 2.30A {Homo sapiens} PDB: 3unw_A* 3ss3_A 3ss4_A 3ss5_A* Length = 534

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 12/95 (12%), Positives = 31/95 (32%), Gaps = 17/95 (17%)

Query: 23  RSLTRQMSRQSSFDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR 82
             L    +   ++D  R+  +        LDP R           +   S   L + + +
Sbjct: 449 HDLVSLCNF-HNYDNLRHFAK-------KLDPRREGG--------DQRHSFGPLDYESLQ 492

Query: 83  GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH 117
            ++  +++ + +     S +    T ++     G 
Sbjct: 493 QEL-ALKETVWKKVSPESNEDISTTVVYRMESLGE 526

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 20/90 (22%), Positives = 34/90 (37%), Gaps = 16/90 (17%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---- 325
            L   L   GR  S   V   A  +   +  +HE     +++ D+KP N L+        
Sbjct: 91  SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNA 147

Query: 326 -QLKISGFGLLRLQYISPEKAKIVFPVSHI 354
             + +  FG+++  Y  P   +      HI
Sbjct: 148 NMIYVVDFGMVK-FYRDPVTKQ------HI 170

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 41.4 bits (96), Expect = 3e-04
 Identities = 30/185 (16%), Positives = 46/185 (24%), Gaps = 52/185 (28%)

Query: 198 ITKGSY-QV--AKWNGTKVWVKIL--------DKESHKDPERINAFT------HELTIVE 240
           I +G + +V     + T V +KI+        +    K  E I            L+   
Sbjct: 28  IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87

Query: 241 KARHPNVVQFVGA--VTQNIP----------------------------MMIVLEY-HAK 269
             R    +       V  + P                            + IVLE+    
Sbjct: 88  CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
            DL     K    S +        L   +            H DL   N+LL      K+
Sbjct: 148 IDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKL 203

Query: 330 SGFGL 334
                
Sbjct: 204 HYTLN 208

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 19/68 (27%), Positives = 33/68 (48%), Gaps = 7/68 (10%)

Query: 271 DLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLK 328
            L S L    +  LS   VL+ A  L   + +LHE +    +H ++  +NI +D   Q +
Sbjct: 143 SLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQ 199

Query: 329 I--SGFGL 334
           +  +G+G 
Sbjct: 200 VTLAGYGF 207

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 21/80 (26%), Positives = 32/80 (40%), Gaps = 8/80 (10%)

Query: 271 DLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---Q 326
            L        R LS   VL  A  +   + ++H       +H D+KP N L+  G    Q
Sbjct: 88  SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQ 144

Query: 327 LKISGFGLLRLQYISPEKAK 346
           + I  FGL + +Y      +
Sbjct: 145 VYIIDFGLAK-KYRDTSTHQ 163

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	359
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.98
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.97
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.97
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.96
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.96
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.95
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.95
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.95
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.95
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.95
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.95
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.94
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.94
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.94
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.94
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.94
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.94
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.94
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.94
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.93
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.93
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.93
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.93
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.93
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.93
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.93
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.93
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.93
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.93
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.93
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.93
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.93
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.93
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.93
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.93
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.93
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.93
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.93
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.93
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.93
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.93
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.93
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.93
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.93
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.93
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.93
3niz_A	311	Rhodanese family protein; structural genomics, str	99.93
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.93
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.92
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.92
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.92
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.92
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.92
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.92
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.92
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.92
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.92
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.92
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.92
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.92
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.92
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.92
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.92
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.92
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.92
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.92
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.92
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.92
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.92
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.92
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.92
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.92
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.92
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.92
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.92
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.92
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.92
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.92
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.92
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.92
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.92
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.92
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.92
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.92
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.92
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.92
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.92
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.92
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.92
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.92
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.92
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.92
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.92
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.92
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.92
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.92
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.92
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.92
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.92
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.92
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.92
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.92
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.92
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.92
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.92
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.92
3bhy_A	283	Death-associated protein kinase 3; death associate	99.92
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.92
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.92
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.92
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.92
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.92
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.92
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.91
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.91
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.91
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.91
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.91
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.91
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.91
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.91
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.91
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.91
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.91
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.91
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.91
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.91
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.91
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.91
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.91
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.91
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.91
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.91
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.91
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.91
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.91
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.91
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.91
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.91
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.91
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.91
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.91
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.91
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.91
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.91
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.91
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.91
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.91
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.91
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.91
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.91
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.91
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.91
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.91
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.91
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.91
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.91
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.91
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.91
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.91
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.91
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.91
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.91
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.91
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.91
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.9
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.9
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.9
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.9
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.9
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.9
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.9
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.9
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.9
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.9
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.9
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.9
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.9
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.9
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.9
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.9
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.9
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.9
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.9
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.9
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.9
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.9
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.9
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.9
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.9
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.9
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.9
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.9
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.9
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.9
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.9
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.9
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.9
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.9
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.89
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.89
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.89
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.89
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.89
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.89
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.89
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.89
3uqc_A	286	Probable conserved transmembrane protein; structur	99.89
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.89
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.89
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.89
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.89
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.89
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.89
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.89
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.89
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.89
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.89
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.89
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.89
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.89
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.89
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.89
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.89
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.89
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.89
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.89
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.89
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.89
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.89
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.89
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.89
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.89
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.89
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.88
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.88
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.88
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.88
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.88
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.88
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.88
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.88
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.88
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.88
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.88
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.88
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.88
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.88
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.88
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.88
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.88
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.88
2rfa_A	232	Transient receptor potential cation channel subfa	99.88
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.88
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.88
2rfa_A	232	Transient receptor potential cation channel subfa	99.88
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.88
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.88
2etb_A	256	Transient receptor potential cation channel subfam	99.88
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.88
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.88
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.88
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.87
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.87
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.87
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.87
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.87
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.87
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.87
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.87
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.87
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.87
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.87
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.87
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.87
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.87
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.87
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.87
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.87
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.87
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.87
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.87
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.87
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.86
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.86
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.86
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.86
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.86
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.86
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.86
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.86
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.86
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.86
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.86
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.86
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.86
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.86
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.86
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.86
2pnn_A	273	Transient receptor potential cation channel subfa	99.86
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.86
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.85
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.85
2pnn_A	273	Transient receptor potential cation channel subfa	99.85
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.85
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.85
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.85
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.85
2etb_A	256	Transient receptor potential cation channel subfam	99.85
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.85
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.85
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.85
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.85
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.84
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.84
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.84
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.84
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.84
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.84
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.84
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.83
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.83
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.83
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.82
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.82
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.81
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.81
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.8
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.79
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.79
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.78
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.77
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.77
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.76
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.75
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.67
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.61
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.05
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.97
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.54
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.53
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.39
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.35
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.07
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.77
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.72
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.7
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.32
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.25
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.17
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.81
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.79
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.7
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.6
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.16
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.02
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.16
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.99
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	90.61
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	88.69
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	88.48
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.24
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.92
3mes_A	424	Choline kinase; malaria, structural genomics, stru	80.24

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.2e-36  Score=272.45  Aligned_cols=143  Identities=24%  Similarity=0.437  Sum_probs=128.6

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+.     .+|+.+|+|++.+....+....+.+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            47777889999998652     3689999999975432223345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||+||+|.+++.+.+.+++..++.|+.||+.||+|||+++   ||||||||+|||++.+|.+||+|||+|+
T Consensus       113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~  180 (311)
T 4aw0_A          113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK  180 (311)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence            9999999999998889999999999999999999999999   9999999999999999999999999996

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.2e-35  Score=264.70  Aligned_cols=152  Identities=27%  Similarity=0.515  Sum_probs=128.8

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+     ..+|+.||+|++.+....+......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3566677899998754     23589999999987655555556679999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      || +|+|.+++...+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+         
T Consensus        94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence            99 6799999998889999999999999999999999999   9999999999999999999999999996         


Q ss_pred             -----ccccCccccc
Q 018204          337 -----LQYISPEKAK  346 (359)
Q Consensus       337 -----~~~~~PE~~~  346 (359)
                           +.|||||...
T Consensus       170 ~~~GT~~Y~APE~~~  184 (275)
T 3hyh_A          170 TSCGSPNYAAPEVIS  184 (275)
T ss_dssp             -----CTTSCHHHHS
T ss_pred             CeeECcccCChhhhc
Confidence                 3599999865

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-34  Score=267.93  Aligned_cols=153  Identities=24%  Similarity=0.478  Sum_probs=129.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+     ..+|+.||||++..... .....+.|.+|+.+++.++|||||++++++.+.+.+|||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4777788999999854     23589999999976554 34556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          266 YHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      ||+||+|.+++...+  .+++..++.|+.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+       
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            999999999997543  4799999999999999999999999   9999999999999999999999999997       


Q ss_pred             --------ccccCcccccc
Q 018204          337 --------LQYISPEKAKI  347 (359)
Q Consensus       337 --------~~~~~PE~~~~  347 (359)
                              ..|||||....
T Consensus       181 ~~~~~~GT~~YmAPE~l~~  199 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICEN  199 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTT
T ss_pred             cccccCCCccccCHHHHCC
Confidence                    35999998763

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.4e-33  Score=257.55  Aligned_cols=140  Identities=27%  Similarity=0.496  Sum_probs=121.6

Q ss_pred             eEeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      ++...+.+|+|+|+.+   .+       ++..||||.+...   .....+.|.+|+.++++++|||||++++++.+.+.+
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            3455667899999754   22       3678999999643   345567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcE
Q 018204          261 MIVLEYHAKGDLASYLQKK-------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL  327 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~  327 (359)
                      |+|||||++|+|.++|+..             ..+++..+..|+.||+.||.|||+++   ||||||||+|||++.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence            9999999999999999763             35999999999999999999999998   9999999999999999999


Q ss_pred             EEecccccc
Q 018204          328 KISGFGLLR  336 (359)
Q Consensus       328 kl~DFGla~  336 (359)
                      ||+|||+|+
T Consensus       168 Ki~DFGla~  176 (299)
T 4asz_A          168 KIGDFGMSR  176 (299)
T ss_dssp             EECCCSCHH
T ss_pred             EECCcccce
Confidence            999999996

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-33  Score=260.34  Aligned_cols=135  Identities=25%  Similarity=0.403  Sum_probs=121.9

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .+...+.+|+|+|+.+.     .+|..||||++..+..        +.+|+.+++.++|||||++++++.+.+.+|||||
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            45666678999998652     3589999999976543        2469999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEecccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DFGla~  336 (359)
                      ||+||+|.++++..+.+++..+..|+.||+.||.|||+++   ||||||||+||||+.+| .+||+|||+|+
T Consensus       131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            9999999999998889999999999999999999999999   99999999999999988 59999999996

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.9e-33  Score=252.55  Aligned_cols=152  Identities=24%  Similarity=0.416  Sum_probs=131.0

Q ss_pred             eeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe----CCcEEEE
Q 018204          193 RKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPMMIV  263 (359)
Q Consensus       193 ~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv  263 (359)
                      +....+|+|+|+.+.     .++..||+|.+..... .....+.|.+|+.+++.++|||||+++++|..    ...+|+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            445568999998652     3578999999975543 44556789999999999999999999999875    3468999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEecccccc------
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR------  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGla~------  336 (359)
                      ||||+||+|.+++.+.+.+++..+..|+.||+.||.|||+++ .+||||||||+|||++. +|.+||+|||+|+      
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~  186 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  186 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc
Confidence            999999999999998889999999999999999999999987 35999999999999974 7999999999997      


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             +.|||||..+
T Consensus       187 ~~~~~GTp~YmAPE~~~  203 (290)
T 3fpq_A          187 AKAVIGTPEFMAPEMYE  203 (290)
T ss_dssp             BEESCSSCCCCCGGGGG
T ss_pred             cCCcccCccccCHHHcC
Confidence                   3588888765

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.6e-33  Score=264.86  Aligned_cols=149  Identities=24%  Similarity=0.399  Sum_probs=131.3

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|+|+|+.+.     .+|+.||||++........   +.+.+|+.+++.++|||||+++++|.+.+.+|||||
T Consensus       152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE  228 (423)
T 4fie_A          152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  228 (423)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSG---GGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHH---HHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence            36677789999998652     3589999999976543332   457899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      ||+||+|.++++. +.+++..+..|+.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+         
T Consensus       229 y~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  304 (423)
T 4fie_A          229 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  304 (423)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred             CCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence            9999999999975 46999999999999999999999999   9999999999999999999999999996         


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|||||...
T Consensus       305 ~~~~GTp~YmAPEvl~  320 (423)
T 4fie_A          305 KSLVGTPYWMAPELIS  320 (423)
T ss_dssp             CCCEECTTTCCHHHHT
T ss_pred             cccccCcCcCCHHHHC
Confidence                  2588888765

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5e-33  Score=254.30  Aligned_cols=158  Identities=31%  Similarity=0.498  Sum_probs=132.0

Q ss_pred             cccCCcceeeEeeccCcccceeEEEE--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc
Q 018204          182 EYELNPLELQVRKADGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  259 (359)
                      .|+++..++.  ..+.+|+|+|+.+.  .....+|||+++... .+....+.|.+|+.++++++|||||++++++. .+.
T Consensus        30 ~Wei~~~~l~--l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~  105 (307)
T 3omv_A           30 YWEIEASEVM--LSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDN  105 (307)
T ss_dssp             CCBCCTTSCC--EEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             CcEEcHHHeE--EeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCe
Confidence            4555554443  45568999998652  234579999986443 35666788999999999999999999999875 456


Q ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-
Q 018204          260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-  337 (359)
                      +|||||||++|+|.+++... +.+++..+..|+.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+. 
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            89999999999999999764 56999999999999999999999998   99999999999999999999999999962 


Q ss_pred             ----------------cccCccccc
Q 018204          338 ----------------QYISPEKAK  346 (359)
Q Consensus       338 ----------------~~~~PE~~~  346 (359)
                                      .|||||..+
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~  207 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIR  207 (307)
T ss_dssp             -----------CCCCTTSCCHHHHH
T ss_pred             ccCCcceeecccccCCCccCHHHhh
Confidence                            478888654

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-33  Score=258.63  Aligned_cols=149  Identities=24%  Similarity=0.399  Sum_probs=130.7

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|+|+|+.+.     .+|+.||||++........   +.+.+|+.+++.++|||||+++++|.+.+.+|||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG---GGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH---HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            36666778999998652     3589999999975543332   357899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      ||+||+|.+++.. +.+++..+..|+.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+         
T Consensus       152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  227 (346)
T 4fih_A          152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  227 (346)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence            9999999999976 47999999999999999999999999   9999999999999999999999999996         


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|||||...
T Consensus       228 ~~~~GTp~YmAPEvl~  243 (346)
T 4fih_A          228 KSLVGTPYWMAPELIS  243 (346)
T ss_dssp             CCCCSCGGGCCHHHHT
T ss_pred             cccccCcCcCCHHHHC
Confidence                  2478888654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7e-33  Score=256.34  Aligned_cols=139  Identities=29%  Similarity=0.494  Sum_probs=120.5

Q ss_pred             EeeccCcccceeEEEE---e-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~---~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +.....+|+|+|+.+.   +       ++..||||.+...   +....+.|.+|+.++++++|||||+++++|.+...+|
T Consensus        43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4455678999998652   2       3678999999643   4556678999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc
Q 018204          262 IVLEYHAKGDLASYLQKK---------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ  326 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~  326 (359)
                      ||||||++|+|.++++..               +++++..+..|+.||+.||.|||+++   ||||||||+|||++.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            999999999999999753               35899999999999999999999998   999999999999999999


Q ss_pred             EEEecccccc
Q 018204          327 LKISGFGLLR  336 (359)
Q Consensus       327 ~kl~DFGla~  336 (359)
                      +||+|||+|+
T Consensus       197 ~Ki~DFGla~  206 (329)
T 4aoj_A          197 VKIGDFGMSR  206 (329)
T ss_dssp             EEECCCC---
T ss_pred             EEEcccccce
Confidence            9999999997

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.4e-34  Score=261.51  Aligned_cols=152  Identities=28%  Similarity=0.401  Sum_probs=127.2

Q ss_pred             eEeeccCcccceeEEEE--------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      +|...+.+|+|+|+.+.        ..++.||+|++.+...... ....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46777789999998652        1467899999965432211 12257889999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc------
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR------  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~------  336 (359)
                      |||||+||+|.+++.+.+.+++..+..++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+|+      
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999999999999889999999999999999999999999   9999999999999999999999999997      


Q ss_pred             ---------ccccCccccc
Q 018204          337 ---------LQYISPEKAK  346 (359)
Q Consensus       337 ---------~~~~~PE~~~  346 (359)
                               +.|||||...
T Consensus       181 ~~~~~~~GT~~YmAPE~~~  199 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVN  199 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHH
T ss_pred             ccccccccCcccCCHHHhc
Confidence                     2488888765

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.98  E-value=1.8e-32  Score=251.35  Aligned_cols=140  Identities=29%  Similarity=0.548  Sum_probs=120.7

Q ss_pred             EeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          192 VRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      ++..+.+|+|+|+.+   .+       .+..||||.+....  +....+.|.+|+.++++++|||||++++++.....++
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            344556899999855   22       45789999996543  2233467999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 018204          262 IVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~  325 (359)
                      +|||||++|+|.++|...                ..+++..+..|+.||+.||.|||+++   ||||||||+||||+.++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            999999999999999643                34899999999999999999999998   99999999999999999


Q ss_pred             cEEEecccccc
Q 018204          326 QLKISGFGLLR  336 (359)
Q Consensus       326 ~~kl~DFGla~  336 (359)
                      .+||+|||+|+
T Consensus       183 ~~Ki~DFGlar  193 (308)
T 4gt4_A          183 NVKISDLGLFR  193 (308)
T ss_dssp             CEEECCSCCBC
T ss_pred             CEEECCcccce
Confidence            99999999997

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.97  E-value=1.1e-31  Score=245.34  Aligned_cols=141  Identities=21%  Similarity=0.366  Sum_probs=119.1

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC-------
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-------  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------  258 (359)
                      +|...+.+|+|+|+.+.     .+|..||||++....  .....+.+.+|+.+++.++|||||+++++|...+       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            36667788999998652     358899999996543  3445567999999999999999999999987544       


Q ss_pred             -----cEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEe
Q 018204          259 -----PMMIVLEYHAKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (359)
Q Consensus       259 -----~~~lv~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~  330 (359)
                           .+|+|||||++|+|.+++.....   .++..+..|+.||+.||.|||+++   ||||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                 37999999999999999987654   455678899999999999999999   9999999999999999999999


Q ss_pred             cccccc
Q 018204          331 GFGLLR  336 (359)
Q Consensus       331 DFGla~  336 (359)
                      |||+|+
T Consensus       161 DFGla~  166 (299)
T 4g31_A          161 DFGLVT  166 (299)
T ss_dssp             CCCCC-
T ss_pred             cCccce
Confidence            999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=252.33  Aligned_cols=141  Identities=27%  Similarity=0.473  Sum_probs=124.5

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe------CCc
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ------NIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~  259 (359)
                      +|...+.+|+|+|+.+.     .+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++..      ...
T Consensus        55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            47777889999998652     358999999996544 344556778999999999999999999998764      357


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +|||||||+ |+|.+++...+.+++..+..|+.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            999999996 689999998889999999999999999999999999   9999999999999999999999999996

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.97  E-value=7e-31  Score=240.74  Aligned_cols=140  Identities=31%  Similarity=0.492  Sum_probs=115.7

Q ss_pred             EeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC----cEEEEE
Q 018204          192 VRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----PMMIVL  264 (359)
Q Consensus       192 ~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv~  264 (359)
                      +...+.+|+|+|+.   +.++|+.||||++....    .....+..|+..+..++||||+++++++....    .+||||
T Consensus         5 i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            5 IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            45566788998874   46789999999996432    12222345666667889999999999998654    589999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK-----PDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||++|+|.++++.. .+++..+..++.|++.||.|||++.     .++||||||||+|||++.++.+||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999764 6999999999999999999999871     1239999999999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=8.3e-31  Score=244.47  Aligned_cols=149  Identities=30%  Similarity=0.499  Sum_probs=124.4

Q ss_pred             cccCCcceeeEeeccCcccceeEEEE---ec-------CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC-Cccccc
Q 018204          182 EYELNPLELQVRKADGITKGSYQVAK---WN-------GTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQF  250 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~~---~~-------g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l  250 (359)
                      +|+++..  ++...+.+|+|+|+.+.   +.       ++.||||.+....  .....+.|.+|+.++..++| ||||++
T Consensus        58 ~wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           58 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            3445443  35566779999998652   22       2579999996543  34556789999999999976 899999


Q ss_pred             eeeEEeC-CcEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 018204          251 VGAVTQN-IPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD  313 (359)
Q Consensus       251 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrD  313 (359)
                      +++|... .++|+|||||++|+|.++|+..                ..+++..+..|+.||+.||.|||+++   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9998764 5799999999999999999753                23899999999999999999999998   99999


Q ss_pred             CCCCcEEEcCCCcEEEeccccccc
Q 018204          314 LKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       314 lk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |||+|||++.++.+||+|||+|+.
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~  234 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARD  234 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSC
T ss_pred             cCccceeeCCCCCEEECcchhhhh
Confidence            999999999999999999999974

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.96  E-value=1.5e-30  Score=258.18  Aligned_cols=153  Identities=25%  Similarity=0.342  Sum_probs=129.9

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCC---CcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESH---KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      +|.....+|+|+|+.+.     .+|+.+|+|++.+...   ...........++.++..++|||||+++++|.+...+|+
T Consensus       190 df~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl  269 (689)
T 3v5w_A          190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF  269 (689)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             HeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence            47777889999998652     3689999999964321   112222222344666777899999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc------
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR------  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~------  336 (359)
                      |||||+||+|.++|.+.+.+++..++.|+.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+      
T Consensus       270 VmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             EECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            9999999999999999889999999999999999999999999   9999999999999999999999999996      


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             +.|||||...
T Consensus       347 ~~t~~GTp~YmAPEvl~  363 (689)
T 3v5w_A          347 PHASVGTHGYMAPEVLQ  363 (689)
T ss_dssp             CCSCCSCGGGCCHHHHS
T ss_pred             CCCccCCcCccCHHHHh
Confidence                   3589999764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.96  E-value=1.6e-29  Score=237.02  Aligned_cols=135  Identities=24%  Similarity=0.351  Sum_probs=118.4

Q ss_pred             eEeeccCcccceeEEEE--------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~  261 (359)
                      .|...+.+|+|+|+.+.        ..++.||+|.+.....     ...+.+|+.++..+ +||||++++++|.+.+.+|
T Consensus        22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            46777789999998652        1357899999865432     23478899999988 6999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DFGla~  336 (359)
                      +|||||+||+|.+++.   .+++..++.++.||+.||+|||+++   ||||||||+|||++.+ +.+||+|||+|+
T Consensus        97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            9999999999999983   5999999999999999999999999   9999999999999876 799999999985

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.95  E-value=2e-28  Score=242.73  Aligned_cols=150  Identities=22%  Similarity=0.451  Sum_probs=131.3

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.+.+.+|+|+|+.+.     .+|+.+|+|++....   ....+.+.+|+.+|+.++||||++++++|.+...+|+|||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            46777789999998652     368999999996543   3345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC--CcEEEeccccccc-----
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG--GQLKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~--~~~kl~DFGla~~-----  337 (359)
                      ||+||+|.+++.. .+.+++..+..|+.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+|+.     
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999999999964 357999999999999999999999999   9999999999999854  8999999999972     


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|||||...
T Consensus       312 ~~~~~~GT~~y~APEv~~  329 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAE  329 (573)
T ss_dssp             EEEEECSSGGGCCHHHHT
T ss_pred             ceeeeEECccccCHHHhC
Confidence                     588888765

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.95  E-value=1.5e-29  Score=212.16  Aligned_cols=133  Identities=35%  Similarity=0.445  Sum_probs=103.0

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      ++.+|+.|+++.|+.+++.+.....+|.+|+||||+|+..|+.+++++|++.|+|+|.+|.+|+||||+||..|+.++|+
T Consensus         8 L~~Aa~~G~~~~v~~Ll~~Gadvn~~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~   87 (169)
T 4gpm_A            8 LIEAAENGNKDRVKDLIENGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVK   87 (169)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHH
Confidence            45677788888888877776555556777888888888888888888888888888888888888888888888888888


Q ss_pred             HHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          123 LLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       123 ~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++   ..++||+++|
T Consensus        88 ~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A  143 (169)
T 4gpm_A           88 LLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSDGRTPLDLA  143 (169)
T ss_dssp             HHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHH
Confidence            8888888888888888888888888888888888888887763   4456666665

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.95  E-value=2.6e-27  Score=219.60  Aligned_cols=152  Identities=28%  Similarity=0.535  Sum_probs=134.5

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+.     .+|+.||+|++..... +....+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            46667778999987542     4689999999976543 45556778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999862        


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||...
T Consensus       172 ~~~gt~~y~aPE~~~  186 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQ  186 (328)
T ss_dssp             TTSSSGGGCCHHHHH
T ss_pred             cccCCcceeCccccc
Confidence                  477787654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.95  E-value=2.3e-27  Score=216.40  Aligned_cols=153  Identities=28%  Similarity=0.489  Sum_probs=137.2

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|.|.|+.+.     ..+..+|+|.+...........+.|.+|+.++..++||||+++++++......|+|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   91 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME   91 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence            46677778888887542     3578999999977666677777889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++         
T Consensus        92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            9999999999998888999999999999999999999999   9999999999999999999999999985         


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|+|||...
T Consensus       169 ~~~~~gt~~y~aPE~~~  185 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAK  185 (294)
T ss_dssp             ------CCSSCCHHHHH
T ss_pred             cCccccCccccCHhHhc
Confidence                   2488888765

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.95  E-value=1e-27  Score=223.13  Aligned_cols=153  Identities=24%  Similarity=0.414  Sum_probs=132.0

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+.     .+|+.+|+|++.+...........+.+|+.++..++||||+++++++.....+|+|||
T Consensus         6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E   85 (337)
T 1o6l_A            6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence            45666778888887542     3588999999965321122234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |++||+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++.        
T Consensus        86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            9999999999988888999999999999999999999998   99999999999999999999999999862        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       163 ~~~~gt~~y~aPE~~~  178 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             CCCEECGGGCCGGGGS
T ss_pred             cccccChhhCChhhhc
Confidence                   488898764

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.94  E-value=1e-28  Score=207.06  Aligned_cols=130  Identities=31%  Similarity=0.357  Sum_probs=113.5

Q ss_pred             CCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      ...+.+..++..+..+.++.+++.+......|.+|+||||+||..|+.++|++|+++|+|||.+|.+|+||||+||..|+
T Consensus        36 ~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~  115 (169)
T 4gpm_A           36 DGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGH  115 (169)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCC
Confidence            34445566677888888888888777666779999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccccc
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~  167 (359)
                      .++|++|+++|+|++.+|..|+||||+|+.+|+.+++++|+++||+++..
T Consensus       116 ~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GA~ie~~  165 (169)
T 4gpm_A          116 KEVVKLLISKGADVNTSDSDGRTPLDLAREHGNEEVVKLLEKQGGWLEHH  165 (169)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTC-------
T ss_pred             HHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCCC
Confidence            99999999999999999999999999999999999999999999998643

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=2.3e-27  Score=235.08  Aligned_cols=135  Identities=13%  Similarity=0.157  Sum_probs=118.1

Q ss_pred             EecCcEEEEEEeccCCCC-------cHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCCCCHHHHHHh
Q 018204          207 KWNGTKVWVKILDKESHK-------DPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK  278 (359)
Q Consensus       207 ~~~g~~vavK~l~~~~~~-------~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  278 (359)
                      .+.|+.+++|++.+....       .....+.|.+|+.+|+++ .|+||+++++++.++..+||||||++|++|.++|..
T Consensus       256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~  335 (569)
T 4azs_A          256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA  335 (569)
T ss_dssp             EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred             ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence            457999999999765321       123446799999999999 799999999999999999999999999999999998


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------------ccccCcc
Q 018204          279 KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------------LQYISPE  343 (359)
Q Consensus       279 ~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------------~~~~~PE  343 (359)
                      .+.++..   .|+.||+.||+|+|++|   ||||||||+|||++.+|.+||+|||+|+               ..||+||
T Consensus       336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE  409 (569)
T 4azs_A          336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNE  409 (569)
T ss_dssp             TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHH
T ss_pred             CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHH
Confidence            8888765   58899999999999999   9999999999999999999999999997               2599999


Q ss_pred             cccc
Q 018204          344 KAKI  347 (359)
Q Consensus       344 ~~~~  347 (359)
                      ....
T Consensus       410 ~l~g  413 (569)
T 4azs_A          410 LFAE  413 (569)
T ss_dssp             HC--
T ss_pred             HhCC
Confidence            8764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.94  E-value=3.5e-27  Score=223.88  Aligned_cols=153  Identities=29%  Similarity=0.468  Sum_probs=132.0

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|.....+|+|+|+.+.     .+++.+|+|++.+.........+.+..|..++..+ +||||+++++++.....+|+||
T Consensus        53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~  132 (396)
T 4dc2_A           53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI  132 (396)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence            46666778999988542     35789999999876555555556788999999887 8999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      ||+++|+|..++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+|+.       
T Consensus       133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  209 (396)
T 4dc2_A          133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  209 (396)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999863       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       210 ~~~~~gt~~Y~aPE~l~  226 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILR  226 (396)
T ss_dssp             BCCCCBCGGGCCHHHHT
T ss_pred             cccccCCcccCCchhhc
Confidence                    477787654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.94  E-value=1e-26  Score=217.14  Aligned_cols=153  Identities=29%  Similarity=0.469  Sum_probs=135.3

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|.....+|+|.|+.+.     .+++.+|+|++.+.........+.+..|..++..+ +||||+++++++.....+|+||
T Consensus        10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            45666678888887542     25889999999877666677777889999999988 8999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      ||+++|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.       
T Consensus        90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            99999999999988888999999999999999999999999   99999999999999999999999999863       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       167 ~~~~~gt~~y~aPE~~~  183 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILR  183 (345)
T ss_dssp             BCCCCSCGGGCCHHHHT
T ss_pred             ccccCCCccccCccccC
Confidence                    377777654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.94  E-value=1.6e-27  Score=220.07  Aligned_cols=153  Identities=28%  Similarity=0.507  Sum_probs=130.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|+|+.+   .  .+|+.+|+|++.+.........+.+.+|..+++.++||||+++++++.+...+|+|||
T Consensus         7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            3555667788888754   2  3589999999965321111234567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |++||+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++.        
T Consensus        87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~  163 (318)
T 1fot_A           87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL  163 (318)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCccccc
Confidence            9999999999998888999999999999999999999998   99999999999999999999999999862        


Q ss_pred             ----cccCccccc
Q 018204          338 ----QYISPEKAK  346 (359)
Q Consensus       338 ----~~~~PE~~~  346 (359)
                          .|+|||...
T Consensus       164 ~gt~~y~aPE~~~  176 (318)
T 1fot_A          164 CGTPDYIAPEVVS  176 (318)
T ss_dssp             CSCTTTCCHHHHT
T ss_pred             cCCccccCHhHhc
Confidence                488888754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.94  E-value=3.5e-27  Score=220.89  Aligned_cols=143  Identities=27%  Similarity=0.400  Sum_probs=125.4

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|.....+|.|+|+.+.     .+|+.+|+|++.+...........+..|..++..+ +||||+++++++.....+|+||
T Consensus        24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            46666778899887542     35889999999754322233445678899999988 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus       104 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          104 EFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence            99999999999998888999999999999999999999999   9999999999999999999999999987

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.94  E-value=2.7e-27  Score=223.77  Aligned_cols=153  Identities=27%  Similarity=0.439  Sum_probs=131.6

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|+|+.+     ..++..+|+|++.............+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            3555667788887643     23578899999965332222334578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+.||+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++.        
T Consensus        96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  172 (384)
T 4fr4_A           96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT  172 (384)
T ss_dssp             CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBC
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCcee
Confidence            9999999999998888999999999999999999999999   99999999999999999999999999962        


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||...
T Consensus       173 ~~~gt~~Y~aPE~~~  187 (384)
T 4fr4_A          173 TMAGTKPYMAPEMFS  187 (384)
T ss_dssp             CCCSCGGGCCGGGTC
T ss_pred             ccCCCccccCCeeec
Confidence                  488898764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.94  E-value=2.1e-26  Score=211.39  Aligned_cols=141  Identities=30%  Similarity=0.505  Sum_probs=124.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  .++..+|+|.+..   .+....+.|.+|+.+++.++||||+++++++......++|||
T Consensus        11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A           11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            3555667888888754   2  2488999998854   245666789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  157 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARL  157 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeeccccee
Confidence            9999999999987 457999999999999999999999999   99999999999999999999999999863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.94  E-value=3.3e-27  Score=220.84  Aligned_cols=153  Identities=28%  Similarity=0.465  Sum_probs=131.6

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  .+|+.+|+|++.+.........+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  121 (350)
T 1rdq_E           42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            4556667788888644   2  2588999999965322222234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+++|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++         
T Consensus       122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~  198 (350)
T 1rdq_E          122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL  198 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCcccc
Confidence            9999999999998888999999999999999999999999   9999999999999999999999999986         


Q ss_pred             ---ccccCccccc
Q 018204          337 ---LQYISPEKAK  346 (359)
Q Consensus       337 ---~~~~~PE~~~  346 (359)
                         ..|+|||...
T Consensus       199 ~gt~~y~aPE~~~  211 (350)
T 1rdq_E          199 CGTPEALAPEIIL  211 (350)
T ss_dssp             EECGGGCCHHHHT
T ss_pred             cCCccccCHHHhc
Confidence               2588888754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=7.4e-28  Score=229.59  Aligned_cols=152  Identities=27%  Similarity=0.386  Sum_probs=127.6

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|+|+.+.     .++..+|+|++.+...........+..|+.++..++||||+++++++.+...+|+|||
T Consensus        70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E  149 (410)
T 3v8s_A           70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  149 (410)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            46666778999988542     2578999999964211111112247789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |++||+|.+++... .+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+|+.        
T Consensus       150 ~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          150 YMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred             CCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence            99999999999764 6999999999999999999999999   99999999999999999999999999852        


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       226 ~~~~~gt~~Y~APE~l~  242 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLK  242 (410)
T ss_dssp             CCSCCSCGGGCCHHHHH
T ss_pred             ccCCcCCccccCHHHhh
Confidence                    477887655

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.94  E-value=1.9e-26  Score=211.98  Aligned_cols=154  Identities=41%  Similarity=0.717  Sum_probs=131.7

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      +|...+.+|.|.|+.   +...|..+|||++..... .....+.+.+|+.+++.++||||+++++++......++||||+
T Consensus        38 ~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  116 (309)
T 3p86_A           38 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYL  116 (309)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECC
T ss_pred             HceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecC
Confidence            456666788888874   356789999999975543 4566678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          268 AKGDLASYLQKKGR---LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       268 ~~gsL~~~l~~~~~---l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      ++|+|.+++...+.   +++..+..++.|++.||.|||+++ .+|+||||||+|||++.++.+||+|||+++        
T Consensus       117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  195 (309)
T 3p86_A          117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS  195 (309)
T ss_dssp             TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred             CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccccc
Confidence            99999999987543   999999999999999999999987 359999999999999999999999999985        


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|+|||...
T Consensus       196 ~~~~~gt~~y~aPE~~~  212 (309)
T 3p86_A          196 SKSAAGTPEWMAPEVLR  212 (309)
T ss_dssp             ------CCTTSCHHHHT
T ss_pred             cccCCCCccccChhhhc
Confidence                   2488888765

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.94  E-value=1.9e-26  Score=216.48  Aligned_cols=155  Identities=26%  Similarity=0.485  Sum_probs=132.4

Q ss_pred             eeeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      .-.|.....+|.|.|+.+.     .+|..+|+|++........   ...+.+.+|+.++..++||||+++++++.....+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            3456777788999988552     2588999999976443211   1235688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC----cEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DFGla~  336 (359)
                      |+||||++||+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||+++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            999999999999999988888999999999999999999999998   99999999999998877    79999999986


Q ss_pred             c--------------cccCccccc
Q 018204          337 L--------------QYISPEKAK  346 (359)
Q Consensus       337 ~--------------~~~~PE~~~  346 (359)
                      .              .|+|||...
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~  191 (361)
T 2yab_A          168 EIEDGVEFKNIFGTPEFVAPEIVN  191 (361)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHT
T ss_pred             EcCCCCccccCCCCccEECchHHc
Confidence            3              377887654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=4.2e-27  Score=224.55  Aligned_cols=143  Identities=24%  Similarity=0.390  Sum_probs=123.2

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|.|+.+   .  .+|+.+|+|++.+...........+..|..++..++||||+++++++.+...+|+|||
T Consensus        62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE  141 (412)
T 2vd5_A           62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME  141 (412)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence            4666677888888744   2  3589999999964322122223457889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |++||+|.+++.+.+ .+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++
T Consensus       142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhe
Confidence            999999999998754 7999999999999999999999999   9999999999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=6.7e-27  Score=224.68  Aligned_cols=143  Identities=21%  Similarity=0.355  Sum_probs=122.9

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|+|+|+.+.     ..++.+|+|++.+...........+..|..++..++||||++++++|.+...+|+|||
T Consensus        75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E  154 (437)
T 4aw2_A           75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD  154 (437)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence            46667788999998542     2478899999964221111112347889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |++||+|.+++.. .+.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus       155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            9999999999987 467999999999999999999999999   9999999999999999999999999985

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.94  E-value=3.4e-26  Score=211.91  Aligned_cols=153  Identities=26%  Similarity=0.426  Sum_probs=124.5

Q ss_pred             eEeeccCcccceeEEEE--------ecCcEEEEEEeccCCCC-cHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~--------~~g~~vavK~l~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      .|.....+|.|.|+.+.        ..|..+|+|++...... .......+.+|+.+++.++||||+++++++.....+|
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   97 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY   97 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence            46666778888887542        36889999999754321 2233456788999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----  337 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----  337 (359)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.    
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence            99999999999999988888999999999999999999999998   99999999999999999999999999862    


Q ss_pred             -----------cccCccccc
Q 018204          338 -----------QYISPEKAK  346 (359)
Q Consensus       338 -----------~~~~PE~~~  346 (359)
                                 .|+|||...
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~  194 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILM  194 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHT
T ss_pred             CccccccCCCcCccCHhhCc
Confidence                       377888654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.93  E-value=5.1e-26  Score=214.32  Aligned_cols=141  Identities=28%  Similarity=0.567  Sum_probs=122.7

Q ss_pred             eEeeccCcccceeEEEE---e---------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC
Q 018204          191 QVRKADGITKGSYQVAK---W---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~---------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  257 (359)
                      .|...+.+|.|.|+.+.   .         .+..+|+|++...  ......+.+.+|+.+++.+ +||||+++++++...
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            45566678888887542   1         2357999999654  3455667899999999999 899999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 018204          258 IPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll  321 (359)
                      ..+|+||||+++|+|.+++....                .+++..+..++.||+.||.|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            99999999999999999998643                4789999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEecccccc
Q 018204          322 DNGGQLKISGFGLLR  336 (359)
Q Consensus       322 ~~~~~~kl~DFGla~  336 (359)
                      +.++.+||+|||+++
T Consensus       237 ~~~~~~kl~DFG~a~  251 (370)
T 2psq_A          237 TENNVMKIADFGLAR  251 (370)
T ss_dssp             CTTCCEEECCCSSCE
T ss_pred             CCCCCEEEccccCCc
Confidence            999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.93  E-value=1.3e-26  Score=216.36  Aligned_cols=143  Identities=25%  Similarity=0.384  Sum_probs=122.7

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|...+.+|+|+|+.+   .  .+|+.+|+|++.+...........+..|..++..+ +||||+++++++.+...+|+||
T Consensus        18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~   97 (345)
T 1xjd_A           18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   97 (345)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4556667888888754   2  35889999999653211112234577899999876 9999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+|+
T Consensus        98 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           98 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            99999999999998888999999999999999999999999   9999999999999999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.93  E-value=7e-26  Score=206.93  Aligned_cols=149  Identities=20%  Similarity=0.442  Sum_probs=129.0

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+     ..+|..+|+|.+........   +.+.+|+.+++.++||||+++++++......|+|||
T Consensus        21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCH---HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHH---HHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            4556667888888754     24588999999975544333   457899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+++++|.+++... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++         
T Consensus        98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            99999999999765 6999999999999999999999998   9999999999999999999999999875         


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|+|||...
T Consensus       174 ~~~~gt~~y~aPE~~~  189 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVT  189 (297)
T ss_dssp             CCCCSCGGGCCHHHHH
T ss_pred             CCccCCcCccChhhhc
Confidence                  2478888654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.93  E-value=1.2e-26  Score=215.78  Aligned_cols=152  Identities=28%  Similarity=0.510  Sum_probs=129.2

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   .  .+|+.+|+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (336)
T 3h4j_B           10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE   89 (336)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence            4666677888888754   2  3688999999864321111122468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+ +|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus        90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            99 6799999988888999999999999999999999999   99999999999999999999999999863        


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||...
T Consensus       166 ~~~gt~~y~aPE~~~  180 (336)
T 3h4j_B          166 TSCGSPNYAAPEVIN  180 (336)
T ss_dssp             CCTTSTTTSCGGGSC
T ss_pred             cccCCcCcCCHHHHc
Confidence                  478888654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.93  E-value=5.7e-26  Score=215.28  Aligned_cols=143  Identities=18%  Similarity=0.288  Sum_probs=125.5

Q ss_pred             eeEeeccCcccc--eeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          190 LQVRKADGITKG--SYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       190 ~~~~~~~~ig~g--~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      -.|.....+|.|  .|+.+   .  .+|..||||++..... .....+.+.+|+.+++.++||||+++++++.....+|+
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            346666778888  76543   2  2588999999976543 34566788999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence            99999999999999875  56999999999999999999999999   9999999999999999999999999874

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.93  E-value=7.5e-26  Score=209.52  Aligned_cols=154  Identities=27%  Similarity=0.498  Sum_probs=131.4

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      -.|.....+|.|.|+.+.     .+|..+|+|++........   ...+.+.+|+.+++.++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            356777788999987552     2588999999975432211   12356889999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC----cEEEeccccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL  337 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DFGla~~  337 (359)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++    .+||+|||+++.
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            99999999999999988888999999999999999999999998   99999999999999887    799999999863


Q ss_pred             --------------cccCccccc
Q 018204          338 --------------QYISPEKAK  346 (359)
Q Consensus       338 --------------~~~~PE~~~  346 (359)
                                    .|+|||...
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~  190 (326)
T 2y0a_A          168 IDFGNEFKNIFGTPEFVAPEIVN  190 (326)
T ss_dssp             CCTTSCCCCCCSCTTTCCHHHHT
T ss_pred             CCCCCccccccCCcCcCCceeec
Confidence                          377777653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.93  E-value=1.1e-25  Score=211.57  Aligned_cols=152  Identities=24%  Similarity=0.423  Sum_probs=132.4

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+.     .+|..+|+|++..... .....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus        30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            56777778999887552     2588999999976543 44556779999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---cEEEeccccccc-----
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DFGla~~-----  337 (359)
                      |+++|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++.     
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            9999999999988888999999999999999999999999   99999999999998654   599999999862     


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       186 ~~~~~~gt~~y~aPE~~~  203 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLK  203 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHT
T ss_pred             ccccCCCCccccCHHHHc
Confidence                     478888654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.93  E-value=2.5e-26  Score=211.18  Aligned_cols=143  Identities=24%  Similarity=0.428  Sum_probs=126.7

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc----EE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----MM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~  261 (359)
                      .|.....+|.|.|+.+   .  ..++.+|+|++......+......+.+|+.++..++||||+++++++.....    .|
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            4666677888888754   2  4688999999987766677777889999999999999999999999876543    49


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            99999999999999998888999999999999999999999998   9999999999999999999999999985

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.93  E-value=1.8e-26  Score=216.06  Aligned_cols=153  Identities=27%  Similarity=0.401  Sum_probs=129.5

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|.....+|.|.|+.+   .  .+|+.+|+|++.+.........+.+..|..++..+ +||+|+++++++.....+|+||
T Consensus        21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~  100 (353)
T 2i0e_A           21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  100 (353)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence            3556667888888754   2  24678999999753221122345678899999887 8999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++.       
T Consensus       101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            99999999999998888999999999999999999999998   99999999999999999999999999863       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       178 ~~~~~gt~~y~aPE~~~  194 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIA  194 (353)
T ss_dssp             BCCCCSCGGGCCHHHHT
T ss_pred             cccccCCccccChhhhc
Confidence                    377777654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.93  E-value=5.5e-26  Score=220.03  Aligned_cols=142  Identities=25%  Similarity=0.388  Sum_probs=116.8

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----CcE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~  260 (359)
                      .|.....+|.|.|+.+     ..+|+.||||++... ..+....+.+.+|+.+++.++||||+++++++...     ..+
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            5777888999999854     236889999999654 33555667899999999999999999999998543     569


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |+||||+. ++|.+++.....+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+.
T Consensus       133 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence            99999985 699999988888999999999999999999999999   99999999999999999999999999963

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.93  E-value=4.2e-26  Score=207.57  Aligned_cols=150  Identities=27%  Similarity=0.527  Sum_probs=126.8

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  .+|+.+|+|++..... .......+.+|+.+++.++||||+++++++......++||||
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   82 (292)
T 3o0g_A            4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence            556667788887643   2  2578999999975543 334456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++ ++.+++.. .+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus        83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            976 66666554 567999999999999999999999998   99999999999999999999999999852        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       159 ~~~~~t~~y~aPE~~~  174 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLF  174 (292)
T ss_dssp             CSCCSCGGGCCHHHHT
T ss_pred             cCCccccCCcChHHHc
Confidence                   388888754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.93  E-value=1.1e-25  Score=208.26  Aligned_cols=142  Identities=27%  Similarity=0.457  Sum_probs=124.2

Q ss_pred             eeEeeccCcccceeEEE---Ee-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          190 LQVRKADGITKGSYQVA---KW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~---~~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      ..|.....+|.|.|+.+   ..     .+..+|||.+....  .....+.|.+|+.+++.++||||+++++++......+
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            35666777888888754   22     34469999996432  4555678999999999999999999999999989999


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence            999999999999999765 57999999999999999999999998   9999999999999999999999999996

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.93  E-value=5.9e-26  Score=213.19  Aligned_cols=149  Identities=31%  Similarity=0.485  Sum_probs=128.2

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   .  .+++.+|+|++.......    +.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            4666667888887643   2  368899999997654333    347899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc--EEEecccccc-------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ--LKISGFGLLR-------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~--~kl~DFGla~-------  336 (359)
                      |+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.  +||+|||+|+       
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~  173 (361)
T 3uc3_A           97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  173 (361)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence            9999999999988888999999999999999999999999   999999999999987765  9999999986       


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|+|||...
T Consensus       174 ~~~~~gt~~y~aPE~~~  190 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLL  190 (361)
T ss_dssp             -------CTTSCHHHHH
T ss_pred             CCCCcCCCCcCChhhhc
Confidence                   2578888654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.93  E-value=2.8e-26  Score=216.19  Aligned_cols=153  Identities=27%  Similarity=0.426  Sum_probs=122.5

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHH-HHhCCCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTI-VEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|.....+|+|.|+.+   .  .++..+|+|++.+...........+..|..+ ++.++||||+++++++.....+|+||
T Consensus        39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~  118 (373)
T 2r5t_A           39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL  118 (373)
T ss_dssp             GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence            4666677888888754   2  2578899999976654444445566777776 46789999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++.       
T Consensus       119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~  195 (373)
T 2r5t_A          119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST  195 (373)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999863       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       196 ~~~~~gt~~y~aPE~~~  212 (373)
T 2r5t_A          196 TSTFCGTPEYLAPEVLH  212 (373)
T ss_dssp             CCSBSCCCCCCCHHHHT
T ss_pred             cccccCCccccCHHHhC
Confidence                    377777654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.93  E-value=2.1e-26  Score=223.44  Aligned_cols=153  Identities=29%  Similarity=0.551  Sum_probs=130.5

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|.|.|+.+   .  .+|+.+|||++.............+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E   96 (476)
T 2y94_A           17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME   96 (476)
T ss_dssp             TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            3556667788888643   2  3589999999964322112234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus        97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~  173 (476)
T 2y94_A           97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR  173 (476)
T ss_dssp             CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBC
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccccc
Confidence            9999999999988888999999999999999999999998   99999999999999999999999999863        


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||...
T Consensus       174 ~~~gt~~y~aPE~~~  188 (476)
T 2y94_A          174 TSCGSPNYAAPEVIS  188 (476)
T ss_dssp             CCCSCSTTCCHHHHT
T ss_pred             ccCCCcCeEChhhcc
Confidence                  377777654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=2.1e-25  Score=206.10  Aligned_cols=149  Identities=19%  Similarity=0.406  Sum_probs=128.4

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+.     .++..+|+|.+...    ......+.+|+.+++.++||||+++++++.....+++|||
T Consensus         6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            45666678888887542     25789999998643    2334568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC--CCcEEEeccccccc-----
Q 018204          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DFGla~~-----  337 (359)
                      |+++++|.+++.... .+++..+..++.|++.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.     
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            999999999997653 6999999999999999999999998   999999999999987  78999999999963     


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       159 ~~~~~~gt~~y~aPE~~~  176 (321)
T 1tki_A          159 NFRLLFTAPEYYAPEVHQ  176 (321)
T ss_dssp             EEEEEESCGGGSCHHHHT
T ss_pred             ccccccCChhhcCcHHhc
Confidence                     478888654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.93  E-value=2.6e-25  Score=214.22  Aligned_cols=153  Identities=20%  Similarity=0.390  Sum_probs=132.2

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      -.|.....+|.|.|+.+.     ..|..+|+|++..... .....+.+.+|+.+++.++||||+++++++......|+||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            356777788999998652     3688999999976543 4445667899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc---CCCcEEEecccccc-----
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD---NGGQLKISGFGLLR-----  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DFGla~-----  336 (359)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+|+     
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            99999999999998888999999999999999999999999   99999999999998   46789999999995     


Q ss_pred             ----------ccccCccccc
Q 018204          337 ----------LQYISPEKAK  346 (359)
Q Consensus       337 ----------~~~~~PE~~~  346 (359)
                                ..|+|||...
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~  186 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLR  186 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHT
T ss_pred             CceeecccCCcccCCHHHhc
Confidence                      2478888755

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.93  E-value=6e-26  Score=214.35  Aligned_cols=141  Identities=33%  Similarity=0.544  Sum_probs=123.7

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      ++...+.+|.|.|+.+   ..  .+..||||.+....  .......|.+|+.+++.++||||+++++++.....+++|||
T Consensus       115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            3555667888888754   33  58899999986432  34555678999999999999999999999999899999999


Q ss_pred             cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+++|+|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            999999999997653 5999999999999999999999999   9999999999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.93  E-value=2.4e-26  Score=221.87  Aligned_cols=153  Identities=24%  Similarity=0.420  Sum_probs=123.8

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+.     ..|..||+|++.............+.+|+.+++.++||||+++++++.....+|+|||
T Consensus       149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            36666778999988552     3588999999975433334445667889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      |+++|+|.+++...+.+++..+..++.||+.||.|||+ ++   |+||||||+|||++.++.+||+|||+|+.       
T Consensus       229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence            99999999999888889999999999999999999998 88   99999999999999999999999999863       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       306 ~~~~~gt~~y~aPE~~~  322 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLE  322 (446)
T ss_dssp             -CCSSSCGGGCCHHHHH
T ss_pred             cccccCCccccCHhhcC
Confidence                    478888654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.93  E-value=5.7e-26  Score=224.05  Aligned_cols=153  Identities=29%  Similarity=0.398  Sum_probs=129.6

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|+|+.+.     .+|+.+|+|++.+...........+.+|+.++..++||||+++++++.+...+|+|||
T Consensus       185 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  264 (576)
T 2acx_A          185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT  264 (576)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            46666778999988542     2689999999964322112223467899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc------
Q 018204          266 YHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~------  337 (359)
                      |++||+|.+++...+  .+++..+..++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+|+.      
T Consensus       265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence            999999999998754  3999999999999999999999998   99999999999999999999999999963      


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       342 ~~~~~GT~~Y~APEvl~  358 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVK  358 (576)
T ss_dssp             EECCCSCGGGCCHHHHT
T ss_pred             ccccCCCccccCHHHHc
Confidence                    377777654

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.93  E-value=1.2e-26  Score=204.04  Aligned_cols=176  Identities=19%  Similarity=0.145  Sum_probs=150.1

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      ++.++..|+.+.++.+++.+......|.+|+||||+||..|+.++|++|++.|+|+|.+|..|+||||+|+..|+.++|+
T Consensus        25 L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~  104 (229)
T 2vge_A           25 LLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICM  104 (229)
T ss_dssp             HHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHH
Confidence            45678899999999999877665666899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCccccc-cccccccccc--cccccceeEeeccccCccccccC---CCCcccCCCCCCCcccCCc-ceeeEeec
Q 018204          123 LLLSKKANIDARD-RWGSTAAADA--KYYGNVEVYNILKARGAKVPKTK---RTPMTVANPREVPEYELNP-LELQVRKA  195 (359)
Q Consensus       123 ~Ll~~ga~~~~~d-~~g~tpl~~A--~~~~~~~~~~~L~~~ga~~~~~~---~tpl~~a~~~~~~~~~l~~-~~~~~~~~  195 (359)
                      +|+++|++++.+| ..|+||||+|  +..|+.+++++|+++|++++..+   .+++.........++++.. ........
T Consensus       105 ~Ll~~ga~~~~~~~~~g~tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~l~~~~~~~~~~~ll~~ga~~~~~~~  184 (229)
T 2vge_A          105 ALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQSMGLMNSGAVYALWDYSAEFGDELSFREGESVTVLRR  184 (229)
T ss_dssp             HHHTTTCCTTCCCSSTTCCTGGGCCTTSTTHHHHHHHHHHHHHHTTTSGGGEEEESSCBCCSSTTBCCBCTTCEEEEEES
T ss_pred             HHHHcCCCcccccCCCCCCHHHHHHHHhcChHHHHHHHHHcCCCcccccCCchHHHHHHhhccccccCcccccccccccc
Confidence            9999999999997 6999999999  99999999999999999986543   4555544444444444433 33446667


Q ss_pred             cCcccceeEEEEecCcEEEEEEe
Q 018204          196 DGITKGSYQVAKWNGTKVWVKIL  218 (359)
Q Consensus       196 ~~ig~g~~~~~~~~g~~vavK~l  218 (359)
                      +..|.+++..+...|+.-+|+..
T Consensus       185 d~~G~TpL~~A~~~g~~~~v~~~  207 (229)
T 2vge_A          185 DGPEETDWWWAALHGQEGYVPRN  207 (229)
T ss_dssp             SCTTCSSEEEEEETTEEEEEEGG
T ss_pred             CCCcccHHHHHHHcCCcceeehh
Confidence            77899999999999998888864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.93  E-value=1.7e-25  Score=205.25  Aligned_cols=142  Identities=30%  Similarity=0.614  Sum_probs=123.3

Q ss_pred             eeEeeccCcccceeEEE---E-------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc
Q 018204          190 LQVRKADGITKGSYQVA---K-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~---~-------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  259 (359)
                      .+|...+.+|.|.|+.+   .       ..+..+|+|++....  .....+.+.+|+.+++.++||||+++++++.....
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            34566667888888644   1       134789999996433  45666789999999999999999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 018204          260 MMIVLEYHAKGDLASYLQKKGR------------------------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLK  315 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk  315 (359)
                      .++||||+++++|.+++.....                        +++..+..++.|++.||.|||+++   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999986533                        889999999999999999999998   9999999


Q ss_pred             CCcEEEcCCCcEEEecccccc
Q 018204          316 PKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       316 ~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+|||++.++.+||+|||+++
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~  198 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSR  198 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCE
T ss_pred             hheEEEcCCCCEEEccccccc
Confidence            999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.93  E-value=5.2e-27  Score=218.03  Aligned_cols=152  Identities=18%  Similarity=0.228  Sum_probs=120.1

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCC-----cHHHHHHHHHHHHHHHhCC---------CCccccc---
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHK-----DPERINAFTHELTIVEKAR---------HPNVVQF---  250 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~-----~~~~~~~~~~Ei~il~~l~---------HpnIv~l---  250 (359)
                      .|.....+|+|+|+.   +..+|..||||++......     .....+.+.+|+.+++.++         ||||+++   
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~  100 (336)
T 2vuw_A           21 KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV  100 (336)
T ss_dssp             HHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred             cchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence            355566788888874   3567999999999765321     2223356889999998886         5555554   


Q ss_pred             --------------eeeEEe-------------CCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-
Q 018204          251 --------------VGAVTQ-------------NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH-  302 (359)
Q Consensus       251 --------------~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH-  302 (359)
                                    ++++..             ...+|+||||+++|++.+.+.+ +.+++..+..++.||+.||.||| 
T Consensus       101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~  179 (336)
T 2vuw_A          101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEA  179 (336)
T ss_dssp             EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH
Confidence                          444443             6789999999999977766644 56899999999999999999999 


Q ss_pred             hCCCCCeEeCCCCCCcEEEcCCC--------------------cEEEeccccccc----------cccCccccc
Q 018204          303 ECKPDPIIHCDLKPKNILLDNGG--------------------QLKISGFGLLRL----------QYISPEKAK  346 (359)
Q Consensus       303 ~~~~~~iiHrDlk~~NIll~~~~--------------------~~kl~DFGla~~----------~~~~PE~~~  346 (359)
                      +++   |+||||||+|||++.++                    .+||+|||+|+.          .|+|||...
T Consensus       180 ~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          180 SLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGC
T ss_pred             hCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhc
Confidence            898   99999999999999887                    899999999973          589999765

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.93  E-value=3.2e-25  Score=204.80  Aligned_cols=141  Identities=20%  Similarity=0.382  Sum_probs=118.4

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC-------
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-------  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-------  258 (359)
                      +|.....+|.|.|+.+   .  .+|..+|||++....  .....+.+.+|+.+++.++||||+++++++....       
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            4566667888888754   2  268899999997543  2334467899999999999999999999986543       


Q ss_pred             --------------------------------------------------cEEEEEecCCCCCHHHHHHhcCC---CCHH
Q 018204          259 --------------------------------------------------PMMIVLEYHAKGDLASYLQKKGR---LSPS  285 (359)
Q Consensus       259 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~---l~~~  285 (359)
                                                                        ..++|||||++++|.+++.....   .++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              38999999999999999987543   5666


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          286 KVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       286 ~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~  212 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT  212 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCccc
Confidence            78999999999999999998   9999999999999999999999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.93  E-value=2.2e-25  Score=204.47  Aligned_cols=152  Identities=26%  Similarity=0.414  Sum_probs=132.0

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  .+|..+|+|.+.... ......+.+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            3566677888888754   2  248899999986543 345556778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.        
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence            9999999999888888999999999999999999999999   99999999999999999999999999852        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       160 ~~~~~~~~y~aPE~~~  175 (311)
T 4agu_A          160 DDEVATRWYRSPELLV  175 (311)
T ss_dssp             ------GGGCCHHHHH
T ss_pred             CCCcCCccccChHHHh
Confidence                   388888754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.93  E-value=3.1e-25  Score=214.32  Aligned_cols=138  Identities=34%  Similarity=0.636  Sum_probs=121.5

Q ss_pred             eEeeccCcccceeEEE---EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC-cEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-PMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lv~e~  266 (359)
                      ++.....+|.|.|+.+   .+.|..||||++....     ..+.|.+|+.+++.++||||+++++++.... .+|+||||
T Consensus       194 ~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          194 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             HeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            3555667888888744   5678999999997543     2346899999999999999999999987765 79999999


Q ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++...+.  +++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            999999999987643  799999999999999999999998   9999999999999999999999999997

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.93  E-value=1.3e-25  Score=206.50  Aligned_cols=152  Identities=28%  Similarity=0.518  Sum_probs=126.6

Q ss_pred             eeEeeccCcccceeEEE---E-ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          190 LQVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      -.|.....+|.|.|+.+   . ..|+.+|+|++..... +......+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            45777777888888744   2 2588999999965432 23344678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      |+++ +|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.       
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence            9985 888888765 45999999999999999999999998   99999999999999999999999999862       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       176 ~~~~~~t~~y~aPE~~~  192 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLM  192 (311)
T ss_dssp             --CCCCCCTTCCHHHHT
T ss_pred             ccCCcccCCcCCHHHhc
Confidence                    388888654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.93  E-value=3.3e-25  Score=204.31  Aligned_cols=153  Identities=24%  Similarity=0.394  Sum_probs=128.3

Q ss_pred             eeeEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC--cEE
Q 018204          189 ELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMM  261 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~  261 (359)
                      .-.|...+.+|.|.|+.+   .  .+|+.+|||++......  ...+.+.+|+.+++.++||||+++++++....  ..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            346777788899998754   2  24889999999754322  22456789999999999999999999988765  789


Q ss_pred             EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE----cCCCcEEEecccc
Q 018204          262 IVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGL  334 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DFGl  334 (359)
                      +||||+++++|.+++....   .+++..+..++.|++.||.|||+++   |+||||||+|||+    +..+.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999997653   3999999999999999999999998   9999999999999    7778899999999


Q ss_pred             ccc--------------cccCccccc
Q 018204          335 LRL--------------QYISPEKAK  346 (359)
Q Consensus       335 a~~--------------~~~~PE~~~  346 (359)
                      ++.              .|+|||...
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhh
Confidence            963              477888654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.93  E-value=9.9e-26  Score=208.45  Aligned_cols=141  Identities=30%  Similarity=0.447  Sum_probs=122.3

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+.     .+++.+|+|++.....  ....+.+.+|+.+++.++||||+++++++......|+|||
T Consensus         8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            46667778888887542     2588999999965432  2223568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+++++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  153 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT  153 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccc
Confidence            9999999999988778999999999999999999999999   9999999999999999999999999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.92  E-value=3.4e-25  Score=207.00  Aligned_cols=152  Identities=26%  Similarity=0.462  Sum_probs=132.5

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   .  .+|..||||.+...........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            4666677889888754   2  4688999999976665566667789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      |+. |+|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.       
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~  210 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF  210 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCC
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcc
Confidence            997 588888754 457999999999999999999999998   99999999999999999999999999863       


Q ss_pred             ----cccCccccc
Q 018204          338 ----QYISPEKAK  346 (359)
Q Consensus       338 ----~~~~PE~~~  346 (359)
                          .|+|||...
T Consensus       211 ~gt~~y~aPE~~~  223 (348)
T 1u5q_A          211 VGTPYWMAPEVIL  223 (348)
T ss_dssp             CSCGGGCCHHHHH
T ss_pred             cCCcceeCHhhhc
Confidence                588888753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.92  E-value=2.8e-25  Score=203.96  Aligned_cols=153  Identities=20%  Similarity=0.329  Sum_probs=132.4

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   .  ..+..+|+|++......+....+.+.+|+.++..++||||+++++++......|+|||
T Consensus        35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 2h34_A           35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR  114 (309)
T ss_dssp             CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence            3555666777777533   2  3588999999976655556666789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++         
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            9999999999998888999999999999999999999998   9999999999999999999999999875         


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|+|||...
T Consensus       192 ~~~~~~~~~y~aPE~~~  208 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFS  208 (309)
T ss_dssp             -----CCGGGCCGGGTC
T ss_pred             ccccCCCcCccCHHHHc
Confidence                   2388888754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.92  E-value=2.4e-25  Score=202.73  Aligned_cols=140  Identities=31%  Similarity=0.578  Sum_probs=122.2

Q ss_pred             eEeeccCcccceeEEE---E------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--Cc
Q 018204          191 QVRKADGITKGSYQVA---K------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~  259 (359)
                      .|.....+|.|.|+.+   .      ..+..+|||++...   .....+.+.+|+.+++.++||||+++++++...  ..
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            4666677888888754   2      25789999999643   455667899999999999999999999998643  56


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||||+++++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            899999999999999998754 4999999999999999999999998   9999999999999999999999999996

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.92  E-value=4.3e-25  Score=198.22  Aligned_cols=149  Identities=32%  Similarity=0.610  Sum_probs=127.5

Q ss_pred             eEeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +|.....+|.|.|+.+   .. .+..+|+|++.......    +.+.+|+.++..++||||+++++++......++||||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4566667788888744   23 45689999997544322    3588999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.        
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence            99999999997754 4999999999999999999999998   99999999999999999999999999862        


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       162 ~~~~~~~~~y~aPE~~~  178 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFH  178 (268)
T ss_dssp             CCSCCCCGGGCCHHHHH
T ss_pred             ccCCCcCcccCCHHHHh
Confidence                    378888654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.92  E-value=1.5e-25  Score=218.43  Aligned_cols=154  Identities=26%  Similarity=0.437  Sum_probs=134.2

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      -.|.....+|.|+|+.+.     .+|..+|||++.............+.+|+.+++.++||||+++++++......|+||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            356777788999988542     368899999997654443444567899999999999999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE---cCCCcEEEecccccc-----
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLR-----  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DFGla~-----  336 (359)
                      ||+.+|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+|+     
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            99999999999998888999999999999999999999999   9999999999999   567899999999985     


Q ss_pred             ---------ccccCccccc
Q 018204          337 ---------LQYISPEKAK  346 (359)
Q Consensus       337 ---------~~~~~PE~~~  346 (359)
                               ..|+|||...
T Consensus       183 ~~~~~~~gt~~y~aPE~~~  201 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLH  201 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHH
T ss_pred             cccccCCCCccccCceeec
Confidence                     3588888765

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.92  E-value=1.1e-24  Score=198.39  Aligned_cols=145  Identities=24%  Similarity=0.344  Sum_probs=130.8

Q ss_pred             eeeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      ...|.....+|+|.|+.+.     ..+..+|+|++...........+.+.+|+.+++.++||||+++++++......++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            3467777888999887542     24788999999876666667778899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCce
Confidence            999999999999988888999999999999999999999998   9999999999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.92  E-value=9.6e-25  Score=202.74  Aligned_cols=145  Identities=24%  Similarity=0.344  Sum_probs=131.2

Q ss_pred             eeeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      ...|.....+|.|.|+.+.     ..+..+|+|++...........+.+.+|+.+++.++||||+++++++......|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            4467778888999987542     24788999999876666667778899999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCce
Confidence            999999999999988888999999999999999999999998   9999999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.92  E-value=5.1e-25  Score=199.31  Aligned_cols=149  Identities=29%  Similarity=0.567  Sum_probs=126.1

Q ss_pred             eEeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +|.....+|.|.|+.+   .. .+..+|+|++.......    +.+.+|+.++..++||||+++++++......++||||
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            4566667888888754   22 45689999997554322    4588999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence            999999999976 456999999999999999999999998   99999999999999999999999999963        


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       178 ~~~~~~~~~y~aPE~~~  194 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLM  194 (283)
T ss_dssp             TTSTTSCGGGCCHHHHH
T ss_pred             ccCCccCcccCCHHHhc
Confidence                    388888755

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.92  E-value=2.8e-25  Score=209.54  Aligned_cols=141  Identities=29%  Similarity=0.481  Sum_probs=120.4

Q ss_pred             eEeeccCcccceeEEEE--------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~--------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .|.....+|.|.|+.+.        ..+..+|||.+....  .....+.|.+|+.++..++||||+++++++......++
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            45566678888887552        135679999996532  45556789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            999999999999998754 6999999999999999999999998   9999999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.92  E-value=9.2e-26  Score=213.02  Aligned_cols=154  Identities=16%  Similarity=0.217  Sum_probs=124.3

Q ss_pred             eeeEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHH---HHHhCCCCccccce-------ee
Q 018204          189 ELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELT---IVEKARHPNVVQFV-------GA  253 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~---il~~l~HpnIv~l~-------~~  253 (359)
                      ...|.....+|.|.|+.+   .  .+|..+|||++...........+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            446777788899998754   2  358999999998654445556678999994   55556899999998       55


Q ss_pred             EEeCC-----------------cEEEEEecCCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCCCe
Q 018204          254 VTQNI-----------------PMMIVLEYHAKGDLASYLQKKGRLSP-------SKVLRFALDLARGMNYLHECKPDPI  309 (359)
Q Consensus       254 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~l~~-------~~~~~i~~qi~~aL~~lH~~~~~~i  309 (359)
                      +...+                 ..|+||||+ +|+|.+++...+.+++       ..+..++.||+.||.|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 389999999 5799999987544544       788889999999999999999   9


Q ss_pred             EeCCCCCCcEEEcCCCcEEEecccccc-----------ccccCccccc
Q 018204          310 IHCDLKPKNILLDNGGQLKISGFGLLR-----------LQYISPEKAK  346 (359)
Q Consensus       310 iHrDlk~~NIll~~~~~~kl~DFGla~-----------~~~~~PE~~~  346 (359)
                      +||||||+|||++.++.+||+|||+|+           ..|+|||...
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~  275 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEA  275 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCCcCccChhhhc
Confidence            999999999999999999999999997           3577888755

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=4.7e-25  Score=198.14  Aligned_cols=149  Identities=30%  Similarity=0.596  Sum_probs=127.7

Q ss_pred             eEeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +|.....+|.|.|+.+   .. .+..+|+|++.......    +.+.+|+.+++.++||||+++++++......++||||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A           11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            3455566788887644   22 67889999997544322    3588999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++++|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.        
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  163 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  163 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence            9999999999764 45899999999999999999999999   99999999999999999999999999962        


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       164 ~~~~~~~~~y~aPE~~~  180 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFS  180 (269)
T ss_dssp             TTSTTCCGGGCCHHHHH
T ss_pred             ccCcccccccCCHHHhc
Confidence                    388888754

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.92  E-value=1.3e-26  Score=195.61  Aligned_cols=138  Identities=27%  Similarity=0.307  Sum_probs=121.3

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCC-CCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      .....+.++..|+++.++.+++....+++ .+.+|+||||+||..|+.++|++|++.|+|+|.+|..|+||||+|+..|+
T Consensus         5 ~~~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~   84 (179)
T 3f6q_A            5 FMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGH   84 (179)
T ss_dssp             --CCHHHHHHHTCHHHHHHHHHCTTSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTC
T ss_pred             HHHHHHHHHHcCCHHHHHHHHhcCcccccccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCC
Confidence            33456788889999999999988665544 48889999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccCC
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN  176 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~  176 (359)
                      .++|++|+++|++++.+|..|+||||+|+..|+.+++++|+++|+++   +..+.||++.+.
T Consensus        85 ~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~  146 (179)
T 3f6q_A           85 RDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAK  146 (179)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCGGGGSC
T ss_pred             HHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCCcHHHHH
Confidence            99999999999999999999999999999999999999999999988   445678888774

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.92  E-value=1.7e-25  Score=204.17  Aligned_cols=152  Identities=32%  Similarity=0.501  Sum_probs=122.5

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCc-----------------------HHHHHHHHHHHHHHHhC
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKD-----------------------PERINAFTHELTIVEKA  242 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~-----------------------~~~~~~~~~Ei~il~~l  242 (359)
                      +|.....+|.|.|+.+     ..++..+|+|++.......                       ....+.+.+|+.+++.+
T Consensus        14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            3566667888888754     2358899999997543211                       12235688999999999


Q ss_pred             CCCccccceeeEEe--CCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEE
Q 018204          243 RHPNVVQFVGAVTQ--NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL  320 (359)
Q Consensus       243 ~HpnIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIl  320 (359)
                      +||||+++++++..  ....++||||+++++|.+++. .+.+++..+..++.|++.||.|||+++   |+||||||+|||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil  169 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLL  169 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEE
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEE
Confidence            99999999999986  567999999999999988654 347999999999999999999999998   999999999999


Q ss_pred             EcCCCcEEEeccccccc---------------cccCccccc
Q 018204          321 LDNGGQLKISGFGLLRL---------------QYISPEKAK  346 (359)
Q Consensus       321 l~~~~~~kl~DFGla~~---------------~~~~PE~~~  346 (359)
                      ++.++.+||+|||+++.               .|+|||...
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~  210 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLS  210 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCC
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhc
Confidence            99999999999999862               478888654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.92  E-value=4.8e-25  Score=203.43  Aligned_cols=155  Identities=26%  Similarity=0.470  Sum_probs=132.2

Q ss_pred             eeeEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          189 ELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      .-.|...+.+|.|.|+.+   .  .+|..+|+|++........   ...+.+.+|+.++..++||||+++++++......
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            345777778899988754   2  2588999999975433221   1245688999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC----cEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DFGla~  336 (359)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++    .+||+|||+++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            999999999999999988888999999999999999999999998   99999999999999888    79999999986


Q ss_pred             c--------------cccCccccc
Q 018204          337 L--------------QYISPEKAK  346 (359)
Q Consensus       337 ~--------------~~~~PE~~~  346 (359)
                      .              .|+|||...
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~  191 (321)
T 2a2a_A          168 EIEDGVEFKNIFGTPEFVAPEIVN  191 (321)
T ss_dssp             ECCTTCCCCCCCSCGGGCCHHHHT
T ss_pred             ecCccccccccCCCCCccCccccc
Confidence            2              477888654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.92  E-value=6.4e-25  Score=215.12  Aligned_cols=154  Identities=24%  Similarity=0.446  Sum_probs=128.4

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcH----------HHHHHHHHHHHHHHhCCCCccccceeeE
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDP----------ERINAFTHELTIVEKARHPNVVQFVGAV  254 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~----------~~~~~~~~Ei~il~~l~HpnIv~l~~~~  254 (359)
                      -.|.....+|.|+|+.+.     ..+..+|+|++........          ...+.+.+|+.+++.++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            357777788999998652     3578999999975432211          2245788999999999999999999999


Q ss_pred             EeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---cEEEec
Q 018204          255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISG  331 (359)
Q Consensus       255 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~---~~kl~D  331 (359)
                      .....+|+|||||++|+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+|
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEE
Confidence            999999999999999999999988888999999999999999999999999   99999999999998876   699999


Q ss_pred             cccccc--------------cccCccccc
Q 018204          332 FGLLRL--------------QYISPEKAK  346 (359)
Q Consensus       332 FGla~~--------------~~~~PE~~~  346 (359)
                      ||+|+.              .|+|||...
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~  221 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK  221 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHT
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhc
Confidence            999962              477777654

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.92  E-value=4.4e-26  Score=171.34  Aligned_cols=93  Identities=42%  Similarity=0.582  Sum_probs=89.7

Q ss_pred             CCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccccccc
Q 018204           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN  150 (359)
Q Consensus        71 ~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~  150 (359)
                      +|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+
T Consensus         1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~   80 (93)
T 1n0q_A            1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH   80 (93)
T ss_dssp             --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ceeEeeccccCcc
Q 018204          151 VEVYNILKARGAK  163 (359)
Q Consensus       151 ~~~~~~L~~~ga~  163 (359)
                      .+++++|+++|++
T Consensus        81 ~~~~~~Ll~~ga~   93 (93)
T 1n0q_A           81 LEVVKLLLEAGAY   93 (93)
T ss_dssp             HHHHHHHHHTTCC
T ss_pred             HHHHHHHHHcCCC
Confidence            9999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.92  E-value=5.7e-25  Score=211.39  Aligned_cols=142  Identities=26%  Similarity=0.387  Sum_probs=124.6

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----CcE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~  260 (359)
                      .|.....+|.|+|+.+.     .+|+.||||++... .......+.+.+|+.+++.++||||+++++++...     ..+
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            46677778999887542     35789999999654 33555667899999999999999999999998766     569


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |+||||+. ++|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            99999996 599999998888999999999999999999999999   99999999999999999999999999963

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.92  E-value=4.7e-25  Score=208.90  Aligned_cols=140  Identities=25%  Similarity=0.449  Sum_probs=114.0

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCC--cEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNI--PMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~~l  262 (359)
                      .|.....+|.|+|+.+     ..+|+.||+|++.... ........+.+|+.++..+. ||||+++++++...+  .+|+
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            4667778899998754     2358899999996543 34555667889999999997 999999999997544  6999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||++ ++|.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            999997 599999876 47999999999999999999999999   9999999999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.92  E-value=5.3e-25  Score=203.71  Aligned_cols=142  Identities=26%  Similarity=0.487  Sum_probs=117.1

Q ss_pred             cCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEecCCC
Q 018204          196 DGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       196 ~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      +.+|.|.|+.+.     .+|..+|||++...      ....+.+|+.++..+. ||||+++++++......|+||||+++
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            568899887542     25889999999643      2345778999999997 99999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---cEEEeccccccc---------
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISGFGLLRL---------  337 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DFGla~~---------  337 (359)
                      |+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++   .+||+|||+++.         
T Consensus        91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  167 (325)
T 3kn6_A           91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK  167 (325)
T ss_dssp             CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence            999999998888999999999999999999999998   99999999999998766   899999999962         


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||...
T Consensus       168 ~~~~t~~y~aPE~~~  182 (325)
T 3kn6_A          168 TPCFTLHYAAPELLN  182 (325)
T ss_dssp             ---------------
T ss_pred             ccCCCcCccCHHHhc
Confidence                  478888654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.92  E-value=4.1e-25  Score=205.33  Aligned_cols=141  Identities=32%  Similarity=0.505  Sum_probs=122.6

Q ss_pred             eEeeccCcccceeEEE---Eec-------CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---KWN-------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~~-------g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      .|.....+|.|.|+.+   ...       +..+|+|++....  .....+.|.+|+.+++.++||||+++++++......
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            4555666788887643   222       3789999996543  455567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 018204          261 MIVLEYHAKGDLASYLQKK------------------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP  316 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~  316 (359)
                      ++||||+++++|.+++...                        ..+++..+..++.||+.||.|||+++   |+||||||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp  202 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  202 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence            9999999999999999763                        46899999999999999999999999   99999999


Q ss_pred             CcEEEcCCCcEEEecccccc
Q 018204          317 KNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       317 ~NIll~~~~~~kl~DFGla~  336 (359)
                      +|||++.++.+||+|||+++
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~  222 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSR  222 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHH
T ss_pred             ceEEECCCCeEEEeecCCCc
Confidence            99999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.92  E-value=3.8e-25  Score=206.97  Aligned_cols=141  Identities=31%  Similarity=0.543  Sum_probs=121.2

Q ss_pred             eEeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCC-
Q 018204          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI-  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~-  258 (359)
                      .|.....+|.|.|+.+.          ..+..+|||++....  .....+.+.+|+.++..+ +||||+++++++.... 
T Consensus        23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            46666778899887542          124789999996442  445567899999999999 7899999999988754 


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCC---------------------------------------------------------
Q 018204          259 PMMIVLEYHAKGDLASYLQKKGR---------------------------------------------------------  281 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  281 (359)
                      .+++||||+++|+|.+++.....                                                         
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence            49999999999999999976532                                                         


Q ss_pred             ---------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          282 ---------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       282 ---------l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                               +++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~  241 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR  241 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEecccee
Confidence                     889999999999999999999998   9999999999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.92  E-value=1.7e-25  Score=203.28  Aligned_cols=150  Identities=29%  Similarity=0.517  Sum_probs=126.8

Q ss_pred             EeeccCcccceeEEE---E-ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      |.....+|.|.|+.+   . ..|+.+|+|.+..... +......+.+|+.+++.++||||+++++++......++||||+
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             chhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            555667888888744   2 2488999999965432 2222346789999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------
Q 018204          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------  336 (359)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------  336 (359)
                      ++ +|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++          
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (288)
T 1ob3_A           83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (288)
T ss_dssp             SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence            76 999998764 56999999999999999999999998   9999999999999999999999999985          


Q ss_pred             -----ccccCccccc
Q 018204          337 -----LQYISPEKAK  346 (359)
Q Consensus       337 -----~~~~~PE~~~  346 (359)
                           ..|+|||...
T Consensus       159 ~~~~t~~y~aPE~~~  173 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLM  173 (288)
T ss_dssp             ---CCCTTCCHHHHT
T ss_pred             cccccccccCchhee
Confidence                 2388888754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.92  E-value=1.5e-24  Score=195.66  Aligned_cols=150  Identities=25%  Similarity=0.420  Sum_probs=130.0

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   .  ..+..+|+|.+.......   .+.+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A           10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4666777888888754   2  246789999997654433   3468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE---cCCCcEEEeccccccc-----
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DFGla~~-----  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.     
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            9999999999988888999999999999999999999999   9999999999999   7888999999999852     


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       164 ~~~~~~~t~~y~aPE~~~  181 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLE  181 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHT
T ss_pred             chhccCCCCCccChHHhc
Confidence                     477888654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.92  E-value=2.4e-25  Score=218.83  Aligned_cols=143  Identities=22%  Similarity=0.334  Sum_probs=122.8

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|+|+.+   .  .+|+.+|+|++.+...........+..|+.+++.++||||+++++++.....+|+|||
T Consensus       186 ~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  265 (543)
T 3c4z_A          186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT  265 (543)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             heEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            4555666888888754   2  3589999999965332222234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |++||+|.+++...    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~  337 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAV  337 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceee
Confidence            99999999999764    35999999999999999999999999   9999999999999999999999999996

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.92  E-value=1.3e-26  Score=192.85  Aligned_cols=136  Identities=25%  Similarity=0.374  Sum_probs=123.6

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCCC-CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~  119 (359)
                      ..++.+++.|+++.++.++.....+... +..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+
T Consensus        10 ~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~   89 (165)
T 3twr_A           10 RQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYE   89 (165)
T ss_dssp             HHHHHHHHHTCHHHHHHHCCTTTTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             HHHHHHHHhCCHHHHHHHHHcCCCCccccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHH
Confidence            3456778899999999999866555444 778999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccCC
Q 018204          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN  176 (359)
Q Consensus       120 ~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~  176 (359)
                      ++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|+++   +..+.||++.+.
T Consensus        90 ~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~a~  149 (165)
T 3twr_A           90 VAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVK  149 (165)
T ss_dssp             HHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTGGGSC
T ss_pred             HHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCChhHhHh
Confidence            999999999999999999999999999999999999999999988   455678888874

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.92  E-value=2e-25  Score=207.52  Aligned_cols=154  Identities=23%  Similarity=0.398  Sum_probs=130.9

Q ss_pred             eeEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcH-----HHHHHHHHHHHHHHhCCCCccccceeeEEeCCc
Q 018204          190 LQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDP-----ERINAFTHELTIVEKARHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~  259 (359)
                      ..|.....+|.|.|+.+     ..++..+|||++........     .....+.+|+.+++.++||||+++++++.....
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            35677777888888643     24688999999976542221     122356789999999999999999999999999


Q ss_pred             EEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-
Q 018204          260 MMIVLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-  337 (359)
Q Consensus       260 ~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-  337 (359)
                      .++||||+.+| +|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++. 
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999999776 99999998888999999999999999999999998   99999999999999999999999999862 


Q ss_pred             -------------cccCccccc
Q 018204          338 -------------QYISPEKAK  346 (359)
Q Consensus       338 -------------~~~~PE~~~  346 (359)
                                   .|+|||...
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~  202 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLM  202 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHT
T ss_pred             CCCCceeccCCCccccChhhhc
Confidence                         578888654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.92  E-value=6.8e-25  Score=214.39  Aligned_cols=152  Identities=24%  Similarity=0.421  Sum_probs=126.0

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|+|+.+.     ..+..+|+|++....... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            57777888999998552     257899999997543221 123568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC---CcEEEeccccccc-----
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DFGla~~-----  337 (359)
                      ||++|+|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++..   +.+||+|||+|+.     
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            9999999999988888999999999999999999999998   9999999999999764   4599999999863     


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       194 ~~~~~~gt~~y~aPE~l~  211 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLR  211 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHT
T ss_pred             cccccCCCcCeeCHHHHc
Confidence                     477777654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.92  E-value=2e-25  Score=201.50  Aligned_cols=153  Identities=28%  Similarity=0.490  Sum_probs=123.0

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  ..|..+|+|++...........+.+.+|+.++..++||||+++++++......++|||
T Consensus        12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (278)
T 3cok_A           12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE   91 (278)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence            3556667788887643   2  3688999999964321111223568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          266 YHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.       
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            99999999999875 56999999999999999999999998   99999999999999999999999999863       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       169 ~~~~~~~~~y~aPE~~~  185 (278)
T 3cok_A          169 HYTLCGTPNYISPEIAT  185 (278)
T ss_dssp             -----------------
T ss_pred             ceeccCCCCcCCcchhc
Confidence                    377888654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.92  E-value=5.1e-25  Score=207.24  Aligned_cols=141  Identities=33%  Similarity=0.490  Sum_probs=120.1

Q ss_pred             eEeeccCcccceeEEE---E-------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---K-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      .|.....+|.|+|+.+   .       ..+..||||.+....  .......+.+|+.+++.++||||+++++++......
T Consensus        72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            4566667888888643   2       235689999986432  344556789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---cEEEe
Q 018204          261 MIVLEYHAKGDLASYLQKKG-------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKIS  330 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~---~~kl~  330 (359)
                      ++||||+++|+|.+++....       .+++..+..++.||+.||.|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997642       4899999999999999999999999   99999999999999655   59999


Q ss_pred             cccccc
Q 018204          331 GFGLLR  336 (359)
Q Consensus       331 DFGla~  336 (359)
                      |||+|+
T Consensus       227 DFG~a~  232 (367)
T 3l9p_A          227 DFGMAR  232 (367)
T ss_dssp             CCHHHH
T ss_pred             CCcccc
Confidence            999996

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.92  E-value=1.3e-24  Score=196.59  Aligned_cols=152  Identities=24%  Similarity=0.426  Sum_probs=131.0

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+.     ..|..+|+|++..... .....+.+.+|+.+++.++||||+++++++......++|||
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            45666678888887542     3588999999975543 44556778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc---EEEeccccccc-----
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DFGla~~-----  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.   +||+|||++..     
T Consensus        86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (284)
T 3kk8_A           86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  162 (284)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence            9999999999988888999999999999999999999998   999999999999987655   99999999852     


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       163 ~~~~~~~~~~y~aPE~~~  180 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLK  180 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHT
T ss_pred             cccCCCCCcCCcCchhhc
Confidence                     477887654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.92  E-value=1.9e-24  Score=195.35  Aligned_cols=152  Identities=21%  Similarity=0.363  Sum_probs=128.2

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|.....+|.|.|+.+   ..  ++..+|+|.+....... .....+.+|+..+..+ +||||+++++++......++||
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            4666677888888754   22  58999999997654433 3446788899999999 9999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC----------------
Q 018204          265 EYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG----------------  324 (359)
Q Consensus       265 e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~----------------  324 (359)
                      ||+++++|.+++...    +.+++..+..++.||+.||.|||+++   |+||||||+|||++.+                
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999764    56999999999999999999999998   9999999999999854                


Q ss_pred             ---CcEEEeccccccc-----------cccCccccc
Q 018204          325 ---GQLKISGFGLLRL-----------QYISPEKAK  346 (359)
Q Consensus       325 ---~~~kl~DFGla~~-----------~~~~PE~~~  346 (359)
                         ..+||+|||+++.           .|+|||...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~  203 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQ  203 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHT
T ss_pred             CCceEEEEcccccccccCCccccCCCccccChhHhc
Confidence               4799999999863           488888765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.92  E-value=9.6e-25  Score=201.63  Aligned_cols=139  Identities=29%  Similarity=0.447  Sum_probs=119.3

Q ss_pred             eeEeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC----cEEE
Q 018204          190 LQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----PMMI  262 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~l  262 (359)
                      .+|...+.+|.|.|+.   +...+..||||++...    ......+..|+.++..++||||+++++++....    .+++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            3566666788888764   4567899999999643    223345667999999999999999999998754    3799


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeEeCCCCCCcEEEcCCCcEEEecc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC----------KPDPIIHCDLKPKNILLDNGGQLKISGF  332 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~----------~~~~iiHrDlk~~NIll~~~~~~kl~DF  332 (359)
                      ||||+++|+|.+++... .+++..+..++.|++.||.|||+.          +   |+||||||+|||++.++.+||+||
T Consensus       100 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999999764 599999999999999999999998          7   999999999999999999999999


Q ss_pred             cccc
Q 018204          333 GLLR  336 (359)
Q Consensus       333 Gla~  336 (359)
                      |+|+
T Consensus       176 g~a~  179 (322)
T 3soc_A          176 GLAL  179 (322)
T ss_dssp             TTCE
T ss_pred             Cccc
Confidence            9995

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.92  E-value=2.3e-24  Score=202.48  Aligned_cols=148  Identities=20%  Similarity=0.278  Sum_probs=125.5

Q ss_pred             eeEeeccCcccceeEEE----------EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC---CCccccceeeEEe
Q 018204          190 LQVRKADGITKGSYQVA----------KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR---HPNVVQFVGAVTQ  256 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~----------~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~  256 (359)
                      ..|.....+|.|.|+.+          ...+..+|+|++....      ...+..|+.++..+.   |+||+++++++..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            45667777899988743          2357899999996432      235777888888886   9999999999999


Q ss_pred             CCcEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC--------
Q 018204          257 NIPMMIVLEYHAKGDLASYLQK-----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--------  323 (359)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~--------  323 (359)
                      .+..|+||||+++|+|.+++..     ...+++..+..++.||+.||.|||+++   ||||||||+|||++.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999974     356999999999999999999999998   999999999999998        


Q ss_pred             ---CCcEEEecccccc-----------------ccccCccccc
Q 018204          324 ---GGQLKISGFGLLR-----------------LQYISPEKAK  346 (359)
Q Consensus       324 ---~~~~kl~DFGla~-----------------~~~~~PE~~~  346 (359)
                         ++.+||+|||+|+                 ..|+|||...
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  258 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS  258 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc
Confidence               8999999999994                 2478888655

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.92  E-value=1.2e-24  Score=205.79  Aligned_cols=141  Identities=32%  Similarity=0.580  Sum_probs=123.6

Q ss_pred             eEeeccCcccceeEEEE---e---------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC
Q 018204          191 QVRKADGITKGSYQVAK---W---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~---------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  257 (359)
                      .|...+.+|+|+|+.+.   .         .+..+|+|++...  ........+.+|+.+++.+ +||||+++++++...
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            46666778999988542   1         1257999999654  3455667899999999999 999999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 018204          258 IPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll  321 (359)
                      ...++||||+++|+|.+++....                .+++..+..++.||+.||.|||+++   |+||||||+|||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            99999999999999999998753                4899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEecccccc
Q 018204          322 DNGGQLKISGFGLLR  336 (359)
Q Consensus       322 ~~~~~~kl~DFGla~  336 (359)
                      +.++.+||+|||+|+
T Consensus       225 ~~~~~~kL~DFG~a~  239 (382)
T 3tt0_A          225 TEDNVMKIADFGLAR  239 (382)
T ss_dssp             CTTCCEEECSCSCCC
T ss_pred             cCCCcEEEcccCccc
Confidence            999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.92  E-value=2.3e-25  Score=225.09  Aligned_cols=143  Identities=26%  Similarity=0.385  Sum_probs=123.6

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|.....+|+|+|+.+   .  ..++.+|||++.+.........+.+..|..++..+ +||+|+++++++.+...+|+||
T Consensus       342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~  421 (674)
T 3pfq_A          342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM  421 (674)
T ss_dssp             TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred             ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence            3666677899988744   2  35788999999753211122335678899999987 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||++||+|.+++...+.+++..+..|+.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus       422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~  490 (674)
T 3pfq_A          422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  490 (674)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred             eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence            99999999999998888999999999999999999999998   9999999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.92  E-value=8.6e-25  Score=199.57  Aligned_cols=141  Identities=28%  Similarity=0.562  Sum_probs=119.3

Q ss_pred             eEeeccCcccceeEEE---E------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--Cc
Q 018204          191 QVRKADGITKGSYQVA---K------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~  259 (359)
                      .|.....+|.|.|+.+   .      ..+..+|+|.+.....  ......+.+|+.+++.++||||+++++++...  ..
T Consensus        22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            3566677888888754   2      2688999999975432  22345788999999999999999999999876  66


Q ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            89999999999999999554 56999999999999999999999998   9999999999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.92  E-value=3.8e-25  Score=206.85  Aligned_cols=153  Identities=24%  Similarity=0.424  Sum_probs=126.4

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCC--CcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESH--KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      .|...+.+|.|.|+.+.     .+|+.+|+|++.....  ......+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            46677788999987552     3588999999853210  0111235688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc---EEEecccccc
Q 018204          264 LEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DFGla~  336 (359)
                      |||+++++|.+++...    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+++
T Consensus       105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999887543    24899999999999999999999998   999999999999987654   9999999985


Q ss_pred             c---------------cccCccccc
Q 018204          337 L---------------QYISPEKAK  346 (359)
Q Consensus       337 ~---------------~~~~PE~~~  346 (359)
                      .               .|+|||...
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~  206 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVK  206 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHT
T ss_pred             EecCCCeeecCCcCCcCccCHHHHc
Confidence            2               477888654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.92  E-value=8.2e-25  Score=198.43  Aligned_cols=150  Identities=26%  Similarity=0.394  Sum_probs=127.6

Q ss_pred             eEeeccCcccceeEEE-----EecC-------cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC
Q 018204          191 QVRKADGITKGSYQVA-----KWNG-------TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g-------~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  258 (359)
                      +|.....+|.|.|+.+     ...+       ..+|+|++....   ....+.+.+|+.+++.++||||+++++++....
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4555667788888744     1223       579999986533   233457899999999999999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc--------EEE
Q 018204          259 PMMIVLEYHAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ--------LKI  329 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~--------~kl  329 (359)
                      ..++||||+++++|.+++...+. +++..+..++.|++.||.|||+++   |+||||||+|||++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence            99999999999999999987654 999999999999999999999999   999999999999998887        999


Q ss_pred             ecccccc-----------ccccCccccc
Q 018204          330 SGFGLLR-----------LQYISPEKAK  346 (359)
Q Consensus       330 ~DFGla~-----------~~~~~PE~~~  346 (359)
                      +|||+++           ..|+|||...
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~y~aPE~~~  190 (289)
T 4fvq_A          163 SDPGISITVLPKDILQERIPWVPPECIE  190 (289)
T ss_dssp             CCCCSCTTTSCHHHHHHTTTTSCHHHHH
T ss_pred             ccCcccccccCccccCCcCcccCHHHhC
Confidence            9999985           3589999765

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.92  E-value=1.8e-24  Score=198.80  Aligned_cols=152  Identities=24%  Similarity=0.279  Sum_probs=125.6

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEE
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      -.|.....+|.|.|+.+.     .+|..+|||++........ ....+..|+..+..+ +||||+++++++.....+++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            357777788999887542     2588999999865544333 334455555555554 999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc------
Q 018204          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR------  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~------  336 (359)
                      |||+ +++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++      
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            9999 66999988764 45999999999999999999999998   9999999999999999999999999985      


Q ss_pred             --------ccccCccccc
Q 018204          337 --------LQYISPEKAK  346 (359)
Q Consensus       337 --------~~~~~PE~~~  346 (359)
                              ..|+|||...
T Consensus       212 ~~~~~~gt~~y~aPE~~~  229 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQ  229 (311)
T ss_dssp             ---CCCCCGGGCCGGGGG
T ss_pred             CCcccCCCccccCHhHhc
Confidence                    2588999765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.92  E-value=5.7e-25  Score=214.95  Aligned_cols=140  Identities=29%  Similarity=0.553  Sum_probs=122.3

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      ++.....+|.|.|+.+   .+  .+..||||.+......    .+.|.+|+.+++.++||||+++++++.....+++|||
T Consensus       221 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             GEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            4556667888888643   33  3789999999754322    3568999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |+++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeeccccee
Confidence            99999999999864  35899999999999999999999999   99999999999999999999999999973

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.92  E-value=3e-24  Score=197.94  Aligned_cols=139  Identities=29%  Similarity=0.573  Sum_probs=122.6

Q ss_pred             EeeccCcccceeEEEE---------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcE
Q 018204          192 VRKADGITKGSYQVAK---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPM  260 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~---------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~  260 (359)
                      +.....+|.|.|+.+.         .++..+|+|++...  ......+.+.+|+.+++.++||||+++++++...  ..+
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            4666778889888651         26789999999754  2455667899999999999999999999999874  578


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++||||+++++|.+++... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence            9999999999999999765 5999999999999999999999999   9999999999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.92  E-value=3.1e-25  Score=200.44  Aligned_cols=153  Identities=27%  Similarity=0.487  Sum_probs=129.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  ..+..+|+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (279)
T 3fdn_A           10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   89 (279)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence            3555666788887744   2  2467899999864332222224568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+++++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.         
T Consensus        90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  166 (279)
T 3fdn_A           90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD  166 (279)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcccccc
Confidence            9999999999988888999999999999999999999998   9999999999999999999999999884         


Q ss_pred             ----ccccCccccc
Q 018204          337 ----LQYISPEKAK  346 (359)
Q Consensus       337 ----~~~~~PE~~~  346 (359)
                          ..|+|||...
T Consensus       167 ~~~~~~y~aPE~~~  180 (279)
T 3fdn_A          167 LCGTLDYLPPEMIE  180 (279)
T ss_dssp             -CCCCTTCCHHHHT
T ss_pred             cCCCCCccCHhHhc
Confidence                3588888754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.92  E-value=2.8e-25  Score=205.85  Aligned_cols=151  Identities=27%  Similarity=0.487  Sum_probs=124.4

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+     ..+++.+|+|++..... .....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  113 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE  113 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence            4666667888887644     23688999999965432 33344567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-----CCCcEEEecccccc----
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-----NGGQLKISGFGLLR----  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~-----~~~~~kl~DFGla~----  336 (359)
                      |+++ +|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++     ..+.+||+|||+++    
T Consensus       114 ~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          114 YAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             CCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             cCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            9975 99999998888999999999999999999999998   99999999999994     44569999999985    


Q ss_pred             -----------ccccCccccc
Q 018204          337 -----------LQYISPEKAK  346 (359)
Q Consensus       337 -----------~~~~~PE~~~  346 (359)
                                 ..|+|||...
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~  210 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILL  210 (329)
T ss_dssp             ----------CCTTCCHHHHT
T ss_pred             cccccCCCcCCccccCHHHhc
Confidence                       2488999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=9.6e-25  Score=203.12  Aligned_cols=141  Identities=31%  Similarity=0.535  Sum_probs=119.3

Q ss_pred             eEeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  259 (359)
                      .|.....+|.|.|+.+   ..       .+..+|+|++....  .....+.+.+|+.++..+ +||||+++++++.....
T Consensus        46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            4566677888888754   21       34579999997432  233446789999999999 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 018204          260 MMIVLEYHAKGDLASYLQKKG-----------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP  316 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~  316 (359)
                      .++||||+++|+|.+++....                       .+++..+..++.||+.||.|||+++   |+||||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp  200 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  200 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence            999999999999999997643                       2789999999999999999999998   99999999


Q ss_pred             CcEEEcCCCcEEEecccccc
Q 018204          317 KNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       317 ~NIll~~~~~~kl~DFGla~  336 (359)
                      +|||++.++.+||+|||+++
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~  220 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLAR  220 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGS
T ss_pred             hhEEEcCCCcEEeCCCccCc
Confidence            99999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.92  E-value=6.2e-25  Score=203.58  Aligned_cols=152  Identities=24%  Similarity=0.392  Sum_probs=130.5

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   .  .+|..+|+|.+.... ......+.+.+|+.+++.++||||+++++++......++|||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            4666667888887633   2  248899999986543 345556678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.        
T Consensus       105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence            9999999888877778999999999999999999999998   99999999999999999999999999852        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       182 ~~~~~t~~y~aPE~~~  197 (331)
T 4aaa_A          182 DDEVATRWYRAPELLV  197 (331)
T ss_dssp             --CCCCCTTCCHHHHT
T ss_pred             CCCcCCccccCccccc
Confidence                   388888754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.92  E-value=2.1e-24  Score=197.95  Aligned_cols=153  Identities=24%  Similarity=0.486  Sum_probs=128.4

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|.|.|+.+   .  .+|..+|+|.+......+......+.+|+.+++.++||||+++++++......++|||
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            4666677888887644   2  3688999999986655567777889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----
Q 018204          266 YHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----  337 (359)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.    
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            9999999999864    356999999999999999999999998   99999999999999999999999999852    


Q ss_pred             -----------cccCccccc
Q 018204          338 -----------QYISPEKAK  346 (359)
Q Consensus       338 -----------~~~~PE~~~  346 (359)
                                 .|++||...
T Consensus       190 ~~~~~~~~~~~~y~aPE~~~  209 (310)
T 2wqm_A          190 TTAAHSLVGTPYYMSPERIH  209 (310)
T ss_dssp             ---------CCSSCCHHHHT
T ss_pred             CccccccCCCeeEeChHHhC
Confidence                       478888654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.92  E-value=1.4e-24  Score=197.37  Aligned_cols=140  Identities=29%  Similarity=0.498  Sum_probs=119.2

Q ss_pred             Eeecc-CcccceeEEEE-------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          192 VRKAD-GITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~-~ig~g~~~~~~-------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      |.... .+|.|.|+.+.       ..+..+|||++.... .+....+.+.+|+.+++.++||||+++++++ .....++|
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv   95 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV   95 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence            44444 67888887542       135789999997543 2344467799999999999999999999998 56778999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           96 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            999999999999998888999999999999999999999998   9999999999999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=8.1e-26  Score=211.76  Aligned_cols=153  Identities=23%  Similarity=0.406  Sum_probs=128.4

Q ss_pred             eEeeccCcccceeEEE---Ee-----cCcEEEEEEeccCCCC-cHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---KW-----NGTKVWVKILDKESHK-DPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-----~g~~vavK~l~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~  260 (359)
                      .|.....+|.|.|+.+   ..     .|..+|||++...... .....+.+.+|+.++..+ +||||+++++++......
T Consensus        55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  134 (355)
T 1vzo_A           55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  134 (355)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence            4666677888888754   22     6889999998643210 111123467799999999 699999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---  337 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---  337 (359)
                      ++||||+++++|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.   
T Consensus       135 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             EEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            999999999999999988888999999999999999999999998   99999999999999999999999999862   


Q ss_pred             -------------cccCccccc
Q 018204          338 -------------QYISPEKAK  346 (359)
Q Consensus       338 -------------~~~~PE~~~  346 (359)
                                   .|+|||...
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~  233 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVR  233 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHT
T ss_pred             CCCCcccCcccCcCccChhhhc
Confidence                         377888654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.92  E-value=3.9e-25  Score=199.24  Aligned_cols=153  Identities=27%  Similarity=0.528  Sum_probs=129.2

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|.|.|+.+   .  .+|+.+|+|++...........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   91 (276)
T 2h6d_A           12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME   91 (276)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence            3555667788887643   2  2588999999964322122234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.        
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  168 (276)
T 2h6d_A           92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR  168 (276)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999863        


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|++||...
T Consensus       169 ~~~~~~~y~aPE~~~  183 (276)
T 2h6d_A          169 TSCGSPNYAAPEVIS  183 (276)
T ss_dssp             --------CCTGGGT
T ss_pred             cccCCccccCHHHHc
Confidence                  378888754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.92  E-value=1.9e-24  Score=203.86  Aligned_cols=139  Identities=27%  Similarity=0.467  Sum_probs=116.2

Q ss_pred             EeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +...+.+|.|.|+.+.     .+|..+|+|++....   ....+.+.+|+.++..++||||+++++++......++||||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            3445568888887442     358899999997543   34456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE--cCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL--DNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll--~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++... ..+++..+..++.||+.||.|||+++   |+||||||+|||+  +.++.+||+|||+++
T Consensus       168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~  237 (373)
T 2x4f_A          168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR  237 (373)
T ss_dssp             CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence            9999999988654 46999999999999999999999999   9999999999999  567889999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.92  E-value=1.2e-24  Score=202.70  Aligned_cols=136  Identities=26%  Similarity=0.444  Sum_probs=117.8

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      .|.....+|.|.|+.+.     .+|..+|+|++......       +.+|+.++..+ +||||+++++++.+....|+||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46666778999887542     25889999999765432       34677888877 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC----CcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG----GQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~----~~~kl~DFGla~  336 (359)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||+...    +.+||+|||+++
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999999998888999999999999999999999999   9999999999998543    359999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.92  E-value=7.5e-25  Score=205.29  Aligned_cols=151  Identities=29%  Similarity=0.514  Sum_probs=132.7

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   ..  ++..+|+|++....  .....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            4666667888888744   22  48899999997543  45566789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++        
T Consensus       112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  188 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  188 (360)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccccccc
Confidence            999999999999888899999999999999999999985 7   9999999999999999999999999985        


Q ss_pred             -----ccccCccccc
Q 018204          337 -----LQYISPEKAK  346 (359)
Q Consensus       337 -----~~~~~PE~~~  346 (359)
                           ..|+|||...
T Consensus       189 ~~~gt~~y~aPE~~~  203 (360)
T 3eqc_A          189 SFVGTRSYMSPERLQ  203 (360)
T ss_dssp             --CCCCTTCCHHHHT
T ss_pred             CCCCCCCeECHHHHc
Confidence                 3588998765

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.92  E-value=1.6e-24  Score=205.16  Aligned_cols=150  Identities=23%  Similarity=0.483  Sum_probs=128.4

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|.|.|+.+.     .+|..+|+|++....   ......+.+|+.++..++||||+++++++.....+++|||
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            46667778899887542     358899999996542   3334578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC--CCcEEEeccccccc-----
Q 018204          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DFGla~~-----  337 (359)
                      |+++|+|.+++...+ .+++..+..++.||+.||.|||+++   |+||||||+|||++.  .+.+||+|||+++.     
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999997654 6999999999999999999999998   999999999999974  46799999999863     


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       206 ~~~~~~gt~~y~aPE~~~  223 (387)
T 1kob_A          206 IVKVTTATAEFAAPEIVD  223 (387)
T ss_dssp             CEEEECSSGGGCCHHHHT
T ss_pred             ceeeeccCCCccCchhcc
Confidence                     477888654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.92  E-value=1.9e-24  Score=200.58  Aligned_cols=141  Identities=28%  Similarity=0.580  Sum_probs=121.6

Q ss_pred             eEeeccCcccceeEEE---E---------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeC
Q 018204          191 QVRKADGITKGSYQVA---K---------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQN  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~---------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~  257 (359)
                      +|...+.+|.|.|+.+   .         ..+..+|+|++....  .......+.+|+.+++.+ +||||+++++++...
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            4556667888888744   2         245689999996543  455567899999999999 899999999999999


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 018204          258 IPMMIVLEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll  321 (359)
                      ...++||||+++|+|.+++....                .+++..+..++.||+.||.|||+++   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            99999999999999999998653                3899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEecccccc
Q 018204          322 DNGGQLKISGFGLLR  336 (359)
Q Consensus       322 ~~~~~~kl~DFGla~  336 (359)
                      +.++.+||+|||+++
T Consensus       191 ~~~~~~kL~Dfg~~~  205 (334)
T 2pvf_A          191 TENNVMKIADFGLAR  205 (334)
T ss_dssp             CTTCCEEECCCTTCE
T ss_pred             cCCCCEEEccccccc
Confidence            999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.92  E-value=2.6e-24  Score=198.67  Aligned_cols=138  Identities=25%  Similarity=0.421  Sum_probs=120.5

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +.....+|.|.|+.+   .  .+|..||||++.......   .+.+.+|+.+++.++||||+++++++......++||||
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            344446788888754   2  258999999997554332   34688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++.. ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~  189 (321)
T 2c30_A          124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA  189 (321)
T ss_dssp             CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeee
Confidence            999999999865 46999999999999999999999998   9999999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.92  E-value=1.6e-24  Score=203.65  Aligned_cols=153  Identities=30%  Similarity=0.487  Sum_probs=131.1

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCC-c----HHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHK-D----PERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~-~----~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  259 (359)
                      .|.....+|.|.|+.+   .  .+|+.||||++...... .    ....+.+.+|+.++..+ +||||+++++++.....
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            4666677888888754   2  25889999999754321 1    22345688999999999 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---  336 (359)
                      .++||||+++++|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++   
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            9999999999999999988788999999999999999999999998   9999999999999999999999999885   


Q ss_pred             -----------ccccCccccc
Q 018204          337 -----------LQYISPEKAK  346 (359)
Q Consensus       337 -----------~~~~~PE~~~  346 (359)
                                 ..|+|||...
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~  272 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILK  272 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHH
T ss_pred             CCcccccCCCCCCccChhhcc
Confidence                       2488888654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.92  E-value=2.5e-24  Score=198.42  Aligned_cols=141  Identities=28%  Similarity=0.492  Sum_probs=121.8

Q ss_pred             eEeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      +|.....+|.|.|+.+.          ..+..+|+|.+....  .......+.+|+.+++.++||||+++++++......
T Consensus        26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  103 (322)
T 1p4o_A           26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT  103 (322)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence            46666678888876432          236789999986433  344556789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEe
Q 018204          261 MIVLEYHAKGDLASYLQKK----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~  330 (359)
                      ++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+
T Consensus       104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~  180 (322)
T 1p4o_A          104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  180 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEEC
Confidence            9999999999999999753          34789999999999999999999998   9999999999999999999999


Q ss_pred             cccccc
Q 018204          331 GFGLLR  336 (359)
Q Consensus       331 DFGla~  336 (359)
                      |||+++
T Consensus       181 Dfg~~~  186 (322)
T 1p4o_A          181 DFGMTR  186 (322)
T ss_dssp             CTTCCC
T ss_pred             cCcccc
Confidence            999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.92  E-value=1.9e-24  Score=195.48  Aligned_cols=153  Identities=24%  Similarity=0.509  Sum_probs=130.4

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDP---ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .|.....+|.|.|+.+   ..  +|+.+|+|++........   ...+.+.+|+.+++.++||||+++++++......++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            4566677888888754   22  588999999975432211   124568899999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC----cEEEeccccccc-
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL-  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DFGla~~-  337 (359)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+||+++.++    .+||+|||+++. 
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999999999988888999999999999999999999998   99999999999998877    799999999863 


Q ss_pred             -------------cccCccccc
Q 018204          338 -------------QYISPEKAK  346 (359)
Q Consensus       338 -------------~~~~PE~~~  346 (359)
                                   .|+|||...
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~  184 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAPEIVN  184 (283)
T ss_dssp             C--------CCCGGGCCHHHHT
T ss_pred             cCCCcccccCCCcCccCcceec
Confidence                         378888654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.92  E-value=1.2e-24  Score=196.75  Aligned_cols=150  Identities=23%  Similarity=0.484  Sum_probs=121.3

Q ss_pred             eEeeccCcccceeEEE---Ee-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---KW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .|.....+|.|.|+.+   ..     .+..+|+|.+...  ......+.+.+|+.+++.++||||+++++++. .+..|+
T Consensus        16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            4556667888888644   22     2456999988643  24555678999999999999999999999874 567899


Q ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----
Q 018204          263 VLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----  337 (359)
                      ||||+++++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.    
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcc
Confidence            999999999999998654 6999999999999999999999998   99999999999999999999999999862    


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~  190 (281)
T 1mp8_A          170 TYYKASKGKLPIKWMAPESIN  190 (281)
T ss_dssp             ---------CCGGGCCHHHHH
T ss_pred             cccccccCCCcccccChhhcc
Confidence                        388888654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.92  E-value=7.9e-25  Score=204.58  Aligned_cols=148  Identities=26%  Similarity=0.434  Sum_probs=120.6

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   ..  .+..+|+|++....     ..+.+.+|+.++..++||||+++++++......++|||
T Consensus        54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4666777888888754   22  46789999997542     22457889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCcEEEeccccccc-----
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DFGla~~-----  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+++.     
T Consensus       129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            9999999999988888999999999999999999999998   999999999999975   88999999999862     


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       206 ~~~~~~gt~~y~aPE~~~  223 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILR  223 (349)
T ss_dssp             -------CGGGSCHHHHT
T ss_pred             ccccccCCCCccCHHHhc
Confidence                     488888765

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.92  E-value=1.1e-24  Score=210.66  Aligned_cols=139  Identities=29%  Similarity=0.516  Sum_probs=120.1

Q ss_pred             eEeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      ++.....+|.|.|+.+   .. .+..||||.+.....    ..+.|.+|+.+++.++||||+++++++. ....++||||
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            4556667889988754   23 367899999975432    2457899999999999999999999876 6679999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      +++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            9999999999754  36899999999999999999999998   99999999999999999999999999973

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.92  E-value=1.1e-24  Score=199.70  Aligned_cols=141  Identities=31%  Similarity=0.508  Sum_probs=123.1

Q ss_pred             eEeeccCcccceeEEE---E-------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVA---K-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  259 (359)
                      .|.....+|.|.|+.+   .       ..+..+|+|.+....  .....+.+.+|+.++..+ +||||+++++++.....
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            4566667888888754   2       135789999996543  344557899999999999 99999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 018204          260 MMIVLEYHAKGDLASYLQKKG------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll  321 (359)
                      .++||||+++|+|.+++....                  .+++..+..++.|++.||.|||+++   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            999999999999999997653                  3899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEecccccc
Q 018204          322 DNGGQLKISGFGLLR  336 (359)
Q Consensus       322 ~~~~~~kl~DFGla~  336 (359)
                      +.++.+||+|||+++
T Consensus       179 ~~~~~~kl~Dfg~~~  193 (313)
T 1t46_A          179 THGRITKICDFGLAR  193 (313)
T ss_dssp             ETTTEEEECCCGGGS
T ss_pred             cCCCCEEEccccccc
Confidence            999999999999986

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.92  E-value=6.6e-26  Score=204.26  Aligned_cols=132  Identities=30%  Similarity=0.329  Sum_probs=78.7

Q ss_pred             eeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHH
Q 018204           45 SFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLL  124 (359)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~L  124 (359)
                      .++..|+.+.++.++..+......+.+|.||||+|+..|+.+++++|++.|+|+|.+|..|+||||+||..|+.++|++|
T Consensus        92 ~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~~~g~~~~v~~L  171 (269)
T 4b93_B           92 VAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALL  171 (269)
T ss_dssp             HHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCGGGHHHH
T ss_pred             HHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHH
Confidence            34445555555555554444444455555555555555555555566666666666666666666666666666666666


Q ss_pred             HhcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccCC
Q 018204          125 LSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN  176 (359)
Q Consensus       125 l~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~  176 (359)
                      +++|+|+|.+|..|+||||+|+..|+.+++++|+++|+++   +..++||+++|.
T Consensus       172 l~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~  226 (269)
T 4b93_B          172 LQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTAVDCAE  226 (269)
T ss_dssp             HHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCSGGGSC
T ss_pred             HHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence            6666666666666666666666666666666666666665   334456666653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.92  E-value=1.4e-24  Score=199.99  Aligned_cols=150  Identities=28%  Similarity=0.522  Sum_probs=116.9

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|.|.|+.+.     .+|..+|+|.+......  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            46667788999887542     35889999999754321  122457899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          266 YHAKGDLASYLQKK------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      |++ ++|.+++...      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.  
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 5999998654      35899999999999999999999998   99999999999999999999999999862  


Q ss_pred             -------------cccCccccc
Q 018204          338 -------------QYISPEKAK  346 (359)
Q Consensus       338 -------------~~~~PE~~~  346 (359)
                                   .|+|||...
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~  181 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLM  181 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHT
T ss_pred             CCcccCCCCcccccccCchHhh
Confidence                         378888654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.91  E-value=3.6e-24  Score=196.89  Aligned_cols=141  Identities=21%  Similarity=0.350  Sum_probs=120.7

Q ss_pred             eeEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe----CCcE
Q 018204          190 LQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPM  260 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~  260 (359)
                      -.|.....+|.|.|+.+   .  ..|..+|+|.+...   .....+.+.+|+.+++.++||||+++++++..    ....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            35777778899988754   2  46889999998653   34556778999999999999999999999873    3478


Q ss_pred             EEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            999999999999999976    356999999999999999999999998   9999999999999999999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.91  E-value=2e-24  Score=195.89  Aligned_cols=151  Identities=25%  Similarity=0.428  Sum_probs=128.1

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+.     ..+..+|+|.+.......  ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            46667778888887542     357899999997654322  23568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE---cCCCcEEEeccccccc-
Q 018204          266 YHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRL-  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DFGla~~-  337 (359)
                      |+++++|.+++...    ..+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++. 
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543    57999999999999999999999998   9999999999999   4567899999999962 


Q ss_pred             -------------cccCccccc
Q 018204          338 -------------QYISPEKAK  346 (359)
Q Consensus       338 -------------~~~~PE~~~  346 (359)
                                   .|+|||..+
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~  199 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK  199 (285)
T ss_dssp             ---------CTTGGGCCHHHHT
T ss_pred             CCcccCcCcccccCcCChHHhc
Confidence                         478888654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.91  E-value=4.4e-24  Score=196.20  Aligned_cols=135  Identities=24%  Similarity=0.374  Sum_probs=118.9

Q ss_pred             cCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCC
Q 018204          196 DGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       196 ~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      +.+|.|.|+.+.     .++..+|||++......   ....+.+|+.++.++ +||||+++++++.....+|+||||+++
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG   95 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCC
Confidence            557888887542     36889999999755432   234688999999885 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc---EEEecccccc
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DFGla~  336 (359)
                      ++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||+++
T Consensus        96 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           96 GSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999988888999999999999999999999998   999999999999998776   9999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.91  E-value=5.9e-25  Score=214.38  Aligned_cols=154  Identities=29%  Similarity=0.466  Sum_probs=130.3

Q ss_pred             eeeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      .-.|.....+|.|+|+.+.     .++..+|||++....... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3457777788888887542     258899999986432111 1235688999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc---CCCcEEEecccccc----
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD---NGGQLKISGFGLLR----  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DFGla~----  336 (359)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+|+    
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            999999999999988888999999999999999999999999   99999999999995   45679999999986    


Q ss_pred             ----------ccccCccccc
Q 018204          337 ----------LQYISPEKAK  346 (359)
Q Consensus       337 ----------~~~~~PE~~~  346 (359)
                                ..|+|||...
T Consensus       177 ~~~~~~~~gt~~y~aPE~~~  196 (486)
T 3mwu_A          177 NTKMKDRIGTAYYIAPEVLR  196 (486)
T ss_dssp             C----CCTTGGGGCCGGGGG
T ss_pred             CCccCCCcCCCCCCCHHHhC
Confidence                      2488888765

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.91  E-value=7.2e-25  Score=202.18  Aligned_cols=144  Identities=30%  Similarity=0.450  Sum_probs=124.2

Q ss_pred             cceeeEeeccCcccceeEEE---E-ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          187 PLELQVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       187 ~~~~~~~~~~~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      ...-.|.....+|.|.|+.+   . ..|..+|+|.+.....   ...+.+.+|+.+++.++||||+++++++......++
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            33445667777888888744   2 2478999999865432   245678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  187 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK  187 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999999999986543    4899999999999999999999998   9999999999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.91  E-value=2.6e-24  Score=196.04  Aligned_cols=153  Identities=29%  Similarity=0.433  Sum_probs=129.8

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCC--c----HHHHHHHHHHHHHHHhCC-CCccccceeeEEeCC
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHK--D----PERINAFTHELTIVEKAR-HPNVVQFVGAVTQNI  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~--~----~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  258 (359)
                      .|.....+|.|.|+.+   .  .+|+.+|+|++......  .    ....+.+.+|+.++..+. ||||+++++++....
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (298)
T 1phk_A           18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   97 (298)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence            4556667788887654   2  25789999999754321  1    233467889999999995 999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-
Q 018204          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-  337 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-  337 (359)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++. 
T Consensus        98 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           98 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            99999999999999999988888999999999999999999999999   99999999999999999999999999853 


Q ss_pred             -------------cccCccccc
Q 018204          338 -------------QYISPEKAK  346 (359)
Q Consensus       338 -------------~~~~PE~~~  346 (359)
                                   .|++||...
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~  196 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIE  196 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHH
T ss_pred             CCCcccccccCCccccCHHHhc
Confidence                         477777643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.91  E-value=2.5e-24  Score=199.11  Aligned_cols=140  Identities=28%  Similarity=0.550  Sum_probs=121.9

Q ss_pred             eEeeccCcccceeEEE---E------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCc
Q 018204          191 QVRKADGITKGSYQVA---K------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~  259 (359)
                      .|.....+|.|.|+.+   .      ..+..+|+|++...   .....+.+.+|+.+++.++||||+++++++..  ...
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            4566667888888754   2      25789999999653   34556679999999999999999999998874  456


Q ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence            99999999999999999763 46999999999999999999999998   9999999999999999999999999996

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.91  E-value=1.3e-24  Score=200.42  Aligned_cols=143  Identities=29%  Similarity=0.492  Sum_probs=113.7

Q ss_pred             eeEeeccCcccceeEEEE---e--cC---cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE-
Q 018204          190 LQVRKADGITKGSYQVAK---W--NG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM-  260 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~---~--~g---~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-  260 (359)
                      .+|.....+|.|.|+.+.   .  .+   ..+|+|++..... .....+.+.+|+.+++.++||||+++++++...... 
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            356667778888887542   1  22   2799999965433 234467899999999999999999999999876554 


Q ss_pred             -----EEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEE
Q 018204          261 -----MIVLEYHAKGDLASYLQKKG------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI  329 (359)
Q Consensus       261 -----~lv~e~~~~gsL~~~l~~~~------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl  329 (359)
                           ++||||+++|+|.+++....      .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 99999999999999996532      5999999999999999999999998   999999999999999999999


Q ss_pred             ecccccc
Q 018204          330 SGFGLLR  336 (359)
Q Consensus       330 ~DFGla~  336 (359)
                      +|||+++
T Consensus       179 ~Dfg~a~  185 (323)
T 3qup_A          179 ADFGLSR  185 (323)
T ss_dssp             CCCCC--
T ss_pred             eeccccc
Confidence            9999996

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.91  E-value=9.8e-25  Score=207.37  Aligned_cols=144  Identities=24%  Similarity=0.372  Sum_probs=122.1

Q ss_pred             eeeEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC--cEE
Q 018204          189 ELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--PMM  261 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~  261 (359)
                      .-.|...+.+|.|.|+.+   .  .+|..+|||++......  ...+.+.+|+.+++.++||||+++++++....  ..+
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            346777788899998754   2  24889999999754321  22356789999999999999999999988755  789


Q ss_pred             EEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE----cCCCcEEEecccc
Q 018204          262 IVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGFGL  334 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DFGl  334 (359)
                      +||||+++|+|.+++....   .+++..+..++.|++.||.|||+++   |+||||||+|||+    +..+.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999997643   3999999999999999999999999   9999999999999    7778899999999


Q ss_pred             ccc
Q 018204          335 LRL  337 (359)
Q Consensus       335 a~~  337 (359)
                      ++.
T Consensus       163 a~~  165 (396)
T 4eut_A          163 ARE  165 (396)
T ss_dssp             CEE
T ss_pred             ceE
Confidence            963

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.91  E-value=4.2e-24  Score=194.72  Aligned_cols=150  Identities=28%  Similarity=0.483  Sum_probs=127.8

Q ss_pred             cccCCcceeeEeeccCcccceeEEEE---e-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceee
Q 018204          182 EYELNPLELQVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA  253 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~~---~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  253 (359)
                      ...+.+....|...+.+|.|.|+.+.   .     .+..+++|.+...  ......+.+.+|+.+++.++||||++++++
T Consensus        17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (298)
T 3f66_A           17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI   94 (298)
T ss_dssp             GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            45566777888888899999998552   1     1235788988643  355666789999999999999999999998


Q ss_pred             EE-eCCcEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEec
Q 018204          254 VT-QNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (359)
Q Consensus       254 ~~-~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  331 (359)
                      +. .....++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus        95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D  171 (298)
T 3f66_A           95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVAD  171 (298)
T ss_dssp             ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECS
T ss_pred             EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECc
Confidence            64 456789999999999999999764 45899999999999999999999998   99999999999999999999999


Q ss_pred             ccccc
Q 018204          332 FGLLR  336 (359)
Q Consensus       332 FGla~  336 (359)
                      ||+++
T Consensus       172 fg~a~  176 (298)
T 3f66_A          172 FGLAR  176 (298)
T ss_dssp             CGGGC
T ss_pred             ccccc
Confidence            99996

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.91  E-value=1.2e-26  Score=186.99  Aligned_cols=124  Identities=20%  Similarity=0.213  Sum_probs=96.5

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCC-CCcHHHHHHHcCC
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGH  117 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~-g~TpLh~A~~~g~  117 (359)
                      ..+.++.++..|+.+.++.+++.+......+.+|+||||+|+. |+.+++++|+++|+|+|.+|.. |+||||+|+..|+
T Consensus        12 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~   90 (136)
T 1d9s_A           12 SDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGF   90 (136)
T ss_dssp             CSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTC
T ss_pred             CccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCC
Confidence            4444556677777777777777765555557778888888888 8888888888888888888887 7888888888888


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcc
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      .+++++|+++|++++.+|..|+||||+|+..++.+++++|+++|++
T Consensus        91 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~Gad  136 (136)
T 1d9s_A           91 LDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGHRDIARYLHAATGD  136 (136)
T ss_dssp             HHHHHHHHHTCCCCCCCSSSSSCHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence            8888888888888888888888888888888888888888887764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=5.5e-24  Score=193.71  Aligned_cols=151  Identities=26%  Similarity=0.485  Sum_probs=129.1

Q ss_pred             CcccCCcceeeEeeccCcccceeEEEE---e--cC---cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCcccccee
Q 018204          181 PEYELNPLELQVRKADGITKGSYQVAK---W--NG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVG  252 (359)
Q Consensus       181 ~~~~l~~~~~~~~~~~~ig~g~~~~~~---~--~g---~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~  252 (359)
                      .++.++.....+...+.+|.|.|+.+.   .  .+   ..+|+|.+...  ......+.+.+|+.+++.++||||+++++
T Consensus        12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   89 (298)
T 3pls_A           12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIG   89 (298)
T ss_dssp             GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            455666777788888889999988542   1  22   26999998643  34556678999999999999999999999


Q ss_pred             eEEeCCcE-EEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEe
Q 018204          253 AVTQNIPM-MIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (359)
Q Consensus       253 ~~~~~~~~-~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~  330 (359)
                      ++...... +++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+
T Consensus        90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~  166 (298)
T 3pls_A           90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVA  166 (298)
T ss_dssp             EECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeC
Confidence            99876654 9999999999999999763 46899999999999999999999998   9999999999999999999999


Q ss_pred             cccccc
Q 018204          331 GFGLLR  336 (359)
Q Consensus       331 DFGla~  336 (359)
                      |||+++
T Consensus       167 Dfg~~~  172 (298)
T 3pls_A          167 DFGLAR  172 (298)
T ss_dssp             CTTSSC
T ss_pred             cCCCcc
Confidence            999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.91  E-value=9.2e-25  Score=197.83  Aligned_cols=153  Identities=29%  Similarity=0.511  Sum_probs=128.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  ..+..+|+|++.............+.+|+.+++.++||||+++++++......++|||
T Consensus        15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            3555666788877643   2  2477899999864321111123568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.         
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (284)
T 2vgo_A           95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT  171 (284)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCC
T ss_pred             eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccccccc
Confidence            9999999999988888999999999999999999999998   9999999999999999999999999885         


Q ss_pred             ----ccccCccccc
Q 018204          337 ----LQYISPEKAK  346 (359)
Q Consensus       337 ----~~~~~PE~~~  346 (359)
                          ..|+|||...
T Consensus       172 ~~~~~~y~aPE~~~  185 (284)
T 2vgo_A          172 MCGTLDYLPPEMIE  185 (284)
T ss_dssp             CCSCGGGCCHHHHT
T ss_pred             ccCCCCcCCHHHhc
Confidence                2488888755

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.91  E-value=2.2e-24  Score=193.72  Aligned_cols=155  Identities=32%  Similarity=0.573  Sum_probs=122.5

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCCc-HHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKD-PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +|...+.+|.|.|+.   +...|..+|+|++....... ....+.+.+|+.+++.++||||+++++++......++||||
T Consensus         8 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (271)
T 3dtc_A            8 ELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF   87 (271)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred             heeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence            355566678887764   35678999999987543222 23346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC--------CCcEEEecccccc--
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--------GGQLKISGFGLLR--  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~--------~~~~kl~DFGla~--  336 (359)
                      +++++|.+++.. +.+++..+..++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+|||+++  
T Consensus        88 ~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~  166 (271)
T 3dtc_A           88 ARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW  166 (271)
T ss_dssp             CTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred             CCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence            999999999864 47999999999999999999999987445889999999999986        6789999999986  


Q ss_pred             -----------ccccCccccc
Q 018204          337 -----------LQYISPEKAK  346 (359)
Q Consensus       337 -----------~~~~~PE~~~  346 (359)
                                 ..|+|||...
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~  187 (271)
T 3dtc_A          167 HRTTKMSAAGAYAWMAPEVIR  187 (271)
T ss_dssp             ---------CCGGGSCHHHHH
T ss_pred             ccccccCCCCccceeCHHHhc
Confidence                       2478888654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=3.5e-24  Score=201.55  Aligned_cols=150  Identities=27%  Similarity=0.455  Sum_probs=123.1

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC------c
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------P  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~  259 (359)
                      .|.....+|.|+|+.+   .  .+|..||||.+.... ......+.+.+|+.+++.++||||+++++++....      .
T Consensus        26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4667777899998754   2  358899999996543 34555677899999999999999999999987653      4


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      +|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.  
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            69999999 7799999976 57999999999999999999999999   99999999999999999999999999963  


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|+|||...
T Consensus       180 ~~~~~~~~t~~y~aPE~~~  198 (367)
T 1cm8_A          180 SEMTGYVVTRWYRAPEVIL  198 (367)
T ss_dssp             SSCCSSCSCGGGCCTHHHH
T ss_pred             cccCcCcCCCCcCCHHHHh
Confidence                      478888654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.91  E-value=5e-24  Score=199.59  Aligned_cols=148  Identities=22%  Similarity=0.356  Sum_probs=127.8

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-----CCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-----HPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~~~~~~~~~  260 (359)
                      .|.....+|.|.|+.+   .  .++..+|||++..    .......+..|+.+++.+.     ||||+++++++......
T Consensus        36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~  111 (360)
T 3llt_A           36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM  111 (360)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred             EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence            4777778899988754   2  2688999999963    2344566788999999986     99999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---------------
Q 018204          261 MIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---------------  323 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---------------  323 (359)
                      ++||||+ +++|.+++....  .+++..+..++.||+.||.|||+++   |+||||||+|||++.               
T Consensus       112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccc
Confidence            9999999 889999998754  5999999999999999999999999   999999999999975               


Q ss_pred             ----------CCcEEEecccccc------------ccccCccccc
Q 018204          324 ----------GGQLKISGFGLLR------------LQYISPEKAK  346 (359)
Q Consensus       324 ----------~~~~kl~DFGla~------------~~~~~PE~~~  346 (359)
                                ++.+||+|||+|+            ..|+|||...
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~  232 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVIL  232 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHT
T ss_pred             cccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHc
Confidence                      7889999999996            3588888765

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=3.7e-25  Score=205.92  Aligned_cols=145  Identities=23%  Similarity=0.397  Sum_probs=119.7

Q ss_pred             eeeEeeccCcccceeEEEE-----ecCcEEEEEEeccCC--CCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKES--HKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      ...|.....+|.|.|+.+.     ..+..+|+|++....  ..+....+.+.+|+.+++.++||||+++++++......+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            3457777788888887542     357789999986432  112334567899999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 018204          262 IVLEYHAKGDLASYLQKK----------------------------------------GRLSPSKVLRFALDLARGMNYL  301 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~qi~~aL~~l  301 (359)
                      +||||+++|+|.+++...                                        ..+++..+..++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999998520                                        1135778889999999999999


Q ss_pred             HhCCCCCeEeCCCCCCcEEEcCCC--cEEEecccccc
Q 018204          302 HECKPDPIIHCDLKPKNILLDNGG--QLKISGFGLLR  336 (359)
Q Consensus       302 H~~~~~~iiHrDlk~~NIll~~~~--~~kl~DFGla~  336 (359)
                      |+++   |+||||||+|||++.++  .+||+|||+++
T Consensus       185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~  218 (345)
T 3hko_A          185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSK  218 (345)
T ss_dssp             HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCE
T ss_pred             HHCC---ccccCCChhhEEEecCCCceEEEeeccccc
Confidence            9998   99999999999998776  89999999986

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.91  E-value=4.5e-26  Score=190.86  Aligned_cols=134  Identities=25%  Similarity=0.326  Sum_probs=116.9

Q ss_pred             cceeeccCCCCCcCcCCcccccCC-CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELT-VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      .++.++..|+++.++.++..+... ...+.+|+||||+|+..|+.++|++|++.|+++|.+|..|+||||+|+..|+.++
T Consensus         5 ~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~   84 (172)
T 3v30_A            5 SIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDI   84 (172)
T ss_dssp             CHHHHHHTTCHHHHHHHHTTCSGGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred             hHHHHHHcCCHHHHHHHHHcCcccccCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHH
Confidence            355678889999999999887664 4448889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus        85 v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A  142 (172)
T 3v30_A           85 VGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLA  142 (172)
T ss_dssp             HHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHH
Confidence            999999999999999999999999999999999999999999874   3456777665

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.91  E-value=2.7e-24  Score=192.63  Aligned_cols=149  Identities=30%  Similarity=0.556  Sum_probs=127.7

Q ss_pred             eEeeccCcccceeEEE---E-ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---K-WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +|.....+|.|.|+.+   . ..+..+|+|.+.......    +.+.+|+.+++.++||||+++++++......++||||
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            3455566788887744   2 257789999997544322    4688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      +++++|.+++... +.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++.        
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  161 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  161 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence            9999999999875 45899999999999999999999998   99999999999999999999999999863        


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       162 ~~~~~~~~~y~aPE~~~  178 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFS  178 (267)
T ss_dssp             TTSTTCCGGGCCHHHHH
T ss_pred             cccccccccccChhhhc
Confidence                    378888654

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.91  E-value=4.3e-25  Score=177.94  Aligned_cols=113  Identities=31%  Similarity=0.391  Sum_probs=103.1

Q ss_pred             CCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccc
Q 018204           65 TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD  144 (359)
Q Consensus        65 ~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~  144 (359)
                      +...|.+|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+
T Consensus         3 d~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~   82 (137)
T 3c5r_A            3 DPFTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHD   82 (137)
T ss_dssp             -CCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHH
T ss_pred             CCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHH
Confidence            44668889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccceeEeeccccCccc---cccCCCCcccCCC
Q 018204          145 AKYYGNVEVYNILKARGAKV---PKTKRTPMTVANP  177 (359)
Q Consensus       145 A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~~  177 (359)
                      |+..|+.+++++|+++|+++   +..+.||++++..
T Consensus        83 A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~  118 (137)
T 3c5r_A           83 AAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDD  118 (137)
T ss_dssp             HHHTTCHHHHHHHHHTTCCTTCCCTTSCCGGGGCCC
T ss_pred             HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHhh
Confidence            99999999999999999988   4556788888754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.91  E-value=1.4e-24  Score=195.43  Aligned_cols=151  Identities=31%  Similarity=0.465  Sum_probs=129.6

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  .++..+|+|++......  ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            4556666788777643   2  25889999999754432  234578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++++|.+++.....+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.        
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999999999987778999999999999999999999998   99999999999999999999999999852        


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       163 ~~~~~~~~~~y~aPE~~~  180 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLK  180 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGT
T ss_pred             cccCCccccCccChHHHh
Confidence                     378888654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.91  E-value=8.3e-25  Score=209.44  Aligned_cols=151  Identities=26%  Similarity=0.426  Sum_probs=124.0

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCC-----cHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHK-----DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      .|...+.+|+|.|+.+.     .++..+|+|++......     .......+.+|+.+++.++||||+++++++. ....
T Consensus       136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~  214 (419)
T 3i6u_A          136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDY  214 (419)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEE
T ss_pred             cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCce
Confidence            46667778888887542     35789999999754311     1222335789999999999999999999875 4568


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---cEEEeccccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---QLKISGFGLLRL  337 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DFGla~~  337 (359)
                      |+||||+++|+|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++..+   .+||+|||+|+.
T Consensus       215 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          215 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            999999999999999988888999999999999999999999998   99999999999997654   599999999963


Q ss_pred             --------------cccCcccc
Q 018204          338 --------------QYISPEKA  345 (359)
Q Consensus       338 --------------~~~~PE~~  345 (359)
                                    .|+|||..
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~  313 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVL  313 (419)
T ss_dssp             CC-----------CTTCCTTTT
T ss_pred             cCCCccccccCCCCCccCceee
Confidence                          47788764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.91  E-value=2.2e-24  Score=193.36  Aligned_cols=153  Identities=22%  Similarity=0.391  Sum_probs=130.2

Q ss_pred             EeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC--CcEEEEEec
Q 018204          192 VRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN--IPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~e~  266 (359)
                      |.....+|.|.|+.   +...+..+|+|++.... ......+.|.+|+.+++.++||||+++++++...  ...++||||
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (271)
T 3kmu_A           12 LNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW   90 (271)
T ss_dssp             CEEEEEEEEETTEEEEEEEETTEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred             hHHHHHhcCCCcceEEEEEECCeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence            44455677777764   45679999999997654 3455567899999999999999999999999876  788999999


Q ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      +++|+|.+++....  .+++..+..++.|++.||.|||+++ .+|+||||||+|||++.++.++|+|||++.        
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  169 (271)
T 3kmu_A           91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM  169 (271)
T ss_dssp             CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTTCB
T ss_pred             cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecccCcc
Confidence            99999999998765  4899999999999999999999976 359999999999999999999999888763        


Q ss_pred             --ccccCccccc
Q 018204          337 --LQYISPEKAK  346 (359)
Q Consensus       337 --~~~~~PE~~~  346 (359)
                        ..|+|||...
T Consensus       170 ~t~~y~aPE~~~  181 (271)
T 3kmu_A          170 YAPAWVAPEALQ  181 (271)
T ss_dssp             SCGGGSCHHHHH
T ss_pred             CCccccChhhhc
Confidence              3588998765

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.91  E-value=8.2e-24  Score=192.12  Aligned_cols=155  Identities=24%  Similarity=0.399  Sum_probs=130.7

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe----CCcE
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPM  260 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~  260 (359)
                      ..+.....+|.|.|+.+.     ..+..+|+|.+..... .....+.+.+|+.+++.++||||+++++++..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            345666678888887542     3577899999875443 45556789999999999999999999999875    3568


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCcEEEecccccc---
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLR---  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DFGla~---  336 (359)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+++ .+|+||||||+|||++ .++.+||+|||+++   
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            999999999999999998888999999999999999999999986 3599999999999998 78999999999985   


Q ss_pred             ----------ccccCccccc
Q 018204          337 ----------LQYISPEKAK  346 (359)
Q Consensus       337 ----------~~~~~PE~~~  346 (359)
                                ..|+|||...
T Consensus       184 ~~~~~~~~~t~~y~aPE~~~  203 (290)
T 1t4h_A          184 ASFAKAVIGTPEFMAPEMYE  203 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGG
T ss_pred             ccccccccCCcCcCCHHHHh
Confidence                      2478888654

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.91  E-value=2.7e-24  Score=199.13  Aligned_cols=137  Identities=23%  Similarity=0.281  Sum_probs=118.6

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      .|.....+|.|.|+.+   .  .+|+.+|||++......     +.+..|+.+++.+ +||||+++++++......++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A           10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            3556667788877533   2  46899999998654322     2478899999999 9999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc-----EEEecccccc
Q 018204          265 EYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~DFGla~  336 (359)
                      ||+ +++|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.     +||+|||+++
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            999 88999999864 57999999999999999999999998   999999999999999887     9999999997

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.91  E-value=6.3e-24  Score=201.40  Aligned_cols=151  Identities=23%  Similarity=0.378  Sum_probs=130.3

Q ss_pred             eeEeeccCcccceeEEEE----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC--CCccccceeeEEeCCcEEEE
Q 018204          190 LQVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR--HPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~lv  263 (359)
                      ..|.....+|.|.|+.+.    ..+..+|||++..... +....+.+.+|+.++..+.  ||||+++++++.....+|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            357778889999998652    2478899999975543 4556678999999999996  59999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc------
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------  337 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~------  337 (359)
                      || +.+++|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.      
T Consensus       135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            99 567899999998888999999999999999999999998   99999999999995 58899999999862      


Q ss_pred             -----------cccCccccc
Q 018204          338 -----------QYISPEKAK  346 (359)
Q Consensus       338 -----------~~~~PE~~~  346 (359)
                                 .|+|||...
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~  229 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIK  229 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHH
T ss_pred             cccCCCCCcCCCccChHHhh
Confidence                       378888754

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.91  E-value=3.4e-26  Score=188.05  Aligned_cols=132  Identities=27%  Similarity=0.300  Sum_probs=119.4

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      ++.+++.|+.+.++.+++.+. +...+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.++++
T Consensus         6 L~~A~~~g~~~~v~~Ll~~g~-~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~   84 (153)
T 1awc_B            6 LLEAARAGQDDEVRILMANGA-PFTTDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVE   84 (153)
T ss_dssp             HHHHHHHTCHHHHHHHHHHTC-CCCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHcCC-CCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHH
Confidence            456778899999998888765 4456888999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCccccccccccccccccccccceeEeeccccCccccc---cCCCCcccC
Q 018204          123 LLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPK---TKRTPMTVA  175 (359)
Q Consensus       123 ~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~---~~~tpl~~a  175 (359)
                      +|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++.   .+.||++.+
T Consensus        85 ~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A  140 (153)
T 1awc_B           85 VLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDIS  140 (153)
T ss_dssp             HHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHH
Confidence            99999999999999999999999999999999999999998853   456777765

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.91  E-value=2.6e-24  Score=196.03  Aligned_cols=139  Identities=22%  Similarity=0.442  Sum_probs=119.8

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe---------
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ---------  256 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---------  256 (359)
                      +|.....+|.|.|+.+   .  .+|..+|+|.+..    .....+.+.+|+.+++.++||||+++++++..         
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4566667788888744   2  3688999999953    34556778999999999999999999998865         


Q ss_pred             ----CCcEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEec
Q 018204          257 ----NIPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (359)
Q Consensus       257 ----~~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  331 (359)
                          ....|+||||+++++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence                356899999999999999998653 5888999999999999999999998   99999999999999999999999


Q ss_pred             ccccc
Q 018204          332 FGLLR  336 (359)
Q Consensus       332 FGla~  336 (359)
                      ||+++
T Consensus       160 fg~~~  164 (303)
T 1zy4_A          160 FGLAK  164 (303)
T ss_dssp             CCCCS
T ss_pred             Ccchh
Confidence            99885

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.91  E-value=4.7e-24  Score=194.47  Aligned_cols=136  Identities=32%  Similarity=0.540  Sum_probs=114.4

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHh--CCCCccccceeeEEeC----CcEE
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK--ARHPNVVQFVGAVTQN----IPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~----~~~~  261 (359)
                      +|...+.+|.|.|+.   +..+|..+|||++....      ...+..|.+++..  ++||||+++++++...    ..++
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            455666788888874   35689999999986431      2345667777766  7999999999987653    4589


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH--------ECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      +||||+++|+|.++++. ..+++..+..++.|++.||.|||        +++   |+||||||+|||++.++.+||+|||
T Consensus        83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCC
Confidence            99999999999999964 46999999999999999999999        777   9999999999999999999999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      +|+
T Consensus       159 ~a~  161 (301)
T 3q4u_A          159 LAV  161 (301)
T ss_dssp             TCE
T ss_pred             Cee
Confidence            985

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.91  E-value=7.4e-26  Score=188.61  Aligned_cols=135  Identities=21%  Similarity=0.266  Sum_probs=122.2

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      ..++.++..|+++.++.+++.+......|.+|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.++
T Consensus         5 t~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~   84 (167)
T 3v31_A            5 LSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDI   84 (167)
T ss_dssp             CCHHHHHHTTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHH
T ss_pred             chHHHHHHCCCHHHHHHHHHcCCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHH
Confidence            34567788999999999998876666678899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus        85 v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A  142 (167)
T 3v31_A           85 VKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLA  142 (167)
T ss_dssp             HHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence            999999999999999999999999999999999999999999874   4456777665

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.91  E-value=3.9e-24  Score=197.81  Aligned_cols=150  Identities=31%  Similarity=0.554  Sum_probs=122.5

Q ss_pred             EeeccCcccceeEEE-----EecCcE--EEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA-----KWNGTK--VWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~-----~~~g~~--vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      |.....+|.|.|+.+     ...+..  +++|.+....  .......+.+|+.++..+ +||||+++++++......++|
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            444555677777543     234554  4889886432  333445789999999999 899999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcE
Q 018204          264 LEYHAKGDLASYLQKKG----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL  327 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~  327 (359)
                      |||+++++|.+++....                .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999997653                6999999999999999999999998   9999999999999999999


Q ss_pred             EEeccccccc--------------cccCccccc
Q 018204          328 KISGFGLLRL--------------QYISPEKAK  346 (359)
Q Consensus       328 kl~DFGla~~--------------~~~~PE~~~  346 (359)
                      ||+|||+++.              .|+|||...
T Consensus       182 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  214 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN  214 (327)
T ss_dssp             EECCTTCEESSCEECCC----CCTTTCCHHHHH
T ss_pred             EEcccCcCccccccccccCCCCCccccChhhhc
Confidence            9999999862              477887653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=4.9e-24  Score=197.85  Aligned_cols=141  Identities=29%  Similarity=0.475  Sum_probs=120.0

Q ss_pred             eEeeccCcccceeEEE---Eec------CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVA---KWN------GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~~------g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      .+...+.+|.|.|+.+   ...      +..+|+|.+....  .......+.+|+.++..++||||+++++++......+
T Consensus        45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4555566788887644   211      2359999996443  4455567999999999999999999999999999999


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence            999999999999999765 56999999999999999999999998   9999999999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.91  E-value=2.9e-24  Score=215.68  Aligned_cols=135  Identities=29%  Similarity=0.522  Sum_probs=118.8

Q ss_pred             CcccceeEEEE---e----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          197 GITKGSYQVAK---W----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       197 ~ig~g~~~~~~---~----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      .+|.|.|+.+.   +    .+..+|||++..... +....+.|.+|+.++..++||||+++++++. ....++||||+++
T Consensus       376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             EeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            57888888552   1    357899999975432 3334567999999999999999999999886 4568999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+|.+++...+.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~  517 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK  517 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHH
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcc
Confidence            999999998888999999999999999999999999   9999999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.91  E-value=2e-24  Score=209.41  Aligned_cols=149  Identities=25%  Similarity=0.387  Sum_probs=124.9

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------Cc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~  259 (359)
                      .|.....+|.|+|+.+     ...|..||||++.... ......+.+.+|+.+++.++||||+++++++...      ..
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            4666778899998855     2358899999997543 3455567789999999999999999999998654      35


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      +|+||||+++ +|.+.+..  .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.  
T Consensus       142 ~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             EEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             EEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence            7999999976 67777753  4999999999999999999999999   99999999999999999999999999962  


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~  236 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVIL  236 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHT
T ss_pred             CCcccCCCcccccccCHHHHc
Confidence                        488888765

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.91  E-value=2.8e-24  Score=194.79  Aligned_cols=149  Identities=28%  Similarity=0.518  Sum_probs=127.5

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  ..+..+|+|.+....    ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus        14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4555666788877633   2  247899999996432    234578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc------
Q 018204          266 YHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~------  337 (359)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.      
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            99999999999874  34999999999999999999999999   99999999999999999999999999862      


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|+|||...
T Consensus       167 ~~~~~~~~~~~y~aPE~~~  185 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLA  185 (288)
T ss_dssp             EEETTEEECGGGCCHHHHH
T ss_pred             ccccCCccccCcCChhhhc
Confidence                      388888654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=9.1e-24  Score=191.63  Aligned_cols=134  Identities=28%  Similarity=0.464  Sum_probs=117.3

Q ss_pred             CcccceeEEE---E----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          197 GITKGSYQVA---K----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       197 ~ig~g~~~~~---~----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      .+|.|.|+.+   .    ..+..+|+|++....  .....+.+.+|+.++..++||||+++++++ .....++||||+++
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~   93 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG   93 (287)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             cccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence            5778887644   2    257789999997542  455667899999999999999999999998 55679999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          270 GDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           94 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccccee
Confidence            9999999654 45999999999999999999999998   9999999999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.91  E-value=7.3e-24  Score=197.41  Aligned_cols=142  Identities=21%  Similarity=0.353  Sum_probs=124.6

Q ss_pred             eeeEeeccCcccceeEEEE----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC--CccccceeeEEeCCcEEE
Q 018204          189 ELQVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH--PNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~l  262 (359)
                      ...|.....+|.|.|+.+.    ..+..+|+|++.... ......+.+.+|+.++..+.|  |||+++++++.....+++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            3457777888999988552    357889999997554 345566789999999999987  999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+ .+++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++ ++.+||+|||+++
T Consensus        87 v~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             EECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             EEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccc
Confidence            9995 57899999999888999999999999999999999998   99999999999997 6789999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.91  E-value=4.3e-24  Score=203.25  Aligned_cols=140  Identities=24%  Similarity=0.397  Sum_probs=117.5

Q ss_pred             cCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHH-hCCCCccccceeeEEe----CCcEEEEEe
Q 018204          196 DGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVE-KARHPNVVQFVGAVTQ----NIPMMIVLE  265 (359)
Q Consensus       196 ~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~----~~~~~lv~e  265 (359)
                      ..+|.|.|+.+.     .+|..+|||++...        ..+.+|+.++. ..+||||+++++++..    ...+|+|||
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E  139 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME  139 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence            457888887542     35789999999632        24567888774 5589999999999875    567999999


Q ss_pred             cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCcEEEeccccccc---
Q 018204          266 YHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRL---  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DFGla~~---  337 (359)
                      |++||+|.+++...+  .+++..+..++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+++.   
T Consensus       140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999998753  5999999999999999999999998   999999999999998   78899999999862   


Q ss_pred             -----------cccCccccc
Q 018204          338 -----------QYISPEKAK  346 (359)
Q Consensus       338 -----------~~~~PE~~~  346 (359)
                                 .|+|||...
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~  236 (400)
T 1nxk_A          217 HNSLTTPCYTPYYVAPEVLG  236 (400)
T ss_dssp             ----------CTTCCGGGSC
T ss_pred             CCccccCCCCCCccCHhhcC
Confidence                       488888754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.91  E-value=2.3e-24  Score=202.40  Aligned_cols=143  Identities=19%  Similarity=0.289  Sum_probs=115.3

Q ss_pred             eeEeeccCcccceeEEEE---e-------cCcEEEEEEeccCCCCcHHHH--------HHHHHHHHHHHhCCCCccccce
Q 018204          190 LQVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERI--------NAFTHELTIVEKARHPNVVQFV  251 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~---~-------~g~~vavK~l~~~~~~~~~~~--------~~~~~Ei~il~~l~HpnIv~l~  251 (359)
                      -.|.....+|.|.|+.+.   .       .+..+|||++...........        ..+..|+..+..++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            367888889999987542   1       257899999865431111111        1234456667788899999999


Q ss_pred             eeEEeC----CcEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc--CC
Q 018204          252 GAVTQN----IPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NG  324 (359)
Q Consensus       252 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~--~~  324 (359)
                      +++...    ...|+||||+ +++|.+++... +.+++..+..++.||+.||.|||+++   |+||||||+|||++  .+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCT
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCC
Confidence            998765    4589999999 99999999876 57999999999999999999999998   99999999999999  88


Q ss_pred             CcEEEecccccc
Q 018204          325 GQLKISGFGLLR  336 (359)
Q Consensus       325 ~~~kl~DFGla~  336 (359)
                      +.+||+|||+|+
T Consensus       191 ~~~kl~DFG~a~  202 (364)
T 3op5_A          191 DQVYLVDYGLAY  202 (364)
T ss_dssp             TCEEECCCTTCE
T ss_pred             CeEEEEECCcce
Confidence            999999999995

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=3.9e-24  Score=201.62  Aligned_cols=150  Identities=28%  Similarity=0.486  Sum_probs=121.9

Q ss_pred             cccCCcceeeEeeccCcccceeEEEE---e--c---CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceee
Q 018204          182 EYELNPLELQVRKADGITKGSYQVAK---W--N---GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA  253 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~~---~--~---g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  253 (359)
                      .+.+......+...+.+|.|.|+.+.   .  .   +..+|+|.+...  .+....+.|.+|+.+++.++||||++++++
T Consensus        81 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~  158 (373)
T 3c1x_A           81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGI  158 (373)
T ss_dssp             TTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEE
T ss_pred             ccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            34455556677777888999987542   1  1   235889988643  244556789999999999999999999998


Q ss_pred             EEe-CCcEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEec
Q 018204          254 VTQ-NIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (359)
Q Consensus       254 ~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  331 (359)
                      +.. .+..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       159 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~D  235 (373)
T 3c1x_A          159 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVAD  235 (373)
T ss_dssp             ECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECC
T ss_pred             EEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEee
Confidence            654 56789999999999999999765 35889999999999999999999998   99999999999999999999999


Q ss_pred             ccccc
Q 018204          332 FGLLR  336 (359)
Q Consensus       332 FGla~  336 (359)
                      ||+++
T Consensus       236 FG~a~  240 (373)
T 3c1x_A          236 FGLAR  240 (373)
T ss_dssp             C----
T ss_pred             ccccc
Confidence            99996

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.91  E-value=8.6e-26  Score=192.66  Aligned_cols=140  Identities=24%  Similarity=0.260  Sum_probs=127.4

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      |....+.++.++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..
T Consensus        32 d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~  111 (192)
T 2rfm_A           32 DSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIF  111 (192)
T ss_dssp             CTTCCCHHHHHHHHTCGGGHHHHHHHHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHhccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHc
Confidence            44555667778889999999999988776666788999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      |+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||++.|
T Consensus       112 ~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A  174 (192)
T 2rfm_A          112 GYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASA  174 (192)
T ss_dssp             TCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHH
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHH
Confidence            99999999999999999999999999999999999999999999999985   4456777766

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.91  E-value=7e-25  Score=202.71  Aligned_cols=149  Identities=31%  Similarity=0.532  Sum_probs=123.5

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  .++..+|+|++.....  ......+.+|+.+++.++||||+++++++......++||||
T Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            566677888888754   2  2578999999964331  11112355799999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      +++ +|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++         
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            975 9999987754 5999999999999999999999999   9999999999999999999999999985         


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|+|||...
T Consensus       158 ~~~~~t~~y~aPE~~~  173 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILL  173 (324)
T ss_dssp             -----CGGGCCHHHHT
T ss_pred             ccccCcccccChhhhc
Confidence                  2488888654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.91  E-value=3.5e-24  Score=197.68  Aligned_cols=151  Identities=27%  Similarity=0.436  Sum_probs=123.6

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCC-----cHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHK-----DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      .|.....+|.|.|+.+.     .++..+|||++......     .......+.+|+.+++.++||||+++++++.... .
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~   89 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y   89 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence            46667778888887542     25789999999654321     1223345889999999999999999999987654 8


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc---EEEeccccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFGLLRL  337 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DFGla~~  337 (359)
                      |+||||+++++|.+++.....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+++.
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            999999999999999988888999999999999999999999998   999999999999987664   99999999862


Q ss_pred             --------------cccCcccc
Q 018204          338 --------------QYISPEKA  345 (359)
Q Consensus       338 --------------~~~~PE~~  345 (359)
                                    .|+|||..
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~  188 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVL  188 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHH
T ss_pred             cccccccccccCCcCccCchhh
Confidence                          58899875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.91  E-value=2.7e-24  Score=199.05  Aligned_cols=140  Identities=23%  Similarity=0.525  Sum_probs=114.3

Q ss_pred             eEeeccCcccceeEEE---Ee--cCc----EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVA---KW--NGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~----~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +|...+.+|.|.|+.+   ..  .+.    ++|+|.+....  .....+.|.+|+.+++.++||||+++++++.... .+
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            4666777888888754   21  344    35777775332  2334467899999999999999999999998754 78


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||+.+|+|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence            999999999999999874 56999999999999999999999998   9999999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.91  E-value=3.1e-24  Score=202.05  Aligned_cols=154  Identities=13%  Similarity=0.162  Sum_probs=114.2

Q ss_pred             eeeEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC--CCCccccce-------eeE
Q 018204          189 ELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA--RHPNVVQFV-------GAV  254 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~-------~~~  254 (359)
                      ...|.....+|.|.|+.+   .  .+|..+|+|++...........+.+.+|+.++..+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            445777888999998854   2  35889999999877665666677788886555555  699987754       444


Q ss_pred             EeC-----------------CcEEEEEecCCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCCCeE
Q 018204          255 TQN-----------------IPMMIVLEYHAKGDLASYLQKK-GRLSPSKV------LRFALDLARGMNYLHECKPDPII  310 (359)
Q Consensus       255 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~qi~~aL~~lH~~~~~~ii  310 (359)
                      ...                 ..+|+||||++ |+|.+++... ..+++...      ..++.||+.||.|||+++   |+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence            433                 23899999998 7999999764 23444444      577799999999999999   99


Q ss_pred             eCCCCCCcEEEcCCCcEEEecccccc------------ccccCccccc
Q 018204          311 HCDLKPKNILLDNGGQLKISGFGLLR------------LQYISPEKAK  346 (359)
Q Consensus       311 HrDlk~~NIll~~~~~~kl~DFGla~------------~~~~~PE~~~  346 (359)
                      ||||||+|||++.++.+||+|||+|+            ..|+|||...
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~  264 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLN  264 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHT
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhcc
Confidence            99999999999999999999999986            3488888764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.91  E-value=4.1e-24  Score=197.95  Aligned_cols=141  Identities=32%  Similarity=0.537  Sum_probs=121.5

Q ss_pred             eEeeccCcccceeEEEE---e--c-----CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVAK---W--N-----GTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~--~-----g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~  259 (359)
                      .|.....+|.|.|+.+.   .  .     +..+|+|.+....  .....+.+.+|+.++..+ +||||+++++++.....
T Consensus        47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            45556678888887542   1  1     2479999996543  345567899999999999 89999999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 018204          260 MMIVLEYHAKGDLASYLQKK--------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG  325 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~  325 (359)
                      .++||||+++|+|.+++...              ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence            99999999999999999753              34799999999999999999999998   99999999999999999


Q ss_pred             cEEEecccccc
Q 018204          326 QLKISGFGLLR  336 (359)
Q Consensus       326 ~~kl~DFGla~  336 (359)
                      .+||+|||+++
T Consensus       202 ~~kl~Dfg~~~  212 (333)
T 2i1m_A          202 VAKIGDFGLAR  212 (333)
T ss_dssp             EEEBCCCGGGC
T ss_pred             eEEECcccccc
Confidence            99999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.91  E-value=4.8e-24  Score=192.64  Aligned_cols=136  Identities=27%  Similarity=0.503  Sum_probs=116.9

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe---------
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ---------  256 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~---------  256 (359)
                      +|...+.+|.|.|+.+   ..  +|..+|+|.+....       +.+.+|+.+++.++||||+++++++..         
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4666667788877633   33  58999999996543       246789999999999999999998854         


Q ss_pred             -------CCcEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcE
Q 018204          257 -------NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL  327 (359)
Q Consensus       257 -------~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~  327 (359)
                             ...+++||||+++++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                   44589999999999999999754  56999999999999999999999998   9999999999999999999


Q ss_pred             EEecccccc
Q 018204          328 KISGFGLLR  336 (359)
Q Consensus       328 kl~DFGla~  336 (359)
                      ||+|||+++
T Consensus       162 kl~Dfg~~~  170 (284)
T 2a19_B          162 KIGDFGLVT  170 (284)
T ss_dssp             EECCCTTCE
T ss_pred             EECcchhhe
Confidence            999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.91  E-value=2.1e-24  Score=203.12  Aligned_cols=150  Identities=27%  Similarity=0.428  Sum_probs=115.6

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------Cc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~  259 (359)
                      .|.....+|.|+|+.+     ..+|..||||++.... ......+.+.+|+.+++.++||||+++++++...      ..
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4666777899988744     2358899999996543 3455567788999999999999999999998654      56


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .|+++|++ +++|.+++.. ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.  
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            89999999 6799998876 57999999999999999999999999   99999999999999999999999999963  


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|+|||...
T Consensus       184 ~~~~~~~~t~~y~aPE~~~  202 (367)
T 2fst_X          184 DEMTGYVATRWYRAPEIML  202 (367)
T ss_dssp             -------CCCTTCCHHHHT
T ss_pred             ccCCCcCcCcCccChHHHc
Confidence                      488998754

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.91  E-value=5.3e-26  Score=183.23  Aligned_cols=121  Identities=29%  Similarity=0.385  Sum_probs=101.2

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      ..++.++..|+.+.++.+++.+......|.+|.||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.++
T Consensus        16 t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~   95 (136)
T 2jab_A           16 KKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEI   95 (136)
T ss_dssp             HHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHH
T ss_pred             HHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHH
Confidence            34456777888888888888766555667788888888888888888888888888888888888888888888888888


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccccC
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g  161 (359)
                      |++|+++|++++.+|..|+||||+|+..|+.+++++|+++|
T Consensus        96 v~~Ll~~g~~~~~~~~~g~tpl~~A~~~~~~~~~~~Ll~~G  136 (136)
T 2jab_A           96 AEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKLN  136 (136)
T ss_dssp             HHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHC-
T ss_pred             HHHHHHcCCCCcCcCCCCCCHHHHHHHCCCHHHHHHHHHcC
Confidence            88888888888888888888888888888888888888765

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.91  E-value=1.3e-25  Score=187.67  Aligned_cols=135  Identities=30%  Similarity=0.411  Sum_probs=123.4

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      ..++.+++.|+++.++.+++.+......+.+|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+..|+.++
T Consensus        16 ~~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~   95 (169)
T 2y1l_E           16 KKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEI   95 (169)
T ss_dssp             HHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHH
T ss_pred             chHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHH
Confidence            34567888999999999998876666678899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus        96 ~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A  153 (169)
T 2y1l_E           96 VEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGKTAFDIS  153 (169)
T ss_dssp             HHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence            999999999999999999999999999999999999999999974   4456777765

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.91  E-value=1.8e-23  Score=191.40  Aligned_cols=138  Identities=33%  Similarity=0.454  Sum_probs=120.4

Q ss_pred             cCcccceeEEE---EecCcEEEEEEeccCCC-CcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          196 DGITKGSYQVA---KWNGTKVWVKILDKESH-KDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       196 ~~ig~g~~~~~---~~~g~~vavK~l~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +.+|.|.|+.+   ...+..+|+|.+..... ......+.+.+|+.+++.++||||+++++++......++||||+++++
T Consensus        37 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  116 (307)
T 2nru_A           37 NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGS  116 (307)
T ss_dssp             CEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             CccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCc
Confidence            45677877643   45789999999975432 233455678999999999999999999999999999999999999999


Q ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          272 LASYLQK---KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       272 L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus       117 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~  181 (307)
T 2nru_A          117 LLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR  181 (307)
T ss_dssp             HHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             HHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccc
Confidence            9999974   245999999999999999999999998   9999999999999999999999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.91  E-value=3.2e-24  Score=207.32  Aligned_cols=138  Identities=31%  Similarity=0.543  Sum_probs=118.7

Q ss_pred             eEeeccCcccceeEEE---Eec-CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---KWN-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~~-g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      .+.....+|.|.|+.+   .+. +..||||.+......    .+.|.+|+.+++.++||||+++++++.. ...++||||
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            3556667888888744   333 467999999754422    2468999999999999999999998865 678999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccce
Confidence            9999999999743  46999999999999999999999998   9999999999999999999999999997

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.91  E-value=4.3e-26  Score=188.18  Aligned_cols=129  Identities=22%  Similarity=0.257  Sum_probs=113.6

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCc-HHHHHHHcCC
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRT-ALHIAACEGH  117 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~T-pLh~A~~~g~  117 (359)
                      ..+.++.++..|+.+.++.+++.+......+.+|+||||+|+ .|+.+++++|++.|+++|.+|..|+| |||+|+..|+
T Consensus        12 ~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~   90 (156)
T 1bi7_B           12 SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF   90 (156)
T ss_dssp             STTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred             chHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCC
Confidence            345566788899999999999887666666889999999984 99999999999999999999999999 9999999999


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccccccC
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~  168 (359)
                      .++|++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++..+
T Consensus        91 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~  141 (156)
T 1bi7_B           91 LDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSN  141 (156)
T ss_dssp             HHHHHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSSCC-------
T ss_pred             HHHHHHHHHcCCCCcccCCCCCCHHHHHHHhCHHHHHHHHHHcCCCCCccC
Confidence            999999999999999999999999999999999999999999999986543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.91  E-value=8.4e-24  Score=195.50  Aligned_cols=141  Identities=30%  Similarity=0.574  Sum_probs=121.0

Q ss_pred             eEeeccCcccceeEEE---E------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC--c
Q 018204          191 QVRKADGITKGSYQVA---K------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI--P  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~  259 (359)
                      .|.....+|.|.|+.+   .      ..|..+|+|.+...   .....+.+.+|+.+++.++||||+++++++....  .
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            4566667888888754   2      25789999999653   3445567999999999999999999999886543  7


Q ss_pred             EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            89999999999999999876 45999999999999999999999998   99999999999999999999999999863

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.90  E-value=1.7e-24  Score=199.92  Aligned_cols=141  Identities=33%  Similarity=0.469  Sum_probs=119.7

Q ss_pred             eEeeccCcccceeEEEE----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      .|.....+|.|.|+.+.    .+|..+|+|++......  .....+.+|+.+++.++||||+++++++......++||||
T Consensus        31 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           31 NFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             SSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             ccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            45566678888887542    25788999999754321  1122588999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKG----RLSPSKVLRFALDLARGMNYLHEC---KPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~lH~~---~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++....    .+++..+..++.|++.||.|||++   +   |+||||||+|||++.++.+||+|||+++
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCcccc
Confidence            99999999998643    399999999999999999999999   7   9999999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.90  E-value=2.2e-24  Score=201.46  Aligned_cols=141  Identities=28%  Similarity=0.457  Sum_probs=117.3

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--------C
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--------N  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------~  257 (359)
                      .|.....+|.|.|+.+   .  .+|..+|+|++....... .....+.+|+.+++.++||||+++++++..        .
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            4666677888887633   2  358899999986544322 223457789999999999999999999887        3


Q ss_pred             CcEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          258 IPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +.+++||||+++ +|.+.+... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence            468999999975 787777654 56999999999999999999999999   9999999999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.90  E-value=1.2e-23  Score=192.42  Aligned_cols=150  Identities=23%  Similarity=0.433  Sum_probs=127.8

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   .  .+|+.+|+|.+.....   ...+.+.+|+.++..++||||+++++++......++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A           10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4666677888888754   2  3588999999975432   223468899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE---cCCCcEEEeccccccc-----
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DFGla~~-----  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||++   +.++.+||+|||+++.     
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            9999999999988888999999999999999999999998   9999999999999   7788999999999862     


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       164 ~~~~~~~~~y~aPE~~~  180 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLA  180 (304)
T ss_dssp             THHHHSCCCBCCTTTBS
T ss_pred             cccccCCCCccChHHhc
Confidence                    478888654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.90  E-value=5.9e-24  Score=195.16  Aligned_cols=141  Identities=31%  Similarity=0.549  Sum_probs=121.0

Q ss_pred             eEeeccCcccceeEEE---E-------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCC-
Q 018204          191 QVRKADGITKGSYQVA---K-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNI-  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~-  258 (359)
                      .|...+.+|.|.|+.+   .       ..+..+|+|++....  .......+.+|+.++..+ +||||+++++++.... 
T Consensus        28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            4666677888888754   2       235789999996543  344556789999999999 7899999999987654 


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc
Q 018204          259 PMMIVLEYHAKGDLASYLQKKGR----------------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD  322 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~  322 (359)
                      .+++||||+++++|.+++.....                +++..+..++.|++.||.|||+++   |+||||||+|||++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~  182 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS  182 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEEC
Confidence            59999999999999999987543                889999999999999999999998   99999999999999


Q ss_pred             CCCcEEEecccccc
Q 018204          323 NGGQLKISGFGLLR  336 (359)
Q Consensus       323 ~~~~~kl~DFGla~  336 (359)
                      .++.+||+|||+++
T Consensus       183 ~~~~~kl~Dfg~~~  196 (316)
T 2xir_A          183 EKNVVKICDFGLAR  196 (316)
T ss_dssp             GGGCEEECCCGGGS
T ss_pred             CCCCEEECCCcccc
Confidence            99999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.90  E-value=8.8e-24  Score=193.85  Aligned_cols=148  Identities=33%  Similarity=0.631  Sum_probs=120.9

Q ss_pred             EeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          192 VRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       192 ~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      |.....+|.|.|+.   +...+..+|+|.+...     ...+.|.+|+.+++.++||||+++++++.  +..++||||++
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             eeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            44555677777763   4567899999998532     23457899999999999999999999876  45799999999


Q ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc-EEEecccccc--------
Q 018204          269 KGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-LKISGFGLLR--------  336 (359)
Q Consensus       269 ~gsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~-~kl~DFGla~--------  336 (359)
                      +++|.+++....   .++...+..++.|++.||.|||+.++.+|+||||||+|||++.++. +||+|||+++        
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~  162 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN  162 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccccc
Confidence            999999998654   3788999999999999999999932122999999999999998886 7999999985        


Q ss_pred             ----ccccCccccc
Q 018204          337 ----LQYISPEKAK  346 (359)
Q Consensus       337 ----~~~~~PE~~~  346 (359)
                          ..|+|||...
T Consensus       163 ~~gt~~y~aPE~~~  176 (307)
T 2eva_A          163 NKGSAAWMAPEVFE  176 (307)
T ss_dssp             --CCTTSSCHHHHT
T ss_pred             CCCCCceEChhhhC
Confidence                3588998765

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.90  E-value=4.9e-26  Score=193.75  Aligned_cols=134  Identities=16%  Similarity=0.104  Sum_probs=115.4

Q ss_pred             cceeeccCCCCCcCcCCcccccCCCCCC-CCCccHHHHHHHcCCH----HHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELTVPEN-LDSTMQLLFMACRGDV----KGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~t~l~~aa~~g~~----~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g  116 (359)
                      ..|.+++.|+++.++.++..+.  ...+ ..|+||||+|+.+|+.    ++|++||++|||||.+|..|+||||+|+..|
T Consensus         9 ~l~~Aa~~g~~~~~~~l~~~~~--~~~~~~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~   86 (186)
T 3t8k_A            9 TVSAAAMLGTYEDFLELFEKGY--EDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGG   86 (186)
T ss_dssp             SHHHHHHHSCHHHHHHHHHHSS--SCHHHHHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHC
T ss_pred             HHHHHHHcCCHHHHHHHHhcCc--ccccccCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcC
Confidence            4568889999999888876542  2333 6799999999999985    5999999999999999999999999999999


Q ss_pred             C------HHHHHHHHhcCCCccccccccc-cccccccccc-----cceeEeeccc-cCcccc---ccCCCCcccCCC
Q 018204          117 H------VEVVKLLLSKKANIDARDRWGS-TAAADAKYYG-----NVEVYNILKA-RGAKVP---KTKRTPMTVANP  177 (359)
Q Consensus       117 ~------~~~v~~Ll~~ga~~~~~d~~g~-tpl~~A~~~~-----~~~~~~~L~~-~ga~~~---~~~~tpl~~a~~  177 (359)
                      +      .++|++|+++|||+|.+|..|+ ||||+|+..+     +.+++++|++ +|++++   ..+.||++++..
T Consensus        87 ~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~TpL~~A~~  163 (186)
T 3t8k_A           87 GNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKR  163 (186)
T ss_dssp             TTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCHHHHHHT
T ss_pred             CcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCHHHHHHH
Confidence            7      6899999999999999999999 9999999844     4568999999 999984   556788888743

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.90  E-value=7e-24  Score=194.33  Aligned_cols=152  Identities=28%  Similarity=0.478  Sum_probs=121.1

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCC--cHHHHHHHHHHHHHHHhC---CCCccccceeeEEeCC--
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHK--DPERINAFTHELTIVEKA---RHPNVVQFVGAVTQNI--  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~--~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~--  258 (359)
                      .|.....+|.|.|+.+   .  .+|+.+|+|++......  .......+.+|+.+++.+   +||||+++++++....  
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~   89 (308)
T 3g33_A           10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD   89 (308)
T ss_dssp             CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC
Confidence            4666677888888643   2  46889999999643211  111112355677776665   5999999999998755  


Q ss_pred             ---cEEEEEecCCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          259 ---PMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       259 ---~~~lv~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                         ..+++|||+. ++|.+++.....  +++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           90 REIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             SEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             CceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCc
Confidence               5899999997 599999987654  999999999999999999999999   9999999999999999999999999


Q ss_pred             cccc--------------cccCccccc
Q 018204          334 LLRL--------------QYISPEKAK  346 (359)
Q Consensus       334 la~~--------------~~~~PE~~~  346 (359)
                      +++.              .|+|||...
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~  192 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLL  192 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHH
T ss_pred             cccccCCCcccCCccccccccCchHHc
Confidence            9862              478888654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.90  E-value=9.6e-24  Score=190.50  Aligned_cols=138  Identities=31%  Similarity=0.530  Sum_probs=117.8

Q ss_pred             eEeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      .|.....+|.|.|+.+   .. .+..+|+|.+......    .+.+.+|+.+++.++||||+++++++. .+..++||||
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            4556667888887744   22 3568999999654332    246889999999999999999999876 4568999999


Q ss_pred             CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++....  .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  157 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLAR  157 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccc
Confidence            99999999997543  6999999999999999999999999   9999999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.90  E-value=2.1e-24  Score=196.88  Aligned_cols=141  Identities=23%  Similarity=0.420  Sum_probs=107.0

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|.|.|+.+     ..++..+|+|.+.....  ....+.+.+|+.++..++||||+++++++......++|||
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            4555667788887643     23688999999864432  2334568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQK--------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+++++|.+++..        .+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            9999999999974        345999999999999999999999998   9999999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.90  E-value=7.1e-24  Score=212.18  Aligned_cols=134  Identities=26%  Similarity=0.481  Sum_probs=116.1

Q ss_pred             CcccceeEEEE---e----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          197 GITKGSYQVAK---W----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       197 ~ig~g~~~~~~---~----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      .+|.|.|+.+.   +    .+..||||++....  .....+.|.+|+.+++.++||||+++++++.. ..+++||||+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            57888887542   2    35679999997543  22344678999999999999999999999875 569999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          270 GDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+|.+++... ..+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++
T Consensus       420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            9999999754 45999999999999999999999998   9999999999999999999999999996

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.90  E-value=1.3e-23  Score=190.88  Aligned_cols=151  Identities=31%  Similarity=0.519  Sum_probs=123.9

Q ss_pred             eEeeccCcccceeEEEE--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          191 QVRKADGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      +|.....+|+|.|+.+.  .....+|+|++.... ......+.|.+|+.+++.++||||+++++++ .....++||||++
T Consensus        25 ~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~  102 (289)
T 3og7_A           25 QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE  102 (289)
T ss_dssp             SCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred             ceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecC
Confidence            35556678888887552  345579999996554 3556677899999999999999999999954 5567899999999


Q ss_pred             CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-----------
Q 018204          269 KGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-----------  336 (359)
Q Consensus       269 ~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-----------  336 (359)
                      +++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++           
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (289)
T 3og7_A          103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF  179 (289)
T ss_dssp             EEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred             CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence            99999999654 46999999999999999999999998   9999999999999999999999999985           


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|+|||...
T Consensus       180 ~~~~gt~~y~aPE~~~  195 (289)
T 3og7_A          180 EQLSGSILWMAPEVIR  195 (289)
T ss_dssp             ----CCCTTCCHHHHC
T ss_pred             cccCCCccccCchhhc
Confidence                  2478888654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.90  E-value=1.5e-23  Score=192.43  Aligned_cols=150  Identities=27%  Similarity=0.480  Sum_probs=124.6

Q ss_pred             eeeEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          189 ELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      ...|.....+|.|.|+.+   .  .+|..+|+|.+.....     .+.+.+|+.++..++||||+++++++......++|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            335666777888888643   2  2488999999975432     24578999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----
Q 018204          264 LEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----  337 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----  337 (359)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++.     
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999999999974 457999999999999999999999999   99999999999999999999999999852     


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|+|||...
T Consensus       180 ~~~~~~~~~~~y~aPE~~~  198 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQ  198 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHS
T ss_pred             cccCccCCCCCccChhhcC
Confidence                      377888654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.90  E-value=5.3e-24  Score=209.97  Aligned_cols=138  Identities=31%  Similarity=0.543  Sum_probs=119.1

Q ss_pred             eEeeccCcccceeEEE---Eec-CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---KWN-GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~~-g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      .+.....+|.|.|+.+   .+. +..||||++......    .+.|.+|+.+++.++||||+++++++.. ..+|+||||
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            3556667888888754   333 467999999754432    2468999999999999999999998865 678999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++...  ..+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            9999999999743  46999999999999999999999999   9999999999999999999999999996

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.90  E-value=9.2e-24  Score=192.74  Aligned_cols=149  Identities=21%  Similarity=0.456  Sum_probs=125.1

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   ..  .+..+|+|++......   ..+.+.+|+.++..++||||+++++++......++|||
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4566666788777633   22  4789999998654322   34568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      |+++++|.+++.. ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++        
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK  173 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence            9999999999876 456999999999999999999999998   9999999999999999999999999873        


Q ss_pred             -------ccccCcccc
Q 018204          337 -------LQYISPEKA  345 (359)
Q Consensus       337 -------~~~~~PE~~  345 (359)
                             ..|+|||..
T Consensus       174 ~~~~~~~~~y~aPE~~  189 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVV  189 (302)
T ss_dssp             -----CCGGGCCHHHH
T ss_pred             cccccCChhhcCCeee
Confidence                   358999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.90  E-value=1.9e-23  Score=189.39  Aligned_cols=152  Identities=29%  Similarity=0.502  Sum_probs=124.2

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHH----HHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERI----NAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~----~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      .|.....+|.|.|+.+   .  .++..+|+|.+...........    +.+.+|+.+++.++||||+++++++....  +
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~   97 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R   97 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence            3555666788877643   2  3588999999975443332222    67899999999999999999999886544  7


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc-----EEEeccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLL  335 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~DFGla  335 (359)
                      +||||+++++|.+++... ..+++..+..++.|++.||.|||+++ .+|+||||||+|||++.++.     +||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             EEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            999999999999988654 46999999999999999999999986 35999999999999988776     999999998


Q ss_pred             c------------ccccCcccc
Q 018204          336 R------------LQYISPEKA  345 (359)
Q Consensus       336 ~------------~~~~~PE~~  345 (359)
                      +            ..|+|||..
T Consensus       177 ~~~~~~~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          177 QQSVHSVSGLLGNFQWMAPETI  198 (287)
T ss_dssp             BCCSSCEECCCCCCTTSCGGGS
T ss_pred             ccccccccccCCCccccCchhh
Confidence            6            247888865

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.90  E-value=1.5e-25  Score=202.02  Aligned_cols=174  Identities=22%  Similarity=0.213  Sum_probs=125.6

Q ss_pred             CCCCCcceeeccCCCCCc-CcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           37 PRRNNMRFSFGRQSSLDP-IRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      +.....++.++..+..+. +..++..+......|.+|+||||+||..|+.++|++|++.|+|++.++..|.||||+|+..
T Consensus        50 ~~~~t~L~~a~~~~~~~~~v~~Ll~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~  129 (269)
T 4b93_B           50 PEFCHPLCQCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQ  129 (269)
T ss_dssp             -------------------------CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHH
T ss_pred             ccCCCHHHHHHHhCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCcccccccc
Confidence            333444555666666654 4555555544455588999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCCC---CCCCcccCCcce
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVANP---REVPEYELNPLE  189 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~~---~~~~~~~l~~~~  189 (359)
                      ++.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||++.|..   .+..++++.. .
T Consensus       130 ~~~~~~~~Ll~~g~~~n~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~-G  208 (269)
T 4b93_B          130 GHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLH-G  208 (269)
T ss_dssp             TCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHT-T
T ss_pred             ChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHC-C
Confidence            99999999999999999999999999999999999999999999999984   456889988732   2333444432 3


Q ss_pred             eeEeeccCcccceeEEEEecCc
Q 018204          190 LQVRKADGITKGSYQVAKWNGT  211 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~~~g~  211 (359)
                      .+....+..|.+++.++..+++
T Consensus       209 ad~~~~d~~G~TpL~~A~~~~~  230 (269)
T 4b93_B          209 ASVQVLNKRQRTAVDCAEQNSK  230 (269)
T ss_dssp             CCSCCCCTTSCCSGGGSCTTCH
T ss_pred             CCCCCcCCCCCCHHHHHHhCCc
Confidence            3445556677888776655543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.90  E-value=1.3e-23  Score=197.80  Aligned_cols=149  Identities=26%  Similarity=0.387  Sum_probs=125.3

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC------c
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------P  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~  259 (359)
                      .|.....+|.|.|+.+     ...+..+|||++.... ......+.+.+|+.+++.++||||+++++++....      .
T Consensus        26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             heeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            4666777899988754     2358899999997543 34556677899999999999999999999987654      6


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .|+||||+++ +|.+++..  .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.  
T Consensus       105 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             EEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             eEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            8999999975 88888863  5899999999999999999999998   99999999999999999999999999862  


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~  199 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVIL  199 (371)
T ss_dssp             -----------CTTCCHHHHT
T ss_pred             cccccCCceecCCccCHHHhc
Confidence                        488888765

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.90  E-value=7.9e-26  Score=187.25  Aligned_cols=131  Identities=21%  Similarity=0.198  Sum_probs=78.1

Q ss_pred             eeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHH
Q 018204           44 FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL  123 (359)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~  123 (359)
                      +.++..|+.+.++.+++.+......+.+|+||||+|+. |+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++
T Consensus        10 ~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~   88 (162)
T 1ihb_A           10 ASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQT   88 (162)
T ss_dssp             HHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHhCCCCccccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHH
Confidence            34555566666666665544444445566666666655 66666666666666666666666666666666666666666


Q ss_pred             HHhcCCCccccccccccccccccccccceeEeeccccCccc----cccCCCCcccC
Q 018204          124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV----PKTKRTPMTVA  175 (359)
Q Consensus       124 Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~----~~~~~tpl~~a  175 (359)
                      |+++|++++.+|..|+||||+|+..|+.+++++|+++|++.    +..+.||++.+
T Consensus        89 Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~t~l~~A  144 (162)
T 1ihb_A           89 LLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLA  144 (162)
T ss_dssp             HHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHH
T ss_pred             HHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCCCCCcCCCCCcHHHHH
Confidence            66666666666666666666666666666666666666542    23344555444

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.90  E-value=1.3e-23  Score=189.85  Aligned_cols=140  Identities=25%  Similarity=0.477  Sum_probs=118.2

Q ss_pred             eEeeccCcccceeEEE---Eec-----CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---KWN-----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~~-----g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      +|.....+|.|.|+.+   ...     +..+|+|.+....  .....+.+.+|+.+++.++||||+++++++.. ...++
T Consensus        13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4555666788877643   221     2359999986543  34556789999999999999999999998764 45799


Q ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence            99999999999999765 45999999999999999999999999   9999999999999999999999999986

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.90  E-value=4.6e-24  Score=194.44  Aligned_cols=150  Identities=24%  Similarity=0.523  Sum_probs=122.3

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |.....+|.|.|+.+   .  .+|+.+|+|.+..... .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (299)
T 2r3i_A            5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   83 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCcc-chhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEEc
Confidence            445556777777643   2  2588999999864432 222235678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          267 HAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      +. ++|.+++...  ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.       
T Consensus        84 ~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  159 (299)
T 2r3i_A           84 LH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  159 (299)
T ss_dssp             CS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             cc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccCCccc
Confidence            97 5999999765  46899999999999999999999998   99999999999999999999999998852       


Q ss_pred             --------cccCccccc
Q 018204          338 --------QYISPEKAK  346 (359)
Q Consensus       338 --------~~~~PE~~~  346 (359)
                              .|+|||...
T Consensus       160 ~~~~~~~~~y~aPE~~~  176 (299)
T 2r3i_A          160 YTHEVVTLWYRAPEILL  176 (299)
T ss_dssp             TTSCBCCCTTCCHHHHT
T ss_pred             cCcccccccccCcHHhh
Confidence                    378888654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.90  E-value=2e-24  Score=199.66  Aligned_cols=140  Identities=24%  Similarity=0.516  Sum_probs=115.4

Q ss_pred             eEeeccCcccceeEEE---E--ecCcE----EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTK----VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~----vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +|.....+|.|.|+.+   .  .++..    +++|.+.....  ......+.+|+.++..++||||+++++++. ....+
T Consensus        14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            4556667888888754   2  23443    78887753321  112234678999999999999999999886 45689


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +||||+++|+|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence            999999999999999764 46999999999999999999999999   9999999999999999999999999996

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.90  E-value=8.8e-24  Score=191.71  Aligned_cols=142  Identities=32%  Similarity=0.583  Sum_probs=113.2

Q ss_pred             eEeeccCcccceeEEE---Ee---cC--cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---KW---NG--TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~---~g--~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      +|...+.+|.|.|+.+   .+   .+  ..+|+|++...........+.+.+|+.++..++||||+++++++.... .++
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   97 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM   97 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence            4666667888887633   22   22  268999987655445566778999999999999999999999987654 899


Q ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||+++++|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence            99999999999999764 56999999999999999999999998   9999999999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.90  E-value=1.4e-23  Score=190.34  Aligned_cols=150  Identities=22%  Similarity=0.393  Sum_probs=119.2

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   .  .+|+.+|+|.+.... ........+..+...++.++||||+++++++......++|||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            4666677888888754   2  268899999996543 233334445556666888899999999999999999999999


Q ss_pred             cCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCcEEEecccccc----
Q 018204          266 YHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----  336 (359)
                      |+++ +|.+++..    ...+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+++    
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9975 88877754    45799999999999999999999998 8   9999999999999999999999999985    


Q ss_pred             ----------ccccCcccc
Q 018204          337 ----------LQYISPEKA  345 (359)
Q Consensus       337 ----------~~~~~PE~~  345 (359)
                                ..|+|||..
T Consensus       163 ~~~~~~~~~t~~y~aPE~~  181 (290)
T 3fme_A          163 DVAKDIDAGCKPYMAPERI  181 (290)
T ss_dssp             -------CCCCCCSCHHHH
T ss_pred             cccccccCCCccccChhhc
Confidence                      248888875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.90  E-value=2.2e-23  Score=191.33  Aligned_cols=142  Identities=25%  Similarity=0.461  Sum_probs=115.8

Q ss_pred             eEeeccCcccceeEEEE---e-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC----
Q 018204          191 QVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----  258 (359)
                      .|...+.+|.|.|+.+.   .     .+..+|+|.+.... ......+.+.+|+.+++.++||||+++++++....    
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            45666677888876431   2     24479999986543 34555678999999999999999999999987654    


Q ss_pred             -cEEEEEecCCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEec
Q 018204          259 -PMMIVLEYHAKGDLASYLQK------KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG  331 (359)
Q Consensus       259 -~~~lv~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  331 (359)
                       ..++||||+++++|.+++..      ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEee
Confidence             45999999999999999843      245999999999999999999999998   99999999999999999999999


Q ss_pred             ccccc
Q 018204          332 FGLLR  336 (359)
Q Consensus       332 FGla~  336 (359)
                      ||+++
T Consensus       191 fg~~~  195 (313)
T 3brb_A          191 FGLSK  195 (313)
T ss_dssp             CSCC-
T ss_pred             cCcce
Confidence            99986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.90  E-value=8.7e-24  Score=190.76  Aligned_cols=148  Identities=33%  Similarity=0.624  Sum_probs=122.1

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-CcEEEEEec
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-IPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lv~e~  266 (359)
                      +|.....+|.|.|+.   +...|..+|+|.+....     ..+.+.+|+.+++.++||||+++++++... ...++||||
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            455556677777753   45679999999986432     235688999999999999999999987554 478999999


Q ss_pred             CCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-------
Q 018204          267 HAKGDLASYLQKKGR--LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~--l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-------  337 (359)
                      +++++|.+++...+.  +++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.       
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  173 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT  173 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccccC
Confidence            999999999976543  899999999999999999999998   99999999999999999999999999862       


Q ss_pred             -----cccCccccc
Q 018204          338 -----QYISPEKAK  346 (359)
Q Consensus       338 -----~~~~PE~~~  346 (359)
                           .|+|||...
T Consensus       174 ~~~~~~y~aPE~~~  187 (278)
T 1byg_A          174 GKLPVKWTAPEALR  187 (278)
T ss_dssp             --CCTTTSCHHHHH
T ss_pred             CCccccccCHHHhC
Confidence                 477888654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.90  E-value=1.1e-23  Score=189.96  Aligned_cols=155  Identities=31%  Similarity=0.499  Sum_probs=126.7

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCcEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv  263 (359)
                      +|.....+|.|.|+.+   .  .+|+.+|+|.+..... .....+.+.+|+.+++.++||||+++++++..  ....++|
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            4555666777777643   2  2588999999975543 44556789999999999999999999998864  5679999


Q ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          264 LEYHAKGDLASYLQKK----GRLSPSKVLRFALDLARGMNYLHECKP--DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~qi~~aL~~lH~~~~--~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |||+++++|.+++...    ..+++..+..++.|++.||.|||+.++  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            9999999999999753    349999999999999999999999761  2399999999999999999999999999852


Q ss_pred             ---------------cccCccccc
Q 018204          338 ---------------QYISPEKAK  346 (359)
Q Consensus       338 ---------------~~~~PE~~~  346 (359)
                                     .|+|||...
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~  189 (279)
T 2w5a_A          166 LNHDTSFAKTFVGTPYYMSPEQMN  189 (279)
T ss_dssp             C---CHHHHHHHSCCTTCCHHHHH
T ss_pred             eccccccccccCCCccccChHHhc
Confidence                           388888755

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.90  E-value=1.4e-23  Score=194.48  Aligned_cols=136  Identities=29%  Similarity=0.475  Sum_probs=110.3

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHH--HHhCCCCccccceeeEEe-----CCcE
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTI--VEKARHPNVVQFVGAVTQ-----NIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~~~~~~-----~~~~  260 (359)
                      +|...+.+|.|.|+.   +...+..+|||++....      ...+..|..+  +..++||||+++++.+..     ...+
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           14 NLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             HhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            355566678888764   35679999999996432      1234444444  445899999999986543     2357


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeEeCCCCCCcEEEcCCCcEEEec
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC---------KPDPIIHCDLKPKNILLDNGGQLKISG  331 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~---------~~~~iiHrDlk~~NIll~~~~~~kl~D  331 (359)
                      ++||||+++|+|.+++... ..++..+..++.||+.||.|||+.         +   |+||||||+|||++.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEee
Confidence            9999999999999999765 458899999999999999999998         7   99999999999999999999999


Q ss_pred             ccccc
Q 018204          332 FGLLR  336 (359)
Q Consensus       332 FGla~  336 (359)
                      ||+++
T Consensus       164 FG~a~  168 (336)
T 3g2f_A          164 FGLSM  168 (336)
T ss_dssp             CTTCE
T ss_pred             cccee
Confidence            99985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=1.6e-23  Score=198.05  Aligned_cols=146  Identities=21%  Similarity=0.370  Sum_probs=119.8

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-------
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-------  257 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-------  257 (359)
                      ..|.....+|.|+|+.+.     .+|..+|+|.+......       ..+|+.+++.++||||+++++++...       
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            356777788999998652     36889999998654322       24699999999999999999998543       


Q ss_pred             -------------------------------CcEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH
Q 018204          258 -------------------------------IPMMIVLEYHAKGDLASYLQ----KKGRLSPSKVLRFALDLARGMNYLH  302 (359)
Q Consensus       258 -------------------------------~~~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~lH  302 (359)
                                                     ..+++||||+++ +|.+.+.    ....+++..+..++.||+.||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           348999999985 8777665    3467999999999999999999999


Q ss_pred             hCCCCCeEeCCCCCCcEEEc-CCCcEEEeccccccc--------------cccCccccc
Q 018204          303 ECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRL--------------QYISPEKAK  346 (359)
Q Consensus       303 ~~~~~~iiHrDlk~~NIll~-~~~~~kl~DFGla~~--------------~~~~PE~~~  346 (359)
                      +++   |+||||||+|||++ .++.+||+|||+|+.              .|+|||...
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~  214 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELML  214 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHT
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhc
Confidence            998   99999999999998 688999999999963              388888654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=2.9e-23  Score=192.21  Aligned_cols=136  Identities=32%  Similarity=0.548  Sum_probs=115.4

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC--CCCccccceeeEEeC----CcEE
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA--RHPNVVQFVGAVTQN----IPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~----~~~~  261 (359)
                      +|...+.+|.|.|+.   +...|..+|||++....      ...+..|..++...  +||||+++++++...    ..++
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           38 QIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            566677788888874   35679999999985432      12345555665554  999999999999887    6799


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHEC--------KPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      +||||+++|+|.++++.. .+++..+..++.|++.||.|||++        +   |+||||||+|||++.++.+||+|||
T Consensus       112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg  187 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLG  187 (337)
T ss_dssp             EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCC
Confidence            999999999999999764 699999999999999999999998        7   9999999999999999999999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      +++
T Consensus       188 ~a~  190 (337)
T 3mdy_A          188 LAV  190 (337)
T ss_dssp             TCE
T ss_pred             Cce
Confidence            984

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.90  E-value=3.4e-23  Score=193.21  Aligned_cols=139  Identities=25%  Similarity=0.398  Sum_probs=119.7

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----CcE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~  260 (359)
                      +|.....+|.|.|+.+   .  .+|..+|||.+...  ........+.+|+.+++.++||||+++++++...     ...
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            4666677888888754   2  24889999999643  3455566788999999999999999999987654     679


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++||||+. ++|.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            99999997 599999876 47999999999999999999999998   9999999999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.90  E-value=1.5e-23  Score=197.53  Aligned_cols=149  Identities=25%  Similarity=0.421  Sum_probs=126.4

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE-----
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM-----  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~-----  260 (359)
                      .|.....+|.|.|+.+.     .+|..+|+|++.... ......+.+.+|+.+++.++||||+++++++......     
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            46667778999987542     358899999996543 3455567889999999999999999999999876654     


Q ss_pred             -EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---
Q 018204          261 -MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---  336 (359)
Q Consensus       261 -~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---  336 (359)
                       ++||||+. ++|.+++.  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++   
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence             99999997 58988874  34999999999999999999999998   9999999999999999999999999996   


Q ss_pred             ---------ccccCccccc
Q 018204          337 ---------LQYISPEKAK  346 (359)
Q Consensus       337 ---------~~~~~PE~~~  346 (359)
                               ..|+|||...
T Consensus       196 ~~~~~~~~t~~y~aPE~~~  214 (371)
T 4exu_A          196 AEMTGYVVTRWYRAPEVIL  214 (371)
T ss_dssp             ----CTTCCCTTSCHHHHS
T ss_pred             cCcCCcccCccccCHHHhc
Confidence                     3588888754

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.90  E-value=1.7e-24  Score=171.26  Aligned_cols=108  Identities=30%  Similarity=0.426  Sum_probs=91.0

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccccc
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYY  148 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~  148 (359)
                      +..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+||..|+.++|++|+++|++++.+|..|+||||+|+..
T Consensus         4 ~~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~   83 (123)
T 3aaa_C            4 GSMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE   83 (123)
T ss_dssp             ---CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHH
T ss_pred             ccccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence            34678899999999999999999999999998888899999999999999999999988999998899999999999988


Q ss_pred             ccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          149 GNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       149 ~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      |+.+++++|+++|++++   ..+.||++.+.
T Consensus        84 ~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~  114 (123)
T 3aaa_C           84 GHVSCVKLLLSKGADKTVKGPDGLTAFEATD  114 (123)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHCC
T ss_pred             CCHHHHHHHHHcCCCCCCcCCCCCCHHHHhC
Confidence            88899999998888874   44567777763

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.90  E-value=1.2e-23  Score=194.82  Aligned_cols=150  Identities=23%  Similarity=0.480  Sum_probs=121.9

Q ss_pred             eEeeccCcccceeEEEE-----ecCcE----EEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTK----VWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~----vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +|.....+|.|.|+.+.     ..+..    +++|.+.....  ....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            46667778888887542     23443    57777754322  223456889999999999999999999988754 88


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---  337 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---  337 (359)
                      +++||+.+|+|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.   
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999764 56999999999999999999999998   99999999999999999999999999963   


Q ss_pred             --------------cccCccccc
Q 018204          338 --------------QYISPEKAK  346 (359)
Q Consensus       338 --------------~~~~PE~~~  346 (359)
                                    .|+|||...
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~  192 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESIL  192 (327)
T ss_dssp             ----------CCCGGGSCHHHHH
T ss_pred             ccccccccCCCccccccCHHHHc
Confidence                          388888654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=4.3e-23  Score=190.76  Aligned_cols=144  Identities=24%  Similarity=0.440  Sum_probs=123.6

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEe--CCcEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQ--NIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~--~~~~~l  262 (359)
                      +|.....+|.|.|+.+     ...+..+|+|++....      .+.+.+|+.+++.+. ||||+++++++..  ....++
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            4677778899988754     2368899999996432      246889999999997 9999999999987  567999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEeccccccc----
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRL----  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DFGla~~----  337 (359)
                      ||||+++++|.+++.   .+++..+..++.|++.||.|||+++   |+||||||+|||++.++ .+||+|||+++.    
T Consensus       111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999885   3899999999999999999999999   99999999999999777 899999999962    


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|++||...
T Consensus       185 ~~~~~~~~~~~y~aPE~~~  203 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLV  203 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHT
T ss_pred             CccccccccccccChhhhc
Confidence                      377888654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.90  E-value=2.3e-23  Score=192.52  Aligned_cols=141  Identities=31%  Similarity=0.469  Sum_probs=117.0

Q ss_pred             eEeeccCcccceeEEE---E-------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---K-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~-------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      .|.....+|.|.|+.+   .       ..+..+|+|.+....  .......+.+|+.+++.++||||+++++++......
T Consensus        31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            4555666777777533   2       245689999996432  344556789999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC---CcEEEe
Q 018204          261 MIVLEYHAKGDLASYLQKKG-------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKIS  330 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~---~~~kl~  330 (359)
                      |+||||+++++|.+++....       .+++..+..++.|++.||.|||+++   |+||||||+|||++.+   ..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998753       4899999999999999999999998   9999999999999854   469999


Q ss_pred             cccccc
Q 018204          331 GFGLLR  336 (359)
Q Consensus       331 DFGla~  336 (359)
                      |||+++
T Consensus       186 Dfg~~~  191 (327)
T 2yfx_A          186 DFGMAR  191 (327)
T ss_dssp             CCHHHH
T ss_pred             cccccc
Confidence            999885

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.90  E-value=3.5e-23  Score=189.15  Aligned_cols=150  Identities=28%  Similarity=0.530  Sum_probs=128.4

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|.|.|+.+   .  ..+..+|+|++......  ...+.+.+|+.++..++||||+++++++......++|||
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            3566667788887643   2  35789999999755432  234678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      |+++++|.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.        
T Consensus       101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A          101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            9999999999865 47999999999999999999999998   99999999999999999999999999852        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       177 ~~~~~~~~y~aPE~~~  192 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIK  192 (303)
T ss_dssp             CCCCSCGGGCCHHHHT
T ss_pred             CccCCCcCccCHHHHh
Confidence                   377887654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=1.1e-23  Score=196.37  Aligned_cols=152  Identities=26%  Similarity=0.461  Sum_probs=122.3

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCc--HHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKD--PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      .|.....+|.|.|+.+.     .+|+.+|+|.+.......  ......+.+|+.+++.++||||+++++++......++|
T Consensus        11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   90 (346)
T 1ua2_A           11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV   90 (346)
T ss_dssp             --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred             ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence            46666678888887542     248899999996533221  11224678999999999999999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----
Q 018204          264 LEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----  337 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----  337 (359)
                      |||+++ +|.+++... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.     
T Consensus        91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999986 899988765 35899999999999999999999999   99999999999999999999999999863     


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|+|||...
T Consensus       167 ~~~~~~~~t~~y~aPE~~~  185 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLF  185 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHT
T ss_pred             ccCCcccccccccCchHhh
Confidence                      378888653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.89  E-value=6.3e-23  Score=186.68  Aligned_cols=137  Identities=18%  Similarity=0.284  Sum_probs=117.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      .|.....+|.|.|+.+   .  .+|..+|+|++......     +.+.+|+.++..+ +|++++++++++......++||
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A           11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            3566666788877643   2  46899999998654322     2467899999999 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc-----EEEecccccc
Q 018204          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ-----LKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~DFGla~  336 (359)
                      ||+ +++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.     +||+|||+++
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 889999998754 5999999999999999999999998   999999999999988776     9999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.89  E-value=4.2e-24  Score=199.04  Aligned_cols=153  Identities=22%  Similarity=0.397  Sum_probs=128.8

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCCcH--------------HHHHHHHHHHHHHHhCCCCccccceee
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDP--------------ERINAFTHELTIVEKARHPNVVQFVGA  253 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~--------------~~~~~~~~Ei~il~~l~HpnIv~l~~~  253 (359)
                      +|.....+|.|.|+.   +..+|..+|+|.+........              ...+.+.+|+.++..++||||++++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  111 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI  111 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred             ceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            466666677777753   345899999999964321111              111578999999999999999999999


Q ss_pred             EEeCCcEEEEEecCCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCC
Q 018204          254 VTQNIPMMIVLEYHAKGDLASY------LQK--KGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNG  324 (359)
Q Consensus       254 ~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~  324 (359)
                      +......++||||+++++|.++      +..  ...+++..+..++.|++.||.|||+ ++   |+||||||+||+++.+
T Consensus       112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTT
T ss_pred             EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCC
Confidence            9999999999999999999998      655  4679999999999999999999999 88   9999999999999999


Q ss_pred             CcEEEeccccccc-------------cccCccccc
Q 018204          325 GQLKISGFGLLRL-------------QYISPEKAK  346 (359)
Q Consensus       325 ~~~kl~DFGla~~-------------~~~~PE~~~  346 (359)
                      +.+||+|||+++.             .|+|||...
T Consensus       189 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFS  223 (348)
T ss_dssp             SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGS
T ss_pred             CcEEEeccccccccccccccCCCCCcCccCchhhc
Confidence            9999999999863             488888765

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.89  E-value=1.7e-23  Score=189.82  Aligned_cols=152  Identities=30%  Similarity=0.480  Sum_probs=129.1

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   .  .+++.+|+|++...... ......+.+|+.+++.++||||+++++++......++|||
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            5666777888887643   2  25889999999654322 2234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC---CcEEEeccccccc-----
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG---GQLKISGFGLLRL-----  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DFGla~~-----  337 (359)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++.+   +.+||+|||+++.     
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            9999999999988788999999999999999999999998   9999999999999764   4699999998862     


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       179 ~~~~~~~~~~y~aPE~~~  196 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLR  196 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHT
T ss_pred             ccccccCcccccChHHhc
Confidence                     488888765

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.89  E-value=4.3e-23  Score=190.44  Aligned_cols=149  Identities=21%  Similarity=0.464  Sum_probs=126.3

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEe------CC
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQ------NI  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~------~~  258 (359)
                      .|.....+|.|.|+.+   ..  .|+.+|+|++......    ...+.+|+.++..+ +||||+++++++..      ..
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            4666677888887643   33  6889999999654332    24578999999998 89999999999987      46


Q ss_pred             cEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          259 PMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence            799999999999999999864  46999999999999999999999998   9999999999999999999999999885


Q ss_pred             c---------------cccCccccc
Q 018204          337 L---------------QYISPEKAK  346 (359)
Q Consensus       337 ~---------------~~~~PE~~~  346 (359)
                      .               .|+|||...
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~  202 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIA  202 (326)
T ss_dssp             -------------CCGGGCCHHHHC
T ss_pred             ecCcCccccccccCCccccChhhhc
Confidence            2               488888754

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.89  E-value=2e-25  Score=183.73  Aligned_cols=131  Identities=21%  Similarity=0.251  Sum_probs=108.5

Q ss_pred             ceeeccCCCCCcCcCCcccccCC-CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELT-VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v  121 (359)
                      ++.++..|+.+.++.+++....+ ...+.+|.||||+ |..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++
T Consensus         6 L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v   84 (156)
T 1bd8_A            6 LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTL   84 (156)
T ss_dssp             HHHHHHHTCHHHHHHHHHTTCCCTTCCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHH
T ss_pred             HHHHHHhCCHHHHHHHHHhhCcCccccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHH
Confidence            44667788888888888773323 3447788999999 888999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       122 ~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      ++|+++|++++.+|..|+||||+|+..|+.+++++|+++ ++++   ..+.||++.|
T Consensus        85 ~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~~~g~t~l~~A  140 (156)
T 1bd8_A           85 KVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELA  140 (156)
T ss_dssp             HHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCCCTTSCCHHHHH
T ss_pred             HHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCcCCCCCCHHHHH
Confidence            999999999999999999999999999999999999888 7663   4456777665

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.89  E-value=9.6e-25  Score=175.83  Aligned_cols=108  Identities=28%  Similarity=0.356  Sum_probs=101.5

Q ss_pred             CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccc-cccccccc
Q 018204           67 PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRW-GSTAAADA  145 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~-g~tpl~~A  145 (359)
                      ..+.+|.||||+|+..|+.+++++|+++|+++|.+|..|+||||+|+. |+.+++++|+++|++++.+|.. |+||||+|
T Consensus         7 ~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A   85 (136)
T 1d9s_A            7 MLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDA   85 (136)
T ss_dssp             CCCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHH
T ss_pred             CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHH
Confidence            347789999999999999999999999999999999999999999999 9999999999999999999999 99999999


Q ss_pred             cccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          146 KYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       146 ~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +..|+.+++++|+++|++++   ..+.||++.+
T Consensus        86 ~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  118 (136)
T 1d9s_A           86 AREGFLDTLVVLHRAGARLDVCDAWGRLPVDLA  118 (136)
T ss_dssp             HHHTCHHHHHHHHHTCCCCCCCSSSSSCHHHHH
T ss_pred             HHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHH
Confidence            99999999999999999984   4466777776

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.89  E-value=1.4e-24  Score=174.86  Aligned_cols=128  Identities=20%  Similarity=0.175  Sum_probs=112.2

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      |......++.++..|+.+.++.+++.+......|.+|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..
T Consensus         7 ~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~   86 (137)
T 3c5r_A            7 NHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKN   86 (137)
T ss_dssp             CTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHc
Confidence            34445556677889999999999988766666788999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcc
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      |+.+++++|+++|++++.+|..|.|||++|+..+..+++.+|.+.+..
T Consensus        87 ~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~l~~l~~~~~s  134 (137)
T 3c5r_A           87 GHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNESS  134 (137)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCGGGGCCCHHHHHHHSCC------
T ss_pred             CCHHHHHHHHHcCCCCCCCCCCCCCHHHHHhhccHHHHHhhccccccC
Confidence            999999999999999999999999999999999999999999887654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.89  E-value=1.5e-23  Score=196.03  Aligned_cols=136  Identities=23%  Similarity=0.289  Sum_probs=115.8

Q ss_pred             eeeEeeccCcccceeEEE---Ee----------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCcccc------
Q 018204          189 ELQVRKADGITKGSYQVA---KW----------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQ------  249 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~~----------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~------  249 (359)
                      .-.|...+.+|.|.|+.+   ..          .+..+|+|++...        +.+.+|+.+++.++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            346777788899888754   21          3789999999654        24788999999999999988      


Q ss_pred             ---------ceeeEEe-CCcEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCC
Q 018204          250 ---------FVGAVTQ-NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK  317 (359)
Q Consensus       250 ---------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~  317 (359)
                               +++++.. ....++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~  188 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE  188 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence                     5666665 67899999999 89999999875  67999999999999999999999998   999999999


Q ss_pred             cEEEcCCC--cEEEecccccc
Q 018204          318 NILLDNGG--QLKISGFGLLR  336 (359)
Q Consensus       318 NIll~~~~--~~kl~DFGla~  336 (359)
                      |||++.++  .+||+|||+++
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~  209 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAF  209 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCB
T ss_pred             HEEEcCCCCceEEEecCccee
Confidence            99999998  89999999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.89  E-value=4.9e-23  Score=187.08  Aligned_cols=140  Identities=13%  Similarity=0.084  Sum_probs=121.9

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|.....+|.|.|+.+   ..  .|+.+|+|++......+....+.|.+|+.++..++||||+++++++...+..|+|||
T Consensus        32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  111 (286)
T 3uqc_A           32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE  111 (286)
T ss_dssp             TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence            3566667788877643   22  388999999987766667777889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                      |++|++|.++++..  .....+..++.|++.||.|||+++   |+||||||+|||++.+|.+||+++|..
T Consensus       112 ~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~  176 (286)
T 3uqc_A          112 WIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATM  176 (286)
T ss_dssp             CCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred             ecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecccc
Confidence            99999999999643  466678999999999999999999   999999999999999999999988765

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.89  E-value=7.1e-23  Score=190.12  Aligned_cols=136  Identities=32%  Similarity=0.550  Sum_probs=117.8

Q ss_pred             eEeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHh--CCCCccccceeeEEeCC----cEE
Q 018204          191 QVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK--ARHPNVVQFVGAVTQNI----PMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~~~~~~~----~~~  261 (359)
                      .|...+.+|.|.|+.   +...|+.+|+|++...      ....+..|..++..  ++||||+++++++....    ..+
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           43 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             cEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            466666778887764   3567999999999543      22457788888887  79999999999998775    799


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLH--------ECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      +||||+++|+|.+++... .+++..+..++.|++.||.|||        +++   |+||||||+|||++.++.+||+|||
T Consensus       117 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECC
Confidence            999999999999999764 6999999999999999999999        777   9999999999999999999999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      +++
T Consensus       193 ~~~  195 (342)
T 1b6c_B          193 LAV  195 (342)
T ss_dssp             TCE
T ss_pred             Cce
Confidence            984

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.89  E-value=6.6e-23  Score=196.27  Aligned_cols=148  Identities=28%  Similarity=0.402  Sum_probs=120.6

Q ss_pred             ceeeEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----
Q 018204          188 LELQVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----  257 (359)
Q Consensus       188 ~~~~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  257 (359)
                      ....|...+.+|.|.|+.+   ..  .|+.||||.+......       +.+|+.+++.++||||+++++++...     
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            3557888888999999855   22  5889999998654321       34699999999999999999988542     


Q ss_pred             -CcEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CcEEEec
Q 018204          258 -IPMMIVLEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISG  331 (359)
Q Consensus       258 -~~~~lv~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~-~~~kl~D  331 (359)
                       ..+++||||+++ ++.+++..    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.+ +.+||+|
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEecc
Confidence             237899999986 67666542    457999999999999999999999998   9999999999999965 5789999


Q ss_pred             cccccc--------------cccCccccc
Q 018204          332 FGLLRL--------------QYISPEKAK  346 (359)
Q Consensus       332 FGla~~--------------~~~~PE~~~  346 (359)
                      ||+++.              .|+|||...
T Consensus       201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~  229 (420)
T 1j1b_A          201 FGSAKQLVRGEPNVSYICSRYYRAPELIF  229 (420)
T ss_dssp             CTTCEECCTTCCCCSCCSCTTSCCHHHHT
T ss_pred             chhhhhcccCCCceeeeeCCCcCCHHHHc
Confidence            999963              388888654

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.89  E-value=1.8e-24  Score=178.98  Aligned_cols=124  Identities=27%  Similarity=0.351  Sum_probs=111.6

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHH
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~  119 (359)
                      +..++.+|..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+
T Consensus        38 g~t~L~~A~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  117 (162)
T 1ihb_A           38 GRTALQVMKLGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLR  117 (162)
T ss_dssp             SCCHHHHCCSSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHH
T ss_pred             CccHHHHHHcCcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHH
Confidence            34444445559999999998887666666889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCC-ccccccccccccccccccccceeEeeccccCcc
Q 018204          120 VVKLLLSKKAN-IDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       120 ~v~~Ll~~ga~-~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      ++++|+++|++ ++.+|..|+||||+|+..|+.+++++|+++||+
T Consensus       118 ~v~~Ll~~g~~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~GAd  162 (162)
T 1ihb_A          118 VVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGAG  162 (162)
T ss_dssp             HHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred             HHHHHHHccCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence            99999999998 699999999999999999999999999999985

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.89  E-value=3.1e-24  Score=178.36  Aligned_cols=122  Identities=23%  Similarity=0.232  Sum_probs=111.7

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHH
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~  119 (359)
                      ...+..++..|+.+.++.+++.+......+.+|+||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+
T Consensus        43 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  122 (165)
T 3twr_A           43 STPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYE  122 (165)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             CCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHH
Confidence            35566778889999999999887766667889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCccccccccccccccccccccceeEeeccccCc
Q 018204          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA  162 (359)
Q Consensus       120 ~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga  162 (359)
                      ++++|+++|+|++.+|..|+||||+|+. ++.+++++|+++|+
T Consensus       123 ~v~~Ll~~ga~~~~~~~~g~t~l~~a~~-~~~~i~~~L~~~gA  164 (165)
T 3twr_A          123 ICKLLLQHGADPTKKNRDGNTPLDLVKD-GDTDIQDLLRGDAA  164 (165)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCTGGGSCT-TCHHHHHHHHTC--
T ss_pred             HHHHHHHcCCCCcccCCCCCChhHhHhc-CChHHHHHHhhccc
Confidence            9999999999999999999999999887 88999999999886

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.89  E-value=1.1e-24  Score=172.27  Aligned_cols=113  Identities=27%  Similarity=0.227  Sum_probs=102.8

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHH
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~  119 (359)
                      ...++.++..|+.+.++.+++.+......+.+|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+
T Consensus         8 ~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~   87 (123)
T 3aaa_C            8 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS   87 (123)
T ss_dssp             HHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHH
T ss_pred             chHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHH
Confidence            34456788899999999999887666666889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCccccccccccccccccccccce
Q 018204          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVE  152 (359)
Q Consensus       120 ~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~  152 (359)
                      +|++|+++|+|++.+|..|+||||+|...+..+
T Consensus        88 ~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~  120 (123)
T 3aaa_C           88 CVKLLLSKGADKTVKGPDGLTAFEATDNQAIKA  120 (123)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHCCCHHHHH
T ss_pred             HHHHHHHcCCCCCCcCCCCCCHHHHhCCHHHHH
Confidence            999999999999999999999999997665544

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.89  E-value=3.4e-24  Score=180.75  Aligned_cols=132  Identities=17%  Similarity=0.143  Sum_probs=120.6

Q ss_pred             CCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018204           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (359)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g  116 (359)
                      ......+..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+..|
T Consensus        37 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~  116 (179)
T 3f6q_A           37 DHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWG  116 (179)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTT
T ss_pred             CCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC
Confidence            33445566778899999999988887666667889999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccccccC
Q 018204          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (359)
Q Consensus       117 ~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~  168 (359)
                      +.++|++|+++|++++.+|..|.|||++|+..++.+++++|+++|++++...
T Consensus       117 ~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~L~~~g~~~~~~~  168 (179)
T 3f6q_A          117 QDQVAEDLVANGALVSICNKYGEMPVDKAKAPLRELLRERAEKMGQNLNRIP  168 (179)
T ss_dssp             CHHHHHHHHHTTCCSSBCCTTSCCGGGGSCHHHHHHHHHHHHHTTCCCSCBC
T ss_pred             CHHHHHHHHHCCCCcchhccCCCCcHHHHHHHHHHHHHHHHHHhhcCcccCC
Confidence            9999999999999999999999999999999999999999999999986543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.89  E-value=1.5e-23  Score=193.94  Aligned_cols=147  Identities=30%  Similarity=0.551  Sum_probs=124.8

Q ss_pred             cCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecCCC
Q 018204          196 DGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       196 ~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      +.+|.|.|+.+.     .+|+.+|+|++....... .....+.+|+.++..+ .||||+++++++......++||||+++
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~  113 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG  113 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence            568888887542     258899999997544322 2235688999999999 469999999999999999999999999


Q ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCcEEEeccccccc-------
Q 018204          270 GDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLRL-------  337 (359)
Q Consensus       270 gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DFGla~~-------  337 (359)
                      |+|.+++...  +.+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+++.       
T Consensus       114 ~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~  190 (327)
T 3lm5_A          114 GEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL  190 (327)
T ss_dssp             EEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------
T ss_pred             CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcccc
Confidence            9999998553  56999999999999999999999998   999999999999998   78999999999963       


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       191 ~~~~gt~~y~aPE~~~  206 (327)
T 3lm5_A          191 REIMGTPEYLAPEILN  206 (327)
T ss_dssp             ---CCCGGGCCHHHHT
T ss_pred             ccccCCcCccCCeeec
Confidence                   478888654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.89  E-value=5.5e-23  Score=191.61  Aligned_cols=144  Identities=19%  Similarity=0.225  Sum_probs=115.5

Q ss_pred             eeeEeeccCcccceeEEE---Ee-----cCcEEEEEEeccCCCCcHHH--------HHHHHHHHHHHHhCCCCcccccee
Q 018204          189 ELQVRKADGITKGSYQVA---KW-----NGTKVWVKILDKESHKDPER--------INAFTHELTIVEKARHPNVVQFVG  252 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~~-----~g~~vavK~l~~~~~~~~~~--------~~~~~~Ei~il~~l~HpnIv~l~~  252 (359)
                      .-.|.....+|.|.|+.+   ..     .+..+|+|++..........        ...+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            346777788899988743   22     56789999987543211111        124667888999999999999999


Q ss_pred             eEEe----CCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC--c
Q 018204          253 AVTQ----NIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG--Q  326 (359)
Q Consensus       253 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~--~  326 (359)
                      ++..    ....|+||||+ +++|.+++...+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++  .
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCc
Confidence            9988    67899999999 8999999987778999999999999999999999998   99999999999999887  9


Q ss_pred             EEEecccccc
Q 018204          327 LKISGFGLLR  336 (359)
Q Consensus       327 ~kl~DFGla~  336 (359)
                      +||+|||+++
T Consensus       192 ~kL~Dfg~a~  201 (345)
T 2v62_A          192 VYLADYGLSY  201 (345)
T ss_dssp             EEECCCTTCE
T ss_pred             EEEEeCCCce
Confidence            9999999995

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.89  E-value=2.8e-23  Score=194.67  Aligned_cols=152  Identities=26%  Similarity=0.390  Sum_probs=124.5

Q ss_pred             eEeeccCcccceeEEE----EecCcEEEEEEeccCCCC--------cHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-
Q 018204          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHK--------DPERINAFTHELTIVEKARHPNVVQFVGAVTQN-  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~--------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-  257 (359)
                      .|.....+|.|.|+.+    ...|..+|||.+......        +....+.+.+|+.+++.++||||+++++++... 
T Consensus        23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  102 (362)
T 3pg1_A           23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE  102 (362)
T ss_dssp             SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred             ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence            4566667888888754    235889999999643321        233457789999999999999999999998543 


Q ss_pred             ----CcEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecc
Q 018204          258 ----IPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (359)
Q Consensus       258 ----~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DF  332 (359)
                          ..+|+||||++ |+|.+++... ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          103 EPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             TTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCT
T ss_pred             CCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEec
Confidence                35899999997 5888888754 36999999999999999999999998   999999999999999999999999


Q ss_pred             cccc--------------ccccCccccc
Q 018204          333 GLLR--------------LQYISPEKAK  346 (359)
Q Consensus       333 Gla~--------------~~~~~PE~~~  346 (359)
                      |+++              ..|+|||...
T Consensus       179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~  206 (362)
T 3pg1_A          179 NLAREDTADANKTHYVTHRWYRAPELVM  206 (362)
T ss_dssp             TC---------------CGGGCCHHHHT
T ss_pred             CcccccccccccceecccceecCcHHhc
Confidence            9996              2488999754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.89  E-value=2.1e-23  Score=194.90  Aligned_cols=149  Identities=26%  Similarity=0.441  Sum_probs=125.6

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc------
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP------  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~------  259 (359)
                      .|.....+|.|.|+.+     ..+|..+|||.+.... ......+.+.+|+.+++.++||||+++++++.....      
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            4566667888888754     2358899999996543 345556778999999999999999999999987653      


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .|+||||+. ++|.+++..  .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.  
T Consensus       104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  177 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD  177 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred             EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence            499999997 588887743  5999999999999999999999998   99999999999999999999999999862  


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|+|||...
T Consensus       178 ~~~~~~~~t~~y~aPE~~~  196 (353)
T 3coi_A          178 AEMTGYVVTRWYRAPEVIL  196 (353)
T ss_dssp             ------CCSBCCSCHHHHS
T ss_pred             CCccccccCcCcCCHHHHh
Confidence                      488888754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.89  E-value=8.9e-23  Score=191.59  Aligned_cols=139  Identities=27%  Similarity=0.464  Sum_probs=120.5

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----CcE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~  260 (359)
                      .|.....+|.|.|+.+     ..++..+|+|++....  .....+.+.+|+.++..++||||+++++++...     ...
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            4777778899988754     2357889999996432  445557789999999999999999999998764     368


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+||||+.+ +|.+++... .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       106 ~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            999999975 999998764 6999999999999999999999999   9999999999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.89  E-value=8.1e-23  Score=185.71  Aligned_cols=134  Identities=26%  Similarity=0.501  Sum_probs=115.0

Q ss_pred             CcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCCCC
Q 018204          197 GITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       197 ~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      .+|.|.|+.+   .  .++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++......++||||+++++
T Consensus        29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS  105 (295)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred             EEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence            4677777643   2  357899999997543   2334568899999999999999999999999999999999999999


Q ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCcEEEecccccc
Q 018204          272 LASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLKISGFGLLR  336 (359)
Q Consensus       272 L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DFGla~  336 (359)
                      |.+++....   .+++..+..++.|++.||.|||+++   |+||||||+||+++. ++.+||+|||+++
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccccc
Confidence            999997652   4678899999999999999999998   999999999999987 8999999999986

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.89  E-value=1.4e-24  Score=189.72  Aligned_cols=140  Identities=16%  Similarity=0.082  Sum_probs=104.2

Q ss_pred             CCcceeeccCCCCCcCcCCcccc--cCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQD--ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      ...+..++..|+.+.++.+++.+  ......+.+|.||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+..|+
T Consensus        73 ~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~  152 (228)
T 2dzn_A           73 WTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGS  152 (228)
T ss_dssp             CCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTC
T ss_pred             CCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCC
Confidence            33445556677777777777765  3334446678888888888888888888888888888888888888888888888


Q ss_pred             HHHHHHHHhcC-CCccccccccccccccccccccceeEeecc-ccCcccc---ccCCCCcccCCCCC
Q 018204          118 VEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNVEVYNILK-ARGAKVP---KTKRTPMTVANPRE  179 (359)
Q Consensus       118 ~~~v~~Ll~~g-a~~~~~d~~g~tpl~~A~~~~~~~~~~~L~-~~ga~~~---~~~~tpl~~a~~~~  179 (359)
                      .+++++|++.| ++++.+|..|+||||+|+..|+.+++++|+ ++|++++   ..+.||++.+...+
T Consensus       153 ~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~l~~A~~~~  219 (228)
T 2dzn_A          153 LKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNEQ  219 (228)
T ss_dssp             HHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBGGGGCSSTT
T ss_pred             HHHHHHHHhcCcccccCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcHHHHHHHHH
Confidence            88888888887 888888888888888888888888888888 7787763   44567777775443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.89  E-value=6.5e-23  Score=206.60  Aligned_cols=150  Identities=23%  Similarity=0.485  Sum_probs=126.1

Q ss_pred             eEeeccCcccceeEEE---Ee-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---KW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .|.....+|.|.|+.+   ..     .+..+|+|.+...  ......+.|.+|+.+++.++||||+++++++. .+..|+
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            4556667888888744   22     2457899988643  24455678999999999999999999999884 567899


Q ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc----
Q 018204          263 VLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL----  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~----  337 (359)
                      ||||+++|+|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.    
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            999999999999998654 6999999999999999999999998   99999999999999999999999999962    


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       545 ~~~~~~~~~~t~~y~aPE~~~  565 (656)
T 2j0j_A          545 TYYKASKGKLPIKWMAPESIN  565 (656)
T ss_dssp             ---------CCGGGCCHHHHH
T ss_pred             cceeccCCCCCcceeCHHHhc
Confidence                        478888654

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.89  E-value=1.2e-24  Score=171.87  Aligned_cols=121  Identities=34%  Similarity=0.440  Sum_probs=107.2

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      +..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.++++
T Consensus         6 L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~   85 (126)
T 1n0r_A            6 LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVK   85 (126)
T ss_dssp             HHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHH
T ss_pred             HHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHH
Confidence            44566778888888888776555566888999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCccccccccccccccccccccceeEeeccccCcc
Q 018204          123 LLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       123 ~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      +|+++|++++.+|..|.|||++|+..|+.+++++|+++|++
T Consensus        86 ~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~Gad  126 (126)
T 1n0r_A           86 LLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY  126 (126)
T ss_dssp             HHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCC
T ss_pred             HHHHcCCCCcccCCCCCCHHHHHHHcCcHHHHHHHHHcCCC
Confidence            99999999999999999999999999999999999999885

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.89  E-value=5.2e-24  Score=188.29  Aligned_cols=127  Identities=24%  Similarity=0.216  Sum_probs=86.5

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHH
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~  119 (359)
                      ...++.++..|+++.++.+++.+......|.+|.||||+||..|+.++|++|+++|+|+|.+|..|+||||+||..|+.+
T Consensus        38 ~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~  117 (239)
T 1ycs_B           38 LALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQ  117 (239)
T ss_dssp             HHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             hHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHH
Confidence            34455556667777777766666544444666777777777777777777777777777777777777777777777777


Q ss_pred             HHHHHHhcCCCccccccccc-cccccc--cccccceeEeeccccCccccc
Q 018204          120 VVKLLLSKKANIDARDRWGS-TAAADA--KYYGNVEVYNILKARGAKVPK  166 (359)
Q Consensus       120 ~v~~Ll~~ga~~~~~d~~g~-tpl~~A--~~~~~~~~~~~L~~~ga~~~~  166 (359)
                      +|++|+++|+|++.+|..|. ||||+|  +..|+.+++++|+++|++++.
T Consensus       118 ~v~~Ll~~ga~~~~~~~~~~~t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~  167 (239)
T 1ycs_B          118 VCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKMGI  167 (239)
T ss_dssp             HHHHHHHTTCCTTCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHHHHTTT
T ss_pred             HHHHHHHcCCCcceecCCCCcchHHHHHHhhhccHHHHHHHHHhhhcccc
Confidence            77777777777777776665 777776  566667777777777766543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.89  E-value=1e-22  Score=195.40  Aligned_cols=148  Identities=28%  Similarity=0.386  Sum_probs=126.3

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC------CCCccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA------RHPNVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~~~~~~~~~  259 (359)
                      .|...+.+|.|.|+.+.     ..+..||||++...    ......+..|+.+++.+      +|+||+++++++.....
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            57777889999998552     24789999999642    34445678888888877      57799999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc--EEEeccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ--LKISGFGLL  335 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~--~kl~DFGla  335 (359)
                      +++||||+. ++|.+++....  .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.  +||+|||+|
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999996 59999997753  4999999999999999999999998   999999999999999887  999999998


Q ss_pred             c------------ccccCccccc
Q 018204          336 R------------LQYISPEKAK  346 (359)
Q Consensus       336 ~------------~~~~~PE~~~  346 (359)
                      +            ..|+|||...
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~  272 (429)
T 3kvw_A          250 CYEHQRVYTYIQSRFYRAPEVIL  272 (429)
T ss_dssp             EETTCCCCSSCSCGGGCCHHHHH
T ss_pred             eecCCcccccCCCCCccChHHHh
Confidence            5            3488998765

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.89  E-value=6.7e-23  Score=188.21  Aligned_cols=138  Identities=28%  Similarity=0.463  Sum_probs=113.2

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEE----------
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT----------  255 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----------  255 (359)
                      .|.....+|.|.|+.+   .  ..|+.+|+|.+...   +....+.+.+|+.+++.++||||+++++++.          
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            4666677888888643   2  24889999998643   4556678899999999999999999998873          


Q ss_pred             ----eCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCcEEEe
Q 018204          256 ----QNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKIS  330 (359)
Q Consensus       256 ----~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~-~~~~~kl~  330 (359)
                          .....++||||++ |+|.+++.. +.+++..+..++.|++.||.|||+++   |+||||||+|||++ .++.+||+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence                3467899999997 599999865 56999999999999999999999998   99999999999997 56799999


Q ss_pred             cccccc
Q 018204          331 GFGLLR  336 (359)
Q Consensus       331 DFGla~  336 (359)
                      |||+++
T Consensus       164 Dfg~~~  169 (320)
T 2i6l_A          164 DFGLAR  169 (320)
T ss_dssp             CCTTCB
T ss_pred             cCcccc
Confidence            999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.89  E-value=9.7e-23  Score=193.50  Aligned_cols=148  Identities=28%  Similarity=0.416  Sum_probs=120.0

Q ss_pred             ceeeEeeccCcccceeEEEE---e-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc----
Q 018204          188 LELQVRKADGITKGSYQVAK---W-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----  259 (359)
Q Consensus       188 ~~~~~~~~~~ig~g~~~~~~---~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----  259 (359)
                      ....|...+.+|.|+|+.+.   . .+..+|+|.+......       ..+|+.+++.++||||+++++++.....    
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            35578888889999998552   2 4556888888654322       2369999999999999999999866443    


Q ss_pred             --EEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCcEEEecc
Q 018204          260 --MMIVLEYHAKGDLASYLQ----KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGF  332 (359)
Q Consensus       260 --~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DF  332 (359)
                        +++||||+++ ++...+.    ....+++..+..++.||+.||.|||+++   |+||||||+|||++ .++.+||+||
T Consensus       111 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          111 VFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             EEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence              8899999987 4444332    2457999999999999999999999999   99999999999999 7999999999


Q ss_pred             ccccc--------------cccCccccc
Q 018204          333 GLLRL--------------QYISPEKAK  346 (359)
Q Consensus       333 Gla~~--------------~~~~PE~~~  346 (359)
                      |+|+.              .|+|||...
T Consensus       187 G~a~~~~~~~~~~~~~~t~~y~aPE~~~  214 (394)
T 4e7w_A          187 GSAKILIAGEPNVSYICSRYYRAPELIF  214 (394)
T ss_dssp             TTCEECCTTCCCCSSCSCGGGCCHHHHT
T ss_pred             CCcccccCCCCCcccccCcCccCHHHHc
Confidence            99963              388888753

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.89  E-value=2.5e-24  Score=190.33  Aligned_cols=132  Identities=27%  Similarity=0.231  Sum_probs=99.3

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      +..+++.|+.+.++.+++.+ .+++.+..|.||||+||..|+.++|++|++.|+|+|.+|..|+||||+||..|+.++|+
T Consensus         9 L~~a~~~~~~~~~~~ll~~g-~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~   87 (239)
T 1ycs_B            9 LPPGKRTNLRKTGSERIAHG-MRVKFNPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVK   87 (239)
T ss_dssp             -----------------------------CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHH
T ss_pred             CchhhhhhhHHHHHHHhccC-CCcccCchhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHH
Confidence            34556677777777777665 44456678999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCccccccccccccccccccccceeEeeccccCccccccC---C-CCcccC
Q 018204          123 LLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK---R-TPMTVA  175 (359)
Q Consensus       123 ~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~---~-tpl~~a  175 (359)
                      +|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++..+   . ||++.+
T Consensus        88 ~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~~~t~l~~a  144 (239)
T 1ycs_B           88 FLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKC  144 (239)
T ss_dssp             HHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHC
T ss_pred             HHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCCCcchHHHH
Confidence            9999999999999999999999999999999999999999985433   3 888877

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.89  E-value=4e-24  Score=192.56  Aligned_cols=112  Identities=30%  Similarity=0.353  Sum_probs=95.0

Q ss_pred             CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCC-CCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccc
Q 018204           67 PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~-g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  145 (359)
                      ..+.+|.||||+|+..|+.++|++|++.|+++|.++.. |+||||+|+..|+.++|++|+++|+|++.+|..|+||||+|
T Consensus       153 ~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A  232 (282)
T 1oy3_D          153 AENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSA  232 (282)
T ss_dssp             CCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             CcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCCHHHHH
Confidence            44778999999999999999999999999999999854 99999999999999999999999999999999999999999


Q ss_pred             cccccceeEeeccccCcccc---ccCCCCcccCCCC
Q 018204          146 KYYGNVEVYNILKARGAKVP---KTKRTPMTVANPR  178 (359)
Q Consensus       146 ~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~~~  178 (359)
                      +..|+.+++++|+++|++++   ..+.||++.+...
T Consensus       233 ~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~a~~~  268 (282)
T 1oy3_D          233 LLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGSD  268 (282)
T ss_dssp             HTSSCHHHHHHHHHTTCCCCCCC-------------
T ss_pred             HHcCCcHHHHHHHHcCCCcCcCCCcccccccccCCc
Confidence            99999999999999999984   4467888887543

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.89  E-value=1.3e-24  Score=181.94  Aligned_cols=133  Identities=20%  Similarity=0.154  Sum_probs=120.7

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      |......+..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..
T Consensus        33 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~  112 (172)
T 3v30_A           33 DERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRG  112 (172)
T ss_dssp             CTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Confidence            34445556677889999999999988766666688999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccccccC
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~  168 (359)
                      |+.++|++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++....+
T Consensus       113 ~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~~~~  165 (172)
T 3v30_A          113 NHVKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKLFQSN  165 (172)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHHSCC-
T ss_pred             CCHHHHHHHHHcCCCccccCCCCCCHHHHHHHhCcHHHHHHHHHHHHHHhccc
Confidence            99999999999999999999999999999999999999999999999875443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.89  E-value=8.3e-23  Score=188.93  Aligned_cols=144  Identities=32%  Similarity=0.526  Sum_probs=121.3

Q ss_pred             ceeeEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEe-----
Q 018204          188 LELQVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQ-----  256 (359)
Q Consensus       188 ~~~~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~-----  256 (359)
                      ....|.....+|.|.|+.+   ..  .+..+|+|.+...   .......+.+|+.++..+. ||||+++++++..     
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3456788888999998754   22  6889999998543   3455567899999999996 9999999999843     


Q ss_pred             ---CCcEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEe
Q 018204          257 ---NIPMMIVLEYHAKGDLASYLQK---KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKIS  330 (359)
Q Consensus       257 ---~~~~~lv~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~  330 (359)
                         ...++++|||+. |+|.+++..   .+.+++..+..++.||+.||.|||+++ .+|+||||||+|||++.++.+||+
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence               345899999996 699998865   456999999999999999999999986 359999999999999999999999


Q ss_pred             cccccc
Q 018204          331 GFGLLR  336 (359)
Q Consensus       331 DFGla~  336 (359)
                      |||+++
T Consensus       181 Dfg~~~  186 (337)
T 3ll6_A          181 DFGSAT  186 (337)
T ss_dssp             CCTTCB
T ss_pred             cCccce
Confidence            999985

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.89  E-value=4.3e-24  Score=166.74  Aligned_cols=101  Identities=41%  Similarity=0.563  Sum_probs=97.0

Q ss_pred             CCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccc
Q 018204           68 ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY  147 (359)
Q Consensus        68 ~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~  147 (359)
                      .|.+|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+.
T Consensus         5 ~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~   84 (115)
T 2l6b_A            5 GSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKK   84 (115)
T ss_dssp             CSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHT
T ss_pred             cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Confidence            46789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccceeEeeccccCccccccC
Q 018204          148 YGNVEVYNILKARGAKVPKTK  168 (359)
Q Consensus       148 ~~~~~~~~~L~~~ga~~~~~~  168 (359)
                      .++.+++++|+++|++++...
T Consensus        85 ~~~~~~~~~Ll~~ga~~n~~~  105 (115)
T 2l6b_A           85 NGHHEIVKLLDAKGADVNARS  105 (115)
T ss_dssp             TTCHHHHHHHHTTSSSHHHHS
T ss_pred             CCCHHHHHHHHHcCCCCCcCC
Confidence            999999999999999986543

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.89  E-value=1.3e-25  Score=197.87  Aligned_cols=120  Identities=21%  Similarity=0.209  Sum_probs=58.4

Q ss_pred             eeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCC------CCCCCCCCCcHHHHHHHcCCH
Q 018204           45 SFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD------VNSIDLDGRTALHIAACEGHV  118 (359)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~------v~~~d~~g~TpLh~A~~~g~~  118 (359)
                      .++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|++      ++..|..|+||||+|+..|+.
T Consensus        51 ~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~  130 (236)
T 1ikn_D           51 LAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYL  130 (236)
T ss_dssp             HHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCH
T ss_pred             HHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCH
Confidence            33444444444444444433333344455555555555555555555554443      344444455555555555555


Q ss_pred             HHHHHHHhcCCCcccccc-ccccccccccccccceeEeeccccCccc
Q 018204          119 EVVKLLLSKKANIDARDR-WGSTAAADAKYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       119 ~~v~~Ll~~ga~~~~~d~-~g~tpl~~A~~~~~~~~~~~L~~~ga~~  164 (359)
                      ++|++|+++|++++.+|. .|+||||+|+..|+.+++++|+++|+++
T Consensus       131 ~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~  177 (236)
T 1ikn_D          131 GIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADV  177 (236)
T ss_dssp             HHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCS
T ss_pred             HHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence            555555555555555544 4555555555555555555555555544

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.88  E-value=1.7e-22  Score=185.57  Aligned_cols=152  Identities=22%  Similarity=0.379  Sum_probs=130.2

Q ss_pred             eeeEeeccCcccceeEEEE----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC--CCccccceeeEEeCCcEEE
Q 018204          189 ELQVRKADGITKGSYQVAK----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR--HPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~l  262 (359)
                      ...|.....+|.|.|+.+.    ..+..+|+|++..... .....+.+.+|+.++..+.  ||||+++++++......++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            3457777788999887542    2478899999965443 4556678999999999997  5999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----  337 (359)
                      ||| +.+++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++. +.+||+|||+++.     
T Consensus       106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence            999 557899999998888999999999999999999999998   999999999999964 8999999999852     


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~  201 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIK  201 (313)
T ss_dssp             ---------CCGGGCCHHHHT
T ss_pred             ccccccCCCCCCCcCCHHHHh
Confidence                        488888765

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.88  E-value=1.2e-22  Score=187.77  Aligned_cols=149  Identities=26%  Similarity=0.466  Sum_probs=117.1

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHH-HHHhCCCCccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELT-IVEKARHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      +|.....+|.|.|+.+   .  .+|+.+|+|.+....  .......+..|+. +++.++||||+++++++...+..++||
T Consensus        23 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            4566677888888754   2  258899999997543  2334445566665 677789999999999999999999999


Q ss_pred             ecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-
Q 018204          265 EYHAKGDLASYLQK-----KGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-  337 (359)
Q Consensus       265 e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-  337 (359)
                      ||+++ +|.+++..     ...+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++. 
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 88888763     45799999999999999999999998 8   99999999999999999999999999863 


Q ss_pred             -------------cccCcccc
Q 018204          338 -------------QYISPEKA  345 (359)
Q Consensus       338 -------------~~~~PE~~  345 (359)
                                   .|+|||..
T Consensus       177 ~~~~~~~~~~gt~~y~aPE~~  197 (327)
T 3aln_A          177 VDSIAKTRDAGCRPYMAPERI  197 (327)
T ss_dssp             ---------------------
T ss_pred             ccccccccCCCCccccCceee
Confidence                         37888875

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.88  E-value=1.5e-24  Score=183.78  Aligned_cols=130  Identities=27%  Similarity=0.257  Sum_probs=105.8

Q ss_pred             eeccCCCCCcCcCCcccccCCC-----------CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHH
Q 018204           45 SFGRQSSLDPIRRSPVQDELTV-----------PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA  113 (359)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~  113 (359)
                      .+++.|..+.++.++.......           ..+.+|.||||+||..|+.+++++|++ |+++|.+|..|+||||+|+
T Consensus         6 ~aa~~~~~~~~~~li~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~   84 (183)
T 3deo_A            6 IGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVA   84 (183)
T ss_dssp             EEEEEETTTEEEEEEEETTCCCCEEEEGGGSCHHHHHHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHH
T ss_pred             HHHHhcCCchhHHHHHHhCCCCccccchhcccccCCCCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHH
Confidence            3445555555555554322211           124578999999999999999999999 9999999999999999999


Q ss_pred             HcCCHHHHHHHHhcCCCccccc-cccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          114 CEGHVEVVKLLLSKKANIDARD-RWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       114 ~~g~~~~v~~Ll~~ga~~~~~d-~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      ..|+.++|++|+++|+++|.+| ..|+||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus        85 ~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  150 (183)
T 3deo_A           85 GLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELA  150 (183)
T ss_dssp             HHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHH
T ss_pred             HcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCCCCCCHHHHH
Confidence            9999999999999999999988 889999999999999999999999999874   4456777766

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.88  E-value=7.3e-23  Score=207.53  Aligned_cols=148  Identities=26%  Similarity=0.372  Sum_probs=122.9

Q ss_pred             eEeeccCcccceeEEE---Ee---cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc-----
Q 018204          191 QVRKADGITKGSYQVA---KW---NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP-----  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~---~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-----  259 (359)
                      .|.....+|.|.|+.+   ..   +|..||||++...  .+......+.+|+.++..++||||+++++++.....     
T Consensus        81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4666777888888754   22   4789999998643  245566778999999999999999999999987665     


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--  337 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--  337 (359)
                      .|+||||++|++|.+++..  .+++..+..++.||+.||.|||+++   ||||||||+|||++.+ .+||+|||+++.  
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            7999999999999988765  6999999999999999999999999   9999999999999875 899999999863  


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|++||...
T Consensus       233 ~~~~~~gt~~y~aPE~~~  250 (681)
T 2pzi_A          233 SFGYLYGTPGFQAPEIVR  250 (681)
T ss_dssp             CCSCCCCCTTTSCTTHHH
T ss_pred             cCCccCCCccccCHHHHc
Confidence                     578888654

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.88  E-value=2e-24  Score=197.65  Aligned_cols=132  Identities=20%  Similarity=0.179  Sum_probs=118.7

Q ss_pred             cceeeccCCCCCcCcCCcccccCCCC------CCCCCccHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHH
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELTVP------ENLDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTALHIA  112 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~t~l~~aa~~---g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A  112 (359)
                      .++.++..|+++.++.++..+.....      .+.+|.||||+|+..   |+.++|++||+.|+|+|.+|..|+||||+|
T Consensus       154 ~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A  233 (301)
T 2b0o_E          154 RLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYA  233 (301)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHH
T ss_pred             HHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Confidence            36778889999999998876644333      588999999999997   999999999999999999999999999999


Q ss_pred             HHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccccccCCCCcccCC
Q 018204          113 ACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVAN  176 (359)
Q Consensus       113 ~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~~tpl~~a~  176 (359)
                      +..|+.++|++|+++|||++.+|..|.||||+|+..|+.+++++|+++|++   .+.||++.|.
T Consensus       234 ~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~---~g~tpLh~A~  294 (301)
T 2b0o_E          234 ALYNQPDCLKLLLKGRALVGTVNEAGETALDIARKKHHKECEELLEQAQAG---TFAFPLHVDY  294 (301)
T ss_dssp             HHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHH---TTSSCCC---
T ss_pred             HHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCC---CCCChhHHHH
Confidence            999999999999999999999999999999999999999999999999997   4678998874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.88  E-value=5.7e-23  Score=187.72  Aligned_cols=142  Identities=31%  Similarity=0.498  Sum_probs=115.7

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCC-cHHHHHHHHHHHHHHHhCCCCccccceeeEE--eCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARHPNVVQFVGAVT--QNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~l  262 (359)
                      .|...+.+|.|.|+.+   .  .++..+|+|++...... .......+.+|+.+++.++||||+++++++.  .....++
T Consensus         6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            3555667788887644   2  35789999999643211 1123467899999999999999999999984  4567999


Q ss_pred             EEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||++++ |.+++..  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            99999875 8787765  346999999999999999999999998   9999999999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.88  E-value=1.4e-22  Score=189.66  Aligned_cols=148  Identities=24%  Similarity=0.367  Sum_probs=111.0

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCc------
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP------  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~------  259 (359)
                      .|.....+|.|.|+.+   .  .+|..+|||.+.......    ..+..++..+..++||||+++++++.....      
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence            4677778899998744   2  358899999986543322    235678888889999999999999876443      


Q ss_pred             -EEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCCCCcEEEcC-CCcEEEec
Q 018204          260 -MMIVLEYHAKGDLASYLQ----KKGRLSPSKVLRFALDLARGMNYLH--ECKPDPIIHCDLKPKNILLDN-GGQLKISG  331 (359)
Q Consensus       260 -~~lv~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~lH--~~~~~~iiHrDlk~~NIll~~-~~~~kl~D  331 (359)
                       +++||||+++ +|...+.    ....+++..+..++.|++.||.|||  +++   |+||||||+|||++. ++.+||+|
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A          100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             EEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECC
T ss_pred             eEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEee
Confidence             8999999986 5555443    4456899999999999999999999  887   999999999999997 89999999


Q ss_pred             cccccc--------------cccCccccc
Q 018204          332 FGLLRL--------------QYISPEKAK  346 (359)
Q Consensus       332 FGla~~--------------~~~~PE~~~  346 (359)
                      ||+++.              .|+|||...
T Consensus       176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~  204 (360)
T 3e3p_A          176 FGSAKKLSPSEPNVAYICSRYYRAPELIF  204 (360)
T ss_dssp             CTTCBCCCTTSCCCSTTSCGGGCCHHHHT
T ss_pred             CCCceecCCCCCcccccCCcceeCHHHHc
Confidence            999963              388888653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.88  E-value=1.3e-22  Score=191.91  Aligned_cols=127  Identities=22%  Similarity=0.339  Sum_probs=105.0

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC--------CCccccceeeEE--
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR--------HPNVVQFVGAVT--  255 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~~~~~--  255 (359)
                      .|.....+|.|.|+.+.     ..++.+|+|++...    ....+.+.+|+.+++.+.        |+||+++++++.  
T Consensus        38 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             eEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            46667778888887542     35789999999632    345567889999999885        788999999987  


Q ss_pred             --eCCcEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCC
Q 018204          256 --QNIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGG  325 (359)
Q Consensus       256 --~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~~~~  325 (359)
                        ....+++||||+ +++|.+++...  ..+++..+..++.||+.||.|||++ +   |+||||||+|||++.++
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~  184 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE  184 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence              445799999999 55777776554  4699999999999999999999998 8   99999999999999775

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.88  E-value=1.8e-23  Score=183.76  Aligned_cols=120  Identities=23%  Similarity=0.274  Sum_probs=104.0

Q ss_pred             cCCcccccCCC---CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcc
Q 018204           56 RRSPVQDELTV---PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID  132 (359)
Q Consensus        56 ~~~~~~~~~~~---~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~  132 (359)
                      +.+++++....   ..+.+|.||||+||..|+.++|++|++.|+|+|.+|..|+||||+||..|+.++|++|++.|+|+|
T Consensus         2 ~~ll~~~~~~~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n   81 (229)
T 2vge_A            2 RSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVN   81 (229)
T ss_dssp             --------CCCCCCCTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTT
T ss_pred             eehhccCCCCccccccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCC
Confidence            44555554433   235578899999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccccccccccccceeEeeccccCcccc----ccCCCCcccC
Q 018204          133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKVP----KTKRTPMTVA  175 (359)
Q Consensus       133 ~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~----~~~~tpl~~a  175 (359)
                      .+|..|+||||+|+..|+.+++++|+++|++++    ..+.||++.+
T Consensus        82 ~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A  128 (229)
T 2vge_A           82 SPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDGATAFEKC  128 (229)
T ss_dssp             CCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTTCCTGGGC
T ss_pred             CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCCCCHHHHH
Confidence            999999999999999999999999999999984    4578999988

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.88  E-value=1.4e-23  Score=184.71  Aligned_cols=183  Identities=19%  Similarity=0.127  Sum_probs=130.7

Q ss_pred             cCCCCCCcceeeccCCCCCcCcCCcccccC----CCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHH
Q 018204           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDEL----TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALH  110 (359)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh  110 (359)
                      .|......+..++..|+.+.++.++.....    ....+.+|.||||+|+..|+.++|++|++.|++++.+|..|+||||
T Consensus         4 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~   83 (236)
T 1ikn_D            4 LTEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLH   83 (236)
T ss_dssp             ---CCCCTTHHHHHTTCSSSSSCCCC-----CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHH
T ss_pred             CCCCCCchhHHHHHcCChhHHHHHHHHhhccHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHH
Confidence            455566667777888888888888876642    3344778889999999999999999999989999988888999999


Q ss_pred             HHHHcCCHHHHHHHHhcCCC------ccccccccccccccccccccceeEeeccccCccccc----cCCCCcccCCC---
Q 018204          111 IAACEGHVEVVKLLLSKKAN------IDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPK----TKRTPMTVANP---  177 (359)
Q Consensus       111 ~A~~~g~~~~v~~Ll~~ga~------~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~----~~~tpl~~a~~---  177 (359)
                      +|+..|+.+++++|++.|++      ++..|..|+||||+|+..|+.+++++|+++|++++.    .+.||++.+..   
T Consensus        84 ~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~  163 (236)
T 1ikn_D           84 LACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQN  163 (236)
T ss_dssp             HHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTC
T ss_pred             HHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCC
Confidence            99999999999999988876      577788888999999888888899999888888743    45688887632   


Q ss_pred             CCCCcccCCcceeeEeeccCcccceeEEEEecCcEEEEEEe
Q 018204          178 REVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKIL  218 (359)
Q Consensus       178 ~~~~~~~l~~~~~~~~~~~~ig~g~~~~~~~~g~~vavK~l  218 (359)
                      .+..++++.. ..+....+..|.+++..+...|...+++.|
T Consensus       164 ~~~v~~Ll~~-ga~~~~~~~~g~tpl~~A~~~~~~~~~~~L  203 (236)
T 1ikn_D          164 PDLVSLLLKC-GADVNRVTYQGYSPYQLTWGRPSTRIQQQL  203 (236)
T ss_dssp             HHHHHHHHTT-TCCSCCCCTTCCCGGGGCTTSSCHHHHHHH
T ss_pred             HHHHHHHHHc-CCCCCcccCCCCCHHHHHHccCchHHHHHH
Confidence            2233333332 233444455677777666555544333333

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.88  E-value=6.9e-24  Score=177.21  Aligned_cols=124  Identities=28%  Similarity=0.341  Sum_probs=114.0

Q ss_pred             CCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      .....+..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+
T Consensus        46 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~  125 (169)
T 2y1l_E           46 SGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGH  125 (169)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCC
Confidence            34455667788999999999998876666678899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccC
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g  161 (359)
                      .++|++|+++|+|++.+|..|.|||++|+..|+.+++++|++.|
T Consensus       126 ~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~G  169 (169)
T 2y1l_E          126 LEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKLN  169 (169)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTC-
T ss_pred             HHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcC
Confidence            99999999999999999999999999999999999999999876

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.88  E-value=6.3e-24  Score=174.43  Aligned_cols=123  Identities=25%  Similarity=0.221  Sum_probs=111.9

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      |......+..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+..
T Consensus        31 ~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~  110 (153)
T 1awc_B           31 DWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEH  110 (153)
T ss_dssp             CTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Confidence            34445556677888999999999987766666788999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCccccccccccccccccccccceeEeecc
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILK  158 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~  158 (359)
                      |+.+++++|+++|++++.+|..|.|||++|+..|+.+++++|.
T Consensus       111 ~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~i~~~L~  153 (153)
T 1awc_B          111 NHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEILQ  153 (153)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHC
T ss_pred             CCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHhC
Confidence            9999999999999999999999999999999999999988763

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.88  E-value=8.6e-24  Score=194.43  Aligned_cols=152  Identities=30%  Similarity=0.476  Sum_probs=125.2

Q ss_pred             eEeeccCcccceeEEEE--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          191 QVRKADGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      +|.....+|.|.|+.+.  ..+..+++|++..... .....+.+.+|+.+++.++||||+++++++......++||||++
T Consensus        34 ~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           34 QLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             CEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             HeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            46677788888886442  2345699999865432 12223457789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-----------
Q 018204          269 KGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-----------  336 (359)
Q Consensus       269 ~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-----------  336 (359)
                      +++|.+++...+ .+++..+..++.|++.||.|||+++   |+||||||+|||++ ++.+||+|||+++           
T Consensus       113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence            999999997754 6999999999999999999999998   99999999999998 6899999999864           


Q ss_pred             ---------ccccCcccccc
Q 018204          337 ---------LQYISPEKAKI  347 (359)
Q Consensus       337 ---------~~~~~PE~~~~  347 (359)
                               ..|+|||....
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~  208 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQ  208 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSC
T ss_pred             cccccCCCcccccChHHhhh
Confidence                     24889997664

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.88  E-value=2.9e-22  Score=185.33  Aligned_cols=148  Identities=24%  Similarity=0.398  Sum_probs=124.9

Q ss_pred             eEeeccCcccceeEEE---E---ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc------cccceeeEEeCC
Q 018204          191 QVRKADGITKGSYQVA---K---WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN------VVQFVGAVTQNI  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~---~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~~  258 (359)
                      .|.....+|.|.|+.+   .   ..+..+|+|++...    ....+.+.+|+.+++.++|++      ++++++++....
T Consensus        15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            4666777888888744   2   25789999999632    344567889999999887665      899999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-------------
Q 018204          259 PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-------------  323 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-------------  323 (359)
                      ..++||||+ +++|.+++...+  .+++..+..++.|++.||.|||+++   |+||||||+|||++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999 789999998765  5899999999999999999999998   999999999999987             


Q ss_pred             ------CCcEEEeccccccc------------cccCccccc
Q 018204          324 ------GGQLKISGFGLLRL------------QYISPEKAK  346 (359)
Q Consensus       324 ------~~~~kl~DFGla~~------------~~~~PE~~~  346 (359)
                            ++.+||+|||+++.            .|+|||...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~  207 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL  207 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHT
T ss_pred             ccccccCCCceEeeCcccccCccccccccCCccccChHHhh
Confidence                  66799999999862            488888754

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.88  E-value=5.1e-24  Score=182.53  Aligned_cols=138  Identities=15%  Similarity=0.252  Sum_probs=121.5

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCC-CCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      ....++.++..|+.+.++.++..+..+++ .+.+|.||||+|+..|+.++|++|++.|+|+|.+|..|+||||+|+..|+
T Consensus         5 ~~~~L~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~   84 (201)
T 3hra_A            5 EVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGR   84 (201)
T ss_dssp             CTTHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             cccHHHHHHHhccHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCC
Confidence            33456678889999999999998875544 48899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHH-hcCCCccccccccccccccccccccceeEeeccccC-ccc---cccCCCCcccCC
Q 018204          118 VEVVKLLL-SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG-AKV---PKTKRTPMTVAN  176 (359)
Q Consensus       118 ~~~v~~Ll-~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g-a~~---~~~~~tpl~~a~  176 (359)
                      .+++++|+ ..|++++.+|..|.||||+|+..|+.+++++|+++| +++   +..+.||++.+.
T Consensus        85 ~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~  148 (201)
T 3hra_A           85 TEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAV  148 (201)
T ss_dssp             HHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCCCTTSCCHHHHHH
T ss_pred             HHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCCCCCCCCHHHHHH
Confidence            99999999 557899999999999999999999999999999999 766   345677887763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.88  E-value=5.1e-23  Score=188.83  Aligned_cols=155  Identities=25%  Similarity=0.333  Sum_probs=122.3

Q ss_pred             eeeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcH---HHHHHHHHHHHHHHhC----CCCccccceeeEEe
Q 018204          189 ELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKA----RHPNVVQFVGAVTQ  256 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~---~~~~~~~~Ei~il~~l----~HpnIv~l~~~~~~  256 (359)
                      ...|.....+|.|.|+.+.     .++..+|+|++........   .....+..|+.++..+    +||||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            3456777778888887542     2578999999965443221   1223456799999988    89999999999999


Q ss_pred             CCcEEEEEec-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCcEEEecccc
Q 018204          257 NIPMMIVLEY-HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGL  334 (359)
Q Consensus       257 ~~~~~lv~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DFGl  334 (359)
                      ....++|||+ +.+++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+||+++ .++.+||+|||+
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcch
Confidence            8999999999 788999999998888999999999999999999999998   99999999999999 789999999999


Q ss_pred             ccc-------------cccCccccc
Q 018204          335 LRL-------------QYISPEKAK  346 (359)
Q Consensus       335 a~~-------------~~~~PE~~~  346 (359)
                      ++.             .|++||...
T Consensus       187 ~~~~~~~~~~~~~~~~~y~aPE~~~  211 (312)
T 2iwi_A          187 GALLHDEPYTDFDGTRVYSPPEWIS  211 (312)
T ss_dssp             CEECCSSCBCCCCSCTTTSCHHHHH
T ss_pred             hhhcccCcccccCCcccccCceeee
Confidence            863             377777543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.88  E-value=1.9e-22  Score=192.09  Aligned_cols=133  Identities=23%  Similarity=0.445  Sum_probs=107.3

Q ss_pred             ccCcccceeEEE---Ee----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCcEEEEEe
Q 018204          195 ADGITKGSYQVA---KW----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIVLE  265 (359)
Q Consensus       195 ~~~ig~g~~~~~---~~----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~e  265 (359)
                      +..+|.|+|+.+   ..    .+..+|+|++......     ..+.+|+.+++.++||||+++++++..  ...+|+|||
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e  100 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD  100 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence            446899998754   21    3678999999754332     247889999999999999999999965  568999999


Q ss_pred             cCCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE----cCCCcEEEecc
Q 018204          266 YHAKGDLASYLQKK---------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL----DNGGQLKISGF  332 (359)
Q Consensus       266 ~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DF  332 (359)
                      |+.+ +|.+++...         ..+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+||
T Consensus       101 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A          101 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             CCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             CCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            9975 888887532         14999999999999999999999999   9999999999999    67789999999


Q ss_pred             cccc
Q 018204          333 GLLR  336 (359)
Q Consensus       333 Gla~  336 (359)
                      |+|+
T Consensus       177 g~a~  180 (405)
T 3rgf_A          177 GFAR  180 (405)
T ss_dssp             TCCC
T ss_pred             CCce
Confidence            9995

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.88  E-value=9.1e-24  Score=170.06  Aligned_cols=107  Identities=34%  Similarity=0.457  Sum_probs=100.2

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccccc
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYY  148 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~  148 (359)
                      ...+.||||+||..|+.++|++|++.|+|+|.+|..|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..
T Consensus        11 ~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~   90 (136)
T 2jab_A           11 GSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFI   90 (136)
T ss_dssp             -CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHH
T ss_pred             cccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHc
Confidence            44689999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccceeEeeccccCcccc---ccCCCCcccC
Q 018204          149 GNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       149 ~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      |+.+++++|+++|++++   ..+.||++.|
T Consensus        91 ~~~~~v~~Ll~~g~~~~~~~~~g~tpl~~A  120 (136)
T 2jab_A           91 GHLEIAEVLLKHGADVNAQDKFGKTAFDIS  120 (136)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             CCHHHHHHHHHcCCCCcCcCCCCCCHHHHH
Confidence            99999999999999874   4467777776

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.88  E-value=3.7e-24  Score=187.72  Aligned_cols=135  Identities=19%  Similarity=0.267  Sum_probs=109.9

Q ss_pred             cceeeccCCCCCcCcCCcccccCC-CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCC-----CCCCCCCCcHHHHHHHc
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELT-VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDV-----NSIDLDGRTALHIAACE  115 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v-----~~~d~~g~TpLh~A~~~  115 (359)
                      .++.++..|+.+.++.+++..+.+ ...|.+|+||||+||..|+.++|++|++.|+++     +.+|..|+||||+|+..
T Consensus         6 ~L~~A~~~g~~~~v~~Ll~~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~   85 (232)
T 2rfa_A            6 PLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVIN   85 (232)
T ss_dssp             HHHHHHHTTCHHHHHHHHTTTCSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHT
T ss_pred             HHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHc
Confidence            345677788888888888874444 444788889999999999999999999888886     77788889999999999


Q ss_pred             CCHHHHHHHHhcCCCcccccc-------------ccccccccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          116 GHVEVVKLLLSKKANIDARDR-------------WGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~-------------~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      |+.++|++|+++|++++.++.             .|+||||+|+..|+.+++++|+++|++++   ..+.||++.+.
T Consensus        86 ~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~  162 (232)
T 2rfa_A           86 QNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILI  162 (232)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred             CCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence            999999999998988888766             68899999988888889999988888874   44677777764

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.88  E-value=4.9e-26  Score=205.13  Aligned_cols=92  Identities=18%  Similarity=0.062  Sum_probs=48.4

Q ss_pred             CCCCcceeeccCCCCCcCcCCcccccC---CCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH
Q 018204           38 RRNNMRFSFGRQSSLDPIRRSPVQDEL---TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~  114 (359)
                      ...+.+..++..|+.+.++.++..+..   ....+.+|+||||+||..|+.++|++|+++|++++.+|..|+||||+|+.
T Consensus         8 ~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~   87 (282)
T 1oy3_D            8 DGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACR   87 (282)
T ss_dssp             TCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHHHTT
T ss_pred             CCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHH
Confidence            333444444555555555555544332   22334455555555555555555555555555555555555555555555


Q ss_pred             cCCHHHHHHHHhcCC
Q 018204          115 EGHVEVVKLLLSKKA  129 (359)
Q Consensus       115 ~g~~~~v~~Ll~~ga  129 (359)
                      .|+.+++++|+++|+
T Consensus        88 ~~~~~~v~~Ll~~~~  102 (282)
T 1oy3_D           88 VRAHTCACVLLQPRP  102 (282)
T ss_dssp             TTCHHHHHHHSSSCC
T ss_pred             cCCcchhHhhhccCC
Confidence            555555555555443

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.88  E-value=4.9e-24  Score=192.93  Aligned_cols=122  Identities=17%  Similarity=0.128  Sum_probs=110.3

Q ss_pred             ceeeccCCCCCcCcCCcccccCCC------CCCCCCccHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTV------PENLDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTALHIAA  113 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~t~l~~aa~~---g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~  113 (359)
                      ++.++..|+++.++.++..+....      ..+.+|.||||+||..   |+.++|++|+++|+|+|.+|..|+||||+|+
T Consensus       134 l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~  213 (278)
T 1dcq_A          134 LCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCC  213 (278)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHH
T ss_pred             hhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHH
Confidence            345677888888888777664422      2367899999999999   9999999999999999999999999999999


Q ss_pred             HcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccc
Q 018204          114 CEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       114 ~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~  164 (359)
                      ..|+.++|++|+++|||++.+|..|.||||+|+..|+.+++++|+++|++.
T Consensus       214 ~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~  264 (278)
T 1dcq_A          214 LTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALSGR  264 (278)
T ss_dssp             HTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTTC
T ss_pred             HcCCHHHHHHHHHcCCCCCCccCCCCCHHHHHHHcCCHHHHHHHHHcCCCC
Confidence            999999999999999999999999999999999999999999999999853

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.88  E-value=5.9e-24  Score=186.44  Aligned_cols=139  Identities=22%  Similarity=0.217  Sum_probs=120.6

Q ss_pred             CCCCCcceeeccCCCCCcCcCCcccccCC-----CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCC--------
Q 018204           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELT-----VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDL--------  103 (359)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~--------  103 (359)
                      ....+.+..++..|+.+.++.+++.+...     ...|.+|.||||+|+..|+.+++++|+++|++++.++.        
T Consensus        35 ~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~  114 (232)
T 2rfa_A           35 AMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRP  114 (232)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCT
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeecc
Confidence            33445566777889999999888876543     34567899999999999999999999999999999876        


Q ss_pred             -----CCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeE----eeccccCccc---------c
Q 018204          104 -----DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY----NILKARGAKV---------P  165 (359)
Q Consensus       104 -----~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~----~~L~~~ga~~---------~  165 (359)
                           .|+||||+|+..|+.++|++|+++|+|+|.+|..|+||||+|+..|+.+++    ++|+++|++.         +
T Consensus       115 ~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~~~~~  194 (232)
T 2rfa_A          115 HNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDHLKSLELVPN  194 (232)
T ss_dssp             TCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCSSCCGGGCCC
T ss_pred             cccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchhhhhhhccCC
Confidence                 799999999999999999999999999999999999999999999999988    9999999865         3


Q ss_pred             ccCCCCcccC
Q 018204          166 KTKRTPMTVA  175 (359)
Q Consensus       166 ~~~~tpl~~a  175 (359)
                      ..+.||++.|
T Consensus       195 ~~g~tpl~~A  204 (232)
T 2rfa_A          195 NQGLTPFKLA  204 (232)
T ss_dssp             TTSCCHHHHH
T ss_pred             CCCCCHHHHH
Confidence            4556777665

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.88  E-value=2.5e-24  Score=195.94  Aligned_cols=120  Identities=20%  Similarity=0.188  Sum_probs=101.8

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCH
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~  118 (359)
                      .+..++.++..|+++.++.+++.+......+.+|.||||+||..|+.++|++|++.|+|+|.+|..|+||||+|+..|+.
T Consensus        40 ~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~  119 (299)
T 1s70_B           40 DGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYL  119 (299)
T ss_dssp             HHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred             CccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCH
Confidence            34456678889999999999988766666688999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCCCccccccccccccccccccccceeEeecc
Q 018204          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILK  158 (359)
Q Consensus       119 ~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~  158 (359)
                      ++|++|+++|++++.+|..|.||||+|+..++.++++.++
T Consensus       120 ~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~ll  159 (299)
T 1s70_B          120 DIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEV  159 (299)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCcCCCCCCHHHHHHhcchHHHHHHHH
Confidence            9999999999999988887777776666666555554433

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.88  E-value=2.8e-24  Score=191.53  Aligned_cols=182  Identities=19%  Similarity=0.146  Sum_probs=136.5

Q ss_pred             CCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCC-CCCCCCCCCCcHHHHHHHc
Q 018204           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGS-DVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga-~v~~~d~~g~TpLh~A~~~  115 (359)
                      ....+.+..++..|+.+.++.+++.+......+.+|+||||+|+..|+.+++++|++.|+ +++.+|..|+||||+|+..
T Consensus        55 ~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~  134 (253)
T 1yyh_A           55 RTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARL  134 (253)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTTSCTTCCCTTCCCHHHHHHHH
T ss_pred             CCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCCCcHHHHHHHc
Confidence            344455666777888888888888776666668888999999999999999999998887 8888888999999999999


Q ss_pred             CCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCC---CCCCCcccCCcce
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN---PREVPEYELNPLE  189 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~---~~~~~~~~l~~~~  189 (359)
                      |+.+++++|++.|++++.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||++.|.   ..+..+++++. .
T Consensus       135 ~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~-g  213 (253)
T 1yyh_A          135 AVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDH-F  213 (253)
T ss_dssp             TCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHT-T
T ss_pred             ChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHc-C
Confidence            99999999999999999989889999999998888899999999888874   44678887762   22333333322 2


Q ss_pred             eeEeeccCcccceeEEEEecCcEEEEEEec
Q 018204          190 LQVRKADGITKGSYQVAKWNGTKVWVKILD  219 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~~~g~~vavK~l~  219 (359)
                      .+....+..|.+++.++...|+..+++.+.
T Consensus       214 a~~~~~d~~g~tpl~~A~~~g~~~i~~~l~  243 (253)
T 1yyh_A          214 ANRDITDHMDRLPRDIAQERMHHDIVRLLD  243 (253)
T ss_dssp             CCTTCCCTTCCCHHHHHHHTTCHHHHHHHH
T ss_pred             CCccccccCCCCHHHHHHHcCCHHHHHHHH
Confidence            223344556777777666666655555443

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.88  E-value=3.6e-24  Score=190.88  Aligned_cols=139  Identities=22%  Similarity=0.237  Sum_probs=118.4

Q ss_pred             CCCCCcceeeccC---CCCCcCcCCcccccCCC-----------CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Q 018204           37 PRRNNMRFSFGRQ---SSLDPIRRSPVQDELTV-----------PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID  102 (359)
Q Consensus        37 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~-----------~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d  102 (359)
                      ....+.+..++..   |+.+.++.+++.+....           ..|.+|.||||+||..|+.++|++|+++|+|+|.+|
T Consensus        41 ~~g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~  120 (256)
T 2etb_A           41 STGKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRA  120 (256)
T ss_dssp             TTTBCHHHHHHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             CCCCCHHHHHHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCccc
Confidence            3444455556666   89999999888764332           234679999999999999999999999999999999


Q ss_pred             CC-------------CCcHHHHHHHcCCHHHHHHHHh---cCCCccccccccccccccccc--cccce-------eEeec
Q 018204          103 LD-------------GRTALHIAACEGHVEVVKLLLS---KKANIDARDRWGSTAAADAKY--YGNVE-------VYNIL  157 (359)
Q Consensus       103 ~~-------------g~TpLh~A~~~g~~~~v~~Ll~---~ga~~~~~d~~g~tpl~~A~~--~~~~~-------~~~~L  157 (359)
                      ..             |+||||+|+..|+.++|++|++   +|+|+|.+|..|+||||+|+.  .++.+       ++++|
T Consensus       121 ~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~L  200 (256)
T 2etb_A          121 CGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDGL  200 (256)
T ss_dssp             CSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHH
Confidence            87             9999999999999999999999   999999999999999999998  77777       99999


Q ss_pred             cccCccc----------cccCCCCcccC
Q 018204          158 KARGAKV----------PKTKRTPMTVA  175 (359)
Q Consensus       158 ~~~ga~~----------~~~~~tpl~~a  175 (359)
                      +++|+++          +..+.||++.|
T Consensus       201 l~~ga~~~~~~~~~~~~d~~g~tpL~~A  228 (256)
T 2etb_A          201 LQMGARLCPTVQLEEISNHQGLTPLKLA  228 (256)
T ss_dssp             HHHHHHHSTTCCGGGCCCTTSCCHHHHH
T ss_pred             HHcCCCcccccccccccCCCCCCHHHHH
Confidence            9999987          33456777665

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.88  E-value=1.1e-22  Score=187.60  Aligned_cols=152  Identities=29%  Similarity=0.507  Sum_probs=121.1

Q ss_pred             eeEeeccCcccceeEEE---E---ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCccccceeeEE-----
Q 018204          190 LQVRKADGITKGSYQVA---K---WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVT-----  255 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~---~---~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~-----  255 (359)
                      -+|.....+|.|.|+.+   .   ..|..+|+|++....... .....+.+|+.+++.+   +||||+++++++.     
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            35667777888888744   2   247889999986433211 1112355677777665   8999999999987     


Q ss_pred             eCCcEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          256 QNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       256 ~~~~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      .....++||||++ |+|.+++....  .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCc
Confidence            4567999999997 59999998753  4999999999999999999999999   9999999999999999999999999


Q ss_pred             cccc--------------cccCccccc
Q 018204          334 LLRL--------------QYISPEKAK  346 (359)
Q Consensus       334 la~~--------------~~~~PE~~~  346 (359)
                      +++.              .|+|||...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~  192 (326)
T 1blx_A          166 LARIYSFQMALTSVVVTLWYRAPEVLL  192 (326)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHT
T ss_pred             ccccccCCCCccccccccceeCHHHHh
Confidence            9863              377777654

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.88  E-value=8.8e-24  Score=185.09  Aligned_cols=172  Identities=24%  Similarity=0.224  Sum_probs=131.5

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      |....+.+..++..|+.+.++.+++.+......+.+|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..
T Consensus        37 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~  116 (231)
T 3aji_A           37 DQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASK  116 (231)
T ss_dssp             CTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHc
Confidence            44455556667778888888888877766566688899999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCCC---CCCCcccCCcce
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVANP---REVPEYELNPLE  189 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~~---~~~~~~~l~~~~  189 (359)
                      |+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||++.+..   .+..++++.. .
T Consensus       117 ~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-g  195 (231)
T 3aji_A          117 NRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQ-G  195 (231)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHT-T
T ss_pred             CCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccCCCCCCHHHHHHHCCCHHHHHHHHHC-C
Confidence            99999999999999999999999999999999999999999999988874   446788887632   2223333322 2


Q ss_pred             eeEeeccCcccceeEEEEe
Q 018204          190 LQVRKADGITKGSYQVAKW  208 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~~  208 (359)
                      .+....+..|.+++..+..
T Consensus       196 a~~~~~~~~g~t~l~~A~~  214 (231)
T 3aji_A          196 ASIYIENKEEKTPLQVAKG  214 (231)
T ss_dssp             CCSCCCCTTSCCHHHHSCH
T ss_pred             CCCCCCCCCCCCHHHHHHh
Confidence            2333445556666655543

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.88  E-value=1.5e-23  Score=190.80  Aligned_cols=139  Identities=24%  Similarity=0.276  Sum_probs=123.5

Q ss_pred             CCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCC--------------
Q 018204           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDL--------------  103 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~--------------  103 (359)
                      ...+.+..++..|+.+.++.+++.+......|.+|+||||+|+..|+.++|++|+++|++++.+|.              
T Consensus        72 ~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~  151 (299)
T 1s70_B           72 DGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAM  151 (299)
T ss_dssp             TCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHH
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHhcch
Confidence            344556667788999999999887766666688999999999999999999999999999987764              


Q ss_pred             ----------------------------------------------CCCcHHHHHHHcCCHHHHHHHHhcCCCccccccc
Q 018204          104 ----------------------------------------------DGRTALHIAACEGHVEVVKLLLSKKANIDARDRW  137 (359)
Q Consensus       104 ----------------------------------------------~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~  137 (359)
                                                                    .|+||||+||..|+.++|++|+++|+|+|.+|..
T Consensus       152 ~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~  231 (299)
T 1s70_B          152 EELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYD  231 (299)
T ss_dssp             HHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTT
T ss_pred             HHHHHHHHhhcCCCchhhhhhhhhHHHHHHHHHHhccCcchhhhcCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCC
Confidence                                                          4678899999999999999999999999999999


Q ss_pred             cccccccccccccceeEeeccccCccc---cccCCCCcccCC
Q 018204          138 GSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN  176 (359)
Q Consensus       138 g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~  176 (359)
                      |+||||+|+..|+.+++++|+++|+++   +..+.||+++|.
T Consensus       232 g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t~l~~A~  273 (299)
T 1s70_B          232 GWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVAD  273 (299)
T ss_dssp             CCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTSCC
T ss_pred             CCcHHHHHHhcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHH
Confidence            999999999999999999999999998   456789999884

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.88  E-value=5.6e-23  Score=189.57  Aligned_cols=154  Identities=23%  Similarity=0.372  Sum_probs=127.7

Q ss_pred             eeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcH---HHHHHHHHHHHHHHhCC--CCccccceeeEEeCCc
Q 018204          190 LQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDP---ERINAFTHELTIVEKAR--HPNVVQFVGAVTQNIP  259 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~---~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~  259 (359)
                      .+|.....+|.|.|+.+.     .++..+|||.+........   .....+..|+.+++.+.  ||||+++++++.....
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            346667778888887442     3588999999975433221   11134667999999996  5999999999999999


Q ss_pred             EEEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCcEEEeccccccc
Q 018204          260 MMIVLEYHAK-GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRL  337 (359)
Q Consensus       260 ~~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DFGla~~  337 (359)
                      .++|||++.+ ++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||++ .++.+||+|||+++.
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            9999999976 899999988888999999999999999999999998   99999999999999 788999999999863


Q ss_pred             -------------cccCccccc
Q 018204          338 -------------QYISPEKAK  346 (359)
Q Consensus       338 -------------~~~~PE~~~  346 (359)
                                   .|+|||...
T Consensus       200 ~~~~~~~~~~gt~~y~aPE~~~  221 (320)
T 3a99_A          200 LKDTVYTDFDGTRVYSPPEWIR  221 (320)
T ss_dssp             CCSSCBCCCCSCGGGSCHHHHH
T ss_pred             cccccccCCCCCccCCChHHhc
Confidence                         477888654

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.87  E-value=1.7e-22  Score=194.03  Aligned_cols=137  Identities=25%  Similarity=0.374  Sum_probs=113.3

Q ss_pred             eeEeeccCcccceeEE----EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEE
Q 018204          190 LQVRKADGITKGSYQV----AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~----~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~  264 (359)
                      ..|...+.+|.|+|+.    ...+|+.||||.+......      .+.+|+.+++.+ +||||+++++++......|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            4566777788888764    2457899999999654322      246799999999 7999999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---C--CcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---G--GQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~--~~~kl~DFGla~  336 (359)
                      |||. |+|.+++.... ..++..+..++.||+.||.|||+++   |+||||||+|||++.   +  ..+||+|||+|+
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            9996 59999997654 3555567899999999999999999   999999999999953   2  358899999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.87  E-value=6.7e-22  Score=180.46  Aligned_cols=130  Identities=24%  Similarity=0.415  Sum_probs=112.4

Q ss_pred             cCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHH-HhCCCCccccceeeEEe----CCcEEEEEe
Q 018204          196 DGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIV-EKARHPNVVQFVGAVTQ----NIPMMIVLE  265 (359)
Q Consensus       196 ~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~----~~~~~lv~e  265 (359)
                      +.+|.|.|+.+     ..++..+|+|++...        ..+.+|+.++ +..+||||+++++++..    ...+++|||
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e   95 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME   95 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence            45788887744     235889999999632        2467788887 66699999999999887    677999999


Q ss_pred             cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DFGla~  336 (359)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+++
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            999999999998764  5999999999999999999999999   999999999999998   7889999999996

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.87  E-value=2e-23  Score=171.72  Aligned_cols=120  Identities=23%  Similarity=0.243  Sum_probs=110.4

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHH
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~  119 (359)
                      +..++.++..|+.+.++.+++.+......|.+|.||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+
T Consensus        36 g~t~L~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~  115 (156)
T 1bd8_A           36 GKTALQVMMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTA  115 (156)
T ss_dssp             SCCHHHHSCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHH
T ss_pred             CCcHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHH
Confidence            34444448899999999999887666667889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCccccccccccccccccccccceeEeecccc
Q 018204          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKAR  160 (359)
Q Consensus       120 ~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~  160 (359)
                      +|++|++. ++++.+|..|.||||+|+..|+.+++++|+++
T Consensus       116 ~v~~Ll~~-~~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~  155 (156)
T 1bd8_A          116 VVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLVDILQGH  155 (156)
T ss_dssp             HHHHHHTT-SCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred             HHHHHHhc-cCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhh
Confidence            99999999 99999999999999999999999999998864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.87  E-value=1e-21  Score=178.45  Aligned_cols=137  Identities=22%  Similarity=0.294  Sum_probs=114.8

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeE-EeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lv~  264 (359)
                      +|.....+|.|.|+.+   .  .+|+.+|+|++.......     .+.+|+.++..+.|++++..+..+ ......++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC-----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh-----HHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            4666667888887644   2  468999999987544322     478899999999998877766655 5667789999


Q ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE---cCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DFGla~  336 (359)
                      ||+ +++|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            999 8899999974 456999999999999999999999998   9999999999999   478899999999986

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.87  E-value=2.2e-23  Score=183.52  Aligned_cols=135  Identities=25%  Similarity=0.249  Sum_probs=94.4

Q ss_pred             cceeeccCCCCCcCcCCccccc----CCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcC
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDE----LTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEG  116 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d-~~g~TpLh~A~~~g  116 (359)
                      ....++..|+.+.++.+++.+.    .....+.+|.||||+|+..|+.+++++|++.|++++..| ..|+||||+|+..|
T Consensus        82 ~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~  161 (241)
T 1k1a_A           82 AAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENN  161 (241)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTT
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCccccccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcC
Confidence            3444555666666666666553    223346677777777777777777777777777777777 67777777777777


Q ss_pred             CHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       117 ~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      +.+++++|+++|+|++.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||++.|.
T Consensus       162 ~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~A~  224 (241)
T 1k1a_A          162 SLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVAR  224 (241)
T ss_dssp             CHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCS
T ss_pred             CHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCHHHHHH
Confidence            7777777777777777777777777777777777777777777777763   34566776664

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.87  E-value=1.1e-23  Score=183.33  Aligned_cols=135  Identities=21%  Similarity=0.167  Sum_probs=80.1

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCC-CCCCCCCCCCcHHHHHHHcCCHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGS-DVNSIDLDGRTALHIAACEGHVE  119 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga-~v~~~d~~g~TpLh~A~~~g~~~  119 (359)
                      +.+..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|+ +++.+|..|+||||+|+..|+.+
T Consensus        27 t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~  106 (223)
T 2f8y_A           27 TALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEG  106 (223)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTCHH
T ss_pred             chHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCcHH
Confidence            33444555666666666665544444445566666666666666666666666654 56666666666666666666666


Q ss_pred             HHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       120 ~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      ++++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||++.|
T Consensus       107 ~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A  165 (223)
T 2f8y_A          107 MLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLA  165 (223)
T ss_dssp             HHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHH
T ss_pred             HHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCHHHHH
Confidence            6666666666666666666666666666666666666666666553   2344555554

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.87  E-value=1.7e-24  Score=189.13  Aligned_cols=171  Identities=17%  Similarity=0.148  Sum_probs=138.0

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccc--cCCCC-CCCCCccHHHHHHHcCCHHHHHHHHHcC--CCCCCCCCCCCcHHH
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQD--ELTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEG--SDVNSIDLDGRTALH  110 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~t~l~~aa~~g~~~~v~~Ll~~g--a~v~~~d~~g~TpLh  110 (359)
                      |....+.+..++..|+.+.++.+++.+  ..... .+..|.||||+|+..|+.+++++|++.|  ++++.+|..|+||||
T Consensus        33 ~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~  112 (228)
T 2dzn_A           33 DQDGRIPLHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLH  112 (228)
T ss_dssp             CTTSCCHHHHHHHTTCHHHHHHHHHTCTTCCGGGCCCTTSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHhccccccccccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHH
Confidence            444555566777889989888888876  22233 5778999999999999999999999999  899999999999999


Q ss_pred             HHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccC-ccc---cccCCCCcccCCC---CCCCcc
Q 018204          111 IAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG-AKV---PKTKRTPMTVANP---REVPEY  183 (359)
Q Consensus       111 ~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g-a~~---~~~~~tpl~~a~~---~~~~~~  183 (359)
                      +|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+++++|+++| +++   +..+.||++.+..   .+...+
T Consensus       113 ~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~~~~~~~v~~  192 (228)
T 2dzn_A          113 LAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVL  192 (228)
T ss_dssp             HHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHH
T ss_pred             HHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCCCHHHHHHHcCCHHHHHH
Confidence            999999999999999999999999999999999999999999999999999 776   4567889888732   233444


Q ss_pred             cCCcceeeEeeccCcccceeEEE
Q 018204          184 ELNPLELQVRKADGITKGSYQVA  206 (359)
Q Consensus       184 ~l~~~~~~~~~~~~ig~g~~~~~  206 (359)
                      ++.....+....+..|.+++..+
T Consensus       193 Ll~~~ga~~~~~~~~g~t~l~~A  215 (228)
T 2dzn_A          193 LVEKYGAEYDLVDNKGAKAEDVA  215 (228)
T ss_dssp             HHHHHCCCSCCBCTTSCBGGGGC
T ss_pred             HHHhcCCCCCccCCCCCcHHHHH
Confidence            44333444555555666666544

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.87  E-value=3.8e-23  Score=184.11  Aligned_cols=125  Identities=22%  Similarity=0.190  Sum_probs=102.2

Q ss_pred             CCCcCcCCcccccCCCCC-CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCC
Q 018204           51 SLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA  129 (359)
Q Consensus        51 ~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga  129 (359)
                      +.+.++.++..+...... |.+|+||||+||..|+.++|++|++.|+++|.+|..|+||||+|+..|+.+++++|++.|+
T Consensus        35 ~~~~v~~Ll~~g~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~  114 (253)
T 1yyh_A           35 APAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRA  114 (253)
T ss_dssp             -----------------CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTT
T ss_pred             ChHHHHHHHHccCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCC
Confidence            788899999887665554 8899999999999999999999999999999999999999999999999999999999987


Q ss_pred             -CccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          130 -NIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       130 -~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                       +++.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus       115 ~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A  164 (253)
T 1yyh_A          115 TDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWA  164 (253)
T ss_dssp             SCTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHH
T ss_pred             CCccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence             999999999999999999999999999999999885   4467888876

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.87  E-value=7.5e-24  Score=184.90  Aligned_cols=108  Identities=26%  Similarity=0.414  Sum_probs=67.9

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhc-CCCccccccccccccccccc
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK-KANIDARDRWGSTAAADAKY  147 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~-ga~~~~~d~~g~tpl~~A~~  147 (359)
                      +.+|.||||+||..|+.++|++|++.|+++|.+|..|+||||+||..|+.++|++|++. |+++|.+|..|+||||+|+.
T Consensus        70 ~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~  149 (222)
T 3ehr_A           70 AESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAW  149 (222)
T ss_dssp             EEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHH
T ss_pred             ccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHH
Confidence            44566666666666666666666666666666666666666666666666666666666 66666666666666666666


Q ss_pred             cccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          148 YGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       148 ~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      .|+.+++++|+++|++++   ..+.||+++|.
T Consensus       150 ~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~  181 (222)
T 3ehr_A          150 KGYADIVQLLLAKGARTDLRNIEKKLAFDMAT  181 (222)
T ss_dssp             HTCHHHHHHHHHHTCCSCCCCTTSCCHHHHCC
T ss_pred             cCCHHHHHHHHHcCCCCccccCCCCCHHHHhc
Confidence            666666666666666552   33455665554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.87  E-value=1.8e-22  Score=201.46  Aligned_cols=142  Identities=30%  Similarity=0.467  Sum_probs=121.0

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe------CCc
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ------NIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~------~~~  259 (359)
                      .|.....+|.|.|+.+     ..+|..+|||++...  ......+.+.+|+.++..++||||+++++++..      ...
T Consensus        15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            4666778899998754     235889999998654  245566789999999999999999999998754      667


Q ss_pred             EEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc---EEEeccc
Q 018204          260 MMIVLEYHAKGDLASYLQKKG---RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ---LKISGFG  333 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DFG  333 (359)
                      .++||||+++|+|.+++....   .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            899999999999999998754   5899999999999999999999998   999999999999997765   9999999


Q ss_pred             cccc
Q 018204          334 LLRL  337 (359)
Q Consensus       334 la~~  337 (359)
                      +++.
T Consensus       170 ~a~~  173 (676)
T 3qa8_A          170 YAKE  173 (676)
T ss_dssp             CCCB
T ss_pred             cccc
Confidence            9863

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.87  E-value=6.6e-24  Score=189.49  Aligned_cols=128  Identities=23%  Similarity=0.256  Sum_probs=112.9

Q ss_pred             cCCCCCcCcCCcccccC-----------CCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC--------------
Q 018204           48 RQSSLDPIRRSPVQDEL-----------TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID--------------  102 (359)
Q Consensus        48 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d--------------  102 (359)
                      +.|..+.++.+++.+..           ....|.+|+||||+||..|+.++|++|+++|+|+|.+|              
T Consensus        58 ~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~  137 (260)
T 3jxi_A           58 SAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYF  137 (260)
T ss_dssp             BTTBCTHHHHHHHHHHHTTCHHHHHTCCBCCSSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSC
T ss_pred             hcCCHHHHHHHHHhcccccchHhhhcccccccccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccc
Confidence            67999999999886532           22335589999999999999999999999999999999              


Q ss_pred             CCCCcHHHHHHHcCCHHHHHHHHh---cCCCcccccccccccccccccccc---------ceeEeeccccCccc------
Q 018204          103 LDGRTALHIAACEGHVEVVKLLLS---KKANIDARDRWGSTAAADAKYYGN---------VEVYNILKARGAKV------  164 (359)
Q Consensus       103 ~~g~TpLh~A~~~g~~~~v~~Ll~---~ga~~~~~d~~g~tpl~~A~~~~~---------~~~~~~L~~~ga~~------  164 (359)
                      ..|+||||+|+..|+.++|++|++   .|+|+|.+|..|+||||+|+..++         .+++++|+++|+++      
T Consensus       138 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~  217 (260)
T 3jxi_A          138 YFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNL  217 (260)
T ss_dssp             CSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCTTCCG
T ss_pred             cCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccccccch
Confidence            689999999999999999999999   999999999999999999998777         68999999999986      


Q ss_pred             ----cccCCCCcccC
Q 018204          165 ----PKTKRTPMTVA  175 (359)
Q Consensus       165 ----~~~~~tpl~~a  175 (359)
                          +..+.||++.|
T Consensus       218 ~~~~d~~g~tpL~~A  232 (260)
T 3jxi_A          218 EALLNNDGLSPLMMA  232 (260)
T ss_dssp             GGCCCTTSCCHHHHH
T ss_pred             hhcccCCCCCHHHHH
Confidence                34456777766

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.87  E-value=5.8e-22  Score=181.96  Aligned_cols=151  Identities=23%  Similarity=0.439  Sum_probs=116.0

Q ss_pred             eEeeccCcccceeEEE---Ee--cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---KW--NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.....+|.|.|+.+   ..  +|..+|+|++..... .......+..+..++..++||||+++++++......++|||
T Consensus        26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            3555566788887643   22  588999999975432 33333445555667888899999999999999999999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      |+ ++.+..+... ...+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++       
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence            99 5566666544 45799999999999999999999995 8   9999999999999999999999999985       


Q ss_pred             -------ccccCccccc
Q 018204          337 -------LQYISPEKAK  346 (359)
Q Consensus       337 -------~~~~~PE~~~  346 (359)
                             ..|+|||...
T Consensus       181 ~~~~~~~~~y~aPE~~~  197 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERID  197 (318)
T ss_dssp             ------CCTTCCHHHHC
T ss_pred             ccccCCCccccChhhcc
Confidence                   2488888764

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.87  E-value=1e-23  Score=175.59  Aligned_cols=129  Identities=20%  Similarity=0.149  Sum_probs=117.7

Q ss_pred             CCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018204           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (359)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g  116 (359)
                      ....+.+..++..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|
T Consensus        34 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~  113 (167)
T 3v31_A           34 EEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGN  113 (167)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTT
T ss_pred             CCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHcC
Confidence            33445566778899999999998887665666889999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc
Q 018204          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP  165 (359)
Q Consensus       117 ~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~  165 (359)
                      +.+++++|+++|+|++.+|..|+|||++|+..|+.+++++|++++++..
T Consensus       114 ~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~L~~~~~~~~  162 (167)
T 3v31_A          114 HVKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLKLL  162 (167)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999999999999999988653

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.87  E-value=1.5e-23  Score=178.71  Aligned_cols=124  Identities=27%  Similarity=0.303  Sum_probs=113.7

Q ss_pred             CCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      .....+..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|+++|.+|..|+||||+|+..|+
T Consensus        67 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~  146 (192)
T 2rfm_A           67 EGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGR  146 (192)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTC
T ss_pred             cCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCC
Confidence            34455666777888888888888876666668899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccC
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g  161 (359)
                      .++|++|+++|++++.+|..|.|||++|+..|+.+++++|+++|
T Consensus       147 ~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~v~~Ll~~~  190 (192)
T 2rfm_A          147 SEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVR  190 (192)
T ss_dssp             HHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCcHHHHHHHHhcc
Confidence            99999999999999999999999999999999999999998865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.87  E-value=8.6e-22  Score=178.87  Aligned_cols=137  Identities=22%  Similarity=0.294  Sum_probs=113.3

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeE-EeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lv~  264 (359)
                      .|...+.+|.|.|+.+   .  ..+..+|+|++......     ..+..|+.++..+.|++++..+..+ ......++||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A           10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4666677788887643   2  46889999987644322     2478899999999998877776655 5667889999


Q ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE---cCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DFGla~  336 (359)
                      ||+ +++|.+++.. ...+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            999 8899999975 456999999999999999999999999   9999999999999   788999999999986

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.87  E-value=3.4e-23  Score=182.07  Aligned_cols=133  Identities=28%  Similarity=0.353  Sum_probs=75.2

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACEGHVEVV  121 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~g-a~v~~~d~~g~TpLh~A~~~g~~~~v  121 (359)
                      +..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.| ++++.+|..|+||||+|+..|+.+++
T Consensus        48 L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~  127 (237)
T 3b7b_A           48 LMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLV  127 (237)
T ss_dssp             HHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTSCCHHHHHHHTTCHHHH
T ss_pred             HHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCCCCHHHHHHHcCCHHHH
Confidence            34444555555555555554444444555556666666666666666666555 55555555566666666666666666


Q ss_pred             HHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       122 ~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      ++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus       128 ~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A  184 (237)
T 3b7b_A          128 KLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIA  184 (237)
T ss_dssp             HHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCCHHHHH
T ss_pred             HHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence            66666666666555556666666665555566666665555553   2334555544

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.87  E-value=1.3e-21  Score=190.20  Aligned_cols=137  Identities=20%  Similarity=0.271  Sum_probs=115.0

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC-ccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP-NVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~  264 (359)
                      .|.....+|.|.|+.+   .  ..+..||||++.......     .+..|+.++..+.|+ +|..+..++......++||
T Consensus         8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            4677788899998754   2  348899999986544322     367899999999875 4555556667778899999


Q ss_pred             ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE---cCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DFGla~  336 (359)
                      ||+ +++|.+++.. .+.+++..+..|+.||+.||.|||+++   ||||||||+||||   +.++.+||+|||+++
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            999 8899999985 457999999999999999999999999   9999999999999   578899999999996

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.87  E-value=7.1e-22  Score=194.63  Aligned_cols=129  Identities=20%  Similarity=0.192  Sum_probs=104.3

Q ss_pred             ccCcccceeEEE---EecCcEEEEEEeccCCCCcHH-----HHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          195 ADGITKGSYQVA---KWNGTKVWVKILDKESHKDPE-----RINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       195 ~~~ig~g~~~~~---~~~g~~vavK~l~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      .+.+|+|.|+.+   ...+..+++|...........     ..+.|.+|+.+++.++||||+++..++......|+||||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~  420 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY  420 (540)
T ss_dssp             -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred             CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence            456899998854   357889999987654433222     235689999999999999999776677777888999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++++|.+++..        +..++.|++.||.|||+++   |+||||||+|||++.  .+||+|||+|+
T Consensus       421 ~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~  477 (540)
T 3en9_A          421 INGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGK  477 (540)
T ss_dssp             CCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred             CCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCE
Confidence            999999999865        5689999999999999999   999999999999998  99999999997

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.87  E-value=1.6e-23  Score=183.41  Aligned_cols=171  Identities=26%  Similarity=0.236  Sum_probs=131.3

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCC-CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCH
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELT-VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~  118 (359)
                      +...+.++..|+++.++.++...... ...+.+|.||||+|+..|+.++|++|++.|++++.+|..|+||||+|+..|+.
T Consensus         7 ~~~l~~A~~~g~~~~v~~ll~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~   86 (231)
T 3aji_A            7 NIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXD   86 (231)
T ss_dssp             SSHHHHHHHHTCHHHHHHHHHHCGGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCH
T ss_pred             cchHHHHHHhCCHHHHHHHHHhchhhhhcCCCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHH
Confidence            34456778889999999888776544 34478899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCC---CCCCCcccCCcceeeE
Q 018204          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN---PREVPEYELNPLELQV  192 (359)
Q Consensus       119 ~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~---~~~~~~~~l~~~~~~~  192 (359)
                      +++++|+++|++++.+|..|.||||+|+..++.+++++|+++|++++   ..+.||++.+.   ..+..++++.. ....
T Consensus        87 ~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-g~~~  165 (231)
T 3aji_A           87 EIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFY-KAST  165 (231)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHT-TCCS
T ss_pred             HHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhc-CCCc
Confidence            99999999999999999999999999999999999999999998874   34567887762   22223333321 1222


Q ss_pred             eeccCcccceeEEEEecCc
Q 018204          193 RKADGITKGSYQVAKWNGT  211 (359)
Q Consensus       193 ~~~~~ig~g~~~~~~~~g~  211 (359)
                      ...+..|.+++..+...|.
T Consensus       166 ~~~~~~g~t~L~~A~~~~~  184 (231)
T 3aji_A          166 NIQDTEGNTPLHLACDEER  184 (231)
T ss_dssp             CCCCTTSCCHHHHHHHTTC
T ss_pred             cccCCCCCCHHHHHHHCCC
Confidence            3334456666665554443

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.87  E-value=2.5e-23  Score=193.01  Aligned_cols=135  Identities=26%  Similarity=0.312  Sum_probs=122.3

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCC-CCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVP-ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~  119 (359)
                      +.++.+++.|+.+.++.++...+.+.+ .|.+|.||||+||..|+.++|++|++.|+|+|.+|..|+||||+|+..|+.+
T Consensus        26 ~~L~~A~~~g~~~~v~~ll~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~  105 (351)
T 3utm_A           26 DELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYE  105 (351)
T ss_dssp             HHHHHHHHHTCHHHHHHHCCTTTTTCCCSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHH
T ss_pred             hhHHHHHHcCCHHHHHHHHHhcCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHH
Confidence            446788999999999999988666654 4889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCccccccccccccccccccccceeEeeccccCccccc---cCCCCcccC
Q 018204          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPK---TKRTPMTVA  175 (359)
Q Consensus       120 ~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~---~~~tpl~~a  175 (359)
                      +|++|+++|++++..|..|.||||+|+..|+.+++++|+++|++++.   .+.++++.+
T Consensus       106 iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~~~l~~a  164 (351)
T 3utm_A          106 VTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMA  164 (351)
T ss_dssp             HHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHC
T ss_pred             HHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCCcchHHH
Confidence            99999999999999999999999999999999999999999998744   345555544

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.86  E-value=5.6e-22  Score=186.24  Aligned_cols=148  Identities=24%  Similarity=0.371  Sum_probs=122.7

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-----------CCccccceeeE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-----------HPNVVQFVGAV  254 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~  254 (359)
                      .|.....+|.|.|+.+   .  .++..+|+|++..    +......+.+|+.++..+.           ||||+++++++
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            4666677888888754   2  3688999999963    2344567889999999876           89999999998


Q ss_pred             EeCC----cEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEc-----
Q 018204          255 TQNI----PMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHEC-KPDPIIHCDLKPKNILLD-----  322 (359)
Q Consensus       255 ~~~~----~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~-~~~~iiHrDlk~~NIll~-----  322 (359)
                      ....    .++++|||+ +++|.+++...  ..+++..+..++.||+.||.|||++ +   |+||||||+|||++     
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            8654    799999999 88999999864  4599999999999999999999998 8   99999999999995     


Q ss_pred             -CCCcEEEecccccc------------ccccCccccc
Q 018204          323 -NGGQLKISGFGLLR------------LQYISPEKAK  346 (359)
Q Consensus       323 -~~~~~kl~DFGla~------------~~~~~PE~~~  346 (359)
                       ..+.+||+|||+++            ..|+|||...
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~  208 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL  208 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH
T ss_pred             cCcceEEEcccccccccCCCCCCCCCCccccCcHHHh
Confidence             34479999999986            3488888765

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.86  E-value=1.5e-21  Score=181.32  Aligned_cols=144  Identities=22%  Similarity=0.386  Sum_probs=108.3

Q ss_pred             Eeec-cCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe----CCcEE
Q 018204          192 VRKA-DGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPMM  261 (359)
Q Consensus       192 ~~~~-~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~  261 (359)
                      |... ..+|.|.|+.+   .  .+|+.+|+|++...    ...   .......+..++||||+++++++..    ...++
T Consensus        30 y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             eEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4443 34688887754   2  25889999999642    221   1222334667799999999999876    44589


Q ss_pred             EEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DFGla~  336 (359)
                      +||||+++|+|.+++...+  .+++..+..++.|++.||.|||+++   |+||||||+|||++.   ++.+||+|||+++
T Consensus       103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999998764  5999999999999999999999998   999999999999986   4559999999996


Q ss_pred             c-------------cccCcccc
Q 018204          337 L-------------QYISPEKA  345 (359)
Q Consensus       337 ~-------------~~~~PE~~  345 (359)
                      .             .|+|||..
T Consensus       180 ~~~~~~~~~~~~t~~y~aPE~~  201 (336)
T 3fhr_A          180 ETTQNALQTPCYTPYYVAPEVL  201 (336)
T ss_dssp             EC--------------------
T ss_pred             eccccccccCCCCcCccChhhh
Confidence            2             37777764

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.86  E-value=3.4e-23  Score=180.30  Aligned_cols=126  Identities=22%  Similarity=0.190  Sum_probs=78.1

Q ss_pred             CCCCcCcCCcccccCCCCC-CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcC
Q 018204           50 SSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK  128 (359)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~g  128 (359)
                      |+.+.++.+++.+...... |.+|.||||+||..|+.++|++|++.|++++.+|..|+||||+|+..|+.+++++|++.|
T Consensus         2 g~~~~i~~Ll~~g~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~   81 (223)
T 2f8y_A            2 DAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNR   81 (223)
T ss_dssp             ---CCEETTEETTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHBT
T ss_pred             CcHHHHHHHHHcCCCcccccCCCCCchHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcC
Confidence            3455555566555444333 556666666666666666666666666666666666666666666666666666666665


Q ss_pred             C-CccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          129 A-NIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       129 a-~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      + +++.+|..|.||||+|+..++.+++++|+++|++++   ..+.||++.+
T Consensus        82 ~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A  132 (223)
T 2f8y_A           82 ATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWA  132 (223)
T ss_dssp             TSCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHH
T ss_pred             CCCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHH
Confidence            5 666666666666666666666666666666666653   3345566554

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.86  E-value=1e-22  Score=184.72  Aligned_cols=137  Identities=21%  Similarity=0.213  Sum_probs=101.8

Q ss_pred             CCCcceeeccCCCCCcCcCCcccc-----------cCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCc
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQD-----------ELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRT  107 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~T  107 (359)
                      .......++..|+.+.+.+++..+           ......+.+|+||||+||..|+.++|++|++.|+++|.+|.+|+|
T Consensus        15 ~~~~lH~Aa~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t   94 (285)
T 3d9h_A           15 VPRGSHMASMDGKQGGMDGSKPAGPRDFPGIRLLSNPLMGDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVS   94 (285)
T ss_dssp             ---------------------------CCSEECCCCTTCSSSCCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCC
T ss_pred             HHHHHHHHhhcCCCCCcccCCCCccccccchhhhhCcccCCCccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence            334456677788877777744332           223456788999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc--ccCCCCcccC
Q 018204          108 ALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP--KTKRTPMTVA  175 (359)
Q Consensus       108 pLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~--~~~~tpl~~a  175 (359)
                      |||+||..|+.++|++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++  ..+.||++.+
T Consensus        95 ~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~g~t~L~~A  164 (285)
T 3d9h_A           95 PLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPESDLASPIHEA  164 (285)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCSCTTSCHHHHH
T ss_pred             HHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Confidence            9999999999999999999999999999999999999999999999999999999874  3356777766

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.86  E-value=1.5e-21  Score=184.37  Aligned_cols=150  Identities=27%  Similarity=0.336  Sum_probs=122.1

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CC-----ccccceeeEEeCCc
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HP-----NVVQFVGAVTQNIP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~~~~~~~~~  259 (359)
                      .|.....+|.|.|+.+.     ..++.||||++..    .......+..|+.++..+. |+     +|+++++++.....
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            46667778888887542     2578999999963    2344566788998888875 44     48999999999999


Q ss_pred             EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc--CCCcEEEeccccc
Q 018204          260 MMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQLKISGFGLL  335 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~--~~~~~kl~DFGla  335 (359)
                      .++||||+++ +|.+++...  +.+++..+..++.|++.||.|||++. .+|+||||||+|||++  .++.+||+|||+|
T Consensus       131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999999965 999999875  45999999999999999999999532 2399999999999995  4778999999999


Q ss_pred             c------------ccccCccccc
Q 018204          336 R------------LQYISPEKAK  346 (359)
Q Consensus       336 ~------------~~~~~PE~~~  346 (359)
                      +            ..|+|||...
T Consensus       209 ~~~~~~~~~~~~t~~y~aPE~~~  231 (382)
T 2vx3_A          209 CQLGQRIYQYIQSRFYRSPEVLL  231 (382)
T ss_dssp             EETTCCCCSSCSCGGGCCHHHHT
T ss_pred             eecccccccccCCccccChHHHc
Confidence            6            2488898765

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.86  E-value=1.1e-22  Score=157.75  Aligned_cols=93  Identities=39%  Similarity=0.487  Sum_probs=86.0

Q ss_pred             CCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccc
Q 018204           65 TVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD  144 (359)
Q Consensus        65 ~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~  144 (359)
                      ..+.+.+|.||||+||..|+.+++++|++.|+|+|.+|..|+||||+||..|+.+++++|+++|++++.+|..|+||||+
T Consensus        17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~   96 (110)
T 2zgd_A           17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDI   96 (110)
T ss_dssp             -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred             ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHH
Confidence            45667899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccceeEeec
Q 018204          145 AKYYGNVEVYNIL  157 (359)
Q Consensus       145 A~~~~~~~~~~~L  157 (359)
                      |+..|+.+++++|
T Consensus        97 A~~~~~~~~~~~L  109 (110)
T 2zgd_A           97 SIDNGNEDLAEIL  109 (110)
T ss_dssp             HHHHTCHHHHHHH
T ss_pred             HHHcCCHHHHHHh
Confidence            9999999988776

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.86  E-value=2.7e-25  Score=209.55  Aligned_cols=178  Identities=21%  Similarity=0.187  Sum_probs=134.6

Q ss_pred             CcceeeccCCCCCcCcCCc--------ccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHH
Q 018204           41 NMRFSFGRQSSLDPIRRSP--------VQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIA  112 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A  112 (359)
                      +.+..++..|+.+.++.++        ..+......|.+|.||||+||..|+.++|++|+++|+|+|.+|..|+||||+|
T Consensus       127 t~Lh~Aa~~g~~~~v~~Ll~~~~~~ll~~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~L~~A  206 (373)
T 2fo1_E          127 TVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA  206 (373)
T ss_dssp             CHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHH
T ss_pred             CHHHHHHHCCCHHHHHHHHHHHHHHHHhcCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcccCCCCCCHHHHH
Confidence            3444567788888888876        34444445588999999999999999999999999999999999999999999


Q ss_pred             HHcCCHHHHHHHHhcC---CCccccccccccccccccccc---cceeEeeccccCccccc-----------cCCCCcccC
Q 018204          113 ACEGHVEVVKLLLSKK---ANIDARDRWGSTAAADAKYYG---NVEVYNILKARGAKVPK-----------TKRTPMTVA  175 (359)
Q Consensus       113 ~~~g~~~~v~~Ll~~g---a~~~~~d~~g~tpl~~A~~~~---~~~~~~~L~~~ga~~~~-----------~~~tpl~~a  175 (359)
                      +..|+.++|++|+++|   ++++..|..|+||||+|+..+   +.+++++|+++|++++.           .+.||++.|
T Consensus       207 ~~~g~~~~v~~Ll~~~~~~~~~~~~d~~g~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~d~~g~t~Lh~A  286 (373)
T 2fo1_E          207 AANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYA  286 (373)
T ss_dssp             HHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHHHH
T ss_pred             HHCCCHHHHHHHHhcCccccChhhcCCCCCCHHHHHHHhCCcchHHHHHHHHHCCCCcccccccccCcccccCCCHHHHH
Confidence            9999999999999998   899999999999999999887   88999999999998864           567888877


Q ss_pred             CCC---CCCcccCCcceeeEeeccCcccceeEEEEecCcEEEEEEe
Q 018204          176 NPR---EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKIL  218 (359)
Q Consensus       176 ~~~---~~~~~~l~~~~~~~~~~~~ig~g~~~~~~~~g~~vavK~l  218 (359)
                      ...   +..++++..........+..|.+++..+...|...+|+.|
T Consensus       287 ~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~L  332 (373)
T 2fo1_E          287 AQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYL  332 (373)
T ss_dssp             HSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHH
T ss_pred             HHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHH
Confidence            432   2233333222223333444556666555444544344433

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.86  E-value=1.3e-23  Score=189.85  Aligned_cols=141  Identities=24%  Similarity=0.265  Sum_probs=121.2

Q ss_pred             cCCCCCCcceeeccCCCCCcCcCCccccc-CCCCCCCCCccHHHHHH-----HcCCHHHHHHHHHcCCCCCCCCCCCCcH
Q 018204           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDE-LTVPENLDSTMQLLFMA-----CRGDVKGVEDLLNEGSDVNSIDLDGRTA  108 (359)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~t~l~~aa-----~~g~~~~v~~Ll~~ga~v~~~d~~g~Tp  108 (359)
                      .|....+.+..++..|+.+.++.+++.+. .....+.+|.||||+|+     ..|+.+++++|++.|++++..|..|+||
T Consensus       107 ~d~~g~T~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~tp  186 (276)
T 4hbd_A          107 ADSNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTA  186 (276)
T ss_dssp             CCTTSCCHHHHHHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCCH
T ss_pred             CCCCCCCHHHHHHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCCH
Confidence            34556666777888999999999998887 44455888999999999     6689999999999999999999999999


Q ss_pred             HHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccc-cCcccc---ccCCCCcccC
Q 018204          109 LHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKA-RGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       109 Lh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~-~ga~~~---~~~~tpl~~a  175 (359)
                      ||+|+..|+.++|++|+++|+|+|.+|..|+||||+|+..|+.+++++|++ .|++++   ..+.||++.|
T Consensus       187 Lh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~TpL~~A  257 (276)
T 4hbd_A          187 LMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGSTALMVA  257 (276)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCCCHHHHH
Confidence            999999999999999999999999999999999999999999999999998 898874   4566777776

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.86  E-value=3.2e-21  Score=179.56  Aligned_cols=148  Identities=22%  Similarity=0.367  Sum_probs=122.5

Q ss_pred             eEeeccCcccceeEEEE-----ecC-cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc------cccceeeEEeCC
Q 018204          191 QVRKADGITKGSYQVAK-----WNG-TKVWVKILDKESHKDPERINAFTHELTIVEKARHPN------VVQFVGAVTQNI  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g-~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~~~~~~~~  258 (359)
                      .|.....+|.|.|+.+.     ..+ ..+|+|++...    ....+.+..|+.+++.+.|++      ++.+++++....
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           20 RYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            46667778888887542     234 68999999632    344567889999999998766      889999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE---------------
Q 018204          259 PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---------------  321 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll---------------  321 (359)
                      ..++||||+ ++++.+++....  .+++..+..++.||+.||.|||+++   |+||||||+|||+               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            999999999 568888776653  6999999999999999999999998   9999999999999               


Q ss_pred             ----cCCCcEEEeccccccc------------cccCccccc
Q 018204          322 ----DNGGQLKISGFGLLRL------------QYISPEKAK  346 (359)
Q Consensus       322 ----~~~~~~kl~DFGla~~------------~~~~PE~~~  346 (359)
                          +.++.+||+|||+++.            .|+|||...
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~  212 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVIL  212 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHT
T ss_pred             cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeee
Confidence                5678899999999862            478888754

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.86  E-value=4.7e-23  Score=174.57  Aligned_cols=124  Identities=26%  Similarity=0.228  Sum_probs=110.4

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCC
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEGH  117 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d-~~g~TpLh~A~~~g~  117 (359)
                      ....++.++..|+.+.++.++. +......|.+|+||||+||..|+.++|++|++.|+|+|.+| ..|+||||+|+..|+
T Consensus        44 g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~  122 (183)
T 3deo_A           44 YETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVR  122 (183)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTC
T ss_pred             CCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCc
Confidence            3445667888999999999998 54445568899999999999999999999999999999999 999999999999999


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcc
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      .+++++|+++|++++.+|..|+||||+|+..++.+....++..++.
T Consensus       123 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~~l~~a~~  168 (183)
T 3deo_A          123 PEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR  168 (183)
T ss_dssp             HHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHHHTCCCCSHHHHHHH
T ss_pred             HHHHHHHHHcCCCCcCCCCCCCCHHHHHHHhccCcccccHHHHHHH
Confidence            9999999999999999999999999999998887777766666554

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.86  E-value=2.8e-23  Score=177.91  Aligned_cols=139  Identities=24%  Similarity=0.257  Sum_probs=122.9

Q ss_pred             CCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHH-HcCCCCCCCCCCCCcHHHHHHHc
Q 018204           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll-~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      ......+..++..|+.+.++.+++.+......+..|.||||+|+..|+.+++++|+ ..|++++.+|..|+||||+|+..
T Consensus        37 ~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~  116 (201)
T 3hra_A           37 TEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEK  116 (201)
T ss_dssp             TTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHT
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHc
Confidence            33445566778889999999999887766667889999999999999999999999 56789999999999999999999


Q ss_pred             CCHHHHHHHHhcC-CCcccccccccccccccccccc-----ceeEeeccccCcccc---ccCCCCcccC
Q 018204          116 GHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGN-----VEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       116 g~~~~v~~Ll~~g-a~~~~~d~~g~tpl~~A~~~~~-----~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      |+.+++++|++.| ++++.+|..|+||||+|+..++     .+++++|+++|++++   ..+.||++.|
T Consensus       117 ~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~l~~A  185 (201)
T 3hra_A          117 GHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNSGRTAMDYA  185 (201)
T ss_dssp             TCHHHHHHHHHHCCCCTTCCCTTSCCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             CCHHHHHHHHHcCCCCcCCCCCCCCCHHHHHHHhccchhhHHHHHHHHHHCCCCCCccCCCCCCHHHHH
Confidence            9999999999999 9999999999999999998887     899999999999985   4456777766

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.86  E-value=1.1e-22  Score=160.48  Aligned_cols=105  Identities=43%  Similarity=0.608  Sum_probs=99.4

Q ss_pred             CCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccccccc
Q 018204           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN  150 (359)
Q Consensus        71 ~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~  150 (359)
                      +|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+
T Consensus         1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~   80 (126)
T 1n0r_A            1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH   80 (126)
T ss_dssp             CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ceeEeeccccCcccc---ccCCCCcccC
Q 018204          151 VEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       151 ~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      .+++++|+++|++++   ..+.||++.+
T Consensus        81 ~~~~~~Ll~~g~~~~~~~~~g~t~l~~A  108 (126)
T 1n0r_A           81 LEVVKLLLEAGADVNAKDKNGRTPLHLA  108 (126)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHHHHHHcCCCCcccCCCCCCHHHHH
Confidence            999999999999874   4456777766

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.86  E-value=6.9e-23  Score=178.74  Aligned_cols=129  Identities=22%  Similarity=0.172  Sum_probs=109.0

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCC
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~-ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      ..+.++.++..|+++.++.+++.+......|.+|+||||+||..|+.++|++|++. |+++|.+|..|+||||+|+..|+
T Consensus        73 g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~  152 (222)
T 3ehr_A           73 IDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGY  152 (222)
T ss_dssp             ESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTC
T ss_pred             cccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCC
Confidence            34556677888999999999987766666788999999999999999999999999 99999999999999999999999


Q ss_pred             HHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccccc
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~  167 (359)
                      .++|++|+++|++++.+|..|.|||++|+..++.++++.|.+.|+.....
T Consensus       153 ~~~v~~Ll~~ga~~~~~~~~g~t~l~~A~~~~~~~~l~~l~~~~~~~~~~  202 (222)
T 3ehr_A          153 ADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLS  202 (222)
T ss_dssp             HHHHHHHHHHTCCSCCCCTTSCCHHHHCCSHHHHHHHC------------
T ss_pred             HHHHHHHHHcCCCCccccCCCCCHHHHhcchhHHHHHHHHhccchhhhcc
Confidence            99999999999999999999999999999999999999999999976433

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.86  E-value=1.2e-23  Score=191.02  Aligned_cols=180  Identities=17%  Similarity=0.091  Sum_probs=134.4

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      |....+.+..++..|+.+.++.+++.+......  +|+||||+||..|+.++|++|+++|+|+|.+|..|+||||+|+..
T Consensus        28 d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~--~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~  105 (285)
T 3kea_A           28 DVHGHSASYYAIADNNVRLVCTLLNAGALKNLL--ENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDS  105 (285)
T ss_dssp             CTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCC--TTCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHT
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCC--CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHc
Confidence            344555566777889999998888876443333  589999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCcccccccc-ccccccccccccceeEeeccccCccccc--cCCCCcccCCCC---CCCcccCCcce
Q 018204          116 GHVEVVKLLLSKKANIDARDRWG-STAAADAKYYGNVEVYNILKARGAKVPK--TKRTPMTVANPR---EVPEYELNPLE  189 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g-~tpl~~A~~~~~~~~~~~L~~~ga~~~~--~~~tpl~~a~~~---~~~~~~l~~~~  189 (359)
                      |+.++|++|+++|++++.+|..| .||||+|+..|+.+++++|+++|++...  .+.||++.|...   +..++++.. .
T Consensus       106 g~~~~v~~Ll~~ga~~~~~~~~g~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~-g  184 (285)
T 3kea_A          106 GNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPSTFDLAILLSCIHITIKNGHVDMMILLLDY-M  184 (285)
T ss_dssp             TCHHHHHHHHHHCGGGGGCSSSGGGSHHHHHHHTTCHHHHHHHHTTSCTTCCCSTHHHHHHHHHHTTCHHHHHHHHHH-H
T ss_pred             CCHHHHHHHHhcCCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHhCCCccccccCCccHHHHHHHcChHHHHHHHHHc-C
Confidence            99999999999999999999999 7999999999999999999999988732  567888877322   223333321 1


Q ss_pred             eeEeeccCcccce-eEEEEecCcEEEEEEe
Q 018204          190 LQVRKADGITKGS-YQVAKWNGTKVWVKIL  218 (359)
Q Consensus       190 ~~~~~~~~ig~g~-~~~~~~~g~~vavK~l  218 (359)
                      .+....+..|.++ +..+...|...+++.|
T Consensus       185 ad~n~~~~~g~t~~L~~A~~~~~~~~v~~L  214 (285)
T 3kea_A          185 TSTNTNNSLLFIPDIKLAIDNKDIEMLQAL  214 (285)
T ss_dssp             HHTCTTCCCBCCTTHHHHHHHTCHHHHHHH
T ss_pred             CCCCcccCCCCChHHHHHHHcCCHHHHHHH
Confidence            2222333344444 4444444444444444

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.86  E-value=1.7e-23  Score=188.44  Aligned_cols=127  Identities=26%  Similarity=0.325  Sum_probs=112.3

Q ss_pred             CCCCCcCcCCcccccC--------C---CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCC--------------
Q 018204           49 QSSLDPIRRSPVQDEL--------T---VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDL--------------  103 (359)
Q Consensus        49 ~~~~~~~~~~~~~~~~--------~---~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~--------------  103 (359)
                      .|+.+.++.+++.+..        .   ...|.+|.||||+||..|+.++|++|+++|+|+|.+|.              
T Consensus        67 ~g~~~~v~~Ll~~ga~~~~~~~~i~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~  146 (273)
T 2pnn_A           67 NGQNDTIALLLDVARKTDSLKQFVNASYTDSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFY  146 (273)
T ss_dssp             TTBCHHHHHHHHHHHHTTCHHHHHTCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCC
T ss_pred             cCChHHHHHHHHhhccccchhHHhhcccccccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCcccccccccccccccccc
Confidence            3888999988887532        1   12466899999999999999999999999999999997              


Q ss_pred             CCCcHHHHHHHcCCHHHHHHHHh---cCCCcccccccccccccccccccc---------ceeEeeccccCcccc------
Q 018204          104 DGRTALHIAACEGHVEVVKLLLS---KKANIDARDRWGSTAAADAKYYGN---------VEVYNILKARGAKVP------  165 (359)
Q Consensus       104 ~g~TpLh~A~~~g~~~~v~~Ll~---~ga~~~~~d~~g~tpl~~A~~~~~---------~~~~~~L~~~ga~~~------  165 (359)
                      .|+||||+|+..|+.++|++|++   .|+|++.+|..|+||||+|+..|+         .+++++|+++|++++      
T Consensus       147 ~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~  226 (273)
T 2pnn_A          147 FGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLE  226 (273)
T ss_dssp             SCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCCGG
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcccccccc
Confidence            89999999999999999999999   999999999999999999999887         789999999999864      


Q ss_pred             ----ccCCCCcccC
Q 018204          166 ----KTKRTPMTVA  175 (359)
Q Consensus       166 ----~~~~tpl~~a  175 (359)
                          ..+.||++.|
T Consensus       227 ~~~d~~g~TpL~~A  240 (273)
T 2pnn_A          227 EITNRKGLTPLALA  240 (273)
T ss_dssp             GCCCTTSCCHHHHH
T ss_pred             cccCCCCCCHHHHH
Confidence                4456777776

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.86  E-value=3.6e-23  Score=170.54  Aligned_cols=107  Identities=28%  Similarity=0.333  Sum_probs=99.6

Q ss_pred             CCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccc-cccccc
Q 018204           68 ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGST-AAADAK  146 (359)
Q Consensus        68 ~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t-pl~~A~  146 (359)
                      .+..|.||||+||..|+.++|++|+++|+++|.+|..|+||||+|+ .|+.++|++|+++|++++.+|..|+| |||+|+
T Consensus         8 ~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~   86 (156)
T 1bi7_B            8 SMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAA   86 (156)
T ss_dssp             --CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHH
T ss_pred             CCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHH
Confidence            3567999999999999999999999999999999999999999985 99999999999999999999999999 999999


Q ss_pred             ccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          147 YYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       147 ~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      ..|+.+++++|+++|++++   ..+.||++.+
T Consensus        87 ~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  118 (156)
T 1bi7_B           87 REGFLDTLVVLHRAGARLDVRDAWGRLPVDLA  118 (156)
T ss_dssp             HHTCHHHHHHHHHHTCCSSCCCTTCCCHHHHH
T ss_pred             HCCCHHHHHHHHHcCCCCcccCCCCCCHHHHH
Confidence            9999999999999999985   4567888877

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.85  E-value=1.6e-23  Score=186.94  Aligned_cols=130  Identities=16%  Similarity=0.135  Sum_probs=115.3

Q ss_pred             CCCCcceeeccCCCCCcCcCCcccccCCCCCC--------------CCCccHHHHHHHcCCHHHHHHHHH---cCCCCCC
Q 018204           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPEN--------------LDSTMQLLFMACRGDVKGVEDLLN---EGSDVNS  100 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~t~l~~aa~~g~~~~v~~Ll~---~ga~v~~  100 (359)
                      ...+.+..++..|+.+.++.+++.+......+              .+|.||||+||..|+.++|++|++   .|+|+|.
T Consensus        92 ~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~  171 (260)
T 3jxi_A           92 RGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQADLRR  171 (260)
T ss_dssp             ESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTC
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcc
Confidence            34455666778899999998888775555555              579999999999999999999999   9999999


Q ss_pred             CCCCCCcHHHHHHHcCC---------HHHHHHHHhcCCCc-------cccccccccccccccccccceeEeeccccCccc
Q 018204          101 IDLDGRTALHIAACEGH---------VEVVKLLLSKKANI-------DARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       101 ~d~~g~TpLh~A~~~g~---------~~~v~~Ll~~ga~~-------~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~  164 (359)
                      +|..|+||||+|+..|+         .+++++|+++|+++       +.+|..|+||||+|+..|+.+++++|+++|++.
T Consensus       172 ~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~  251 (260)
T 3jxi_A          172 QDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIAD  251 (260)
T ss_dssp             CCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred             cCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccccccchhhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCc
Confidence            99999999999999888         79999999999999       789999999999999999999999999999876


Q ss_pred             ccc
Q 018204          165 PKT  167 (359)
Q Consensus       165 ~~~  167 (359)
                      ...
T Consensus       252 ~~~  254 (260)
T 3jxi_A          252 AAA  254 (260)
T ss_dssp             HC-
T ss_pred             ccc
Confidence            433

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.85  E-value=5.4e-23  Score=197.40  Aligned_cols=169  Identities=24%  Similarity=0.263  Sum_probs=110.6

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      ..+..++..|+.+.++.+++.+......+.+|.||||+|+..|+.++|++|++.|+++|.+|..|+||||+|+..|+.++
T Consensus       214 t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~  293 (437)
T 1n11_A          214 TPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPV  293 (437)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHH
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHH
Confidence            33445556777777777776665555556677777777777777777777777777777777777777777777777777


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCCC---CCCCcccCCcceeeEee
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVANP---REVPEYELNPLELQVRK  194 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~~---~~~~~~~l~~~~~~~~~  194 (359)
                      +++|+++|++++.+|..|+||||+|+.+|+.+++++|+++|++++   ..+.||++.|..   .+..++++.. ..+...
T Consensus       294 ~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~~~g~t~L~~A~~~g~~~iv~~Ll~~-ga~~~~  372 (437)
T 1n11_A          294 ADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKN-GASPNE  372 (437)
T ss_dssp             HHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHT-TCCSCC
T ss_pred             HHHHHhCCccCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHCChHHHHHHHHHC-cCCCCC
Confidence            777777777777777777777777777777777777777777763   335677766522   2222333321 222333


Q ss_pred             ccCcccceeEEEEecC
Q 018204          195 ADGITKGSYQVAKWNG  210 (359)
Q Consensus       195 ~~~ig~g~~~~~~~~g  210 (359)
                      .+..|.+++.++...|
T Consensus       373 ~~~~g~t~l~~A~~~g  388 (437)
T 1n11_A          373 VSSDGTTPLAIAKRLG  388 (437)
T ss_dssp             CCSSSCCHHHHHHHTT
T ss_pred             CCCCCCCHHHHHHHcC
Confidence            4445566665554444

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.85  E-value=3.2e-23  Score=186.52  Aligned_cols=126  Identities=17%  Similarity=0.145  Sum_probs=113.6

Q ss_pred             CCCCcceeeccCCCCCcCcCCcccccCCCCCCC--------------CCccHHHHHHHcCCHHHHHHHHH---cCCCCCC
Q 018204           38 RRNNMRFSFGRQSSLDPIRRSPVQDELTVPENL--------------DSTMQLLFMACRGDVKGVEDLLN---EGSDVNS  100 (359)
Q Consensus        38 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~t~l~~aa~~g~~~~v~~Ll~---~ga~v~~  100 (359)
                      ...+.++.++..|+.+.++.+++.+......+.              +|.||||+||..|+.++|++|++   .|+|+|.
T Consensus       100 ~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~  179 (273)
T 2pnn_A          100 KGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPADISA  179 (273)
T ss_dssp             TTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTC
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCCCcee
Confidence            455556677789999999988888655444454              79999999999999999999999   9999999


Q ss_pred             CCCCCCcHHHHHHHcCC---------HHHHHHHHhcCCCcc-------ccccccccccccccccccceeEeeccccCcc
Q 018204          101 IDLDGRTALHIAACEGH---------VEVVKLLLSKKANID-------ARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       101 ~d~~g~TpLh~A~~~g~---------~~~v~~Ll~~ga~~~-------~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      +|..|+||||+|+..|+         .+++++|+++|+++|       .+|..|+||||+|+..|+.+++++|+++|+.
T Consensus       180 ~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~  258 (273)
T 2pnn_A          180 RDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH  258 (273)
T ss_dssp             CCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTC
T ss_pred             eCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcccccccccccCCCCCCHHHHHHHhChHHHHHHHHHCCCC
Confidence            99999999999999998         899999999999997       4899999999999999999999999999994

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.85  E-value=4.8e-21  Score=184.07  Aligned_cols=134  Identities=28%  Similarity=0.384  Sum_probs=107.5

Q ss_pred             eeccCcccceeEEE----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEEEecC
Q 018204          193 RKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       193 ~~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      ...+.+|.|+|+.+    ..+|..||||.+....      .+.+.+|+.++..+ +||||+++++++.....+|+|||||
T Consensus        18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            33455677776533    4578999999986432      23577899999876 8999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-------------CcE
Q 018204          268 AKGDLASYLQKKGRL-------SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-------------GQL  327 (359)
Q Consensus       268 ~~gsL~~~l~~~~~l-------~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~-------------~~~  327 (359)
                      . |+|.+++......       ++..+..++.||+.||.|||+++   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 5999999875432       22245679999999999999998   9999999999999754             489


Q ss_pred             EEecccccc
Q 018204          328 KISGFGLLR  336 (359)
Q Consensus       328 kl~DFGla~  336 (359)
                      ||+|||+++
T Consensus       168 kL~DFG~a~  176 (434)
T 2rio_A          168 LISDFGLCK  176 (434)
T ss_dssp             EECCCTTCE
T ss_pred             EEcccccce
Confidence            999999986

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.85  E-value=6.6e-23  Score=186.05  Aligned_cols=138  Identities=23%  Similarity=0.195  Sum_probs=121.9

Q ss_pred             CCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018204           37 PRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (359)
Q Consensus        37 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g  116 (359)
                      ....+.+..++..|+.+.++.+++.+......|.+|.||||+||..|+.++|++|++.|+++|.+|..|+||||+|+..|
T Consensus        57 ~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~  136 (285)
T 3d9h_A           57 VSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSG  136 (285)
T ss_dssp             CCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHT
T ss_pred             ccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcC
Confidence            33445566778899999999999887665566889999999999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          117 HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       117 ~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +.++|++|+++|++++..+ .|.||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus       137 ~~~~v~~Ll~~g~~~~~~~-~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A  197 (285)
T 3d9h_A          137 SWDCVNLLLQHGASVQPES-DLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLA  197 (285)
T ss_dssp             CHHHHHHHHHTTCCSSCSC-TTSCHHHHHHHHTCHHHHHHHHHTTCCTTCCBTTTBCHHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCC-CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHH
Confidence            9999999999999998754 59999999999999999999999999884   4456888776

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.85  E-value=1e-22  Score=180.68  Aligned_cols=103  Identities=30%  Similarity=0.321  Sum_probs=57.0

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEGHVEVV  121 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d-~~g~TpLh~A~~~g~~~~v  121 (359)
                      ++.++..|+.+.++.++. +......|.+|+||||+||..|+.++|++|+++|+|+|.+| ..|+||||+||..|+.++|
T Consensus        49 L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v  127 (244)
T 3ui2_A           49 WWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVV  127 (244)
T ss_dssp             HHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHH
T ss_pred             HHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHH
Confidence            344455555555555555 32223335555555555555555555555555555555555 5555555555555555555


Q ss_pred             HHHHhcCCCcccccccccccccccc
Q 018204          122 KLLLSKKANIDARDRWGSTAAADAK  146 (359)
Q Consensus       122 ~~Ll~~ga~~~~~d~~g~tpl~~A~  146 (359)
                      ++|+++|+|++.+|..|+||||+|+
T Consensus       128 ~~Ll~~ga~~~~~d~~g~t~l~~A~  152 (244)
T 3ui2_A          128 EALVELGADIEVEDERGLTALELAR  152 (244)
T ss_dssp             HHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred             HHHHHCCCCCCCCCCCCCcHHHHHH
Confidence            5555555555555555555555554

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.85  E-value=6.2e-23  Score=185.44  Aligned_cols=114  Identities=31%  Similarity=0.349  Sum_probs=106.4

Q ss_pred             cCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHh-
Q 018204           48 RQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS-  126 (359)
Q Consensus        48 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~-  126 (359)
                      ..++.+.++.++..+......+.+|.||||+||..|+.++|++|++.|+|+|.+|..|+||||+|+..|+.++|++|++ 
T Consensus       159 ~~~~~~~v~~Ll~~g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~  238 (276)
T 4hbd_A          159 TQDDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAV  238 (276)
T ss_dssp             SHHHHHHHHHHHHHSCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTS
T ss_pred             hhhhHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhc
Confidence            4566777888888887777778899999999999999999999999999999999999999999999999999999999 


Q ss_pred             cCCCccccccccccccccccccccceeEeeccccC
Q 018204          127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (359)
Q Consensus       127 ~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g  161 (359)
                      .|+|++.+|..|+||||+|+..|+.+++++|++++
T Consensus       239 ~gad~~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~~  273 (276)
T 4hbd_A          239 PSCDISLTDRDGSTALMVALDAGQSEIASMLYSRM  273 (276)
T ss_dssp             TTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHHC
T ss_pred             CCCCCcCcCCCCCCHHHHHHHcCCHHHHHHHHhcc
Confidence            89999999999999999999999999999999875

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.85  E-value=2.8e-23  Score=185.08  Aligned_cols=127  Identities=18%  Similarity=0.162  Sum_probs=114.4

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCC-------------CccHHHHHHHcCCHHHHHHHHH---cCCCCCCCC
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLD-------------STMQLLFMACRGDVKGVEDLLN---EGSDVNSID  102 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~t~l~~aa~~g~~~~v~~Ll~---~ga~v~~~d  102 (359)
                      ..+.+..++..|+.+.++.+++.+......+..             |.||||+||..|+.++|++|++   .|+|+|.+|
T Consensus        90 g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d  169 (256)
T 2etb_A           90 GHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATD  169 (256)
T ss_dssp             TCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCC
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccC
Confidence            445566777889999999888886555445554             9999999999999999999999   999999999


Q ss_pred             CCCCcHHHHHHH--cCCHH-------HHHHHHhcCCCc-------cccccccccccccccccccceeEeeccccCcccc
Q 018204          103 LDGRTALHIAAC--EGHVE-------VVKLLLSKKANI-------DARDRWGSTAAADAKYYGNVEVYNILKARGAKVP  165 (359)
Q Consensus       103 ~~g~TpLh~A~~--~g~~~-------~v~~Ll~~ga~~-------~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~  165 (359)
                      ..|+||||+|+.  .++.+       +|++|+++|+|+       +.+|..|+||||+|+..|+.+++++|+++|++..
T Consensus       170 ~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~  248 (256)
T 2etb_A          170 SLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGA  248 (256)
T ss_dssp             TTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHSTTCCGGGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCcccccccccccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCCC
Confidence            999999999999  88998       999999999999       9999999999999999999999999999998763

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.85  E-value=7.5e-23  Score=181.53  Aligned_cols=127  Identities=28%  Similarity=0.262  Sum_probs=108.2

Q ss_pred             eeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHH
Q 018204           45 SFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLL  124 (359)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~L  124 (359)
                      -.+..|..+.+.......   ...+.+|.||||+||..|+.++|++|++ |+|+|.+|..|+||||+||..|+.++|++|
T Consensus        21 ~~~~~g~~~~~~~~~~~~---~~~~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~L   96 (244)
T 3ui2_A           21 IEWKDGHSPSWVPSSYIA---ADVVSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLL   96 (244)
T ss_dssp             EEESSCCCCEEEEGGGSC---HHHHHHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHH
T ss_pred             HHHHcCCCcccccccccc---cccccCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHH
Confidence            344455555544433221   2234579999999999999999999999 999999999999999999999999999999


Q ss_pred             HhcCCCccccc-cccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          125 LSKKANIDARD-RWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       125 l~~ga~~~~~d-~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +++|+++|.+| ..|+||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus        97 l~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A  151 (244)
T 3ui2_A           97 AEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDERGLTALELA  151 (244)
T ss_dssp             HHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHH
T ss_pred             HHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHH
Confidence            99999999999 889999999999999999999999999984   5567888776

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.85  E-value=1.2e-22  Score=178.71  Aligned_cols=141  Identities=23%  Similarity=0.180  Sum_probs=104.2

Q ss_pred             cCCCCCCcceeeccCCCCCcCcCCcc----cccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHH
Q 018204           35 FDPRRNNMRFSFGRQSSLDPIRRSPV----QDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALH  110 (359)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh  110 (359)
                      .|....+.++.++..|+++.++.+++    .+......|.+|.||||+|+..|+.+++++|++.|++++.+|..|+||||
T Consensus         5 ~d~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~   84 (241)
T 1k1a_A            5 ADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAH   84 (241)
T ss_dssp             --CTTCCHHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred             cCCCCCcHHHHHHHcCCHHHHHHHHHHHHhcCCCCCcccccCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHH
Confidence            34555556667777788777777765    33333444677888888888888888888888888888888888888888


Q ss_pred             HHHHcCCHHHHHHHHhcCC----CccccccccccccccccccccceeEeeccccCcccc----ccCCCCcccC
Q 018204          111 IAACEGHVEVVKLLLSKKA----NIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP----KTKRTPMTVA  175 (359)
Q Consensus       111 ~A~~~g~~~~v~~Ll~~ga----~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~----~~~~tpl~~a  175 (359)
                      +|+..|+.+++++|++.|+    +++..|..|+||||+|+..|+.+++++|+++|++++    ..+.||++.+
T Consensus        85 ~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A  157 (241)
T 1k1a_A           85 LACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHA  157 (241)
T ss_dssp             HHHHTTCHHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHH
T ss_pred             HHHHcCCHHHHHHHHHcCCCccccccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHH
Confidence            8888888888888888876    777888888888888888888888888888887764    3345666665

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.85  E-value=8.6e-23  Score=191.40  Aligned_cols=126  Identities=9%  Similarity=0.003  Sum_probs=110.6

Q ss_pred             CCCcceeeccCC--CCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCC-----CCCCCCCCCcHHHH
Q 018204           39 RNNMRFSFGRQS--SLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSD-----VNSIDLDGRTALHI  111 (359)
Q Consensus        39 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~-----v~~~d~~g~TpLh~  111 (359)
                      ....+..++..|  ..+.++.+++.+......|.+|.||||+||..|+.++|++|++.|++     +|.+|..|+||||+
T Consensus       138 g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~  217 (364)
T 3ljn_A          138 GQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHW  217 (364)
T ss_dssp             CCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHH
T ss_pred             CCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHH
Confidence            444555667777  78888888888666566688899999999999999999999999988     99999999999999


Q ss_pred             HHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccc
Q 018204          112 AACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       112 A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~  164 (359)
                      ||..|+.++|++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++.
T Consensus       218 A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~  270 (364)
T 3ljn_A          218 AILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVF  270 (364)
T ss_dssp             HHTTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTCCHHHHHHHHHHSCHH
T ss_pred             HHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhChHHHHHHHHHcCCch
Confidence            99999999999999999999999999999999999999999999999998875

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.85  E-value=2.1e-22  Score=177.01  Aligned_cols=135  Identities=24%  Similarity=0.289  Sum_probs=81.6

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      ..+..++..|+.+.++.+++.+......+.+|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.++
T Consensus        13 t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~   92 (237)
T 3b7b_A           13 SPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEV   92 (237)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHH
T ss_pred             CHHHHHHHcCcHHHHHHHHHcCCCcCccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHH
Confidence            33444555666666666655554444445566666666666666666666666666666666666666666666666666


Q ss_pred             HHHHHhcC-CCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          121 VKLLLSKK-ANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       121 v~~Ll~~g-a~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +++|++.| ++++..|..|+||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus        93 ~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A  151 (237)
T 3b7b_A           93 VQYLLSNGQMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWA  151 (237)
T ss_dssp             HHHHHTTTCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHHhCCCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHH
Confidence            66666665 5666666666666666666666666666666666553   2344555544

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.84  E-value=5.6e-23  Score=192.64  Aligned_cols=108  Identities=16%  Similarity=0.160  Sum_probs=83.9

Q ss_pred             CCCCCccHHHHHHHcC--CHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCC-----cccccccccc
Q 018204           68 ENLDSTMQLLFMACRG--DVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN-----IDARDRWGST  140 (359)
Q Consensus        68 ~~~~~~t~l~~aa~~g--~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~-----~~~~d~~g~t  140 (359)
                      .+.+|.||||+||..|  +.++|++|++.|+|+|.+|..|+||||+|+..|+.++|++|+++|++     +|.+|..|+|
T Consensus       134 ~~~~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t  213 (364)
T 3ljn_A          134 KHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNS  213 (364)
T ss_dssp             EEESCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCC
T ss_pred             CCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCc
Confidence            4556778888888888  78888888888888888888888888888888888888888887777     7788888888


Q ss_pred             ccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          141 AAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       141 pl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      |||+|+..|+.+++++|+++|++++   ..+.||++.|
T Consensus       214 ~L~~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A  251 (364)
T 3ljn_A          214 HLHWAILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLS  251 (364)
T ss_dssp             TTHHHHTTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHH
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence            8888888888888888888887764   3456676665

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.84  E-value=6.9e-23  Score=185.96  Aligned_cols=127  Identities=20%  Similarity=0.167  Sum_probs=112.2

Q ss_pred             eccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH
Q 018204           46 FGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL  125 (359)
Q Consensus        46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll  125 (359)
                      ..+..+...+.+++...+ ....|.+|.||||+||..|+.++|++|++.|+++|.+|  |+||||+|+..|+.++|++|+
T Consensus         6 ~i~~~~~~~v~~lL~~~~-~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll   82 (285)
T 3kea_A            6 RINTWKSKQLKSFLSSKD-TFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILL   82 (285)
T ss_dssp             TGGGCCHHHHHHHHHSTT-TTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHH
T ss_pred             HHHhcCHHHHHHHHHhCC-CCccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHH
Confidence            344556666777776664 34568899999999999999999999999999999984  999999999999999999999


Q ss_pred             hcCCCccccccccccccccccccccceeEeeccccCcccccc---C-CCCcccC
Q 018204          126 SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT---K-RTPMTVA  175 (359)
Q Consensus       126 ~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~---~-~tpl~~a  175 (359)
                      ++|++++.+|..|+||||+|+..|+.+++++|+++|++++..   + .||++.+
T Consensus        83 ~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~~t~L~~A  136 (285)
T 3kea_A           83 FSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHA  136 (285)
T ss_dssp             HTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCSSSGGGSHHHHH
T ss_pred             HCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCccCCCCCCCHHHHH
Confidence            999999999999999999999999999999999999998543   4 5888776

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.84  E-value=1.9e-22  Score=181.45  Aligned_cols=125  Identities=26%  Similarity=0.266  Sum_probs=115.4

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCC-CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v  121 (359)
                      ++.+++.|+++.++.+++.+...... +..|+||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+.+++
T Consensus         9 L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v   88 (285)
T 1wdy_A            9 LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLL   88 (285)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHH
Confidence            45677889999999999887554444 77899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCccccccccccccccccccccceeEeeccccCcccccc
Q 018204          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT  167 (359)
Q Consensus       122 ~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~  167 (359)
                      ++|+++|++++.+|..|+||||+|+..|+.+++++|+++|++++..
T Consensus        89 ~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~  134 (285)
T 1wdy_A           89 KLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLR  134 (285)
T ss_dssp             HHHHHTTCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             HHHHHcCCCCCccCcccCCHHHHHHHhCCHHHHHHHHHhCCCcccc
Confidence            9999999999999999999999999999999999999999988544

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.84  E-value=2.7e-23  Score=176.72  Aligned_cols=125  Identities=13%  Similarity=0.088  Sum_probs=104.6

Q ss_pred             cceeeccCCCCC----cCcCCcccccCCCCCCCCCccHHHHHHHcCC------HHHHHHHHHcCCCCCCCCCCCC-cHHH
Q 018204           42 MRFSFGRQSSLD----PIRRSPVQDELTVPENLDSTMQLLFMACRGD------VKGVEDLLNEGSDVNSIDLDGR-TALH  110 (359)
Q Consensus        42 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~------~~~v~~Ll~~ga~v~~~d~~g~-TpLh  110 (359)
                      .+..++..|+.+    .++.+++.+.....+|.+|+||||+|+..|+      .++|++||++|||||.+|..|+ ||||
T Consensus        41 ~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh  120 (186)
T 3t8k_A           41 ILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFK  120 (186)
T ss_dssp             HHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTG
T ss_pred             HHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHH
Confidence            344445555433    4556666665555669999999999999987      6889999999999999999999 9999


Q ss_pred             HHHHcC-----CHHHHHHHHh-cCCCccccccccccccccccccccceeEeeccccCccccc
Q 018204          111 IAACEG-----HVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPK  166 (359)
Q Consensus       111 ~A~~~g-----~~~~v~~Ll~-~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~  166 (359)
                      +|+..|     +.+++++|++ +|+|++.+|..|.||||+|+..|+.+++++|.+...+.+.
T Consensus       121 ~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~~~~~  182 (186)
T 3t8k_A          121 NIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKYNL  182 (186)
T ss_dssp             GGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHHHHTC
T ss_pred             HHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHHHHhc
Confidence            999944     4679999999 9999999999999999999999999999999987665443

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.84  E-value=5.5e-23  Score=190.33  Aligned_cols=134  Identities=19%  Similarity=0.120  Sum_probs=78.2

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCC---HHHHHHHHHcC-CCCCCCCCCCCcHHHHHHH----
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGD---VKGVEDLLNEG-SDVNSIDLDGRTALHIAAC----  114 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~---~~~v~~Ll~~g-a~v~~~d~~g~TpLh~A~~----  114 (359)
                      ++.++..|+.+.++.+++.+......|.+|+||||+||..|+   .++++.|++.+ +++|.+|..|+||||+|+.    
T Consensus       135 Lh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~~~d~~g~tpLh~A~~~~~~  214 (327)
T 1sw6_A          135 LHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHIIITSGM  214 (327)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHHHHHHHHTS
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccccCCCCCCCCHHHHHHHHccc
Confidence            334444555555555555443333445555555555555555   45555555554 4555555555555555555    


Q ss_pred             cCCHHHHHHHHhcCC---------------------------------------------Cccccccccccccccccccc
Q 018204          115 EGHVEVVKLLLSKKA---------------------------------------------NIDARDRWGSTAAADAKYYG  149 (359)
Q Consensus       115 ~g~~~~v~~Ll~~ga---------------------------------------------~~~~~d~~g~tpl~~A~~~~  149 (359)
                      .|+.++|++|++.++                                             ++|.+|..|+||||+|+..|
T Consensus       215 ~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~~n~~d~~G~TpLh~A~~~g  294 (327)
T 1sw6_A          215 TGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARLG  294 (327)
T ss_dssp             TTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHHHHHHHHC
T ss_pred             cccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHcC
Confidence            566666666666532                                             46666667777777777777


Q ss_pred             cceeEeeccccCccc---cccCCCCcccCC
Q 018204          150 NVEVYNILKARGAKV---PKTKRTPMTVAN  176 (359)
Q Consensus       150 ~~~~~~~L~~~ga~~---~~~~~tpl~~a~  176 (359)
                      +.+++++|+++|+++   +..++||+++|.
T Consensus       295 ~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~  324 (327)
T 1sw6_A          295 NISIVDALLDYGADPFIANKSGLRPVDFGA  324 (327)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred             CHHHHHHHHHcCCCCcccCCCCCCHHHHHH
Confidence            777777777777776   334566766653

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.84  E-value=4e-22  Score=186.95  Aligned_cols=121  Identities=25%  Similarity=0.303  Sum_probs=106.1

Q ss_pred             ceeeccC-CCCCcCcCCcccccCCCCCC--CCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHH
Q 018204           43 RFSFGRQ-SSLDPIRRSPVQDELTVPEN--LDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVE  119 (359)
Q Consensus        43 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~  119 (359)
                      ++.++.. |+++.++.++..+......+  .+|.||||+||..|+.++|++||++|+|+|.+|..|+||||+|+..|+.+
T Consensus       203 L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~  282 (368)
T 3jue_A          203 LFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTG  282 (368)
T ss_dssp             HHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHH
T ss_pred             HHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHH
Confidence            3455666 88888888887776555555  78999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCccccccccccccccccccccceeEeeccccCcc
Q 018204          120 VVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       120 ~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      +|++|+++|||++.+|..|.||||+|+..++.+++++|+..+..
T Consensus       283 ~v~~LL~~Gad~~~~d~~G~TpL~~A~~~g~~~iv~lLl~~~~~  326 (368)
T 3jue_A          283 LACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLRLAKMR  326 (368)
T ss_dssp             HHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHC-
T ss_pred             HHHHHHHCcCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence            99999999999999999999999999999999999999987753

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.84  E-value=2e-22  Score=193.41  Aligned_cols=121  Identities=26%  Similarity=0.230  Sum_probs=64.7

Q ss_pred             eeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHH
Q 018204           44 FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL  123 (359)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~  123 (359)
                      ..++..|+++.++.+++.+......+..|.||||+||..|+.++|++|++.|+++|.+|.+|+||||+||..|+.++|++
T Consensus        19 ~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~   98 (437)
T 1n11_A           19 HVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKL   98 (437)
T ss_dssp             HHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHHHHHH
T ss_pred             HHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHH
Confidence            33444555555555555443333334455555555555555555555555555555555555555555555555555555


Q ss_pred             HHhcCCCccccccccccccccccccccceeEeeccccCccc
Q 018204          124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       124 Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~  164 (359)
                      |+++|++++..|..|.||||+|+..|+.+++++|++++++.
T Consensus        99 Ll~~ga~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~  139 (437)
T 1n11_A           99 LLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQ  139 (437)
T ss_dssp             HHHHTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCS
T ss_pred             HHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCC
Confidence            55555555555555555555555555555555555555443

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.83  E-value=8.8e-22  Score=177.02  Aligned_cols=130  Identities=20%  Similarity=0.162  Sum_probs=117.3

Q ss_pred             CCCcceeeccCCCCCcCcCCccc-ccCCCCCCCCCccHHHHHHHcCC----HHHHHHHHHcCCCCCCCCCCCCcHHHHHH
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQ-DELTVPENLDSTMQLLFMACRGD----VKGVEDLLNEGSDVNSIDLDGRTALHIAA  113 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~l~~aa~~g~----~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~  113 (359)
                      ....+..++..|+.+.++.+++. +......+..|.||||+|+..|+    .+++++|++.|+|+|.+|..|+||||+|+
T Consensus       148 g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~  227 (285)
T 1wdy_A          148 GATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV  227 (285)
T ss_dssp             CCCHHHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHH
T ss_pred             CCcHHHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHH
Confidence            44556667778999999999987 44444558899999999999999    99999999999999999999999999999


Q ss_pred             HcCCHHHHHHHHh-cCCCccccccccccccccccccccceeEeeccccCccccccC
Q 018204          114 CEGHVEVVKLLLS-KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (359)
Q Consensus       114 ~~g~~~~v~~Ll~-~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~  168 (359)
                      ..|+.++|++|++ .|++++.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus       228 ~~~~~~~v~~Ll~~~g~~~~~~~~~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~d  283 (285)
T 1wdy_A          228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD  283 (285)
T ss_dssp             HTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred             HcCCHHHHHHHHhccCCCccccCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCCccc
Confidence            9999999999999 799999999999999999999999999999999999987654

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.83  E-value=6.8e-22  Score=173.35  Aligned_cols=141  Identities=19%  Similarity=0.182  Sum_probs=122.1

Q ss_pred             cCCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHH
Q 018204           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAA  113 (359)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d-~~g~TpLh~A~  113 (359)
                      +|.......+.++..|+++.++.+++.+......+.+|.||||+|+..|+.++|++|++.|++++..+ ..|+||||+|+
T Consensus         5 ~d~~~~~~l~~A~~~g~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~   84 (240)
T 3eu9_A            5 IDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWAT   84 (240)
T ss_dssp             CSCGGGCCHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHH
T ss_pred             cccccchHHHHHHHcCChHHHHHHHHcCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHH
Confidence            45555666778889999999999998876656668889999999999999999999999999988655 55999999999


Q ss_pred             HcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          114 CEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       114 ~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      ..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||++.+
T Consensus        85 ~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a  149 (240)
T 3eu9_A           85 RQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWA  149 (240)
T ss_dssp             HHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             HcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCccccCCCCCcHHHHH
Confidence            9999999999999999999999999999999999999999999999999874   3456777765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=1.1e-20  Score=171.25  Aligned_cols=137  Identities=12%  Similarity=0.004  Sum_probs=104.7

Q ss_pred             eccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcH---------------HHHHHHHHHHHHHHhCCCCccccceeeE
Q 018204          194 KADGITKGSYQVA---KW-NGTKVWVKILDKESHKDP---------------ERINAFTHELTIVEKARHPNVVQFVGAV  254 (359)
Q Consensus       194 ~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~---------------~~~~~~~~Ei~il~~l~HpnIv~l~~~~  254 (359)
                      ....+|.|.|+.+   .. +|..+|+|.+........               .....+.+|+.+++.++  | +++.+++
T Consensus        94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~  170 (282)
T 1zar_A           94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY  170 (282)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred             ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence            4456788877643   22 588999999964321110               23467899999999999  5 6666655


Q ss_pred             EeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       255 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                      .. +..|+||||++|++|.+ +..      .....++.|++.||.|||+++   |+||||||+|||++ ++.+||+|||+
T Consensus       171 ~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          171 AW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             EE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             ec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            44 55799999999999988 421      234579999999999999999   99999999999999 99999999999


Q ss_pred             cccc--ccCcccc
Q 018204          335 LRLQ--YISPEKA  345 (359)
Q Consensus       335 a~~~--~~~PE~~  345 (359)
                      |+..  +++||..
T Consensus       239 a~~~~~~~a~e~l  251 (282)
T 1zar_A          239 SVEVGEEGWREIL  251 (282)
T ss_dssp             CEETTSTTHHHHH
T ss_pred             CeECCCCCHHHHH
Confidence            9843  6677654

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.83  E-value=8.6e-22  Score=182.59  Aligned_cols=133  Identities=23%  Similarity=0.295  Sum_probs=120.1

Q ss_pred             eeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHc---CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           44 FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACR---GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~---g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      +.++..++.+.+..++.........+..|.||||+|+..   +..+++++|++.|+|+|.+|..|+||||+|+..|+.++
T Consensus       183 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~t~L~~A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~  262 (351)
T 3utm_A          183 LQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDV  262 (351)
T ss_dssp             HHHHHTTCHHHHHHHTTTCCTTCCCTTTCCCHHHHHHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred             HHHHHhccHHHHHHHHHhhcccccCCCCCCCHHHHHHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHH
Confidence            345667777888888887777777888999999999999   55899999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      |++|+++|+|+|.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||++++.
T Consensus       263 v~~Ll~~ga~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~gad~~~~~~~g~tal~~a~  321 (351)
T 3utm_A          263 MEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN  321 (351)
T ss_dssp             HHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHSC
T ss_pred             HHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCChhhhhh
Confidence            999999999999999999999999999999999999999999984   45677887773

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.82  E-value=1.2e-20  Score=180.24  Aligned_cols=153  Identities=17%  Similarity=0.226  Sum_probs=112.9

Q ss_pred             eeeEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC-Cccccc---------e--
Q 018204          189 ELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQF---------V--  251 (359)
Q Consensus       189 ~~~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l---------~--  251 (359)
                      ...+.....+|+|.|+.+   .  .+|+.||||++...........+.|.+|+.++..+.| .|....         .  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345666778899999855   2  2489999999975544444445678999999999987 221111         1  


Q ss_pred             ----------eeEEe-----CCcEEEEEecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 018204          252 ----------GAVTQ-----NIPMMIVLEYHAKGDLASYLQK-------KGRLSPSKVLRFALDLARGMNYLHECKPDPI  309 (359)
Q Consensus       252 ----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~i  309 (359)
                                .++..     ....+++|+++ +++|.++++.       ...+++..+..++.||+.||.|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                      11111     12467788876 5799998852       123778888999999999999999999   9


Q ss_pred             EeCCCCCCcEEEcCCCcEEEecccccc-----------ccccCcccc
Q 018204          310 IHCDLKPKNILLDNGGQLKISGFGLLR-----------LQYISPEKA  345 (359)
Q Consensus       310 iHrDlk~~NIll~~~~~~kl~DFGla~-----------~~~~~PE~~  345 (359)
                      |||||||+|||++.++.+||+|||+++           ..|+|||..
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~  279 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT  279 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCccccCCCCceeCchhh
Confidence            999999999999999999999999986           358889876

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.82  E-value=7.8e-22  Score=185.84  Aligned_cols=178  Identities=23%  Similarity=0.188  Sum_probs=105.9

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcC---CCCCCCCCCCCcHHHHHHHcC
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG---SDVNSIDLDGRTALHIAACEG  116 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~g---a~v~~~d~~g~TpLh~A~~~g  116 (359)
                      .+.+..++..|+.+.++.+++.+......+.+|.||||+||..|+.++|++|++.|   ++++.+|..|+||||+|+..|
T Consensus       167 ~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~~g~t~L~~A~~~~  246 (373)
T 2fo1_E          167 NTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNE  246 (373)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSC
T ss_pred             CCHHHHHHHcChHHHHHHHHHCCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHhcCccccChhhcCCCCCCHHHHHHHhC
Confidence            33444555666666666666665544455666777777777777777777777766   677777777777777777666


Q ss_pred             ---CHHHHHHHHhcCCCccc--------cccccccccccccccccceeEeeccccC-cccc---ccCCCCcccCC---CC
Q 018204          117 ---HVEVVKLLLSKKANIDA--------RDRWGSTAAADAKYYGNVEVYNILKARG-AKVP---KTKRTPMTVAN---PR  178 (359)
Q Consensus       117 ---~~~~v~~Ll~~ga~~~~--------~d~~g~tpl~~A~~~~~~~~~~~L~~~g-a~~~---~~~~tpl~~a~---~~  178 (359)
                         +.+++++|+++|++++.        +|..|+||||+|+..|+.+++++|++++ ++++   ..+.||++.|.   ..
T Consensus       247 ~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~  326 (373)
T 2fo1_E          247 GRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRI  326 (373)
T ss_dssp             STTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCH
T ss_pred             CcchHHHHHHHHHCCCCcccccccccCcccccCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCH
Confidence               67777777777777665        4556777777777777777777777654 5553   34556666652   22


Q ss_pred             CCCcccCCcceeeEeeccCcccceeEEEEecCcEEEEEEe
Q 018204          179 EVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKIL  218 (359)
Q Consensus       179 ~~~~~~l~~~~~~~~~~~~ig~g~~~~~~~~g~~vavK~l  218 (359)
                      +..++++.. ..+....+..|.+++..+...|+..+++.|
T Consensus       327 ~iv~~Ll~~-gad~~~~d~~g~t~l~~A~~~g~~~iv~~L  365 (373)
T 2fo1_E          327 EVVMYLIQQ-GASVEAVDATDHTARQLAQANNHHNIVDIF  365 (373)
T ss_dssp             HHHHHHHHT-TCCSSCCCSSSCCHHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHHHc-CCCccCCCCCCCCHHHHHHHcCCHHHHHHH
Confidence            222333321 222333344455555555555544444443

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.81  E-value=3.2e-21  Score=178.73  Aligned_cols=132  Identities=21%  Similarity=0.175  Sum_probs=98.4

Q ss_pred             cceeeccCCCCCcCcCCcccccCCC-CCCCCCccHHHHHHHcCC----HHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcC
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELTV-PENLDSTMQLLFMACRGD----VKGVEDLLNEGSDVNSIDLDGRTALHIAACEG  116 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~t~l~~aa~~g~----~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g  116 (359)
                      .+..++..|+.+.++.++...+.++ ..+..|.|+||+++..++    .+++++|+++|+|+|.+|..|+||||+|+..|
T Consensus       171 ~L~~A~~~g~~~~v~~LL~~~gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~  250 (337)
T 4g8k_A          171 ALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKK  250 (337)
T ss_dssp             HHHHHHHHTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTT
T ss_pred             HHHHHHHCCCHHHHHHHHhccCCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhh
Confidence            3455667788887777776544444 347778888887766433    35677888888888888888888888888888


Q ss_pred             CHHHHHHHHhc-CCCccccccccccccccccccccceeEeeccccCccccccCCCCcccC
Q 018204          117 HVEVVKLLLSK-KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVA  175 (359)
Q Consensus       117 ~~~~v~~Ll~~-ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~~tpl~~a  175 (359)
                      +.++|++|++. |+++|.+|..|+||||+|+..|+.+++++|+++|++++..  +|++.|
T Consensus       251 ~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~--~~L~~A  308 (337)
T 4g8k_A          251 HLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG--DLVMTA  308 (337)
T ss_dssp             CHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC--CHHHHH
T ss_pred             hhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC--CHHHHH
Confidence            88888888875 7888888888888888888888888888888888877643  466655

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.81  E-value=3.4e-22  Score=184.96  Aligned_cols=108  Identities=14%  Similarity=0.078  Sum_probs=95.3

Q ss_pred             CcCcCCcccccCCCC--CCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC---HHHHHHHHhc
Q 018204           53 DPIRRSPVQDELTVP--ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH---VEVVKLLLSK  127 (359)
Q Consensus        53 ~~~~~~~~~~~~~~~--~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~---~~~v~~Ll~~  127 (359)
                      ..+.+++...+.+++  .|.+|+||||+||..|+.++|++||++|+|+|.+|..|+||||+|+..|+   .++++.|++.
T Consensus       110 ~~~~~~l~~~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~  189 (327)
T 1sw6_A          110 QEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDY  189 (327)
T ss_dssp             HHHHHHCTTSCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHH
T ss_pred             HHHHHHHHhcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHh
Confidence            344444444444444  58899999999999999999999999999999999999999999999999   7899999998


Q ss_pred             C-CCccccccccccccccccc----cccceeEeecccc
Q 018204          128 K-ANIDARDRWGSTAAADAKY----YGNVEVYNILKAR  160 (359)
Q Consensus       128 g-a~~~~~d~~g~tpl~~A~~----~~~~~~~~~L~~~  160 (359)
                      + ++++.+|..|+||||+|+.    .|+.+++++|++.
T Consensus       190 ~~~~~~~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~  227 (327)
T 1sw6_A          190 LYPCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDI  227 (327)
T ss_dssp             HGGGGGEECTTCCCHHHHHHHHHTSTTCHHHHHHHHHH
T ss_pred             hhccccCCCCCCCCHHHHHHHHccccccHHHHHHHHHH
Confidence            6 8899999999999999998    8899999999877

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.80  E-value=6.1e-21  Score=176.86  Aligned_cols=112  Identities=21%  Similarity=0.248  Sum_probs=82.2

Q ss_pred             CCCCcCcCCcccccCCC-CCCCCCccHHHHHHHcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhc
Q 018204           50 SSLDPIRRSPVQDELTV-PENLDSTMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK  127 (359)
Q Consensus        50 ~~~~~~~~~~~~~~~~~-~~~~~~~t~l~~aa~~g~~~~v~~Ll~~-ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~  127 (359)
                      ++.+.+.++|.+.+.++ .++.+|+||||+||..|+.++|++|++. |+|+|.+|.+|+||||+|+..|+.++|++|+++
T Consensus       216 ~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~  295 (337)
T 4g8k_A          216 SDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKR  295 (337)
T ss_dssp             TTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTT
T ss_pred             ccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHC
Confidence            33344444444444443 3477788888888888888888888875 788888888888888888888888888888888


Q ss_pred             CCCccccccccccccccccccccceeEeeccccCccccc
Q 018204          128 KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPK  166 (359)
Q Consensus       128 ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~  166 (359)
                      |||+|.+     ||||+|+..|+.+++++|+++||+++.
T Consensus       296 GAd~n~~-----~~L~~A~~~~~~~iv~~Ll~~GA~~d~  329 (337)
T 4g8k_A          296 GASTDCG-----DLVMTARRNYDHSLVKVLLSHGAKEDF  329 (337)
T ss_dssp             SCSSTTC-----CHHHHHHHTTCHHHHHHHHHTTCCC--
T ss_pred             CCCCCCC-----CHHHHHHHcCCHHHHHHHHHCcCCCCC
Confidence            8887754     488888888888888888888887754

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.79  E-value=1.6e-20  Score=146.24  Aligned_cols=107  Identities=27%  Similarity=0.320  Sum_probs=94.7

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      |......++.++..|+.+.++.+++.+......|.+|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..
T Consensus         6 d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~   85 (115)
T 2l6b_A            6 SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKN   85 (115)
T ss_dssp             SCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTT
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHC
Confidence            33445556677889999999999988766666688999999999999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCcccccccccccc
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAA  142 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl  142 (359)
                      |+.+++++|+++|||+|.++..|.||-
T Consensus        86 ~~~~~~~~Ll~~ga~~n~~~~~~~~~~  112 (115)
T 2l6b_A           86 GHHEIVKLLDAKGADVNARSWGSSHHH  112 (115)
T ss_dssp             TCHHHHHHHHTTSSSHHHHSCCCC---
T ss_pred             CCHHHHHHHHHcCCCCCcCCccccccc
Confidence            999999999999999999999999984

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.79  E-value=1.6e-20  Score=164.52  Aligned_cols=137  Identities=22%  Similarity=0.249  Sum_probs=120.2

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCC-CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      ....+..++..|+.+.++.+++.+...... +..|.||||+|+..|+.+++++|++.|++++.+|..|+||||+|+..|+
T Consensus        42 g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~  121 (240)
T 3eu9_A           42 NVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGH  121 (240)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCH
Confidence            334556677889999999998887655545 4559999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCcccccccccccccccccccc-ceeEeeccccCccccc----cCCCCcccC
Q 018204          118 VEVVKLLLSKKANIDARDRWGSTAAADAKYYGN-VEVYNILKARGAKVPK----TKRTPMTVA  175 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~-~~~~~~L~~~ga~~~~----~~~tpl~~a  175 (359)
                      .+++++|+++|++++.+|..|.||||+|+..++ .+++++|.+.|++++.    .+.||++.+
T Consensus       122 ~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~~~~g~t~L~~A  184 (240)
T 3eu9_A          122 TSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWA  184 (240)
T ss_dssp             HHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCCTTTCCCHHHHH
T ss_pred             HHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhhccCCCcHHHHH
Confidence            999999999999999999999999999997666 7899999999999854    345777776

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.78  E-value=4.1e-20  Score=173.27  Aligned_cols=108  Identities=25%  Similarity=0.347  Sum_probs=100.4

Q ss_pred             CCCCccHHHHHHHc-CCHHHHHHHHHcCCCCCCCC--CCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccc
Q 018204           69 NLDSTMQLLFMACR-GDVKGVEDLLNEGSDVNSID--LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (359)
Q Consensus        69 ~~~~~t~l~~aa~~-g~~~~v~~Ll~~ga~v~~~d--~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  145 (359)
                      +..+.|+||+||.. |+.++|+.||++|+|+|..|  ..|+||||+||..|+.++|++|+++|+|+|.+|..|+||||+|
T Consensus       196 ~~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A  275 (368)
T 3jue_A          196 SLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHA  275 (368)
T ss_dssp             -CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             cCCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHH
Confidence            34578899999999 99999999999999999999  8999999999999999999999999999999999999999999


Q ss_pred             cccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          146 KYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       146 ~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      +..|+.+++++|+++|++++   ..+.||+++|.
T Consensus       276 ~~~g~~~~v~~LL~~Gad~~~~d~~G~TpL~~A~  309 (368)
T 3jue_A          276 TILGHTGLACLFLKRGADLGARDSEGRDPLTIAM  309 (368)
T ss_dssp             HHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred             HHcCcHHHHHHHHHCcCCCCCcCCCCCCHHHHHH
Confidence            99999999999999999984   45678888773

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.77  E-value=1.5e-19  Score=135.32  Aligned_cols=88  Identities=34%  Similarity=0.426  Sum_probs=80.7

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      ++.++..|+.+.++.+++.+......|.+|+||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.++++
T Consensus         6 L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~   85 (93)
T 1n0q_A            6 LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVK   85 (93)
T ss_dssp             HHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHH
Confidence            44567788888888888887666667899999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCC
Q 018204          123 LLLSKKAN  130 (359)
Q Consensus       123 ~Ll~~ga~  130 (359)
                      +|+++||+
T Consensus        86 ~Ll~~ga~   93 (93)
T 1n0q_A           86 LLLEAGAY   93 (93)
T ss_dssp             HHHHTTCC
T ss_pred             HHHHcCCC
Confidence            99999986

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.77  E-value=2e-21  Score=182.71  Aligned_cols=133  Identities=13%  Similarity=-0.021  Sum_probs=111.7

Q ss_pred             CcceeeccCCCCCcCcCCcccccCCC---CCCCCCccHHHHHHHcCCHHHHHHHHHcCCC---CCCCCCCCCcHHHHHHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPVQDELTV---PENLDSTMQLLFMACRGDVKGVEDLLNEGSD---VNSIDLDGRTALHIAAC  114 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~---v~~~d~~g~TpLh~A~~  114 (359)
                      +.+..+++.|+++.++.+++.+..+.   ..+..|.||||+||.+|+.++|++|+++|+|   ++..+.+ +||||+||.
T Consensus        94 T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa~  172 (376)
T 2aja_A           94 VICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAAE  172 (376)
T ss_dssp             HHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHHH
T ss_pred             CHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHHH
Confidence            45667888999999999998876432   3355789999999999999999999999986   2333333 999999999


Q ss_pred             cCCHHHHHHHHhcCCCccc--ccccccccccccc-ccccceeEeeccccCccccccCCCCcccCCCC
Q 018204          115 EGHVEVVKLLLSKKANIDA--RDRWGSTAAADAK-YYGNVEVYNILKARGAKVPKTKRTPMTVANPR  178 (359)
Q Consensus       115 ~g~~~~v~~Ll~~ga~~~~--~d~~g~tpl~~A~-~~~~~~~~~~L~~~ga~~~~~~~tpl~~a~~~  178 (359)
                      +|+.++|++|+++|++++.  +|..|+||||+|+ ..|+.+++++|+++|++    +.||++.|...
T Consensus       173 ~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~Aa~~~G~~eiv~~Ll~~ga~----~~taL~~Aa~~  235 (376)
T 2aja_A          173 NGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVM----LAYAEIHEFEY  235 (376)
T ss_dssp             TTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHH----HHHHHHCTTTT
T ss_pred             CCCHHHHHHHHHcCCccchhccCCCCCCHHHHHHHHCCCHHHHHHHHhCCCc----cchHHHHHHHC
Confidence            9999999999999999998  9999999999999 99999999999998864    67788877443

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E*

Probab=99.76  E-value=2.5e-19  Score=175.05  Aligned_cols=104  Identities=21%  Similarity=0.327  Sum_probs=97.5

Q ss_pred             CccHHHHHHHcCCHHHHHHHHHcCCCCCCC------CCCCCcHHHHHHH---cCCHHHHHHHHhcCCCcccccccccccc
Q 018204           72 STMQLLFMACRGDVKGVEDLLNEGSDVNSI------DLDGRTALHIAAC---EGHVEVVKLLLSKKANIDARDRWGSTAA  142 (359)
Q Consensus        72 ~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~------d~~g~TpLh~A~~---~g~~~~v~~Ll~~ga~~~~~d~~g~tpl  142 (359)
                      ..+.||.|+..|+.++|+.||+.|+|+|.+      |..|+||||+||.   .|+.++|++|+++|||+|.+|..|+|||
T Consensus       132 ~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpL  211 (497)
T 3lvq_E          132 EPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTAL  211 (497)
T ss_dssp             CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHH
T ss_pred             cHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHH
Confidence            447899999999999999999999999988      8999999999966   9999999999999999999999999999


Q ss_pred             ccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          143 ADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       143 ~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      |+|+..|+.+++++|+++|++++   ..+.||++.|
T Consensus       212 h~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  247 (497)
T 3lvq_E          212 HYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIA  247 (497)
T ss_dssp             HHHTTTTCHHHHHHHHHTCCCCSCCCTTCCCHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHH
Confidence            99999999999999999999984   5567898876

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.75  E-value=2.9e-19  Score=163.36  Aligned_cols=106  Identities=21%  Similarity=0.314  Sum_probs=98.2

Q ss_pred             CCccHHHHHHHcCCHHHHHHHHHcCCCCCC------CCCCCCcHHHHHHHc---CCHHHHHHHHhcCCCccccccccccc
Q 018204           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNS------IDLDGRTALHIAACE---GHVEVVKLLLSKKANIDARDRWGSTA  141 (359)
Q Consensus        71 ~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~------~d~~g~TpLh~A~~~---g~~~~v~~Ll~~ga~~~~~d~~g~tp  141 (359)
                      .+.++|+.|+..|+.+.|+.|++.|+|+|.      .|..|+||||+|+..   |+.++|++|+++|+|+|.+|..|+||
T Consensus       150 ~~~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~Tp  229 (301)
T 2b0o_E          150 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA  229 (301)
T ss_dssp             -CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCH
T ss_pred             chHHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCH
Confidence            356789999999999999999999999998      699999999999997   99999999999999999999999999


Q ss_pred             cccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          142 AADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       142 l~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      ||+|+..|+.+++++|+++|++++   ..+.||++.|.
T Consensus       230 Lh~A~~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~  267 (301)
T 2b0o_E          230 LHYAALYNQPDCLKLLLKGRALVGTVNEAGETALDIAR  267 (301)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCCSCCCTTSCCHHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHH
Confidence            999999999999999999999984   45678888873

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.74  E-value=5.6e-19  Score=159.62  Aligned_cols=105  Identities=24%  Similarity=0.301  Sum_probs=96.5

Q ss_pred             CccHHHHHHHcCCHHHHHHHHHcCCCC------CCCCCCCCcHHHHHHHc---CCHHHHHHHHhcCCCcccccccccccc
Q 018204           72 STMQLLFMACRGDVKGVEDLLNEGSDV------NSIDLDGRTALHIAACE---GHVEVVKLLLSKKANIDARDRWGSTAA  142 (359)
Q Consensus        72 ~~t~l~~aa~~g~~~~v~~Ll~~ga~v------~~~d~~g~TpLh~A~~~---g~~~~v~~Ll~~ga~~~~~d~~g~tpl  142 (359)
                      ..++|+.|+..|+.+.++.+++.|+++      +..|..|+||||+||..   |+.++|++|+++|+|+|.+|..|+|||
T Consensus       130 ~l~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpL  209 (278)
T 1dcq_A          130 KLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTAL  209 (278)
T ss_dssp             HHHHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHH
T ss_pred             hhhhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHH
Confidence            457899999999999999999999995      45589999999999999   999999999999999999999999999


Q ss_pred             ccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          143 ADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       143 ~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      |+|+..|+.+++++|+++|++++   ..+.||++.|.
T Consensus       210 h~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~  246 (278)
T 1dcq_A          210 HYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAK  246 (278)
T ss_dssp             HHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHcCCCCCCccCCCCCHHHHHH
Confidence            99999999999999999999984   45678888773

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=1e-17  Score=149.72  Aligned_cols=136  Identities=18%  Similarity=0.204  Sum_probs=97.8

Q ss_pred             EeeccCcccceeEEE---E--ecCcE--EEEEEeccCCCCc---------------------HHHHHHHHHHHHHHHhCC
Q 018204          192 VRKADGITKGSYQVA---K--WNGTK--VWVKILDKESHKD---------------------PERINAFTHELTIVEKAR  243 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~--vavK~l~~~~~~~---------------------~~~~~~~~~Ei~il~~l~  243 (359)
                      +.....+|.|.|+.+   .  .+|..  +|||++.......                     ......+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            344456788887643   3  37888  9999975432110                     112236789999999998


Q ss_pred             CCccccceeeEEeCCcEEEEEecCCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCCCC
Q 018204          244 HPNVVQFVGAVTQNIPMMIVLEYHAK-G----DLASYLQKKGRLSPSKVLRFALDLARGMNYLH-ECKPDPIIHCDLKPK  317 (359)
Q Consensus       244 HpnIv~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~~~~iiHrDlk~~  317 (359)
                      |+++....-+..  ...++||||+.+ |    +|.++...   .++..+..++.|++.||.||| +++   |+||||||+
T Consensus       129 ~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~  200 (258)
T 1zth_A          129 EAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEY  200 (258)
T ss_dssp             HTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTT
T ss_pred             hCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHH
Confidence            886532222222  356899999942 3    67766432   234567889999999999999 888   999999999


Q ss_pred             cEEEcCCCcEEEeccccccc
Q 018204          318 NILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       318 NIll~~~~~~kl~DFGla~~  337 (359)
                      |||++.  .++|+|||+|..
T Consensus       201 NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             SEEESS--SEEECCCTTCEE
T ss_pred             HEEEcC--cEEEEECccccc
Confidence            999998  999999999974

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.67  E-value=8.5e-19  Score=164.83  Aligned_cols=110  Identities=18%  Similarity=0.131  Sum_probs=90.5

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCC---CCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCC---cccccccccccc
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDV---NSIDLDGRTALHIAACEGHVEVVKLLLSKKAN---IDARDRWGSTAA  142 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v---~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~---~~~~d~~g~tpl  142 (359)
                      +.++.||||+||..|+.++|++|++.|+..   +..|..|+||||+||.+|+.++|++|+++|+|   .+..+.. +|||
T Consensus        89 g~~~~T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpL  167 (376)
T 2aja_A           89 GIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAF  167 (376)
T ss_dssp             TCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHH
T ss_pred             CCCcCCHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHH
Confidence            346789999999999999999999999832   34456789999999999999999999999987   3333344 9999


Q ss_pred             ccccccccceeEeeccccCcc-----ccccCCCCcccCC-CCC
Q 018204          143 ADAKYYGNVEVYNILKARGAK-----VPKTKRTPMTVAN-PRE  179 (359)
Q Consensus       143 ~~A~~~~~~~~~~~L~~~ga~-----~~~~~~tpl~~a~-~~~  179 (359)
                      |+|+..|+.+++++|+++|++     .+..+.||++.|. ...
T Consensus       168 h~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~TpL~~Aa~~~G  210 (376)
T 2aja_A          168 RLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRG  210 (376)
T ss_dssp             HHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTC
T ss_pred             HHHHHCCCHHHHHHHHHcCCccchhccCCCCCCHHHHHHHHCC
Confidence            999999999999999999999     4556789998876 443

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.61  E-value=1.3e-16  Score=123.22  Aligned_cols=90  Identities=21%  Similarity=0.282  Sum_probs=79.8

Q ss_pred             cCCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHH
Q 018204           35 FDPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAAC  114 (359)
Q Consensus        35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~  114 (359)
                      +|...+..++.++..|+.+.++.++..+......|.+|.||||+||..|+.+++++|+++|+|+|.+|..|+||||+|+.
T Consensus        20 ~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~   99 (110)
T 2zgd_A           20 MGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDISID   99 (110)
T ss_dssp             --CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred             cCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHHHHH
Confidence            44445556778888999999999998876656668899999999999999999999999999999999999999999999


Q ss_pred             cCCHHHHHHH
Q 018204          115 EGHVEVVKLL  124 (359)
Q Consensus       115 ~g~~~~v~~L  124 (359)
                      .|+.+++++|
T Consensus       100 ~~~~~~~~~L  109 (110)
T 2zgd_A          100 NGNEDLAEIL  109 (110)
T ss_dssp             HTCHHHHHHH
T ss_pred             cCCHHHHHHh
Confidence            9999999987

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=1.1e-15  Score=142.69  Aligned_cols=133  Identities=15%  Similarity=0.071  Sum_probs=88.5

Q ss_pred             EeeccCcccceeEEE----EecCcEEEEEEeccCCCC--------------cH-HH--H--HHHHHHHHHHHhCCCCccc
Q 018204          192 VRKADGITKGSYQVA----KWNGTKVWVKILDKESHK--------------DP-ER--I--NAFTHELTIVEKARHPNVV  248 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~--------------~~-~~--~--~~~~~Ei~il~~l~HpnIv  248 (359)
                      |.+...+|.|.++.+    ...|..+|||+++.....              .. ..  .  -...+|...+.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            455667788887643    246899999998532110              00 00  0  1123455666666444433


Q ss_pred             cceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---
Q 018204          249 QFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG---  325 (359)
Q Consensus       249 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~---  325 (359)
                      ...-+...  ..+|||||++|++|.++..    .  .....++.|++.+|.|||+++   ||||||||.|||++.+|   
T Consensus       177 vp~p~~~~--~~~LVME~i~G~~L~~l~~----~--~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          177 VPEPIAQS--RHTIVMSLVDALPMRQVSS----V--PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CCCEEEEE--TTEEEEECCSCEEGGGCCC----C--SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSS
T ss_pred             CCeeeecc--CceEEEEecCCccHhhhcc----c--HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcc
Confidence            22211122  2479999999988865432    1  234678899999999999998   99999999999998876   


Q ss_pred             -------cEEEeccccc
Q 018204          326 -------QLKISGFGLL  335 (359)
Q Consensus       326 -------~~kl~DFGla  335 (359)
                             .+.|+||+-+
T Consensus       246 d~~~~~~~~~iID~~Q~  262 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQM  262 (397)
T ss_dssp             CTTSEEEEEEECCCTTC
T ss_pred             cccccccceEEEEeCCc
Confidence                   3899999977

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.18  E-value=1.3e-10  Score=103.27  Aligned_cols=123  Identities=11%  Similarity=0.036  Sum_probs=93.2

Q ss_pred             EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHH
Q 018204          207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPS  285 (359)
Q Consensus       207 ~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~  285 (359)
                      ...+..+++|+.........   ..+.+|+.+++.+. +..++++++++...+..|+||||++|.+|.+.+.     +..
T Consensus        34 ~~~~~~~vlK~~~~~~~~~~---~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~  105 (263)
T 3tm0_A           34 VGENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQ  105 (263)
T ss_dssp             ECSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTT
T ss_pred             ECCCCcEEEEeCCcccCCCH---HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----Ccc
Confidence            34478899999864221111   24788999999884 6778889999988889999999999999877631     112


Q ss_pred             HHHHHHHHHHHHHHHHHhCC--------------------------------------------------------CCCe
Q 018204          286 KVLRFALDLARGMNYLHECK--------------------------------------------------------PDPI  309 (359)
Q Consensus       286 ~~~~i~~qi~~aL~~lH~~~--------------------------------------------------------~~~i  309 (359)
                      ....++.+++++|..||+..                                                        +..+
T Consensus       106 ~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l  185 (263)
T 3tm0_A          106 SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVF  185 (263)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEE
T ss_pred             cHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceE
Confidence            23477889999999999811                                                        1238


Q ss_pred             EeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          310 IHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       310 iHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      +|+|++|.|||++.++.+.|+||+.+..
T Consensus       186 ~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          186 SHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             ECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ECCCCCcCcEEEECCcEEEEEEchhccc
Confidence            9999999999998766677999998863

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.05  E-value=1.3e-09  Score=96.26  Aligned_cols=121  Identities=19%  Similarity=0.171  Sum_probs=86.8

Q ss_pred             eEEEEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc--cccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC
Q 018204          203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN--VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG  280 (359)
Q Consensus       203 ~~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  280 (359)
                      |.+....|..+++|+......      ..+..|+.+++.+.+.+  +++++.+....+..++||||++|.++.  ..   
T Consensus        37 ~~~~~~~g~~~vlK~~~~~~~------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---  105 (264)
T 1nd4_A           37 FRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---  105 (264)
T ss_dssp             EEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---
T ss_pred             EEEecCCCCeEEEEeCCcccc------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---
Confidence            433333467799999754311      24678999998885444  556888887777899999999998873  21   


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------------
Q 018204          281 RLSPSKVLRFALDLARGMNYLHECK-------------------------------------------------------  305 (359)
Q Consensus       281 ~l~~~~~~~i~~qi~~aL~~lH~~~-------------------------------------------------------  305 (359)
                      ..+.   ..++.+++..|..||+..                                                       
T Consensus       106 ~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  182 (264)
T 1nd4_A          106 HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  182 (264)
T ss_dssp             CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCC
Confidence            1222   356777888888888643                                                       


Q ss_pred             CCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       306 ~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      +..++|+|++|.|||++.++.+.|+|||.+..
T Consensus       183 ~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          183 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            11289999999999998776677999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.97  E-value=3.1e-09  Score=98.96  Aligned_cols=127  Identities=14%  Similarity=0.175  Sum_probs=91.0

Q ss_pred             EecCcEEEEEEec--cCCCCcHHHHHHHHHHHHHHHhCCC--CccccceeeEEeC---CcEEEEEecCCCCCHHHHHHhc
Q 018204          207 KWNGTKVWVKILD--KESHKDPERINAFTHELTIVEKARH--PNVVQFVGAVTQN---IPMMIVLEYHAKGDLASYLQKK  279 (359)
Q Consensus       207 ~~~g~~vavK~l~--~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~  279 (359)
                      ...+..+++|...  ....  ......+.+|..+++.+..  ..+++++.++.+.   +..|+||||++|..+.+..  .
T Consensus        58 ~~~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~  133 (359)
T 3dxp_A           58 VTPGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--L  133 (359)
T ss_dssp             ECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--C
T ss_pred             EECCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--c
Confidence            3345678888764  2211  1122357889999999874  4577888877665   3489999999997774311  1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------------------
Q 018204          280 GRLSPSKVLRFALDLARGMNYLHECK------------------------------------------------------  305 (359)
Q Consensus       280 ~~l~~~~~~~i~~qi~~aL~~lH~~~------------------------------------------------------  305 (359)
                      ..+++.....++.+++..|..||+..                                                      
T Consensus       134 ~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  213 (359)
T 3dxp_A          134 PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDA  213 (359)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTS
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccC
Confidence            24678888899999999999999731                                                      


Q ss_pred             -CCCeEeCCCCCCcEEEcCCCc--EEEeccccccc
Q 018204          306 -PDPIIHCDLKPKNILLDNGGQ--LKISGFGLLRL  337 (359)
Q Consensus       306 -~~~iiHrDlk~~NIll~~~~~--~kl~DFGla~~  337 (359)
                       +..++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       214 ~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          214 DLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence             234899999999999997753  68999999974

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.54  E-value=3.8e-07  Score=82.67  Aligned_cols=122  Identities=19%  Similarity=0.163  Sum_probs=86.6

Q ss_pred             CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCcc--ccceeeEEeCC---cEEEEEecCCCCCHHHHHHhcCCCC
Q 018204          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNV--VQFVGAVTQNI---PMMIVLEYHAKGDLASYLQKKGRLS  283 (359)
Q Consensus       210 g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnI--v~l~~~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~l~  283 (359)
                      +..+++|+...     ......+.+|..+++.+ .+..+  ++++.......   ..|+||++++|.++.....  ..++
T Consensus        40 ~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~  112 (304)
T 3sg8_A           40 NRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLP  112 (304)
T ss_dssp             TTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSC
T ss_pred             CCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCC
Confidence            46688888642     23445788999999887 44333  34444332222   3589999999988865433  2477


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------------CCC
Q 018204          284 PSKVLRFALDLARGMNYLHECK-------------------------------------------------------PDP  308 (359)
Q Consensus       284 ~~~~~~i~~qi~~aL~~lH~~~-------------------------------------------------------~~~  308 (359)
                      ......++.+++..|..||+..                                                       +..
T Consensus       113 ~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  192 (304)
T 3sg8_A          113 KQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPC  192 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCce
Confidence            7778888888888888888621                                                       123


Q ss_pred             eEeCCCCCCcEEEcC--CCcEEEecccccccc
Q 018204          309 IIHCDLKPKNILLDN--GGQLKISGFGLLRLQ  338 (359)
Q Consensus       309 iiHrDlk~~NIll~~--~~~~kl~DFGla~~~  338 (359)
                      ++|+|++|.||+++.  .+.+.|+||+.+..+
T Consensus       193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             EECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             eEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence            799999999999998  456889999998743

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.39  E-value=5.6e-06  Score=73.35  Aligned_cols=119  Identities=14%  Similarity=0.129  Sum_probs=86.3

Q ss_pred             cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHH
Q 018204          209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKV  287 (359)
Q Consensus       209 ~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~  287 (359)
                      .+..+++|.-..      .....+..|...++.+. +--+.+++.++...+..|+|||+++|.++.+.....    ....
T Consensus        49 ~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~  118 (272)
T 4gkh_A           49 NAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSG  118 (272)
T ss_dssp             TCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGH
T ss_pred             CCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHH
Confidence            356788887642      23446788999998874 334667888888888999999999998887765432    1223


Q ss_pred             HHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeEeC
Q 018204          288 LRFALDLARGMNYLHECK-------------------------------------------------------PDPIIHC  312 (359)
Q Consensus       288 ~~i~~qi~~aL~~lH~~~-------------------------------------------------------~~~iiHr  312 (359)
                      ..+..++...|.-||+..                                                       +..++|+
T Consensus       119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG  198 (272)
T 4gkh_A          119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG  198 (272)
T ss_dssp             HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred             HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence            445666777777777431                                                       1127899


Q ss_pred             CCCCCcEEEcCCCcEEEeccccccc
Q 018204          313 DLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       313 Dlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      |+.+.|||++.++.+-|+||+.+.+
T Consensus       199 Dl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          199 DFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCeEEEECCeEEEEEECccccc
Confidence            9999999999877778999999863

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.35  E-value=5.6e-06  Score=75.11  Aligned_cols=121  Identities=19%  Similarity=0.142  Sum_probs=81.6

Q ss_pred             CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC---ccccceeeEE-eCCcEEEEEecCCCCCHHHHHHhcCCCCHH
Q 018204          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHP---NVVQFVGAVT-QNIPMMIVLEYHAKGDLASYLQKKGRLSPS  285 (359)
Q Consensus       210 g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~  285 (359)
                      |..+++|+-.     .......+..|..++..+.+.   .+++++.+.. ..+..+++||+++|.++....-  ..++..
T Consensus        39 g~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~  111 (306)
T 3tdw_A           39 NGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDD  111 (306)
T ss_dssp             TTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHH
T ss_pred             CCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHH
Confidence            6778888852     233456788999999999753   3455665553 3456789999999988766321  123444


Q ss_pred             HHHHHHHHHHHHHHHHHhC---------------------------------------------------------CCCC
Q 018204          286 KVLRFALDLARGMNYLHEC---------------------------------------------------------KPDP  308 (359)
Q Consensus       286 ~~~~i~~qi~~aL~~lH~~---------------------------------------------------------~~~~  308 (359)
                      ....++.++...|..||+.                                                         .+..
T Consensus       112 ~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~  191 (306)
T 3tdw_A          112 AKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPR  191 (306)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCE
T ss_pred             HHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCe
Confidence            4555555555555555542                                                         1224


Q ss_pred             eEeCCCCCCcEEEcC---CCc-EEEeccccccc
Q 018204          309 IIHCDLKPKNILLDN---GGQ-LKISGFGLLRL  337 (359)
Q Consensus       309 iiHrDlk~~NIll~~---~~~-~kl~DFGla~~  337 (359)
                      ++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            699999999999987   355 58999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.77  E-value=1.9e-05  Score=72.92  Aligned_cols=31  Identities=13%  Similarity=0.252  Sum_probs=26.2

Q ss_pred             CCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       307 ~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            3589999999999999644579999999863

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.72  E-value=0.00079  Score=61.27  Aligned_cols=31  Identities=19%  Similarity=0.280  Sum_probs=27.7

Q ss_pred             CCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       307 ~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ..++|+|+++.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            3499999999999998888899999998864

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.32  E-value=0.0025  Score=60.11  Aligned_cols=30  Identities=13%  Similarity=0.266  Sum_probs=26.5

Q ss_pred             CCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       307 ~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ..++|+|++|.|||++.++ ++|+||+.+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            3499999999999998877 99999998874

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.25  E-value=0.0013  Score=61.49  Aligned_cols=30  Identities=20%  Similarity=0.258  Sum_probs=25.5

Q ss_pred             CCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       307 ~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ..++|+|+.|.|||++.++ ++++||..+..
T Consensus       227 ~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~  256 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  256 (397)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence            3489999999999998764 89999988863

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.17  E-value=0.0048  Score=55.83  Aligned_cols=59  Identities=20%  Similarity=0.118  Sum_probs=44.1

Q ss_pred             ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC---CCccccceeeEEeCCcEEEEEecCCCCCH
Q 018204          208 WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR---HPNVVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       208 ~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      ..+..+++|+....      ....|..|...++.+.   ...+++++.+....+..++||||++|..+
T Consensus        57 ~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           57 DEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             SSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             ECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            34678888887532      1345788998888873   35677888887777889999999998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.81  E-value=0.0038  Score=56.77  Aligned_cols=32  Identities=19%  Similarity=0.283  Sum_probs=27.4

Q ss_pred             CCeEeCCCCCCcEEEcCC----CcEEEecccccccc
Q 018204          307 DPIIHCDLKPKNILLDNG----GQLKISGFGLLRLQ  338 (359)
Q Consensus       307 ~~iiHrDlk~~NIll~~~----~~~kl~DFGla~~~  338 (359)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..+
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            458999999999999874    67999999998743

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.79  E-value=0.0068  Score=54.26  Aligned_cols=29  Identities=28%  Similarity=0.467  Sum_probs=24.9

Q ss_pred             CeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          308 PIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       308 ~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4799999999999 5667789999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.70  E-value=0.012  Score=53.05  Aligned_cols=29  Identities=21%  Similarity=0.084  Sum_probs=25.2

Q ss_pred             CCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       307 ~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            3489999999999998 4 899999998864

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.60  E-value=0.032  Score=49.45  Aligned_cols=63  Identities=21%  Similarity=0.246  Sum_probs=39.4

Q ss_pred             eeEEEEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCC-c--cccceeeEEeCCcEEEEEecCCCCC
Q 018204          202 SYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHP-N--VVQFVGAVTQNIPMMIVLEYHAKGD  271 (359)
Q Consensus       202 ~~~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hp-n--Iv~l~~~~~~~~~~~lv~e~~~~gs  271 (359)
                      +|.+...+|+.+++|+-........   ..|..|+..|+.+.-. .  +++++.+  .  .-++||||++++.
T Consensus        31 vyrv~l~DG~~~~vK~~~~~~~~~~---~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~   96 (288)
T 3f7w_A           31 LYRVELADGTPLFVKALPDDAPALD---GLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTSCEEEEEECCTTCCCCT---THHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred             EEEEEECCCCEEEEEEeCCCCcchh---hHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence            4555556789999998754332221   2477899999988432 2  3344432  2  3478999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.16  E-value=0.042  Score=50.07  Aligned_cols=31  Identities=23%  Similarity=0.320  Sum_probs=27.4

Q ss_pred             CCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       307 ~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3489999999999999888899999998763

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.02  E-value=0.014  Score=54.16  Aligned_cols=120  Identities=15%  Similarity=0.181  Sum_probs=70.0

Q ss_pred             CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc-cccceeeEEeCCcEEEEEecCCCCCHH--------------H
Q 018204          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN-VVQFVGAVTQNIPMMIVLEYHAKGDLA--------------S  274 (359)
Q Consensus       210 g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lv~e~~~~gsL~--------------~  274 (359)
                      +..+++++..... .   ....+.+|..+++.+.-.+ ..++++.+..    .+||||++|..|.              +
T Consensus        82 ~~~~vlR~~g~~~-~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~  153 (379)
T 3feg_A           82 PREVLLRLYGAIL-Q---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIAT  153 (379)
T ss_dssp             CSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHH
T ss_pred             CCeEEEEECCCcc-c---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHH
Confidence            4677888753211 1   1234568999998874323 3556655432    3899999975432              1


Q ss_pred             HH---Hhc-----CCC--CHHHHHHHHHHHHH-------------------HHHHHH----hC-CCCCeEeCCCCCCcEE
Q 018204          275 YL---QKK-----GRL--SPSKVLRFALDLAR-------------------GMNYLH----EC-KPDPIIHCDLKPKNIL  320 (359)
Q Consensus       275 ~l---~~~-----~~l--~~~~~~~i~~qi~~-------------------aL~~lH----~~-~~~~iiHrDlk~~NIl  320 (359)
                      .+   +..     +..  -+..+.++..++..                   .+.+|.    .. .+..++|+|+.+.|||
T Consensus       154 ~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil  233 (379)
T 3feg_A          154 KMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNIL  233 (379)
T ss_dssp             HHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEE
T ss_pred             HHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEE
Confidence            11   111     111  13455555544422                   233333    22 2234899999999999


Q ss_pred             EcCC----CcEEEeccccccc
Q 018204          321 LDNG----GQLKISGFGLLRL  337 (359)
Q Consensus       321 l~~~----~~~kl~DFGla~~  337 (359)
                      ++.+    +.+.++||..+..
T Consensus       234 ~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          234 LLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EESCC---CCEEECCCTTCEE
T ss_pred             EcCCCCccCcEEEEecccCCc
Confidence            9876    7899999999873

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.99  E-value=0.029  Score=50.42  Aligned_cols=44  Identities=20%  Similarity=0.299  Sum_probs=32.5

Q ss_pred             HHHHHHHHHhC----CCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          294 LARGMNYLHEC----KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       294 i~~aL~~lH~~----~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      +...+.++...    .+..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            44455566532    123589999999999998876668999998863

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=90.61  E-value=0.095  Score=48.14  Aligned_cols=29  Identities=28%  Similarity=0.392  Sum_probs=24.5

Q ss_pred             CeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          308 PIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       308 ~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      .++|+|+.+.|||++.++ +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            489999999999998655 89999998863

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=88.69  E-value=0.2  Score=47.60  Aligned_cols=30  Identities=27%  Similarity=0.464  Sum_probs=26.1

Q ss_pred             CeEeCCCCCCcEEEc-------------------------------------CCCcEEEeccccccc
Q 018204          308 PIIHCDLKPKNILLD-------------------------------------NGGQLKISGFGLLRL  337 (359)
Q Consensus       308 ~iiHrDlk~~NIll~-------------------------------------~~~~~kl~DFGla~~  337 (359)
                      .++|+|+.+.|||++                                     .++.+.|+||..|..
T Consensus       291 v~cHnDl~~gNIL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lIDfEya~~  357 (458)
T 2qg7_A          291 VLCHCDLLSSNIINTVGGGEAGELGEAGETGEGGETGEGGETGEGGETGEGGEGDSISFIDFEYSCP  357 (458)
T ss_dssp             EEECSCCCGGGEEECCC-----------------------------------CCCCEEECCCTTCEE
T ss_pred             eEEecCCCCCcEEeecccccccccccccccccccccccccccccccccccCCCCCeEEEEeecCCCC
Confidence            479999999999998                                     466799999998874

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=88.48  E-value=0.15  Score=48.04  Aligned_cols=30  Identities=30%  Similarity=0.416  Sum_probs=25.1

Q ss_pred             CeEeCCCCCCcEEEcCC----------------------------CcEEEeccccccc
Q 018204          308 PIIHCDLKPKNILLDNG----------------------------GQLKISGFGLLRL  337 (359)
Q Consensus       308 ~iiHrDlk~~NIll~~~----------------------------~~~kl~DFGla~~  337 (359)
                      .++|+|+.+.|||++.+                            +.+.|+||..+..
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            48999999999999875                            6799999998864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=84.24  E-value=0.47  Score=44.10  Aligned_cols=29  Identities=28%  Similarity=0.362  Sum_probs=24.8

Q ss_pred             eEeCCCCCCcEEE------cCCCcEEEeccccccc
Q 018204          309 IIHCDLKPKNILL------DNGGQLKISGFGLLRL  337 (359)
Q Consensus       309 iiHrDlk~~NIll------~~~~~~kl~DFGla~~  337 (359)
                      ++|+|+.+.|||+      +.+..+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      3456799999999974

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.92  E-value=3.9  Score=34.42  Aligned_cols=83  Identities=11%  Similarity=0.112  Sum_probs=59.4

Q ss_pred             CCCccccceeeEEeCCcEEEEEecCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEeCCCCCCcEE
Q 018204          243 RHPNVVQFVGAVTQNIPMMIVLEYHAKG-DLASYLQKKGRLSPSKVLRFALDLARGMN-YLHECKPDPIIHCDLKPKNIL  320 (359)
Q Consensus       243 ~HpnIv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~qi~~aL~-~lH~~~~~~iiHrDlk~~NIl  320 (359)
                      .||.+  -..+-...+.+.+.++.-+++ ++. .++   .++....++++.+|+.-.. +++.     -+|--|.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~---~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR---KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH---TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH---hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence            56777  344446667777777765443 333 332   4678888888888887665 4443     578899999999


Q ss_pred             EcCCCcEEEecccccc
Q 018204          321 LDNGGQLKISGFGLLR  336 (359)
Q Consensus       321 l~~~~~~kl~DFGla~  336 (359)
                      ++.++.++|.-.|+-.
T Consensus       117 f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          117 FNRALEPFFLHVGVKE  132 (219)
T ss_dssp             ECTTCCEEESCCEETT
T ss_pred             EeCCCcEEEEEcCCcc
Confidence            9999999999999753

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=80.24  E-value=0.72  Score=43.28  Aligned_cols=29  Identities=17%  Similarity=0.414  Sum_probs=25.9

Q ss_pred             CeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          308 PIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       308 ~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      .++|+|+.+.||+ +.++.+.++||..|..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4799999999999 7788999999999863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	359
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-33
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-33
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-32
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-30
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-30
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-30
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-30
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	5e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-28
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-28
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-28
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-27
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-27
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-27
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	6e-27
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-27
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-26
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-26
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-26
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-26
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-26
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-26
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-25
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-25
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-25
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-24
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-24
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-24
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-24
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-24
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-24
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-23
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-23
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-23
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-23
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	5e-22
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-16
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-14
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	6e-13
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	1e-12
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	1e-10
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-22
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-22
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-21
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-21
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-21
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-21
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-20
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-20
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-20
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-19
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-19
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-19
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-19
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-19
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	8e-19
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-18
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-18
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-17
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	5e-17
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	7e-15
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	3e-10
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	3e-09
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	5e-09
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-16
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-15
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	3e-15
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	2e-11
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	6e-11
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	1e-04
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	2e-04
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-15
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-15
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	2e-14
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	2e-12
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-07
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-06
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	5e-06
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	0.001
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	0.004
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	8e-14
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	9e-11
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	6e-09
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	8e-09
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	3e-06
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	5e-13
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	2e-12
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	1e-07
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	2e-04
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-12
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-12
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-11
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	9e-10
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	1e-09
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	3e-12
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	1e-11
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	2e-11
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	8e-09
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	4e-12
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	8e-11
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	2e-10
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	8e-06
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	2e-10
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	5e-10
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	6e-09
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	4e-04
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-10
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	1e-09
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	5e-09
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	6e-08
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	0.004
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	2e-09
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	1e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-09
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	5e-09
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	9e-08
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-07
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	9e-07
d1dcqa1	154	d.211.1.1 (A:369-522) Pyk2-associated protein beta	6e-09
d1ycsb1	130	d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens)	3e-08
d1ycsb1	130	d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens)	9e-05
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	4e-08
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	1e-06
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	3e-06
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	4e-08
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	4e-06
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	6e-04
d1bi7b_	125	d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma	6e-06
d1bi7b_	125	d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma	1e-05
d1myoa_	118	d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus)	0.004

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (312), Expect = 1e-33
 Identities = 35/148 (23%), Positives = 59/148 (39%), Gaps = 14/148 (9%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
             N   V +K +     +  E+      E+  ++K RHPN +Q+ G   +     +V+EY
Sbjct: 37  VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
                       K  L   ++        +G+ YLH      +IH D+K  NILL   G 
Sbjct: 97  CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGL 153

Query: 327 LKISGFGLLRL-----------QYISPE 343
           +K+  FG   +            +++PE
Sbjct: 154 VKLGDFGSASIMAPANSFVGTPYWMAPE 181

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 5e-33
 Identities = 50/160 (31%), Positives = 83/160 (51%), Gaps = 12/160 (7%)

Query: 182 EYELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTI 238
           ++E+   ++ V +   I  GS+  V   KW+G  V VK+L+  +   P+++ AF +E+ +
Sbjct: 2   DWEIPDGQITVGQR--IGSGSFGTVYKGKWHGD-VAVKMLNV-TAPTPQQLQAFKNEVGV 57

Query: 239 VEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARG 297
           + K RH N++ F+G  T    + IV ++     L  +L   + +    K++  A   A+G
Sbjct: 58  LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 298 MNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           M+YLH      IIH DLK  NI L     +KI  FGL  +
Sbjct: 117 MDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATV 153

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 6e-32
 Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 17/150 (11%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G  +  K++  E    P   N    EL ++ +   P +V F GA   +  + I +E+
Sbjct: 28  KPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L   L+K GR+    + + ++ + +G+ YL E     I+H D+KP NIL+++ G+
Sbjct: 86  MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGE 143

Query: 327 LKISGFGLLR-------------LQYISPE 343
           +K+  FG+                 Y+SPE
Sbjct: 144 IKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-30
 Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 7/131 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K        K++D +S ++ E    +  E+ I+    HPN+V+ + A      + I++E+
Sbjct: 34  KETSVLAAAKVIDTKSEEELED---YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90

Query: 267 HAKGDLASYLQKKGR-LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
            A G + + + +  R L+ S++          +NYLH+ K   IIH DLK  NIL    G
Sbjct: 91  CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDG 147

Query: 326 QLKISGFGLLR 336
            +K++ FG+  
Sbjct: 148 DIKLADFGVSA 158

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-30
 Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 16/150 (10%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +   + +K+L K   +     +    E+ I    RHPN+++  G       + ++LEY
Sbjct: 28  KQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G +   LQK  +    +   +  +LA  ++Y H  +   +IH D+KP+N+LL + G+
Sbjct: 88  APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGE 144

Query: 327 LKISGFGLLR-------------LQYISPE 343
           LKI+ FG                L Y+ PE
Sbjct: 145 LKIADFGWSVHAPSSRRTTLCGTLDYLPPE 174

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 3e-30
 Identities = 56/180 (31%), Positives = 87/180 (48%), Gaps = 18/180 (10%)

Query: 183 YELNPLELQVRKADGITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTIV 239
           + LN  EL++ +   I KG +  V    + G KV VK +  ++        AF  E +++
Sbjct: 2   WALNMKELKLLQT--IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ-----AFLAEASVM 54

Query: 240 EKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALDLAR 296
            + RH N+VQ +G + +    + IV EY AKG L  YL+ +GR  L    +L+F+LD+  
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 297 GMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
            M YL        +H DL  +N+L+      K+S FGL +    S  +     PV    P
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVKWTAP 169

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 8e-30
 Identities = 44/152 (28%), Positives = 67/152 (44%), Gaps = 17/152 (11%)

Query: 198 ITKGSY-QV--AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV 254
           I KG + +V   KW G +V VKI      +   R      E+      RH N++ F+ A 
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA----EIYQTVMLRHENILGFIAAD 66

Query: 255 TQN----IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-----CK 305
            ++      + +V +YH  G L  YL  +  ++   +++ AL  A G+ +LH        
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125

Query: 306 PDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
              I H DLK KNIL+   G   I+  GL   
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 5e-29
 Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 5/131 (3%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +     V VKI+D +  +  +       E+ I +   H NVV+F G   +     + LEY
Sbjct: 27  RVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            + G+L   ++    +      RF   L  G+ YLH      I H D+KP+N+LLD    
Sbjct: 85  CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDN 141

Query: 327 LKISGFGLLRL 337
           LKIS FGL  +
Sbjct: 142 LKISDFGLATV 152

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 2e-28
 Identities = 34/140 (24%), Positives = 63/140 (45%), Gaps = 3/140 (2%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
                +  +KIL+K       ++   T E  ++ +  HP  V+       +  +   L Y
Sbjct: 30  LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  Y++K G    +    +  ++   + YLH      IIH DLKP+NILL+    
Sbjct: 90  AKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMH 146

Query: 327 LKISGFGLLRLQYISPEKAK 346
           ++I+ FG  ++     ++A+
Sbjct: 147 IQITDFGTAKVLSPESKQAR 166

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 3e-28
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 16/167 (9%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY-QV--AKWN-GTKVWVKILDKESHKDPERINAF 232
           P    E+E+    L++ +   +  G + +V    +N  TKV VK L + S         F
Sbjct: 2   PWWEDEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----F 55

Query: 233 THELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRF 290
             E  ++++ +H  +V+    VTQ  P+ I+ EY   G L  +L+     +L+ +K+L  
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114

Query: 291 ALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           A  +A GM ++ E      IH DL+  NIL+ +    KI+ FGL RL
Sbjct: 115 AAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL 158

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (272), Expect = 3e-28
 Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 20/153 (13%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGA----VTQNIPMMIVL 264
              +V    L        ER   F  E  +++  +HPN+V+F  +    V     +++V 
Sbjct: 33  TTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91

Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL-DN 323
           E    G L +YL++   +    +  +   + +G+ +LH   P PIIH DLK  NI +   
Sbjct: 92  ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGP 150

Query: 324 GGQLKISGFGLLRLQ-------------YISPE 343
            G +KI   GL  L+             +++PE
Sbjct: 151 TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPE 183

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-27
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 5/131 (3%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K     V VKIL  E+  DP   +    E  ++++  +P +V+ +G        M+V+E 
Sbjct: 31  KKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEM 88

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G L  YLQ+   +    ++     ++ GM YL E      +H DL  +N+LL     
Sbjct: 89  AELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHY 145

Query: 327 LKISGFGLLRL 337
            KIS FGL + 
Sbjct: 146 AKISDFGLSKA 156

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-27
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 9/139 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT--QNIPMMIVL 264
           K +G  +  K LD  S  + E+      E+ ++ + +HPN+V++   +    N  + IV+
Sbjct: 26  KSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84

Query: 265 EYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHE--CKPDPIIHCDLKPKN 318
           EY   GDLAS + K    +  L    VLR    L   +   H        ++H DLKP N
Sbjct: 85  EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144

Query: 319 ILLDNGGQLKISGFGLLRL 337
           + LD    +K+  FGL R+
Sbjct: 145 VFLDGKQNVKLGDFGLARI 163

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (266), Expect = 3e-27
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 12/164 (7%)

Query: 179 EVPEYELNPLELQVRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHE 235
              ++E+   ++ ++    +  G Y       W    + V +  K   +D   +  F  E
Sbjct: 8   NYDKWEMERTDITMKHK--LGGGQYGEVYEGVWKKYSLTVAV--KTLKEDTMEVEEFLKE 63

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSPSKVLRFALD 293
             ++++ +HPN+VQ +G  T+  P  I+ E+   G+L  YL++  R  +S   +L  A  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           ++  M YL +      IH DL  +N L+     +K++ FGL RL
Sbjct: 124 ISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 6e-27
 Identities = 42/139 (30%), Positives = 62/139 (44%), Gaps = 5/139 (3%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
           +G +         V VK L  +    PE ++ F  E+  +    H N+++  G V    P
Sbjct: 26  RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P 84

Query: 260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           M +V E    G L   L+K  G      + R+A+ +A GM YL        IH DL  +N
Sbjct: 85  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARN 141

Query: 319 ILLDNGGQLKISGFGLLRL 337
           +LL     +KI  FGL+R 
Sbjct: 142 LLLATRDLVKIGDFGLMRA 160

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 8e-27
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 14/158 (8%)

Query: 185 LNPLELQVRKADGITKGSYQV---AKW-NGTKVWVKILDKESHKDPERINAFTHELTIVE 240
           ++P +L   K   +  G + V    KW     V +K++ + S  + E    F  E  ++ 
Sbjct: 1   IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54

Query: 241 KARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYL-QKKGRLSPSKVLRFALDLARGMN 299
              H  +VQ  G  T+  P+ I+ EY A G L +YL + + R    ++L    D+   M 
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114

Query: 300 YLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           YL        +H DL  +N L+++ G +K+S FGL R 
Sbjct: 115 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 1e-26
 Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 41/191 (21%)

Query: 181 PEYELNPLELQVRKADGITKGSY-QV--AKWNGT-------KVWVKILDKESHKDPERIN 230
            ++E     L+  K   +  G++ +V  A   G        +V VK+L +++  D     
Sbjct: 30  LKWEFPRENLEFGKV--LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSERE 85

Query: 231 AFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK---------- 279
           A   EL ++ +   H N+V  +GA T + P+ ++ EY   GDL +YL+ K          
Sbjct: 86  ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145

Query: 280 -------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
                          L+   +L FA  +A+GM +L        +H DL  +N+L+ +G  
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 202

Query: 327 LKISGFGLLRL 337
           +KI  FGL R 
Sbjct: 203 VKICDFGLARD 213

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 3e-26
 Identities = 37/130 (28%), Positives = 60/130 (46%), Gaps = 7/130 (5%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
               V +K+L + +  +         E  I+ +  +P +V+ +G V Q   +M+V+E   
Sbjct: 35  KQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAG 91

Query: 269 KGDLASYL-QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL 327
            G L  +L  K+  +  S V      ++ GM YL E      +H DL  +N+LL N    
Sbjct: 92  GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYA 148

Query: 328 KISGFGLLRL 337
           KIS FGL + 
Sbjct: 149 KISDFGLSKA 158

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 4e-26
 Identities = 27/131 (20%), Positives = 61/131 (46%), Gaps = 7/131 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
              G +V ++ ++ +     E      +E+ ++ + ++PN+V ++ +      + +V+EY
Sbjct: 42  VATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G L   + +       ++     +  + + +LH  +   +IH D+K  NILL   G 
Sbjct: 99  LAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGS 154

Query: 327 LKISGFGLLRL 337
           +K++ FG    
Sbjct: 155 VKLTDFGFCAQ 165

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  102 bits (256), Expect = 5e-26
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 10/137 (7%)

Query: 207 KWNGTKVWVKILDKES------HKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIP 259
           K    +  VKI+D          +  E   A   E+ I+ K   HPN++Q       N  
Sbjct: 25  KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84

Query: 260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
             +V +   KG+L  YL +K  LS  +  +    L   +  LH+     I+H DLKP+NI
Sbjct: 85  FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENI 141

Query: 320 LLDNGGQLKISGFGLLR 336
           LLD+   +K++ FG   
Sbjct: 142 LLDDDMNIKLTDFGFSC 158

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  104 bits (260), Expect = 7e-26
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 6/133 (4%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHE---LTIVEKARHPNVVQFVGAVTQNIPMMIV 263
              G    +K LDK+  K  +      +E   L++V     P +V    A      +  +
Sbjct: 26  ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           L+    GDL  +L + G  S + +  +A ++  G+ ++H      +++ DLKP NILLD 
Sbjct: 86  LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDE 142

Query: 324 GGQLKISGFGLLR 336
            G ++IS  GL  
Sbjct: 143 HGHVRISDLGLAC 155

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  104 bits (259), Expect = 7e-26
 Identities = 30/133 (22%), Positives = 59/133 (44%), Gaps = 9/133 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +  G     K +      D E       E+  +   RHP +V    A   +  M+++ E+
Sbjct: 48  RATGNNFAAKFVMTPHESDKET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104

Query: 267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL--DN 323
            + G+L   +  +  ++S  + + +   + +G+ ++HE      +H DLKP+NI+     
Sbjct: 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKR 161

Query: 324 GGQLKISGFGLLR 336
             +LK+  FGL  
Sbjct: 162 SNELKLIDFGLTA 174

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  103 bits (259), Expect = 9e-26
 Identities = 31/133 (23%), Positives = 63/133 (47%), Gaps = 9/133 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G     K ++     D        +E++I+ +  HP ++    A      M+++LE+
Sbjct: 51  KATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107

Query: 267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--N 323
            + G+L   +  +  ++S ++V+ +      G+ ++HE     I+H D+KP+NI+ +   
Sbjct: 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKK 164

Query: 324 GGQLKISGFGLLR 336
              +KI  FGL  
Sbjct: 165 ASSVKIIDFGLAT 177

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 1e-25
 Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 39/194 (20%)

Query: 176 NPREVP---EYELNPLELQVRKADGITKGSY----------QVAKWNGTKVWVKILDKES 222
           +P ++P   ++E     L   K   +  G++           +       V VK+L   +
Sbjct: 8   DPTQLPYDHKWEFPRNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65

Query: 223 HKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG- 280
           H       A   EL ++     H N+V  +GA T   P +++ EY   GDL ++L++K  
Sbjct: 66  H--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 281 -----------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
                             L    +L F+  +A+GM +L        IH DL  +NILL +
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTH 180

Query: 324 GGQLKISGFGLLRL 337
           G   KI  FGL R 
Sbjct: 181 GRITKICDFGLARD 194

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  101 bits (253), Expect = 2e-25
 Identities = 41/139 (29%), Positives = 70/139 (50%), Gaps = 6/139 (4%)

Query: 200 KGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP 259
            G  ++       V +K L     +   R   F  E +I+ +  HPNV+   G VT++ P
Sbjct: 44  SGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNVIHLEGVVTKSTP 101

Query: 260 MMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           +MI+ E+   G L S+L++  G+ +  +++     +A GM YL +      +H DL  +N
Sbjct: 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARN 158

Query: 319 ILLDNGGQLKISGFGLLRL 337
           IL+++    K+S FGL R 
Sbjct: 159 ILVNSNLVCKVSDFGLSRF 177

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 38/133 (28%), Positives = 69/133 (51%), Gaps = 3/133 (2%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K +G    +KILDK+     ++I    +E  I++    P +V+   +   N  + +V+EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
            A G++ S+L++ GR S      +A  +     YLH      +I+ DLKP+N+L+D  G 
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGY 179

Query: 327 LKISGFGLLRLQY 339
           ++++ FG  +   
Sbjct: 180 IQVTDFGFAKRVK 192

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 7e-25
 Identities = 34/131 (25%), Positives = 58/131 (44%), Gaps = 4/131 (3%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIVLE 265
           K       +K L K+     + +     E  ++  A  HP +            +  V+E
Sbjct: 24  KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
           Y   GDL  ++Q   +   S+   +A ++  G+ +LH      I++ DLK  NILLD  G
Sbjct: 84  YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDG 140

Query: 326 QLKISGFGLLR 336
            +KI+ FG+ +
Sbjct: 141 HIKIADFGMCK 151

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 2e-24
 Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 8/136 (5%)

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI 262
           +     N  KV +K + + +  + +    F  E  ++ K  HP +VQ  G   +  P+ +
Sbjct: 22  HLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77

Query: 263 VLEYHAKGDLASYLQKKGRL-SPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL 321
           V E+   G L+ YL+ +  L +   +L   LD+  GM YL E     +IH DL  +N L+
Sbjct: 78  VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLV 134

Query: 322 DNGGQLKISGFGLLRL 337
                +K+S FG+ R 
Sbjct: 135 GENQVIKVSDFGMTRF 150

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.6 bits (245), Expect = 2e-24
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 20/194 (10%)

Query: 171 PMTVANPREVPEYELNPLELQVRKADGITKGSY-QV--AKWNGT-KVWVKILDKESHKDP 226
           P T    ++   +E+    L++     + +G + +V    WNGT +V +K L   +    
Sbjct: 2   PQTQGLAKD--AWEIPRESLRLEVK--LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE 57

Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR--LSP 284
                F  E  +++K RH  +VQ    V++  P+ IV EY +KG L  +L+ +    L  
Sbjct: 58  A----FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRL 112

Query: 285 SKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEK 344
            +++  A  +A GM Y+        +H DL+  NIL+      K++ FGL RL   +   
Sbjct: 113 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169

Query: 345 AK--IVFPVSHIDP 356
           A+    FP+    P
Sbjct: 170 ARQGAKFPIKWTAP 183

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 2e-24
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 29/202 (14%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINA 231
           P   P  + N ++ Q    D I +G++        K +G ++   I   + +   +    
Sbjct: 1   PTIYPVLDWNDIKFQ----DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 232 FTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------- 279
           F  EL ++ K   HPN++  +GA      + + +EY   G+L  +L+K            
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 280 -----GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL 334
                  LS  ++L FA D+ARGM+YL +      IH DL  +NIL+      KI+ FGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 173

Query: 335 LRLQYISPEKAKIVFPVSHIDP 356
            R Q +  +K     PV  +  
Sbjct: 174 SRGQEVYVKKTMGRLPVRWMAI 195

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 98.4 bits (244), Expect = 4e-24
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 29/153 (18%)

Query: 209 NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA 268
             T V VK+L +E+  D +    F  E  ++ +  +PN+V+ +G      PM ++ EY A
Sbjct: 42  PFTMVAVKMLKEEASADMQA--DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 99

Query: 269 KGDLASYLQKKGR------------------------LSPSKVLRFALDLARGMNYLHEC 304
            GDL  +L+                            LS ++ L  A  +A GM YL E 
Sbjct: 100 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159

Query: 305 KPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL 337
           K    +H DL  +N L+     +KI+ FGL R 
Sbjct: 160 K---FVHRDLATRNCLVGENMVVKIADFGLSRN 189

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 5e-24
 Identities = 37/167 (22%), Positives = 77/167 (46%), Gaps = 13/167 (7%)

Query: 182 EYELNPLELQVRKADGITKGSY------QVAKWNGTKVWVKILDKESHKDPERINAFTHE 235
           +YE+    +++ +   I +G +               + V I   ++         F  E
Sbjct: 1   DYEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 58

Query: 236 LTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDL 294
              + +  HP++V+ +G +T+N P+ I++E    G+L S+LQ +   L  + ++ +A  L
Sbjct: 59  ALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117

Query: 295 ARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
           +  + YL   +    +H D+  +N+L+ +   +K+  FGL R    S
Sbjct: 118 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 98.2 bits (244), Expect = 6e-24
 Identities = 37/127 (29%), Positives = 63/127 (49%), Gaps = 3/127 (2%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           + NG    +K+L KE     +++     E  ++    HP +++  G       + ++++Y
Sbjct: 26  RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L S L+K  R        +A ++   + YLH      II+ DLKP+NILLD  G 
Sbjct: 86  IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGH 142

Query: 327 LKISGFG 333
           +KI+ FG
Sbjct: 143 IKITDFG 149

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 97.4 bits (242), Expect = 1e-23
 Identities = 33/135 (24%), Positives = 66/135 (48%), Gaps = 8/135 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K     V +K + K++ +  E   +  +E+ ++ K +HPN+V           + ++++ 
Sbjct: 31  KRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL---DN 323
            + G+L   + +KG  +     R    +   + YLH+     I+H DLKP+N+L    D 
Sbjct: 89  VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDE 145

Query: 324 GGQLKISGFGLLRLQ 338
             ++ IS FGL +++
Sbjct: 146 DSKIMISDFGLSKME 160

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 3e-23
 Identities = 33/142 (23%), Positives = 63/142 (44%), Gaps = 3/142 (2%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G    +KIL KE     + +     E  +++  RHP +     A   +  +  V+EY
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
              G+L  +L ++   +  +   +  ++   + YLH      +++ D+K +N++LD  G 
Sbjct: 87  ANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGH 143

Query: 327 LKISGFGLLRLQYISPEKAKIV 348
           +KI+ FGL +         K  
Sbjct: 144 IKITDFGLCKEGISDGATMKTF 165

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.3 bits (239), Expect = 3e-23
 Identities = 24/134 (17%), Positives = 54/134 (40%), Gaps = 10/134 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
             +      K +  +   D         E++I+  ARH N++    +      ++++ E+
Sbjct: 27  TSSKKTYMAKFVKVKG-TDQVL---VKKEISILNIARHRNILHLHESFESMEELVMIFEF 82

Query: 267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-- 323
            +  D+   +      L+  +++ +   +   + +LH      I H D++P+NI+     
Sbjct: 83  ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRR 139

Query: 324 GGQLKISGFGLLRL 337
              +KI  FG  R 
Sbjct: 140 SSTIKIIEFGQARQ 153

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 94.8 bits (235), Expect = 5e-23
 Identities = 34/134 (25%), Positives = 55/134 (41%), Gaps = 7/134 (5%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP----MMI 262
                 V VK+L  +  +DP     F  E        HP +V          P      I
Sbjct: 29  LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88

Query: 263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           V+EY     L   +  +G ++P + +    D  + +N+ H+     IIH D+KP NI++ 
Sbjct: 89  VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMIS 145

Query: 323 NGGQLKISGFGLLR 336
               +K+  FG+ R
Sbjct: 146 ATNAVKVMDFGIAR 159

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.6 bits (234), Expect = 8e-23
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 33/197 (16%)

Query: 177 PREVPEYELNPLELQVRKADGITKGSY----------QVAKWNGTKVWVKILDKESHKDP 226
           P +  ++E     L++ K   + +G++                   V VK+L + +    
Sbjct: 2   PYDASKWEFPRDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59

Query: 227 ERINAFTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKGDLASYLQKKGR---- 281
            R    +    ++    H NVV  +GA T+   P+M+++E+   G+L++YL+ K      
Sbjct: 60  HR-ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118

Query: 282 ------------LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKI 329
                       L+   ++ ++  +A+GM +L   K    IH DL  +NILL     +KI
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKI 175

Query: 330 SGFGLLRLQYISPEKAK 346
             FGL R  Y  P+  +
Sbjct: 176 CDFGLARDIYKDPDYVR 192

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 9e-23
 Identities = 46/198 (23%), Positives = 92/198 (46%), Gaps = 30/198 (15%)

Query: 182 EYELNPLELQVRKADGITKGSY----------QVAKWNGTKVWVKILDKESHKDPERINA 231
           E+E+   ++ + +   + +GS+           V     T+V +K +++ +         
Sbjct: 14  EWEVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIE 69

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGR---------- 281
           F +E +++++    +VV+ +G V+Q  P ++++E   +GDL SYL+              
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 282 LSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYIS 341
            S SK+++ A ++A GM YL+       +H DL  +N ++     +KI  FG+ R  Y +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 342 PEKA---KIVFPVSHIDP 356
                  K + PV  + P
Sbjct: 187 DYYRKGGKGLLPVRWMSP 204

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.9 bits (232), Expect = 5e-22
 Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 6/180 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L +A   G +  V++LL  G+  N  ++   T LH+AA  GH EV K LL  KA ++A+ 
Sbjct: 4   LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVANPREVPEYELNPLEL-- 190
           +   T    A   G+  +  +L    A          TP+ +A      E  L  LE   
Sbjct: 64  KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEA 123

Query: 191 QVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF 250
                         VA   G     ++L +               L +     + ++V+ 
Sbjct: 124 SQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKL 183

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.7 bits (190), Expect = 2e-16
 Identities = 30/84 (35%), Positives = 46/84 (54%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   +  G++K V+ LL   +DVN+    G + LH AA +GH ++V LLL   A+ +   
Sbjct: 301 LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVS 360

Query: 136 RWGSTAAADAKYYGNVEVYNILKA 159
             G+T  A AK  G + V ++LK 
Sbjct: 361 SDGTTPLAIAKRLGYISVTDVLKV 384

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.5 bits (174), Expect = 2e-14
 Identities = 33/149 (22%), Positives = 49/149 (32%), Gaps = 5/149 (3%)

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV-- 164
           T LH+A+  GH+ +VK LL + A+ +  +    T    A   G+ EV   L    AKV  
Sbjct: 2   TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNA 61

Query: 165 -PKTKRTPMTVA--NPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTKVWVKILDKE 221
             K  +TP+  A           L         A         +A   G    V  L ++
Sbjct: 62  KAKDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEK 121

Query: 222 SHKDPERINAFTHELTIVEKARHPNVVQF 250
                         L +  K     V + 
Sbjct: 122 EASQACMTKKGFTPLHVAAKYGKVRVAEL 150

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.9 bits (162), Expect = 6e-13
 Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 11/200 (5%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A +  V+    LL  G   N+  + G T LH+AA EGH E+V LLLSK+AN +  +
Sbjct: 202 LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGN 261

Query: 136 RWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTV-------ANPREVPEYELNPL 188
           + G T        G+V V ++L   G  V  T R   T         N + V     +  
Sbjct: 262 KSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQA 321

Query: 189 ELQVRKADGITKGSYQVAKWNGTKVWVKILDKESHKDPERINAFTH-ELTIVEKARHPNV 247
           ++  +   G +      A   G    V +L  ++   P  +++     L I ++  + +V
Sbjct: 322 DVNAKTKLGYS--PLHQAAQQGHTDIVTLL-LKNGASPNEVSSDGTTPLAIAKRLGYISV 378

Query: 248 VQFVGAVTQNIPMMIVLEYH 267
              +  VT     ++V + H
Sbjct: 379 TDVLKVVTDETSFVLVSDKH 398

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.2 bits (160), Expect = 1e-12
 Identities = 25/84 (29%), Positives = 37/84 (44%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
             L   A  G V+  E LL   +  N+   +G T LH+A    ++++VKLLL +  +  +
Sbjct: 134 TPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHS 193

Query: 134 RDRWGSTAAADAKYYGNVEVYNIL 157
               G T    A     VEV   L
Sbjct: 194 PAWNGYTPLHIAAKQNQVEVARSL 217

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.4 bits (145), Expect = 1e-10
 Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 3/98 (3%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
            +    +   G T LH+AA  G V V +LLL + A+ +A  + G T    A ++ N+++ 
Sbjct: 122 EASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIV 181

Query: 155 NILKARGAKV---PKTKRTPMTVANPREVPEYELNPLE 189
            +L  RG           TP+ +A  +   E   + L+
Sbjct: 182 KLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQ 219

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 92.3 bits (228), Expect = 6e-22
 Identities = 35/135 (25%), Positives = 66/135 (48%), Gaps = 4/135 (2%)

Query: 203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI 262
           Y+     G    +K +  E  +D    +    E++I+++ +H N+V+    +     +++
Sbjct: 19  YKAQNNYGETFALKKIRLE-KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVL 77

Query: 263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           V E+  +         +G L       F L L  G+ Y H+ +   ++H DLKP+N+L++
Sbjct: 78  VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLIN 134

Query: 323 NGGQLKISGFGLLRL 337
             G+LKI+ FGL R 
Sbjct: 135 REGELKIADFGLARA 149

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 9e-22
 Identities = 34/135 (25%), Positives = 59/135 (43%), Gaps = 10/135 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV----TQNIPMMI 262
             N  +V +K +     +          E+ I+ + RH N++     +     + +  + 
Sbjct: 30  NVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87

Query: 263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
           ++ +    DL   L K   LS   +  F   + RG+ Y+H      ++H DLKP N+LL+
Sbjct: 88  LVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 143

Query: 323 NGGQLKISGFGLLRL 337
               LKI  FGL R+
Sbjct: 144 TTCDLKICDFGLARV 158

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 2e-21
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 36/186 (19%)

Query: 181 PEYELNPLELQVRKADGITKGSY------------QVAKWNGTKVWVKILDKESHKDPER 228
           P +EL    L + K   + +G++            +      TKV VK+L  ++ +    
Sbjct: 6   PRWELPRDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63

Query: 229 INAFTHELTIVEK-ARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQ---------- 277
                 E+ +++   +H N++  +GA TQ+ P+ +++EY +KG+L  YLQ          
Sbjct: 64  --DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 278 ------KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISG 331
                  + +LS   ++  A  +ARGM YL        IH DL  +N+L+     +KI+ 
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIAD 178

Query: 332 FGLLRL 337
           FGL R 
Sbjct: 179 FGLARD 184

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.0 bits (225), Expect = 2e-21
 Identities = 31/131 (23%), Positives = 60/131 (45%), Gaps = 5/131 (3%)

Query: 209 NGTKVWVKILDKESHK--DPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
            G KV + +  KE  +   P+       E  ++    +P+V + +G    +   +I    
Sbjct: 33  EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLM 92

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
                L    + K  +    +L + + +A+GMNYL + +   ++H DL  +N+L+     
Sbjct: 93  PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQH 149

Query: 327 LKISGFGLLRL 337
           +KI+ FGL +L
Sbjct: 150 VKITDFGLAKL 160

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 5e-21
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 17/173 (9%)

Query: 184 ELNPLELQVRKADGITKGSY-QV--AKWNGT------KVWVKILDKESHKDPERINAFTH 234
           E++P  +  +K  G   G + +V       +       V +K L        ++   F  
Sbjct: 3   EIHPSCVTRQKVIG--AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLG 58

Query: 235 ELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAKGDLASY-LQKKGRLSPSKVLRFALD 293
           E  I+ +  H N+++  G +++  PMMI+ EY   G L  +  +K G  S  +++     
Sbjct: 59  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118

Query: 294 LARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQYISPEKAK 346
           +A GM YL        +H DL  +NIL+++    K+S FGL R+    PE   
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 7e-21
 Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 11/170 (6%)

Query: 178 REVPEYELNPLELQVRKADGITKGSY------QVAKWNGTKVWVKILDKESHKDPERINA 231
           + V    + P  L V   + I +G +       +   +G K+   +       D   ++ 
Sbjct: 15  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 74

Query: 232 FTHELTIVEKARHPNVVQFVGAVTQ-NIPMMIVLEYHAKGDLASYLQ-KKGRLSPSKVLR 289
           F  E  I++   HPNV+  +G   +     ++VL Y   GDL ++++ +    +   ++ 
Sbjct: 75  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134

Query: 290 FALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRLQY 339
           F L +A+GM +L   K    +H DL  +N +LD    +K++ FGL R  Y
Sbjct: 135 FGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 181

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 1e-20
 Identities = 34/132 (25%), Positives = 59/132 (44%), Gaps = 5/132 (3%)

Query: 207 KWNGTKVWVKILDKE--SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVL 264
           K     V +K +     S            E+ ++++  HPN++  + A      + +V 
Sbjct: 20  KNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVF 79

Query: 265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG 324
           ++               L+PS +  + L   +G+ YLH+     I+H DLKP N+LLD  
Sbjct: 80  DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDEN 136

Query: 325 GQLKISGFGLLR 336
           G LK++ FGL +
Sbjct: 137 GVLKLADFGLAK 148

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 1e-20
 Identities = 34/139 (24%), Positives = 60/139 (43%), Gaps = 12/139 (8%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIP------- 259
           +  G KV +K +  E+ K+   I     E+ I++  +H NVV  +               
Sbjct: 32  RKTGQKVALKKVLMENEKEGFPIT-ALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90

Query: 260 -MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
            + +V ++              + + S++ R    L  G+ Y+H  K   I+H D+K  N
Sbjct: 91  SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAAN 147

Query: 319 ILLDNGGQLKISGFGLLRL 337
           +L+   G LK++ FGL R 
Sbjct: 148 VLITRDGVLKLADFGLARA 166

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.1 bits (215), Expect = 3e-20
 Identities = 36/164 (21%), Positives = 70/164 (42%), Gaps = 15/164 (9%)

Query: 187 PLELQVRKADGITKGSY-QVAKW----NGTKVWVKILDKESHKDPERI---NAFTHELTI 238
           PLE Q +    +  G +  V       +   V +K ++K+   D   +        E+ +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60

Query: 239 VEKAR--HPNVVQFVGAVTQNIPMMIVLEY-HAKGDLASYLQKKGRLSPSKVLRFALDLA 295
           ++K       V++ +    +    +++LE      DL  ++ ++G L       F   + 
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 296 RGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRLQ 338
             + + H C    ++H D+K +NIL+D N G+LK+  FG   L 
Sbjct: 121 EAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL 161

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.6 bits (211), Expect = 1e-19
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 10/157 (6%)

Query: 207 KWNGTKVWVKILDKE---SHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIV 263
           K  G +   K + K    S +          E++I+++ +HPNV+           ++++
Sbjct: 32  KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91

Query: 264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN 323
           LE  A G+L  +L +K  L+  +   F   +  G+ YLH      I H DLKP+NI+L +
Sbjct: 92  LELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLD 148

Query: 324 GG----QLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
                 ++KI  FGL        E   I      + P
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 185

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.9 bits (212), Expect = 2e-19
 Identities = 31/137 (22%), Positives = 55/137 (40%), Gaps = 21/137 (15%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGA----VTQNIPMM 261
           K    K  +K+L                E+ +  +A + P++V+ V            ++
Sbjct: 34  KRTQEKFALKMLQDCPK--------ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85

Query: 262 IVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNI 319
           IV+E    G+L S +Q +G    +  +       +   + YLH      I H D+KP+N+
Sbjct: 86  IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENL 142

Query: 320 LLD---NGGQLKISGFG 333
           L         LK++ FG
Sbjct: 143 LYTSKRPNAILKLTDFG 159

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.2 bits (207), Expect = 4e-19
 Identities = 32/138 (23%), Positives = 65/138 (47%), Gaps = 4/138 (2%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           +     V +K +  +   D    ++   E+ ++++ +H N+V+    +  +  + +V E+
Sbjct: 24  RETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82

Query: 267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQ 326
             +     +    G L P  V  F   L +G+ + H      ++H DLKP+N+L++  G+
Sbjct: 83  CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGE 139

Query: 327 LKISGFGLLRLQYISPEK 344
           LK++ FGL R   I    
Sbjct: 140 LKLANFGLARAFGIPVRC 157

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.5 bits (208), Expect = 6e-19
 Identities = 34/136 (25%), Positives = 57/136 (41%), Gaps = 12/136 (8%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IPM 260
              G KV +K L +    +         EL +++  RH NV+  +   T +         
Sbjct: 40  GRTGAKVAIKKLYRPFQSELFA-KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98

Query: 261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            +V+ +   G     L K  +L   ++      + +G+ Y+H       IH DLKP N+ 
Sbjct: 99  YLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLA 153

Query: 321 LDNGGQLKISGFGLLR 336
           ++   +LKI  FGL R
Sbjct: 154 VNEDCELKILDFGLAR 169

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.8 bits (206), Expect = 7e-19
 Identities = 36/158 (22%), Positives = 71/158 (44%), Gaps = 11/158 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFT--HELTIVEKARHPNVVQFVGAVT-----QNIP 259
           K  G  V +K +  ++ ++   ++       L  +E   HPNVV+     T     +   
Sbjct: 30  KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89

Query: 260 MMIVLEYHAKGDLASYLQ-KKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKN 318
           + +V E+  +       +  +  +    +      L RG+++LH  +   ++H DLKP+N
Sbjct: 90  LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQN 146

Query: 319 ILLDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           IL+ + GQ+K++ FGL R+         +V  + +  P
Sbjct: 147 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (206), Expect = 8e-19
 Identities = 32/137 (23%), Positives = 64/137 (46%), Gaps = 5/137 (3%)

Query: 200 KGSYQVAKWNGTKVWVKILDKES-HKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQN 257
                     G    +K+L K +  +  +       E  ++E  R  P +V    A    
Sbjct: 42  LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101

Query: 258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPK 317
             + ++L+Y   G+L ++L ++ R +  +V  +  ++   + +LH+     II+ D+K +
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 158

Query: 318 NILLDNGGQLKISGFGL 334
           NILLD+ G + ++ FGL
Sbjct: 159 NILLDSNGHVVLTDFGL 175

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.9 bits (204), Expect = 2e-18
 Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 28/179 (15%)

Query: 174 VANPREVPEYELNPLELQVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPER 228
           VA P + P+    P E+       I  GS+ V        +G  V +K + ++       
Sbjct: 7   VATPGQGPD---RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---- 59

Query: 229 INAFTHELTIVEKARHPNVVQFVGAVTQ------NIPMMIVLEYHAKG---DLASYLQKK 279
                 EL I+ K  H N+V+              + + +VL+Y  +        Y + K
Sbjct: 60  ---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK 116

Query: 280 GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRL 337
             L    V  +   L R + Y+H      I H D+KP+N+LLD +   LK+  FG  + 
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 82.6 bits (203), Expect = 2e-18
 Identities = 43/208 (20%), Positives = 75/208 (36%), Gaps = 27/208 (12%)

Query: 164 VPKTKRTPMTVANPREVPEYELNPLELQVRKADG------ITKGSYQVA-----KWNGTK 212
           VP   R    V   R    ++     ++    D       + +G Y          N  K
Sbjct: 3   VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK 62

Query: 213 VWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQ--NIPMMIVLEYHAK 269
           V VKIL     K          E+ I+E  R  PN++     V    +    +V E+   
Sbjct: 63  VVVKILKPVKKKK------IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116

Query: 270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-GGQLK 328
            D     Q    L+   +  +  ++ + ++Y H      I+H D+KP N+++D+   +L+
Sbjct: 117 TDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLR 170

Query: 329 ISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           +  +GL    +   E    V       P
Sbjct: 171 LIDWGLAEFYHPGQEYNVRVASRYFKGP 198

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 2e-17
 Identities = 27/131 (20%), Positives = 62/131 (47%), Gaps = 5/131 (3%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY 266
           K  G  V +K +  ++  +    +    E++++++  HPN+V+ +  +     + +V E+
Sbjct: 24  KLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82

Query: 267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
             +             +    +  +   L +G+ + H      ++H DLKP+N+L++  G
Sbjct: 83  LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEG 139

Query: 326 QLKISGFGLLR 336
            +K++ FGL R
Sbjct: 140 AIKLADFGLAR 150

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.1 bits (191), Expect = 5e-17
 Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 1/77 (1%)

Query: 89  EDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKY 147
             LL+ G+DVN     G+T L +A  + H+ +V+ LL ++   I+  D  G TA   A  
Sbjct: 203 HLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVE 262

Query: 148 YGNVEVYNILKARGAKV 164
               ++  +L  RGA  
Sbjct: 263 LKLKKIAELLCKRGAST 279

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.9 bits (175), Expect = 7e-15
 Identities = 18/61 (29%), Positives = 31/61 (50%), Gaps = 1/61 (1%)

Query: 76  LLFMACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDAR 134
           L+    +  +  V+ LL  E  ++N  D DG+TAL +A      ++ +LL  + A+ D  
Sbjct: 223 LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG 282

Query: 135 D 135
           D
Sbjct: 283 D 283

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.1 bits (139), Expect = 3e-10
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 2/101 (1%)

Query: 75  QLLFMACR-GDVKGVEDLLNEGSDVNSIDLD-GRTALHIAACEGHVEVVKLLLSKKANID 132
            LL  A +  DV  V+ LL  G++VN  + + G T LH A      ++V+LLL   A+  
Sbjct: 7   HLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPV 66

Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
            R + G+T    A   G+V++  +  ++GA V +      T
Sbjct: 67  LRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGFT 107

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.0 bits (131), Expect = 3e-09
 Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 15/134 (11%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNV----E 152
              +   G TAL  AA +GHVEV+K+LL +  A+++A D  G  A   A    +      
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200

Query: 153 VYNILKARGAKV---PKTKRTPMTVANPREVPEY-----ELNPLELQVRKADGITKGSYQ 204
           + ++L   GA V    +  +TP+ +A  ++         E   +E+    +DG T  +  
Sbjct: 201 ITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKT--ALL 258

Query: 205 VAKWNGTKVWVKIL 218
           +A     K   ++L
Sbjct: 259 LAVELKLKKIAELL 272

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (129), Expect = 5e-09
 Identities = 11/52 (21%), Positives = 23/52 (44%), Gaps = 1/52 (1%)

Query: 103 LDGRTALHIAACEGHVEVVKLLLSKKANIDARD-RWGSTAAADAKYYGNVEV 153
           ++    L  A     V++V+ LL   AN++ ++   G T   +A      ++
Sbjct: 3   VEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDI 54

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 75.6 bits (185), Expect = 4e-16
 Identities = 20/153 (13%), Positives = 46/153 (30%), Gaps = 14/153 (9%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIVLE 265
             N  +V +K   + S            E    +       +        + +  ++V++
Sbjct: 27  LLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-- 323
                          + S   V   A  +   +  +HE     +++ D+KP N L+    
Sbjct: 82  LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPN 138

Query: 324 ---GGQLKISGFGLLRLQYISPEKAKIVFPVSH 353
                 + +  FG+++       K  I +    
Sbjct: 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 74.5 bits (182), Expect = 1e-15
 Identities = 21/121 (17%), Positives = 42/121 (34%), Gaps = 9/121 (7%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV-TQNIPMMIVLE 265
              G +V +K+   ++            E  I +  +    +  +     +    ++V+E
Sbjct: 29  IAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83

Query: 266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG 325
                    +     + S   VL  A  +   + Y+H       IH D+KP N L+  G 
Sbjct: 84  LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGK 140

Query: 326 Q 326
           +
Sbjct: 141 K 141

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 72.8 bits (177), Expect = 3e-15
 Identities = 22/67 (32%), Positives = 38/67 (56%), Gaps = 1/67 (1%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           GS+ +  D DG+T + +AA EG +EVV  L+ + A+++A D    TA   A+   +  + 
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270

Query: 155 NIL-KAR 160
           +I  + R
Sbjct: 271 DIFDRCR 277

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 61.3 bits (147), Expect = 2e-11
 Identities = 12/50 (24%), Positives = 24/50 (48%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
           ++  A  G ++ V  L+ +G+ V ++D    TA  +A    H  +V +  
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFD 274

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 60.1 bits (144), Expect = 6e-11
 Identities = 16/87 (18%), Positives = 27/87 (31%), Gaps = 9/87 (10%)

Query: 77  LFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-------- 128
           L     G     E +  E  ++       RT LH  A     E  + L+  +        
Sbjct: 6   LHTEAAGSYAITEPITRESVNIID-PRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAG 64

Query: 129 ANIDARDRWGSTAAADAKYYGNVEVYN 155
           A+++A D   +T    A       +  
Sbjct: 65  ADVNAMDCDENTPLMLAVLARRRRLVA 91

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 41.3 bits (95), Expect = 1e-04
 Identities = 32/102 (31%), Positives = 46/102 (45%), Gaps = 4/102 (3%)

Query: 78  FMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDR 136
             A     KG +   +  +  +S    GRTALH AA   ++ +VK L+ +K +N D +D 
Sbjct: 160 ASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDE 219

Query: 137 WGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
            G T    A   G +EV   L  +GA V     T  T   +A
Sbjct: 220 DGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLA 261

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 40.5 bits (93), Expect = 2e-04
 Identities = 12/60 (20%), Positives = 18/60 (30%), Gaps = 2/60 (3%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
           +    LH  A  G   + + +  +  NI    R   T         + E    L    AK
Sbjct: 1   ESPIKLHTEAA-GSYAITEPITRESVNI-IDPRHNRTVLHWIASNSSAEKSEDLIVHEAK 58

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.0 bits (178), Expect = 5e-15
 Identities = 35/132 (26%), Positives = 57/132 (43%), Gaps = 8/132 (6%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM----I 262
              G +V VK L +   +          EL +++  +H NV+  +   T    +     +
Sbjct: 40  TKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98

Query: 263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD 322
            L  H  G   + + K  +L+   V      + RG+ Y+H      IIH DLKP N+ ++
Sbjct: 99  YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN 155

Query: 323 NGGQLKISGFGL 334
              +LKI  FGL
Sbjct: 156 EDCELKILDFGL 167

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.7 bits (177), Expect = 7e-15
 Identities = 33/156 (21%), Positives = 56/156 (35%), Gaps = 13/156 (8%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM----- 261
                 V +K L +   ++         EL +++   H N++  +   T    +      
Sbjct: 39  AVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97

Query: 262 -IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNIL 320
            +V+E             +  L   ++      +  G+ +LH      IIH DLKP NI+
Sbjct: 98  YLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV 151

Query: 321 LDNGGQLKISGFGLLRLQYISPEKAKIVFPVSHIDP 356
           + +   LKI  FGL R    S      V    +  P
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 71.1 bits (173), Expect = 2e-14
 Identities = 19/96 (19%), Positives = 29/96 (30%), Gaps = 6/96 (6%)

Query: 76  LLFMACR----GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           + F+A        +  +  LL     V  I  +   A  +AA  GH+ V+  L       
Sbjct: 93  ICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTE 152

Query: 132 DARDR--WGSTAAADAKYYGNVEVYNILKARGAKVP 165
                      A   A   G++ V N L        
Sbjct: 153 IMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEA 188

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 65.3 bits (158), Expect = 2e-12
 Identities = 19/108 (17%), Positives = 33/108 (30%), Gaps = 6/108 (5%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH---VEVVKLL 124
           +N++   QLL   C        +     SD +   +       +AA  G    ++ + LL
Sbjct: 56  KNMEQVRQLL---CLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLL 112

Query: 125 LSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPM 172
           L+    +         A   A   G++ V N L               
Sbjct: 113 LTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAE 160

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 50.3 bits (119), Expect = 1e-07
 Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 5/56 (8%)

Query: 76  LLFMACRGDVKGVEDLLNEGSD-----VNSIDLDGRTALHIAACEGHVEVVKLLLS 126
           L+       +  +  LL+           +I  D    L +A   G+     LLLS
Sbjct: 283 LIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLS 338

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 47.2 bits (111), Expect = 1e-06
 Identities = 15/97 (15%), Positives = 25/97 (25%), Gaps = 6/97 (6%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLD--GRTALHIAACEGHVEVVKLLLSKKANID- 132
             +A   G +  +  L           +      A  +AA  GH+ V+  L         
Sbjct: 130 FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEAT 189

Query: 133 --ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKT 167
              +          A   G+  V N L      +   
Sbjct: 190 AMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYA 226

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 45.3 bits (106), Expect = 5e-06
 Identities = 10/87 (11%), Positives = 19/87 (21%), Gaps = 10/87 (11%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA-----N 130
              ++    V  +                    L     E  ++ ++ LLS         
Sbjct: 255 AFKLSNPDGVFDLVT-----KSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAP 309

Query: 131 IDARDRWGSTAAADAKYYGNVEVYNIL 157
                   +     A   GN     +L
Sbjct: 310 TATIPGDANELLRLALRLGNQGACALL 336

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 38.3 bits (88), Expect = 0.001
 Identities = 10/138 (7%), Positives = 31/138 (22%), Gaps = 36/138 (26%)

Query: 68  ENLDSTMQLLFMACRGDVKGVEDLLNEGSDVN----------------------SIDLDG 105
           +  +          RG    +  LL+    +                       +   + 
Sbjct: 193 QAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFEYGEKYVNPFIARHVNRLKEM 252

Query: 106 RTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA--- 162
             A  ++  +G  ++V        +   +  +             ++    L +      
Sbjct: 253 HDAFKLSNPDGVFDLV------TKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKA 306

Query: 163 -----KVPKTKRTPMTVA 175
                 +P      + +A
Sbjct: 307 LAPTATIPGDANELLRLA 324

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 36.4 bits (83), Expect = 0.004
 Identities = 16/110 (14%), Positives = 29/110 (26%), Gaps = 11/110 (10%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSI---DLDGRTALHIAACEGHVEVVKLLLSKKANID 132
               A  G +  +  L        +      +       A   GH  V+  LL     + 
Sbjct: 165 FRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLA 224

Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPE 182
             +            YG   V   +     ++ K       ++NP  V +
Sbjct: 225 YAEIHEFE-------YGEKYVNPFIARHVNRL-KEMHDAFKLSNPDGVFD 266

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 69.0 bits (167), Expect = 8e-14
 Identities = 22/66 (33%), Positives = 35/66 (53%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L   A +G  + ++ L+    DVN  D DG T LH AA  G  E  ++L+    +++A +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262

Query: 136 RWGSTA 141
           + G TA
Sbjct: 263 KVGQTA 268

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 59.7 bits (143), Expect = 9e-11
 Identities = 15/55 (27%), Positives = 22/55 (40%)

Query: 101 IDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYN 155
           +  D       A   G  E V  LL + A+I+  +  G TA   A    NV++  
Sbjct: 36  VKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVK 90

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 54.0 bits (128), Expect = 6e-09
 Identities = 33/114 (28%), Positives = 50/114 (43%)

Query: 48  RQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRT 107
           R    +     PV          D     L     GD + V  LL  G+D+N  ++DG T
Sbjct: 16  RWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLT 75

Query: 108 ALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG 161
           ALH A  + +V++VK L+   ANI+  D  G      A   G +++   L ++G
Sbjct: 76  ALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQG 129

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 54.0 bits (128), Expect = 8e-09
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 3/89 (3%)

Query: 91  LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGN 150
           L +   +       G TALH+AA +G+ EV+KLL+  + +++ +D  G T    A ++G 
Sbjct: 185 LNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGK 244

Query: 151 VEVYNILKARGAKV---PKTKRTPMTVAN 176
            E   IL      +    K  +T   VA+
Sbjct: 245 EEACRILVENLCDMEAVNKVGQTAFDVAD 273

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 46.3 bits (108), Expect = 3e-06
 Identities = 14/58 (24%), Positives = 27/58 (46%), Gaps = 6/58 (10%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAA--CEGHVEVVKLLLSKKANI 131
           L   A  G  +    L+    D+ +++  G+TA  +A     G++E ++    KK N+
Sbjct: 236 LHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDILGYLEELQ----KKQNL 289

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 66.6 bits (161), Expect = 5e-13
 Identities = 14/57 (24%), Positives = 29/57 (50%)

Query: 85  VKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTA 141
           ++ ++      + +N+ D +G T L+IAA  G++ +V  LL   A+    ++ G   
Sbjct: 239 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP 295

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 65.1 bits (157), Expect = 2e-12
 Identities = 23/120 (19%), Positives = 39/120 (32%), Gaps = 9/120 (7%)

Query: 65  TVPENLDSTMQLLFMACRGDVKGVEDLLNEGS-DVN-SIDLDGRTALHIAACEGHVEVVK 122
              E   S  Q   ++    ++ V D       ++N  +D  G T LH      ++E+VK
Sbjct: 65  RNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLELVK 124

Query: 123 LLLSKKANIDARDRWGSTAAADAKYYGN-------VEVYNILKARGAKVPKTKRTPMTVA 175
            L+   +N    D  G +    A    N         + + L           RT +   
Sbjct: 125 HLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHI 184

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 50.0 bits (118), Expect = 1e-07
 Identities = 16/91 (17%), Positives = 33/91 (36%), Gaps = 6/91 (6%)

Query: 91  LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSK---KANIDARDRWGSTAAADAKY 147
           +  +   + S   +  +  +    E    +++ L  K      ++A+D  G T    A  
Sbjct: 209 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 268

Query: 148 YGNVEVYNILKARGAKV---PKTKRTPMTVA 175
            GN+ + + L   GA      K+   P+   
Sbjct: 269 LGNISIVDALLDYGADPFIANKSGLRPVDFG 299

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 40.4 bits (93), Expect = 2e-04
 Identities = 11/38 (28%), Positives = 19/38 (50%), Gaps = 1/38 (2%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDLDGRTALHIAA 113
           L +A R G++  V+ LL+ G+D    +  G   +   A
Sbjct: 263 LNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.2 bits (155), Expect = 2e-12
 Identities = 32/100 (32%), Positives = 50/100 (50%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDA 133
             L   A  G  + V+ LL +G+ VN+++ +G T LH AA +   E+  +LL   AN DA
Sbjct: 72  SPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDA 131

Query: 134 RDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMT 173
           +D + +TA   A   GN+++ +IL    A          T
Sbjct: 132 KDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNT 171

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.1 bits (152), Expect = 3e-12
 Identities = 31/110 (28%), Positives = 58/110 (52%), Gaps = 3/110 (2%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKK 128
           N +    L + A +   +    LL  G++ ++ D    TA+H AA +G+++++ +LL  K
Sbjct: 100 NQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYK 159

Query: 129 ANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA 175
           A+ + +D  G+T    A     VE   +L ++GA +    K ++TP+ VA
Sbjct: 160 ASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVA 209

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.8 bits (146), Expect = 2e-11
 Identities = 36/186 (19%), Positives = 57/186 (30%), Gaps = 39/186 (20%)

Query: 72  STMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEG-------------- 116
           S + +  +A  G ++ +++ +    S     D D RTALH A   G              
Sbjct: 3   SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVP 62

Query: 117 -------------------HVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL 157
                                E+VK LL K A ++A ++ G T    A      E+  +L
Sbjct: 63  VNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVML 122

Query: 158 KARGAKV---PKTKRTPM--TVANPREVPEYELNPLELQVRKADGITKGSYQVAKWNGTK 212
              GA        + T M    A       + L   +      D        +A      
Sbjct: 123 LEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERV 182

Query: 213 VWVKIL 218
              K+L
Sbjct: 183 EEAKLL 188

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (133), Expect = 9e-10
 Identities = 9/57 (15%), Positives = 26/57 (45%), Gaps = 1/57 (1%)

Query: 69  NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL 125
           + +    L        V+  + L+++G+ +   + + +T L +A   G   ++K ++
Sbjct: 166 DTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMV 221

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.4 bits (132), Expect = 1e-09
 Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 1/82 (1%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           +   A +G++K +  LL   +  N  D +G T LH+A  E  VE  KLL+S+ A+I   +
Sbjct: 140 MHRAAAKGNLKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIEN 199

Query: 136 RWGSTAAADAKYYGNVEVYNIL 157
           +   T    AK  G   +   +
Sbjct: 200 KEEKTPLQVAK-GGLGLILKRM 220

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 64.0 bits (154), Expect = 3e-12
 Identities = 14/58 (24%), Positives = 22/58 (37%), Gaps = 1/58 (1%)

Query: 78  FMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
                     +E LL  G+D  +    GRT L  A    +  + +LL +  A  +  D
Sbjct: 198 LAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 62.0 bits (149), Expect = 1e-11
 Identities = 17/60 (28%), Positives = 23/60 (38%), Gaps = 3/60 (5%)

Query: 99  NSIDLDGRTALHIAACEGHVEVVKLLLSKKAN---IDARDRWGSTAAADAKYYGNVEVYN 155
             +  DG TALH+A    H   +  LL   A    +D ++  G TA   A   G      
Sbjct: 3   GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE 62

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 60.9 bits (146), Expect = 2e-11
 Identities = 21/61 (34%), Positives = 29/61 (47%)

Query: 106 RTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP 165
           RT LH+A       V++LLL   A+  AR   G T    A    N  +  +L+A GA  P
Sbjct: 193 RTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEP 252

Query: 166 K 166
           +
Sbjct: 253 E 253

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 53.6 bits (127), Expect = 8e-09
 Identities = 26/118 (22%), Positives = 42/118 (35%), Gaps = 4/118 (3%)

Query: 77  LFMACR-GDVKGVEDLLNEGSDVNSIDL---DGRTALHIAACEGHVEVVKLLLSKKANID 132
           L +A        ++ LL   +    +DL    G+TALH+AA  G    V+ L +  A + 
Sbjct: 13  LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVL 72

Query: 133 ARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTPMTVANPREVPEYELNPLEL 190
             +R G TA   A          +L       P+         +    P+    P  +
Sbjct: 73  VAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDTYLTQSQDCTPDTSHAPAAV 130

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.9 bits (151), Expect = 4e-12
 Identities = 18/81 (22%), Positives = 37/81 (45%), Gaps = 1/81 (1%)

Query: 74  MQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANID 132
              L  A   +   +  LL + G++VN+    G +ALH A+  G + +V+ L+   A+  
Sbjct: 145 RSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSS 204

Query: 133 ARDRWGSTAAADAKYYGNVEV 153
            ++    T    A+    +++
Sbjct: 205 LKNCHNDTPLMVARSRRVIDI 225

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.1 bits (141), Expect = 8e-11
 Identities = 10/52 (19%), Positives = 23/52 (44%)

Query: 71  DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK 122
             +  L   + RG +  V  L+  G+D +  +    T L +A     +++++
Sbjct: 176 SGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVARSRRVIDILR 227

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.5 bits (137), Expect = 2e-10
 Identities = 13/49 (26%), Positives = 20/49 (40%), Gaps = 4/49 (8%)

Query: 104 DGRTALHIAACEGHVEVVKLLLS----KKANIDARDRWGSTAAADAKYY 148
           DG T LHIA  +G++  V  L++        +D  +    T    A   
Sbjct: 2   DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVIT 50

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (102), Expect = 8e-06
 Identities = 38/189 (20%), Positives = 67/189 (35%), Gaps = 15/189 (7%)

Query: 77  LFMACR-GDVKGVEDLLNE----GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANI 131
           L +A   G++  V  L+N     G +++  +   +T LH+A       VV+LL++  A+ 
Sbjct: 7   LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 66

Query: 132 DARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTKRTP----MTVANPREVPEYELNP 187
            A DR G TAA  A  + +      L    A             +T  +     E +   
Sbjct: 67  MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETV 126

Query: 188 LELQVRKADGITKGSY------QVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEK 241
             L  R AD               A  N +   V++L +       ++ + +  L     
Sbjct: 127 QLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASG 186

Query: 242 ARHPNVVQF 250
                +V+ 
Sbjct: 187 RGLLPLVRT 195

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 57.5 bits (137), Expect = 2e-10
 Identities = 12/50 (24%), Positives = 22/50 (44%)

Query: 75  QLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLL 124
            L   A  G  +  + LL+  ++    D   R    +A+   H ++V+LL
Sbjct: 159 PLFLAAREGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLL 208

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 56.3 bits (134), Expect = 5e-10
 Identities = 21/82 (25%), Positives = 34/82 (41%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARD 135
           L + A   + + V  LL   ++ ++ D    T L +AA EG  E  K LL   AN +  D
Sbjct: 127 LHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITD 186

Query: 136 RWGSTAAADAKYYGNVEVYNIL 157
                    A    + ++  +L
Sbjct: 187 HMDRLPRDVASERLHHDIVRLL 208

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 53.3 bits (126), Expect = 6e-09
 Identities = 14/38 (36%), Positives = 24/38 (63%), Gaps = 1/38 (2%)

Query: 88  VEDLLNEGSDVNS-IDLDGRTALHIAACEGHVEVVKLL 124
           + DLL +G+++N+ +D  G T+LH+AA     +  K L
Sbjct: 5   ISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.0 bits (89), Expect = 4e-04
 Identities = 10/40 (25%), Positives = 20/40 (50%), Gaps = 1/40 (2%)

Query: 119 EVVKLLLSKKANIDAR-DRWGSTAAADAKYYGNVEVYNIL 157
           +V+  LL++ A ++A  D+ G T+   A  +   +    L
Sbjct: 3   QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 57.0 bits (136), Expect = 9e-10
 Identities = 28/149 (18%), Positives = 54/149 (36%), Gaps = 28/149 (18%)

Query: 207 KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI-------- 258
             N T V +KI+      D     A   E+ ++++    +  +       +I        
Sbjct: 35  MVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90

Query: 259 --------PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPII 310
                    +M+               +   +    V + +  L  G++Y+H      II
Sbjct: 91  HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--II 148

Query: 311 HCDLKPKNILLD------NGGQLKISGFG 333
           H D+KP+N+L++      N  Q+KI+  G
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLG 177

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.7 bits (132), Expect = 1e-09
 Identities = 10/49 (20%), Positives = 19/49 (38%), Gaps = 4/49 (8%)

Query: 104 DGRTALHIAACEGHV----EVVKLLLSKKANIDARDRWGSTAAADAKYY 148
           DG + LH+A          EV++ +    A ++ ++    T    A   
Sbjct: 1   DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVIT 49

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.7 bits (127), Expect = 5e-09
 Identities = 10/55 (18%), Positives = 17/55 (30%)

Query: 76  LLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
           L       +   V  LL  G+DVN +   G +   +        + + L      
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 6e-08
 Identities = 14/60 (23%), Positives = 26/60 (43%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK 163
           +GRTALH+A    + ++V LLL   A+++     G +         +  +   L     +
Sbjct: 144 NGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.0 bits (81), Expect = 0.004
 Identities = 7/47 (14%), Positives = 18/47 (38%), Gaps = 5/47 (10%)

Query: 76  LLFMACR-GDVKGVEDLL----NEGSDVNSIDLDGRTALHIAACEGH 117
            L +A    +     +++     + + +N  +   +T LH+A     
Sbjct: 5   FLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQ 51

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.7 bits (127), Expect = 2e-09
 Identities = 10/32 (31%), Positives = 17/32 (53%)

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRWG 138
             L  AA  G +E +  LL    N++A++ +G
Sbjct: 3   NELASAAARGDLEQLTSLLQNNVNVNAQNGFG 34

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (113), Expect = 1e-07
 Identities = 10/30 (33%), Positives = 14/30 (46%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSK 127
           V   +  G TA  +A   G  EVV L+ + 
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQAN 155

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 53.2 bits (127), Expect = 5e-09
 Identities = 18/149 (12%), Positives = 39/149 (26%), Gaps = 30/149 (20%)

Query: 203 YQVAKWNGTKVWVKILDK---------------ESHKDPERINAFTHELTIVEKARHPNV 247
           +        +  VK                   + H     I +  +E   ++K +   V
Sbjct: 17  FNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 76

Query: 248 VQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPD 307
            +            +++E     +L     +               +   +   +     
Sbjct: 77  PKVYAWEG----NAVLMELIDAKELYRVRVENPD-------EVLDMILEEVAKFYHR--- 122

Query: 308 PIIHCDLKPKNILLDNGGQLKISGFGLLR 336
            I+H DL   N+L+   G + I  F    
Sbjct: 123 GIVHGDLSQYNVLVSEEG-IWIIDFPQSV 150

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.1 bits (128), Expect = 5e-09
 Identities = 13/56 (23%), Positives = 24/56 (42%), Gaps = 1/56 (1%)

Query: 107 TALHIAACEGHVEVVKLLL-SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG 161
             LH A  E     V+ LL SK + +  +D+ G      +  +   E+ + L ++ 
Sbjct: 2   YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKM 57

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 50.2 bits (118), Expect = 9e-08
 Identities = 10/54 (18%), Positives = 20/54 (37%), Gaps = 4/54 (7%)

Query: 78  FMACRGDVKGVEDLL-NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKAN 130
                G       L+   G++ + +D  G  A  +A    + +V K  L+   +
Sbjct: 178 HALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKFFLNNVVD 228

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 49.0 bits (115), Expect = 2e-07
 Identities = 13/44 (29%), Positives = 19/44 (43%), Gaps = 2/44 (4%)

Query: 77  LFMACR-GDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHV 118
           L  AC   +   V++LL+   S +   D DGR  LH +      
Sbjct: 4   LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAH 47

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 47.1 bits (110), Expect = 9e-07
 Identities = 21/66 (31%), Positives = 25/66 (37%), Gaps = 4/66 (6%)

Query: 98  VNSIDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNVEVYNI 156
           VN  D  G T L  A  EGH +   LL+ K  A  D  D  G+ A   A    N +V   
Sbjct: 165 VNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKF 221

Query: 157 LKARGA 162
                 
Sbjct: 222 FLNNVV 227

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 52.3 bits (124), Expect = 6e-09
 Identities = 19/135 (14%), Positives = 37/135 (27%), Gaps = 43/135 (31%)

Query: 72  STMQLLFMACR-GDVKGVEDLLNEGSDVN------SIDLDGRTALHIAA---CEGHVEVV 121
           + +  L  A +  D+ G+     +G D+       +      TALH+A        + +V
Sbjct: 5   AKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIV 64

Query: 122 KLLLSKKANI---------------------------------DARDRWGSTAAADAKYY 148
             L+    N+                                 +  +  G T    AK  
Sbjct: 65  DFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRL 124

Query: 149 GNVEVYNILKARGAK 163
            +     +L    + 
Sbjct: 125 KHEHCEELLTQALSG 139

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.7 bits (117), Expect = 3e-08
 Identities = 9/46 (19%), Positives = 20/46 (43%), Gaps = 3/46 (6%)

Query: 89  EDLLNEGSDVNSIDL-DGRTA--LHIAACEGHVEVVKLLLSKKANI 131
           + L+  G+ V ++   D +TA        EG+ +  + L   +  +
Sbjct: 84  KFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 129

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 9e-05
 Identities = 4/31 (12%), Positives = 14/31 (45%)

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRW 137
             L  ++ EG  ++V+ ++ +  +    +  
Sbjct: 3   ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDE 33

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 49.9 bits (117), Expect = 4e-08
 Identities = 12/51 (23%), Positives = 25/51 (49%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLL 124
             L +       + VE L+  G+DV++     +TA  I+   G+ ++ ++L
Sbjct: 102 TALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL 152

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 45.2 bits (105), Expect = 1e-06
 Identities = 23/64 (35%), Positives = 37/64 (57%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           G+DVN+ D+   TALH A    H EVV+LL+   A++  + ++  TA   +   GN ++ 
Sbjct: 90  GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149

Query: 155 NILK 158
            IL+
Sbjct: 150 EILQ 153

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 44.5 bits (103), Expect = 3e-06
 Identities = 10/37 (27%), Positives = 17/37 (45%), Gaps = 1/37 (2%)

Query: 104 DGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGST 140
           D    L  AA  G  + V++L++  A     D  G++
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTS 36

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.8 bits (117), Expect = 4e-08
 Identities = 13/53 (24%), Positives = 22/53 (41%)

Query: 74  MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLS 126
              + +A +     V   L   SD++  D  G T L +A   G  ++V +L  
Sbjct: 102 ALPIHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQG 154

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (102), Expect = 4e-06
 Identities = 13/37 (35%), Positives = 20/37 (54%), Gaps = 1/37 (2%)

Query: 105 GRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGST 140
               L  AA  G V+ V+ LL ++  + DA +R+G T
Sbjct: 2   AGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKT 38

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (86), Expect = 6e-04
 Identities = 22/63 (34%), Positives = 32/63 (50%), Gaps = 1/63 (1%)

Query: 95  GSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVY 154
           G+DVN  D  G   +H+A  EGH  VV  L   ++++  RD  G T    A   G  ++ 
Sbjct: 91  GADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLTPLELALQRGAQDLV 149

Query: 155 NIL 157
           +IL
Sbjct: 150 DIL 152

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 6e-06
 Identities = 7/22 (31%), Positives = 12/22 (54%)

Query: 105 GRTALHIAACEGHVEVVKLLLS 126
           GR  + +A   GH +V + L +
Sbjct: 102 GRLPVDLAEELGHRDVARYLRA 123

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (97), Expect = 1e-05
 Identities = 12/31 (38%), Positives = 16/31 (51%)

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRW 137
             L  AA  G VE V+ LL   AN +A + +
Sbjct: 5   DWLATAAARGRVEEVRALLEAGANPNAPNSY 35

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 118

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 34.9 bits (78), Expect = 0.004
 Identities = 5/31 (16%), Positives = 12/31 (38%)

Query: 107 TALHIAACEGHVEVVKLLLSKKANIDARDRW 137
                A   G ++ VK  ++K  +++     
Sbjct: 4   KEFMWALKNGDLDEVKDYVAKGEDVNRTLEG 34

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	359
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.98
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.98
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.97
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.97
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.97
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.96
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.96
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.96
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.96
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.96
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.96
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.96
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.96
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.95
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.95
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.95
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.95
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.95
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.95
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.95
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.95
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.95
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.95
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.95
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.94
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.94
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.94
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.94
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.94
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.94
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.94
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.94
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.94
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.93
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.93
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.93
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.92
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.92
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.91
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.91
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.91
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.9
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.9
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.89
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.89
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.86
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.86
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.86
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.85
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.84
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.83
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.83
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.83
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.83
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.82
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.82
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.81
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.81
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.81
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.81
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.8
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.8
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.8
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.79
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.78
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.78
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.78
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.78
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.77
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.77
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.76
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.75
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.75
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.75
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.75
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.72
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.7
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.68
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.64
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.27
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.94
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.28
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.65
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.43
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.99

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-34  Score=256.92  Aligned_cols=141  Identities=30%  Similarity=0.440  Sum_probs=123.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+   .  .+|+.+|||++.....  ....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            4667778999999855   2  3588999999975432  2234568999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||++|+|.+++...+.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~  151 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLAT  151 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhhe
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999996

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-34  Score=252.73  Aligned_cols=153  Identities=27%  Similarity=0.465  Sum_probs=134.1

Q ss_pred             EeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|+|+|+.+.     .+|+.+|+|++.+....+....+.+.+|+.+++.++||||+++++++.+...+|+||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            5666778999988652     35889999998643322222345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----------  336 (359)
                      |++|+|.+++...+.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+          
T Consensus        88 ~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~  164 (263)
T d2j4za1          88 APLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL  164 (263)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEET
T ss_pred             cCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCccccc
Confidence            999999999998888999999999999999999999999   9999999999999999999999999996          


Q ss_pred             ---ccccCcccccc
Q 018204          337 ---LQYISPEKAKI  347 (359)
Q Consensus       337 ---~~~~~PE~~~~  347 (359)
                         ..|+|||....
T Consensus       165 ~Gt~~Y~APE~~~~  178 (263)
T d2j4za1         165 CGTLDYLPPEMIEG  178 (263)
T ss_dssp             TEEGGGCCHHHHTT
T ss_pred             CCCCcccCHHHHcC
Confidence               36999998763

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.98  E-value=1.1e-32  Score=251.08  Aligned_cols=153  Identities=25%  Similarity=0.392  Sum_probs=137.8

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|+|+|+.+.     .+|..||||++......+....+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            46667788999997542     3588999999987766667777889999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      ||++|+|..++...+.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+         
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~  172 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV  172 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCCCccc
Confidence            9999999888887788999999999999999999999999   9999999999999999999999999997         


Q ss_pred             --ccccCccccc
Q 018204          337 --LQYISPEKAK  346 (359)
Q Consensus       337 --~~~~~PE~~~  346 (359)
                        +.|||||...
T Consensus       173 GT~~Y~APE~~~  184 (309)
T d1u5ra_         173 GTPYWMAPEVIL  184 (309)
T ss_dssp             SCGGGCCHHHHT
T ss_pred             cCccccCHHHHh
Confidence              3599999764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.9e-33  Score=255.80  Aligned_cols=152  Identities=29%  Similarity=0.495  Sum_probs=133.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+   .  .+|..+|+|++....  +....+.+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus         7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4666678899998754   2  358999999997543  23344678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCcEEEecccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR--------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~--------  336 (359)
                      ||+||+|.+++.+.+.+++..+..++.|++.||.|||+ ++   |+||||||+|||++.+|.+||+|||+|+        
T Consensus        85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  161 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  161 (322)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence            99999999999988889999999999999999999997 57   9999999999999999999999999996        


Q ss_pred             -----ccccCcccccc
Q 018204          337 -----LQYISPEKAKI  347 (359)
Q Consensus       337 -----~~~~~PE~~~~  347 (359)
                           ..|+|||....
T Consensus       162 ~~~GT~~Y~APEvl~~  177 (322)
T d1s9ja_         162 SFVGTRSYMSPERLQG  177 (322)
T ss_dssp             --CCSSCCCCHHHHHC
T ss_pred             cccCCccccCchHHcC
Confidence                 35899998763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.4e-33  Score=254.56  Aligned_cols=153  Identities=24%  Similarity=0.424  Sum_probs=134.3

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+   .  .+|+.+|+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            3666777899999865   2  4689999999975432222345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      ||+||+|.+++...+.+++..++.++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+|+.        
T Consensus        86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            9999999999999889999999999999999999999999   99999999999999999999999999972        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       163 ~~~~GT~~Y~aPE~~~  178 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             CCCEECGGGCCGGGGS
T ss_pred             ccceeCHHHhhhhhcc
Confidence                   488888765

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=248.41  Aligned_cols=149  Identities=26%  Similarity=0.455  Sum_probs=130.9

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |+....+|+|+|+.+   .  .+|..+|||++.....   ...+.|.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            566677899999855   2  3578999999975432   2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          267 HAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |++|+|.+++.+ .+.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+         
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~  167 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  167 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence            999999999765 456999999999999999999999999   9999999999999999999999999985         


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|+|||...
T Consensus       168 ~~~~Gt~~y~APE~l~  183 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVM  183 (288)
T ss_dssp             TCCCSCCTTCCHHHHT
T ss_pred             cccccccccCCHHHHh
Confidence                  3599999764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.7e-33  Score=249.98  Aligned_cols=153  Identities=26%  Similarity=0.474  Sum_probs=133.2

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+   .  .+|+.+|||++.+....+....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            3666778899988754   2  3588999999964332222334578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      ||+||+|.+++...+.+++..+..++.|++.||.|||+++   ||||||||+|||++.++.+||+|||+|+.        
T Consensus        89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999998889999999999999999999999999   99999999999999999999999999962        


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|+|||...
T Consensus       166 ~~~~~~GT~~Y~APE~~~  183 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLT  183 (288)
T ss_dssp             ----CCCCGGGCCHHHHH
T ss_pred             ccccccCCccccCceeec
Confidence                     478888765

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.3e-32  Score=244.54  Aligned_cols=148  Identities=20%  Similarity=0.438  Sum_probs=129.9

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|+|+|+.+   .  .+|+.||||++.......   .+.+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            555667899998754   2  458999999997654433   34689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      |+||+|.+++.. +.+++..+..++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+|+.         
T Consensus        99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            999999998876 46999999999999999999999999   99999999999999999999999999962         


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|+|||...
T Consensus       175 ~~~gt~~Y~aPE~~~  189 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVT  189 (293)
T ss_dssp             CCCSCGGGCCHHHHS
T ss_pred             ccccCCCccChhhhc
Confidence                  488888765

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-31  Score=239.67  Aligned_cols=153  Identities=25%  Similarity=0.428  Sum_probs=130.4

Q ss_pred             EeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe----CCcEEE
Q 018204          192 VRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ----NIPMMI  262 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~l  262 (359)
                      ++....+|+|+|+.+.     .++..||+|.+..... .....+.|.+|++++++++||||+++++++..    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            3444568999998652     2578999999976543 34556789999999999999999999999875    345899


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCcEEEeccccccc----
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD-NGGQLKISGFGLLRL----  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DFGla~~----  337 (359)
                      |||||++|+|.+++.+.+.+++..+..++.||+.||.|||+++ .+||||||||+|||++ .++.+||+|||+|+.    
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            9999999999999998888999999999999999999999986 3599999999999996 578999999999972    


Q ss_pred             ---------cccCccccc
Q 018204          338 ---------QYISPEKAK  346 (359)
Q Consensus       338 ---------~~~~PE~~~  346 (359)
                               .|||||...
T Consensus       169 ~~~~~~GT~~Y~aPE~~~  186 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYE  186 (270)
T ss_dssp             SBEESCSSCCCCCGGGGG
T ss_pred             ccCCcccCccccCHHHhC
Confidence                     588888765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=2.8e-32  Score=249.12  Aligned_cols=153  Identities=28%  Similarity=0.507  Sum_probs=134.0

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+   .  .+|+.+|||++.+.........+.+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            3666777889988754   2  4589999999965432222334678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      ||+||+|..++.....+++..+..++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+|+.        
T Consensus        85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~  161 (316)
T d1fota_          85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL  161 (316)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred             ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccccccc
Confidence            9999999999999889999999999999999999999999   99999999999999999999999999973        


Q ss_pred             ----cccCccccc
Q 018204          338 ----QYISPEKAK  346 (359)
Q Consensus       338 ----~~~~PE~~~  346 (359)
                          .|+|||...
T Consensus       162 ~Gt~~Y~APE~l~  174 (316)
T d1fota_         162 CGTPDYIAPEVVS  174 (316)
T ss_dssp             CSCTTTCCHHHHT
T ss_pred             cCcccccCHHHHc
Confidence                599999865

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1.3e-31  Score=241.54  Aligned_cols=148  Identities=27%  Similarity=0.503  Sum_probs=127.1

Q ss_pred             CCcccCCcceeeEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeE
Q 018204          180 VPEYELNPLELQVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV  254 (359)
Q Consensus       180 ~~~~~l~~~~~~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  254 (359)
                      ..+|+++..+  +...+.+|+|+|+.+   .  .+|..||||++......    .+.|.+|+.+++.++||||+++++++
T Consensus         9 ~~~wei~~~~--~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_           9 YDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             CCTTBCCGGG--EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccEecHHH--eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccE
Confidence            3456666554  445567889988743   2  25789999998654332    34689999999999999999999999


Q ss_pred             EeCCcEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecc
Q 018204          255 TQNIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGF  332 (359)
Q Consensus       255 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DF  332 (359)
                      .+.+.+++|||||++|+|.+++...  ..+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccc
Confidence            9999999999999999999999764  46899999999999999999999998   999999999999999999999999


Q ss_pred             cccc
Q 018204          333 GLLR  336 (359)
Q Consensus       333 Gla~  336 (359)
                      |+|+
T Consensus       160 G~a~  163 (287)
T d1opja_         160 GLSR  163 (287)
T ss_dssp             CCTT
T ss_pred             ccee
Confidence            9997

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.7e-31  Score=238.12  Aligned_cols=150  Identities=31%  Similarity=0.488  Sum_probs=127.3

Q ss_pred             EeeccCcccceeEEEE--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          192 VRKADGITKGSYQVAK--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      |...+.+|+|+|+.+.  ..+..||||++..... +....+.|.+|+.++++++||||+++++++. ...+++|||||++
T Consensus        10 ~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~   87 (276)
T d1uwha_          10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEG   87 (276)
T ss_dssp             CCCCSEEEECSSCEEEEEESSSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCE
T ss_pred             EEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCC
Confidence            4455678999998552  2345799999975543 3445678999999999999999999999865 4568999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----------
Q 018204          270 GDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----------  337 (359)
Q Consensus       270 gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----------  337 (359)
                      |+|.+++... ..+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|+.           
T Consensus        88 g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~  164 (276)
T d1uwha_          88 SSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE  164 (276)
T ss_dssp             EEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----------
T ss_pred             CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCccccc
Confidence            9999999765 56999999999999999999999998   99999999999999999999999999852           


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|||||..+
T Consensus       165 ~~~gt~~y~APE~l~  179 (276)
T d1uwha_         165 QLSGSILWMAPEVIR  179 (276)
T ss_dssp             -CCCCGGGCCHHHHT
T ss_pred             ccccCcccCCHHHHh
Confidence                  488888754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.5e-31  Score=236.48  Aligned_cols=155  Identities=32%  Similarity=0.497  Sum_probs=124.1

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--CCcEEEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--NIPMMIV  263 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv  263 (359)
                      +|...+.+|+|+|+.+     ..+|+.||+|.+..... +....+.|.+|+.+++.++||||+++++++.+  ...+|+|
T Consensus         5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            3566677899999854     23588999999976544 45556789999999999999999999999864  4568999


Q ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEeCCCCCCcEEEcCCCcEEEecccccc-
Q 018204          264 LEYHAKGDLASYLQK----KGRLSPSKVLRFALDLARGMNYLHECKP--DPIIHCDLKPKNILLDNGGQLKISGFGLLR-  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~~--~~iiHrDlk~~NIll~~~~~~kl~DFGla~-  336 (359)
                      ||||++|+|.+++..    .+.+++..++.++.||+.||.|||+.++  .+||||||||+|||++.++.+||+|||+|+ 
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864    3569999999999999999999998641  249999999999999999999999999996 


Q ss_pred             --------------ccccCccccc
Q 018204          337 --------------LQYISPEKAK  346 (359)
Q Consensus       337 --------------~~~~~PE~~~  346 (359)
                                    +.|+|||...
T Consensus       164 ~~~~~~~~~~~~gt~~Y~APE~l~  187 (269)
T d2java1         164 LNHDTSFAKAFVGTPYYMSPEQMN  187 (269)
T ss_dssp             C-----------CCCSCCCHHHHT
T ss_pred             cccCCCccccCCCCcccCCHHHHc
Confidence                          2488888764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.3e-31  Score=235.31  Aligned_cols=138  Identities=30%  Similarity=0.587  Sum_probs=118.9

Q ss_pred             EeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecC
Q 018204          192 VRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYH  267 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~  267 (359)
                      |...+.+|+|.|+.+   .+ ++..||||.+......    .+.|.+|+.+++.++||||+++++++...+..++||||+
T Consensus         7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            455667889888744   33 5678999999754432    246899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          268 AKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       268 ~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++|+|.+++... ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhe
Confidence            999999998765 45899999999999999999999998   9999999999999999999999999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1.3e-31  Score=247.97  Aligned_cols=154  Identities=28%  Similarity=0.458  Sum_probs=134.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+   .  .+|+.+|||++.+....+....+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            4666778899998754   2  3589999999964332222334578999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---------  336 (359)
                      |+.+|+|.+++...+.+++..++.++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+|+         
T Consensus       122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~  198 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL  198 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred             cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccccccc
Confidence            9999999999998889999999999999999999999999   9999999999999999999999999997         


Q ss_pred             ---ccccCcccccc
Q 018204          337 ---LQYISPEKAKI  347 (359)
Q Consensus       337 ---~~~~~PE~~~~  347 (359)
                         ..|||||....
T Consensus       199 ~Gt~~Y~APE~~~~  212 (350)
T d1rdqe_         199 CGTPEALAPEIILS  212 (350)
T ss_dssp             EECGGGCCHHHHTT
T ss_pred             cCccccCCHHHHcC
Confidence               35999998653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.8e-31  Score=236.09  Aligned_cols=135  Identities=29%  Similarity=0.521  Sum_probs=117.4

Q ss_pred             CcccceeEEEE---e----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          197 GITKGSYQVAK---W----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       197 ~ig~g~~~~~~---~----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      .+|+|+|+.+.   +    .++.||||++.... .++...+.|.+|+.++++++||||+++++++.. +..++|||||++
T Consensus        14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            58999998652   1    24679999996544 344556789999999999999999999999864 567999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          270 GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+|.+++.....+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~  155 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK  155 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhh
Confidence            999999998888999999999999999999999998   9999999999999999999999999997

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=1.7e-30  Score=232.94  Aligned_cols=143  Identities=29%  Similarity=0.417  Sum_probs=126.8

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCc------HHHHHHHHHHHHHHHhCC-CCccccceeeEEeCC
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKD------PERINAFTHELTIVEKAR-HPNVVQFVGAVTQNI  258 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~------~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~  258 (359)
                      +|...+.+|+|+|+.+   +  .+|+.+|||++.......      ....+.+.+|+.++++++ ||||+++++++.++.
T Consensus         4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            3566777899998854   2  368899999997654332      223456889999999997 999999999999999


Q ss_pred             cEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          259 PMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .+|+|||||++|+|.++++..+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999998889999999999999999999999999   9999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=3.9e-31  Score=240.55  Aligned_cols=151  Identities=23%  Similarity=0.438  Sum_probs=123.9

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|+|+|+.+   .  .+|+.+|||++.......  ....+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            666778899998744   2  358899999997654322  235688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc---CCCcEEEecccccc-------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD---NGGQLKISGFGLLR-------  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DFGla~-------  336 (359)
                      |+||+|.+++...+.+++..+..++.||+.||.|||+++   ||||||||+|||+.   .++.+||+|||+|+       
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            999999999998889999999999999999999999999   99999999999995   47899999999996       


Q ss_pred             -------ccccCcccccc
Q 018204          337 -------LQYISPEKAKI  347 (359)
Q Consensus       337 -------~~~~~PE~~~~  347 (359)
                             ..|+|||....
T Consensus       166 ~~~~~GT~~y~APE~~~~  183 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQ  183 (307)
T ss_dssp             -------CTTSCHHHHTT
T ss_pred             eeeeeeCccccCcHHHcC
Confidence                   35899997653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-30  Score=236.24  Aligned_cols=153  Identities=27%  Similarity=0.505  Sum_probs=132.8

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCc---HHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKD---PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .|...+.+|+|+|+.+   .  .+|+.+|||++.+.....   ....+.|.+|+.+++.++||||+++++++.+...+|+
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4777788999999865   2  358899999997543221   1234678999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC----cEEEeccccccc-
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG----QLKISGFGLLRL-  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DFGla~~-  337 (359)
                      |||||++|+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++    .+||+|||+|+. 
T Consensus        91 v~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          91 ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            9999999999999998888999999999999999999999999   99999999999998876    499999999962 


Q ss_pred             -------------cccCccccc
Q 018204          338 -------------QYISPEKAK  346 (359)
Q Consensus       338 -------------~~~~PE~~~  346 (359)
                                   .|+|||...
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~  189 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVN  189 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHT
T ss_pred             CCCccccccCCCCcccCHHHHc
Confidence                         488888765

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=2.1e-31  Score=247.94  Aligned_cols=152  Identities=26%  Similarity=0.359  Sum_probs=127.3

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHH---HHHHHHHhCCCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFT---HELTIVEKARHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~---~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      |...+.+|+|+|+.+   .  .+|+.||||++.+...........+.   .|+.+++.++||||+++++++...+.+|+|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            556667899998755   2  35899999998643211111112233   446777778899999999999999999999


Q ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          264 LEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      ||||+||+|.+++.....+++..+..++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+|+       
T Consensus        86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~  162 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  162 (364)
T ss_dssp             ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred             EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence            999999999999998888999999999999999999999999   9999999999999999999999999996       


Q ss_pred             ------ccccCccccc
Q 018204          337 ------LQYISPEKAK  346 (359)
Q Consensus       337 ------~~~~~PE~~~  346 (359)
                            ..|+|||...
T Consensus       163 ~~~~GT~~y~APE~~~  178 (364)
T d1omwa3         163 HASVGTHGYMAPEVLQ  178 (364)
T ss_dssp             CSCCSCGGGCCHHHHS
T ss_pred             cccccccccchhHHhh
Confidence                  3589999764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=1e-30  Score=236.98  Aligned_cols=141  Identities=30%  Similarity=0.526  Sum_probs=117.9

Q ss_pred             eEeeccCcccceeEEE---Ee--cC---cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---KW--NG---TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~--~g---~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      .+...+.+|+|+|+.+   ..  .+   ..+|||.+....  .....+.|.+|+.++++++||||+++++++.....+++
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3555667899998754   22  22   257888875432  45566789999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||||++|+|.+++... +.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~  176 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  176 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccce
Confidence            99999999999988774 46999999999999999999999998   9999999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=2.9e-30  Score=238.85  Aligned_cols=150  Identities=22%  Similarity=0.456  Sum_probs=130.3

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|.+.+.+|+|+|+.+.     .+|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            46667789999998652     358999999996543   3345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC--CCcEEEecccccc------
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN--GGQLKISGFGLLR------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DFGla~------  336 (359)
                      ||+||+|.+++.. .+.+++..+..|+.||+.||.|||+++   ||||||||+|||++.  ++.+||+|||+|+      
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999999999954 457999999999999999999999999   999999999999964  5789999999996      


Q ss_pred             --------ccccCccccc
Q 018204          337 --------LQYISPEKAK  346 (359)
Q Consensus       337 --------~~~~~PE~~~  346 (359)
                              ..|||||...
T Consensus       181 ~~~~~~gT~~Y~aPEv~~  198 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAE  198 (350)
T ss_dssp             CEEEECSCTTTCCHHHHH
T ss_pred             ccceecCcccccCHHHHc
Confidence                    2588888765

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.8e-30  Score=232.35  Aligned_cols=146  Identities=31%  Similarity=0.508  Sum_probs=122.6

Q ss_pred             CcccCCcceeeEeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe
Q 018204          181 PEYELNPLELQVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ  256 (359)
Q Consensus       181 ~~~~l~~~~~~~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~  256 (359)
                      .+|+++..  +|...+.+|+|+|+.+   .. .+..||||++......    .+.|.+|+.++++++||||+++++++. 
T Consensus         6 ~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~-   78 (272)
T d1qpca_           6 DEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (272)
T ss_dssp             CTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             CCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeec-
Confidence            45555544  4555667899999854   33 4578999999754432    246899999999999999999999775 


Q ss_pred             CCcEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          257 NIPMMIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       257 ~~~~~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                      .+.+++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGl  155 (272)
T d1qpca_          79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGL  155 (272)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccc
Confidence            45689999999999999987543  35999999999999999999999998   99999999999999999999999999


Q ss_pred             cc
Q 018204          335 LR  336 (359)
Q Consensus       335 a~  336 (359)
                      |+
T Consensus       156 a~  157 (272)
T d1qpca_         156 AR  157 (272)
T ss_dssp             CE
T ss_pred             eE
Confidence            97

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.1e-30  Score=230.17  Aligned_cols=134  Identities=27%  Similarity=0.468  Sum_probs=117.1

Q ss_pred             CcccceeEEEE-------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCCC
Q 018204          197 GITKGSYQVAK-------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHAK  269 (359)
Q Consensus       197 ~ig~g~~~~~~-------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~  269 (359)
                      .+|+|+|+.+.       ..+..||||++....  +....+.|.+|+.++++++||||+++++++.. +.+|+|||||++
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~   92 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG   92 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCC
Confidence            37889887542       134579999996543  45567789999999999999999999998864 568999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          270 GDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       270 gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |+|.+++... +.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus        93 g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          93 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhh
Confidence            9999998654 56999999999999999999999998   9999999999999999999999999997

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.96  E-value=4.6e-30  Score=237.63  Aligned_cols=150  Identities=23%  Similarity=0.486  Sum_probs=130.2

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      .|...+.+|+|+|+.+.     .+|+.||||++....   ......+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            36777789999998652     358999999997543   3334578899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc--CCCcEEEecccccc------
Q 018204          266 YHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLD--NGGQLKISGFGLLR------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~--~~~~~kl~DFGla~------  336 (359)
                      ||+||+|.+++...+ ++++..++.|+.||+.||.|||+++   ||||||||+|||++  .++.+||+|||+|+      
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            999999999876544 6999999999999999999999999   99999999999998  57899999999996      


Q ss_pred             --------ccccCccccc
Q 018204          337 --------LQYISPEKAK  346 (359)
Q Consensus       337 --------~~~~~PE~~~  346 (359)
                              ..|+|||...
T Consensus       184 ~~~~~~gt~~y~aPE~~~  201 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVD  201 (352)
T ss_dssp             CEEEECSSGGGCCHHHHT
T ss_pred             ceeeccCcccccCHHHHc
Confidence                    2488888765

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.96  E-value=4.7e-30  Score=230.31  Aligned_cols=152  Identities=26%  Similarity=0.436  Sum_probs=135.4

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC----cEEE
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----PMMI  262 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~l  262 (359)
                      |...+.+|+|+|+.+   .  .+|+.||||++......+......|.+|+.+++.++||||+++++++....    .+|+
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            566677899998754   2  358999999998777777777788999999999999999999999988654    3899


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc------
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR------  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~------  336 (359)
                      |||||+|++|.+++...+.+++..+..++.||+.||.|||+++   ||||||||+|||++.++..+|+|||+++      
T Consensus        89 vmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            9999999999999998889999999999999999999999999   9999999999999999999999999875      


Q ss_pred             ------------ccccCccccc
Q 018204          337 ------------LQYISPEKAK  346 (359)
Q Consensus       337 ------------~~~~~PE~~~  346 (359)
                                  ..|+|||...
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~  187 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQAR  187 (277)
T ss_dssp             -------------TTCCHHHHT
T ss_pred             ccccccccccCcccccCHHHHc
Confidence                        2589999865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6e-30  Score=234.74  Aligned_cols=148  Identities=30%  Similarity=0.523  Sum_probs=121.5

Q ss_pred             cccCCcceeeEeeccCcccceeEEEE---ec--C-----cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccc
Q 018204          182 EYELNPLELQVRKADGITKGSYQVAK---WN--G-----TKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQF  250 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~~---~~--g-----~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l  250 (359)
                      .|+++..  ++...+.+|+|+|+.+.   ..  +     ..||+|.+....  +......|.+|+.++.++ +||||+++
T Consensus        31 kwei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l  106 (325)
T d1rjba_          31 KWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNL  106 (325)
T ss_dssp             GGBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence            3445444  35556788999998652   21  1     268999986543  233445789999999998 89999999


Q ss_pred             eeeEEeCCcEEEEEecCCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 018204          251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKG-----------------------RLSPSKVLRFALDLARGMNYLHECKPD  307 (359)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~~lH~~~~~  307 (359)
                      ++++...+.+|+|||||++|+|.++++...                       .+++..+..|+.||+.||.|||+++  
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--  184 (325)
T d1rjba_         107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--  184 (325)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            999999999999999999999999997542                       3889999999999999999999998  


Q ss_pred             CeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          308 PIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       308 ~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                       ||||||||+|||++.++.+||+|||+|+
T Consensus       185 -IiHRDlKp~Nill~~~~~~Kl~DFGla~  212 (325)
T d1rjba_         185 -CVHRDLAARNVLVTHGKVVKICDFGLAR  212 (325)
T ss_dssp             -EEETTCSGGGEEEETTTEEEECCCGGGS
T ss_pred             -eeeccCchhccccccCCeEEEeeccccc
Confidence             9999999999999999999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.6e-29  Score=231.37  Aligned_cols=139  Identities=18%  Similarity=0.384  Sum_probs=122.1

Q ss_pred             EeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          192 VRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      |...+.+|+|+|+.+.     .+|+.+|||++....    .....+.+|+.+++.++||||++++++|.+.+.+|+||||
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            5666788999998652     358899999997543    2234578999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC--CcEEEeccccccc
Q 018204          267 HAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG--GQLKISGFGLLRL  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~--~~~kl~DFGla~~  337 (359)
                      |+||+|.+++...+ .+++..++.|+.||+.||.|||+++   |+||||||+|||++.+  ..+||+|||+++.
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhc
Confidence            99999999998765 6999999999999999999999999   9999999999999854  4799999999973

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-29  Score=224.90  Aligned_cols=139  Identities=29%  Similarity=0.572  Sum_probs=122.7

Q ss_pred             eEeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +|...+.+|+|+|+.+   .+ ++..||||++.......    +.|.+|+.+++.++||||+++++++.+++.+++||||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            3456678999999865   23 46689999997654432    4689999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          267 HAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       267 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|+|.+++... ..+++..+..++.|+++||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhe
Confidence            9999999997654 56999999999999999999999998   9999999999999999999999999996

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-29  Score=226.79  Aligned_cols=140  Identities=29%  Similarity=0.487  Sum_probs=119.4

Q ss_pred             EeeccCcccceeEEE---Eec--C----cEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          192 VRKADGITKGSYQVA---KWN--G----TKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~~~--g----~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      +...+.+|+|+|+.+   .+.  +    ..||||.+....  .......|.+|+.+++.++||||+++++++......++
T Consensus         9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            445556889988754   222  1    369999986433  34555679999999999999999999999999999999


Q ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||||.++++.+++... +.+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence            99999999999988665 56999999999999999999999998   9999999999999999999999999996

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-30  Score=236.31  Aligned_cols=148  Identities=25%  Similarity=0.418  Sum_probs=122.2

Q ss_pred             cCcccceeEEEE-----ecCcEEEEEEeccCCCCc--HHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEecCC
Q 018204          196 DGITKGSYQVAK-----WNGTKVWVKILDKESHKD--PERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEYHA  268 (359)
Q Consensus       196 ~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~  268 (359)
                      +.+|+|+|+.+.     .+|+.||||++.......  ....+.+.+|+.+++.++||||+++++++.....+|+||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            357888888652     358899999996543221  1123468899999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc-----------
Q 018204          269 KGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL-----------  337 (359)
Q Consensus       269 ~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~-----------  337 (359)
                      ++++..+......+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.           
T Consensus        84 ~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          84 TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            8877777666677999999999999999999999999   99999999999999999999999999962           


Q ss_pred             ----cccCccccc
Q 018204          338 ----QYISPEKAK  346 (359)
Q Consensus       338 ----~~~~PE~~~  346 (359)
                          .|+|||...
T Consensus       161 ~gt~~y~aPE~~~  173 (299)
T d1ua2a_         161 VVTRWYRAPELLF  173 (299)
T ss_dssp             CCCCTTCCHHHHT
T ss_pred             ecChhhccHHHHc
Confidence                478888654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9e-30  Score=232.82  Aligned_cols=152  Identities=26%  Similarity=0.387  Sum_probs=128.4

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHH-hCCCCccccceeeEEeCCcEEEEEe
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVE-KARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      |...+.+|+|+|+.+   .  .+|+.||||++.+.........+.+..|..++. .++||||+++++++.+.+.+|+|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            556677888888754   2  368999999996532212223345667777665 6899999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc--------
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL--------  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~--------  337 (359)
                      ||++|+|.+++...+.+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+.        
T Consensus        84 y~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          84 YLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             ecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            9999999999998889999999999999999999999999   99999999999999999999999999972        


Q ss_pred             -------cccCccccc
Q 018204          338 -------QYISPEKAK  346 (359)
Q Consensus       338 -------~~~~PE~~~  346 (359)
                             .|+|||...
T Consensus       161 ~~~~gt~~y~aPE~~~  176 (320)
T d1xjda_         161 NTFCGTPDYIAPEILL  176 (320)
T ss_dssp             CCCCSCGGGCCHHHHT
T ss_pred             cccCCCCCcCCHHHHc
Confidence                   377777665

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-29  Score=226.06  Aligned_cols=145  Identities=30%  Similarity=0.516  Sum_probs=122.7

Q ss_pred             cccCCcceeeEeeccCcccceeEEE---Ee-cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC
Q 018204          182 EYELNPLELQVRKADGITKGSYQVA---KW-NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN  257 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~---~~-~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~  257 (359)
                      +|+++..  +++..+.+|+|+|+.+   .. .+..||||++......    .+.|.+|+.++++++||||+++++++. .
T Consensus        11 ~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~   83 (285)
T d1fmka3          11 AWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-E   83 (285)
T ss_dssp             CSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence            4555443  4667777899998754   23 4568999999654432    246899999999999999999999885 4


Q ss_pred             CcEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccc
Q 018204          258 IPMMIVLEYHAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLL  335 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla  335 (359)
                      +.+++||||+++|+|..++..  .+.+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchh
Confidence            568999999999999998854  356999999999999999999999998   999999999999999999999999999


Q ss_pred             c
Q 018204          336 R  336 (359)
Q Consensus       336 ~  336 (359)
                      +
T Consensus       161 ~  161 (285)
T d1fmka3         161 R  161 (285)
T ss_dssp             C
T ss_pred             h
Confidence            6

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-29  Score=229.31  Aligned_cols=151  Identities=25%  Similarity=0.533  Sum_probs=123.3

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|...+.+|+|+|+.+   .  .+|+.||||++..... .....+.+.+|++++++++||||+++++++.+...+|+|||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            3566677889988754   2  3589999999965432 22334678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc-------
Q 018204          266 YHAKGDLASYLQK--KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR-------  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~-------  336 (359)
                      |+.+ ++.+++..  ...+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+       
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            9976 55555533  356999999999999999999999999   9999999999999999999999999996       


Q ss_pred             --------ccccCccccc
Q 018204          337 --------LQYISPEKAK  346 (359)
Q Consensus       337 --------~~~~~PE~~~  346 (359)
                              ..|+|||...
T Consensus       158 ~~~~~~gt~~y~apE~~~  175 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILL  175 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHT
T ss_pred             cceeecccceeeehhhhc
Confidence                    2477888543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1e-28  Score=220.97  Aligned_cols=146  Identities=24%  Similarity=0.469  Sum_probs=117.9

Q ss_pred             ccCCcceeeEeeccCcccceeEEE---Ee-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeE
Q 018204          183 YELNPLELQVRKADGITKGSYQVA---KW-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAV  254 (359)
Q Consensus       183 ~~l~~~~~~~~~~~~ig~g~~~~~---~~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  254 (359)
                      |+++..  +|...+.+|+|+|+.+   .+     .+..+|||.+...  ......+.|.+|+.+++.++||||+++++++
T Consensus         2 ~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~   77 (273)
T d1mp8a_           2 YEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVI   77 (273)
T ss_dssp             CBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            445443  4566678899999754   22     1346888887543  3455567899999999999999999999998


Q ss_pred             EeCCcEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          255 TQNIPMMIVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       255 ~~~~~~~lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      . .+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++   ||||||||+||+++.++.+||+|||
T Consensus        78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred             e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccch
Confidence            5 56789999999999999987654 46999999999999999999999999   9999999999999999999999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      +|+
T Consensus       154 ~a~  156 (273)
T d1mp8a_         154 LSR  156 (273)
T ss_dssp             ---
T ss_pred             hhe
Confidence            997

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.1e-28  Score=224.75  Aligned_cols=141  Identities=32%  Similarity=0.563  Sum_probs=117.2

Q ss_pred             EeeccCcccceeEEE---E--ecCc--EEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccceeeEEeCCcEEEE
Q 018204          192 VRKADGITKGSYQVA---K--WNGT--KVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQFVGAVTQNIPMMIV  263 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~--~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv  263 (359)
                      +...+.+|+|+|+.+   .  .+|.  .||||.+....  .....+.|.+|+.++..+ +||||+++++++...+.+++|
T Consensus        12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            334567899999755   2  2343  46777765332  333456799999999998 799999999999999999999


Q ss_pred             EecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcE
Q 018204          264 LEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQL  327 (359)
Q Consensus       264 ~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~  327 (359)
                      |||+++|+|.++++..                ..+++..+..++.||+.||.|+|+++   ||||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999999753                45899999999999999999999998   9999999999999999999


Q ss_pred             EEeccccccc
Q 018204          328 KISGFGLLRL  337 (359)
Q Consensus       328 kl~DFGla~~  337 (359)
                      ||+|||+|+.
T Consensus       167 kl~DfG~a~~  176 (309)
T d1fvra_         167 KIADFGLSRG  176 (309)
T ss_dssp             EECCTTCEES
T ss_pred             EEcccccccc
Confidence            9999999973

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.8e-28  Score=225.53  Aligned_cols=144  Identities=22%  Similarity=0.373  Sum_probs=119.0

Q ss_pred             Eeecc-CcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHh-CCCCccccceeeEEe----CCcE
Q 018204          192 VRKAD-GITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEK-ARHPNVVQFVGAVTQ----NIPM  260 (359)
Q Consensus       192 ~~~~~-~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~----~~~~  260 (359)
                      |.+.. .+|+|+|+.+   .  .+|+.||||++...        ..+.+|+.++.+ .+||||++++++|.+    ...+
T Consensus        13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            44433 4788888754   2  35889999999642        246789988665 589999999999875    4679


Q ss_pred             EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCcEEEeccccc
Q 018204          261 MIVLEYHAKGDLASYLQKK--GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLL  335 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DFGla  335 (359)
                      |+|||||+||+|.+++...  ..+++..++.|+.||+.||.|||+++   |+||||||+|||++.   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            9999999999999999875  36999999999999999999999999   999999999999986   457999999999


Q ss_pred             cc--------------cccCccccc
Q 018204          336 RL--------------QYISPEKAK  346 (359)
Q Consensus       336 ~~--------------~~~~PE~~~  346 (359)
                      +.              .|+|||...
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~  186 (335)
T d2ozaa1         162 KETTSHNSLTTPCYTPYYVAPEVLG  186 (335)
T ss_dssp             EECCCCCCCCCCSCCCSSCCCCCCC
T ss_pred             eeccCCCccccccCCcccCCcHHHc
Confidence            73              477777644

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=2.5e-28  Score=221.54  Aligned_cols=141  Identities=32%  Similarity=0.510  Sum_probs=122.6

Q ss_pred             eEeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~  260 (359)
                      +|...+.+|+|+|+.+   .+       ++..||||++....  .....+.|.+|+.+++.++||||+++++++......
T Consensus        14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            3556667899998754   33       23689999986433  455567899999999999999999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 018204          261 MIVLEYHAKGDLASYLQKKG------------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKP  316 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~  316 (359)
                      +++|||+++|+|.+++....                        .+++..+..|+.|++.||+|||+++   ||||||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp  168 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT  168 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence            99999999999999996532                        3788999999999999999999998   99999999


Q ss_pred             CcEEEcCCCcEEEecccccc
Q 018204          317 KNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       317 ~NIll~~~~~~kl~DFGla~  336 (359)
                      +|||++.++.+||+|||+|+
T Consensus       169 ~NILld~~~~~Kl~DFGls~  188 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSR  188 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHH
T ss_pred             cceEECCCCcEEEccchhhe
Confidence            99999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.95  E-value=5.2e-29  Score=224.44  Aligned_cols=152  Identities=26%  Similarity=0.447  Sum_probs=130.1

Q ss_pred             eEeeccCcccceeEEE----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEec
Q 018204          191 QVRKADGITKGSYQVA----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLEY  266 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~  266 (359)
                      +|...+.+|+|+|+.+    ..+|+.||||++..... +....+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            3566677899988754    23578999999965432 233346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc---------
Q 018204          267 HAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL---------  337 (359)
Q Consensus       267 ~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~---------  337 (359)
                      +.++.+..+.+..+.+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+|..         
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            988777777676778999999999999999999999998   99999999999999999999999999852         


Q ss_pred             ------cccCccccc
Q 018204          338 ------QYISPEKAK  346 (359)
Q Consensus       338 ------~~~~PE~~~  346 (359)
                            .|++||...
T Consensus       159 ~~~~~~~y~~pE~~~  173 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLM  173 (286)
T ss_dssp             ---CCCTTCCHHHHT
T ss_pred             eecccchhhhHHHHh
Confidence                  478888754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3e-28  Score=217.76  Aligned_cols=143  Identities=32%  Similarity=0.581  Sum_probs=114.3

Q ss_pred             eEeeccCcccceeEEE---Eec-----CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEE
Q 018204          191 QVRKADGITKGSYQVA---KWN-----GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~~~-----g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l  262 (359)
                      +|+..+.+|+|.|+.+   ...     ...||||++.+....+....+.|.+|+.+++.++||||+++++++.+ ..+++
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence            3666678899999744   222     23689999977665566677889999999999999999999999965 56799


Q ss_pred             EEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          263 VLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ||||+++|++.+++... +.+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            99999999999887654 56999999999999999999999998   99999999999999999999999999974

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-28  Score=217.06  Aligned_cols=154  Identities=33%  Similarity=0.604  Sum_probs=125.5

Q ss_pred             ccCCcceeeEeeccCcccceeEEE---EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe-CC
Q 018204          183 YELNPLELQVRKADGITKGSYQVA---KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ-NI  258 (359)
Q Consensus       183 ~~l~~~~~~~~~~~~ig~g~~~~~---~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~  258 (359)
                      |+++..+  +...+.+|+|+|+.+   ...|..||||.+....     ..+.|.+|+.++++++||||+++++++.. .+
T Consensus         2 w~i~~~~--~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           2 WALNMKE--LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CBCCGGG--EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHHH--eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            4454444  344566888888744   6789999999996432     23568999999999999999999998864 45


Q ss_pred             cEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          259 PMMIVLEYHAKGDLASYLQKKG--RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       259 ~~~lv~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      .+|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccce
Confidence            6899999999999999996543  4899999999999999999999998   9999999999999999999999999997


Q ss_pred             c------------cccCccccc
Q 018204          337 L------------QYISPEKAK  346 (359)
Q Consensus       337 ~------------~~~~PE~~~  346 (359)
                      .            .|+|||...
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~l~  173 (262)
T d1byga_         152 EASSTQDTGKLPVKWTAPEALR  173 (262)
T ss_dssp             ----------CCTTTSCHHHHH
T ss_pred             ecCCCCccccccccCCChHHHh
Confidence            3            477777653

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.2e-28  Score=221.63  Aligned_cols=140  Identities=23%  Similarity=0.526  Sum_probs=117.0

Q ss_pred             eEeeccCcccceeEEEE---e--cCc----EEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEE
Q 018204          191 QVRKADGITKGSYQVAK---W--NGT----KVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~---~--~g~----~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  261 (359)
                      +|+..+.+|+|+|+.+.   +  +|+    +||+|.+....  +....+.|.+|+.+++.++||||+++++++.+. ..+
T Consensus        10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_          10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence            47777889999998652   2  333    58888886432  223446799999999999999999999998764 578


Q ss_pred             EEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKK-GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++||+.+|+|.+++... ..+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence            889999999999988764 56999999999999999999999998   9999999999999999999999999996

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.3e-28  Score=220.25  Aligned_cols=153  Identities=22%  Similarity=0.366  Sum_probs=127.7

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHH---HHHHHHHHHHHHHhCC--CCccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPE---RINAFTHELTIVEKAR--HPNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~---~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~~~~  260 (359)
                      +|.+.+.+|+|+|+.+   .  .+|..||||++.+....+..   ....+.+|+.+++.++  ||||+++++++.+.+..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            4677778899999865   2  35899999999754332211   1123568999999986  89999999999999999


Q ss_pred             EEEEecCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CcEEEeccccccc-
Q 018204          261 MIVLEYHAK-GDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNG-GQLKISGFGLLRL-  337 (359)
Q Consensus       261 ~lv~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DFGla~~-  337 (359)
                      ++||||+.+ +++.+++.....+++..++.++.||+.||.|||+++   |+||||||+|||++.+ +.+||+|||+|+. 
T Consensus        85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceec
Confidence            999999976 688899988888999999999999999999999999   9999999999999854 7999999999962 


Q ss_pred             ------------cccCccccc
Q 018204          338 ------------QYISPEKAK  346 (359)
Q Consensus       338 ------------~~~~PE~~~  346 (359)
                                  .|+|||...
T Consensus       162 ~~~~~~~~~GT~~y~aPE~~~  182 (273)
T d1xwsa_         162 KDTVYTDFDGTRVYSPPEWIR  182 (273)
T ss_dssp             CSSCBCCCCSCGGGSCHHHHH
T ss_pred             ccccccccccCCCcCCHHHHc
Confidence                        477777654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.3e-28  Score=218.64  Aligned_cols=148  Identities=30%  Similarity=0.523  Sum_probs=113.9

Q ss_pred             cccCCcceeeEeeccCcccceeEEEE---e-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccc
Q 018204          182 EYELNPLELQVRKADGITKGSYQVAK---W-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQF  250 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~~---~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l  250 (359)
                      +|+++..  +|...+.+|+|+|+.+.   +       .++.||||.+....  .....+.+..|..++.++ +|+||+.+
T Consensus         7 ~wei~~~--~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           7 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             HHBCCGG--GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccHH--HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            4444443  35566788999998652   1       24689999986433  344556788888888777 68899999


Q ss_pred             eeeEEeC-CcEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Q 018204          251 VGAVTQN-IPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCD  313 (359)
Q Consensus       251 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrD  313 (359)
                      ++++... ..+++|||||++|+|.+++...                ..+++..+..++.||+.||.|||+++   |||||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence            9987654 4689999999999999999753                23889999999999999999999998   99999


Q ss_pred             CCCCcEEEcCCCcEEEecccccc
Q 018204          314 LKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       314 lk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||+|||++.++.+||+|||+|+
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~  182 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLAR  182 (299)
T ss_dssp             CCGGGEEECGGGCEEECC-----
T ss_pred             CCccceeECCCCcEEEccCcchh
Confidence            99999999999999999999996

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.1e-27  Score=221.52  Aligned_cols=150  Identities=27%  Similarity=0.451  Sum_probs=123.2

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC------c
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI------P  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------~  259 (359)
                      .|.....+|+|+|+.+.     .+|+.||||++.... ......+.+.+|+.+++.++||||++++++|...+      .
T Consensus        19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            57777889999998552     358999999997543 35556678999999999999999999999997654      4


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---  336 (359)
                      +|+||||+ +.+|..+++. +.+++..++.++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+   
T Consensus        98 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccC
Confidence            79999999 5577777654 57999999999999999999999999   9999999999999999999999999997   


Q ss_pred             ---------ccccCccccc
Q 018204          337 ---------LQYISPEKAK  346 (359)
Q Consensus       337 ---------~~~~~PE~~~  346 (359)
                               ..|+|||...
T Consensus       173 ~~~~~~~~t~~y~aPE~~~  191 (346)
T d1cm8a_         173 SEMTGYVVTRWYRAPEVIL  191 (346)
T ss_dssp             SSCCSSCSCGGGCCTHHHH
T ss_pred             CccccccccccccCHHHHc
Confidence                     3588998754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.2e-27  Score=216.20  Aligned_cols=149  Identities=30%  Similarity=0.479  Sum_probs=127.0

Q ss_pred             cccCCcceeeEeeccCcccceeEEEE----------ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCccccc
Q 018204          182 EYELNPLELQVRKADGITKGSYQVAK----------WNGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPNVVQF  250 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~~----------~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l  250 (359)
                      +|+++..+  +...+.+|.|+|+.+.          ..+..+|||.+....  .......|.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~--~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          17 KWEFPRNR--LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             GGBCCGGG--EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHHH--eEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            45555544  4445678999998652          134689999997543  345556799999999999 69999999


Q ss_pred             eeeEEeCCcEEEEEecCCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 018204          251 VGAVTQNIPMMIVLEYHAKGDLASYLQKKG------------------RLSPSKVLRFALDLARGMNYLHECKPDPIIHC  312 (359)
Q Consensus       251 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHr  312 (359)
                      ++++......++|||||++|+|.+++....                  .+++..+..++.||+.||+|||+++   +|||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr  169 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR  169 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence            999999999999999999999999997542                  4889999999999999999999999   9999


Q ss_pred             CCCCCcEEEcCCCcEEEeccccccc
Q 018204          313 DLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       313 Dlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ||||+|||++.++.+||+|||+++.
T Consensus       170 DLKp~NIl~~~~~~~ki~DfG~~~~  194 (311)
T d1t46a_         170 DLAARNILLTHGRITKICDFGLARD  194 (311)
T ss_dssp             CCSGGGEEEETTTEEEECCCGGGSC
T ss_pred             ccccccccccccCcccccccchhee
Confidence            9999999999999999999999973

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.4e-27  Score=220.58  Aligned_cols=140  Identities=26%  Similarity=0.430  Sum_probs=116.0

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC----cEE
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----PMM  261 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~  261 (359)
                      .|.....+|+|+|+.+     ..+|+.+|||++.+..  .....+.+.+|+.+++.++||||+++++++....    ..+
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            3777788999999754     2358999999996533  4555678899999999999999999999987643    234


Q ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          262 IVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       262 lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ++++|+.+|+|.++++.. .+++..++.++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+|+
T Consensus        87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence            444556689999999764 6999999999999999999999999   9999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6e-27  Score=213.11  Aligned_cols=148  Identities=28%  Similarity=0.488  Sum_probs=123.1

Q ss_pred             cCCcceeeEeeccCcccceeEEEE---e-----cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEE
Q 018204          184 ELNPLELQVRKADGITKGSYQVAK---W-----NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVT  255 (359)
Q Consensus       184 ~l~~~~~~~~~~~~ig~g~~~~~~---~-----~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  255 (359)
                      .+......+...+.+|+|+|+.+.   .     ....||||.+...  .+....+.|.+|+.++++++||||+++++++.
T Consensus        21 ~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   98 (311)
T d1r0pa_          21 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL   98 (311)
T ss_dssp             BCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             EeChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEE
Confidence            333444444445668999998652   2     1235899998642  35666788999999999999999999999987


Q ss_pred             eC-CcEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccc
Q 018204          256 QN-IPMMIVLEYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFG  333 (359)
Q Consensus       256 ~~-~~~~lv~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFG  333 (359)
                      .. +..++|||||++|+|.+++.... .+++..+..++.|++.||.|+|+.+   |+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_          99 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             ETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             ecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEeccc
Confidence            64 57999999999999999987653 5788889999999999999999998   9999999999999999999999999


Q ss_pred             ccc
Q 018204          334 LLR  336 (359)
Q Consensus       334 la~  336 (359)
                      +++
T Consensus       176 ~~~  178 (311)
T d1r0pa_         176 LAR  178 (311)
T ss_dssp             GGC
T ss_pred             chh
Confidence            997

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.2e-27  Score=215.04  Aligned_cols=150  Identities=32%  Similarity=0.577  Sum_probs=121.2

Q ss_pred             CCcccCCcceeeEeeccCcccceeEEE---Ee---------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC-CCCc
Q 018204          180 VPEYELNPLELQVRKADGITKGSYQVA---KW---------NGTKVWVKILDKESHKDPERINAFTHELTIVEKA-RHPN  246 (359)
Q Consensus       180 ~~~~~l~~~~~~~~~~~~ig~g~~~~~---~~---------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l-~Hpn  246 (359)
                      .++|.++...  |...+.+|.|+|+.+   ..         .+..||||.+....  .......+.+|...+.++ +|||
T Consensus         5 ~~~~~i~~~~--~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hpn   80 (299)
T d1fgka_           5 DPRWELPRDR--LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN   80 (299)
T ss_dssp             CTTTBCCGGG--EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcCcccHHH--eEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCe
Confidence            3456665543  445567899999754   21         12479999986543  345567788999999888 7999


Q ss_pred             cccceeeEEeCCcEEEEEecCCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 018204          247 VVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKK----------------GRLSPSKVLRFALDLARGMNYLHECKPDPII  310 (359)
Q Consensus       247 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~ii  310 (359)
                      |+++++++.++..+++|||||++|+|.+++...                ..+++..+..++.||+.||+|||+++   ||
T Consensus        81 Iv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---iv  157 (299)
T d1fgka_          81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CI  157 (299)
T ss_dssp             BCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             EEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EE
Confidence            999999999999999999999999999999754                24899999999999999999999999   99


Q ss_pred             eCCCCCCcEEEcCCCcEEEecccccc
Q 018204          311 HCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       311 HrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ||||||+|||++.++.+||+|||+++
T Consensus       158 HrDiKp~NiLl~~~~~~kl~dfg~~~  183 (299)
T d1fgka_         158 HRDLAARNVLVTEDNVMKIADFGLAR  183 (299)
T ss_dssp             CSCCSGGGEEECTTCCEEECSTTCCC
T ss_pred             eeeecccceeecCCCCeEeccchhhc
Confidence            99999999999999999999999997

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.3e-27  Score=215.72  Aligned_cols=148  Identities=28%  Similarity=0.491  Sum_probs=125.8

Q ss_pred             cccCCcceeeEeeccCcccceeEEE---Ee-------cCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccce
Q 018204          182 EYELNPLELQVRKADGITKGSYQVA---KW-------NGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFV  251 (359)
Q Consensus       182 ~~~l~~~~~~~~~~~~ig~g~~~~~---~~-------~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  251 (359)
                      +|++++.+  +...+.+|+|+|+.+   .+       .+..||||++....  .......|.+|+.++++++||||++++
T Consensus        14 ~~ei~~~~--~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~   89 (308)
T d1p4oa_          14 EWEVAREK--ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLL   89 (308)
T ss_dssp             TTBCCGGG--EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             ceeecHHH--eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence            45665543  445667899998754   22       24689999996443  445556799999999999999999999


Q ss_pred             eeEEeCCcEEEEEecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 018204          252 GAVTQNIPMMIVLEYHAKGDLASYLQKK----------GRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILL  321 (359)
Q Consensus       252 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll  321 (359)
                      +++......++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++   |+||||||+|||+
T Consensus        90 ~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLl  166 (308)
T d1p4oa_          90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  166 (308)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             eEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceee
Confidence            9999999999999999999999998643          23688999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEecccccc
Q 018204          322 DNGGQLKISGFGLLR  336 (359)
Q Consensus       322 ~~~~~~kl~DFGla~  336 (359)
                      +.++.+||+|||+|+
T Consensus       167 d~~~~~Kl~DFGla~  181 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTR  181 (308)
T ss_dssp             CTTCCEEECCTTCCC
T ss_pred             cCCceEEEeecccce
Confidence            999999999999997

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.9e-27  Score=214.59  Aligned_cols=140  Identities=31%  Similarity=0.492  Sum_probs=112.9

Q ss_pred             EeeccCcccceeEE---EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCC----cEEEEE
Q 018204          192 VRKADGITKGSYQV---AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNI----PMMIVL  264 (359)
Q Consensus       192 ~~~~~~ig~g~~~~---~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lv~  264 (359)
                      +...+.+|+|.|+.   +..+|..||||++....    .....+..|+..+..++||||+++++++....    .+|+||
T Consensus         5 ~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           5 IVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             EEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            34445678888764   36789999999986432    22222334555556789999999999998654    589999


Q ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECK-----PDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      |||++|+|.+++++. .+++.....++.|++.||.|+|+..     ..+||||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999875 6999999999999999999999741     0239999999999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.1e-27  Score=211.17  Aligned_cols=143  Identities=24%  Similarity=0.471  Sum_probs=127.6

Q ss_pred             eEeeccCcccceeEEE-----EecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeCCcEEEEEe
Q 018204          191 QVRKADGITKGSYQVA-----KWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQNIPMMIVLE  265 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~-----~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e  265 (359)
                      +|+..+.+|+|+|+.+     ..+|+.||||++..... .......+.+|+.+++.++||||+++++++......+++++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            4667778899988754     23678999999975543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          266 YHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       266 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ++.++++..+++..+.+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||.|+.
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~  150 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhc
Confidence            9999999998888888999999999999999999999999   99999999999999999999999999973

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=6.1e-27  Score=216.77  Aligned_cols=139  Identities=27%  Similarity=0.361  Sum_probs=114.7

Q ss_pred             ceeeEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----
Q 018204          188 LELQVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----  257 (359)
Q Consensus       188 ~~~~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----  257 (359)
                      .+..|...+.+|+|+|+.+.     .+|+.||||++......       +.+|+.+++.++||||++++++|...     
T Consensus        18 ~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             ccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            35678888889999998652     35899999999754422       34699999999999999999998643     


Q ss_pred             -CcEEEEEecCCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEecc
Q 018204          258 -IPMMIVLEYHAKGDLASYL---QKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGF  332 (359)
Q Consensus       258 -~~~~lv~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DF  332 (359)
                       .++|+|||||+++.+..+.   .....+++..++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+||
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCC
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecc
Confidence             3589999999875333332   33456999999999999999999999999   99999999999999875 8999999


Q ss_pred             cccc
Q 018204          333 GLLR  336 (359)
Q Consensus       333 Gla~  336 (359)
                      |+++
T Consensus       168 G~a~  171 (350)
T d1q5ka_         168 GSAK  171 (350)
T ss_dssp             TTCE
T ss_pred             cchh
Confidence            9996

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.8e-28  Score=220.96  Aligned_cols=143  Identities=24%  Similarity=0.378  Sum_probs=124.4

Q ss_pred             eEeeccCcccceeEEEE--------ecCcEEEEEEeccCCCC-cHHHHHHHHHHHHHHHhCCC-CccccceeeEEeCCcE
Q 018204          191 QVRKADGITKGSYQVAK--------WNGTKVWVKILDKESHK-DPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~--------~~g~~vavK~l~~~~~~-~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~  260 (359)
                      +|...+.+|+|+|+.+.        .+|+.+|||.+.+.... +....+.+.+|+.++++++| |||+++++++.+...+
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence            37777789999998652        14789999998643211 11223457889999999977 8999999999999999


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      +++|||+.+|+|.+++...+.+++..+..++.||+.||.|+|+++   |+||||||+|||++.++.+||+|||+|+
T Consensus       105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999999888999999999999999999999999   9999999999999999999999999996

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.94  E-value=9.9e-27  Score=213.45  Aligned_cols=144  Identities=24%  Similarity=0.427  Sum_probs=121.6

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeC--CcEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQN--IPMMI  262 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~l  262 (359)
                      +|.....+|+|+|+.+   .  .+|+.||||++....      .+.+.+|+.+++.+. ||||++++++|...  ..+++
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            4777788999999865   2  358999999996432      245789999999995 99999999998754  56999


Q ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-cEEEeccccccc----
Q 018204          263 VLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGG-QLKISGFGLLRL----  337 (359)
Q Consensus       263 v~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DFGla~~----  337 (359)
                      |||||++++|..+.   +.+++..++.++.||+.||.|||+++   ||||||||+|||++.++ .+||+|||+|+.    
T Consensus       110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999987663   46999999999999999999999999   99999999999998755 699999999963    


Q ss_pred             ----------cccCccccc
Q 018204          338 ----------QYISPEKAK  346 (359)
Q Consensus       338 ----------~~~~PE~~~  346 (359)
                                .|+|||...
T Consensus       184 ~~~~~~~~t~~y~aPE~~~  202 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLV  202 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHT
T ss_pred             CcccccccCccccCccccc
Confidence                      477888644

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.5e-27  Score=215.52  Aligned_cols=142  Identities=25%  Similarity=0.384  Sum_probs=116.4

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEe--------C
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQ--------N  257 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--------~  257 (359)
                      .|...+.+|+|+|+.+   .  .+|+.||||++...... ......+.+|+.+++.++||||+++++++..        .
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            4667778899988754   2  35889999998654332 2233567899999999999999999998854        3


Q ss_pred             CcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc
Q 018204          258 IPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR  336 (359)
Q Consensus       258 ~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~  336 (359)
                      ..+|+||||+.++.+..+......+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence            468999999988766656555667999999999999999999999999   9999999999999999999999999995

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.8e-26  Score=213.40  Aligned_cols=151  Identities=26%  Similarity=0.405  Sum_probs=123.6

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC-----CcE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN-----IPM  260 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~  260 (359)
                      .|.....+|+|+|+.+   .  .+|+.||||++..... +....+.+.+|+.+++.++||||+++++++...     ...
T Consensus        19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            3677778899998744   2  3689999999975543 455566789999999999999999999998643     234


Q ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc----
Q 018204          261 MIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR----  336 (359)
Q Consensus       261 ~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~----  336 (359)
                      +++|+|+.+|+|.+++.. +.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+|.    
T Consensus        98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence            566777889999999865 47999999999999999999999999   9999999999999999999999999986    


Q ss_pred             --------ccccCccccc
Q 018204          337 --------LQYISPEKAK  346 (359)
Q Consensus       337 --------~~~~~PE~~~  346 (359)
                              ..|++||...
T Consensus       174 ~~~~~~g~~~y~apE~~~  191 (348)
T d2gfsa1         174 EMTGYVATRWYRAPEIML  191 (348)
T ss_dssp             GGSSSCHHHHTSCHHHHT
T ss_pred             ccccccccccccCchhhc
Confidence                    2489999744

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=6.4e-27  Score=182.33  Aligned_cols=106  Identities=30%  Similarity=0.449  Sum_probs=97.6

Q ss_pred             ccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccce
Q 018204           73 TMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVE  152 (359)
Q Consensus        73 ~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~  152 (359)
                      .|||++|+.+|+.++|++|+++|+|+|.+|..|+||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+.+|+.+
T Consensus         3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~   82 (118)
T d1myoa_           3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS   82 (118)
T ss_dssp             HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred             ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence            48999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             eEeeccccCccc---cccCCCCcccCCCC
Q 018204          153 VYNILKARGAKV---PKTKRTPMTVANPR  178 (359)
Q Consensus       153 ~~~~L~~~ga~~---~~~~~tpl~~a~~~  178 (359)
                      ++++|+++|+++   +..+.||++.+...
T Consensus        83 ~v~~Ll~~Gad~~~~d~~G~t~l~~a~~~  111 (118)
T d1myoa_          83 CVKLLLSKGADKTVKGPDGLTALEATDNQ  111 (118)
T ss_dssp             HHHHHHTTCCCSSSSSSSTCCCCCTCSST
T ss_pred             hhhhhhcccccceeeCCCCCCHHHHHhHH
Confidence            999999999988   45567899888543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.5e-26  Score=208.54  Aligned_cols=153  Identities=27%  Similarity=0.434  Sum_probs=119.7

Q ss_pred             eeEeeccCcccceeEEE---Ee--c-CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhC---CCCccccceeeEEe----
Q 018204          190 LQVRKADGITKGSYQVA---KW--N-GTKVWVKILDKESHKDPERINAFTHELTIVEKA---RHPNVVQFVGAVTQ----  256 (359)
Q Consensus       190 ~~~~~~~~ig~g~~~~~---~~--~-g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~----  256 (359)
                      -+|.....+|+|+|+.+   ..  + ++.||||++....... .....+.+|+.+++.+   +||||++++++|..    
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            35777778999999865   22  2 5678999986543221 1112355677776655   89999999999863    


Q ss_pred             -CCcEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          257 -NIPMMIVLEYHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       257 -~~~~~lv~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                       ...++++|||+.++++...... ...+++..++.++.|++.||+|||+++   ||||||||+|||++..+.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhh
Confidence             2468999999988766544433 346999999999999999999999999   99999999999999999999999999


Q ss_pred             cc--------------ccccCccccc
Q 018204          335 LR--------------LQYISPEKAK  346 (359)
Q Consensus       335 a~--------------~~~~~PE~~~  346 (359)
                      ++              +.|+|||...
T Consensus       163 ~~~~~~~~~~~~~~gT~~Y~APE~~~  188 (305)
T d1blxa_         163 ARIYSFQMALTSVVVTLWYRAPEVLL  188 (305)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHT
T ss_pred             hhhhcccccCCCcccChhhcCcchhc
Confidence            86              3588888754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.1e-25  Score=206.71  Aligned_cols=150  Identities=25%  Similarity=0.362  Sum_probs=124.4

Q ss_pred             eEeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccceeeEEeC------Cc
Q 018204          191 QVRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQFVGAVTQN------IP  259 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~~  259 (359)
                      .|+..+.+|.|+|+.+.     .+|+.+|||++..... +......+.+|+.+++.++||||++++++|...      ..
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            47778889999998552     3589999999976543 455667789999999999999999999998643      57


Q ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccccc---
Q 018204          260 MMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGLLR---  336 (359)
Q Consensus       260 ~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGla~---  336 (359)
                      +|+|||||.+ ++.+.+.  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++   
T Consensus        97 ~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence            8999999976 5555553  46999999999999999999999999   9999999999999999999999999986   


Q ss_pred             -----------ccccCcccccc
Q 018204          337 -----------LQYISPEKAKI  347 (359)
Q Consensus       337 -----------~~~~~PE~~~~  347 (359)
                                 ..|+|||....
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~  192 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILG  192 (355)
T ss_dssp             ----------CCTTCCHHHHTT
T ss_pred             cccccccccccccccChhhhcC
Confidence                       35899998753

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.91  E-value=1.7e-24  Score=195.22  Aligned_cols=137  Identities=18%  Similarity=0.287  Sum_probs=116.9

Q ss_pred             eEeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC-CccccceeeEEeCCcEEEEE
Q 018204          191 QVRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH-PNVVQFVGAVTQNIPMMIVL  264 (359)
Q Consensus       191 ~~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv~  264 (359)
                      .|.+.+.+|+|+|+.+   .  .+|+.+|||++......     ..+..|++.+..+.| +|++.+++++......++||
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            3666778899999854   2  35889999998654322     236788999999976 89999999999999999999


Q ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-----CCcEEEecccccc
Q 018204          265 EYHAKGDLASYLQKKG-RLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN-----GGQLKISGFGLLR  336 (359)
Q Consensus       265 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~-----~~~~kl~DFGla~  336 (359)
                      ||+ +++|.+++...+ .++..++..++.|++.||.|||+++   ||||||||+|||++.     .+.+||+|||+|+
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            999 679999987654 6999999999999999999999999   999999999999974     5689999999996

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=4.8e-26  Score=177.29  Aligned_cols=105  Identities=30%  Similarity=0.262  Sum_probs=98.6

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      ++.+++.|+++.++.+++.+......+.+|+||||+||..|+.+++++|++.|+|+|.+|..|+||||+|+.+|+.++|+
T Consensus         6 L~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~   85 (118)
T d1myoa_           6 FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVK   85 (118)
T ss_dssp             HHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHH
T ss_pred             HHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhhhh
Confidence            45788999999999999887665666889999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCccccccccccccccccc
Q 018204          123 LLLSKKANIDARDRWGSTAAADAKY  147 (359)
Q Consensus       123 ~Ll~~ga~~~~~d~~g~tpl~~A~~  147 (359)
                      +|+++|||++.+|..|.||||+|..
T Consensus        86 ~Ll~~Gad~~~~d~~G~t~l~~a~~  110 (118)
T d1myoa_          86 LLLSKGADKTVKGPDGLTALEATDN  110 (118)
T ss_dssp             HHHTTCCCSSSSSSSTCCCCCTCSS
T ss_pred             hhhcccccceeeCCCCCCHHHHHhH
Confidence            9999999999999999999999953

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.91  E-value=4.3e-24  Score=193.16  Aligned_cols=136  Identities=22%  Similarity=0.268  Sum_probs=110.5

Q ss_pred             EeeccCcccceeEEE---E--ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccccc-eeeEEeCCcEEEEEe
Q 018204          192 VRKADGITKGSYQVA---K--WNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVVQF-VGAVTQNIPMMIVLE  265 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~---~--~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l-~~~~~~~~~~~lv~e  265 (359)
                      |.+.+.+|+|+|+.+   .  .+|+.||||++......     ..+..|+.+++.++|++++.. ..++......++|||
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            666778899999755   2  35889999998754332     236789999999988776555 555667788999999


Q ss_pred             cCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCcEEEecccccc
Q 018204          266 YHAKGDLASYLQK-KGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDN---GGQLKISGFGLLR  336 (359)
Q Consensus       266 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DFGla~  336 (359)
                      |+. +++.+.+.. .+.+++..+..++.|++.||+|||+++   ||||||||+|||++.   +..+||+|||+|+
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          84 LLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcce
Confidence            995 577666654 457999999999999999999999999   999999999999865   4469999999997

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.90  E-value=1e-25  Score=183.54  Aligned_cols=120  Identities=18%  Similarity=0.152  Sum_probs=101.7

Q ss_pred             eeccCCCCCcCcCCcccccC------CCCCCCCCccHHHHHHH---cCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHc
Q 018204           45 SFGRQSSLDPIRRSPVQDEL------TVPENLDSTMQLLFMAC---RGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACE  115 (359)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~t~l~~aa~---~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~  115 (359)
                      .+.+.+++..+..++.++..      ....+..|.||||+|+.   .|+.++|++|++.|+|+|.+|.+|+||||+||..
T Consensus        12 ~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~   91 (154)
T d1dcqa1          12 EAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLT   91 (154)
T ss_dssp             HHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHT
T ss_pred             HHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhcccccccccc
Confidence            44455555555555443321      12235679999999997   4789999999999999999999999999999999


Q ss_pred             CCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCccc
Q 018204          116 GHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       116 g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~  164 (359)
                      |+.++|++|+++|+|++.+|..|+||||+|+.+|+.+++++|++.++..
T Consensus        92 ~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A~~~~~~~i~~~L~~~~~~~  140 (154)
T d1dcqa1          92 DNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEHCEELLTQALSGR  140 (154)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTTC
T ss_pred             ccccccccccccCccccccCCCCCCHHHHHHHcCCHHHHHHHHHhCCCC
Confidence            9999999999999999999999999999999999999999999987653

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.6e-25  Score=177.45  Aligned_cols=118  Identities=25%  Similarity=0.231  Sum_probs=81.1

Q ss_pred             eeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHH
Q 018204           44 FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL  123 (359)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~  123 (359)
                      +.+|..|+++.++.+++.+.....+|.+|+||||+|+..|+.+++++|++.|+|+|.+|.+|+||||+|+.+|+.++|++
T Consensus         6 ~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~   85 (130)
T d1ycsb1           6 LDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKF   85 (130)
T ss_dssp             HHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHH
T ss_pred             HHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHHH
Confidence            45666777777777776665444556677777777777777777777777777777777777777777777777777777


Q ss_pred             HHhcCCCcccccc-ccccccc--cccccccceeEeeccccC
Q 018204          124 LLSKKANIDARDR-WGSTAAA--DAKYYGNVEVYNILKARG  161 (359)
Q Consensus       124 Ll~~ga~~~~~d~-~g~tpl~--~A~~~~~~~~~~~L~~~g  161 (359)
                      |+++|||++..+. .|.||++  .|...|+.+++++|++.+
T Consensus        86 Ll~~ga~v~~~~~~~~~~~~~~~~a~~~g~~eiv~~L~~~~  126 (130)
T d1ycsb1          86 LVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQ  126 (130)
T ss_dssp             HHHTTCCTTCCCSSSCCCHHHHCCSSSTTCCCHHHHHHHHH
T ss_pred             HHHcCCCcccccCCCCCCHHHHHHHHHcChHHHHHHHHhHH
Confidence            7777777776654 3555543  345666777777776543

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.6e-24  Score=171.54  Aligned_cols=94  Identities=34%  Similarity=0.388  Sum_probs=91.1

Q ss_pred             cHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccccccccee
Q 018204           74 MQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEV  153 (359)
Q Consensus        74 t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~  153 (359)
                      +.||.||..|+.++|++|+++|+|+|.+|.+|+||||+||..|+.+++++|++.|+|+|.+|.+|+||||+|+.+|+.++
T Consensus         3 ~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~   82 (130)
T d1ycsb1           3 ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV   82 (130)
T ss_dssp             HHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred             HHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHH
Confidence            67999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EeeccccCcccccc
Q 018204          154 YNILKARGAKVPKT  167 (359)
Q Consensus       154 ~~~L~~~ga~~~~~  167 (359)
                      +++|+++|++++..
T Consensus        83 v~~Ll~~ga~v~~~   96 (130)
T d1ycsb1          83 CKFLVESGAAVFAM   96 (130)
T ss_dssp             HHHHHHTTCCTTCC
T ss_pred             HHHHHHcCCCcccc
Confidence            99999999998643

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=2.5e-25  Score=174.98  Aligned_cols=117  Identities=23%  Similarity=0.271  Sum_probs=105.7

Q ss_pred             cceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC-cHHHHHHHcCCHHH
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGR-TALHIAACEGHVEV  120 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~-TpLh~A~~~g~~~~  120 (359)
                      .+..++..|+++.++.+++.+......+.+|.||||+| ..|+.++|++|+++|+|+|.+|..|. ||||+||..|+.++
T Consensus         6 ~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a-~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~   84 (125)
T d1bi7b_           6 WLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVM-MMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDT   84 (125)
T ss_dssp             HHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSS-CTTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHH
T ss_pred             HHHHHHHCCCHHHHHHHHHcCCcccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc
Confidence            45578889999999999988755556688999999865 57999999999999999999998876 69999999999999


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccc
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKA  159 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~  159 (359)
                      |++|+++|+|++.+|..|+||||+|+.+|+.+++++|++
T Consensus        85 v~~Ll~~ga~~~~~d~~G~T~l~~A~~~g~~~~v~~Lls  123 (125)
T d1bi7b_          85 LVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRA  123 (125)
T ss_dssp             HHHHHHHTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHSS
T ss_pred             cccccccccccccccCCCCCHHHHHHHcCCHHHHHHHHh
Confidence            999999999999999999999999999999999999876

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.86  E-value=1.4e-23  Score=188.18  Aligned_cols=138  Identities=25%  Similarity=0.306  Sum_probs=114.8

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC----------------
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID----------------  102 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d----------------  102 (359)
                      .+..++.+|..|+++.|+.+++.+......|.+|.||||+|+.+|+.++|++|+++|++++..+                
T Consensus        40 ~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~~~  119 (291)
T d1s70b_          40 DGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYL  119 (291)
T ss_dssp             HHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCH
T ss_pred             CchHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeeccccccccccccccccccccccccccc
Confidence            3445678899999999999998875555669999999999999999999999999888755433                


Q ss_pred             -----------------------------------------------------------------------------CCC
Q 018204          103 -----------------------------------------------------------------------------LDG  105 (359)
Q Consensus       103 -----------------------------------------------------------------------------~~g  105 (359)
                                                                                                   ..|
T Consensus       120 ~~~~~l~~~~~~~~~~~~~~~~~~~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  199 (291)
T d1s70b_         120 DIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSG  199 (291)
T ss_dssp             HHHHHHHHTTCCTTCCCTTSCCHHHHCCSHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTC
T ss_pred             chhhcccccCcccccccccCccccccccccccchhccccccccccccccccccccccccccchhhhcccccccccccCCC
Confidence                                                                                         356


Q ss_pred             CcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          106 RTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       106 ~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      .||||+|+..|+.+++++|++.|+|+|.+|..|+||||+|+..|+.+++++|+++|++++   ..+.||+++|.
T Consensus       200 ~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~~A~  273 (291)
T d1s70b_         200 GTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVAD  273 (291)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTSCC
T ss_pred             CChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHH
Confidence            677778888888888888888899999899999999999999999999999999998874   34568888874

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=2.5e-23  Score=179.84  Aligned_cols=133  Identities=23%  Similarity=0.257  Sum_probs=109.6

Q ss_pred             eeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHH
Q 018204           44 FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKL  123 (359)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~  123 (359)
                      ..++..|..+.++.+++.+......|.+|.||||+|+..|+.+++++|+++|+|++.+|..|.||||+|+..|+.+++++
T Consensus        75 ~~~~~~~~~~i~~~Ll~~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~  154 (223)
T d1uoha_          75 HIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHI  154 (223)
T ss_dssp             HHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHH
T ss_pred             cccccccccchhHHHhccCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhh
Confidence            34444566666666666654444558888999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          124 LLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       124 Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      |++.|+++|.+|..|+||||+|+..|+.+++++|+++|++++   ..++||+++|.
T Consensus       155 L~~~~~~i~~~d~~g~TpL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~tpl~~A~  210 (223)
T d1uoha_         155 LLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK  210 (223)
T ss_dssp             HHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHCC
T ss_pred             hccccceeeeccCCCCceeccccccCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence            999999999999999999999999999999999999998874   45678888773

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=1.7e-23  Score=164.45  Aligned_cols=104  Identities=28%  Similarity=0.349  Sum_probs=95.6

Q ss_pred             CCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccc-cccccccccc
Q 018204           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGS-TAAADAKYYG  149 (359)
Q Consensus        71 ~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~-tpl~~A~~~~  149 (359)
                      .+.++||+||.+|+.++|++|+++|+|+|.+|.+|+||||+|+ .|+.++|++|+++|+++|.+|..|. ||||+|+..|
T Consensus         2 p~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g   80 (125)
T d1bi7b_           2 PSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREG   80 (125)
T ss_dssp             CSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHT
T ss_pred             CChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-cccccccccccccccccccccccccccccccccccc
Confidence            3678999999999999999999999999999999999999775 7999999999999999999999887 6999999999


Q ss_pred             cceeEeeccccCcccc---ccCCCCcccC
Q 018204          150 NVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       150 ~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +.+++++|+++|++++   ..++||++.|
T Consensus        81 ~~~~v~~Ll~~ga~~~~~d~~G~T~l~~A  109 (125)
T d1bi7b_          81 FLDTLVVLHRAGARLDVRDAWGRLPVDLA  109 (125)
T ss_dssp             CHHHHHHHHHHTCCSSCCCTTCCCHHHHH
T ss_pred             cccccccccccccccccccCCCCCHHHHH
Confidence            9999999999999884   4567788776

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.8e-23  Score=170.46  Aligned_cols=132  Identities=21%  Similarity=0.256  Sum_probs=89.8

Q ss_pred             cceeeccCCCCCcCcCCcccccCCCCC-CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH
Q 018204           42 MRFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV  120 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~  120 (359)
                      .++.+|..|+++.|+.++..++.+++. |..|+||||+|+ .|+.++|++|++.|+|+|..+..|.+||+.|+..++.++
T Consensus         5 ~L~~Aa~~g~~~~vk~lL~~~~~~~n~~d~~g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~   83 (156)
T d1bd8a_           5 RLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDT   83 (156)
T ss_dssp             HHHHHHHHTCHHHHHHHHHTTCCCTTCCCTTSCCHHHHSC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHH
T ss_pred             HHHHHHHcCCHHHHHHHHHhCCCCCCccCCCCCccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence            345566677777777777665444433 667777777654 467777777777777777777777777777777777777


Q ss_pred             HHHHHhcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccC
Q 018204          121 VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVA  175 (359)
Q Consensus       121 v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a  175 (359)
                      +++++++|+++|.+|..|+||||+|+..|+.+++++|+ .|+++   +..++||++.|
T Consensus        84 ~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G~TpL~~A  140 (156)
T d1bd8a_          84 LKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRDARGLTPLELA  140 (156)
T ss_dssp             HHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCCTTSCCHHHHH
T ss_pred             cccccccccccccccCCCCeeecccccccccccccccc-ccccccccCCCCCCHHHHH
Confidence            77777777777777777777777777777777777665 45554   33445666655

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.84  E-value=4.1e-23  Score=167.40  Aligned_cols=114  Identities=29%  Similarity=0.314  Sum_probs=70.9

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHH------------------------------
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLL------------------------------   92 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll------------------------------   92 (359)
                      +..+++.|+.+.++.+++.+. +.+.|..|+||||+|+..++.++++.++                              
T Consensus         6 L~~Aa~~g~~~~v~~LL~~ga-~~~~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (153)
T d1awcb_           6 LLEAARAGQDDEVRILMANGA-PFTTDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVE   84 (153)
T ss_dssp             HHHHHHHTCHHHHHHHHHHTC-CCCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHH
T ss_pred             HHHHHHCCCHHHHHHHHHcCC-CcccccCCCccccccccccccccccccccccccccccccccccccccccccccceeee
Confidence            345666777777777776654 4446677777777777777777766665                              


Q ss_pred             ---HcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeec
Q 018204           93 ---NEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNIL  157 (359)
Q Consensus        93 ---~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L  157 (359)
                         ..|++++.+|.+|+||||+||..|+.++|++|++.|+|++.+|..|.||||+|+.+|+.+++++|
T Consensus        85 ~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~~~g~~eiv~lL  152 (153)
T d1awcb_          85 VLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLAEIL  152 (153)
T ss_dssp             HHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred             cccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHHHcCCHHHHHhC
Confidence               44555555555566666666666666666666555666655555566666666555555555544

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.83  E-value=1.5e-21  Score=171.19  Aligned_cols=100  Identities=32%  Similarity=0.336  Sum_probs=94.0

Q ss_pred             CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCC-CCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccc
Q 018204           66 VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSI-DLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAAD  144 (359)
Q Consensus        66 ~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~-d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~  144 (359)
                      ..++.+|.||||+||..|+.++|++|++.|++.+.+ +..|+||||+|+..|+.++|++|+++|+|++.+|..|.||||+
T Consensus       152 n~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t~L~~  231 (255)
T d1oy3d_         152 EAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGS  231 (255)
T ss_dssp             TCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred             ccccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCCCHHHH
Confidence            345889999999999999999999999999998864 6889999999999999999999999999999999999999999


Q ss_pred             ccccccceeEeeccccCcccc
Q 018204          145 AKYYGNVEVYNILKARGAKVP  165 (359)
Q Consensus       145 A~~~~~~~~~~~L~~~ga~~~  165 (359)
                      |+..++.+++++|+++||+-+
T Consensus       232 A~~~~~~~i~~~Ll~~Ga~~~  252 (255)
T d1oy3d_         232 ALLRPNPILARLLRAHGAPEP  252 (255)
T ss_dssp             HHTSSCHHHHHHHHHTTCCCC
T ss_pred             HHHCCCHHHHHHHHHcCCCCC
Confidence            999999999999999999743

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=4.2e-22  Score=162.31  Aligned_cols=121  Identities=23%  Similarity=0.228  Sum_probs=110.5

Q ss_pred             CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCH
Q 018204           39 RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (359)
Q Consensus        39 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~  118 (359)
                      .+..++.+|..|+.+.++.++..+......+.+|.+||+.++..++.++++.+++.|+++|.+|..|+||||+||..|+.
T Consensus        35 ~g~t~L~~A~~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~  114 (156)
T d1bd8a_          35 FGKTALQVMMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHT  114 (156)
T ss_dssp             TSCCHHHHSCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCH
T ss_pred             CCCcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCCeeeccccccccc
Confidence            44556677778999999999887766566688899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhcCCCccccccccccccccccccccceeEeecccc
Q 018204          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKAR  160 (359)
Q Consensus       119 ~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~  160 (359)
                      +++++|+ .|+|++.+|..|+||||+|+.+|+.+++++|++|
T Consensus       115 ~i~~~L~-~~~~~~~~d~~G~TpL~~A~~~g~~~iv~~Ll~h  155 (156)
T d1bd8a_         115 AVVSFLA-AESDLHRRDARGLTPLELALQRGAQDLVDILQGH  155 (156)
T ss_dssp             HHHHHHH-TTSCTTCCCTTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred             ccccccc-ccccccccCCCCCCHHHHHHHcCCHHHHHHHHhh
Confidence            9999887 6999999999999999999999999999999876

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.83  E-value=2.1e-22  Score=173.86  Aligned_cols=76  Identities=24%  Similarity=0.219  Sum_probs=55.7

Q ss_pred             CCCCCCcHHHHHHHcCCHHHHHHHHhcC-CCccccccccccccccccccccceeEeeccc-cCccc---cccCCCCcccC
Q 018204          101 IDLDGRTALHIAACEGHVEVVKLLLSKK-ANIDARDRWGSTAAADAKYYGNVEVYNILKA-RGAKV---PKTKRTPMTVA  175 (359)
Q Consensus       101 ~d~~g~TpLh~A~~~g~~~~v~~Ll~~g-a~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~-~ga~~---~~~~~tpl~~a  175 (359)
                      +|..|+||||+|+..|+.+++++|++.| .++|.+|.+|+||||+|+.+|+.+++++|++ .|+++   +..+.||+++|
T Consensus       134 ~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~l~~A  213 (229)
T d1ixva_         134 KDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVA  213 (229)
T ss_dssp             CCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCTGGGC
T ss_pred             cCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCCCCHHHHH
Confidence            4446777788888888888888888775 5677778888888888888888888887775 47776   34456777776


Q ss_pred             C
Q 018204          176 N  176 (359)
Q Consensus       176 ~  176 (359)
                      .
T Consensus       214 ~  214 (229)
T d1ixva_         214 L  214 (229)
T ss_dssp             S
T ss_pred             h
Confidence            4

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=1.6e-22  Score=174.73  Aligned_cols=136  Identities=31%  Similarity=0.336  Sum_probs=112.6

Q ss_pred             CCcceeeccCCCCCcCcCCcccccCCC-CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCH
Q 018204           40 NNMRFSFGRQSSLDPIRRSPVQDELTV-PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV  118 (359)
Q Consensus        40 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~  118 (359)
                      +.+.+.+|..|+++.+++++.+....+ ..|.+|+||||+||..|+.+++++|+..+.+....+..+.|+++.|+..|+.
T Consensus         4 ~~~~~~~a~~G~~~~v~~~l~~~~~~~~~~D~~G~TpLh~Aa~~g~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (223)
T d1uoha_           4 NLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGRD   83 (223)
T ss_dssp             SSHHHHHHHTTCHHHHHHHHHHCGGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTCCCHHHHHHHHTCH
T ss_pred             HHHHHHHHHhCCHHHHHHHHHhCCCcCcCcCCCCCCHHHHHHHhhhhccccccccccccccccccccccccccccccccc
Confidence            445667789999999999887765554 4488999999999999999999999988888888888888888888888888


Q ss_pred             HHHHHHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          119 EVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       119 ~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +++++|+++|+|++.+|..|+||||+|+.+|+.+++++|+++|++++   ..+.||++.+
T Consensus        84 ~i~~~Ll~~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a  143 (223)
T d1uoha_          84 EIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRA  143 (223)
T ss_dssp             HHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             chhHHHhccCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhh
Confidence            88888888888888888888888888888888888888888888774   3345666554

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.82  E-value=2.8e-21  Score=171.23  Aligned_cols=136  Identities=26%  Similarity=0.249  Sum_probs=110.5

Q ss_pred             CcceeeccCCCCCcCcCCcc--------cccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHH
Q 018204           41 NMRFSFGRQSSLDPIRRSPV--------QDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIA  112 (359)
Q Consensus        41 ~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A  112 (359)
                      +.+..+|..|+.+.++.++.        .+.....+|.+|+||||+|+..|+.++|++|+++|||+|.+|.+|.||||+|
T Consensus        35 T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t~l~~a  114 (277)
T d2fo1e1          35 TVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA  114 (277)
T ss_dssp             CHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHH
T ss_pred             cHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeeccccccccccccccccccccccccccccccccccch
Confidence            44456777888888888753        3333344589999999999999999999999999999999998888888888


Q ss_pred             HHcCCHHH------------------------------------------------------------------------
Q 018204          113 ACEGHVEV------------------------------------------------------------------------  120 (359)
Q Consensus       113 ~~~g~~~~------------------------------------------------------------------------  120 (359)
                      +..|+.++                                                                        
T Consensus       115 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~~  194 (277)
T d2fo1e1         115 AANRDFGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYA  194 (277)
T ss_dssp             HHTTCHHHHHHHTTSHHHHHTTSCCCTTSCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSCCSGGGTSSSSCCCCCTHHHH
T ss_pred             hhhcchhhhhhhhhcccccccccccccccchhHHHHHhcccccccccccccccccccccccccccccccccCCCCccccc
Confidence            66665543                                                                        


Q ss_pred             --------HHHHH-hcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccCC
Q 018204          121 --------VKLLL-SKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN  176 (359)
Q Consensus       121 --------v~~Ll-~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~  176 (359)
                              +++++ ..|.+++.+|..|+||||+|+..|+.+++++|+++|+++   +..+.||+++|.
T Consensus       195 ~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~L~~A~  262 (277)
T d2fo1e1         195 AQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQ  262 (277)
T ss_dssp             HSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHHH
T ss_pred             cccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCHHHHHH
Confidence                    44333 457788889999999999999999999999999999998   456678988873

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=6.6e-21  Score=162.06  Aligned_cols=135  Identities=24%  Similarity=0.181  Sum_probs=103.4

Q ss_pred             cceeeccCCCCCcCcCCcc---cccCC-CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCC--------------
Q 018204           42 MRFSFGRQSSLDPIRRSPV---QDELT-VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDL--------------  103 (359)
Q Consensus        42 ~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~--------------  103 (359)
                      .+..++..|+++.++.++.   +.+.+ ...|.+|+||||+||..|+.++|++|++.|++++..+.              
T Consensus         6 pLh~A~~~g~~~~v~~Ll~~~~~~g~~in~~d~~g~TpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~~~~~~~a~~~~~   85 (228)
T d1k1aa_           6 PLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRS   85 (228)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             HHHHHHHcCCHHHHHHHHHHHHHCCCCCCccCCCCCccceehhccccccccccccccccccccccccccccccccccccc
Confidence            3446667777777776654   22333 34477788888888888888888888888887666443              


Q ss_pred             ---------------------------------------------------------CCCcHHHHHHHcCCHHHHHHHHh
Q 018204          104 ---------------------------------------------------------DGRTALHIAACEGHVEVVKLLLS  126 (359)
Q Consensus       104 ---------------------------------------------------------~g~TpLh~A~~~g~~~~v~~Ll~  126 (359)
                                                                               .|.||||.|+..+...+++.+++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~~~~  165 (228)
T d1k1aa_          86 PTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQ  165 (228)
T ss_dssp             HHHHHHHHHHSCTTSCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHH
T ss_pred             ccchhhhhhccccccccccccccccccccccccccccchhhhhhhccccccccccccchhhHHHHHHHhhhhhhhhhhhh
Confidence                                                                     46667777777777777888888


Q ss_pred             cCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccCC
Q 018204          127 KKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVAN  176 (359)
Q Consensus       127 ~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a~  176 (359)
                      .|.+++.+|..|.||||+|+..|+.+++++|+++|++++   ..+.||+++|.
T Consensus       166 ~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A~  218 (228)
T d1k1aa_         166 HGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVAR  218 (228)
T ss_dssp             TTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCS
T ss_pred             hccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence            888888888899999999999999999999999999884   45788998874

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.81  E-value=8.8e-22  Score=174.56  Aligned_cols=113  Identities=18%  Similarity=0.231  Sum_probs=100.3

Q ss_pred             CCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHH--------HHcCCCCCCCCCCCCcHHHHHHHcCCHHHH
Q 018204           50 SSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDL--------LNEGSDVNSIDLDGRTALHIAACEGHVEVV  121 (359)
Q Consensus        50 ~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~L--------l~~ga~v~~~d~~g~TpLh~A~~~g~~~~v  121 (359)
                      ++...+.+.+.+.+++...+.+|+||||+||..|+.++|++|        ++.|||||.+|.+|+||||+|+.+|+.++|
T Consensus        11 ~~~~~~~~~l~~~~~n~~~~~~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv   90 (277)
T d2fo1e1          11 AGSYAITEPITRESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLV   90 (277)
T ss_dssp             HSSSCCCSCCSTTTTTTCCCSSCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHH
T ss_pred             CCCHHHHHHHHhcCCCcCCCCCCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeecccccccccccc
Confidence            455677777777777666656799999999999999999887        567999999999999999999999999999


Q ss_pred             HHHHhcCCCccccccccccccccccccccceeEeeccccCc
Q 018204          122 KLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA  162 (359)
Q Consensus       122 ~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga  162 (359)
                      ++|+++|||++.+|..|.|||++|...++.++..++...+.
T Consensus        91 ~~Ll~~Gad~n~~~~~g~t~l~~a~~~~~~~~~~~l~~~~~  131 (277)
T d2fo1e1          91 AYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSTK  131 (277)
T ss_dssp             HHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSHH
T ss_pred             ccccccccccccccccccccccchhhhcchhhhhhhhhccc
Confidence            99999999999999999999999999999888888776543

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.81  E-value=5.6e-21  Score=172.55  Aligned_cols=108  Identities=21%  Similarity=0.256  Sum_probs=92.2

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCH-------HHHHHHH----------------
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHV-------EVVKLLL----------------  125 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~-------~~v~~Ll----------------  125 (359)
                      |.+|+||||+||..|+.++|++||+.|||++.+|..|+||||.||..++.       +++++|.                
T Consensus       104 D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~~g~t~lh~  183 (301)
T d1sw6a_         104 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHH  183 (301)
T ss_dssp             STTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcccccCCHHHH
Confidence            78899999999999999999999999999999999999999999986642       3433332                


Q ss_pred             --------------------------hcCC-------------------------------------Ccccccccccccc
Q 018204          126 --------------------------SKKA-------------------------------------NIDARDRWGSTAA  142 (359)
Q Consensus       126 --------------------------~~ga-------------------------------------~~~~~d~~g~tpl  142 (359)
                                                ..+.                                     .+|.+|..|+|||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~D~~G~TpL  263 (301)
T d1sw6a_         184 IIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCL  263 (301)
T ss_dssp             HHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHH
T ss_pred             HHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCCCCCCCCHH
Confidence                                      2211                                     1688899999999


Q ss_pred             ccccccccceeEeeccccCccc---cccCCCCcccCC
Q 018204          143 ADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN  176 (359)
Q Consensus       143 ~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~  176 (359)
                      |+|++.|+.+++++|+++||++   +..+.||+++|.
T Consensus       264 h~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~  300 (301)
T d1sw6a_         264 NIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA  300 (301)
T ss_dssp             HHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred             HHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence            9999999999999999999988   556789998873

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.81  E-value=3.4e-20  Score=171.53  Aligned_cols=148  Identities=22%  Similarity=0.384  Sum_probs=114.2

Q ss_pred             EeeccCcccceeEEEE-----ecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-----------CCccccceeeEE
Q 018204          192 VRKADGITKGSYQVAK-----WNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-----------HPNVVQFVGAVT  255 (359)
Q Consensus       192 ~~~~~~ig~g~~~~~~-----~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~~~~~  255 (359)
                      |.+...+|.|+|+.+.     .+|+.||||++...    ....+.+.+|+.+++.++           |+||+++++++.
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            6778889999997552     46899999999643    334456788998888775           578999998876


Q ss_pred             eC--CcEEEEEecCCCCCH-HHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCC----
Q 018204          256 QN--IPMMIVLEYHAKGDL-ASYLQ--KKGRLSPSKVLRFALDLARGMNYLHE-CKPDPIIHCDLKPKNILLDNGG----  325 (359)
Q Consensus       256 ~~--~~~~lv~e~~~~gsL-~~~l~--~~~~l~~~~~~~i~~qi~~aL~~lH~-~~~~~iiHrDlk~~NIll~~~~----  325 (359)
                      ..  ...+++++++..+.. .....  ....+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++    
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred             eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence            43  456677776655433 33222  23468999999999999999999998 76   99999999999998765    


Q ss_pred             --cEEEecccccc------------ccccCccccc
Q 018204          326 --QLKISGFGLLR------------LQYISPEKAK  346 (359)
Q Consensus       326 --~~kl~DFGla~------------~~~~~PE~~~  346 (359)
                        .++++|||.|+            ..|+|||...
T Consensus       168 ~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~  202 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL  202 (362)
T ss_dssp             EEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH
T ss_pred             cceeeEeecccccccccccccccccccccChhhcc
Confidence              39999999996            3588888655

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.81  E-value=2.7e-21  Score=156.42  Aligned_cols=105  Identities=31%  Similarity=0.352  Sum_probs=94.2

Q ss_pred             CCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH------------------------------
Q 018204           71 DSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV------------------------------  120 (359)
Q Consensus        71 ~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~------------------------------  120 (359)
                      |..||||.||..|+.++|++||++|++++ .|..|+||||+|+..++.++                              
T Consensus         1 d~~t~L~~Aa~~g~~~~v~~LL~~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   79 (153)
T d1awcb_           1 DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGH   79 (153)
T ss_dssp             CHHHHHHHHHHHTCHHHHHHHHHHTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTC
T ss_pred             CCCHHHHHHHHCCCHHHHHHHHHcCCCcc-cccCCCcccccccccccccccccccccccccccccccccccccccccccc
Confidence            35699999999999999999999999998 69999999999988877775                              


Q ss_pred             ---HHHHHhcCCCccccccccccccccccccccceeEeeccccCccc---cccCCCCcccCC
Q 018204          121 ---VKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKV---PKTKRTPMTVAN  176 (359)
Q Consensus       121 ---v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a~  176 (359)
                         +++|+.+|++++.+|..|+||||+|+..|+.+++++|+++|+++   +..+.||+++|.
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~Tpl~~A~  141 (153)
T d1awcb_          80 ANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISI  141 (153)
T ss_dssp             HHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHH
T ss_pred             ceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCCHHHHHH
Confidence               67777789999999999999999999999999999999999988   455678888773

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.80  E-value=1e-20  Score=165.86  Aligned_cols=96  Identities=22%  Similarity=0.133  Sum_probs=91.1

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCC---CCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccc
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSD---VNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~---v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  145 (359)
                      +.+|.||||+||.+|+.++|++||+.|++   +|.+|..|.||||+||..|+.++|++|+++|||++.+|..|.||||+|
T Consensus         6 ~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~~A   85 (255)
T d1oy3d_           6 TEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLA   85 (255)
T ss_dssp             CTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHHH
T ss_pred             CcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhhhh
Confidence            56899999999999999999999999998   778899999999999999999999999999999999999999999999


Q ss_pred             cccccceeEeeccccCccc
Q 018204          146 KYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       146 ~~~~~~~~~~~L~~~ga~~  164 (359)
                      +..++.+++++|++.+...
T Consensus        86 ~~~~~~~~~~~Ll~~~~~~  104 (255)
T d1oy3d_          86 CRVRAHTCACVLLQPRPSH  104 (255)
T ss_dssp             TTTTCHHHHHHHSSSCCSS
T ss_pred             hccCchHHHHHHHhhccch
Confidence            9999999999998877654

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.80  E-value=7.3e-21  Score=164.07  Aligned_cols=117  Identities=24%  Similarity=0.141  Sum_probs=104.2

Q ss_pred             eeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcC-CCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           44 FSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEG-SDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        44 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~g-a~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      ..++..+..+.+..++..+......+.+|+||||+|+..|+.+++++|++.| .++|.+|.+|+||||+|+..|+.++|+
T Consensus       110 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~  189 (229)
T d1ixva_         110 HLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAV  189 (229)
T ss_dssp             HHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHH
T ss_pred             ccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccHHHHH
Confidence            3445567777777777777777777899999999999999999999999997 689999999999999999999999999


Q ss_pred             HHHhc-CCCccccccccccccccccccccceeEeeccccCcc
Q 018204          123 LLLSK-KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAK  163 (359)
Q Consensus       123 ~Ll~~-ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~  163 (359)
                      +|++. |+|++.+|..|+||||+|+.   .+++++|+++|+|
T Consensus       190 ~Ll~~~gad~~~~d~~g~t~l~~A~~---~~~~~~Ll~~g~d  228 (229)
T d1ixva_         190 LLVEKYGAEYDLVDNKGAKAEDVALN---EQVKKFFLNNVVD  228 (229)
T ss_dssp             HHHHHHCCCSCCCCTTSCCTGGGCSC---HHHHHHHHHHCCC
T ss_pred             HHHHhcCCCCCCcCCCCCCHHHHHhh---HHHHHHHHHcCCC
Confidence            99975 99999999999999999984   4688999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.80  E-value=7.5e-20  Score=154.00  Aligned_cols=129  Identities=15%  Similarity=0.081  Sum_probs=97.1

Q ss_pred             eccCcccceeEEE----EecCcEEEEEEeccCCCC---------------cHHHHHHHHHHHHHHHhCCCCccccceeeE
Q 018204          194 KADGITKGSYQVA----KWNGTKVWVKILDKESHK---------------DPERINAFTHELTIVEKARHPNVVQFVGAV  254 (359)
Q Consensus       194 ~~~~ig~g~~~~~----~~~g~~vavK~l~~~~~~---------------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  254 (359)
                      +++.+|+|+|+.+    ..+|+.+|||+++.....               .......+..|...+..+.|++++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            4566888888754    346899999987532110               011223456788999999999999877653


Q ss_pred             EeCCcEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCcEEEecccc
Q 018204          255 TQNIPMMIVLEYHAKGDLASYLQKKGRLSPSKVLRFALDLARGMNYLHECKPDPIIHCDLKPKNILLDNGGQLKISGFGL  334 (359)
Q Consensus       255 ~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~~~~~~i~~qi~~aL~~lH~~~~~~iiHrDlk~~NIll~~~~~~kl~DFGl  334 (359)
                          ..+++|||+++..+.       .++...+..++.|++.+|.|||+++   |+||||||+|||+++++ ++|+|||+
T Consensus        84 ----~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~  148 (191)
T d1zara2          84 ----GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQ  148 (191)
T ss_dssp             ----TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTT
T ss_pred             ----CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCC
Confidence                237999999885542       2455567789999999999999999   99999999999998654 89999999


Q ss_pred             ccc
Q 018204          335 LRL  337 (359)
Q Consensus       335 a~~  337 (359)
                      |+.
T Consensus       149 a~~  151 (191)
T d1zara2         149 SVE  151 (191)
T ss_dssp             CEE
T ss_pred             ccc
Confidence            863

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=3.3e-20  Score=159.52  Aligned_cols=133  Identities=23%  Similarity=0.190  Sum_probs=87.5

Q ss_pred             eccCCCCCcCcCCcc----cccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHH-
Q 018204           46 FGRQSSLDPIRRSPV----QDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEV-  120 (359)
Q Consensus        46 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~-  120 (359)
                      ++..|+.+.+..++.    .+......|.+|+||||+||..|+.+++++|++.|+|++.+|..|+||||+|+..|+.++ 
T Consensus         9 A~~~g~~~~~~~li~~~~~~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~   88 (221)
T d1iknd_           9 AIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASV   88 (221)
T ss_dssp             HHHTTCSSSSSCCCC-----CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHH
T ss_pred             HHHcCCHHHHHHHHHHHHhCCCCcccCCCCCCcccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            344555444444332    222233346667777777777777777777777777777666666666666655555554 


Q ss_pred             --------------------------------------HHHHHhcCCCccccc-cccccccccccccccceeEeeccccC
Q 018204          121 --------------------------------------VKLLLSKKANIDARD-RWGSTAAADAKYYGNVEVYNILKARG  161 (359)
Q Consensus       121 --------------------------------------v~~Ll~~ga~~~~~d-~~g~tpl~~A~~~~~~~~~~~L~~~g  161 (359)
                                                            +++|+..|++++..+ ..|+||||+|+..|+.+++++|+++|
T Consensus        89 ~~l~~~~~~~~~~~~~~~~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~g  168 (221)
T d1iknd_          89 GVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCG  168 (221)
T ss_dssp             HHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTT
T ss_pred             chhhhhcccccccccccccccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcC
Confidence                                                  455555666666554 46899999999999999999999999


Q ss_pred             cccc---ccCCCCcccCCCC
Q 018204          162 AKVP---KTKRTPMTVANPR  178 (359)
Q Consensus       162 a~~~---~~~~tpl~~a~~~  178 (359)
                      ++++   ..+.||+++|...
T Consensus       169 ad~~~~~~~G~tpl~~A~~~  188 (221)
T d1iknd_         169 ADVNRVTYQGYSPYQLTWGR  188 (221)
T ss_dssp             CCSCCCCTTCCCGGGGCTTS
T ss_pred             CcccccCCCCCCHHHHHHHC
Confidence            8884   4567888887543

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=3.2e-21  Score=156.51  Aligned_cols=132  Identities=21%  Similarity=0.205  Sum_probs=110.8

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      +..+|..|+++.++.+++.+......|.+|.||||+|+ .|+.+++++|+++|+|++.++..|.|||+.++..++.++++
T Consensus         5 Lh~Aa~~g~~~~v~~Ll~~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~   83 (156)
T d1ihba_           5 LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQ   83 (156)
T ss_dssp             HHHHHHHTCHHHHHHHTTSCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHH
T ss_pred             HHHHHHcCCHHHHHHHHHCCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccccc
Confidence            44677888999999988887665666888999998764 78999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCccccccccccccccccccccceeEeeccccCc-cc---cccCCCCcccC
Q 018204          123 LLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGA-KV---PKTKRTPMTVA  175 (359)
Q Consensus       123 ~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga-~~---~~~~~tpl~~a  175 (359)
                      .|++.|.+++..|..|.+|+++|+..++.+++++|+++++ +.   +..+.||++.|
T Consensus        84 ~l~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~Ll~~~~~~~~~~d~~g~TpL~~A  140 (156)
T d1ihba_          84 TLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLA  140 (156)
T ss_dssp             HHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccCCCCCCHHHHH
Confidence            9999999999999999999999999999999988888876 33   44456777776

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=3.7e-20  Score=157.27  Aligned_cols=107  Identities=20%  Similarity=0.211  Sum_probs=94.2

Q ss_pred             CCCcCcCCcccccCC-CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCC
Q 018204           51 SLDPIRRSPVQDELT-VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKA  129 (359)
Q Consensus        51 ~~~~~~~~~~~~~~~-~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga  129 (359)
                      ....+...+...+.+ ...+..|.|||++|+..|..++++.|++.++++|.+|..|.||||+||..|+.++|++|+++||
T Consensus       101 ~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~ga  180 (209)
T d1ot8a_         101 AIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFA  180 (209)
T ss_dssp             TCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTC
T ss_pred             cchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCC
Confidence            333333333333333 3457889999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccccccccccccccccccceeEeec
Q 018204          130 NIDARDRWGSTAAADAKYYGNVEVYNIL  157 (359)
Q Consensus       130 ~~~~~d~~g~tpl~~A~~~~~~~~~~~L  157 (359)
                      |++.+|..|+||||+|+++|+.+++++|
T Consensus       181 d~n~~d~~g~Tpl~~A~~~~~~~iv~lL  208 (209)
T d1ot8a_         181 NREITDHMDRLPRDVASERLHHDIVRLL  208 (209)
T ss_dssp             CTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred             CCCCcCCCCCCHHHHHHHcCCHHHHhhc
Confidence            9999999999999999999999999886

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=1e-20  Score=176.90  Aligned_cols=112  Identities=26%  Similarity=0.271  Sum_probs=63.6

Q ss_pred             eccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHH
Q 018204           46 FGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLL  125 (359)
Q Consensus        46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll  125 (359)
                      ++..++.+.++.+++.+......+.++.||||.|+..|+.++++++++.|+|+|.+|.+|+||||+|+.+|+.++|++|+
T Consensus       271 a~~~~~~~i~~~Ll~~g~~~~~~~~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll  350 (408)
T d1n11a_         271 VAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLL  350 (408)
T ss_dssp             HHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHH
T ss_pred             hhhcCcHHHHHHHHHCCCccccccccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHH
Confidence            33444444444444433333333445556666666666666666666666666666666666666666666666666666


Q ss_pred             hcCCCccccccccccccccccccccceeEeec
Q 018204          126 SKKANIDARDRWGSTAAADAKYYGNVEVYNIL  157 (359)
Q Consensus       126 ~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L  157 (359)
                      ++|||+|.+|.+|+||||+|+++|+.+++++|
T Consensus       351 ~~GAd~n~~d~~G~t~L~~A~~~~~~~iv~~L  382 (408)
T d1n11a_         351 KNGASPNEVSSDGTTPLAIAKRLGYISVTDVL  382 (408)
T ss_dssp             HTTCCSCCCCSSSCCHHHHHHHTTCHHHHHHH
T ss_pred             HCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHH
Confidence            66666666666666666666666665555433

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.78  E-value=4.9e-22  Score=183.18  Aligned_cols=122  Identities=15%  Similarity=0.045  Sum_probs=76.6

Q ss_pred             ceeeccCCCCCcC---cCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC--CCCCcHHHHHHHcCC
Q 018204           43 RFSFGRQSSLDPI---RRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID--LDGRTALHIAACEGH  117 (359)
Q Consensus        43 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d--~~g~TpLh~A~~~g~  117 (359)
                      ++.+|..|..+.+   +.++..+......+.+|+||||+||.+||.++|++|++.|++++..|  .+|+||||+||.+||
T Consensus        94 L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~  173 (346)
T d2ajaa1          94 CFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGH  173 (346)
T ss_dssp             HHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTC
T ss_pred             HHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhh
Confidence            3445566654443   23333333333346677777777777777777777777777777655  347777777777777


Q ss_pred             HHHHHHHHhcCCCc---cccccccccccccccccccceeEeeccccCccc
Q 018204          118 VEVVKLLLSKKANI---DARDRWGSTAAADAKYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       118 ~~~v~~Ll~~ga~~---~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~  164 (359)
                      .+||++|++.|++.   +..+..|.||++.|+.+|+.+++++|+++|+++
T Consensus       174 ~~iv~~Ll~~~~~~~~~~~~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~  223 (346)
T d2ajaa1         174 LHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVML  223 (346)
T ss_dssp             HHHHHHHHHSCGGGHHHHHHHHHHHHHHHHHSTTCCHHHHHHHTTSHHHH
T ss_pred             HHHHHHHHHcCCcccccccccCCCcchhhHHhhcCHHHHHHHHHhCCCCc
Confidence            77777777777654   333445566666777777777777777777665

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.77  E-value=7.5e-21  Score=175.14  Aligned_cols=98  Identities=20%  Similarity=0.155  Sum_probs=87.1

Q ss_pred             CCCCCCccHHHHHHHcCCHHHHHH---HHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccc--ccccc
Q 018204           67 PENLDSTMQLLFMACRGDVKGVED---LLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDR--WGSTA  141 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g~~~~v~~---Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~--~g~tp  141 (359)
                      .++..|.||||+||.+||.+++++   |++.|+++|.+|.+|+||||+||.+||.++|++|++.|++++..+.  .|+||
T Consensus        85 ~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~  164 (346)
T d2ajaa1          85 KKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHA  164 (346)
T ss_dssp             HHTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHH
T ss_pred             hccCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCCh
Confidence            446689999999999999888776   7899999999999999999999999999999999999999998874  69999


Q ss_pred             cccccccccceeEeeccccCccc
Q 018204          142 AADAKYYGNVEVYNILKARGAKV  164 (359)
Q Consensus       142 l~~A~~~~~~~~~~~L~~~ga~~  164 (359)
                      ||+|+.+|+.+++++|++.|++.
T Consensus       165 L~~Aa~~g~~~iv~~Ll~~~~~~  187 (346)
T d2ajaa1         165 FRLAAENGHLHVLNRLCELAPTE  187 (346)
T ss_dssp             HHHHHHTTCHHHHHHHHHSCGGG
T ss_pred             hHHHHHHhhHHHHHHHHHcCCcc
Confidence            99999999999999999999865

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=3.7e-20  Score=164.61  Aligned_cols=126  Identities=21%  Similarity=0.167  Sum_probs=109.3

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCC-CCCCccHHHHHHHc----CCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCC
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPE-NLDSTMQLLFMACR----GDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGH  117 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~t~l~~aa~~----g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~  117 (359)
                      +..+++.|+.+.++.+++..+.+++. +..|.++++.+...    +..+++++|++.|+|+|.+|..|.||||+|+..|+
T Consensus       152 L~~A~~~~~~~~~~~Ll~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~  231 (285)
T d1wdya_         152 LMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKH  231 (285)
T ss_dssp             HHHHHHHTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTC
T ss_pred             HHHHHHcCCHHHHHHHHhccCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCc
Confidence            44567888888888888776655544 77788877766443    45578999999999999999999999999999999


Q ss_pred             HHHHHHHHhc-CCCccccccccccccccccccccceeEeeccccCccccccC
Q 018204          118 VEVVKLLLSK-KANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVPKTK  168 (359)
Q Consensus       118 ~~~v~~Ll~~-ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~~~~  168 (359)
                      .++|++|++. |+|+|.+|.+|.||||+|+.+|+.+++++|+++||+++..+
T Consensus       232 ~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d  283 (285)
T d1wdya_         232 LGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGD  283 (285)
T ss_dssp             HHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSS
T ss_pred             HHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccc
Confidence            9999999985 99999999999999999999999999999999999987654

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.76  E-value=3.1e-19  Score=159.37  Aligned_cols=93  Identities=27%  Similarity=0.320  Sum_probs=84.8

Q ss_pred             CCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccc
Q 018204           66 VPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (359)
Q Consensus        66 ~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  145 (359)
                      ...+.+|.||||+|+..|+.++++.|++.|+|+|.+|.+|+||||+||..|+.++|++|+++|||++.+|..|+||||+|
T Consensus       193 ~~~~~~g~t~L~~a~~~~~~~~~~~Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~~A  272 (291)
T d1s70b_         193 VRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVA  272 (291)
T ss_dssp             CCCTTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTSC
T ss_pred             ccccCCCCChhhHHHHcCChhhhcccccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHH
Confidence            34567899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccceeEeeccccCc
Q 018204          146 KYYGNVEVYNILKARGA  162 (359)
Q Consensus       146 ~~~~~~~~~~~L~~~ga  162 (359)
                      +.    +++++|.+...
T Consensus       273 ~e----~~~~~L~~~~~  285 (291)
T d1s70b_         273 DE----DILGYLEELQK  285 (291)
T ss_dssp             CS----GGGHHHHHHHH
T ss_pred             HH----HHHHHHHHHhh
Confidence            75    56666665443

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.75  E-value=1.5e-19  Score=146.58  Aligned_cols=101  Identities=25%  Similarity=0.325  Sum_probs=91.6

Q ss_pred             HHHHHHHcCCHHHHHHHHHcCCCCCCC------CCCCCcHHHHHHHc---CCHHHHHHHHhcCCCccccccccccccccc
Q 018204           75 QLLFMACRGDVKGVEDLLNEGSDVNSI------DLDGRTALHIAACE---GHVEVVKLLLSKKANIDARDRWGSTAAADA  145 (359)
Q Consensus        75 ~l~~aa~~g~~~~v~~Ll~~ga~v~~~------d~~g~TpLh~A~~~---g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A  145 (359)
                      .|..|+..+++..+..++..|+|++.+      +..|+||||+|+..   |+.++|++|+++|+|+|.+|..|+||||+|
T Consensus         9 ~L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A   88 (154)
T d1dcqa1           9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYC   88 (154)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHH
T ss_pred             HHHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccc
Confidence            456778899999999999999998765      78899999999974   789999999999999999999999999999


Q ss_pred             cccccceeEeeccccCccc---cccCCCCcccC
Q 018204          146 KYYGNVEVYNILKARGAKV---PKTKRTPMTVA  175 (359)
Q Consensus       146 ~~~~~~~~~~~L~~~ga~~---~~~~~tpl~~a  175 (359)
                      +..|+.+++++|+++|+++   +..+.||+++|
T Consensus        89 ~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A  121 (154)
T d1dcqa1          89 CLTDNAECLKLLLRGKASIEIANESGETPLDIA  121 (154)
T ss_dssp             HHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             cccccccccccccccCccccccCCCCCCHHHHH
Confidence            9999999999999999988   45567888877

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=1.7e-19  Score=146.11  Aligned_cols=132  Identities=26%  Similarity=0.339  Sum_probs=116.6

Q ss_pred             ccccccCCC--CCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCc
Q 018204           30 SRQSSFDPR--RNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRT  107 (359)
Q Consensus        30 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~T  107 (359)
                      .++.+++..  .+..++.+|..|+.+.++.+++.+......+.+|.|+|+.++..|+.+.++.|+..+.+++..|..|.|
T Consensus        22 ~~g~d~n~~d~~g~TpL~~A~~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  101 (156)
T d1ihba_          22 QNNVNVNAQNGFGRTALQVMKLGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNL  101 (156)
T ss_dssp             TSCCCTTCCCTTSCCHHHHCCSSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             HCCCCcCccCCcccccccccccccccccccccccccccccccccCccccccccccccccccccccccccccccccccccc
Confidence            344444422  455666788889988888888777665666889999999999999999999999999999999999999


Q ss_pred             HHHHHHHcCCHHHHHHHHhcCC-CccccccccccccccccccccceeEeeccccC
Q 018204          108 ALHIAACEGHVEVVKLLLSKKA-NIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (359)
Q Consensus       108 pLh~A~~~g~~~~v~~Ll~~ga-~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g  161 (359)
                      |||+|+..|+.+++++|+++|+ +++.+|..|.||||+|+..++.+++++|+++|
T Consensus       102 ~l~~a~~~~~~~~~~~Ll~~~~~~~~~~d~~g~TpL~~A~~~~~~~iv~~Ll~~G  156 (156)
T d1ihba_         102 PLHLAAKEGHLRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANG  156 (156)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTC
T ss_pred             ccccccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHhcC
Confidence            9999999999999999999986 89999999999999999999999999999987

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=9.3e-20  Score=170.22  Aligned_cols=133  Identities=22%  Similarity=0.313  Sum_probs=119.2

Q ss_pred             ceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHH
Q 018204           43 RFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVK  122 (359)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~  122 (359)
                      ...++..++.+.++.++.........+..|.|||+.|+..|+.+++++|++.|++++..+..+.||||.|+..++.++++
T Consensus       235 l~~a~~~~~~~~~~~~~~~~~~~~~~~~~g~~~l~~a~~~~~~~i~~~Ll~~g~~~~~~~~~~~t~L~~~~~~~~~~~~~  314 (408)
T d1n11a_         235 LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVK  314 (408)
T ss_dssp             HHHHHHTTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHH
T ss_pred             HHHHHHhCcHhHhhhhhccccccccccCCCCChhhhhhhcCcHHHHHHHHHCCCccccccccccccchhhcccCcceeee
Confidence            33455677777777766666555566889999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCccccccccccccccccccccceeEeeccccCcccc---ccCCCCcccC
Q 018204          123 LLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARGAKVP---KTKRTPMTVA  175 (359)
Q Consensus       123 ~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~ga~~~---~~~~tpl~~a  175 (359)
                      +|++.|+++|.+|.+|.||||+|+.+|+.+++++|+++||+++   ..++||+++|
T Consensus       315 ~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t~L~~A  370 (408)
T d1n11a_         315 FLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTTPLAIA  370 (408)
T ss_dssp             HHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCCHHHHH
T ss_pred             eeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHH
Confidence            9999999999999999999999999999999999999999984   5568888887

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.75  E-value=1.8e-19  Score=152.99  Aligned_cols=108  Identities=32%  Similarity=0.329  Sum_probs=92.2

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCC-----------------------------------------------
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSI-----------------------------------------------  101 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~-----------------------------------------------  101 (359)
                      |.+|.||||+||..|+.++|++|++.|+++|.+                                               
T Consensus        20 d~~G~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (209)
T d1ot8a_          20 DKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNARMHDGTTPLILAAR   99 (209)
T ss_dssp             HHHCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTCCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            667888888888888888888887777666554                                               


Q ss_pred             --------------------CCCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccccccceeEeeccccC
Q 018204          102 --------------------DLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKYYGNVEVYNILKARG  161 (359)
Q Consensus       102 --------------------d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~~~~~~~~~~L~~~g  161 (359)
                                          |..|+||||+|+..|..++++.|++.+++++.+|..|.||||+|+..|+.+++++|+++|
T Consensus       100 ~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~g  179 (209)
T d1ot8a_         100 LAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNF  179 (209)
T ss_dssp             TTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTT
T ss_pred             ccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCC
Confidence                                447899999999999999999999999999999999999999999999999999999999


Q ss_pred             cccc---ccCCCCcccCC
Q 018204          162 AKVP---KTKRTPMTVAN  176 (359)
Q Consensus       162 a~~~---~~~~tpl~~a~  176 (359)
                      ++++   ..+.||+++|.
T Consensus       180 ad~n~~d~~g~Tpl~~A~  197 (209)
T d1ot8a_         180 ANREITDHMDRLPRDVAS  197 (209)
T ss_dssp             CCTTCCCTTSCCHHHHHH
T ss_pred             CCCCCcCCCCCCHHHHHH
Confidence            9874   45678888763

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=1.6e-18  Score=148.89  Aligned_cols=96  Identities=25%  Similarity=0.236  Sum_probs=85.3

Q ss_pred             CCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCC-CCCCcHHHHHHHcCCHHHHHHHHhcCCCccccccccccccccccc
Q 018204           69 NLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSID-LDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAKY  147 (359)
Q Consensus        69 ~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d-~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~~  147 (359)
                      ..+|.||||.|+..|+.+.+++|+..|++++..+ .+|+||||+|+..|+.++|++|+++|||++.+|..|+||||+|+.
T Consensus       108 ~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~~  187 (221)
T d1iknd_         108 NYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWG  187 (221)
T ss_dssp             CTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTT
T ss_pred             ccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHHHH
Confidence            3456777777778888888888888888888765 679999999999999999999999999999999999999999999


Q ss_pred             cccceeEeeccccCccc
Q 018204          148 YGNVEVYNILKARGAKV  164 (359)
Q Consensus       148 ~~~~~~~~~L~~~ga~~  164 (359)
                      .++.+++++|.+.+.+.
T Consensus       188 ~~~~~~~~~l~~~~~~~  204 (221)
T d1iknd_         188 RPSTRIQQQLGQLTLEN  204 (221)
T ss_dssp             SSCHHHHHHHHTTSCGG
T ss_pred             CCCHHHHHHHHHcCCcc
Confidence            99999999999987653

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.70  E-value=3.4e-18  Score=154.00  Aligned_cols=111  Identities=17%  Similarity=0.122  Sum_probs=89.6

Q ss_pred             CCCCCCcceeeccCCCCCcCcCCcccccCCCCCCCCCccHHHHHHHcCCH-------HHHHHH-----------------
Q 018204           36 DPRRNNMRFSFGRQSSLDPIRRSPVQDELTVPENLDSTMQLLFMACRGDV-------KGVEDL-----------------   91 (359)
Q Consensus        36 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~-------~~v~~L-----------------   91 (359)
                      |...++.+..+|..|+++.++.+++.+.....+|..|+||||.|+..|+.       +++++|                 
T Consensus       104 D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d~~g~t~lh~  183 (301)
T d1sw6a_         104 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHH  183 (301)
T ss_dssp             STTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEECTTCCCHHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcccccCCHHHH
Confidence            44444556667889999999999988766666688999999999986642       233322                 


Q ss_pred             -------------------------HHcCC-------------------------------------CCCCCCCCCCcHH
Q 018204           92 -------------------------LNEGS-------------------------------------DVNSIDLDGRTAL  109 (359)
Q Consensus        92 -------------------------l~~ga-------------------------------------~v~~~d~~g~TpL  109 (359)
                                               +..+.                                     .+|.+|.+|+|||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~~D~~G~TpL  263 (301)
T d1sw6a_         184 IIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCL  263 (301)
T ss_dssp             HHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTCCCTTSCCHH
T ss_pred             HHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccCCCCCCCCHH
Confidence                                     22221                                     1789999999999


Q ss_pred             HHHHHcCCHHHHHHHHhcCCCcccccccccccccccc
Q 018204          110 HIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK  146 (359)
Q Consensus       110 h~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~  146 (359)
                      |+||..|+.++|++|+++|||++.+|+.|+|||++|+
T Consensus       264 h~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~  300 (301)
T d1sw6a_         264 NIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA  300 (301)
T ss_dssp             HHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred             HHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence            9999999999999999999999999999999999996

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=2e-17  Score=140.00  Aligned_cols=89  Identities=20%  Similarity=0.263  Sum_probs=84.4

Q ss_pred             CCCCCCccHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhcCCCcccccccccccccccc
Q 018204           67 PENLDSTMQLLFMACRGDVKGVEDLLNEGSDVNSIDLDGRTALHIAACEGHVEVVKLLLSKKANIDARDRWGSTAAADAK  146 (359)
Q Consensus        67 ~~~~~~~t~l~~aa~~g~~~~v~~Ll~~ga~v~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpl~~A~  146 (359)
                      .....+.++|+.|+..+...+++.+++.|.+++.+|..|.||||+|+..|+.++|++|+++|||+|.+|..|+||||+|+
T Consensus       139 ~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~A~  218 (228)
T d1k1aa_         139 VDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMVAR  218 (228)
T ss_dssp             CCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTTCS
T ss_pred             ccccchhhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence            33567999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccceeEe
Q 018204          147 YYGNVEVYN  155 (359)
Q Consensus       147 ~~~~~~~~~  155 (359)
                      .+|+.++++
T Consensus       219 ~~~~~divk  227 (228)
T d1k1aa_         219 SRRVIDILR  227 (228)
T ss_dssp             SHHHHHHHT
T ss_pred             hCCCccccC
Confidence            999988763

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=1e-16  Score=141.92  Aligned_cols=90  Identities=21%  Similarity=0.228  Sum_probs=75.4

Q ss_pred             ccCCCCCcC-cCCcccccCCCCCCCCCccHHHHHHHcCCHHHHHHHHHc-CCCCCCCCCCCCcHHHHHHHcCCHHHHHHH
Q 018204           47 GRQSSLDPI-RRSPVQDELTVPENLDSTMQLLFMACRGDVKGVEDLLNE-GSDVNSIDLDGRTALHIAACEGHVEVVKLL  124 (359)
Q Consensus        47 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~t~l~~aa~~g~~~~v~~Ll~~-ga~v~~~d~~g~TpLh~A~~~g~~~~v~~L  124 (359)
                      +..++...+ +.+++.+.....++.+|.||||+||..|+.++|++||+. |+|||.+|.+|.||||+|+.+|+.++|++|
T Consensus       193 ~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~L  272 (285)
T d1wdya_         193 SDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELL  272 (285)
T ss_dssp             SCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHH
Confidence            334444444 344554444444588999999999999999999999985 999999999999999999999999999999


Q ss_pred             HhcCCCcccccc
Q 018204          125 LSKKANIDARDR  136 (359)
Q Consensus       125 l~~ga~~~~~d~  136 (359)
                      +++|||+|++|.
T Consensus       273 l~~GAd~n~~d~  284 (285)
T d1wdya_         273 CKRGASTDCGDL  284 (285)
T ss_dssp             HHHSSCSCCSSC
T ss_pred             HHCCCCCCcccC
Confidence            999999999884

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.27  E-value=2.7e-06  Score=72.85  Aligned_cols=124  Identities=11%  Similarity=0.034  Sum_probs=83.6

Q ss_pred             EEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCC-CCccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcCCCCH
Q 018204          206 AKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKAR-HPNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKGRLSP  284 (359)
Q Consensus       206 ~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~l~~  284 (359)
                      ....+..+++|...........   .+..|...+..+. +--+.+++.+....+..++||++++|.++.+.....  .. 
T Consensus        33 v~~~~~~~vlk~~~~~~~~~~~---~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--~~-  106 (263)
T d1j7la_          33 LVGENENLYLKMTDSRYKGTTY---DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--QS-  106 (263)
T ss_dssp             EECSSCEEEEEEECGGGTTSTT---CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC--SC-
T ss_pred             EEeCCCeEEEEEcCCCcccchh---hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc--cc-
Confidence            3456677888888644322221   3567888877764 333567788888888899999999998876543211  11 


Q ss_pred             HHHHHHHHHHHHHHHHHHhCC--------------------------------------------------------CCC
Q 018204          285 SKVLRFALDLARGMNYLHECK--------------------------------------------------------PDP  308 (359)
Q Consensus       285 ~~~~~i~~qi~~aL~~lH~~~--------------------------------------------------------~~~  308 (359)
                        ...++.++...+.-||+..                                                        +..
T Consensus       107 --~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  184 (263)
T d1j7la_         107 --PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELV  184 (263)
T ss_dssp             --HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEE
T ss_pred             --HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcE
Confidence              2334555566666666421                                                        112


Q ss_pred             eEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          309 IIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       309 iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      ++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEeeccCcceeecCCceEEEeechhccc
Confidence            78999999999999877677999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.94  E-value=2e-05  Score=66.94  Aligned_cols=121  Identities=20%  Similarity=0.182  Sum_probs=74.4

Q ss_pred             eEEEEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCC--CccccceeeEEeCCcEEEEEecCCCCCHHHHHHhcC
Q 018204          203 YQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARH--PNVVQFVGAVTQNIPMMIVLEYHAKGDLASYLQKKG  280 (359)
Q Consensus       203 ~~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~  280 (359)
                      |.+....+..+++|........      .+..|...++.+..  -.+.+++.+..+.+..++||++++|.++.+.     
T Consensus        28 ~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~-----   96 (255)
T d1nd4a_          28 FRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS-----   96 (255)
T ss_dssp             EEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS-----
T ss_pred             EEEEeCCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc-----
Confidence            4333334666888877544322      35667777776643  2356778777788889999999988554221     


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHH---------------------------------------------------hCCC---
Q 018204          281 RLSPSKVLRFALDLARGMNYLH---------------------------------------------------ECKP---  306 (359)
Q Consensus       281 ~l~~~~~~~i~~qi~~aL~~lH---------------------------------------------------~~~~---  306 (359)
                      ..+..   ..+.++...|.-||                                                   ...+   
T Consensus        97 ~~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  173 (255)
T d1nd4a_          97 HLAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE  173 (255)
T ss_dssp             CCCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred             cccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccC
Confidence            01111   11122222233333                                                   2211   


Q ss_pred             -CCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          307 -DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       307 -~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                       ..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence             1279999999999999877778999998863

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.28  E-value=0.00056  Score=61.86  Aligned_cols=29  Identities=21%  Similarity=0.236  Sum_probs=25.4

Q ss_pred             CeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          308 PIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       308 ~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      .++|+|+.|.|||++.++ ++|+||..|.+
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            489999999999998765 89999998864

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.65  E-value=0.0053  Score=53.58  Aligned_cols=132  Identities=13%  Similarity=0.049  Sum_probs=71.8

Q ss_pred             eeEEEEecCcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCccc--cce-----eeEEeCCcEEEEEecCCCCCH--
Q 018204          202 SYQVAKWNGTKVWVKILDKESHKDPERINAFTHELTIVEKARHPNVV--QFV-----GAVTQNIPMMIVLEYHAKGDL--  272 (359)
Q Consensus       202 ~~~~~~~~g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv--~l~-----~~~~~~~~~~lv~e~~~~gsL--  272 (359)
                      +|.+...+|..+++|+.+......    +.+..|...+..|...++.  ..+     ..+...+..+.++++++|..+  
T Consensus        38 vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          38 VYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             EEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             eEEEEcCCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            444444568889999987553322    2366788877776432221  111     123445678899999986322  


Q ss_pred             ---HHHH---------Hh----c-----CCCC-------------------HHHHHHHHHHHHHHHHHHHh----CCCCC
Q 018204          273 ---ASYL---------QK----K-----GRLS-------------------PSKVLRFALDLARGMNYLHE----CKPDP  308 (359)
Q Consensus       273 ---~~~l---------~~----~-----~~l~-------------------~~~~~~i~~qi~~aL~~lH~----~~~~~  308 (359)
                         ..+-         +.    .     ...+                   ......+...+...+..+..    ..|..
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence               1111         10    0     0111                   11111122222233333332    22345


Q ss_pred             eEeCCCCCCcEEEcCCCcEEEeccccccccc
Q 018204          309 IIHCDLKPKNILLDNGGQLKISGFGLLRLQY  339 (359)
Q Consensus       309 iiHrDlk~~NIll~~~~~~kl~DFGla~~~~  339 (359)
                      +||+|+.+.|||++. + ..++||+-+..++
T Consensus       194 liHgDlh~~NvL~~~-~-~~~IDFdd~~~g~  222 (325)
T d1zyla1         194 RLHGDCHAGNILWRD-G-PMFVDLDDARNGP  222 (325)
T ss_dssp             ECCSSCSGGGEEESS-S-EEECCCTTCCEEC
T ss_pred             eecCCCCcccEEEeC-C-ceEEechhcccCc
Confidence            899999999999974 3 4589999987543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.43  E-value=0.0075  Score=52.13  Aligned_cols=31  Identities=19%  Similarity=0.205  Sum_probs=27.7

Q ss_pred             CCeEeCCCCCCcEEEcCCCcEEEeccccccc
Q 018204          307 DPIIHCDLKPKNILLDNGGQLKISGFGLLRL  337 (359)
Q Consensus       307 ~~iiHrDlk~~NIll~~~~~~kl~DFGla~~  337 (359)
                      .++||+|+.+.||+++.+...-|+||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccceeEeccccccc
Confidence            3599999999999999888788999999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.99  E-value=0.039  Score=49.14  Aligned_cols=54  Identities=15%  Similarity=0.142  Sum_probs=32.3

Q ss_pred             CcEEEEEEeccCCCCcHHHHHHHHHHHHHHHhCCCCc-cccceeeEEeCCcEEEEEecCCCCCH
Q 018204          210 GTKVWVKILDKESHKDPERINAFTHELTIVEKARHPN-VVQFVGAVTQNIPMMIVLEYHAKGDL  272 (359)
Q Consensus       210 g~~vavK~l~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lv~e~~~~gsL  272 (359)
                      ...+.+++.. ... .  . ....+|..+++.+.-.+ .+++++++..    ++|+||++|.++
T Consensus        74 ~~~vllRi~g-~~~-~--~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          74 PNKVLLRVYF-NPE-T--E-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             CSEEEEEEEC-SCC-C--H-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             CCcEEEEecC-Ccc-h--h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            3567777764 221 1  1 13457888888874333 4566666542    689999987433